,Date,Title,Url
0,2020-01-01,대웅제약토종주름약나보타중국임상시험본격착수,https://www.ajunews.com/view/20191231110518871
1,2020-01-01,대웅제약경구용장티푸스백신비보티프발매,http://www.viva100.com/main/view.php?key=20200101010000048
2,2020-01-01,대웅제약경구용장티푸스백신비보티프발매,http://www.dailymedi.com/detail.php?number=851357&thread=22r05
3,2020-01-01,대웅제약나보타中임상3상진행,http://www.fnnews.com/news/202001011831390931
4,2020-01-01,대웅제약나보타중국임상3상착수,http://www.dt.co.kr/contents.html?article_no=2020010202101531102001&ref=naver
5,2020-01-02,대웅제약경구용장티푸스백신비보티프국내출시,http://www.g-enews.com/ko-kr/news/article/news_all/20191231170805749569d76442fa_1/article.html
6,2020-01-02,대웅0030902일000변동증권그래프및거래동향,http://www.gokorea.kr/news/articleView.html?idxno=618058
7,2020-01-02,1월2일대웅주가차트13000원039,http://nbntv.co.kr/news/view/792990
8,2020-01-02,대웅제약경구용장티푸스백신비보티프발매,http://www.bokuennews.com/news/article.html?no=185225
9,2020-01-02,대웅제약나보타중국임상3상본격착수,https://www.paxnetnews.com/articles/55445
10,2020-01-02,2020신년사대웅제약혁신신약성과창출이어질것”,http://www.mhj21.com/126636
11,2020-01-02,전승호대웅제약대표글로벌2025비전위해전사적역량집중”,http://www.viva100.com/main/view.php?key=20200102010000419
12,2020-01-02,데일리주식정보대웅003090오전11시07분기준외주식시황,https://www.dailysecu.com/news/articleView.html?idxno=91796
13,2020-01-02,대웅제약2020년혁신신약개발성과창출이어지는원년,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239185
14,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://medipana.com/news/news_viewer.asp?NewsNum=251065&MainKind=A&NewsKind=5&vCount=12&vKind=1
15,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://medipana.com/news/news_viewer.asp?NewsNum=251065&MainKind=A&NewsKind=5&vCount=12&vKind=1
16,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.nbnnews.co.kr/news/articleView.html?idxno=355429
17,2020-01-02,2020재계신년사전승호대웅제약사장글로벌2025비전위해전사적역량집중,http://www.newslock.co.kr/news/articleView.html?idxno=24769
18,2020-01-02,신년사전승호대웅제약사장펙수프라잔글로벌에서인정받는약될것,http://moneys.mt.co.kr/news/mwView.php?no=2020010211068077678
19,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성원년,http://www.newspim.com/news/view/20200102000461
20,2020-01-02,신년사2020대웅제약올해혁신신약성과창출원년”,https://www.paxnetnews.com/articles/55452
21,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.g-enews.com/ko-kr/news/article/news_all/202001021122224974aca1a8c21a_1/article.html
22,2020-01-02,대웅제약글로벌2025비전달성위한변화와혁신이룰것”,http://sports.hankooki.com/lpage/economy/202001/sp20200102112307137020.htm
23,2020-01-02,대웅제약전승호사장글로벌2025비전달성에전사적역량집중,http://www.medisobizanews.com/news/articleView.html?idxno=65441
24,2020-01-02,대웅제약2일036변화종목그래프살펴보기,http://www.gokorea.kr/news/articleView.html?idxno=618509
25,2020-01-02,대웅제약2020년혁신신약성과창출원년될것,http://www.biospectator.com/view/news_view.php?varAtcId=9234
26,2020-01-02,전승호대웅제약대표2025년100개국수출망구축”,http://news.mt.co.kr/mtview.php?no=2020010211203711544
27,2020-01-02,대웅제약경구용장티푸스백신비보티프국내판매,http://www.ekn.kr/news/article.html?no=473400
28,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.sporbiz.co.kr/news/articleView.html?idxno=405518
29,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.ekn.kr/news/article.html?no=473448
30,2020-01-02,글로벌2025비전달성위해전사적역량집중하자대웅제약시무식개최항상준비하고도전하라,http://www.updownnews.co.kr/news/articleView.html?idxno=213188
31,2020-01-02,신년사대웅제약글로벌2025비전달성위해전사적역량집중,http://www.dailysmart.co.kr/news/articleView.html?idxno=20475
32,2020-01-02,신년메시지전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.ceoscoredaily.com/news/article.html?no=64441
33,2020-01-02,전승호대웅제약사장2020년글로벌비전달성위한변화와혁신의원년,http://www.newsprime.co.kr/news/article.html?no=488857
34,2020-01-02,신년사전승호대웅제약사장2020년혁신신약개발성과창출원년,http://www.edaily.co.kr/news/newspath.asp?newsid=02656806625633784
35,2020-01-02,전승호대웅제약대표올해신약개발성과본격창출하는한해될것,https://www.sedaily.com/NewsView/1YXHOAZ0AV
36,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.bosa.co.kr/news/articleView.html?idxno=2119158
37,2020-01-02,대웅제약종목검색2일현재137000원,http://nbntv.co.kr/news/view/793531
38,2020-01-02,대웅제약2020년RD성과창출의원년,http://www.newsis.com/view/?id=NISX20200102_0000877406&cID=13001&pID=13000
39,2020-01-02,대웅제약나보타中임상3상착수,http://www.monews.co.kr/news/articleView.html?idxno=207386
40,2020-01-02,2일데일리주가정보대웅제약069620오후12시12분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=92277
41,2020-01-02,대웅제약나보타중국임상3상본격착수,http://www.polinews.co.kr/news/article.html?no=447306
42,2020-01-02,대웅제약경구용장티푸스백신비보티프발매,http://www.polinews.co.kr/news/article.html?no=447308
43,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.newsway.co.kr/news/view?tp=1&ud=2020010211524339382
44,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59030
45,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.metroseoul.co.kr/news/newsview?newscd=2020010200093
46,2020-01-02,대웅제약글로벌2025비전달성위해역량집중”,http://www.econovill.com/news/articleView.html?idxno=381617
47,2020-01-02,대웅제약올해는혁신신약성과창출의원년,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89807
48,2020-01-02,신년사전승호대웅제약대표올해신약개발성과창출하는한해될것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010212420043166
49,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.etnews.com/20200102000099
50,2020-01-02,대웅제약전승호사장글로벌블록버스터되도록역량강화,http://health.chosun.com/site/data/html_dir/2020/01/02/2020010201873.html
51,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중,https://asiatime.co.kr/news/newsview.php?ncode=1065584943481021
52,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”,http://www.polinews.co.kr/news/article.html?no=447318
53,2020-01-02,대웅제약글로벌2025비전달성전사적역량집중”,http://www.bokuennews.com/news/article.html?no=185255
54,2020-01-02,전승호대웅제약사장글로벌사업확대,http://www.finomy.com/news/articleView.html?idxno=73684
55,2020-01-02,전승호대웅제약사장글로벌2025비전달성위해전사적역량집중,http://www.pressm.kr/news/articleView.html?idxno=26929
56,2020-01-02,대웅제약글로벌2025비전달성목표전사적역량집중,http://kormedi.com/?p=1308788
57,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”,http://www.mdtoday.co.kr/mdtoday/index.html?no=374134
58,2020-01-02,전승호대웅제약시무식에서신약개발성과본격창출하는한해,http://www.businesspost.co.kr/BP?command=article_view&num=157724
59,2020-01-02,대웅제약나보타중국임상3상본격착수중국임상연구자회의개최,http://www.wsobi.com/news/articleView.html?idxno=87726
60,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”다짐,http://www.getnews.co.kr/view.php?ud=20200102144727387441d0c69529_16
61,2020-01-02,대웅제약글로벌2025비전달성위해역량집중,http://www.ebn.co.kr/news/view/1015880/?sc=naver
62,2020-01-02,전승호대웅제약사장신약개발의성과창출하는해만들겠다,http://www.newsworks.co.kr/news/articleView.html?idxno=422898
63,2020-01-02,2020년신년사전승호대웅제약사장글로벌사업확대미래성장동력육성”,http://inthenews.co.kr/article-30370/
64,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.wikileaks-kr.org/news/articleView.html?idxno=73931
65,2020-01-02,신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중,http://www.newswatch.kr/news/articleView.html?idxno=26239
66,2020-01-02,신년사전승호대웅제약사장글로벌2025비전에전사적역량집중”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1840733
67,2020-01-02,대웅제약비전달성위해혁신도전이어갈것”올해혁신신약성과가시화,http://www.donga.com/news/article/all/20200102/99059459/1
68,2020-01-02,대웅제약2020년대웅제약혁신신약개발성과창출로이어지는원년될것,http://www.medigatenews.com/news/1064712562
69,2020-01-02,대웅건설2020시무식겸수주안전기원제개최,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202001021544072400078
70,2020-01-02,전승호대웅제약대표신약개발성과창출할것,https://view.asiae.co.kr/article/2020010216150074453
71,2020-01-02,전승호대웅제약2025년까지10위권100개국수출달성,http://www.dt.co.kr/contents.html?article_no=2020010202109931102008&ref=naver
72,2020-01-02,대웅제약불확실한미래속에서지속성장도모,http://www.sisaon.co.kr/news/articleView.html?idxno=107079
73,2020-01-02,대웅제약경구용장티푸스백신비보티프발매,http://www.monews.co.kr/news/articleView.html?idxno=207387
74,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”,http://www.lawissue.co.kr/view.php?ud=202001021647208438204ead0791_12
75,2020-01-02,전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.segyebiz.com/newsView/20200102512895?OutUrl=naver
76,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.economytalk.kr/news/articleView.html?idxno=202710
77,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중”,http://newsbrite.net/132215
78,2020-01-02,전승호대웅제약사장글로벌사업확대미래성장동력육성,http://www.100ssd.co.kr/news/articleView.html?idxno=66411
79,2020-01-02,신년사전승호대웅제약사장글로벌사업확대와미래성장동력육성해야”,http://news.mk.co.kr/newsRead.php?no=6399&year=2020
80,2020-01-02,신년사전승호대웅제약사장2020년신약개발성과를창출하는한해가될것,http://www.seoulwire.com/news/articleView.html?idxno=265123
81,2020-01-02,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.newscj.com/news/articleView.html?idxno=696381
82,2020-01-02,대웅제약보툴리눔톡신제재나보타중국3상착수2022년중국출시목표,http://www.econonews.co.kr/news/articleView.html?idxno=101624
83,2020-01-03,대웅제약글로벌 2025비전달성위해전사적역량집중,http://www.businesskorea.co.kr/news/articleView.html?idxno=39779
84,2020-01-03,대웅제약시무식개최글로벌2025비전달성위해전사적역량집중,http://www.thefirstmedia.net/news/articleView.html?idxno=52614
85,2020-01-03,신년사와직장인의과제18대웅제약유한양행동아쏘시오홀딩스올해키워드는능동적자세,http://www.news2day.co.kr/145636
86,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.bosa.co.kr/news/articleView.html?idxno=2119220
87,2020-01-03,대웅제약마케팅영업총괄부사장에40대이창재승진,http://medipana.com/news/news_viewer.asp?NewsNum=251121&MainKind=A&NewsKind=5&vCount=12&vKind=1
88,2020-01-03,대웅제약이창재본부장과대웅바이오진성곤본부장각각마케팅영업총괄부사장으로승진,http://www.g-enews.com/ko-kr/news/article/news_all/202001030725111007aca1a8c21a_1/article.html
89,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://www.viva100.com/main/view.php?key=20200103010000815
90,2020-01-03,나이아닌성과중심40대부사장인사낸대웅제약,https://view.asiae.co.kr/article/2020010307505723830
91,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장승진,http://www.medisobizanews.com/news/articleView.html?idxno=65478
92,2020-01-03,대웅제약이창재본부장 마케팅영업총괄부사장으로승진  ,http://www.businesskorea.co.kr/news/articleView.html?idxno=39784
93,2020-01-03,대웅제약그룹임원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=89833
94,2020-01-03,대웅제약마케팅영업부사장에43세이창재본부장,http://www.dailypharm.com/Users/News/NewsView.html?ID=260579&REFERER=NP
95,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://www.wikileaks-kr.org/news/articleView.html?idxno=73978
96,2020-01-03,대웅제약총괄부사장에이창재본부장세대교체속도,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010308244279825
97,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.newsway.co.kr/news/view?tp=1&ud=2020010308263516916
98,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장승진,http://news.mt.co.kr/mtview.php?no=2020010308145992397
99,2020-01-03,40대젊은피수혈대웅제약신임부사장에이창재본부장선임,http://moneys.mt.co.kr/news/mwView.php?no=2020010308298061169
100,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장,https://www.kpanews.co.kr/article/show.asp?idx=209926&category=D
101,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://www.newspim.com/news/view/20200103000061
102,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239229
103,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.segyebiz.com/newsView/20200103502247?OutUrl=naver
104,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장승진,https://asiatime.co.kr/news/newsview.php?ncode=1065569603257530
105,2020-01-03,대웅제약이창재마케팅영업부사장승진40대젊은리더,http://www.newsis.com/view/?id=NISX20200103_0000878307&cID=13001&pID=13000
106,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://news1.kr/articles/?3807867
107,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장선임,http://biz.newdaily.co.kr/site/data/html/2020/01/03/2020010300009.html
108,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.dailysmart.co.kr/news/articleView.html?idxno=20535
109,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.seoulwire.com/news/articleView.html?idxno=265168
110,2020-01-03,인사대웅그룹,http://www.seoulfn.com/news/articleView.html?idxno=367735
111,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.ebn.co.kr/news/view/1016007/?sc=naver
112,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.econovill.com/news/articleView.html?idxno=381715
113,2020-01-03,인사대웅제약,http://daily.hankooki.com/lpage/society/202001/dh20200103091929137910.htm
114,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.econovill.com/news/articleView.html?idxno=381715
115,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,https://www.sedaily.com/NewsView/1YXI3Y45TU
116,2020-01-03,1월3일대웅주식시황077변동,http://www.gokorea.kr/news/articleView.html?idxno=619993
117,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.ajunews.com/view/20200103092703673
118,2020-01-03,대웅제약젊은리더눈길40대이창재진성곤본부장부사장으로승진,http://www.paxetv.com/news/articleView.html?idxno=84105
119,2020-01-03,인사대웅제약,https://www.youthdaily.co.kr/news/article.html?no=25976
120,2020-01-03,1월3일대웅금일증시12950원077,http://nbntv.co.kr/news/view/795186
121,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.mdtoday.co.kr/mdtoday/index.html?no=374198
122,2020-01-03,인사대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.todaykorea.co.kr/news/view.php?no=267098
123,2020-01-03,인사대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.medicaltimes.com/Users/Inform/index.html?mode=View&ID=8853
124,2020-01-03,인사대웅제약이창재본부장부사장승진마케팅영업총괄,http://www.monews.co.kr/news/articleView.html?idxno=207415
125,2020-01-03,인사대웅제약,http://www.fnnews.com/news/202001030944429574
126,2020-01-03,대웅제약대웅바이오마케팅영업부사장에각각이창재진성곤본부장임명,http://inthenews.co.kr/article-30496/
127,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://kormedi.com/?p=1308845
128,2020-01-03,인사대웅제약,http://www.asiatoday.co.kr/view.php?key=20200103010001342
129,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.lawissue.co.kr/view.php?ud=202001030948281525204ead0791_12
130,2020-01-03,인사중앙그룹신한금융투자세계일보대웅제약,https://biz.seoul.co.kr/news/newsView.php?id=20200103500022&wlog_tag3=naver
131,2020-01-03,대웅이창재본부장마케팅영업총괄부사장승진,http://www.dailymedi.com/detail.php?number=851437&thread=22r05
132,2020-01-03,인사대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.nbnnews.co.kr/news/articleView.html?idxno=355771
133,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진40대젊은리더배치,http://www.ceoscoredaily.com/news/article.html?no=64531
134,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59055
135,2020-01-03,대웅제약이창재마케팅영업총괄부사장승진,https://www.paxnetnews.com/articles/55528
136,2020-01-03,대웅제약신임이창재마케팅영업총괄부사장선임,http://www.newstomato.com/ReadNews.aspx?no=943423
137,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.m-i.kr/news/articleView.html?idxno=669535
138,2020-01-03,제약산업대웅제약경구용장티푸스백신비보티프발매外,http://www.kukinews.com/news/article.html?no=733981
139,2020-01-03,대웅제약마케팅영업총괄부사장에이창재본부장승진젊은리더발탁,http://www.ekn.kr/news/article.html?no=473658
140,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.medigatenews.com/board/people/view/708
141,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.newspost.kr/news/articleView.html?idxno=75048
142,2020-01-03,대웅제약성과중심인재중용”40대이창재부사장승진,http://www.sporbiz.co.kr/news/articleView.html?idxno=405839
143,2020-01-03,능력과성과중심으로인재중용대웅제약마케팅영업총괄부사장으로이창재본부장선임,http://www.updownnews.co.kr/news/articleView.html?idxno=213251
144,2020-01-03,대웅이창재본부장마케팅영업총괄부사장승진,http://www.whosaeng.com/115067
145,2020-01-03,대웅제약정기임원인사,http://www.bokuennews.com/news/article.html?no=185317
146,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.economytalk.kr/news/articleView.html?idxno=202740
147,2020-01-03,인사대웅제약,http://www.joongboo.com/news/articleView.html?idxno=363390155
148,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장승진,http://www.newsprime.co.kr/news/article.html?no=489032
149,2020-01-03,젊어진대웅제약40대리더부사장승진,http://www.sisaweek.com/news/articleView.html?idxno=129602
150,2020-01-03,대웅제약사장이어부사장도40대파격배치철저한성과위주,http://news1.kr/articles/?3808104
151,2020-01-03,대웅제약부사장으로이창재대웅바이오부사장으로진성곤승진,http://www.businesspost.co.kr/BP?command=article_view&num=157955
152,2020-01-03,1월3일대웅제약주식종목시세134500원147,http://nbntv.co.kr/news/view/795546
153,2020-01-03,젊어지는대웅제약40대이창재본부장부사장승진,http://www.donga.com/news/article/all/20200103/99069890/1
154,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장승진,http://www.etnews.com/20200103000091
155,2020-01-03,인사세계일보대웅제약한국청소년정책연구원광주동구,http://www.businesspost.co.kr/BP?command=article_view&num=157981
156,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.newswatch.kr/news/articleView.html?idxno=26260
157,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://newsbrite.net/132241
158,2020-01-03,대웅제약대웅바이오성별나이상관없이인재중용,http://www.newslock.co.kr/news/articleView.html?idxno=24803
159,2020-01-03,나이보다성과40대부사장선택한대웅제약,https://biz.chosun.com/site/data/html_dir/2020/01/03/2020010301706.html?utm_source=naver&utm_medium=original&utm_campaign=biz
160,2020-01-03,대웅제약인사40대이창재마케팅∙영업총괄부사장,http://www.thevaluenews.co.kr/news/view.php?idx=157961
161,2020-01-03,대웅제약40대본부장부사장으로발탁,http://www.edaily.co.kr/news/newspath.asp?newsid=02669926625634112
162,2020-01-03,이창재대웅제약본부장부사장승진마케팅영업총괄,http://www.finomy.com/news/articleView.html?idxno=73743
163,2020-01-03,대웅제약대표이어부사장도40대선임나이보단능력,http://www.upinews.kr/newsView/upi202001030068
164,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.koreastocknews.com/news/articleView.html?idxno=49340
165,2020-01-03,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.sisafocus.co.kr/news/articleView.html?idxno=229208
166,2020-01-03,오늘의인사대웅제약웰컴금융그룹외,http://www.ajunews.com/view/20200103135732858
167,2020-01-03,인사대웅제약,http://www.fetv.co.kr/news/article.html?no=44346
168,2020-01-03,대웅제약정기임원인사이창재본부장총괄부사장승진,http://www.mediapen.com/news/view/489946
169,2020-01-03,대웅제약젊은피전진배치이창재본부장부사장승진,http://www.shinailbo.co.kr/news/articleView.html?idxno=1239000
170,2020-01-03,전승호대웅제약대표글로벌2025달성위해역량집중,http://www.shinailbo.co.kr/news/articleView.html?idxno=1239014
171,2020-01-03,대웅제약이창재본부장부사장으로승진40대젊은리더,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001030372&t=NN
172,2020-01-03,인사대웅제약;화성산업;웰컴금융그룹등,https://www.hankyung.com/society/article/2020010315621
173,2020-01-03,대웅제약인사,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4025275
174,2020-01-03,대웅제약글로벌2025비전달성위해전사적역량집중,http://www.wsobi.com/news/articleView.html?idxno=87874
175,2020-01-03,1월3일인사대웅제약한국청소년정책연구원外,http://www.news2day.co.kr/145758
176,2020-01-03,대웅제약정기임원인사단행이창재본부장마케팅영업총괄부사장승진,http://www.ftoday.co.kr/news/articleView.html?idxno=113637
177,2020-01-03,이창재대웅제약본부장마케팅영업총괄부사장으로승진,http://www.newscj.com/news/articleView.html?idxno=696677
178,2020-01-04,인사대웅제약,https://www.ajunews.com/view/20200103160052998
179,2020-01-04,대웅제약이창재본부장마케팅영업총괄부사장으로승진발표,http://www.thefirstmedia.net/news/articleView.html?idxno=52682
180,2020-01-04,경제계인사대웅제약외,https://biz.chosun.com/site/data/html_dir/2020/01/04/2020010400127.html?utm_source=naver&utm_medium=original&utm_campaign=biz
181,2020-01-04,대웅제약이창재마케팅영업총괄부사장승진대웅바이오진성곤본부장도부사장승진,http://www.econonews.co.kr/news/articleView.html?idxno=101889
182,2020-01-04,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.getnews.co.kr/view.php?ud=20200104164921668941d0c69529_16
183,2020-01-05,인사대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.polinews.co.kr/news/article.html?no=447719
184,2020-01-06,CEO신년사전승호대웅제약사장글로벌2025비전달성위해전사적역량집중”,http://www.cnbnews.com/news/article.html?no=432824
185,2020-01-06,대웅제약40대젊은리더십주목역동적인조직으로탈바꿈,http://www.rapportian.com/news/articleView.html?idxno=122529
186,2020-01-06,1월6일대웅주식시황309변동,http://www.gokorea.kr/news/articleView.html?idxno=621100
187,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239276
188,2020-01-06,시세보기대웅주가6일현재12550원,http://nbntv.co.kr/news/view/796404
189,2020-01-06,대웅인피온세계최초동물세포유래바이오의약품할랄인증획득,http://www.getnews.co.kr/view.php?ud=20200106093226108041d0c69529_16
190,2020-01-06,대웅제약빈혈치료제에포디온할랄인증,https://www.sedaily.com/NewsView/1YXJHS9XU0
191,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.etoday.co.kr/news/section/newsview.php?idxno=1841651
192,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.ebn.co.kr/news/view/1016295/?sc=naver
193,2020-01-06,대웅세계첫EPO제제할랄인증획득,http://news.mt.co.kr/mtview.php?no=2020010609230823389
194,2020-01-06,대웅인피온동물세포유래바이오의약품할랄인증획득,http://www.etnews.com/20200106000038
195,2020-01-06,대웅인피온동물세포유래바이오의약품할랄인증획득,https://asiatime.co.kr/news/newsview.php?ncode=1065572937489458
196,2020-01-06,대웅제약인도네시아합작법인대웅인피온통해바이오의약품할랄인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=20635
197,2020-01-06,대웅제약인도네시아법인빈혈치료제할랄인증,http://yna.kr/AKR20200106038900017?did=1195m
198,2020-01-06,대웅제약인도네시아합작사적혈구생성인자제제할랄인증받아,http://news.mk.co.kr/newsRead.php?no=14107&year=2020
199,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=356202
200,2020-01-06,대웅제약인도네시아합작법인바이오시밀러할랄인증획득,http://www.newspim.com/news/view/20200106000238
201,2020-01-06,대웅제약세계첫동물세포유래바이오의약품에포디온할랄인증,http://www.medisobizanews.com/news/articleView.html?idxno=65541
202,2020-01-06,대웅제약EPO제제인도네시아할랄인증,http://www.biospectator.com/view/news_view.php?varAtcId=9258
203,2020-01-06,대웅제약인도네시아법인빈혈치료제할랄인증,http://yna.kr/PYH20200106041600017?did=1196m
204,2020-01-06,대웅제약인도네시아법인빈혈치료제할랄인증,http://yna.kr/PYH20200106041600017?did=1196m
205,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020010609541703882
206,2020-01-06,대웅인피온세계최초동물세포바이오의약품할랄인증획득,http://www.viva100.com/main/view.php?key=20200106010001486
207,2020-01-06,대웅제약인도네시아합작법인대웅인피온통해세계최초동물세포유래바이오의약품할랄인증획득,http://newsbrite.net/132300
208,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1359797
209,2020-01-06,대웅제약동물세포유래바이오시밀러할랄인증,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001060144&t=NN
210,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.bokuennews.com/news/article.html?no=185350
211,2020-01-06,대웅인피온동물세포유래바이오의약품할랄인증획득,http://news.heraldcorp.com/view.php?ud=20200106000162
212,2020-01-06,대웅제약대웅인포인통해바이오의약품할랄인증회득,http://medipana.com/news/news_viewer.asp?NewsNum=251191&MainKind=A&NewsKind=5&vCount=12&vKind=1
213,2020-01-06,대웅제약인도네시아합작법인바이오의약품할랄인증획득,http://weekly.cnbnews.com/news/article.html?no=131968
214,2020-01-06,대웅제약印尼법인빈혈치료제할랄인증,https://view.asiae.co.kr/article/2020010610202941024
215,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.m-i.kr/news/articleView.html?idxno=670025
216,2020-01-06,대웅인피온동물세포유래바이오의약품할랄인증획득,http://www.newsprime.co.kr/news/article.html?no=489202
217,2020-01-06,대웅제약인도네시아법인빈혈치료제에포디온할랄인증,http://www.pressm.kr/news/articleView.html?idxno=26971
218,2020-01-06,대웅인피온에포디온할랄인증획득,https://www.paxnetnews.com/articles/55580
219,2020-01-06,대웅제약인니합작법인통해동물세포유래바이오의약품할랄인증획득,http://www.newstomato.com/ReadNews.aspx?no=943754
220,2020-01-06,대웅제약인도네시아합작대웅인피온할랄인증,http://www.fnnews.com/news/202001061036454649
221,2020-01-06,대웅제약인도네시아법인에포디온할랄인증받아,https://cnbc.sbs.co.kr/article_hub/10000968266?division=NAVER
222,2020-01-06,대웅제약동물세포유래바이오의약품글로벌최초할랄인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020010610428026929
223,2020-01-06,대웅제약대웅인피온통해동물세포유래바이오의약품할랄인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59083
224,2020-01-06,대웅제약적혈구생성인자제제할랄인증획득,http://www.mhj21.com/126709
225,2020-01-06,대웅제약인니합작법인서에포디온동물세포유래바이오의약품할랄인증,http://www.newslock.co.kr/news/articleView.html?idxno=24838
226,2020-01-06,대웅제약동물세포유래바이오약최초할랄인증,http://www.bosa.co.kr/news/articleView.html?idxno=2119330
227,2020-01-06,대웅인피온세계최초동물세포유래바이오의약품할랄인증획득,http://www.ceoscoredaily.com/news/article.html?no=64605
228,2020-01-06,대웅제약인도네시아법인빈혈치료제에포디온할랄인증,http://kormedi.com/?p=1308946
229,2020-01-06,대웅제약합작법인대웅인피온세계최초할랄인증,http://daily.hankooki.com/lpage/ittech/202001/dh20200106114430145630.htm
230,2020-01-06,대웅제약인도네시아법인적혈구생성인자제제할랄인증획득,http://www.seoulwire.com/news/articleView.html?idxno=265461
231,2020-01-06,대웅제약인도네시아에서바이오의약품할랄인증획득,http://www.joseilbo.com/news/news_read.php?uid=389980&class=27&grp=
232,2020-01-06,대웅인도네시아현지화전략속도외형확대기대,http://www.dailypharm.com/Users/News/NewsView.html?ID=260636&REFERER=NP
233,2020-01-06,대웅인피온인도네시아서바이오시밀러에포디온할랄인증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075839
234,2020-01-06,1월6일대웅제약증권매매221132500원,http://nbntv.co.kr/news/view/796773
235,2020-01-06,대웅제약인니합작법인대웅인피온세계최초동물세포유래바이오의약품할랄인증획득,http://www.g-enews.com/ko-kr/news/article/news_all/202001061313188500aca1a8c21a_1/article.html
236,2020-01-06,대웅제약인니합작대웅인피온바이오의약품할랄인증획득,http://www.metroseoul.co.kr/news/newsview?newscd=2020010600091
237,2020-01-06,대웅제약인도네시아합작법인세계최초동물세포유래바이오의약품할랄인증획득,http://www.koreaittimes.com/news/articleView.html?idxno=94922
238,2020-01-06,대웅제약인도네시아합작법인동물세포유래바이오의약품할랄인증획득,http://news.mk.co.kr/newsRead.php?no=15427&year=2020
239,2020-01-06,대웅제약빈혈치료제할랄인증,https://www.hankyung.com/it/article/202001065597i
240,2020-01-06,대웅제약인도네시아합작법인에포디온할랄인증획득,http://inthenews.co.kr/article-30698/
241,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.wsobi.com/news/articleView.html?idxno=87948
242,2020-01-06,대웅제약인도네시아합작법인대웅인피온통해동물세포유래바이오의약품할랄인증획득,http://www.lawissue.co.kr/view.php?ud=202001061420323236204ead0791_12
243,2020-01-06,대웅인피온세계최초동물세포유래바이오의약품할랄인증획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=39846
244,2020-01-06,대웅제약인도네시아법인빈혈치료제바이오시밀러할랄인증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010614302158839
245,2020-01-06,대웅제약인도네시아법인빈혈치료제바이오시밀러할랄인증,https://biz.chosun.com/site/data/html_dir/2020/01/06/2020010602174.html?utm_source=naver&utm_medium=original&utm_campaign=biz
246,2020-01-06,대웅제약동물세포유래바이오의약품으로인도네시아할랄인증받아,http://www.businesspost.co.kr/BP?command=article_view&num=158220
247,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증,https://www.nocutnews.co.kr/news/5268460
248,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증,http://www.wikileaks-kr.org/news/articleView.html?idxno=74212
249,2020-01-06,대웅제약빈혈치료제에포디온할랄인증,http://www.seoulfn.com/news/articleView.html?idxno=367990
250,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.ekn.kr/news/article.html?no=474114
251,2020-01-06,대웅인피온무슬림시장진출가속화에포디온인도네시아서할랄인증,http://kpenews.com/View.aspx?No=645042
252,2020-01-06,대웅제약중동의약품시장진출청신호대웅인피온통해세계최초동물세포유래바이오의약품할랄인증획득,http://www.updownnews.co.kr/news/articleView.html?idxno=213344
253,2020-01-06,대웅제약이창재본부장마케팅영업총괄부사장으로승진,http://www.kukinews.com/news/article.html?no=734841
254,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.medigatenews.com/news/3384340765
255,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.dailian.co.kr/news/view/858933/?sc=naver
256,2020-01-06,대웅제약동물세포유래바이오의약품할랄인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=374358
257,2020-01-06,대웅제약대웅인피온통해바이오의약품할랄인증획득,http://www.newsian.co.kr/news/articleView.html?idxno=39232
258,2020-01-06,대웅제약세계최초바이오의약품할랄인증획득,http://www.donga.com/news/article/all/20200106/99105613/1
259,2020-01-06,대웅제약인도네시아합작법인대웅인피온바이오의약품할랄인증,http://news1.kr/articles/?3810105
260,2020-01-06,대웅인피온동물세포유래바이오약할랄인증획득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1239597
261,2020-01-06,대웅인피온바이오의약품에할랄인증이슬람진출확대,http://health.chosun.com/site/data/html_dir/2020/01/06/2020010602872.html
262,2020-01-06,대웅제약印尼합작사대웅인피온빈혈치료제에포디온할랄인증,http://www.dt.co.kr/contents.html?article_no=2020010702101931102002&ref=naver
263,2020-01-06,대웅제약인도네시아합작법인대웅인피온바이오의약품할랄인증획득,http://www.newscj.com/news/articleView.html?idxno=697343
264,2020-01-06,대웅제약인도네시아법인빈혈치료제할랄인증,http://www.edaily.co.kr/news/newspath.asp?newsid=03899926625635096
265,2020-01-06,대웅제약세계최초동물세포유래바이오의약품할랄인증획득,http://www.polinews.co.kr/news/article.html?no=447978
266,2020-01-07,대웅제약인도네시아합작법인대웅인피온통해동물세포유래바이오의약품할랄인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=52733
267,2020-01-07,대웅인피온세계첫동물세포유래바이오약할랄인증,http://www.dailymedi.com/detail.php?number=851554&thread=22r05
268,2020-01-07,보톡스보툴리눔톡신테마오전시황상승률상위종목메디톡스195휴온스132대웅제약114등,http://www.gokorea.kr/news/articleView.html?idxno=621952
269,2020-01-07,1월7일대웅종목정보081변동,http://www.gokorea.kr/news/articleView.html?idxno=622010
270,2020-01-07,1월7일대웅종목검색12450원081,http://nbntv.co.kr/news/view/797292
271,2020-01-07,대웅제약주식실시간7일현재134000원,http://nbntv.co.kr/news/view/797787
272,2020-01-07,데일리증권대웅003090오후12시06분기준및증권정보와종목동정,https://www.dailysecu.com/news/articleView.html?idxno=93571
273,2020-01-07,보톡스보툴리눔톡신테마오후시황상승률상위종목메디톡스523휴젤247대웅제약227등,http://www.gokorea.kr/news/articleView.html?idxno=623405
274,2020-01-07,13시28분보톡스보툴리눔톡신오후의테마종목메디톡스대웅제약등이주도,http://nbntv.co.kr/news/view/798575
275,2020-01-07,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목메디톡스17000원563휴젤9300원245대웅제약3000원227상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156000
276,2020-01-07,머크콩코르대웅품안에순환기경쟁력↑,http://www.monews.co.kr/news/articleView.html?idxno=207465
277,2020-01-07,대웅제약vs메디톡스보톡스전쟁끝이보인다,http://www.edaily.co.kr/news/newspath.asp?newsid=03663766625635424
278,2020-01-07,보톡스보툴리눔톡신테마마감시황상승률상위종목메디톡스699휴젤289대웅제약152등,http://www.gokorea.kr/news/articleView.html?idxno=623779
279,2020-01-08,★주식인사이드대웅제약주가132000원1월8일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1056185
280,2020-01-08,대웅0030908일248변동증권그래프살펴보기,http://www.gokorea.kr/news/articleView.html?idxno=624027
281,2020-01-08,1월8일대웅종목검색33111700원,http://nbntv.co.kr/news/view/799628
282,2020-01-08,대웅제약인니합작법인대웅인피온적혈구제제에포디온할랄인증획득,http://www.cnbnews.com/news/article.html?no=433112
283,2020-01-08,대웅제약0696208일336변동종목그래프및거래동향,http://www.gokorea.kr/news/articleView.html?idxno=624479
284,2020-01-08,대웅제약영국아박타사와줄기세포기반면역질환치료제개발박차,http://www.getnews.co.kr/view.php?ud=2020010810410640241d0c69529_16
285,2020-01-08,대웅제약英아박타와줄기세포기반면역질환치료제개발위한JV설립키로,http://news.mk.co.kr/newsRead.php?no=23164&year=2020
286,2020-01-08,대웅제약英아박타사와조인트벤처설립면역질환치료제개발박차,http://www.segye.com/content/html/2020/01/08/20200108505902.html?OutUrl=naver
287,2020-01-08,대웅제약英아박타와조인트벤처설립파트너십,http://www.newspim.com/news/view/20200108000369
288,2020-01-08,대웅제약英바이오텍과조인트벤처,https://www.sedaily.com/NewsView/1YXKFJG4ZW
289,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.medisobizanews.com/news/articleView.html?idxno=65638
290,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.newsway.co.kr/news/view?tp=1&ud=2020010810501400847
291,2020-01-08,대웅제약영국아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.lawissue.co.kr/view.php?ud=202001081053119987204ead0791_12
292,2020-01-08,대웅제약아박타JV설립면역질환치료제개발,http://www.etnews.com/20200108000087
293,2020-01-08,대웅면역질환치료제개발출사표,http://www.whosaeng.com/115169
294,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환약개발,http://www.newsis.com/view/?id=NISX20200108_0000882656&cID=13001&pID=13000
295,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.bosa.co.kr/news/articleView.html?idxno=2119467
296,2020-01-08,​​대웅제약면역질환치료제개발속도英아박타와조인트벤처설립,http://www.etoday.co.kr/news/section/newsview.php?idxno=1842745
297,2020-01-08,대웅제약영국아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.nbnnews.co.kr/news/articleView.html?idxno=356973
298,2020-01-08,대웅제약영국아박타와조인트벤처설립계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=251327&MainKind=A&NewsKind=5&vCount=12&vKind=1
299,2020-01-08,대웅제약영국아박타와조인트벤처설립계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=251327&MainKind=A&NewsKind=5&vCount=12&vKind=1
300,2020-01-08,대웅제약英바이오기업과합작법인면역질환치료제개발,https://view.asiae.co.kr/article/2020010811050188307
301,2020-01-08,대웅제약英기업과JV설립면역질환치료제개발,http://news.mt.co.kr/mtview.php?no=2020010811004015718
302,2020-01-08,대웅제약英아박타사와조인트벤처설립세포치료제개발박차,http://www.viva100.com/main/view.php?key=20200108010002522
303,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발박차,http://daily.hankooki.com/lpage/ittech/202001/dh20200108110737145630.htm
304,2020-01-08,대웅제약영국아박타JV설립면역질환치료제개발,http://yna.kr/AKR20200108077400017?did=1195m
305,2020-01-08,대웅제약면역질환치료제개발맞손英아박타와조인트벤처설립,http://www.ezyeconomy.com/news/articleView.html?idxno=96901
306,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.newsprime.co.kr/news/article.html?no=489510
307,2020-01-08,1월8일대웅제약주식추천주336129500원,http://nbntv.co.kr/news/view/800118
308,2020-01-08,대웅제약영국아박타와조인트벤처설립,http://www.fnnews.com/news/202001081114351298
309,2020-01-08,국민연금셀트리온유한양행대웅제약품었다,http://news.mt.co.kr/mtview.php?no=2020010710520870343
310,2020-01-08,대웅제약 영국 아박타사와 조인트벤처 설립 통해 면역질환 치료제 개발 박차 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=39931
311,2020-01-08,대웅제약영국아박타사와조인트벤처설립면역질환치료제개발박차,http://www.ceoscoredaily.com/news/article.html?no=64700
312,2020-01-08,대웅제약英아박타손잡고면역질환치료제개발한다,https://www.hankyung.com/it/article/202001081499i
313,2020-01-08,대웅제약英아박타와JV설립면역질환신약개발,http://www.biospectator.com/view/news_view.php?varAtcId=9273
314,2020-01-08,대웅제약英아박타와합작기업신설,http://www.dt.co.kr/contents.html?article_no=2020010802109931102002&ref=naver
315,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,http://www.metroseoul.co.kr/news/newsview?newscd=2020010800068
316,2020-01-08,​​대웅제약英아박타조인트벤처설립면역질환치료제개발,http://kormedi.com/?p=1309102
317,2020-01-08,대웅제약英아박타와면역질환치료제개발박차,http://www.dailysmart.co.kr/news/articleView.html?idxno=20765
318,2020-01-08,대웅제약아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59119
319,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239377
320,2020-01-08,데일리주식정보대웅제약069620오후12시25분기준외매매동향,https://www.dailysecu.com/news/articleView.html?idxno=94339
321,2020-01-08,대웅제약英아박타사와조인트벤처설립면역질환치료제개발,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075895
322,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,http://www.mediapen.com/news/view/491077
323,2020-01-08,대웅제약아박타조인트벤처설립면역질환치료제개발,http://www.pressm.kr/news/articleView.html?idxno=27017
324,2020-01-08,대웅제약英아박타사와조인트벤처설립통해면역질환치료제개발박차,http://www.medigatenews.com/news/3683394603
325,2020-01-08,대웅제약英바이오텍아박타와조인트벤처설립계약면역질환치료제개발,http://www.donga.com/news/article/all/20200108/99135298/1
326,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발,http://www.econovill.com/news/articleView.html?idxno=382189
327,2020-01-08,대웅제약英아박타社와조인트벤처설립면역질환신약개발착수,http://www.newswatch.kr/news/articleView.html?idxno=26392
328,2020-01-08,대웅제약영국바이오기업과JV설립면역질환치료제개발,http://moneys.mt.co.kr/news/mwView.php?no=2020010813578032687
329,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.economytalk.kr/news/articleView.html?idxno=202891
330,2020-01-08,대웅제약영국바이오회사와합작사전승호면역질환치료제개발,http://www.businesspost.co.kr/BP?command=article_view&num=158603
331,2020-01-08,대웅제약영국바이오텍과JV설립면역질환치료제개발박차,http://www.newstomato.com/ReadNews.aspx?no=944421
332,2020-01-08,대웅제약英아박타와조인트벤처설립통해면역질환치료제개발박차,http://www.m-i.kr/news/articleView.html?idxno=670988
333,2020-01-08,대웅제약조인트벤처통해면역질환치료제개발,http://www.mhj21.com/126758
334,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,https://asiatime.co.kr/news/newsview.php?ncode=1065588195441979
335,2020-01-08,대웅제약英아박타와조인트벤처설립면역질환치료제개발,http://www.seoulwire.com/news/articleView.html?idxno=265905
336,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발박차”,http://sports.hankooki.com/lpage/economy/202001/sp20200108144230137020.htm
337,2020-01-08,대웅제약영국아박타와조인트벤처설립,http://news.bizwatch.co.kr/article/consumer/2020/01/08/0011/naver
338,2020-01-08,대웅제약아박타사와면역질환치료제개발,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001080263&t=NN
339,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.newsian.co.kr/news/articleView.html?idxno=39307
340,2020-01-08,대웅제약영국아박타사와조인트벤처면역질환치료제개발박차,http://www.enewstoday.co.kr/news/articleView.html?idxno=1360410
341,2020-01-08,대웅제약영국아박타와조인트벤처설립,http://www.ebn.co.kr/news/view/1016802/?sc=naver
342,2020-01-08,심상찮은대웅제약의글로벌행보,http://www.wikileaks-kr.org/news/articleView.html?idxno=74415
343,2020-01-08,대웅제약英아박타조인트벤처설립통해면역질환치료제개발박차,http://www.ftoday.co.kr/news/articleView.html?idxno=113723
344,2020-01-08,대웅제약英아박타와조인트벤처설립세포치료제연구,https://biz.chosun.com/site/data/html_dir/2020/01/08/2020010802414.html?utm_source=naver&utm_medium=original&utm_campaign=biz
345,2020-01-08,대웅제약영국아박타사와조인트벤처통해면역질환치료제개발나서,http://www.thefirstmedia.net/news/articleView.html?idxno=52806
346,2020-01-08,대웅제약영국아박타와JV설립면역질환치료제개발,http://www.monews.co.kr/news/articleView.html?idxno=207536
347,2020-01-08,대웅제약면역질환치료제개발박차영국아박타와조인트벤처설립,http://www.g-enews.com/ko-kr/news/article/news_all/20200108151455537069d76442fa_1/article.html
348,2020-01-08,Bio톡스메디톡스vs대웅제약균주소송전3가지시나리오,http://www.newspim.com/news/view/20200108000874
349,2020-01-08,대웅英아박타社면역질환치료제JV설립,http://www.dailymedi.com/detail.php?number=851624&thread=22r05
350,2020-01-08,대웅제약아박타와면역질환제개발조인트벤처설립,http://www.shinailbo.co.kr/news/articleView.html?idxno=1240320
351,2020-01-08,대웅제약영국아박타사와함께면역질환치료제개발박차,http://www.ekn.kr/news/article.html?no=474605
352,2020-01-08,면역질환치료제개발박차대웅제약아박타社와조인트벤처설립,http://kpenews.com/View.aspx?No=647218
353,2020-01-08,대웅제약영국기업과조인트벤처설립면역질환신약개발,http://news1.kr/articles/?3812078
354,2020-01-08,대웅제약영국아박타와조인트벤처설립면역질환치료제개발박차,http://www.mdtoday.co.kr/mdtoday/index.html?no=374550
355,2020-01-08,대웅제약오너처벌해야”청와대청원등장대체무슨일이,http://www.ajunews.com/view/20200108171616267
356,2020-01-08,대웅제약아박타면역질환치료제개발위해조인트벤처설립,http://www.k-health.com/news/articleView.html?idxno=46852
357,2020-01-08,대웅제약영국아박타사와조인트벤처설립통해면역질환치료제개발박차,http://newsbrite.net/132427
358,2020-01-08,대웅제약면역질환치료제개발위해영국아박타와JV설립,http://www.seoulfn.com/news/articleView.html?idxno=368264
359,2020-01-08,대웅제약 영국 아박타와 조인트벤처 설립면역질환 치료제 개발 박차,http://www.newslock.co.kr/news/articleView.html?idxno=24910
360,2020-01-08,대웅제약英아박타와조인트벤처설립,http://www.fnnews.com/news/202001081903450882
361,2020-01-08,대웅제약영국아박타와면역질환치료제개발박차,http://www.wsobi.com/news/articleView.html?idxno=88139
362,2020-01-08,대웅제약영국아박타사와조인트벤처설립면역질환치료제개발박차,http://www.newscj.com/news/articleView.html?idxno=698003
363,2020-01-08,대웅제약영국아박타사와조인트벤처설립,http://www.polinews.co.kr/news/article.html?no=448255
364,2020-01-09,메디톡스vs대웅제약보톡스전쟁6월판가름난다,http://www.mdtoday.co.kr/mdtoday/index.html?no=374575
365,2020-01-09,윤재승전회장복귀설놓고갑론을박연초부터어수선한대웅,http://www.sisajournal-e.com/news/articleView.html?idxno=211774
366,2020-01-09,대웅제약4분기영업익컨센서스하회전망목표가↓삼성증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1843131
367,2020-01-09,대웅제약영국바이오텍과함께면역질환치료제개발,http://news.heraldcorp.com/view.php?ud=20200109000041
368,2020-01-09,★주식인사이드대웅제약주가131000원1월9일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1056484
369,2020-01-09,1월9일대웅종목정보085변동,http://www.gokorea.kr/news/articleView.html?idxno=626032
370,2020-01-09,대웅제약▲1500주가목표액210000원삼성증권소송리스크가관건,http://nbntv.co.kr/news/view/801838
371,2020-01-09,대웅제약줄기세포면역질환치료제개발나서,http://www.bokuennews.com/news/article.html?no=185503
372,2020-01-09,1월9일대웅오늘증권시세16912000원,http://nbntv.co.kr/news/view/801909
373,2020-01-09,대웅제약4Q실적컨센서스밑돌듯목표주가87하향,http://www.econovill.com/news/articleView.html?idxno=382270
374,2020-01-09,1월9일대웅제약종목정보039변동,http://www.gokorea.kr/news/articleView.html?idxno=626488
375,2020-01-09,대웅제약아박타조인트벤처설립면역질환치료제개발박차,http://www.cnbnews.com/news/article.html?no=433251
376,2020-01-09,1월9일대웅제약주식증권039130000원,http://nbntv.co.kr/news/view/802396
377,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.getnews.co.kr/view.php?ud=20200109110305376741d0c69529_16
378,2020-01-09,대웅제약글로벌빅파마와RD로드맵공유,http://www.dailypharm.com/Users/News/NewsView.html?ID=260762&REFERER=NP
379,2020-01-09,대웅제약JP모건컨퍼런스에서해외진출전략공개,https://www.sedaily.com/NewsView/1YXKVYYUX9
380,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가신약개발로드맵제시,http://www.viva100.com/main/view.php?key=20200109010003002
381,2020-01-09,대웅제약JP모건컨퍼런스서글로벌사업RD로드맵제시,http://www.medisobizanews.com/news/articleView.html?idxno=65684
382,2020-01-09,대웅JP모건컨퍼런스서글로벌사업과RD로드맵제시,http://medipana.com/news/news_viewer.asp?NewsNum=251378&MainKind=A&NewsKind=5&vCount=12&vKind=1
383,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과 R로드맵제시,http://www.businesskorea.co.kr/news/articleView.html?idxno=39974
384,2020-01-09,대웅제약글로벌사업RD로드맵제시,http://www.bosa.co.kr/news/articleView.html?idxno=2119555
385,2020-01-09,대웅제약JP모건서연구개발해외진출전략로드맵공개,http://www.newspim.com/news/view/20200109000820
386,2020-01-09,대웅제약JP모건컨퍼런스서신약로드맵공개,http://news.mt.co.kr/mtview.php?no=2020010911220101552
387,2020-01-09,대웅제약美JP모건서글로벌RD전략공개한다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020010911255683952
388,2020-01-09,대웅제약비용부담늘어4분기영업이익기대이하추정,http://www.businesspost.co.kr/BP?command=article_view&num=158761
389,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업RD로드맵발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1843288
390,2020-01-09,대웅제약JP모건컨퍼런스통해신약개발로드맵공개,http://www.rapportian.com/news/articleView.html?idxno=122654
391,2020-01-09,데일리주가정보대웅003090오후12시06분기준외증시동향,https://www.dailysecu.com/news/articleView.html?idxno=94849
392,2020-01-09,대웅제약나보타ITC소송상반기일단락되나,http://medipana.com/news/news_viewer.asp?NewsNum=251382&MainKind=A&NewsKind=5&vCount=12&vKind=1
393,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.dailysmart.co.kr/news/articleView.html?idxno=20820
394,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업RD로드맵제시,http://www.mdtoday.co.kr/mdtoday/index.html?no=374634
395,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.newslock.co.kr/news/articleView.html?idxno=24943
396,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참석RD로드맵공개,http://www.metroseoul.co.kr/news/newsview?newscd=2020010900091
397,2020-01-09,대웅제약JP모건컨퍼런스서RD로드맵제시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1075935
398,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서RD로드맵제시,http://www.newsway.co.kr/news/view?tp=1&ud=2020010913080455025
399,2020-01-09,윤제승대웅제약전회장분식회계및허위공시의혹경영복귀설솔솔,http://www.newsworker.co.kr/news/articleView.html?idxno=57100
400,2020-01-09,대웅제약JP모건참가RD로드맵제시,https://www.paxnetnews.com/articles/55706
401,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.nbnnews.co.kr/news/articleView.html?idxno=357438
402,2020-01-09,대웅JP모건컨퍼런스서신약파이프라인조인트벤처공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239420
403,2020-01-09,대웅제약JP모건컨퍼런스서나보타펙수프라잔로드맵발표,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001090483&t=NN
404,2020-01-09,글로벌사업과RD로드맵제시대웅제약JP모건헬스케어컨퍼런스에서자사우수성발표,http://www.updownnews.co.kr/news/articleView.html?idxno=213512
405,2020-01-09,대웅제약오는15일美서글로벌전략발표한국제약경쟁력각인시킬것”,http://www.donga.com/news/article/all/20200109/99155096/1
406,2020-01-09,대웅제약해외진출전략RD로드맵제시,http://www.newsprime.co.kr/news/article.html?no=489653
407,2020-01-09,대웅제약전승호사장JP모건헬스케어컨퍼런스서글로벌전략발표,http://www.koreaittimes.com/news/articleView.html?idxno=94990
408,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌∙RD전략발표,http://www.pressm.kr/news/articleView.html?idxno=27040
409,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가,http://www.whosaeng.com/115205
410,2020-01-09,대웅제약美서신약개발전략발표,https://view.asiae.co.kr/article/2020010914411403223
411,2020-01-09,대웅제약JP모건헬스케어컨퍼런스글로벌사업및RD로드맵제시,http://www.ekn.kr/news/article.html?no=474806
412,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서RD로드맵공개,http://www.segyebiz.com/newsView/20200109509802?OutUrl=naver
413,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.wikileaks-kr.org/news/articleView.html?idxno=74502
414,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가,http://www.ebn.co.kr/news/view/1017005/?sc=naver
415,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.medigatenews.com/news/2994010038
416,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서해외진출전략신약로드맵공개,http://it.chosun.com/site/data/html_dir/2020/01/09/2020010902581.html
417,2020-01-09,대웅제약이지듀메이크업라인할인이벤트진행,http://moneys.mt.co.kr/news/mwView.php?no=2020010915008054059
418,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서해외진출및신약개발전략발표,http://news.mk.co.kr/newsRead.php?no=30043&year=2020
419,2020-01-09,대웅제약JP모건헬스케어컨퍼런스참가글로벌사업및RD로드맵제시,http://www.ezyeconomy.com/news/articleView.html?idxno=96945
420,2020-01-09,대웅제약미국서신약개발로드맵공개,http://news.mk.co.kr/newsRead.php?no=30134&year=2020
421,2020-01-09,JP모건헬스케어전승호사장대웅제약가치확실히알린다,http://www.econovill.com/news/articleView.html?idxno=382310
422,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://newsbrite.net/132472
423,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59138
424,2020-01-09,대웅제약JP모건서글로벌사업RD로드맵제시,http://www.newstomato.com/ReadNews.aspx?no=944788
425,2020-01-09,대웅제약JP모건헬스케어콘퍼런스참가글로벌사업과RD로드맵제시,http://sports.hankooki.com/lpage/economy/202001/sp20200109160600137020.htm
426,2020-01-09,대웅제약JP모건컨퍼런스서글로벌사업RD로드맵공개,http://inthenews.co.kr/article-31389/
427,2020-01-09,靑국민청원인윤재승전대웅제약회장이135억원횡령증거도다수확보,http://www.sisajournal-e.com/news/articleView.html?idxno=211867
428,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서전승호사장발표,http://www.polinews.co.kr/news/article.html?no=448370
429,2020-01-09,윤재승대웅제약회장130억원회삿돈횡령불기소청원檢외압의혹제기,http://www.beyondpost.co.kr/view.php?ud=202001081927184295c5c1bde209_30
430,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.dailian.co.kr/news/view/859992/?sc=naver
431,2020-01-09,대웅제약JP모건헬스케어콘퍼런스서글로벌RD전략발표,http://www.asiatoday.co.kr/view.php?key=20200109010005276
432,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.m-i.kr/news/articleView.html?idxno=671525
433,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서신약개발계획발표한다,http://www.sisafocus.co.kr/news/articleView.html?idxno=229598
434,2020-01-09,대웅제약JP모건헬스케어컨퍼런스글로벌사업과RD로드맵제시,http://www.segye.com/content/html/2020/01/09/20200109515063.html?OutUrl=naver
435,2020-01-09,대웅제약메디톡스균주분쟁종착역보여진쪽은치명적타격불가피,http://www.businesspost.co.kr/BP?command=article_view&num=158887
436,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.newscj.com/news/articleView.html?idxno=698374
437,2020-01-09,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.lawissue.co.kr/view.php?ud=202001092107362534204ead0791_12
438,2020-01-09,대웅제약JP모건헬스케어컨퍼런스서글로벌사업과RD로드맵제시,http://www.thefirstmedia.net/news/articleView.html?idxno=52874
439,2020-01-09,대웅제약15일美서신약개발로드맵공개,http://www.seoulwire.com/news/articleView.html?idxno=266162
440,2020-01-09,대웅제약아박타면역질환치료제위한조인트벤처세워,https://www.kpanews.co.kr/article/show.asp?idx=210030&category=D
441,2020-01-10,영업강자대웅제약펙수프라잔케이캡의대항마될까,http://www.newsis.com/view/?id=NISX20200109_0000884632&cID=13001&pID=13000
442,2020-01-10,대웅각고끝할랄인증세포주햄스터생존여부확인도,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239433
443,2020-01-10,JP모건참가대웅글로벌사업및RD로드맵제시,http://www.monews.co.kr/news/articleView.html?idxno=207565
444,2020-01-10,★주식인사이드대웅제약주가130000원1월10일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1056781
445,2020-01-10,대웅10일169변동폭보여및증권시세,http://www.gokorea.kr/news/articleView.html?idxno=628076
446,2020-01-10,주식현황대웅주가10일현재12050원,http://nbntv.co.kr/news/view/804358
447,2020-01-10,대웅466상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/01/10/2020011001347.html?utm_source=naver&utm_medium=original&utm_campaign=biz
448,2020-01-10,대웅제약전일대비536이시각1만8952주거래,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001100177&t=NN
449,2020-01-10,대웅제약5이상상승주가20일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202001107698L
450,2020-01-10,대웅제약06962010일651변화증권그래프및종목분석,http://www.gokorea.kr/news/articleView.html?idxno=628527
451,2020-01-10,대웅제약JP모건컨퍼런스서글로벌사업RD로드맵공개,http://www.cnbnews.com/news/article.html?no=433381
452,2020-01-10,대웅상승중전일대비508외국인8436주순매수중,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001100259&t=NN
453,2020-01-10,대웅제약오늘증권시세10일현재138000원,http://nbntv.co.kr/news/view/804841
454,2020-01-10,대웅5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202001108063L
455,2020-01-10,대웅머크독점메트포르민서방정시장후발주자등장,http://www.dailypharm.com/Users/News/NewsView.html?ID=260803&REFERER=NP
456,2020-01-10,대웅제약JP모건헬스케어컨퍼런스에서글로벌사업과RD로드맵제시,http://www.kukinews.com/news/article.html?no=736342
457,2020-01-10,대웅제약728상승중하락추세중이평선뚫고급등,http://www.newspim.com/news/view/20200110000651
458,2020-01-10,바이오시밀러복제바이오의약품테마오후시황상승률상위종목한올바이오파마977대웅제약766알테오젠562등,http://www.gokorea.kr/news/articleView.html?idxno=628940
459,2020-01-10,보톡스보툴리눔톡신테마오후시황상승률상위종목제테마773대웅제약766메디톡스309등,http://www.gokorea.kr/news/articleView.html?idxno=628936
460,2020-01-10,치매관련주테마오후시황상승률상위종목대웅제약766리메드618SK케미칼599등,http://www.gokorea.kr/news/articleView.html?idxno=628977
461,2020-01-10,제약업종13시현재주식시황상승률상위종목한올바이오파마3100원891대웅제약9500원728티움바이오1100원683,http://www.cctvnews.co.kr/news/articleView.html?idxno=156710
462,2020-01-10,10일13시바이오시밀러복제바이오의약품테마주시황오후한올바이오파마대웅제약등이상승세견인중,http://nbntv.co.kr/news/view/805271
463,2020-01-10,13시24분보톡스보툴리눔톡신테마주오후시황대웅제약제테마등이상승세주도,http://nbntv.co.kr/news/view/805276
464,2020-01-10,제약업종돋보기제약견인종목에이프로젠제약870상승한올바이오파마862대웅제약728상승,http://nbntv.co.kr/news/view/805302
465,2020-01-10,10일13시치매관련주테마주시황오후대웅제약리메드등이주도,http://nbntv.co.kr/news/view/805341
466,2020-01-10,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목대웅제약9000원690제테마1150원556메디톡스8400원255상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156779
467,2020-01-10,바이오시밀러복제바이오의약품테마13시현재주식시황상승률상위종목에이프로젠제약125원988한올바이오파마2950원848대웅제약9000원690상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156775
468,2020-01-10,치매관련주테마13시현재주식시황상승률상위종목에이프로젠제약125원988대웅제약9000원690리메드850원656상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156800
469,2020-01-10,제약업종오후시황상승률상위종목한올바이오파마805대웅제약651에이프로젠제약632등,http://www.gokorea.kr/news/articleView.html?idxno=629142
470,2020-01-10,보톡스보툴리눔톡신테마주시황마감제테마대웅제약등이주도,http://nbntv.co.kr/news/view/805903
471,2020-01-10,바이오시밀러복제바이오의약품테마주마감한올바이오파마대웅제약등이주도,http://nbntv.co.kr/news/view/805921
472,2020-01-10,치매관련주테마주시황마감리메드대웅제약등이주도,http://nbntv.co.kr/news/view/805961
473,2020-01-10,업종이슈제약업주요종목10일종가티움바이오1600원994상승한올바이오파마2700원776상승대웅제약8500원651상승,http://nbntv.co.kr/news/view/805991
474,2020-01-10,제약업종마감시황상승률상위종목티움바이오994한올바이오파마776대웅제약651등,http://www.gokorea.kr/news/articleView.html?idxno=629659
475,2020-01-10,보톡스보툴리눔톡신테마마감시황상승률상위종목제테마870대웅제약651메디톡스446등,http://www.gokorea.kr/news/articleView.html?idxno=629701
476,2020-01-10,바이오시밀러복제바이오의약품테마마감시황상승률상위종목한올바이오파마776대웅제약651LG화학604등,http://www.gokorea.kr/news/articleView.html?idxno=629719
477,2020-01-10,치매관련주테마마감시황상승률상위종목리메드772대웅제약651SK케미칼599등,http://www.gokorea.kr/news/articleView.html?idxno=629752
478,2020-01-10,한미일양대웅등중국인도네시아서실적고공행진,http://www.bokuennews.com/news/article.html?no=185546
479,2020-01-10,대웅제약JP모건헬스케어컨퍼런스서글로벌사업RD로드맵제시,http://www.newsian.co.kr/news/articleView.html?idxno=39380
480,2020-01-10,대웅재단2020년AI기반연구자지원사업확대예정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59167
481,2020-01-10,대웅재단올해인공지능연구자지원사업확대,http://www.donga.com/news/article/all/20200110/99175938/1
482,2020-01-10,대웅재단2020년AI기반헬스케어연구석박사에지원확대,http://www.medisobizanews.com/news/articleView.html?idxno=65753
483,2020-01-10,대웅재단2020년AI기반연구자지원사업확대,http://medipana.com/news/news_viewer.asp?NewsNum=251451&MainKind=A&NewsKind=5&vCount=12&vKind=1
484,2020-01-11,대웅재단2020년AI기반연구자지원사업확대하기로,https://www.kpanews.co.kr/article/show.asp?idx=210072&category=D
485,2020-01-12,대웅재단2020년AI기반연구자지원사업확대,http://www.viva100.com/main/view.php?key=20200112010003711
486,2020-01-12,대웅재단AI인공지능기반연구자지원사업확대,http://www.dailymedi.com/detail.php?number=851719&thread=22r05
487,2020-01-12,대웅제약JP모건헬스케어컨퍼런스신약로드맵공개,http://weekly.cnbnews.com/news/article.html?no=132056
488,2020-01-13,★주식인사이드대웅제약주가140500원1월13일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1057231
489,2020-01-13,보톡스보툴리눔톡신테마09시현재주식시황상승률상위종목파마리서치프로덕트1200원339메디톡스8300원241대웅제약2500원180상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=156918
490,2020-01-13,대웅13일000변화종목그래프살펴보기,http://www.gokorea.kr/news/articleView.html?idxno=630104
491,2020-01-13,대웅증권주식13일현재12300원,http://nbntv.co.kr/news/view/806866
492,2020-01-13,대웅재단2020년AI기반연구자지원사업확대예정,http://www.bosa.co.kr/news/articleView.html?idxno=2119734
493,2020-01-13,대웅제약주가06962013일216변화,http://www.gokorea.kr/news/articleView.html?idxno=630556
494,2020-01-13,대웅제약주식현황13일현재143000원,http://nbntv.co.kr/news/view/807336
495,2020-01-13,제약산업대웅인피온세계최초동물세포유래바이오의약품할랄인증外,http://www.kukinews.com/news/article.html?no=737010
496,2020-01-13,삼성바이오셀트리온대웅제약등JP모건서KBIO눈도장찍는다,http://daily.hankooki.com/lpage/ittech/202001/dh20200113143154145630.htm
497,2020-01-13,대웅제약메디톡스보톡스소송올해끝나나,http://www.newsian.co.kr/news/articleView.html?idxno=39421
498,2020-01-13,서창우대웅인피온대표印尼고급사립병원크게늘어고가재생치료제시장선점을,http://news.mk.co.kr/newsRead.php?no=41837&year=2020
499,2020-01-13,햄스터재판승소로할랄약품인증대웅동남아무슬림공략,http://news.mk.co.kr/newsRead.php?no=41838&year=2020
500,2020-01-13,제약바이오CEO미국총집결한미약품셀트리온삼성바이오로직스JW중외제약대웅제약등JP모건컨퍼런스참가,https://www.sisa-news.com/news/article.html?no=123122
501,2020-01-14,SK대웅제약뛰어든다줄기세포치료제시장볼륨업,http://www.viva100.com/main/view.php?key=20200112010003690
502,2020-01-14,전승호윤재춘대웅제약대표매출늘리고영업이익개선,http://www.datanews.co.kr/news/article.html?no=105754
503,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구,http://www.viva100.com/main/view.php?key=20200114010004456
504,2020-01-14,대웅제약AI결합된신약설계플랫폼가진美A2A와항암제공동개발키로,http://news.mk.co.kr/newsRead.php?no=42882&year=2020
505,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입 ,http://www.dailian.co.kr/news/view/861067?sc=Naver
506,2020-01-14,대웅제약美바이오기업과AI기반항암신약공동연구,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020011409081164856
507,2020-01-14,대웅제약미국A2A파마와맞손AI기반항암신약공동연구,http://www.etoday.co.kr/news/section/newsview.php?idxno=1844756
508,2020-01-14,대웅제약美A2A와항암신약공동연구파트너십,http://news.mt.co.kr/mtview.php?no=2020011409031644062
509,2020-01-14,대웅제약미국기업과항암신약공동연구나서,http://moneys.mt.co.kr/news/mwView.php?no=2020011409048083936
510,2020-01-14,대웅제약美A2A파마사와AI기반항암신약공동연구돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=20994
511,2020-01-14,대웅제약美A2A파마사와AI기반항암신약공동연구돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=20994
512,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구,http://medipana.com/news/news_viewer.asp?NewsNum=251550&MainKind=A&NewsKind=5&vCount=12&vKind=1
513,2020-01-14,대웅제약A2A파마社와AI기반항암신약공동연구,http://www.consumuch.com/news/articleView.html?idxno=47212
514,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.getnews.co.kr/view.php?ud=20200114091832454441d0c69529_16
515,2020-01-14,대웅제약美A2A파마와AI항암신약공동연구계약,http://www.biospectator.com/view/news_view.php?varAtcId=9312
516,2020-01-14,대웅제약美바이오기업과AI항암신약공동연구개발,http://www.newspim.com/news/view/20200114000148
517,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,http://www.metroseoul.co.kr/news/newsview?newscd=2020011400014
518,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2020011409234410159
519,2020-01-14,대웅제약미국바이오텍과AI연구돌입항암신약개발,http://www.newsis.com/view/?id=NISX20200114_0000887953&cID=13001&pID=13000
520,2020-01-14,대웅제약 미국 A2A 파마社와 AI 기반항암신약공동연구  ,http://www.medisobizanews.com/news/articleView.html?idxno=65811
521,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=358700
522,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구돌입,http://www.asiatoday.co.kr/view.php?key=20200114010007378
523,2020-01-14,대웅제약A2A파마AI기반항암신약공동연구돌입,https://asiatime.co.kr/news/newsview.php?ncode=1065571496000768
524,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,https://www.sedaily.com/NewsView/1YXN6TIZS2
525,2020-01-14,JP모건첫희소식대웅제약AI신약개발파트너찾다,http://www.bosa.co.kr/news/articleView.html?idxno=2119805
526,2020-01-14,대웅제약미국AI기반신약개발기업과공동연구,http://yna.kr/AKR20200114047800017?did=1195m
527,2020-01-14,대웅제약미국벤처와AI기반항암제개발제휴,http://www.dailypharm.com/Users/News/NewsView.html?ID=260894&REFERER=NP
528,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구돌입,http://www.m-i.kr/news/articleView.html?idxno=672433
529,2020-01-14,대웅제약미국AI기반신약개발기업과공동연구,http://yna.kr/PYH20200114031600017?did=1196m
530,2020-01-14,대웅제약美A2A파마와맞손AI기반항암신약공동연구,http://www.seoulwire.com/news/articleView.html?idxno=266646
531,2020-01-14,대웅제약미국A2A파마와AI기반항암신약연구돌입,http://www.news2day.co.kr/146425
532,2020-01-14,대웅제약AI로항암신약개발한다美바이오기업과파트너십체결,http://it.chosun.com/site/data/html_dir/2020/01/14/2020011401256.html
533,2020-01-14,대웅제약미국A2A파마사와AI기반항암신약공동연구돌입,http://www.ezyeconomy.com/news/articleView.html?idxno=97045
534,2020-01-14,대웅제약미국A2A와AI기반항암신약공동연구돌입,http://www.newstomato.com/ReadNews.aspx?no=945530
535,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구돌입,http://inthenews.co.kr/article-31761/
536,2020-01-14,대웅제약AI활용항암제개발 돌입,http://www.seoulfn.com/news/articleView.html?idxno=368735
537,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=374970
538,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.newsfc.co.kr/news/articleView.html?idxno=39412
539,2020-01-14,대웅제약美바이오기업과항암신약공동개발추진,http://www.rapportian.com/news/articleView.html?idxno=122739
540,2020-01-14,대웅제약 A2A 파마사와 AI 기반항암신약공동연구돌입  ,http://www.newslock.co.kr/news/articleView.html?idxno=25031
541,2020-01-14,대웅제약미국신약설계플랫폼기업과항암파트너십,http://health.chosun.com/site/data/html_dir/2020/01/14/2020011401375.html
542,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구,http://www.etnews.com/20200114000037
543,2020-01-14,대웅제약AI기반항암신약개발나선다,http://www.whosaeng.com/115283
544,2020-01-14,대웅제약JP모건서AI기반항암신약물질개발협약오픈이노베이션강화,http://news1.kr/articles/?3816186
545,2020-01-14,AI기반연구통해신약개발성공가능성UP대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.updownnews.co.kr/news/articleView.html?idxno=213691
546,2020-01-14,대웅제약A2A파마사와AI기반항암신약개발JP모건헬스케어컨퍼런스2020,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001140201&t=NN
547,2020-01-14,대웅제약미국A2A파마社와AI활용신약개발돌입,http://www.edaily.co.kr/news/newspath.asp?newsid=02489526625637720
548,2020-01-14,대웅제약美A2A파마사와AI항암신약공동연구,https://biz.chosun.com/site/data/html_dir/2020/01/14/2020011401495.html?utm_source=naver&utm_medium=original&utm_campaign=biz
549,2020-01-14,대웅제약인공지능기반항암제연구돌입,https://www.paxnetnews.com/articles/55829
550,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://newsbrite.net/132653
551,2020-01-14,대웅제약06962014일071변화,http://www.gokorea.kr/news/articleView.html?idxno=632425
552,2020-01-14,대웅제약미국바이오기업A2A파마사와AI기반항암신약공동연구,http://www.paxetv.com/news/articleView.html?idxno=84732
553,2020-01-14,대웅제약미국인공지능기반바이오사와항암신약공동개발,https://cnbc.sbs.co.kr/article_hub/10000969288?division=NAVER
554,2020-01-14,대웅제약美A2A파마AI기반항암신약공동연구,http://www.dailymedi.com/detail.php?number=851787&thread=22r05
555,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,http://www.ceoscoredaily.com/news/article.html?no=64905
556,2020-01-14,대웅제약증권플러스14일현재140500원,http://nbntv.co.kr/news/view/809660
557,2020-01-14,대웅제약美AI기반바이오기업과항암신약공동연구,http://www.dt.co.kr/contents.html?article_no=2020011402109931102003&ref=naver
558,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구,http://www.econovill.com/news/articleView.html?idxno=382666
559,2020-01-14,대웅제약미AI기반신약개발기업과공동연구,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4033459
560,2020-01-14,대웅제약A2A와AI기반항암신약공동연구,http://www.finomy.com/news/articleView.html?idxno=74104
561,2020-01-14,대웅제약美A2A파마와AI기반항암신약공동연구돌입,http://www.cnbnews.com/news/article.html?no=433729
562,2020-01-14,데일리증권대웅003090오후12시10분기준,https://www.dailysecu.com/news/articleView.html?idxno=96845
563,2020-01-14,대웅제약美기업과AI기반항암신약공동연구나서,http://www.newswatch.kr/news/articleView.html?idxno=26564
564,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59212
565,2020-01-14,대웅제약美A2A파마사와AI기반항암신약공동연구돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=113812
566,2020-01-14,대웅제약미국바이오기업과AI기반항암신약공동연구”,http://sports.hankooki.com/lpage/economy/202001/sp20200114135418137020.htm
567,2020-01-14,대웅제약美A2A파마와항암신약공동연구들어간다,http://news.mk.co.kr/newsRead.php?no=45074&year=2020
568,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구계약체결,http://www.pressm.kr/news/articleView.html?idxno=27116
569,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.lawissue.co.kr/view.php?ud=202001141433045133204ead0791_12
570,2020-01-14,대웅제약미국A2A파마사와AI기반항암신약공동연구돌입,http://www.ekn.kr/news/article.html?no=475619
571,2020-01-14,대웅제약美A2A파마와항암신약공동연구개발,http://www.newsprime.co.kr/news/article.html?no=490160
572,2020-01-14,대웅제약A2A파마와AI기반항암신약공동연구,http://www.ebn.co.kr/news/view/1017655/?sc=naver
573,2020-01-14,대웅제약미국A2A파마와AI기반항암신약공동연구돌입,http://www.medigatenews.com/news/2284229536
574,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.wikileaks-kr.org/news/articleView.html?idxno=74854
575,2020-01-14,대웅제약미국바이오회사와인공지능기반항암신약공동연구시작,http://www.businesspost.co.kr/BP?command=article_view&num=159455
576,2020-01-14,대웅제약A2A파마AI기반항암신약연구개발돌입,http://www.mediapen.com/news/view/492546
577,2020-01-14,대웅제약美A2A파마와인공지능기반항암신약공동연구,https://www.hankyung.com/finance/article/2020011465676
578,2020-01-14,대웅제약A2A파마와AI기반항암신약공동연구파트너십계약,http://digitalchosun.dizzo.com/site/data/html_dir/2020/01/14/2020011480146.html
579,2020-01-14,대웅제약AI기반항암신약공동연구돌입,http://www.bokuennews.com/news/article.html?no=185671
580,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.joseilbo.com/news/news_read.php?uid=390469&class=27&grp=
581,2020-01-14,대웅제약A2A파마맞손AI기반항암신약연구,http://www.mhj21.com/126853
582,2020-01-14,대웅제약미국A2A파마와AI기반항암제개발나선다,https://www.kpanews.co.kr/article/show.asp?idx=210149&category=D
583,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구계약,http://www.sporbiz.co.kr/news/articleView.html?idxno=408382
584,2020-01-14,대웅제약A2A파마항암신약공동연구개발파트너십체결,http://www.k-health.com/news/articleView.html?idxno=46898
585,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.businesskorea.co.kr/news/articleView.html?idxno=40155
586,2020-01-14,대웅제약미국A2A파마사와AI기반항암신약공동연구돌입,http://www.newsian.co.kr/news/articleView.html?idxno=39458
587,2020-01-14,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.newscj.com/news/articleView.html?idxno=699634
588,2020-01-14,대웅제약美A2A파마社와AI기반항암신약공동연구돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=53079
589,2020-01-15,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.polinews.co.kr/news/article.html?no=449043
590,2020-01-15,종근당대웅제약도1조클럽진입유력신약개발글로벌진출가속,https://biz.chosun.com/site/data/html_dir/2020/01/14/2020011403631.html?utm_source=naver&utm_medium=original&utm_campaign=biz
591,2020-01-15,뉴스브리핑1월15일노트북2020영상편집자저임금종근당대웅제약도1조클럽,http://it.chosun.com/site/data/html_dir/2020/01/15/2020011500370.html
592,2020-01-15,대웅제약소송비용축소로올해영업이익개선전망SK증권,http://www.ajunews.com/view/20200115083253204
593,2020-01-15,대웅제약미국A2A파마社와AI기반항암신약공동연구돌입,http://www.kukinews.com/news/article.html?no=737614
594,2020-01-15,대웅제약美A2A파마와항암신약개발맞손,http://www.monews.co.kr/news/articleView.html?idxno=207639
595,2020-01-15,대웅제약AI이용한항암신약개발착수,http://news.heraldcorp.com/view.php?ud=20200115000069
596,2020-01-15,리포트브리핑대웅제약나보타소송비용은점진적으로축소중목표가220000원SK증권,http://www.newspim.com/news/view/20200115000198
597,2020-01-15,대웅주가00309015일082변동,http://www.gokorea.kr/news/articleView.html?idxno=633672
598,2020-01-15,오늘주식대웅주가15일현재12200원,http://nbntv.co.kr/news/view/811141
599,2020-01-15,대웅제약15일000변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=634139
600,2020-01-15,1월15일대웅제약실시간주식현황139500원036,http://nbntv.co.kr/news/view/811660
601,2020-01-15,데일리주식정보대웅제약069620오후12시23분기준및종목관련동향정보,https://www.dailysecu.com/news/articleView.html?idxno=97432
602,2020-01-15,대웅제약美바이오기업과항암신약공동개발,http://www.shinailbo.co.kr/news/articleView.html?idxno=1242016
603,2020-01-15,국민청원에등장한윤재승전대웅제약회장왜,http://www.sisaon.co.kr/news/articleView.html?idxno=107709
604,2020-01-15,대웅메디톡스보톡스진실게임마지막싸움막오른다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1845164
605,2020-01-16,더벨2020승부수대웅제약개방형협력강조파이프라인확대주력,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202001141304442000108196
606,2020-01-16,★주식인사이드대웅제약주가140500원1월16일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1057972
607,2020-01-16,대웅16일123변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=635698
608,2020-01-16,대웅오늘주식시장16일현재12350원,http://nbntv.co.kr/news/view/813565
609,2020-01-16,한올바이오대웅제약안구건조증신약임상3상Topline결과발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239635
610,2020-01-16,한올바이오대웅제약HL0363상Topline결과발표,http://medipana.com/news/news_viewer.asp?NewsNum=251645&MainKind=A&NewsKind=5&vCount=12&vKind=1
611,2020-01-16,장중수급포착대웅외국인3일연속순매수행진주가164,http://www.newspim.com/news/view/20200116000323
612,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상톱라인결과발표,https://www.sedaily.com/NewsView/1YXO3XM0RY
613,2020-01-16,한올바이오파마대웅제약안구건조증신약글로벌임상3상성공,http://www.newspim.com/news/view/20200116000285
614,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상VELOS2성공적인Topline결과”발표,http://newsbrite.net/132722
615,2020-01-16,대웅제약주가16일143변화,http://www.gokorea.kr/news/articleView.html?idxno=636152
616,2020-01-16,한올바이오파마대웅제약안구건조증신약美임상3상효과확인,http://news1.kr/articles/?3818270
617,2020-01-16,1월16일대웅제약주식현황036140000원,http://nbntv.co.kr/news/view/814070
618,2020-01-16,유한양행대웅제약올해영업이익대폭증가전망,http://medipana.com/news/news_viewer.asp?NewsNum=251665&MainKind=A&NewsKind=5&vCount=12&vKind=1
619,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상탑라인결과공개,http://www.dailian.co.kr/news/view/861765?sc=Naver
620,2020-01-16,한올바이오파마대웅제약안구건조신약3상성공적,http://www.newsis.com/view/?id=NISX20200116_0000890983&cID=13001&pID=13000
621,2020-01-16,한올바이오파마대웅제약안구건조증신약미국임상3상성공적”,http://www.mdtoday.co.kr/mdtoday/index.html?no=375202
622,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상성공적인탑라인결과발표,http://www.medigatenews.com/news/2090598891
623,2020-01-16,한올바이오파마대웅제약안구건조증신약임상3상의성공적인Topline결과발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59259
624,2020-01-16,대웅제약피로회복에너지생성큰도움,http://www.dt.co.kr/contents.html?article_no=2020011702101931033002&ref=naver
625,2020-01-17,한올바이오파마대웅제약안구건조증신약3상탑라인결과성공적,https://www.kpanews.co.kr/article/show.asp?idx=210219&category=D
626,2020-01-17,대웅VS메디톡스승자만산다보톡스잔혹사끝맺을까,http://moneys.mt.co.kr/news/mwView.php?no=2020010717538023010
627,2020-01-17,1조클럽제약사5곳압축대웅종근당진입유력,http://www.mdtoday.co.kr/mdtoday/index.html?no=375212
628,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://daily.hankooki.com/lpage/ittech/202001/dh20200117085143145630.htm
629,2020-01-17,대웅제약신약개발현황글로벌사업전략제시,http://www.ebn.co.kr/news/view/1018149/?sc=naver
630,2020-01-17,전승호대웅제약사장올해펙수프라잔글로벌임상성과주목,http://news.mk.co.kr/newsRead.php?no=56133&year=2020
631,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.getnews.co.kr/view.php?ud=20200117090407784941d0c69529_16
632,2020-01-17,대웅제약JP모건서오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1846271
633,2020-01-17,대웅제약오픈콜라보레이션으로희귀질환치료제개발할것,https://www.sedaily.com/NewsView/1YXOKEJ675
634,2020-01-17,대웅제약펙수프라잔올해국내허가美中임상진입,http://www.biospectator.com/view/news_view.php?varAtcId=9344
635,2020-01-17,대웅제약펙수프라잔올해국내허가美中임상진입,http://www.biospectator.com/view/news_view.php?varAtcId=9344
636,2020-01-17,대웅제약JP모건헬스케어컨퍼런스서신약개발로드맵제시,http://www.dailian.co.kr/news/view/862058?sc=Naver
637,2020-01-17,대웅제약희귀난치성질환치료제개발에역량집중,http://www.medisobizanews.com/news/articleView.html?idxno=65946
638,2020-01-17,대웅제약펙수프라잔연내미국중국임상시험진입,http://www.newspim.com/news/view/20200117000151
639,2020-01-17,대웅제약올해RD성과나와희귀질환약로드맵제시,http://www.newsis.com/view/?id=NISX20200117_0000891835&cID=13001&pID=13000
640,2020-01-17,대웅제약희귀난치성질환치료제개발에집중할것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020011709291048638
641,2020-01-17,1월17일대웅증권주식08112400원,http://nbntv.co.kr/news/view/815898
642,2020-01-17,대웅제약JP모건서RD성과발표로드맵제시,http://www.mhj21.com/126891
643,2020-01-17,전승호대웅제약대표2020년은RD성과가가시화되는한해가될것”,http://www.ceoscoredaily.com/news/article.html?no=65063
644,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.segye.com/content/html/2020/01/17/20200117503683.html?OutUrl=naver
645,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://medipana.com/news/news_viewer.asp?NewsNum=251714&MainKind=A&NewsKind=5&vCount=12&vKind=1
646,2020-01-17,대웅희귀난치성신약개발에역량집중,http://www.bokuennews.com/news/article.html?no=185769
647,2020-01-17,JP모건헬스케어대웅제약희귀난치질환치료제개발로드맵제시,http://www.econovill.com/news/articleView.html?idxno=382978
648,2020-01-17,대웅제약JP모간서혁신신약글로벌로드맵공개,http://news.mt.co.kr/mtview.php?no=2020011709092954619
649,2020-01-17,대웅제약 오픈콜라보레이션통한 희귀난치성질환치료제개발로드맵제시,http://www.businesskorea.co.kr/news/articleView.html?idxno=40260
650,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.mdtoday.co.kr/mdtoday/index.html?no=375292
651,2020-01-17,대웅제약올해글로벌사업전략및신약RD로드맵공개,http://www.sisaweek.com/news/articleView.html?idxno=130115
652,2020-01-17,대웅제약위식도역류질환치료제美中임상진행,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90050
653,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.nbnnews.co.kr/news/articleView.html?idxno=359880
654,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://newsbrite.net/132776
655,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://newsbrite.net/132776
656,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.dailysmart.co.kr/news/articleView.html?idxno=21156
657,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.bosa.co.kr/news/articleView.html?idxno=2120040
658,2020-01-17,대웅제약펙수프라잔올해美中임상진입,http://www.etnews.com/20200117000054
659,2020-01-17,대웅제약올해미국중국서펙수프라잔임상진입JP모건헬스케어컨퍼런스2020,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001170197&t=NN
660,2020-01-17,대웅제약06962017일073변동,http://www.gokorea.kr/news/articleView.html?idxno=638188
661,2020-01-17,전승호대표올해대웅제약RD성과가시화”,https://www.paxnetnews.com/articles/55995
662,2020-01-17,대웅제약오픈콜라보레이션으로희귀질환치료제개발로드맵제시,http://www.metroseoul.co.kr/news/newsview?newscd=2020011700046
663,2020-01-17,대웅제약희귀난치성질환치료제개발청사진,http://news1.kr/articles/?3819263
664,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59276
665,2020-01-17,1월17일대웅제약오늘증시073138500원,http://nbntv.co.kr/news/view/816397
666,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.asiatoday.co.kr/view.php?key=20200117010009854
667,2020-01-17,대웅세계투자자들에신약개발로드맵제시,http://www.dailymedi.com/detail.php?number=851922&thread=22r05
668,2020-01-17,대웅제약펙수프라잔희귀질환치료제등글로벌로드맵제시차별화오픈콜라보중요,http://www.newslock.co.kr/news/articleView.html?idxno=25146
669,2020-01-17,대웅제약전승호대표희귀난치성질환치료제개발로드맵제시,http://www.insightkorea.co.kr/news/articleView.html?idxno=75623
670,2020-01-17,대웅제약희귀난치성질환치료제개발현황발표,http://www.pressm.kr/news/articleView.html?idxno=27188
671,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.newstomato.com/ReadNews.aspx?no=946443
672,2020-01-17,전승호대웅제약은개방형협력으로난치성질환신약개발집중,http://www.businesspost.co.kr/BP?command=article_view&num=160027
673,2020-01-17,대웅제약올해美中서펙수프라잔임상진입,http://www.ezyeconomy.com/news/articleView.html?idxno=97179
674,2020-01-17,대웅제약RD성과이룬펙수프라잔의로드맵공개,http://www.polinews.co.kr/news/article.html?no=449398
675,2020-01-17,대웅제약희귀난치성질환혁신신약개발역량집중,http://www.newsprime.co.kr/news/article.html?no=490683
676,2020-01-17,전승호대웅제약대표올해주요RD성과가시화”2020년사업전략발표,http://www.donga.com/news/article/all/20200117/99270681/1
677,2020-01-17,대웅제약펙수프라잔연내美中임상시험진입JPM컨퍼런스서밝혀,http://inthenews.co.kr/article-32285/
678,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵발표,http://www.joseilbo.com/news/news_read.php?uid=390673&class=27&grp=
679,2020-01-17,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.newswatch.kr/news/articleView.html?idxno=26717
680,2020-01-17,대웅제약글로벌오픈콜라보네이션으로연구개발고도화,https://jhealthmedia.joins.com/article/article_view.asp?pno=21297
681,2020-01-17,대웅제약올해는글로벌오픈콜라보레이션고도화에집중할것,http://kormedi.com/?p=1309763
682,2020-01-17,대웅제약희귀난치질환치료제개발역량집중,http://www.monews.co.kr/news/articleView.html?idxno=207715
683,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.medigatenews.com/news/1488923959
684,2020-01-17,대웅제약펙수프라잔美中임상시험추진,http://www.edaily.co.kr/news/newspath.asp?newsid=03378406625638704
685,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.lawissue.co.kr/view.php?ud=202001171654136688204ead0791_12
686,2020-01-17,전승호대웅제약대표RD성과가시화될것,http://www.shinailbo.co.kr/news/articleView.html?idxno=1242897
687,2020-01-17,대웅제약오픈콜라보레이션통한희귀난치성질환치료제개발로드맵제시,http://www.newscj.com/news/articleView.html?idxno=700562
688,2020-01-18,전승호사장대웅제약글로벌도약이끌까,http://moneys.mt.co.kr/news/mwView.php?no=2020011515358056632
689,2020-01-18,대웅제약희귀난치성질환치료제개발로드맵제시,http://www.newsian.co.kr/news/articleView.html?idxno=39542
690,2020-01-19,대웅제약글로벌오픈콜라보레이션고도화집중”,http://www.fetv.co.kr/news/article.html?no=45464
691,2020-01-19,대웅제약올해연구개발RD성과나와난치성질환치료제등희귀질환약로드맵제시,http://www.econonews.co.kr/news/articleView.html?idxno=104273
692,2020-01-19,대웅제약美바이오기업과AI기반항암신약공동연구,http://weekly.cnbnews.com/news/article.html?no=132181
693,2020-01-20,대웅제약실적개선에도주가부진속타는소액주주,http://www.asiatoday.co.kr/view.php?key=20200119010010379
694,2020-01-20,대웅주가20일041변동,http://www.gokorea.kr/news/articleView.html?idxno=639788
695,2020-01-20,1월20일대웅주식시세현황12300원000,http://nbntv.co.kr/news/view/818470
696,2020-01-20,대웅제약20일108변화,http://www.gokorea.kr/news/articleView.html?idxno=640258
697,2020-01-20,대웅제약주식추천주20일현재137500원,http://nbntv.co.kr/news/view/818966
698,2020-01-20,20일데일리증권대웅제약069620오후12시37분기준및종목동정과증시정보,https://www.dailysecu.com/news/articleView.html?idxno=99463
699,2020-01-20,대웅메디톡스보톡스전쟁6월윤곽느슨한규제문제,http://www.mediapen.com/news/view/493997
700,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단식,http://www.medisobizanews.com/news/articleView.html?idxno=66027
701,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://medipana.com/news/news_viewer.asp?NewsNum=251809&MainKind=A&NewsKind=5&vCount=12&vKind=1
702,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.metroseoul.co.kr/news/newsview?newscd=2020012000157
703,2020-01-20,대웅제약참치마요프로젝트2기봉사단창단식개최,http://news.mk.co.kr/newsRead.php?no=65032&year=2020
704,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.nbnnews.co.kr/news/articleView.html?idxno=360689
705,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newswatch.kr/news/articleView.html?idxno=26793
706,2020-01-20,청와대국민청원게시판에윤재승전대웅제약회장횡령혐의처벌청원,http://nbntv.co.kr/news/view/819845
707,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.etoday.co.kr/news/section/newsview.php?idxno=1847133
708,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newspim.com/news/view/20200120000900
709,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.businesskorea.co.kr/news/articleView.html?idxno=40369
710,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.wikileaks-kr.org/news/articleView.html?idxno=75441
711,2020-01-20,대웅제약발달장애인위한참지마요프로젝트교육봉사단창단,http://www.donga.com/news/article/all/20200120/99326175/1
712,2020-01-20,대웅제약발달장애인위한참지마요제2기교육봉사단창단,http://www.kpinews.co.kr/news/articleView.html?idxno=109539
713,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239770
714,2020-01-20,메디톡스휴젤대웅K보톡스3파전중국으로경쟁무대옮겨,http://biz.newdaily.co.kr/site/data/html/2020/01/20/2020012000197.html
715,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59308
716,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단식진행,http://www.cnbnews.com/news/article.html?no=434491
717,2020-01-20,대웅제약참지마요프로젝트2기교육봉사단창단,http://www.dailian.co.kr/news/view/862836?sc=Naver
718,2020-01-20,반등노리는바이오제약대웅제약역류성식도염등난치성질환치료제개발매진,https://www.sedaily.com/NewsView/1YXPY0LZYV
719,2020-01-20,대웅제약참지마요제2기교육봉사단창단,http://www.ekn.kr/news/article.html?no=476761
720,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.getnews.co.kr/view.php?ud=20200120174913831441d0c69529_16
721,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://newsbrite.net/132913
722,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.lawissue.co.kr/view.php?ud=20200120180217883204ead0791_12
723,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.mdtoday.co.kr/mdtoday/index.html?no=375497
724,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.econovill.com/news/articleView.html?idxno=383266
725,2020-01-20,뉴스투데이L대웅제약 건강한삶을위한참지마요프로젝트제2기교육봉사단창단,http://www.news2day.co.kr/146917
726,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단발달장애인의건강한삶위해,http://www.thefirstmedia.net/news/articleView.html?idxno=53299
727,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,https://www.kpanews.co.kr/article/show.asp?idx=210294&category=D
728,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newscj.com/news/articleView.html?idxno=701158
729,2020-01-20,대웅제약건강한삶과소통의프로젝트참지마요봉사단22일부터활동시작,http://www.paxetv.com/news/articleView.html?idxno=85210
730,2020-01-20,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.polinews.co.kr/news/article.html?no=449754
731,2020-01-21,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.dailymedi.com/detail.php?number=852035&thread=22r05
732,2020-01-21,한미약품2년연속처방실적선두대웅바이오껑충,http://www.dailypharm.com/Users/News/NewsView.html?ID=261101&REFERER=NP
733,2020-01-21,대웅제약나보타8개월간미국서400억원어치팔려,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1076301
734,2020-01-21,2020설특집대웅생명과학건강보조식품침향단선보여,http://sports.chosun.com/news/ntype.htm?id=202001220100144440009124&servicedate=20200121
735,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.ebn.co.kr/news/view/1018653/?sc=naver
736,2020-01-21,대웅제약한국머크의심혈관질환치료제콩코르영업돌입,http://news.mk.co.kr/newsRead.php?no=67205&year=2020
737,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newstomato.com/ReadNews.aspx?no=947040
738,2020-01-21,09시14분바이오시밀러복제바이오의약품오전테마시황에이프로젠제약대웅제약등이주도,http://nbntv.co.kr/news/view/820338
739,2020-01-21,21일09시보톡스보툴리눔톡신테마주시황오전대웅제약디에스케이등이주도,http://nbntv.co.kr/news/view/820389
740,2020-01-21,바이오시밀러복제바이오의약품테마오전시황상승률상위종목에이프로젠제약226대웅제약147셀트리온145등,http://www.gokorea.kr/news/articleView.html?idxno=641609
741,2020-01-21,바이오시밀러복제바이오의약품테마오전시황상승률상위종목에이프로젠제약226대웅제약147셀트리온145등,http://www.gokorea.kr/news/articleView.html?idxno=641609
742,2020-01-21,대웅제약심혈관치료제콩고르국내판매실시,https://asiatime.co.kr/news/newsview.php?ncode=1065571817392869
743,2020-01-21,대웅제약심혈관치료제콩코르판매돌입순환기계시장경쟁력강화,http://www.getnews.co.kr/view.php?ud=20200121092431120941d0c69529_16
744,2020-01-21,대웅제약콩코르국내판매돌입순환기치료제막강라인업,http://www.medisobizanews.com/news/articleView.html?idxno=66041
745,2020-01-21,대웅제약심혈관치료제콩코르국내판매‥순환기계강화,http://medipana.com/news/news_viewer.asp?NewsNum=251837&MainKind=A&NewsKind=5&vCount=12&vKind=1
746,2020-01-21,대웅21일040변화,http://www.gokorea.kr/news/articleView.html?idxno=641673
747,2020-01-21,대웅제약순환기계시장최강자입지강화나서심혈관치료제콩코르국내판매돌입,http://www.ftoday.co.kr/news/articleView.html?idxno=113989
748,2020-01-21,대웅심혈관치료약콩코르국내판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90098
749,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020012109323248190
750,2020-01-21,1월21일대웅주식장00012550원,http://nbntv.co.kr/news/view/820569
751,2020-01-21,대웅제약심혈관치료제콩코르국내판권계약순환기계라인업확대,http://www.pressm.kr/news/articleView.html?idxno=27238
752,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.metroseoul.co.kr/news/newsview?newscd=2020012100029
753,2020-01-21,대웅제약심혈관치료제콩코르판매돌입,http://www.skyedaily.com/news/news_view.html?ID=97966
754,2020-01-21,대웅제약한국머크심혈관치료제콩코르국내판매돌입,http://www.fnnews.com/news/202001210944447294
755,2020-01-21,대웅제약한국머크심혈관치료제콩코르국내판매돌입,https://www.sedaily.com/NewsView/1YXQDY3XRP
756,2020-01-21,대웅제약머크社심혈관치료제콩코르국내판매,http://www.newspim.com/news/view/20200121000222
757,2020-01-21,대웅제약심혈관치료제콩코르판매,https://www.paxnetnews.com/articles/56124
758,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.etnews.com/20200121000033
759,2020-01-21,대웅제약심혈관치료제콩코르국내판매개시,http://it.chosun.com/site/data/html_dir/2020/01/21/2020012101099.html
760,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newsis.com/view/?id=NISX20200121_0000894964&cID=13001&pID=13000
761,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.seoulwire.com/news/articleView.html?idxno=267773
762,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=360969
763,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1362944
764,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.dailian.co.kr/news/view/862966?sc=Naver
765,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,https://biz.chosun.com/site/data/html_dir/2020/01/21/2020012101291.html?utm_source=naver&utm_medium=original&utm_campaign=biz
766,2020-01-21,대웅제약주가06962021일074변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=642142
767,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://news.mk.co.kr/newsRead.php?no=67976&year=2020
768,2020-01-21,대웅제약참지마요프로젝트2기교육봉사단창단,http://www.bosa.co.kr/news/articleView.html?idxno=2120223
769,2020-01-21,실시간주식현황대웅제약주가21일현재137000원,http://nbntv.co.kr/news/view/821088
770,2020-01-21,대웅제약심혈관치료제콩코르국내판권획득순환기계약물라인업확대,http://www.paxetv.com/news/articleView.html?idxno=85266
771,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.lawissue.co.kr/view.php?ud=202001211107489363204ead0791_12
772,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59321
773,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=21377
774,2020-01-21,대웅제약종근당할랄인증획득80조원할랄시장뛰어든다,http://www.segyebiz.com/newsView/20200121505797?OutUrl=naver
775,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입한국머크바이오파마와판권계약,http://www.updownnews.co.kr/news/articleView.html?idxno=214023
776,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.insightkorea.co.kr/news/articleView.html?idxno=75756
777,2020-01-21,대웅제약심혈관치료제콩코르국내판매시작,http://www.newslock.co.kr/news/articleView.html?idxno=25209
778,2020-01-21,성공적이라더니대웅제약한올임상3상미충족,https://www.sedaily.com/NewsView/1YXQDPIKKQ
779,2020-01-21,데일리증권대웅003090오후12시05분기준및주체별매매동향,https://www.dailysecu.com/news/articleView.html?idxno=99933
780,2020-01-21,대웅제약심혈관치료제콩코르韓판매돌입순환기계시장경쟁력강화,http://www.segye.com/content/html/2020/01/21/20200121507060.html?OutUrl=naver
781,2020-01-21,대웅제약한국머크바이오파마심혈관질환치료제의국내판매시작,http://www.businesspost.co.kr/BP?command=article_view&num=160446
782,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://newsbrite.net/132933
783,2020-01-21,대웅제약심혈관치료제콩코르판매개시,http://www.koreaittimes.com/news/articleView.html?idxno=95168
784,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.dailymedi.com/detail.php?number=852059&thread=22r05
785,2020-01-21,콩코르판매나선대웅제약순환기계경쟁력강화,http://www.monews.co.kr/news/articleView.html?idxno=207778
786,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.ekn.kr/news/article.html?no=476961
787,2020-01-21,​​대웅제약심혈관치료제콩코르국내판매순환기계시장입지강화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1847616
788,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newswatch.kr/news/articleView.html?idxno=26819
789,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.bosa.co.kr/news/articleView.html?idxno=2120241
790,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.joseilbo.com/news/news_read.php?uid=390860&class=27&grp=
791,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=375570
792,2020-01-21,대웅제약장중하락세전일대비1029이시각거래량9만8479주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001210307&t=NN
793,2020-01-21,대웅제약1029VI발동,https://biz.chosun.com/site/data/html_dir/2020/01/21/2020012101963.html?utm_source=naver&utm_medium=original&utm_campaign=biz
794,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.econovill.com/news/articleView.html?idxno=383347
795,2020-01-21,대웅생명과학몸속순환을잘되게하는건강보조식품침향단선보여,http://www.sporbiz.co.kr/news/articleView.html?idxno=410030
796,2020-01-21,대웅제약오후갑자기11급락에투자자들당황12만원선마저무너지나,http://www.econonews.co.kr/news/articleView.html?idxno=104645
797,2020-01-21,주식한올바이오파마임상평가지표달성못해30가까이하락대웅제약은,http://www.ggilbo.com/news/articleView.html?idxno=739982
798,2020-01-21,대웅제약순환기계시장경쟁력강화,http://www.m-i.kr/news/articleView.html?idxno=674931
799,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.wikileaks-kr.org/news/articleView.html?idxno=75576
800,2020-01-21,대웅제약콩코르국내판매돌입순환기계시장경쟁력강화,http://www.bokuennews.com/news/article.html?no=185890
801,2020-01-21,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.wsobi.com/news/articleView.html?idxno=88954
802,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.wsobi.com/news/articleView.html?idxno=88945
803,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.koreastocknews.com/news/articleView.html?idxno=49825
804,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.medigatenews.com/news/3716867888
805,2020-01-21,표21일코스피주가Top50하락률한올바이오파마주가하락률1위2559내려장마감체시스백광소재대웅제약까뮤이앤씨주가순으로상위기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=99509
806,2020-01-21,뉴스투데이L대웅제약심혈관치료제콩코르국내판매,http://www.news2day.co.kr/147002
807,2020-01-21,한올바이오대웅제약안구건조증신약임상3상실패에주가도출렁,http://www.asiatoday.co.kr/view.php?key=20200121010012263
808,2020-01-21,대웅제약1조클럽가입2020년에는확실하다,http://www.insightkorea.co.kr/news/articleView.html?idxno=75785
809,2020-01-21,대웅제약참지마요프로젝트제2기교육봉사단창단,http://www.newsian.co.kr/news/articleView.html?idxno=39597
810,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newscj.com/news/articleView.html?idxno=701537
811,2020-01-21,대웅제약한국머크바이오파마콩코르품목판권계약,https://www.kpanews.co.kr/article/show.asp?idx=210341&category=D
812,2020-01-21,대웅제약심혈관치료제콩코르국내판매돌입순환기계시장경쟁력강화,http://www.thefirstmedia.net/news/articleView.html?idxno=53387
813,2020-01-22,출근길신약1차평가지표미충족한올바이오파마대웅제약주춤,http://moneys.mt.co.kr/news/mwView.php?no=2020012116458075806
814,2020-01-22,대웅제약심혈관치료제콩코르국내판매돌입,http://www.polinews.co.kr/news/article.html?no=449937
815,2020-01-22,작년블록버스터처방약220개대웅한미최다,http://www.dailypharm.com/Users/News/NewsView.html?ID=261098&REFERER=NP
816,2020-01-22,대웅제약나보타사각턱개선임상3상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=375625
817,2020-01-22,대웅제약임상실패여파로파이프라인가치하락목표가↓삼성증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1847988
818,2020-01-22,대웅22일085변동,http://www.gokorea.kr/news/articleView.html?idxno=643664
819,2020-01-22,증권투자대웅주가22일현재11850원,http://nbntv.co.kr/news/view/822979
820,2020-01-22,대웅제약차별화전략으로글로벌헬스케어그룹도약,http://www.dailysmart.co.kr/news/articleView.html?idxno=21419
821,2020-01-22,대웅제약목표주가하향안구건조증치료제임상지연돼가치하락,http://www.businesspost.co.kr/BP?command=article_view&num=160613
822,2020-01-22,대웅제약전날9급락딛고상승세로급락여파벗어나나,http://www.econonews.co.kr/news/articleView.html?idxno=104785
823,2020-01-22,리포트브리핑대웅제약지연되었을뿐끝이아닌HL036목표가180000원삼성증권,http://www.newspim.com/news/view/20200122000584
824,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.getnews.co.kr/view.php?ud=20200122112003608741d0c69529_16
825,2020-01-22,대웅제약펙수프라잔5천만달러멕시코수출계약,http://www.consumuch.com/news/articleView.html?idxno=47317
826,2020-01-22,대웅제약주가06962022일121변동,http://www.gokorea.kr/news/articleView.html?idxno=644079
827,2020-01-22,대웅제약펙수프라잔5000만달러규모멕시코수출계약,http://www.fnnews.com/news/202001221121528915
828,2020-01-22,1월22일대웅제약주가차트161126000원,http://nbntv.co.kr/news/view/823438
829,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=239866
830,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약582억규모,http://www.ceoscoredaily.com/news/article.html?no=65266
831,2020-01-22,대웅제약펙수프라잔멕시코5천만弗수출계약,http://www.biospectator.com/view/news_view.php?varAtcId=9383
832,2020-01-22,대웅제약차세대항궤양제펙수프라잔글로벌첫진출,http://www.newsis.com/view/?id=NISX20200122_0000896679&cID=13001&pID=13000
833,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결글로벌진출신호탄,http://www.metroseoul.co.kr/news/newsview?newscd=2020012200085
834,2020-01-22,대웅제약펙수프라잔글로벌진출포문멕시코수출계약,http://www.donga.com/news/article/all/20200122/99358867/1
835,2020-01-22,대웅제약펙수프라잔글로벌진출신호탄쏘아올려,http://www.bosa.co.kr/news/articleView.html?idxno=2120321
836,2020-01-22,대웅제약펙수프라잔5000만달러규모중남미수출계약,http://www.newswatch.kr/news/articleView.html?idxno=26875
837,2020-01-22,대웅제약 펙수프라잔Fexuprazan멕시코수출계약,http://www.businesskorea.co.kr/news/articleView.html?idxno=40466
838,2020-01-22,대웅제약펙수프라잔멕시코수출글로벌시장진출신호탄,http://www.medisobizanews.com/news/articleView.html?idxno=66113
839,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://yna.kr/AKR20200122094600017?did=1195m
840,2020-01-22,대웅제약펙수프라잔멕시코수출글로벌시장진출신호탄,http://www.ezyeconomy.com/news/articleView.html?idxno=97286
841,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=261173&REFERER=NP
842,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=375682
843,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=61010
844,2020-01-22,대웅제약멕시코에펙수프라잔수출계약체결,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202001220236&t=NN
845,2020-01-22,보톡스보툴리눔톡신테마오후시황상승률상위종목휴젤824파마리서치프로덕트420대웅제약242등,http://www.gokorea.kr/news/articleView.html?idxno=644445
846,2020-01-22,​​대웅제약멕시코에펙수프라잔5000만달러규모수출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1848199
847,2020-01-22,대웅제약펙수프라잔글로벌진출멕시코5000만달러수출계약,https://biz.chosun.com/site/data/html_dir/2020/01/22/2020012201832.html?utm_source=naver&utm_medium=original&utm_campaign=biz
848,2020-01-22,보톡스보툴리눔톡신테마13시현재주식시황상승률상위종목휴젤34800원839파마리서치프로덕트1400원367대웅제약3000원242상승,http://www.cctvnews.co.kr/news/articleView.html?idxno=158775
849,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약,http://www.insightkorea.co.kr/news/articleView.html?idxno=75802
850,2020-01-22,대웅제약자체개발펙수프라잔글로벌시장진출신호탄,http://medipana.com/news/news_viewer.asp?NewsNum=251919&MainKind=A&NewsKind=5&vCount=12&vKind=1
851,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://newsbrite.net/132986
852,2020-01-22,대웅제약멕시코에펙수프라잔수출계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2020012213364006671
853,2020-01-22,대웅제약멕시코에펙수프라잔수출계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2020012213364006671
854,2020-01-22,대웅제약위식도역류치료제첫해외수출,https://www.nocutnews.co.kr/news/5277312
855,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔으로중남미시장노크,https://www.sedaily.com/NewsView/1YXQUFQAPF
856,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.m-i.kr/news/articleView.html?idxno=675265
857,2020-01-22,대웅제약펙수프라잔멕시코시장진출한다,http://www.etnews.com/20200122000170
858,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://news.mk.co.kr/newsRead.php?no=73654&year=2020
859,2020-01-22,대웅제약멕시코제약사에580억규모펙수프라잔수출,http://www.newspim.com/news/view/20200122000822
860,2020-01-22,대웅제약위식도역류질환치료제를멕시코에5천만달러수출계약,http://www.businesspost.co.kr/BP?command=article_view&num=160674
861,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://www.seoulwire.com/news/articleView.html?idxno=268026
862,2020-01-22,대웅제약위식도역류질환치료제멕시코수출계약,http://www.rapportian.com/news/articleView.html?idxno=122953
863,2020-01-22,대웅제약위식도역류질환치료제펙수프라잔멕시코수출계약”,http://sports.hankooki.com/lpage/economy/202001/sp20200122135556137020.htm
864,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.nbnnews.co.kr/news/articleView.html?idxno=361577
865,2020-01-22,대웅제약펙수프라잔멕시코수출계약약580억원규모,http://inthenews.co.kr/article-32886/
866,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.newstomato.com/ReadNews.aspx?no=947422
867,2020-01-22,대웅제약펙수프라잔멕시코수출계약글로벌시장진출포문,http://www.ajunews.com/view/20200122143335860
868,2020-01-22,대웅제약멕시코목샤8과펙수프라잔수출계약체결,http://news.mk.co.kr/newsRead.php?no=73987&year=2020
869,2020-01-22,대웅제약멕시코에위식도역류질환치료제펙수프라잔수출,http://www.finomy.com/news/articleView.html?idxno=74435
870,2020-01-22,대웅제약위식도역류치료제펙수프라잔첫수출,http://news.mt.co.kr/mtview.php?no=2020012214170510904
871,2020-01-22,대웅제약위식도역류치료제멕시코수출580억원규모,http://it.chosun.com/site/data/html_dir/2020/01/22/2020012202237.html
872,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,https://asiatime.co.kr/news/newsview.php?ncode=1065591714045074
873,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.dailian.co.kr/news/view/863434?sc=Naver
874,2020-01-22,대웅제약펙수프라잔5000만달러규모멕시코수출계약,http://www.asiatoday.co.kr/view.php?key=20200122010012917
875,2020-01-22,대웅제약식도역류질환치료제멕시코에5000만弗규모수출,https://www.hankyung.com/it/article/202001224178i
876,2020-01-22,대웅제약멕시코에5천만달러수출계약,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90127
877,2020-01-22,전세계시장확대나선대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려멕시코수출계약체결,http://www.updownnews.co.kr/news/articleView.html?idxno=214122
878,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.wikileaks-kr.org/news/articleView.html?idxno=75686
879,2020-01-22,대웅제약위식도역류질환치료제로멕시코진출,https://cnbc.sbs.co.kr/article_hub/10000970313?division=NAVER
880,2020-01-22,대웅제약멕시코에위식도역류질환치료제수출계약2020년현지발매목표,http://www.paxetv.com/news/articleView.html?idxno=85368
881,2020-01-22,대웅제약펙수프라잔580억멕시코수출계약글로벌진출신호탄,http://news1.kr/articles/?3823365
882,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.economytalk.kr/news/articleView.html?idxno=203326
883,2020-01-22,대웅제약글로벌시장진출본격화,https://jhealthmedia.joins.com/article/article_view.asp?pno=21313
884,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.dailysmart.co.kr/news/articleView.html?idxno=21480
885,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.ebn.co.kr/news/view/1018998/?sc=naver
886,2020-01-22,대웅제약안구건조증치료제HL0363상1차지표충족실패”,http://www.wikitree.co.kr/main/news_view.php?id=499190
887,2020-01-22,대웅제약펙수프라잔중남미2위멕시코시장진출글로벌진출본격화,http://www.ekn.kr/news/article.html?no=477261
888,2020-01-22,보톡스보툴리눔톡신테마마감시황상승률상위종목휴젤964파마리서치프로덕트696대웅제약242등,http://www.gokorea.kr/news/articleView.html?idxno=645289
889,2020-01-22,대웅제약위식도역류질환치료제5천만달러기술수출,http://www.edaily.co.kr/news/newspath.asp?newsid=03909766625640344
890,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결글로벌시장진출본격화,http://www.newslock.co.kr/news/articleView.html?idxno=25275
891,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59362
892,2020-01-22,대웅제약펙수프라잔멕시코5000만달러수출계약체결,https://www.kpanews.co.kr/article/show.asp?idx=210373&category=D
893,2020-01-22,대웅제약펙수프라잔글로벌시장진출본격화중남미2위시장멕시코수출,http://www.pressm.kr/news/articleView.html?idxno=27280
894,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.wsobi.com/news/articleView.html?idxno=89033
895,2020-01-22,대웅제약펙수프라잔5000만불수출계약,http://www.dailymedi.com/detail.php?number=852119&thread=22r05
896,2020-01-22,대웅제약멕시코목샤8과펙수프라잔수출계약,http://www.shinailbo.co.kr/news/articleView.html?idxno=1244476
897,2020-01-22,대웅제약위식도역류질환신약글로벌진출첫발,http://www.monews.co.kr/news/articleView.html?idxno=207817
898,2020-01-22,대웅제약펙수프라잔멕시코수출계약체결,http://www.bokuennews.com/news/article.html?no=185951
899,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려최고의제약사들과제휴통해전세계시장확대나설것,http://www.segye.com/content/html/2020/01/22/20200122515958.html?OutUrl=naver
900,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.lawissue.co.kr/view.php?ud=202001221833139977204ead0791_12
901,2020-01-22,대웅제약펙수프라잔글로벌시장진출본격화,https://www.paxnetnews.com/articles/56222
902,2020-01-22,대웅제약위식도역류치료제글로벌진출첫신호탄,http://www.econovill.com/news/articleView.html?idxno=383533
903,2020-01-22,대웅제약펙수프라잔멕시코수출계약거점확보,http://www.mhj21.com/127035
904,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.newscj.com/news/articleView.html?idxno=701766
905,2020-01-22,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.polinews.co.kr/news/article.html?no=450102
906,2020-01-23,대웅제약펙수프라잔멕시코수출계약체결중남미두번째큰의약품시장,http://www.thefirstmedia.net/news/articleView.html?idxno=53456
907,2020-01-23,대웅제약펙수프라잔글로벌시장진출신호탄쏘아올려,http://www.medigatenews.com/news/3191661129
908,2020-01-23,★주식인사이드대웅제약주가128000원1월23일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1059257
909,2020-01-23,대웅제약중남미2위규모멕시코의약품시장진출,http://news.heraldcorp.com/view.php?ud=20200123000075
910,2020-01-23,09시18분보톡스보툴리눔톡신테마주오전시황대웅제약디에스케이등이주도,http://nbntv.co.kr/news/view/825086
911,2020-01-23,대웅23일000변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=645591
912,2020-01-23,주간추천종목SK증권대웅제약애경산업아비코전자,http://www.greened.kr/news/articleView.html?idxno=234167
913,2020-01-23,대웅주식종목시세23일현재11900원,http://nbntv.co.kr/news/view/825291
914,2020-01-23,대웅제약주가06962023일157변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=646047
915,2020-01-23,대웅제약종목검색23일현재125500원,http://nbntv.co.kr/news/view/825781
916,2020-01-23,대웅펙수프라잔식도염완치환자유지요법으로임상,http://www.dailypharm.com/Users/News/NewsView.html?ID=261209&REFERER=NP
917,2020-01-23,대웅제약심혈관치료제콩코르국내판매돌입,http://www.newsian.co.kr/news/articleView.html?idxno=39646
918,2020-01-24,대웅00309024일084변화,http://www.gokorea.kr/news/articleView.html?idxno=647568
919,2020-01-24,1월24일대웅주식장08412000원,http://nbntv.co.kr/news/view/827597
920,2020-01-24,대웅제약주식그래프24일현재126000원,http://nbntv.co.kr/news/view/828115
921,2020-01-25,이번주추천종목SK증권대웅제약애경산업등,http://www.asiatoday.co.kr/view.php?key=20200123010013350
922,2020-01-25,주간추천종목현대차BNK금융지주케이엠더블유대웅제약애경산업아비코전자,http://www.lawissue.co.kr/view.php?ud=2020012512044141519817d053b9_12
923,2020-01-26,주간추천종목SK증권대웅제약애경산업아비코전자,http://www.fntimes.com/html/view.php?ud=2020012613282722816c0eb6f11e_18
924,2020-01-26,대웅제약위식도역류질환치료제펙수프라잔멕시코진출,http://weekly.cnbnews.com/news/article.html?no=132257
925,2020-01-27,대웅제약영업활동현금흐름전년비6배개선으로작년잉여현금흐름흑자전환,http://www.ceoscoredaily.com/news/article.html?no=65140
926,2020-01-27,대웅주가00309027일084변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=649389
927,2020-01-27,대웅주식종목27일현재12000원,http://nbntv.co.kr/news/view/830090
928,2020-01-27,대웅제약06962027일079변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=649781
929,2020-01-27,1월27일대웅제약오늘주식장079126000원,http://nbntv.co.kr/news/view/830605
930,2020-01-28,SK증권대웅제약애경산업아비코전자,http://www.seoulfn.com/news/articleView.html?idxno=369934
931,2020-01-28,배당주식대웅주가28일현재11800원,http://nbntv.co.kr/news/view/832249
932,2020-01-28,대웅제약06962028일159변화,http://www.gokorea.kr/news/articleView.html?idxno=651223
933,2020-01-28,대웅제약주가차트28일현재125000원,http://nbntv.co.kr/news/view/832606
934,2020-01-28,바른의료연구소대웅제약이제기한명예훼손업무방해금지가처분소송승소,http://www.medigatenews.com/news/1687535917
935,2020-01-28,바른의료연구소대웅제약명예훼손등소송서승소,http://www.ftoday.co.kr/news/articleView.html?idxno=114132
936,2020-01-28,우루사과대광고의혹대웅제약의료단체상대소송에서패소,http://www.todaykorea.co.kr/news/view.php?no=267769
937,2020-01-29,제약남방시대②대웅제약이인도네시아시장석권한비결,http://www.edaily.co.kr/news/newspath.asp?newsid=01338246625642640
938,2020-01-29,★주식인사이드대웅제약주가124000원1월29일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1059967
939,2020-01-29,대웅00309029일000변화,http://www.gokorea.kr/news/articleView.html?idxno=652697
940,2020-01-29,1월29일대웅주식추천주00011800원,http://nbntv.co.kr/news/view/834445
941,2020-01-29,대웅제약주가29일120변화,http://www.gokorea.kr/news/articleView.html?idxno=653159
942,2020-01-29,주식시세현황대웅제약주가29일현재123000원,http://nbntv.co.kr/news/view/834936
943,2020-01-29,29일데일리증권대웅003090오후12시07분기준및매매동향,https://www.dailysecu.com/news/articleView.html?idxno=103515
944,2020-01-29,29일데일리주가정보대웅제약069620오후12시28분기준외매매동향,https://www.dailysecu.com/news/articleView.html?idxno=103644
945,2020-01-29,법원우루사대웅제약간수치개선임상입증안됐다판결,http://www.wolyo.co.kr/news/articleView.html?idxno=100148
946,2020-01-30,대웅종근당중동시장공략바이오항암제승부수,http://www.dailypharm.com/Users/News/NewsView.html?ID=261168&REFERER=NP
947,2020-01-30,대웅제약나보타수출균주소송자신감UP5년내5천억도전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240019
948,2020-01-30,브랜드평판분석대웅의약품제조및판매,http://www.futurekorea.co.kr/news/articleView.html?idxno=127226
949,2020-01-30,브랜드평판분석대웅제약소비자니즈맞춘홈페이지운영,http://www.futurekorea.co.kr/news/articleView.html?idxno=127227
950,2020-01-30,이인영대웅제약현대자동차등민간차원에서도中국민돕는자발적운동시작”,http://www.kukinews.com/news/article.html?no=742537
951,2020-01-30,★주식인사이드대웅제약주가124500원1월30일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1060257
952,2020-01-30,대웅00309030일042변화,http://www.gokorea.kr/news/articleView.html?idxno=654672
953,2020-01-30,배당주식대웅주가30일현재11900원,http://nbntv.co.kr/news/view/836823
954,2020-01-30,대웅제약나보타출시11개월만에500억원매출달성올해는800억원목표”,http://www.thepublic.kr/news/newsview.php?ncode=1065577131453842
955,2020-01-30,주식증권대웅제약주가30일현재122500원,http://nbntv.co.kr/news/view/837352
956,2020-01-30,30일데일리증권대웅003090오후12시08분기준및매매동향,https://www.dailysecu.com/news/articleView.html?idxno=104130
957,2020-01-30,전승호號대웅제약글로벌도약막아서는소송리스크,http://www.wikileaks-kr.org/news/articleView.html?idxno=76164
958,2020-01-31,★주식인사이드대웅제약주가121500원1월31일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1060581
959,2020-01-31,증권플러스대웅주가31일현재11500원,http://nbntv.co.kr/news/view/839228
960,2020-01-31,대웅00309031일254변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=656642
961,2020-02-03,나보타성공신화대웅제약글로벌시장가시적성과기대,http://www.bosa.co.kr/news/articleView.html?idxno=2120797
962,2020-02-03,대웅1천억대블록버스터중점육성글로벌진출속도,http://www.dailypharm.com/Users/News/NewsView.html?ID=261398&REFERER=NP
963,2020-02-03,대웅제약전승호사장창사이래가장화려한파이프라인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240125
964,2020-02-03,대웅베스트퍼스트신약으로글로벌공략해볼만하다,https://www.kpanews.co.kr/article/show.asp?idx=210538&category=D
965,2020-02-03,★주식인사이드대웅제약주가116000원2월3일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1060976
966,2020-02-03,대웅0030903일175변동,http://www.gokorea.kr/news/articleView.html?idxno=658450
967,2020-02-03,2월3일대웅주식현황26211150원,http://nbntv.co.kr/news/view/841621
968,2020-02-03,대웅제약목표주가하향자체개발보톨리눔톡신유럽출시는기대,http://www.businesspost.co.kr/BP?command=article_view&num=161934
969,2020-02-03,대웅제약0696203일254변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=658896
970,2020-02-03,2월3일대웅제약금일증시085117000원,http://nbntv.co.kr/news/view/842113
971,2020-02-03,리포트브리핑대웅제약반기나보타유럽출시기대목표가170000원NH투자증권,http://www.newspim.com/news/view/20200203000555
972,2020-02-03,3일데일리주식정보대웅003090오후12시11분기준외주식시황,https://www.dailysecu.com/news/articleView.html?idxno=105361
973,2020-02-04,★주식인사이드대웅제약주가117500원2월4일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1061317
974,2020-02-04,2월4일대웅배당주식08811400원,http://nbntv.co.kr/news/view/843916
975,2020-02-04,대웅주가4일088변화,http://www.gokorea.kr/news/articleView.html?idxno=660339
976,2020-02-04,2월4일대웅제약오늘주식시세120500원212,http://nbntv.co.kr/news/view/844426
977,2020-02-04,대웅제약글로벌학술교류나보타프로그램개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=364777
978,2020-02-04,대웅제약나보타프랑스서글로벌학술교류프로그램개최,http://www.ekn.kr/news/article.html?no=479405
979,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼개최,http://www.bosa.co.kr/news/articleView.html?idxno=2120904
980,2020-02-04,대웅제약나보타글로벌학술교류포럼서차별화된제품력전파,http://www.medisobizanews.com/news/articleView.html?idxno=66482
981,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.lawissue.co.kr/view.php?ud=202002041201498801204ead0791_12
982,2020-02-04,대웅제약0696204일169변화,http://www.gokorea.kr/news/articleView.html?idxno=660741
983,2020-02-04,대웅제약제8회나보타에스테틱포럼개최,http://www.polinews.co.kr/news/article.html?no=451376
984,2020-02-04,대웅제약 프랑스에서 나보타에스테틱포럼 개최차별화된제품력전파,http://www.businesskorea.co.kr/news/articleView.html?idxno=40849
985,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.ezyeconomy.com/news/articleView.html?idxno=97610
986,2020-02-04,대웅제약나보타글로벌학술교류프로그램통해제품전파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240221
987,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.newsway.co.kr/news/view?tp=1&ud=2020020411464311429
988,2020-02-04,대웅제약프랑스파리서나보타글로벌학술교류개최자체개발제품알리다,http://www.paxetv.com/news/articleView.html?idxno=85886
989,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.dailysmart.co.kr/news/articleView.html?idxno=21909
990,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼개최,http://www.insightkorea.co.kr/news/articleView.html?idxno=76154
991,2020-02-04,대웅제약프랑스서나보타에스테틱포럼개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=376611
992,2020-02-04,대웅제약佛서나보타글로벌포럼개최차별화된제품력전파,http://www.viva100.com/main/view.php?key=20200204010001192
993,2020-02-04,대웅제약글로벌학술교류행사열어보툴리눔톡신제품경쟁력알려,http://www.businesspost.co.kr/BP?command=article_view&num=162197
994,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼차별화된제품력전파,http://www.newsprime.co.kr/news/article.html?no=492047
995,2020-02-04,대웅제약제8회나보타에스테틱포럼NAFNABOTAAestheticForum개최,http://www.pressm.kr/news/articleView.html?idxno=27428
996,2020-02-04,대웅제약글로벌포럼서보툴리눔톡신제품력전파,http://kormedi.com/?p=1310645
997,2020-02-04,차별화된제품력전파대웅제약나보타파리에서글로벌학술교류프로그램개최,http://www.updownnews.co.kr/news/articleView.html?idxno=214602
998,2020-02-04,대웅제약나보타글로벌학술교류가져차별화된제품력전파,http://www.metroseoul.co.kr/news/newsview?newscd=2020020400112
999,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.g-enews.com/ko-kr/news/article/news_all/20200204140112456869d76442fa_1/article.html
1000,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59512
1001,2020-02-04,대웅제약나보타제8회나보타에스테틱포럼서차별화된제품력전파,http://www.cnbnews.com/news/article.html?no=435855
1002,2020-02-04,대웅제약프랑스서포럼열고나보타경쟁력알려,http://www.koreastocknews.com/news/articleView.html?idxno=50142
1003,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://medipana.com/news/news_viewer.asp?NewsNum=252414&MainKind=A&NewsKind=5&vCount=12&vKind=1
1004,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최7개국의사참가,http://www.etoday.co.kr/news/section/newsview.php?idxno=1852476
1005,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://news.mt.co.kr/mtview.php?no=2020020414352126515
1006,2020-02-04,대웅제약프랑스파리서나보타에스테틱포럼개최,http://news.mk.co.kr/newsRead.php?no=113978&year=2020
1007,2020-02-04,제약오늘대웅제약나보타글로벌학술교류프로그램개최휴메딕스남성비뇨기필러시장진출선언,http://www.sisaon.co.kr/news/articleView.html?idxno=108628
1008,2020-02-04,대웅제약나보타에스테틱포럼개최,http://www.ebn.co.kr/news/view/1020516/?sc=naver
1009,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.wikileaks-kr.org/news/articleView.html?idxno=76575
1010,2020-02-04,대웅제약프랑스에서나보타학술교류프로그램개최,http://www.mediapen.com/news/view/497662
1011,2020-02-04,대웅제약나보타글로벌학술교류프로그램성료,http://www.dailymedi.com/detail.php?number=852472&thread=22r05
1012,2020-02-04,대웅제약나보타글로벌포럼개최신제품경쟁력전파,https://www.youthdaily.co.kr/news/article.html?no=27794
1013,2020-02-04,대웅제약나보타글로벌학술교류프로그램차별화된제품력전파,http://www.newswatch.kr/news/articleView.html?idxno=27300
1014,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.segye.com/content/html/2020/02/04/20200204512057.html?OutUrl=naver
1015,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.medigatenews.com/news/1612547858
1016,2020-02-04,대웅제약프랑스제8회나보타에스테틱포럼서나보타경쟁력알려,http://www.newslock.co.kr/news/articleView.html?idxno=25532
1017,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.dailian.co.kr/news/view/866207?sc=Naver
1018,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://newsbrite.net/133346
1019,2020-02-04,뉴스투데이L대웅제약글로벌학술프로그램에서나보타경쟁력알려,http://www.news2day.co.kr/147668
1020,2020-02-04,대웅제약나보타글로벌학술교류행사서경쟁력강조,http://www.econovill.com/news/articleView.html?idxno=384608
1021,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최차별화된제품력전파,http://www.newscj.com/news/articleView.html?idxno=705267
1022,2020-02-04,대웅제약제8회나보타에스테틱포럼개최차별화된제품력전파,http://www.ftoday.co.kr/news/articleView.html?idxno=114327
1023,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4049962
1024,2020-02-04,대웅제약나보타글로벌학술교류프로그램개최,http://www.thefirstmedia.net/news/articleView.html?idxno=53886
1025,2020-02-05,막바지향하는메디톡스대웅제약균주전쟁ITC심리시작,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1076798
1026,2020-02-05,★주식인사이드대웅제약주가117500원2월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1061625
1027,2020-02-05,대웅제약NAF개최나보타차별점홍보 ,http://www.monews.co.kr/news/articleView.html?idxno=208059
1028,2020-02-05,대웅0030905일000변동,http://www.gokorea.kr/news/articleView.html?idxno=662156
1029,2020-02-05,2월5일대웅주식실시간04311700원,http://nbntv.co.kr/news/view/846152
1030,2020-02-05,대웅제약佛서나보타학술교류프로그램진행,http://www.whosaeng.com/115652
1031,2020-02-05,메디톡스대웅균주戰美심리시작,http://www.ebn.co.kr/news/view/1020673/?sc=naver
1032,2020-02-06,대웅제약도진통제가격인상이지엔6공급가8↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=261534&REFERER=NP
1033,2020-02-06,메디톡스VS대웅제약보툴리눔톡신균주두고美재판진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=376766
1034,2020-02-06,대웅제약vs메디톡스보톡스균주분쟁마무리국면ITC심리中,http://www.greened.kr/news/articleView.html?idxno=235930
1035,2020-02-06,장중수급포착대웅외국인3일연속순매수행진주가128,http://www.newspim.com/news/view/20200206000445
1036,2020-02-06,제약산업대웅제약나보타프랑스파리학술교류포럼개최外,http://www.kukinews.com/news/article.html?no=745658
1037,2020-02-06,대웅제약우루사피로회복효과논란확산식약처제재할까,http://www.wolyo.co.kr/news/articleView.html?idxno=100364
1038,2020-02-06,보톡스보툴리눔톡신테마마감시황상승률상위종목디에스케이994대웅제약343메디톡스300등,http://www.gokorea.kr/news/articleView.html?idxno=662871
1039,2020-02-07,더벨RD힘싣는대웅제약1300억돌파추산,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202002051547301240103057
1040,2020-02-07,★주식인사이드대웅제약주가121500원2월7일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1062161
1041,2020-02-07,돌풍일으킨대웅제약올로맥스신규용량추가,http://medipana.com/news/news_viewer.asp?NewsNum=252549&MainKind=A&NewsKind=5&vCount=12&vKind=1
1042,2020-02-07,대웅제약올래맥스신규용량식약처허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=376987
1043,2020-02-09,대웅제약파리에서나보타포럼개최,http://weekly.cnbnews.com/news/article.html?no=132461
1044,2020-02-09,유유광동대웅제약조직체계수직→수평개편,http://www.dailymedi.com/detail.php?number=852627&thread=22r05
1045,2020-02-10,★주식인사이드대웅제약주가118500원2월10일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1062527
1046,2020-02-11,★주식인사이드대웅제약주가119500원2월11일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1062845
1047,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240461
1048,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.wsobi.com/news/articleView.html?idxno=90161
1049,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.viva100.com/main/view.php?key=20200211010003547
1050,2020-02-11,대웅제약美바이오업계와항암신약공동연구로주가상승세견인중,http://nbntv.co.kr/news/view/846679
1051,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2121250
1052,2020-02-11,대웅제약덴티가드랩국제디자인상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90428
1053,2020-02-11,대웅제약덴티가드랩iF디자인어워드서본상수상,https://asiatime.co.kr/news/newsview.php?ncode=1065572710862219
1054,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://medipana.com/news/news_viewer.asp?NewsNum=252665&MainKind=A&NewsKind=5&vCount=12&vKind=1
1055,2020-02-11,대웅제약맞춤치약덴티가드랩세계3대디자인상수상,http://www.medisobizanews.com/news/articleView.html?idxno=66703
1056,2020-02-11,대웅제약덴티가드랩패키지디자인우수성인정받아iF디자인어워드에서본상수상,http://www.updownnews.co.kr/news/articleView.html?idxno=214908
1057,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.m-i.kr/news/articleView.html?idxno=680400
1058,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=377210
1059,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.dailysmart.co.kr/news/articleView.html?idxno=22185
1060,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.newspim.com/news/view/20200211000277
1061,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://news.mt.co.kr/mtview.php?no=2020021110011762886
1062,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.newsway.co.kr/news/view?tp=1&ud=2020021110110801999
1063,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.seoulwire.com/news/articleView.html?idxno=270484
1064,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://newsbrite.net/133562
1065,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.nbnnews.co.kr/news/articleView.html?idxno=367012
1066,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.metroseoul.co.kr/news/newsview?newscd=2020021100040
1067,2020-02-11,대웅제약덴티가드랩獨iF디자인어워드본상수상,http://news.mk.co.kr/newsRead.php?no=139374&year=2020
1068,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수장,http://www.dailian.co.kr/news/view/867645?sc=Naver
1069,2020-02-11,대웅제약덴티가드랩치약iF디자인어워드본상,http://www.newstomato.com/ReadNews.aspx?no=951224
1070,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.newslock.co.kr/news/articleView.html?idxno=25665
1071,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.ekn.kr/news/article.html?no=480763
1072,2020-02-11,대웅제약 덴티가드랩iF 디자인어워드 본상글로벌디자인우수성인정,http://www.businesskorea.co.kr/news/articleView.html?idxno=41114
1073,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.youthdaily.co.kr/news/article.html?no=28386
1074,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.asiatoday.co.kr/view.php?key=20200211010006060
1075,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.ebn.co.kr/news/view/1021447/?sc=naver
1076,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.cnbnews.com/news/article.html?no=436575
1077,2020-02-11,대웅제약덴티가드랩iF디자인어워드인정받아,http://www.whosaeng.com/115741
1078,2020-02-11,제약워치대웅제약덴티가드랩iF디자인어워드본상外,http://www.newswatch.kr/news/articleView.html?idxno=27606
1079,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.bokuennews.com/news/article.html?no=186518
1080,2020-02-11,대웅제약덴티가드랩디자인상수상,http://www.dailymedi.com/detail.php?number=852718&thread=22r05
1081,2020-02-11,대웅제약맞춤치약덴티가드랩iF디자인어워드본상수상,http://www.insightkorea.co.kr/news/articleView.html?idxno=76334
1082,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.lawissue.co.kr/view.php?ud=202002111219235796204ead0791_12
1083,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1855577
1084,2020-02-11,제약오늘대웅제약덴티가드랩iF디자인어워드본상한미LAPSTripleAgonst글로벌시장게임체인저예고,http://www.sisaon.co.kr/news/articleView.html?idxno=108970
1085,2020-02-11,뉴스투데이L대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.news2day.co.kr/148007
1086,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.donga.com/news/article/all/20200211/99637475/1
1087,2020-02-11,대웅제약맞춤치약덴티가드랩if디자인어워드본상수상글로벌디자인우수성인정,http://www.paxetv.com/news/articleView.html?idxno=86272
1088,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.mediapen.com/news/view/499542
1089,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.pressm.kr/news/articleView.html?idxno=27540
1090,2020-02-11,제약산업대웅제약덴티가드랩iF디자인어워드본상外,http://www.kukinews.com/news/article.html?no=747595
1091,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.wikileaks-kr.org/news/articleView.html?idxno=77125
1092,2020-02-11,대웅제약덴티가드랩글로벌디자인우수성인정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59614
1093,2020-02-11,대웅제약덴티가드랩글로벌서디자인우수성인정,http://www.econovill.com/news/articleView.html?idxno=385286
1094,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드패키지부문수상,http://www.greened.kr/news/articleView.html?idxno=236756
1095,2020-02-11,대웅제약덴티가드랩獨iF디자인어워드본상수상,http://www.ezyeconomy.com/news/articleView.html?idxno=97821
1096,2020-02-11,대웅제약덴티가드랩iF디자인어워드패키지부문본상수상,http://www.g-enews.com/ko-kr/news/article/news_all/2020021116415922869d76442fa_1/article.html
1097,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.thepublic.kr/news/newsview.php?ncode=1065597324432327
1098,2020-02-11,대웅제약덴티가드랩iF디자인어워드서본상,http://www.mhj21.com/127500
1099,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상글로벌디자인우수성인정,http://www.sporbiz.co.kr/news/articleView.html?idxno=414496
1100,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상,http://www.ajunews.com/view/20200211183455499
1101,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.newscj.com/news/articleView.html?idxno=707642
1102,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상영예,https://www.kpanews.co.kr/article/show.asp?idx=210790&category=D
1103,2020-02-11,대웅제약덴티가드랩독일iF디자인어워드본상수상,http://www.thefirstmedia.net/news/articleView.html?idxno=54210
1104,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://www.polinews.co.kr/news/article.html?no=452322
1105,2020-02-11,대웅제약덴티가드랩iF디자인어워드본상수상,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4056432
1106,2020-02-12,★주식인사이드대웅제약주가119500원2월12일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1063184
1107,2020-02-12,대웅제약글로벌신약개발가속화에이디엠코리아와협약,http://medipana.com/news/news_viewer.asp?NewsNum=252704&MainKind=A&NewsKind=5&vCount=12&vKind=1
1108,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.medisobizanews.com/news/articleView.html?idxno=66748
1109,2020-02-12,대웅제약에이디엠코리아와맞손글로벌신약개발가속화,http://www.seoulwire.com/news/articleView.html?idxno=270673
1110,2020-02-12,대웅제약에이디엠코리아와공동임상개발협약,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202002120117&t=NN
1111,2020-02-12,대웅제약에이디엠코리아와협약글로벌신약개발앞당긴다,http://www.mediapen.com/news/view/499716
1112,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.nbnnews.co.kr/news/articleView.html?idxno=367388
1113,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축글로벌신약개발가속화,http://www.viva100.com/main/view.php?key=20200212010003969
1114,2020-02-12,대웅제약국내CRO와손잡고글로벌신약개발가속,http://www.econovill.com/news/articleView.html?idxno=385341
1115,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.newsway.co.kr/news/view?tp=1&ud=2020021209240128860
1116,2020-02-12,대웅제약에이디엠코리아와공동임상개발MOU체결,https://asiatime.co.kr/news/newsview.php?ncode=1065572204511774
1117,2020-02-12,대웅제약에이디엠코리아와글로벌임상연구MOU,http://moneys.mt.co.kr/news/mwView.php?no=2020021209318014082
1118,2020-02-12,대웅제약신약개발가속화공동임상체계구축글로벌진출강화,http://www.newswatch.kr/news/articleView.html?idxno=27674
1119,2020-02-12,대웅제약에이디엠코리아글로벌임상연구개발MOU체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=377360
1120,2020-02-12,대웅제약 에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.businesskorea.co.kr/news/articleView.html?idxno=41176
1121,2020-02-12,대웅제약에이디엠코리아와공동임상개발MOU,http://www.bosa.co.kr/news/articleView.html?idxno=2121323
1122,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.dailian.co.kr/news/view/867963?sc=Naver
1123,2020-02-12,대웅제약에이디엠코리아와공동임상개발MOU체결,http://www.newspim.com/news/view/20200212000365
1124,2020-02-12,대웅제약임상시험기관과MOU임상성공글로벌진출기대,http://news.mt.co.kr/mtview.php?no=2020021209580154181
1125,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축MOU,http://news.mk.co.kr/newsRead.php?no=144071&year=2020
1126,2020-02-12,대웅제약에이디엠코리아공동임상개발체계구축MOU체결글로벌신약개발가속화,http://www.greened.kr/news/articleView.html?idxno=236857
1127,2020-02-12,대웅제약노련한CRO와손잡고신약개발박차,http://www.edaily.co.kr/news/newspath.asp?newsid=02378006625669864
1128,2020-02-12,대웅제약에이디엠코리아글로벌신약개발위해MOU체결,http://www.k-health.com/news/articleView.html?idxno=47224
1129,2020-02-12,대웅제약에이디엠코리아MOU체결신약개발및글로벌진출가속화,http://www.paxetv.com/news/articleView.html?idxno=86307
1130,2020-02-12,대웅제약에이디엠코리아와맞손글로벌신약개발가속화,http://www.ezyeconomy.com/news/articleView.html?idxno=97841
1131,2020-02-12,대웅제약에이디엠코리아글로벌신약개발가속화위한MOU체결,http://www.ekn.kr/news/article.html?no=481010
1132,2020-02-12,대웅제약CRO에이디엠코리아와글로벌신약개발협약,http://www.newsis.com/view/?id=NISX20200212_0000916264&cID=13001&pID=13000
1133,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://newsbrite.net/133613
1134,2020-02-12,대웅제약글로벌신약개발가속화,http://www.ebn.co.kr/news/view/1021629/?sc=naver
1135,2020-02-12,대웅제약ADM코리아와공동임상체계구축,http://www.dailypharm.com/Users/News/NewsView.html?ID=261762&REFERER=NP
1136,2020-02-12,대웅제약에이디엠코리아와공동임상개발협약,http://www.metroseoul.co.kr/news/newsview?newscd=2020021200060
1137,2020-02-12,제약오늘대웅제약에이디엠코리아와공동임상개발체계구축업무협약체결동성제약이지엔신규컬러2종출시,http://www.sisaon.co.kr/news/articleView.html?idxno=109011
1138,2020-02-12,대웅제약에이디엠코리아와MOU공동임상체계구축,http://www.bokuennews.com/news/article.html?no=186557
1139,2020-02-12,대웅제약에이디엠코리아와협약체결글로벌신약개발가속화,http://www.pressm.kr/news/articleView.html?idxno=27569
1140,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.lawissue.co.kr/view.php?ud=20200212111600595204ead0791_12
1141,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축,http://www.newstomato.com/ReadNews.aspx?no=951563
1142,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축업무협약,http://www.insightkorea.co.kr/news/articleView.html?idxno=76369
1143,2020-02-12,대웅제약에이디엠코리아와글로벌임상MOU,https://www.hankyung.com/it/article/202002129894i
1144,2020-02-12,대웅제약공동임상개발체계구축나선다,http://www.monews.co.kr/news/articleView.html?idxno=208238
1145,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.dailysmart.co.kr/news/articleView.html?idxno=22257
1146,2020-02-12,대웅제약에이디엠코리아글로벌임상연구맞손,http://www.newsprime.co.kr/news/article.html?no=492959
1147,2020-02-12,대웅제약에이디엠코리아공동임상MOU체결글로벌신약개발가속화,http://www.newslock.co.kr/news/articleView.html?idxno=25697
1148,2020-02-12,대웅제약에이디엠코리아와손잡고글로벌신약개발가속화,http://www.etnews.com/20200212000211
1149,2020-02-12,대웅제약임상시험인프라구축에이디엠코리아와협약,http://www.100ssd.co.kr/news/articleView.html?idxno=67139
1150,2020-02-12,대웅제약에이디엠코리아와손잡고글로벌신약개발속도,http://www.etoday.co.kr/news/section/newsview.php?idxno=1856108
1151,2020-02-12,2월12일대웅제약실시간증시121000원126,http://nbntv.co.kr/news/view/847270
1152,2020-02-12,대웅제약에이디엠코리아와협약통해글로벌신약개발가속화전략적인공동임상체계구축해임상성공극대화할것,http://www.segye.com/content/html/2020/02/12/20200212510171.html?OutUrl=naver
1153,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59637
1154,2020-02-12,대웅제약임상시험성공높이기위해임상시험수탁기관과손잡아,http://www.businesspost.co.kr/BP?command=article_view&num=163515
1155,2020-02-12,대웅제약에이디엠코리아와의협약을통해글로벌신약개발가속화,http://www.wikileaks-kr.org/news/articleView.html?idxno=77225
1156,2020-02-12,대웅제약전문임상수탁기관과MOU신약개발가속화,http://www.upinews.kr/newsView/upi202002120101
1157,2020-02-12,대웅제약에이디엠코리아와협약체결,http://www.wsobi.com/news/articleView.html?idxno=90335
1158,2020-02-12,대웅제약에이디엠코리아와협약통해글로벌신약개발가속화,http://www.medigatenews.com/news/2282273147
1159,2020-02-12,대웅제약에이디엠코리아와협약체결글로벌신약개발가속화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1367503
1160,2020-02-12,대웅제약에이디엠코리아와MOU체결,http://www.polinews.co.kr/news/article.html?no=452424
1161,2020-02-12,대웅제약에이디엠코리아와공동임상개발체계구축업무협약,http://www.donga.com/news/article/all/20200212/99660098/1
1162,2020-02-12,대웅제약에이디엠코리아와MOU신약개발가속화,http://sports.hankooki.com/lpage/economy/202002/sp20200212163129137020.htm
1163,2020-02-12,시경Today제약대웅에이디엠코리아와협약신약개발가속화외,http://www.meconomynews.com/news/articleView.html?idxno=38060
1164,2020-02-12,대웅제약국내임상시험수탁기관에이디엠코리아와신약개발위한MOU체결,http://www.g-enews.com/ko-kr/news/article/news_all/2020021216494439969d76442fa_1/article.html
1165,2020-02-12,대웅제약에이디엠코리아와MOU글로벌신약개발가속화,http://www.m-i.kr/news/articleView.html?idxno=681108
1166,2020-02-12,대웅제약에이디엠코리아와공동임상개발협약,http://www.newscj.com/news/articleView.html?idxno=708005
1167,2020-02-12,대웅제약에이디엠코리아공동임상체계구축협약,https://www.kpanews.co.kr/article/show.asp?idx=210821&category=D
1168,2020-02-12,대웅제약에이디엠코리아와임상성공극대화협약,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4057520
1169,2020-02-13,대웅제약에이디엠코리아와협약을통해글로벌신약개발가속화,http://www.thefirstmedia.net/news/articleView.html?idxno=54263
1170,2020-02-13,★주식인사이드대웅제약주가119500원2월13일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1063566
1171,2020-02-13,대웅주가13일000변화,http://www.gokorea.kr/news/articleView.html?idxno=665246
1172,2020-02-13,대웅제약주식종목13일현재119000원,http://nbntv.co.kr/news/view/848025
1173,2020-02-13,대웅제약맞춤치약덴티가드랩獨iF디자인어워드본상수상,http://www.munhwa.com/news/view.html?no=2020021301032603000001
1174,2020-02-13,종근당대웅제약셀트리온첫매출1조클럽,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202002130343&t=NNv
1175,2020-02-13,코스피대웅제약2019년매출액1조52억원영업이익314억원,http://news.kmib.co.kr/article/view.asp?arcid=0014236268&code=61141211&cp=nv
1176,2020-02-13,실적속보잠정대웅제약별도20194Q영업이익1354억원,http://www.fntimes.com/html/view.php?ud=2020021317000992465dfa8bd265_18
1177,2020-02-13,대웅제약지난해영업익314억원전년比22증가,http://www.ftoday.co.kr/news/articleView.html?idxno=114587
1178,2020-02-13,대웅제약사상첫1조원돌파나보타임팩타민성장견인,http://news.mt.co.kr/mtview.php?no=2020021317083597665
1179,2020-02-13,대웅제약매출1조52억영업이익314억첫1조클럽가입,http://www.wikileaks-kr.org/news/articleView.html?idxno=77371
1180,2020-02-13,악재불구전승호사장의대웅제약매출1조돌파,http://www.whosaeng.com/115803
1181,2020-02-13,대웅제약작년매출액사상첫1조원돌파,http://www.asiatoday.co.kr/view.php?key=20200213010008225
1182,2020-02-13,대웅제약지난해영업익314원전년비22↑,http://www.ebn.co.kr/news/view/1021896/?sc=naver
1183,2020-02-13,대웅제약2019년별도매출기준사상첫1조원돌파,http://www.koreaittimes.com/news/articleView.html?idxno=95532
1184,2020-02-13,대웅제약별도기준매출사상첫1조원돌파,http://medipana.com/news/news_viewer.asp?NewsNum=252801&MainKind=A&NewsKind=5&vCount=12&vKind=1
1185,2020-02-13,대웅제약지난해매출액1조52억원기록사상첫1조클럽입성,http://www.newslock.co.kr/news/articleView.html?idxno=25770
1186,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.lawissue.co.kr/view.php?ud=202002131726167702204ead0791_12
1187,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.mdtoday.co.kr/mdtoday/index.html?no=377564
1188,2020-02-13,대웅제약지난해매출액1조돌파영업익22↑,http://www.newspim.com/news/view/20200213001426
1189,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.sisaon.co.kr/news/articleView.html?idxno=109127
1190,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.etnews.com/20200213000400
1191,2020-02-13,대웅제약작년영업이익314억원전년동기대비22↑,http://news.mk.co.kr/newsRead.php?no=152153&year=2020
1192,2020-02-13,대웅제약지난해매출1조52억원1조클럽진입성공,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020021317320247085
1193,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.newsway.co.kr/news/view?tp=1&ud=2020021317370087491
1194,2020-02-13,대웅제약별도매출기준첫1조돌파,http://www.dailypharm.com/Users/News/NewsView.html?ID=261833&REFERER=NP
1195,2020-02-13,대웅제약첫매출1조클럽가입,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202002130476&t=NN
1196,2020-02-13,대웅제약지난해영업익314억전년比22증가,http://www.ajunews.com/view/20200213173723741
1197,2020-02-13,대웅제약지난해사상최대실적달성별도기준첫1조돌파,http://www.greened.kr/news/articleView.html?idxno=237166
1198,2020-02-13,대웅제약별도기준매출사상첫1조돌파,http://www.newstomato.com/ReadNews.aspx?no=952114
1199,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://www.medigatenews.com/news/177827538
1200,2020-02-13,대웅제약지난해사상최대실적달성별도기준첫1조돌파,http://www.greened.kr/news/articleView.html?idxno=237166
1201,2020-02-13,대웅제약사상첫매출1조원돌파의약품성장견인,http://sports.hankooki.com/lpage/economy/202002/sp20200213174642137020.htm
1202,2020-02-13,대웅제약사상첫별도매출1조돌파악재불구선방,http://www.newsis.com/view/?id=NISX20200213_0000918611&cID=13001&pID=13000
1203,2020-02-13,대웅제약별도매출기준사상첫1조원돌파전년대비65성장,http://www.consumernews.co.kr/news/articleView.html?idxno=601246
1204,2020-02-13,대웅제약별도기준매출첫1조돌파전문일반약사업고루성장,http://news1.kr/articles/?3842107
1205,2020-02-13,대웅제약별도매출기준사상첫1조원돌파전년대비매출액65상승,http://www.paxetv.com/news/articleView.html?idxno=86454
1206,2020-02-13,대웅제약작년별도매출첫1조원돌파,http://www.biospectator.com/view/news_view.php?varAtcId=9539
1207,2020-02-13,대웅제약사상처음으로1조클럽진입,http://www.mhj21.com/127564
1208,2020-02-13,대웅제약지난해매출별도기준첫1조돌파,https://www.ajunews.com/view/20200213172633712
1209,2020-02-13,대웅제약작년별도기준매출1조돌파,http://www.finomy.com/news/articleView.html?idxno=75128
1210,2020-02-13,대웅제약소송악재에도1조클럽가입,https://www.paxnetnews.com/articles/57065
1211,2020-02-13,대웅제약별도매출기준사상첫1조돌파작년영업익314억,http://www.newsprime.co.kr/news/article.html?no=493251
1212,2020-02-13,대웅제약지난해매출1조원첫돌파나보타수출효과,http://yna.kr/AKR20200213164800017?did=1195m
1213,2020-02-13,대웅제약별도재무제표기준매출사상첫1조원돌파,http://www.seoulfn.com/news/articleView.html?idxno=371906
1214,2020-02-13,대웅제약작년매출1조원첫돌파나보타실적견인,https://view.asiae.co.kr/article/2020021318050464491
1215,2020-02-13,대웅제약사상첫1조클럽진입나보타수출영향,http://www.getnews.co.kr/view.php?ud=2020021318091492707f7a2feaf6_16
1216,2020-02-13,대웅제약작년매출첫1조원돌파영업이익은314억원,http://sports.chosun.com/news/ntype.htm?id=202002140100102170006583&servicedate=20200213
1217,2020-02-13,대웅제약매출사상첫1조원돌파나보타및주력제품성과,http://www.ekn.kr/news/article.html?no=481504
1218,2020-02-13,대웅제약전승호號별도기준매출사상첫1조원돌파,http://www.sisaweek.com/news/articleView.html?idxno=130995
1219,2020-02-13,대웅제약지난해영업익314억전년比22증가,http://biz.newdaily.co.kr/site/data/html/2020/02/13/2020021300249.html
1220,2020-02-13,대웅제약별도기준첫매출1조원돌파,http://www.dailymedi.com/detail.php?number=852820&thread=22r05
1221,2020-02-13,대웅제약사상첫매출1조원돌파영업익22증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240622
1222,2020-02-13,대웅제약사상첫매출1조원돌파쾌거나보다미국진출덕분”,http://www.thepublic.kr/news/newsview.php?ncode=1065603638054432
1223,2020-02-13,대웅제약지난해매출1조52억영업익도소폭성장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1856927
1224,2020-02-13,대웅제약사상첫1조매출달성ETCOTC고른성장,http://www.koreastocknews.com/news/articleView.html?idxno=50437
1225,2020-02-13,대웅제약매출기준사상첫1조원돌파,http://www.nbnnews.co.kr/news/articleView.html?idxno=368160
1226,2020-02-13,대웅제약별도매출기준사상첫1조원돌파1조클럽가입,http://it.chosun.com/site/data/html_dir/2020/02/13/2020021303621.html
1227,2020-02-13,대웅제약작년매출1조52억원영업이익314억원달성별도매출기준사상첫1조원돌파,http://www.thefirstmedia.net/news/articleView.html?idxno=54313
1228,2020-02-13,대웅제약사상첫매출1조돌파,http://www.m-i.kr/news/articleView.html?idxno=681542
1229,2020-02-13,한미종근당대웅매출1조클럽가입빅5제약모두1조돌파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240624
1230,2020-02-13,대웅제약사상첫매출1조원클럽멤버신고합니다,http://www.medisobizanews.com/news/articleView.html?idxno=66834
1231,2020-02-13,대웅제약개별매출기준첫1조원돌파1조클럽가입,https://biz.chosun.com/site/data/html_dir/2020/02/13/2020021303760.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1232,2020-02-13,대웅제약1조클럽가입매출영업이익314억달성,http://www.k-health.com/news/articleView.html?idxno=47273
1233,2020-02-13,대웅제약작년매출1조신기록영업이익은소송비용탓에약간늘어,http://www.businesspost.co.kr/BP?command=article_view&num=163846
1234,2020-02-13,대웅제약연간매출1조원돌파악재불구견고해진수익구조”,http://www.donga.com/news/article/all/20200213/99682098/1
1235,2020-02-13,대웅제약지난해매출1조클럽발디뎠다,http://www.mediapen.com/news/view/500277
1236,2020-02-13,대웅제약매출1조클럽가입오너공백극복,http://www.straightnews.co.kr/news/articleView.html?idxno=66612
1237,2020-02-13,대웅제약별도매출기준사상첫1조돌파나보타美수출성과,http://www.segyebiz.com/newsView/20200213516799?OutUrl=naver
1238,2020-02-13,대웅제약별도매출기준사상첫1조원돌파,http://daily.hankooki.com/lpage/industry/202002/dh20200213203101147950.htm
1239,2020-02-13,대웅제약지난해별도영업익314억원기록전년대비22증가,http://www.econovill.com/news/articleView.html?idxno=385573
1240,2020-02-13,대웅제약2019년매출1조52억별도첫1조원달성,https://www.kpanews.co.kr/article/show.asp?idx=210863&category=D
1241,2020-02-14,대웅제약의뒷심악재뚫고하이킥,http://www.newsclaim.co.kr/news/articleView.html?idxno=3978
1242,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59669
1243,2020-02-14,대웅제약별도매출기준사상첫1조돌파,http://www.bosa.co.kr/news/articleView.html?idxno=2121446
1244,2020-02-14,대웅제약대표품목의빈자리목표가↓대신,http://news.mt.co.kr/mtview.php?no=2020021408111691566
1245,2020-02-14,리포트브리핑대웅제약지금은실적개선보다는불확실성해소가보고싶다목표가140000원한국투자증권,http://www.newspim.com/news/view/20200214000069
1246,2020-02-14,하이로우대웅제약불확실성여전목표가22↓한국투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020021408513272504
1247,2020-02-14,리포트브리핑대웅제약내우외환으로고전하는실적상반기까지감내필요목표가180000원KTB투자증권,http://www.newspim.com/news/view/20200214000140
1248,2020-02-14,★주식인사이드대웅제약주가118000원2월14일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1063897
1249,2020-02-14,바이오시밀러복제바이오의약품테마오전시황상승률상위종목알테오젠310대웅제약299LG화학146등,http://www.gokorea.kr/news/articleView.html?idxno=666315
1250,2020-02-14,대웅제약지난해별도매출기준사상첫1조원돌파,http://www.dailian.co.kr/news/view/868486?sc=Naver
1251,2020-02-14,대웅제약작년사상첫매출1조원돌파영업익은314억원,http://www.viva100.com/main/view.php?key=20200214010004890
1252,2020-02-14,2월14일대웅주식종목04311700원,http://nbntv.co.kr/news/view/848855
1253,2020-02-14,뉴스락주식네비2월14일대웅제약메디톡스소송리스크해소여부가열쇠,http://www.newslock.co.kr/news/articleView.html?idxno=25779
1254,2020-02-14,대웅제약지난해1조52억원매출영업이익314억원달성,http://www.bokuennews.com/news/article.html?no=186648
1255,2020-02-14,대웅제약첫매출1조클럽가입1조52억매출,http://www.newswatch.kr/news/articleView.html?idxno=27756
1256,2020-02-14,대웅제약별도매출기준사상첫1조원돌파나보다미국진출쾌거,http://www.businesskorea.co.kr/news/articleView.html?idxno=41293
1257,2020-02-14,대웅제약미국수출된나보타덕별도매출기준사상첫1조원돌파,http://www.ceoscoredaily.com/news/article.html?no=66125
1258,2020-02-14,주식실시간대웅제약주가14일현재119500원,http://nbntv.co.kr/news/view/849163
1259,2020-02-14,NH투자증권대웅제약실적개선보다불확실성해소가보고싶다”,http://www.econovill.com/news/articleView.html?idxno=385603
1260,2020-02-14,대웅제약별도매출기준사상첫1조원돌파기염RD주요신약파이프라인성과가시화기대,http://www.segye.com/content/html/2020/02/14/20200214504682.html?OutUrl=naver
1261,2020-02-14,대웅제약지난해별도기준사상첫1조원돌파매출액1조52억영업익314억,http://www.g-enews.com/ko-kr/news/article/news_all/2020021410100646369d76442fa_1/article.html
1262,2020-02-14,대웅제약별도매출기준첫1조돌파,http://www.rapportian.com/news/articleView.html?idxno=123405
1263,2020-02-14,리포트브리핑대웅제약소송의피로감만덜어진다면목표가190000원DB금융투자,http://www.newspim.com/news/view/20200214000517
1264,2020-02-14,대웅제약매출1조52억원1조클럽첫가입,http://www.monews.co.kr/news/articleView.html?idxno=208297
1265,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://newsbrite.net/133725
1266,2020-02-14,리포트브리핑대웅제약4Q19Reveiw끝나지않았던알비스영향목표가160000원유안타증권,http://www.newspim.com/news/view/20200214000602
1267,2020-02-14,대웅제약사상첫매출1조클럽가입연구개발성과에주목,http://www.joseilbo.com/news/news_read.php?uid=392051&class=17&grp=
1268,2020-02-14,대웅제약소송비에다위장약매출감소로이익개선은하반기나가능,http://www.businesspost.co.kr/BP?command=article_view&num=163964
1269,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://www.enewstoday.co.kr/news/articleView.html?idxno=1368021
1270,2020-02-14,리포트브리핑대웅제약4Q19Review알비스의공백을감안하면선방NotRated미래에셋대우,http://www.newspim.com/news/view/20200214000698
1271,2020-02-14,대웅알비스공백에도첫매출1조주력제품선전,http://www.dailypharm.com/Users/News/NewsView.html?ID=261850&REFERER=NP
1272,2020-02-14,알비스공백컸나대웅제약4분기어닝쇼크,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1077180
1273,2020-02-14,리포트브리핑대웅제약대표품목의빈자리목표가170000원대신증권,http://www.newspim.com/news/view/20200214000798
1274,2020-02-14,대웅제약사상첫매출1조돌파영업익314억달성,http://www.pressm.kr/news/articleView.html?idxno=27614
1275,2020-02-14,대웅제약메디톡스와진행중인소송의피로감반영”,http://www.wikitree.co.kr/main/news_view.php?id=505412
1276,2020-02-14,대웅제약발암물질악재에도사상첫별도기준매출1조돌파,https://asiatime.co.kr/news/newsview.php?ncode=1065583052352053
1277,2020-02-14,대웅제약별도매출기준사상첫1조원돌파,http://www.wsobi.com/news/articleView.html?idxno=90556
1278,2020-02-14,보툴리눔전쟁승자는대웅제약소송불확실성에올해도실적타격,http://www.whitepaper.co.kr/news/articleView.html?idxno=189236
1279,2020-02-14,대웅제약지난해매출65증가,http://www.kukinews.com/news/article.html?no=749316
1280,2020-02-14,대웅제약지난해영업익314억전년比22↑,http://www.cnbnews.com/news/article.html?no=437077
1281,2020-02-16,종근당대웅첫1조매출제약업계1조클럽사상최다가능성,http://www.viva100.com/main/view.php?key=20200216010005340
1282,2020-02-16,대웅제약별도매출기준매출1조원돌파,http://www.polinews.co.kr/news/article.html?no=452872
1283,2020-02-17,★주식인사이드대웅제약주가119500원2월17일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1064239
1284,2020-02-17,대웅시세보기17일현재11750원,http://nbntv.co.kr/news/view/849993
1285,2020-02-17,대웅제약첫1조매출달성,http://news.heraldcorp.com/view.php?ud=20200217000120
1286,2020-02-17,대웅제약주식추천주17일현재117500원,http://nbntv.co.kr/news/view/850293
1287,2020-02-17,대웅제약알비스판매중단에4분기어닝쇼크빈자리메울수있을까,http://www.greened.kr/news/articleView.html?idxno=237687
1288,2020-02-18,부고김태섭대웅씨티대표이사빙모상,http://www.gasnews.com/news/articleView.html?idxno=90457
1289,2020-02-18,★주식인사이드대웅제약주가117500원2월18일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1064545
1290,2020-02-18,대웅주가18일128변화,http://www.gokorea.kr/news/articleView.html?idxno=668522
1291,2020-02-18,대웅제약06962018일042변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=668762
1292,2020-02-18,보톡스보툴리눔톡신테마오후시황상승률상위종목파마리서치프로덕트1263제테마020대웅제약042등,http://www.gokorea.kr/news/articleView.html?idxno=669260
1293,2020-02-18,보톡스보툴리눔톡신테마마감시황상승률상위종목파마리서치프로덕트1302대웅제약보합세디에스케이080등,http://www.gokorea.kr/news/articleView.html?idxno=669424
1294,2020-02-18,종근당대웅제약1조클럽가입적극적인RD투자결실,http://www.newsprime.co.kr/news/article.html?no=493804
1295,2020-02-19,대웅제약VS메디톡스보툴리눔톡신균주전쟁최후승자는,http://www.g-enews.com/ko-kr/news/article/news_all/20200217105655757269d76442fa_1/article.html
1296,2020-02-19,위탁생산위주파모티딘제제대웅제약자체생산움직임,http://medipana.com/news/news_viewer.asp?NewsNum=252954&MainKind=A&NewsKind=5&vCount=12&vKind=1
1297,2020-02-19,더벨네이버누락바이오텍실투자자는대웅오너,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202002181006112080104935
1298,2020-02-19,★주식인사이드대웅제약주가118500원2월19일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1064870
1299,2020-02-19,대웅19일043변화,http://www.gokorea.kr/news/articleView.html?idxno=669601
1300,2020-02-19,비즈헬스대웅VS메디톡스의보툴리눔톡신균주전쟁올해안에끝난다,http://www.bizwnews.com/news/articleView.html?idxno=13071
1301,2020-02-19,보령듀카로출시한미대웅일동제약과경쟁,http://www.dailymedi.com/detail.php?number=852990&thread=22r05
1302,2020-02-19,노갑용전대웅제약부사장휴먼스헬스케어설립,http://www.bosa.co.kr/news/articleView.html?idxno=2121738
1303,2020-02-19,잠정실적대웅작년4Q매출액3523억80영업이익196억81연결,https://www.hankyung.com/finance/article/202002197941L
1304,2020-02-19,대웅작년영업익1075억전년比254↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03575206625672160
1305,2020-02-19,공시대웅지난해영업익1075억원전년비254↑,http://www.newsway.co.kr/news/view?tp=1&ud=2020021915063153981
1306,2020-02-19,공시대웅지난해영업익1075억원전년비254↑,http://www.newsway.co.kr/news/view?tp=1&ud=2020021915062816230
1307,2020-02-19,잠정실적대웅제약4Q실적매출액2876억원전년동기대비56증가영업이익73감소연결,http://www.newspim.com/news/view/20200219000945
1308,2020-02-19,잠정실적대웅제약3년중가장낮은영업이익매출액은직전대비68↑연결,https://www.hankyung.com/finance/article/202002198034L
1309,2020-02-19,대웅제약작년영업익446억전년비819↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859123
1310,2020-02-19,대웅지난해영업익1075억전년비254↑,http://news.heraldcorp.com/view.php?ud=20200219000739
1311,2020-02-19,대웅제약지난해영업익447억전년비819↑,http://news.heraldcorp.com/view.php?ud=20200219000740
1312,2020-02-19,대웅제약작년영업익446억전년比819↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03706406625672160
1313,2020-02-19,공시대웅제약지난해영업익447억원전년비819↑,http://www.newsway.co.kr/news/view?tp=1&ud=2020021915341276606
1314,2020-02-19,대웅지난해영업익1075억전년比254↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=378074
1315,2020-02-19,실적발표토비스삼일기업공사대웅메디파트너생명공학,http://www.businesspost.co.kr/BP?command=article_view&num=164637
1316,2020-02-19,대웅제약작년영업익446억전년비819↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859155
1317,2020-02-19,실적발표대웅제약화천기공브릿지바이오코오롱플라스틱,http://www.businesspost.co.kr/BP?command=article_view&num=164651
1318,2020-02-19,대웅제약작년영업익447억전년비819↑,http://www.asiatoday.co.kr/view.php?key=20200219010011464
1319,2020-02-19,대웅제약지난해영업익446억8709만원전년比819증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=378088
1320,2020-02-19,대웅제약라니티딘나보타소송한올3상등계속된악재에도흑자전환성공,http://www.medigatenews.com/news/627445548
1321,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240826
1322,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.businesskorea.co.kr/news/articleView.html?idxno=41593
1323,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.newspim.com/news/view/20200220000100
1324,2020-02-20,대웅제약나보타브라질판매허가,http://www.hankookilbo.com/news/npath/202002200930790267?did=NA
1325,2020-02-20,대웅제약보톡스나보타중남미최대브라질시장뚫었다,http://www.edaily.co.kr/news/newspath.asp?newsid=01823686625672488
1326,2020-02-20,대웅제약나보타중남미최대시장브라질진출,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859390
1327,2020-02-20,★주식인사이드대웅제약주가120000원2월20일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1065083
1328,2020-02-20,게시판대웅제약나보타브라질품목허가획득,http://yna.kr/AKR20200220039700017?did=1195m
1329,2020-02-20,대웅제약나보타브라질품목허가중남미최대시장진출,http://www.medisobizanews.com/news/articleView.html?idxno=67043
1330,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.newsway.co.kr/news/view?tp=1&ud=2020022009142859244
1331,2020-02-20,대웅제약나보타브라질서품목허가획득,https://asiatime.co.kr/news/newsview.php?ncode=1065571171042938
1332,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.m-i.kr/news/articleView.html?idxno=683366
1333,2020-02-20,대웅제약나보타브라질진출중남미공략나서,http://moneys.mt.co.kr/news/mwView.php?no=2020022009158091431
1334,2020-02-20,대웅제약나보타브라질서품목허가취득,http://www.mhj21.com/127758
1335,2020-02-20,대웅제약브라질서나보타품목허가획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020022009214443360
1336,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.metroseoul.co.kr/news/newsview?newscd=2020022000010
1337,2020-02-20,대웅제약보툴리눔톡신나보타브라질품목허가승인,http://www.consumuch.com/news/articleView.html?idxno=47660
1338,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.enewstoday.co.kr/news/articleView.html?idxno=1369097
1339,2020-02-20,대웅제약브라질서나보타시판허가받아,http://news.mk.co.kr/newsRead.php?no=174464&year=2020
1340,2020-02-20,대웅제약나보타브라질서품목허가획득중남미최대시장진출,http://www.greened.kr/news/articleView.html?idxno=238150
1341,2020-02-20,대웅제약나보타브라질서품목허가획득중남미시장입지강화,http://www.newslock.co.kr/news/articleView.html?idxno=25914
1342,2020-02-20,대웅제약나보타중남미최대시장브라질품목허가획득,http://www.ftoday.co.kr/news/articleView.html?idxno=114724
1343,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.ezyeconomy.com/news/articleView.html?idxno=98101
1344,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.biospectator.com/view/news_view.php?varAtcId=9585
1345,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.etnews.com/20200220000037
1346,2020-02-20,대웅제약나보타중남미시장공략브라질품목허가획득,http://www.newsprime.co.kr/news/article.html?no=494069
1347,2020-02-20,대웅제약나보타중남미최대브라질품목허가획득,http://www.medigatenews.com/news/832748802
1348,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.dailian.co.kr/news/view/869789?sc=Naver
1349,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.ekn.kr/news/article.html?no=482712
1350,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.mediapen.com/news/view/501909
1351,2020-02-20,대웅제약나보타중남미최대시장진출,http://www.nbnnews.co.kr/news/articleView.html?idxno=370120
1352,2020-02-20,대웅제약나보타중남미시장공략본격화,http://www.koreastocknews.com/news/articleView.html?idxno=50676
1353,2020-02-20,대웅전일대비513상승중최근주가반등흐름,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202002200213&t=NN
1354,2020-02-20,대웅제약나보타브라질허가중남미최대시장진출,http://www.newsis.com/view/?id=NISX20200220_0000925221&cID=13001&pID=13000
1355,2020-02-20,대웅제약나보타중남미최대시장브라질서품목허가,http://www.consumernews.co.kr/news/articleView.html?idxno=601472
1356,2020-02-20,대웅제약나보타브라질품목허가중남미최대시장진출,http://www.newstomato.com/ReadNews.aspx?no=953474
1357,2020-02-20,대웅제약나보타브라질시장진출,http://www.monews.co.kr/news/articleView.html?idxno=208432
1358,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미시장진출,http://www.asiatoday.co.kr/view.php?key=20200220010011852
1359,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.rapportian.com/news/articleView.html?idxno=123532
1360,2020-02-20,대웅상승출발후현재는812↑긴조정끝내고골든크로스발생,http://www.newspim.com/news/view/20200220000441
1361,2020-02-20,대웅940상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/02/20/2020022001701.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1362,2020-02-20,대웅제약나보타브라질에품목허가획득중남미시장입지강화계획,http://www.paxetv.com/news/articleView.html?idxno=86741
1363,2020-02-20,특징주대웅12450원20일10시45분등락률641,http://www.getnews.co.kr/view.php?ud=202002201046391340c20b95ebe0_16
1364,2020-02-20,대웅제약나보타브라질품목허가획득,https://www.paxnetnews.com/articles/57320
1365,2020-02-20,대웅제약나보타중남미최대시장브라질진출,http://www.sisaweek.com/news/articleView.html?idxno=131151
1366,2020-02-20,fnRASSI대웅003090현재1068↑,http://www.fnnews.com/news/202002201055138313
1367,2020-02-20,대웅제약나보타브라질허가획득중남미최대시장진출,http://www.viva100.com/main/view.php?key=20200220010007193
1368,2020-02-20,대웅제약나보타브라질품목허가획득중남미시장진출,http://news.mt.co.kr/mtview.php?no=2020022011062758448
1369,2020-02-20,대웅제약나보타로중남미시장공략본격화,https://jhealthmedia.joins.com/article/article_view.asp?pno=21413
1370,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.ebn.co.kr/news/view/1022804/?sc=naver
1371,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=378149
1372,2020-02-20,대웅제약보툴리눔톡신제제나보타브라질진출,https://cnbc.sbs.co.kr/article_hub/10000973606?division=NAVER
1373,2020-02-20,대웅제약나보타중남미최대시장브라질서품목허가획득,http://www.insightkorea.co.kr/news/articleView.html?idxno=76715
1374,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.ceoscoredaily.com/news/article.html?no=66324
1375,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2121800
1376,2020-02-20,장중수급포착대웅외국인기관동시순매수주가684,http://www.newspim.com/news/view/20200220000577
1377,2020-02-20,대웅제약나보타브라질진출중남미본격공략,http://www.upinews.kr/newsView/upi202002200058
1378,2020-02-20,대웅제약브라질에서보툴리눔톡신품목허가얻어중남미공략,http://www.businesspost.co.kr/BP?command=article_view&num=164774
1379,2020-02-20,대웅제약보톡스나보타중남미시장진출본격화브라질시판허가,http://www.ntoday.co.kr/news/articleView.html?idxno=70985
1380,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.lawissue.co.kr/view.php?ud=202002201320482770204ead0791_12
1381,2020-02-20,제약업종오후시황상승률상위종목메드팩토733대웅513티움바이오438등,http://www.gokorea.kr/news/articleView.html?idxno=671489
1382,2020-02-20,대웅제약나보타브라질품목허가획득중남미공략박차,http://www.donga.com/news/article/all/20200220/99793600/1
1383,2020-02-20,제약오늘대웅제약나보타브라질품목허가획득으로중남미최대시장진출유한양행아임뉴런社플랫폼기술활용한신약개발공동연구진행,http://www.sisaon.co.kr/news/articleView.html?idxno=109375
1384,2020-02-20,대웅제약나보타브라질서품목허가획득중남미최대시장진출,http://www.cnbnews.com/news/article.html?no=437663
1385,2020-02-20,대웅제약자체개발보툴리눔톡신제제나보타브라질품목허가획득,http://www.pressm.kr/news/articleView.html?idxno=27707
1386,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.updownnews.co.kr/news/articleView.html?idxno=215322
1387,2020-02-20,대웅제약나보타중남미시장본격공략브라질서품목허가획득,http://kpenews.com/View.aspx?No=755293
1388,2020-02-20,대웅제약나보타브라질품목허가획득중남미시장진출,http://www.dailysmart.co.kr/news/articleView.html?idxno=22636
1389,2020-02-20,대웅제약나보타브라질품목허가획득,http://www.dailymedi.com/detail.php?number=853042&thread=22r05
1390,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출미용적응증치료적응증동시허가획득으로빠른성장기대,http://www.segye.com/content/html/2020/02/20/20200220512794.html?OutUrl=naver
1391,2020-02-20,대웅제약브라질서나보타품목허가획득,http://www.seoulfn.com/news/articleView.html?idxno=372573
1392,2020-02-20,국내보톡스4社희비대웅휴온스휴젤활짝메디톡스울상,http://www.viva100.com/main/view.php?key=20200220010007098
1393,2020-02-20,대웅제약브라질서나보타판매허가획득,http://www.finomy.com/news/articleView.html?idxno=75338
1394,2020-02-20,제약업종마감시황상승률상위종목메드팩토1133대웅684티움바이오677등,http://www.gokorea.kr/news/articleView.html?idxno=671558
1395,2020-02-20,대웅제약보툴리눔톡신나보타브라질진출,https://view.asiae.co.kr/article/2020022016163400270
1396,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장,http://www.econovill.com/news/articleView.html?idxno=386166
1397,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.thefirstmedia.net/news/articleView.html?idxno=54618
1398,2020-02-20,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://newsbrite.net/133951
1399,2020-02-20,대웅제약나보타글로벌영토확장에박차브라질서품목허가획득,http://www.g-enews.com/ko-kr/news/article/news_all/20200220165102389369d76442fa_1/article.html
1400,2020-02-20,대웅제약나보타브라질품목허가획득중남미최대시장진출,http://www.newscj.com/news/articleView.html?idxno=710544
1401,2020-02-21,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.polinews.co.kr/news/article.html?no=453454
1402,2020-02-21,오늘기업사람MH에탄올주LS대웅제약서울옥션현대차,https://cnbc.sbs.co.kr/article_hub/10000973735?division=NAVER
1403,2020-02-21,★주식인사이드대웅제약주가118500원2월21일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1065411
1404,2020-02-21,대웅제약우루사지난해매출882억원역대최대,http://www.ceoscoredaily.com/news/article.html?no=66368
1405,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://medipana.com/news/news_viewer.asp?NewsNum=253083&MainKind=A&NewsKind=5&vCount=12&vKind=1
1406,2020-02-21,대웅제약우루사3년연속역대최고매출경신,http://www.consumuch.com/news/articleView.html?idxno=47678
1407,2020-02-21,대웅제약우루사지난해882억원어치팔렸다,http://www.econovill.com/news/articleView.html?idxno=386203
1408,2020-02-21,대웅제약우루사3년연속최고매출882억원기록,http://moneys.mt.co.kr/news/mwView.php?no=2020022109258024397
1409,2020-02-21,대웅제약우루사지난해매출882억3년연속최대치,http://www.etoday.co.kr/news/section/newsview.php?idxno=1859999
1410,2020-02-21,대웅제약우루사작년882억매출3년연속최대,http://www.edaily.co.kr/news/newspath.asp?newsid=01886006625672816
1411,2020-02-21,대웅제약우루사폭풍성장3년연속최고매출기록경신,http://www.medisobizanews.com/news/articleView.html?idxno=67089
1412,2020-02-21,대웅제약대표품목우루사3년연속최고매출기록경신,http://daily.hankooki.com/lpage/ittech/202002/dh20200221093528145630.htm
1413,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240883
1414,2020-02-21,대웅우루사최고매출3년연속갱신,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90628
1415,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.bosa.co.kr/news/articleView.html?idxno=2121860
1416,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newspim.com/news/view/20200221000255
1417,2020-02-21,대웅제약주가21일042변화,http://www.gokorea.kr/news/articleView.html?idxno=671815
1418,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.mediapen.com/news/view/502214
1419,2020-02-21,대웅제약우루사매출882억원최고매출기록경신,http://www.viva100.com/main/view.php?key=20200221010007566
1420,2020-02-21,대웅제약우루사3년연속최고매출갱신,https://asiatime.co.kr/news/newsview.php?ncode=1065572164488824
1421,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newsway.co.kr/news/view?tp=1&ud=2020022109535678573
1422,2020-02-21,대웅제약우루사3년연속매출기록경신,http://www.ebn.co.kr/news/view/1022963/?sc=naver
1423,2020-02-21,대웅제약우루사매출882억3년연속최고기록경신,http://www.newsis.com/view/?id=NISX20200221_0000926759&cID=13001&pID=13000
1424,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.dailysmart.co.kr/news/articleView.html?idxno=22658
1425,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.enewstoday.co.kr/news/articleView.html?idxno=1369450
1426,2020-02-21,대웅제약우루사3년연속역대최고매출경신,http://www.koreastocknews.com/news/articleView.html?idxno=50737
1427,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.m-i.kr/news/articleView.html?idxno=683796
1428,2020-02-21,대웅제약의효자우루사3년연속최고매출,http://www.mhj21.com/127810
1429,2020-02-21,대웅제약우루사지난해매출882억3년연속최고기록,http://www.mdtoday.co.kr/mdtoday/index.html?no=378269
1430,2020-02-21,대웅제약우루사3년연속최고매출기록경신900억원달성눈앞,http://www.ezyeconomy.com/news/articleView.html?idxno=98148
1431,2020-02-21,대웅제약우루사지난해매출882억원3년연속최고기록경신,http://www.metroseoul.co.kr/news/newsview?newscd=2020022100023
1432,2020-02-21,대웅제약우루사3년연속최고매출기록갈아치워조제용연매출첫500억돌파,http://www.greened.kr/news/articleView.html?idxno=238361
1433,2020-02-21,대웅제약우루사매출일신우일신,http://www.whosaeng.com/115948
1434,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.dailian.co.kr/news/view/870165?sc=Naver
1435,2020-02-21,대웅제약우루사2019년매출800억원돌파3년연속최고매출경신,http://www.sisaweek.com/news/articleView.html?idxno=131186
1436,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.nbnnews.co.kr/news/articleView.html?idxno=370594
1437,2020-02-21,대웅제약우루사매출882억3년연속최고매출,http://news.mt.co.kr/mtview.php?no=2020022110251284679
1438,2020-02-21,뉴스투데이L대웅제약우루사3년연속최고매출기록조제용연간매출최초500억원돌파,http://www.news2day.co.kr/148536
1439,2020-02-21,대웅제약우루사작년매출882억달성,http://www.rapportian.com/news/articleView.html?idxno=123566
1440,2020-02-21,대웅제약우루사3년연속최고매출경신전년대비11↑,http://www.businesskorea.co.kr/news/articleView.html?idxno=41654
1441,2020-02-21,대웅제약우루사전년대비약11성장최고매출기록,http://www.pressm.kr/news/articleView.html?idxno=27732
1442,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.lawissue.co.kr/view.php?ud=20200221112342302204ead0791_12
1443,2020-02-21,대웅제약간판제품우루사공격적마케팅으로3년연속최고매출,http://www.medigatenews.com/news/1915290430
1444,2020-02-21,대웅제약우루사3년연속역대최고매출기록경신,http://www.newsprime.co.kr/news/article.html?no=494222
1445,2020-02-21,대웅제약우루사연매출800억돌파,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1077493
1446,2020-02-21,대웅제약우루사매출최고치경신900억원눈앞,http://sports.hankooki.com/lpage/economy/202002/sp20200221131242137020.htm
1447,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newslock.co.kr/news/articleView.html?idxno=25956
1448,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.bokuennews.com/news/article.html?no=186899
1449,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59781
1450,2020-02-21,대웅제약우루사작년매출882억신기록,http://www.finomy.com/news/articleView.html?idxno=75369
1451,2020-02-21,대웅제약우루사파워브랜드입증3년연속두자릿수성장률,http://www.seoulfn.com/news/articleView.html?idxno=372718
1452,2020-02-21,대웅제약우루사매출신기록3년째달성전승호처방영역확대,http://www.businesspost.co.kr/BP?command=article_view&num=165005
1453,2020-02-21,대웅제약우루사작년882억원어치팔려3년연속최대매출기록경신,http://news.mk.co.kr/newsRead.php?no=181285&year=2020
1454,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://newsbrite.net/133995
1455,2020-02-21,대웅제약간판제품우루사3년연속최고매출경신약882억원기록경신,http://www.paxetv.com/news/articleView.html?idxno=86809
1456,2020-02-21,대웅제약우루사지난해매출882억3년연속최고매출기록경신,http://www.cnbnews.com/news/article.html?no=437781
1457,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.sisaon.co.kr/news/articleView.html?idxno=109436
1458,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.wikileaks-kr.org/news/articleView.html?idxno=78126
1459,2020-02-21,대웅제약우루사작년매출882억3년연속최고매출경신,http://www.asiatoday.co.kr/view.php?key=20200221010012711
1460,2020-02-21,대웅제약우루사3년연속최고매출기록경신최초500억돌파,http://www.newswatch.kr/news/articleView.html?idxno=28022
1461,2020-02-21,대웅우루사지난해매출800억원돌파,http://www.shinailbo.co.kr/news/articleView.html?idxno=1252443
1462,2020-02-21,대웅제약우루사작년매출882억3년연속최대,http://inthenews.co.kr/article-36647/
1463,2020-02-21,대웅제약우루사3년연속최고매출기록경신조제용우루사연간매출최초500억원돌파,http://www.segye.com/content/html/2020/02/21/20200221513137.html?OutUrl=naver
1464,2020-02-21,대웅제약우루사3년연속매출신기록경신900억고지눈앞,http://www.donga.com/news/article/all/20200221/99815438/1
1465,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.updownnews.co.kr/news/articleView.html?idxno=215384
1466,2020-02-21,대웅제약우루사2019년매출882억3년째경신,http://health.chosun.com/site/data/html_dir/2020/02/21/2020022102830.html
1467,2020-02-21,대웅제약우루사3년연속최고매출기록경신,https://www.vop.co.kr/A00001469967.html
1468,2020-02-21,대웅제약우루사3년연속최고매출기록경신,http://www.newscj.com/news/articleView.html?idxno=710876
1469,2020-02-21,대웅제약우루사3년연속최고매출기록경신,https://www.kpanews.co.kr/article/show.asp?idx=211054&category=D
1470,2020-02-22,유한종근당대웅제약등대구경북재택근무전환,http://www.dailymedi.com/detail.php?number=853101&thread=22r05
1471,2020-02-22,대웅제약우루사작년매출882억원전년대비약11성장,http://www.thefirstmedia.net/news/articleView.html?idxno=54725
1472,2020-02-23,대웅제약우루사3년연속최고매출기록경신,http://www.polinews.co.kr/news/article.html?no=453651
1473,2020-02-23,대웅제약우루사3년연속최고매출기록경신,http://www.segyebiz.com/newsView/20200223503868?OutUrl=naver
1474,2020-02-24,★주식인사이드대웅제약주가116000원2월24일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1065827
1475,2020-02-24,대웅제약의료진대상WECARE캠페인시행위질환치료정보제공,http://www.viva100.com/main/view.php?key=20200224010008337
1476,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.m-i.kr/news/articleView.html?idxno=684364
1477,2020-02-24,대웅제약의료진대상WECARE캠페인시행위질환치료정보제공,http://www.dailian.co.kr/news/view/870597?sc=Naver
1478,2020-02-24,대웅제약의료진대상WECARE캠페인시행위질환치료정보제공,http://www.pressm.kr/news/articleView.html?idxno=27747
1479,2020-02-24,대웅제약위질환치료정보제공온라인캠페인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90692
1480,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240945
1481,2020-02-24,대웅제약의료진대상WECARE캠페인위장관손상예방정보제공,http://www.medisobizanews.com/news/articleView.html?idxno=67142
1482,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.nbnnews.co.kr/news/articleView.html?idxno=371257
1483,2020-02-24,대웅제약의료진대상위케어캠페인진행위질환치료온라인강의제공,http://www.greened.kr/news/articleView.html?idxno=238692
1484,2020-02-24,대웅제약위질환치료정보WECARE캠페인시행,http://www.dailysmart.co.kr/news/articleView.html?idxno=22714
1485,2020-02-24,대웅제약의료진대상위케어캠페인진행위질환치료온라인강의제공,http://www.greened.kr/news/articleView.html?idxno=238692
1486,2020-02-24,대웅제약NSAIDs로인한위질환치료정보공유캠페인나서,http://news.mk.co.kr/newsRead.php?no=187998&year=2020
1487,2020-02-24,대웅제약06962024일298변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=672979
1488,2020-02-24,재계톡톡소송전한창인대웅메디톡스실적시즌맞아웃고울고,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=188142
1489,2020-02-24,대웅의료진대상WECARE캠페인,http://www.dailymedi.com/detail.php?number=853155&thread=22r05
1490,2020-02-24,대웅제약의료진대상WECARE캠페인진행,http://www.bosa.co.kr/news/articleView.html?idxno=2121960
1491,2020-02-24,대웅제약의료진에위질환치료정보제공하는WECARE캠페인,http://www.insightkorea.co.kr/news/articleView.html?idxno=77091
1492,2020-02-24,대웅제약WECARE캠페인통해위질환치료정보제공,http://www.newspim.com/news/view/20200224000287
1493,2020-02-24,대웅제약의료진대상WECARE캠페인실시,http://medipana.com/news/news_viewer.asp?NewsNum=253152&MainKind=A&NewsKind=5&vCount=12&vKind=1
1494,2020-02-24,대웅제약의료진대상위케어캠페인실시,https://asiatime.co.kr/news/newsview.php?ncode=1065573532766848
1495,2020-02-24,대웅제약의료진대상WECARE캠페인위질환치료정보공유,http://www.asiatoday.co.kr/view.php?key=20200224010013614
1496,2020-02-24,대웅제약의료진대상위질환치료정보제공,http://news.mt.co.kr/mtview.php?no=2020022410260358524
1497,2020-02-24,대웅제약의료진대상위질환치료정보온라인세미나,http://www.etoday.co.kr/news/section/newsview.php?idxno=1860797
1498,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://newsbrite.net/134033
1499,2020-02-24,대웅제약WECARE캠페인의료진대상위치료정보제공,http://www.medigatenews.com/news/2623427131
1500,2020-02-24,대웅제약WECARE캠페인전개,http://www.monews.co.kr/news/articleView.html?idxno=208510
1501,2020-02-24,대웅제약우루사3년연속최고매출기록경신,http://www.monews.co.kr/news/articleView.html?idxno=208505
1502,2020-02-24,대웅제약오늘부터의료진대상WECARE캠페인진행,http://www.ekn.kr/news/article.html?no=483436
1503,2020-02-24,뉴스투데이L대웅제약WECARE캠페인으로의료진대상위질환치료정보제공,http://www.news2day.co.kr/148600
1504,2020-02-24,대웅제약WECARE캠페인통해위질환치료정보제공,http://www.ebn.co.kr/news/view/1023232/?sc=naver
1505,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.bokuennews.com/news/article.html?no=186971
1506,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.updownnews.co.kr/news/articleView.html?idxno=215421
1507,2020-02-24,대웅제약의료진대상위질환치료온라인세미나,http://www.mediapen.com/news/view/502870
1508,2020-02-24,대웅제약 의료진대상4주간 WECARE 캠페인 통해위질환치료정보제공,http://www.newslock.co.kr/news/articleView.html?idxno=25992
1509,2020-02-24,대웅제약의료진대상WECARE캠페인위질환치료정보제공,http://www.metroseoul.co.kr/article/20200224500190
1510,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59798
1511,2020-02-24,대웅제약의료진대상WECARE캠페인실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=378435
1512,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.businesskorea.co.kr/news/articleView.html?idxno=41746
1513,2020-02-24,대웅제약의료진대상WECARE캠페인위질환치료정보제공,http://www.ezyeconomy.com/news/articleView.html?idxno=98221
1514,2020-02-24,대웅등5개제약바이오혁신성실용화연계우수전문가포상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240969
1515,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.thepublic.kr/news/newsview.php?ncode=1065579447826599
1516,2020-02-24,대웅제약의료진대상최신위질환치료정보제공,http://www.donga.com/news/article/all/20200224/99846564/1
1517,2020-02-24,대웅제약WECARE캠페인위질환치료정보제공,http://www.whosaeng.com/115980
1518,2020-02-24,대웅제약의료진대상최신위질환치료정보제공위케어캠페인시행,http://www.newswatch.kr/news/articleView.html?idxno=28062
1519,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.lawissue.co.kr/view.php?ud=202002241427379480204ead0791_12
1520,2020-02-24,제약오늘대웅제약의료진대상WECARE캠페인시행동성제약모발건강도움주는프로비올출시,http://www.sisaon.co.kr/news/articleView.html?idxno=109505
1521,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.cnbnews.com/news/article.html?no=437951
1522,2020-02-24,대웅제약의료진대상WECARE캠페인실시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1370050
1523,2020-02-24,대웅제약의료진대상위케어캠페인시행약제로인한위질환치료정보제공,http://www.paxetv.com/news/articleView.html?idxno=86933
1524,2020-02-24,대웅제약위장관손상최신지견공유WECARE캠페인시행,http://www.iminju.net/news/articleView.html?idxno=52171
1525,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.thefirstmedia.net/news/articleView.html?idxno=54777
1526,2020-02-24,대웅제약의료진대상WECARE캠페인열어,http://www.econovill.com/news/articleView.html?idxno=386553
1527,2020-02-24,대웅제약의료진대상WECARE캠페인진행,http://www.k-health.com/news/articleView.html?idxno=47393
1528,2020-02-24,전승호대웅제약사장2년연속1조클럽가입비결,http://www.insightkorea.co.kr/news/articleView.html?idxno=77102
1529,2020-02-24,대웅제약WECARE캠페인실시,http://www.wsobi.com/news/articleView.html?idxno=91028
1530,2020-02-24,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.newscj.com/news/articleView.html?idxno=711649
1531,2020-02-24,대웅제약의료진대상WECARE캠페인시행,http://www.polinews.co.kr/news/article.html?no=453857
1532,2020-02-25,★주식인사이드대웅제약주가109000원2월25일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1066162
1533,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=240993
1534,2020-02-25,대웅제약올로맥스신규용량추가시장확대,http://news.mt.co.kr/mtview.php?no=2020022509090255675
1535,2020-02-25,대웅제약올로맥스로고혈압치료제라인업강화,http://www.newspim.com/news/view/20200225000187
1536,2020-02-25,대웅제약올로맥스신규용량추가로제품군강화,http://www.edaily.co.kr/news/newspath.asp?newsid=01945046625674128
1537,2020-02-25,대웅제약올로맥스신규용량추가고혈압치료제라인업강화,http://www.etnews.com/20200225000040
1538,2020-02-25,대웅주가25일132변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=673785
1539,2020-02-25,대웅제약올로맥스신규용량출시라인업강화,http://www.dailypharm.com/Users/News/NewsView.html?ID=262146&REFERER=NP
1540,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나서나,https://www.dailian.co.kr/news/view/870908?sc=Naver
1541,2020-02-25,대웅제약올로맥스시장확대박차신규용량라인업강화,http://medipana.com/news/news_viewer.asp?NewsNum=253203&MainKind=A&NewsKind=5&vCount=12&vKind=1
1542,2020-02-25,대웅제약올로맥스신규용량추가시장확대가속,http://www.etoday.co.kr/news/section/newsview.php?idxno=1861358
1543,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.bokuennews.com/news/article.html?no=187010
1544,2020-02-25,대웅제약올로맥스신규용량출시시장확대나선다,http://www.mediapen.com/news/view/503126
1545,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.dailysmart.co.kr/news/articleView.html?idxno=22769
1546,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.ebn.co.kr/news/view/1023379/?sc=naver
1547,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,http://www.mhj21.com/127861
1548,2020-02-25,대웅제약고혈압치료제올로맥스신규용량추가로라인업강화,http://www.medisobizanews.com/news/articleView.html?idxno=67181
1549,2020-02-25,대웅제약올로맥스신규용량추가,https://www.paxnetnews.com/articles/57489
1550,2020-02-25,대웅제약고혈압이상지질혈증치료제올로맥스용량추가라인업강화,http://www.newslock.co.kr/news/articleView.html?idxno=26006
1551,2020-02-25,대웅제약올로맥스고혈압치료제완벽라인업구축,http://www.pressm.kr/news/articleView.html?idxno=27776
1552,2020-02-25,대웅제약올로맥스신규용량추가로시장확대나서,http://www.nbnnews.co.kr/news/articleView.html?idxno=371689
1553,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.mdtoday.co.kr/mdtoday/index.html?no=378537
1554,2020-02-25,대웅제약고혈압치료제올로맥스라인업강화시장확대나서,http://www.greened.kr/news/articleView.html?idxno=238904
1555,2020-02-25,대웅제약개량신약올로맥스신규용량추가5월출시예정,http://www.ceoscoredaily.com/news/article.html?no=66472
1556,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,https://asiatime.co.kr/news/newsview.php?ncode=1065572413529182
1557,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.bosa.co.kr/news/articleView.html?idxno=2122054
1558,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.segyebiz.com/newsView/20200225504291?OutUrl=naver
1559,2020-02-25,대웅제약고혈압고지혈증복합제올로맥스신규용량허가받아,http://news.mk.co.kr/newsRead.php?no=192867&year=2020
1560,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.ezyeconomy.com/news/articleView.html?idxno=98256
1561,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.newsis.com/view/?id=NISX20200225_0000930932&cID=13001&pID=13000
1562,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.newsway.co.kr/news/view?tp=1&ud=2020022510080851493
1563,2020-02-25,대웅올로맥스2개신규용량5월출시,http://www.whosaeng.com/116001
1564,2020-02-25,대웅제약올로맥스신규용량추가고혈압치료제라인업강화,http://sports.hankooki.com/lpage/economy/202002/sp20200225102641137020.htm
1565,2020-02-25,대웅제약고혈압이상지질혈증치료제올로맥스용량추가고혈압치료제완벽라인업구축,http://www.paxetv.com/news/articleView.html?idxno=86992
1566,2020-02-25,대웅제약올로맥스신용량2종추가라인업확대,http://www.biospectator.com/view/news_view.php?varAtcId=9625
1567,2020-02-25,대웅제약올로맥스신규용량출시고혈압치료제라인업강화,http://www.cnbnews.com/news/article.html?no=438007
1568,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화나서,http://www.ekn.kr/news/article.html?no=483649
1569,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대,http://www.m-i.kr/news/articleView.html?idxno=684870
1570,2020-02-25,대웅제약고혈압이상지질혈증올로맥스신규용량추가,http://health.chosun.com/site/data/html_dir/2020/02/25/2020022501728.html
1571,2020-02-25,대웅제약올로맥스라인업강화신규용량추가러시장확대나서,http://www.ftoday.co.kr/news/articleView.html?idxno=114868
1572,2020-02-25,대웅제약3제복합제올로맥스신규용량추가,http://www.medigatenews.com/news/3437745735
1573,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59807
1574,2020-02-25,대웅제약올로맥스신규용량추가시장확대나선다,http://www.metroseoul.co.kr/article/20200225500112
1575,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1370222
1576,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,http://www.newsprime.co.kr/news/article.html?no=494590
1577,2020-02-25,대웅제약고혈압이상지질혈증치료제용량추가해제품군넓혀,http://www.businesspost.co.kr/BP?command=article_view&num=165446
1578,2020-02-25,대웅제약올로맥스신규용량추가고혈압치료라인업강화,http://moneys.mt.co.kr/news/mwView.php?no=2020022512168058293
1579,2020-02-25,제약산업대웅제약위질환치료정보알려,http://www.kukinews.com/news/article.html?no=753568
1580,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://newsbrite.net/134094
1581,2020-02-25,대웅제약올로맥스신규용량허가고혈압치료제시장확대,http://www.viva100.com/main/view.php?key=20200225010009122
1582,2020-02-25,뉴스투데이L대웅제약올로맥스용량추가로라인업강화,https://www.news2day.co.kr/148659
1583,2020-02-25,대웅제약올로맥스신규용량추가라인업강화,http://www.dailymedi.com/detail.php?number=853230&thread=22r05
1584,2020-02-25,제약오늘한미약품짜먹는맥시부펜출시대웅제약올로맥스신규용량추가로라인업강화,http://www.sisaon.co.kr/news/articleView.html?idxno=109595
1585,2020-02-25,대웅제약올로맥스신규용량추가시장확대나선다 ,http://www.monews.co.kr/news/articleView.html?idxno=208540
1586,2020-02-25,대웅제약의료진대상WECARE캠페인통해위질환치료정보제공,http://www.g-enews.com/ko-kr/news/article/news_all/202002251515335431aca1a8c21a_1/article.html
1587,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.wikileaks-kr.org/news/articleView.html?idxno=78397
1588,2020-02-25,대웅제약올로맥스용량추가로고혈압치료제라인업확대,http://www.econovill.com/news/articleView.html?idxno=386687
1589,2020-02-25,대웅제약올로맥스라인업강화신규용량식약처허가완료로4종갖추게돼,http://kpenews.com/View.aspx?No=758908
1590,2020-02-25,제약사1조클럽새내기셀트리온대웅제약도약비결은,http://www.wikileaks-kr.org/news/articleView.html?idxno=78394
1591,2020-02-25,대웅제약고혈압치료제올로맥스용량추가라인업강화,http://www.100ssd.co.kr/news/articleView.html?idxno=67404
1592,2020-02-25,종근당대웅제약셀트리온등제약사3곳1조클럽입성올해는신약개발성과등으로수익성개선도기대,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003883783
1593,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.polinews.co.kr/news/article.html?no=453974
1594,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.lawissue.co.kr/view.php?ud=202002251803294416204ead0791_12
1595,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.thepublic.kr/news/newsview.php?ncode=1065598507067000
1596,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화시장확대나선다,http://www.thefirstmedia.net/news/articleView.html?idxno=54840
1597,2020-02-25,대웅제약올로맥스신규용량추가로라인업강화,http://www.newscj.com/news/articleView.html?idxno=712070
1598,2020-02-26,대웅제약올로맥스신규용량추가,https://www.kpanews.co.kr/article/show.asp?idx=211137&category=D
1599,2020-02-26,의료제약업계단신용인세브란스병원대웅제약알보젠코리아에스디랩코리아,http://www.g-enews.com/ko-kr/news/article/news_all/20200224143512505269d76442fa_1/article.html
1600,2020-02-26,대웅보툴리눔제제주보북미진출첫해매출425억,http://www.dailypharm.com/Users/News/NewsView.html?ID=262186&REFERER=NP
1601,2020-02-26,대웅제약작년최대매출낸원동력은우루사수익성도개선,http://www.consumernews.co.kr/news/articleView.html?idxno=601710
1602,2020-02-26,★주식인사이드대웅제약주가111000원2월26일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1066515
1603,2020-02-26,대웅제약나보타브라질품목허가획득으로중남미최대시장진출,http://www.wsobi.com/news/articleView.html?idxno=91244
1604,2020-02-26,시경Today제약대웅제약올로맥스신규용량추가로라인업강화外,http://www.meconomynews.com/news/articleView.html?idxno=38492
1605,2020-02-27,단독대웅나보타기술수출로6년간66억원확보,http://www.dailypharm.com/Users/News/NewsView.html?ID=262226&REFERER=NP
1606,2020-02-27,더벨대웅제약아박타JV아피셀테라퓨틱스사업윤곽,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202002260744164200107821
1607,2020-02-27,대웅제약임직원들건강위해코로나19대응재택근무확대시행,http://www.mdtoday.co.kr/mdtoday/index.html?no=378802
1608,2020-02-27,대웅제약코로나19대응영업판매직원전원재택근무,http://www.medisobizanews.com/news/articleView.html?idxno=67287
1609,2020-02-27,대웅제약코로나19로재택근무확대시행,http://www.ebn.co.kr/news/view/1023780/?sc=naver
1610,2020-02-27,대웅제약전체영업마케팅재택근무,http://www.edaily.co.kr/news/newspath.asp?newsid=01908966625674784
1611,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.newspim.com/news/view/20200227000127
1612,2020-02-27,★주식인사이드대웅제약주가110000원2월27일9시4분기준,http://www.newsinside.kr/news/articleView.html?idxno=1066851
1613,2020-02-27,대웅제약임직원건강위해코로나19대응재택근무시행,http://www.mediapen.com/news/view/503747
1614,2020-02-27,대웅제약코로나19확산에재택근무확대시행,http://daily.hankooki.com/lpage/ittech/202002/dh20200227091207145630.htm
1615,2020-02-27,대웅제약코로나19사태로재택근무확대시행”,http://www.viva100.com/main/view.php?key=20200227010009863
1616,2020-02-27,대웅제약임직원들건강위해코로나19대응재택근무확대시행,https://www.dailian.co.kr/news/view/871480?sc=Naver
1617,2020-02-27,대웅제약코로나19확산방지위해임직원자택근무확대,https://asiatime.co.kr/news/newsview.php?ncode=1065571199836950
1618,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://medipana.com/news/news_viewer.asp?NewsNum=253305&MainKind=A&NewsKind=5&vCount=12&vKind=1
1619,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.newsway.co.kr/news/view?tp=1&ud=2020022709242341859
1620,2020-02-27,대웅제약코로나19대응위해임직원재택근무확대시행,http://www.greened.kr/news/articleView.html?idxno=239307
1621,2020-02-27,대웅제약오늘부터전체영업마케팅직원재택근무실시,http://moneys.mt.co.kr/news/mwView.php?no=2020022708508015062
1622,2020-02-27,대웅제약재택근무확대시행임직원건강이최우선,http://www.newsis.com/view/?id=NISX20200227_0000934161&cID=13001&pID=13000
1623,2020-02-27,대웅제약코로나19예방재택근무시차출근제확대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1862551
1624,2020-02-27,대웅제약사내코로나19확산저지위해재택근무시차출근제시행,http://news.mk.co.kr/newsRead.php?no=202466&year=2020
1625,2020-02-27,코로나19비상대웅제약확산방지위해임직원재택근무확대,http://www.m-i.kr/news/articleView.html?idxno=685664
1626,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.etnews.com/20200227000048
1627,2020-02-27,대웅제약코로나19대응임직원들건강위한재택근무시행,http://www.pressm.kr/news/articleView.html?idxno=27822
1628,2020-02-27,대웅제약코로나19대응재택근무시차출근제시행,http://www.seoulwire.com/news/articleView.html?idxno=400894
1629,2020-02-27,대웅제약임직원들건강위해코로나19대응재택근무확대시행,http://www.segyebiz.com/newsView/20200227505022?OutUrl=naver
1630,2020-02-27,대웅제약코로나19방지재택근무확대시행,http://www.medigatenews.com/news/1136471727
1631,2020-02-27,대웅제약임직원건강위해코로나19대응재택근무확대,http://www.metroseoul.co.kr/article/20200227500112
1632,2020-02-27,대웅제약코로나19확산재택근무확대,http://www.dailymedi.com/detail.php?number=853309&thread=22r05
1633,2020-02-27,대웅제약코로나19여파에임직원재택근무시차출근확대시행,http://www.sisaweek.com/news/articleView.html?idxno=131366
1634,2020-02-27,코로나19대웅제약재택근무시차출근제시행,http://www.ftoday.co.kr/news/articleView.html?idxno=114964
1635,2020-02-27,대웅제약코로나19확산에재택근무확대,http://www.mhj21.com/127956
1636,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.dailysmart.co.kr/news/articleView.html?idxno=22916
1637,2020-02-27,대웅제약코로나19예방위해재택근무확대시행,http://www.ekn.kr/news/article.html?no=484192
1638,2020-02-27,대웅제약코로나19확산관련재택근무확대시행,http://www.donga.com/news/article/all/20200227/99901681/1
1639,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.polinews.co.kr/news/article.html?no=454197
1640,2020-02-27,대웅제약재택근무확대시행임직원건강지키기,http://www.bosa.co.kr/news/articleView.html?idxno=2122243
1641,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://www.nbnnews.co.kr/news/articleView.html?idxno=372783
1642,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.newslock.co.kr/news/articleView.html?idxno=26074
1643,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.asiatoday.co.kr/view.php?key=20200227010016158
1644,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://newsbrite.net/134204
1645,2020-02-27,대웅제약코로나19대응재택근무확대시행,http://www.bokuennews.com/news/article.html?no=187149
1646,2020-02-27,대웅제약재택근무확대코로나19대응,http://www.monews.co.kr/news/articleView.html?idxno=208627
1647,2020-02-27,대웅제약임직원건강위해코로나19대응재택근무확대시행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59863
1648,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://www.lawissue.co.kr/view.php?ud=202002271350015985204ead0791_12
1649,2020-02-27,대웅제약임직원들의건강을위해코로나19대응재택근무확대시행,http://www.wikileaks-kr.org/news/articleView.html?idxno=78648
1650,2020-02-27,대웅제약임직원들의건강위해재택근무확대시행스마트워크환경구축,http://www.paxetv.com/news/articleView.html?idxno=87171
1651,2020-02-27,대웅제약코로나19확산방지위해27일부터무기한재택근무,http://www.businesspost.co.kr/BP?command=article_view&num=165912
1652,2020-02-27,대웅제약코로나19확산에재택근무확대시행,http://www.koreastocknews.com/news/articleView.html?idxno=51026
1653,2020-02-27,코로나19대웅제약임직원건강위해재택근무확대,http://www.econovill.com/news/articleView.html?idxno=387068
1654,2020-02-27,대웅제약재택근무시차출근제시행,http://www.finomy.com/news/articleView.html?idxno=75584
1655,2020-02-27,대웅주당100원현금배당결정,http://news.kmib.co.kr/article/view.asp?arcid=0014292159&code=61141211&cp=nv
1656,2020-02-27,대웅제약주당600원현금배당결정,http://news.kmib.co.kr/article/view.asp?arcid=0014292285&code=61141211&cp=nv
1657,2020-02-27,대웅제약코로나19선제적예방나서재택근무확대시행”,http://sports.hankooki.com/lpage/economy/202002/sp20200227173518137020.htm
1658,2020-02-27,유가증권시장공시에스원대웅제약코스맥스,http://news.mk.co.kr/newsRead.php?no=206059&year=2020
1659,2020-02-27,대웅제약코로나19로재택근무확대시행,http://www.g-enews.com/ko-kr/news/article/news_all/20200227174213553569d76442fa_1/article.html
1660,2020-02-27,대웅제약코로나19대응임직원들건강위해재택근무확대시행,http://www.thefirstmedia.net/news/articleView.html?idxno=54994
1661,2020-02-27,대웅제약재택근무확대시행코로나19확산대응,http://www.newscj.com/news/articleView.html?idxno=712861
1662,2020-02-27,대웅제약보통주1주당600원총62억현금배당,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241164
1663,2020-02-28,★주식인사이드대웅제약주가106500원2월28일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1067164
1664,2020-02-28,대웅제약06962028일369변동폭보여,http://www.gokorea.kr/news/articleView.html?idxno=677022
1665,2020-02-28,대웅제약주당600원현금배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=378990
1666,2020-02-28,대웅주당600원현금배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=378995
1667,2020-02-28,대웅골다공증주사오리지널상품명아클라스타사용,http://www.dailypharm.com/Users/News/NewsView.html?ID=262292&REFERER=NP
1668,2020-02-28,대웅제약코로나19대응재택근무확대시행,http://www.newswatch.kr/news/articleView.html?idxno=28229
1669,2020-02-29,대웅휴온스벤처투자엑셀러레이터신사업눈길,http://www.dailypharm.com/Users/News/NewsView.html?ID=262303&REFERER=NP
1670,2020-03-01,전승호대웅제약신약개발에인공지능접목해시간과비용줄인다,http://www.businesspost.co.kr/BP?command=article_view&num=166284
1671,2020-03-02,대웅제약골다공증치료제졸레드론산새품목허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=379082
1672,2020-03-02,녹십자홀딩스대웅연매출1조원넘어서,http://www.bokuennews.com/news/article.html?no=187269
1673,2020-03-02,대웅690VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/02/2020030202290.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1674,2020-03-02,대웅394상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/02/2020030202292.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1675,2020-03-02,대웅5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003028605L
1676,2020-03-02,공시대웅200억원규모자기주식취득결정,http://www.newsway.co.kr/news/view?tp=1&ud=2020030213103624818
1677,2020-03-02,대웅200억규모자사주취득결정,http://www.newspim.com/news/view/20200302000843
1678,2020-03-02,대웅200억규모자사주취득결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1864207
1679,2020-03-02,대웅200억규모자사주취득,http://www.edaily.co.kr/news/newspath.asp?newsid=03237366625699384
1680,2020-03-02,대웅200억규모자사주취득결정,https://view.asiae.co.kr/article/2020030213215872729
1681,2020-03-02,대웅전일대비739올라하락흐름중단기급등발생,http://www.newspim.com/news/view/20200302000878
1682,2020-03-02,특징주대웅10900원2일13시30분장시작대비739상승,http://www.getnews.co.kr/view.php?ud=202003021331395439c20b91e195_16
1683,2020-03-02,대웅200억규모자사주취득결정,http://news.heraldcorp.com/view.php?ud=20200302000638
1684,2020-03-02,대웅200억규모자사주취득결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=379188
1685,2020-03-02,대웅제약전일대비524이시각거래량3만1924주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003020281&t=NN
1686,2020-03-02,대웅제약5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003029097L
1687,2020-03-02,대웅제약보합출발후꾸준히올라714↑차트하락세중상승전환,http://www.newspim.com/news/view/20200302001113
1688,2020-03-02,대웅제약952VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/02/2020030202873.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1689,2020-03-02,제약업종마감시황상승률상위종목서울제약2992에이치엘사이언스1243대웅1182등,http://www.gokorea.kr/news/articleView.html?idxno=679017
1690,2020-03-02,대웅자사주200억규모사들이기로결정주주가치제고,http://www.businesspost.co.kr/BP?command=article_view&num=166473
1691,2020-03-02,보톡스보툴리눔톡신테마마감시황상승률상위종목파마리서치프로덕트1021대웅제약952휴젤718등,http://www.gokorea.kr/news/articleView.html?idxno=679102
1692,2020-03-02,대웅제약메디톡스보톡스분쟁합의로마무리되나,http://www.upinews.kr/newsView/upi202003020124
1693,2020-03-02,시설안전공단코로나19대웅비대위구성및청사사무실소독,http://www.cnbnews.com/news/article.html?no=438692
1694,2020-03-02,표2일코스피주가Top50상승률하나니켈2호주가상승률1위2339올라장마감덕성우유양디앤유키다리스튜디오대웅주가순으로상위기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=103358
1695,2020-03-03,휴온스대웅제약엑셀러레이터新사업에주목,http://www.mdtoday.co.kr/mdtoday/index.html?no=379207
1696,2020-03-03,★주식인사이드대웅제약주가114000원3월3일9시6분기준,http://www.newsinside.kr/news/articleView.html?idxno=1067810
1697,2020-03-03,대웅주가0030903일088변화,http://www.gokorea.kr/news/articleView.html?idxno=679249
1698,2020-03-03,대웅증권플러스3일현재11350원,http://nbntv.co.kr/news/view/862563
1699,2020-03-03,대웅200억규모자사주매입결정주주가치제고,http://www.greened.kr/news/articleView.html?idxno=240114
1700,2020-03-03,대웅200억원규모자사주매입결정주주가치제고책임경영자신감,http://www.ekn.kr/news/article.html?no=485219
1701,2020-03-03,대웅200억원자사주매입결정주주가치제고와자신감,http://www.metroseoul.co.kr/article/20200303500072
1702,2020-03-03,대웅200억원규모자사주매입주주가치제고,http://www.ftoday.co.kr/news/articleView.html?idxno=115163
1703,2020-03-03,대웅200억원자사주매입,http://www.consumuch.com/news/articleView.html?idxno=47827
1704,2020-03-03,6개사매출65증가대웅흑자전환성공,http://www.bokuennews.com/news/article.html?no=187333
1705,2020-03-03,대웅200억원규모자사주매입결정,http://www.newsway.co.kr/news/view?tp=1&ud=2020030310231535285
1706,2020-03-03,대웅200억규모자사주매입주주가치제고차원,http://www.newsis.com/view/?id=NISX20200303_0000940339&cID=13001&pID=13000
1707,2020-03-03,대웅200억원규모자사주매입주주가치제고와경영성과자신감”,http://www.viva100.com/main/view.php?key=20200303010001037
1708,2020-03-03,대웅주주가치제고위해자사주200억원매입결정,http://medipana.com/news/news_viewer.asp?NewsNum=253543&MainKind=A&NewsKind=5&vCount=12&vKind=1
1709,2020-03-03,대웅200억원규모자사주매입결정,http://www.dailysmart.co.kr/news/articleView.html?idxno=23149
1710,2020-03-03,대웅200억원규모자사주매입전체주식의34,http://www.medisobizanews.com/news/articleView.html?idxno=67444
1711,2020-03-03,대웅200억규모자사주매입올해성장자신”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1864708
1712,2020-03-03,대웅200억원규모자사주매입결정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=59955
1713,2020-03-03,3월3일대웅제약금일증시112000원261,http://nbntv.co.kr/news/view/862958
1714,2020-03-03,대웅200억원규모자사주매입결정주주가치제고와경영성과자신감,http://www.nbnnews.co.kr/news/articleView.html?idxno=374292
1715,2020-03-03,대웅200억원규모자사주매입결정주주가치제고와경영성과자신감,http://www.thepublic.kr/news/newsview.php?ncode=1065575635628968
1716,2020-03-03,대웅200억원규모자사주매입결정주주가치제고,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241316
1717,2020-03-03,대웅200억원규모자사주매입주주가치제고목적,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003030574&t=NN
1718,2020-03-03,대웅200억규모자사주매입주주가치제고,http://www.newsprime.co.kr/news/article.html?no=495544
1719,2020-03-03,대웅200억원규모자사주매입 ,http://www.monews.co.kr/news/articleView.html?idxno=208772
1720,2020-03-03,대웅200억규모자사주매입주주가치제고,http://www.mhj21.com/128050
1721,2020-03-03,대웅200억원규모자사주매입결정주주가치제고,http://www.asiatoday.co.kr/view.php?key=20200303010001579
1722,2020-03-03,대웅주주가치제고위해팔걷어,http://www.whosaeng.com/116166
1723,2020-03-03,대웅200억규모자사주매입결정주주가치제고와경영성과자신감,http://www.ezyeconomy.com/news/articleView.html?idxno=98505
1724,2020-03-03,대웅총발행주식34200억원규모자사주매입,http://www.pressm.kr/news/articleView.html?idxno=27912
1725,2020-03-03,대웅200억원대자사주매입,http://www.dailymedi.com/detail.php?number=853522&thread=22r05
1726,2020-03-03,대웅200억원규모자사주매입결정,http://www.bokuennews.com/news/article.html?no=187338
1727,2020-03-03,대웅제약지주사대웅200억원규모자사주매입결정,http://www.insightkorea.co.kr/news/articleView.html?idxno=77882
1728,2020-03-03,대웅200억원규모자사주매입결정,http://www.etnews.com/20200303000117
1729,2020-03-03,대웅200억들여자사주197만주매입발행주식34규모,http://news.mt.co.kr/mtview.php?no=2020030311141623613
1730,2020-03-03,대웅200억원규모자사주매입전체발행주식약34규모,http://www.betanews.net:8080/article/1142373.html
1731,2020-03-03,대웅200억원규모자사주매입결정,http://www.ebn.co.kr/news/view/1024567/?sc=naver
1732,2020-03-03,대웅자사주200억원매입주주가치제고,http://moneys.mt.co.kr/news/mwView.php?no=2020030310238060148
1733,2020-03-03,대웅전체발행주34수준자사주200억원매입결정,http://www.newslock.co.kr/news/articleView.html?idxno=26211
1734,2020-03-03,제약산업대웅200억원자사주매입,http://www.kukinews.com/news/article.html?no=756819
1735,2020-03-03,대웅200억원규모자사주매입결정,http://www.econovill.com/news/articleView.html?idxno=387592
1736,2020-03-03,대웅자사주200억규모사기로윤재춘주주가치와책임경영의지,http://www.businesspost.co.kr/BP?command=article_view&num=166588
1737,2020-03-03,대웅200억원규모자사주매입결정주주가치제고와경영성과자신감나타내,http://www.wsobi.com/news/articleView.html?idxno=91681
1738,2020-03-03,대웅주주가치제고위해자사주197만주매입,http://www.shinailbo.co.kr/news/articleView.html?idxno=1255488
1739,2020-03-03,대웅200억원규모자사주매입결정,http://www.bosa.co.kr/news/articleView.html?idxno=2122573
1740,2020-03-03,대웅200억원규모자사주매입결정주주가치제고,https://www.dailian.co.kr/news/view/872761?sc=Naver
1741,2020-03-03,대웅제약200억원규모자사주매입결정주주가치제고차원,http://www.newswatch.kr/news/articleView.html?idxno=28346
1742,2020-03-03,대웅200억규모자사주매입결정,https://www.paxnetnews.com/articles/57784
1743,2020-03-03,대웅200억규모자사주매입주주가치제고,https://www.kpanews.co.kr/article/show.asp?idx=211349&category=D
1744,2020-03-03,대웅200억원규모자사주매입결정주주가치제고와경영성과자신감,http://newsbrite.net/134377
1745,2020-03-03,대웅200억원규모자사주매입결정,http://www.medigatenews.com/news/457348867
1746,2020-03-03,대웅200억원자사주매입,https://www.nocutnews.co.kr/news/5301081
1747,2020-03-03,대웅200억원규모자사주매입결정주주가치제고,http://sports.hankooki.com/lpage/economy/202003/sp20200303143959137020.htm
1748,2020-03-03,대웅제약매출1조원돌파에도주가부진자사주매입으로주가부양나서,http://www.asiatoday.co.kr/view.php?key=20200303010001680
1749,2020-03-03,대웅200억자사주매입주주가치제고차원,http://www.mediapen.com/news/view/505222
1750,2020-03-03,대웅200억규모자사주매입주주가치제고,http://www.wikileaks-kr.org/news/articleView.html?idxno=79169
1751,2020-03-03,대웅주주가치제고를위해자사주식약200억매입결정건실한경영성과기대,http://www.paxetv.com/news/articleView.html?idxno=87423
1752,2020-03-03,대웅200억원규모자사주매입결정주주가치제고경영성과자신감,http://www.segye.com/content/html/2020/03/03/20200303512107.html?OutUrl=naver
1753,2020-03-03,대웅200억규모자사주매입,http://www.dailypharm.com/Users/News/NewsView.html?ID=262425&REFERER=NP
1754,2020-03-03,대웅200억규모자사주매입결정,https://asiatime.co.kr/news/newsview.php?ncode=1065593522776311
1755,2020-03-03,대웅200억원규모자사주매입주주가치제고차원,http://www.seoulwire.com/news/articleView.html?idxno=401637
1756,2020-03-03,대웅200억원규모자사주매입결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=379333
1757,2020-03-03,대웅200억원규모자사주매입결정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1372111
1758,2020-03-03,대웅지난해경영성과주주배당보다자사주200억원매입선택,http://www.joseilbo.com/news/news_read.php?uid=393074&class=17&grp=
1759,2020-03-03,대웅200억규모자사주매입으로주주가치제고,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003891683
1760,2020-03-03,대웅200억원규모자사주매입결정주주가치제고위한선택,http://inthenews.co.kr/article-38262/
1761,2020-03-03,대웅200억원규모자사주매입결정,http://www.edaily.co.kr/news/newspath.asp?newsid=04100006625699712
1762,2020-03-03,대웅200억원규모자사주매입주주가치제고경영성과자신감”,http://www.cnbnews.com/news/article.html?no=438827
1763,2020-03-03,대웅200억원규모자사주매입결정주주가치제고와경영성과자신감,http://www.updownnews.co.kr/news/articleView.html?idxno=215821
1764,2020-03-03,대웅자사주197만주매입주주가치제고,http://www.finomy.com/news/articleView.html?idxno=75760
1765,2020-03-03,대웅주주가치제고위해자사주200억원매입,http://www.g-enews.com/ko-kr/news/article/news_all/20200303144552491469d76442fa_1/article.html
1766,2020-03-03,대웅우루사매출882억처방조제500억돌파,http://www.dailymedi.com/detail.php?number=853548&thread=22r12
1767,2020-03-03,대웅200억규모자사주매입결정주주가치제고경영성과자신감,http://www.m-i.kr/news/articleView.html?idxno=687540
1768,2020-03-03,경영성과자신감대웅200억원규모자사주매입,http://www.donga.com/news/article/all/20200303/99988282/1
1769,2020-03-03,대웅200억원규모자사주매입결정주주가치제고,http://www.newscj.com/news/articleView.html?idxno=714390
1770,2020-03-04,빅데이터MSI시장심리톱5KB금융삼성화재SK이노베이션LS대웅제약,http://www.newsis.com/view/?id=NISX20200304_0000941694&cID=10401&pID=10400
1771,2020-03-04,연중기획기업과나눔대웅제약느린학습자의징검다리되다,http://www.cnbnews.com/news/article.html?no=438831
1772,2020-03-04,★주식인사이드대웅제약주가112000원3월4일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1068149
1773,2020-03-04,대웅주주가치제고200억원규모자사주매입미래성장자신감,http://www.sisaweek.com/news/articleView.html?idxno=131597
1774,2020-03-04,메디톡스균주소송9부능선넘나대웅이메디톡스균주사용,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020030411492326005
1775,2020-03-04,美ITC변호사대웅이메디톡스균주사용하고있다,http://www.ebn.co.kr/news/view/1024782/?sc=naver
1776,2020-03-04,메디톡스ITC변호사대웅이메디톡스균주사용에볼루스가합의요청”,http://www.viva100.com/main/view.php?key=20200304010001674
1777,2020-03-04,美ITC변호사대웅이메디톡스균주사용하고있다”,http://www.whosaeng.com/116200
1778,2020-03-04,메디톡스美ITC소속변호사대웅균주도용의견재판부제출,https://www.hankyung.com/finance/article/2020030453336
1779,2020-03-04,메디톡스美ITC변호사대웅이메디톡스균주사용재판부제출”,http://daily.hankooki.com/lpage/ittech/202003/dh20200304121744145630.htm
1780,2020-03-04,美ITC변호사대웅이메디톡스균주사용”,https://www.paxnetnews.com/articles/57841
1781,2020-03-04,美ITC소속변호사대웅제약이메디톡스균주사용”의견제출,http://www.edaily.co.kr/news/newspath.asp?newsid=03129126625700040
1782,2020-03-04,美국제무역위변호사메디톡스균주대웅이사용,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90965
1783,2020-03-04,메디톡스美ITC소속변호사대웅제약이메디톡스균주사용의견제출,http://www.greened.kr/news/articleView.html?idxno=240386
1784,2020-03-04,대웅제약991VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/04/2020030401941.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1785,2020-03-04,美ITC변호사대웅제약메디톡스균주사용의견제출,http://news.mt.co.kr/mtview.php?no=2020030412511016353
1786,2020-03-04,대웅제약전일대비1063이시각13만3101주거래,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003040243&t=NN
1787,2020-03-04,메디톡스대웅제약보툴리눔균주가메디톡스균주입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241387
1788,2020-03-04,대웅제약낮부터갑작스런12급락에투자자들당황10만원선붕괴,http://www.econonews.co.kr/news/articleView.html?idxno=110884
1789,2020-03-04,메디톡스美ITC소속변호사도대웅이메디톡스균주도용의견내,http://www.asiatoday.co.kr/view.php?key=20200304010002608
1790,2020-03-04,메디톡스ITC변호사대웅이메디톡스균주사용동의”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1865416
1791,2020-03-04,메디톡스ITC변호사대웅메디톡스균주도용재판부제출,http://www.mediapen.com/news/view/505536
1792,2020-03-04,美ITC소속변호사도대웅이메디톡스균주도용의견,http://news.mk.co.kr/newsRead.php?no=228121&year=2020
1793,2020-03-04,메디톡스美ITC변호사대웅이메디톡스균주사용동의,http://www.seoulwire.com/news/articleView.html?idxno=401772
1794,2020-03-04,특징주메디톡스대웅제약균주사용동의에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020030413538028069
1795,2020-03-04,메디톡스美ITC소속변호사대웅제약이메디톡스균주사용한다의견서제출,http://news.mk.co.kr/newsRead.php?no=228182&year=2020
1796,2020-03-04,美ITC소속변호사대웅이메디톡스균주사용하고있다”고재판부제출,http://www.lawissue.co.kr/view.php?ud=202003041408546999204ead0791_12
1797,2020-03-04,메디톡스균주戰고지점령ITC변호사대웅이균주도용,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003040251&t=NN
1798,2020-03-04,美ITC변호사대웅이메디톡스균주도용에볼루스도합의요청”,http://www.mdtoday.co.kr/mdtoday/index.html?no=379447
1799,2020-03-04,美ITC변호사대웅제약메디톡스균주도용,http://www.finomy.com/news/articleView.html?idxno=75798
1800,2020-03-04,특징주메디톡스대웅제약美ITC소속변호사의견에희비교차,http://news.mk.co.kr/newsRead.php?no=228530&year=2020
1801,2020-03-04,메디톡스는ITC에제출한자료모두공개하라대웅제약美ITC승소확신,http://www.segye.com/content/html/2020/03/04/20200304512590.html?OutUrl=naver
1802,2020-03-04,대웅제약메디톡스와의美ITC소송승리확신,http://news.mk.co.kr/newsRead.php?no=228660&year=2020
1803,2020-03-04,대웅제약ITC승소확신메디톡스허위자료냈다반격,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020030414491078505
1804,2020-03-04,메디톡스美ITC소속변호사대웅이메디톡스균주사용하고있다대웅의견에불과승소확신,http://www.etnews.com/20200304000231
1805,2020-03-04,대웅제약美ITC승소확신메디톡스증거다수허위,http://www.ebn.co.kr/news/view/1024822/?sc=naver
1806,2020-03-04,대웅제약보툴리눔톡신균주미국ITC승소확신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241400
1807,2020-03-04,대웅메디톡스보툴리눔균주공방재판서도평행선,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1132359&REFERER=NP
1808,2020-03-04,대웅제약미국ITC승소확신소송성립되지않을수도,http://www.newspim.com/news/view/20200304001231
1809,2020-03-04,메디톡스대웅제약보톡수균주출처놓고법정공방팽팽종합,http://www.newspim.com/news/view/20200304001268
1810,2020-03-04,대웅제약메디톡스주장반박메디톡스가합의제안했지만거절”,http://daily.hankooki.com/lpage/ittech/202003/dh20200304150510145630.htm
1811,2020-03-04,메디톡스대웅제약보툴리눔균주다툼기술도용”vs아니다”,http://www.edaily.co.kr/news/newspath.asp?newsid=03834326625700040
1812,2020-03-04,대웅제약메디톡스ITC재판허위자료제출합의도먼저제안”,http://www.viva100.com/main/view.php?key=20200304010001817
1813,2020-03-04,다시불붙은대웅제약과메디톡스美ITC소송전첨예한대립,http://www.metroseoul.co.kr/article/20200304500372
1814,2020-03-04,대웅제약미국ITC승소확신메디톡스ITC제출자료모두공개요구,http://newsclaim.co.kr/View.aspx?No=767198
1815,2020-03-04,대웅제약美ITC승소확신메디톡스증거허위반박,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003040312&t=NN
1816,2020-03-04,대웅제약ITC승소확신메디톡스허위자료냈다반박,http://www.mediapen.com/news/view/505590
1817,2020-03-04,대웅제약메디톡스의균주소유권침해사실등증명된것없어,http://www.medisobizanews.com/news/articleView.html?idxno=67501
1818,2020-03-04,대웅제약메디톡스설전ITC승소확신동상이몽,http://www.upinews.kr/newsView/upi202003040111
1819,2020-03-04,대웅메디톡스ITC소송승소확신공방재점화,http://medipana.com/news/news_viewer.asp?NewsNum=253629&MainKind=A&NewsKind=5&vCount=12&vKind=1
1820,2020-03-04,메디톡스대웅진실게임누구말이맞나,http://moneys.mt.co.kr/news/mwView.php?no=2020030414478083650
1821,2020-03-04,대웅제약메디톡스는ITC제출자료전부공개하라,http://news.mk.co.kr/newsRead.php?no=229218&year=2020
1822,2020-03-04,대웅메디톡스와美소송승소확신,http://www.whosaeng.com/116209
1823,2020-03-04,메디톡스미국국제무역위변호사도편들어”대웅제약무모한주장”,http://www.businesspost.co.kr/BP?command=article_view&num=166848
1824,2020-03-04,대웅제약미ITC변호사의견재판영향없다주장ITC승소확신한다,http://www.lawissue.co.kr/view.php?ud=20200304152714293204ead0791_12
1825,2020-03-04,대웅제약미국ITC승소확신메디톡스는ITC에제출한자료모두를공개하라요구,http://www.nbnnews.co.kr/news/articleView.html?idxno=374871
1826,2020-03-04,메디톡스대웅제약미국ITC서보툴리눔공방격화,http://www.econovill.com/news/articleView.html?idxno=387799
1827,2020-03-04,대웅제약메디톡스서로美ITC승소확신5년째진실게임종합,https://www.hankyung.com/finance/article/2020030461306
1828,2020-03-04,대웅제약메디톡스美ICT재판서균주관련허위자료제출”,http://www.donga.com/news/article/all/20200304/100005614/1
1829,2020-03-04,대웅제약메디톡스ITC제출자료모두공개하라,http://www.finomy.com/news/articleView.html?idxno=75805
1830,2020-03-04,대웅제약메디톡스와의보툴리눔소송에급락,http://www.newstomato.com/ReadNews.aspx?no=956837
1831,2020-03-04,바이오주대부분올라메디톡스앱클론급등대웅제약급락,http://www.businesspost.co.kr/BP?command=article_view&num=166896
1832,2020-03-04,메디톡스대웅제약보툴리눔톡신치열한공방전,http://www.asiatoday.co.kr/view.php?key=20200304010002805
1833,2020-03-04,보톡스전쟁재점화메디톡스선제공격에대웅제약즉각반박,http://www.etoday.co.kr/news/section/newsview.php?idxno=1865630
1834,2020-03-04,美ITC변호사대웅제약메디톡스균주사용의견제출,https://biz.chosun.com/site/data/html_dir/2020/03/04/2020030403070.html?utm_source=naver&utm_medium=original&utm_campaign=biz
1835,2020-03-04,메디톡스vs대웅제약美ITC소송최종판결앞두고재격돌,http://biz.newdaily.co.kr/site/data/html/2020/03/04/2020030400183.html
1836,2020-03-04,대웅제약메디톡스다시불붙은보톡스균주공방서로美ITC승소확신,http://www.ekn.kr/news/article.html?no=485580
1837,2020-03-04,대웅제약미국ITC승소확신메디톡스ITC에제출한자료모두공개하라”요구,http://www.thepublic.kr/news/newsview.php?ncode=1065592774331626
1838,2020-03-04,대웅제약메디톡스ITC제출자료모두공개하라강력요구,http://www.pressm.kr/news/articleView.html?idxno=27974
1839,2020-03-04,대웅vs메디톡스재판에서도평행선지속 ,http://www.monews.co.kr/news/articleView.html?idxno=208830
1840,2020-03-04,대웅오히려메디톡스가합의요청허위자료도제출,http://news.mt.co.kr/mtview.php?no=2020030416450399190
1841,2020-03-04,대웅제약 미국 ITC 승소 확신메디톡스는 ITC에 제출한 자료 모두를 공개하라 요구,http://newsbrite.net/134451
1842,2020-03-04,대웅제약메디톡스는ITC제출자료전부공개하라”,http://www.newsway.co.kr/news/view?tp=1&ud=2020030416512245963
1843,2020-03-04,대웅제약VS메디톡스끝이보이지않는균주전쟁,http://www.pinpointnews.co.kr/view.php?ud=202003041700299439f090c8dbcb_45
1844,2020-03-04,다시불붙은보톡스균주전쟁대웅메디톡스ITC재판서대립각,http://www.newsprime.co.kr/news/article.html?no=495798
1845,2020-03-04,대웅제약vs메디톡스美ITC승소최종판결앞두고재공방,http://www.m-i.kr/news/articleView.html?idxno=687991
1846,2020-03-04,표4일코스피주가Top50하락률대양금속주가하락률1위1224내려장마감대웅제약신풍제약신한인버스2X금선물ETN신한인버스2X천연가스선물ETN주가순으로상위,http://www.fintechpost.co.kr/news/articleView.html?idxno=103537
1847,2020-03-04,대웅제약메디톡스증거허위ITC승소가능성주장반박,https://www.dailian.co.kr/news/view/873242?sc=Naver
1848,2020-03-04,美ITC승소확신메디톡스대웅이우리균주사용,https://www.dailian.co.kr/news/view/873240?sc=Naver
1849,2020-03-04,대웅메디톡스는ITC제출내용모두공개해라,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90974
1850,2020-03-04,대웅메디톡스는ITC제출내용모두공개해라,http://www.medical-tribune.co.kr/news/articleView.html?idxno=90974
1851,2020-03-04,대웅제약메디톡스는ITC에제출한자료모두를공개하라요구,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60004
1852,2020-03-04,美ITC소속변호사대웅이메디톡스균주사용하고있다고재판부제출,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60003
1853,2020-03-04,대웅제약 미국 ITC 승소 확신메디톡스는 ITC에 제출한 자료 모두를 공개하라 요구,http://www.businesskorea.co.kr/news/articleView.html?idxno=42230
1854,2020-03-04,메디톡스美소송자신vs대웅제약허위사실주장,http://www.dailymedi.com/detail.php?number=853592&thread=22r05
1855,2020-03-04,대웅제약메디톡스美ITC에허위자료제출모든자료공개해야”,http://www.ajunews.com/view/20200304174649332
1856,2020-03-04,대웅200억원규모자사주매입결정주주가치제고와경영성과자신감표명,http://www.thefirstmedia.net/news/articleView.html?idxno=55252
1857,2020-03-04,메디톡스대웅제약美ITC소속변호사의견에엇갈린주가,http://www.mdtoday.co.kr/mdtoday/index.html?no=379501
1858,2020-03-04,대웅美ITC승소확신메디톡스3가지주장반박,http://www.dailypharm.com/Users/News/NewsView.html?ID=262482&REFERER=NP
1859,2020-03-04,대웅제약미국ITC승소확신메디톡스는ITC에제출한자료모두를공개하라,http://www.thevaluenews.co.kr/news/view.php?idx=158577
1860,2020-03-04,대웅제약메디톡스는ITC에제출한자료모두를공개하라美ITC승소확신,http://www.newscj.com/news/articleView.html?idxno=714791
1861,2020-03-04,대웅제약메디톡스는ITC에제출한자료를모두공개하라반격나서,http://www.greened.kr/news/articleView.html?idxno=240479
1862,2020-03-04,메디톡스美ITC소속변호사대웅이메디톡스균주사용하고있다고재판부제출,http://www.thefirstmedia.net/news/articleView.html?idxno=55286
1863,2020-03-04,대웅제약美ITC승소확신메디톡스ITC제출한자료공개요구,http://www.thefirstmedia.net/news/articleView.html?idxno=55284
1864,2020-03-05,대웅제약vs메디톡스보툴리눔균주법적공방또다시시작,http://medicalworldnews.co.kr/news/view.php?idx=1510934529
1865,2020-03-05,출근길메디톡스대웅보툴리눔톡신균주출처놓고공방,http://moneys.mt.co.kr/news/mwView.php?no=2020030417308083632
1866,2020-03-05,美ITC소송두고메디톡스대웅승소확신격화된보툴리눔공방,http://www.mdtoday.co.kr/mdtoday/index.html?no=379481
1867,2020-03-05,대웅제약메디톡스ITC판결앞두고또다시공방,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1078106
1868,2020-03-05,메디톡스대웅공방재점화관전포인트는,http://moneys.mt.co.kr/news/mwView.php?no=2020030508388082725
1869,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://medipana.com/news/news_viewer.asp?NewsNum=253656&MainKind=A&NewsKind=5&vCount=12&vKind=1
1870,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.dailysmart.co.kr/news/articleView.html?idxno=23253
1871,2020-03-05,★주식인사이드대웅제약주가100000원3월5일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1068473
1872,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.medisobizanews.com/news/articleView.html?idxno=67514
1873,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241425
1874,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241425
1875,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.newsis.com/view/?id=NISX20200305_0000943449&cID=13001&pID=13000
1876,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.newsway.co.kr/news/view?tp=1&ud=2020030509185208759
1877,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.mediapen.com/news/view/505751
1878,2020-03-05,대웅제약발달장애인위한코로나19도서배포,https://asiatime.co.kr/news/newsview.php?ncode=1065571198417937
1879,2020-03-05,대웅제약발달장애인위해코로나19쉬운글도서배포,http://www.viva100.com/main/view.php?key=20200305010002068
1880,2020-03-05,대웅제약참지마요코로나19정보담은쉬운글도서제작배포,http://news.mk.co.kr/newsRead.php?no=231699&year=2020
1881,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60008
1882,2020-03-05,대웅제약발달장애인눈높이맞춘코로나19도서배포,http://moneys.mt.co.kr/news/mwView.php?no=2020030509108025187
1883,2020-03-05,대웅제약발달장애인이해돕는코로나19안내도서배포,https://www.news1.kr/articles/?3863360
1884,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.mdtoday.co.kr/mdtoday/index.html?no=379528
1885,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://news.mt.co.kr/mtview.php?no=2020030509492697585
1886,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.newsfc.co.kr/news/articleView.html?idxno=40090
1887,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.asiatoday.co.kr/view.php?key=20200305010003159
1888,2020-03-05,대웅제약참지마요발달장애인위한코로나예방법도서제작배포,http://www.100ssd.co.kr/news/articleView.html?idxno=67565
1889,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.koreaittimes.com/news/articleView.html?idxno=95924
1890,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.ekn.kr/news/article.html?no=485683
1891,2020-03-05,대웅제약발달장애인을위한코로나19도서무료배포,http://sports.hankooki.com/lpage/economy/202003/sp20200305102505137020.htm
1892,2020-03-05,대한민국이좋다대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.m-i.kr/news/articleView.html?idxno=688207
1893,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.metroseoul.co.kr/article/20200305500104
1894,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.bokuennews.com/news/article.html?no=187446
1895,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.nbnnews.co.kr/news/articleView.html?idxno=375096
1896,2020-03-05,대웅제약전날10급락딛고보합10만원선회복하나,http://www.econonews.co.kr/news/articleView.html?idxno=110993
1897,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,https://www.dailian.co.kr/news/view/873400?sc=Naver
1898,2020-03-05,美ITC변호사대웅제약메디톡스균주사용”의견제출,http://www.sportsworldi.com/content/html/2020/03/05/20200305506641.html
1899,2020-03-05,대웅제약 발달장애인위한 코로나19 쉬운글도서제작배포,http://www.ntoday.co.kr/news/articleView.html?idxno=71289
1900,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://daily.hankooki.com/lpage/ittech/202003/dh20200305105632145630.htm
1901,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.ebn.co.kr/news/view/1024970/?sc=naver
1902,2020-03-05,힘을내요대한민국대웅제약 발달장애인위해 코로나19 쉬운글도서배포,http://www.newslock.co.kr/news/articleView.html?idxno=26259
1903,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.thevaluenews.co.kr/news/view.php?idx=158587
1904,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.insightkorea.co.kr/news/articleView.html?idxno=77931
1905,2020-03-05,대웅제약美파트너사보톡스균주戰변수부각,http://www.ebn.co.kr/news/view/1024963/?sc=naver
1906,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.sportsseoul.com/news/read/890818
1907,2020-03-05,대웅발달장애인을위한코로나19쉬운글도서배포,http://www.dailypharm.com/Users/News/NewsView.html?ID=262505&REFERER=NP
1908,2020-03-05,장애인도코로나19알아야한다”대웅제약코로나19쉬운글도서배포,http://www.donga.com/news/article/all/20200305/100018898/1
1909,2020-03-05,대웅제약코로나19쉬운글도서배포,http://www.bosa.co.kr/news/articleView.html?idxno=2122747
1910,2020-03-05,중부지방국세청대웅바이오세무조사착수조사악몽재현여부주목,http://www.sisajournal-e.com/news/articleView.html?idxno=214832
1911,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://newsbrite.net/134478
1912,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1372639
1913,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.lawissue.co.kr/view.php?ud=202003051240185925204ead0791_12
1914,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.cnbnews.com/news/article.html?no=439002
1915,2020-03-05,보톡스전쟁6월판가름메디톡스대웅둘중하나치명타,http://www.viva100.com/main/view.php?key=20200305010002041
1916,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.polinews.co.kr/news/article.html?no=455042
1917,2020-03-05,대웅메디톡스보톡스전쟁메디톡스승기잡나,http://www.koreastocknews.com/news/articleView.html?idxno=51311
1918,2020-03-05,에볼루스대웅제약파트너사로서보툴리눔톡신지식재산에확신”,http://www.businesspost.co.kr/BP?command=article_view&num=167005
1919,2020-03-05,대웅제약발달장애인위해코로나19쉽게설명한책만들어배포,http://www.businesspost.co.kr/BP?command=article_view&num=167033
1920,2020-03-05,대웅제약발달장애인쉬운이해코로나19도서배포,http://www.pressm.kr/news/articleView.html?idxno=28005
1921,2020-03-05,대웅200억규모자사주매입주주가치제고책임경영의지,http://www.newsian.co.kr/news/articleView.html?idxno=40479
1922,2020-03-05,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.updownnews.co.kr/news/articleView.html?idxno=215911
1923,2020-03-05,대웅제약코로나19이해위한발달장애인용도서배포,http://www.finomy.com/news/articleView.html?idxno=75831
1924,2020-03-05,대웅제약라니티딘이어메트포르민회수가능성↑매출타격우려,http://biz.newdaily.co.kr/site/data/html/2020/03/05/2020030500192.html
1925,2020-03-05,뉴스투데이L대웅제약발달장애인용코로나19쉬운글도서배포,https://www.news2day.co.kr/149222
1926,2020-03-05,거짓말ITC승소자신등대웅제약메디톡스공방5년째평행선,http://www.betanews.net:8080/article/1143967.html
1927,2020-03-05,메디톡스대웅제약보톡스전쟁미ITC6월예비판결승자는,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003894383
1928,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,https://www.kpanews.co.kr/article/show.asp?idx=211443&category=D
1929,2020-03-05,대웅제약전국특수학교등을위한코로나19쉬운글도서배포,http://www.thepublic.kr/news/newsview.php?ncode=1065588596128566
1930,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.econovill.com/news/articleView.html?idxno=388018
1931,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.newscj.com/news/articleView.html?idxno=715221
1932,2020-03-05,대웅제약발달장애인위한코로나19쉬운글도서배포,http://www.wsobi.com/news/articleView.html?idxno=91967
1933,2020-03-06,대웅제약메디톡스보톡스균주분쟁법정밖난타전승자없는진흙탕싸움,http://www.greened.kr/news/articleView.html?idxno=240714
1934,2020-03-06,5년새매출144↑대웅바이오제네릭강자우뚝,http://www.dailypharm.com/Users/News/NewsView.html?ID=262522&REFERER=NP
1935,2020-03-06,제약CEO오너리스크잠재운대웅제약전승호보톡스소송전도이길까,http://isplus.live.joins.com/news/article/article.asp?total_id=23723583
1936,2020-03-06,대웅바이오지난해매출3215억5년간매출2배이상늘어,http://www.mdtoday.co.kr/mdtoday/index.html?no=379675
1937,2020-03-06,★주식인사이드대웅제약주가100500원3월6일9시5분기준,http://www.newsinside.kr/news/articleView.html?idxno=1068825
1938,2020-03-06,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.mhj21.com/128143
1939,2020-03-06,대웅제약vs메디톡스보톡스전쟁결말이다가오고있다,http://www.insightkorea.co.kr/news/articleView.html?idxno=77952
1940,2020-03-06,공시대웅윤재춘대표1만8825주장내매수,http://www.newsway.co.kr/news/view?tp=1&ud=2020030611422565953
1941,2020-03-06,공시대웅제약전승호대표1000주장내매수,http://www.newsway.co.kr/news/view?tp=1&ud=2020030611483593410
1942,2020-03-06,대웅그룹윤재춘전승호사장이창재부사장자사주매입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241492
1943,2020-03-06,대웅그룹윤재춘전승호사장이창재부사장자사주매입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241492
1944,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.wsobi.com/news/articleView.html?idxno=92035
1945,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.bosa.co.kr/news/articleView.html?idxno=2122833
1946,2020-03-06,대웅그룹경영진 4억원규모자사주매입책임경영과미래성장자신감 표명​,http://www.businesskorea.co.kr/news/articleView.html?idxno=42345
1947,2020-03-06,대웅그룹경영진4억규모회사주식매입,http://www.greened.kr/news/articleView.html?idxno=240824
1948,2020-03-06,대웅그룹경영진4억원치자사주매입책임경영,http://www.newsis.com/view/?id=NISX20200306_0000945544&cID=13001&pID=13000
1949,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영미래성장자신,http://www.medisobizanews.com/news/articleView.html?idxno=67571
1950,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영,http://www.mediapen.com/news/view/506230
1951,2020-03-06,대웅제약경영진4억원규모자사주장내매수,http://www.medigatenews.com/news/987634611
1952,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.enewstoday.co.kr/news/articleView.html?idxno=1372839
1953,2020-03-06,대웅그룹경영진4억규모자사주매입,http://www.mdtoday.co.kr/mdtoday/index.html?no=379716
1954,2020-03-06,대웅그룹경영진4억원규모자사주장내매수,http://www.koreastocknews.com/news/articleView.html?idxno=51386
1955,2020-03-06,대웅그룹경영진4억원대자사주매입,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1078192
1956,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://news.mt.co.kr/mtview.php?no=2020030613055412896
1957,2020-03-06,대웅그룹경영진4억규모자사주매입미래성장자신”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1866575
1958,2020-03-06,대웅그룹경영진4억규모자사주매입책임경영미래성장자신감표명​,http://www.ezyeconomy.com/news/articleView.html?idxno=98643
1959,2020-03-06,대웅그룹경영진4억규모자사주매입책임경영의지표명,http://www.newsprime.co.kr/news/article.html?no=496111
1960,2020-03-06,대웅그룹경영진나서4억원규모자사주매입이달에만두번째,http://www.donga.com/news/article/all/20200306/100039331/1
1961,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.newspim.com/news/view/20200306000696
1962,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감,http://www.pressm.kr/news/articleView.html?idxno=28031
1963,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.segyebiz.com/newsView/20200306509404?OutUrl=naver
1964,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://daily.hankooki.com/lpage/ittech/202003/dh20200306135952145630.htm
1965,2020-03-06,제약오늘대웅그룹경영진4억규모자사주매입유사나헬스사이언스대구광역시재난안전대책본부에종합비타민기부,http://www.sisaon.co.kr/news/articleView.html?idxno=110101
1966,2020-03-06,대웅그룹경영진4억원규모자사주매입,https://www.hankyung.com/it/article/202003061836i
1967,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영표명,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020030614030181394
1968,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://medipana.com/news/news_viewer.asp?NewsNum=253751&MainKind=A&NewsKind=5&vCount=12&vKind=1
1969,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영의지,http://www.asiatoday.co.kr/view.php?key=20200306010004142
1970,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감표명,http://www.segye.com/content/html/2020/03/06/20200306510111.html?OutUrl=naver
1971,2020-03-06,대웅바이오신임대표에윤재춘진성곤각자대표체제전환,http://www.asiatoday.co.kr/view.php?key=20200306010004150
1972,2020-03-06,대웅그룹고위경영진4억규모자사주매입,http://www.dailypharm.com/Users/News/NewsView.html?ID=262556&REFERER=NP
1973,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.segye.com/content/html/2020/03/06/20200306510147.html?OutUrl=naver
1974,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.ftoday.co.kr/news/articleView.html?idxno=115311
1975,2020-03-06,대웅바이오윤재춘진성곤각자대표이사체제전환,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241498
1976,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.businesskorea.co.kr/news/articleView.html?idxno=42353
1977,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.ebn.co.kr/news/view/1025204/?sc=naver
1978,2020-03-06,대웅바이오신임대표에윤재춘진성곤각자대표체제로책임경영강화,http://www.greened.kr/news/articleView.html?idxno=240837
1979,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://inthenews.co.kr/article-38874/
1980,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.ekn.kr/news/article.html?no=486018
1981,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.newsis.com/view/?id=NISX20200306_0000945773&cID=13001&pID=13000
1982,2020-03-06,대웅바이오신임대표선임,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60055
1983,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60053
1984,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://news.mt.co.kr/mtview.php?no=2020030614435873522
1985,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.newstomato.com/ReadNews.aspx?no=957437
1986,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.mdtoday.co.kr/mdtoday/index.html?no=379730
1987,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감표명,http://www.ekn.kr/news/article.html?no=486020
1988,2020-03-06,대웅바이오윤재춘진성곤투톱체제원료바이오강화목표,http://moneys.mt.co.kr/news/mwView.php?no=2020030614308065821
1989,2020-03-06,대웅바이오신임대표선임,http://www.bosa.co.kr/news/articleView.html?idxno=2122852
1990,2020-03-06,대웅바이오윤재춘진성곤각자대표선임,http://www.biospectator.com/view/news_view.php?varAtcId=9730
1991,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.ebn.co.kr/news/view/1025217/?sc=naver
1992,2020-03-06,대웅바이오윤재춘진성곤투톱체제원료완제의약품전문성강화,http://www.medisobizanews.com/news/articleView.html?idxno=67579
1993,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.mediapen.com/news/view/506271
1994,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.newspim.com/news/view/20200306000803
1995,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.seoulwire.com/news/articleView.html?idxno=402176
1996,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제,http://medipana.com/news/news_viewer.asp?NewsNum=253753&MainKind=A&NewsKind=5&vCount=12&vKind=1
1997,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.newsprime.co.kr/news/article.html?no=496145
1998,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://biz.newdaily.co.kr/site/data/html/2020/03/06/2020030600161.html
1999,2020-03-06,대웅그룹경영진4억원규모자사주매입,https://www.paxnetnews.com/articles/57967
2000,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.dailypharm.com/Users/News/NewsView.html?ID=262562&REFERER=NP
2001,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.segyebiz.com/newsView/20200306511514?OutUrl=naver
2002,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.dailysmart.co.kr/news/articleView.html?idxno=23369
2003,2020-03-06,대웅바이오신임대표윤재춘진성곤선임,http://www.pressm.kr/news/articleView.html?idxno=28032
2004,2020-03-06,대웅그룹경영진4억규모자사주매입,https://asiatime.co.kr/news/newsview.php?ncode=1065591998650138
2005,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.medigatenews.com/news/1684680197
2006,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.m-i.kr/news/articleView.html?idxno=688763
2007,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.etoday.co.kr/news/section/newsview.php?idxno=1866692
2008,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영의지,http://www.seoulwire.com/news/articleView.html?idxno=402194
2009,2020-03-06,대웅대웅제약경영진4억원어치자사주매입자신감책임경영,http://www.upinews.kr/newsView/upi202003060103
2010,2020-03-06,대웅그룹경영진4억규모자사주매입주주가치제고책임경영일환,http://sports.chosun.com/news/ntype.htm?id=202003070100050210003056&servicedate=20200306
2011,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로,http://www.finomy.com/news/articleView.html?idxno=75889
2012,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.wikileaks-kr.org/news/articleView.html?idxno=79640
2013,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로,http://www.whosaeng.com/116263
2014,2020-03-06,대웅그룹경영진4억규모자사주매입책임경영과미래성장자신감표명​,http://www.m-i.kr/news/articleView.html?idxno=688803
2015,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제전환,http://www.nbnnews.co.kr/news/articleView.html?idxno=375629
2016,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감표명​​,http://www.nbnnews.co.kr/news/articleView.html?idxno=375628
2017,2020-03-06,대웅그룹경영진4억원규모자사주매입,https://www.news2day.co.kr/149276
2018,2020-03-06,게시판대웅그룹경영진4억원규모자사주매입,http://yna.kr/AKR20200306142900017?did=1195m
2019,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.dailymedi.com/detail.php?number=853676&thread=22r05
2020,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영의지,http://news.tf.co.kr/read/economy/1784559.htm
2021,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,https://www.paxnetnews.com/articles/57974
2022,2020-03-06,대웅바이오신임대표이사로윤재춘진성곤선임각자대표체제로전환,http://www.updownnews.co.kr/news/articleView.html?idxno=215976
2023,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감표명​,http://www.lawissue.co.kr/view.php?ud=202003061627481488204ead0791_12
2024,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://newsbrite.net/134545
2025,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감표명,http://newsbrite.net/134544
2026,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.lawissue.co.kr/view.php?ud=202003061635593621204ead0791_12
2027,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,https://www.news2day.co.kr/149277
2028,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.insightkorea.co.kr/news/articleView.html?idxno=77968
2029,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://it.chosun.com/site/data/html_dir/2020/03/06/2020030602516.html
2030,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환원료완제의약품전문성강화,http://sports.hankooki.com/lpage/economy/202003/sp20200306164705137020.htm
2031,2020-03-06,대웅그룹경영진윤재춘진성곤각자대표체제로전환,http://newsclaim.co.kr/View.aspx?No=769743
2032,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.bokuennews.com/news/article.html?no=187523
2033,2020-03-06,대웅그룹경영진4억원규모자사주매입미래성장자신감표명,http://www.consumernews.co.kr/news/articleView.html?idxno=602253
2034,2020-03-06,대웅그룹경영진4억원규모자사주매입,https://www.news1.kr/articles/?3865389
2035,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00004&news_seq_no=4079947
2036,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.fntoday.co.kr/news/articleView.html?idxno=212132
2037,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.monews.co.kr/news/articleView.html?idxno=208898
2038,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환,http://www.monews.co.kr/news/articleView.html?idxno=208897
2039,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://moneys.mt.co.kr/news/mwView.php?no=2020030617088093796
2040,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영나서,https://www.dailian.co.kr/news/view/873840?sc=Naver
2041,2020-03-06,대웅바이오윤재춘진성곤각자대표체제전환투트랙전략가동”,http://www.donga.com/news/article/all/20200306/100044419/1
2042,2020-03-06,대웅바이오신임대표선임제2의도약노린다,http://www.mhj21.com/128162
2043,2020-03-06,대웅바이오신임대표에윤재춘진성곤선임,http://www.bokuennews.com/news/article.html?no=187524
2044,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영의지,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003895789
2045,2020-03-06,대웅바이오신임대표로윤재춘진성곤선임하며각자대표체제로전환,http://www.g-enews.com/ko-kr/news/article/news_all/20200306164000243569d76442fa_1/article.html
2046,2020-03-06,대웅바이오각자대표이사선임,http://news.mk.co.kr/newsRead.php?no=239518&year=2020
2047,2020-03-06,대웅바이오신임윤재춘진성곤각자대표체제전환,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003895864
2048,2020-03-06,대웅제약그룹윤재춘전승호이창재등경영진이4억원어치자사주매입,http://news.mk.co.kr/newsRead.php?no=239681&year=2020
2049,2020-03-06,대웅대웅제약경영진자사주4억원매입,http://www.shinailbo.co.kr/news/articleView.html?idxno=1256831
2050,2020-03-06,대웅바이오신임대표윤재춘부사장진성곤선임각자대표체제로전환,http://www.thefirstmedia.net/news/articleView.html?idxno=55374
2051,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감표명,http://www.thefirstmedia.net/news/articleView.html?idxno=55373
2052,2020-03-06,대웅바이오윤재춘사장진성곤부사장각자대표체제로전환,http://www.ceoscoredaily.com/news/article.html?no=66978
2053,2020-03-06,대웅그룹경영진자사주매입책임경영,http://sports.khan.co.kr/news/sk_index.html?art_id=202003061813003&sec_id=564001&pt=nv
2054,2020-03-06,대웅그룹경영진4억원치자사주매입책임경영,http://www.seoulfn.com/news/articleView.html?idxno=374544
2055,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1078219
2056,2020-03-06,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.seoulfn.com/news/articleView.html?idxno=374547
2057,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영과미래성장자신감표명,http://www.thevaluenews.co.kr/news/view.php?idx=158618
2058,2020-03-06,대웅바이오신임윤재춘진성곤각자대표체제로전환,http://www.thevaluenews.co.kr/news/view.php?idx=158619
2059,2020-03-06,대웅바이오각자대표이사체제로바꾸고윤재춘진성곤선임,http://www.businesspost.co.kr/BP?command=article_view&num=167313
2060,2020-03-06,윤재춘전승호대웅과대웅제약주식각각2억과1억사들여,http://www.businesspost.co.kr/BP?command=article_view&num=167328
2061,2020-03-06,대웅바이오원료전문의약품전문성강화윤재춘진성곤각자대표체제,http://www.econovill.com/news/articleView.html?idxno=388156
2062,2020-03-06,대웅그룹경영진4억원규모자사주매입,http://www.econovill.com/news/articleView.html?idxno=388157
2063,2020-03-06,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.newscj.com/news/articleView.html?idxno=715593
2064,2020-03-06,대웅그룹경영진4억원규모자사주매입책임경영자신감,http://www.newscj.com/news/articleView.html?idxno=715596
2065,2020-03-07,대웅제약발달장애인을위한코로나19쉬운글도서배포,http://www.thefirstmedia.net/news/articleView.html?idxno=55394
2066,2020-03-07,경제계인사대웅바이오새대표이사에윤재춘진성곤씨,https://biz.chosun.com/site/data/html_dir/2020/03/07/2020030700161.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2067,2020-03-07,박일경의바이오돋보기메디톡스vs대웅제약보톡스전쟁왜,http://www.edaily.co.kr/news/newspath.asp?newsid=01558006625701024
2068,2020-03-07,대웅바이오윤재춘진성곤신임대표선임,http://www.betanews.net:8080/article/1144645.html
2069,2020-03-07,대웅그룹경영진4억원규모자사주매입,https://www.kpanews.co.kr/article/show.asp?idx=211485&category=D
2070,2020-03-07,故신격호명예회장49재조계사대웅전서막재치뤄,http://www.edaily.co.kr/news/newspath.asp?newsid=01653126625701024
2071,2020-03-08,대웅바이오윤재춘진성곤각자대표체제로전환,http://www.viva100.com/main/view.php?key=20200308010003067
2072,2020-03-08,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.cnbnews.com/news/article.html?no=439218
2073,2020-03-08,대웅그룹경영진4억원규모자사주매입주주가치제고일환”,http://www.viva100.com/main/view.php?key=20200308010003075
2074,2020-03-08,대웅바이오윤재춘진성곤각자대표체제전환,http://www.polinews.co.kr/news/article.html?no=455362
2075,2020-03-09,대웅그룹경영진4억원규모자사주매입,http://www.g-enews.com/ko-kr/news/article/news_all/20200309024056899469d76442fa_1/article.html
2076,2020-03-09,대웅바이오윤재춘진성곤각자대표체제로전환,http://kormedi.com/?p=1313029
2077,2020-03-09,대웅그룹경영진4억원규모자사주매입,http://www.dailymedi.com/detail.php?number=853743&thread=22r05
2078,2020-03-09,인사대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.thepublic.kr/news/newsview.php?ncode=1065577196600971
2079,2020-03-09,대웅제약특별관계자지분변동,http://news.kmib.co.kr/article/view.asp?arcid=0014336061&code=61141211&cp=nv
2080,2020-03-09,대웅제약특별관계자지분변동,http://www.mdtoday.co.kr/mdtoday/index.html?no=379918
2081,2020-03-09,걱정말아요대웅제약전승호사장자사주1000주매입,http://www.wikileaks-kr.org/news/articleView.html?idxno=79813
2082,2020-03-10,메디톡스대웅자사주매입美보톡스균소송자신감피력,http://www.ebn.co.kr/news/view/1025649/?sc=naver
2083,2020-03-10,일동보령대웅일양메디팜등7개임신테스트기검사결과부정확,https://www.news1.kr/articles/?3868363
2084,2020-03-10,임신테스트기일동보령메디팜일양칸젠대웅제품부정확,https://www.ibabynews.com/news/articleView.html?idxno=83180
2085,2020-03-10,일동보령일양대웅등임신테스트기7개제품결과부정확,http://www.upinews.kr/newsView/upi202003100074
2086,2020-03-10,일동보령대웅일양메디팜임신테스트기30이상부정확,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=115234
2087,2020-03-11,일동제약보령컨슈머메디팜일양약품칸젠대웅제약임신테스트기민감도기준미달,http://medicalworldnews.co.kr/news/view.php?idx=1510934620
2088,2020-03-11,메디톡스vs대웅제약ITC소송승패따라벌어질결과는,https://www.dailian.co.kr/news/view/874828?sc=Naver
2089,2020-03-11,대웅제약신약DWP16001병용투여임상돌입,http://www.finomy.com/news/articleView.html?idxno=76027
2090,2020-03-11,파주연천축협코로나19장기화수위대웅,http://www.fntimes.com/html/view.php?ud=20200311181809216dd55077bc2_18
2091,2020-03-11,전승호대웅제약신약개발경쟁력키우기위해스타트업투자본격화,http://www.businesspost.co.kr/BP?command=article_view&num=168037
2092,2020-03-12,대웅바이오신임대표선임윤재춘진성곤각자대표체제로전환,http://www.wsobi.com/news/articleView.html?idxno=92522
2093,2020-03-12,대웅제약vs메디톡스판박이제2의균주전쟁,http://www.edaily.co.kr/news/newspath.asp?newsid=04070486625702664
2094,2020-03-13,양윤선메디포스트대표대웅제약사외이사퇴임줄기세포치료제협업끝,http://www.consumernews.co.kr/news/articleView.html?idxno=602518
2095,2020-03-13,더벨보톡스열전대웅제약2조미국시장가장먼저연다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202003052227002560108434
2096,2020-03-13,하이로우대웅제약ITC소송부담목표가↓한화투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020031308493712965
2097,2020-03-13,대웅제약전일대비1024하락이시각거래량1만2683주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003130106&t=NN
2098,2020-03-13,대웅제약목표주가낮아져영업위축에나보타소송도불확실,http://www.businesspost.co.kr/BP?command=article_view&num=168337
2099,2020-03-13,리포트브리핑대웅제약최악의시나리오기반영중목표가120000원삼성증권,http://www.newspim.com/news/view/20200313000287
2100,2020-03-13,리포트브리핑대웅제약업황업데이트목표가120000원한화투자증권,http://www.newspim.com/news/view/20200313000329
2101,2020-03-13,대웅제약연결대상종속기업매출기여도1위한올,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241766
2102,2020-03-13,라니티딘직격탄대웅일동스티렌제네릭되살려,http://www.dailypharm.com/Users/News/NewsView.html?ID=262779&REFERER=NP
2103,2020-03-13,대웅제약메디톡스와의ITC소송이슈에관심집중”,http://www.wikitree.co.kr/articles/513629
2104,2020-03-13,대웅제약하락출발후꾸준히올라976↑차트하락세중상승전환,http://www.newspim.com/news/view/20200313000621
2105,2020-03-13,특징주대웅제약79000원13일13시0분장시작대비647상승,http://www.getnews.co.kr/view.php?ud=202003131301404290c20b927e9b_16
2106,2020-03-13,대웅제약5이상상승전일기관대량순매도,https://www.hankyung.com/finance/article/202003139214L
2107,2020-03-13,대웅하락출발후꾸준히올라1547↑차트하락세중상승전환,http://www.newspim.com/news/view/20200313000623
2108,2020-03-13,대웅15이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003139220L
2109,2020-03-13,일양약품대웅제약희비엇갈려일양약품상한가반해대웅제약4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=112173
2110,2020-03-13,대웅제약코로나19치료효과일양약품슈펙트판권보유↑,http://www.sentv.co.kr/news/view/569845
2111,2020-03-13,대웅제약나보타미국ITC결정기반영영향제한적,http://www.beyondpost.co.kr/view.php?ud=202003131439321443c5c1bde209_30
2112,2020-03-13,주식대웅제약1488급등코로나19치료효과슈펙트가뭐길래,http://www.ggilbo.com/news/articleView.html?idxno=752634
2113,2020-03-13,일양약품슈펙트코로나19치료효과에대웅제약주가상승왜,http://moneys.mt.co.kr/news/mwView.php?no=2020031314588048055
2114,2020-03-13,특징주일양약품녹십자셀대웅제약상한가서킷브레이커장세뚫고급등,http://www.thevaluenews.co.kr/news/view.php?idx=158736
2115,2020-03-13,일양약품슈펙트코로나19치료제개발기대대웅제약도주가상승,http://sports.hankooki.com/lpage/economy/202003/sp20200313175652137020.htm
2116,2020-03-13,일양약품슈펙트코로나19치료효과에상한가국내판권가진대웅제약5↑,http://www.segye.com/content/html/2020/03/13/20200313512136.html?OutUrl=naver
2117,2020-03-13,대웅제약전략적오픈콜라보레이션통한미래가치창출신약개발박차,http://www.ftoday.co.kr/news/articleView.html?idxno=115592
2118,2020-03-13,양윤선메디포스트대표대웅제약사외이사물러나,http://www.dailymedi.com/detail.php?number=853962&thread=22r12
2119,2020-03-16,삭센다비만약시장독식가능성대웅알보젠부상전망,http://www.dailymedi.com/detail.php?number=854007&thread=22r05
2120,2020-03-16,라니티딘퇴출여파대웅일동제약스티렌제네릭다시품목허가획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=380455
2121,2020-03-16,대웅제약747상승출발,http://www.newspim.com/news/view/20200316000198
2122,2020-03-16,일양약품대웅제약급등에상한가까지특히일양약품2거래일연속상한가,http://www.econonews.co.kr/news/articleView.html?idxno=112440
2123,2020-03-16,대웅제약5이상상승업황업데이트한화투자증권BUY유지,https://www.hankyung.com/finance/article/202003163150L
2124,2020-03-16,대웅제약상승출발후현재554이시각거래량30만5649주,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003160210&t=NN
2125,2020-03-16,주식대웅제약305하락후반등슈펙트코로나19치료제개발기대,http://www.ggilbo.com/news/articleView.html?idxno=753044
2126,2020-03-16,대웅제약000VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/16/2020031601637.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2127,2020-03-17,대웅제약의불확실성ITC소송경우의수3가지,http://moneys.mt.co.kr/news/mwView.php?no=2020031611398065243
2128,2020-03-17,明약이야기④피로는간때문이야국내대표간장약대웅제약우루사,http://www.asiatoday.co.kr/view.php?key=20200316010009983
2129,2020-03-17,매출1조제약기업은8곳콜마유한녹십자광동셀트리온한미대웅종근당,http://www.medigatenews.com/news/2550264139
2130,2020-03-17,일양약품대웅제약급락에무너지는주가특히일양약품갑작스런10급락,http://www.econonews.co.kr/news/articleView.html?idxno=112607
2131,2020-03-17,일양약품대웅제약하락에급락까지특히일양약품가파른하락세로7급락,http://www.econonews.co.kr/news/articleView.html?idxno=112708
2132,2020-03-18,제약대웅제약혁신적연구기술로넥스트나보타만든다,http://news.mk.co.kr/newsRead.php?no=278665&year=2020
2133,2020-03-18,대웅바이오인도네시아법인설립해외공략속도,http://www.ceoscoredaily.com/news/article.html?no=67321
2134,2020-03-18,중부국세청대웅바이오세무조사착수,http://www.sejungilbo.com/news/articleView.html?idxno=20558
2135,2020-03-18,일양약품대웅제약희비엇갈려특히일양약품하락부진이어지나,http://www.econonews.co.kr/news/articleView.html?idxno=112764
2136,2020-03-18,대웅세계최초폐섬유증신약글로벌임상순항,http://www.dailypharm.com/Users/News/NewsView.html?ID=262911&REFERER=NP
2137,2020-03-18,대웅제약상승흐름전일대비528이평선역배열상황에서반등시도,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003180142&t=NN
2138,2020-03-18,대웅제약5이상상승업황업데이트한화투자증권BUY유지,https://www.hankyung.com/finance/article/202003180174L
2139,2020-03-18,대웅제약세계최초코로나19감염동반폐섬유증신약개발↑,http://www.sentv.co.kr/news/view/570053
2140,2020-03-18,대웅제약상승출발후현재는1121↑긴하락구간에서주가급등,http://www.newspim.com/news/view/20200318000688
2141,2020-03-18,대웅127상승중차트하락세중상승전환,http://www.newspim.com/news/view/20200318000687
2142,2020-03-18,대웅1233VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/18/2020031802142.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2143,2020-03-18,대웅제약462VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/18/2020031802144.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2144,2020-03-18,대웅842상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/18/2020031802143.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2145,2020-03-18,대웅10이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003180383L
2146,2020-03-18,특징주대웅제약85900원18일11시0분장시작대비1199상승,http://www.getnews.co.kr/view.php?ud=202003181101394233c20b93777c_16
2147,2020-03-18,일양약품대웅제약엇갈리는주가여전특히일양약품오후가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=112830
2148,2020-03-19,일양약품대웅제약하락부진딛고상승세로특히일양약품19폭락벗어나3만원선회복하나,http://www.econonews.co.kr/news/articleView.html?idxno=112881
2149,2020-03-19,대웅774VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/19/2020031903746.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2150,2020-03-19,대웅제약790VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/19/2020031903946.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2151,2020-03-19,대웅제약전일대비1008하락중이시각11만9986주거래,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003190334&t=NN
2152,2020-03-19,일양약품대웅제약급락에폭락까지특히일양약품12폭락에투자자들어떡하나,http://www.econonews.co.kr/news/articleView.html?idxno=112961
2153,2020-03-19,녹십자대웅삼진제약등유명진통제WHO사용금지권고이부프로펜성분소비자혼란,http://www.topdaily.kr/news/articleView.html?idxno=65292
2154,2020-03-20,대웅제약코로나19에도성장세위기서빛났다,http://www.bosa.co.kr/news/articleView.html?idxno=2123709
2155,2020-03-20,대웅vs엘러간벨카이라특허분쟁2년째표류중,http://www.dailypharm.com/Users/News/NewsView.html?ID=262990&REFERER=NP
2156,2020-03-20,일양약품대웅제약급락벗어나상승세로특히대웅제약가파른상승세로4상승,http://www.econonews.co.kr/news/articleView.html?idxno=113000
2157,2020-03-20,대웅제약5이상상승최근5일간기관대량순매도,https://www.hankyung.com/finance/article/202003206320L
2158,2020-03-20,대웅전일대비71올라하락흐름중단기급등발생,http://www.newspim.com/news/view/20200320001397
2159,2020-03-20,대웅972VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/20/2020032002656.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2160,2020-03-20,대웅10이상상승주가반등시도단기중기이평선역배열,https://www.hankyung.com/finance/article/202003207500L
2161,2020-03-20,대웅제60기 대웅제약제18기주주총회개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=42997
2162,2020-03-20,대웅제약매출1조52억원달성파이프라인순항,http://www.dailypharm.com/Users/News/NewsView.html?ID=263021&REFERER=NP
2163,2020-03-20,대웅제약나보타미국유럽포함선진국진출본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242073
2164,2020-03-20,대웅제약나보타미국유럽포함선진국진출본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242073
2165,2020-03-20,대웅대웅제약정우방감사신규선임등주주총회개최,http://www.ftoday.co.kr/news/articleView.html?idxno=115819
2166,2020-03-20,주총대웅제약매출1조원첫돌파나보타글로벌진출확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020032013123789042
2167,2020-03-20,대웅대웅제약정기주총개최윤재춘대표이사글로벌사업영역확대”,http://www.mdtoday.co.kr/mdtoday/index.html?no=381178
2168,2020-03-20,대웅대웅제약주총신약개발성과가시화원년,http://www.newsis.com/view/?id=NISX20200320_0000963681&cID=13001&pID=13000
2169,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://medipana.com/news/news_viewer.asp?NewsNum=254432&MainKind=A&NewsKind=5&vCount=12&vKind=1
2170,2020-03-20,대웅지난해매출1조3657억원영업이익1075억원,http://www.ceoscoredaily.com/news/article.html?no=67495
2171,2020-03-20,주총현장전승호대웅제약대표올해본격적으로성과나타날것,http://news.mk.co.kr/newsRead.php?no=290596&year=2020
2172,2020-03-20,대웅대웅제약정기주총성과가시화원년될것,http://www.mediapen.com/news/view/510164
2173,2020-03-20,대웅대웅제약주주총회개최글로벌사업확대통해건실한성과창출”,http://www.donga.com/news/article/all/20200320/100254454/1
2174,2020-03-20,대웅대웅제약정기주주총회개최책임경영으로실적창출계속하겠다,http://www.sporbiz.co.kr/news/articleView.html?idxno=423515
2175,2020-03-20,대웅제약첫매출1조원신약개발성과본격화기대,http://news.mt.co.kr/mtview.php?no=2020032013474388208
2176,2020-03-20,대웅대웅제약주주총회글로벌사업확대나보타성과본격화”,http://www.viva100.com/main/view.php?key=20200320010008460
2177,2020-03-20,대웅제약전우방감사신규선임글로벌사업확대다양한파이프확보,http://www.medisobizanews.com/news/articleView.html?idxno=68037
2178,2020-03-20,대웅대웅제약주주총회개최경영진책임경영체제구축,http://www.newsprime.co.kr/news/article.html?no=498012
2179,2020-03-20,전승호대웅제약대표이사나보타미국유럽등선진국본격진출,http://www.m-i.kr/news/articleView.html?idxno=693546
2180,2020-03-20,대웅제약594상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/20/2020032003565.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2181,2020-03-20,주식대웅제약281소폭상승백혈병신약슈펙트는무엇,http://www.ggilbo.com/news/articleView.html?idxno=754282
2182,2020-03-20,대웅대웅제약2020년주주총회개최대웅제약사상처음으로별도매출기준1조원돌파,http://www.updownnews.co.kr/news/articleView.html?idxno=216585
2183,2020-03-20,주총전승호대웅제약대표미국유럽진출등신약개발성과나타날것,http://moneys.mt.co.kr/news/mwView.php?no=2020032013358084981
2184,2020-03-20,대웅제약엑셀러레이터사업착수벤처기업키운다,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003200386&t=NN
2185,2020-03-20,주총대웅대웅제약주주총회개최글로벌사업영역확대할것,https://www.dailian.co.kr/news/view/877599?sc=Naver
2186,2020-03-20,대웅제약사상처음으로별도매출기준1조원돌파신기록,http://www.segye.com/content/html/2020/03/20/20200320509337.html?OutUrl=naver
2187,2020-03-20,주총대웅대웅제약책임경영체제구축글로벌사업확대,http://www.dailysmart.co.kr/news/articleView.html?idxno=23976
2188,2020-03-20,2020주총대웅대웅제약글로벌사업영역확대”,http://www.newsway.co.kr/news/view?tp=1&ud=2020032014374259041
2189,2020-03-20,대웅대웅제약정기주총개최엑셀레이터사업추가,http://www.kpinews.co.kr/news/articleView.html?idxno=112935
2190,2020-03-20,주총대웅대웅제약주주총회개최글로벌사업확대,http://www.newspim.com/news/view/20200320002294
2191,2020-03-20,대웅대웅제약주주총회개최감사선임정관변경등의결,http://www.greened.kr/news/articleView.html?idxno=243174
2192,2020-03-20,전승호대웅제약대표올해신약개발성과본격화,http://www.asiatoday.co.kr/view.php?key=20200320010013047
2193,2020-03-20,대웅제약전승호대표글로벌사업영역확대파이프라인확보통해글로벌2025비전달성할것”,https://www.news2day.co.kr/149917
2194,2020-03-20,대웅대웅제약정기주주총회개최,http://www.ebn.co.kr/news/view/1027392/?sc=naver
2195,2020-03-20,전승호대웅제약대표올해신약개발성과본격화글로벌사업확대”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873000
2196,2020-03-20,대웅대웅제약주주총회개최19년실적보고및신규사업위한정관변경등안건의결,http://www.paxetv.com/news/articleView.html?idxno=88607
2197,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=379478
2198,2020-03-20,대웅대웅제약정기주주총회대웅윤재춘대표자회사성장힘입어건실한경영성과지속”,http://www.thepublic.kr/news/newsview.php?ncode=1065591392128812
2199,2020-03-20,18기주총대웅제약나보타선진시장진출본격화강조,http://www.bosa.co.kr/news/articleView.html?idxno=2123796
2200,2020-03-20,대웅제약신규사업추가전우방감사선임신약개발본격화,http://www.medigatenews.com/news/2331461074
2201,2020-03-20,대웅대웅제약매출1조원돌파주총서보고비전2025박차,http://www.econovill.com/news/articleView.html?idxno=390060
2202,2020-03-20,대웅대웅제약주총글로벌사업확대할것,http://health.chosun.com/site/data/html_dir/2020/03/20/2020032004594.html
2203,2020-03-20,대웅제약매출1조원돌파신약개발성과본격화될것,http://sports.hankooki.com/lpage/economy/202003/sp20200320154800137020.htm
2204,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60299
2205,2020-03-20,대웅제약지난해1조원돌파보툴리눔진출본격화할것,http://kormedi.com/?p=1313753
2206,2020-03-20,대웅대웅제약정기주주총회개최올해신약개발성과본격화될것,http://www.ekn.kr/news/article.html?no=488945
2207,2020-03-20,대웅제약사상처음으로별도매출기준1조원돌파,http://www.fnnews.com/news/202003201611334420
2208,2020-03-20,대웅제약별도기준매출1조돌파,http://www.whosaeng.com/116553
2209,2020-03-20,2020주총대웅제약글로벌사업영역확대및다양한파이프라인확보의지재천명,http://www.newslock.co.kr/news/articleView.html?idxno=26611
2210,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://newsbrite.net/135005
2211,2020-03-20,㈜대웅대웅제약정기주주총회개최,http://www.g-enews.com/ko-kr/news/article/news_all/20200320151543906769d76442fa_1/article.html
2212,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.lawissue.co.kr/view.php?ud=202003201704329954204ead0791_12
2213,2020-03-20,대웅대웅제약주주총회개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1376000
2214,2020-03-20,대웅대웅제약주총해외사업집중방침,http://www.economytalk.kr/news/articleView.html?idxno=204961
2215,2020-03-20,대웅대웅제약주총사업고도화로글로벌사업확대,http://www.meconomynews.com/news/articleView.html?idxno=39344
2216,2020-03-20,대웅제60기대웅제약제18기주주총회개최,http://www.thefirstmedia.net/news/articleView.html?idxno=55951
2217,2020-03-21,2020제약회사주주총회대웅대웅제약일동제약일동홀딩스신약개발과사업다각화매진,http://www.polinews.co.kr/news/article.html?no=456858
2218,2020-03-22,대웅제약보툴리눔톡신품질자신전승호싼가격으로유럽들어간다,http://www.businesspost.co.kr/BP?command=article_view&num=169637
2219,2020-03-22,대웅대웅제약정기주주총회개최,http://www.cnbnews.com/news/article.html?no=440729
2220,2020-03-22,대웅코로나19위기상황에서전문약처방선전,http://www.dailymedi.com/detail.php?number=854259&thread=22r05
2221,2020-03-23,단독메디톡스균주절취거짓인줄알면서도대웅제약소송이용하려고허위주장”,http://www.segye.com/content/html/2020/03/22/20200322506999.html?OutUrl=naver
2222,2020-03-23,일양약품대웅제약하락세로부진특히일양약품다시하락수렁빠지나,http://www.econonews.co.kr/news/articleView.html?idxno=113382
2223,2020-03-23,거짓알고서도소송메디톡스대웅제약균주분쟁점입가경,http://news.mt.co.kr/mtview.php?no=2020032308031313668
2224,2020-03-23,지노믹트리대웅제약얼리텍®대장암검사마케팅및판매협력MOU체결,http://news.heraldcorp.com/view.php?ud=20200323000197
2225,2020-03-23,대웅제약지노믹트리얼리텍대장암검사마케팅판매MOU,http://www.medisobizanews.com/news/articleView.html?idxno=68074
2226,2020-03-23,지노믹트리대웅제약대장암검사MOU,http://www.medical-tribune.co.kr/news/articleView.html?idxno=91349
2227,2020-03-23,지노믹트리대웅제약얼리텍대장암검사판매협력MOU,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873644
2228,2020-03-23,지노믹트리대웅제약대장암조기진단마케팅판매협약,http://www.biospectator.com/view/news_view.php?varAtcId=9848
2229,2020-03-23,지노믹트리대웅제약얼리텍®대장암검사마케팅및판매맞손,http://www.viva100.com/main/view.php?key=20200323010009137
2230,2020-03-23,지노믹트리대웅제약과얼리텍®판매협력MOU체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873635
2231,2020-03-23,지노믹트리대웅제약과얼리텍®판매협력MOU체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873635
2232,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사마케팅협약체결,http://www.fnnews.com/news/202003231040308142
2233,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅판매협력MOU체결,https://sports.donga.com/article/all/20200323/100301424/1
2234,2020-03-23,대웅제60기대웅제약제18기주주총회성황리개최,http://www.pressm.kr/news/articleView.html?idxno=28386
2235,2020-03-23,지노믹트리대웅제약과대장암조기검사마케팅맞손,http://www.edaily.co.kr/news/newspath.asp?newsid=02492806625706272
2236,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사마케팅판매협력,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020032311061566189
2237,2020-03-23,지노믹트리대웅제약과대장암검사MOU체결,http://www.newsis.com/view/?id=NISX20200323_0000965939&cID=10401&pID=10400
2238,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅및판매협력MOU체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60305
2239,2020-03-23,지노믹트리대웅제약대장암검사공동마케팅나서,http://www.monews.co.kr/news/articleView.html?idxno=209331
2240,2020-03-23,지노믹트리대웅얼리텍대장암검사마케팅판매협력MOU,http://www.ebn.co.kr/news/view/1027614/?sc=naver
2241,2020-03-23,공시대웅바이오주당15만원중간배당,http://www.fnnews.com/news/202003231128303526
2242,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅MOU,http://medipana.com/news/news_viewer.asp?NewsNum=254513&MainKind=A&NewsKind=5&vCount=12&vKind=1
2243,2020-03-23,지노믹트리대웅제약과손잡고대장암조기진단검사공동판매,http://www.businesspost.co.kr/BP?command=article_view&num=169746
2244,2020-03-23,대웅바이오주당15만원중간배당,http://www.newsprime.co.kr/news/article.html?no=498182
2245,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅및판매협력MOU체결,http://sports.chosun.com/news/ntype.htm?id=202003240100180360011364&servicedate=20200323
2246,2020-03-23,실적호조대웅바이오300억배당잔치업계최대규모,http://www.dailypharm.com/Users/News/NewsView.html?ID=263075&REFERER=NP
2247,2020-03-23,대웅제약대장암검사얼리텍판다,http://www.whosaeng.com/116586
2248,2020-03-23,대웅바이오주당15만원중간배당결정,http://www.edaily.co.kr/news/newspath.asp?newsid=02965126625706272
2249,2020-03-23,대웅바이오중간배당1주당15만원현금배당결정,http://www.newspim.com/news/view/20200323000655
2250,2020-03-23,지노믹트리대웅제약대장암키트판매협력,https://www.hankyung.com/it/article/202003232730i
2251,2020-03-23,대웅제약나보타미국캐나다진출올해유럽눈앞,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=241899
2252,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사협력MOU체결,http://news.mk.co.kr/newsRead.php?no=298096&year=2020
2253,2020-03-23,대웅제약전일대비571상승이시각거래량10만4690주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003230361&t=NN
2254,2020-03-23,대웅제약571상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/23/2020032303112.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2255,2020-03-23,대웅제약5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003233111L
2256,2020-03-23,대웅제약586VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/23/2020032303125.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2257,2020-03-23,면역력이답이다비타민B군8종에피로회복까지대웅제약임팩타민프리미엄,http://www.metroseoul.co.kr/article/20200323500253
2258,2020-03-23,지노믹트리대웅제약과얼리텍대장암검사판매협력MOU체결,http://www.m-i.kr/news/articleView.html?idxno=694191
2259,2020-03-23,대웅제약하락출발후현재는796↑차트하락세중상승전환,http://www.newspim.com/news/view/20200323000712
2260,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅판매협력MOU,http://www.mdtoday.co.kr/mdtoday/index.html?no=381367
2261,2020-03-23,지노믹트리대웅제약판매협력MOU체결대장암체외분자진단검사시장확대,http://www.paxetv.com/news/articleView.html?idxno=88694
2262,2020-03-23,SR제약바이오지노믹트리대웅제약과대장암검사마케팅및판매협력,http://www.srtimes.kr/news/articleView.html?idxno=57911
2263,2020-03-23,대웅바이오주당15만원중간배당결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=381389
2264,2020-03-23,대웅자회사대웅바이오로부터300억규모중간배당받아,http://www.businesspost.co.kr/BP?command=article_view&num=169819
2265,2020-03-23,대웅바이오300억원규모현금배당결정,http://medipana.com/news/news_viewer.asp?NewsNum=254534&MainKind=A&NewsKind=5&vCount=12&vKind=1
2266,2020-03-23,대웅자회사대웅제약주식300억원에추가취득,http://yna.kr/AKR20200323157000008?did=1195m
2267,2020-03-23,대웅자회사대웅제약주식300억원에추가취득,http://news.einfomax.co.kr/news/articleView.html?idxno=4078430
2268,2020-03-23,공시대웅자회사대웅제약주식44만1826주추가취득,http://www.newsway.co.kr/news/view?tp=1&ud=2020032317355175682
2269,2020-03-23,대웅제약자기주식처분결정,http://news.kmib.co.kr/article/view.asp?arcid=0014394646&code=61141211&cp=nv
2270,2020-03-23,대웅제약300억원자사주처분으로미래성정동력투자확대,http://www.metroseoul.co.kr/article/20200323500410
2271,2020-03-23,대웅제약자회사한올바이오파마주식100억원에추가취득,http://yna.kr/AKR20200323161700008?did=1195m
2272,2020-03-23,대웅제약100억규모한올바이오파마지분취득결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1873993
2273,2020-03-23,대웅자회사대웅제약주식300억원에추가취득,http://www.asiatoday.co.kr/view.php?key=20200323010014466
2274,2020-03-23,대웅제약자사주처분통해미래성장동력투자확대,https://www.fetv.co.kr/news/article.html?no=50756
2275,2020-03-23,대웅제약자회사한올바이오파마주식100억원에추가취득,http://news.einfomax.co.kr/news/articleView.html?idxno=4078435
2276,2020-03-23,대웅제약자사주처분한올바이오파마100억원주식취득등미래성장동력투자,http://www.etnews.com/20200323000264
2277,2020-03-23,공시대웅제약자회사한올바이오파마주식100억원에추가취득,http://www.newsway.co.kr/news/view?tp=1&ud=2020032317575951861
2278,2020-03-23,대웅제약자사주처분300억원현금확보미래성장동력투자확대,http://www.businesskorea.co.kr/news/articleView.html?idxno=43115
2279,2020-03-23,대웅제약지주사에지분39처분해현금300억원확보,http://www.donga.com/news/article/all/20200323/100311091/1
2280,2020-03-23,대웅제약㈜대웅에자사주처분300억원현금확보,http://daily.hankooki.com/lpage/ittech/202003/dh20200323175516145630.htm
2281,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.nbnnews.co.kr/news/articleView.html?idxno=380009
2282,2020-03-23,대웅300억원규모대웅제약주식추가취득,http://moneys.mt.co.kr/news/mwView.php?no=2020032317518084188
2283,2020-03-23,대웅제약자사주39처분300억현금확보,http://www.edaily.co.kr/news/newspath.asp?newsid=04372246625706272
2284,2020-03-23,대웅제약자사주처분통해미래성장동력투자확대,http://www.kpinews.co.kr/news/articleView.html?idxno=113084
2285,2020-03-23,대웅제약자사주처분통해미래성장동력투자확대,http://www.ebn.co.kr/news/view/1027718/?sc=naver
2286,2020-03-23,대웅제약자사주처분현금300억원확보미래성장동력에투자,http://www.mediapen.com/news/view/510931
2287,2020-03-23,대웅제약300억규모자사주처분미래성장동력투자확대,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874001
2288,2020-03-23,대웅제약자사주300억원처분미래성장동력에투자확대,http://sports.hankooki.com/lpage/economy/202003/sp20200323181351137020.htm
2289,2020-03-23,대웅제약지주사대웅에자사주처분300억원확보,http://www.econovill.com/news/articleView.html?idxno=390425
2290,2020-03-23,배당금으로RD투자대웅의영리한자회사활용법,http://www.dailypharm.com/Users/News/NewsView.html?ID=263097&REFERER=NP
2291,2020-03-23,대웅제약지주사에지분39처분300억원현금확보,http://www.seoulwire.com/news/articleView.html?idxno=404466
2292,2020-03-23,대웅제약지주사대웅에자사주처분300억원현금확보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242155
2293,2020-03-23,대웅제약자사주처분으로300억확보미래성장동력에투자,http://www.newsway.co.kr/news/view?tp=1&ud=2020032318191494618
2294,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.lawissue.co.kr/view.php?ud=202003231824401306204ead0791_12
2295,2020-03-23,대웅제약미래성장동력확보위해300억원규모자사주처분”,http://news.mk.co.kr/newsRead.php?no=300394&year=2020
2296,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.pressm.kr/news/articleView.html?idxno=28400
2297,2020-03-23,대웅제약자사주39처분300억규모현금확보,http://www.newsprime.co.kr/news/article.html?no=498242
2298,2020-03-23,대웅제약300억규모자사주처분미래성장동력투자,http://news.mt.co.kr/mtview.php?no=2020032318185671685
2299,2020-03-23,대웅제약자사주처분현금300억확보RD에통큰투자,http://www.medisobizanews.com/news/articleView.html?idxno=68112
2300,2020-03-23,대웅제약자사주처분전승호300억확보해성장동력에투자”,http://www.businesspost.co.kr/BP?command=article_view&num=169880
2301,2020-03-23,대웅제약자사주처분통해미래성장동력에대한투자확대,http://newsbrite.net/135067
2302,2020-03-23,대웅제약대웅에자사주처분현금확보로투자확대,http://medipana.com/news/news_viewer.asp?NewsNum=254544&MainKind=A&NewsKind=5&vCount=12&vKind=1
2303,2020-03-23,대웅제약자사주처분통해미래성장동력에투자확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=381462
2304,2020-03-23,지노믹트리대웅제약얼리텍대장암검사마케팅판매협력MOU,https://www.kpanews.co.kr/article/show.asp?idx=211922&category=D
2305,2020-03-24,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60336
2306,2020-03-24,대웅제약지주사㈜대웅에자사주처분미래성장동력에대한투자확대,http://www.thefirstmedia.net/news/articleView.html?idxno=56031
2307,2020-03-24,대웅알비스원료변경진행판매재개노린다,http://www.dailypharm.com/Users/News/NewsView.html?ID=263086&REFERER=NP
2308,2020-03-24,희망RD대웅제약창사이래가장화려한신약라인업보유,http://www.newsis.com/view/?id=NISX20200320_0000964379&cID=13001&pID=13000
2309,2020-03-24,노갑용전대웅제약부사장모친상,http://www.bosa.co.kr/news/articleView.html?idxno=2123938
2310,2020-03-24,지노믹트리대웅제약얼리텍대장암검사마케팅MOU체결,http://www.bosa.co.kr/news/articleView.html?idxno=2123933
2311,2020-03-24,대웅제약지주사대웅에자사주39처분,http://www.bosa.co.kr/news/articleView.html?idxno=2123940
2312,2020-03-24,대웅제약300억확보RD확대한올바이오지분확대,http://www.biospectator.com/view/news_view.php?varAtcId=9857
2313,2020-03-24,코스피코스닥23일주요공시대웅제약자회사한올바이오파마주식100억원에추가취득”등,http://www.betanews.net:8080/article/1152851.html
2314,2020-03-24,전일주요공시대웅제약인터로조클리오등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874014
2315,2020-03-24,더벨대웅그룹잇따른자사주매입주가부양올인,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202003231932522240104941
2316,2020-03-24,대웅제약한올바이오파마주식100억원추가취득,http://www.medisobizanews.com/news/articleView.html?idxno=68117
2317,2020-03-24,대웅제약한올바이오파마주식100억원추가취득,http://www.ebn.co.kr/news/view/1027737/?sc=naver
2318,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈편의성접근성개선,http://news.mt.co.kr/mtview.php?no=2020032408411188284
2319,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242164
2320,2020-03-24,대웅제약한올바이오파마주식100억원추가매수결정,http://www.koreastocknews.com/news/articleView.html?idxno=52135
2321,2020-03-24,대웅제약한올바이오파마주식100억추가투자,http://www.getnews.co.kr/view.php?ud=2020032408455426562fe691f917_16
2322,2020-03-24,대웅제약지주사대웅에300억규모자사주처분,http://www.greened.kr/news/articleView.html?idxno=243603
2323,2020-03-24,장마감후공시대웅제약한올바이오파마주식100억추가취득결정外,http://www.ezyeconomy.com/news/articleView.html?idxno=99172
2324,2020-03-24,대웅제약한올바이오파마주식100억어치추가매수,http://www.rapportian.com/news/articleView.html?idxno=124201
2325,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.nbnnews.co.kr/news/articleView.html?idxno=380059
2326,2020-03-24,대웅제약홈페이지사용자친화전면리뉴얼,http://www.medical-tribune.co.kr/news/articleView.html?idxno=91381
2327,2020-03-24,대웅제약5이상상승외국인기관각각3일6일연속순매수,https://www.hankyung.com/finance/article/202003245223L
2328,2020-03-24,대웅제약자사주처분에관계사주가에긍정적KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01781046625706600
2329,2020-03-24,대웅5이상상승주가5일이평선상회단기중기이평선역배열,https://www.hankyung.com/finance/article/202003245296L
2330,2020-03-24,대웅제약홈페이지리뉴얼글로벌헬스케어기업브랜드강화,http://www.kpinews.co.kr/news/articleView.html?idxno=113094
2331,2020-03-24,대웅제약공식웹사이트새단장편의성높였다,http://www.mediapen.com/news/view/511016
2332,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.dailysmart.co.kr/news/articleView.html?idxno=24068
2333,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,https://www.fetv.co.kr/news/article.html?no=50776
2334,2020-03-24,대웅제약공식웹사이트전면리뉴얼고객편의성접근성개선”,http://www.viva100.com/main/view.php?key=20200324010009613
2335,2020-03-24,대웅제약한올바이오파마주식100억추가취득,http://www.newsis.com/view/?id=NISX20200324_0000967315&cID=13001&pID=13000
2336,2020-03-24,한올바이오파마대웅제약이지분추가확보”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874172
2337,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성과접근성개선,http://www.m-i.kr/news/articleView.html?idxno=694449
2338,2020-03-24,대웅제약공식웹사이트전면리뉴얼고객편의성개선,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571703786319
2339,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.bosa.co.kr/news/articleView.html?idxno=2123954
2340,2020-03-24,대웅제약웹사이트전면리뉴얼편의성향상접근성개선 ,http://www.medisobizanews.com/news/articleView.html?idxno=68122
2341,2020-03-24,일양약품대웅제약모두3대상승특히대웅제약7만원선회복,http://www.econonews.co.kr/news/articleView.html?idxno=113539
2342,2020-03-24,대웅제약공식웹사이트리뉴얼편의접근성개선,http://www.newsis.com/view/?id=NISX20200324_0000967332&cID=13001&pID=13000
2343,2020-03-24,대웅제약공식웹사이트전면리뉴얼고객편의성접근성개선,http://www.asiatoday.co.kr/view.php?key=20200324010014696
2344,2020-03-24,대웅제약웹사이트리뉴얼오픈고객편의성및접근성개선,http://www.newspim.com/news/view/20200324000452
2345,2020-03-24,대웅제약공식웹사이트리뉴얼고객편의성접근성개선,http://medipana.com/news/news_viewer.asp?NewsNum=254554&MainKind=A&NewsKind=5&vCount=12&vKind=1
2346,2020-03-24,대웅제약공식웹사이트리뉴얼오픈고객편의성과접근성개선,http://www.sportsseoul.com/news/read/897202?ref=naver
2347,2020-03-24,대웅제약공식웹사이트리뉴얼편의성과접근성개선”,http://www.newsway.co.kr/news/view?tp=1&ud=2020032409425749811
2348,2020-03-24,한올바이오파마대웅제약이주식100억원추가취득,https://www.sedaily.com/NewsView/1Z0BNWBTJP
2349,2020-03-24,대웅제약자사주300억원처분한올바이오파마지분추가취득,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003240116&t=NN
2350,2020-03-24,대웅제약신약개발홈페이지서확인된다,http://www.sisafocus.co.kr/news/articleView.html?idxno=235318
2351,2020-03-24,공시한올바이오파마대웅제약이주식100억원추가취득,http://www.fnnews.com/news/202003241000486851
2352,2020-03-24,대웅제약연구개발현황전면배치등공식웹사이트리뉴얼,http://www.newslock.co.kr/news/articleView.html?idxno=26670
2353,2020-03-24,대웅제약전일대비515상승중이시각거래량4만290주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003240202&t=NN
2354,2020-03-24,대웅734상승중긴하락구간에서주가급등,http://www.newspim.com/news/view/20200324000857
2355,2020-03-24,대웅제약공식홈페이지리뉴얼오픈편의성접근성개선,http://sports.hankooki.com/lpage/economy/202003/sp20200324100710137020.htm
2356,2020-03-24,지노믹트리대웅제약얼리텍대장암검사공동마케팅,http://www.doctorsnews.co.kr/news/articleView.html?idxno=133978
2357,2020-03-24,대웅제약지주사에자사주처분한올바이오파마지분확대RD투자,http://www.sisaweek.com/news/articleView.html?idxno=132243
2358,2020-03-24,대웅제약공식웹사이트전면리뉴얼,http://www.newsfc.co.kr/news/articleView.html?idxno=40396
2359,2020-03-24,특징주대웅제약72200원24일10시20분등락률633,http://www.getnews.co.kr/view.php?ud=202003241022355654c20b962ac2_16
2360,2020-03-24,대웅제약공식홈페이지전면리뉴얼오픈편의성접근성개선,http://www.seoulwire.com/news/articleView.html?idxno=404544
2361,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성및접근성↑,http://www.ekn.kr/news/article.html?no=489496
2362,2020-03-24,대웅제약300억규모자사주처분통해미래성장동력확보한올바이오파마지분추가취득,http://www.ekn.kr/news/article.html?no=489491
2363,2020-03-24,대웅제약자사주처분하며미래성장RD에투자,http://health.chosun.com/site/data/html_dir/2020/03/24/2020032402229.html
2364,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼,http://www.etnews.com/20200324000086
2365,2020-03-24,대웅제약공식웹사이트리뉴얼고객편의성과접근성개선,http://www.econovill.com/news/articleView.html?idxno=390483
2366,2020-03-24,대웅제약자사주처분통해현금300억확보,http://www.wikileaks-kr.org/news/articleView.html?idxno=81323
2367,2020-03-24,대웅제약자사주처분통해미래성장동력에대한투자확대,http://www.bokuennews.com/news/article.html?no=188143
2368,2020-03-24,대웅제약지주사대웅에자사주39처분,http://www.cnbnews.com/news/article.html?no=440898
2369,2020-03-24,대웅제약공식웹사이트전면개편브랜드강화편의성향상,http://www.greened.kr/news/articleView.html?idxno=243663
2370,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.bokuennews.com/news/article.html?no=188147
2371,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60346
2372,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.cstimes.com/news/articleView.html?idxno=407321
2373,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60345
2374,2020-03-24,고객편의성과접근성강화대웅제약공식홈페이지전면개편,http://kpenews.com/View.aspx?No=785645
2375,2020-03-24,대웅제약고객편의성과접근성개선위해공식웹사이트전면리뉴얼오픈,http://www.updownnews.co.kr/news/articleView.html?idxno=216698
2376,2020-03-24,대웅1295VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/24/2020032402796.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2377,2020-03-24,대웅제약자사주팔아미래성장동력에투자,http://www.whosaeng.com/116609
2378,2020-03-24,대웅제약사용자친화홈페이지로개편,https://www.news2day.co.kr/150031
2379,2020-03-24,대웅그룹의자금순환묘수4개계열사맞춤형처방,http://www.dailypharm.com/Users/News/NewsView.html?ID=263099&REFERER=NP
2380,2020-03-24,지노믹트리대웅제약과얼리텍대장암검사국내영업협력,http://www.etnews.com/20200324000128
2381,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.lawissue.co.kr/view.php?ud=20200324125251907204ead0791_12
2382,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.ebn.co.kr/news/view/1027842/?sc=naver
2383,2020-03-24,장중수급포착대웅외국인기관동시순매수주가1957,http://www.newspim.com/news/view/20200324001940
2384,2020-03-24,대웅제약급등전일대비795↑하락흐름중단기급등발생,http://www.newspim.com/news/view/20200324001947
2385,2020-03-24,대웅2460상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/24/2020032403513.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2386,2020-03-24,대웅제약계열대웅바이오세무조사국세청리턴매치,http://www.topdaily.kr/news/articleView.html?idxno=65375
2387,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성접근성개선,http://www.mdtoday.co.kr/mdtoday/index.html?no=381530
2388,2020-03-24,대웅제약고객편의성과정보접근성개선공식웹사이트리뉴얼오픈,http://www.pressm.kr/news/articleView.html?idxno=28429
2389,2020-03-24,대웅제약한올바이오파마주식100억원추가취득,http://www.ajunews.com/view/20200324135906356
2390,2020-03-24,대웅제약웹사이트전면개편고객편의성과접근성개선,http://www.koreaittimes.com/news/articleView.html?idxno=96337
2391,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://newsbrite.net/135097
2392,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://newsbrite.net/135100
2393,2020-03-24,대웅제약대웅에자사주39처분한올바이오파마는지분취득,http://www.polinews.co.kr/news/article.html?no=457176
2394,2020-03-24,효능성분으로약검색대웅제약공식웹사이트새단장,http://theviewers.co.kr/View.aspx?No=786169
2395,2020-03-24,대웅제약공식홈페이지리뉴얼오픈사용자친화적개선,http://www.100ssd.co.kr/news/articleView.html?idxno=67901
2396,2020-03-24,대웅제약자사주처분해미래성장동력투자확대,http://www.medigatenews.com/news/1634871408
2397,2020-03-24,메디톡스대웅제약나란히자사주매입러시왜,http://moneys.mt.co.kr/news/mwView.php?no=2020032414068085694
2398,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://www.sportsseoul.com/news/read/897444?ref=naver
2399,2020-03-24,대웅제약미래성장동력투자확대 ,http://www.monews.co.kr/news/articleView.html?idxno=209373
2400,2020-03-24,대웅제약한올바이오파마주식100억추가취득,http://www.skyedaily.com/news/news_view.html?ID=101392
2401,2020-03-24,대웅제약공식웹사이트전면리뉴얼편의성과접근성개선”,http://www.sporbiz.co.kr/news/articleView.html?idxno=424721
2402,2020-03-24,대웅제약편의접근성높인공식웹사이트공개,http://www.economytalk.kr/news/articleView.html?idxno=205045
2403,2020-03-24,대웅제약자사주처분통해미래성장동력에대한투자확대,https://www.thepublic.kr/news/newsview.php?ncode=1065592432827135
2404,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈고객편의성접근성개선,https://www.thepublic.kr/news/newsview.php?ncode=1065592313604773
2405,2020-03-24,대웅제약기업브랜드강화공식웹사이트리뉴얼,http://newsclaim.co.kr/View.aspx?No=786219
2406,2020-03-24,대웅제약한올바이오파마주식100억원추가취득결정,http://www.medigatenews.com/news/2090542604
2407,2020-03-24,대웅제약홈페이지편의성개선,http://www.seoulfn.com/news/articleView.html?idxno=376541
2408,2020-03-24,미래성장동력투자확대VS주가안정목적대웅제약지주회사에자사주300억규모처분,http://theviewers.co.kr/View.aspx?No=786466
2409,2020-03-24,대웅제약편의성․접근성개선웹사이트전면손질,http://www.whosaeng.com/116625
2410,2020-03-24,대웅한올바이오파마주식100억추가취득예정,http://www.dailymedi.com/detail.php?number=854355&thread=22r05
2411,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,http://www.enewstoday.co.kr/news/articleView.html?idxno=1376721
2412,2020-03-24,대웅제약고객편의성과접근성개선공식웹사이트전면리뉴얼오픈,http://www.wsobi.com/news/articleView.html?idxno=93569
2413,2020-03-24,대웅제약공식웹사이트전면리뉴얼오픈,https://www.kpanews.co.kr/article/show.asp?idx=211955&category=D
2414,2020-03-25,1년만에절반날아간대웅주가자사주매입에주가반등효과,http://www.asiatoday.co.kr/view.php?key=20200324010015270
2415,2020-03-25,대웅제약턱밑지방개선주사제시장뛰어드나,https://www.paxnetnews.com/articles/58525
2416,2020-03-25,일양약품대웅제약모두상승흐름특히대웅제약가파른상승세로5상승,http://www.econonews.co.kr/news/articleView.html?idxno=113677
2417,2020-03-25,대웅제약급등전일대비1102↑긴하락구간에서주가급등,http://www.newspim.com/news/view/20200325001313
2418,2020-03-25,대웅제약1578VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/25/2020032501563.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2419,2020-03-25,대웅전일대비1311올라차트하락세중상승전환,http://www.newspim.com/news/view/20200325001320
2420,2020-03-25,대웅1311VI발동,https://biz.chosun.com/site/data/html_dir/2020/03/25/2020032501573.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2421,2020-03-25,대웅933상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/25/2020032501575.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2422,2020-03-25,대웅통큰자금운용세마리토끼잡는다,http://www.ebn.co.kr/news/view/1028035/?sc=naver
2423,2020-03-25,중기부대웅제약에과태료500만원부과기술침해행정조사거부,https://view.asiae.co.kr/article/2020032508300369251
2424,2020-03-25,대웅제약보톡스기술불법취득조사거부첫과태료부과처분,http://news.mt.co.kr/mtview.php?no=2020032508564823694
2425,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료첫사례,https://www.news1.kr/articles/?3884782
2426,2020-03-25,중기부대웅제약에첫과태료부과처분기술침해행정조사거부,http://www.asiatoday.co.kr/view.php?key=20200325010015439
2427,2020-03-25,기술침해행정조사거부대웅제약에과태료500만원,http://www.newsis.com/view/?id=NISX20200325_0000969149&cID=13001&pID=13000
2428,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료부과,http://yna.kr/AKR20200325077800030?did=1195m
2429,2020-03-25,대웅제약기술침해행정조사거부과태료1호기업불명예,http://www.m-i.kr/news/articleView.html?idxno=694991
2430,2020-03-25,중기부기술침해행정조사거부대웅제약에과태료500만원부과,http://www.fnnews.com/news/202003250828210691
2431,2020-03-25,중기부대웅제약에과태료500만원부과기술침해행정조사거부,https://view.asiae.co.kr/article/2020032508300369251
2432,2020-03-25,보톡스균주기술침해조사거부대웅제약에과태료,https://www.ytn.co.kr/_ln/0102_202003251202370556
2433,2020-03-25,중기부기술침해조사거부한대웅제약에과태료부과,http://www.ajunews.com/view/20200325084614966
2434,2020-03-25,중기부기술침해조사거부한대웅제약에과태료부과,http://www.ajunews.com/view/20200325084614966
2435,2020-03-25,中企기술침해대웅제약조사도거부해과태료부과,http://www.metroseoul.co.kr/article/20200325500073
2436,2020-03-25,대웅제약중기부기술침해조사거부과태료500만원부과받아,http://www.etoday.co.kr/news/section/newsview.php?idxno=1874873
2437,2020-03-25,메디톡스기술침해조사거부한대웅제약에과태료500만원,https://news.chosun.com/site/data/html_dir/2020/03/25/2020032502311.html?utm_source=naver&utm_medium=original&utm_campaign=news
2438,2020-03-25,중소기업기술침해의혹행정조사거부한대웅제약에과태료부과,http://news.kbs.co.kr/news/view.do?ncd=4409677&ref=A
2439,2020-03-25,기술침해행정조사거부한대웅제약중기부첫과태료처분내려,http://www.viva100.com/main/view.php?key=20200325010010336
2440,2020-03-25,중기부행정조사거부한대웅제약에500만원과태료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020032511524824192
2441,2020-03-25,중기부기술침해행정조사거부대웅제약에과태료500만원첫부과,http://www.etnews.com/20200325000149
2442,2020-03-25,중기부대웅제약에기술침해행정조사거부과태료500만원부과,http://news.kbiz.or.kr/news/articleView.html?idxno=65548
2443,2020-03-25,중기부행정조사거부대웅제약에과태료부과,http://www.shinailbo.co.kr/news/articleView.html?idxno=1262891
2444,2020-03-25,대웅제약기술침해행정조사거부로첫과태료부과,http://www.dt.co.kr/contents.html?article_no=2020032502109931731004&ref=naver
2445,2020-03-25,대웅제약특별관계자지분변동,http://news.kmib.co.kr/article/view.asp?arcid=0014403328&code=61141211&cp=nv
2446,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료500만원부과,http://www.ekn.kr/news/article.html?no=489880
2447,2020-03-25,대웅제약메디톡스기술침해조사거부과태료500만원,http://moneys.mt.co.kr/news/mwView.php?no=2020032513578010444
2448,2020-03-25,기술침해조사거부한대웅제약에과태료500만원중기부행정조사첫제재,http://biz.newdaily.co.kr/site/data/html/2020/03/25/2020032500146.html
2449,2020-03-25,중기부메디톡스기술침해혐의조사거부한대웅제약에과태료부과,http://news.mk.co.kr/newsRead.php?no=309196&year=2020
2450,2020-03-25,중기부기술침해행정조사거부한대웅제약에과태료처분,https://www.hankyung.com/finance/article/2020032502386
2451,2020-03-25,중기부기술침해행정조사거부대웅제약에500만원과태료부과,http://www.econovill.com/news/articleView.html?idxno=390715
2452,2020-03-25,대웅제약중소기업기술침해과태료500만원부과받아,http://www.sisafocus.co.kr/news/articleView.html?idxno=235487
2453,2020-03-25,기술침해행정조사거부한대웅제약첫과태료부과처분,http://www.chungnamilbo.com/news/articleView.html?idxno=537231
2454,2020-03-25,중소벤처기업부대웅제약기술침해조사거부에과태료부과,http://www.mediapen.com/news/view/511565
2455,2020-03-25,중기부행정조사거부대웅제약에과태료500만원부과,http://www.ebn.co.kr/news/view/1028115/?sc=naver
2456,2020-03-25,조사안받는대신500만원”기술침해의혹대웅제약중기부과태료부과첫사례,http://theviewers.co.kr/View.aspx?No=787726
2457,2020-03-25,기술침해행정조사거부대웅제약첫과태료처분,http://www.anewsa.com/detail.php?number=2090157&thread=10
2458,2020-03-25,메디톡스소송비용충당대웅제약300억자사주매각,http://www.wikileaks-kr.org/news/articleView.html?idxno=81500
2459,2020-03-25,보톡스분쟁관련대웅제약기술침해행정조사거부과태료부과,http://www.kidd.co.kr/news/215244
2460,2020-03-25,중기부대웅제약에과태료500만원부과기술침해행정조사거부,http://www.newsworks.co.kr/news/articleView.html?idxno=443176
2461,2020-03-25,대웅제약특별관계자지분율변동,http://www.mdtoday.co.kr/mdtoday/index.html?no=381771
2462,2020-03-25,기술침해행정조사거부한대웅제약에첫과태료부과,https://www.seoul.co.kr/news/newsView.php?id=20200325500209&wlog_tag3=naver
2463,2020-03-25,중기부대웅제약에과태료부과기술침해관련행정조사거부,https://www.hankyung.com/economy/article/2020032509141
2464,2020-03-25,기술침해조사거부대웅제약첫과태료,https://www.sedaily.com/NewsView/1Z0C5KR5RA
2465,2020-03-25,보톡스분쟁허우적대는대웅제약중기부조사거부에제재,http://www.seouleconews.com/news/articleView.html?idxno=54034
2466,2020-03-25,보톡스균주기술침해조사거부대웅제약에과태료,https://www.ytn.co.kr/_ln/0102_202003251806276762
2467,2020-03-25,대웅제약중소기업기술침해행정조사거부해과태료500만원,http://www.businesspost.co.kr/BP?command=article_view&num=170319
2468,2020-03-25,중기부기술침해조사거부대웅제약에과태료500만원,http://www.seoulfn.com/news/articleView.html?idxno=376720
2469,2020-03-25,보톡스균주현장조사거부대웅제약에첫과태료,https://www.ytn.co.kr/_ln/0102_202003252336273858
2470,2020-03-26,대웅제약공식웹사이트전면리뉴얼오픈고객편의성과접근성개선,http://www.thefirstmedia.net/news/articleView.html?idxno=56129
2471,2020-03-26,대웅제약알비스원료변경통해재출시가능성대두,http://www.bosa.co.kr/news/articleView.html?idxno=2124080
2472,2020-03-26,기술침해행정조사거부한대웅제약에과태료500만원,http://www.mdtoday.co.kr/mdtoday/index.html?no=381798
2473,2020-03-26,대웅제약보톡스기술불법취득조사거부첫과태료부과,http://news.jtbc.joins.com/article/article.aspx?news_id=NB11942028
2474,2020-03-26,대웅제약기술침해조사거부했다500만원과태료,http://www.mhj21.com/128744
2475,2020-03-26,대웅제약브랜드서체DW임팩타민체무료배포,http://newsclaim.co.kr/View.aspx?No=788105
2476,2020-03-26,대웅제약DW임팩타민체서체무료배포,http://www.consumuch.com/news/articleView.html?idxno=48116
2477,2020-03-26,대웅제약브랜드서체DW임팩타민체개발BI강화,http://www.greened.kr/news/articleView.html?idxno=244058
2478,2020-03-26,대웅제약브랜드서체DW임팩타민체개발및무료배포소비자접점확대,http://www.ekn.kr/news/article.html?no=490045
2479,2020-03-26,대웅제약브랜드서체DW임팩타민체개발,http://www.ebn.co.kr/news/view/1028214/?sc=naver
2480,2020-03-26,일양약품대웅제약희비엇갈려특히일양약품급등하루만에지지부진,http://www.econonews.co.kr/news/articleView.html?idxno=113814
2481,2020-03-26,대웅제약정부기술침해행정조사거부중기부과태료부과,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003917574
2482,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,https://www.fetv.co.kr/news/article.html?no=51075
2483,2020-03-26,대웅제약DW임팩타민체개발해임팩타민BI강화,http://medipana.com/news/news_viewer.asp?NewsNum=254681&MainKind=A&NewsKind=5&vCount=12&vKind=1
2484,2020-03-26,대웅제약브랜드서체DW임팩타민체개발활기넘치고임팩트있는특징서체에표현,http://www.pressm.kr/news/articleView.html?idxno=28498
2485,2020-03-26,대웅제약비타민브랜드임팩타민특징살린서체무료배포,http://news.mk.co.kr/newsRead.php?no=312470&year=2020
2486,2020-03-26,대웅제약개발브랜드서체DW임팩타민체무료배포,http://www.medisobizanews.com/news/articleView.html?idxno=68231
2487,2020-03-26,대웅제약임팩타민글씨체로브랜드이미지강화,http://health.chosun.com/site/data/html_dir/2020/03/26/2020032602215.html
2488,2020-03-26,대웅제약브랜드서체개발로임팩타민BI강화,http://www.newsis.com/view/?id=NISX20200326_0000970881&cID=13001&pID=13000
2489,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.ezyeconomy.com/news/articleView.html?idxno=99272
2490,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60383
2491,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.ezyeconomy.com/news/articleView.html?idxno=99272
2492,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.cstimes.com/news/articleView.html?idxno=407644
2493,2020-03-26,대웅제약브랜드서체DW임팩타민체개발,http://www.dailymedi.com/detail.php?number=854417&thread=22r05
2494,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.viva100.com/main/view.php?key=20200326010010736
2495,2020-03-26,대웅제약브랜드서체DW임팩타민체개발브랜드이미지강화,http://www.seoulwire.com/news/articleView.html?idxno=404899
2496,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=381856
2497,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,https://www.dailian.co.kr/news/view/878894?sc=Naver
2498,2020-03-26,대웅제약임팩타민체무료배포브랜드가치강화,http://moneys.mt.co.kr/news/mwView.php?no=2020032610588041790
2499,2020-03-26,대웅제약DW임팩타민체무료배포하며소비자접점확대추진,http://www.g-enews.com/ko-kr/news/article/news_all/20200326105845769369d76442fa_1/article.html
2500,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.metroseoul.co.kr/article/20200326500157
2501,2020-03-26,대웅제약브랜드서체DW임팩타민체무료배포임팩타민BI강화,http://www.thepublic.kr/news/newsview.php?ncode=1065574945670411
2502,2020-03-26,대웅제약서체DW임팩타민체개발,http://www.econovill.com/news/articleView.html?idxno=390860
2503,2020-03-26,대웅제약브랜드서체개발통해임팩타민BI강화,http://www.dailysmart.co.kr/news/articleView.html?idxno=24216
2504,2020-03-26,중기부기술침해행정조사거부대웅제약에과태료500만원부과,http://www.betanews.net:8080/article/1154417.html
2505,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=380789
2506,2020-03-26,대웅제약상승흐름전일대비509이시각거래량8만7913주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003260196&t=NN
2507,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.sporbiz.co.kr/news/articleView.html?idxno=425365
2508,2020-03-26,대웅제약이종욱고문이달말회사떠난다,http://www.pharmnews.com/news/articleView.html?idxno=100206
2509,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.m-i.kr/news/articleView.html?idxno=695576
2510,2020-03-26,중기부기술침해대웅제약에과태료,http://www.naeil.com/news_view/?id_art=344835
2511,2020-03-26,기술침해행정조사거부한대웅제약첫과태료부과처분,http://www.korea.kr/news/pressReleaseView.do?newsId=156382250&call_from=naver_news
2512,2020-03-26,대웅메디톡스끝나지않는보톡스전쟁,http://www.mediapen.com/news/view/511875
2513,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.lawissue.co.kr/view.php?ud=202003261434327688204ead0791_12
2514,2020-03-26,대웅제약브랜드서체DW임팩타민체개발배포,http://www.bosa.co.kr/news/articleView.html?idxno=2124143
2515,2020-03-26,대웅제약브랜드서체DW임팩타민체무료배포,http://www.mediapen.com/news/view/511933
2516,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242314
2517,2020-03-26,대웅제약브랜드서체DW임팩타민체로접점늘린다,http://www.mhj21.com/128763
2518,2020-03-26,대웅제약브랜드서체DW임팩타민체개발무료배포브랜드이미지강화,http://www.paxetv.com/news/articleView.html?idxno=88995
2519,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.updownnews.co.kr/news/articleView.html?idxno=216853
2520,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://newsbrite.net/135184
2521,2020-03-26,대웅제약DW임팩타민체개발통해임팩타민BI강화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065593238839722
2522,2020-03-26,대웅제약DW임팩타민브랜드서체개발무료배포,http://www.kpinews.co.kr/news/articleView.html?idxno=113401
2523,2020-03-26,4년째이어진보톡스진흙탕싸움대웅메디톡스모두독배드나,http://news.mk.co.kr/newsRead.php?no=316010&year=2020
2524,2020-03-26,대웅제약브랜드서체DW임팩타민체배포눈길,http://www.sisaweek.com/news/articleView.html?idxno=132358
2525,2020-03-26,대웅제약브랜드서체DW임팩타민체개발,https://www.kpanews.co.kr/article/show.asp?idx=212025&category=D
2526,2020-03-26,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.cnbnews.com/news/article.html?no=441346
2527,2020-03-26,대웅제약임팩타민프리미엄비타민B군8종함유피로회복탁월,https://www.sedaily.com/NewsView/1Z0CKVWPWG
2528,2020-03-26,대웅제약메디톡스가중소기업과태료처분억울하다,http://www.mediapen.com/news/view/511873
2529,2020-03-26,뉴스투데이L대웅제약브랜드서체DW임팩타민체개발,https://www.news2day.co.kr/150267
2530,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.wsobi.com/news/articleView.html?idxno=93800
2531,2020-03-26,연속순매수기관대웅제약9일째매수,http://www.itooza.com/common/iview.php?no=2020032617004380576
2532,2020-03-26,메디톡스대웅제약의기술침해행정조사거부소식에上,http://www.mdtoday.co.kr/mdtoday/index.html?no=381971
2533,2020-03-26,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.thevaluenews.co.kr/news/view.php?idx=158963
2534,2020-03-27,대웅제약브랜드서체DW임팩타민체무료배포,http://news.kbiz.or.kr/news/articleView.html?idxno=65627
2535,2020-03-27,대웅제약중기부행정조사거부로과태료부과,http://www.topdaily.kr/news/articleView.html?idxno=65455
2536,2020-03-27,대웅제약브랜드서체DW임팩타민체무료배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1377344
2537,2020-03-27,대웅제약브랜드서체DW임팩타민체개발임팩타민BI강화,http://www.polinews.co.kr/news/article.html?no=457544
2538,2020-03-27,일양약품대웅제약모두상승세로특히일양약품가파른상승세로4상승,http://www.econonews.co.kr/news/articleView.html?idxno=113995
2539,2020-03-27,대웅제약서체DW임팩타민체개발통해브랜드이미지강화,http://www.newslock.co.kr/news/articleView.html?idxno=26773
2540,2020-03-27,대웅제약브랜드서체DW임팩타민체개발,http://kormedi.com/?p=1314191
2541,2020-03-27,메디톡스vs대웅제약보톡스전쟁끝날까,http://www.babytimes.co.kr/news/articleView.html?idxno=34524
2542,2020-03-27,대웅제약보톡스분쟁기술침해행정조사거부과태료부과,http://www.pinpointnews.co.kr/view.php?ud=202003271505295685f090c8dbcb_45
2543,2020-03-28,알비스판금대웅제약새로운항궤양제찾아라,http://www.dailypharm.com/Users/News/NewsView.html?ID=263266&REFERER=NP
2544,2020-03-30,이종욱경영고문퇴진대웅제약참장점많은회사,http://www.bosa.co.kr/news/articleView.html?idxno=2124252
2545,2020-03-30,대웅제약메디톡스관련중기부행정조사소송종결까지중지돼야,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242381
2546,2020-03-30,대웅제약코로나19소송비용이중고목표가29↓KB,http://www.edaily.co.kr/news/newspath.asp?newsid=01456326625708568
2547,2020-03-30,메디톡스관련중소벤처기업부의행정조사에대한대웅제약의입장,http://www.nbnnews.co.kr/news/articleView.html?idxno=381543
2548,2020-03-30,대웅제약코로나19와소송이중고목표가↓,http://www.asiatoday.co.kr/view.php?key=20200330010018280
2549,2020-03-30,대웅제약성장세둔화소송비용증가로실적감소KB증권,http://www.ajunews.com/view/20200330080839357
2550,2020-03-30,리포트브리핑대웅제약소송의피로감이만든주가목표가120000원하이투자증권,http://www.newspim.com/news/view/20200330000075
2551,2020-03-30,대웅제약중소벤처기업부행정조사중지해야,http://news.mt.co.kr/mtview.php?no=2020033008374376595
2552,2020-03-30,대웅제약메디톡스관련중기부행정조사소송종결까지중지돼야”,http://newsclaim.co.kr/View.aspx?No=790908
2553,2020-03-30,대웅중기부조사메디톡스소송종결까지중지돼야,http://www.dailypharm.com/Users/News/NewsView.html?ID=263296&REFERER=NP
2554,2020-03-30,대웅제약중기부행정조사는부당균주소송종결까지중단해야,http://www.ajunews.com/view/20200330084517431
2555,2020-03-30,대웅제약소송종결시까지중기부행정조사중지돼야,http://www.enewstoday.co.kr/news/articleView.html?idxno=1377732
2556,2020-03-30,대웅제약중기부보톡스관련행정조사중단해달라,http://www.newspim.com/news/view/20200330000077
2557,2020-03-30,대웅제약중소벤처기업부에메디톡스관련행정조사중단요청,http://www.wikileaks-kr.org/news/articleView.html?idxno=81840
2558,2020-03-30,하이로우대웅제약코로나19소송비용이중고목표가↓KB증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020033009125852715
2559,2020-03-30,대웅제약메디톡스관련중기부행정조사중단돼야,http://www.medisobizanews.com/news/articleView.html?idxno=68320
2560,2020-03-30,특징주대웅9980원30일9시15분장시작대비606상승,http://www.getnews.co.kr/view.php?ud=202003300916499315c20b9611a0_16
2561,2020-03-30,대웅제약124상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/03/30/2020033001416.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2562,2020-03-30,메디톡스중소기업아닌데대웅중기부행정조사중지해야,http://moneys.mt.co.kr/news/mwView.php?no=2020033009148031602
2563,2020-03-30,대웅제약중기부행정조사소송종결시까지중지해야,http://www.newsis.com/view/?id=NISX20200330_0000974927&cID=13001&pID=13000
2564,2020-03-30,대웅제약코로나19에소송비용까지이중고목표가하향KB증권,http://www.newstomato.com/ReadNews.aspx?no=962635
2565,2020-03-30,대웅제약메디톡스관련중기부행정조사소송종결까지중지돼야,http://www.asiatoday.co.kr/view.php?key=20200330010018373
2566,2020-03-30,대웅제약행정조사소송종결시까지중지해야,http://medipana.com/news/news_viewer.asp?NewsNum=254809&MainKind=A&NewsKind=5&vCount=12&vKind=1
2567,2020-03-30,대웅제약메디톡스와소송종결시까지중기부행정조사중단돼야,http://www.etoday.co.kr/news/section/newsview.php?idxno=1876926
2568,2020-03-30,트라파코대웅제약제품생산확대올해1015개목표,https://www.theguru.co.kr/news/article.html?no=9773
2569,2020-03-30,이종욱대웅제약고문명예퇴진제3의인생RD돕는일하고싶다,http://www.wikileaks-kr.org/news/articleView.html?idxno=81859
2570,2020-03-30,대웅제약메디톡스와소송중행정조사중지요청한속내는,https://www.fetv.co.kr/news/article.html?no=51383
2571,2020-03-30,대웅제약일방적가해자로규정한행정조사중지돼야,http://www.shinailbo.co.kr/news/articleView.html?idxno=1264393
2572,2020-03-30,대웅제약메디톡스관련중기부행정조사는부당,http://www.bosa.co.kr/news/articleView.html?idxno=2124280
2573,2020-03-30,대웅제약행정조사부당메디톡스나약한피해자행세,http://www.upinews.kr/newsView/upi202003300031
2574,2020-03-30,대웅제약중기부행정조사메디톡스와소송종결까지중지돼야,https://www.hankyung.com/finance/article/2020033006006
2575,2020-03-30,메디톡스관련중소벤처기업부행정조사에대한대웅제약입장발표,http://www.pressm.kr/news/articleView.html?idxno=28562
2576,2020-03-30,일양약품대웅제약상승에급등까지특히일양약품갑작스런7급등,http://www.econonews.co.kr/news/articleView.html?idxno=114351
2577,2020-03-30,대웅제약메디톡스와소송종결시까지중기부행정조사중지해야,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003300181&t=NN
2578,2020-03-30,대웅제약메디톡스명백한거짓중소기업도아니야중기부행정조사부당,http://www.newslock.co.kr/news/articleView.html?idxno=26815
2579,2020-03-30,리포트브리핑대웅제약코로나19와소송비용의이중고목표가120000원KB증권,http://www.newspim.com/news/view/20200330000401
2580,2020-03-30,대웅제약중소벤처기업부행정조사중지돼야”,http://www.whosaeng.com/116717
2581,2020-03-30,대웅제약중기부과태료부과에반발일방적가해자로규정,http://www.newsprime.co.kr/news/article.html?no=499093
2582,2020-03-30,대웅메디톡스중소기업아냐중기부행정조사중단하라,http://www.medigatenews.com/news/2859683093
2583,2020-03-30,대웅제약중기부행정조사메디톡스소송종결시까지중지돼야,http://www.greened.kr/news/articleView.html?idxno=244582
2584,2020-03-30,대웅메디톡스중소기업아냐중기부행정조사중단하라,http://www.medigatenews.com/news/2859683093
2585,2020-03-30,대웅제약중소벤처기업부행정조사메디톡스와의소송끝날때까지종결돼야,http://www.ceoscoredaily.com/news/article.html?no=67868
2586,2020-03-30,대웅제약중기부행정조사메디톡스와소송종결될때까지중단해야”,http://www.mdtoday.co.kr/mdtoday/index.html?no=382218
2587,2020-03-30,대웅제약중기부행정조사중단촉구,http://www.dailymedi.com/detail.php?number=854532&thread=22r05
2588,2020-03-30,대웅제약중기부메디톡스소송종결까지행정조사중지해야,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1079141
2589,2020-03-30,대웅제약중기부행정조사반발메디톡스와소송종결까지중단돼야,http://www.sisaweek.com/news/articleView.html?idxno=132432
2590,2020-03-30,대웅제약중기부행정조사종결까지중지돼야메디톡스중소기업아냐”,http://www.econovill.com/news/articleView.html?idxno=391352
2591,2020-03-30,메디톡스관련중소벤처기업부의행정조사에대한대웅제약의입장,http://newsbrite.net/135272
2592,2020-03-30,대웅제약중기부기술침해행정조사중지해야,http://www.mediapen.com/news/view/512874
2593,2020-03-30,대웅제약메디톡스간막장보톡스균주전쟁출혈가시화,http://www.metroseoul.co.kr/article/20200330500341
2594,2020-03-30,대웅제약메디톡스기술침해절대아냐”,http://theviewers.co.kr/View.aspx?No=791719
2595,2020-03-30,대웅제약메디톡스와소송종결될때까지중기부기술침해조사중단돼야,http://news.mk.co.kr/newsRead.php?no=328819&year=2020
2596,2020-03-30,대웅제약보툴리눔톡신미국점유율확대로매출늘어실적에긍정적,http://www.businesspost.co.kr/BP?command=article_view&num=170998
2597,2020-03-30,대웅제약중기부행정조사소송종결시까지중단돼야,http://www.ebn.co.kr/news/view/1028817/?sc=naver
2598,2020-03-30,대웅제약중기부행정조사에반발메디톡스중소기업아냐,http://www.updownnews.co.kr/news/articleView.html?idxno=216968
2599,2020-03-30,동아에스티대웅제약삼일제약은코로나19왕따제약사제약업종강세속하락거듭하며자사주매입까지,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003922125
2600,2020-03-30,대웅제약보톡스행정조사처분에부당한처사,http://www.pharmnews.com/news/articleView.html?idxno=100223
2601,2020-03-30,대웅제약중기부행정조사소송종결시까지중지돼야”,http://www.cnbnews.com/news/article.html?no=441638
2602,2020-03-30,대웅제약중기부부당한행정조사중단하라,http://www.finomy.com/news/articleView.html?idxno=76675
2603,2020-03-30,대웅제약정부현장조사끝내거부메디톡스와소송戰끝날때까지미루자”,http://www.edaily.co.kr/news/newspath.asp?newsid=04168886625708568
2604,2020-03-31,대웅제약브랜드서체DW임팩타민체개발통해임팩타민BI강화,http://www.thefirstmedia.net/news/articleView.html?idxno=56284
2605,2020-03-31,메디톡스vs대웅제약보톡스전쟁韓제약산업경쟁력발목잡나,http://www.asiatoday.co.kr/view.php?key=20200330010018868
2606,2020-03-31,보톡스전쟁중대웅제약중기부에이유있는항변,http://isplus.live.joins.com/news/article/article.asp?total_id=23743269
2607,2020-03-31,5대제약사RD크게늘렸다대웅제약505최고증가율,http://www.medisobizanews.com/news/articleView.html?idxno=68366
2608,2020-03-31,일양약품대웅제약상승에급등까지특히일양약품갑작스런13급등,http://www.econonews.co.kr/news/articleView.html?idxno=114483
2609,2020-03-31,대웅제약중소벤처기업부행정조사거부,http://www.betanews.net:8080/article/1156412.html
2610,2020-03-31,메디톡스대웅보톡스균주전중기부행정조사,http://www.ebn.co.kr/news/view/1422167/?sc=naver
2611,2020-03-31,셀트리온한미약품대웅제약유한양행종근당JW중외제약보령제약RD투자광동제약꼴찌,http://www.globale.co.kr/view.php?ud=202003311356207183084e0343a0_36
2612,2020-03-31,중기부대웅제약기술침해행정조사ITC소송과는독립적절차,http://biz.newdaily.co.kr/site/data/html/2020/03/31/2020033100245.html
2613,2020-03-31,대웅유한한독휴온스바이오벤처키운다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202003310299&t=NNv
2614,2020-03-31,정점치닫는대웅메디톡스보톡스전쟁,http://health.chosun.com/site/data/html_dir/2020/03/31/2020033104906.html
2615,2020-04-01,대웅제약라니티딘원료수급해안정성분석한다알비스판매재개되나,http://www.mdtoday.co.kr/mdtoday/index.html?no=382470
2616,2020-04-01,대웅5이상상승주가상승중단기간골든크로스형성,https://www.hankyung.com/finance/article/202004016998L
2617,2020-04-01,일양약품대웅제약희비엇갈려특히일양약품갑작스런12폭락에투자자들당황,http://www.econonews.co.kr/news/articleView.html?idxno=114632
2618,2020-04-01,메디톡스사면초가대웅제약과보톡스전쟁불리해지나,http://www.insightkorea.co.kr/news/articleView.html?idxno=78650
2619,2020-04-01,대웅전일대비536외국인1331주순매수,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004010693&t=NN
2620,2020-04-01,라니티딘제제허가갱신판매재개는미지수대웅제약안전성분석중,http://theviewers.co.kr/View.aspx?No=797369
2621,2020-04-01,대웅제약임팩타민서체개발을통한브랜드임팩트전달,https://www.jungle.co.kr/magazine/201635
2622,2020-04-01,메디톡스vs대웅제약美ITC결과국내소송에미칠영향두고상반된해석,http://biz.newdaily.co.kr/site/data/html/2020/04/01/2020040100311.html
2623,2020-04-01,보톡스분쟁메디톡스대웅제약ITC보고서갈등일단락,http://www.finomy.com/news/articleView.html?idxno=76797
2624,2020-04-02,메디톡스미국ITC소송자료로WGSSNP대신VS대웅포자감정만허용,http://www.medigatenews.com/news/4099106173
2625,2020-04-02,대웅메디톡스ITC보고서제출합의에도여전한입장차,http://moneys.mt.co.kr/news/mwView.php?no=2020040208468034145
2626,2020-04-02,4년째절차공방중인메디톡스대웅제약보톡스균주소송전,http://www.nongaek.com/news/articleView.html?idxno=68314
2627,2020-04-02,대웅건설주태안군에코로나19극복위한사랑의성금기탁,http://www.joongdo.co.kr/main/view.php?key=20200402010000679
2628,2020-04-02,일양약품대웅제약가파른하락세특히일양약품전날17폭락이어5하락,http://www.econonews.co.kr/news/articleView.html?idxno=114772
2629,2020-04-02,대웅건설코로나19극복성금1000만원기탁,http://www.ggilbo.com/news/articleView.html?idxno=757830
2630,2020-04-02,균주전쟁5년차대웅제약메디톡스보고서제출방식에서또결렬,http://theviewers.co.kr/View.aspx?No=798818
2631,2020-04-02,공시한올바이오파마최대주주대웅제약보통주6만8010주취득”,http://www.newsway.co.kr/news/view?tp=1&ud=2020040215515274546
2632,2020-04-02,대탈출정종연PDn번방가입루머강경대웅유포자및악플러법적책임물을것”,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020040216044977366
2633,2020-04-02,대웅건설㈜코로나19극복성금1천만원기탁,http://www.ccdailynews.com/news/articleView.html?idxno=1060153
2634,2020-04-02,대웅건설코로나극복성금1000만원전달,http://www.dtnews24.com/news/articleView.html?idxno=575301
2635,2020-04-02,태안군대웅건설취약계층방역에사용해주세요,http://www.ccdn.co.kr/news/articleView.html?idxno=640910
2636,2020-04-02,대웅건설태안군에취약계층방역성금1000만원,http://www.cctoday.co.kr/news/articleView.html?idxno=2061897
2637,2020-04-03,대웅제약위식도역류질환치료제DWP14012임상3상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=382875
2638,2020-04-03,일양약품대웅제약모두상승세로특히일양약품매수세쏟아지며3상승,http://www.econonews.co.kr/news/articleView.html?idxno=114901
2639,2020-04-03,공시국민연금대웅제약지분율819로감소,http://www.newsway.co.kr/news/view?tp=1&ud=2020040311102790487
2640,2020-04-03,FDA모든라니티딘시장퇴출대웅제약어쩌나,http://theviewers.co.kr/View.aspx?No=801414
2641,2020-04-03,대웅제약효자항궤양제판매재개추진전승호안전성입증이열쇠,http://www.businesspost.co.kr/BP?command=article_view&num=172021
2642,2020-04-04,경북구미봉곡동대웅솔랜드안에서말티즈발견보호,https://www.notepet.co.kr/news/abandon/abandon_view/?idx=24775
2643,2020-04-06,제약사급여유한종근당한미광동대웅제약順,http://www.dailymedi.com/detail.php?number=854786&thread=22r05
2644,2020-04-06,대웅제약1일1회복용치매약메만틴서방정개발,http://www.dailypharm.com/Users/News/NewsView.html?ID=263508&REFERER=NP
2645,2020-04-06,2020PowerProduct대웅제약나보타,http://www.bosa.co.kr/news/articleView.html?idxno=2124707
2646,2020-04-06,대웅제약메만틴해외수출용임상돌입자체개발진행,http://medipana.com/news/news_viewer.asp?NewsNum=255146&MainKind=A&NewsKind=5&vCount=12&vKind=1
2647,2020-04-06,대웅5이상상승주가상승중단기간골든크로스형성,https://www.hankyung.com/finance/article/202004067648L
2648,2020-04-06,대웅제약치매치료제메만틴서방정임상1상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=383062
2649,2020-04-06,일양약품대웅제약모두상승세로일양약품3상승이어대웅제약4상승,http://www.econonews.co.kr/news/articleView.html?idxno=115169
2650,2020-04-06,민사소송형사고소진행美서는ITC소송대웅행정조사거부재확인,http://www.wikileaks-kr.org/news/articleView.html?idxno=82648
2651,2020-04-06,보톡스기술유출갈등조사요구하는정부버티는대웅제약,http://health.chosun.com/site/data/html_dir/2020/04/06/2020040603368.html
2652,2020-04-07,도네페질에이어메만틴까지대웅제약치매치료제개발속도,http://www.mdtoday.co.kr/mdtoday/index.html?no=383187
2653,2020-04-07,디지털마케팅잘하는제약회사톱3한미대웅HK이노엔,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=242756
2654,2020-04-07,한미대웅HK이노엔등디지털마케팅잘하는제약사,http://www.medisobizanews.com/news/articleView.html?idxno=68594
2655,2020-04-07,의사들이꼽은디지털마케팅잘하는기업은한미약품대웅제약에이치케이이노엔,http://www.etoday.co.kr/news/section/newsview.php?idxno=1880606
2656,2020-04-07,일양약품대웅제약희비엇갈려일양약품3하락반해대웅제약3상승,http://www.econonews.co.kr/news/articleView.html?idxno=115360
2657,2020-04-07,대웅제약전일대비51상승최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004070320&t=NN
2658,2020-04-08,디지털마케팅활동잘하고있는회사는한미약품대웅제약HK이노엔GSK순,http://medicalworldnews.co.kr/news/view.php?idx=1510935051
2659,2020-04-08,일양약품대웅제약모두하락부진특히일양약품2하락,http://www.econonews.co.kr/news/articleView.html?idxno=115510
2660,2020-04-10,대웅제약과도한소송비용지출목표가↓NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01443206625734808
2661,2020-04-10,대웅제약코로나19로영업타격소송비용까지목표가↓,http://www.asiatoday.co.kr/view.php?key=20200410010006111
2662,2020-04-10,HotLine대웅제약소송및코로나19영향에실적부진할것목표가↓,http://news.mk.co.kr/newsRead.php?no=375868&year=2020
2663,2020-04-10,한미대웅HK이노엔前CJ헬스케어우수,http://www.dailymedi.com/detail.php?number=854993&thread=22r12
2664,2020-04-10,하이로우과도한소송비용대웅제약1분기도실적부진NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020041008505610459
2665,2020-04-10,1분기실적컨센서스하회예상NH투자證대웅제약목표가↓,http://www.whitepaper.co.kr/news/articleView.html?idxno=191954
2666,2020-04-10,대웅제약코로나19소송비용악재1분기실적부진NH투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1882194
2667,2020-04-10,리포트브리핑대웅제약과도한소송비용지출로부진한실적목표가110000원NH투자증권,http://www.newspim.com/news/view/20200410000104
2668,2020-04-10,대웅제약코로나영향등으로1분기실적부진목표가↓,http://www.seoulfn.com/news/articleView.html?idxno=378736
2669,2020-04-10,NH투자증권대웅제약과도한소송비지출로실적↓목표가하향,http://www.straightnews.co.kr/news/articleView.html?idxno=71810
2670,2020-04-10,증시현황대웅제약과도한소송비용지출부진한실적하반기반등,http://www.newscape.co.kr/news/view.php?idx=45049
2671,2020-04-10,특징주대웅제약과도한소송비용1Q20실적부진전망,http://www.sisaon.co.kr/news/articleView.html?idxno=111511
2672,2020-04-10,제약세금1위유한양행종근당대웅제약순,https://www.taxwatch.co.kr/article/tax/2020/04/10/0002/naver
2673,2020-04-10,대웅제약과도한소송비용지출과우루사매출감소실적부진전망,http://www.sisafocus.co.kr/news/articleView.html?idxno=236815
2674,2020-04-10,대웅제약120억원의소송비용반영으로1분기부진한실적예상”,http://www.wikitree.co.kr/articles/522622
2675,2020-04-11,대웅아모레퍼시픽과우루사상표분쟁서승소,http://www.dailypharm.com/Users/News/NewsView.html?ID=263714&REFERER=NP
2676,2020-04-13,10대제약사대표약품매출호조대웅제약비처방우루사24감소,http://www.consumernews.co.kr/news/articleView.html?idxno=603858
2677,2020-04-13,대웅제약소송비용매출감소목표가하향SK,http://www.ebn.co.kr/news/view/1424015/?sc=naver
2678,2020-04-13,리포트브리핑대웅제약나보타소송비용은2분기부터축소전망목표가140000원SK증권,http://www.newspim.com/news/view/20200413000094
2679,2020-04-13,대웅제약파트너아박타10분만에코로나판정진단키트개발추진,https://www.theguru.co.kr/news/article.html?no=10110
2680,2020-04-13,메디톡스대웅제약과의ITC소송노이즈는언제든주가폭락으로”,http://www.wikitree.co.kr/articles/523108
2681,2020-04-13,대웅제약2분기전문의약품매출회복가능소송비용도감소예상,http://www.businesspost.co.kr/BP?command=article_view&num=173550
2682,2020-04-13,3중고대웅제약알비스ETC매출감소에소송비용증가,http://www.inews24.com/view/1257547
2683,2020-04-14,KBiz리뷰대웅제약파트너아박타간편코로나진단키트개발추진4월14일,https://www.theguru.co.kr/news/article.html?no=10124
2684,2020-04-14,상장제약원가소폭절감한미대웅매출원가율↓,http://www.dailypharm.com/Users/News/NewsView.html?ID=263716&REFERER=NP
2685,2020-04-14,대웅제약목표가29하향소송불확실성해소필요키움證,http://news.mt.co.kr/mtview.php?no=2020041408063626990
2686,2020-04-14,키움證대웅제약소송이쥔주가방향,http://www.newsis.com/view/?id=NISX20200414_0000993362&cID=10401&pID=10400
2687,2020-04-14,대웅제약1분기실적시장기대치밑돌것목표가↓”,https://www.sedaily.com/NewsView/1Z1GYXKV9C
2688,2020-04-14,대웅제약1분기컨센서스하회가능성소송결과주목”키움,http://www.etoday.co.kr/news/section/newsview.php?idxno=1883399
2689,2020-04-14,대웅제약목표주가낮아져코로나19로영업위축에소송비용도늘어,http://www.businesspost.co.kr/BP?command=article_view&num=173709
2690,2020-04-14,키움증권대웅제약나보타관련소송실적투자심리발목,http://www.kpinews.co.kr/news/articleView.html?idxno=114719
2691,2020-04-14,2020파워기업대웅제약2025년까지100개국에수출한다,http://moneys.mt.co.kr/news/mwView.php?no=2020032714538013023
2692,2020-04-14,대웅349상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041401216.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2693,2020-04-14,파스퇴르대웅니클로사마이드코로나19치료제임상준비,http://www.mhj21.com/129291
2694,2020-04-14,대웅5이상상승외국인기관각각3일연속순매수3일연속순매도,https://www.hankyung.com/finance/article/202004148400L
2695,2020-04-14,대웅그룹한국파스퇴르연구소코로나19치료제임상시험진입준비,http://www.asiatoday.co.kr/view.php?key=20200414010008164
2696,2020-04-14,대웅제약코로나19영향과소송비용증가로1분기실적은기대이하”,http://www.wikitree.co.kr/articles/523452
2697,2020-04-14,특징주대웅12350원14일10시10분장시작대비786상승,http://www.getnews.co.kr/view.php?ud=20200414101146460c20b947b81_16
2698,2020-04-14,코로나19한국파스퇴르연구소대웅그룹치료제임상준비,http://www.ftoday.co.kr/news/articleView.html?idxno=200792
2699,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.newslock.co.kr/news/articleView.html?idxno=27168
2700,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,https://www.fetv.co.kr/news/article.html?no=52644
2701,2020-04-14,대웅파스퇴르연구소코로나치료제연구협력,http://www.ebn.co.kr/news/view/1424272/?sc=naver
2702,2020-04-14,파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상,http://www.metroseoul.co.kr/article/20200414500042
2703,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제개발착수,http://www.viva100.com/main/view.php?key=20200414010005203
2704,2020-04-14,한국파스퇴르연구소대웅그룹 니클로사마이드 코로나19 치료제 임상준비,http://www.businesskorea.co.kr/news/articleView.html?idxno=44165
2705,2020-04-14,대웅그룹한국파스퇴르연구소니클로사마이드코로나19치료제개발에맞손,http://www.greened.kr/news/articleView.html?idxno=247081
2706,2020-04-14,한국파스퇴르硏대웅그룹코로나19치료제개발협력,http://www.medisobizanews.com/news/articleView.html?idxno=68832
2707,2020-04-14,한국파스퇴르연구소대웅코로나19치료제개발연구협력,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003938871
2708,2020-04-14,코로나19한국파스퇴르연구소대웅코로나19치료제임상시험준비,http://www.ajunews.com/view/20200414100739705
2709,2020-04-14,리포트브리핑대웅제약소송불확실성해소만이해답목표가120000원키움증권,http://www.newspim.com/news/view/20200414000372
2710,2020-04-14,대웅파스퇴르硏DWRX2003코로나19치료제임상준비,http://medipana.com/news/news_viewer.asp?NewsNum=255550&MainKind=A&NewsKind=5&vCount=12&vKind=1
2711,2020-04-14,한국파스퇴르연대웅그룹니클로사마이드코로나19치료제임상준비,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243063
2712,2020-04-14,파스퇴르硏대웅제약코로나19치료제임상착수,https://www.zdnet.co.kr/view/?no=20200414101240
2713,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.ekn.kr/news/article.html?no=493817
2714,2020-04-14,구충제로코로나19치료한다대웅임상준비,https://view.asiae.co.kr/article/2020041410273585508
2715,2020-04-14,대웅그룹구충제성분으로코로나치료제개발착수,http://www.koreastocknews.com/news/articleView.html?idxno=52852
2716,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.segye.com/content/html/2020/04/14/20200414508151.html?OutUrl=naver
2717,2020-04-14,대웅그룹한국파스퇴르연구소코로나19치료제임상준비,http://newsclaim.co.kr/View.aspx?No=809555
2718,2020-04-14,파스퇴르대웅코로나치료제개발맞손7월임상진입,http://www.newsis.com/view/?id=NISX20200414_0000993607&cID=13001&pID=13000
2719,2020-04-14,대웅제약347상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041401403.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2720,2020-04-14,한국파스퇴르연구소대웅그룹코로나19치료제니클로사마이드임상착수,http://www.m-i.kr/news/articleView.html?idxno=701787
2721,2020-04-14,파스퇴르연구소대웅구충제니클로사마이드코로나19치료제임상준비,http://www.medigatenews.com/news/2916788197
2722,2020-04-14,파스퇴르연구소대웅구충제로코로나19치료제개발추진,http://yna.kr/AKR20200414057400017?did=1195m
2723,2020-04-14,한국파스퇴르연구소대웅코로나19치료제임상준비,https://www.asiatime.co.kr/news/newsview.php?ncode=1065575167381352
2724,2020-04-14,대웅파스퇴르연구소와구충제니클로사마이드코로나19치료제개발착수,http://www.etoday.co.kr/news/section/newsview.php?idxno=1883479
2725,2020-04-14,대웅제약그룹한국파스퇴르연구소와코로나19치료제개발나서,http://news.mk.co.kr/newsRead.php?no=390276&year=2020
2726,2020-04-14,파스퇴르연구소대웅니클로사마이드코로나19치료제임상준비,http://www.consumuch.com/news/articleView.html?idxno=48370
2727,2020-04-14,대웅제약파스퇴르연구소와구충제로코로나19임상한다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020041410375588650
2728,2020-04-14,파스퇴르대웅코로나치료제개발맞손7월임상진입,http://www.topstarnews.net/news/articleView.html?idxno=761766
2729,2020-04-14,대웅제약전일대비515상승중최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004140198&t=NN
2730,2020-04-14,파스퇴르연구소대웅그룹코로나19치료제연구맞손,https://www.sedaily.com/NewsView/1Z1GZZG68K
2731,2020-04-14,대웅제약5이상상승소송불확실성해소만이해답키움증권BUY상향,https://www.hankyung.com/finance/article/202004148615L
2732,2020-04-14,대웅제약988VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041401483.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2733,2020-04-14,대웅한국파스퇴르硏코로나치료제개발착수,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004140188&t=NN
2734,2020-04-14,파스퇴르대웅구충제니클로사마이드코로나19치료제임상착수,http://www.joseilbo.com/news/news_read.php?uid=396088&class=27&grp=
2735,2020-04-14,한국파스퇴르연구소대웅그룹코로나19치료제임상준비,http://www.ceoscoredaily.com/news/article.html?no=68471
2736,2020-04-14,키움증권대웅제약목표주가하향나보타관련소송결과주목,http://www.m-i.kr/news/articleView.html?idxno=701779
2737,2020-04-14,파스퇴르연구소대웅코로나19치료제개발협력,http://www.bokuennews.com/news/article.html?no=188915
2738,2020-04-14,대웅제약알비스판매중단여파1Q영업익하락,http://www.press9.kr/news/articleView.html?idxno=44306
2739,2020-04-14,대웅한국파스퇴르연구소구충제로코로나19치료제개발,http://news.mt.co.kr/mtview.php?no=2020041410410423305
2740,2020-04-14,파스퇴르연구소대웅그룹구충제로코로나19치료제개발나섰다,http://www.insightkorea.co.kr/news/articleView.html?idxno=79082
2741,2020-04-14,한국파스퇴르연구소대웅구충제로코로나19치료제개발협력,https://www.seoul.co.kr/news/newsView.php?id=20200414500044&wlog_tag3=naver
2742,2020-04-14,대웅그룹구충제코로나19치료제임상준비,http://www.edaily.co.kr/news/newspath.asp?newsid=02522326625736120
2743,2020-04-14,파스퇴르대웅니클로사마이드코로나19치료제임상준비,http://www.fnnews.com/news/202004141049026104
2744,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.whosaeng.com/117060
2745,2020-04-14,대웅주가와거래량모두강세최근5거래일최고거래량돌파,https://www.tfmedia.co.kr/news/article.html?no=83293
2746,2020-04-14,파스퇴르연구소대웅구충제코로나19치료제임상준비,http://sports.chosun.com/news/ntype.htm?id=202004150100111330006881&servicedate=20200414
2747,2020-04-14,대웅파스퇴르연구소코로나19치료제공동개발착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=263784&REFERER=NP
2748,2020-04-14,파스퇴르硏대웅제약코로나19치료제임상시험에맞손,http://www.dt.co.kr/contents.html?article_no=2020041402109931731001&ref=naver
2749,2020-04-14,한국파스퇴르연구소대웅그룹구충제성분으로코로나19치료제임상준비,http://it.chosun.com/site/data/html_dir/2020/04/14/2020041401575.html
2750,2020-04-14,특징주대웅제약렘데시비르대비40배항바이러스효과니클로사마이드코로나19개발부각,http://www.etoday.co.kr/news/section/newsview.php?idxno=1883518
2751,2020-04-14,한국파스퇴르연구소대웅그룹코로나19치료제개발연구협력,http://www.newsprime.co.kr/news/article.html?no=501060
2752,2020-04-14,시황분석대웅제약전일대비568상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004141101354363edd30d18f7_45
2753,2020-04-14,파스퇴르대웅니클로사마이드코로나19치료제개발착수,http://health.chosun.com/site/data/html_dir/2020/04/14/2020041401662.html
2754,2020-04-14,한국파스퇴르연구소대웅그룹코로나19치료제개발연구협력착수7월임상진입목표,http://www.paxetv.com/news/articleView.html?idxno=90291
2755,2020-04-14,대웅한국파스퇴르니클로사마이드코로나19치료제임상준비,http://daily.hankooki.com/lpage/industry/202004/dh20200414110819148390.htm
2756,2020-04-14,또구충제대웅파스퇴르니클로사마이드코로나19치료제임상7월목표,http://theviewers.co.kr/View.aspx?No=809692
2757,2020-04-14,파스퇴르연구소대웅코로나19치료제맞손7월임상신청목표,https://www.news1.kr/articles/?3906498
2758,2020-04-14,대웅그룹코로나19치료제개발나섰다,http://www.bosa.co.kr/news/articleView.html?idxno=2125252
2759,2020-04-14,대웅그룹파스퇴르연구소와구충제성분코로나19치료제개발,http://www.newspim.com/news/view/20200414000334
2760,2020-04-14,대웅그룹한국파스퇴르연구소와코로나19치료제개발착수,http://www.kpinews.co.kr/news/articleView.html?idxno=114744
2761,2020-04-14,대웅한국파스퇴르코로나19치료제개발연구협력,http://www.mediapen.com/news/view/517149
2762,2020-04-14,파스퇴르연구소대웅구충제로코로나19치료제개발7월중임상신청,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041401777.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2763,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.mdtoday.co.kr/mdtoday/index.html?no=383998
2764,2020-04-14,특징주노터스대웅↑렘데시비르대비40배효능치료제개발기대,http://inthenews.co.kr/article-45280/
2765,2020-04-14,코로나19파스퇴르연구소대웅구충제로코로나19치료제개발착수,http://www.econovill.com/news/articleView.html?idxno=393247
2766,2020-04-14,대웅파스퇴르연구소와구충제로코로나19치료제개발,http://www.newsway.co.kr/news/view?tp=1&ud=2020041411275354674
2767,2020-04-14,대웅코로나19치료제개발착수7월임상계획,http://www.dailymedi.com/detail.php?number=855128&thread=22r05
2768,2020-04-14,파스퇴르연구소대웅구충제성분코로나19치료제임상준비”,http://news.kbs.co.kr/news/view.do?ncd=4424529&ref=A
2769,2020-04-14,한국파스퇴르연구소대웅니클로사마이드코로나19치료제임상준비,http://news.heraldcorp.com/view.php?ud=20200414000498
2770,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://newsbrite.net/135795
2771,2020-04-14,파스퇴르대웅코로나19치료제7월임상준비,http://www.daejonilbo.com/news/newsitem.asp?pk_no=1418580
2772,2020-04-14,파스퇴르대웅구충제로코로나19치료제개발추진,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4119684
2773,2020-04-14,파스퇴르연구소대웅구충제로코로나19치료제개발착수,http://www.seoulfn.com/news/articleView.html?idxno=379192
2774,2020-04-14,제약산업대웅파스퇴르연구소니클로사마이드코로나19치료제개발도전,http://www.kukinews.com/news/article.html?no=776583
2775,2020-04-14,한국파스퇴르대웅제약구충제코로나19치료제로개발,http://moneys.mt.co.kr/news/mwView.php?no=2020041410168043124
2776,2020-04-14,파스퇴르연구소대웅그룹코로나치료제개발맞손,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1133162&REFERER=NP
2777,2020-04-14,대웅그룹구충제로코로나19치료제개발나서 ,http://www.monews.co.kr/news/articleView.html?idxno=209938
2778,2020-04-14,파스퇴르연구소대웅테라퓨틱스구충제로코로나19치료제개발협력,http://www.hankookilbo.com/news/npath/202004141138341421?did=NA
2779,2020-04-14,파스퇴르硏대웅구충제로코로나19임상시험추진,http://www.inews24.com/view/1257855
2780,2020-04-14,한국파스퇴르연구소대웅니클로사마이드코로나19치료제임상,https://www.dailian.co.kr/news/view/883807?sc=Naver
2781,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.thepublic.kr/news/newsview.php?ncode=1065580352881758
2782,2020-04-14,대웅도코로나19치료제개발가세구충제성분으로임상준비,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1079725
2783,2020-04-14,대웅917VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041402086.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2784,2020-04-14,파스퇴르연구소대웅그룹코로나19치료제개발나선다,http://www.beyondpost.co.kr/view.php?ud=202004141231296041c5c1bde209_30
2785,2020-04-14,강세토픽2020년임상예정제약바이오테마대웅제약2671젬백스696,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041402137.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2786,2020-04-14,시황분석대웅전일대비1659상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=20200414131118690edd30a67a5_45
2787,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.nbnnews.co.kr/news/articleView.html?idxno=385742
2788,2020-04-14,대웅제약코로나19치료제임상시험준비소식에주가강세,http://www.whitepaper.co.kr/news/articleView.html?idxno=192136
2789,2020-04-14,대웅그룹한국파스퇴르연구소구충제활용코로나19치료제개발착수,http://www.donga.com/news/article/all/20200414/100647993/1
2790,2020-04-14,대웅그룹한국파스퇴르연구소구충제니클로사마이드로코로나19치료제개발착수,http://www.ezyeconomy.com/news/articleView.html?idxno=99910
2791,2020-04-14,파스퇴르연구소대웅구충제로코로나19치료제개발중”,http://news.kmib.co.kr/article/view.asp?arcid=0014476100&code=61141411&cp=nv
2792,2020-04-14,특징주대웅코로나19치료제개발소식에12상승,http://moneys.mt.co.kr/news/mwView.php?no=2020041413328031905
2793,2020-04-14,오후거래급증주점검대웅거래량↑그외종목은,http://www.itooza.com/common/iview.php?no=2020041413175072687
2794,2020-04-14,대웅파스퇴르연구소코로나19치료제임상준비,http://www.economytalk.kr/news/articleView.html?idxno=205482
2795,2020-04-14,부광약품대웅제약제약주갑작스런급등부광약품24급등이어대웅제약13급등,http://www.econonews.co.kr/news/articleView.html?idxno=116358
2796,2020-04-14,대웅그룹파스퇴르연구소와구충제활용한코로나19치료제개발,http://www.businesspost.co.kr/BP?command=article_view&num=173782
2797,2020-04-14,파스퇴르대웅코로나19치료제임상준비대웅제약주가꿈틀,http://sports.hankooki.com/lpage/economy/202004/sp20200414135236137020.htm
2798,2020-04-14,대웅제약신풍제약희비엇갈려대웅제약11급등반해신풍제약12폭락,http://www.econonews.co.kr/news/articleView.html?idxno=116363
2799,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.etnews.com/20200414000174
2800,2020-04-14,파스퇴르硏대웅니클로사마이드구충제로코로나19치료제개발7월임상시험,http://news.kbiz.or.kr/news/articleView.html?idxno=66308
2801,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.pressm.kr/news/articleView.html?idxno=29003
2802,2020-04-14,대웅파르퇴르硏코로나19치료제공동개발착수,http://www.g-enews.com/ko-kr/news/article/news_all/20200414142805439302a28bce39_1/article.html
2803,2020-04-14,대웅제약대웅주가장중급등구충제성분코로나19치료제개발,http://www.businesspost.co.kr/BP?command=article_view&num=173796
2804,2020-04-14,파스퇴르대웅코로나치료제공동개발착수,http://www.sporbiz.co.kr/news/articleView.html?idxno=430528
2805,2020-04-14,강세토픽치매치료테마대웅제약936젬백스591,https://biz.chosun.com/site/data/html_dir/2020/04/14/2020041402641.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2806,2020-04-14,파스퇴르연구소대웅구충제로코로나19치료제개발협력”,http://isplus.live.joins.com/news/article/article.asp?total_id=23754387
2807,2020-04-14,파스퇴르연구소대웅코로나19치료제임상준비착수,http://www.busan.com/view/busan/view.php?code=2020041415012629923
2808,2020-04-14,대웅그룹한국파스퇴르연구소코로나19치료제연구협력착수,http://www.100ssd.co.kr/news/articleView.html?idxno=68242
2809,2020-04-14,한국파스퇴르대웅코로나치료제공동개발착수,http://www.doctorstimes.com/news/articleView.html?idxno=210662
2810,2020-04-14,한국파스퇴르연구소대웅구충제성분활용한코로나19치료제개발착수,http://www.newsworks.co.kr/news/articleView.html?idxno=448058
2811,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60732
2812,2020-04-14,대웅그룹파스퇴르코로나19치료제개발협력,http://www.finomy.com/news/articleView.html?idxno=77240
2813,2020-04-14,파스퇴르연구소대웅테라퓨틱스구충제로코로나19치료제개발추진,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4120255
2814,2020-04-14,한국파스퇴르연구소대웅구충제로코로나19치료제임상준비,http://www.ajunews.com/view/20200414165826177
2815,2020-04-14,파스퇴르연구소대웅구충제니클로사마이드로코로나19치료제개발추진렘데시비르40배클로로퀸26배,http://www.topstarnews.net/news/articleView.html?idxno=762164
2816,2020-04-14,대웅그룹한국파스퇴르연구소와니클로사마이드코로나19치료제임상준비,https://www.news2day.co.kr/151226
2817,2020-04-14,대웅한국파스퇴르硏코로나치료제개발협력착수,https://cnbc.sbs.co.kr/article_hub/10000979840?division=NAVER
2818,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.lawissue.co.kr/view.php?ud=202004141850398264204ead0791_12
2819,2020-04-14,14일기관순매도Top10KODEX200선물인버스2X1782억대웅제약72억하나금융지주40억KODEX골드선물H27억기관순매도나서코스닥시장에서는에스티팜압타바이오CJ,http://www.fintechpost.co.kr/news/articleView.html?idxno=109400
2820,2020-04-14,한국파스퇴르연구소대웅그룹니클로사마이드코로나19치료제임상준비,http://www.wsobi.com/news/articleView.html?idxno=95379
2821,2020-04-15,대웅파스퇴르연구소와코로나19치료제개발,https://www.ajunews.com/view/20200414104836771
2822,2020-04-15,시황분석대웅제약전일대비1146상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004150932272731edd30fbd99_45
2823,2020-04-15,한국파스퇴르연구소대웅그룹과코로나19치료제니클로사마이드임상준비,http://www.thefirstmedia.net/news/articleView.html?idxno=56951
2824,2020-04-15,대웅그룹구충제활용코로나19치료제개발착수파스퇴르연구소협력,http://www.thevaluenews.co.kr/news/view.php?idx=159188
2825,2020-04-16,비즈헬스한국콜마광동제약대웅한올바이오파마유한건강생활등,http://www.bizwnews.com/news/articleView.html?idxno=13363
2826,2020-04-16,대웅779상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/16/2020041600861.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2827,2020-04-16,대웅5이상상승주가상승중단기간골든크로스형성,https://www.hankyung.com/finance/article/202004163132L
2828,2020-04-16,대웅제약5이상상승소송불확실성해소만이해답키움증권BUY상향,https://www.hankyung.com/finance/article/202004163130L
2829,2020-04-16,대웅제약708상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/16/2020041600892.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2830,2020-04-16,시황분석대웅제약전일대비519상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004160926425649edd308ffdd_45
2831,2020-04-16,대웅그룹코로나19임상준비중,http://www.whosaeng.com/117085
2832,2020-04-16,대웅장시작후꾸준히올라574이시각거래량45만8659주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004160132&t=NN
2833,2020-04-16,대웅제약신사업확장속도낸다,http://newsclaim.co.kr/View.aspx?No=810895
2834,2020-04-16,대웅제약건강기능식품군강화간장눈등효과6종출시,https://www.sedaily.com/NewsView/1Z1HXCCP8K
2835,2020-04-16,대웅제약건강기능식품6종출시,http://www.newsis.com/view/?id=NISX20200416_0000996066&cID=13001&pID=13000
2836,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.econovill.com/news/articleView.html?idxno=393443
2837,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.segye.com/content/html/2020/04/16/20200416511320.html?OutUrl=naver
2838,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.metroseoul.co.kr/article/20200416500117
2839,2020-04-16,대웅제약생활습관맞춤건강기능식품6종출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=83553
2840,2020-04-16,대웅제약에너씨슬등건강기능식품6종출시,http://www.kpinews.co.kr/news/articleView.html?idxno=114829
2841,2020-04-16,대웅제약건강기능식품6종출시,http://www.newspim.com/news/view/20200416000460
2842,2020-04-16,대웅제약건강기능식품사업확장건기식6종출시,http://www.viva100.com/main/view.php?key=20200416010005956
2843,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.etnews.com/20200416000097
2844,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,https://www.fetv.co.kr/news/article.html?no=52741
2845,2020-04-16,대웅제약건강기능식품6종출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60745
2846,2020-04-16,대웅제약예방관리필수간장눈혈행특화건기식6종출시,http://theviewers.co.kr/View.aspx?No=810921
2847,2020-04-16,대웅제약건강기능식품6종으로新사업확장,http://health.chosun.com/site/data/html_dir/2020/04/16/2020041601590.html
2848,2020-04-16,대웅제약건강기능식품으로사업영역확대,http://www.koreastocknews.com/news/articleView.html?idxno=52889
2849,2020-04-16,대웅제약고품질건강기능식품6종출시신사업확장나서,http://www.pressm.kr/news/articleView.html?idxno=29020
2850,2020-04-16,대웅제약건강기능식품6종출시헬스케어사업확장나선다,http://www.greened.kr/news/articleView.html?idxno=247317
2851,2020-04-16,대웅제약건강기능식품6종출시간장눈건강을위한고품질제품라인업구성,http://www.paxetv.com/news/articleView.html?idxno=90383
2852,2020-04-16,대웅제약건강기능식품6종으로신사업확장,http://www.fnnews.com/news/202004161052298653
2853,2020-04-16,대웅제약간기능개선등건기식6종출시신사업확장,http://moneys.mt.co.kr/news/mwView.php?no=2020041610488094545
2854,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.edaily.co.kr/news/newspath.asp?newsid=02522326625736776
2855,2020-04-16,대웅제약신사업확장건기식6종출시,http://daily.hankooki.com/lpage/industry/202004/dh20200416105957148390.htm
2856,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.thepublic.kr/news/newsview.php?ncode=1065576780641047
2857,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.segyebiz.com/newsView/20200416511874?OutUrl=naver
2858,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.bosa.co.kr/news/articleView.html?idxno=2125317
2859,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.mdtoday.co.kr/mdtoday/index.html?no=384124
2860,2020-04-16,대웅제약증상별맞춤건강기능식품6종출시,http://www.insightkorea.co.kr/news/articleView.html?idxno=79133
2861,2020-04-16,대웅제약건강기능식품6종출시사업영역확장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1884295
2862,2020-04-16,대웅제약맞춤건기식6종출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065576789158594
2863,2020-04-16,대웅제약가정의달앞두고6종건기식승부수,http://www.press9.kr/news/articleView.html?idxno=44321
2864,2020-04-16,대웅제약소비자생활습관맞춤건기식6종출시신사업확장나선다,http://www.ekn.kr/news/article.html?no=494182
2865,2020-04-16,대웅파스퇴르구충제로코로나19치료제개발맞손,http://www.sisaweek.com/news/articleView.html?idxno=132989
2866,2020-04-16,대웅제약신사업확장건기식품6종출시,http://www.medical-tribune.co.kr/news/articleView.html?idxno=91879
2867,2020-04-16,대웅제약간장눈혈행챙기는건강기능식품6종출시,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003941289
2868,2020-04-16,대웅제약신사업영역확장나서건강기능식품6종출시,http://medipana.com/news/news_viewer.asp?NewsNum=255612&MainKind=A&NewsKind=5&vCount=12&vKind=1
2869,2020-04-16,대웅제약건강기능식품6종출시사업영역확대,http://news.mt.co.kr/mtview.php?no=2020041611451835267
2870,2020-04-16,건강기능식품강화나선대웅제약에너씨슬등신제품6종출시,http://www.donga.com/news/article/all/20200416/100685750/1
2871,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://newsbrite.net/135853
2872,2020-04-16,대웅제약간장눈혈행등건강기능식품6종출시,http://www.asiatoday.co.kr/view.php?key=20200416010009745
2873,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.businesskorea.co.kr/news/articleView.html?idxno=44282
2874,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243126
2875,2020-04-16,에너씨슬세노메가출시대웅제약건식분야눈독,http://www.whosaeng.com/117112
2876,2020-04-16,대웅제약건강기능식품6종출시신사업확대에속도,http://www.ajunews.com/view/20200416123911321
2877,2020-04-16,부광약품대웅제약제약주상승에급등까지부광약품6급등이어대웅제약2상승,http://www.econonews.co.kr/news/articleView.html?idxno=116601
2878,2020-04-16,대웅제약신풍제약희비엇갈려대웅제약2상승반해신풍제약12폭락,http://www.econonews.co.kr/news/articleView.html?idxno=116602
2879,2020-04-16,대웅제약건기식6종출시신사업확장나선다,http://www.dailysmart.co.kr/news/articleView.html?idxno=25159
2880,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.ceoscoredaily.com/news/article.html?no=68531
2881,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.nbnnews.co.kr/news/articleView.html?idxno=386108
2882,2020-04-16,대웅제약건강기능식품6종출시,http://www.ebn.co.kr/news/view/1429783/?sc=naver
2883,2020-04-16,대웅제약건강기능식품6종출시신사업확장추진,http://www.enewstoday.co.kr/news/articleView.html?idxno=1381760
2884,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.pharmnews.com/news/articleView.html?idxno=100315
2885,2020-04-16,대웅제약신개념건강기능식품6종선뵈,http://www.g-enews.com/ko-kr/news/article/news_all/20200416140217529951638db705_1/article.html
2886,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.m-i.kr/news/articleView.html?idxno=702451
2887,2020-04-16,대웅코로나19치료제개발소식에2거래일연속강세,http://www.koreastocknews.com/news/articleView.html?idxno=52900
2888,2020-04-16,대웅제약맞춤형건강기능식품6종출시,http://www.finomy.com/news/articleView.html?idxno=77265
2889,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.mediapen.com/news/view/518153
2890,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.pinpointnews.co.kr/view.php?ud=202004161425189054f090c8dbcb_45
2891,2020-04-16,대웅제약고품질건강기능식품6종내놓으며신사업진출,http://www.businesspost.co.kr/BP?command=article_view&num=174040
2892,2020-04-16,대웅제약건강기능식품6종출시신사업확장,https://www.dailian.co.kr/news/view/884559?sc=Naver
2893,2020-04-16,대웅제약건강기능식품으로사업영역확대소비자증상별제품6종출시,http://kpenews.com/View.aspx?No=811400
2894,2020-04-16,뉴스투데이L대웅제약증상별맞춤건기식6종출시로신사업확장,https://www.news2day.co.kr/151327
2895,2020-04-16,대웅제약건강기능식품6종출시신사업확장,http://www.upinews.kr/newsView/upi202004160114
2896,2020-04-16,대웅제약건강기능식품6종출시신사업확대,http://www.dailymedi.com/detail.php?number=855202&thread=22r05
2897,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.sporbiz.co.kr/news/articleView.html?idxno=431114
2898,2020-04-16,대웅제약건강기능식품6종출시신사업확장나서,https://jhealthmedia.joins.com/article/article_view.asp?pno=21661
2899,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.lawissue.co.kr/view.php?ud=202004161557456753204ead0791_12
2900,2020-04-16,대웅제약신사업확장나선다소비자생활습관과증상별맞춤건강기능식품6종출시,http://www.updownnews.co.kr/news/articleView.html?idxno=217643
2901,2020-04-16,대웅제약건강기능식품6종출시,http://www.joseilbo.com/news/news_read.php?uid=396322&class=27&grp=
2902,2020-04-16,대웅제약간장눈혈행챙기는건강기능식품6종출시,http://www.100ssd.co.kr/news/articleView.html?idxno=68265
2903,2020-04-16,코로나에울고웃고대웅제약부광약품주가고공행진,http://www.whitepaper.co.kr/news/articleView.html?idxno=192228
2904,2020-04-16,대웅제약건기식신제품출시카테고리확대,http://www.meconomynews.com/news/articleView.html?idxno=40401
2905,2020-04-16,대웅제약건강기능식품사업확장,http://www.seoulfn.com/news/articleView.html?idxno=379457
2906,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.wsobi.com/news/articleView.html?idxno=95513
2907,2020-04-16,대웅제약건강기능식품6종출시신사업확장나선다,http://www.thevaluenews.co.kr/news/view.php?idx=159205
2908,2020-04-16,대웅제약간장눈등건강기능식품6종라인업출시,https://www.kpanews.co.kr/article/show.asp?idx=212569&category=D
2909,2020-04-17,씨티씨바이오아미코젠대웅구충제→코로나19치료제,http://www.dailymedi.com/detail.php?number=855210&thread=22r05
2910,2020-04-17,한올바이오파마지분확대나선대웅목표량30부족전망,http://medipana.com/news/news_viewer.asp?NewsNum=255649&MainKind=A&NewsKind=5&vCount=12&vKind=1
2911,2020-04-17,더벨대웅家2세윤재훈의알피바이오내년IPO타진,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202004160821258980102989
2912,2020-04-17,리포트브리핑대웅니클로사마이드물질을이용한코로나19치료제개발착수NotRatedDS투자증권,http://www.newspim.com/news/view/20200417000092
2913,2020-04-17,대웅제약신풍제약희비엇갈려대웅제약4하락반해신풍제약8급등,http://www.econonews.co.kr/news/articleView.html?idxno=116740
2914,2020-04-17,DS투자증권대웅코로나19치료제로효능높은니클로사마이드최대수혜주,http://www.fnnews.com/news/202004170933505309
2915,2020-04-17,대웅257상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/17/2020041700937.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2916,2020-04-17,대웅제약건기식사업확장신제품6종출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1270730
2917,2020-04-17,에볼루스코로나때문에대웅나보타유럽발매연기,http://www.dailypharm.com/Users/News/NewsView.html?ID=263864&REFERER=NP
2918,2020-04-17,RD투자한미약품유한양행녹십자종근당대웅제약순,http://www.wikileaks-kr.org/news/articleView.html?idxno=83702
2919,2020-04-17,대웅제약맞춤건강기능식품6종출시신사업확장본격화,http://www.newslock.co.kr/news/articleView.html?idxno=27263
2920,2020-04-18,니클로사마이드최대수혜주대웅제약외국인매수전환땐상승폭발가능성,http://www.thekpm.com/view.php?ud=202004180701286922861beb2d9d_17
2921,2020-04-18,대웅제약나보타코로나19로유럽발매지연,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1079849
2922,2020-04-19,전승호대웅제약인도네시아할랄인증앞세워이슬람권으로간다,http://www.businesspost.co.kr/BP?command=article_view&num=174394
2923,2020-04-19,대웅제약과소송에도영향,https://www.hankyung.com/it/article/2020041999261
2924,2020-04-20,대웅아모레퍼시픽과우루사상표권분쟁서勝,http://www.mdtoday.co.kr/mdtoday/index.html?no=383914
2925,2020-04-20,대웅제약20이상상승소송불확실성해소만이해답키움증권BUY상향,https://www.hankyung.com/finance/article/202004200636L
2926,2020-04-20,대웅15이상상승니클로사마이드물질을이용한코로나19치료제개발착수,https://www.hankyung.com/finance/article/202004200637L
2927,2020-04-20,특징주대웅제약메디톡스제재소식에급등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004200086&t=NN
2928,2020-04-20,특징주국내1위보톡스메디톡신퇴출에휴젤대웅제약급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1885321
2929,2020-04-20,대웅제약신풍제약희비엇갈려대웅제약갑작스런12급등반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=116957
2930,2020-04-20,특징주대웅제약휴젤메디톡신품목허가취소반사이익기대감에강세,http://news.mk.co.kr/newsRead.php?no=408743&year=2020
2931,2020-04-20,특징주대웅제약휴젤메디톡스판매중지에급등,http://www.inews24.com/view/1258925
2932,2020-04-20,대웅제약15강세메디톡스와분쟁서유리한고지전망,http://news.mt.co.kr/mtview.php?no=2020042008345252245
2933,2020-04-20,시황분석대웅제약전일대비1579상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004200924478738edd30b65ed_45
2934,2020-04-20,특징주대웅제약메디톡신판매중지반사이익기대감에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020042009258088439
2935,2020-04-20,헬스케어주관심집중휴젤엔지켐생명과학대웅제약강세,http://www.g-enews.com/ko-kr/news/article/news_all/202004200925497741edf69f862c_1/article.html
2936,2020-04-20,특징주대웅제약휴젤메디톡신품목허가취소반사이익기대감에↑,http://www.viva100.com/main/view.php?key=20200420010006974
2937,2020-04-20,메디톡스下경쟁사대웅제약휴젤은두자릿수상승,http://news.mt.co.kr/mtview.php?no=2020042009333920363
2938,2020-04-20,코스피코스닥동반상승출발대웅제약네이처셀휴젤에넥스급등,http://www.businesspost.co.kr/BP?command=article_view&num=174469
2939,2020-04-20,TF특징주대웅제약메디톡스톡신제품허가취소소식에급등,http://news.tf.co.kr/read/economy/1790644.htm
2940,2020-04-20,특징주대웅제약보톡스경쟁사메디톡스악재소식에급등,http://www.asiatoday.co.kr/view.php?key=20200420010011352
2941,2020-04-20,메디톡스메디톡신공백이노톡스가채워대웅과ITC소송별개,http://moneys.mt.co.kr/news/mwView.php?no=2020042009018088015
2942,2020-04-20,주식대웅제약1244휴젤1842급등메디톡신품목허가취소에반사이익기대감부각,http://www.ggilbo.com/news/articleView.html?idxno=761832
2943,2020-04-20,대웅장시작후꾸준히올라809이시각76만463주거래,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004200143&t=NN
2944,2020-04-20,대웅제약상승흐름전일대비134최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004200150&t=NN
2945,2020-04-20,특징주메디톡스하한가대웅제약은급등,http://www.polinews.co.kr/news/article.html?no=460317
2946,2020-04-20,메디톡스메디톡신이슈속장중급락vs휴젤대웅제약은장중급등,http://www.choicenews.co.kr/news/articleView.html?idxno=70114
2947,2020-04-20,메디톡신허가취소에메디톡스30↓대웅휴젤급등,http://www.whitepaper.co.kr/news/articleView.html?idxno=192398
2948,2020-04-20,메디톡스판매중지명령에하한가대웅제약등경쟁사급등,https://biz.chosun.com/site/data/html_dir/2020/04/20/2020042001583.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2949,2020-04-20,메디톡스메디톡신허가취소가능성휴젤대웅제약웃는다,https://www.news1.kr/articles/?3912049
2950,2020-04-20,휴젤대웅주가급등메디톡신퇴출위기에반사이익,http://www.dailypharm.com/Users/News/NewsView.html?ID=263915&REFERER=NP
2951,2020-04-20,TF특징주메디톡스제품판매중단에급락휴젤대웅제약반사이익,http://news.tf.co.kr/read/economy/1790666.htm
2952,2020-04-20,메디톡스주가제조금지에초반하한가경쟁사휴젤대웅제약은급등,http://www.businesspost.co.kr/BP?command=article_view&num=174489
2953,2020-04-20,박능후장관코로나19대웅국제공조강조,https://www.kpanews.co.kr/article/show.asp?idx=212618&category=C
2954,2020-04-20,메디톡스메디톡신주제조판매정지처분에행정소송대웅ITC소송영향없어,http://www.etnews.com/20200420000163
2955,2020-04-20,허가취소메디톡스下반사이익기대감에대웅제약휴젤급등,http://news.mt.co.kr/mtview.php?no=2020042014441104893
2956,2020-04-20,대웅제약과소송에검찰식약처압박까지메디톡스에무슨일이,http://www.opinionnews.co.kr/news/articleView.html?idxno=32618
2957,2020-04-20,보톡스株희비메디톡스하한가휴젤대웅제약급등,http://www.edaily.co.kr/news/newspath.asp?newsid=04040966625738088
2958,2020-04-20,특징주메디톡스제품판매중지소식에하한가휴젤대웅제약강세,http://www.seoulwire.com/news/articleView.html?idxno=408534
2959,2020-04-20,메디톡스메디톡신악재에하한가휴젤대웅제약반사이익종합,https://www.news1.kr/articles/?3912696
2960,2020-04-20,메디톡스추락에경쟁사휴젤대웅제약껑충,https://www.hankyung.com/finance/article/202004202273i
2961,2020-04-20,메디톡스판매중단위기대웅제약휴젤반사익보나,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004200341&t=NNv
2962,2020-04-20,휴젤보톡스경쟁반사이익대웅제약도매출향상기대,https://www.hankyung.com/it/article/2020042028791
2963,2020-04-20,메디톡스외국인매수에도하한가충격왜경쟁사인대웅제약휴젤주가는폭등,http://www.smartfn.co.kr/view.php?ud=202004201855491661861beb2d9d_46
2964,2020-04-21,메디톡스잇단악재휴젤대웅제약휴온스호재,http://www.dailymedi.com/detail.php?number=855328&thread=22r05
2965,2020-04-21,이슈돋보기보톡스3중고겪는메디톡스대웅제약과소송향방은,http://www.asiatoday.co.kr/view.php?key=20200420010011912
2966,2020-04-21,빅데이터MSI시장심리톱5CJ현대로템대웅제약SK포스코,http://www.newsis.com/view/?id=NISX20200421_0001000385&cID=10401&pID=10400
2967,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전붙이세요”,http://daily.hankooki.com/lpage/industry/202004/dh20200421091907148390.htm
2968,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.viva100.com/main/view.php?key=20200421010007493
2969,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.fnnews.com/news/202004210923346165
2970,2020-04-21,대웅제약신풍제약희비엇갈려대웅제약3하락반해신풍제약소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=117153
2971,2020-04-21,대웅제약”여드름짜기전미리붙이세요”,http://newsclaim.co.kr/View.aspx?No=814280
2972,2020-04-21,대웅제약여드름에붙이는이지덤뷰티릴리프출시,http://www.m-i.kr/news/articleView.html?idxno=703710
2973,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전붙이세요”,https://www.fetv.co.kr/news/article.html?no=53011
2974,2020-04-21,대웅제약여드름진정제패치이지덤뷰티릴리프시판,http://www.g-enews.com/ko-kr/news/article/news_all/20200421093119349351638db705_1/article.html
2975,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.greened.kr/news/articleView.html?idxno=248003
2976,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572936656693
2977,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,https://www.sedaily.com/NewsView/1Z1K7KPEQY
2978,2020-04-21,티안나게여드름케어대웅제약새로운이지덤뷰티릴리프패치출시,http://theviewers.co.kr/View.aspx?No=814368
2979,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.newslock.co.kr/news/articleView.html?idxno=27346
2980,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.dailymedi.com/detail.php?number=855338&thread=22r05
2981,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.ekn.kr/news/article.html?no=495014
2982,2020-04-21,대웅제약여드름짜기전붙이세요,http://www.bosa.co.kr/news/articleView.html?idxno=2125566
2983,2020-04-21,대웅제약여드름짜기전붙이는패치출시,http://www.newsis.com/view/?id=NISX20200421_0001000573&cID=13001&pID=13000
2984,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://moneys.mt.co.kr/news/mwView.php?no=2020042110018059081
2985,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.press9.kr/news/articleView.html?idxno=44367
2986,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=60807
2987,2020-04-21,대웅제약여드름짜기전에붙이는이지덤뷰티릴리프출시,http://www.kpinews.co.kr/news/articleView.html?idxno=115094
2988,2020-04-21,리포트브리핑대웅제약이벤트가주도하는상반기목표가140000원DB금융투자,http://www.newspim.com/news/view/20200421000350
2989,2020-04-21,여드름짜지말고붙이세요대웅제약패치출시,http://news.mt.co.kr/mtview.php?no=2020042110213598412
2990,2020-04-21,대웅제약여드름짜기전에붙이는이지덤뷰티릴리프출시,http://www.thepublic.kr/news/newsview.php?ncode=1065575137118496
2991,2020-04-21,대웅제약여드름짜기전붙이는이지덤뷰티릴리프출시,http://medipana.com/news/news_viewer.asp?NewsNum=255839&MainKind=A&NewsKind=5&vCount=12&vKind=1
2992,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://sports.hankooki.com/lpage/economy/202004/sp20200421104058136980.htm
2993,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=384511
2994,2020-04-21,대웅제약여드름짜기전붙이는이지덤뷰티릴리프선봬,http://www.insightkorea.co.kr/news/articleView.html?idxno=79281
2995,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.100ssd.co.kr/news/articleView.html?idxno=68346
2996,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=25343
2997,2020-04-21,대웅제약이지덤뷰티릴리프출시,http://www.segyebiz.com/newsView/20200421510964?OutUrl=naver
2998,2020-04-21,대웅제약보톡스시장강자로급부상하나,http://www.m-i.kr/news/articleView.html?idxno=703785
2999,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전미리붙이세요,http://www.nbnnews.co.kr/news/articleView.html?idxno=387077
3000,2020-04-21,대웅제약이지덤뷰티릴리프출시”여드름짜기전미리붙이세요”,http://newsbrite.net/136017
3001,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜지말고붙이세요,http://www.metroseoul.co.kr/article/20200421500227
3002,2020-04-21,대웅제약ITC소송불확실성해소기대”,http://www.wikitree.co.kr/articles/525534
3003,2020-04-21,오늘의신상품대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.econovill.com/news/articleView.html?idxno=393988
3004,2020-04-21,대웅제약여드름진정돕는이지덤뷰티릴리프출시,http://news.mk.co.kr/newsRead.php?no=415114&year=2020
3005,2020-04-21,메디톡스제보자위법증언자대웅제약출신말고도많다,http://www.upinews.kr/newsView/upi202004210065
3006,2020-04-21,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.asiatoday.co.kr/view.php?key=20200421010012634
3007,2020-04-21,대웅제약여드름패치이지덤출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=84047
3008,2020-04-21,신상품대웅제약이지덤여드름패치,http://www.seoulfn.com/news/articleView.html?idxno=379978
3009,2020-04-21,대웅제약여드름진정도움이지덤뷰티릴리프선보여,http://www.pressm.kr/news/articleView.html?idxno=29168
3010,2020-04-21,대웅제약이지덤뷰티릴리프출시”여드름짜기전미리붙이세요”,http://www.lawissue.co.kr/view.php?ud=20200421162446169204ead0791_12
3011,2020-04-21,시황분석대웅제약전일대비573하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004211631324078edd300bd09_45
3012,2020-04-21,대웅제약여드름짜기전붙이는패치내놔,http://www.economytalk.kr/news/articleView.html?idxno=205589
3013,2020-04-21,대웅제약여드름진정돕는이지덤뷰티릴리프출시,http://kormedi.com/?p=1315811
3014,2020-04-21,뉴스투데이L대웅제약여드름진정패치이지덤뷰티릴리프출시,https://www.news2day.co.kr/151573
3015,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.donga.com/news/article/all/20200421/100750389/1
3016,2020-04-21,대웅제약이지덤뷰티릴리프출시여드름짜기전미리붙이세요,http://www.businesskorea.co.kr/news/articleView.html?idxno=44564
3017,2020-04-21,대웅제약여드름패치이지덤뷰티릴리프출시,http://www.k-health.com/news/articleView.html?idxno=48152
3018,2020-04-21,대웅2세윤재훈회장삼성동단독주택대웅개발90억에매수,http://www.bizhankook.com/article/19845
3019,2020-04-22,대웅제약여드름진정패치이지덤뷰티릴리프출시,http://www.thefirstmedia.net/news/articleView.html?idxno=57173
3020,2020-04-22,제약대웅제약난치병질환신약에집중올해부터결실기대,http://news.mk.co.kr/newsRead.php?no=416980&year=2020
3021,2020-04-22,대웅글리아타민1분기제네릭처방선두236억,http://www.dailypharm.com/Users/News/NewsView.html?ID=263975&REFERER=NP
3022,2020-04-22,우정바이오이종욱전대웅제약CEO영입드림팀완성,http://www.bosa.co.kr/news/articleView.html?idxno=2125608
3023,2020-04-22,DS證대웅코로나19치료후보물질중가장높은효과예상”,http://www.sentv.co.kr/news/view/571919
3024,2020-04-22,리포트브리핑대웅코로나19치료후보물질중대웅의니클로사마이드가치료효과가장높을것으로예상NotRatedDS투자증권,http://www.newspim.com/news/view/20200422000087
3025,2020-04-22,대웅니콜로사마이드코로나19치료효과높아DS,http://www.edaily.co.kr/news/newspath.asp?newsid=01718726625738744
3026,2020-04-22,대웅10이상상승코로나19치료후보물질중대웅의니클로사마이드가치료효과가장높을것으로예상,https://www.hankyung.com/finance/article/202004226826L
3027,2020-04-22,특징주대웅니클로사마이드코로나19치료효과에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01902406625738744
3028,2020-04-22,종목DB금융투자대웅제약소송비용감소불확실성해소기대매수”,http://www.sporbiz.co.kr/news/articleView.html?idxno=432593
3029,2020-04-22,대웅1855VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/22/2020042200965.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3030,2020-04-22,대웅제약신풍제약희비엇갈려대웅제약7급등반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=117350
3031,2020-04-22,대웅제약1075상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/22/2020042200989.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3032,2020-04-22,대웅2582상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/22/2020042200980.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3033,2020-04-22,대웅제약5이상상승이벤트가주도하는상반기DB금융투자BUY유지,https://www.hankyung.com/finance/article/202004226996L
3034,2020-04-22,대웅주가200상승중거래량급증,https://www.tfmedia.co.kr/news/article.html?no=83671
3035,2020-04-22,대웅제약1215VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/22/2020042201117.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3036,2020-04-22,대웅2982상한가,https://biz.chosun.com/site/data/html_dir/2020/04/22/2020042201116.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3037,2020-04-22,대웅상한가↑도달전일외국인대량순매수,https://www.hankyung.com/finance/article/202004227141L
3038,2020-04-22,이시각상한가대웅▲410022일오전9시48분,http://www.etoday.co.kr/news/section/newsview.php?idxno=1886458
3039,2020-04-22,시황분석대웅제약전일대비1963상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004220952486424edd3046faa_45
3040,2020-04-22,대웅상한가진입이시각거래량258만1815주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004220141&t=NN
3041,2020-04-22,대웅제약전일대비1542상승중최근주가반등흐름,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004220143&t=NN
3042,2020-04-22,fnRASSI대웅상한가기록,http://www.fnnews.com/news/202004221003451594
3043,2020-04-22,시황분석대웅전일대비2982상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004221005135295edd3004957_45
3044,2020-04-22,특징주니클로사마이드코로나19치료효과높다에대웅노터스↑,http://inthenews.co.kr/article-46391/
3045,2020-04-22,특징주대웅니클로사마이드코로나19치료효과에29급등,http://moneys.mt.co.kr/news/mwView.php?no=2020042210138016703
3046,2020-04-22,대웅대웅제약주가초반급등코로나19치료효과약물보유,http://www.businesspost.co.kr/BP?command=article_view&num=174900
3047,2020-04-22,주식대웅제약1495눈부신상승세메디톡스추락에반사이익계속될까,http://www.ggilbo.com/news/articleView.html?idxno=762541
3048,2020-04-22,주식대웅2982상한가니클로사마이드코로나19치료효과에급등,http://www.ggilbo.com/news/articleView.html?idxno=762542
3049,2020-04-22,오전급등주점검대웅상한가외재무상태는,http://www.itooza.com/common/iview.php?no=2020042210103727384
3050,2020-04-22,대웅주가급등코로나19효과약물보유,http://www.smartfn.co.kr/view.php?ud=2020042210511656552f72f4a00b_46
3051,2020-04-22,대웅니클로사마이드코로나19치료효과높을것분석에상한가,http://www.koreastocknews.com/news/articleView.html?idxno=53046
3052,2020-04-22,코스피코스닥장중하락폭축소대웅한진중공업오스템급등,http://www.businesspost.co.kr/BP?command=article_view&num=174949
3053,2020-04-22,대웅제약코로나19수혜주주목에주가상승특징주,http://www.kukinews.com/news/article.html?no=779756
3054,2020-04-22,대웅제약메디톡스와균주소송의불확실성을올해해소가능,http://www.businesspost.co.kr/BP?command=article_view&num=174939
3055,2020-04-22,코스피미국한국재정정책확대영향1900선육박대웅보유물질코로나19치료효과상한가,http://www.econonews.co.kr/news/articleView.html?idxno=117447
3056,2020-04-22,대웅제약나보타에쏠리는눈국내보톡스시장재편될까,http://www.opinionnews.co.kr/news/articleView.html?idxno=32731
3057,2020-04-22,22일특징주대웅하나니켈12호상한가삼표시멘트등SOC株강세,http://www.newsworks.co.kr/news/articleView.html?idxno=450223
3058,2020-04-22,메디톡스대웅제약과의균주제조기술도용소송끝나지않았다”,http://www.pinpointnews.co.kr/view.php?ud=202004221720048585f090c8dbcb_45
3059,2020-04-22,메디톡스대웅보톡스전쟁외국社만웃는다,https://www.hankyung.com/it/article/202004229306i
3060,2020-04-22,표최근3일상승종목코스피Top10하나니켈2호2988↑상승종목1위대웅하나니켈1호성신양회성신양회우주가순으로상위시세기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=110572
3061,2020-04-23,코로나한랭전선에떨고있니유한대웅GC녹십자방한복무장,http://www.medisobizanews.com/news/articleView.html?idxno=69117
3062,2020-04-23,대웅000VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/23/2020042300812.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3063,2020-04-23,대웅1289상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/23/2020042300851.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3064,2020-04-23,대웅10이상상승코로나19치료후보물질중대웅의니클로사마이드가치료효과가장높을것으로예상,https://www.hankyung.com/finance/article/202004231075L
3065,2020-04-23,시황분석대웅전일대비1373상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004230905396162edd307f2ef_45
3066,2020-04-23,대웅제약신풍제약모두하락부진대웅제약1낙폭이어신풍제약2낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=117469
3067,2020-04-23,특징주대웅니클로사마이드코로나19치료효과에2거래일강세,http://moneys.mt.co.kr/news/mwView.php?no=2020042309408015807
3068,2020-04-23,대웅상승출발후현재532기관7000주순매도,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004230195&t=NN
3069,2020-04-23,갑질회장윤재승떠나니대웅제약1조클럽가입1Q성적표는,http://www.inews24.com/view/1260076
3070,2020-04-23,바이오헬쓰케어업종내주목해야할종목TOP7안트로젠대웅앱클론등관심,http://www.g-enews.com/ko-kr/news/article/news_all/202004231044273887edf69f862c_1/article.html
3071,2020-04-23,시황분석대웅제약전일대비216하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004231633281904edd30908ea_45
3072,2020-04-24,대웅678상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/24/2020042400816.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3073,2020-04-24,대웅5이상상승코로나19치료후보물질중대웅의니클로사마이드가치료효과가장높을것으로예상,https://www.hankyung.com/finance/article/202004245419L
3074,2020-04-24,대웅1150VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/24/2020042400845.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3075,2020-04-24,대웅제약1013VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/24/2020042400903.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3076,2020-04-24,대웅제약5이상상승이벤트가주도하는상반기DB금융투자BUY유지,https://www.hankyung.com/finance/article/202004245462L
3077,2020-04-24,특징주대웅니클로사마이드코로나19치료효과에강세,https://www.dailian.co.kr/news/view/886159?sc=Naver
3078,2020-04-24,특징주대웅제약125000원24일9시20분장시작대비965상승,http://www.getnews.co.kr/view.php?ud=202004240921454262c20b972990_16
3079,2020-04-24,시황분석대웅전일대비1829상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004240932306234edd3062d1b_45
3080,2020-04-24,대웅제약신풍제약희비엇갈려대웅제약3상승반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=117588
3081,2020-04-24,코스피코스닥동반하락출발대웅모나리자스페코알서포트급등,http://www.businesspost.co.kr/BP?command=article_view&num=175308
3082,2020-04-24,대웅장시작후꾸준히올라1681이시각거래량534만2199주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004240567&t=NN
3083,2020-04-24,2020제약RD대웅제약희귀난치성질환치료신약개발에역량집중,http://daily.hankooki.com/lpage/column/202004/dh20200424100010148550.htm?s_ref=nv
3084,2020-04-24,특징주대웅니클로사마이드코로나19치료효과에연일강세,http://moneys.mt.co.kr/news/mwView.php?no=2020042410098085411
3085,2020-04-24,대웅제약264상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/04/24/2020042402240.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3086,2020-04-24,주식대웅2212니클로사마이드에쏠리는기대감매수세↑,http://www.ggilbo.com/news/articleView.html?idxno=763231
3087,2020-04-24,대웅파미셀코로나관련주희비엇갈려대웅22폭등반해파미셀12폭락,http://www.econonews.co.kr/news/articleView.html?idxno=117699
3088,2020-04-24,대웅주가와거래량모두강세최근5거래일최고거래량돌파,https://www.tfmedia.co.kr/news/article.html?no=83856
3089,2020-04-24,표장중시황24일코스피주가Top55상승률STX중공업주가상승률1위2337올라장중거래중동일고무벨트신한브렌트원유선물ETNH대웅대신WTI원유선물ETNH,http://www.fintechpost.co.kr/news/articleView.html?idxno=110969
3090,2020-04-24,이종목이궁금해서대웅코로나19에소송관련이슈까지향후전망은,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020042415225184094
3091,2020-04-24,시황분석대웅제약전일대비088하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=20200424163930195edd3032c8b_45
3092,2020-04-24,전승호대웅제약코로나19치료제로연구개발능력증명하고싶다,http://www.businesspost.co.kr/BP?command=article_view&num=175392
3093,2020-04-24,주간헬스케어TOP7대웅아미코젠뷰웍스휴온스글로벌바이넥스휴젤신풍제약훨훨,http://www.g-enews.com/ko-kr/news/article/news_all/202004241715522900edf69f862c_1/article.html
3094,2020-04-24,코스피주가상승률Top10대신WTI원유선물ETNH대웅동일고무벨트STX중공업신한브렌트원유선물ETNH주가순으로24일장마감,http://www.fintechpost.co.kr/news/articleView.html?idxno=111027
3095,2020-04-24,헬스케어업종대웅상승률눈에띄네외국인과기관은3거래일매도공세,http://www.smartfn.co.kr/view.php?ud=202004241953556265861beb2d9d_46
3096,2020-04-25,표24일코스피주가Top50상승률대신WTI원유선물ETNH주가상승률1위1996올라장마감대웅동일고무벨트STX중공업신한브렌트원유선물ETNH주가순으로상위,http://www.fintechpost.co.kr/news/articleView.html?idxno=110977
3097,2020-04-25,표최근5일상승종목코스피Top10동일고무벨트544↑상승종목1위하나니켈1호한진중공업대웅에이프로젠KIC주가순으로상위시세기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=110998
3098,2020-04-25,표최근10일상승종목코스피Top10KG동부제철7407↑상승종목1위대웅동일고무벨트대한유화이수화학주가순으로상위시세기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=111173
3099,2020-04-26,대웅제약메디톡스판매금지코로나치료제개발로승승장구,http://www.mediapen.com/news/view/520616
3100,2020-04-26,대웅코로나19백신치료제니클로사미드개발에속도낸다,http://www.paxetv.com/news/articleView.html?idxno=91044
3101,2020-04-26,인도네시아로눈돌린종근당대웅동아ST신흥시장서K바이오러브콜,http://www.ajunews.com/view/20200426105944689
3102,2020-04-26,대웅건설정원웅회장 지역건설활력소될혁신도시지정힘보탤것,http://www.cctoday.co.kr/news/articleView.html?idxno=2066252
3103,2020-04-26,주간종합코스피상승률Top10동일고무벨트539↑주간상승률1위대웅한진중공업하나니켈1호대호에이엘주가순으로상위기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=111344
3104,2020-04-27,한미대웅종근당녹십자등상반기신입경력사원채용,http://www.dailymedi.com/detail.php?number=855528&thread=22r05
3105,2020-04-27,베스트워스트상승재료쏟아진코스피대웅남광토건대한유화급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1888119
3106,2020-04-27,대웅제약신풍제약모두상승세로대웅제약하락수렁벗어나나,http://www.econonews.co.kr/news/articleView.html?idxno=117971
3107,2020-04-27,대웅5이상상승코로나19치료후보물질중대웅의니클로사마이드가치료효과가장높을것으로예상,https://www.hankyung.com/finance/article/202004272141L
3108,2020-04-27,대웅952VI발동,https://biz.chosun.com/site/data/html_dir/2020/04/27/2020042701208.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3109,2020-04-27,대웅102852주신고가,https://biz.chosun.com/site/data/html_dir/2020/04/27/2020042701213.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3110,2020-04-27,시황분석대웅전일대비977상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202004270951499264edd3036097_45
3111,2020-04-27,fnRASSI대웅52주신고가702↑,http://www.fnnews.com/news/202004270959184523
3112,2020-04-27,대웅전일대비526장중반등세최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202004270150&t=NN
3113,2020-04-27,대웅52주신고가경신코로나19치료후보물질중대웅의니클로사마이드가치료효과가장높을것으로예상,https://www.hankyung.com/finance/article/202004274214L
3114,2020-04-28,대웅제약신풍제약모두하락부진대웅제약하락이어신풍제약가파른하락세로5하락,http://www.econonews.co.kr/news/articleView.html?idxno=118093
3115,2020-04-29,모사프리드후발주자에문열어준대웅제약성공할까,http://www.dailypharm.com/Users/News/NewsView.html?ID=264171&REFERER=NP
3116,2020-04-29,대웅제약신풍제약모두하락부진대웅제약2하락이어신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=118283
3117,2020-04-29,종근당원더톡스로보툴리눔톡신시장진출휴젤대웅휴온스와경쟁,http://www.viva100.com/main/view.php?key=20200429010010438
3118,2020-04-29,대웅제약모사프리드서방정시장판도바꾸나,http://medipana.com/news/news_viewer.asp?NewsNum=256263&MainKind=A&NewsKind=5&vCount=12&vKind=1
3119,2020-04-29,안아파도약먹는다식약처대웅제약구취제거약일반의약품허가,http://theviewers.co.kr/View.aspx?No=832743
3120,2020-04-29,연속순매도기관대웅9일째팔아,http://www.itooza.com/common/iview.php?no=2020042917131695730
3121,2020-05-01,대웅제약모사프리드성분서방제제수탁생산확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=385474
3122,2020-05-04,대웅제약파트너아박타코로나진단키트개발속도,https://www.theguru.co.kr/news/article.html?no=10603
3123,2020-05-04,대웅제약신풍제약희비엇갈려대웅제약2하락반해신풍제약14급등,http://www.econonews.co.kr/news/articleView.html?idxno=118746
3124,2020-05-04,표최근3일하락종목코스피Top10진원생명과학2311↑하락종목1위대웅퍼스텍대한유화에이프로젠KIC주가순으로상위시세기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=112494
3125,2020-05-05,표최근10일하락종목코스피Top10진원생명과학2425↑하락종목1위대웅KG동부제철대한유화퍼스텍주가순으로상위시세기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=112603
3126,2020-05-06,제약대웅제약임팩타민길어진집콕에부쩍약해진부모님비타민B어때요,http://news.mk.co.kr/newsRead.php?no=459670&year=2020
3127,2020-05-06,대웅제약연구개발에연간1천억투입,http://www.g-enews.com/ko-kr/news/article/news_all/20200504140425850951638db705_1/article.html
3128,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,https://www.fetv.co.kr/news/article.html?no=53855
3129,2020-05-06,대웅제약펙수프라잔3상임상데이터최초공개,http://newsclaim.co.kr/View.aspx?No=835169
3130,2020-05-06,대웅제약펙수프라잔임상3상데이터최초공개,http://medipana.com/news/news_viewer.asp?NewsNum=256388&MainKind=A&NewsKind=5&vCount=12&vKind=1
3131,2020-05-06,대웅제약 위식도역류질환치료제펙수프라잔 3상임상데이터최초공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=45279
3132,2020-05-06,신풍제약대웅제약희비엇갈려신풍제약갑작스런7급락반해대웅제약상승,http://www.econonews.co.kr/news/articleView.html?idxno=119040
3133,2020-05-06,대웅제약펙수프라잔3상임상데이터공개안전성확인”,http://www.ajunews.com/view/20200506091509021
3134,2020-05-06,대웅제약역류성식도염신약펙수프라잔3상결과최초공개점막결손치료율99,https://www.sedaily.com/NewsView/1Z2N9EMLN3
3135,2020-05-06,대웅제약위식도역류치료제펙수프라잔3상데이터공개,http://www.press9.kr/news/articleView.html?idxno=44519
3136,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상결과최초공개,http://www.ezyeconomy.com/news/articleView.html?idxno=100537
3137,2020-05-06,대웅제약차세대위식도역류질환치료제글로벌시장상업화속도,http://moneys.mt.co.kr/news/mwView.php?no=2020050609098052610
3138,2020-05-06,대웅제약펙수프라잔임상3상데이터공개,https://www.ebn.co.kr/news/view/1432242?sc=Naver
3139,2020-05-06,대웅제약위식도역류질환치료제임상3상서효과입증,http://news.mt.co.kr/mtview.php?no=2020050609173261143
3140,2020-05-06,대웅제약펙수프라잔3상데이터최초공개유효성안전성입증”,http://www.viva100.com/main/view.php?key=20200506010000947
3141,2020-05-06,대웅제약차세대위식도역류질환치료제펙수프라잔3상임상결과공개,http://www.donga.com/news/article/all/20200506/100921015/1
3142,2020-05-06,대웅제약위식도역류질환신약펙수프라잔임상3상결과발표,http://news.mk.co.kr/newsRead.php?no=460190&year=2020
3143,2020-05-06,대웅제약위식도역류질환신약3상데이터최초공개,http://www.newsis.com/view/?id=NISX20200506_0001014799&cID=13001&pID=13000
3144,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.fnnews.com/news/202005060933298471
3145,2020-05-06,대웅제약펙수프라잔3상데이터공개점막결손99치료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020050609331751887
3146,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=25917
3147,2020-05-06,대웅제약美소화기학회서펙수프라잔3상임상데이터최초공개,http://www.ekn.kr/news/article.html?no=497467
3148,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상공개,http://www.mediapen.com/news/view/522564
3149,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.lawissue.co.kr/view.php?ud=202005060941573191204ead0791_12
3150,2020-05-06,대웅제약펙수프라잔국내3상임상데이터공개,http://www.consumuch.com/news/articleView.html?idxno=48586
3151,2020-05-06,대웅제약위식도역류질환치료제로글로벌40조시장진출한다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=116978
3152,2020-05-06,대웅제약美소화기학회서우수포스터펙수프라잔3상임상데이터최초공개,http://www.pressm.kr/news/articleView.html?idxno=29452
3153,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.youthdaily.co.kr/news/article.html?no=36277
3154,2020-05-06,가슴쓰림개선효과톡톡대웅제약펙수프라잔3상임상데이터공개,http://theviewers.co.kr/View.aspx?No=835292
3155,2020-05-06,대웅제약위식도역류질환치료제3상임상데이터공개,http://www.ftoday.co.kr/news/articleView.html?idxno=201452
3156,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상서우수,http://www.econovill.com/news/articleView.html?idxno=395415
3157,2020-05-06,대웅위식도역류치료제펙수프라잔임상3상서99치료율결과,http://health.chosun.com/site/data/html_dir/2020/05/06/2020050601268.html
3158,2020-05-06,대웅제약위식도역류질환치료제임상3상결과공개,http://www.newspim.com/news/view/20200506000227
3159,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.medigatenews.com/news/2525772930
3160,2020-05-06,대웅제약펙수프라잔임상3상데이터공개,http://www.mhj21.com/129938
3161,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243843
3162,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.edaily.co.kr/news/newspath.asp?newsid=02181206625766296
3163,2020-05-06,대웅제약펙수프라잔3상임상데이터공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571858529785
3164,2020-05-06,대웅제약PCAB신약점막결손치료율99,http://www.monews.co.kr/news/articleView.html?idxno=210368
3165,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.thepublic.kr/news/newsview.php?ncode=1065575732247136
3166,2020-05-06,대웅제약위식도역류질환신약3상서효과입증”,http://www.newsway.co.kr/news/view?tp=1&ud=2020050610414095226
3167,2020-05-06,대웅제약미국소화기학회서펙수프라잔임상3상데이터공개,http://www.kpinews.co.kr/news/articleView.html?idxno=116098
3168,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상공개,http://sports.hankooki.com/lpage/economy/202005/sp20200506104605137020.htm?s_ref=nv
3169,2020-05-06,대웅제약위식도역류질환신약3상임상데이터공개,http://kormedi.com/?p=1316561
3170,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,https://www.fetv.co.kr/news/article.html?no=53899
3171,2020-05-06,대웅제약美소화기학회서펙수프라잔3상임상데이터최초공개,http://www.asiatoday.co.kr/view.php?key=20200506010001827
3172,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.g-enews.com/ko-kr/news/article/news_all/20200506110626434751638db705_1/article.html
3173,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.press9.kr/news/articleView.html?idxno=44528
3174,2020-05-06,대웅제약펙수프라잔치료효과안전성확인임상3상결과첫공개,http://www.metroseoul.co.kr/article/20200506500147
3175,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.mhj21.com/129952
3176,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.ekn.kr/news/article.html?no=497554
3177,2020-05-06,대웅제약40조위식도역류질환치료제시장공략,http://www.m-i.kr/news/articleView.html?idxno=707610
3178,2020-05-06,대웅제약올로맥스신규함량출시라인업4개로확대,http://www.metroseoul.co.kr/article/20200506500150
3179,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243855
3180,2020-05-06,대웅제약위식도역류질환치료제3상임상데이터발표,http://www.newsfc.co.kr/news/articleView.html?idxno=40915
3181,2020-05-06,대웅제약올로맥스환자위해고함량제품개발,http://newsclaim.co.kr/View.aspx?No=835546
3182,2020-05-06,대웅제약올로맥스신규함량출시4개라인업구축,http://medipana.com/news/news_viewer.asp?NewsNum=256417&MainKind=A&NewsKind=5&vCount=12&vKind=1
3183,2020-05-06,대웅제약올로맥스신규함량출시4개라인업구축,http://news.mt.co.kr/mtview.php?no=2020050611200081579
3184,2020-05-06,더강한효과대웅제약고혈압약올로맥스신규함량출시,http://theviewers.co.kr/View.aspx?No=835567
3185,2020-05-06,대웅제약올로맥스신규함량출시처방영역넓혀,http://www.insightkorea.co.kr/news/articleView.html?idxno=79662
3186,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.edaily.co.kr/news/newspath.asp?newsid=02712566625766296
3187,2020-05-06,대웅제약올로맥스새용량2종출시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1133508&REFERER=NP
3188,2020-05-06,대웅제약올메사르탄함량두배늘린올로맥스2종출시,http://inthenews.co.kr/article-48080/
3189,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.newsis.com/view/?id=NISX20200506_0001015154&cID=13001&pID=13000
3190,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1385421
3191,2020-05-06,대웅제약위식도역류질환신약의미국임상에서증상개선확인,http://www.businesspost.co.kr/BP?command=article_view&num=176702
3192,2020-05-06, 대웅제약위식도역류질환치료제펙수프라잔3상임상최초공개,http://www.newslock.co.kr/news/articleView.html?idxno=27683
3193,2020-05-06,대웅제약올로맥스2개신규제형추가,http://www.whosaeng.com/117528
3194,2020-05-06,대웅제약펙수프라잔3상임상데이터최초공개,http://www.bosa.co.kr/news/articleView.html?idxno=2126272
3195,2020-05-06,대웅제약소화기신약펙수프라잔3상결과첫공개,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1133513&REFERER=NP
3196,2020-05-06,4가지라인업구축대웅제약올로맥스신규함량출시로처방영역확대,http://www.koreaittimes.com/news/articleView.html?idxno=97290
3197,2020-05-06,대웅펙수프라잔효과․안전성입증,http://www.whosaeng.com/117529
3198,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터공개,http://www.joseilbo.com/news/news_read.php?uid=397457&class=27&grp=
3199,2020-05-06,대웅제약PCAB신약펙수프라잔3상공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1080372
3200,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.businesskorea.co.kr/news/articleView.html?idxno=45308
3201,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.bosa.co.kr/news/articleView.html?idxno=2126282
3202,2020-05-06,대웅제약펙수프라잔내시경치료증상개선에효과,http://www.finomy.com/news/articleView.html?idxno=77765
3203,2020-05-06,대웅제약올로맥스처방확대신규함량출시,http://www.viva100.com/main/view.php?key=20200506010001135
3204,2020-05-06,대웅제약고혈압고지혈증치료복합제올로맥스신규용량출시,http://news.mk.co.kr/newsRead.php?no=461895&year=2020
3205,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.bokuennews.com/news/article.html?no=189636
3206,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.youthdaily.co.kr/news/article.html?no=36325
3207,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=390178
3208,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.nbnnews.co.kr/news/articleView.html?idxno=390171
3209,2020-05-06,대웅제약고혈압藥올로맥스高함량제품출시,https://www.sedaily.com/NewsView/1Z2N992UUV
3210,2020-05-06,대웅제약올로맥스신규함량출시 ,http://www.monews.co.kr/news/articleView.html?idxno=210386
3211,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,https://www.dailian.co.kr/news/view/888189?sc=Naver
3212,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시처방영역확대,http://sports.hankooki.com/lpage/economy/202005/sp20200506141646137020.htm?s_ref=nv
3213,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔임상3상데이터최초공개,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891203
3214,2020-05-06,대웅제약올로맥스신규함량출시처방영업강화,http://www.kpinews.co.kr/news/articleView.html?idxno=116124
3215,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.segye.com/content/html/2020/05/06/20200506514310.html?OutUrl=naver
3216,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://newsbrite.net/136514
3217,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://newsbrite.net/136517
3218,2020-05-06,대웅제약올로맥스신규함량출시처방영역본격확대,http://www.m-i.kr/news/articleView.html?idxno=707757
3219,2020-05-06,대웅제약펙수프라잔점막결손치료율99,http://www.seoulfn.com/news/articleView.html?idxno=381483
3220,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.newslock.co.kr/news/articleView.html?idxno=27699
3221,2020-05-06,대웅제약올로맥스4개라인업구축처방영역확대,http://www.economytalk.kr/news/articleView.html?idxno=205824
3222,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891234
3223,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시,http://www.mediapen.com/news/view/522755
3224,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.dailysmart.co.kr/news/articleView.html?idxno=25951
3225,2020-05-06,대웅제약고혈압이상지질혈증치료제올로맥스라인업강화처방영역확대,http://www.donga.com/news/article/all/20200506/100930492/1
3226,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.updownnews.co.kr/news/articleView.html?idxno=218359
3227,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61022
3228,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61015
3229,2020-05-06,대웅제약고혈압치료제올로맥스신규함량출시,http://www.100ssd.co.kr/news/articleView.html?idxno=68546
3230,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.lawissue.co.kr/view.php?ud=20200506164334854204ead0791_12
3231,2020-05-06,대웅제약고혈압이상지지혈증치료제올로맥스신규함량출시,http://www.newstomato.com/ReadNews.aspx?no=970245
3232,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.econovill.com/news/articleView.html?idxno=395509
3233,2020-05-06,대웅제약올로맥스신규함량출시4가지라인업구축,http://www.ajunews.com/view/20200506170059670
3234,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=385835
3235,2020-05-06,대웅제약올로맥스신규함량출시처방영역확대,http://www.dailymedi.com/detail.php?number=855798&thread=22r05
3236,2020-05-06,대웅제약올로맥스처방영역확대올메사르탄함량늘려신규출시,http://kpenews.com/View.aspx?No=836141
3237,2020-05-06,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=385844
3238,2020-05-06,대웅제약올로맥스신규함량출시로처방영역을확대,http://www.paxetv.com/news/articleView.html?idxno=91548
3239,2020-05-06,코로나에도제약사1Q선방종근당한미녹십자맑음유한대웅흐림,http://www.upinews.kr/newsView/upi202005060113
3240,2020-05-06,대웅제약역류성식도염신약펙수프라잔임상3상99치요율달성,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005060392&t=NN
3241,2020-05-06,대웅제약올로맥스신규함량출시,http://www.k-health.com/news/articleView.html?idxno=48348
3242,2020-05-06,대웅제약올로맥스신규함량출시로처방영역확대,http://www.thevaluenews.co.kr/news/view.php?idx=159374
3243,2020-05-07,대웅제약위식도역류질환치료제펙수프라잔3상임상데이터최초공개,https://www.news2day.co.kr/152326
3244,2020-05-07,유한한미종근당등정상근무전환대웅대원금주결정,http://www.dailymedi.com/detail.php?number=855810&thread=22r05
3245,2020-05-07,대웅제약신풍제약모두상승세로특히대웅제약1상승에11만원선눈앞,http://www.econonews.co.kr/news/articleView.html?idxno=119246
3246,2020-05-07,대웅제약위식도역류질환치료신약펙수프라잔임상공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1276356
3247,2020-05-07,대웅제약펙수프라잔미국DDW약효안전성확인,http://www.doctorsnews.co.kr/news/articleView.html?idxno=134486
3248,2020-05-07,대웅제약올로맥스신규함량출시처방영역확대,http://www.doctorsnews.co.kr/news/articleView.html?idxno=134487
3249,2020-05-07,대웅제약계열사대웅바이오불법리베이트로검찰송치된중외제약전철밟나,http://www.datasom.co.kr/news/articleView.html?idxno=105707
3250,2020-05-07,코스피대웅제약2020년1분기누적매출액2284억원영업이익13억원,http://news.kmib.co.kr/article/view.asp?arcid=0014555695&code=61141211&cp=nv
3251,2020-05-07,대웅제약1Q영업익12억원전년比87↓,http://www.edaily.co.kr/news/newspath.asp?newsid=04083606625766624
3252,2020-05-07,대웅제약1Q영업익13억전년비88↓,http://www.dailypharm.com/Users/News/NewsView.html?ID=264380&REFERER=NP
3253,2020-05-07,실적속보잠정대웅제약별도20201Q영업이익1251억원,http://www.fntimes.com/html/view.php?ud=2020050717510011335dfa8341a5_18
3254,2020-05-07,대웅제약1분기영업익13억원전년比88↓,https://view.asiae.co.kr/article/2020050717551272504
3255,2020-05-07,공시대웅제약1분기영업익12억5100만원전년比877↓,http://www.newsway.co.kr/news/view?tp=1&ud=2020050717572613605
3256,2020-05-07,대웅제약1분기매출액2283억원전년대비41↓,https://www.sedaily.com/NewsView/1Z2NQJ4DHJ
3257,2020-05-07,대웅제약1분기매출액2284억원전년비41↓,http://www.mediapen.com/news/view/523136
3258,2020-05-07,대웅제약1분기매출2284억원영업익13억원,http://newsclaim.co.kr/View.aspx?No=837521
3259,2020-05-07,대웅제약2020년1분기실적발표,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61050
3260,2020-05-07,대웅제약1분기영업이익13억원전년동기대비877↓,http://news.mk.co.kr/newsRead.php?no=468709&year=2020
3261,2020-05-07,대웅제약1분기영업이익13억전년比88↓,http://www.asiatoday.co.kr/view.php?key=20200507010003117
3262,2020-05-07,대웅제약나보타수출증가에도소송비로1분기매출↓,http://www.medigatenews.com/news/569963298
3263,2020-05-07,대웅나보타소송라니티딘타격1분기영업익전년比88↓,http://www.press9.kr/news/articleView.html?idxno=44547
3264,2020-05-07,대웅제약나보타소송비용코로나로1Q영업익88↓,http://www.newsis.com/view/?id=NISX20200507_0001017325&cID=13001&pID=13000
3265,2020-05-07,대웅제약1Q영업익전년比88↓코로나19소송비용탓,http://news.mt.co.kr/mtview.php?no=2020050719001934499
3266,2020-05-07,대웅제약1분기영업익13억전년比877급감,http://biz.newdaily.co.kr/site/data/html/2020/05/07/2020050700258.html
3267,2020-05-07,대웅제약1분기영업이익13억원전년比88급감,http://www.edaily.co.kr/news/newspath.asp?newsid=04270566625766624
3268,2020-05-07,대웅제약1분기12억원전년비877↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891980
3269,2020-05-07,대웅제약1분기영업익12억5100만원전년比88↓,http://www.newspim.com/news/view/20200507001066
3270,2020-05-07,대웅제약1분기영업이익13억원전년동기대비88↓,http://www.econovill.com/news/articleView.html?idxno=395683
3271,2020-05-07,대웅제약2020년1분기매출액2284억원영업이익13억원,http://newsbrite.net/136599
3272,2020-05-07,대웅제약올로맥스신규함량출시로처방영역확대,http://www.wsobi.com/news/articleView.html?idxno=96971
3273,2020-05-07,코로나19직격탄대웅JW중외영업익뚝,http://www.newsway.co.kr/news/view?tp=1&ud=2020050720343561205
3274,2020-05-07,대웅제약1분기영업이익13억원전년비88↓,https://www.dailian.co.kr/news/view/888661?sc=Naver
3275,2020-05-07,대웅제약1분기영업익13억원전년동기대비88감소,https://www.news2day.co.kr/152403
3276,2020-05-07,대웅제약1분기영업익전년比88↓나보타OTC매출은늘어,http://www.seoulwire.com/news/articleView.html?idxno=410821
3277,2020-05-07,실적발표JW홀딩스JW중외제약JW생명과학대웅제약,http://www.businesspost.co.kr/BP?command=article_view&num=177094
3278,2020-05-07,대웅제약나보타대미수출액96억원증가글로벌시장공략가속화,http://www.businesskorea.co.kr/news/articleView.html?idxno=45389
3279,2020-05-07,대웅제약나보타對美수출96억↗‥글로벌시장가속화,http://medipana.com/news/news_viewer.asp?NewsNum=256517&MainKind=A&NewsKind=5&vCount=12&vKind=1
3280,2020-05-07,대웅제약코로나19에소송비용겹쳐1분기영업이익급감,http://www.businesspost.co.kr/BP?command=article_view&num=177090
3281,2020-05-07,대웅제약1분기영업이익88↓나보타소송비용137억원영향,http://www.donga.com/news/article/all/20200507/100953434/1
3282,2020-05-07,대웅제약1분기영업이익13억전년比88감소,https://www.fetv.co.kr/news/article.html?no=54068
3283,2020-05-07,대웅제약1분기매출2284억전년비4줄어,https://www.kpanews.co.kr/article/show.asp?idx=213004&category=D
3284,2020-05-08,대웅제약2020년1분기실적발표,http://www.lawissue.co.kr/view.php?ud=202005080018303215204ead0791_12
3285,2020-05-08,대웅제약라니티딘사태에코로나19직격탄,http://www.bosa.co.kr/news/articleView.html?idxno=2126396
3286,2020-05-08,대웅제약나보타소송비용코로나19등손익영향영업익감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=243954
3287,2020-05-08,대웅제약나보타수출300늘었는데손해소송비용탓,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1080454
3288,2020-05-08,전일주요공시대웅제약카카오한진중공업홀딩스,http://www.etoday.co.kr/news/section/newsview.php?idxno=1891988
3289,2020-05-08,대웅제약1분기영업익13억원전년비88↓,https://www.ebn.co.kr/news/view/1432728?sc=Naver
3290,2020-05-08,대웅제약1Q영업익13억원전년比88↓나보타소송비용직격탄,http://moneys.mt.co.kr/news/mwView.php?no=2020050808218078936
3291,2020-05-08,나보타소송비용영향대웅제약1분기영업익13억전년比88↓,http://www.newsprime.co.kr/news/article.html?no=503593
3292,2020-05-08,리포트브리핑대웅제약소송비용제외시실적양호2Q부터실적긍정적기대목표가170000원KTB투자증권,http://www.newspim.com/news/view/20200508000129
3293,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.youthdaily.co.kr/news/article.html?no=36486
3294,2020-05-08,코로나영향대웅제약1분기영업익13억전년比88↓,http://www.wikileaks-kr.org/news/articleView.html?idxno=85534
3295,2020-05-08,대웅제약11일안플원출시5주년웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=116271
3296,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61052
3297,2020-05-08,대웅제약2020년1분기실적발표나보타소송코로나19까지손익에영향컸다,http://www.paxetv.com/news/articleView.html?idxno=91646
3298,2020-05-08,대웅제약항혈전제안플원출시5주년맞이웹심포지엄,https://www.sedaily.com/NewsView/1Z2O6ASD4D
3299,2020-05-08,대웅제약안플원출시5주년웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=256529&MainKind=A&NewsKind=5&vCount=12&vKind=1
3300,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=44555
3301,2020-05-08,대웅제약안플원출시5주년맞아심포지엄개최,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572459035538
3302,2020-05-08,대웅제약1분기영업이익88↓메디톡스소송영향,http://www.upinews.kr/newsView/upi202005080016
3303,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.koreaittimes.com/news/articleView.html?idxno=97351
3304,2020-05-08,대웅제약신풍제약지지부진한주가신풍제약소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=119427
3305,2020-05-08,대웅제약1분기영업이익전년비88감소한13억원,http://www.ceoscoredaily.com/news/article.html?no=69244
3306,2020-05-08,종목삼성증권대웅제약소송비용점차감소될것매수,http://www.sporbiz.co.kr/news/articleView.html?idxno=436818
3307,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.medigatenews.com/news/2097804961
3308,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.ekn.kr/news/article.html?no=498003
3309,2020-05-08,대웅제약장기지속형당뇨병바이오신약본격개발,http://www.medisobizanews.com/news/articleView.html?idxno=69516
3310,2020-05-08,대웅제약나보타美수출300↑껑충,http://www.whosaeng.com/117597
3311,2020-05-08,5번째생일파티는웹에서대웅제약인플원5주년기념심포지엄웹개최,http://theviewers.co.kr/View.aspx?No=837808
3312,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=26056
3313,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최사포그릴레이트성분재조명,http://www.segye.com/content/html/2020/05/08/20200508507801.html?OutUrl=naver
3314,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최사포그릴레이트성분재조명,http://www.segye.com/content/html/2020/05/08/20200508507801.html?OutUrl=naver
3315,2020-05-08,대웅제약안플원5周기념웹심포지엄,http://www.dailymedi.com/detail.php?number=855863&thread=22r05
3316,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.newsis.com/view/?id=NISX20200508_0001017691&cID=13001&pID=13000
3317,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=54099
3318,2020-05-08,대웅제약나보타소송코로나19여파로1분기영업익전년대비88감소,http://sports.hankooki.com/lpage/economy/202005/sp20200508101218137020.htm?s_ref=nv
3319,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.viva100.com/main/view.php?key=20200508010001808
3320,2020-05-08,대웅제약안플원출시5주년웹심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=210456
3321,2020-05-08,대웅제약1분기영업익13억원라니티딘사태등으로전년比88↓,http://www.updownnews.co.kr/news/articleView.html?idxno=218450
3322,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.econovill.com/news/articleView.html?idxno=395746
3323,2020-05-08,대웅제약항혈전제안플원출시5주년맞이웹심포지엄개최,http://moneys.mt.co.kr/news/mwView.php?no=2020050809368082538
3324,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=708381
3325,2020-05-08,대웅제약안플원출시5주년기념포털사이트닥터빌서심포지엄개최,http://www.pressm.kr/news/articleView.html?idxno=29547
3326,2020-05-08,대웅제약2020년1분기실적발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1385888
3327,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.greened.kr/news/articleView.html?idxno=250456
3328,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2126423
3329,2020-05-08,대웅제약항혈전제안플원출시5주년웹심포지엄개최,http://news.mt.co.kr/mtview.php?no=2020050810583669009
3330,2020-05-08,대웅제약1분기나보타소송코로나19여파에고전,http://www.sisaweek.com/news/articleView.html?idxno=133611
3331,2020-05-08,대웅제약1분기영업이익88감소나보타소송코로나19등영향,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117067
3332,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1385891
3333,2020-05-08,대웅제약나보타대미수출액96억원증가글로벌시장공략가속화,http://www.wsobi.com/news/articleView.html?idxno=97041
3334,2020-05-08,대웅제약1분기영업익13억전년比88↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=386057
3335,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1892174
3336,2020-05-08,리포트브리핑대웅제약여전한소송비용부담다가오는ITC예비판정주목목표가120000원삼성증권,http://www.newspim.com/news/view/20200508000700
3337,2020-05-08,리포트브리핑대웅제약실적과모멘텀사이목표가140000원대신증권,http://www.newspim.com/news/view/20200508000727
3338,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=45433
3339,2020-05-08,대웅제약안플원출시5주년웹심포지엄개최,http://isplus.live.joins.com/news/article/article.asp?total_id=23772049
3340,2020-05-08,대웅제약보툴리눔톡신균주소송비용줄어2분기실적반등가능,http://www.businesspost.co.kr/BP?command=article_view&num=177164
3341,2020-05-08,코로나영향유한양행대웅제약1분기성적저조2분기전망은,http://www.wikileaks-kr.org/news/articleView.html?idxno=85592
3342,2020-05-08,대웅제약영업이익감소에도보톡스매출174↑,http://www.m-i.kr/news/articleView.html?idxno=708360
3343,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=390836
3344,2020-05-08,대웅제약2020년1분기실적발표,http://www.nbnnews.co.kr/news/articleView.html?idxno=390832
3345,2020-05-08,1Q대웅제약코로나19소송여파고전나보타글로벌시장공략가속화,http://www.thepublic.kr/news/newsview.php?ncode=1065589480858746
3346,2020-05-08,대웅제약항혈전제안플원출시5주년기념웹심포지엄개최키로,http://news.mk.co.kr/newsRead.php?no=471805&year=2020
3347,2020-05-08,대웅제약1분기2284억영업이익13억,http://www.g-enews.com/ko-kr/news/article/news_all/20200508143840200251638db705_1/article.html
3348,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,https://www.ebn.co.kr/news/view/1432864?sc=Naver
3349,2020-05-08,제약워치대웅제약안플원출시5주년기념웹심포지엄개최外,http://www.newswatch.kr/news/articleView.html?idxno=29756
3350,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=202005081521127175204ead0791_12
3351,2020-05-08,대웅제약올로맥스신규함량출시,http://weekly.hankooki.com/lpage/economy/202005/wk20200508153312146380.htm?s_ref=nv
3352,2020-05-08,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.iminju.net/news/articleView.html?idxno=53569
3353,2020-05-08,보톡스전쟁타격대웅제약나보타소송비용영향1분기실적큰폭하락,http://theviewers.co.kr/View.aspx?No=838597
3354,2020-05-08,뉴스투데이L대웅제약안플원출시5주년기념웹심포지엄개최,https://www.news2day.co.kr/152457
3355,2020-05-08,주간신상태그헤라비욘드스파오대웅제약글래드호텔외,http://www.newsprime.co.kr/news/article.html?no=503718
3356,2020-05-08,뉴스워커_대웅제약안플원출시5주년기념웹심포지엄개최,http://www.newsworker.co.kr/news/articleView.html?idxno=70429
3357,2020-05-08,대웅제약안플원의료진과효능처방옵션공유자리마련,http://www.100ssd.co.kr/news/articleView.html?idxno=68622
3358,2020-05-08,대웅제약항혈전제안플원출시5주년기념웹심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=386133
3359,2020-05-08,대웅제약오는11일안플원출시5주년기념웹심포지엄열어,https://www.kpanews.co.kr/article/show.asp?idx=213047&category=D
3360,2020-05-09,공동생동규제결국철폐수순대웅메디카콜마반사이익기대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020050818490580727
3361,2020-05-09,표최근7일하락종목코스피Top10진원생명과학2455↑하락종목1위한화우대웅퍼스텍롯데케미칼주가순으로상위시세기록,http://www.fintechpost.co.kr/news/articleView.html?idxno=112982
3362,2020-05-09,대웅제약1Q영업익88↓먹구름ITC소송비부담여전,http://www.mediapen.com/news/view/523581
3363,2020-05-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.viva100.com/main/view.php?key=20200510010002169
3364,2020-05-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.thepublic.kr/news/newsview.php?ncode=1065602337506351
3365,2020-05-11,대웅제약1분기최악의영업실적에도선방평가이유는,http://www.pharmnews.com/news/articleView.html?idxno=100452
3366,2020-05-11,대웅대원학자금전액지원종근당상여금650,http://www.dailypharm.com/Users/News/NewsView.html?ID=264391&REFERER=NP
3367,2020-05-11,대웅취화제정허가구취제거제시장첫도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=264287&REFERER=NP
3368,2020-05-11,대웅제약지난해10대제약사가운데유일하게세금추징당해,http://www.consumernews.co.kr/news/articleView.html?idxno=604823
3369,2020-05-11,더벨CompanyWatch대웅제약톡신나보타로알비스빈자리채웠다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202005081531150320105381
3370,2020-05-11,대웅제약신풍제약희비엇갈려대웅제약하락반해신풍제약상승,http://www.econonews.co.kr/news/articleView.html?idxno=119708
3371,2020-05-11,100세시대건강기능식품에베팅한제약업계종근당대웅제약등맹활약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003967961
3372,2020-05-11,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=57878
3373,2020-05-11,대웅제약1분기경영실적매출액2284억원나보타대미수출액96억원증가,http://www.thefirstmedia.net/news/articleView.html?idxno=57879
3374,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈특별행사진행,http://www.econovill.com/news/articleView.html?idxno=396134
3375,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://medipana.com/news/news_viewer.asp?NewsNum=256676&MainKind=A&NewsKind=5&vCount=12&vKind=1
3376,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://newsclaim.co.kr/View.aspx?No=840688
3377,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩웹사이트오픈,http://www.viva100.com/main/view.php?key=20200512010002882
3378,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.bosa.co.kr/news/articleView.html?idxno=2126582
3379,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61103
3380,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://www.greened.kr/news/articleView.html?idxno=250943
3381,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩브랜드웹사이트오픈,http://www.kpinews.co.kr/news/articleView.html?idxno=116459
3382,2020-05-12,대웅제약덴티가드랩웹사이트오픈31일까지특별이벤트,http://www.metroseoul.co.kr/article/20200512500076
3383,2020-05-12,대웅제약생애주기별맞춤치약덴티가드랩이벤트팡팡,http://moneys.mt.co.kr/news/mwView.php?no=2020051209418069133
3384,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://www.updownnews.co.kr/news/articleView.html?idxno=218552
3385,2020-05-12,대웅제약덴티가드랩브랜드사이트오픈기념특별이벤트진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573763517491
3386,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈특별이벤트도실시,http://www.m-i.kr/news/articleView.html?idxno=709294
3387,2020-05-12,대웅제약신풍제약모두하락부진대웅제약1하락이어신풍제약역시1하락,http://www.econonews.co.kr/news/articleView.html?idxno=119944
3388,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.youthdaily.co.kr/news/article.html?no=36737
3389,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트,https://www.fetv.co.kr/news/article.html?no=54343
3390,2020-05-12,대웅제약덴티가드랩홈페이지에서구강건강챙기세요,https://www.sedaily.com/NewsView/1Z2Q0Y43RR
3391,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.dailysmart.co.kr/news/articleView.html?idxno=26196
3392,2020-05-12,대웅전일대비549상승중외국인1259주순매수,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005120176&t=NN
3393,2020-05-12,대웅5이상상승기관3일연속순매수86만주,https://www.hankyung.com/finance/article/202005128172L
3394,2020-05-12,대웅제약생애주기치약덴티가드랩홈페이지오픈이벤트,http://news.mt.co.kr/mtview.php?no=2020051210322218114
3395,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩브랜드웹사이트오픈,http://sports.hankooki.com/lpage/economy/202005/sp20200512103921136980.htm?s_ref=nv
3396,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.newspim.com/news/view/20200512000389
3397,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://newsbrite.net/136716
3398,2020-05-12,대웅제약덴비가드랩브랜드웹사이트오픈33가격할인,http://www.asiatoday.co.kr/view.php?key=20200512010005493
3399,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지최대33할인이벤트진행,http://www.ekn.kr/news/article.html?no=498702
3400,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.newsis.com/view/?id=NISX20200512_0001021644&cID=13001&pID=13000
3401,2020-05-12,대웅제약구강건강을위한정보와제품구매등토탈솔루션제공,http://www.g-enews.com/ko-kr/news/article/news_all/20200512114332787051638db705_1/article.html
3402,2020-05-12,대웅주보美매출전분기보다46↓사용량은증가,http://www.dailypharm.com/Users/News/NewsView.html?ID=264489&REFERER=NP
3403,2020-05-12,대웅제약구강생애주기별맞춤치약덴티가드랩웹사이트오픈,http://www.mdtoday.co.kr/mdtoday/index.html?no=386342
3404,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.lawissue.co.kr/view.php?ud=202005121301487046204ead0791_12
3405,2020-05-12,대웅제약생애주기별구강건강웹사이트오픈토탈솔루션제공,http://www.100ssd.co.kr/news/articleView.html?idxno=68655
3406,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈31일까지특별이벤트진행,http://www.nbnnews.co.kr/news/articleView.html?idxno=391519
3407,2020-05-12,대웅제약구강생애주기별맞춤치약사이트열고기념이벤트,http://www.businesspost.co.kr/BP?command=article_view&num=177661
3408,2020-05-12,뉴스투데이L대웅제약생애주기별맞춤치약덴티가드랩웹사이트오픈,https://www.news2day.co.kr/152617
3409,2020-05-12,대웅제약덴티가드랩웹사이트오픈기념이벤트진행,http://weekly.hankooki.com/lpage/economy/202005/wk20200512151741146380.htm?s_ref=nv
3410,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈,https://www.ebn.co.kr/news/view/1433338?sc=Naver
3411,2020-05-12,오늘의장바구니롯데마트인터파크안다르대웅제약외,http://www.newsprime.co.kr/news/article.html?no=504149
3412,2020-05-12,대웅제약덴티가드랩브랜드웹사이트오픈이벤트실시,http://daily.hankooki.com/lpage/industry/202005/dh20200512162004148390.htm?s_ref=nv
3413,2020-05-12,구강관리끝판왕대웅제약덴티가드랩브랜드웹사이트열었다,http://theviewers.co.kr/View.aspx?No=841666
3414,2020-05-12,대웅제약생애주기맞춤치약덴티가드랩브랜드웹사이트오픈,http://www.donga.com/news/article/all/20200512/101014447/1
3415,2020-05-12,대웅제약덴티가드랩브랜드웹사이트선봬,https://www.kpanews.co.kr/article/show.asp?idx=213137&category=D
3416,2020-05-13,대웅제약덴티가드랩브랜드웹사이트오픈,http://www.thefirstmedia.net/news/articleView.html?idxno=57911
3417,2020-05-13,대웅제약신풍제약희비엇갈려대웅제약2하락반해신풍제약1상승,http://www.econonews.co.kr/news/articleView.html?idxno=120087
3418,2020-05-13,이제는K바이오시대④대웅제약넥스트나보타로제2의도약꿈꾼다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117165
3419,2020-05-13,대웅전일대비587상승외국인78576주순매도,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005130223&t=NN
3420,2020-05-13,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202005133016L
3421,2020-05-13,대웅792상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/13/2020051301841.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3422,2020-05-13,대웅938VI발동,https://biz.chosun.com/site/data/html_dir/2020/05/13/2020051301843.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3423,2020-05-13,대웅제약195상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/13/2020051301848.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3424,2020-05-13,특징주대웅18650원13일11시40분장시작대비971상승,http://www.getnews.co.kr/view.php?ud=202005131141506771c20b95a5d6_16
3425,2020-05-14,1Q뒷걸음질대웅제약윤재춘전승호號2Q도가시밭길,http://www.inews24.com/view/1264250
3426,2020-05-14,대웅제약신풍제약상승에급등까지대웅제약소폭상승이어신풍제약8급등,http://www.econonews.co.kr/news/articleView.html?idxno=120252
3427,2020-05-14,오송팜대웅제약과일본시장공략제품공동개발협약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244219
3428,2020-05-14,오송팜대웅제약일본향제품공동개발협약체결,http://medipana.com/news/news_viewer.asp?NewsNum=256813&MainKind=A&NewsKind=5&vCount=12&vKind=1
3429,2020-05-14,오송팜대웅제약과일본향제품공동개발협약,http://www.mdtoday.co.kr/mdtoday/index.html?no=386601
3430,2020-05-14,오송팜대웅제약과일본시장공략제품공동개발협약,http://www.bosa.co.kr/news/articleView.html?idxno=2126769
3431,2020-05-14,대웅540상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/14/2020051401510.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3432,2020-05-14,대웅상승출발후현재568외국인5784주순매수,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005140200&t=NN
3433,2020-05-14,대웅5이상상승기관5일연속순매수146만주,https://www.hankyung.com/finance/article/202005147125L
3434,2020-05-14,오송팜대웅일본시장타깃의약품공동개발협약,http://www.dailypharm.com/Users/News/NewsView.html?ID=264580&REFERER=NP
3435,2020-05-14,오송팜대웅제약과손잡고日시장공략나서,http://www.whosaeng.com/117789
3436,2020-05-14,오송팜대웅제약과일본향제품공동개발협약,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61175
3437,2020-05-14,코로나에갈린제약사희비유한대웅제약어닝쇼크,http://www.whitepaper.co.kr/news/articleView.html?idxno=193361
3438,2020-05-14,오송팜대웅제약일본의약품시장공동공략,http://www.doctorsnews.co.kr/news/articleView.html?idxno=134590
3439,2020-05-15,오송팜대웅제약일본제품공동개발협약맺어,https://www.kpanews.co.kr/article/show.asp?idx=213207&category=D
3440,2020-05-15,단독대웅메디톡스판정앞두고ITC변호사돌연사망,http://www.press9.kr/news/articleView.html?idxno=44658
3441,2020-05-15,대웅제약신풍제약희비엇갈려특히신풍제약가파른하락세로4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=120401
3442,2020-05-15,대웅제약장시작후꾸준히올라583최근단기조정후반등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005150218&t=NN
3443,2020-05-15,대웅제약5이상상승외국인3일연속순매수7857주,https://www.hankyung.com/finance/article/202005151964L
3444,2020-05-15,특징주대웅제약렘데시비르600배효과나파모스타트와유사한치료제생산부각,http://www.edaily.co.kr/news/newspath.asp?newsid=02758486625769248
3445,2020-05-15,대웅제약680VI발동,https://biz.chosun.com/site/data/html_dir/2020/05/15/2020051502220.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3446,2020-05-15,대웅113상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/15/2020051502224.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3447,2020-05-15,대웅제약728상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/15/2020051502231.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3448,2020-05-15,시황분석대웅제약전일대비534상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202005151443172867edd30d1253_45
3449,2020-05-15,대웅제약덴티가드랩브랜드사이트오픈해,http://www.cnbnews.com/news/article.html?no=446679
3450,2020-05-18,대웅제약1Q영업익55감소매출비RD비22,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244361
3451,2020-05-18,메디톡신보툴렉스자리노리는종근당휴온스와대웅제약,http://weekly.cnbnews.com/news/article.html?no=133948
3452,2020-05-18,대웅제약신풍제약모두하락부진대웅제약4하락이어신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=120791
3453,2020-05-18,시지바이오관상동맥용스텐트품목허가획득대웅제약통해출시,https://www.etoday.co.kr/news/view/1895564
3454,2020-05-18,시지바이오관상동맥용스텐트품목허가대웅제약통해출시,http://www.yakup.com/news/index.html?mode=view&cat=14&nid=244395
3455,2020-05-18,시지바이오관상동맥용스탠트식약처허가획득대웅제약판매,http://news.mt.co.kr/mtview.php?no=2020051816062982012
3456,2020-05-19,대웅바이오베아셉트서울대병원랜딩종병안착,http://www.dailypharm.com/Users/News/NewsView.html?ID=264688&REFERER=NP
3457,2020-05-19,대웅제약유한양행위궤양개량신약공동개발2021년발매예정,http://www.ceoscoredaily.com/news/article.html?no=69591
3458,2020-05-19,10대제약사중8곳1분기매출증가유한양행대웅제약동반부진,http://www.consumernews.co.kr/news/articleView.html?idxno=605143
3459,2020-05-19,대웅코로나19치료강력후보물질둘다보유한국내유일한업체DS,http://www.edaily.co.kr/news/newspath.asp?newsid=01420246625770560
3460,2020-05-19,대웅코로나19치료후보물질둘다보유DS,http://news.mt.co.kr/mtview.php?no=2020051908162969959
3461,2020-05-19,리포트브리핑대웅현존하는가장강력한코로나19치료후보물질니클로사마이드와나파모스타트둘다보유한유일업체NotRatedDS투자증권,http://www.newspim.com/news/view/20200519000106
3462,2020-05-19,DS투자증권대웅코로나19치료후보물질니클로사마이드나파모스타트보유”,http://www.fnnews.com/news/202005190842044911
3463,2020-05-19,대웅5이상상승현존하는가장강력한코로나19치료후보물질니클로사마이드와나파모스타트둘다보유한유일업체,https://www.hankyung.com/finance/article/202005191564L
3464,2020-05-19,특징주대웅18250원19일9시5분등락률735,http://www.getnews.co.kr/view.php?ud=2020051909065294c20b9410ff_16
3465,2020-05-19,특징주대웅코로나19치료물질보유분석에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01935206625770560
3466,2020-05-19,대웅제약신풍제약지지부진한주가대웅제약10만원선무너지나,http://www.econonews.co.kr/news/articleView.html?idxno=120907
3467,2020-05-19,뉴스투데이L대웅제약언택트마케팅으로포스트코로나시대경쟁력확보,https://www.news2day.co.kr/153003
3468,2020-05-19,시지바이오관상동맥용스텐트품목허가획득대웅제약통해출시,http://news.heraldcorp.com/view.php?ud=20200519000708
3469,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.lawissue.co.kr/view.php?ud=202005191457269320204ead0791_12
3470,2020-05-19,건강기능식품이름은대웅제약토스행운퀴즈이벤트진행,https://www.fetv.co.kr/news/article.html?no=54906
3471,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.g-enews.com/ko-kr/news/article/news_all/20200519150245913151638db705_1/article.html
3472,2020-05-19,대웅제약건강기능식품인지도높이는토스행운퀴즈진행,http://www.wsobi.com/news/articleView.html?idxno=97767
3473,2020-05-19,대웅제약20일토스행운퀴즈이벤트진행건기식이름을맞춰라,http://www.ekn.kr/news/article.html?no=500143
3474,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.anewsa.com/detail.php?number=2128882&thread=10
3475,2020-05-19,대웅제약건기식인지도제고토스행운퀴즈이벤트진행,http://medipana.com/news/news_viewer.asp?NewsNum=257095&MainKind=A&NewsKind=5&vCount=12&vKind=1
3476,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.bosa.co.kr/news/articleView.html?idxno=2127071
3477,2020-05-19,대웅제약토스행운퀴즈이벤트,http://newsclaim.co.kr/View.aspx?No=847982
3478,2020-05-19,유한양행대웅종근당치매약건강보험적용취소되나,http://www.finomy.com/news/articleView.html?idxno=78155
3479,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=387162
3480,2020-05-19,대웅제약건강기능식품토스행운퀴즈이벤트진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244472
3481,2020-05-19,건기식인지도와체험의기회대웅제약토스에서행운퀴즈이벤트,http://kpenews.com/View.aspx?No=848040
3482,2020-05-19,대웅제약토스행운퀴즈이벤트진행건강기능식품의이름은무엇일까요,http://newsbrite.net/137055
3483,2020-05-19,대웅제약토스행운퀴즈진행정답자에토스머니증정,http://www.kpinews.co.kr/news/articleView.html?idxno=117007
3484,2020-05-19,대웅제약토스앱통해건강기능식품홍보이벤트나서,http://news.mk.co.kr/newsRead.php?no=512043&year=2020
3485,2020-05-19,대웅제약토스행운퀴즈이벤트실시건강기능식품이름은,http://www.m-i.kr/news/articleView.html?idxno=711737
3486,2020-05-19,대웅제약20일토스행운퀴즈이벤트진행20만명에게토스머니제공,http://sports.hankooki.com/lpage/economy/202005/sp20200519170604136980.htm?s_ref=nv
3487,2020-05-19,대웅제약토스서이벤트진행건기식이름맞추기,http://www.econovill.com/news/articleView.html?idxno=397239
3488,2020-05-19,대웅제약건강기능식품홍보이벤트진행,http://www.100ssd.co.kr/news/articleView.html?idxno=68829
3489,2020-05-19,대웅제약인지도↑토스행운퀴즈이벤트진행,http://www.whosaeng.com/117894
3490,2020-05-19,대웅제약토스행운퀴즈이벤트밀크씨슬제품이름은,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117381
3491,2020-05-19,대웅제약토스행운퀴즈이벤트진행,http://www.thefirstmedia.net/news/articleView.html?idxno=58264
3492,2020-05-20,대웅제약20일오전11시토스행운퀴즈이벤트정답은,http://www.bizwnews.com/news/articleView.html?idxno=13616
3493,2020-05-20,대웅수익성개선세두드러질전망KTB투자증권,http://news.mt.co.kr/mtview.php?no=2020052007574132707
3494,2020-05-20,대웅양호한실적기대KTB,http://www.fnnews.com/news/202005200804415986
3495,2020-05-20,대웅코로나테마보다본연가치가매력매수KTB투자,https://www.etoday.co.kr/news/view/1896486
3496,2020-05-20,리포트브리핑대웅COVID테마보다는본연의기업가치가매력적목표가28000원KTB투자증권,http://www.newspim.com/news/view/20200520000089
3497,2020-05-20,I리포트대웅수익성개선세두드러질전망KTB證,http://www.inews24.com/view/1266406
3498,2020-05-20,대웅양호한실적전망KTB투자증권,http://www.seoulfn.com/news/articleView.html?idxno=383044
3499,2020-05-20,대웅주가상승예상자회사대웅바이오지분가치재평가가능,http://www.businesspost.co.kr/BP?command=article_view&num=178875
3500,2020-05-20,대웅비상장자회사인대웅바이오호실적에실적개선가능성↑KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=02020486625770888
3501,2020-05-20,대웅제약몰에힌트대웅제약토스행운퀴즈이벤트진행,http://theviewers.co.kr/View.aspx?No=848472
3502,2020-05-20,대웅제약토스행운퀴즈이벤트진행건강기능식품의이름은,http://www.newsworker.co.kr/news/articleView.html?idxno=71642
3503,2020-05-20,대웅제약신풍제약모두하락부진특히신풍제약1낙폭에2만원선붕괴,http://www.econonews.co.kr/news/articleView.html?idxno=121093
3504,2020-05-20,대웅제약에너씨슬토스행운퀴즈정답은,http://www.ccreview.co.kr/news/articleView.html?idxno=260449
3505,2020-05-20,토스행운퀴즈대웅제약에너씨슬정답발표,http://www.anewsa.com/detail.php?number=2129480&thread=10
3506,2020-05-20,대웅제약토스행운퀴즈실시간정답업데이트,http://www.ggilbo.com/news/articleView.html?idxno=769318
3507,2020-05-20,대웅제약밀크씨슬이름은토스행운퀴즈정답은,http://www.newsworks.co.kr/news/articleView.html?idxno=456312
3508,2020-05-20,대웅제약에너씨슬토스행운퀴즈정답은,https://www.asiatime.co.kr/news/newsview.php?ncode=1065580023464686
3509,2020-05-20,대웅제약밀크씨슬토스행운퀴즈정답에쏠린관심선착순퀴즈이벤트,https://nc.asiae.co.kr/view.htm?idxno=2020052011311966649
3510,2020-05-20,대웅제약에너씨슬콜레다운토스행운퀴즈정답은,http://www.ccdn.co.kr/news/articleView.html?idxno=646294
3511,2020-05-20,대웅제약토스행운퀴즈이벤트진행건강기능식품의이름은무엇일까요,http://www.nbnnews.co.kr/news/articleView.html?idxno=393676
3512,2020-05-20,1Q매출톱10상장제약사매출비RD비톱3대웅셀트리온한미,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244494
3513,2020-05-20,피곤한간대웅제약밀크씨슬어때요불순물엄격한시험통과한제품만제공,http://www.thekpm.com/view.php?ud=202005201401453333861beb2d9d_17
3514,2020-05-20,대웅제약밀크씨슬토스행운퀴즈정답총망라,http://www.joygm.com/news/articleView.html?idxno=84522
3515,2020-05-21,대웅제약신풍제약모두하락세로대웅제약소폭하락이어신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=121246
3516,2020-05-21,대웅제약올로스타제네릭나오나매출영향은미지수,http://medipana.com/news/news_viewer.asp?NewsNum=257216&MainKind=A&NewsKind=5&vCount=12&vKind=1
3517,2020-05-21,매출10RD투자하는대웅제약오픈이노베이션넘어오픈콜라보로미래성장,http://www.medigatenews.com/news/3541898120
3518,2020-05-21,대웅제약의언택트마케팅관심,http://www.lawissue.co.kr/view.php?ud=202005211545291353204ead0791_12
3519,2020-05-22,대웅제약올로스타특허방어실패후발약물나오나,http://www.mdtoday.co.kr/mdtoday/index.html?no=387487
3520,2020-05-22,대웅제약국제미용성형학회웨비나에서나보타우수성알렸다,http://www.getnews.co.kr/view.php?ud=2020052209043119132fe691f917_16
3521,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알려,http://newsclaim.co.kr/View.aspx?No=851047
3522,2020-05-22,대웅제약IMCAS아카데미웨비나성료나보타우수성알려,http://www.kpinews.co.kr/news/articleView.html?idxno=117213
3523,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성시술법소개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244626
3524,2020-05-22,대웅제약세계의료진에게나보타우수성알려,http://www.koreastocknews.com/news/articleView.html?idxno=53788
3525,2020-05-22,대웅제약IMCAS웨비나서나보타우수성소개,http://www.press9.kr/news/articleView.html?idxno=44736
3526,2020-05-22,대웅제약IMCAS 웨비나에서나보타우수성알렸다,http://www.businesskorea.co.kr/news/articleView.html?idxno=46189
3527,2020-05-22,한국보톡스대웅제약나보타우수성IMCAS웨비나통해소통,http://theviewers.co.kr/View.aspx?No=851101
3528,2020-05-22,대웅제약코로나속전세계미용성형전문가와소통확대,http://www.newsis.com/view/?id=NISX20200522_0001033388&cID=13001&pID=13000
3529,2020-05-22,대웅제약IMCAS웨비나서나보타우수성전파,http://www.dailysmart.co.kr/news/articleView.html?idxno=26776
3530,2020-05-22,대웅제약IMCAS웨비나서나보타우수성전파,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571948698815
3531,2020-05-22,대웅제약IMCAS웨비나서나보타우수성시술법알려,http://medipana.com/news/news_viewer.asp?NewsNum=257271&MainKind=A&NewsKind=5&vCount=12&vKind=1
3532,2020-05-22,대웅제약IMCAS웨비나서나보타우수성및시술법알려,http://www.ekn.kr/news/article.html?no=500754
3533,2020-05-22,대웅제약신풍제약희비엇갈려대웅제약1상승반해신풍제약소폭하락,http://www.econonews.co.kr/news/articleView.html?idxno=121381
3534,2020-05-22,대웅제약국제미용성형학회에서나보타우수성소개,http://www.youthdaily.co.kr/news/article.html?no=37737
3535,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알려,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117479
3536,2020-05-22,대웅제약전세계전문가1700명참석IMCAS웨비나서나보타우수성소개,http://www.pressm.kr/news/articleView.html?idxno=29900
3537,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다전세계전문가들과소통확대,http://newsbrite.net/137199
3538,2020-05-22,주식대웅제약신풍제약주가희비엇갈려특히대웅제약1상승반해신풍제약매도세에소폭하락,http://www.ggilbo.com/news/articleView.html?idxno=770014
3539,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알렸다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61316
3540,2020-05-22,대웅제약웨비나쏠쏠하네전세계미용성형전문가에나보타소개,http://moneys.mt.co.kr/news/mwView.php?no=2020052209568074997
3541,2020-05-22,대웅제약국제미용성형학회에서나보타우수성알려,http://news.heraldcorp.com/view.php?ud=20200522000197
3542,2020-05-22,대웅제약전문가세미나서나보타우수성소개,http://www.upinews.kr/newsView/upi202005220025
3543,2020-05-22,대웅제약라이브웨비나시술법소개,http://www.g-enews.com/ko-kr/news/article/news_all/2020052210225772451638db705_1/article.html
3544,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알려,https://www.dailian.co.kr/news/view/891906?sc=Naver
3545,2020-05-22,대웅제약IMCAS웨비나서나보타시술법소개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1388910
3546,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.greened.kr/news/articleView.html?idxno=252628
3547,2020-05-22,대웅제약국제미용성형학회웨비나참석해나보타우수성알려,http://www.newslock.co.kr/news/articleView.html?idxno=28149
3548,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.mdtoday.co.kr/mdtoday/index.html?no=387541
3549,2020-05-22,대웅제약세계3대미용학회참가나보타우수성시술법소개,http://www.consumuch.com/news/articleView.html?idxno=48887
3550,2020-05-22,대웅제약IMCAS웨비나서나보타홍보나서,http://www.mhj21.com/130492
3551,2020-05-22,대웅제약국제미용성형학회웨비나통해나보타소개,https://www.etoday.co.kr/news/view/1897693
3552,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.bosa.co.kr/news/articleView.html?idxno=2127268
3553,2020-05-22,대웅제약국제미용성형학회플랫폼서나보타우수성알려,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052211144923979
3554,2020-05-22,대웅제약IMCAS웨비나서나보타소개,http://www.sporbiz.co.kr/news/articleView.html?idxno=440931
3555,2020-05-22,대웅제약세계3대미용학회IMCAS웨비나서나보타우수성알려,http://www.updownnews.co.kr/news/articleView.html?idxno=219009
3556,2020-05-22,대웅제약보툴리눔톡신나보타우수성소개,http://www.pharmnews.com/news/articleView.html?idxno=100527
3557,2020-05-22,글로벌톡신브랜드로입지대웅제약라이브웨비나열고나보타소개,http://kpenews.com/View.aspx?No=851386
3558,2020-05-22,대웅제약나보타우수성시술법소개효능과안전성입증,http://www.newsprime.co.kr/news/article.html?no=505276
3559,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.segye.com/content/html/2020/05/22/20200522510221.html?OutUrl=naver
3560,2020-05-22,대웅제약미용성형전문가1700여명에나보타우수성알려,http://daily.hankooki.com/lpage/industry/202005/dh20200522115307148390.htm?s_ref=nv
3561,2020-05-22,대웅제약국제미용성형학회에서자체보툴리눔톡신우수성알려,http://www.businesspost.co.kr/BP?command=article_view&num=179309
3562,2020-05-22,대웅바이오세무조사에촉각곤두세운CSO업계,http://www.sisajournal-e.com/news/articleView.html?idxno=218708
3563,2020-05-22,메디톡스메디톡신법원식약처명령집행정지소식에급등대웅제약휴젤등관련주주가는,http://www.topstarnews.net/news/articleView.html?idxno=788568
3564,2020-05-22,대웅제약나보타실시간온라인세미나개최전세계의료진소통확대,https://www.donga.com/news/article/all/20200522/101172172/1
3565,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.nbnnews.co.kr/news/articleView.html?idxno=394358
3566,2020-05-22,대웅제약전세계미용성형전문가와소통나보타우수성알려,http://sports.hankooki.com/lpage/economy/202005/sp20200522135835137020.htm?s_ref=nv
3567,2020-05-22,대웅제약IMCAS웨비나통해나보타시술법소개,http://www.medigatenews.com/news/2538070558
3568,2020-05-22,대웅제약국제미용성형학회웨비나서나보타우수성알렸다,http://www.sisaweek.com/news/articleView.html?idxno=134061
3569,2020-05-22,대웅제약국제미용성형학회온라인강의플랫폼서나보타홍보,http://news.mk.co.kr/newsRead.php?no=526104&year=2020
3570,2020-05-22,대웅제약IMCAS웨비나서나보타우수성알렸다,http://www.m-i.kr/news/articleView.html?idxno=712746
3571,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.lawissue.co.kr/view.php?ud=202005221529344884204ead0791_12
3572,2020-05-22,대웅제약전문가1700명참석한자리서나보타우수성알렸다”,http://www.econovill.com/news/articleView.html?idxno=397775
3573,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알려,http://news.mt.co.kr/mtview.php?no=2020052209151086875
3574,2020-05-22,대웅제약IMCAS웨비나서나보타시술법소개,https://www.ebn.co.kr/news/view/1435013?sc=Naver
3575,2020-05-22,대웅제약IMCAS웨비나통해나보타우수성알렸다,http://www.mediapen.com/news/view/527192
3576,2020-05-22,대웅제약온라인라이브통해나보타우수성소개,http://www.economytalk.kr/news/articleView.html?idxno=206142
3577,2020-05-22,대웅제약세계의료진에나보타시술법소개,http://www.dailymedi.com/detail.php?number=856375&thread=22r05
3578,2020-05-22,뉴스투데이L대웅제약IMCAS웨비나에서나보타우수성알렸다,https://www.news2day.co.kr/153281
3579,2020-05-22,대웅제약IMCAS웨비나서나보타우수성전파,http://www.koreaittimes.com/news/articleView.html?idxno=97703
3580,2020-05-22,대웅제약공격마케팅주목경쟁사위기는기회,https://www.paxnetnews.com/articles/60835
3581,2020-05-22,대웅제약IMCAS웨비나열어나보타자랑,http://www.seoulfn.com/news/articleView.html?idxno=383476
3582,2020-05-22,대웅제약IMCAS웨비나에서나보타우수성알렸다,http://www.ybsn.tv/news/articleView.html?idxno=13894
3583,2020-05-23,대웅제약IMCASACADEMY에서라이브웨비나통해나보타우수성알리다,http://www.paxetv.com/news/articleView.html?idxno=92776
3584,2020-05-25,1Q상위10개상장제약판관비증감률톱3셀트리온GC녹십자대웅,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244666
3585,2020-05-25,대웅제약이지에프외용액인니서할랄인증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=117324
3586,2020-05-25,대웅제약이지에프외용액할랄인증획득80조규모중동시장진출,http://news.mt.co.kr/mtview.php?no=2020052509024828544
3587,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증,https://www.etoday.co.kr/news/view/1898235
3588,2020-05-25,대웅제약당뇨병성족부궤양치료제할랄인증80조원무슬림공략,http://www.upinews.kr/newsView/upi202005250005
3589,2020-05-25,대웅제약이지에프외용액할랄인증획득,https://www.ebn.co.kr/news/view/1435116?sc=Naver
3590,2020-05-25,대웅인피온이지에프외용액할랄인증획득,http://www.press9.kr/news/articleView.html?idxno=44751
3591,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.lawissue.co.kr/view.php?ud=202005250911538565204ead0791_12
3592,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.viva100.com/main/view.php?key=20200525010006783
3593,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244700
3594,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,https://www.fetv.co.kr/news/article.html?no=55260
3595,2020-05-25,대웅제약이지에프외용액할랄인증획득중동의약품시장겨냥,http://www.econovill.com/news/articleView.html?idxno=397931
3596,2020-05-25,대웅제약 IMCAS 웨비나에서 나보타 우수성알렸다 ,http://www.greened.kr/news/articleView.html?idxno=252890
3597,2020-05-25,대웅제약중동신흥시장진출청신호이지에프외용액하랄인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020052509188057711
3598,2020-05-25,대웅제약국내1호바이오신약이지에프외용액할랄인증,http://www.ekn.kr/news/article.html?no=501090
3599,2020-05-25,대웅제약국내바이오신약1호할랄인증,http://www.edaily.co.kr/news/newspath.asp?newsid=01869606625772528
3600,2020-05-25,대웅제약대웅인피온통해이지에프외용액할랄인증획득,http://medipana.com/news/news_viewer.asp?NewsNum=257354&MainKind=A&NewsKind=5&vCount=12&vKind=1
3601,2020-05-25,대웅제약바이오신약1호이지에프외용액할랄인증,http://www.wikileaks-kr.org/news/articleView.html?idxno=87012
3602,2020-05-25,대웅인피온이지에프외용액인니할랄인증,http://www.dailypharm.com/Users/News/NewsView.html?ID=264899&REFERER=NP
3603,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.m-i.kr/news/articleView.html?idxno=713212
3604,2020-05-25,대웅이지에프외용액인니할랄인증,http://www.whosaeng.com/118023
3605,2020-05-25,대웅제약이지에프외용액할랄인증획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572178836651
3606,2020-05-25,대웅인피온이지에프외용액할랄인증획득,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117526
3607,2020-05-25,인도네시아할랄인증대웅제약대웅인피온중동의약품시장진출,http://theviewers.co.kr/View.aspx?No=852511
3608,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://yna.kr/AKR20200525036800017?did=1195m
3609,2020-05-25,대웅제약인니법인당뇨발치료제할랄인증,https://www.sedaily.com/NewsView/1Z2W00DLXW
3610,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://newsbrite.net/137288
3611,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.newspim.com/news/view/20200525000133
3612,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1389248
3613,2020-05-25,대웅제약신풍제약희비엇갈려대웅제약소폭하락반해신풍제약1상승,http://www.econonews.co.kr/news/articleView.html?idxno=121654
3614,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://yna.kr/PYH20200525024300017?did=1196m
3615,2020-05-25,대웅제약이지에프외용액인도네시아할랄인증,http://www.bosa.co.kr/news/articleView.html?idxno=2127364
3616,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.ajunews.com/view/20200525094151364
3617,2020-05-25,대웅제약80조중동시장교두보마련,https://www.paxnetnews.com/articles/60847
3618,2020-05-25,대웅제약인니법인당뇨발치료제할랄인증획득,http://it.chosun.com/site/data/html_dir/2020/05/25/2020052501031.html
3619,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005250089&t=NN
3620,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.bokuennews.com/news/article.html?no=190353
3621,2020-05-25,할랄인증받은국내1호바이오신약대웅제약인도네시아서이지에프외용액인증획득,https://www.donga.com/news/article/all/20200525/101196523/1
3622,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=46301
3623,2020-05-25,대웅제약이지에프외용액할랄인증80조중동공략,http://www.newsis.com/view/?id=NISX20200525_0001035435&cID=13001&pID=13000
3624,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.g-enews.com/ko-kr/news/article/news_all/20200525100957536751638db705_1/article.html
3625,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.monews.co.kr/news/articleView.html?idxno=210883
3626,2020-05-25,대웅제약바이오신약1호로무슬림의약품시장첫발,http://health.chosun.com/site/data/html_dir/2020/05/25/2020052501152.html
3627,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,https://www.dailian.co.kr/news/view/892308?sc=Naver
3628,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://www.mediapen.com/news/view/527581
3629,2020-05-25,대웅인피온바이오신약1호이지에프외용액할랄인증획득,http://www.youthdaily.co.kr/news/article.html?no=37914
3630,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.fnnews.com/news/202005251029414111
3631,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.cnbnews.com/news/article.html?no=447605
3632,2020-05-25,대웅인피온인니기관서이지에프외용액할랄인증받아,http://news.mk.co.kr/newsRead.php?no=531953&year=2020
3633,2020-05-25,대웅인피온이지에프외용액인도네시아할랄인증획득,http://www.newsprime.co.kr/news/article.html?no=505377
3634,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득쾌거,http://www.pressm.kr/news/articleView.html?idxno=29936
3635,2020-05-25,대웅족부궤양치료제할랄인증,http://news.mk.co.kr/newsRead.php?no=532014&year=2020
3636,2020-05-25,대웅제약이지에프외용액인도네시아서할랄인증획득,http://www.sisaweek.com/news/articleView.html?idxno=134092
3637,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020052510555995202
3638,2020-05-25,인벤티지랩대웅제약장기지속형주사제공동개발,http://www.biospectator.com/view/news_view.php?varAtcId=10404
3639,2020-05-25,대웅제약당뇨병성족부궤양치료제이지에프외용액할랄인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=387696
3640,2020-05-25,대웅제약족부궤양치료제할랄인증,http://www.seoulfn.com/news/articleView.html?idxno=383554
3641,2020-05-25,대웅제약인벤티지랩과맞손장기지속형주사제사업확대,http://www.segye.com/content/html/2020/05/25/20200525505184.html?OutUrl=naver
3642,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.thepublic.kr/news/newsview.php?ncode=1065575706664605
3643,2020-05-25,인벤티지랩대웅제약과전략적파트너쉽협약체결,https://www.news1.kr/articles/?3944053
3644,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244723
3645,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052511062688631
3646,2020-05-25,인벤티지랩대웅제약과장기지속형주사제개발파트너십체결,http://www.metroseoul.co.kr/article/20200525500104
3647,2020-05-25,인벤티지랩대웅제약과장기지속형주사제공동개발맞손,http://it.chosun.com/site/data/html_dir/2020/05/25/2020052500801.html
3648,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.youthdaily.co.kr/news/article.html?no=37937
3649,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.press9.kr/news/articleView.html?idxno=44762
3650,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=26900
3651,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.kpinews.co.kr/news/articleView.html?idxno=117369
3652,2020-05-25,대웅제약장기지속형주사제사업확대인벤티지랩과파트너십,https://www.etoday.co.kr/news/view/1898346
3653,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업부문서맞손,http://www.econovill.com/news/articleView.html?idxno=397986
3654,2020-05-25,대웅제약인벤티지랩과파트너십계약장기지속형주사제사업확대,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005250192&t=NN
3655,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61356
3656,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61342
3657,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업확대,http://medipana.com/news/news_viewer.asp?NewsNum=257382&MainKind=A&NewsKind=5&vCount=12&vKind=1
3658,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://newsbrite.net/137309
3659,2020-05-25,대웅제약이지에프외용액할랄인증획득80조시장공략,http://www.metroseoul.co.kr/article/20200525500169
3660,2020-05-25,대웅제약중동의약품시장진출에탄력이지에프외용액印泥서할랄인증,http://kpenews.com/View.aspx?No=852813
3661,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호할랄인증,http://www.medigatenews.com/news/1860915199
3662,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.koreaittimes.com/news/articleView.html?idxno=97725
3663,2020-05-25,대웅제약바이오신약할랄인증잇단획득80조중동시장공략,http://news.mt.co.kr/mtview.php?no=2020052511331268818
3664,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업확대,http://www.mdtoday.co.kr/mdtoday/index.html?no=387728
3665,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1133868&REFERER=NP
3666,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.ceoscoredaily.com/news/article.html?no=69815
3667,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.bosa.co.kr/news/articleView.html?idxno=2127416
3668,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업위해파트너십체결,http://www.k-health.com/news/articleView.html?idxno=48596
3669,2020-05-25,대웅제약인벤티지랩과장기지속형주사제RD협력파트너십체결,http://news.mk.co.kr/newsRead.php?no=532541&year=2020
3670,2020-05-25,대웅제약인벤티지랩파트너십계약,http://www.g-enews.com/ko-kr/news/article/news_all/2020052511450741551638db705_1/article.html
3671,2020-05-25,대웅제약인벤티지랩맞손장기지속형주사제사업확대,http://www.newsprime.co.kr/news/article.html?no=505398
3672,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.lawissue.co.kr/view.php?ud=202005251203204109204ead0791_12
3673,2020-05-25,대웅제약장기지속형주사제사업확대나서,http://www.bokuennews.com/news/article.html?no=190387
3674,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.dailymedi.com/detail.php?number=856432&thread=22r05
3675,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1081006
3676,2020-05-25,대웅제약인벤티지랩과파트너십장기지속형주사제사업확대,http://www.consumuch.com/news/articleView.html?idxno=48899
3677,2020-05-25,대웅제약인벤티지랩과장기지속형주사제공동개발맞손,http://www.ekn.kr/news/article.html?no=501190
3678,2020-05-25,대웅제약할랄인증으로무슬림시장공략본격화,http://www.sporbiz.co.kr/news/articleView.html?idxno=441399
3679,2020-05-25,대웅제약인벤티지랩장기지속형주사제개발파트너십,http://www.mediapen.com/news/view/527655
3680,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.m-i.kr/news/articleView.html?idxno=713370
3681,2020-05-25,대웅제약장기지속형주사제사업확대,https://www.paxnetnews.com/articles/60866
3682,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.newsis.com/view/?id=NISX20200525_0001035788&cID=13001&pID=13000
3683,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=394840
3684,2020-05-25,제약워치대웅제약인벤티지랩과맞손장기지속형주사제사업확대外,http://www.newswatch.kr/news/articleView.html?idxno=30177
3685,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.greened.kr/news/articleView.html?idxno=252971
3686,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.nbnnews.co.kr/news/articleView.html?idxno=394854
3687,2020-05-25,대웅제약인벤티지랩협업장기지속형주사제사업확대,http://www.newslock.co.kr/news/articleView.html?idxno=28200
3688,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증,http://www.newstomato.com/ReadNews.aspx?no=973892
3689,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,https://www.fetv.co.kr/news/article.html?no=55304
3690,2020-05-25,대웅제약장기지속형주사제사업정조준,http://www.whosaeng.com/118035
3691,2020-05-25,인벤티지랩대웅제약과장기지속형주사제전략적제휴,http://news.mk.co.kr/newsRead.php?no=533439&year=2020
3692,2020-05-25,대웅제약장기지속형주사제사업확대 ,http://www.monews.co.kr/news/articleView.html?idxno=210892
3693,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052514273759706
3694,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.getnews.co.kr/view.php?ud=2020052514470270662fe691f917_16
3695,2020-05-25,대웅제약이지에프외용액할랄인증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1081015
3696,2020-05-25,대웅제약인벤티지랩과파트너십체결장기지속형주사제사업확대,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117545
3697,2020-05-25,대웅제약대웅인피온통해바이오신약이지에프외용액할랄인증획득,http://www.getnews.co.kr/view.php?ud=2020052514530014942fe691f917_16
3698,2020-05-25,대웅제약나보타우수성전세계알렸다,http://www.whosaeng.com/118046
3699,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.mhj21.com/130563
3700,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,https://www.hankyung.com/it/article/202005253140i
3701,2020-05-25,뉴스투데이L대웅제약인벤티지랩과장기지속형주사제사업확대,https://www.news2day.co.kr/153336
3702,2020-05-25,게시판대웅제약인벤티지랩과장기지속형주사제공동연구,http://yna.kr/AKR20200525115900017?did=1195m
3703,2020-05-25,대웅제약인벤티지랩과장기지속형주사제공동연구,http://yna.kr/PYH20200525164400017?did=1196m
3704,2020-05-25,대웅제약인벤티지랩장기지속형주사제사업확대나선다,http://www.paxetv.com/news/articleView.html?idxno=92874
3705,2020-05-25,대웅제약인벤티지랩과장기지속형주사제사업확대,http://www.newstomato.com/ReadNews.aspx?no=974039
3706,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.businesspost.co.kr/BP?command=article_view&num=179634
3707,2020-05-25,대웅제약국내1호바이오신약이지에프외용액할랄인증,http://www.fnnews.com/news/202005251701062408
3708,2020-05-25,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=58482
3709,2020-05-25,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.thefirstmedia.net/news/articleView.html?idxno=58471
3710,2020-05-25,대웅제약1회주사로3개월효과가는장기지속형주사제확대,http://health.chosun.com/site/data/html_dir/2020/05/25/2020052503117.html
3711,2020-05-25,비즈피플대웅제약장기지속형주사제파이프라인발굴,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052516232128303
3712,2020-05-25,투약횟수뚝대웅제약인벤티지랩장기지속형주사제사업맞손,http://theviewers.co.kr/View.aspx?No=853450
3713,2020-05-25,대웅제약장기지속형주사제사업확대인벤티지랩과협업,http://www.edaily.co.kr/news/newspath.asp?newsid=03827766625772528
3714,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.koreastocknews.com/news/articleView.html?idxno=53868
3715,2020-05-25,대웅제약장기지속형주사제사업확대,http://www.dailypharm.com/Users/News/NewsView.html?ID=264926&REFERER=NP
3716,2020-05-25,대웅제약국내바이오신약1호이지에프외용액할랄인증획득,http://news.kbiz.or.kr/news/articleView.html?idxno=67753
3717,2020-05-25,대웅제약인도네시아법인당뇨발치료제할랄인증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4162116
3718,2020-05-26,대웅제약대웅인피온통해국내바이오신약1호이지에프외용액할랄인증획득,http://www.ybsn.tv/news/articleView.html?idxno=14162
3719,2020-05-26,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://www.ybsn.tv/news/articleView.html?idxno=14166
3720,2020-05-26,대웅제약인벤티지랩장기지속형주사제파트너십맺어,https://www.kpanews.co.kr/article/show.asp?idx=213449&category=D
3721,2020-05-26,대웅제약바이오신약이지에프외용액할랄인증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1282361
3722,2020-05-26,시판당뇨약발암물질검출대웅제약제일약품등31개제조판매중지,https://www.fetv.co.kr/news/article.html?no=55377
3723,2020-05-26,발암추정물질쓴한미유한대웅당뇨병약판매중단,https://www.ajunews.com/view/20200526083020266
3724,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,https://www.fetv.co.kr/news/article.html?no=55380
3725,2020-05-26,대웅제약참지마요프로젝트온라인진행,https://www.ebn.co.kr/news/view/1435338?sc=Naver
3726,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.businesskorea.co.kr/news/articleView.html?idxno=46389
3727,2020-05-26,대웅제약발달장애인대상비대면봉사활동전개,http://www.wikileaks-kr.org/news/articleView.html?idxno=87126
3728,2020-05-26,대웅제약발달장애인멘토링비대면봉사활동지속전개,http://www.youthdaily.co.kr/news/article.html?no=38029
3729,2020-05-26,대웅제약온라인으로비대면봉사활동,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052609241792067
3730,2020-05-26,대웅제약온라인으로비대면봉사활동실시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571972910906
3731,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244763
3732,2020-05-26,코로나19사태의봉사활동은비대면이대세대웅제약 온라인으로 비대면봉사활동 전개 ,http://www.greened.kr/news/articleView.html?idxno=253109
3733,2020-05-26,대웅제약신풍제약희비엇갈려대웅제약소폭상승반해신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=121827
3734,2020-05-26,대웅제약코로나위기속임직원비대면봉사활동실시,http://www.koreastocknews.com/news/articleView.html?idxno=53871
3735,2020-05-26,발달장애인멘토링봉사대웅제약참지마요프로젝트온라인비대면방식으로지속,http://theviewers.co.kr/View.aspx?No=853878
3736,2020-05-26,대웅제약사회공헌참지마요프로젝트온라인봉사활동펼쳐,http://www.kpinews.co.kr/news/articleView.html?idxno=117450
3737,2020-05-26,대웅제약온라인통해비대면봉사활동지속전개,http://www.m-i.kr/news/articleView.html?idxno=713609
3738,2020-05-26,대웅제약참지마요프로젝트온라인으로봉사활동지속,http://www.metroseoul.co.kr/article/20200526500075
3739,2020-05-26,대웅제약온라인으로비대면멘토링봉사활동지속전개,http://www.econovill.com/news/articleView.html?idxno=398134
3740,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://newsbrite.net/137339
3741,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.newsway.co.kr/news/view?tp=1&ud=2020052609593184529
3742,2020-05-26,대웅제약봉사활동도온라인으로발달장애인의사소통카드제작,https://www.sedaily.com/NewsView/1Z2WFRJ04N
3743,2020-05-26,대웅제약발달장애인의사소통돕는참지마요프로젝트실시,http://www.rapportian.com/news/articleView.html?idxno=125419
3744,2020-05-26,대웅제약언택트봉사활동온라인참지마요프로젝트진행,http://moneys.mt.co.kr/news/mwView.php?no=2020052609128027149
3745,2020-05-26,대웅제약참지마요프로젝트온라인비대면봉사활동지속전개,http://www.pressm.kr/news/articleView.html?idxno=29983
3746,2020-05-26,바이오톡스텍대웅테라퓨틱스코로나19치료제독성연구착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244768
3747,2020-05-26,대웅제약코로나19에온라인비대면봉사활동지속전개,http://medipana.com/news/news_viewer.asp?NewsNum=257439&MainKind=A&NewsKind=5&vCount=12&vKind=1
3748,2020-05-26,바이오톡스텍대웅테라퓨틱스코로나19치료제독성연구착수,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005260158&t=NN
3749,2020-05-26,대웅제약참지마요프로젝트온라인비대면봉사활동으로지속,http://www.paxetv.com/news/articleView.html?idxno=92921
3750,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.dailysmart.co.kr/news/articleView.html?idxno=26970
3751,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61375
3752,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.bosa.co.kr/news/articleView.html?idxno=2127485
3753,2020-05-26,바이오톡스텍대웅테라퓨틱스코로나19치료제독성연구착수,http://www.mdtoday.co.kr/mdtoday/index.html?no=387850
3754,2020-05-26,대웅제약온라인으로비대면봉사활동전개,http://www.bokuennews.com/news/article.html?no=190435
3755,2020-05-26,대웅제약발달장애인대상참지마요프로젝트봉사온라인으로이어가,http://news.mk.co.kr/newsRead.php?no=536634&year=2020
3756,2020-05-26,대웅제약코로나19에봉사활동도언택트,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005260202&t=NN
3757,2020-05-26,대웅제약온라인으로봉사활동지속전개,http://www.newsfc.co.kr/news/articleView.html?idxno=41243
3758,2020-05-26,대웅제약참지마요프로젝트온라인통한비대면봉사활동지속,http://www.newslock.co.kr/news/articleView.html?idxno=28225
3759,2020-05-26,대웅제약온라인으로발달장애인과함께하는임직원멘토링봉사활동진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=387873
3760,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.lawissue.co.kr/view.php?ud=202005261301526611204ead0791_12
3761,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.updownnews.co.kr/news/articleView.html?idxno=219129
3762,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.nbnnews.co.kr/news/articleView.html?idxno=395164
3763,2020-05-26,대웅제약참지마요프로젝트온라인활동전개,https://www.donga.com/news/article/all/20200526/101217835/1
3764,2020-05-26,바이오톡스텍대웅테라퓨틱스의코로나19치료제니클로사마이드독성연구착수,http://www.fnnews.com/news/202005261344441344
3765,2020-05-26,대웅제약이즈에프외용액할랄인증획득80조규모중동시장공략나서,http://www.asiatoday.co.kr/view.php?key=20200525010013247
3766,2020-05-26,봉사활동도비대면대웅제약멘토링프로그램진행,http://weekly.hankooki.com/lpage/economy/202005/wk20200526143912146380.htm?s_ref=nv
3767,2020-05-26,코로나에도쉬지않는봉사대웅제약온라인으로비대면봉사활동,http://www.getnews.co.kr/view.php?ud=202005261447546692fe691f917_16
3768,2020-05-26,대웅제약참지마요프로젝트발달장애인위한봉사활동진행,http://sports.hankooki.com/lpage/economy/202005/sp20200526144818136980.htm?s_ref=nv
3769,2020-05-26,발암위험물질메트포르민한미중외유한대웅등대형제약사제품도포함,https://www.hankyung.com/it/article/202005266930i
3770,2020-05-26,대웅제약온라인으로비대면봉사활동지속전개,http://www.medigatenews.com/news/2931646147
3771,2020-05-26,대웅제약온라인으로비대면봉사진행,http://www.segye.com/content/html/2020/05/26/20200526511137.html?OutUrl=naver
3772,2020-05-26,대웅제약인벤티지랩과손잡고장기지속형주사제사업확대,http://weekly.hankooki.com/lpage/economy/202005/wk20200526153942146380.htm?s_ref=nv
3773,2020-05-26,JW중외제약유한양행한미약품대웅제약당뇨약서발암추정물질검출31개제품제조판매중지,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003986133
3774,2020-05-26,대웅제약온라인으로장애인멘토링봉사활동,http://www.finomy.com/news/articleView.html?idxno=78386
3775,2020-05-26,시경Today제약대웅제약온라인으로비대면봉사활동지속전개外,http://www.meconomynews.com/news/articleView.html?idxno=41760
3776,2020-05-26,대웅제약코로나여파에온라인으로비대면봉사활동벌여,https://www.dailian.co.kr/news/view/892786?sc=Naver
3777,2020-05-26,대웅제약온라인비대면봉사활동지속,http://www.whosaeng.com/118092
3778,2020-05-26,대웅제약온라인통해발달장애인멘토링활동전개,http://www.100ssd.co.kr/news/articleView.html?idxno=68972
3779,2020-05-26,대웅제약온라인으로발달장애인봉사활동진행,http://www.cnbnews.com/news/article.html?no=447893
3780,2020-05-26,김창수의e뉴스브리핑시판당뇨약발암물질검출대웅제약제일약품등31개제조판매중지外,https://www.fetv.co.kr/news/article.html?no=55464
3781,2020-05-26,메트포르민암가능성낮다지만대웅제약그룹JW중외타격우려,http://www.sisajournal-e.com/news/articleView.html?idxno=218881
3782,2020-05-26,대웅제약온라인으로비대면봉사활동지속,http://www.ajunews.com/view/20200526172739973
3783,2020-05-26,대웅제약발달장애인증상표현교육온라인진행,http://news.mt.co.kr/mtview.php?no=2020052617404498781
3784,2020-05-26,대웅제약의사소통카드감수온라인봉사활동실시,http://www.mediapen.com/news/view/528101
3785,2020-05-26,비즈피플대웅제약발달장애멘토링온라인봉사활동진행외2건,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020052616584174768
3786,2020-05-26,대웅제약봉사활동온라인비대면으로펼쳐,https://www.kpanews.co.kr/article/show.asp?idx=213482&category=D
3787,2020-05-27,뉴스투데이L대웅제약발달장애인임직원멘토링온라인진행,https://www.news2day.co.kr/153463
3788,2020-05-27,대웅제약온라인으로비대면봉사활동지속전개,http://www.thefirstmedia.net/news/articleView.html?idxno=58589
3789,2020-05-27,메디톡스vs대웅제약균주전쟁마무리단계상처뿐인결과,https://www.dailian.co.kr/news/view/892766?sc=Naver
3790,2020-05-27,대웅전략약물메트포르민서방1000mg판금불운,http://www.dailypharm.com/Users/News/NewsView.html?ID=264958&REFERER=NP
3791,2020-05-27,또터진발암물질사태중외한올대웅순으로매출상위,http://www.medigatenews.com/news/1521571123
3792,2020-05-27,미국전ITC위원장메디톡스대웅균주논란ITC가맡을사안아냐,https://www.news1.kr/articles/?3946072
3793,2020-05-27,대웅제약신풍제약지지부진특히신풍제약4거래일만에하락세로,http://www.econonews.co.kr/news/articleView.html?idxno=121999
3794,2020-05-27,e커머스에꽂힌제약업계동아제약대웅제약JW중외제약잇따라쇼핑몰오픈,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003987580
3795,2020-05-28,대웅제약신풍제약희비엇갈려대웅제약1하락반해신풍제약1상승,http://www.econonews.co.kr/news/articleView.html?idxno=122198
3796,2020-05-28,대웅제약베트남진출숨고르기코로나에기술이전지연,https://www.theguru.co.kr/news/article.html?no=11221
3797,2020-05-28,대웅제약142상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/28/2020052802475.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3798,2020-05-28,대웅제약전일대비569이시각거래량23만8501주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202005280306&t=NN
3799,2020-05-28,대웅110상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/05/28/2020052802636.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3800,2020-05-28,대웅제약5이상상승주가상승세단기이평선역배열구간,https://www.hankyung.com/finance/article/202005286315L
3801,2020-05-28,대웅유종상SK바이오팜신해인포함5명보건산업진흥원장표창,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244915
3802,2020-05-28,대웅유종상센터장등우수전문가5명보건산업진흥원장표창,http://www.medisobizanews.com/news/articleView.html?idxno=70059
3803,2020-05-29,대웅제약잼라이브퀴즈이벤트로제품인지도제고,https://www.ebn.co.kr/news/view/1435960?sc=Naver
3804,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://newsbrite.net/137501
3805,2020-05-29,장건강도움되는건기식은”대웅제약잼라이브이벤트진행,https://www.fetv.co.kr/news/article.html?no=55732
3806,2020-05-29,대웅제약잼라이브이벤트진행장건강건기식은,http://www.press9.kr/news/articleView.html?idxno=44822
3807,2020-05-29,대웅제약건기식체험기회확대잼라이브퀴즈이벤트실시,http://medipana.com/news/news_viewer.asp?NewsNum=257652&MainKind=A&NewsKind=5&vCount=12&vKind=1
3808,2020-05-29,대웅제약장건강에도움을주는건강기능식품은,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117696
3809,2020-05-29,대웅제약건강기능식품정보체험제공할퀴즈이벤트나서,http://news.mk.co.kr/newsRead.php?no=550470&year=2020
3810,2020-05-29,대웅제약잼라이브이벤트진행건강기능식품이름맞추기,http://sports.hankooki.com/lpage/economy/202005/sp20200529095910136980.htm?s_ref=nv
3811,2020-05-29,대웅제약잼라이브퀴즈이벤트진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244940
3812,2020-05-29,장건강에도움을주는건강기능식품은대웅제약잼라이브퀴즈이벤트진행,http://theviewers.co.kr/View.aspx?No=857828
3813,2020-05-29,장에좋은건강기능식품은대웅제약퀴즈쇼이벤트,http://news.mt.co.kr/mtview.php?no=2020052910193573150
3814,2020-05-29,대웅제약신풍제약희비엇갈려특히대웅제약가파른하락세로4하락,http://www.econonews.co.kr/news/articleView.html?idxno=122343
3815,2020-05-29,대웅제약장건강에도움주는건기식은,http://moneys.mt.co.kr/news/mwView.php?no=2020052910178017730
3816,2020-05-29,대웅제약소비자대상잼라이브이벤트진행,http://www.pressm.kr/news/articleView.html?idxno=30086
3817,2020-05-29,대웅제약건강기능식품6종잼라이브서퀴즈이벤트,http://www.kpinews.co.kr/news/articleView.html?idxno=117748
3818,2020-05-29,대웅제약잼라이브퀴즈이벤트진행,http://www.bosa.co.kr/news/articleView.html?idxno=2127745
3819,2020-05-29,대웅제약잼라이브이벤트진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61463
3820,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.businesskorea.co.kr/news/articleView.html?idxno=46638
3821,2020-05-29,11개제약사대웅제약올로스타제네릭우판권획득,http://medipana.com/news/news_viewer.asp?NewsNum=257664&MainKind=A&NewsKind=5&vCount=12&vKind=1
3822,2020-05-29,대웅제약잼라이브이벤트장건강에도움을주는건강기능식품진행,http://www.newslock.co.kr/news/articleView.html?idxno=28331
3823,2020-05-29,대웅제약잼라이브이벤트장건강에도움을주는건기식은,http://www.metroseoul.co.kr/article/20200529500086
3824,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.nbnnews.co.kr/news/articleView.html?idxno=396186
3825,2020-05-29,대웅제약잼라이브이벤트추진,http://www.g-enews.com/ko-kr/news/article/news_all/2020052913253954451638db705_1/article.html
3826,2020-05-29,대웅제약건강관련온라인퀴즈쇼이벤트진행,https://www.donga.com/news/article/all/20200529/101272473/1
3827,2020-05-29,대웅제약오는31일오후9시잼라이브이벤트진행,http://www.getnews.co.kr/view.php?ud=202005291335422362fe691f917_16
3828,2020-05-29,대웅제약잼라이브이벤트진행,http://www.lawissue.co.kr/view.php?ud=202005291354323528204ead0791_12
3829,2020-05-29,대웅제약잼라이브서건식체험이벤트진행,http://www.whosaeng.com/118217
3830,2020-05-29,뉴스투데이L대웅제약소비자대상잼라이브이벤트진행,https://www.news2day.co.kr/153652
3831,2020-05-29,대웅제약잼라이브이벤트진행장건강에도움을주는건기식은,http://www.mdtoday.co.kr/mdtoday/index.html?no=388309
3832,2020-05-29,대웅제약잼라이브이벤트진행,http://daily.hankooki.com/lpage/industry/202005/dh20200529155030148390.htm?s_ref=nv
3833,2020-05-29,대웅제약잼라이브진행장건강에도움을주는건강기능식품은,http://www.paxetv.com/news/articleView.html?idxno=93208
3834,2020-05-29,대웅제약잼라이브서건기식퀴즈이벤트열어,https://www.kpanews.co.kr/article/show.asp?idx=213589&category=D
3835,2020-05-30,650억원아리셉트국내허가권대웅제약서한독으로,http://www.dailypharm.com/Users/News/NewsView.html?ID=265072&REFERER=NP
3836,2020-05-31,대웅제약라이브퀴즈쇼잼라이브진행,http://www.dailymedi.com/detail.php?number=856647&thread=22r05
3837,2020-05-31,대웅휴온스할랄인증획득세계인구4분의1이슬람타깃,http://weekly.cnbnews.com/news/article.html?no=134201
3838,2020-05-31,대웅제약락피더스에너씨슬등잼라이브퀴즈이벤트,http://www.consumuch.com/news/articleView.html?idxno=48994
3839,2020-06-01,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.ybsn.tv/news/articleView.html?idxno=15097
3840,2020-06-01,대웅제약신풍제약모두지지부진대웅제약보합이어신풍제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=122708
3841,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈서최초선보여,http://www.pressm.kr/news/articleView.html?idxno=30118
3842,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,https://www.fetv.co.kr/news/article.html?no=55884
3843,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏와디즈서공개,http://www.press9.kr/news/articleView.html?idxno=44846
3844,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈서최초공개,http://www.getnews.co.kr/view.php?ud=2020060110063819062fe691f917_16
3845,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서최초공개,http://medipana.com/news/news_viewer.asp?NewsNum=257744&MainKind=A&NewsKind=5&vCount=12&vKind=1
3846,2020-06-01,대웅제약양치힘좋은칫솔덴티가드랩그립핏공개,http://news.mt.co.kr/mtview.php?no=2020060110070340265
3847,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈에서공개,http://www.cnbnews.com/news/article.html?no=448514
3848,2020-06-01,대웅제약와디즈서덴티가드랩그립핏칫솔공개,http://www.kpinews.co.kr/news/articleView.html?idxno=117825
3849,2020-06-01,대웅제약와디즈통해덴티가드랩그립핏칫솔펀딩나서,http://news.mk.co.kr/newsRead.php?no=558003&year=2020
3850,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈최초공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245023
3851,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서최초공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574629619919
3852,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏최초공개,http://www.m-i.kr/news/articleView.html?idxno=715487
3853,2020-06-01,대웅덴티가드랩그립핏칫솔와디즈서최초공개,http://www.mhj21.com/130866
3854,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://newsbrite.net/137614
3855,2020-06-01,오늘의장바구니롯데백화점현대그린푸드CJ오쇼핑대웅제약외,http://www.newsprime.co.kr/news/article.html?no=506170
3856,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=388478
3857,2020-06-01,신제품홍보도펀딩으로대웅제약덴트가드랩그립핏칫솔공개,http://weekly.hankooki.com/lpage/economy/202006/wk20200601111934146380.htm?s_ref=nv
3858,2020-06-01,대웅제약양치힘이좋은특허칫솔,http://www.g-enews.com/ko-kr/news/article/news_all/20200601112316789951638db705_1/article.html
3859,2020-06-01,상장제약1Q매출비RD비톱5이수앱지스엔지켐대웅메디톡스셀트리온,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=244928
3860,2020-06-01,대웅제약양치힘이좋은특허칫솔개발,http://www.bosa.co.kr/news/articleView.html?idxno=2127871
3861,2020-06-01,불용재고약반품잘해주는제약한미대웅일동순,http://www.dailypharm.com/Users/News/NewsView.html?ID=265104&REFERER=NP
3862,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈최초공개,http://www.viva100.com/main/view.php?key=20200601010000226
3863,2020-06-01,양치힘이남달라”대웅제약와디즈서덴티가드랩그립핏칫솔공개,http://www.asiatoday.co.kr/view.php?key=20200601010000530
3864,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.metroseoul.co.kr/article/20200601500260
3865,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서공개,http://www.whosaeng.com/118247
3866,2020-06-01,속보대웅제약부천소사구영업사원코로나19양성판정,http://moneys.mt.co.kr/news/mwView.php?no=2020060114198062269
3867,2020-06-01,대웅제약덴티가드랩그립핏칫솔와디즈서최초공개,http://www.dailysmart.co.kr/news/articleView.html?idxno=27468
3868,2020-06-01,대웅제약경인지점직원코로나19확진판정,http://www.press9.kr/news/articleView.html?idxno=44851
3869,2020-06-01,대웅제약부천영업사원코로나19확진쿠팡물류센터발아냐,http://moneys.mt.co.kr/news/mwView.php?no=2020060114288079217
3870,2020-06-01,뉴스투데이L대웅제약덴티가드랩그립핏칫솔와디즈에서최초공개,https://www.news2day.co.kr/153762
3871,2020-06-01,대웅영업사원코로나확진병원약국등수차례방문,https://www.paxnetnews.com/articles/61153
3872,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.nbnnews.co.kr/news/articleView.html?idxno=396636
3873,2020-06-01,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=224378
3874,2020-06-01,대웅제약영업사원코로나19확진1명추가확진가능성,http://www.viva100.com/main/view.php?key=20200601010000291
3875,2020-06-01,대웅제약부천지점영업사원코로나19확진,http://www.dt.co.kr/contents.html?article_no=2020060102109931102002&ref=naver
3876,2020-06-01,대웅제약특허칫솔덴티카드랩그립핏와디즈서공개,http://www.econovill.com/news/articleView.html?idxno=399002
3877,2020-06-01,대웅제약부천영업사원코로나19확진판정감염경로미확인,http://www.ajunews.com/view/20200601151220114
3878,2020-06-01,콜린알포급여재평가가동대웅바이오종근당등제약업계긴장,http://www.sisajournal-e.com/news/articleView.html?idxno=219147
3879,2020-06-01,대웅제약메디톡스보툴리눔균주공방이번주분수령,http://www.shinailbo.co.kr/news/articleView.html?idxno=1284554
3880,2020-06-01,대웅제약영업사원코로나19확진판정병의원불안감고조,http://www.medigatenews.com/news/2520834612
3881,2020-06-01,대웅제약영업사원코로나19확진영업소방역완료,http://www.dailypharm.com/Users/News/NewsView.html?ID=265127&REFERER=NP
3882,2020-06-01,대웅제약부천담당영맨코로나19확진,http://www.monews.co.kr/news/articleView.html?idxno=211110
3883,2020-06-01,대웅제약부천영업사원코로나19확진판정,http://www.newsway.co.kr/news/view?tp=1&ud=2020060116094563574
3884,2020-06-01,대웅제약영업사원코로나19확진자발생임직원들에입단속,http://www.wolyo.co.kr/news/articleView.html?idxno=105830
3885,2020-06-01,대웅제약덴티가드랩그립핏칫솔공개,http://www.lawissue.co.kr/view.php?ud=202006011623302945204ead0791_12
3886,2020-06-01,대웅제약영업사원코로나19확진영업인력첫사례,http://www.newstomato.com/ReadNews.aspx?no=975494
3887,2020-06-01,병의원코로나공포재점화대웅제약영업사원코로나19확진쿠팡과관계없어”,http://theviewers.co.kr/View.aspx?No=860151
3888,2020-06-01,대웅제약영업사원2명코로나19확진,http://www.newspim.com/news/view/20200601000994
3889,2020-06-01,대웅제약22일까지양치힘좋은덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.updownnews.co.kr/news/articleView.html?idxno=219371
3890,2020-06-01,대웅제약양치힘좋은특허칫솔덴티가드랩그립핏칫솔와디즈서최초공개,http://www.newslock.co.kr/news/articleView.html?idxno=28370
3891,2020-06-01,대웅제약영업사원코로나확진,https://www.ebn.co.kr/news/view/1436325?sc=Naver
3892,2020-06-01,제약사도뚫렸다대웅제약영업사원2명코로나19확진,http://news.heraldcorp.com/view.php?ud=20200601000940
3893,2020-06-01,대웅제약영업사원2인코로나19확진약국들르지않은듯,https://www.kpanews.co.kr/article/show.asp?idx=213618&category=D
3894,2020-06-01,대웅제약부천영업사원코로나19확진쿠팡근무자가족아냐,http://www.mediapen.com/news/view/529688
3895,2020-06-01,대웅제약양치힘좋은덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=46765
3896,2020-06-01,제약업계도코로나19엄습대웅제약영업사원코로나19확진,http://www.whitepaper.co.kr/news/articleView.html?idxno=194002
3897,2020-06-01,대웅제약영업사원코로나19확진거래처추가확진사례없어,http://www.asiatoday.co.kr/view.php?key=20200601010000797
3898,2020-06-01,대웅제약영업사원코로나19확진판정임직원들에함구령,http://www.newsfc.co.kr/news/articleView.html?idxno=41312
3899,2020-06-01,대웅제약양치힘이좋은특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.ybsn.tv/news/articleView.html?idxno=15274
3900,2020-06-02,메디톡스대웅제약보톡스분쟁이번주누구의주름살이펴질까,http://www.hankookilbo.com/news/npath/202006011571350424?did=NA
3901,2020-06-02,대기업매출액감소속종근당∙대웅제약∙셀트리온매출1조클럽진입,http://www.g-enews.com/ko-kr/news/article/news_all/202006020605097193a218188523_1/article.html
3902,2020-06-02,이번주결판메디톡스대웅제약누가승리할까,http://moneys.mt.co.kr/news/mwView.php?no=2020060208508030878
3903,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.getnews.co.kr/view.php?ud=2020060209462498432fe691f917_16
3904,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.press9.kr/news/articleView.html?idxno=44862
3905,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.viva100.com/main/view.php?key=20200602010000471
3906,2020-06-02,대웅제약발달장애인위한ACC그림카드기부대상기관모집,http://www.mhj21.com/130893
3907,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.youthdaily.co.kr/news/article.html?no=38682
3908,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,https://www.fetv.co.kr/news/article.html?no=56040
3909,2020-06-02,대웅제약발달장애인질병표현그림카드기부대상기관모집,http://news.mt.co.kr/mtview.php?no=2020060209500721228
3910,2020-06-02,대웅제약질병표현AAC카드기부대상기관모집,http://www.kpinews.co.kr/news/articleView.html?idxno=117947
3911,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.ekn.kr/news/article.html?no=502887
3912,2020-06-02,대웅제약질병표현AAC그림카드기부대상기관모집,http://www.koreastocknews.com/news/articleView.html?idxno=54117
3913,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.g-enews.com/ko-kr/news/article/news_all/20200602100417856551638db705_1/article.html
3914,2020-06-02,그림카드로아픈곳표현대웅제약발달장애인위한AAC그림카드기부신청기관모집,http://theviewers.co.kr/View.aspx?No=860507
3915,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://medipana.com/news/news_viewer.asp?NewsNum=257820&MainKind=A&NewsKind=5&vCount=12&vKind=1
3916,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://newsbrite.net/137649
3917,2020-06-02,대웅제약발달장애인AAC그림카드기부대상기관모집,https://www.paxnetnews.com/articles/61196
3918,2020-06-02,대웅제약신풍제약희비엇갈려대웅제약2상승반해신풍제약3하락,http://www.econonews.co.kr/news/articleView.html?idxno=122854
3919,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.m-i.kr/news/articleView.html?idxno=715897
3920,2020-06-02,종합신규16명2일경기도코로나19확진자총869명대웅제약관련확진자추가,http://digitalchosun.dizzo.com/site/data/html_dir/2020/06/02/2020060280072.html
3921,2020-06-02,대웅제약발달장애인위한AAC그림카드기부기관모집,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573837292432
3922,2020-06-02,대웅제약부천점영업사원코로나19확진지역감염의심,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574411463641
3923,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.metroseoul.co.kr/article/20200602500126
3924,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.cnbnews.com/news/article.html?no=448674
3925,2020-06-02,대웅장중반등세전일대비698외국인5795주순매수중,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006020168&t=NN
3926,2020-06-02,대웅제약전일대비583최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006020170&t=NN
3927,2020-06-02,대웅727상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/02/2020060201513.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3928,2020-06-02,대웅제약5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006021230L
3929,2020-06-02,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006021231L
3930,2020-06-02,대웅제약참지마요프로젝트발달장애인위한AAC그림카드기부대상기관모집,http://www.pressm.kr/news/articleView.html?idxno=30157
3931,2020-06-02,부천담당대웅제약영업사원코로나확진병원약국비상,https://www.news1.kr/articles/?3952534
3932,2020-06-02,대웅제약발달장애인 위한AAC그림카드기부 기관모집,http://www.economytalk.kr/news/articleView.html?idxno=206330
3933,2020-06-02,대웅제약참지마요프로젝트일환AAC그림카드기부대상기관모집,http://www.newsprime.co.kr/news/article.html?no=506341
3934,2020-06-02,대웅제약경인지역영업사원코로나19확진판정,http://www.wikileaks-kr.org/news/articleView.html?idxno=87857
3935,2020-06-02,대웅제약참지마요프로젝트보완대체의사소통카드지원받을기관모집나서,http://news.mk.co.kr/newsRead.php?no=562621&year=2020
3936,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.thepublic.kr/news/newsview.php?ncode=1065576837582848
3937,2020-06-02,확진영업사원동선숨기는대웅제약영업비밀,http://news.mt.co.kr/mtview.php?no=2020060211254752255
3938,2020-06-02,대웅제약발달장애인위한AAC그림카드제작기부,http://www.bosa.co.kr/news/articleView.html?idxno=2127960
3939,2020-06-02,뉴스투데이L대웅제약발달장애인위한AAC그림카드기부대상기관모집,https://www.news2day.co.kr/153831
3940,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.enewstoday.co.kr/news/articleView.html?idxno=1391134
3941,2020-06-02,대웅제약영업사원2명코로나19확진판정,https://www.sedaily.com/NewsView/1Z3VDKJZTW
3942,2020-06-02,美ITC메디톡스대웅예비최종판결모두한달연기,http://www.newsis.com/view/?id=NISX20200602_0001045207&cID=13001&pID=13000
3943,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61527
3944,2020-06-02,ITC대웅제약제출추가증거자료채택예비판결7월로연기,https://www.news1.kr/articles/?3952699
3945,2020-06-02,메디톡스대웅제약ITC판결다음달6일로연기,https://www.sedaily.com/NewsView/1Z3VDCC9N0
3946,2020-06-02,대웅제약발달장애인AAC그림카드기부대상기관모집,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245112
3947,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.wsobi.com/news/articleView.html?idxno=98617
3948,2020-06-02,대웅제약발달장애인위한의사소통그림카드기부대상기관모집,https://www.donga.com/news/article/all/20200602/101323359/1
3949,2020-06-02,대웅제약발달장애인위한질병표현그림카드기부기관모집,http://www.100ssd.co.kr/news/articleView.html?idxno=69130
3950,2020-06-02,美ITC메디톡스대웅제약예비판정내달6일로연기,https://www.paxnetnews.com/articles/61207
3951,2020-06-02,메디톡스대웅제약美ITC판결다음달6일로연기,https://www.fetv.co.kr/news/article.html?no=56065
3952,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.welfarenews.net/news/articleView.html?idxno=74015
3953,2020-06-02,美국제무역위원회대웅메디톡스예비판결내달6일로연기,http://www.viva100.com/main/view.php?key=20200602010000596
3954,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.nbnnews.co.kr/news/articleView.html?idxno=396840
3955,2020-06-02,메디톡스품목취소영향美ITC대웅제약소송연기,http://www.newspim.com/news/view/20200602000656
3956,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://moneys.mt.co.kr/news/mwView.php?no=2020060211538070945
3957,2020-06-02,대웅제약발달장애인AAC그림카드기부대상기관모집,http://www.asiatoday.co.kr/view.php?key=20200602010001335
3958,2020-06-02,메디톡스대웅제약운명의날내달로연기7월6일결착,https://www.hankyung.com/it/article/2020060215026
3959,2020-06-02,메디톡스대웅제약ITC판결한달연기,http://www.edaily.co.kr/news/newspath.asp?newsid=03034006625797784
3960,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://sports.hankooki.com/lpage/economy/202006/sp20200602141558136980.htm?s_ref=nv
3961,2020-06-02,대웅제약메디톡스운명의날한달연기식약처결정주목,http://www.upinews.kr/newsView/upi202006020067
3962,2020-06-02,대웅제약사회공헌참지마요프로젝트진행,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=224428
3963,2020-06-02,대웅제약메디톡스ITC소송예비판결내달로연기,http://medipana.com/news/news_viewer.asp?NewsNum=257846&MainKind=A&NewsKind=5&vCount=12&vKind=1
3964,2020-06-02,대웅제약영업사원코로나19확진판정,http://www.seoulfn.com/news/articleView.html?idxno=384546
3965,2020-06-02,대웅주가와거래량모두강세최근5거래일최고거래량돌파,https://www.tfmedia.co.kr/news/article.html?no=85733
3966,2020-06-02,미국대웅메디톡스소송돌연연기중간결과7월최종판결11월,http://www.medigatenews.com/news/1999935913
3967,2020-06-02,대웅843VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/02/2020060202451.html?utm_source=naver&utm_medium=original&utm_campaign=biz
3968,2020-06-02,대웅vs메디톡스ITC판결한달연기,http://www.whosaeng.com/118298
3969,2020-06-02,메디톡스대웅제약ITC판결한달연기,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020060214405937051
3970,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.updownnews.co.kr/news/articleView.html?idxno=219425
3971,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.dailysmart.co.kr/news/articleView.html?idxno=27551
3972,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,https://www.kpanews.co.kr/article/show.asp?idx=213659&category=D
3973,2020-06-02,대웅발달장애인AAC그림카드기부대상기관모집,http://www.dailymedi.com/detail.php?number=856729&thread=22r05
3974,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.mediapen.com/news/view/529957
3975,2020-06-02,메디톡스대웅제약美ITC균주분쟁예비판결한달연기,http://it.chosun.com/site/data/html_dir/2020/06/02/2020060202736.html
3976,2020-06-02,메디톡스대웅제약美ITC예비판결다음달6일로연기,http://www.asiatoday.co.kr/view.php?key=20200602010001435
3977,2020-06-02,대웅제약AAC그림카드기부대상모집,http://www.seoulfn.com/news/articleView.html?idxno=384550
3978,2020-06-02,대웅제약메디톡스ITC판결1달연기,http://www.econovill.com/news/articleView.html?idxno=399197
3979,2020-06-02,제약사도뚫렸다”대웅제약영업사원2명코로나19확진,https://www.fetv.co.kr/news/article.html?no=56085
3980,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.newslock.co.kr/news/articleView.html?idxno=28419
3981,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.sportsseoul.com/news/read/922576?ref=naver
3982,2020-06-02,끝날듯말듯메디톡스대웅제약보톡스전쟁ITC예비판결한달연기,http://theviewers.co.kr/View.aspx?No=861227
3983,2020-06-02,대웅제약vs메디톡스ITC예비판결일7월6일로연기,http://news.mt.co.kr/mtview.php?no=2020060216292011444
3984,2020-06-02,대웅제약전승호vs메디톡스정현호ITC전쟁최후의승자는,https://www.fetv.co.kr/news/article.html?no=56092
3985,2020-06-02,ITC대웅제약메디톡스분쟁예비판결돌연한달연기,https://www.sedaily.com/NewsView/1Z3VE2MU4N
3986,2020-06-02,운명의날한달연기승소확신하는대웅메디톡스,http://health.chosun.com/site/data/html_dir/2020/06/02/2020060203180.html
3987,2020-06-02,대웅확진자2명외전원음성추가감염우려덜어,http://www.dailypharm.com/Users/News/NewsView.html?ID=265200&REFERER=NP
3988,2020-06-02,대웅제약메디톡스ITC예비판결일한달연기,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006020379&t=NN
3989,2020-06-02,메디톡스vs대웅제약보톡스분쟁한달연기,http://moneys.mt.co.kr/news/mwView.php?no=2020060217198067698
3990,2020-06-02,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.thefirstmedia.net/news/articleView.html?idxno=58848
3991,2020-06-02,메디톡스대웅제약보툴리눔균주분쟁ITC예비판정한달연기,http://yna.kr/AKR20200602164500017?did=1195m
3992,2020-06-02,메디톡스대웅제약보툴리눔균주분쟁ITC예비판정연기,http://www.ekn.kr/news/article.html?no=503042
3993,2020-06-02,대웅제약치매치료제공백을편의성높인새치료제개발로만회힘써,http://www.businesspost.co.kr/BP?command=article_view&num=180999
3994,2020-06-02,부천지역대웅제약영업사원2명코로나19확진,http://inthenews.co.kr/article-51879/
3995,2020-06-02,보톡스균주공방메디톡스대웅제약美ITC예비판결한달연기,https://cnbc.sbs.co.kr/article_hub/10000985075?division=NAVER
3996,2020-06-02,ITC메디톡스대웅제약분쟁예비판정11월로연기,http://www.kukinews.com/news/article.html?no=794629
3997,2020-06-02,보툴리눔균주분쟁메디톡스대웅제약ITC예비판정한달연기,http://www.newsway.co.kr/news/view?tp=1&ud=2020060219222835725
3998,2020-06-02,글로벌Biz24美ITC메디톡스대웅제약보툴리눔균주분쟁예비판정연기,http://www.g-enews.com/ko-kr/news/article/news_all/202006021920346911e8b8a793f7_1/article.html
3999,2020-06-02,메디톡스대웅제약ITC예비판정한달연기,http://www.hankookilbo.com/news/npath/202006021918084781?did=NA
4000,2020-06-02,메디톡스대웅제약균주전쟁ITC예비판정한달연기,https://www.dailian.co.kr/news/view/894503?sc=Naver
4001,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.lawissue.co.kr/view.php?ud=202006021939122803204ead0791_12
4002,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=388717
4003,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.betanews.net:8080/article/1186348.html
4004,2020-06-02,대웅제약메디톡스균주분쟁의미국국제무역위예비판결7월로연기,http://www.businesspost.co.kr/BP?command=article_view&num=181015
4005,2020-06-02,메디톡스대웅제약ITC예비판정한달연기,http://www.cstimes.com/news/articleView.html?idxno=416373
4006,2020-06-02,데일리안오늘뉴스종합메디톡스대웅제약균주전쟁ITC예비판정한달연기수도권개척교회집단감염확산등,https://www.dailian.co.kr/news/view/894505?sc=Naver
4007,2020-06-02,대웅제약발달장애인위한AAC그림카드기부대상기관모집,http://www.econovill.com/news/articleView.html?idxno=399263
4008,2020-06-02,대웅제약특허칫솔덴티가드랩그립핏칫솔와디즈에서최초공개,http://www.thefirstmedia.net/news/articleView.html?idxno=58874
4009,2020-06-03,대웅제약잼라이브이벤트진행장건강에도움을주는건강기능식품은,http://www.thefirstmedia.net/news/articleView.html?idxno=58893
4010,2020-06-03,대웅제약발달장애인을위한AAC그림카드기부대상기관모집,http://www.ybsn.tv/news/articleView.html?idxno=15465
4011,2020-06-03,메디톡스대웅제약ITC예비판정한달연기,http://www.seoulfn.com/news/articleView.html?idxno=384599
4012,2020-06-03,대웅제약영업사원2명코로나19확진영업소잠정폐쇄”,http://www.mdtoday.co.kr/mdtoday/index.html?no=388688
4013,2020-06-03,메디톡스대웅제약美ITC판결한달연기,http://www.mdtoday.co.kr/mdtoday/index.html?no=388683
4014,2020-06-03,대웅제약ITC소송유리한입지가능성↑KTB투자증권,http://www.fnnews.com/news/202006030828115377
4015,2020-06-03,리포트브리핑대웅제약ITC소송이슈에연연할필요가없는주가목표가170000원KTB투자증권,http://www.newspim.com/news/view/20200603000118
4016,2020-06-03,메디톡스대웅제약보툴리눔균주분쟁ITC예비판정한달연기,http://www.fntoday.co.kr/news/articleView.html?idxno=219073
4017,2020-06-03,대웅제약ITC소송서유리한입지설가능성커KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=02010646625798112
4018,2020-06-03,메디톡스대웅제약ITC예비판결내달로연기,https://www.ebn.co.kr/news/view/1436591?sc=Naver
4019,2020-06-03,대웅5이상상승COVID테마보다는본연의기업가치가매력적KTB투자증권BUY신규,https://www.hankyung.com/finance/article/202006034971L
4020,2020-06-03,부천30대확진자대웅제약영업사원동선접촉자파악주력,https://www.seoul.co.kr/news/newsView.php?id=20200603500027&wlog_tag3=naver
4021,2020-06-03,부천시장대웅제약영업사원증상발현이후5곳다녔다”,http://www.kukinews.com/news/article.html?no=794790
4022,2020-06-03,대웅제약영업사원2명코로나19확진경인지점폐쇄,https://www.sisa-news.com/news/article.html?no=126808
4023,2020-06-03,비즈헬스대웅제약보툴리눔톡신균주전쟁굳히기들어가,http://www.bizwnews.com/news/articleView.html?idxno=13782
4024,2020-06-03,부천30대대웅제약영업사원코로나19확진병원약국비상,http://www.pinpointnews.co.kr/view.php?ud=2020060313294499822365609d9b_45
4025,2020-06-03,부천코로나19확진자누구대웅제약경인사무소30대남성,http://www.g-enews.com/ko-kr/news/article/news_all/202006031328532404e4869c120_1/article.html
4026,2020-06-03,대웅제약부천지역영업사원코로나19확진판정사내입단속논란,http://www.datasom.co.kr/news/articleView.html?idxno=106327
4027,2020-06-03,美ITC대웅제약메디톡스보톡스소송예비판결내달로연기,http://www.newsian.co.kr/news/articleView.html?idxno=41756
4028,2020-06-03,코로나19확진대웅제약부천담당영업사원병원약국5곳방문,https://www.news1.kr/articles/?3954468
4029,2020-06-03,대웅제약코로나19확진영업사원2명으로늘어,http://www.mediapen.com/news/view/530283
4030,2020-06-03,코로나19확진대웅제약부천담당영업사원5명접촉동선공개,https://www.news1.kr/articles/?3954704
4031,2020-06-04,메디톡스지금이라도염기서열공개”vs대웅최종판결까지가보자”,http://daily.hankooki.com/lpage/industry/202006/dh20200604070004148390.htm?s_ref=nv
4032,2020-06-04,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006049500L
4033,2020-06-04,통계로보는경제제약업계코로나19영향은셀트리온종근당한미↑유한대웅↓,http://weekly.cnbnews.com/news/article.html?no=134262
4034,2020-06-04,대웅737상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/04/2020060402228.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4035,2020-06-04,메디톡스대웅제약ITC판결놓고동상이몽,https://www.ebn.co.kr/news/view/1436860?sc=Naver
4036,2020-06-04,이인애의뒷담화메디톡스대웅제약진흙탕균주싸움5년째2배비싼외국보톡스만맞아야하나,http://theviewers.co.kr/View.aspx?No=863843
4037,2020-06-05,시황분석대웅제약전일대비5상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006050955034006edd30cbc4a_45
4038,2020-06-05,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006054176L
4039,2020-06-05,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006054198L
4040,2020-06-05,대웅제약전일대비50상승중최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006050132&t=NN
4041,2020-06-05,대웅전일대비509상승이시각거래량44만1464주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006050136&t=NN
4042,2020-06-05,대웅840상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501388.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4043,2020-06-05,특징주대웅20850원5일10시30분등락률611,http://www.getnews.co.kr/view.php?ud=202006051031591698c20b949a59_16
4044,2020-06-05,특징주대웅제약117000원5일10시45분등락률636,http://www.getnews.co.kr/view.php?ud=202006051046551702c20b962611_16
4045,2020-06-05,fnRASSI대웅003090현재916↑,http://www.fnnews.com/news/202006051103037482
4046,2020-06-05,대웅1094VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501683.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4047,2020-06-05,대웅제약818상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501863.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4048,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.getnews.co.kr/view.php?ud=2020060511450074342fe691f917_16
4049,2020-06-05,대웅132352주신고가,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501884.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4050,2020-06-05,대웅제약코로나19치료제동물효능시험효과확인,http://www.consumuch.com/news/articleView.html?idxno=49125
4051,2020-06-05,대웅52주신고가경신단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006054946L
4052,2020-06-05,대웅그룹니클로사마이드코로나19치료효과입증,http://www.ekn.kr/news/article.html?no=503656
4053,2020-06-05,대웅그룹개발코로나19치료제치료효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2128214
4054,2020-06-05,대웅그룹니클로사마이드의코로나19치료효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61593
4055,2020-06-05,대웅제약1182VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501909.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4056,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.fnnews.com/news/202006051155580977
4057,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.youthdaily.co.kr/news/article.html?no=39015
4058,2020-06-05,특징주대웅제약동물효력시험서코로나19치료효과입증급등,https://view.asiae.co.kr/article/2020060512012536637
4059,2020-06-05,대웅제약니클로사마이드코로나19동물효력시험성공적,http://moneys.mt.co.kr/news/mwView.php?no=2020060511468016440
4060,2020-06-05,시황분석대웅전일대비2239상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006051202054566edd302c902_45
4061,2020-06-05,특징주대웅제약대웅니클로사마이드코로나19동물임상서완전사멸강세,https://www.etoday.co.kr/news/view/1902910
4062,2020-06-05,대웅2977상한가,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501932.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4063,2020-06-05,특징주대웅제약코로나19치료제바이러스완전제거확인급등,http://www.edaily.co.kr/news/newspath.asp?newsid=02394406625798768
4064,2020-06-05,대웅주가2824상승중최근5거래일최고거래량돌파,https://www.tfmedia.co.kr/news/article.html?no=85948
4065,2020-06-05,이시각상한가대웅▲58505일오후12시4분,https://www.etoday.co.kr/news/view/1902911
4066,2020-06-05,대웅그룹코로나치료제동물시험서효과연내임상완료,http://www.newsis.com/view/?id=NISX20200605_0001049577&cID=13001&pID=13000
4067,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=47052
4068,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060501973.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4069,2020-06-05,대웅상한가↑도달단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006055031L
4070,2020-06-05,대웅그룹코로나치료제동물시험효과연내임상완료,http://www.g-enews.com/ko-kr/news/article/news_all/202006051214401692a218188523_1/article.html
4071,2020-06-05,대웅니클로사마이드전임상서코로나19효과,http://www.dailypharm.com/Users/News/NewsView.html?ID=265318&REFERER=NP
4072,2020-06-05,대웅제약니클로사마이드코로나19치료효과입증,http://news.mk.co.kr/newsRead.php?no=577143&year=2020
4073,2020-06-05,대웅그룹코로나19치료제니클로사마이드동물시험효과확인,http://news.mt.co.kr/mtview.php?no=2020060512182557660
4074,2020-06-05,대웅그룹코로나치료제동물시험서효과연내임상완료,http://www.topstarnews.net/news/articleView.html?idxno=798737
4075,2020-06-05,대웅그룹니클로사마이드동물효력시험코로나19치료효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245259
4076,2020-06-05,코로나19제약주폭등일양약품SK바이오랜드아이센스진매트리스대웅제약동화약품종목이화제폭발,http://www.g-enews.com/ko-kr/news/article/news_all/20200605121900156451638db705_1/article.html
4077,2020-06-05,대웅그룹동물효력시험통해코로나19치료효과입증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020060512375715108
4078,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.ceoscoredaily.com/news/article.html?no=70215
4079,2020-06-05,니클로사마이드효과입증대웅주가↑나파모스타트카모스타트도관심,http://www.getnews.co.kr/view.php?ud=2020060512491683492fe691f917_16
4080,2020-06-05,대웅그룹코로나19치료제동물실험서효과입증,http://it.chosun.com/site/data/html_dir/2020/06/05/2020060502080.html
4081,2020-06-05,코로나19치료제효과대웅대웅제약주가급등,http://news.mt.co.kr/mtview.php?no=2020060512581253425
4082,2020-06-05,대웅테라퓨틱스니클로사마이드코로나19치료효과입증,http://www.press9.kr/news/articleView.html?idxno=44907
4083,2020-06-05,대웅제약대웅테라퓨틱스동물효능시험서코로나19치료제효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=389028
4084,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020060513141566570
4085,2020-06-05,대웅제약코로나19치료제후보물질동물실험서효과,http://yna.kr/AKR20200605080700017?did=1195m
4086,2020-06-05,특징주대웅대웅제약동물시험서코로나19치료제효과입증에급등,http://moneys.mt.co.kr/news/mwView.php?no=2020060513108065494
4087,2020-06-05,대웅제약대웅대웅테라퓨틱스코로나치료제효과확인에급등,http://www.koreastocknews.com/news/articleView.html?idxno=54244
4088,2020-06-05,대웅제약보톡스보툴리눔톡신테마상승세에2273↑,https://view.asiae.co.kr/article/2020060513261976628
4089,2020-06-05,특징주대웅주가니클로사마이드코로나19효과에급등,http://www.anewsa.com/detail.php?number=2142399&thread=18
4090,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.medigatenews.com/news/1051484738
4091,2020-06-05,대웅제약일양약품제약주갑작스런급등대웅제약24급등이어일양약품17급등,http://www.econonews.co.kr/news/articleView.html?idxno=123300
4092,2020-06-05,대웅그룹니클로사마이드동물효력시험코로나19치료효과입증,http://www.newsprime.co.kr/news/article.html?no=506874
4093,2020-06-05,대웅제약코로나19치료후보물질동물실험효과,https://www.sedaily.com/NewsView/1Z3WQMHKR0
4094,2020-06-05,대웅제약코로나19치료제후보물질동물시험서항바이러스효과확인,http://news.kbiz.or.kr/news/articleView.html?idxno=68258
4095,2020-06-05,조아제약이어대웅제약제약주낮부터갑작스런급등대웅제약25급등이어조아제약역시13급등,http://www.econonews.co.kr/news/articleView.html?idxno=123303
4096,2020-06-05,대웅니클로사마이드전임상서코로나치료효과,https://www.ebn.co.kr/news/view/1437042?sc=Naver
4097,2020-06-05,대웅니클로사마이드동물실험서코로나19치료효과확인,http://www.mediapen.com/news/view/530744
4098,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.newstomato.com/ReadNews.aspx?no=976403
4099,2020-06-05,SR제약바이오대웅테라퓨틱스코로나19치료제효능확인,http://www.srtimes.kr/news/articleView.html?idxno=63904
4100,2020-06-05,대웅그룹니클로사마이드코로나19치료효과입증결과발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1391976
4101,2020-06-05,대웅제약니클로사마이드에코로나19치료효과동물시험통해효력입증,http://www.startuptoday.co.kr/news/articleView.html?idxno=43387
4102,2020-06-05,대웅제약코로나19치료제동물시험서효과확인,http://www.newspim.com/news/view/20200605000563
4103,2020-06-05,대웅제약니클로사마이드동물효능시험서코로나19바이러스감소,http://news.mk.co.kr/newsRead.php?no=577644&year=2020
4104,2020-06-05,대웅그룹니클로사마이드동물시험으로코로나19치료효과입증,https://www.fetv.co.kr/news/article.html?no=56342
4105,2020-06-05,대웅그룹코로나19치료제동물시험서효과확인,http://www.asiatoday.co.kr/view.php?key=20200605010003505
4106,2020-06-05,코로나치료효능뚜렷확신대세상승파미셀씨젠에서대웅제약대웅으로옮겨붙나,http://www.thekpm.com/view.php?ud=202006051403008258861beb2d9d_17
4107,2020-06-05,대웅대웅제약주가장중급등코로나19치료제동물실험효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=181486
4108,2020-06-05,포털검색상위종목삼성전자대웅제약드림텍대웅조아제약투자자들관심증가,http://www.g-enews.com/ko-kr/news/article/news_all/202006051404044511edf69f862c_1/article.html
4109,2020-06-05,대웅그룹니클로사마이드코로나19치료효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=258035&MainKind=A&NewsKind=5&vCount=12&vKind=1
4110,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.greened.kr/news/articleView.html?idxno=254882
4111,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=397731
4112,2020-06-05,대웅제약코로나치료제동물시험진행,https://www.paxnetnews.com/articles/61353
4113,2020-06-05,강세토픽2020년임상예정제약바이오테마대웅제약2500앱클론718,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060502388.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4114,2020-06-05,대웅그룹DWRX2003동물실험서코로나19치료효과입증,https://www.asiatime.co.kr/news/newsview.php?ncode=1065586395135622
4115,2020-06-05,머니e종목대웅제약대웅코로나19치료제효능입증성공에급등,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020060514220949722
4116,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://newsbrite.net/137828
4117,2020-06-05,대웅제약족제비대상임상서코로나바이러스감소확인,http://www.kpinews.co.kr/news/articleView.html?idxno=118283
4118,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.lawissue.co.kr/view.php?ud=202006051429221562204ead0791_12
4119,2020-06-05,대웅니클로사마이드동물시험서코로나19치료효과입증,http://www.econovill.com/news/articleView.html?idxno=399743
4120,2020-06-05,충북코스피제약업종유유제약4대상승수익률창출대웅도2977↑,http://nbntv.co.kr/news/view/869445
4121,2020-06-05,대웅그룹구충제니클로사마이드코로나19동물실험서효과,https://www.news1.kr/articles/?3956467
4122,2020-06-05,시황네이버증권검색상위종목30위시황대웅대웅제약드림텍조아제약일양약품급등,http://www.topstarnews.net/news/articleView.html?idxno=798852
4123,2020-06-05,대웅제약코로나19치료제후보물질동물실험서효과보여,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003998446
4124,2020-06-05,대웅제약니클로사마이드동물실험서3일째부터코로나19바이러스완전제거확인”,https://jhealthmedia.joins.com/article/article_view.asp?pno=21915
4125,2020-06-05,대웅제약3000상한가,https://biz.chosun.com/site/data/html_dir/2020/06/05/2020060502537.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4126,2020-06-05,포스트코로나대웅그룹니클로사마이드동물시험서코로나19치료효과입증,http://www.etnews.com/20200605000147
4127,2020-06-05,이시각상한가대웅제약▲330005일오후14시46분,https://www.etoday.co.kr/news/view/1902997
4128,2020-06-05,대웅제약상한가↑도달ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006055566L
4129,2020-06-05,대웅그룹니클로사마이드코로나19동물효력시험치료효과확인,http://www.insightkorea.co.kr/news/articleView.html?idxno=80437
4130,2020-06-05,대웅구충제성분코로나치료제동물실험효과,https://news.chosun.com/site/data/html_dir/2020/06/05/2020060502393.html?utm_source=naver&utm_medium=original&utm_campaign=news
4131,2020-06-05,구충제가옳았다”대웅제약동물시험통해니클로사마이드코로나19치료효과입증,https://www.donga.com/news/article/all/20200605/101380300/1
4132,2020-06-05,fnRASSI대웅제약상한가기록,http://www.fnnews.com/news/202006051513419589
4133,2020-06-05,대웅제약니클로사마이드코로나19치료효과입증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4174786
4134,2020-06-05,시황보톡스보툴리눔톡신테마주대웅제약급등제테마휴젤상승,http://www.topstarnews.net/news/articleView.html?idxno=798892
4135,2020-06-05,대웅제약코로나19치료제개발순항주가고공행진,http://sports.hankooki.com/lpage/economy/202006/sp20200605151546137020.htm?s_ref=nv
4136,2020-06-05,시황바이오시밀러복제바이오의약품테마주대웅제약상한가알테오젠급등한미약품LG화학셀트리온녹십자상승,http://www.topstarnews.net/news/articleView.html?idxno=798903
4137,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.segye.com/content/html/2020/06/05/20200605509779.html?OutUrl=naver
4138,2020-06-05,대웅제약니클로사마이드전임상서바이러스완전제거효과,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=117941
4139,2020-06-05,시황제약업체테마주대웅제약상한가동화약품일양약품조아제약급등,http://www.topstarnews.net/news/articleView.html?idxno=798909
4140,2020-06-05,대웅제약코로나19치료제후보물질동물실험서효과,http://www.seoulfn.com/news/articleView.html?idxno=384967
4141,2020-06-05,fnRASSI오늘의상한가대웅제약300↑,http://www.fnnews.com/news/202006051537514570
4142,2020-06-05,fnRASSI장마감거래소상승종목대웅제약300↑,http://www.fnnews.com/news/202006051537575015
4143,2020-06-05,대웅그룹니클로사마이드동물서코로나19효과입증,https://www.hankyung.com/finance/article/2020060558296
4144,2020-06-05,대웅니클로사마이드동물시험서코로나19치료효과,http://www.dailymedi.com/detail.php?number=856854&thread=22r05
4145,2020-06-05,대웅제약코로나19치료제동물실험효과,http://www.thevaluenews.co.kr/news/view.php?idx=159669
4146,2020-06-05,특징주대웅제약코로나치료제동물실험효과에상한가,http://yna.kr/AKR20200605120300002?did=1195m
4147,2020-06-05,대웅그룹니클로사마이드동물실험서코로나19치료효과,http://www.wikileaks-kr.org/news/articleView.html?idxno=88273
4148,2020-06-05,페럿시험서항바이러스효과확인대웅그룹니클로사마이드코로나19치료효과입증,http://www.newswatch.kr/news/articleView.html?idxno=30455
4149,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,https://www.dailian.co.kr/news/view/895446?sc=Naver
4150,2020-06-05,대웅제약코로나19치료제동물실험효과확인,http://www.dailysmart.co.kr/news/articleView.html?idxno=27803
4151,2020-06-05,대웅그룹코로나19치료제DWRX2003효과입증,https://www.news2day.co.kr/154105
4152,2020-06-05,대웅제약코로나19치료제동물실험효과에상한가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4174890
4153,2020-06-05,대웅제약코로나19치료용물질동물시험서효과입증,http://www.100ssd.co.kr/news/articleView.html?idxno=69206
4154,2020-06-05,구충제코로나치료제로개발대웅니클로사마이드치료효과확인,http://www.viva100.com/main/view.php?key=20200605010001500
4155,2020-06-05,대웅제약코로나치료제동물실험효과상한가,https://www.etoday.co.kr/news/view/1903056
4156,2020-06-05,급등락주짚어보기코로나19치료제개발기대감대웅제약동화약품일양약품급등,https://www.etoday.co.kr/news/view/1903058
4157,2020-06-05,대웅제약코로나19치료제동물효능시험성공,http://weekly.hankooki.com/lpage/economy/202006/wk20200605162413146380.htm?s_ref=nv
4158,2020-06-05,단독ITC재판부대웅제약추가자료연관성있다고판단,http://www.newsis.com/view/?id=NISX20200605_0001050009&cID=13001&pID=13000
4159,2020-06-05,충북코스닥제약업종신일제약02↑수익률은마이너스대웅도2977↑,http://nbntv.co.kr/news/view/869486
4160,2020-06-05,특징주대웅제약코로나19치료제동물실험효과에상한가,http://www.kukinews.com/news/article.html?no=795873
4161,2020-06-05,충북코스닥제약업종옵티팜25대폭등수익률기대대웅도2977↑,http://nbntv.co.kr/news/view/869469
4162,2020-06-05,충북코스닥제약업종셀트리온제약06↓수익률은UP대웅은2977↑,http://nbntv.co.kr/news/view/869475
4163,2020-06-05,충북코스닥제약업종서울제약1대상승수익률양호대웅도2977↑,http://nbntv.co.kr/news/view/869470
4164,2020-06-05,충북코스닥제약업종바이온1대상승수익률건전대웅도2977↑,http://nbntv.co.kr/news/view/869485
4165,2020-06-05,충북코스닥제약업종노바렉스수익률은건전대웅은2977↑,http://nbntv.co.kr/news/view/869494
4166,2020-06-05,충북코스닥제약업종디에이치피코리아5대폭등수익률창출대웅도2977↑,http://nbntv.co.kr/news/view/869499
4167,2020-06-05,대웅제약주가30상승무슨일이,http://www.anewsa.com/detail.php?number=2142555&thread=09
4168,2020-06-05,충북코스닥제약업종넥스트BT04↑수익률쑥쑥대웅도2977↑,http://nbntv.co.kr/news/view/869505
4169,2020-06-05,충북코스닥제약업종엔지켐생명과학1대상승수익률건전대웅도2977↑,http://nbntv.co.kr/news/view/869510
4170,2020-06-05,충북코스닥제약업종하이텍팜1대상승수익률창출대웅도2977↑,http://nbntv.co.kr/news/view/869497
4171,2020-06-05,특징주대웅제약코로나19치료제동물실험효과에상승,http://www.youthdaily.co.kr/news/article.html?no=39051
4172,2020-06-05,대웅그룹코로나19치료제후보물질니클로사마이드동물효력시험통해효과입증,http://www.paxetv.com/news/articleView.html?idxno=93689
4173,2020-06-05,대웅제약지주회사대웅코로나치료제동물실험효과에상한가,http://www.newsfc.co.kr/news/articleView.html?idxno=41367
4174,2020-06-05,대웅그룹니클로사마이드동물효력시험진행코로나19치료효과입증,http://www.pressm.kr/news/articleView.html?idxno=30299
4175,2020-06-05,대웅니클로사마이드동물시험코로나19치료효과입증,http://www.upinews.kr/newsView/upi202006050073
4176,2020-06-05,김창수의e뉴스브리핑대웅그룹니클로사마이드동물시험으로코로나19치료효과입증外,https://www.fetv.co.kr/news/article.html?no=56375
4177,2020-06-05,5일금요일특징주는삼성전자대웅제약셀트리온,http://www.leaders.kr/news/articleView.html?idxno=200825
4178,2020-06-05,대웅니클로사마이드동물시험서코로나19효과입증,http://www.monews.co.kr/news/articleView.html?idxno=211233
4179,2020-06-05,팩트체크대웅제약코로나확진판정직원내부입단속의혹사측사실무근,http://www.startuptoday.co.kr/news/articleView.html?idxno=43235
4180,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.joseilbo.com/news/news_read.php?uid=399588&class=27&grp=
4181,2020-06-05,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=58997
4182,2020-06-05,주식대웅제약2409코로나19치료제소식에주가폭등관련내용은,http://www.ggilbo.com/news/articleView.html?idxno=774032
4183,2020-06-05,대웅그룹니클로사마이드코로나19동물실험치료효과,https://www.cjb.co.kr/home/sub.php?menukey=61&mod=view&P_NO=200605010&PRO_CODE=4
4184,2020-06-06,마감대웅제약코로나19치료제동물에효과상한가일양약품러시아임상기대급등,https://www.asiatime.co.kr/news/newsview.php?ncode=1065624948254534
4185,2020-06-06,메디톡스대웅제약보톡스전쟁에ITC예비판정한달연기,https://www.nocutnews.co.kr/news/5356524
4186,2020-06-06,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.thepublic.kr/news/newsview.php?ncode=1065597361029741
4187,2020-06-06,대웅제약동화약품호재발표에상승장더해져상한가기록,http://medipana.com/news/news_viewer.asp?NewsNum=258049&MainKind=A&NewsKind=5&vCount=12&vKind=1
4188,2020-06-06,대웅제약니클로사마이드동물효력시험통해코로나19치료효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=28522
4189,2020-06-06,6일토요일10시현재특징주는대웅제약삼성전자셀트리온,http://www.leaders.kr/news/articleView.html?idxno=200852
4190,2020-06-06,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=224561
4191,2020-06-06,대웅그룹니클로사마이드동물효력시험코로나19치료효과입증,http://www.koreaittimes.com/news/articleView.html?idxno=98023
4192,2020-06-06,시황6월5일네이버증권검색상위종목30위장마감시황삼성전자대웅제약SK텔레콤삼성전자우카카오등상황은,http://www.topstarnews.net/news/articleView.html?idxno=799330
4193,2020-06-06,기업분석코로나19치료제로상한가친대웅대웅제약어떤회사,http://www.g-enews.com/ko-kr/news/article/news_all/202006061357004712c5557f8da8_1/article.html
4194,2020-06-07,대웅니클로사마이드동물실험에서코로나19치료효과입증,http://weekly.cnbnews.com/news/article.html?no=134320
4195,2020-06-07,대웅그룹니클로사마이드동물효력시험서코로나19항바이러스효과입증,http://www.m-i.kr/news/articleView.html?idxno=717387
4196,2020-06-07,7일일요일10시현재특징주는삼성전자대웅제약셀트리온,http://www.leaders.kr/news/articleView.html?idxno=200890
4197,2020-06-07,대웅그룹니클로사마이드동물시험으로코로나19치료효과입증,http://www.metroseoul.co.kr/article/20200607500154
4198,2020-06-07,시황6월5일바이오시밀러복제바이오의약품테마주장마감시황대웅제약알테오젠한미약품LG화학셀트리온등상황은,http://www.topstarnews.net/news/articleView.html?idxno=799811
4199,2020-06-07,시황6월5일제약업체테마주의장마감시황대웅제약동화약품일양약품조아제약KPX생명과학등상황은,http://www.topstarnews.net/news/articleView.html?idxno=799818
4200,2020-06-07,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.segyebiz.com/newsView/20200607505577?OutUrl=naver
4201,2020-06-07,코로나치료제개발가속화상한가동화약품대웅제약급등일양약품부광약품,http://www.ggilbo.com/news/articleView.html?idxno=774346
4202,2020-06-07,이주의주식흐름은조선업철강업대박셀트리온급등일본불매관련주관심집중에대웅제약등제약주상한가,http://www.ggilbo.com/news/articleView.html?idxno=774373
4203,2020-06-08,자정택배뉴스한국인정서에딱맞는제약주정신없이뜀박질일양약품동화제약대웅제약JW중외제약조아제약셀트리온꼭짓점은,http://www.g-enews.com/ko-kr/news/article/news_all/20200607185735163951638db705_1/article.html
4204,2020-06-08,제약바이오주덜커덩수출424↓씨젠셀트리온대웅제약메디톡스파미셀SK케미칼바이오랜드2차폭발,http://www.g-enews.com/ko-kr/news/article/news_all/202006080448227634a01bf698f_1/article.html
4205,2020-06-08,6월바이오제약상승률상위종목은엘앤케이바이오셀트리온제약대웅제약동화약품순,http://www.g-enews.com/ko-kr/news/article/news_all/202006080608172947edf69f862c_1/article.html
4206,2020-06-08,대웅테라퓨틱스대웅제약마이크로니들활용한성장호르몬개발시작,http://www.ceoscoredaily.com/news/article.html?no=70217
4207,2020-06-08,메디톡스VS대웅제약ITC및국내민사소송균주분쟁의진실은일상톡톡플러스,http://www.segye.com/content/html/2020/06/07/20200607509270.html?OutUrl=naver
4208,2020-06-08,코로나관련주대웅제약동화약품일양약품호재코로나치료제이슈는계속씨젠등진단키트관련주는,http://www.ggilbo.com/news/articleView.html?idxno=774392
4209,2020-06-08,증시키워드대웅제약일양약품코로나19치료제개발기대감에급등조선주는숨고르기,https://www.etoday.co.kr/news/view/1903388
4210,2020-06-08,시황분석대웅전일대비706상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006080901222157edd3045892_45
4211,2020-06-08,대웅78452주신고가,https://biz.chosun.com/site/data/html_dir/2020/06/08/2020060800566.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4212,2020-06-08,대웅52주신고가경신전일외국인대량순매수,https://www.hankyung.com/finance/article/202006080854L
4213,2020-06-08,대웅5이상상승전일외국인대량순매수,https://www.hankyung.com/finance/article/202006080861L
4214,2020-06-08,일양약품대웅제약제약주희비엇갈려대웅제약4하락반해일양약품19급등,http://www.econonews.co.kr/news/articleView.html?idxno=123532
4215,2020-06-08,대웅275VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/08/2020060800791.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4216,2020-06-08,주식일양약품대웅제약희비갈려일양약품은멈추지않는상승세대웅제약은3대하락,http://www.ggilbo.com/news/articleView.html?idxno=774413
4217,2020-06-08,대웅주가2만4550원전일대비373,https://view.asiae.co.kr/article/2020060809461434218
4218,2020-06-08,재계톡톡대웅제약코로나19확진자입단속논란에진땀,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=583969
4219,2020-06-08,대웅제약ITC소송이슈에연연할필요가없는주가주가13만5500원524,https://view.asiae.co.kr/article/2020060810471872119
4220,2020-06-08,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증”,http://www.cnbnews.com/news/article.html?no=449386
4221,2020-06-08,대웅코로나19치료제동물시험서효과입증,http://www.whosaeng.com/118418
4222,2020-06-08,대웅그룹코로나19치료제동물실험효과입증,http://www.doctorstimes.com/news/articleView.html?idxno=211206
4223,2020-06-08,일양약품대웅제약엇갈리는주가여전일양약품25급등반해대웅제약4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=123626
4224,2020-06-08,대웅제약發코로나19후폭풍제약영업비대면강화되나,https://www.asiatime.co.kr/news/newsview.php?ncode=1065580046418005
4225,2020-06-08,대웅제약에거부당한중기부조사규정바꿨다,https://www.nocutnews.co.kr/news/5357445
4226,2020-06-08,대웅200억원규모자기주식취득완료,http://medipana.com/news/news_viewer.asp?NewsNum=258134&MainKind=A&NewsKind=5&vCount=12&vKind=1
4227,2020-06-08,유가증권시장공시대웅삼성물산삼성바이오로직스등,http://news.mk.co.kr/newsRead.php?no=587298&year=2020
4228,2020-06-09,함양대웅한우촌식당사랑의무료식사,http://www.gnnews.co.kr/news/articleView.html?idxno=446970
4229,2020-06-09,함양대웅한우촌식당어르신초대식사제공,http://www.idomin.com/news/articleView.html?idxno=731350
4230,2020-06-09,대웅그룹니클로사마이드동물효력시험통해코로나19치료효과입증,http://www.ybsn.tv/news/articleView.html?idxno=16331
4231,2020-06-09,병원가도되나요”대웅제약영업맨코로나19확진병의원대면영업기피심화,http://theviewers.co.kr/View.aspx?No=866576
4232,2020-06-09,일양약품대웅제약제약주희비엇갈려특히일양약품가파른하락세로5낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=123701
4233,2020-06-09,리포트브리핑대웅니클로사마이드동물임상폐에서코로나19바이러스완전제거NotRatedDS투자증권,http://www.newspim.com/news/view/20200609000148
4234,2020-06-09,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006095462L
4235,2020-06-09,대웅투자자검색급증주가2만5450원43,https://view.asiae.co.kr/article/2020060909364577446
4236,2020-06-09,DS투자증권대웅니클로사마이드동물임상긍정적맞춤형코로나치료제기대,http://www.fnnews.com/news/202006090955065146
4237,2020-06-09,대웅3개월간200억규모자기주식취득지분율2854,http://www.mdtoday.co.kr/mdtoday/index.html?no=389296
4238,2020-06-09,대웅전일대비512상승이시각거래량273만2725주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006090222&t=NN
4239,2020-06-09,대웅제약상승출발후현재519최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006090231&t=NN
4240,2020-06-09,대웅963상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060901733.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4241,2020-06-09,대웅1230VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060901745.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4242,2020-06-09,대웅제약630상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060901746.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4243,2020-06-09,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006096588L
4244,2020-06-09,시황분석대웅제약전일대비63상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006091132171579edd30bc0c0_45
4245,2020-06-09,대웅137352주신고가,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060901764.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4246,2020-06-09,특징주대웅제약144000원9일11시35분등락률667,http://www.getnews.co.kr/view.php?ud=202006091136491564c20b99e7dc_16
4247,2020-06-09,대웅52주신고가경신니클로사마이드동물임상폐에서코로나19바이러스완전제거,https://www.hankyung.com/finance/article/202006096673L
4248,2020-06-09,시황분석대웅전일대비1885상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006091144014395edd30148e2_45
4249,2020-06-09,대웅제약1185VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060901826.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4250,2020-06-09,시황보톡스보툴리눔톡신테마주6월9일12시10분현재장중시황대웅제약디에스케이휴젤파마리서치프로덕트제테마등상황은,http://www.topstarnews.net/news/articleView.html?idxno=801475
4251,2020-06-09,시황코로나19진단치료제백신개발등테마주6월9일12시35분현재장중시황제일약품대웅대웅제약JW중외제약뉴지랩등상황은,http://www.topstarnews.net/news/articleView.html?idxno=801487
4252,2020-06-09,fnRASSI대웅00309052주신고가984↑,http://www.fnnews.com/news/202006091301036007
4253,2020-06-09,대웅대웅제약급등니클로사마이드동물임상긍정적,http://www.ggilbo.com/news/articleView.html?idxno=774851
4254,2020-06-09,대웅제약이어JW중외제약급등대웅제약15급등이어JW중외제약8급등,http://www.econonews.co.kr/news/articleView.html?idxno=123794
4255,2020-06-09,대웅제약부광약품모두급등대웅제약14급등이어부광약품23급등,http://www.econonews.co.kr/news/articleView.html?idxno=123798
4256,2020-06-09,이시각증시제약주강세제일약품상한가대웅대웅제약부광약품10이상급등,http://www.g-enews.com/ko-kr/news/article/news_all/202006091328105870edf69f862c_1/article.html
4257,2020-06-09,STOCK대웅니클로사마이드코로나19맞춤치료제기대에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020060913328039985
4258,2020-06-09,강세토픽2020년임상예정제약바이오테마대웅제약1333종근당876,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060902303.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4259,2020-06-09,강세토픽치매치료테마대웅제약1444종근당977,https://biz.chosun.com/site/data/html_dir/2020/06/09/2020060902446.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4260,2020-06-09,시황제약업체테마주6월9일15시2분현재장중시황제일약품신풍제약부광약품대웅제약테라젠이텍스등상황은,http://www.topstarnews.net/news/articleView.html?idxno=801639
4261,2020-06-09,대웅제약코로나19확진자발생에병의원대면영업손사래,http://www.seouleconews.com/news/articleView.html?idxno=55060
4262,2020-06-09,함양읍대웅한우촌식당사랑의무료식사,http://www.gnmaeil.com/news/articleView.html?idxno=451385
4263,2020-06-10,대웅의자사주활용법주가안정지배력↑일거양득,http://www.press9.kr/news/articleView.html?idxno=44933
4264,2020-06-10,대웅제약일양약품제약주희비엇갈려대웅제약1상승반해일양약품2하락,http://www.econonews.co.kr/news/articleView.html?idxno=123908
4265,2020-06-10,대웅5이상상승니클로사마이드동물임상폐에서코로나19바이러스완전제거,https://www.hankyung.com/finance/article/202006100095L
4266,2020-06-10,대웅97252주신고가,https://biz.chosun.com/site/data/html_dir/2020/06/10/2020061000931.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4267,2020-06-10,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006100158L
4268,2020-06-10,특징주대웅30650원10일9시15분등락률830,http://www.getnews.co.kr/view.php?ud=202006100917039383c20b9616fb_16
4269,2020-06-10,대웅52주신고가경신니클로사마이드동물임상폐에서코로나19바이러스완전제거,https://www.hankyung.com/finance/article/202006100168L
4270,2020-06-10,대웅1325VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/10/2020061000942.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4271,2020-06-10,시황분석대웅전일대비777상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006100916426848edd301de04_45
4272,2020-06-10,특징주대웅제약158500원10일9시20분등락률673,http://www.getnews.co.kr/view.php?ud=202006100922053210c20b994deb_16
4273,2020-06-10,주식 에이비엘바이오 1141기대감상승‥ 한미약품앱클론대웅제약젬백스는,http://www.ggilbo.com/news/articleView.html?idxno=775185
4274,2020-06-10,대웅상승출발후현재53이시각거래량368만6188주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006100147&t=NN
4275,2020-06-10,부자들은경제신문을읽는다메디톡스결국메디톡신패배대웅대웅제약트레이딩대응유효,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020061013331139906
4276,2020-06-10,대웅제약일양약품부광약품신풍제약시총7조넘어중견제약코로나수혜로질풍노도,http://www.thevaluenews.co.kr/news/view.php?idx=159716
4277,2020-06-10,대웅그룹니클로사마이드코로나19치료효과입증,http://www.doctorsnews.co.kr/news/articleView.html?idxno=134932
4278,2020-06-11,코로나19종목멈칫일양약품부광약품대웅제약셀트리온제약진원생명과학↓신풍제약씨젠파미셀엔지켐생명과학제넥신아이진↑,http://www.g-enews.com/ko-kr/news/article/news_all/20200611021926399851638db705_1/article.html
4279,2020-06-11,대웅5이상상승니클로사마이드동물임상폐에서코로나19바이러스완전제거,https://www.hankyung.com/finance/article/202006114871L
4280,2020-06-11,대웅제약5이상상승ITC소송이슈에연연할필요가없는주가KTB투자증권BUY유지,https://www.hankyung.com/finance/article/202006114872L
4281,2020-06-11,대웅제약일양약품제약주상승에급등까지특히대웅제약갑작스런6급등,http://www.econonews.co.kr/news/articleView.html?idxno=124078
4282,2020-06-11,시황분석대웅제약전일대비634상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006110928362081edd301a897_45
4283,2020-06-11,대웅커뮤니티활발주가071,https://view.asiae.co.kr/article/2020061111333900564
4284,2020-06-11,메디톡스대웅증거기사두고균주戰신경전,https://www.ebn.co.kr/news/view/1437858?sc=Naver
4285,2020-06-11,콜린알포제제선별급여결정대웅바이오종근당등130개제약사여파,http://www.sisajournal-e.com/news/articleView.html?idxno=219677
4286,2020-06-12,대웅제약의사몰래처방통계데이터빼돌렸다,https://www.paxnetnews.com/articles/61605
4287,2020-06-12,일양약품대웅제약제약주하락에급락까지일양약품8급락이어대웅제약5하락,http://www.econonews.co.kr/news/articleView.html?idxno=124198
4288,2020-06-12,이종욱전대웅제약부회장우정바이오회장으로자리옮겨,http://www.wikileaks-kr.org/news/articleView.html?idxno=88804
4289,2020-06-12,특징주대웅29850원12일10시0분장시작대비661상승,http://www.getnews.co.kr/view.php?ud=202006121002011969c20b99ac58_16
4290,2020-06-13,대웅제약병의원청구자료유출의혹제기,http://www.medigatenews.com/news/1811820519
4291,2020-06-13,메디톡스대웅제약신경전에결과관심집중메디톡신200단위출하승인에주가상승세이어질까,http://www.ggilbo.com/news/articleView.html?idxno=776072
4292,2020-06-15,대웅제약제약바이오액셀러레이터진출,http://www.press9.kr/news/articleView.html?idxno=44975
4293,2020-06-15,일양약품대웅제약제약주하락에급락까지특히일양약품가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=124452
4294,2020-06-15,대웅제약제약바이오유망벤처기업육성,http://www.wikileaks-kr.org/news/articleView.html?idxno=88901
4295,2020-06-15,대웅제약벤처투자강화,http://www.g-enews.com/ko-kr/news/article/news_all/20200615091207648751638db705_1/article.html
4296,2020-06-15,대웅제약액셀러레이터등록제약바이오유망기업키운다,http://news.mt.co.kr/mtview.php?no=2020061509145432214
4297,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.mediapen.com/news/view/532899
4298,2020-06-15,대웅제약액셀러레이터등록제약바이오벤처직접육성,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245550
4299,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://medipana.com/news/news_viewer.asp?NewsNum=258401&MainKind=A&NewsKind=5&vCount=12&vKind=1
4300,2020-06-15,대웅제약제약바이오전문엑셀러레이터로등록,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571480903141
4301,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://newsbrite.net/138157
4302,2020-06-15,대웅제약제약바이오전문엑셀러레이터로등록,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571480903141
4303,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.newsway.co.kr/news/view?tp=1&ud=2020061509105101678
4304,2020-06-15,대웅제약 유망제약바이오벤처직접키운다,http://www.businesskorea.co.kr/news/articleView.html?idxno=47521
4305,2020-06-15,대웅제약유망제약바이오벤처기업육성나서,https://www.fetv.co.kr/news/article.html?no=56936
4306,2020-06-15,대웅제약유망바이오벤처육성나선다,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006150093&t=NN
4307,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.dailypharm.com/Users/News/NewsView.html?ID=265569&REFERER=NP
4308,2020-06-15,대웅제약유망제약바이오벤처직접키운다,https://biz.chosun.com/site/data/html_dir/2020/06/15/2020061500999.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4309,2020-06-15,대웅제약제약바이오벤처육성위해액셀러레이터등록,http://news.mk.co.kr/newsRead.php?no=609626&year=2020
4310,2020-06-15,대웅제약엑셀러레이터등록제약바이오벤처육성나선다,http://www.asiatoday.co.kr/view.php?key=20200615010008842
4311,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.newsis.com/view/?id=NISX20200615_0001059445&cID=13001&pID=13000
4312,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.econovill.com/news/articleView.html?idxno=400882
4313,2020-06-15,대웅제약유망벤처전략지원연구에서사업화까지,http://moneys.mt.co.kr/news/mwView.php?no=2020061509068053384
4314,2020-06-15,대웅제약제약바이오전문엑셀러레이터등록,http://www.biospectator.com/view/news_view.php?varAtcId=10594
4315,2020-06-15,대웅제약유망벤처직접육성액셀러레이터등록,https://www.sedaily.com/NewsView/1Z41BFGVJA
4316,2020-06-15,대웅제약액셀러레이터등록스타트업키운다,http://www.mhj21.com/131453
4317,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.newspim.com/news/view/20200615000214
4318,2020-06-15,대웅제약제약바이오전문액셀러레이터로등록,http://www.lawissue.co.kr/view.php?ud=202006151001071709204ead0791_12
4319,2020-06-15,유망벤처직접키운다대웅제약제약바이오전문엑셀러레이터등록,http://theviewers.co.kr/View.aspx?No=872384
4320,2020-06-15,대웅제약국내유망제약바이오스타트업발굴해직접키운다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118207
4321,2020-06-15,대웅제약액셀러레이터등록제약바이오벤처육성,http://www.kpinews.co.kr/news/articleView.html?idxno=118961
4322,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.bokuennews.com/news/article.html?no=191271
4323,2020-06-15,대웅제약유망제약바이오벤처직접키운다스타트업과 에코시스템구축,http://www.sisaweek.com/news/articleView.html?idxno=134733
4324,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.m-i.kr/news/articleView.html?idxno=719811
4325,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.seoulwire.com/news/articleView.html?idxno=416127
4326,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.bosa.co.kr/news/articleView.html?idxno=2128689
4327,2020-06-15,대웅제약유망제약바이오벤처기업직접키운다,http://www.fnnews.com/news/202006151022521655
4328,2020-06-15,대웅제약유망제약바이오벤처엑셀러레이터등록,http://www.medigatenews.com/news/1657454732
4329,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.etnews.com/20200615000064
4330,2020-06-15,대웅제약바이오벤처직접육성,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93032
4331,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.thepublic.kr/news/newsview.php?ncode=1065575471210651
4332,2020-06-15,대웅제약 유망제약바이오육성나서중소기업벤처부액셀러레이터최종등록,http://www.newslock.co.kr/news/articleView.html?idxno=28701
4333,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.ybsn.tv/news/articleView.html?idxno=17428
4334,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.datasom.co.kr/news/articleView.html?idxno=106548
4335,2020-06-15,대웅제약유망한제약바이오벤처직접키운다,http://www.monews.co.kr/news/articleView.html?idxno=211419
4336,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.insightkorea.co.kr/news/articleView.html?idxno=80635
4337,2020-06-15,대웅제약유망제약바이오벤처육성나선다,http://www.dailysmart.co.kr/news/articleView.html?idxno=28286
4338,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://news.mk.co.kr/newsRead.php?no=610465&year=2020
4339,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.getnews.co.kr/view.php?ud=2020061511190734772fe691f917_16
4340,2020-06-15,대웅제약액셀러레이터로제약바이오벤처육성,http://www.economytalk.kr/news/articleView.html?idxno=206542
4341,2020-06-15,대웅커뮤니티활발주가017,https://view.asiae.co.kr/article/2020061511332196608
4342,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.segyebiz.com/newsView/20200615509199?OutUrl=naver
4343,2020-06-15,대웅제약제약바이오벤처기업육성위해투자교육박차,http://www.100ssd.co.kr/news/articleView.html?idxno=69392
4344,2020-06-15,대웅제약전문액셀러레이터등록유망제약바이오벤처육성,http://www.newsprime.co.kr/news/article.html?no=507821
4345,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://inthenews.co.kr/article-53848/
4346,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.mdtoday.co.kr/mdtoday/index.html?no=389907
4347,2020-06-15,시황분석대웅전일대비507상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006151302108233edd308615a_45
4348,2020-06-15,대웅402상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/15/2020061502120.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4349,2020-06-15,대웅장중반등세전일대비822외국인기관동시순매수중,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006150253&t=NN
4350,2020-06-15,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006157913L
4351,2020-06-15,대웅874VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/15/2020061502124.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4352,2020-06-15,대웅제약혁신제약바이오벤처키운다전문액셀러레이터등록,http://www.metroseoul.co.kr/article/20200615500260
4353,2020-06-15,대웅제약전문액셀러레이터등록유망제약바이오벤처직접육성,https://www.news1.kr/articles/?3965471
4354,2020-06-15,대웅제약엑셀러레이터등록제약바이오벤처육성,http://sports.hankooki.com/lpage/economy/202006/sp20200615140700136980.htm?s_ref=nv
4355,2020-06-15,대웅제약유망제약바이오벤처육성나선다,http://www.ekn.kr/news/article.html?no=505333
4356,2020-06-15,뉴스투데이L대웅제약유망제약바이오벤처육성나선다,https://www.news2day.co.kr/154606
4357,2020-06-15,대웅제약중기부액셀러레이터최종등록,https://www.ebn.co.kr/news/view/1438308?sc=Naver
4358,2020-06-15,대웅제약유망제약바이오벤처직접키운다,https://sports.donga.com/article/all/20200615/101515075/1
4359,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.nbnnews.co.kr/news/articleView.html?idxno=399827
4360,2020-06-15,대웅제약액셀러레이터로등록마쳐전승호유망벤처와함께성장,http://www.businesspost.co.kr/BP?command=article_view&num=182734
4361,2020-06-15,대웅제약병의원처방데이타불법수집폭로직원들에게도둑질을지시,http://hobbyen.co.kr/news/newsview.php?ncode=1065592563735408
4362,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61735
4363,2020-06-15,제약바이오벤처육성팔걷는대웅제약,http://www.fnnews.com/news/202006151651036696
4364,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.seoulfn.com/news/articleView.html?idxno=385857
4365,2020-06-15,대웅제약유망제약바이오벤처기업육성나서外,https://www.fetv.co.kr/news/article.html?no=57016
4366,2020-06-15,대웅제약제약바이오스타트업직접육성액셀러레이터등록完,https://www.donga.com/news/article/all/20200615/101518932/1
4367,2020-06-15,대웅제약제약바이오유망벤처육성앞장,http://www.shinailbo.co.kr/news/articleView.html?idxno=1289173
4368,2020-06-15,대웅제약유망제약바이오벤처직접키운다,https://www.dailian.co.kr/news/view/897807?sc=Naver
4369,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://www.thevaluenews.co.kr/news/view.php?idx=159765
4370,2020-06-15,대웅제약유망제약바이오벤처직접키운다,http://news.kbiz.or.kr/news/articleView.html?idxno=68690
4371,2020-06-15,대웅제약엑셀러레이터등록제약바이오벤처직접키운다,https://www.kpanews.co.kr/article/show.asp?idx=213959&category=D
4372,2020-06-16,대웅제약제약바이오전문액셀러레이터등록유망스타트업과에코시스템구축,http://www.thefirstmedia.net/news/articleView.html?idxno=59337
4373,2020-06-16,대웅제약유망제약바이오벤처직접키운다,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=224887
4374,2020-06-16,코로나재확산다시뜨는제약바이오주씨젠셀트리온일양약품파미셀SK케미칼대웅제약메디톡스,http://www.g-enews.com/ko-kr/news/article/news_all/2020061520281769834a01bf698f_1/article.html
4375,2020-06-16,대웅제약액셀러레이터등록유망제약바이오벤처지원프로그램운영,http://www.pressm.kr/news/articleView.html?idxno=30489
4376,2020-06-16,대웅5이상상승전일외국인대량순매수,https://www.hankyung.com/finance/article/202006161133L
4377,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.fetv.co.kr/news/article.html?no=57051
4378,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://newsbrite.net/138199
4379,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://daily.hankooki.com/lpage/industry/202006/dh20200616092711148390.htm?s_ref=nv
4380,2020-06-16,대웅제약일양약품제약주상승에급등까지대웅제약4상승이어일양약품7급등,http://www.econonews.co.kr/news/articleView.html?idxno=124611
4381,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.mhj21.com/131485
4382,2020-06-16,대웅제약감염병예방쉬운글도서배포,http://www.whosaeng.com/118640
4383,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://news.mt.co.kr/mtview.php?no=2020061609271628690
4384,2020-06-16,대웅제약발달장애인을위한감염병예방도서무료배포​,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118258
4385,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,https://www.sedaily.com/NewsView/1Z41S3SPKP
4386,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://medipana.com/news/news_viewer.asp?NewsNum=258481&MainKind=A&NewsKind=5&vCount=12&vKind=1
4387,2020-06-16,대웅제약발달장애인용감염병예방도서배포,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574314070237
4388,2020-06-16,대웅장시작후꾸준히올라789최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006160137&t=NN
4389,2020-06-16,대웅제약발달장애인위한감염병예방도서배포,http://www.bosa.co.kr/news/articleView.html?idxno=2128774
4390,2020-06-16,대웅제약상승흐름전일대비511최근주가상승흐름유지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006160191&t=NN
4391,2020-06-16,대웅제약 발달장애인을위한 감염병예방 쉬운글도서배포,http://www.businesskorea.co.kr/news/articleView.html?idxno=47587
4392,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.m-i.kr/news/articleView.html?idxno=720217
4393,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245610
4394,2020-06-16,코로나19예방법쉬운책으로대웅제약발달장애인위한도서배포,http://theviewers.co.kr/View.aspx?No=873798
4395,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.ajunews.com/view/20200616102208430
4396,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.ekn.kr/news/article.html?no=505531
4397,2020-06-16,대웅제약발달장애인감염병예방쉬운글도서배포,http://www.newsis.com/view/?id=NISX20200616_0001061135&cID=13001&pID=13000
4398,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.youthdaily.co.kr/news/article.html?no=39688
4399,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.thepublic.kr/news/newsview.php?ncode=1065575528111062
4400,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61767
4401,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1394096
4402,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.getnews.co.kr/view.php?ud=2020061611165747502fe691f917_16
4403,2020-06-16,대웅제약발달장애인감염병예방도서배포,http://moneys.mt.co.kr/news/mwView.php?no=2020061610598057537
4404,2020-06-16,대웅제약참지마요프로젝트감염병예방쉬운글도서제작배포,http://www.kpinews.co.kr/news/articleView.html?idxno=119114
4405,2020-06-16,대웅주가2만9400원789게시판북적,https://view.asiae.co.kr/article/2020061611335582608
4406,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.press9.kr/news/articleView.html?idxno=44997
4407,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.koreaittimes.com/news/articleView.html?idxno=98263
4408,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.metroseoul.co.kr/article/20200616500193
4409,2020-06-16,대웅제약감염병예방관련발달장애인의이해돕는쉬운글도서제작,http://www.g-enews.com/ko-kr/news/article/news_all/20200616123842613851638db705_1/article.html
4410,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.dailysmart.co.kr/news/articleView.html?idxno=28350
4411,2020-06-16,대웅제약등니클로사마이드동물시험서코로나19치료효과입증,https://www.kpanews.co.kr/article/show.asp?idx=213758&category=D
4412,2020-06-16,대웅제약발달장애인이해돕는감염병예방쉬운글도서배포,http://www.pressm.kr/news/articleView.html?idxno=30525
4413,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.nbnnews.co.kr/news/articleView.html?idxno=400103
4414,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://sports.hankooki.com/lpage/economy/202006/sp20200616144813136980.htm?s_ref=nv
4415,2020-06-16,대웅제약발달장애인용감염병예방쉬운글도서배포,https://www.ebn.co.kr/news/view/1438524?sc=Naver
4416,2020-06-16,클로즈업무한협업앞세워공격경영속도내는대웅제약전승호,https://www.fetv.co.kr/news/article.html?no=57088
4417,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.newsway.co.kr/news/view?tp=1&ud=2020061614565477249
4418,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.greened.kr/news/articleView.html?idxno=256316
4419,2020-06-16,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.ybsn.tv/news/articleView.html?idxno=17820
4420,2020-06-16,대웅발달장애인위한감염병예방도서제작,http://www.dailymedi.com/detail.php?number=857197&thread=22r05
4421,2020-06-16,대웅제약발달장애인이읽기쉬운감염병예방도서제작배포,http://www.100ssd.co.kr/news/articleView.html?idxno=69420
4422,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://jhealthmedia.joins.com/article/article_view.asp?pno=21977
4423,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서제작배포,http://www.mdtoday.co.kr/mdtoday/index.html?no=390126
4424,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.lawissue.co.kr/view.php?ud=202006161928457699204ead0791_12
4425,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서500권배포,https://www.donga.com/news/article/all/20200616/101541436/1
4426,2020-06-16,대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.kpanews.co.kr/article/show.asp?idx=213993&category=D
4427,2020-06-16,대웅제약 발달장애인위한 감염병예방쉬운글도서배포,http://www.newslock.co.kr/news/articleView.html?idxno=28753
4428,2020-06-17,뉴스투데이L대웅제약발달장애인위한감염병예방쉬운글도서배포,https://www.news2day.co.kr/154759
4429,2020-06-17,단독직원에게처방내역빼내게한대웅제약,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202006170600015&code=940100
4430,2020-06-17,아침신문보기직원에게처방내역도둑질시킨대웅제약,https://imnews.imbc.com/replay/2020/nwtoday/article/5812723_32531.html
4431,2020-06-17,대웅영업맨악용지누스환자정보그대로노출,https://www.paxnetnews.com/articles/61705
4432,2020-06-17,대웅제약일양약품제약주모두상승세로대웅제약소폭상승이어일양약품3상승,http://www.econonews.co.kr/news/articleView.html?idxno=124760
4433,2020-06-17,대웅제약발달장애인위한감염병예방쉬운글도서배포,http://www.polinews.co.kr/news/article.html?no=466139
4434,2020-06-17,대웅제약유망제약바이오벤처직접키운다,http://www.wsobi.com/news/articleView.html?idxno=99495
4435,2020-06-17,대웅제약발달장애인위한감염병예방쉬운글도서500권배포,http://www.eroun.net/news/articleView.html?idxno=12310
4436,2020-06-17,영업사원이용해환자개인정보유출한대웅제약관련사항확인중,https://www.asiatime.co.kr/news/newsview.php?ncode=1065593192706448
4437,2020-06-17,대웅제약발달장애인 위한감염병예방 쉬운글제작배포,http://www.economytalk.kr/news/articleView.html?idxno=206604
4438,2020-06-17,대웅제약신종리베이트논란영업사원에처방내역입수지시,http://www.newsprime.co.kr/news/article.html?no=508195
4439,2020-06-17,대웅제약직원에병원약국처방데이터확보지시논란사측확인중,http://www.ftoday.co.kr/news/articleView.html?idxno=202959
4440,2020-06-17,전세계코로나19확진자급증에치료제개발부광약품신풍제약일양약품GC녹십자SK케미칼대웅제약시가총액껑충,http://www.thekpm.com/view.php?ud=202006171711261035861beb2d9d_17
4441,2020-06-17,전승호이끄는대웅제약에무슨일이,http://www.newsway.co.kr/news/view?tp=1&ud=2020061717435388332
4442,2020-06-17,대웅제약병의원처방데이터불법수집논란사실확인중,http://www.mediapen.com/news/view/533815
4443,2020-06-17,대웅제약영업사원에병원정보및환자개인정보불법수집지시논란,http://theviewers.co.kr/View.aspx?No=876438
4444,2020-06-18,대웅제약발달장애인을위한감염병예방쉬운글도서배포,http://www.thefirstmedia.net/news/articleView.html?idxno=59472
4445,2020-06-18,속보메디톡스보톡스끝내허가취소식약처메디톡신퇴출대웅제약ITC판결연기,http://www.g-enews.com/ko-kr/news/article/news_all/2020061807082786544a01bf698f_1/article.html
4446,2020-06-18,메디톡신취소확정대웅제약과ITC분쟁에악영향주나,https://www.sedaily.com/NewsView/1Z42OO9BHX
4447,2020-06-18,시황분석대웅전일대비1317상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006180901094092edd307801d_45
4448,2020-06-18,대웅제약지노믹트리대장암체외진단검사얼리텍공동프로모션조인식,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020061809014059592
4449,2020-06-18,대웅52주신고가경신니클로사마이드동물임상폐에서코로나19바이러스완전제거,https://www.hankyung.com/finance/article/202006180614L
4450,2020-06-18,대웅제약보톡스보툴리눔톡신테마상승세에813↑,https://view.asiae.co.kr/article/2020061809070131755
4451,2020-06-18,대웅10이상상승니클로사마이드동물임상폐에서코로나19바이러스완전제거,https://www.hankyung.com/finance/article/202006180623L
4452,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.getnews.co.kr/view.php?ud=2020061809041484112fe691f917_16
4453,2020-06-18,대웅제약10이상상승전일외국인대량순매수,https://www.hankyung.com/finance/article/202006180600L
4454,2020-06-18,대웅제약지노믹트리대장암진단검사얼리텍코프로모션,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245714
4455,2020-06-18,특징주식약처의메디톡신취소에대웅제약등후발보톡스주급등,http://news.mk.co.kr/newsRead.php?no=623947&year=2020
4456,2020-06-18,특징주메디톡스허가취소에급락대웅대웅제약급등,http://www.inews24.com/view/1274401
4457,2020-06-18,대웅제약지노믹트리얼리텍 공동프로모션조인식진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=47721
4458,2020-06-18,대웅제약얼리텍으로헬스케어진단시장진출,https://jhealthmedia.joins.com/article/article_view.asp?pno=21987
4459,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61818
4460,2020-06-18,특징주대웅제약휴젤등식약처메디톡신취소에급등,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572195607635
4461,2020-06-18,대웅제약헬스케어진단시장사업확대,http://www.dailypharm.com/Users/News/NewsView.html?ID=265699&REFERER=NP
4462,2020-06-18,국내1호보톡스메디톡신허가취소메디톡스대웅제약과소송전직격탄,http://www.dt.co.kr/contents.html?article_no=2020061802109931102001&ref=naver
4463,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동판매계약,http://www.press9.kr/news/articleView.html?idxno=45023
4464,2020-06-18,대웅제약지노믹트리대장암체외진단공동마케팅,http://www.biospectator.com/view/news_view.php?varAtcId=10632
4465,2020-06-18,메디톡신허가취소에대웅제약등급등반사이익기대,https://www.hankyung.com/finance/article/2020061808106
4466,2020-06-18,대웅제약지노믹트리대장암진단검사얼리텍공동프로모션,http://news.mt.co.kr/mtview.php?no=2020061809263417656
4467,2020-06-18,특징주메디톡스대웅제약식약처결정에주가희비,https://www.dailian.co.kr/news/view/898514?sc=Naver
4468,2020-06-18,대웅제약지노믹트리대장암검사시장확대나서,https://www.fetv.co.kr/news/article.html?no=57244
4469,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,https://www.youthdaily.co.kr/news/article.html?no=39907
4470,2020-06-18,시황분석대웅제약전일대비671상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202006180940518210edd30037d8_45
4471,2020-06-18,게시판대웅제약지노믹트리대장암체외진단얼리텍공동판매,http://yna.kr/AKR20200618049600017?did=1195m
4472,2020-06-18,특징주메디톡스반사이익기대감대웅제약휴젤강세,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006180112&t=NN
4473,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션나선다,http://medipana.com/news/news_viewer.asp?NewsNum=258616&MainKind=A&NewsKind=5&vCount=12&vKind=1
4474,2020-06-18,대장암검사시장확대대웅제약지노믹트리얼리텍코프로모션계약,http://theviewers.co.kr/View.aspx?No=876836
4475,2020-06-18,대웅제약지노믹트리개발대장암체외진단기판매,https://www.news1.kr/articles/?3969040
4476,2020-06-18,메디톡신보톡스허가취소에대웅제약휴젤등급등,https://biz.chosun.com/site/data/html_dir/2020/06/18/2020061801337.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4477,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동판매헬스케어진단시장진출,http://www.ekn.kr/news/article.html?no=506011
4478,2020-06-18,메디톡스대웅제약급등에폭락으로희비엇갈려메디톡스17폭락반해대웅제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=124960
4479,2020-06-18,TF특징주대웅제약메디톡신허가취소반사이익6대상승,http://news.tf.co.kr/read/economy/1798109.htm
4480,2020-06-18,대웅제약전일대비565상승이시각거래량48만3614주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006180161&t=NN
4481,2020-06-18,관심종목메디톡스경쟁업체들반사이익휴젤대웅제약주가상승,http://www.getnews.co.kr/view.php?ud=2020061809592633892aaae0046f_16
4482,2020-06-18,메디톡스메디톡신허가취소에주가급락휴젤제테마휴온스글로벌대웅제약관련주주가는,http://www.topstarnews.net/news/articleView.html?idxno=807614
4483,2020-06-18,대웅제약지노믹트리와얼리텍대장암검사공동프로모션체결,http://www.kpinews.co.kr/news/articleView.html?idxno=119301
4484,2020-06-18,대웅제약지노믹트리와얼리텍공동프로모션조인식진행양사간시너지창출기대,http://www.updownnews.co.kr/news/articleView.html?idxno=219949
4485,2020-06-18,대웅제약지노믹트리와얼리텍공동프로모션조인식진행,http://www.m-i.kr/news/articleView.html?idxno=721125
4486,2020-06-18,대웅제약대장암체외진단얼리텍공동영업나선다,http://www.metroseoul.co.kr/article/20200618500085
4487,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.ybsn.tv/news/articleView.html?idxno=18206
4488,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션진행,http://www.econovill.com/news/articleView.html?idxno=401400
4489,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.segyebiz.com/newsView/20200618508433?OutUrl=naver
4490,2020-06-18,대웅제약지노믹트리대장암검사공동프로모션,http://www.newsis.com/view/?id=NISX20200618_0001064113&cID=13001&pID=13000
4491,2020-06-18,대웅제약지노믹트리와얼리텍시장확대협력,http://www.mhj21.com/131600
4492,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행헬스케어진단시장까지사업영역확대,http://newsbrite.net/138303
4493,2020-06-18,대웅제약지노믹트리대장암체외진단검사얼리텍공동프로모션진행,http://www.k-health.com/news/articleView.html?idxno=48945
4494,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행헬스케어시장사업확대,http://www.paxetv.com/news/articleView.html?idxno=94444
4495,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.thepublic.kr/news/newsview.php?ncode=1065574058623627
4496,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동마케팅,http://sports.hankooki.com/lpage/economy/202006/sp20200618104614137020.htm?s_ref=nv
4497,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식,http://www.bosa.co.kr/news/articleView.html?idxno=2128955
4498,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572963422788
4499,2020-06-18,대웅제약지노믹트리와대장암검사공동프로모션,http://www.choicenews.co.kr/news/articleView.html?idxno=71894
4500,2020-06-18,대웅제약체외진단시장에도손뻗친다,http://www.monews.co.kr/news/articleView.html?idxno=211529
4501,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.datasom.co.kr/news/articleView.html?idxno=106646
4502,2020-06-18,메디톡신취소ITC재판연기대웅제약신의한수되나,http://www.edaily.co.kr/news/newspath.asp?newsid=02532166625803032
4503,2020-06-18,대웅주가3만1300원179게시판북적,https://view.asiae.co.kr/article/2020061811330731462
4504,2020-06-18,대웅제약지노믹트리대장암체외진단얼리텍공동판매,http://yna.kr/PYH20200618049200017?did=1196m
4505,2020-06-18,대웅제약지노믹트리대장암진단얼리텍공동프로모션,http://www.mdtoday.co.kr/mdtoday/index.html?no=390331
4506,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1394669
4507,2020-06-18,뉴스투데이L대웅제약지노믹트리와얼리텍공동프로모션조인식진행,https://www.news2day.co.kr/154869
4508,2020-06-18,대웅제약지노믹트리대장암체외진단얼리텍공동판매,http://www.seoulfn.com/news/articleView.html?idxno=386247
4509,2020-06-18,메디톡신취소확정대웅제약ITC분쟁에도영향줄까,http://www.mediapen.com/news/view/533986
4510,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션계약,http://www.iminju.net/news/articleView.html?idxno=54524
4511,2020-06-18,대웅상승출발후현재504외국인11000주순매도중,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006180258&t=NN
4512,2020-06-18,대웅제약얼리텍도입헬스케어진단시장사업영역확대,http://www.newsprime.co.kr/news/article.html?no=508290
4513,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.pressm.kr/news/articleView.html?idxno=30603
4514,2020-06-18,대웅제약지노믹트리와손잡고대장암진단기공동판매,http://www.businesspost.co.kr/BP?command=article_view&num=183312
4515,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.nbnnews.co.kr/news/articleView.html?idxno=400730
4516,2020-06-18,대웅제약얼리텍대장암검사시장확대나서,http://www.dailysmart.co.kr/news/articleView.html?idxno=28466
4517,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션진단검사사업확대,http://kormedi.com/?p=1318856
4518,2020-06-18,대웅제약지노믹트리체외대장암검사얼리텍공동프로모션진행,https://www.donga.com/news/article/all/20200618/101573304/1
4519,2020-06-18,대웅제약지노믹트리대장암진단검사얼리텍코프로모션계약맺어,http://news.mk.co.kr/newsRead.php?no=627085&year=2020
4520,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.lawissue.co.kr/view.php?ud=202006181547584846204ead0791_12
4521,2020-06-18,메디톡신허가취소반사이익대웅휴젤주가훨훨,http://www.dailypharm.com/Users/News/NewsView.html?ID=265725&REFERER=NP
4522,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션,http://www.bokuennews.com/news/article.html?no=191496
4523,2020-06-18,대웅제약얼리텍병․의원영업․마케팅진행,http://www.whosaeng.com/118758
4524,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션,http://www.medigatenews.com/news/3204965810
4525,2020-06-18,대웅제약지노믹트리와얼리텍공동프로모션계약진행,http://www.newspost.kr/news/articleView.html?idxno=79435
4526,2020-06-18,대웅제약지노믹트리대장암검사키트시장공략,http://www.sisaweek.com/news/articleView.html?idxno=134898
4527,2020-06-18,땡큐메디톡신”기회잡은대웅종근당휴젤과한판승부,http://www.viva100.com/main/view.php?key=20200618010004248
4528,2020-06-18,메디톡스허가취소날벼락대웅휴젤반사익,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006180290&t=NNv
4529,2020-06-18,사설환자투약정보빼내고영업사원입막음까지한대웅제약,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202006182023025&code=990101
4530,2020-06-18,메디톡신허가취소휴젤대웅제약휴온스글로벌반사이익,http://www.medigatenews.com/news/2605795270
4531,2020-06-18,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://news.kbiz.or.kr/news/articleView.html?idxno=68899
4532,2020-06-19,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.thefirstmedia.net/news/articleView.html?idxno=59530
4533,2020-06-19,덱사메타손돌풍다시뜨는제약바이오주신풍제약에이비엘일양부광약품대웅메디톡스씨젠SK바이오랜드,http://www.g-enews.com/ko-kr/news/article/news_all/2020061810022972914a01bf698f_1/article.html
4534,2020-06-19,단독작년에도처방통계불법수집”복지부대웅제약수사의뢰검토,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202006190600035&code=940202
4535,2020-06-19,메디톡스메디톡신허가취소에휴젤대웅제약휴온스글로벌반사이익,http://www.anewsa.com/detail.php?number=2153763&thread=18
4536,2020-06-19,메디톡신퇴출휴젤대웅제약반사이익주가기대감,http://moneys.mt.co.kr/news/mwView.php?no=2020061909088016353
4537,2020-06-19,대웅제약 우루사 담석예방효과 SCI급국제학술지에등재,http://www.businesskorea.co.kr/news/articleView.html?idxno=47798
4538,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.youthdaily.co.kr/news/article.html?no=39997
4539,2020-06-19,메디톡신품목허가취소대웅제약휴젤반사이익수혜,https://cnbc.sbs.co.kr/article_hub/10000987008?division=NAVER
4540,2020-06-19,대웅제약우루사담석예방효과학술지등재,http://www.mhj21.com/131659
4541,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지실려,https://www.etoday.co.kr/news/view/1908184
4542,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.bosa.co.kr/news/articleView.html?idxno=2129030
4543,2020-06-19,대웅제약우루사담석예방효과입증국제학술지등재,http://moneys.mt.co.kr/news/mwView.php?no=2020061909148050510
4544,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://medipana.com/news/news_viewer.asp?NewsNum=258679&MainKind=A&NewsKind=5&vCount=12&vKind=1
4545,2020-06-19,대웅제약우루사담석예방효과입증,http://www.koreastocknews.com/news/articleView.html?idxno=54636
4546,2020-06-19,대웅제약우루사의담석예방효과美의사협회학술지등재,http://www.kpinews.co.kr/news/articleView.html?idxno=119410
4547,2020-06-19,대웅제약우루사담석예방효과SCI급학술지등재,http://www.newsis.com/view/?id=NISX20200619_0001065588&cID=13001&pID=13000
4548,2020-06-19,대웅제약우루사수술받은위암환자의담석예방효능논문SCI급학술지등재,http://news.mk.co.kr/newsRead.php?no=629106&year=2020
4549,2020-06-19,대웅제약우루사임상결과JAMA장식,http://www.whosaeng.com/118779
4550,2020-06-19,대웅제약우루사담석예방효과SCI급학술지에등재,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572789932627
4551,2020-06-19,대웅제약우루사담석예방효과SCI급학술지등재,http://www.g-enews.com/ko-kr/news/article/news_all/202006190941473560a218188523_1/article.html
4552,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지JAMASurgery등재,http://www.pressm.kr/news/articleView.html?idxno=30611
4553,2020-06-19,대웅제약우루사위암환자담석예방에효과있다,http://www.econovill.com/news/articleView.html?idxno=401543
4554,2020-06-19,대웅제약우루사담석예방효과국제학술지등재,http://www.press9.kr/news/articleView.html?idxno=45039
4555,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61848
4556,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://news.mt.co.kr/mtview.php?no=2020061909250872974
4557,2020-06-19,대웅제약우루사위암환자담석예방효과입증,http://www.biospectator.com/view/news_view.php?varAtcId=10640
4558,2020-06-19,대웅제약 우루사 담석예방효과 SCI급국제학술지에등재,http://www.greened.kr/news/articleView.html?idxno=256807
4559,2020-06-19,대웅제약우루사담석예방효과입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118412
4560,2020-06-19,조계사대웅전서불지르고벽화태워30대현행범체포,https://news.joins.com/article/olink/23400151
4561,2020-06-19,대웅제약우루사담석예방효과SCI급학술지등재,http://www.newspim.com/news/view/20200619000234
4562,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재담석예방효과입증한세계최초연구,http://newsbrite.net/138365
4563,2020-06-19,위암환자담석공포해소기대대웅제약국제학술지에우루사담석예방효과등재,http://theviewers.co.kr/View.aspx?No=878116
4564,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.ekn.kr/news/article.html?no=506243
4565,2020-06-19,대웅제약우루사담성예방효과국제학술지에등재,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020061910424853831
4566,2020-06-19,대웅제약우루사위암환자담석예방효과SCI급국제학술지등재,http://www.insightkorea.co.kr/news/articleView.html?idxno=80746
4567,2020-06-19,대웅우루사담석예방효과SCI급국제학술지등재,http://www.dailymedi.com/detail.php?number=857315&thread=22r05
4568,2020-06-19,우루사대웅제약담석예방효과 SCI급국제학술지등재,http://www.economytalk.kr/news/articleView.html?idxno=206632
4569,2020-06-19,대웅제약우루사담석예방효과입증국제학술지에등재,http://www.koreaittimes.com/news/articleView.html?idxno=98375
4570,2020-06-19,메디톡스품목허가취소휴젤대웅제약반사이익얻나,https://www.ebn.co.kr/news/view/1438988?sc=Naver
4571,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.getnews.co.kr/view.php?ud=2020061911191240152fe691f917_16
4572,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.sisaweek.com/news/articleView.html?idxno=134918
4573,2020-06-19,대웅제약우루사담석예방효과국제학술지등재,http://www.dailysmart.co.kr/news/articleView.html?idxno=28537
4574,2020-06-19,대웅제약우루사위암환자담석예방효과입증,http://www.monews.co.kr/news/articleView.html?idxno=211550
4575,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.medigatenews.com/news/2035681504
4576,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.enewstoday.co.kr/news/articleView.html?idxno=1394957
4577,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.mdtoday.co.kr/mdtoday/index.html?no=390467
4578,2020-06-19,대웅제약우루사담석예방임상결과국제학술지등재,http://www.pharmnews.com/news/articleView.html?idxno=100717
4579,2020-06-19,대웅제약지노믹트리얼리텍공동프로모션조인식진행,http://www.newslock.co.kr/news/articleView.html?idxno=28839
4580,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.newsprime.co.kr/news/article.html?no=508436
4581,2020-06-19,대웅제약환자정보불법수집의혹영업사원에병의원처방통계데이터확보강요,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004014511
4582,2020-06-19,대웅제약검색상위랭킹주가478,https://view.asiae.co.kr/article/2020061914342758718
4583,2020-06-19,대웅제약우루사임상연구국제적인정담석예방효과국제학술지에등재,http://kpenews.com/View.aspx?No=878683
4584,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.mediapen.com/news/view/534362
4585,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.ybsn.tv/news/articleView.html?idxno=18531
4586,2020-06-19,대웅제약간기능개선우루사의담석예방효과를국제학술지에실어,http://www.businesspost.co.kr/BP?command=article_view&num=183532
4587,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.metroseoul.co.kr/article/20200619500156
4588,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.ebn.co.kr/news/view/1439045?sc=Naver
4589,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.lawissue.co.kr/view.php?ud=202006191518555362204ead0791_12
4590,2020-06-19,대웅제약우루사담석예방효과임상국제학술지게재,http://www.shinailbo.co.kr/news/articleView.html?idxno=1290712
4591,2020-06-19,뉴스투데이L대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.news2day.co.kr/154970
4592,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지등재,https://www.donga.com/news/article/all/20200619/101589979/1
4593,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.nbnnews.co.kr/news/articleView.html?idxno=401085
4594,2020-06-19,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.paxetv.com/news/articleView.html?idxno=94607
4595,2020-06-19,대웅제약우루사담석예방효과국제학술지에등재,http://www.100ssd.co.kr/news/articleView.html?idxno=69522
4596,2020-06-20,대웅제약지노믹트리대장암검사공동프로모션얼리텍도입헬스케어진단시장사업확대,http://www.econonews.co.kr/news/articleView.html?idxno=125212
4597,2020-06-20,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.wikileaks-kr.org/news/articleView.html?idxno=89312
4598,2020-06-20,대웅제약우루사담석예방효과SCI급국제학술지에등재,http://www.thepublic.kr/news/newsview.php?ncode=1065598537502648
4599,2020-06-20,고지점한대웅제약ITC서도이길까,http://www.mediapen.com/news/view/534496
4600,2020-06-20,술취해조계사대웅전서방화한30대구속갈림길,https://view.asiae.co.kr/article/2020062014054832520
4601,2020-06-20,대웅제약우루사담석예방효과SCI급국제학술지등재,http://www.thefirstmedia.net/news/articleView.html?idxno=59583
4602,2020-06-21,국산코로나백신첫임상투여대웅중외한미도도전장,http://news.mt.co.kr/mtview.php?no=2020061916520695746
4603,2020-06-22,코로나19펜데믹에공포한곳서만하루3500명감염모더나는3만명대상백신개발국내선셀트리온대웅제약부광약품신풍제약씨젠파미셀일양약품옵티팜동국제약주목,http://www.thekpm.com/view.php?ud=202006220505058592861beb2d9d_17
4604,2020-06-22,벼랑끝메디톡스대웅제약반사이익얻을까,http://it.chosun.com/site/data/html_dir/2020/06/20/2020062000757.html
4605,2020-06-22,대웅제약2년만에벨카이라특허분쟁첫승소,http://www.dailypharm.com/Users/News/NewsView.html?ID=265774&REFERER=NP
4606,2020-06-22,대웅지원받은지누스실소유주는누구,https://www.paxnetnews.com/articles/61783
4607,2020-06-22,지이크대웅제약우루사와간肝x지콜라보컬렉션전개,http://www.fashionn.com/board/read_new.php?table=1006&number=33521
4608,2020-06-22,신원지이크대웅제약우루사와간肝x지콜라보제품출시,http://www.newsworks.co.kr/news/articleView.html?idxno=465509
4609,2020-06-22,대웅제약펜믹스엘러간벨카이라특허회피성공,http://medipana.com/news/news_viewer.asp?NewsNum=258786&MainKind=A&NewsKind=5&vCount=12&vKind=1
4610,2020-06-22,대웅엘러간상대벨카이라특허분쟁첫승勝,http://www.dailymedi.com/detail.php?number=857396&thread=22r12
4611,2020-06-22,대웅제약윤재승의꼼수①묻지마코로나19치료제로상한가치고빠지기,http://www.globale.co.kr/news/articleView.html?idxno=10574
4612,2020-06-22,신원남성복지이크대웅제약우루사와이색협업,https://www.asiatime.co.kr/news/newsview.php?ncode=1065592217887350
4613,2020-06-22,신원지이크대웅제약우루사콜라보,https://www.ebn.co.kr/news/view/1439287?sc=Naver
4614,2020-06-22,남성복지이크x대웅제약우루사간肝x지컬래버레이션,http://www.busan.com/view/busan/view.php?code=2020062216112272713
4615,2020-06-22,지이크SIEG대웅제약우루사와손잡고간肝x지콜라보제품출시,http://www.apparelnews.co.kr/news/news_view/?idx=183448
4616,2020-06-22,신원지이크SIEG대웅제약우루사손잡고간肝x지콜라보머리부터간끝까지간지 ,http://www.kdfnews.com/news/articleView.html?idxno=49554
4617,2020-06-22,대웅제약수출길넓히고美희귀약지정도,https://www.sedaily.com/NewsView/1Z44KYXXA8
4618,2020-06-22,소간지말고곰간x지콜라보신원지이크대웅제약우루사와협업,http://www.megaeconomy.co.kr/news/articleView.html?idxno=94208
4619,2020-06-23,대웅제약엘러간벨카이라특허회피드디어성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=390724
4620,2020-06-23,대웅제약나보타대만품목허가중화권진출초읽기,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=245872
4621,2020-06-23,중화권진출초읽기”대웅제약나보타대만품목허가,https://www.fetv.co.kr/news/article.html?no=57565
4622,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.getnews.co.kr/view.php?ud=2020062309075235222fe691f917_16
4623,2020-06-23,대웅제약나보타대만품목허가획득중화권진출초읽기,http://www.ekn.kr/news/article.html?no=506811
4624,2020-06-23,대웅제약보톡스나보타대만허가,http://www.dailypharm.com/Users/News/NewsView.html?ID=265833&REFERER=NP
4625,2020-06-23,대웅제약나보타대만서허가중화권진출초읽기,https://www.news1.kr/articles/?3973367
4626,2020-06-23,대웅제약나보타대만품목허가획득하반기출시,https://www.etoday.co.kr/news/view/1909367
4627,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://medipana.com/news/news_viewer.asp?NewsNum=258827&MainKind=A&NewsKind=5&vCount=12&vKind=1
4628,2020-06-23,대웅제약나보타대만품목허가중화권진출,http://www.press9.kr/news/articleView.html?idxno=45064
4629,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가,http://yna.kr/AKR20200623039500017?did=1195m
4630,2020-06-23,대웅제약나보타중화권진출초읽기,http://www.seoulwire.com/news/articleView.html?idxno=417265
4631,2020-06-23,대웅제약보톡스나보타대만품목허가중화권진출초읽기,http://www.m-i.kr/news/articleView.html?idxno=722416
4632,2020-06-23,대웅제약나보타대만품목허가획득중화권진출교두보,http://www.pressm.kr/news/articleView.html?idxno=30668
4633,2020-06-23,대웅제약보톡스나보타중화권교두보확보,http://www.edaily.co.kr/news/newspath.asp?newsid=01922086625804672
4634,2020-06-23,대웅제약나보타대만서품목허가中시장공략박차,http://news.mt.co.kr/mtview.php?no=2020062309165139558
4635,2020-06-23,대만땅밟는대웅제약나보타중화권진출초석,http://health.chosun.com/site/data/html_dir/2020/06/23/2020062301039.html
4636,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.dailysmart.co.kr/news/articleView.html?idxno=28685
4637,2020-06-23,대웅나보타대만서품목허가올하반기발매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93201
4638,2020-06-23,대웅제약나보타대만허가52개국획득,http://www.newsis.com/view/?id=NISX20200623_0001069127&cID=13001&pID=13000
4639,2020-06-23,대웅제약미간주름개선나보타대만품목허가획득,http://www.economytalk.kr/news/articleView.html?idxno=206668
4640,2020-06-23,대웅제약나보타대만품목허가로아시아시장확대나서,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118517
4641,2020-06-23,대웅제약나보타대만서품목허가올하반기발매,http://www.mdtoday.co.kr/mdtoday/index.html?no=390749
4642,2020-06-23,나보타아시아시장영향력확대대웅제약하반기대만출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=89485
4643,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,https://www.dailian.co.kr/news/view/899653?sc=Naver
4644,2020-06-23,대웅제약대만서보툴리눔톡신나보타시판허가받아,http://news.mk.co.kr/newsRead.php?no=640721&year=2020
4645,2020-06-23,대웅제약대만서나보타품목허가획득으로아시아입지강화,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006230106&t=NN
4646,2020-06-23,대웅제약나보타대만서품목허가획득하반기발매,http://www.newspim.com/news/view/20200623000155
4647,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020062309425470304
4648,2020-06-23,메트포르민관련주코로나여성당뇨병환자사망률↓대웅제약신풍제약등관심,http://www.ccreview.co.kr/news/articleView.html?idxno=267121
4649,2020-06-23,대웅제약보톡스나보타대만품목허가,https://www.ebn.co.kr/news/view/1439412?sc=Naver
4650,2020-06-23,대웅中진출교두보대만겨냥올하반기나보타판매,http://moneys.mt.co.kr/news/mwView.php?no=2020062309228090110
4651,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가획득중화권진출초읽기,http://www.startuptoday.co.kr/news/articleView.html?idxno=44801
4652,2020-06-23,대웅제약나보타대만품목허가획득아시아시장영향력확대,http://www.newsprime.co.kr/news/article.html?no=508689
4653,2020-06-23,대만품목허가대웅제약나보타중화권진출초읽기,http://www.koreaittimes.com/news/articleView.html?idxno=98445
4654,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://newsbrite.net/138510
4655,2020-06-23,대웅제약나보타대만품목허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2129202
4656,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://inthenews.co.kr/article-55185/
4657,2020-06-23,대웅제약나보타대만서품목허가획득중화권진출초읽기,https://www.youthdaily.co.kr/news/article.html?no=40266
4658,2020-06-23,대웅제약나보타대만품목허가획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61892
4659,2020-06-23,대웅제약나보타대만품목허가받으며중화권진출,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573048040111
4660,2020-06-23,대웅제약나보타대만서미간주름품목허가획득,https://www.hankyung.com/it/article/202006237311i
4661,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가,http://www.topstarnews.net/news/articleView.html?idxno=810774
4662,2020-06-23,대웅제약나보타대만서품목허가획득하반기발매,http://www.consumernews.co.kr/news/articleView.html?idxno=607325
4663,2020-06-23,대웅제약나보타대만서품목허가획득중화권진줄교두보확보,http://www.insightkorea.co.kr/news/articleView.html?idxno=80809
4664,2020-06-23,신원지이크대웅제약우루사간肝x지컬래버,http://www.fashionbiz.co.kr/TN/?cate=2&recom=2&idx=178822
4665,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.thepublic.kr/news/newsview.php?ncode=1065575213298214
4666,2020-06-23,대웅제약나보타대만시장품목허가중화권진출초읽기,http://theviewers.co.kr/View.aspx?No=880973
4667,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가획득,http://www.seoulfn.com/news/articleView.html?idxno=386706
4668,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.munhwa.com/news/view.html?no=20200623MW104202296861
4669,2020-06-23,대웅제약나보타대만서품목허가중화권진출초읽기,http://news.mk.co.kr/newsRead.php?no=641280&year=2020
4670,2020-06-23,대웅제약나보타대만식품약물관리서품목허가획득,http://www.kpinews.co.kr/news/articleView.html?idxno=119670
4671,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.newsway.co.kr/news/view?tp=1&ud=2020062311160741728
4672,2020-06-23,대웅제약나보타미간주름적응증대만품목허가,http://www.pharmnews.com/news/articleView.html?idxno=100735
4673,2020-06-23,대웅제약나보타대만TFDA품목허가획득,http://www.medigatenews.com/news/3990034547
4674,2020-06-23,대웅제약나보타대만품목허가획득,http://it.chosun.com/site/data/html_dir/2020/06/23/2020062302007.html
4675,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.segyebiz.com/newsView/20200623511273?OutUrl=naver
4676,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.fnnews.com/news/202006231149426528
4677,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.metroseoul.co.kr/article/20200623500239
4678,2020-06-23,대웅제약보툴리눔톡신나보타대만서품목허가획득,https://www.asiatoday.co.kr/view.php?key=20200623010014214
4679,2020-06-23,대웅제약나보타대만품목허가획득중화권진출초읽기,https://www.donga.com/news/article/all/20200623/101646077/1
4680,2020-06-23,대웅제약나보타대만품목허가아시아시장영향력확대,http://www.thevaluenews.co.kr/news/view.php?idx=159847
4681,2020-06-23,대웅제약 나보타 대만품목허가로중화권진출초읽기,http://www.greened.kr/news/articleView.html?idxno=257325
4682,2020-06-23,대웅전일대비525올라외국인43602주순매수,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006230291&t=NN
4683,2020-06-23,대웅361상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/23/2020062302568.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4684,2020-06-23,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006238793L
4685,2020-06-23,대웅885VI발동,https://biz.chosun.com/site/data/html_dir/2020/06/23/2020062302600.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4686,2020-06-23,특징주대웅32150원23일14시30분장시작대비646상승,http://www.getnews.co.kr/view.php?ud=20200623143158172c20b9a6863_16
4687,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.nbnnews.co.kr/news/articleView.html?idxno=401780
4688,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.ybsn.tv/news/articleView.html?idxno=19083
4689,2020-06-23,대웅제약중화권보툴리눔톡신시장진출대만서나보타품목허가획득,http://www.g-enews.com/ko-kr/news/article/news_all/20200623152756190269d76442fa_1/article.html
4690,2020-06-23,대웅제약보톡스나보타대만서품목허가,http://sports.khan.co.kr/news/sk_index.html?art_id=202006231559013&sec_id=561801&pt=nv
4691,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.businesskorea.co.kr/news/articleView.html?idxno=47953
4692,2020-06-23,대웅제약나보타대만품목허가획득중화권진출초읽기,http://sports.hankooki.com/lpage/economy/202006/sp20200623165521137020.htm?s_ref=nv
4693,2020-06-23,대웅제약 나보타대만품목허가중화권진출초읽기,http://www.newslock.co.kr/news/articleView.html?idxno=28947
4694,2020-06-23,대웅제약나보타하반기대만본격진출,http://www.koreastocknews.com/news/articleView.html?idxno=54750
4695,2020-06-23,대웅제약대만에서보툴리눔톡신제제품목허가받아,http://www.businesspost.co.kr/BP?command=article_view&num=184114
4696,2020-06-23,대웅제약보톡스나보타중화권간다,http://www.dt.co.kr/contents.html?article_no=2020062402101031820002&ref=naver
4697,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://www.lawissue.co.kr/view.php?ud=202006232032443650204ead0791_12
4698,2020-06-23,대웅제약나보타대만품목허가로중화권진출초읽기,http://news.kbiz.or.kr/news/articleView.html?idxno=69096
4699,2020-06-23,뉴스투데이L대웅제약나보타대만TFDA로부터품목허가,https://www.news2day.co.kr/155227
4700,2020-06-24,SK바이오팜청약30조제약바이오주2차폭발파미셀일양약품옵티팜바이오팜신풍대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/2020062405310745594a01bf698f_1/article.html
4701,2020-06-24,뿔난의료계대웅제약불매할까,https://www.paxnetnews.com/articles/61830
4702,2020-06-24,대웅5이상상승단기중기이평선정배열로상승세,https://www.hankyung.com/finance/article/202006241924L
4703,2020-06-24,장중수급포착대웅외국인기관동시순매수주가239,http://www.newspim.com/news/view/20200624000313
4704,2020-06-24,대웅제약보톡스나보타메디톡신주춤하는사이판로확대,http://www.sisaweek.com/news/articleView.html?idxno=135035
4705,2020-06-24,대웅전일대비622상승중이시각86만1367주거래,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006240234&t=NN
4706,2020-06-24,대웅734상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/06/24/2020062402306.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4707,2020-06-24,특징주대웅34350원24일13시5분장시작대비905상승,http://www.getnews.co.kr/view.php?ud=202006241306526897c20b97de03_16
4708,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.lawissue.co.kr/view.php?ud=202006241350287152204ead0791_12
4709,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=48018
4710,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트간콜레스테롤케어동시에도와주는제품은,https://www.fetv.co.kr/news/article.html?no=57723
4711,2020-06-24,대웅제약간과콜레스테롤케어동시에도와주는제품은,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118592
4712,2020-06-24,대웅제약건기식홍보캐시워크돈버는퀴즈이벤트,http://news.mt.co.kr/mtview.php?no=2020062414122183646
4713,2020-06-24,대웅제약건기식알리기박차돈버는퀴즈이벤트진행,http://medipana.com/news/news_viewer.asp?NewsNum=258937&MainKind=A&NewsKind=5&vCount=12&vKind=1
4714,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행간과콜레스테롤케어를동시에도와주는제품은,http://www.nbnnews.co.kr/news/articleView.html?idxno=402065
4715,2020-06-24,대웅제약캐시워크돈버는퀴즈진행간과콜레스테롤케어를동시에도와주는제품은,http://theviewers.co.kr/View.aspx?No=882807
4716,2020-06-24,대웅제약x캐시워크돈버는퀴즈이벤트,http://www.upinews.kr/newsView/upi202006240086
4717,2020-06-24,대웅제약건강기능식품캐시워크퀴즈이벤트문제등장,http://www.100ssd.co.kr/news/articleView.html?idxno=69601
4718,2020-06-24,오늘의장바구니이마트GS홈쇼핑이베이코리아대웅제약외,http://www.newsprime.co.kr/news/article.html?no=508926
4719,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.bosa.co.kr/news/articleView.html?idxno=2129320
4720,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행간과콜레스테롤케어를동시에도와주는제품은,http://newsbrite.net/138606
4721,2020-06-24,대웅제약캐시위크앱서건강기능식품문제내는돈버는퀴즈이벤트나서,http://news.mk.co.kr/newsRead.php?no=648277&year=2020
4722,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=61933
4723,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=390971
4724,2020-06-24,뉴스투데이L대웅제약캐시워크돈버는퀴즈이벤트로자사건기식알린다,https://www.news2day.co.kr/155293
4725,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.whosaeng.com/118900
4726,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.bokuennews.com/news/article.html?no=191704
4727,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,https://www.youthdaily.co.kr/news/article.html?no=40454
4728,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.thefirstmedia.net/news/articleView.html?idxno=59710
4729,2020-06-24,대웅제약건강기능식품퀴즈이벤트진행,http://www.dailymedi.com/detail.php?number=857501&thread=22r05
4730,2020-06-24,대웅제약캐시워크돈버는퀴즈이벤트열어,http://www.econovill.com/news/articleView.html?idxno=402214
4731,2020-06-25,대웅제약나보타대만품목허가받아,https://www.kpanews.co.kr/article/show.asp?idx=214182&category=D
4732,2020-06-25,대웅제약건기식소비자이벤트캐시워크돈버는퀴즈이벤트열어,https://www.kpanews.co.kr/article/show.asp?idx=214190&category=D
4733,2020-06-25,대웅제약나보타대만품목허가로중화권진출순항,http://www.thefirstmedia.net/news/articleView.html?idxno=59758
4734,2020-06-25,코로나192차대폭발다우지수와르르씨젠영업익급증삼성전자LG화학옵티팜대웅제약파미셀일양약품셀트리온제약주가출렁,http://www.thekpm.com/view.php?ud=202006250543468007861beb2d9d_17
4735,2020-06-25,하루확진자3만6000명LTE급속도씨젠수젠텍코젠바이오텍출혈경쟁괜찮나그리고부광약품신풍제약옵티팜신일제약중외제약대웅제약,http://www.thekpm.com/view.php?ud=202006250734314819861beb2d9d_17
4736,2020-06-25,통계불법수집대웅제약전사마케팅활용,https://www.paxnetnews.com/articles/62018
4737,2020-06-25,대웅제약보툴리눔톡신나보타글로벌브랜드화속도낸다,http://www.dt.co.kr/contents.html?article_no=2020062502109919607003&ref=naver
4738,2020-06-25,대웅제약캐시워크돈버는퀴즈이벤트진행,http://www.wsobi.com/news/articleView.html?idxno=99976
4739,2020-06-25,경찰조계사대웅전서불지른30대기소의견송치,http://yna.kr/AKR20200625080800004?did=1195m
4740,2020-06-25,대웅제약 25일캐시워크돈버는퀴즈이벤트진행,http://www.greened.kr/news/articleView.html?idxno=257714
4741,2020-06-25,글로벌시장우리가간다”대웅제약나보타이을신약RD박차,http://www.kukinews.com/news/article.html?no=802980
4742,2020-06-25,대웅제약캐시워크돈버는퀴즈이벤트진행어떤퀴즈나오나,http://www.anewsa.com/detail.php?number=2159023&thread=10
4743,2020-06-25,에너씨슬콜레다운대웅제약캐시워크돈버는퀴즈2시정답실시간정답OPEN,https://nc.asiae.co.kr/view.htm?idxno=2020062513365186319
4744,2020-06-25,술취해조계사대웅전서불지른30대남성기소의견송치,http://www.segye.com/content/html/2020/06/25/20200625513844.html?OutUrl=naver
4745,2020-06-25,대웅제약캐시워크퀴즈이벤트진행,http://www.newsworks.co.kr/news/articleView.html?idxno=466877
4746,2020-06-25,대웅제약캐시워크돈버는퀴즈오후2시문제정답은,http://www.anewsa.com/detail.php?number=2159129&thread=10
4747,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://enter.etoday.co.kr/view/news_view.php?varAtcId=182666
4748,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.joygm.com/news/articleView.html?idxno=85492
4749,2020-06-25,이인애의뒷담화대웅제약하나제약영업수완뒤민낯,http://theviewers.co.kr/View.aspx?No=884120
4750,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,https://www.asiatime.co.kr/news/newsview.php?ncode=1065591466489256
4751,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답업데이트,http://www.anewsa.com/detail.php?number=2159178&thread=10
4752,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.ccdn.co.kr/news/articleView.html?idxno=651265
4753,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈25일정답총정리,http://www.ajunews.com/view/20200625145648622
4754,2020-06-25,캐시워크대웅제약에너씨슬콜레다운돈버는퀴즈정답은무엇일까,http://www.newsfarm.co.kr/news/articleView.html?idxno=57036
4755,2020-06-25,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈업데이트정답은,http://www.joygm.com/news/articleView.html?idxno=85494
4756,2020-06-25,매일반복되는야근대웅제약밀크씨슬주목도급상승피로한간을위한선택에너씨슬,http://www.thekpm.com/view.php?ud=202006251538125831861beb2d9d_17
4757,2020-06-25,자율성높이자업무효율상승대웅제약사내문화변화바람,http://www.meconomynews.com/news/articleView.html?idxno=42820
4758,2020-06-25,국내제약바이오10개사미국보스턴에둥지대웅제약동성제약동아에스티보령제약삼일제약아밀로이드솔루션일동제약종근당현대약품휴온스,http://www.topstarnews.net/news/articleView.html?idxno=812430
4759,2020-06-25,대웅제약동아에스티등10개제약사미국보스턴CIC입주완료,https://www.sedaily.com/NewsView/1Z45YKJNJF
4760,2020-06-25,제약협회대웅동아보령등10개사미국보스턴CIC진출,http://www.medigatenews.com/news/848099157
4761,2020-06-25,대웅제약등10곳제약사최대의약품시장미국에새둥지틀어,http://www.wikileaks-kr.org/news/articleView.html?idxno=89730
4762,2020-06-25,종근당대웅제약등제약바이오10개사미국보스턴에둥지,http://www.dt.co.kr/contents.html?article_no=2020062502109931820010&ref=naver
4763,2020-06-25,대웅바이오종근당매출효자치매치료제임상재평가로부담커져,http://www.businesspost.co.kr/BP?command=article_view&num=184494
4764,2020-06-26,SK바이오팜31조원오늘일제방출코로나관련주폭발대웅제약파미셀코미팜SK바이오팜일양,http://www.g-enews.com/ko-kr/news/article/news_all/2020062602425236264a01bf698f_1/article.html
4765,2020-06-26,의사들이선호하는디지털마케팅제약사는한미대웅MSD,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134410&REFERER=NP
4766,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=48115
4767,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246019
4768,2020-06-26,우루사를입자대웅제약지이크와우루사브랜드활용패션상품출시,https://www.fetv.co.kr/news/article.html?no=57887
4769,2020-06-26,우루사를입는다대웅제약지이크와손잡고패션상품출시,http://www.mediapen.com/news/view/536033
4770,2020-06-26,대웅제약정장브랜드지이크와협업젊은층에우루사공략,http://www.kpinews.co.kr/news/articleView.html?idxno=119953
4771,2020-06-26,대웅제약젊은감성더한우루사BI활용패션상품출시,http://www.ekn.kr/news/article.html?no=507615
4772,2020-06-26,대웅제약지이크와우루사브랜드활용패션상품선보여,http://www.pressm.kr/news/articleView.html?idxno=30788
4773,2020-06-26,대웅제약지이크우루사브랜드활용패션상품출시,http://medipana.com/news/news_viewer.asp?NewsNum=259040&MainKind=A&NewsKind=5&vCount=12&vKind=1
4774,2020-06-26,대웅제약지이크콜라보레이션이제입는우루사,http://moneys.mt.co.kr/news/mwView.php?no=2020062609238058968
4775,2020-06-26,대웅제약지이크와 우루사 콜라보패션상품출시우루사를입자,http://www.greened.kr/news/articleView.html?idxno=257855
4776,2020-06-26,의사들이뽑은디지털마케팅한미대웅MSD순,http://www.dailypharm.com/Users/News/NewsView.html?ID=265948&REFERER=NP
4777,2020-06-26,대웅제약우루사티셔츠출시뉴트로열풍가세,https://www.dailian.co.kr/news/view/900593?sc=Naver
4778,2020-06-26,대웅제약젊은감성정장브랜드지이크와코라보우루사티셔츠슬리퍼양말출시,http://theviewers.co.kr/View.aspx?No=884829
4779,2020-06-26,대웅제약지이크와우루사브랜드활용패션출시이제는입는우루사,https://www.etoday.co.kr/news/view/1910994
4780,2020-06-26,대웅제약지이크협업우루사 브랜드활용패션상품출시,http://www.newslock.co.kr/news/articleView.html?idxno=29021
4781,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.m-i.kr/news/articleView.html?idxno=723762
4782,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시이제는입는우루사,http://www.dailysmart.co.kr/news/articleView.html?idxno=28881
4783,2020-06-26,대웅제약우루사정장브랜드지이크컬래버제약패션협업,http://www.consumuch.com/news/articleView.html?idxno=49525
4784,2020-06-26,대웅제약지이크와우루사패션상품출시,https://www.asiatoday.co.kr/view.php?key=20200626010016575
4785,2020-06-26,대웅제약뉴트로열풍에가세우루사를신는다,http://www.sisaweek.com/news/articleView.html?idxno=135131
4786,2020-06-26,뉴스투데이L대웅제약패션브랜드지이크와우루사패션상품3종출시,https://www.news2day.co.kr/155414
4787,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.fnnews.com/news/202006261043046090
4788,2020-06-26,대웅제약우루사x지이크패션상품출시 ,http://www.seoulfn.com/news/articleView.html?idxno=387150
4789,2020-06-26,이제는입는우루사대웅제약지이크와우루사브랜드활용한패션상품선보여,http://www.betanews.net:8080/article/1198141.html
4790,2020-06-26,대웅제약입는우루사출시패션브랜드지이크맞손,http://www.newstomato.com/ReadNews.aspx?no=980444
4791,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,https://jhealthmedia.joins.com/article/article_view.asp?pno=22033
4792,2020-06-26,대웅제약정장브랜드지이크와협업우루사곰담긴패션상품선봬,http://www.getnews.co.kr/view.php?ud=2020062611250972452fe691f917_16
4793,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020062611240540190
4794,2020-06-26,이제우루사를입는다대웅제약지이크패션상품출시,http://yna.kr/AKR20200626065500017?did=1195m
4795,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://newsbrite.net/138692
4796,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=391224
4797,2020-06-26,대웅제약이제는입는우루사,http://www.bosa.co.kr/news/articleView.html?idxno=2129453
4798,2020-06-26,한미대웅유한녹십자보령비대면마케팅평점,http://www.dailymedi.com/detail.php?number=857574&thread=22r05
4799,2020-06-26,이번엔우루사다대웅제약지이크와티셔츠슬리퍼등선보여,http://www.ajunews.com/view/20200626123843370
4800,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시이제는입는우루사,http://www.nbnnews.co.kr/news/articleView.html?idxno=402625
4801,2020-06-26,패션계진출한우루사대웅제약지이크협업패션상품3종출시,https://www.donga.com/news/article/all/20200626/101701889/1
4802,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시이제는입는우루사,http://www.ybsn.tv/news/articleView.html?idxno=19721
4803,2020-06-26,주간신상태크아모레퍼시픽LF세븐일레븐대웅제약신라호텔외,http://www.newsprime.co.kr/news/article.html?no=509200
4804,2020-06-26,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.lawissue.co.kr/view.php?ud=202006261447559692204ead0791_12
4805,2020-06-26,대웅제약정장브랜드지이크와협업해우루사활용패션상품내놔,http://www.businesspost.co.kr/BP?command=article_view&num=184627
4806,2020-06-26,대웅제약지이크우루사활용한패션상품출시,http://www.finomy.com/news/articleView.html?idxno=79583
4807,2020-06-26,대웅제약우루사패션브랜드지이크와협업통한패션상품3종출시,http://news.mk.co.kr/newsRead.php?no=657232&year=2020
4808,2020-06-26,대웅제약지이크우루사브랜드활용한패션상품출시,https://www.ebn.co.kr/news/view/1440120?sc=Naver
4809,2020-06-26,우루사입으면피로가싹대웅제약지이크이색콜라보,https://www.sedaily.com/NewsView/1Z46F3JILF
4810,2020-06-26,대웅제약우루사×지이크이색콜라보여름패션3종출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200626018
4811,2020-06-26,종근당셀트리온GC녹십자대웅제약코로나19치료제개발선두주자는,http://www.insightkorea.co.kr/news/articleView.html?idxno=80895
4812,2020-06-26,우루사입으세요지이크대웅제약과머리부터간끝까지컬렉션,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202006260336&t=NN
4813,2020-06-26,이제는입는우루사대웅제약패션상품출시,http://www.koreaittimes.com/news/articleView.html?idxno=98584
4814,2020-06-27,대웅제약x지이크우루사브랜드활용한패션상품출시,http://news.kbiz.or.kr/news/articleView.html?idxno=69277
4815,2020-06-27,대웅제약부광약품등정부코로나19치료제후보물질연구기업지정임박,http://www.thevaluenews.co.kr/news/view.php?idx=159913
4816,2020-06-28,대웅제약지이크와우루사브랜드활용한패션상품출시,http://www.thepublic.kr/news/newsview.php?ncode=1065595996098329
4817,2020-06-28,입는피로회복제대웅제약우루사티셔츠와양말로재탄생,http://www.metroseoul.co.kr/article/20200628500143
4818,2020-06-28,시경Today제약대웅제약지이크와우루사브랜드활용패션상품출시外,http://www.meconomynews.com/news/articleView.html?idxno=42854
4819,2020-06-28,대웅제약우루사지이크와콜라보상품출시,http://www.dailymedi.com/detail.php?number=857602&thread=22r05
4820,2020-06-29,우루사정장대웅제약의짜릿한외도,https://www.sedaily.com/NewsView/1Z47Q1OBSP
4821,2020-06-29,대웅제약참지마요사회공헌프로그램2기해단식성료,http://www.kpinews.co.kr/news/articleView.html?idxno=120050
4822,2020-06-29,대웅제약참지마요프로젝트2기봉사단비대면해단식,http://www.press9.kr/news/articleView.html?idxno=45129
4823,2020-06-29,대웅제약참지마요프로젝트제2기대학생80명봉사단비대면해단식실시,http://www.pressm.kr/news/articleView.html?idxno=30829
4824,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식,http://medipana.com/news/news_viewer.asp?NewsNum=259110&MainKind=A&NewsKind=5&vCount=12&vKind=1
4825,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.businesskorea.co.kr/news/articleView.html?idxno=48193
4826,2020-06-29,대웅제약참지마요프로젝트대학생봉사단비대면해단식,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246084
4827,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.m-i.kr/news/articleView.html?idxno=724229
4828,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식성료,http://www.ekn.kr/news/article.html?no=507966
4829,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,https://www.fetv.co.kr/news/article.html?no=58030
4830,2020-06-29,대웅제약참지마요제2기봉사단비대면해단식진행,http://www.mediapen.com/news/view/536603
4831,2020-06-29,대웅제약참지마요프로젝트대학생봉사단비대면해단식진행,https://www.youthdaily.co.kr/news/article.html?no=40716
4832,2020-06-29,대웅제약참지마요프로젝트대학생봉사단2기의비대면해단식진행,http://news.mk.co.kr/newsRead.php?no=661965&year=2020
4833,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://newsbrite.net/138757
4834,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단비대면해단식실시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572814986722
4835,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식비대면진행발달장애인교육봉사,http://theviewers.co.kr/View.aspx?No=886331
4836,2020-06-29,대웅제약사회공헌참지마요프로젝트2기대학생봉사단해단식,http://news.mt.co.kr/mtview.php?no=2020062909595672754
4837,2020-06-29,대웅제약제2기대학생봉사단비대면해단식진행,http://www.bosa.co.kr/news/articleView.html?idxno=2129535
4838,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식,http://www.newsprime.co.kr/news/article.html?no=509312
4839,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.thepublic.kr/news/newsview.php?ncode=1065576460774530
4840,2020-06-29,대웅제약참지마요프로젝트봉사단비대면해단식진행,http://www.mhj21.com/132071
4841,2020-06-29,대웅제약참지마요프로젝트2기대학생봉사단해단식,http://moneys.mt.co.kr/news/mwView.php?no=2020062910448011126
4842,2020-06-29,대웅제약화상프로그램으로참지마요프로젝트2기해단식진행,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=225513
4843,2020-06-29,대웅제약참지마요2기활동마무리 ,http://www.seoulfn.com/news/articleView.html?idxno=387361
4844,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.lawissue.co.kr/view.php?ud=202006291249178348204ead0791_12
4845,2020-06-29,대웅제약참지마요프로젝트2기비대면해단식진행,http://www.dailysmart.co.kr/news/articleView.html?idxno=28966
4846,2020-06-29,재계톡톡대웅제약영업직원환자정보불법수집폭로,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=663514
4847,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.nbnnews.co.kr/news/articleView.html?idxno=403058
4848,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=391423
4849,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.updownnews.co.kr/news/articleView.html?idxno=220312
4850,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.getnews.co.kr/view.php?ud=2020062914173892352fe691f917_16
4851,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단해단식진행,http://sports.hankooki.com/lpage/economy/202006/sp20200629144208136980.htm?s_ref=nv
4852,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.ybsn.tv/news/articleView.html?idxno=20124
4853,2020-06-29,대웅제약참지마요프로젝트2기봉사단화상해단식,http://www.consumuch.com/news/articleView.html?idxno=49552
4854,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식,http://www.ajunews.com/view/20200629170505216
4855,2020-06-29,대웅제약26일참지마요대학생봉사단해단식진행,http://www.finomy.com/news/articleView.html?idxno=79667
4856,2020-06-29,대웅제약참지마요2기대학생봉사단비대면해단식진행,http://www.100ssd.co.kr/news/articleView.html?idxno=69724
4857,2020-06-29,뉴스투데이L대웅제약참지마요프로젝트2기대학생봉사단비대면해단식진행,https://www.news2day.co.kr/155589
4858,2020-06-29,대웅제약참지마요프로젝트제2기대학생봉사단비대면해단식진행,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62000
4859,2020-06-29,대웅참지마요프로젝트대학생봉사단비대면해단식,http://www.whosaeng.com/118998
4860,2020-06-30,대웅제약참지마요프로젝트대학생봉사단비대면해단식열어,https://www.kpanews.co.kr/article/show.asp?idx=214295&category=D
4861,2020-06-30,대웅제약비만예방포스터디자인공모전개최,https://www.fetv.co.kr/news/article.html?no=58134
4862,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246142
4863,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://medipana.com/news/news_viewer.asp?NewsNum=259165&MainKind=A&NewsKind=5&vCount=12&vKind=1
4864,2020-06-30,대웅제약비만예방포스터디자인공모전개최,https://www.ebn.co.kr/news/view/1440416/?sc=Naver
4865,2020-06-30,대웅제약비만예방포스터공모질병이라는인식강화해야”,http://theviewers.co.kr/View.aspx?No=887620
4866,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://news.mt.co.kr/mtview.php?no=2020063009245108537
4867,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.kpinews.co.kr/news/articleView.html?idxno=120173
4868,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.press9.kr/news/articleView.html?idxno=45146
4869,2020-06-30,대웅제약비만예방포스터디자인공모전개최심각성알리기위해기획,http://www.m-i.kr/news/articleView.html?idxno=724686
4870,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62006
4871,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=118794
4872,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.koreaittimes.com/news/articleView.html?idxno=98640
4873,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://news.mk.co.kr/newsRead.php?no=666598&year=2020
4874,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.fnnews.com/news/202006300946414249
4875,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://newsbrite.net/138816
4876,2020-06-30,대웅제약비만예방포스터디자인공모연다,http://www.mhj21.com/132102
4877,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.newsis.com/view/?id=NISX20200630_0001077642&cID=13001&pID=13000
4878,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.youthdaily.co.kr/news/article.html?no=40847
4879,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.polinews.co.kr/news/article.html?no=467443
4880,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=48266
4881,2020-06-30,대웅제약비만의심각성알리기위한포스터공모전개최,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573248208175
4882,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.newsway.co.kr/news/view?tp=1&ud=2020063010350981560
4883,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.getnews.co.kr/view.php?ud=2020063010425671412fe691f917_16
4884,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.ekn.kr/news/article.html?no=508308
4885,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://sports.hankooki.com/lpage/economy/202006/sp20200630104913136980.htm?s_ref=nv
4886,2020-06-30,대웅제약내달1일비만예방포스터디자인공모전개최,http://www.newslock.co.kr/news/articleView.html?idxno=29115
4887,2020-06-30,대웅제약비만경각심차원비만예방포스터디자인공모전개최,http://www.pressm.kr/news/articleView.html?idxno=30890
4888,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.ybsn.tv/news/articleView.html?idxno=20261
4889,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=29025
4890,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.bosa.co.kr/news/articleView.html?idxno=2129653
4891,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.whosaeng.com/119053
4892,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.ajunews.com/view/20200630135002876
4893,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.iminju.net/news/articleView.html?idxno=54781
4894,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=403423
4895,2020-06-30,대웅제약비만예방포스터디자인공모전개최사회적인식강화차원,http://www.paxetv.com/news/articleView.html?idxno=95209
4896,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.mediapen.com/news/view/537120
4897,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.lawissue.co.kr/view.php?ud=202006301514201563204ead0791_12
4898,2020-06-30,대웅전일대비517하락거래량은전일3배이상,https://www.tfmedia.co.kr/news/article.html?no=87389
4899,2020-06-30,대웅제약비만심각성알린다포스터디자인공모전개최,http://www.econovill.com/news/articleView.html?idxno=402788
4900,2020-06-30,대웅제약비만예방포스터디자인공모전,http://www.fnnews.com/news/202006301716232497
4901,2020-06-30,대웅제약비만은질병알리는포스터공모전개최,http://www.100ssd.co.kr/news/articleView.html?idxno=69768
4902,2020-06-30,대웅제약비만예방포스터디자인공모전개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=391652
4903,2020-07-01,대웅제약비만예방포스터디자인공모전개최,http://www.thefirstmedia.net/news/articleView.html?idxno=59944
4904,2020-07-01,SK바이오팜첫날200제약바이오2차폭발대웅동성동아보령삼일일동종근당현대,http://www.g-enews.com/ko-kr/news/article/news_all/2020063020274638444a01bf698f_1/article.html
4905,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.getnews.co.kr/view.php?ud=2020070109072344662fe691f917_16
4906,2020-07-01,양치힘강조한특허칫솔대웅제약덴티가드랩그립핏칫솔출시,https://www.fetv.co.kr/news/article.html?no=58236
4907,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.mediapen.com/news/view/537294
4908,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.youthdaily.co.kr/news/article.html?no=40973
4909,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.kpinews.co.kr/news/articleView.html?idxno=120304
4910,2020-07-01,대웅제약양치힘좋은칫솔덴티가드랩그립핏정식출시,http://news.mt.co.kr/mtview.php?no=2020070109220277791
4911,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.m-i.kr/news/articleView.html?idxno=725170
4912,2020-07-01,대웅제약덴티가드랩그립핏칫솔출시프라그제거에필요한양치힘강조,http://theviewers.co.kr/View.aspx?No=888964
4913,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://medipana.com/news/news_viewer.asp?NewsNum=259276&MainKind=A&NewsKind=5&vCount=12&vKind=1
4914,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=29082
4915,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.press9.kr/news/articleView.html?idxno=45166
4916,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=58285
4917,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.newsis.com/view/?id=NISX20200701_0001079345&cID=13001&pID=13000
4918,2020-07-01,대웅제약항혈전제안플원출시5주년기념웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=120339
4919,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.youthdaily.co.kr/news/article.html?no=41001
4920,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246225
4921,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.bokuennews.com/news/article.html?no=191944
4922,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572520327885
4923,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,https://www.asiatoday.co.kr/view.php?key=20200701010000272
4924,2020-07-01,대웅제약안플원웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=45170
4925,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.wsobi.com/news/articleView.html?idxno=100357
4926,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://newsbrite.net/138874
4927,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://newsbrite.net/138884
4928,2020-07-01,대웅제약항혈전제안플원출시5주년웹심포지엄개최,http://www.consumuch.com/news/articleView.html?idxno=49573
4929,2020-07-01,대웅제약안플원 출시 5주년기념 2차심포지엄개최,http://www.economytalk.kr/news/articleView.html?idxno=206841
4930,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=259297&MainKind=A&NewsKind=5&vCount=12&vKind=1
4931,2020-07-01,대웅제약안플원두번째웹심포지엄진행,http://www.whosaeng.com/119084
4932,2020-07-01,대웅제약안플원 출시 5주년기념 2차웹심포지엄개최,http://www.greened.kr/news/articleView.html?idxno=258588
4933,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=391722
4934,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.koreaittimes.com/news/articleView.html?idxno=98679
4935,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=725265
4936,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62049
4937,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62060
4938,2020-07-01,대웅제약안플원출시5주년2차웹심포지엄개최,http://www.newslock.co.kr/news/articleView.html?idxno=29161
4939,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.bosa.co.kr/news/articleView.html?idxno=2129737
4940,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1397487
4941,2020-07-01,대웅제약자유로운사내문화조성힘써여름엔사무실에서반바지,http://www.thefirstmedia.net/news/articleView.html?idxno=59965
4942,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2129747
4943,2020-07-01,와디즈서목표의10배펀딩대웅제약덴티가드랩그립핏칫솔출시,http://news.mk.co.kr/newsRead.php?no=673218&year=2020
4944,2020-07-01,대웅제약2일항혈전제안플원출시5주년기념2차웹심포지엄개최,http://news.mk.co.kr/newsRead.php?no=673351&year=2020
4945,2020-07-01,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=211833
4946,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,https://www.ebn.co.kr/news/view/1440735/?sc=Naver
4947,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=403723
4948,2020-07-01,대웅제약안플원출시5주년기념닥터빌서2차웹심포지엄개최,http://www.pressm.kr/news/articleView.html?idxno=30969
4949,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.metroseoul.co.kr/article/20200701500437
4950,2020-07-01,대웅제약2일항혈전제안플원출시5주년2차웹심포지엄,http://news.mt.co.kr/mtview.php?no=2020070115305612640
4951,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최처방옵션및정보공유,http://www.paxetv.com/news/articleView.html?idxno=95317
4952,2020-07-01,대웅제약안플원출시5주년맞이2차웹심포지움열어,https://www.kpanews.co.kr/article/show.asp?idx=214369&category=D
4953,2020-07-01,대웅제약와디즈인기얻은덴티가드랩그립핏칫솔선봬,https://www.kpanews.co.kr/article/show.asp?idx=214371&category=D
4954,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1397632
4955,2020-07-01,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.mediapen.com/news/view/537566
4956,2020-07-01,대웅제약항혈전제안플원출시5주년기념2차심포지엄개최,https://www.donga.com/news/article/all/20200701/101777693/1
4957,2020-07-01,대웅제약안플원출시5주년웹심포지엄개최,http://www.100ssd.co.kr/news/articleView.html?idxno=69786
4958,2020-07-01,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=2020070119553889204ead0791_12
4959,2020-07-01,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.lawissue.co.kr/view.php?ud=202007012117322214204ead0791_12
4960,2020-07-01,뉴스투데이L대웅제약안플원출시5주년기념2차웹심포지엄개최,https://www.news2day.co.kr/155755
4961,2020-07-01,오늘의신상품대웅제약덴티가드랩그립핏칫솔출시,http://www.econovill.com/news/articleView.html?idxno=403132
4962,2020-07-02,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=60041
4963,2020-07-02,대웅제약덴티가드랩그립핏칫솔정식출시,http://www.thefirstmedia.net/news/articleView.html?idxno=60047
4964,2020-07-02,대웅바이오종근당콜린알포세레이트포기안한다,http://www.bosa.co.kr/news/articleView.html?idxno=2129764
4965,2020-07-02,대웅제약안플원2차웹심포지엄진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571277217065
4966,2020-07-02,대웅제약안플원출시5주년기념2차웹심포지엄개최,http://www.thepublic.kr/news/newsview.php?ncode=1065575037493184
4967,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62100
4968,2020-07-02,대웅제약메티톡스로이직한前직원상대손배소허위사실유포,http://www.newspim.com/news/view/20200702000608
4969,2020-07-02,대웅제약메디톡스이직전직원소송허위사실유포,https://www.hankyung.com/finance/article/2020070248636
4970,2020-07-02,대웅제약메디톡스로이직한전직원상대허위사실유포혐의로소송,http://www.kukinews.com/news/article.html?no=805507
4971,2020-07-02,대웅제약메디톡스로이직한유모씨상대손해배상청구소송제기,http://www.wikileaks-kr.org/news/articleView.html?idxno=90177
4972,2020-07-02,대웅제약메디톡스로이직한전직원상대로소송허위사실유포혐의,http://www.ajunews.com/view/20200702113954874
4973,2020-07-02,대웅제약메디톡스이직한전직원허위사실유포로고소,https://www.news1.kr/articles/?3983868
4974,2020-07-02,대웅제약메디톡스로이직한전직원에소송ITC에허위자료제출”,http://daily.hankooki.com/lpage/industry/202007/dh20200702114714148390.htm?s_ref=nv
4975,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기∙∙허위사실유포혐의,http://www.businesskorea.co.kr/news/articleView.html?idxno=48408
4976,2020-07-02,대웅제약메디톡스이직직원에소송허위사실유포,http://news.mt.co.kr/mtview.php?no=2020070211470627783
4977,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기허위사실유포혐의,http://www.updownnews.co.kr/news/articleView.html?idxno=220459
4978,2020-07-02,대웅제약메디톡스로이직한전직원제소허위사실유포,http://www.newsis.com/view/?id=NISX20200702_0001081431&cID=13001&pID=13000
4979,2020-07-02,대웅제약메디톡스이직前직원허위사실유포로고소”,http://www.youthdaily.co.kr/news/article.html?no=41131
4980,2020-07-02,대웅제약메디톡스로이직한대웅제약前직원상대소송제기”,https://biz.chosun.com/site/data/html_dir/2020/07/02/2020070202065.html?utm_source=naver&utm_medium=original&utm_campaign=biz
4981,2020-07-02,대웅제약메디톡스이직전직원상대소송제기허위사실유포혐의”,http://www.viva100.com/main/view.php?key=20200702010000433
4982,2020-07-02,대웅제약메디톡스로이직한전직원상대로소송제기,http://www.econovill.com/news/articleView.html?idxno=403191
4983,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기,http://www.medigatenews.com/news/1841067745
4984,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기”,http://www.newsway.co.kr/news/view?tp=1&ud=2020070211402196851
4985,2020-07-02,대웅제약메디톡스로이직한대웅제약전직원허위사실유포혐의로고소,http://www.sisafocus.co.kr/news/articleView.html?idxno=242611
4986,2020-07-02,대웅제약소송위해메디톡스로이직전직원상대소송제기,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246291
4987,2020-07-02,대웅제약소송위해메디톡스이직대웅제약전직원상대소송제기허위사실유포혐의”,http://newsclaim.co.kr/View.aspx?No=890942
4988,2020-07-02,대웅제약메디톡스이직전직원상대소송제기허위사실유포,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070212555998992
4989,2020-07-02,대웅제약메디톡스로이직한前직원상대소송제기,http://www.pharmnews.com/news/articleView.html?idxno=100812
4990,2020-07-02,대웅제약메디톡스이직전직원상대손해배상청구소송제기허위사실유포했다”,https://www.donga.com/news/article/all/20200702/101789997/1
4991,2020-07-02,대웅제약메디톡스로이직한前직원상대소송,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007020238&t=NN
4992,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기∙∙∙허위사실유포혐의,http://www.nbnnews.co.kr/news/articleView.html?idxno=404046
4993,2020-07-02,대웅제약메디톡스로이직한전직원에허위사실유포혐의로손배소,http://news.mk.co.kr/newsRead.php?no=678397&year=2020
4994,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기허위사실유포혐의,https://www.sedaily.com/NewsView/1Z55B5ZAQT
4995,2020-07-02,대웅제약메디톡스이직직원에게손배소허위사실유포,http://moneys.mt.co.kr/news/mwView.php?no=2020070213328092550
4996,2020-07-02,대웅제약메디톡스로이직한대웅前직원상대소송제기,http://www.edaily.co.kr/news/newspath.asp?newsid=02952006625830584
4997,2020-07-02,대웅제약메디톡스로이직한전직원소송허위사실유포,http://www.seoulwire.com/news/articleView.html?idxno=418614
4998,2020-07-02,대웅제약메디톡스로이직한前직원소송허위사실유포”,http://inthenews.co.kr/article-56725/
4999,2020-07-02,대웅제약허위사실유포한메디톡스이직前직원상대로소송제기,http://it.chosun.com/site/data/html_dir/2020/07/02/2020070202479.html
5000,2020-07-02,대웅제약메디톡스로이직한유모씨에손해배상청구,http://www.kpinews.co.kr/news/articleView.html?idxno=120522
5001,2020-07-02,대웅제약메디톡스로이직전직원에허위사실유포손배소,http://yna.kr/AKR20200702110200017?did=1195m
5002,2020-07-02,대웅제약메디톡스이직전직원소송허위사실유포,http://www.dailysmart.co.kr/news/articleView.html?idxno=29198
5003,2020-07-02,대웅제약메디톡스이직한前직원에소송허위사실유포했다”,https://www.etoday.co.kr/news/view/1913421
5004,2020-07-02,대웅제약메디톡스로이직대웅제약前직원상대소송제기”,https://www.fetv.co.kr/news/article.html?no=58439
5005,2020-07-02,대웅제약메디톡스로옮긴前직원에허위사실유포손배소,http://news.mk.co.kr/newsRead.php?no=678826&year=2020
5006,2020-07-02,美ITC예비판정D4대웅제약전면공세vs메디톡스담담왜,https://www.paxnetnews.com/articles/62518
5007,2020-07-02,대웅제약메디톡스이직한전직원상대소송제기,http://www.getnews.co.kr/view.php?ud=2020070214492848552fe691f917_16
5008,2020-07-02,대웅제약메디톡스로이직한전직원상대소송허위사실유포혐의,http://www.newsprime.co.kr/news/article.html?no=509804
5009,2020-07-02,대웅제약메디톡스이직전직원제소허위사실유포,https://view.asiae.co.kr/article/2020070215013197317
5010,2020-07-02,대웅제약메디톡스로이직한전직원상대소송제기허위사실유포혐의,http://www.m-i.kr/news/articleView.html?idxno=725926
5011,2020-07-02,대웅제약소송위해메디톡스이직한전직원소송제기,http://medipana.com/news/news_viewer.asp?NewsNum=259394&MainKind=A&NewsKind=5&vCount=12&vKind=1
5012,2020-07-02,대웅제약메디톡스이직한전직원소송허위사실유포,http://sports.hankooki.com/lpage/economy/202007/sp20200702151423137020.htm?s_ref=nv
5013,2020-07-02,대웅제약메디톡스로이직한전직원상대로손해배상청구소송,http://www.businesspost.co.kr/BP?command=article_view&num=185541
5014,2020-07-02,대웅제약소송위해메디톡스로이직한대웅제약전직원상대소송제기∙∙∙허위사실유포혐의”,http://newsbrite.net/138956
5015,2020-07-02,대웅제약메디톡스이직전직원A씨소송허위사실유포했다,http://www.ftoday.co.kr/news/articleView.html?idxno=203494
5016,2020-07-02,대웅제약메디톡스로이직한전직원에허위사실유포소송,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4204063
5017,2020-07-02,대웅제약닥터빌에서안플원2차웨비나개최,http://www.medigatenews.com/news/2142416364
5018,2020-07-02,대웅제약메디톡스이직한전직원에허위사실유포손배청구,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004029060
5019,2020-07-02,대웅제약메디톡스로이직한대웅제약전직원에소송제기”,https://www.dailian.co.kr/news/view/902265?sc=Naver
5020,2020-07-02,대웅제약타사이직직원에소송허위사실유포혐의,http://www.finomy.com/news/articleView.html?idxno=79848
5021,2020-07-02,대웅제약메디톡스이직전직원상대허위사실유포손배소,http://www.seoulfn.com/news/articleView.html?idxno=387890
5022,2020-07-02,대웅제약메디톡스이직한전직원상대손배소제기,http://www.mediapen.com/news/view/537797
5023,2020-07-02,대웅제약메디톡스위기노려보톡스분쟁뒤집기시도,http://www.seouleconews.com/news/articleView.html?idxno=55418
5024,2020-07-02,대웅제약공익신고자대리인메디톡스흠집내기합세ITC예비판정앞두고불안감표출,http://theviewers.co.kr/View.aspx?No=902466
5025,2020-07-02,대웅제약메디톡스이직한前직원소송제기허위사실유포혐의,http://www.todaykorea.co.kr/news/articleView.html?idxno=273286
5026,2020-07-02,대웅제약메디톡스로이직대웅전직원에소송,https://www.kpanews.co.kr/article/show.asp?idx=214397&category=D
5027,2020-07-02,대웅제약메디톡스로이직한직원상대손배소,https://hankookilbo.com/News/Read/A2020070217030002353?did=NA
5028,2020-07-02,끝나지않은보톡스전쟁대웅제약메디톡스이직자상대허위사실유포소송,http://sports.chosun.com/news/ntype.htm?id=202007030100027240001479&servicedate=20200702
5029,2020-07-02,대웅제약메디톡스이직직원에허위사실유포손배소,http://news.kmib.co.kr/article/view.asp?arcid=0014759367&code=61141411&cp=nv
5030,2020-07-02,대웅제약비만예방포스터디자인공모전열어,https://www.kpanews.co.kr/article/show.asp?idx=214399&category=D
5031,2020-07-02,대웅제약ITC소송제출된모든자료공개해확인하면누가거짓말하는지알수있다,http://www.segye.com/content/html/2020/07/02/20200702520730.html?OutUrl=naver
5032,2020-07-02,올상반기제약사세무조사동광제약등5곳대웅바이오주목,http://www.sisajournal-e.com/news/articleView.html?idxno=220656
5033,2020-07-02,김창수의e뉴스브리핑대웅제약메디톡스로이직대웅제약前직원상대소송제기”外,https://www.fetv.co.kr/news/article.html?no=58469
5034,2020-07-02,대웅제약메디톡스이직前직원상대소송∙∙∙허위사실유포그만해야,http://www.newslock.co.kr/news/articleView.html?idxno=29223
5035,2020-07-02,대웅제약메디톡스직원허위사실유포혐의고소,http://www.100ssd.co.kr/news/articleView.html?idxno=69810
5036,2020-07-02,대웅제약메디톡스이직한前직원상대로소송제기,http://www.cstimes.com/news/articleView.html?idxno=420721
5037,2020-07-02,대웅제약메디톡스로이직前직원에허위사실유포손배소,https://www.asiatoday.co.kr/view.php?key=20200702010001727
5038,2020-07-03,대웅제약메디톡스ITC소송다음주결판진실게임끝이보인다,https://www.dailian.co.kr/news/view/902281?sc=Naver
5039,2020-07-03,대웅메디톡스이직前직원명예훼손등소송제기,http://www.dailymedi.com/detail.php?number=857801&thread=22r05
5040,2020-07-03,다우지수상승속SK바이오팜돌풍계속오스코텍종근당바이오삼성바이오로직스제일약품동국제약셀트리온부광약품신풍제약신일제약대웅제약위더스제약주가주목,http://www.thekpm.com/view.php?ud=202007030657185736861beb2d9d_17
5041,2020-07-03,대웅제약소송위해메디톡스로이직한전직원에소송제기,http://www.doctorstimes.com/news/articleView.html?idxno=211468
5042,2020-07-03,지속되는보툴리눔진실공방대웅제약전직원소송나선까닭,http://www.iminju.net/news/articleView.html?idxno=54915
5043,2020-07-03,사활건메디톡스와의5년전쟁대웅제약패소시2조원대美시장잃을수도,http://www.whitepaper.co.kr/news/articleView.html?idxno=195348
5044,2020-07-05,대웅제약메디톡스보톡스진실게임드디어끝난다,https://www.etoday.co.kr/news/view/1913891
5045,2020-07-05,보톡스원료분쟁대웅제약메디톡스간운명이번주갈린다,http://yna.kr/AKR20200704024400017?did=1195m
5046,2020-07-05,5년분쟁의끝대웅제약메디톡스다음주ITC소송결판,http://www.mediapen.com/news/view/538362
5047,2020-07-05,보톡스원료둘러싼대웅제약메디톡스진실게임5년전쟁누가승자될까,http://news.heraldcorp.com/view.php?ud=20200705000009
5048,2020-07-05,대웅제약vs메디톡스보툴리눔균주공방6일판가름,http://www.shinailbo.co.kr/news/articleView.html?idxno=1295746
5049,2020-07-05,대웅제약vs메디톡스보톡스균주진실게임승자는이번주결과앞둬,http://www.metroseoul.co.kr/article/20200705500197
5050,2020-07-05,대웅제약vs메디톡스균주분쟁사실상이번주판가름날듯,http://www.segye.com/content/html/2020/07/05/20200705509165.html?OutUrl=naver
5051,2020-07-05,대웅제약메디톡스간보톡스원료분쟁이번주일단락전망,http://news.mk.co.kr/newsRead.php?no=687389&year=2020
5052,2020-07-05,대웅제약메디톡스보톡스원료분쟁이주내판가름,http://www.sportsseoul.com/news/read/933739?ref=naver
5053,2020-07-05,한번내린결정번복않는美ITC어느손들어줄까대웅제약VS메디톡스보톡스원료분쟁판결임박,http://www.thevaluenews.co.kr/news/view.php?idx=159995
5054,2020-07-05,메디톡스대웅제약이번주균주논란결판,http://www.edaily.co.kr/news/newspath.asp?newsid=01758086625831568
5055,2020-07-05,대웅메디톡스보톡스분쟁이번주ITC판결로판가름,http://news.mk.co.kr/newsRead.php?no=687755&year=2020
5056,2020-07-05,보톡스분쟁메디톡스대웅제약ITC예비판결코앞,http://www.skyedaily.com/news/news_view.html?ID=107700
5057,2020-07-05,메디톡스대웅제약보톡스5년진실게임끝낼까,http://www.hani.co.kr/arti/economy/marketing/952342.html
5058,2020-07-06,전문기자칼럼대웅제약vs메디톡스타협이최선책,http://www.edaily.co.kr/news/newspath.asp?newsid=01220166625831896
5059,2020-07-06,보톡스분쟁메디톡스대웅제약오늘윤곽잡힌다ITC예비판결예정,http://moneys.mt.co.kr/news/mwView.php?no=2020070522388070467
5060,2020-07-06,이번주대웅메디톡스보톡스원료분쟁예비판결나온다,http://www.pharmnews.com/news/articleView.html?idxno=100823
5061,2020-07-06,대웅제약vs메디톡스ITC예비판정결과발표임박,http://www.dailypharm.com/Users/News/NewsView.html?ID=266256&REFERER=NP
5062,2020-07-06,초점대웅제약메디톡스균주분쟁승자는누구,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2000607
5063,2020-07-06,7일대웅제약vs메디톡스5년균주전쟁끝낸다최후승자는,http://news.mt.co.kr/mtview.php?no=2020070120321052884
5064,2020-07-06,대웅제약vs메디톡스이번주운명의날4년분쟁예비승자는,http://daily.hankooki.com/lpage/industry/202007/dh20200706070019148390.htm?s_ref=nv
5065,2020-07-06,대웅제약VS메디톡스보툴리눔톡신4년전쟁승자는,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246353
5066,2020-07-06,메디톡스대웅제약K보톡스승자는누구,http://www.econovill.com/news/articleView.html?idxno=403500
5067,2020-07-06,구충제다음은줄기세포”대웅제약줄기세포코로나19치료제임상1상개시,https://www.donga.com/news/article/all/20200706/101832533/1
5068,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제항바이러스효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246363
5069,2020-07-06,대웅제약줄기세포 코로나19 호흡기증상치료제로인도네시아임상 1상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=48528
5070,2020-07-06,대웅제약줄기세포코로나치료제인도네시아1상승인,http://www.newsis.com/view/?id=NISX20200706_0001084453&cID=13001&pID=13000
5071,2020-07-06,대웅제약줄기세포활용코로나19치료제인도네시아임상1상승인,http://www.sentv.co.kr/news/view/575728
5072,2020-07-06,대웅호흡기치료제印尼서임상승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93430
5073,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.lawissue.co.kr/view.php?ud=202007060757189858204ead0791_12
5074,2020-07-06,대웅제약줄기세포로코로나19치료제도전인도네시아서임상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020070607408043095
5075,2020-07-06,대웅제약줄기세포코로나19치료제印尼서임상1상승인연내한국에서2상임상진행,http://www.pinpointnews.co.kr/view.php?ud=202007060758544792365609d9b_45
5076,2020-07-06,대웅제약줄기세포코로나치료제인도네시아1상승인,http://www.g-enews.com/ko-kr/news/article/news_all/202007060757393170a218188523_1/article.html
5077,2020-07-06,대웅제약코로나19호흡기증상줄기세포치료제인도네시아임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=726525
5078,2020-07-06,대웅제약줄기세포코로나치료제인도네시아서임상1상승인,http://www.ekn.kr/news/article.html?no=509420
5079,2020-07-06,대웅제약줄기세포코로나호흡기치료제인니1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2129947
5080,2020-07-06,대웅제약인니서줄기세포활용한코로나19증상치료후보임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=688679&year=2020
5081,2020-07-06,대웅제약코로나19치료제임상1상승인셀트리온부광약품신일제약신풍제약등주가상승불댕기나,http://www.thekpm.com/view.php?ud=202007060821395611861beb2d9d_17
5082,2020-07-06,대웅제약코로나줄기세포치료제인도네시아임상1상승인,https://view.asiae.co.kr/article/2020070608273305777
5083,2020-07-06,메디톡스대웅제약보톡스분쟁곧일단락,https://hankookilbo.com/News/Read/A2020070516590000574?did=NA
5084,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.newspim.com/news/view/20200706000036
5085,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인니임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=41338
5086,2020-07-06,대웅제약줄기세포로코로나치료제도전연내2상진입,http://news.mt.co.kr/mtview.php?no=2020070608262367875
5087,2020-07-06,대웅제약줄기세포활용코로나19치료제인니서임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070608294911858
5088,2020-07-06,대웅제약코로나19치료제인도네시아임상1상승인,http://www.newstomato.com/ReadNews.aspx?no=982207
5089,2020-07-06,대웅제약코로나19호흡기증상치료제인도네시아서임상1상승인,http://www.pressm.kr/news/articleView.html?idxno=31073
5090,2020-07-06,대웅제약코로나19줄기세포치료제인니임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=259494&MainKind=A&NewsKind=5&vCount=12&vKind=1
5091,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020070608514572237
5092,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.fnnews.com/news/202007060831210916
5093,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아1상승인,http://health.chosun.com/site/data/html_dir/2020/07/06/2020070600638.html
5094,2020-07-06,오늘의키워드보톡스전쟁일단락오늘대웅제약메디톡신예비판결,https://cnbc.sbs.co.kr/article_hub/10000988730?division=NAVER
5095,2020-07-06,대웅제약줄기세포인니서코로나치료제임상승인,https://www.ebn.co.kr/news/view/1441216/?sc=Naver
5096,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인니임상1상승인,http://daily.hankooki.com/lpage/industry/202007/dh20200706090350148390.htm?s_ref=nv
5097,2020-07-06,대웅제약줄기세포코로나치료제인도네시아에서임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4206944
5098,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.ajunews.com/view/20200706090222795
5099,2020-07-06,대웅제약DWP710인니서코로나임상1상진행,http://www.whosaeng.com/119183
5100,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.newsprime.co.kr/news/article.html?no=510010
5101,2020-07-06,대웅제약메디톡스5년보톡스진실공방ITC판결로분수령,http://www.inews24.com/view/1279164
5102,2020-07-06,대웅제약메디톡스보톡스원료분쟁내일분수령승자는누구,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4206965
5103,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://newsbrite.net/139082
5104,2020-07-06,대웅제약줄기세포이용코로나19치료제인도네시아임상1상승인,https://www.etoday.co.kr/news/view/1914268
5105,2020-07-06,대웅제약코로나19치료제인도네시아임상1상승인,http://isplus.live.joins.com/news/article/article.asp?total_id=23817897
5106,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아서임상1상승인,http://it.chosun.com/site/data/html_dir/2020/07/06/2020070600824.html
5107,2020-07-06,대웅제약줄기세포코로나19치료제로인도네시아1상승인,http://www.press9.kr/news/articleView.html?idxno=45206
5108,2020-07-06,대웅제약인니서줄기세포코로나19치료제임상1상승인,http://inthenews.co.kr/article-57105/
5109,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아1상승인,http://www.mediapen.com/news/view/538590
5110,2020-07-06,대웅제약vs메디톡스보톡스원료분쟁끝이보인다최후승자는,http://www.wolyo.co.kr/news/articleView.html?idxno=106642
5111,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=392132
5112,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,https://www.fetv.co.kr/news/article.html?no=58616
5113,2020-07-06,대웅제약코로나19줄기세포치료제인도네시아임상승인,http://www.medigatenews.com/news/2525966519
5114,2020-07-06,전승호대웅제약사장코로나19대체의약품개발속도,http://www.wikileaks-kr.org/news/articleView.html?idxno=90347
5115,2020-07-06,대웅제약인니서줄기세포코로나19치료제임상돌입,http://www.viva100.com/main/view.php?key=20200706010000971
5116,2020-07-06,대웅제약보툴리눔분쟁판결앞두고하락세,http://www.whitepaper.co.kr/news/articleView.html?idxno=195368
5117,2020-07-06,대웅제약줄기세포코로나치료제인도네시아임상1상승인,https://www.sedaily.com/NewsView/1Z574NY3JN
5118,2020-07-06,대웅제약인도네시아서코로나19치료제임상돌입,http://www.finomy.com/news/articleView.html?idxno=79934
5119,2020-07-06,메디톡스대웅제약보톡스전쟁오늘밤예비판정나온다,http://moneys.mt.co.kr/news/mwView.php?no=2020070608228066626
5120,2020-07-06,대웅제약줄기세포 코로나19 호흡기증상치료제임상 印尼1상승인,http://www.economytalk.kr/news/articleView.html?idxno=206918
5121,2020-07-06,대웅제약인니서중간엽줄기세포이용코로나치료제임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=120687
5122,2020-07-06,대웅제약코로나19치료제인도네시아임상1상승인,http://www.seoulfn.com/news/articleView.html?idxno=388124
5123,2020-07-06,대웅제약코로나19 호흡기증상치료제인도네시아서임상 1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119015
5124,2020-07-06,대웅제약코로나19호흡기증상치료제개발가속화,http://www.sisaweek.com/news/articleView.html?idxno=135411
5125,2020-07-06,대웅제약DWP710인도네시아임상1상승인,http://www.bokuennews.com/news/article.html?no=192123
5126,2020-07-06,대웅제약줄기세포코로나19치료제임상1상승인,http://sports.hankooki.com/lpage/economy/202007/sp20200706100853137020.htm?s_ref=nv
5127,2020-07-06,대웅제약줄기세포코로나19치료제인니서임상1상승인,http://yna.kr/AKR20200706045500017?did=1195m
5128,2020-07-06,대웅제약인도네시아서코로나치료제임상1상승인,http://www.upinews.kr/newsView/upi202007060025
5129,2020-07-06,보톡스전쟁대웅제약메디톡스ITC예비판결임박누가울고웃을까,http://www.ajunews.com/view/20200706101539934
5130,2020-07-06,대웅제약줄기세포 코로나19 호흡기증상치료제로인도네시아임상 1상승인,http://www.greened.kr/news/articleView.html?idxno=259219
5131,2020-07-06,대웅제약줄기세포이용코로나19치료제인도네시아서1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=70980
5132,2020-07-06,대웅코로나19호흡기증상치료제印尼임상1상승인,http://www.dailymedi.com/detail.php?number=857881&thread=22r05
5133,2020-07-06,대웅제약인니서줄기세포코로나19치료제임상1상진행,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571003647008
5134,2020-07-06,대웅제약코로나19증상치료제인도네시아서임상1상승인,http://www.econovill.com/news/articleView.html?idxno=403546
5135,2020-07-06,대웅제약줄기세포코로나19치료제인니서임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=29395
5136,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인도네시아임상1상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1398501
5137,2020-07-06,대웅제약vs메디톡스보톡스분쟁7일분수령ICT예비판결예정,http://www.newsworks.co.kr/news/articleView.html?idxno=469945
5138,2020-07-06,대웅제약메디톡스5년균주분쟁최후승자주목,http://www.dailysmart.co.kr/news/articleView.html?idxno=29408
5139,2020-07-06,대웅제약줄기세포코로나19치료제인니임상돌입연내2상임상목표,http://www.getnews.co.kr/view.php?ud=2020070611175283442fe691f917_16
5140,2020-07-06,균주전쟁판결앞둔대웅제약전승호사장코로나19도메디톡스와맞불,http://www.babytimes.co.kr/news/articleView.html?idxno=37576
5141,2020-07-06,대웅제약인도네시아서줄기세포이용코로나19치료제임상1상승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=81097
5142,2020-07-06,메디톡스vs대웅제약ITC예비판정Dday보톡스안을승자는,http://www.newspim.com/news/view/20200706000386
5143,2020-07-06,대웅제약줄기세포코로나19치료제인니임상1상승인,https://www.hankyung.com/finance/article/2020070665936
5144,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.metroseoul.co.kr/article/20200706500143
5145,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.press9.kr/news/articleView.html?idxno=45210
5146,2020-07-06,대웅제약혈행혈압건강에좋은건기식세노메가큐텐출시,http://www.ekn.kr/news/article.html?no=509529
5147,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://medipana.com/news/news_viewer.asp?NewsNum=259536&MainKind=A&NewsKind=5&vCount=12&vKind=1
5148,2020-07-06,대웅제약혈압혈행건강돕는건기식세노메가큐텐출시,http://www.medisobizanews.com/news/articleView.html?idxno=70984
5149,2020-07-06,대웅제약줄기세포코로나19치료제인니임상1상승인호흡기증상치료효과확인할것,http://theviewers.co.kr/View.aspx?No=904863
5150,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아1상승인,http://www.wolyo.co.kr/news/articleView.html?idxno=106658
5151,2020-07-06,대웅제약혈압혈행개선신제품세노메가큐텐출시,http://news.mt.co.kr/mtview.php?no=2020070611430898809
5152,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.updownnews.co.kr/news/articleView.html?idxno=220557
5153,2020-07-06,대웅제약메디톡스균주출처공방첫결론임박,http://medipana.com/news/news_viewer.asp?NewsNum=259530&MainKind=A&NewsKind=5&vCount=12&vKind=1
5154,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인니임상1상승인,http://www.pharmnews.com/news/articleView.html?idxno=100826
5155,2020-07-06,혈행개선혈압건강한알로”대웅제약세노메가큐텐출시,https://www.fetv.co.kr/news/article.html?no=58665
5156,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.getnews.co.kr/view.php?ud=2020070612261036282fe691f917_16
5157,2020-07-06,대웅제약코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62133
5158,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62144
5159,2020-07-06,대웅제약건기식세노메가큐텐출시혈압과혈행을한알로,http://www.metroseoul.co.kr/article/20200706500174
5160,2020-07-06,부자들은경제신문을읽는다대웅제약VS메디톡스최후승자는,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070612555171577
5161,2020-07-06,메디톡스대웅제약5년균주전쟁7일판가름,http://www.viva100.com/main/view.php?key=20200706010001077
5162,2020-07-06,대웅제약438상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/07/06/2020070601771.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5163,2020-07-06,시황분석대웅제약전일대비956상승주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202007061316093973edd30f5664_45
5164,2020-07-06,대웅제약757VI발동,https://biz.chosun.com/site/data/html_dir/2020/07/06/2020070601773.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5165,2020-07-06,대웅제약상승출발후현재956최근단기조정후반등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007060241&t=NN
5166,2020-07-06,대웅장시작후꾸준히올라797기관22000주순매도중,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007060243&t=NN
5167,2020-07-06,대웅159상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/07/06/2020070601777.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5168,2020-07-06,대웅제약중간엽줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.paxetv.com/news/articleView.html?idxno=95542
5169,2020-07-06,대웅5이상상승주가반등으로5일이평선넘어섬단기이평선역배열구간,https://www.hankyung.com/finance/article/202007066955L
5170,2020-07-06,신풍제약대웅제약제약주가파른상승신풍제약5급등이어대웅제약3상승,http://www.econonews.co.kr/news/articleView.html?idxno=127603
5171,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.etnews.com/20200706000220
5172,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.m-i.kr/news/articleView.html?idxno=726714
5173,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=392170
5174,2020-07-06,대웅제약코로나19치료제임상승인319상승,http://www.ccreview.co.kr/news/articleView.html?idxno=269794
5175,2020-07-06,대웅제약복합제올로스타올로맥스차별화된경쟁력주목,http://www.bosa.co.kr/news/articleView.html?idxno=2130008
5176,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=404801
5177,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시혈행개선과혈압건강을한알로,http://www.nbnnews.co.kr/news/articleView.html?idxno=404795
5178,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인,http://www.cstimes.com/news/articleView.html?idxno=421119
5179,2020-07-06,대웅제약코로나19줄기세포치료제로인도네시아임상1상진행,http://www.businesspost.co.kr/BP?command=article_view&num=185983
5180,2020-07-06,글로벌의약품시장메카美보스턴에둥지튼종근당대웅제약보령제약등10개제약사제약바이오협회주도로공유오피스입주해美시장공략강화,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004032623
5181,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.lawissue.co.kr/view.php?ud=202007061427489269204ead0791_12
5182,2020-07-06,대웅제약줄기세포 코로나19 호흡기치료제인도네시아임상 1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=29305
5183,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시혈행개선과혈압건강을한알로,http://www.ybsn.tv/news/articleView.html?idxno=21219
5184,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시혈행개선과혈압건강을한알로,http://newsbrite.net/139130
5185,2020-07-06,대웅제약건기식세노메가큐텐출시,http://www.bokuennews.com/news/article.html?no=192154
5186,2020-07-06,대웅제약혈행혈압까지한알로케어하는세노메가큐텐출시,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119048
5187,2020-07-06,대웅제약혈압혈행동시케어건강기능식품세노메가큐텐출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200706011
5188,2020-07-06,메디톡스대웅제약의보톡스이전투구어떻게시작됐나,https://www.asiatime.co.kr/news/newsview.php?ncode=1065586427633025
5189,2020-07-06,오늘의신상품대웅제약혈행혈압건강챙기는세노메가큐텐출시,http://www.econovill.com/news/articleView.html?idxno=403600
5190,2020-07-06,대웅제약세노메가큐텐출시혈압혈행건강케어,http://www.kpinews.co.kr/news/articleView.html?idxno=120755
5191,2020-07-06,대웅제약VS메디톡스오늘보톡스분쟁ITC예비판결결과나온다보톡스보툴리눔톡신테마주7월6일14시55분현재장중시황,http://www.topstarnews.net/news/articleView.html?idxno=817815
5192,2020-07-06,대웅제약줄기세포코로나19치료제로인니서임상1상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=03194726625831896
5193,2020-07-06,대웅제약줄기세포코로나19치료제로인도네시아임상1상승인,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=225872
5194,2020-07-06,대웅제약혈행개선과혈압건강건강기능식품세노메가큐텐출시,http://www.k-health.com/news/articleView.html?idxno=49175
5195,2020-07-06,대웅제약건기식신제품세노메가큐텐출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=29415
5196,2020-07-06,뉴스투데이L대웅제약혈압혈행건강동시케어가능한세노메가큐텐출시,https://www.news2day.co.kr/156038
5197,2020-07-06,대웅제약건강기능식품신제품세노메가큐텐출시,http://www.edaily.co.kr/news/newspath.asp?newsid=03411206625831896
5198,2020-07-06,대웅제약카모스타트제제코로나19임상2상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=266282&REFERER=NP
5199,2020-07-06,대웅제약혈행혈압관리건강기능식품세노메가큐텐출시,http://news.mk.co.kr/newsRead.php?no=691593&year=2020
5200,2020-07-06,대웅제약세노메가큐텐플러스출시,https://www.ebn.co.kr/news/view/1441359/?sc=Naver
5201,2020-07-06,대웅제약vs메디톡스5년보톡스전쟁이르면오늘결론,http://www.newsway.co.kr/news/view?tp=1&ud=2020070614395653549
5202,2020-07-06,대웅제약코로나19호흡기치료제인도네시아임상1상,http://www.mhj21.com/132396
5203,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=100641
5204,2020-07-06,대웅제약코로나19치료제인도네시아서임상1상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=69870
5205,2020-07-06,대웅제약줄기세포코로나19치료제인도네시아임상1상승인올해안2상진입,http://www.startuptoday.co.kr/news/articleView.html?idxno=46192
5206,2020-07-06,대웅제약인도네시아서코로나치료제임상1상승인,http://www.koreastocknews.com/news/articleView.html?idxno=55097
5207,2020-07-06,대웅제약코로나19치료제개발임상2상승인,http://www.bokuennews.com/news/article.html?no=192160
5208,2020-07-06,대웅제약vs메디톡스기술탈취논란판결앞두고주가는엇갈려,http://www.whitepaper.co.kr/news/articleView.html?idxno=195387
5209,2020-07-06,김창수의e뉴스브리핑대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인外,https://www.fetv.co.kr/news/article.html?no=58699
5210,2020-07-06,줄기세포치료제가코로나에효과대웅제약印尼서코로나임상,http://news.mk.co.kr/newsRead.php?no=692144&year=2020
5211,2020-07-06,대웅제약지이크×우루사브랜드이색컬래버,https://www.jungle.co.kr/magazine/201806
5212,2020-07-06,대웅제약세노메가큐텐출시한알로혈행및혈압건강,http://theviewers.co.kr/View.aspx?No=905304
5213,2020-07-06,메디톡스vs대웅제약5년간의균주전쟁분수령ITC예비판결임박,http://www.youthdaily.co.kr/news/article.html?no=41434
5214,2020-07-06,메디톡스vs대웅제약5년보톡스균분쟁결과임박,https://cnbc.sbs.co.kr/article_hub/10000988806?division=NAVER
5215,2020-07-06,대웅제약줄기세포코로나19치료제인니서임상1상승인안정성확인,http://www.dt.co.kr/contents.html?article_no=2020070702101831102002&ref=naver
5216,2020-07-06,관점뉴스대웅제약과메디톡스의안타까운보톡스전쟁1라운드결과는,https://www.news2day.co.kr/156069
5217,2020-07-06,대웅제약줄기세포코로나19호흡기증상치료제인도네시아임상1상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=69732
5218,2020-07-06,대웅제약GC녹십자셀임상승인단계진행가속화,http://www.polinews.co.kr/news/article.html?no=468192
5219,2020-07-07,임상의맥①대웅제약급등날고민김씨어떻게,http://www.edaily.co.kr/news/newspath.asp?newsid=01272646625832224
5220,2020-07-07,종근당JW중외한독매수대원대웅한미약품매도,http://www.dailymedi.com/detail.php?number=857917&thread=22r05
5221,2020-07-07,메디톡스대웅제약보톡스원료분쟁미ITC영업상비밀침해혐의예비판결임박,http://www.seoulwire.com/news/articleView.html?idxno=419061
5222,2020-07-07,다우지수또환호SK바이오팜상장이후메디톡스대웅제약이연제약부광약품주목도상승,http://www.thekpm.com/view.php?ud=202007070701111922861beb2d9d_17
5223,2020-07-07,메디톡스대웅제약보톨리눔균주분쟁서누가웃을까,http://www.anewsa.com/detail.php?number=2168365&thread=10
5224,2020-07-07,로스탁대웅제약호이스타정코로나19치료제임상2상승인,http://www.lawissue.co.kr/view.php?ud=20200707073850815204ead0791_12
5225,2020-07-07,대웅제약美협력사에볼루스시간외서21급락,https://www.hankyung.com/finance/article/2020070796097
5226,2020-07-07,메디톡스대웅제약균주분쟁분위기악화메디톡스로이직한전직원제소,http://www.ccreview.co.kr/news/articleView.html?idxno=270017
5227,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://medipana.com/news/news_viewer.asp?NewsNum=259568&MainKind=A&NewsKind=5&vCount=12&vKind=1
5228,2020-07-07,1보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/AKR20200707021300017?did=1195m
5229,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,https://news.sbs.co.kr/news/endPage.do?news_id=N1005871156&plink=ORI&cooper=NAVER
5230,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해10년수입금지,http://news.mt.co.kr/mtview.php?no=2020070707500210060
5231,2020-07-07,美ITC메디톡스에손대웅제약보톡스수입금지10년,https://news.chosun.com/site/data/html_dir/2020/07/07/2020070700469.html?utm_source=naver&utm_medium=original&utm_campaign=news
5232,2020-07-07,속보메디톡스손들어준美ITC대웅제약영업비밀침해,https://view.asiae.co.kr/article/2020070707544039214
5233,2020-07-07,대웅제약480억규모美에볼루스사모전환사채취득,https://view.asiae.co.kr/article/2020070707554147127
5234,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://news.mk.co.kr/newsRead.php?no=692888&year=2020
5235,2020-07-07,메디톡스손들어준ITC대웅제약예비결정명백한오판이의절차착수,http://www.sentv.co.kr/news/view/575794
5236,2020-07-07,1보美ITC대웅제약메디톡스영업비밀침해,http://www.newspim.com/news/view/20200707000052
5237,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,https://www.hankyung.com/economy/article/2020070796467
5238,2020-07-07,속보美ITC대웅제약메디톡스의영업비밀침해10년수입금지,http://www.newsis.com/view/?id=NISX20200706_0001085781&cID=13001&pID=13000
5239,2020-07-07,속보美ITC대웅제약메디톡스의영업비밀침해10년수입금지,http://www.newsis.com/view/?id=NISX20200706_0001085781&cID=13001&pID=13000
5240,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고이의제기,http://yna.kr/AKR20200707021900017?did=1195m
5241,2020-07-07,속보美ITC메디톡스손들어줘대웅제약영업비밀침해10년수입금지,http://www.fnnews.com/news/202007070755437297
5242,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00008&news_seq_no=4208118
5243,2020-07-07,속보미국ITC대웅제약보톡스균주메디톡스와동일,http://www.edaily.co.kr/news/newspath.asp?newsid=01479286625832224
5244,2020-07-07,2보ITC대웅제약나보타10년수입금지명령,http://www.newspim.com/news/view/20200707000055
5245,2020-07-07,속보美ITC메디톡스승소판결대웅제약메디톡스영업비밀침해”,http://www.viva100.com/main/view.php?key=20200707010001189
5246,2020-07-07,미국ITC대웅제약이메디톡스영업비밀침해”,https://www.sedaily.com/NewsView/1Z57KBLZUW
5247,2020-07-07,속보美ITC대웅제약나보타10년수입금지권고,https://view.asiae.co.kr/article/2020070708005680696
5248,2020-07-07,공시대웅제약480억규모美에볼루스사모전환사채취득,http://www.fnnews.com/news/202007070758010786
5249,2020-07-07,속보美ITC대웅제약나보타10년수입금지권고,https://view.asiae.co.kr/article/2020070708005680696
5250,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고이의제기,http://www.newsway.co.kr/news/view?tp=1&ud=2020070707582049342
5251,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고,https://www.hankyung.com/economy/article/2020070796557
5252,2020-07-07,ITC예비결정서메디톡스웃었다대웅제약이의절차착수,https://www.kpanews.co.kr/article/show.asp?idx=214479&category=D
5253,2020-07-07,ITC메디톡스손들어줘대웅제약보톡스수입금지10년,http://www.ekn.kr/news/article.html?no=509623
5254,2020-07-07,속보대웅제약美ITC예비결정명백한오판이의절차착수,http://www.fnnews.com/news/202007070759438945
5255,2020-07-07,속보미국ITC메디톡스손들어줬다대웅제약명백한오판,http://www.ccreview.co.kr/news/articleView.html?idxno=270018
5256,2020-07-07,속보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://biz.newdaily.co.kr/site/data/html/2020/07/07/2020070700012.html
5257,2020-07-07,ITC예비판결서대웅제약나보타10년수입금지결정,http://medipana.com/news/news_viewer.asp?NewsNum=259569&MainKind=A&NewsKind=5&vCount=12&vKind=1
5258,2020-07-07,속보美ITC메디톡스손들어줘대웅제약보톡스10년간수입금지권고,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070700501.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5259,2020-07-07,공시대웅제약480억규모美에볼루스사모전환사채취득,http://www.newsway.co.kr/news/view?tp=1&ud=2020070708030174880
5260,2020-07-07,보톡스전쟁1차전메디톡스승리대웅ITC결과납득할수없어,http://www.koreastocknews.com/news/articleView.html?idxno=55110
5261,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해1보,https://www.asiatoday.co.kr/view.php?key=20200707010003564
5262,2020-07-07,속보미ITC대웅제약보톡스10년간수입금지메디톡스손들어줘,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070047&t=NN
5263,2020-07-07,美ITC메디톡스손들어줘대웅제약10년수입금지철퇴,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070048&t=NN
5264,2020-07-07,메디톡스승기잡아대웅제약영업비밀침해,http://www.edaily.co.kr/news/newspath.asp?newsid=01521926625832224
5265,2020-07-07,속보美ITC메디톡스손들었다대웅제약영업비밀침해,https://www.etoday.co.kr/news/view/1914694
5266,2020-07-07,메디톡스주가변동오르락내리락대웅제약보톡스영업비밀침해소송웃었다,http://kpenews.com/View.aspx?No=905457
5267,2020-07-07,美ITC메디톡스손대웅제약영업비밀침해1보,http://www.seoulfn.com/news/articleView.html?idxno=388233
5268,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해,https://www.etoday.co.kr/news/view/1914697
5269,2020-07-07,메디톡스손들어준ITC 대웅제약나보타10년수입금지권고,https://hankookilbo.com/News/Read/A2020070708030000306?did=NA
5270,2020-07-07,속보대웅제약ITC예비결정명백한오판이의절차착수,https://www.hankyung.com/finance/article/2020070796907
5271,2020-07-07,대웅제약호이스타정코로나19치료제로2상승인하반기중3상,http://www.medisobizanews.com/news/articleView.html?idxno=71001
5272,2020-07-07,속보美ITC대웅제약나보타10년수입금지명령권고,https://www.etoday.co.kr/news/view/1914699
5273,2020-07-07,대웅제약이메디톡스영업비밀침해,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93450
5274,2020-07-07,상보美ITC대웅제약이메디톡스영업비밀침해10년간나보타수입금지예비판결,http://news.mk.co.kr/newsRead.php?no=692929&year=2020
5275,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해”,http://www.youthdaily.co.kr/news/article.html?no=41444
5276,2020-07-07,메디톡스완승메디톡스승기잡아대웅제약영업비밀침해,http://www.edaily.co.kr/news/newspath.asp?newsid=01554726625832224
5277,2020-07-07,속보ITC대웅제약나보타美10년수입금지권고,http://moneys.mt.co.kr/news/mwView.php?no=2020070708128089822
5278,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해나보타10년수입금지,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070708094180052
5279,2020-07-07,美ITC메디톡스손들었다대웅나보타10년수입금지,https://www.paxnetnews.com/articles/62648
5280,2020-07-07,메디톡스손들어준美ITC대웅제약명백한오판이의절차착수”,http://www.ajunews.com/view/20200707080826653
5281,2020-07-07,메디톡스대웅제약과균주전쟁서승리9부능선넘어,http://www.newstomato.com/ReadNews.aspx?no=982458
5282,2020-07-07,ITC예비결정은명백한오판”대웅제약이의절차착수,http://www.newsway.co.kr/news/view?tp=1&ud=2020070708082900642
5283,2020-07-07,속보미국ITC메디톡스손들어줬다대웅제약나보타10년수입금지,http://www.anewsa.com/detail.php?number=2168380&thread=10
5284,2020-07-07,속보미국ITC대웅제약나보타10년수입금지권고,http://www.kukinews.com/newsView/kuk202007070015
5285,2020-07-07,메디톡스손들어준美ITC대웅제약나보타10년수입금지권고,http://news.mt.co.kr/mtview.php?no=2020070708040436188
5286,2020-07-07,美ITC메디톡스손들어줘대웅제약보톡스10년간수입금지,https://www.asiatoday.co.kr/view.php?key=20200707010003570
5287,2020-07-07,2보미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/AKR20200707024400017?did=1195m
5288,2020-07-07,대웅제약ITC예비결정은명백한오판”이의절차착수,http://www.viva100.com/main/view.php?key=20200707010001195
5289,2020-07-07,美ITC메디톡스손들어줘대웅제약나보타10년수입금지,http://www.econovill.com/news/articleView.html?idxno=403658
5290,2020-07-07,속보대웅제약영업비밀침해”미국ITC메디톡스손들어줘,http://www.kukinews.com/newsView/kuk202007070016
5291,2020-07-07,5년보톡스전쟁메디톡스손들어준美ITC대웅제약영업비밀침해상보,https://view.asiae.co.kr/article/2020070708230701298
5292,2020-07-07,대웅제약美ITC나보타10년수입금지명령에명백한오판,http://www.newspim.com/news/view/20200707000065
5293,2020-07-07,美ITC대웅제약메디톡스영업비밀침해판정,http://www.dailypharm.com/Users/News/NewsView.html?ID=266297&REFERER=NP
5294,2020-07-07,대웅제약ITC예비결정은명백한오판”이의절차착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246420
5295,2020-07-07,미국ITC메디톡스손들어줘대웅제약수입금지10년,https://www.dailian.co.kr/news/view/903025?sc=Naver
5296,2020-07-07,종합美ITC대웅제약이메디톡스영업비밀침해대웅이의절차진행할것,http://news.mk.co.kr/newsRead.php?no=692957&year=2020
5297,2020-07-07,속보미국ITC대웅제약10년간수입금지예비결정”,http://www.mediapen.com/news/view/538839
5298,2020-07-07,대웅제약vs메디톡스ITC예비판결나보타수입금지10년,https://www.news1.kr/articles/?3987905
5299,2020-07-07,美ITC대웅이메디톡스영업비밀침해나보타10년수입금지,https://www.etoday.co.kr/news/view/1914714
5300,2020-07-07,美ITC대웅제약메디톡스영업비밀침해”10년수입금지,https://www.donga.com/news/article/all/20200707/101849738/2
5301,2020-07-07,대웅제약ITC예비결정은명백한오판”이의절차착수,http://www.kukinews.com/newsView/kuk202007070019
5302,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해했다,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00008&news_seq_no=4208148
5303,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해,http://www.kukinews.com/newsView/kuk202007070018
5304,2020-07-07,미국ITC대웅제약에10년간수입금지권고,http://www.g-enews.com/ko-kr/news/article/news_all/202007070827376802a218188523_1/article.html
5305,2020-07-07,ITC대웅메디톡스영업비밀침해대웅납득불가,http://moneys.mt.co.kr/news/mwView.php?no=2020070708168033048
5306,2020-07-07,대웅제약호이스타정코로나19치료제2상승인,http://www.biospectator.com/view/news_view.php?varAtcId=10779
5307,2020-07-07,대웅제약미국파트너에볼루스에480억규모CB투자,https://www.etoday.co.kr/news/view/1914722
5308,2020-07-07,대웅제약VS메디톡스보톡스전쟁예비결정ITC는,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246421
5309,2020-07-07,서울와이어7일모닝브리핑ITC메디톡스손들어줘대웅제약나보타10년간수입금지권고파장일파만파,http://www.seoulwire.com/news/articleView.html?idxno=419071
5310,2020-07-07,대웅제약ITC판결은단순권고이의제기,https://www.paxnetnews.com/articles/62649
5311,2020-07-07,ITC예비판결敗대웅제약명백한오판이의절차착수할것”,http://www.youthdaily.co.kr/news/article.html?no=41447
5312,2020-07-07,5년분쟁서메디톡스승기ITC대웅이영업비밀침해종합,https://www.hankyung.com/finance/article/2020070797757
5313,2020-07-07,균주전쟁종지부ITC대웅제약수입금지10년결정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134586&REFERER=NP
5314,2020-07-07,미ITC메디톡스손들어줘대웅제약영업비밀침해대웅제약10년간수입금지권고,http://news.heraldcorp.com/view.php?ud=20200707000039
5315,2020-07-07,보톡스전쟁메디톡스승리美ITC대웅제약영업비밀침해”,http://news.kmib.co.kr/article/view.asp?arcid=0014773109&code=61141111&cp=nv
5316,2020-07-07,美ITC메디톡스손들어줬다대웅제약메디톡스영업비밀침해1보,http://www.fnnews.com/news/202007070832402719
5317,2020-07-07,美ITC대웅제약이메디톡스비밀침해”대웅제약이의절차착수”,http://daily.hankooki.com/lpage/industry/202007/dh20200707083303148390.htm?s_ref=nv
5318,2020-07-07,속보美ITC대웅제약메디톡스영업비밀침해,http://www.shinailbo.co.kr/news/articleView.html?idxno=1296431
5319,2020-07-07,해설제약바이오보톡스전쟁메디톡스압승미국ITC예비판정대웅제약나보타운명은,http://www.g-enews.com/ko-kr/news/article/news_all/2020070708340498234a01bf698f_1/article.html
5320,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246422
5321,2020-07-07,대웅제약美ITC결정납득불가이의절차착수,https://www.etoday.co.kr/news/view/1914726
5322,2020-07-07,2보미국ITC대웅제약메디톡스영업비밀침해10년수입금지권고,http://www.seoulwire.com/news/articleView.html?idxno=419074
5323,2020-07-07,증시키워드미ITC보톡스판결에메디톡스대웅제약주가는SK바이오팜상한가언제까지,https://www.etoday.co.kr/news/view/1914730
5324,2020-07-07,메디톡스완승기사회생메디톡스vs최대위기대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=01708886625832224
5325,2020-07-07,대웅제약췌장염식도염치료제코로나19치료제로2상승인,http://news.mt.co.kr/mtview.php?no=2020070708413645311
5326,2020-07-07,ITC예비결정은명백한오판대웅제약이의절차착수,http://www.m-i.kr/news/articleView.html?idxno=726928
5327,2020-07-07,대웅제약ITC예비결정은명백한오판11월최종결정서승소할것,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070066&t=NN
5328,2020-07-07,대웅제약ITC예비결정은명백한오판,http://www.bosa.co.kr/news/articleView.html?idxno=2130047
5329,2020-07-07,보톡스전쟁메디톡스승기잡아美대웅제약나보타수입금지,http://biz.newdaily.co.kr/site/data/html/2020/07/07/2020070700023.html
5330,2020-07-07,메디톡스손들어준ITC대웅이의절차돌입예고,http://www.press9.kr/news/articleView.html?idxno=45218
5331,2020-07-07,美ITC메디톡스손들어줬다대웅제약영업비밀침해,http://www.sisajournal-e.com/news/articleView.html?idxno=220827
5332,2020-07-07,대웅제약역류성식도염치료제코로나19치료제임상2상승인,http://www.newspim.com/news/view/20200707000085
5333,2020-07-07,美ITC대웅나보타10년수입금지권고예비판결,http://www.biospectator.com/view/news_view.php?varAtcId=10780
5334,2020-07-07,보톡스5년전쟁종지부찍나美ITC대웅제약제품10년수입금지,http://www.enewstoday.co.kr/news/articleView.html?idxno=1398768
5335,2020-07-07,ITC예비판결勝메디톡스대웅제약거짓주장입증국내서민형사소송진행”,http://www.youthdaily.co.kr/news/article.html?no=41454
5336,2020-07-07,미국ITC대웅제약이메디톡스영업비밀침해대웅제약명백한오판종합,http://www.seoulwire.com/news/articleView.html?idxno=419075
5337,2020-07-07,종합美ITC대웅제약메디톡스영업비밀침해,http://www.fnnews.com/news/202007070851372508
5338,2020-07-07,美ITC보톡스균분쟁서메디톡스손들어줘대웅영업비밀침해,http://www.getnews.co.kr/view.php?ud=2020070708510971532fe691f917_16
5339,2020-07-07,美ITC보톡스균분쟁서메디톡스손들어줘대웅영업비밀침해,http://www.getnews.co.kr/view.php?ud=2020070708510971532fe691f917_16
5340,2020-07-07,美ITC대웅제약이메디톡스영업비밀침해나보타10년간수입금지”종합,http://www.ajunews.com/view/20200707085111709
5341,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해10년수입금지,https://www.ytn.co.kr/_ln/0103_202007070857278957
5342,2020-07-07,ITC대웅제약메디톡스영업비밀침해10년수입금지권고,http://news.tf.co.kr/read/economy/1800778.htm
5343,2020-07-07,5년보톡스전쟁대웅美ITC자국산업보호위해정책적판단,https://view.asiae.co.kr/article/2020070708595459832
5344,2020-07-07,美보톡스전쟁서대웅제약일단패,https://www.nocutnews.co.kr/news/5373655
5345,2020-07-07,아침지금미대웅제약메디톡스영업비밀침해,http://news.jtbc.joins.com/article/article.aspx?news_id=NB11958387
5346,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.seoulwire.com/news/articleView.html?idxno=419078
5347,2020-07-07,美ITC메디톡스손대웅제약10년간수입금지권고종합,http://www.seoulfn.com/news/articleView.html?idxno=388245
5348,2020-07-07,대웅제약000VI발동,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070700738.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5349,2020-07-07,대웅제약000VI발동,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070700738.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5350,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스승기종합,http://yna.kr/AKR20200707024451017?did=1195m
5351,2020-07-07,대웅제약ITC예비결정은명백한오판이의절차착수,http://www.medisobizanews.com/news/articleView.html?idxno=71007
5352,2020-07-07,메디톡스美ITC예비판결로대웅균주도용확인,http://news.mt.co.kr/mtview.php?no=2020070708591211934
5353,2020-07-07,5년보톡스전쟁메디톡스승기ITC대웅제약영업비밀침해”종합,http://www.newsway.co.kr/news/view?tp=1&ud=2020070709023968259
5354,2020-07-07,균주전쟁메디톡스완승ITC대웅제약보톡스10년간수입금지,https://www.hankyung.com/it/article/202007079862i
5355,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.press9.kr/news/articleView.html?idxno=45219
5356,2020-07-07,미ITC대웅제약메디톡스영업비밀침해”10년수입금지권고,https://www.seoul.co.kr/news/newsView.php?id=20200707500011&wlog_tag3=naver
5357,2020-07-07,특징주대웅대웅제약메디톡스영업비밀침해소식에동반급락,https://www.etoday.co.kr/news/view/1914753
5358,2020-07-07,대웅제약메디톡스ITC결정에폭락에상한가로엇갈리는주가대웅제약21폭락반해메디톡스상한가,http://www.econonews.co.kr/news/articleView.html?idxno=127662
5359,2020-07-07,메디톡스上대웅제약20균주논란판정에희비,https://www.hankyung.com/finance/article/2020070798526
5360,2020-07-07,대웅제약메디톡스손들어준미국ITC예비결정에명백한오판이의절차착수,http://www.consumernews.co.kr/news/articleView.html?idxno=608149
5361,2020-07-07,특징주메디톡스대웅제약美ITC예비판결에희비교차메디톡스上직행,http://news.mk.co.kr/newsRead.php?no=693172&year=2020
5362,2020-07-07,시황분석대웅전일대비1488하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=202007070910375431edd30c1ee8_45
5363,2020-07-07,美ITC대웅제약보톡스10년간수입금지희비엇갈린메디톡스대웅,http://www.sisafocus.co.kr/news/articleView.html?idxno=242875
5364,2020-07-07,특징주메디톡스대웅제약균주도용확인에상한가직행,https://www.etoday.co.kr/news/view/1914759
5365,2020-07-07,메디톡스美ITC대웅제약나보타10년간수입금지균주도용밝혀져,http://www.newspim.com/news/view/20200707000118
5366,2020-07-07,메디톡스韓법원ITC참고대웅혐의낱낱이밝힌다,http://moneys.mt.co.kr/news/mwView.php?no=2020070708408011507
5367,2020-07-07,시황분석대웅제약전일대비1948하락주요종목실시간분석,http://www.pinpointnews.co.kr/view.php?ud=20200707091239820edd30c1ef1_45
5368,2020-07-07,美ITC메디톡스손들어줘대웅10년간수입금지,http://www.dt.co.kr/contents.html?article_no=2020070702109931102001&ref=naver
5369,2020-07-07,대웅제약주보FDA허가1년4개월만에철수위기종합,https://www.sedaily.com/NewsView/1Z57LYXTN6
5370,2020-07-07,특징주美ITC판정에표정엇갈린메디톡스대웅제약,https://www.sedaily.com/NewsView/1Z57LSDENO
5371,2020-07-07,승기잡은메디톡스ITC대웅제약나보타10년수입금지권고,http://www.mediapen.com/news/view/538870
5372,2020-07-07,美ITC메디톡스손들어줘대웅제약10년간수입금지”권고긴장,http://www.sporbiz.co.kr/news/articleView.html?idxno=452694
5373,2020-07-07,메디톡스ITC예비판결서대웅제약이메디톡스균주도용,http://www.medisobizanews.com/news/articleView.html?idxno=71009
5374,2020-07-07,특징주메디톡스美ITC승소에상한가대웅제약은급락,http://www.inews24.com/view/1279629
5375,2020-07-07,대웅제약식도염치료제호이스타정코로나19치료제임상2상승인,https://www.sedaily.com/NewsView/1Z57KNRAMN
5376,2020-07-07,대웅대웅제약모두갑작스런폭락에투자자들당황대웅12폭락이어대웅제약17폭락,http://www.econonews.co.kr/news/articleView.html?idxno=127670
5377,2020-07-07,ITC대웅메디톡스기술탈취맞다대웅제약주가급락,http://www.whitepaper.co.kr/news/articleView.html?idxno=195404
5378,2020-07-07,특징주메디톡스대웅제약美소송예비판결에엇갈린희비,http://www.edaily.co.kr/news/newspath.asp?newsid=01925366625832224
5379,2020-07-07,속보7일오전9시증시메디톡스30급등대웅제약20급락,https://news.joins.com/article/olink/23413509
5380,2020-07-07,특징주메디톡스대웅제약보톡스원료판결에주가희비극명,https://www.dailian.co.kr/news/view/903068?sc=Naver
5381,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.koreaittimes.com/news/articleView.html?idxno=98815
5382,2020-07-07,미ITC보톡스분쟁서메디톡스손들어줘대웅제약최종판결서승소할것,http://kormedi.com/?p=1320017
5383,2020-07-07,특징주균주분쟁판결에메디톡스웃고대웅제약울고,http://inthenews.co.kr/article-57364/
5384,2020-07-07,특징주대웅제약메디톡스영업비밀침해예비판결하락,http://moneys.mt.co.kr/news/mwView.php?no=2020070709198016350
5385,2020-07-07,메디톡스美ITC판결로결정적승기잡아대웅제약보톡스사업치명타,http://www.greened.kr/news/articleView.html?idxno=259456
5386,2020-07-07,대웅제약메디톡스균주도용했다美ITC행정판사결론,http://www.wikileaks-kr.org/news/articleView.html?idxno=90428
5387,2020-07-07,특징주美ITC판결에메디톡스상한가대웅제약과희비,http://www.newspim.com/news/view/20200707000188
5388,2020-07-07,보톡스소송전메디톡스활짝대웅제약미국시장타격불가피,http://isplus.live.joins.com/news/article/article.asp?total_id=23818948
5389,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인빠른치료제개발예상,http://www.paxetv.com/news/articleView.html?idxno=95631
5390,2020-07-07,특징주대웅ITC예비판정에급락대웅제약메디톡스영업비밀침해,http://moneys.mt.co.kr/news/mwView.php?no=2020070709268036892
5391,2020-07-07,특징주대웅22250원7일9시25분장시작대비697상승,http://www.getnews.co.kr/view.php?ud=202007070927037273c20b9e16f2_16
5392,2020-07-07,5년보톡스전쟁메디톡스대웅거짓입증국내서도같은결론확신,https://view.asiae.co.kr/article/2020070709304945193
5393,2020-07-07,메디톡스美ITC대웅제약나보타10년간수입금지균주도용밝혀져”,http://www.newsway.co.kr/news/view?tp=1&ud=2020070709253090156
5394,2020-07-07,대웅제약췌장염식도염치료제코로나19치료임상2상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020070708548038090
5395,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스승기,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4208261
5396,2020-07-07,메디톡스vs대웅제약미국ITC메디톡스손들어줘,https://www.news2day.co.kr/156093
5397,2020-07-07,대웅제약vs메디톡스보툴리늄균주전쟁메디톡스승기잡았다,http://www.pinpointnews.co.kr/view.php?ud=202007070929499714f090c8dbcb_45
5398,2020-07-07,특징주메디톡스상한가ITC대웅제약영업비밀침해예비판결,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573033954965
5399,2020-07-07,ITC승소메디톡스대웅제약거짓주장들통,https://www.paxnetnews.com/articles/62653
5400,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.ybsn.tv/news/articleView.html?idxno=21316
5401,2020-07-07,특징주메디톡스대웅제약과보톡스분쟁승기에상한가,https://www.asiatoday.co.kr/view.php?key=20200707010003681
5402,2020-07-07,균주분쟁美ITC대웅제약영업비밀침해”예비판결메디톡스승기잡았다,https://www.fetv.co.kr/news/article.html?no=58736
5403,2020-07-07,대웅제약480억규모美에볼루스사모전환사채취득,http://www.edaily.co.kr/news/newspath.asp?newsid=02013926625832224
5404,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스손들어줘,http://sports.chosun.com/news/ntype.htm?id=202007080100064320004220&servicedate=20200707
5405,2020-07-07,대웅제약호이스타정;코로나19치료제임상2상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=120812
5406,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.metroseoul.co.kr/article/20200707500050
5407,2020-07-07,보톡스진실공방5년메디톡스가대웅제약이겼다,http://www.bizhankook.com/article/20252
5408,2020-07-07,포털검색상위종목SK바이오팜강세메디톡스와대웅제약주가희비교차,http://www.g-enews.com/ko-kr/news/article/news_all/202007070920074571edf69f862c_1/article.html
5409,2020-07-07,대웅제약호이스타정코로나치료제개발임상2상승인,http://isplus.live.joins.com/news/article/article.asp?total_id=23818961
5410,2020-07-07,메디톡스ITC예비판결은대웅주장거짓이라는증거,http://www.m-i.kr/news/articleView.html?idxno=726970
5411,2020-07-07,대웅제약카모스타트성분호이스타정의코로나19임상2상승인받아,http://news.mk.co.kr/newsRead.php?no=693417&year=2020
5412,2020-07-07,ITC예비결정은명백한오판대웅제약이의절차착수,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62153
5413,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62152
5414,2020-07-07,美ITC메디톡스손들어줬다대웅제약보톡스10년간수입금지,http://www.ezyeconomy.com/news/articleView.html?idxno=102761
5415,2020-07-07,메디톡스ITC예비판결승국내서도대웅혐의낱낱이밝힐것”,http://www.kukinews.com/newsView/kuk202007070064
5416,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.etnews.com/20200707000039
5417,2020-07-07,美첫진출국산보톡스10년간수입금지대웅제약미국사업차질,http://yna.kr/AKR20200707045600017?did=1195m
5418,2020-07-07,TF특징주보톡스전쟁승기잡은메디톡스상한가대웅제약급락,http://news.tf.co.kr/read/economy/1800799.htm
5419,2020-07-07,美ITC예비판정이슈메디톡스장중급등vs대웅제약장중추락,http://www.choicenews.co.kr/news/articleView.html?idxno=72453
5420,2020-07-07,보툴리눔논란메디톡스미ITC예비판결승리대웅제약최종판결서승소확신,http://www.kpinews.co.kr/news/articleView.html?idxno=120815
5421,2020-07-07,특징주메디톡스대웅제약美ITC판결에희비,http://www.cstimes.com/news/articleView.html?idxno=421252
5422,2020-07-07,메디톡스완승사활건메디톡스대웅제약왜이지경까지,http://www.edaily.co.kr/news/newspath.asp?newsid=02050006625832224
5423,2020-07-07,대웅제약메디톡스균주도용했다”미국ITC판결,http://www.joseilbo.com/news/news_read.php?uid=401565&class=27&grp=
5424,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://yna.kr/AKR20200707051500017?did=1195m
5425,2020-07-07,특징주대웅제약메디톡스영업비밀침해”美ITC예비판결에급락,http://www.kukinews.com/newsView/kuk202007070076
5426,2020-07-07,메디톡스대웅제약미국ITC예비판결에주가희비교차,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4208319
5427,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://daily.hankooki.com/lpage/industry/202007/dh20200707095025148390.htm?s_ref=nv
5428,2020-07-07,대웅제약호이스타정코로나19치료제로식약처임상2상승인받아,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572441830135
5429,2020-07-07,대웅제약ITC예비판결납득할수없어이의절차할것,https://www.hankyung.com/it/article/202007070331i
5430,2020-07-07,메디톡스대웅제약보톡스분쟁미국ITC대웅제약에영업비밀침해예비판결,http://news.kbs.co.kr/news/view.do?ncd=4488311&ref=A
5431,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://it.chosun.com/site/data/html_dir/2020/07/07/2020070701185.html
5432,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,https://www.fetv.co.kr/news/article.html?no=58745
5433,2020-07-07,美ITC대웅제약10년간수입금지보톡스戰승기잡은메디톡스종합,http://www.newspim.com/news/view/20200707000269
5434,2020-07-07,대웅장중하락세전일대비119이시각거래량135만8919주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070139&t=NN
5435,2020-07-07,보톡스전쟁승기잡은메디톡스ITC대웅제약영업비밀침해,http://www.cstimes.com/news/articleView.html?idxno=421253
5436,2020-07-07,특징주미국ITC영업비밀침해예비판결에대웅제약하락,https://www.ebn.co.kr/news/view/1441444/?sc=Naver
5437,2020-07-07,대웅제약전일대비1498하락이시각거래량97만8184주,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007070141&t=NN
5438,2020-07-07,그래픽메디톡스대웅제약보톡스원료분쟁주요일지,http://yna.kr/GYH20200707000800044?did=1363m
5439,2020-07-07,대웅제약코로나19치료제임상2상승인주목,https://news.imaeil.com/Economy/2020070710000596387
5440,2020-07-07,대웅제약ITC예비판결은오판”이의절차착수,http://www.kukinews.com/newsView/kuk202007070069
5441,2020-07-07,대웅제약호이스타코로나19치료제임상2상승인,http://www.econovill.com/news/articleView.html?idxno=403690
5442,2020-07-07,ITC대웅제약이메디톡스영업비밀침해나보타수입금지권고,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119074
5443,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,https://www.etoday.co.kr/news/view/1914811
5444,2020-07-07,메디톡스5년분쟁승기ITC대웅제약이영업비밀침해,https://www.ebn.co.kr/news/view/1441443/?sc=Naver
5445,2020-07-07,대웅제약메디톡스보톡스분쟁양사공멸로마무리되나,http://www.upinews.kr/newsView/upi202007070016
5446,2020-07-07,메디톡스주가초반급등대웅제약급락균주소송예비판결영향,http://www.businesspost.co.kr/BP?command=article_view&num=186143
5447,2020-07-07,특징주메디톡스상한가대웅제약15↓영업비밀침해소송희비,http://www.viva100.com/main/view.php?key=20200707010001242
5448,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.segyebiz.com/newsView/20200707508408?OutUrl=naver
5449,2020-07-07,대웅제약ITC예비결정은명백한오판입장이의절차착수,http://www.pressm.kr/news/articleView.html?idxno=31118
5450,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,https://www.dailian.co.kr/news/view/903084?sc=Naver
5451,2020-07-07,이데일리N美ITC메디톡스손들어줘대웅제약이의절차착수外,http://www.edaily.co.kr/news/newspath.asp?newsid=02259926625832224
5452,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인췌장염식도염약,http://theviewers.co.kr/View.aspx?No=905740
5453,2020-07-07,대웅제약식도염치료제호이스타정코로나19치료제임상2상직행,http://kbench.com/?q=node/212135
5454,2020-07-07,미국ITC대웅제약영업비밀침해나보타10년수입금지메디톡스손들어줘,http://www.queen.co.kr/news/articleView.html?idxno=337965
5455,2020-07-07,ICT판정에엇갈린주가메디톡스활짝대웅제약침울,http://moneys.mt.co.kr/news/mwView.php?no=2020070710078027508
5456,2020-07-07,메디톡스美ITC승소주가폭등대웅제약명백한오판이의절차착수,http://www.babytimes.co.kr/news/articleView.html?idxno=37627
5457,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.dt.co.kr/contents.html?article_no=2020070702109931102002&ref=naver
5458,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.sisaweek.com/news/articleView.html?idxno=135457
5459,2020-07-07,메디톡스미국ITC소송서승기대웅제약명백한오판,http://sports.hankooki.com/lpage/economy/202007/sp20200707101933137020.htm?s_ref=nv
5460,2020-07-07,보톡스전쟁승기잡은메디톡스ITC대웅제약영업비밀침해,http://www.newsprime.co.kr/news/article.html?no=510184
5461,2020-07-07,ITC대웅제약메디톡스영업비밀침해나보타수입금지10년예비판결,http://www.newsworks.co.kr/news/articleView.html?idxno=470285
5462,2020-07-07,대웅제약美ITC판결예비결정자체효력없다,http://www.wikileaks-kr.org/news/articleView.html?idxno=90437
5463,2020-07-07,메디톡스보톡스전쟁승리대웅제약은수출금지손배소이어질듯,http://www.koreastocknews.com/news/articleView.html?idxno=55114
5464,2020-07-07,5년보톡스전쟁메디톡스가이겼다美ITC대웅제약영업비밀침해종합,https://view.asiae.co.kr/article/2020070710284058769
5465,2020-07-07,대웅제약역류성식도염치료제호이스타정코로나19치료제임상2상승인,http://www.newsprime.co.kr/news/article.html?no=510188
5466,2020-07-07,특징주＂대웅제약메디톡스영업비밀침해했다美판결이후주가폭락,http://www.nspna.com/news/?mode=view&newsid=439496
5467,2020-07-07,미국ITC행정판사대웅제약메디톡스균주도용했다”나보타10년간수입금지,http://medicalworldnews.co.kr/news/view.php?idx=1510936456
5468,2020-07-07,메디톡스균주분쟁서승기美ITC대웅제약메디톡스영업비밀침해,http://www.wolyo.co.kr/news/articleView.html?idxno=106680
5469,2020-07-07,메디톡스웃고대웅제약울고창사75주년최대위기직면,http://www.startuptoday.co.kr/news/articleView.html?idxno=46281
5470,2020-07-07,메디톡스손들어준美ITC대웅제약메디톡스영업비밀침해”,http://inthenews.co.kr/article-57387/
5471,2020-07-07,미국ITC대웅제약나보타10년수입금지권고영업비밀침해,http://www.womaneconomy.kr/news/articleView.html?idxno=91980
5472,2020-07-07,오늘의제약대웅제약종근당광동제약,http://www.babytimes.co.kr/news/articleView.html?idxno=37630
5473,2020-07-07,메디톡스美ITC소송서대웅제약상대로승기,http://it.chosun.com/site/data/html_dir/2020/07/07/2020070701487.html
5474,2020-07-07,미국첫진출국산보톡스10년간수입금지미국ITC예비판결에대웅제약메디톡스운명엇갈려,http://www.topstarnews.net/news/articleView.html?idxno=818111
5475,2020-07-07,미ITC대웅제약메디톡스영업비밀침해예비판결,http://www.rapportian.com/news/articleView.html?idxno=126418
5476,2020-07-07,대웅보툴리눔균주및제조기술도용美ITC결정납득안돼”반박,http://www.polinews.co.kr/news/article.html?no=468209
5477,2020-07-07,美ITC예비판결균주분쟁서메디톡스손들어줘대웅제약명백한오판이의절차착수,http://www.updownnews.co.kr/news/articleView.html?idxno=220603
5478,2020-07-07,대웅제약호이스타정 코로나19 치료제임상 2상승인,http://www.economytalk.kr/news/articleView.html?idxno=206940
5479,2020-07-07,3번째코로나19치료제후보”대웅제약안전성입증한카모스타트임상2상진행,https://www.donga.com/news/article/all/20200707/101852467/1
5480,2020-07-07,대웅제약명백한오판”이의절차착수,http://www.whosaeng.com/119229
5481,2020-07-07,대웅제약췌장염치료제호이스타정코로나19치료제임상2상시험승인,http://news.mk.co.kr/newsRead.php?no=694085&year=2020
5482,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://newsbrite.net/139173
5483,2020-07-07,ITC예비결정은명백한오판”대웅제약이의절차착수,http://newsbrite.net/139174
5484,2020-07-07,美ITC대웅제약메디톡스보톡스기술도용,http://www.finomy.com/news/articleView.html?idxno=80012
5485,2020-07-07,메디톡스사실상승리대웅제약남은기회3번,https://www.hankyung.com/finance/article/2020070708546
5486,2020-07-07,대웅제약나보타美에서10년간수입금지ITC메디톡스손들어줘,http://www.whitepaper.co.kr/news/articleView.html?idxno=195411
5487,2020-07-07,대웅제약호이스타정코로나19치료제식약처임상2상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4208465
5488,2020-07-07,대웅제약美ITC나보타수입금지권고자국산업보호위한오판,https://www.news1.kr/photos/view/?4275718
5489,2020-07-07,美ICT대웅제약나보타수입금지권고,https://www.news1.kr/photos/view/?4275719
5490,2020-07-07,美ITC대웅제약영업비밀침해예비판결메디톡스보톡스전쟁승기,http://www.etnews.com/20200707000119
5491,2020-07-07,대웅제약美ITC권고납득할수없는결정,https://www.news1.kr/photos/view/?4275717
5492,2020-07-07,미국ITC대웅제약영업비밀침해예비판결메디톡스승기,http://www.topstarnews.net/news/articleView.html?idxno=818117
5493,2020-07-07,美ICT대웅제약나보타수입금지권고,https://www.news1.kr/photos/view/?4275716
5494,2020-07-07,대웅제약나보타美ICT수입금지권고,https://www.news1.kr/photos/view/?4275720
5495,2020-07-07,대웅제약ITC예비결정이의제기메디톡스손들어준ITC명백한오판주장,http://theviewers.co.kr/View.aspx?No=905894
5496,2020-07-07,대웅제약美ICT나보타수입금지권고명백한오판,https://www.news1.kr/photos/view/?4275727
5497,2020-07-07,더벨메디톡스대웅제약에판정승국내소송영향은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202007071026037800107180
5498,2020-07-07,5년동안무슨일이메디톡스대웅제약보톡스전쟁1라운드종료,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070710094336159
5499,2020-07-07,메디톡스손들어준美ITC대웅제약영업비밀침해맞다,http://www.sisajournal.com/news/articleView.html?idxno=202214
5500,2020-07-07,메디톡스5년균주전쟁서승기대웅ITC오판이의신청할것,http://news.mt.co.kr/mtview.php?no=2020070710552031265
5501,2020-07-07,대웅제약과균주분쟁서승기잡은메디톡스,https://www.news1.kr/photos/view/?4275750
5502,2020-07-07,메디톡스대웅제약과균주분쟁서승기잡나,https://www.news1.kr/photos/view/?4275752
5503,2020-07-07,보톡스전쟁에서대웅제약패배종합,https://www.nocutnews.co.kr/news/5373796
5504,2020-07-07,종합보톡스전쟁메디톡스판정승대웅명백한오판이의절차착수”,http://www.viva100.com/main/view.php?key=20200707010001280
5505,2020-07-07,美진출국산보톡스10년간수입금지돼대웅제약사업차질종합,http://yna.kr/AKR20200707045651017?did=1195m
5506,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=392281
5507,2020-07-07,대웅제약480억규모美에볼루스사모전환사채취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=392283
5508,2020-07-07,메디톡스균주분쟁서승기美ICT대웅제약나보타수입금지권고,https://www.news1.kr/photos/view/?4275771
5509,2020-07-07,메디톡스보톡스전쟁승기美ITC대웅제약영업비밀침해,http://www.newsquest.co.kr/news/articleView.html?idxno=77612
5510,2020-07-07,보톡스전쟁美ITC메디톡스에손대웅제약명백한오판,http://www.dailysmart.co.kr/news/articleView.html?idxno=29474
5511,2020-07-07,보톡스분쟁이긴메디톡스상한가대웅제약은하락세,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070701747.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5512,2020-07-07,종합美ITC10년간대웅제약나보타수입금지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1296560
5513,2020-07-07,대웅제약미국ITC예비판결에명백한오판,http://www.insightkorea.co.kr/news/articleView.html?idxno=81129
5514,2020-07-07,5년보톡스전쟁메디톡스승기대웅제약납득할수없다,http://4th.kr/View.aspx?No=905946
5515,2020-07-07,美ITC대웅제약메디톡스균주도용판결나보타10년간수입금지,http://www.mdtoday.co.kr/mdtoday/index.html?no=392263
5516,2020-07-07,메디톡스대웅제약상대균주도용소송서승기나보타10년간수입금지,http://www.kdpress.co.kr/news/articleView.html?idxno=96199
5517,2020-07-07,美ITC예비판결메디톡스勝대웅영업비밀침해,http://www.dailymedi.com/detail.php?number=857932&thread=22r05
5518,2020-07-07,美ITC대웅제약이메디톡스영업비밀도용”판결,https://cnbc.sbs.co.kr/article_hub/10000988877?division=NAVER
5519,2020-07-07,ITC대웅제약메디톡스영업비밀침해”,http://www.munhwa.com/news/view.html?no=2020070701072127097001
5520,2020-07-07,대웅제약미국의예비판결은오판메디톡스국내소송에적극활용,http://www.businesspost.co.kr/BP?command=article_view&num=186163
5521,2020-07-07,보톡스5년전쟁승자는메디톡스美ITC대웅제약메디톡스영업비밀침해판정,http://www.sportsseoul.com/news/read/934390?ref=naver
5522,2020-07-07,보톡스전쟁승소의지대웅제약480억원규모美파트너에볼루스사모전환사채취득,https://www.donga.com/news/article/all/20200707/101854196/1
5523,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.dailysportshankook.co.kr/news/articleView.html?idxno=225921
5524,2020-07-07,톡신전쟁희비갈린대웅메디톡스뒤집기냐굳히기냐,https://www.kpanews.co.kr/article/show.asp?idx=214483&category=D
5525,2020-07-07,미국ITC대웅제약영업비밀침해예비판결미국나보타사업위기,http://www.newsfc.co.kr/news/articleView.html?idxno=41751
5526,2020-07-07,보톡스전쟁서대웅제약고개푹美ITC메디톡스손들어줘,http://www.seouleconews.com/news/articleView.html?idxno=55484
5527,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707106200013?did=1196m
5528,2020-07-07,미국ITC대웅제약영업비밀침해,http://yna.kr/PYH20200707106500013?did=1196m
5529,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707105900013?did=1196m
5530,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707107000013?did=1196m
5531,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707106700013?did=1196m
5532,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707106100013?did=1196m
5533,2020-07-07,미국ITC대웅제약영업비밀침해,http://yna.kr/PYH20200707106600013?did=1196m
5534,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707106800013?did=1196m
5535,2020-07-07,미국ITC대웅제약영업비밀침해,http://yna.kr/PYH20200707106400013?did=1196m
5536,2020-07-07,대웅제약영업비밀침해예비판결메디톡스승기,http://yna.kr/PYH20200707106000013?did=1196m
5537,2020-07-07,미국ITC대웅제약영업비밀침해,http://yna.kr/PYH20200707106300013?did=1196m
5538,2020-07-07,미국ITC메디톡스손들어줘대웅제약영업비밀침해,http://yna.kr/PYH20200707106900013?did=1196m
5539,2020-07-07,대웅제약ITC예비결정은명백한오판이의절차착수,http://www.businesskorea.co.kr/news/articleView.html?idxno=48637
5540,2020-07-07,ITC메디톡스분쟁대웅제약에영업비밀침해예비판결,http://news.kbs.co.kr/news/view.do?ncd=4488488&ref=A
5541,2020-07-07,메디톡스대웅제약에천문학적손해배상청구할까,http://www.newsis.com/view/?id=NISX20200707_0001086556&cID=13001&pID=13000
5542,2020-07-07,대웅제약ITC예비결정은명백한오판법적구속력없어,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200707012
5543,2020-07-07,재기메디톡스vs위기대웅제약희비엇갈린국산보톡스전쟁,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4208591
5544,2020-07-07,ITC예비판결에메디톡스국내도승소자신vs대웅명백한오판,http://news.tf.co.kr/read/economy/1800867.htm
5545,2020-07-07,미국ITC메디톡스손들어줘메디톡스민형사진행대웅제약이의절차착수,http://www.efnews.co.kr/news/articleView.html?idxno=85564
5546,2020-07-07,4년균주전쟁총정리메디톡스승기잡았다벼랑끝대웅제약명백한오판”,http://www.thepublic.kr/news/newsview.php?ncode=1065578001061466
5547,2020-07-07,뉴스투데이L대웅제약호이스타정코로나19치료제임상2상승인,https://www.news2day.co.kr/156114
5548,2020-07-07,신풍제약대웅제약급등에폭락으로희비엇갈려대웅제약16폭락반해신풍제약22급등,http://www.econonews.co.kr/news/articleView.html?idxno=127758
5549,2020-07-07,대웅제약호이스타정코로나19임상2상승인,https://www.hankyung.com/it/article/202007070850i
5550,2020-07-07,대웅제약나보타예비판결메디톡스에패소주가급락,http://www.ccreview.co.kr/news/articleView.html?idxno=270053
5551,2020-07-07,미국첫진출대웅제약보톡스수출길막히나,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202007071348001&code=920501
5552,2020-07-07,메디톡스완승대웅제약vs메디톡스타협가능성은,http://www.edaily.co.kr/news/newspath.asp?newsid=02870006625832224
5553,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2130083
5554,2020-07-07,메디톡스대웅제약보톡스논란업계진입장벽높일것,https://www.hankyung.com/finance/article/2020070717526
5555,2020-07-07,ITC예판서승기잡은메디톡스당연한결과대웅제약이의절차착수,https://www.asiatime.co.kr/news/newsview.php?ncode=1065586884024044
5556,2020-07-07,전화연결삼성전자2분기영업익8조1천억어닝서프라이즈비건코로나뚫고방한북미와마주앉을생각없어미ITC대웅제약메디톡스영업비밀침해,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004033801
5557,2020-07-07,ITC예비결정은명백한오판대웅제약이의절차착수,http://www.nbnnews.co.kr/news/articleView.html?idxno=405130
5558,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.newstomato.com/ReadNews.aspx?no=982584
5559,2020-07-07,보톡스전쟁메디톡스勝대웅손배규모조兆단위달할수있어,http://www.getnews.co.kr/view.php?ud=2020070714262172052fe691f917_16
5560,2020-07-07,메디톡스대웅제약과ITC분쟁서승기국내서도주름펼까,http://www.mediapen.com/news/view/538985
5561,2020-07-07,대웅제약호이스타정코로나19치료제2상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=214495&category=D
5562,2020-07-07,승기잡은메디톡스총공세수세몰린대웅제약이의절차착수”,http://www.pinpointnews.co.kr/view.php?ud=202007071437295475f090c8dbcb_45
5563,2020-07-07,美첫진출국산보톡스10년간수입금지대웅제약미국사업차질,http://www.fntoday.co.kr/news/articleView.html?idxno=223316
5564,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=29499
5565,2020-07-07,美ITC메디톡스손들어줘대웅제약도용인정,http://www.todaykorea.co.kr/news/articleView.html?idxno=273492
5566,2020-07-07,식약처대웅제약호이스타정코로나19치료임상2상승인,http://www.todaykorea.co.kr/news/articleView.html?idxno=273484
5567,2020-07-07,흔들리는K보톡스선두주자들대웅제약⋅메디톡스분쟁의승리자는,https://biz.chosun.com/site/data/html_dir/2020/07/07/2020070702444.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5568,2020-07-07,메디톡스대웅제약보톡스싸움일단락남은건상처뿐,https://www.hankyung.com/it/article/2020070719606
5569,2020-07-07,대웅제약ITC균주소송판정패신뢰도하락불가피,http://www.shinailbo.co.kr/news/articleView.html?idxno=1296691
5570,2020-07-07,美ITC대웅제약메디톡스균주도용맞다”나보타수입금지까지,http://theviewers.co.kr/View.aspx?No=906255
5571,2020-07-07,美ITC대웅제약보톡스10년간수입금지메디톡스승기,http://www.newspost.kr/news/articleView.html?idxno=79685
5572,2020-07-07,대웅제약췌장염치료제호이스타정코로나19치료제로임상2상승인,https://www.news1.kr/articles/?3988595
5573,2020-07-07,대웅제약코로나19치료제임상2상식약처승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=186216
5574,2020-07-07,대웅제약줄기세포코로나19호흡기증상치료제로인도네시아임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=60224
5575,2020-07-07,ITC나보타미국수입배제권고궁지몰린대웅제약,https://hankookilbo.com/News/Read/A2020070709400001854?did=NA
5576,2020-07-07,대웅제약ITC예비결정서10년수입금지명령,https://view.asiae.co.kr/article/2020070715264114453
5577,2020-07-07,대웅제약호이스타정코로나치료제임상2상승인,http://www.getnews.co.kr/view.php?ud=2020070715271228382fe691f917_16
5578,2020-07-07,메디톡스4년보톡스균주전쟁판정승대웅제약10년수입금지,http://www.metroseoul.co.kr/article/20200707500410
5579,2020-07-07,fnRASSI장마감거래소하락종목대웅제약172↓,http://www.fnnews.com/news/202007071536437323
5580,2020-07-07,승기잡은메디톡스대웅제약은나보타판매등해외사업난항예상,http://www.sisajournal-e.com/news/articleView.html?idxno=220853
5581,2020-07-07,美ITC예비판결서메디톡스손들어줘대웅제약이의절차나설것,http://news.mk.co.kr/newsRead.php?no=695812&year=2020
5582,2020-07-07,대웅제약호이스타코로나19치료제임상2상승인,http://www.monews.co.kr/news/articleView.html?idxno=211942
5583,2020-07-07,메디톡스보톡스전쟁승리조짐에상한가마감대웅제약17↓,http://news.mt.co.kr/mtview.php?no=2020070715502739794
5584,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.m-i.kr/news/articleView.html?idxno=727258
5585,2020-07-07,메디톡스완승기사회생메디톡스대웅제약균주훔친게사실로,http://www.edaily.co.kr/news/newspath.asp?newsid=03499766625832224
5586,2020-07-07,미국ITC대웅제약메디톡스영업비밀침해”,http://www.sentv.co.kr/news/view/575849
5587,2020-07-07,대웅제약ITC영업비밀침해로10년수입금지명령예비결정”,http://www.edaily.co.kr/news/newspath.asp?newsid=03614566625832224
5588,2020-07-07,대웅제약ITC영업비밀침해로10년수입금지명령예비결정,https://view.asiae.co.kr/article/2020070716151983016
5589,2020-07-07,대웅제약ITC판결이후병의원달래기중,https://www.ebn.co.kr/news/view/1441539/?sc=Naver
5590,2020-07-07,2조원의꿈은어디로대웅제약보툴리눔톡신사업비상,http://www.whitepaper.co.kr/news/articleView.html?idxno=195425
5591,2020-07-07,대웅제약이끄는전승호ITC판결로보톡스사업주름,http://www.newsway.co.kr/news/view?tp=1&ud=2020070715083294946
5592,2020-07-07,대웅제약나보타10년간美수입금지,http://www.lawissue.co.kr/view.php?ud=202007071641413516f4ab64559d_12
5593,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.bokuennews.com/news/article.html?no=192208
5594,2020-07-07,미국ITC대웅제약나보타수입10년금지예비판결내려,http://ilyo.co.kr/?ac=article_view&entry_id=374136
5595,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=03739206625832224
5596,2020-07-07,대웅제약메디톡스균주갈등ITC판결로다시주목받는폴카임보고서,http://www.ajunews.com/view/20200707164650381
5597,2020-07-07,메디톡스완승기사회생한메디톡스대웅제약상대민형사소송우위,http://www.edaily.co.kr/news/newspath.asp?newsid=03765446625832224
5598,2020-07-07,美ITC대웅제약메디톡스영업비밀침해대웅제약이의절차착수,http://www.fnnews.com/news/202007071528597480
5599,2020-07-07,대웅제약보톡스균주는어디서왔을까수백억원대소송승자는,http://news.kbs.co.kr/news/view.do?ncd=4488628&ref=A
5600,2020-07-07,대웅제약보톡스균주도용했다나보타美서퇴출위기,http://news.mk.co.kr/newsRead.php?no=696484&year=2020
5601,2020-07-07,대웅제약美ITC예비결정에최종판결서적극소명할것”,http://www.mdtoday.co.kr/mdtoday/index.html?no=392346
5602,2020-07-07,메디톡스손들어준美ITC대웅제약나보타10년간수입금지,https://www.asiatoday.co.kr/view.php?key=20200707010004225
5603,2020-07-07,보톡스전쟁5년미국은메디톡스선택남은불씨움켜쥔대웅제약,http://www.ajunews.com/view/20200707163817366
5604,2020-07-07,지긋지긋한균주전쟁승기잡은메디톡스대웅명백한오판,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070716295159961
5605,2020-07-07,대웅제약에승소한메디톡스다른국내보톡스제품들도조사해야”,http://www.segye.com/content/html/2020/07/07/20200707520784.html?OutUrl=naver
5606,2020-07-07,ITC예비판결로기선제압한메디톡스대웅제약의새전략은,http://daily.hankooki.com/lpage/industry/202007/dh20200707174217148390.htm?s_ref=nv
5607,2020-07-07,보톡스전쟁승기잡은메디톡스美ITC대웅제약영업비밀침해,http://www.fnnews.com/news/202007071801509407
5608,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=69899
5609,2020-07-07,메디톡스보톡스분쟁美ITC소송서승기대웅제약명백한오판,http://www.ntoday.co.kr/news/articleView.html?idxno=73549
5610,2020-07-07,메디톡스손들어준美ITC대웅제약10년간수입금지,http://www.dt.co.kr/contents.html?article_no=2020070802100151102001&ref=naver
5611,2020-07-07,기사회생메디톡스국내소송도청신호대웅제약美시장퇴출위기,http://www.dt.co.kr/contents.html?article_no=2020070802100451102001&ref=naver
5612,2020-07-07,지진全破대웅파크맨션2차도철거,http://www.hidomin.com/news/articleView.html?idxno=426573
5613,2020-07-07,메디톡스균주전에승기대웅제약손실눈덩이,https://cnbc.sbs.co.kr/article_hub/10000988919?division=NAVER
5614,2020-07-07,메디톡스기사회생美ITC대웅제약메디톡스영업비밀침해,http://www.opinionnews.co.kr/news/articleView.html?idxno=36252
5615,2020-07-07,美ITC메디톡스대웅제약균주전쟁예비판결미국내나보타수입금지,http://www.wsobi.com/news/articleView.html?idxno=100708
5616,2020-07-07,주름살펴진메디톡스벼랑끝몰린대웅제약,https://www.seoul.co.kr/news/newsView.php?id=20200708020021&wlog_tag3=naver
5617,2020-07-07,대웅제약호이스타정코로나19치료제임상2상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=69786
5618,2020-07-08,ITC대웅제약보톡스10년간수입금지”,https://news.joins.com/article/olink/23414169
5619,2020-07-08,코로나19공기감염가능성씨젠수출급증셀트리온부광약품메디톡스대웅제약주목,http://www.thekpm.com/view.php?ud=20200708040619782861beb2d9d_17
5620,2020-07-08,ITC가던진주사위대웅제약메디톡스운명가를까,https://www.dailian.co.kr/news/view/903257?sc=Naver
5621,2020-07-08,균주도둑공방승기잡은메디톡스뒤집겠다는대웅,http://www.kukinews.com/newsView/kuk202007070320
5622,2020-07-08,ITC대웅제약도용명시국내민사에영향미칠까,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134601&REFERER=NP
5623,2020-07-08,파국향하는보톡스전쟁대웅제약메디톡스상처만남았다,http://www.econovill.com/news/articleView.html?idxno=403813
5624,2020-07-08,출근길대웅제약예비판결이대로갈까삼성전자아무도예상못한깜짝실적外경제,https://www.etoday.co.kr/news/view/1915059
5625,2020-07-08,대웅제약보톡스분쟁현장조사이어과태료도거부,http://yna.kr/AKR20200707156900030?did=1195m
5626,2020-07-08,메디톡스vs대웅제약보톡스균주소송이제시작,http://www.medigatenews.com/news/1134607154
5627,2020-07-08,병원진화나선대웅제약ITC판결국내판매와무관,http://www.press9.kr/news/articleView.html?idxno=45227
5628,2020-07-08,김대성의종목분석메디톡스상한가vs대웅제약주가곤두박질,http://www.joseilbo.com/news/news_read.php?uid=401632&class=53&grp=
5629,2020-07-08,보톡스분쟁관련현장조사과태료거부한대웅제약,https://www.hankyung.com/economy/article/2020070841067
5630,2020-07-08,현장조사거부대웅제약과태료부과도이의제기,http://news.kmib.co.kr/article/view.asp?arcid=0014777466&code=61141111&cp=nv
5631,2020-07-08,대웅제약메디톡스와의보톡스분쟁현장조사이어과태료도거부,http://www.topstarnews.net/news/articleView.html?idxno=818324
5632,2020-07-08,대웅대웅제약소송장기화가능성부담투자의견↓KTB증권,https://www.etoday.co.kr/news/view/1915162
5633,2020-07-08,대웅제약보톡스전쟁에목표가↓KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01472726625832552
5634,2020-07-08,대웅제약ITC예비판결로소송장기화가능성부담KTB,http://news.mt.co.kr/mtview.php?no=2020070808241119828
5635,2020-07-08,대웅제약보톡스분쟁현장조사과태료거부,http://www.getnews.co.kr/view.php?ud=2020070808235686992fe691f917_16
5636,2020-07-08,KTB證대웅ITC패소로수출빨간불목표주가하향,http://www.newsis.com/view/?id=NISX20200708_0001087475&cID=10401&pID=10400
5637,2020-07-08,SK證대웅제약ITC소송에서패소투자의견목표가↓,http://www.newsis.com/view/?id=NISX20200708_0001087498&cID=10401&pID=10400
5638,2020-07-08,대웅제약ITC예비판정부정적투자의견목표가↓,http://www.inews24.com/view/1279924
5639,2020-07-08,리포트브리핑대웅제약끝이보이지않는소송의결과불확실성잔재목표가120000원KTB투자증권,http://www.newspim.com/news/view/20200708000102
5640,2020-07-08,전일주요공시대한항공알테오젠대웅제약외,https://www.etoday.co.kr/news/view/1915178
5641,2020-07-08,리포트브리핑대웅대웅제약소송장기화가능성이부담목표가25000원KTB투자증권,http://www.newspim.com/news/view/20200708000108
5642,2020-07-08,메디톡스대웅제약균주전쟁의역사,https://www.paxnetnews.com/articles/62669
5643,2020-07-08,대웅제약보톡스분쟁현장조사이어과태료부과거부,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007080074&t=NN
5644,2020-07-08,리포트브리핑대웅제약ITC소송에서패소목표가100000원SK증권,http://www.newspim.com/news/view/20200708000140
5645,2020-07-08,오늘기업오늘사람LG전자대웅제약틱톡SK바이오팜,https://cnbc.sbs.co.kr/article_hub/10000988957?division=NAVER
5646,2020-07-08,대웅제약보툴리눔톡신분쟁관련중기부현장조사이어과태료도거부,http://www.youthdaily.co.kr/news/article.html?no=41553
5647,2020-07-08,대웅제약보톡스분쟁관련중기부현장조사이어과태료도거부,http://www.seoulwire.com/news/articleView.html?idxno=419258
5648,2020-07-08,대웅제약소송장기화우려목표가↓KTB증권,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007080071&t=NN
5649,2020-07-08,미ITC메디톡스vs대웅소송에메디톡스손들어줘,http://www.doctorstimes.com/news/articleView.html?idxno=211510
5650,2020-07-08,대웅제약호이스타정코로나19치료제임상2상승인,http://www.doctorstimes.com/news/articleView.html?idxno=211511
5651,2020-07-08,ITC판결승기에메디톡스이틀째급등대웅제약약세,https://www.hankyung.com/finance/article/2020070846656
5652,2020-07-08,대웅제약ITC패소로수출빨간불주가는↓,http://www.whitepaper.co.kr/news/articleView.html?idxno=195448
5653,2020-07-08,대웅제약보톡스분쟁현장조사과태료거부법원간다,http://moneys.mt.co.kr/news/mwView.php?no=2020070808218099573
5654,2020-07-08,대웅제약최근5일개인19만7630주순매수주가10만8500원181,https://view.asiae.co.kr/article/2020070809320461896
5655,2020-07-08,주름깊어진韓보톡스대웅제약美수입금지메디톡스식약처허가취소,http://www.inews24.com/view/1279943
5656,2020-07-08,대웅제약보톡스기술침해행정조사거부로부과받은과태료에이의제기,http://news.mk.co.kr/newsRead.php?no=697806&year=2020
5657,2020-07-08,특징주휴젤대웅제약나보타수입금지반사이익에상승세,http://moneys.mt.co.kr/news/mwView.php?no=2020070809408096681
5658,2020-07-08,대웅제약보톡스분쟁현장조사이어과태료도거부,http://www.ekn.kr/news/article.html?no=509951
5659,2020-07-08,SK증권대웅제약美ITC패소목표주가투자의견↓,http://www.ezyeconomy.com/news/articleView.html?idxno=102819
5660,2020-07-08,이데일리N대웅제약보톡스분쟁현장조사이어과태료도거부外,http://www.edaily.co.kr/news/newspath.asp?newsid=02187766625832552
5661,2020-07-08,대웅제약주가하락나보타미국시장에서쫓겨나나,http://www.mediasr.co.kr/news/articleView.html?idxno=60743
5662,2020-07-08,대웅제약호이스타정코로나19치료제임상시작,http://www.finomy.com/news/articleView.html?idxno=80014
5663,2020-07-08,메디톡스대웅제약보톡스전쟁에주가도희비,http://sports.hankooki.com/lpage/economy/202007/sp20200708102630137020.htm?s_ref=nv
5664,2020-07-08,증권가대웅제약균주전쟁패배목표가줄하향,http://www.sentv.co.kr/news/view/575881
5665,2020-07-08,대웅제약보톡스분쟁현장조사거부과태료에이의제기,http://www.cstimes.com/news/articleView.html?idxno=421422
5666,2020-07-08,메디톡스대웅제약싸움에속으로웃는美엘러간,https://view.asiae.co.kr/article/2020070810013143904
5667,2020-07-08,ITC예비판결대웅제약나보타균주출처조사로번지나,https://www.ebn.co.kr/news/view/1441667/?sc=Naver
5668,2020-07-08,대웅제약혈행개선과혈압건강위한건기식세노메가큐텐출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200708091903819369d76442fa_1/article.html
5669,2020-07-08,보톡스분쟁현장조사거부한대웅제약과태료도거부,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4209685
5670,2020-07-08,지분가치하락대웅제약주가비틀메디톡스신풍제약상승셀트리온제약녹십자하락,http://www.thekpm.com/view.php?ud=20200708111015742861beb2d9d_17
5671,2020-07-08,보톡스분쟁관련중기부현장조사거부한대웅제약,https://biz.chosun.com/site/data/html_dir/2020/07/08/2020070801913.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5672,2020-07-08,뉴스후균주전쟁한숨돌린메디톡스대웅퇴출걱정노심초사,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020070811014180169
5673,2020-07-08,영업비밀도용”대가대웅제약수백억원손실위기,https://cnbc.sbs.co.kr/article_hub/10000989002?division=NAVER
5674,2020-07-08,중기부행정조사거부한대웅제약과태료도부당법정으로,http://www.whitepaper.co.kr/news/articleView.html?idxno=195454
5675,2020-07-08,대웅제약보톡스현장조사거부과태료에이의제기,http://daily.hankooki.com/lpage/industry/202007/dh20200708131716148390.htm?s_ref=nv
5676,2020-07-08,메디톡스대웅제약실적전망도희비,https://www.paxnetnews.com/articles/62721
5677,2020-07-08,대웅제약구충제니클로사마이드코로나19치료제임상가속화,https://www.fetv.co.kr/news/article.html?no=58866
5678,2020-07-08,대웅제약 코로나19치료제후보물질니클로사마이드DWRX2003 글로벌임상가속화,http://www.greened.kr/news/articleView.html?idxno=259732
5679,2020-07-08,美수출위기닥친대웅제약ITC판결뒤집힌사례는,http://www.viva100.com/main/view.php?key=20200708010001556
5680,2020-07-08,대웅제약필리핀서코로나19치료제임상승인신청,http://www.kpinews.co.kr/news/articleView.html?idxno=120944
5681,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.wsobi.com/news/articleView.html?idxno=100790
5682,2020-07-08,대웅제약코로나19치료제니클로사마이드글로벌임상가속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246494
5683,2020-07-08,메디톡스대웅제약희비엇갈려메디톡스18급등반해대웅제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=127888
5684,2020-07-08,7월8일뉴스락주식네비대웅제약소송장기화로목표주가하향조정,http://www.newslock.co.kr/news/articleView.html?idxno=29370
5685,2020-07-08,대웅제약코로나19치료물질글로벌임상가속화,http://www.medisobizanews.com/news/articleView.html?idxno=71068
5686,2020-07-08,대웅제약구충제니클로사마이드코로나19글로벌임상가속화,http://www.econovill.com/news/articleView.html?idxno=403902
5687,2020-07-08,로스탁대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.lawissue.co.kr/view.php?ud=202007081342147837204ead0791_12
5688,2020-07-08,대웅제약니클로사마이드필리핀인도현지임상1상IND신청,http://www.newsprime.co.kr/news/article.html?no=510358
5689,2020-07-08,대웅제약구충제필리핀서코로나19임상준비동남아겨냥,http://moneys.mt.co.kr/news/mwView.php?no=2020070813238057718
5690,2020-07-08,대웅제약니클로사마이드글로벌임상가속화코로나19치료제로개발위해역량집중,http://www.newslock.co.kr/news/articleView.html?idxno=29376
5691,2020-07-08,대웅제약코로나19치료제개발위한니클로사마이드글로벌임상가속화,http://www.youthdaily.co.kr/news/article.html?no=41608
5692,2020-07-08,대웅제약에등돌리는증권街한올바이오파마가희망,https://www.hankyung.com/finance/article/2020070862326
5693,2020-07-08,대웅제약코로나19치료제필리핀임상시험계획서제출,http://yna.kr/AKR20200708102600017?did=1195m
5694,2020-07-08,대웅제약니클로사마이드필리핀인도현지임상1상IND신청완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=392458
5695,2020-07-08,대웅제약니클로사마이드코로나글로벌임상확대,http://www.newsis.com/view/?id=NISX20200708_0001088185&cID=13001&pID=13000
5696,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.bosa.co.kr/news/articleView.html?idxno=2130156
5697,2020-07-08,대웅제약필리핀서구충제니클로사마이드코로나19임상신청,http://www.newspim.com/news/view/20200708000739
5698,2020-07-08,대웅제약코로나19치료제글로벌임상가속화,https://www.hankyung.com/it/article/202007086231i
5699,2020-07-08,대웅제약니클로사마이드코로나글로벌임상확대,http://www.newsway.co.kr/news/view?tp=1&ud=2020070814220611101
5700,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.dailypharm.com/Users/News/NewsView.html?ID=266348&REFERER=NP
5701,2020-07-08,대웅제약필리핀서코로나치료제임상계획제출,https://view.asiae.co.kr/article/2020070814280810994
5702,2020-07-08,대웅제약코로나치료효과구충제필리핀서임상,http://news.mt.co.kr/mtview.php?no=2020070814234213034
5703,2020-07-08,대웅제약중기부현장조사불응이어과태료도거부,http://www.mediapen.com/news/view/539290
5704,2020-07-08,대웅제약니클로사마이드필리핀인도임상1상IND신청완료,http://inthenews.co.kr/article-57665/
5705,2020-07-08,대웅제약니클로사마이드DWRX2003필리핀인도임상가속화,http://www.pressm.kr/news/articleView.html?idxno=31185
5706,2020-07-08,보톡스분쟁관련중기부현장조사거부한대웅제약과태료도거부,http://www.startuptoday.co.kr/news/articleView.html?idxno=46556
5707,2020-07-08,대웅제약코로나19치료제필리핀임상시험계획서제출,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4210020
5708,2020-07-08,세계에서유일한제형으로개발추진”대웅제약구충제코로나19치료제임상확대,https://www.donga.com/news/article/all/20200708/101875331/1
5709,2020-07-08,대웅제약필리핀에코로나19치료제임상시험계획서제출,http://www.ekn.kr/news/article.html?no=510052
5710,2020-07-08,대웅제약니클로사마이드코로나19글로벌임상가속화,http://medipana.com/news/news_viewer.asp?NewsNum=259671&MainKind=A&NewsKind=5&vCount=12&vKind=1
5711,2020-07-08,대웅제약니클로사마이드성분코로나치료제글로벌임상가속화,http://www.getnews.co.kr/view.php?ud=2020070814460091152fe691f917_16
5712,2020-07-08,대웅제약코로나19치료제개발위해니클로사마이드글로벌임상가속,http://www.metroseoul.co.kr/article/20200708500354
5713,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.press9.kr/news/articleView.html?idxno=45237
5714,2020-07-08,대웅제약니클로사마이드코로나19글로벌임상가속화,http://www.dailysmart.co.kr/news/articleView.html?idxno=29559
5715,2020-07-08,대웅제약DWRX2003글로벌임상가속화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065591363602129
5716,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.nbnnews.co.kr/news/articleView.html?idxno=405487
5717,2020-07-08,대웅제약인도서니클로사마이드임상진입신청,http://news.mk.co.kr/newsRead.php?no=700186&year=2020
5718,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.m-i.kr/news/articleView.html?idxno=727622
5719,2020-07-08,대웅제약필리핀에코로나19치료제임상계획신청,http://www.koreastocknews.com/news/articleView.html?idxno=55171
5720,2020-07-08,대웅제약필리핀에코로나19치료제임상계획서제출,http://www.seoulfn.com/news/articleView.html?idxno=388457
5721,2020-07-08,대웅제약필리핀인도서니클로사마이드코로나19치료제임상착수,http://www.viva100.com/main/view.php?key=20200708010001686
5722,2020-07-08,대웅제약코로나19치료제후보물질니클로사마이드글로벌임상가속화,http://www.ceoscoredaily.com/news/article.html?no=71291
5723,2020-07-08,대웅제약코로나19치료제후보물질니클로사마이드글로벌임상가속화,http://www.paxetv.com/news/articleView.html?idxno=95757
5724,2020-07-08,대웅제약니클로사마이드필리핀임상신청글로벌개발가속,https://www.etoday.co.kr/news/view/1915466
5725,2020-07-08,대웅제약니클로사마이드글로벌임상가속도,http://www.monews.co.kr/news/articleView.html?idxno=211973
5726,2020-07-08,대웅제약코로나치료제개발위해필리핀에임상시험계획신청,https://www.asiatoday.co.kr/view.php?key=20200708010004969
5727,2020-07-08,대웅제약필리핀에코로나치료제임상시험계획서제출,http://www.dt.co.kr/contents.html?article_no=2020070902101031102001&ref=naver
5728,2020-07-08,보톡스5년전쟁승리한메디톡스대웅제약글로벌진출빨간불,http://www.enewstoday.co.kr/news/articleView.html?idxno=1399293
5729,2020-07-08,대웅제약니클로사마이드글로벌임상가속화,http://www.whosaeng.com/119287
5730,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화필리핀인도등으로해외임상확대,http://newsbrite.net/139254
5731,2020-07-08,대웅제약니클로사마이드글로벌임상가속화필리핀인도등으로확대,http://www.koreaittimes.com/news/articleView.html?idxno=98879
5732,2020-07-08,대웅제약보톡스분쟁현장조사과태료거부,http://www.seoulfn.com/news/articleView.html?idxno=388461
5733,2020-07-08,오늘Who전승호대웅제약의앨러간도전야심찬꿈물거품위기,http://www.businesspost.co.kr/BP?command=article_view&num=186432
5734,2020-07-08,팜스원주대웅제약코로나19극복면역력증강비타민제기탁,http://www.nbnnews.co.kr/news/articleView.html?idxno=405549
5735,2020-07-08,팜스원대웅제약코로나19극복면역력증강비타민제및성금기탁,http://daily.hankooki.com/lpage/society/202007/dh20200708164034148510.htm?s_ref=nv
5736,2020-07-08,대웅제약니클로사마이드필리핀인도에임상1상신청,http://www.medigatenews.com/news/2182621479
5737,2020-07-08,대웅제약니클로사마이드코로나19글로벌임상가속화,https://www.dailian.co.kr/news/view/903638?sc=Naver
5738,2020-07-08,팜스원주대웅제약구례군에코로나19극복면역력증강비타민제기탁,http://www.anewsa.com/detail.php?number=2169987&thread=09
5739,2020-07-08,메디톡스대웅제약보톡스싸움진짜승자는엘러간,http://www.opinionnews.co.kr/news/articleView.html?idxno=36321
5740,2020-07-08,대웅제약코로나19치료제니클로사마이드DWRX2003글로벌임상가속화,http://www.thepublic.kr/news/newsview.php?ncode=1065600658576811
5741,2020-07-08,구례군에팜스원주대웅제약코로나19극복비타민제기탁,http://www.enewstoday.co.kr/news/articleView.html?idxno=1399326
5742,2020-07-08,김창수의e뉴스브리핑대웅제약니클로사마이드글로벌임상가속화外,https://www.fetv.co.kr/news/article.html?no=58888
5743,2020-07-08,sk바이오팜매수열풍비트코인연상부광약품셀트리온녹십자수젠텍씨젠메디톡스대웅제약출렁,http://www.thekpm.com/view.php?ud=202007081722324681861beb2d9d_17
5744,2020-07-08,대웅제약구충제필리핀서코로나19임상준비,http://it.chosun.com/site/data/html_dir/2020/07/08/2020070803592.html
5745,2020-07-08,팜스원㈜대웅제약코로나19극복면역력증강비타민제기탁,https://view.asiae.co.kr/article/2020070817562278528
5746,2020-07-08,대웅제약코로나치료제임상계획서필리핀식약처에제출,http://www.edaily.co.kr/news/newspath.asp?newsid=04122966625832552
5747,2020-07-08,대웅제약니클로사마이드DWRX2003글로벌임상가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62196
5748,2020-07-08,팜스원대웅제약구례군에코로나19극복비타민제기탁,http://www.ccreview.co.kr/news/articleView.html?idxno=270522
5749,2020-07-08,구례팜스원대웅제약코로나19극복면역력증강비타민제기탁,http://www.nspna.com/news/?mode=view&newsid=439969
5750,2020-07-08,대웅제약코로나치료물질필리핀서도임상시험추진,https://www.hankyung.com/it/article/2020070881631
5751,2020-07-08,美ITC메디톡스균주도용대웅제약나보타수입금지10년”,http://www.betanews.net:8080/article/1203583.html
5752,2020-07-08,팜스원주대웅제약코로나19극복면역력증강비타민제기탁,http://www.newsworker.co.kr/news/articleView.html?idxno=77499
5753,2020-07-08,뉴스투데이L대웅제약코로나19치료제후보물질니클로사마이드임상에속도,https://www.news2day.co.kr/156257
5754,2020-07-08,대웅제약코로나19치료제니클로사마이드글로벌임상가속화,http://news.kbiz.or.kr/news/articleView.html?idxno=69842
5755,2020-07-09,SK증권}대웅제약ITC소송에서패소기나긴균주싸움에서일단락,http://www.g-enews.com/ko-kr/news/article/news_all/202007090617032611442088f476_1/article.html
5756,2020-07-09,대웅제약파트너에볼루스ITC결정동의못해이의제기할것,http://www.press9.kr/news/articleView.html?idxno=45239
5757,2020-07-09,기사회생메디톡스美ITC10년간대웅제약나보타수입금지”,http://www.mdtoday.co.kr/mdtoday/index.html?no=392487
5758,2020-07-09,대웅제약보툴리눔톡신분쟁현장조사거부과태료에이의제기,http://www.mdtoday.co.kr/mdtoday/index.html?no=392510
5759,2020-07-09,영업비밀침해체면구긴대웅제약나보타美시장진출1년여만에퇴출위기,http://www.youthdaily.co.kr/news/article.html?no=41647
5760,2020-07-09,뉴스브리핑7월9일대웅제약임상아반떼N라인정보보호의날,http://it.chosun.com/site/data/html_dir/2020/07/08/2020070804033.html
5761,2020-07-09,더벨코너몰린대웅제약파트너사에볼루스CB투자승부수,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202007081647052320109349
5762,2020-07-09,팜스원주대웅제약코로나19극복면역력증강비타민제기탁,http://www.breaknews.com/741280
5763,2020-07-09,메디톡스보톡스분쟁서승기잡아대웅제약美ITC오판이의신청할것,http://www.dailypop.kr/news/articleView.html?idxno=45793
5764,2020-07-09,좋은약돋보기대웅제약자체개발복합제올로스타올로맥스,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62201
5765,2020-07-09,대웅제약니클로사마이드글로벌임상진행코로나19치료제개발가속화,http://theviewers.co.kr/View.aspx?No=908202
5766,2020-07-09,대웅제약오픈콜라보레이션을통해혁신신약개발가속화,http://www.lawissue.co.kr/view.php?ud=202007091117545958204ead0791_12
5767,2020-07-09,메디톡스대웅제약보톡스전쟁최종승자는엘러간,http://www.newsprime.co.kr/news/article.html?no=510511
5768,2020-07-09,여름엔반바지대웅제약자율적사내문화강화,http://www.meconomynews.com/news/articleView.html?idxno=43305
5769,2020-07-09,여름엔사무실에서반바지대웅제약사내문화눈길,http://www.newstomato.com/ReadNews.aspx?no=983155
5770,2020-07-09,ITC소송의끝메디톡스대웅제약모두새드엔딩,http://ilyo.co.kr/?ac=article_view&entry_id=374243
5771,2020-07-09,대웅제약혁신신약개발가속화,http://www.mhj21.com/132590
5772,2020-07-09,대웅제약제약업계반항아이번엔중기부과태료부과이의제기,http://theviewers.co.kr/View.aspx?No=909078
5773,2020-07-09,나이스신용평가ITC예비판정대웅제약수익성악화,http://news.mt.co.kr/mtview.php?no=2020070917125458917
5774,2020-07-09,오늘의토막뉴스영업비밀침해체면구긴대웅제약나보타美시장진출1년여만에퇴출위기外,http://www.youthdaily.co.kr/news/article.html?no=41742
5775,2020-07-09,대웅제약나보타美퇴출위기에수익성회복어려워져,https://www.ajunews.com/view/20200709165727164
5776,2020-07-09,대웅제약美파트너사주주집단소송가능성↑,https://www.ajunews.com/view/20200709185657269
5777,2020-07-10,오늘의제약대웅제약한미약품동국제약,http://www.babytimes.co.kr/news/articleView.html?idxno=37781
5778,2020-07-10,대웅제약올로스타올로맥스고혈압복합제시장서두각,http://www.biospectator.com/view/news_view.php?varAtcId=10812
5779,2020-07-10,대웅제약덴티가드랩치약그립핏칫솔출시,http://www.iminju.net/news/articleView.html?idxno=55111
5780,2020-07-10,시경Today제약대웅제약생리통발생원인다스리는진통제신중히골라야,http://www.meconomynews.com/news/articleView.html?idxno=43346
5781,2020-07-10,대웅제약임직원자율성높이고효율은올리는사내문화눈길,http://www.viva100.com/main/view.php?key=20200710010002068
5782,2020-07-10,RD경쟁력인정대웅제약아태지역혁신제약사12위에선정,http://kpenews.com/View.aspx?No=909971
5783,2020-07-10,대웅제약에볼루스500억투자美판매자신감vs무리수,http://www.koreastocknews.com/news/articleView.html?idxno=55255
5784,2020-07-10,위클리제약바이오미국ITC대웅메디톡스영업비밀침해예비판결外,https://www.etoday.co.kr/news/view/1916388
5785,2020-07-10,여름엔반바지입고출근”대웅제약자율성효율성UP,http://daily.hankooki.com/lpage/industry/202007/dh20200710152128148390.htm?s_ref=nv
5786,2020-07-10,대웅제약오픈콜라보레이션통해혁신신약개발가속화,http://www.kukinews.com/newsView/kuk202007100257
5787,2020-07-10,대웅제약이긴메디톡스메디톡신판매재개할수있을까,http://www.sisajournal-e.com/news/articleView.html?idxno=221029
5788,2020-07-10,대웅제약美ITC예비판결서메디톡스에패소,http://hobbyen.co.kr/news/newsview.php?ncode=1065596618895103
5789,2020-07-10,나이스신평ITC판정대웅제약신용도에부정적,http://www.finomy.com/news/articleView.html?idxno=80209
5790,2020-07-11,주간산업동향메디톡스대웅제약과보톡스전쟁서승기잡았다,http://www.cstimes.com/news/articleView.html?idxno=421825
5791,2020-07-11,식품의약품안전처코로나19치료제백신임상12건승인부광약품엔지켐생명과학신풍제약종근당크리스탈지노믹스대웅제약국제백신연구소제넥신등렘데시비르및클로로퀸등5건임상종료,http://www.econonews.co.kr/news/articleView.html?idxno=128339
5792,2020-07-11,이주의CEODOWN전승호대웅제약대표이사나보타미국발충격,http://www.econovill.com/news/articleView.html?idxno=404061
5793,2020-07-12,한국코로나19치료제백신12건임상시험진행중크리스탈지노믹스대웅제약추가승인,http://www.ccreview.co.kr/news/articleView.html?idxno=271226
5794,2020-07-12,보툴리눔톡신균주도용의혹대웅제약11월최종패소땐최대위기,https://www.hankyung.com/it/article/2020071200331
5795,2020-07-12,대웅휴온스한미코로나19치료제백신개발현황공개,http://weekly.cnbnews.com/news/article.html?no=134865
5796,2020-07-13,우리도있어요대웅제약vs메디톡스닮은제2균주전쟁,http://www.edaily.co.kr/news/newspath.asp?newsid=01341526625834192
5797,2020-07-13,베스트워스트피라맥스기대에신풍제약64급등미국ITC판정에대웅제약13급락,https://www.etoday.co.kr/news/view/1916727
5798,2020-07-13,대웅균주도용예비판결관리강화로이어지나,https://www.paxnetnews.com/articles/62787
5799,2020-07-13,메디톡스대웅제약보톡스전쟁끝나지않는총성,https://www.donga.com/news/article/all/20200710/101917870/1
5800,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.press9.kr/news/articleView.html?idxno=45265
5801,2020-07-13,대웅제약웨어러블심전도기모비케어출시,https://www.fetv.co.kr/news/article.html?no=59157
5802,2020-07-13,대웅제약사용편의성높인웨어러블심전도기모비케어출시,http://www.ekn.kr/news/article.html?no=510763
5803,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200713093218867651638db705_1/article.html
5804,2020-07-13,대웅제약웨어러블심전도기기모비케어출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572957011842
5805,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어판매,http://www.kpinews.co.kr/news/articleView.html?idxno=121217
5806,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.youthdaily.co.kr/news/article.html?no=41907
5807,2020-07-13,대웅제약모비케어출시부정맥조기진단기대,http://www.mhj21.com/132675
5808,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://medipana.com/news/news_viewer.asp?NewsNum=259833&MainKind=A&NewsKind=5&vCount=12&vKind=1
5809,2020-07-13,메디톡스대웅제약손배청구10억α,https://view.asiae.co.kr/article/2020071309534866706
5810,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.econovill.com/news/articleView.html?idxno=404371
5811,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62257
5812,2020-07-13,대웅제약부정맥검출용웨어러블심전도기모비케어출시,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119278
5813,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=266470&REFERER=NP
5814,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어출시,http://www.pressm.kr/news/articleView.html?idxno=31277
5815,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=29807
5816,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어출시,http://www.medisobizanews.com/news/articleView.html?idxno=71152
5817,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://news.mt.co.kr/mtview.php?no=2020071309332774674
5818,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.bokuennews.com/news/article.html?no=192410
5819,2020-07-13,대웅제약가슴에붙이는심전도기모비케어출시,http://health.chosun.com/site/data/html_dir/2020/07/13/2020071301192.html
5820,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02122166625834192
5821,2020-07-13,장중코로나관련주녹십자신풍제약씨젠껑충vs대웅하락,http://www.choicenews.co.kr/news/articleView.html?idxno=72636
5822,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.newspim.com/news/view/20200713000179
5823,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.getnews.co.kr/view.php?ud=2020071310125164632fe691f917_16
5824,2020-07-13,대웅제약패치형심전도기모비케어판매연속72시간심전도검사가능,http://theviewers.co.kr/View.aspx?No=911054
5825,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://moneys.mt.co.kr/news/mwView.php?no=2020071310008059207
5826,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.newsis.com/view/?id=NISX20200713_0001092687&cID=13001&pID=13000
5827,2020-07-13,대웅제약패치형심전도기모비케어판매시작,https://www.sedaily.com/NewsView/1Z5ACOZNO0
5828,2020-07-13,대웅제약코로나19치료제개발위해니클로사마이드글로벌임상연구가속화,http://www.g-enews.com/ko-kr/news/article/news_all/2020071310023451669d76442fa_1/article.html
5829,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.mediapen.com/news/view/540327
5830,2020-07-13,뉴스투데이L대웅제약패치형심전도기모비케어출시,https://www.news2day.co.kr/156432
5831,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://newsbrite.net/139421
5832,2020-07-13,대웅제약 웨어러블심전도기 모비케어 출시,http://www.greened.kr/news/articleView.html?idxno=260375
5833,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246642
5834,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://news.mk.co.kr/newsRead.php?no=715068&year=2020
5835,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.medigatenews.com/news/1339702705
5836,2020-07-13,대웅370상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/07/13/2020071301560.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5837,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://www.lawissue.co.kr/view.php?ud=202007131109485833204ead0791_12
5838,2020-07-13,대웅제약웨어러블심전도기모비케어출시,https://biz.chosun.com/site/data/html_dir/2020/07/13/2020071301569.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5839,2020-07-13,대웅제약ITC예비결정전례없는중대오류최종승소자신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246646
5840,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://www.seoulwire.com/news/articleView.html?idxno=419971
5841,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62264
5842,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.metroseoul.co.kr/article/20200713500196
5843,2020-07-13,대웅제약ITC예비결정은중대한오류최종승소자신,http://www.medisobizanews.com/news/articleView.html?idxno=71162
5844,2020-07-13,대웅제약ITC예비결정에중대한오류발견최종승소자신”,http://daily.hankooki.com/lpage/industry/202007/dh20200713112603148390.htm?s_ref=nv
5845,2020-07-13,대웅제약ITC예비결정전례없는중대오류최종승소자신”,http://www.econovill.com/news/articleView.html?idxno=404401
5846,2020-07-13,대웅ITC예비판결추론만으로균주절취판정,https://www.paxnetnews.com/articles/62882
5847,2020-07-13,대웅커뮤니티활발주가174,https://view.asiae.co.kr/article/2020071311343067761
5848,2020-07-13,대웅제약ITC예비판결중대한오류최종승소할것”,http://www.viva100.com/main/view.php?key=20200713010002484
5849,2020-07-13,대웅제약ITC예비결정전례없는중대한오류,http://medipana.com/news/news_viewer.asp?NewsNum=259841&MainKind=A&NewsKind=5&vCount=12&vKind=1
5850,2020-07-13,대웅제약ITC예비결정전례없는오류승소자신,http://www.press9.kr/news/articleView.html?idxno=45270
5851,2020-07-13,대웅제약ITC예비결정중대한오류있어11월승소자신,http://moneys.mt.co.kr/news/mwView.php?no=2020071311358037281
5852,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://newsclaim.co.kr/View.aspx?No=911385
5853,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.lawissue.co.kr/view.php?ud=202007131154119481204ead0791_12
5854,2020-07-13,대웅제약패치형심전도기모비케어출시,http://yna.kr/AKR20200713067000017?did=1195m
5855,2020-07-13,씨어스테크놀로지개발첨단심전도기대웅제약판매개시,http://www.joseilbo.com/news/news_read.php?uid=401929&class=27&grp=
5856,2020-07-13,대웅제약나보타균주도용예비판결에멘붕,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=715592
5857,2020-07-13,끝날때까진끝난게아니다대웅ITC승소자신감,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134703&REFERER=NP
5858,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신,http://www.newsis.com/view/?id=NISX20200713_0001093023&cID=13001&pID=13000
5859,2020-07-13,대웅제약반격ITC추론기반균주절취결론,http://www.bosa.co.kr/news/articleView.html?idxno=2130414
5860,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.koreaittimes.com/news/articleView.html?idxno=98983
5861,2020-07-13,대웅제약ITC예비결정자국엘러간만보호중대한오류범해,https://www.news1.kr/articles/?3994020
5862,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.monews.co.kr/news/articleView.html?idxno=212076
5863,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://newsbrite.net/139428
5864,2020-07-13,대웅제약씨어스웨어러블심전도기모비케어출시,http://www.biospectator.com/view/news_view.php?varAtcId=10828
5865,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신”,http://www.newsway.co.kr/news/view?tp=1&ud=2020071312525605244
5866,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.ybsn.tv/news/articleView.html?idxno=22281
5867,2020-07-13,대웅美ITC균주절취입증못해중대오류,https://view.asiae.co.kr/article/2020071313035287707
5868,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=392903
5869,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.updownnews.co.kr/news/articleView.html?idxno=220849
5870,2020-07-13,대웅제약웨어러블심전도기모비케어판매,http://www.consumuch.com/news/articleView.html?idxno=49723
5871,2020-07-13,대웅제약패치형심전도기모비케어출시,http://yna.kr/PYH20200713089300017?did=1196m
5872,2020-07-13,대웅제약ITC예비결정은전례없는중대오류,http://www.m-i.kr/news/articleView.html?idxno=728827
5873,2020-07-13,대웅제약미국ITC예비판결중대오류최종승소자신,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020071313311033865
5874,2020-07-13,대웅제약ITC예비결정전례없는중대오류최종승소할것,http://www.dailysmart.co.kr/news/articleView.html?idxno=29835
5875,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신,http://www.wolyo.co.kr/news/articleView.html?idxno=106858
5876,2020-07-13,대웅제약패치형웨어러블심전도기모비케어출시,http://news.kbiz.or.kr/news/articleView.html?idxno=70070
5877,2020-07-13,보툴리눔소송대웅제약과매디톡스안개속의앞날,http://www.g-enews.com/ko-kr/news/article/news_all/2020071313433770251638db705_1/article.html
5878,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://www.paxetv.com/news/articleView.html?idxno=95985
5879,2020-07-13,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.nbnnews.co.kr/news/articleView.html?idxno=406541
5880,2020-07-13,대웅제약ITC전례없는오류최종결정뒤집을것,http://www.dailypharm.com/Users/News/NewsView.html?ID=266483&REFERER=NP
5881,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신,https://www.hankyung.com/finance/article/2020071326496
5882,2020-07-13,대웅제약ITC판결은오류에기반한것최종승소자신,https://www.hankyung.com/it/article/202007132096i
5883,2020-07-13,대웅제약ITC예비결정중대한오류최종승소자신,http://www.newsprime.co.kr/news/article.html?no=510875
5884,2020-07-13,대웅제약간편한웨어러블심전도기모비케어출시,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200713005
5885,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://sports.hankooki.com/lpage/economy/202007/sp20200713141108136980.htm?s_ref=nv
5886,2020-07-13,대웅제약ITC예비판결은중대오류메디톡스도결국빈손,http://www.ajunews.com/view/20200713140035072
5887,2020-07-13,대웅제약ITC예비결정중대오류메디톡스는외국기업엘러간만도와주고있다,http://www.topstarnews.net/news/articleView.html?idxno=819625
5888,2020-07-13,대웅제약美ITC예비판결오류있다최종판결승소할것”,https://www.etoday.co.kr/news/view/1917089
5889,2020-07-13,대웅제약ITC예비결정전례없는중대한오류저질러”,http://www.mdtoday.co.kr/mdtoday/index.html?no=392912
5890,2020-07-13,대웅제약ITC예비판결은중대한오류최종승소자신,http://yna.kr/AKR20200713094500017?did=1195m
5891,2020-07-13,대웅제약ITC판결중대한오류최종승소자신있다,http://www.newspim.com/news/view/20200713000723
5892,2020-07-13,대웅제약ITC예비결정중대오류자국엘러간만보호,http://www.thevaluenews.co.kr/news/view.php?idx=160091
5893,2020-07-13,대웅제약패치형심전도기모비케어출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4214710
5894,2020-07-13,대웅제약ITC예비결정은중대한오류최종승소자신,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4214715
5895,2020-07-13,대웅ITC예비판결결정문분석결과발표추론만으로중대오류범해일상톡톡플러스,http://www.segye.com/content/html/2020/07/13/20200713512105.html?OutUrl=naver
5896,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,https://www.asiatoday.co.kr/view.php?key=20200713010007684
5897,2020-07-13,대웅제약ITC예비결정중대한오류범해최종승소자신,http://www.mediapen.com/news/view/540425
5898,2020-07-13,대웅제약부정맥검출용패치형심전도기모비케어출시,http://www.todaykorea.co.kr/news/articleView.html?idxno=273815
5899,2020-07-13,메디톡스vs대웅제약균주전쟁다시과열상처뿐인싸움될것,http://www.metroseoul.co.kr/article/20200713500367
5900,2020-07-13,대웅제약ITC예비결정전례없는중대한오류승소자신,http://www.ceoscoredaily.com/news/article.html?no=71424
5901,2020-07-13,대웅제약ITC예비결정전례없는중대한오류”주장최종승소자신,http://www.thepublic.kr/news/newsview.php?ncode=1065587527990644
5902,2020-07-13,대웅제약패치형심전도기모비케어출시,http://www.seoulfn.com/news/articleView.html?idxno=388897
5903,2020-07-13,대웅제약ITC예비결정전례없는중대한오류최종승소자신,http://news.mt.co.kr/mtview.php?no=2020071314474111458
5904,2020-07-13,대웅제약웨어러블심전도기모비케어출시,https://www.ebn.co.kr/news/view/1442282/?sc=Naver
5905,2020-07-13,대웅제약ITC예비판결중대한오류최종승소자신,https://www.fetv.co.kr/news/article.html?no=59223
5906,2020-07-13,대웅제약ITC예비결정중대한오류11월승소자신,http://www.getnews.co.kr/view.php?ud=2020071315232642762fe691f917_16
5907,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1400279
5908,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.etnews.com/20200713000281
5909,2020-07-13,대웅제약ITC예비판결은엘러간의승리,https://hankookilbo.com/News/Read/A2020071315430001404?did=NA
5910,2020-07-13,대웅제약ITC예비결정중대한오류최종결정은11월,http://weekly.hankooki.com/lpage/economy/202007/wk20200713160025146380.htm?s_ref=nv
5911,2020-07-13,대웅제약美ITC예비판결중대한오류범해11월최종결정서승소의지다져,http://hobbyen.co.kr/news/newsview.php?ncode=1065596352486957
5912,2020-07-13,대웅제약장시간심전도검사가능한모비케어판매나서,http://news.mk.co.kr/newsRead.php?no=717103&year=2020
5913,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=48881
5914,2020-07-13,대웅제약ITC가메디톡스일방적인주장을받아들여최종승소자신있어”,http://inthenews.co.kr/article-58370/
5915,2020-07-13,대웅제약ITC예비결정중대한오류최종승소자신한다,https://www.news2day.co.kr/156471
5916,2020-07-13,대웅제약ITC예비판결중대한오류실체적진실과거리멀다,http://www.newsworks.co.kr/news/articleView.html?idxno=471927
5917,2020-07-13,대웅제약메디톡스가스스로발등찍어ITC최종승소자신,https://www.dailian.co.kr/news/view/904754?sc=Naver
5918,2020-07-13,대웅제약보톡스패배ITC결정전례없는중대오류,https://www.nocutnews.co.kr/news/5377461
5919,2020-07-13,대웅제약ITC예비결정전례없는중대한오류”최종승소자신,http://www.pinpointnews.co.kr/view.php?ud=20200713165007227f090c8dbcb_45
5920,2020-07-13,대웅제약ITC예비결정전례없는중대한오류,http://www.monews.co.kr/news/articleView.html?idxno=212082
5921,2020-07-13,대웅제약ITC예비결정美앨러간만보호중대한오류범했다,https://biz.chosun.com/site/data/html_dir/2020/07/13/2020071303118.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5922,2020-07-13,대웅제약웨어러블심전도기모비케어출시,http://www.fnnews.com/news/202007131652112910
5923,2020-07-13,대웅제약vs메디톡스보톡스전쟁11월ITC최종결론은,http://www.wikileaks-kr.org/news/articleView.html?idxno=90848
5924,2020-07-13,대웅제약ITC예비결정중대오류최종승소자신주장,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007130321&t=NN
5925,2020-07-13,대웅ITC예비판결은자국산업보호에눈먼오판,http://www.shinailbo.co.kr/news/articleView.html?idxno=1298665
5926,2020-07-13,대웅제약ITC예비결정은오류최종승소자신있어”,http://theviewers.co.kr/View.aspx?No=911888
5927,2020-07-13,대웅제약ITC예비판결중대한오류범해최종승리할것,http://www.whitepaper.co.kr/news/articleView.html?idxno=195603
5928,2020-07-13,대웅제약메디톡스난타전지속대웅ITC예비결정전례없는중대한오류최종승소자신,http://www.kdpress.co.kr/news/articleView.html?idxno=96307
5929,2020-07-13,대웅제약ITC예비판결오류최종승소자신,http://www.seoulfn.com/news/articleView.html?idxno=388928
5930,2020-07-13,대웅제약씨어스테크놀로지가개발한패치형부정맥진단기기판매,http://www.businesspost.co.kr/BP?command=article_view&num=187129
5931,2020-07-13,대웅제약균주소송의미국국제무역위예비판결에중대한오류있어,http://www.businesspost.co.kr/BP?command=article_view&num=187133
5932,2020-07-13,대웅제약보톡스관련ITC예비결정은추론불과한전례없는오판”,https://www.donga.com/news/article/all/20200713/101950699/1
5933,2020-07-13,대웅제약붙이는웨어러블심전도기모비케어선봬,https://www.kpanews.co.kr/article/show.asp?idx=214639&category=D
5934,2020-07-13,대웅제약ITC예비결정중대한오류최종승소할것,https://www.kpanews.co.kr/article/show.asp?idx=214638&category=D
5935,2020-07-14,종목PICK대웅제약ITC중대한오류범했다주장투자에는유의해야,https://www.asiatoday.co.kr/view.php?key=20200713010007813
5936,2020-07-14,대웅제약ITC예비판정중대오류메디톡스반박예고,http://www.medigatenews.com/news/4132123391
5937,2020-07-14,대웅제약92g초소형웨어러블심전도기출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2000853
5938,2020-07-14,진실공방밀린대웅제약신용등급도내려갈까,https://www.paxnetnews.com/articles/62886
5939,2020-07-14,갱년기증상완화도움”대웅제약마그네슘비타민B복합제마그온맥스출시,https://www.fetv.co.kr/news/article.html?no=59244
5940,2020-07-14,대웅제약마그온맥스출시갱년기증상완화도움,http://www.kpinews.co.kr/news/articleView.html?idxno=121321
5941,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.youthdaily.co.kr/news/article.html?no=42005
5942,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://medipana.com/news/news_viewer.asp?NewsNum=259889&MainKind=A&NewsKind=5&vCount=12&vKind=1
5943,2020-07-14,대웅제약마그온맥스출시갱년기증상완화도움,http://www.mediapen.com/news/view/540551
5944,2020-07-14,대웅제약마그온신규라인업구축마그네슘강화한마그온맥스출시,http://kpenews.com/View.aspx?No=912225
5945,2020-07-14,대웅제약마그온신규라인업구축마그네슘강화한마그온맥스출시,http://kpenews.com/View.aspx?No=912225
5946,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://www.ybsn.tv/news/articleView.html?idxno=22432
5947,2020-07-14,대웅제약갱년기완화마그온맥스출시,http://www.wikileaks-kr.org/news/articleView.html?idxno=90882
5948,2020-07-14,대웅제약ITC예비결정전례없는중대한오류,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200713012
5949,2020-07-14,대웅제약비타민B마그네슘보강한근육경련개선제출시,http://moneys.mt.co.kr/news/mwView.php?no=2020071409048027112
5950,2020-07-14,대웅제약갱년기증상개선마그온맥스출시,http://news.mt.co.kr/mtview.php?no=2020071409231292388
5951,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62286
5952,2020-07-14,대웅제약갱년기증상완화도움마그온맥스출시,https://www.etoday.co.kr/news/view/1917402
5953,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화도움,http://www.m-i.kr/news/articleView.html?idxno=729050
5954,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020071409340189459
5955,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,https://www.sedaily.com/NewsView/1Z5ASWUC6I
5956,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.bosa.co.kr/news/articleView.html?idxno=2130455
5957,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246683
5958,2020-07-14,대웅제약갱년기증상개선복합제마그온맥스출시,http://www.medisobizanews.com/news/articleView.html?idxno=71185
5959,2020-07-14,SR유통대웅제약ITC예비판결중대한오류승소자신,http://www.srtimes.kr/news/articleView.html?idxno=67116
5960,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.bokuennews.com/news/article.html?no=192475
5961,2020-07-14,대웅제약갱년기증상완화제마그온맥스출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02204166625834520
5962,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.newspim.com/news/view/20200714000226
5963,2020-07-14,대웅제약마그네슘비타민B 복합제 마그온맥스 출시갱년기증상에도움,http://www.greened.kr/news/articleView.html?idxno=260542
5964,2020-07-14,대웅전일대비537최근단기조정후반등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007140136&t=NN
5965,2020-07-14,대웅5이상상승전일외국인대량순매수,https://www.hankyung.com/finance/article/202007145945L
5966,2020-07-14,오늘의신상품대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.econovill.com/news/articleView.html?idxno=404528
5967,2020-07-14,대웅제약김성중팀장홍보실실장발령,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246687
5968,2020-07-14,대웅제약갱년기증상완화마그온맥스출시,http://www.pharmnews.com/news/articleView.html?idxno=100889
5969,2020-07-14,대웅847상승폭확대,https://biz.chosun.com/site/data/html_dir/2020/07/14/2020071401193.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5970,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020071410082638484
5971,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.newsis.com/view/?id=NISX20200714_0001094075&cID=13001&pID=13000
5972,2020-07-14,대웅제약갱년기증상완화일반의약품마그온맥스출시,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007140118&t=NN
5973,2020-07-14,대웅제약갱년기증상완화마그온맥스출시,http://sports.hankooki.com/lpage/economy/202007/sp20200714102109136980.htm?s_ref=nv
5974,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.metroseoul.co.kr/article/20200714500070
5975,2020-07-14,ITC예비결정전례없는중대한오류대웅제약최종승소자신,http://www.healthinnews.co.kr/news/articleView.html?idxno=13694
5976,2020-07-14,대웅제약갱년기증상도움주는마그네슘비타민B복합제출시,http://daily.hankooki.com/lpage/industry/202007/dh20200714103538148390.htm?s_ref=nv
5977,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://newsbrite.net/139459
5978,2020-07-14,뉴스투데이L대웅제약마그네숨비타민B보강된마그온맥스출시,https://www.news2day.co.kr/156511
5979,2020-07-14,대웅제약마그온맥스출시갱년기증상완화도움,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119322
5980,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.viva100.com/main/view.php?key=20200714010002730
5981,2020-07-14,대웅제약웨어러블심전도기모비케어출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=13692
5982,2020-07-14,제약빅52분기희비교차종근당유한녹십자웃고대웅한미울고,http://www.viva100.com/main/view.php?key=20200714010002732
5983,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화도움 ,http://www.updownnews.co.kr/news/articleView.html?idxno=220900
5984,2020-07-14,대웅제약마그온맥스출시,https://www.ebn.co.kr/news/view/1442399/?sc=Naver
5985,2020-07-14,대웅커뮤니티활발주가496,https://view.asiae.co.kr/article/2020071411345036507
5986,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.thepublic.kr/news/newsview.php?ncode=1065576354491252
5987,2020-07-14,시경Today건강대웅제약마그네슘비타민B복합제마그온맥스출시外,http://www.meconomynews.com/news/articleView.html?idxno=43446
5988,2020-07-14,대웅제약갱년기증상개선마그온맥스출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=393018
5989,2020-07-14,과기부대웅제약한국야쿠르트등우수기업연구소지정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1400484
5990,2020-07-14,과기정통부대웅제약등19개우수기업연구소선정,https://www.asiatoday.co.kr/view.php?key=20200714010008183
5991,2020-07-14,과기정통부상반기우수기업연구소에대웅제약등19곳지정,http://yna.kr/AKR20200714066400017?did=1195m
5992,2020-07-14,대웅제약한국야쿠르트우수기업연구소지정,http://news.mt.co.kr/mtview.php?no=2020071409543761311
5993,2020-07-14,대웅제약한국야쿠르트등19곳우수기업연구소지정,http://www.dongascience.com/news/view/38167
5994,2020-07-14,정부대웅제약의약연구소등19개우수기업연구소선정,http://www.newsis.com/view/?id=NISX20200714_0001094126&cID=13001&pID=13000
5995,2020-07-14,과기정통부대웅제약등19곳우수기업연구소지정,https://biz.chosun.com/site/data/html_dir/2020/07/14/2020071401148.html?utm_source=naver&utm_medium=original&utm_campaign=biz
5996,2020-07-14,대웅제약등19개연구소한국형K연구개발우수연구소선정,https://www.etoday.co.kr/news/view/1917517
5997,2020-07-14,과기정통부대웅제약등우수기업연구소19곳지정,http://biz.newdaily.co.kr/site/data/html/2020/07/14/2020071400022.html
5998,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.wsobi.com/news/articleView.html?idxno=101082
5999,2020-07-14,대웅제약마그온맥스출시갱년기증상완화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065570891042888
6000,2020-07-14,대웅제약웨어러블심전도기모비케어판매,http://www.whosaeng.com/119436
6001,2020-07-14,대웅제약갱년기증상완화위한마그온맥스출시,http://news.mk.co.kr/newsRead.php?no=720174&year=2020
6002,2020-07-14,인사대웅제약,http://www.mediapen.com/news/view/540705
6003,2020-07-14,과기정통부대웅제약등19개우수기업연구소지정,http://news.heraldcorp.com/view.php?ud=20200714000690
6004,2020-07-14,대웅제약의약연구소등19개우수기업연구소지정,http://www.etnews.com/20200714000196
6005,2020-07-14,대웅제약한국야쿠르트등19개우수기업연구소선정,http://www.fnnews.com/news/202007141405346506
6006,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://www.nbnnews.co.kr/news/articleView.html?idxno=406876
6007,2020-07-14,대웅제약근육경련갱녕기증상완화제마그온맥스선봬,http://www.100ssd.co.kr/news/articleView.html?idxno=70036
6008,2020-07-14,메디톡스대웅승소자신ITC판결문보지않고거짓주장,http://www.getnews.co.kr/view.php?ud=2020071414262971112fe691f917_16
6009,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.pressm.kr/news/articleView.html?idxno=31335
6010,2020-07-14,메디톡스대웅제약주장ITC가받아들이지않은내용예비판결로진실밝혀져”,https://www.fetv.co.kr/news/article.html?no=59294
6011,2020-07-14,메디톡스대웅제기주장은ITC행정판사가받아들이지않은내용,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=246714
6012,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시갱년기증상완화에도움되는성분보강,http://www.healthinnews.co.kr/news/articleView.html?idxno=13695
6013,2020-07-14,메디톡스ITC예비판결문은비공개대웅제약주장은거짓또는위반,http://www.seoulwire.com/news/articleView.html?idxno=420198
6014,2020-07-14,메디톡스대웅주장은ITC판사가받아들이지않은내용일뿐,http://www.medisobizanews.com/news/articleView.html?idxno=71202
6015,2020-07-14,보톡스위기대웅제약당뇨병치료제로돌파할까,http://www.bizhankook.com/article/20288
6016,2020-07-14,메디톡스대웅의주장은거짓명백한진실밝혀진것맞불,http://www.metroseoul.co.kr/article/20200714500280
6017,2020-07-14,메디톡스대웅ITC규정위반,https://www.paxnetnews.com/articles/62933
6018,2020-07-14,정부대웅제약등19개우수기업연구소지정,http://www.newsprime.co.kr/news/article.html?no=511045
6019,2020-07-14,메디톡스대웅제약예비판결전문공개되면더이상변명못해”,http://www.pinpointnews.co.kr/view.php?ud=202007141454135700f090c8dbcb_45
6020,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1400618
6021,2020-07-14,메디톡스ITC예비판결문은비공개대웅제약주장은거짓,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007140261&t=NN
6022,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.getnews.co.kr/view.php?ud=2020071414574175722fe691f917_16
6023,2020-07-14,메디톡스대웅제약주장거짓예비판결로진실밝혀진것”,http://www.viva100.com/main/view.php?key=20200714010002840
6024,2020-07-14,메디톡스대웅이제기한주장은ITC행정판사가받아들이지않은내용일뿐,http://www.m-i.kr/news/articleView.html?idxno=729273
6025,2020-07-14,과기정통부대웅제약한국야쿠르트등19개우수기업연구소지정,http://www.marketnews.co.kr/news/articleView.html?idxno=48487
6026,2020-07-14,대웅제약메디톡스ITC결과두고또해석차오류vs규정위반,http://biz.newdaily.co.kr/site/data/html/2020/07/14/2020071400138.html
6027,2020-07-14,메디톡스대웅제약주장ITC가받아들이지않은내용,http://medipana.com/news/news_viewer.asp?NewsNum=259944&MainKind=A&NewsKind=5&vCount=12&vKind=1
6028,2020-07-14,과기정통부대웅제약야쿠르트등19곳상반기우수기업연구소지정,http://www.ajunews.com/view/20200714151613166
6029,2020-07-14,메디톡스대웅측ITC판결오류주장은황당,http://news.mk.co.kr/newsRead.php?no=720845&year=2020
6030,2020-07-14,대웅제약마그온맥스출시,http://www.finomy.com/news/articleView.html?idxno=80309
6031,2020-07-14,인사대웅제약홍보실장상무김성중,http://kpenews.com/View.aspx?No=913017
6032,2020-07-14,메디톡스대웅이제기한모든주장ITC행정판사가받아들이지않아,http://www.newsprime.co.kr/news/article.html?no=511057
6033,2020-07-14,메디톡스ITC예비판결문30일간비공개대웅거짓주장,https://www.hankyung.com/finance/article/2020071476696
6034,2020-07-14,대웅제약한국야쿠르트등19개우수기업연구소지정,http://www.dt.co.kr/contents.html?article_no=2020071402109931731004&ref=naver
6035,2020-07-14,대웅제약갱년기증상완화마그온맥스출시,http://www.fnnews.com/news/202007141530430215
6036,2020-07-14,대웅제약마그온맥스출시마그네슘비타민B,http://www.consumuch.com/news/articleView.html?idxno=49762
6037,2020-07-14,메디톡스vs대웅제약이제는장외전치열한언론공방,http://www.babytimes.co.kr/news/articleView.html?idxno=37886
6038,2020-07-14,제약오늘JW중외제약치주질환보조치료제덴드리스캡슐출시대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.sisaon.co.kr/news/articleView.html?idxno=115521
6039,2020-07-14,메디톡스ITC예비판결로진실밝혀졌다대웅주장은거짓”,http://daily.hankooki.com/lpage/industry/202007/dh20200714153533148390.htm?s_ref=nv
6040,2020-07-14,메디톡스미국예비판결전문공개되면대웅제약은변명못한다,http://www.businesspost.co.kr/BP?command=article_view&num=187238
6041,2020-07-14,메디톡스대웅제약의반박거짓주장혹은규정위반,https://view.asiae.co.kr/article/2020071415433517253
6042,2020-07-14,메디톡스대웅제약ITC규정위반”,http://theviewers.co.kr/View.aspx?No=913042
6043,2020-07-14,메디톡스대웅에강력한카운터펀치전문공개할까,http://moneys.mt.co.kr/news/mwView.php?no=2020071415228089992
6044,2020-07-14,ITC나보타판결에흔들리는대웅제약2분기실적흐림,http://www.wikileaks-kr.org/news/articleView.html?idxno=90914
6045,2020-07-14,메디톡스대웅측주장ITC가인정하지않은부분,http://www.mediapen.com/news/view/540747
6046,2020-07-14,메디톡스ITC예비판결로이미진실드러나오류라는대웅제약에반박,https://www.dailian.co.kr/news/view/905013?sc=Naver
6047,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200714155920825951638db705_1/article.html
6048,2020-07-14,메디톡스대웅주장ITC행정판사받아들이지않은내용”,http://www.econovill.com/news/articleView.html?idxno=404595
6049,2020-07-14,메디톡스ITC예비판결문은30일비공개규정대웅주장은거짓,https://www.etoday.co.kr/news/view/1917692
6050,2020-07-14,넥스틴대웅제약등우수기업연구소19곳지정,http://www.edaily.co.kr/news/newspath.asp?newsid=03844166625834520
6051,2020-07-14,메디톡스대웅이제기한모든주장은ITC행정판사가받아들이지않은내용,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62305
6052,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.todaykorea.co.kr/news/articleView.html?idxno=273885
6053,2020-07-14,메디톡스대웅거짓주장ITC예비판결문은30일간비공개,http://inthenews.co.kr/article-58668/
6054,2020-07-14,정부상반기우수기업연구소대웅제약한국야쿠르트19개지정,http://www.viva100.com/main/view.php?key=20200714010002894
6055,2020-07-14,창원시공무원에대한폭언과폭행적극대웅한다,http://www.kndaily.co.kr/news/articleView.html?idxno=160700
6056,2020-07-14,메디톡스ITC예비판결문은비공개대웅제약에반박,http://www.newspim.com/news/view/20200714001034
6057,2020-07-14,메디톡스대웅제약ITC규정어겼거나거짓주장중,http://www.medigatenews.com/news/1318477568
6058,2020-07-14,대웅제약갱년기증상완화마그온맥스출시마그네슘비타민B복합제,http://theviewers.co.kr/View.aspx?No=913155
6059,2020-07-14,메디톡스대웅제기한모든주장거짓이거나ITC규정위반한것,http://www.bokuennews.com/news/article.html?no=192503
6060,2020-07-14,메디톡스ITC예비판결문30일간비공개대웅주장은거짓,https://www.asiatoday.co.kr/view.php?key=20200714010008706
6061,2020-07-14,메디톡스대웅제약측모든주장은ITC가인정하지않은내용,http://www.newsworks.co.kr/news/articleView.html?idxno=472415
6062,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.lawissue.co.kr/view.php?ud=2020071419230193204ead0791_12
6063,2020-07-14,메디톡스대웅의주장은ITC행정판사가받아들이지않은내용”,http://www.mdtoday.co.kr/mdtoday/index.html?no=393123
6064,2020-07-14,과기정통부대웅제약등19사우수기업연구소지정,http://www.segye.com/content/html/2020/07/14/20200714523323.html?OutUrl=naver
6065,2020-07-14,메디톡스대웅측주장ITC받아들이지않은내용뿐,https://www.kpanews.co.kr/article/show.asp?idx=214678&category=D
6066,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스선봬,https://www.kpanews.co.kr/article/show.asp?idx=214681&category=D
6067,2020-07-14,ITC예비결정두고대웅제약vs메디톡스11월최종결정관심UP,http://medicalworldnews.co.kr/news/view.php?idx=1510936584
6068,2020-07-14,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.thefirstmedia.net/news/articleView.html?idxno=60515
6069,2020-07-14,메디톡스ITC행정판사예비판결전문공개되면대웅은더이상변명할수도없을것,http://www.thefirstmedia.net/news/articleView.html?idxno=60505
6070,2020-07-15,KBIO5년균주전쟁메디톡스웃고대웅제약울고,http://moneys.mt.co.kr/news/mwView.php?no=2020071010178061657
6071,2020-07-15,美ITC예비판결불구대웅제약vs메디톡스대립격화,http://www.dailymedi.com/detail.php?number=858194&thread=22r05
6072,2020-07-15,대웅제약자회사힐리언스국내여행증가로매출부진만회할까,http://www.ceoscoredaily.com/news/article.html?no=71464
6073,2020-07-15,대웅제약vs메디톡스보톡스논쟁여전히진흙탕,http://www.cstimes.com/news/articleView.html?idxno=422205
6074,2020-07-15,대웅에볼루스ITC예비판결로파트너십삐걱,https://www.paxnetnews.com/articles/62896
6075,2020-07-15,대웅제약에볼루스CB취득속내는,https://www.paxnetnews.com/articles/62903
6076,2020-07-15,메디톡스ITC대웅의모든주장수용안해”,http://www.shinailbo.co.kr/news/articleView.html?idxno=1299230
6077,2020-07-15,상반기우수기업연구소에대웅제약등19개사,https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&s_hcd=&key=202007141654327952
6078,2020-07-15,대웅제약과메디톡스평행선달려ITC판결두고샅바싸움치열,https://www.fetv.co.kr/news/article.html?no=59366
6079,2020-07-15,메디톡스에카운터펀치맞은대웅제약美법원소송카드만지작,http://www.newsway.co.kr/news/view?tp=1&ud=2020071419120260249
6080,2020-07-15,메디톡스대웅승자없는치킨게임주름살깊은K보톡스,http://news.heraldcorp.com/view.php?ud=20200715000486
6081,2020-07-15,위키시선독한전쟁대웅제약메디톡스승자가있을까,http://www.wikileaks-kr.org/news/articleView.html?idxno=91000
6082,2020-07-15,대웅제약마그네슘비타민B복합제마그온맥스출시,http://www.mhj21.com/132798
6083,2020-07-15,종목이슈메디톡스vs대웅제약끝나지않은ITC논쟁불확실성지속,http://www.newspim.com/news/view/20200715001114
6084,2020-07-16,부고김명숙별세김경환부인상대웅대영모친상外,https://www.donga.com/news/article/all/20200716/101990867/1
6085,2020-07-16,메디대웅더격해진장외설전,https://view.asiae.co.kr/article/2020071610302936975
6086,2020-07-16,곧판결문나오는데대웅메디톡스美ITC예비판결놓고또논쟁하는이유는,http://news.mk.co.kr/newsRead.php?no=730109&year=2020
6087,2020-07-16,대웅메디톡스영업비밀침해ITC예비판결뒤바뀔수있나,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200716008
6088,2020-07-16,대웅제약메디톡스美ITC예비판결놓고또논쟁,http://www.youthdaily.co.kr/news/article.html?no=42256
6089,2020-07-17,대웅제약주식중립으로낮아져미국균주소송불확실성지속,http://www.businesspost.co.kr/BP?command=article_view&num=187730
6090,2020-07-17,오늘의제약동국제약한미약품메디톡스대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=37971
6091,2020-07-17,메디톡스대웅제약이균주훔쳐갔다ITC예비판결국내소송영향미칠까,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200717011
6092,2020-07-18,ITC예비결정승자메디톡스도대웅제약도아닌슬픈현실,http://newsclaim.co.kr/View.aspx?No=917064
6093,2020-07-18,이기자의메디컬나우김성중대웅제약팀장상무승진배경보니,http://www.sisajournal-e.com/news/articleView.html?idxno=221333
6094,2020-07-20,메디톡스대웅ITC균주실험결과국내법원제출,https://www.paxnetnews.com/articles/63089
6095,2020-07-20,대웅제약보툴리눔소송불확실성지속에주가↓,http://www.whitepaper.co.kr/news/articleView.html?idxno=195785
6096,2020-07-20,메디톡스대웅제약ITC제출자료국내민사재판부에제출,https://www.hankyung.com/finance/article/2020072070986
6097,2020-07-20,기자수첩6년혈투메디톡스대웅제약상처만남았다,http://news.bizwatch.co.kr/article/consumer/2020/07/20/0017/naver
6098,2020-07-20,증권가전문가들이대웅제약투자의견을중립으로낮춘까닭은,http://www.wikileaks-kr.org/news/articleView.html?idxno=91260
6099,2020-07-20,안국마케팅전략실장에대웅출신박민철이사영입,http://www.dailypharm.com/Users/News/NewsView.html?ID=266716&REFERER=NP
6100,2020-07-20,대웅제약웨어러블심전도기모비케어출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200720161937579869d76442fa_1/article.html
6101,2020-07-21,안국약품대웅휴온스출신박민철이사영입,http://weekly.cnbnews.com/news/article.html?no=135001
6102,2020-07-21,기자수첩대웅제약메디톡스소모전끝내야,http://www.shinailbo.co.kr/news/articleView.html?idxno=1301450
6103,2020-07-21,콜린알포소송로펌대웅바이오종근당선택달랐다,http://www.sisajournal-e.com/news/articleView.html?idxno=221441
6104,2020-07-21,대웅메디톡스보톡스균주싸움수백억원대소송승자는,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200721006
6105,2020-07-22,대웅제약한미약품동병상련실적악화에숨고르기,http://www.ajunews.com/view/20200721161055238
6106,2020-07-22,대웅제약우루사중국의약품재임상착수,http://www.press9.kr/news/articleView.html?idxno=45353
6107,2020-07-22,대웅제약500억규모단기차입금증가,https://www.etoday.co.kr/news/view/1920907
6108,2020-07-22,공시대웅제약500억원단기차입결정,http://www.fnnews.com/news/202007221717351936
6109,2020-07-22,대웅제약500억원단기차입결정,http://www.edaily.co.kr/news/newspath.asp?newsid=04027846625837144
6110,2020-07-22,공시대웅제약500억규모단기차입금증가결정,http://www.newsway.co.kr/news/view?tp=1&ud=2020072217360448796
6111,2020-07-22,대웅제약500억원단기차입결정,http://www.newsprime.co.kr/news/article.html?no=511946
6112,2020-07-22,대웅제약500억원단기차입결정,https://www.asiatoday.co.kr/view.php?key=20200722010013775
6113,2020-07-23,기업공시7월22일대웅제약운영자금용단기차입금500억증가등,https://www.sedaily.com/NewsView/1Z5EY18RNF
6114,2020-07-23,전일주요공시대웅제약게임빌LG이노텍등,https://www.etoday.co.kr/news/view/1920942
6115,2020-07-23,대웅제약500억원단기차입,http://www.bokuennews.com/news/article.html?no=192796
6116,2020-07-23,장마감후공시대웅제약500억규모단기차입금결정外,http://www.ezyeconomy.com/news/articleView.html?idxno=103335
6117,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.press9.kr/news/articleView.html?idxno=45370
6118,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247044
6119,2020-07-23,대웅제약뉴트로우루사리미티드에디션발매,http://www.kpinews.co.kr/news/articleView.html?idxno=122063
6120,2020-07-23,대웅제약우루사뉴트로패키지한정출시,http://www.mediapen.com/news/view/542966
6121,2020-07-23,오늘의제약종근당건강광동제약대웅제약아스트라제네카,http://www.babytimes.co.kr/news/articleView.html?idxno=38108
6122,2020-07-23,대웅제약우루사 뉴트로한정판출시,http://www.greened.kr/news/articleView.html?idxno=261983
6123,2020-07-23,대웅제약뉴트로트렌드맞춘우루사리미티드에디션출시,http://www.youthdaily.co.kr/news/article.html?no=42767
6124,2020-07-23,대웅제약우루사뉴트로한정판출시​중년층향수자극,https://www.dailian.co.kr/news/view/907145?sc=Naver
6125,2020-07-23,대웅제약2020우루사리미티드에디션뉴트로한정판출시,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119660
6126,2020-07-23,대웅제약뉴트로감성더한우루사한정판발매,http://moneys.mt.co.kr/news/mwView.php?no=2020072309218021518
6127,2020-07-23,대웅제약우루사뉴트로한정판에디션출시,http://www.ekn.kr/news/article.html?no=512956
6128,2020-07-23,대웅제약뉴트로디자인우루사리미티드에디션한정판출시,http://www.medisobizanews.com/news/articleView.html?idxno=71417
6129,2020-07-23,대웅제약500억원단기차입결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=393968
6130,2020-07-23,대웅제약우루사뉴트로한정판출시,http://newsbrite.net/139776
6131,2020-07-23,대웅제약우루사뉴트로한정판출시복고감성담았다,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020072309462030942
6132,2020-07-23,콜라보로젊어진우루사대웅제약리미티드에디션출시,http://www.viva100.com/main/view.php?key=20200723010004598
6133,2020-07-23,우루사의끝없는변신대웅제약우루사뉴트로한정판출시,http://daily.hankooki.com/lpage/industry/202007/dh20200723095727148390.htm?s_ref=nv
6134,2020-07-23,대웅제약뉴트로감성맞춘우루사한정판출시,http://news.mt.co.kr/mtview.php?no=2020072309500549127
6135,2020-07-23,대웅제약우루사뉴트로한정판선봬,http://www.insightkorea.co.kr/news/articleView.html?idxno=81471
6136,2020-07-23,대웅제약우루사뉴트로패키지디자인한정판매,http://sports.chosun.com/news/ntype.htm?id=202007240100219950014942&servicedate=20200723
6137,2020-07-23,대웅제약우루사리미티드에디션출시,http://www.ybsn.tv/news/articleView.html?idxno=23844
6138,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=13767
6139,2020-07-23,대웅제약우루사뉴트로한정판출시,http://yna.kr/AKR20200723060300017?did=1195m
6140,2020-07-23,대웅제약우루사뉴트로Newtro한정판출시​,http://www.pharmnews.com/news/articleView.html?idxno=100969
6141,2020-07-23,대웅제약뉴트로한정판우루사출시향수와신선한재미동시에,http://theviewers.co.kr/View.aspx?No=921720
6142,2020-07-23,대웅제약80년대느낌담아우루사뉴트로한정판출시,http://www.newsis.com/view/?id=NISX20200723_0001105121&cID=13001&pID=13000
6143,2020-07-23,대웅제약우루사뉴트로특별한정판발매,http://www.smartfn.co.kr/view.php?ud=202007231025028423d5d29c6899_46
6144,2020-07-23,우루사의변신은계속대웅제약우루사뉴트로한정판출시​,http://www.upinews.kr/newsView/upi202007230029
6145,2020-07-23,대웅제약우루사뉴트로한정판출시중년층향수자극,https://www.asiatime.co.kr/news/newsview.php?ncode=1065576632388001
6146,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=30314
6147,2020-07-23,대웅제약우루사리미티드에디션발매,http://www.bosa.co.kr/news/articleView.html?idxno=2131076
6148,2020-07-23,대웅제약우루사뉴트로입는다한정판패키지출시,http://www.consumuch.com/news/articleView.html?idxno=49901
6149,2020-07-23,대웅제약우루사뉴트로한정판우루사리미티드에디션출시​,http://www.pressm.kr/news/articleView.html?idxno=31603
6150,2020-07-23,우루사의변신은계속된다”대웅제약우루사뉴트로한정판출시​,https://www.fetv.co.kr/news/article.html?no=59872
6151,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.newstomato.com/ReadNews.aspx?no=985831
6152,2020-07-23,대웅제약우루사뉴트로한정판출시,https://biz.chosun.com/site/data/html_dir/2020/07/23/2020072301796.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6153,2020-07-23,우루사변신”대웅제약우루사뉴트로한정판우루사리미티드에디션출시,http://www.betanews.net:8080/article/1211303.html
6154,2020-07-23,우루사의변신은계속된다대웅제약우루사뉴트로한정판출시,http://www.metroseoul.co.kr/article/20200723500129
6155,2020-07-23,대웅제약간기능개선제우루사뉴트로한정판출시,http://www.getnews.co.kr/view.php?ud=2020072311250239172fe691f917_16
6156,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.bokuennews.com/news/article.html?no=192811
6157,2020-07-23,대웅제약뉴트로트렌드맞춰우루사한정판출시​,http://www.newslock.co.kr/news/articleView.html?idxno=29721
6158,2020-07-23,대웅제약우루사뉴트로한정판출시변신은계속된다,http://www.m-i.kr/news/articleView.html?idxno=731933
6159,2020-07-23,대웅제약우루사뉴트로한정판출시,https://www.asiatoday.co.kr/view.php?key=20200723010014189
6160,2020-07-23,대웅제약MZ세대맞춤우루사뉴트로한정판출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001115
6161,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62452
6162,2020-07-23,대웅제약우루사뉴트로한정판선봬,https://www.kpanews.co.kr/article/show.asp?idx=214905&category=D
6163,2020-07-23,대웅제약우루사뉴트로한정판출시우루사의변신은계속된다”,http://www.thepublic.kr/news/newsview.php?ncode=1065579090031228
6164,2020-07-23,대웅제약우루사뉴트로한정판출시​,https://www.ebn.co.kr/news/view/1443787/?sc=Naver
6165,2020-07-23,이인애의뒷담화갑질피해자외면하는대웅제약윤재승마케팅사임한전회장이름왜자꾸꺼내나,http://theviewers.co.kr/View.aspx?No=922251
6166,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=394020
6167,2020-07-23,우루사의변신은계속된다대웅제약우루사뉴트로한정판출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=409377
6168,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.edaily.co.kr/news/newspath.asp?newsid=03148806625837472
6169,2020-07-23,대웅제약우루사리미티드에디션출시,http://www.finomy.com/news/articleView.html?idxno=80736
6170,2020-07-23,대웅제약간기능개선제우루사뉴트로디자인포장의한정판내놔,http://www.businesspost.co.kr/BP?command=article_view&num=188622
6171,2020-07-23,대웅제약뉴트로감성입힌우루사리미티드에디션출시,http://news.mk.co.kr/newsRead.php?no=755916&year=2020
6172,2020-07-23,대웅제약등161개기업근무혁신우수기업선정,https://www.asiatoday.co.kr/view.php?key=20200723010014544
6173,2020-07-23,대웅제약우루사뉴트로한정판출시,http://www.dailymedi.com/detail.php?number=858518&thread=22r05
6174,2020-07-23,대웅제약뉴트로버전우루사리미티드에디션출시,http://www.updownnews.co.kr/news/articleView.html?idxno=221270
6175,2020-07-23,오늘의신상품대웅제약우루사뉴트로한정판출시,http://www.econovill.com/news/articleView.html?idxno=405745
6176,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.thefirstmedia.net/news/articleView.html?idxno=60908
6177,2020-07-23,대웅제약우루사뉴트로한정판출시​,http://www.lawissue.co.kr/view.php?ud=202007231816082892204ead0791_12
6178,2020-07-23,젊어지는우루사대웅제약우루사리미티드에디션출시,https://www.donga.com/news/article/all/20200723/102132333/1
6179,2020-07-23,대웅제약겹악재에실적방어안간힘지금믿을건우루사뿐,http://www.businesspost.co.kr/BP?command=article_view&num=188733
6180,2020-07-23,뉴스투데이L대웅제약우루사뉴트로한정판출시,https://www.news2day.co.kr/157194
6181,2020-07-23,대웅제약우루사뉴트로한정판출시,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4226216
6182,2020-07-24,신상품대웅제약우루사뉴트로한정판 ,http://www.seoulfn.com/news/articleView.html?idxno=389980
6183,2020-07-24,대웅제약단기차입금500억증가배경은,https://www.paxnetnews.com/articles/63313
6184,2020-07-24,대웅제약의한올바이오파마인수5년성과합격점,http://news.mk.co.kr/newsRead.php?no=757617&year=2020
6185,2020-07-24,대웅제약단기차입자금에볼루스로해결하나,https://www.ebn.co.kr/news/view/1444000/?sc=Naver
6186,2020-07-24,끝나지않은대웅제약과메디톡스의보톡스전쟁,https://news.chosun.com/site/data/html_dir/2020/07/24/2020072402708.html?utm_source=naver&utm_medium=original&utm_campaign=news
6187,2020-07-24,대웅제약우루사뉴트로한정판출시​,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200724016
6188,2020-07-24,대웅우루사도뉴트로한정판출시,http://weekly.cnbnews.com/news/article.html?no=135062
6189,2020-07-24,주간신상태그아모레퍼시픽애경산업버커루대웅제약롯데호텔외,http://www.newsprime.co.kr/news/article.html?no=512230
6190,2020-07-24,대웅제약윤재승마케팅원고의뢰받은사람있는데준사람은없어귀신이곡할노릇”,http://theviewers.co.kr/View.aspx?No=923669
6191,2020-07-25,연재기획①대웅제약vs메디톡스보툴리눔톡신전쟁톺아보기균주도용의진실은,http://newsclaim.co.kr/View.aspx?No=923971
6192,2020-07-27,대웅제약우루사뉴트로한정판출시,http://www.g-enews.com/ko-kr/news/article/news_all/20200726182712389669d76442fa_1/article.html
6193,2020-07-27,더벨대웅제약500억단기차입이갖는세가지의미,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202007231517055240108534
6194,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=260491&MainKind=A&NewsKind=5&vCount=12&vKind=1
6195,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.ekn.kr/news/article.html?no=513590
6196,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.youthdaily.co.kr/news/article.html?no=42990
6197,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://www.fetv.co.kr/news/article.html?no=60052
6198,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247148
6199,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.sentv.co.kr/news/view/576769
6200,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://daily.hankooki.com/lpage/industry/202007/dh20200727090516148390.htm?s_ref=nv
6201,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://newsbrite.net/139866
6202,2020-07-27,로스탁대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.lawissue.co.kr/view.php?ud=202007270912302205204ead0791_12
6203,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.newsis.com/view/?id=NISX20200727_0001108404&cID=13001&pID=13000
6204,2020-07-27,대웅제약지노믹트리코로나19진단키트공급계약체결,http://www.press9.kr/news/articleView.html?idxno=45388
6205,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020072709062962690
6206,2020-07-27,대웅제약지노믹트리와고감도코로나19진단키트글로벌공급계약,http://www.medisobizanews.com/news/articleView.html?idxno=71478
6207,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급공동협력시너지창출기대,http://theviewers.co.kr/View.aspx?No=924480
6208,2020-07-27,대웅제약지노믹트리의코로나19진단키트글로벌공급맡기로,http://news.mk.co.kr/newsRead.php?no=764582&year=2020
6209,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외판매계약,http://news.mt.co.kr/mtview.php?no=2020072709140137520
6210,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=01912246625838784
6211,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.bosa.co.kr/news/articleView.html?idxno=2131244
6212,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=394270
6213,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급협력,https://www.etoday.co.kr/news/view/1922229
6214,2020-07-27,대웅제약지노믹트리코로나19진단키트글로벌공급계약체결,http://moneys.mt.co.kr/news/mwView.php?no=2020072709038090188
6215,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=30440
6216,2020-07-27,대웅제약지노믹트리코로나19진단키트수출계약,http://health.chosun.com/site/data/html_dir/2020/07/27/2020072701131.html
6217,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://inthenews.co.kr/article-60991/
6218,2020-07-27,대웅제약코로나19진단키트해외공급계약체결,http://www.seoulwire.com/news/articleView.html?idxno=421754
6219,2020-07-27,대웅제약지노믹트리코로나진단키트해외공급계약체결,http://www.newspim.com/news/view/20200727000117
6220,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://sports.chosun.com/news/ntype.htm?id=202007280100249020017052&servicedate=20200727
6221,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://biz.chosun.com/site/data/html_dir/2020/07/27/2020072701170.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6222,2020-07-27,지노믹트리대웅제약과코로나19진단키트해외공급계약체결,http://www.paxetv.com/news/articleView.html?idxno=96830
6223,2020-07-27,검체채취4시간이내결과확인대웅제약코로나진단키트공급,http://www.wikileaks-kr.org/news/articleView.html?idxno=91693
6224,2020-07-27,대웅제약지노믹트리와코로나19분자진단키트해외공급,http://www.kpinews.co.kr/news/articleView.html?idxno=122293
6225,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급,http://www.viva100.com/main/view.php?key=20200727010005242
6226,2020-07-27,대웅제약지노믹트리와손잡고코로나19진단키트수출한다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119740
6227,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573301559852
6228,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.getnews.co.kr/view.php?ud=2020072709501738582fe691f917_16
6229,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.biospectator.com/view/news_view.php?varAtcId=10920
6230,2020-07-27,대웅제약지노믹트리와코로나19진단키트공급계약,http://www.mhj21.com/133202
6231,2020-07-27,대웅제약4시간내확인지노믹트리코로나19진단키트해외공급,http://yna.kr/AKR20200727039600017?did=1195m
6232,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.sisafocus.co.kr/news/articleView.html?idxno=244219
6233,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.fnnews.com/news/202007270958592717
6234,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급,http://www.medical-tribune.co.kr/news/articleView.html?idxno=93858
6235,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=13789
6236,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.m-i.kr/news/articleView.html?idxno=732591
6237,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급,http://www.newstomato.com/ReadNews.aspx?no=986392
6238,2020-07-27,대웅제약지노믹트리개발진단키트해외공급계약4시간내코로나19확인,http://www.startuptoday.co.kr/news/articleView.html?idxno=48754
6239,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,https://www.dailian.co.kr/news/view/907979/?sc=Naver
6240,2020-07-27,대웅제약지노믹트리코로나19키트글로벌판매공급계약,http://www.newsprime.co.kr/news/article.html?no=512281
6241,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급,http://www.seoulfn.com/news/articleView.html?idxno=390196
6242,2020-07-27,대웅제약코로나19진단키트해외공급,http://www.whosaeng.com/119736
6243,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.medigatenews.com/news/1848578930
6244,2020-07-27,대웅제약지노믹트리 코로나19 진단키트해외공급계약체결,http://www.economytalk.kr/news/articleView.html?idxno=207247
6245,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.upinews.kr/newsView/upi202007270030
6246,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007270208&t=NN
6247,2020-07-27,대웅제약지노믹트리코로나19진단키트해외판매,https://view.asiae.co.kr/article/2020072710483307076
6248,2020-07-27,대웅제약지노믹트리코로나진단키트해외공급,http://www.dailypharm.com/Users/News/NewsView.html?ID=266945&REFERER=NP
6249,2020-07-27,대웅제약지노믹트리코로나19진단키트글로벌판매계약,http://www.pressm.kr/news/articleView.html?idxno=31690
6250,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.metroseoul.co.kr/article/20200727500159
6251,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.thepublic.kr/news/newsview.php?ncode=1065575761474492
6252,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=49555
6253,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://sports.hankooki.com/lpage/economy/202007/sp20200727112710137020.htm?s_ref=nv
6254,2020-07-27,대웅제약지노믹트리 코로나19 분자진단키트해외공급체결,http://www.newslock.co.kr/news/articleView.html?idxno=29818
6255,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1403398
6256,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1134960&REFERER=NP
6257,2020-07-27,대웅제약4시간내확인지노믹트리코로나19진단키트해외공급,http://www.topstarnews.net/news/articleView.html?idxno=822932
6258,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62501
6259,2020-07-27,대웅제약지노믹트리코로나19키트해외공급계약,https://www.hankyung.com/it/article/202007271270i
6260,2020-07-27,대웅제약지노믹트리와코로나키트해외공급계약체결,http://www.koreastocknews.com/news/articleView.html?idxno=55727
6261,2020-07-27,대웅제약지노믹트리진단키트아큐라디텍글로벌공급,http://www.todaykorea.co.kr/news/articleView.html?idxno=274549
6262,2020-07-27,대웅제약지노믹트리와코로나19 진단키트해외공급계약,http://www.greened.kr/news/articleView.html?idxno=262510
6263,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결外,http://www.newswatch.kr/news/articleView.html?idxno=50182
6264,2020-07-27,오늘의제약대웅제약한미헬스케어GC녹십자의료재단,http://www.babytimes.co.kr/news/articleView.html?idxno=38213
6265,2020-07-27,대웅지노믹트리코로나진단키트해외공급계약,https://www.ebn.co.kr/news/view/1444217/?sc=Naver
6266,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.econovill.com/news/articleView.html?idxno=406078
6267,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=410200
6268,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.ftoday.co.kr/news/articleView.html?idxno=204316
6269,2020-07-27,명인제약대웅제약등부패방지경영시스템인증제약사불법리베이트多실효성의문,http://theviewers.co.kr/View.aspx?No=925231
6270,2020-07-27,흔들리는대웅제약1년만에매출1조클럽탈락위기,http://www.wikileaks-kr.org/news/articleView.html?idxno=91729
6271,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.bokuennews.com/news/article.html?no=192954
6272,2020-07-27,대웅제약지노믹트리의코로나19진단키트를해외공급하는계약,http://www.businesspost.co.kr/BP?command=article_view&num=189136
6273,2020-07-27,대웅제약지노믹트리손잡고코로나19진단키트해외공급,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001218
6274,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200727009
6275,2020-07-27,대웅제약과지노믹트리코로나19진단키트해외공급계약체결,http://www.wsobi.com/news/articleView.html?idxno=101801
6276,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약,http://www.dailymedi.com/detail.php?number=858635&thread=22r05
6277,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급협력,https://www.news2day.co.kr/157377
6278,2020-07-27,김창수의e뉴스브리핑대웅제약지노믹트리코로나19진단키트해외공급계약체결外,https://www.fetv.co.kr/news/article.html?no=60122
6279,2020-07-27,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://www.mediapen.com/news/view/544110
6280,2020-07-27,대웅제약지노믹트리코로나19진단키트해외공급계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=60988
6281,2020-07-27,대웅지노믹트리코로나19진단키트수출,http://www.finomy.com/news/articleView.html?idxno=80927
6282,2020-07-27,대웅제약지노믹트리와코로나19진단키트파트너십,http://www.shinailbo.co.kr/news/articleView.html?idxno=1303679
6283,2020-07-27,대웅제약코로나19진단키트아큐라디텍지노믹트리와글로벌공급나서,http://www.kdpress.co.kr/news/articleView.html?idxno=96568
6284,2020-07-28,한미3277억1위종근당대웅제약HK이노엔유한順,http://www.dailymedi.com/detail.php?number=858648&thread=22r05
6285,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=260555&MainKind=A&NewsKind=5&vCount=12&vKind=1
6286,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.youthdaily.co.kr/news/article.html?no=43103
6287,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=122366
6288,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄,http://www.medisobizanews.com/news/articleView.html?idxno=71512
6289,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.mediapen.com/news/view/544147
6290,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념웹심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247208
6291,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최웨어러블심전도기,http://theviewers.co.kr/View.aspx?No=925836
6292,2020-07-28,대웅제약지노믹트리와코로나19진단키트해외공급계약체결,http://kormedi.com/?p=1321205
6293,2020-07-28,게시판대웅제약모비케어출시기념웹심포지엄개최,http://yna.kr/AKR20200728038900017?did=1195m
6294,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572295329340
6295,2020-07-28,대웅제약웨어러블심전도기런칭웨비나개최,http://moneys.mt.co.kr/news/mwView.php?no=2020072809148029908
6296,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.metroseoul.co.kr/article/20200728500050
6297,2020-07-28,대웅제약모비케어런칭기념웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2131326
6298,2020-07-28,대웅제약오는30일모비케어론칭웹심포지엄개최,http://www.viva100.com/main/view.php?key=20200728010005475
6299,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄개최,http://news.mt.co.kr/mtview.php?no=2020072809283085562
6300,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119784
6301,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=60165
6302,2020-07-28,대웅제약웨어러블심전도기모비케어웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=45401
6303,2020-07-28,대웅제약웨어러블심전도측정기모비케어출시기념웹심포지엄개최,http://news.mk.co.kr/newsRead.php?no=769335&year=2020
6304,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=733016
6305,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.healthinnews.co.kr/news/articleView.html?idxno=13800
6306,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://newsbrite.net/139937
6307,2020-07-28,대웅제약웨어러블심전도기런칭기념웹심포지엄개최,http://www.ekn.kr/news/article.html?no=513921
6308,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최,http://www.mhj21.com/133300
6309,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념웹심포지엄개최,http://www.getnews.co.kr/view.php?ud=2020072810443648142fe691f917_16
6310,2020-07-28,대웅제약웨어러블심전도기모비케어심포지엄개최,http://www.econovill.com/news/articleView.html?idxno=406189
6311,2020-07-28,대웅제약모비케어출시기념웹심포지엄개최,http://www.consumuch.com/news/articleView.html?idxno=49952
6312,2020-07-28,대웅제약 웨어러블심전도기 모비케어 런칭기념웹심포지엄개최,http://www.greened.kr/news/articleView.html?idxno=262667
6313,2020-07-28,오늘의제약동화약품CG녹십자랩셀대웅제약셀트리온,http://www.babytimes.co.kr/news/articleView.html?idxno=38247
6314,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62513
6315,2020-07-28,대웅제약 웨어러블심전도기모비케어 런칭기념웹심포지엄진행,http://www.newslock.co.kr/news/articleView.html?idxno=29856
6316,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.iminju.net/news/articleView.html?idxno=55680
6317,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=20200728131325630204ead0791_12
6318,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.updownnews.co.kr/news/articleView.html?idxno=221384
6319,2020-07-28,벤처투자돈몰리는바이오의료대웅제약보령제약발빠른행보,http://www.viva100.com/main/view.php?key=20200728010005505
6320,2020-07-28,대웅제약모비케어런칭기념웹심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=394457
6321,2020-07-28,뉴스투데이L대웅제약모비케어런칭기념웹심포지엄개최,https://www.news2day.co.kr/157438
6322,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=410589
6323,2020-07-28,치매약시장매출1위대웅바이오글리아타민매출80이상위험,http://theviewers.co.kr/View.aspx?No=926565
6324,2020-07-28,대웅제약웨어러블심전도기런칭기념웹심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=30545
6325,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1403827
6326,2020-07-28,대웅제약모비케어론칭기념웹심포지엄개최,https://www.ebn.co.kr/news/view/1444440/?sc=Naver
6327,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄,http://daily.hankooki.com/lpage/industry/202007/dh20200728175722148390.htm?s_ref=nv
6328,2020-07-28,대웅제약웨어러블심전도기모비케어런칭기념웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=61048
6329,2020-07-28,대웅제약웨어러블심전도기모비케어론칭기념온라인심포지엄개최,https://www.donga.com/news/article/all/20200728/102198960/1
6330,2020-07-28,대웅제약웨어러블심전도기모비케어런칭웹심포지엄개최,http://www.medigatenews.com/news/2769713394
6331,2020-07-29,대웅제약심전도기모비케어런칭웹심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001260
6332,2020-07-29,대웅제약발달장애인을위한의사소통그림책배포,http://www.press9.kr/news/articleView.html?idxno=45411
6333,2020-07-29,발달장애인질병표현돕는다대웅제약질병표현을돕는의사소통그림책배포,http://www.youthdaily.co.kr/news/article.html?no=43203
6334,2020-07-29,대웅제약발달장애인질병표현돕는그림책배포,http://www.medisobizanews.com/news/articleView.html?idxno=71544
6335,2020-07-29,대웅제약질병표현을돕는의사소통그림책배포,http://www.kpinews.co.kr/news/articleView.html?idxno=122478
6336,2020-07-29,대웅제약질병표현을돕는의사소통그림책AAC그림책배포발달장애인위한제작,http://www.pressm.kr/news/articleView.html?idxno=31755
6337,2020-07-29,대웅제약발달장애인돕는의사소통그림책배포,https://www.fetv.co.kr/news/article.html?no=60260
6338,2020-07-29,대웅제약질병표현을돕는의사소통그림책제작배포,http://medipana.com/news/news_viewer.asp?NewsNum=260611&MainKind=A&NewsKind=5&vCount=12&vKind=1
6339,2020-07-29,대웅제약발달장애인위한AAC그림책배포,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572549905450
6340,2020-07-29,대웅제약발달장애인의사소통돕는그림책무료배포,http://www.econovill.com/news/articleView.html?idxno=406295
6341,2020-07-29,대웅제약질병표현의사소통그림책배포,https://www.ebn.co.kr/news/view/1444526/?sc=Naver
6342,2020-07-29,사회공헌특집62대웅제약 발달장애인 위한의사소통그림책 배포,http://www.economytalk.kr/news/articleView.html?idxno=207291
6343,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.m-i.kr/news/articleView.html?idxno=733340
6344,2020-07-29,대웅제약질병표현돕는AAC그림책배포발달장애인의사소통위해,http://theviewers.co.kr/View.aspx?No=927204
6345,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.paxetv.com/news/articleView.html?idxno=97037
6346,2020-07-29,대웅제약발달장애인위해의사소통그림책배포,http://www.mhj21.com/133339
6347,2020-07-29,대웅제약발달장애인질병표현돕는그림책제작,http://www.bosa.co.kr/news/articleView.html?idxno=2131400
6348,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.healthinnews.co.kr/news/articleView.html?idxno=13821
6349,2020-07-29,대웅제약 발달장애인을위한 질병표현을돕는의사소통그림책 배포,http://www.greened.kr/news/articleView.html?idxno=262838
6350,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://sports.hankooki.com/lpage/economy/202007/sp20200729102149136980.htm?s_ref=nv
6351,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.newsfc.co.kr/news/articleView.html?idxno=42040
6352,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://newsbrite.net/139988
6353,2020-07-29,대웅제약발달장애인위한의사소통그림책배포,http://www.dailysmart.co.kr/news/articleView.html?idxno=30584
6354,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.getnews.co.kr/view.php?ud=2020072910585175862fe691f917_16
6355,2020-07-29,대웅제약발달장애인을위한질병표현의사소통그림책배포,http://www.medigatenews.com/news/2753086442
6356,2020-07-29,대웅제약발달장애인의사소통그림책배포,http://www.consumuch.com/news/articleView.html?idxno=49986
6357,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.mdtoday.co.kr/mdtoday/index.html?no=394579
6358,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62541
6359,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.thepublic.kr/news/newsview.php?ncode=1065577450634082
6360,2020-07-29,대웅제약발달장애인위한AAC그림책제작배포,http://www.whosaeng.com/119813
6361,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.metroseoul.co.kr/article/20200729500261
6362,2020-07-29,치료기회놓치지마요대웅제약발달장애인들의질병표현돕는다,https://www.kpanews.co.kr/article/show.asp?idx=215061&category=D
6363,2020-07-29,대웅제약발달장애인위한질병표현돕는의사소통그림책제작배포,http://www.newslock.co.kr/news/articleView.html?idxno=29905
6364,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.datasom.co.kr/news/articleView.html?idxno=107441
6365,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.nbnnews.co.kr/news/articleView.html?idxno=410952
6366,2020-07-29,대웅제약발달장애인의사소통용그림책배포,http://www.seoulfn.com/news/articleView.html?idxno=390487
6367,2020-07-29,단독대웅제약나보타중국임상3상속도다음달인체투약돌입,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020072915335362792
6368,2020-07-29,대웅제약발달장애인위한의사소통그림책배포,http://www.wsobi.com/news/articleView.html?idxno=102015
6369,2020-07-29,대웅제약발달장애인위한질병표현을돕는의사소통그림책제작배포,http://news.mk.co.kr/newsRead.php?no=777263&year=2020
6370,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책AAC그림책배포,http://www.lawissue.co.kr/view.php?ud=202007291814509545204ead0791_12
6371,2020-07-29,마지막동아줄마저대웅제약아직도맞을매남았다,http://ilyo.co.kr/?ac=article_view&entry_id=376052
6372,2020-07-29,대웅제약보톡스나보타다음달中서인체투약시작,https://www.asiatoday.co.kr/view.php?key=20200729010018141
6373,2020-07-29,대웅제약발달장애인을위한질병표현을돕는의사소통그림책배포,http://www.thefirstmedia.net/news/articleView.html?idxno=61136
6374,2020-07-30,뉴스투데이L대웅제약발달장애인위한질병표현돕는의사소통그림책배포,https://www.news2day.co.kr/157604
6375,2020-07-30,종근당대웅바이오등콜린알포세레이트급여축소결정에소송,http://www.medigatenews.com/news/2790973992
6376,2020-07-30,대웅제약발달장애인위한의사소통그림책배포,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001307
6377,2020-07-30,대웅제약아박타줄기세포치료제개발등제휴확대,http://www.medisobizanews.com/news/articleView.html?idxno=71572
6378,2020-07-30,대웅제약발달장애인위한질병표현돕는의사소통그림책배포,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247311
6379,2020-07-30,대웅제약질병표현을돕는의사소통그림책제작배포발달장애인도와,http://www.polinews.co.kr/news/article.html?no=470355
6380,2020-07-30,대웅제약신풍제약제약주갑작스런급등대웅제약7급등이어신풍제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=130497
6381,2020-07-30,대웅제약발달장애인위한질병표현을돕는의사소통그림책배포,http://www.enewstoday.co.kr/news/articleView.html?idxno=1404212
6382,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.lawissue.co.kr/view.php?ud=202007301001325816204ead0791_12
6383,2020-07-30,대웅제약나보타수면중이갈이완화효과입증,https://www.ebn.co.kr/news/view/1444747/?sc=Naver
6384,2020-07-30,대웅제약 나보타 연구자임상통해수면중이갈이증상완화효과입증,http://www.greened.kr/news/articleView.html?idxno=263056
6385,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020073009595529380
6386,2020-07-30,대웅제약나보타이갈이증상완화에도효과연구자임상결과발표,https://www.sedaily.com/NewsView/1Z5I690S04
6387,2020-07-30,대웅제약나보타수면중이갈이증상완화입증연구자임상결과발표,http://www.pressm.kr/news/articleView.html?idxno=31806
6388,2020-07-30,대웅제약나보타연구자임상서수면이갈이완화확인,http://www.newsis.com/view/?id=NISX20200730_0001112848&cID=13001&pID=13000
6389,2020-07-30,대웅제약나보타수면중이갈이완화효과입증,http://www.medisobizanews.com/news/articleView.html?idxno=71588
6390,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.getnews.co.kr/view.php?ud=2020073010172824332fe691f917_16
6391,2020-07-30,대웅제약나보타수면중이갈이증상완화에효과,http://daily.hankooki.com/lpage/industry/202007/dh20200730101936148390.htm?s_ref=nv
6392,2020-07-30,대웅제약보툴리눔톡신나보타수면이갈이증상완화,http://yna.kr/AKR20200730062200017?did=1195m
6393,2020-07-30,대웅제약보톡스나보타수면중이갈이증상완화효과확인,http://www.metroseoul.co.kr/article/20200730500075
6394,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,https://www.fetv.co.kr/news/article.html?no=60352
6395,2020-07-30,특징주대웅제약나보타수면중이갈이완화효과입증소식에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020073010278055944
6396,2020-07-30,대웅제약나보타임상결과수면중이갈이증상해소입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=49753
6397,2020-07-30,보톡스약으로이갈이치료효과확인한대웅제약,http://news.mt.co.kr/mtview.php?no=2020073010304943645
6398,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://www.newsprime.co.kr/news/article.html?no=512775
6399,2020-07-30,대웅제약나보타수면중이갈이증상완화효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=13845
6400,2020-07-30,대웅제약나보타수면중이갈이에도효과,https://view.asiae.co.kr/article/2020073010353014033
6401,2020-07-30,대웅제약나보타수면중이갈이증상완화연구논문나와,http://www.kpinews.co.kr/news/articleView.html?idxno=122621
6402,2020-07-30,대웅제약미용치료제나보타수면중이갈이증상완화확인,http://www.dt.co.kr/contents.html?article_no=2020073002109931102001&ref=naver
6403,2020-07-30,대웅제약나보타수면중이갈이완화효과입증,https://www.asiatime.co.kr/news/newsview.php?ncode=1065575464856794
6404,2020-07-30,오늘의제약한미약품동아STGC녹십자녹십자홀딩스동아제약광동제약대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=38296
6405,2020-07-30,대웅제약임상통해나보타수면중이갈이완화효과입증,http://www.m-i.kr/news/articleView.html?idxno=733760
6406,2020-07-30,특징주대웅제약나보타수면중이갈이완화효과입증에강세,https://www.asiatoday.co.kr/view.php?key=20200730010018418
6407,2020-07-30,대웅제약보툴리눔톡신나보타의수면중이갈이연구결과SCI급학술지게재,http://news.mk.co.kr/newsRead.php?no=779374&year=2020
6408,2020-07-30,대웅제약나보타수면중이갈이증상완화효과,http://www.bosa.co.kr/news/articleView.html?idxno=2131492
6409,2020-07-30,이갈이완화효과입증소식에대웅제약강세,https://biz.chosun.com/site/data/html_dir/2020/07/30/2020073001543.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6410,2020-07-30,대웅제약보톡스나보타수면중이갈이개선입증,http://health.chosun.com/site/data/html_dir/2020/07/30/2020073001561.html
6411,2020-07-30,대웅제약나보타수면중이갈이증상완화효과확인,https://www.etoday.co.kr/news/view/1923891
6412,2020-07-30,대웅제약나보타이갈이증상완화효과입증,http://www.viva100.com/main/view.php?key=20200730010006043
6413,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020073010462406480
6414,2020-07-30,대웅제약나보타수면중이갈이증상완화에효과,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4232862
6415,2020-07-30,대웅제약나보타연구자임상서수면이갈이완화확인,http://inthenews.co.kr/article-61616/
6416,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증치료시장확대잠재력,http://www.thepublic.kr/news/newsview.php?ncode=1065575463801488
6417,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247336
6418,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증”,http://www.youthdaily.co.kr/news/article.html?no=43330
6419,2020-07-30,대웅제약나보타수면이갈이증상완화효과입증,http://www.press9.kr/news/articleView.html?idxno=45426
6420,2020-07-30,대웅제약보툴리눔톡신나보타수면중이갈이증상완화,http://www.econovill.com/news/articleView.html?idxno=406501
6421,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://newsbrite.net/140027
6422,2020-07-30,대웅제약보툴리눔나보타수면중이갈이증상완화효과입증,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007300195&t=NN
6423,2020-07-30,대웅제약보툴리눔톡신나보타수면이갈이증상완화,http://www.topstarnews.net/news/articleView.html?idxno=823686
6424,2020-07-30,대웅제약英아박타와코로나치료제개발추진,https://www.theguru.co.kr/news/article.html?no=12858
6425,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=394724
6426,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62568
6427,2020-07-30,대웅제약보톨리늄톡신나보타투여하면이갈이증상줄어든다,https://www.news1.kr/articles/?4011555
6428,2020-07-30,중국서활로찾는국산보톡스휴젤대웅제약꽃길걸을까,http://www.viva100.com/main/view.php?key=20200730010006038
6429,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.sisaweek.com/news/articleView.html?idxno=136237
6430,2020-07-30,대웅제약나보타수면이갈이증상완화확인,http://www.seoulfn.com/news/articleView.html?idxno=390581
6431,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=30673
6432,2020-07-30,잠잘때이갈이줄어요대웅제약나보타이갈이감소효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020073010408020325
6433,2020-07-30,추가적인치료제개발가능성확인”대웅제약나보타수면중이갈이완화효과입증,https://www.donga.com/news/article/all/20200730/102229956/1
6434,2020-07-30,대웅제약나보타연구자임상서수면중이갈이완화효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=29942
6435,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=411298
6436,2020-07-30,대웅제약나보타수면중이갈이증상완화에도효과적,https://www.asiatoday.co.kr/view.php?key=20200730010018757
6437,2020-07-30,대웅제약나보타수면중이갈이감소효과입증,http://www.koreastocknews.com/news/articleView.html?idxno=55864
6438,2020-07-30,대웅제약나보타수면중이갈이환자에효과입증,http://www.mediapen.com/news/view/544850
6439,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,http://kormedi.com/?p=1321409
6440,2020-07-30,대웅제약나보타수면중이갈이증상완화효과입증,https://www.dailian.co.kr/news/view/909107/?sc=Naver
6441,2020-07-30,대웅제약나보타수면중이갈이완화효과,http://www.dailymedi.com/detail.php?number=858767&thread=22r05
6442,2020-07-30,대웅제약나보타수면중이갈이증상완화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001329
6443,2020-07-30,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1404429
6444,2020-07-30,대웅제약2분기매출2259억영업손실47억,http://www.edaily.co.kr/news/newspath.asp?newsid=04188566625839768
6445,2020-07-30,대웅제약2Q영업손실47억원적자전환,http://www.ftoday.co.kr/news/articleView.html?idxno=204495
6446,2020-07-30,메디톡스와나보타소송비용반영대웅제약2분기영업손실47억원,https://www.asiatoday.co.kr/view.php?key=20200730010019014
6447,2020-07-30,대웅제약2분기영업손실47억적자전환,http://www.dailypharm.com/Users/News/NewsView.html?ID=267084&REFERER=NP
6448,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://www.seoulwire.com/news/articleView.html?idxno=422328
6449,2020-07-30,대웅제약2분기영업손실47억원적자전환,https://biz.chosun.com/site/data/html_dir/2020/07/30/2020073003723.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6450,2020-07-30,코로나19여파한미동아에스티대웅녹십자2분기실적고전,http://www.ajunews.com/view/20200730154737066
6451,2020-07-30,대웅제약2분기매출액2260억원전년대비142감소,http://medipana.com/news/news_viewer.asp?NewsNum=260751&MainKind=A&NewsKind=5&vCount=12&vKind=1
6452,2020-07-30,공시대웅제약2분기영업손실47억적자전환,http://www.newsway.co.kr/news/view?tp=1&ud=2020073017532362615
6453,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://www.econovill.com/news/articleView.html?idxno=406573
6454,2020-07-30,대웅제약2분기실적발표적극적인RD투자로성장동력육성,http://www.lawissue.co.kr/view.php?ud=202007301754573843204ead0791_12
6455,2020-07-30,대웅제약실적타격에도RD투자확대,http://www.press9.kr/news/articleView.html?idxno=45431
6456,2020-07-30,대웅제약2분기47억원영업손실라니티딘성분약판매중지소송비용등영향,https://www.sedaily.com/NewsView/1Z5I71S5NA
6457,2020-07-30,대웅제약2분기매출2260억원전년대비142감소,http://www.medisobizanews.com/news/articleView.html?idxno=71615
6458,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://www.edaily.co.kr/news/newspath.asp?newsid=04208246625839768
6459,2020-07-30,대웅제약2분기영업손실47억원적자전환,http://news.mk.co.kr/newsRead.php?no=782347&year=2020
6460,2020-07-30,코로나19소송비용에대웅제약2분기영업손실47억원적자전환,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020073017535153899
6461,2020-07-30,대웅제약2Q실적영업손실47억원RD비용296억원,http://www.mediapen.com/news/view/545093
6462,2020-07-30,대웅제약2Q영업손실47억위장약판매중지조치연구개발비증가,http://www.newspim.com/news/view/20200730001216
6463,2020-07-30,대웅제약2분기영업손실47억원소송비영향적자전환,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202007300394&t=NN
6464,2020-07-30,대웅제약2분기영업손실47억불순물악재등여파,http://www.dailypharm.com/Users/News/NewsView.html?ID=267087&REFERER=NP
6465,2020-07-30,대웅제약2Q영업익적자전환매출액도142감소,https://www.news1.kr/articles/?4012165
6466,2020-07-30,대웅제약2Q영업손실47억RD투자확대,http://www.newsis.com/view/?id=NISX20200730_0001113803&cID=13001&pID=13000
6467,2020-07-30,대웅제약2분기매출액2260억원전년比142감소,http://health.chosun.com/site/data/html_dir/2020/07/30/2020073003809.html
6468,2020-07-30,대웅제약2분기매출2260억전년比142감소영업이익적자전환,http://www.joseilbo.com/news/news_read.php?uid=403165&class=27&grp=
6469,2020-07-30,적자전환대웅제약2Q순손실눈에띄네,https://www.paxnetnews.com/articles/63662
6470,2020-07-30,나보타소송영향대웅제약2분기영업익매출모두감소,http://www.wikileaks-kr.org/news/articleView.html?idxno=92066
6471,2020-07-30,대웅제약2Q영업손실47억원적자전환,http://inthenews.co.kr/article-61705/
6472,2020-07-30,대웅제약2분기매출2259억영업손실47억적자전환,https://www.dailian.co.kr/news/view/909154/?sc=Naver
6473,2020-07-30,대웅제약2분기영업손실47억원으로적자전환,https://www.hankyung.com/finance/article/202007307219i
6474,2020-07-30,대웅제약소송후유증2분기실적적자전환,http://www.upinews.kr/newsView/upi202007300091
6475,2020-07-30,대웅제약2분기영업손실47억원RD투자비용증가,http://www.viva100.com/main/view.php?key=20200730010006204
6476,2020-07-30,대웅제약2분기적자전환에도RD투자22늘려,http://news.mt.co.kr/mtview.php?no=2020073018032765296
6477,2020-07-30,대웅제약2분기영업손실47억적자전환,http://www.newsprime.co.kr/news/article.html?no=512893
6478,2020-07-30,대웅제약2분기영업손실47억전년동기대비적자전환,http://yna.kr/AKR20200730172600017?did=1195m
6479,2020-07-30,대웅제약2분기영업손실47억원알비스판매중지나보타소송비용영향,https://www.news2day.co.kr/157671
6480,2020-07-30,대웅제약2Q영업손실47억기록RD증가와코로나영향,http://www.m-i.kr/news/articleView.html?idxno=734097
6481,2020-07-30,대웅제약2분기영업손실47억코로나19소송비용등영향”,http://www.newsway.co.kr/news/view?tp=1&ud=2020073018140479535
6482,2020-07-30,대웅제약2분기영업손실47억적자전환,https://view.asiae.co.kr/article/2020073018353620941
6483,2020-07-30,대웅제약2Q영업손실47억원적자전환,http://it.chosun.com/site/data/html_dir/2020/07/30/2020073003923.html
6484,2020-07-30,대웅제약2분기영업손실47억적자전환,http://www.mdtoday.co.kr/mdtoday/index.html?no=394812
6485,2020-07-30,대웅제약2분기영업손실47억적자전환,https://www.ebn.co.kr/news/view/1444901/?sc=Naver
6486,2020-07-30,대웅제약2Q영업손실47억원RD투자비용증가”,http://www.youthdaily.co.kr/news/article.html?no=43387
6487,2020-07-30,나보타소송비용에대웅제약2분기영업익적자전환,http://news.mk.co.kr/newsRead.php?no=782476&year=2020
6488,2020-07-30,대웅제약2분기적자불구RD투자221↑,https://www.donga.com/news/article/all/20200730/102236657/1
6489,2020-07-30,대웅제약2Q영업손실47억,http://www.seoulfn.com/news/articleView.html?idxno=390667
6490,2020-07-30,뉴스투데이L대웅제약나보타수면중이갈이증상완화효과입증,https://www.news2day.co.kr/157674
6491,2020-07-30,대웅제약2분기매출액은2260억원영업손실47억원,http://newsbrite.net/140046
6492,2020-07-30,대웅제약2Q전년비매출14감소영업익적전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247363
6493,2020-07-30,대웅제약2분기영업손실47억원나보타소송비용등영향,http://www.cstimes.com/news/articleView.html?idxno=424491
6494,2020-07-30,대웅제약2분기영업손실47억적자전환,https://cnbc.sbs.co.kr/article_hub/10000991398?division=NAVER
6495,2020-07-30,대웅제약2분기매출2260억전년比142↓,https://www.fetv.co.kr/news/article.html?no=60423
6496,2020-07-30,대웅제약자체보툴리눔톡의수면이갈이완화효과인정받아,http://www.businesspost.co.kr/BP?command=article_view&num=189786
6497,2020-07-30,대웅제약의약품판매중지와소송비용영향으로2분기적자전환,http://www.businesspost.co.kr/BP?command=article_view&num=189819
6498,2020-07-30,대웅제약보툴리눔톡신나보타연구자임상서수면이갈이완화확인연세대치과대학구강내과김성택교수팀연구진행,http://www.econonews.co.kr/news/articleView.html?idxno=130587
6499,2020-07-30,대웅제약 2Q영업익47억원적자전환RD296억원전년比221↑,http://www.greened.kr/news/articleView.html?idxno=263220
6500,2020-07-30,대웅제약2분기적자전환에도RD투자증가,http://www.medigatenews.com/news/1033552913
6501,2020-07-30,대웅제약2분기적자전환에도RD투자증가,http://www.medigatenews.com/news/3124293216
6502,2020-07-30,대웅제약2분기영업손실48억적자전환,http://www.biospectator.com/view/news_view.php?varAtcId=10962
6503,2020-07-30,대웅제약2분기매출액2260억원지난해보다142감소,http://daily.hankooki.com/lpage/industry/202007/dh20200730233719148390.htm?s_ref=nv
6504,2020-07-31,대웅제약적극적인RD투자로성장동력육성,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62586
6505,2020-07-31,KBiz리뷰대웅제약줄기세포활용코로나19치료제개발추진7월31일,https://www.theguru.co.kr/news/article.html?no=12876
6506,2020-07-31,대웅제약2020년2분기실적보다는소송관련불확실성,http://www.g-enews.com/ko-kr/news/article/news_all/20200731070105926442088f476_1/article.html
6507,2020-07-31,대웅제약나보타미용성형넘어치료시장진출타진,http://www.edaily.co.kr/news/newspath.asp?newsid=01715446625840096
6508,2020-07-31,특징주대웅제약2분기적자전환에약세,http://www.seoulfn.com/news/articleView.html?idxno=390691
6509,2020-07-31,특징주대웅제약2분기적자전환에약세,http://www.inews24.com/view/1286669
6510,2020-07-31,대웅제약2Q영업손실47억원전년比적자전환,http://www.getnews.co.kr/view.php?ud=2020073109350560422fe691f917_16
6511,2020-07-31,대웅제약2분기매출액2260억원전년비142↓,http://www.bokuennews.com/news/article.html?no=193143
6512,2020-07-31,대웅제약2분기영업손실47억원적자전환,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572355111440
6513,2020-07-31,대웅제약개방형협력으로RD경쟁력높인다,http://www.finomy.com/news/articleView.html?idxno=81113
6514,2020-07-31,오늘의제약2분기실적발표​GC녹십자대웅제약유비케어제이브이엠,http://www.babytimes.co.kr/news/articleView.html?idxno=38332
6515,2020-07-31,대웅제약적극적인RD투자성장동력육성노력,http://www.pressm.kr/news/articleView.html?idxno=31861
6516,2020-07-31,대웅제약우루사뉴트로마케팅으로MZ세대공략,http://www.ajunews.com/view/20200731094649483
6517,2020-07-31,대웅제약미래신약개발핵심오픈콜라보레이션확대나서,http://www.newslock.co.kr/news/articleView.html?idxno=29951
6518,2020-07-31,대웅제약2분기적자전환영업손실47억,http://www.koreastocknews.com/news/articleView.html?idxno=55885
6519,2020-07-31,대웅제약2분기실적발표영업손실47억원적자전환,http://www.updownnews.co.kr/news/articleView.html?idxno=221542
6520,2020-07-31,대웅제약2분기RD에만300억투자,http://www.whosaeng.com/119873
6521,2020-07-31,함양대웅한우촌식당지역주민초청점심제공,http://www.knnews.co.kr/news/articleView.php?idxno=1330776
6522,2020-07-31,대웅제약2분기매출액2260억원전년동기대비142감소,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=119924
6523,2020-07-31,대웅제약2분기실적발표적극적인RD투자로성장동력육성,http://www.nbnnews.co.kr/news/articleView.html?idxno=411615
6524,2020-07-31,적극적RD투자성장동력육성에대웅제약2분기전년동기比적자전환,http://www.betanews.net:8080/article/1215556.html
6525,2020-07-31,대웅제약소송코로나19전방위직격탄2Q영업익적자전환,http://moneys.mt.co.kr/news/mwView.php?no=2020073018298055965
6526,2020-07-31,대웅제약이제약바이오엑셀러레이터사업진출한까닭은,http://www.insightkorea.co.kr/news/articleView.html?idxno=81689
6527,2020-07-31,대웅제약2분기영업손실47억원적자전환,http://www.wolyo.co.kr/news/articleView.html?idxno=107630
6528,2020-07-31,대웅메디톡스미국소송역시장기화,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200731012
6529,2020-08-01,연재기획②대웅제약vs메디톡스보툴리눔균주출처톺아보기,http://newsclaim.co.kr/View.aspx?No=930494
6530,2020-08-01,대웅제약질병표현을돕는의사소통그림책배포,http://weekly.cnbnews.com/news/article.html?no=135210
6531,2020-08-01,대웅제약나보타수면중이갈이치료효과입증,http://weekly.cnbnews.com/news/article.html?no=135216
6532,2020-08-02,KBiz리뷰LG화학LG전자美전기차부품공장인수대웅제약英아박타와코로나치료제개발7월4주차,https://www.theguru.co.kr/news/article.html?no=12934
6533,2020-08-02,K진단키트금주의진단키트소식은대웅제약엑세스바이오앤디포스,http://www.seoulwire.com/news/articleView.html?idxno=422453
6534,2020-08-02,정부치매극복기술지원한다면SK케미칼신신제약이연제약대웅제약환인제약에시선,http://www.pinpointnews.co.kr/view.php?ud=202008021431148687861beb2d9d_45
6535,2020-08-03,함양대웅한우촌식당지역주민에식사나눔,http://www.idomin.com/news/articleView.html?idxno=735698
6536,2020-08-03,대웅제약펙수프라잔적응증확대매출효자되나,http://www.press9.kr/news/articleView.html?idxno=45433
6537,2020-08-03,의약품생산5년간연평균71성장제조업의3배생산실적TOP5는한미약품종근당대웅제약녹십자셀트리온,http://www.topstarnews.net/news/articleView.html?idxno=824388
6538,2020-08-03,작년의약품생산1위한미약품종근당대웅녹십자,http://www.dailymedi.com/detail.php?number=858887&thread=22r05
6539,2020-08-03,대웅제약연이은악재에올해1조클럽유지불투명,http://www.sisajournal-e.com/news/articleView.html?idxno=221959
6540,2020-08-03,제약톱52Q실적희비종근당질주대웅풀썩,http://www.upinews.kr/newsView/upi202008030082
6541,2020-08-03,코로나19속엇갈린실적유한양행종근당희한미대웅비왜,http://www.wolyo.co.kr/news/articleView.html?idxno=107691
6542,2020-08-03,대웅제약2분기실적발표적극적인RD투자로성장동력육성,http://www.thefirstmedia.net/news/articleView.html?idxno=61256
6543,2020-08-03,대웅제약나보타연구자임상통해수면중이갈이증상완화효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=61261
6544,2020-08-04,제약업계코로나로명암갈려2분기잠정실적한미GC성장대웅동아ST축소,http://weekly.cnbnews.com/news/article.html?no=135252
6545,2020-08-04,대웅그룹우수인재육성인턴십채용활짝,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247496
6546,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴50여명모집,http://www.lawissue.co.kr/view.php?ud=202008041003363394204ead0791_12
6547,2020-08-04,대웅그룹우수인재육성을위한인턴십50명채용,http://www.fnnews.com/news/202008041028312615
6548,2020-08-04,게시판대웅그룹가을학기학점연계형현장실습인턴모집,http://yna.kr/AKR20200804060900017?did=1195m
6549,2020-08-04,대웅그룹우수인재육성위한인턴십채용활짝,http://medipana.com/news/news_viewer.asp?NewsNum=260905&MainKind=A&NewsKind=5&vCount=12&vKind=1
6550,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴모집,http://www.newsprime.co.kr/news/article.html?no=513301
6551,2020-08-04,대웅그룹우수인재육성위한인턴십채용,http://www.bosa.co.kr/news/articleView.html?idxno=2131749
6552,2020-08-04,대웅그룹우수인재육성인턴십채용문호활짝,http://www.medisobizanews.com/news/articleView.html?idxno=71715
6553,2020-08-04,대웅그룹가을학기인턴십참가자모집,http://www.newsway.co.kr/news/view?tp=1&ud=2020080410333115319
6554,2020-08-04,대웅그룹우수인재육성인턴십채용활짝,http://www.newsis.com/view/?id=NISX20200804_0001117696&cID=13001&pID=13000
6555,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴모집,https://www.etoday.co.kr/news/view/1925516
6556,2020-08-04,대웅학점연계형장기현장실습인턴모집,http://www.consumuch.com/news/articleView.html?idxno=50036
6557,2020-08-04,대웅그룹우수인재육성을위한인턴십채용,http://www.healthinnews.co.kr/news/articleView.html?idxno=13889
6558,2020-08-04,대웅그룹학점연계형인턴50명모집,http://www.monews.co.kr/news/articleView.html?idxno=212477
6559,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴모집,https://www.dailian.co.kr/news/view/910057/?sc=Naver
6560,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴50여명모집,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=120033
6561,2020-08-04,채용공고대웅그룹학점연계형인턴십채용,http://www.economytalk.kr/news/articleView.html?idxno=207394
6562,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴모집,http://www.youthdaily.co.kr/news/article.html?no=43650
6563,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴50여명모집,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62639
6564,2020-08-04,대웅그룹인턴50여명모집,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001466
6565,2020-08-04,대웅그룹가을학기인턴50여명온라인모집,http://www.koreastocknews.com/news/articleView.html?idxno=55970
6566,2020-08-04,대웅그룹우수인재육성위한인턴십지원자모집학점연계형장기현장실습,http://www.m-i.kr/news/articleView.html?idxno=735048
6567,2020-08-04,대웅그룹우수인재육성위한인턴십채용,http://www.newspim.com/news/view/20200804000544
6568,2020-08-04,대웅그룹우수인재육성을위한인턴십채용활짝,http://www.metroseoul.co.kr/article/20200804500192
6569,2020-08-04,제약업계2분기희비교차유한종근당웃고한미대웅침울,http://news.heraldcorp.com/view.php?ud=20200804000497
6570,2020-08-04,대웅그룹우수인재육성위한채용지속가을학기인턴십모집,http://www.businesskorea.co.kr/news/articleView.html?idxno=49989
6571,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴50여명모집,https://www.asiatoday.co.kr/view.php?key=20200804010001649
6572,2020-08-04,대웅그룹학점연계형장기현장실습인턴50여명모집,http://news.mt.co.kr/mtview.php?no=2020080412034359859
6573,2020-08-04,대웅그룹우수인재육성인턴십50명채용,http://www.wikileaks-kr.org/news/articleView.html?idxno=92308
6574,2020-08-04,대웅그룹학점연계장기현장실습인턴50여명모집,http://www.biospectator.com/view/news_view.php?varAtcId=10991
6575,2020-08-04,대웅그룹우수인재육성가을학기인턴십참가자모집,http://www.dailysmart.co.kr/news/articleView.html?idxno=30918
6576,2020-08-04,대웅그룹가을학기인턴십채용장기현장실습인턴50명모집,http://www.pressm.kr/news/articleView.html?idxno=31967
6577,2020-08-04,대한민국굿잡스대웅그룹우수인재육성위한인턴십채용진행,http://www.newslock.co.kr/news/articleView.html?idxno=30050
6578,2020-08-04,대웅그룹우수인재육성을위한인턴십채용,http://daily.hankooki.com/lpage/industry/202008/dh20200804133519148390.htm?s_ref=nv
6579,2020-08-04,대웅그룹우수인재육성위한인턴십채용,http://www.mdtoday.co.kr/mdtoday/index.html?no=395176
6580,2020-08-04,대웅그룹인턴십프로그램선보여가을학기학점연계형장기현장실습인턴50여명모집,http://newsbrite.net/140151
6581,2020-08-04,대웅그룹우수인재육성을위한인턴십채용활짝가을학기학점연계형장기현장실습인턴50여명모집,http://www.nbnnews.co.kr/news/articleView.html?idxno=412595
6582,2020-08-04,대웅그룹가을학기학점연계형인턴십50명모집,https://www.asiatime.co.kr/news/newsview.php?ncode=1065593002824782
6583,2020-08-04,펄펄끓는코로나주왜종근당유한양행웃고한미약품대웅제약울고씨젠신풍제약은,http://www.pinpointnews.co.kr/view.php?ud=202008041547205017861beb2d9d_45
6584,2020-08-04,대웅그룹장기현장실습인턴50명모집9월부터4개월간직무경험,https://www.donga.com/news/article/all/20200804/102295897/1
6585,2020-08-04,대웅그룹가을학기학점연계형인턴십프로그램운영인턴50여명모집,http://sports.hankooki.com/lpage/economy/202008/sp20200804155211136980.htm?s_ref=nv
6586,2020-08-04,대웅그룹우수인재육성위한인턴십채용온라인모집,http://www.100ssd.co.kr/news/articleView.html?idxno=70489
6587,2020-08-04,대웅가을학기학점연계형현장실습인턴50여명모집,http://www.dailymedi.com/detail.php?number=858940&thread=22r05
6588,2020-08-04,시경Today건강대웅그룹가을학기학점연계형장기현장실습인턴50여명모집外,http://www.meconomynews.com/news/articleView.html?idxno=44180
6589,2020-08-04,대웅그룹가을학기학점연계형장기현장실습인턴50여명모집,http://www.worktoday.co.kr/news/articleView.html?idxno=9262
6590,2020-08-04,대웅바이오종근당복지부의치매치료제선별급여결정에소송대응,http://www.businesspost.co.kr/BP?command=article_view&num=190472
6591,2020-08-04,대웅그룹가을학기학점연계형현장실습인턴모집,http://www.seoulfn.com/news/articleView.html?idxno=391132
6592,2020-08-04,대웅그룹우수인재육성을위한인턴십채용,http://www.bokuennews.com/news/article.html?no=193240
6593,2020-08-05,악재겹친대웅제약하반기에는회복될까,https://www.asiatime.co.kr/news/newsview.php?ncode=1065592063611426
6594,2020-08-05,특징주종근당유한양행웃고한미약품대웅제약울고제약바이오株주가희비갈렸다,http://www.ccreview.co.kr/news/articleView.html?idxno=276117
6595,2020-08-05,더벨대웅제약적자전환감내하고RD비용늘린까닭,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202008031514056240106863
6596,2020-08-05,코로나19에유한양행종근당웃고한미대웅울고실적희비,http://www.inews24.com/view/1288003
6597,2020-08-05,단독공정위대웅제약심판대올린다부당특허소송남발,http://www.etnews.com/20200805000229
6598,2020-08-06,제약업계빅52분기실적희비교차유한종근당선방녹십자한미대웅부진,http://www.youthdaily.co.kr/news/article.html?no=43837
6599,2020-08-06,대웅대웅제약오후갑자기가파른상승대웅제약2상승이어대웅5상승,http://www.econonews.co.kr/news/articleView.html?idxno=131412
6600,2020-08-06,특징주대웅美FDA최초니클로사마이드코로나19임상승인상승,http://www.newsprime.co.kr/news/article.html?no=513640
6601,2020-08-06,대웅제약종근당상한가에급락으로희비엇갈려대웅제약상한가반해종근당6급락,http://www.econonews.co.kr/news/articleView.html?idxno=131418
6602,2020-08-06,특징주대웅미국FDA니클로사마이드코로나19임상승인부각에강세,http://moneys.mt.co.kr/news/mwView.php?no=2020080614348062820
6603,2020-08-06,대웅제약국내외제약바이오기업과개방형협력신약개발박차,http://www.100ssd.co.kr/news/articleView.html?idxno=70519
6604,2020-08-06,주식대웅대웅제약오후갑작스런급등상한가달성 그이유는,http://www.ggilbo.com/news/articleView.html?idxno=788048
6605,2020-08-06,니클로사마이드관련주대웅제약대웅과동반급등,http://www.ccreview.co.kr/news/articleView.html?idxno=276416
6606,2020-08-06,니클로사마이드관련주대웅29급등니클로사마이드美FDA임상승인,http://www.ccreview.co.kr/news/articleView.html?idxno=276417
6607,2020-08-06,6일오늘의상한가종목총정리대웅대웅제약등코로나19제약바이오주급등,http://www.ccreview.co.kr/news/articleView.html?idxno=276419
6608,2020-08-06,한경팩트체크급등한대웅ITC예비판결문공개우려,https://www.hankyung.com/it/article/202008060511i
6609,2020-08-06,보톡스에라니티딘사태까지실적뚝대웅제약1조클럽위태,http://www.enewstoday.co.kr/news/articleView.html?idxno=1405923
6610,2020-08-06,6일특징주총정리니클로사마이드관련주대웅급등솔브레인첫날상한가,http://www.ccreview.co.kr/news/articleView.html?idxno=276421
6611,2020-08-06,급등락주짚어보기분할재상장첫날솔브레인上대웅코로나치료제임상승인호재에급등,https://www.etoday.co.kr/news/view/1926729
6612,2020-08-06,씨젠또급등상승랠리무섭네대웅상한가그리고셀트리온카카오비틀,http://www.pinpointnews.co.kr/view.php?ud=202008061648368486861beb2d9d_45
6613,2020-08-06,6일특징주대웅솔브레인전진바이오팜급등세코로나테마강세,http://www.newsworks.co.kr/news/articleView.html?idxno=478609
6614,2020-08-06,대웅제약우루사뉴트로마케팅으로MZ세대공략,http://www.econovill.com/news/articleView.html?idxno=407401
6615,2020-08-06,오늘의토막뉴스제약업계빅52분기실적희비교차유한종근당선방녹십자한미대웅부진外,http://www.youthdaily.co.kr/news/article.html?no=43968
6616,2020-08-06,특징주대웅코로나19임상승인호재상한가,http://www.youthdaily.co.kr/news/article.html?no=43974
6617,2020-08-06,대웅제약수면중이갈이나보타로증상개선미용치료로시장확대,http://www.polinews.co.kr/news/article.html?no=471085
6618,2020-08-06,상한가종목대웅JW중외제약우상한가마감뒤이어솔브레인솔브레인홀딩스전진바이오팜상한가,http://www.econonews.co.kr/news/articleView.html?idxno=131428
6619,2020-08-06,마감대웅니클로사마이드FDA임상승인상한가솔브레인솔브레인홀딩스급등,https://www.asiatime.co.kr/news/newsview.php?ncode=1065617975956170
6620,2020-08-06,뉴스투데이L대웅그룹가을학기인턴50여명모집,https://www.news2day.co.kr/158175
6621,2020-08-07,항궤양신약PCAB시장이노엔선점vs대웅도전,http://www.dailypharm.com/Users/News/NewsView.html?ID=267251&REFERER=NP
6622,2020-08-07,대웅줄기세포에꾸준한관심급성간부전치료제개발나서,http://www.ceoscoredaily.com/news/article.html?no=72161
6623,2020-08-07,니클라소마이드관련주대웅대웅제약장초반하락세코로나효과매우우수,http://www.ccreview.co.kr/news/articleView.html?idxno=276661
6624,2020-08-07,대웅제약ITC예비결정문분석조목조목반박이의신청서제출,http://www.pressm.kr/news/articleView.html?idxno=32096
6625,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류조목조목반박,http://newsbrite.net/140247
6626,2020-08-07,대웅대웅제약급등하루만에하락에급락까지특히대웅제약갑작스런7급락,http://www.econonews.co.kr/news/articleView.html?idxno=131454
6627,2020-08-07,대웅제약ITC에이의신청예비결정문편향왜곡의극치”,http://daily.hankooki.com/lpage/industry/202008/dh20200807090921148390.htm?s_ref=nv
6628,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡극치”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247642
6629,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류반박,https://biz.chosun.com/site/data/html_dir/2020/08/07/2020080700969.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6630,2020-08-07,대웅제약ITC예비판결문편향과왜곡의극치,http://medipana.com/news/news_viewer.asp?NewsNum=261055&MainKind=A&NewsKind=5&vCount=12&vKind=1
6631,2020-08-07,ITC예비판결문전문공개에대웅제약영업비밀침해했다는구체적근거없어,https://www.sedaily.com/NewsView/1Z6HJNKYWQ
6632,2020-08-07,대웅제약ITC예비결정은편향왜곡의극치,http://www.medisobizanews.com/news/articleView.html?idxno=71791
6633,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치,https://www.hankyung.com/it/article/202008072906i
6634,2020-08-07,대웅제약美ITC에예비결정문이의신청서제출,https://www.paxnetnews.com/articles/63958
6635,2020-08-07,대웅제약ITC예비결정문편향왜곡됐다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94088
6636,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62684
6637,2020-08-07,대웅제약ITC에이의신청서제출예비결정편향과왜곡의극치”,http://www.viva100.com/main/view.php?key=20200807010001283
6638,2020-08-07,대웅제약ITC에이의신청서제출예비결정에중대한오류반박,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020080709540165768
6639,2020-08-07,대웅제약ITC에이의신청예비결정오류반박,http://www.mediapen.com/news/view/546940
6640,2020-08-07,대웅제약ITC에이의신청제출구체증거없는명백한오판,http://www.newsis.com/view/?id=NISX20200807_0001121835&cID=13001&pID=13000
6641,2020-08-07,대웅제약美ITC에이의신청서제출,http://www.medigatenews.com/news/2097723041
6642,2020-08-07,대웅제약ITC명백한오판11월반드시승소할것,http://www.koreastocknews.com/news/articleView.html?idxno=56071
6643,2020-08-07,대웅제약ITC예비결정문분석증거없이추론에기반한결론,http://www.press9.kr/news/articleView.html?idxno=45477
6644,2020-08-07,대웅제약美ITC에이의신청서제출예비판결문오류반박,http://it.chosun.com/site/data/html_dir/2020/08/07/2020080701307.html
6645,2020-08-07,메디톡스대웅제약2차전예고ICT에공식이의신청,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135134&REFERER=NP
6646,2020-08-07,대웅제약ITC에이의신청예비결정문편향과왜곡의극치,http://www.seoulwire.com/news/articleView.html?idxno=423237
6647,2020-08-07,대웅제약ITC에이의신청예비판결문편향왜곡극치,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008070154&t=NN
6648,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치,http://www.dailysmart.co.kr/news/articleView.html?idxno=31069
6649,2020-08-07,ITC예비판결명백한오판대웅제약ITC에이의신청서제출,http://moneys.mt.co.kr/news/mwView.php?no=2020080709598052183
6650,2020-08-07,대웅제약ITC예비결정편향과왜곡의극치진실가려질것,http://www.newspim.com/news/view/20200807000228
6651,2020-08-07,대웅제약ITC에이의신청서제출예비결정문편향과왜곡의극치”,https://www.dailian.co.kr/news/view/910899/?sc=Naver
6652,2020-08-07,편향과왜곡의극치대웅제약ITC에이의신청서제출,http://www.newsprime.co.kr/news/article.html?no=513739
6653,2020-08-07,대웅제약미ITC예비판결문편향과왜곡뒤집힐가능성있어,http://yna.kr/AKR20200807056800017?did=1195m
6654,2020-08-07,대웅제약美ITC에이의신청명백한오판이다,https://www.asiatoday.co.kr/view.php?key=20200807010003738
6655,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류반박,http://www.youthdaily.co.kr/news/article.html?no=44026
6656,2020-08-07,대웅제약미ITC예비판결문편향왜곡됐다,http://www.ekn.kr/news/article.html?no=515940
6657,2020-08-07,대웅제약미ITC자국산업보호위해무리수남발,http://www.bosa.co.kr/news/articleView.html?idxno=2131971
6658,2020-08-07,대웅제약메디톡스영업비밀침해소송관련 미ITC예비판결문편향과왜곡”,https://www.seoul.co.kr/news/newsView.php?id=20200807500071&wlog_tag3=naver
6659,2020-08-07,대웅제약ITC에이의신청서제출예비결정문편향적,http://www.newstomato.com/ReadNews.aspx?no=988836
6660,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치추론기반한부당판결,http://www.startuptoday.co.kr/news/articleView.html?idxno=50084
6661,2020-08-07,대웅제약ITC예비결정문분석증거없이추론에기반한결론,http://www.insightkorea.co.kr/news/articleView.html?idxno=81888
6662,2020-08-07,美ITC대웅제약균주메디톡스서왔다”,https://www.hankyung.com/it/article/202008073447i
6663,2020-08-07,대웅제약대웅장중주가급락무슨일,http://www.choicenews.co.kr/news/articleView.html?idxno=73440
6664,2020-08-07,대웅제약메디톡스손들어준美ITC예비판결문에편향과왜곡의극치,http://news.mk.co.kr/newsRead.php?no=810586&year=2020
6665,2020-08-07,대웅제약ITC예비결정문편향왜곡극치이의신청서제출,http://www.sisafocus.co.kr/news/articleView.html?idxno=245099
6666,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치,http://www.pharmnews.com/news/articleView.html?idxno=101068
6667,2020-08-07,대웅제약ITC예비결정구체적인증거없어추론에기반한결론에불과,http://www.ceoscoredaily.com/news/article.html?no=72204
6668,2020-08-07,대웅제약ITC보툴리눔톡신예비판결왜곡됐다,https://hankookilbo.com/News/Read/A2020080709240005986?did=NA
6669,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치”,http://www.econovill.com/news/articleView.html?idxno=407473
6670,2020-08-07,대웅제약미국ITC보톡스예비판결문편향과왜곡뒤집힐가능성있어,http://www.topstarnews.net/news/articleView.html?idxno=825348
6671,2020-08-07,특징주대웅제약메디톡스美ITC예비판결문공개로또희비교차,http://news.mk.co.kr/newsRead.php?no=810738&year=2020
6672,2020-08-07,대웅제약ITC에이의신청서제출편향과왜곡의극치,http://www.ezyeconomy.com/news/articleView.html?idxno=103931
6673,2020-08-07,대웅제약美ITC예비결정오판이의신청제출,http://www.dailypharm.com/Users/News/NewsView.html?ID=267263&REFERER=NP
6674,2020-08-07,ITC예비결정문조목조목반박한대웅제약편향왜곡의극치”,http://www.segye.com/content/html/2020/08/07/20200807508489.html?OutUrl=naver
6675,2020-08-07,대웅국제무역委예비결정정식문제제기,http://www.dailymedi.com/detail.php?number=859052&thread=22r05
6676,2020-08-07,대웅제약편향과왜곡극치ITC예비결정문맹비난,http://www.wikileaks-kr.org/news/articleView.html?idxno=92527
6677,2020-08-07,대웅대웅제약하락에폭락으로무너지는주가대웅5하락이어대웅제약10폭락,http://www.econonews.co.kr/news/articleView.html?idxno=131555
6678,2020-08-07,ITC메디톡스대웅제약보톡스분쟁예비판결문공개,http://news.mk.co.kr/newsRead.php?no=811020&year=2020
6679,2020-08-07,대웅제약ITC예비결정반박편향과왜곡의극치,http://www.monews.co.kr/news/articleView.html?idxno=212588
6680,2020-08-07,대웅제약ITC예비결정문편향적이고왜곡많아이의신청서제출,http://www.newslock.co.kr/news/articleView.html?idxno=30149
6681,2020-08-07,대웅제약美ITC에이의신청서제출예비판결문편향과왜곡의극치”,http://inthenews.co.kr/article-62945/
6682,2020-08-07,대웅제약미ITC예비판결오판이의신청제출”,http://www.newsway.co.kr/news/view?tp=1&ud=2020080714200695096
6683,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치”,http://www.pinpointnews.co.kr/view.php?ud=202008071420498070f090c8dbcb_45
6684,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치주장,http://www.newsfc.co.kr/news/articleView.html?idxno=42196
6685,2020-08-07,대웅제약ITC예비결정편향왜곡의극치이의신청,http://news.mt.co.kr/mtview.php?no=2020080714312145796
6686,2020-08-07,대웅제약ITC결정문중대한오류발견이의신청,http://www.upinews.kr/newsView/upi202008070032
6687,2020-08-07,ITC대웅균주도용판단근거염기서열분석,https://www.paxnetnews.com/articles/63974
6688,2020-08-07,대웅제약ITC에이의신청서제출예비결정문분석결과편향과왜곡의극치”,http://www.mdtoday.co.kr/mdtoday/index.html?no=395522
6689,2020-08-07,대웅제약ITC예비결정은사실을편향왜곡해11월최종결정에서승소할것”,https://jhealthmedia.joins.com/article/article_view.asp?pno=22217
6690,2020-08-07,대웅제약미국국제무역위예비결정문에중대오류이의신청서제출,http://www.businesspost.co.kr/BP?command=article_view&num=190910
6691,2020-08-07,美ITC대웅제약균주메디톡스서왔다”대웅이의신청서제출,http://www.edaily.co.kr/news/newspath.asp?newsid=02847046625865024
6692,2020-08-07,美ITC대웅제약메디톡스보톡스균주유전적으로유사,https://www.hankyung.com/it/article/202008074390i
6693,2020-08-07,美ITC대웅제약균주메디톡스에서왔다,http://www.whitepaper.co.kr/news/articleView.html?idxno=196307
6694,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡의극치,http://www.nbnnews.co.kr/news/articleView.html?idxno=413624
6695,2020-08-07,대웅제약ITC예비판결탄핵추진ITC행정판사미국기업엘러간편들어,https://www.news2day.co.kr/158210
6696,2020-08-07,대웅제약ITC예비결정문편향과왜곡의극치”,http://www.getnews.co.kr/view.php?ud=2020080715512514962fe691f917_16
6697,2020-08-07,美ITC대웅제약메디톡스균주6개돌연변이일치,https://www.hankyung.com/finance/article/202008074806i
6698,2020-08-07,대웅제약ITC예비결정문은편향과왜곡의극치,http://www.m-i.kr/news/articleView.html?idxno=736150
6699,2020-08-07,美ITC대웅제약균주메디톡스서왔다대웅이의신청종합,https://www.hankyung.com/finance/article/202008075062i
6700,2020-08-07,대웅제약美ITC예비판결문편향왜곡뒤집힐수도,http://www.seoulfn.com/news/articleView.html?idxno=391454
6701,2020-08-07,대웅제약美ITC예비판결문편향왜곡뒤집힐수도,http://www.seoulfn.com/news/articleView.html?idxno=391454
6702,2020-08-07,대웅ITC예비결정문분석결과편향왜곡의극치,http://www.shinailbo.co.kr/news/articleView.html?idxno=1307240
6703,2020-08-07,美ITC대웅제약보톡스균주메디톡스와동일,https://www.hankyung.com/it/article/2020080751371
6704,2020-08-07,미국ITC대웅제약나보타10년수입금지예비결정대웅제약메디톡스에미칠영향은,http://www.ltn.kr/news/articleView.html?idxno=29248
6705,2020-08-07,대웅제약ITC나보타수입금지예비결정편향극치vs메디톡스증거기반과학적결론,http://www.ltn.kr/news/articleView.html?idxno=29249
6706,2020-08-07,메디톡스대웅제약수년째보톡스전쟁두회사간무슨일이,http://www.ltn.kr/news/articleView.html?idxno=29247
6707,2020-08-07,대웅제약ITC에이의신청서제출예비결정오류조목조목반박,http://www.thefirstmedia.net/news/articleView.html?idxno=61425
6708,2020-08-07,대웅제약ITC예비결정문분석결과편향과왜곡극치,https://www.kpanews.co.kr/article/show.asp?idx=215236&category=D
6709,2020-08-08,대웅제약ITC에예비판정오류조목조목반박이의신청서제출편향왜곡의극치,http://www.updownnews.co.kr/news/articleView.html?idxno=221828
6710,2020-08-08,연재기획③대웅제약vs메디톡스톺아보기ITC소송이노톡스상관관계,http://newsclaim.co.kr/View.aspx?No=1043249
6711,2020-08-08,ITC예비결정문공개에다시불붙는대웅제약메디톡스진실공방,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001591
6712,2020-08-08,대웅제약ITC예비결정문은편향과왜곡의극치,http://www.datasom.co.kr/news/articleView.html?idxno=107661
6713,2020-08-08,대웅제약美ITC예비판결불복편향과왜곡의극치”이의신청서제출,http://www.thepublic.kr/news/newsview.php?ncode=1065597850491339
6714,2020-08-08,지난주제약업계주요이슈대웅제약보툴리눔톡신관련ITC예비결정오류발견반박外,http://www.youthdaily.co.kr/news/article.html?no=44087
6715,2020-08-09,대웅제약미ITC예비결정은편향과왜곡의극치,http://www.legaltimes.co.kr/news/articleView.html?idxno=54815
6716,2020-08-10,대웅메디톡스균주다툼정작의사들관심없다,http://www.press9.kr/news/articleView.html?idxno=45483
6717,2020-08-10,대웅대웅제약지지부진한주가대웅제약2하락이어대웅소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=131768
6718,2020-08-10,메디톡스美ITC증거사실로대웅제약균주도용혐의입증,http://www.medisobizanews.com/news/articleView.html?idxno=71828
6719,2020-08-10,메디톡스美ITC예비판결문통해대웅의균주및공정도용사실명백해져,http://news.mk.co.kr/newsRead.php?no=817645&year=2020
6720,2020-08-10,메디톡스美ITC과학적증거로대웅제약도용혐의입증,https://www.hankyung.com/it/article/202008100032i
6721,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약의도용혐의명백히입증”,http://www.pinpointnews.co.kr/view.php?ud=202008100913435161f090c8dbcb_45
6722,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의입증,http://biz.newdaily.co.kr/site/data/html/2020/08/10/2020081000023.html
6723,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의명백히입증”,https://www.fetv.co.kr/news/article.html?no=61035
6724,2020-08-10,메디톡스미국ITC대웅제약의균주제조공정도용혐의입증”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247697
6725,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약의균주도용혐의명백히입증,http://www.seoulwire.com/news/articleView.html?idxno=423439
6726,2020-08-10,메디톡스ITC대웅제약균주제조공정도용입증,https://www.ebn.co.kr/news/view/1446020/?sc=Naver
6727,2020-08-10,메디톡스ITC과학적증거와사실로대웅제약균주도용혐의입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020081009213771458
6728,2020-08-10,니클로사마이드관련주대웅소폭상승미국FDA임상승인,http://www.ccreview.co.kr/news/articleView.html?idxno=277079
6729,2020-08-10,메디톡스美ITC대웅제약이자사균주및제조공정도용혐의입증,https://www.asiatoday.co.kr/view.php?key=20200810010004737
6730,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의입증”,http://www.viva100.com/main/view.php?key=20200810010001666
6731,2020-08-10,특징주대웅제약급락할까메디톡스대웅제약자체개발모두거짓,http://www.ccreview.co.kr/news/articleView.html?idxno=277080
6732,2020-08-10,메디톡스ITC대웅제약보툴리눔균주도용혐의명백히입증”,http://www.getnews.co.kr/view.php?ud=2020081009363053082fe691f917_16
6733,2020-08-10,메디톡스ITC대웅제약의균주제조공정도용혐의입증,http://medipana.com/news/news_viewer.asp?NewsNum=261113&MainKind=A&NewsKind=5&vCount=12&vKind=1
6734,2020-08-10,메디톡스美ITC대웅제약의도용혐의명백히입증대웅주장은거짓”,http://daily.hankooki.com/lpage/industry/202008/dh20200810094527148390.htm?s_ref=nv
6735,2020-08-10,메디톡스미국ITC과학적증거로대웅제약균주도용입증,http://yna.kr/AKR20200810041500017?did=1195m
6736,2020-08-10,메디톡스미국ITC과학적증거로대웅제약도용혐의명백히입증,http://www.ekn.kr/news/article.html?no=516292
6737,2020-08-10,메디톡스美ITC대웅제약균주도용혐의입증,http://www.newspim.com/news/view/20200810000219
6738,2020-08-10,메디톡스美ITC대웅제약균주도용혐의명백히입증이유살펴보니,https://www.etoday.co.kr/news/view/1927522
6739,2020-08-10,메디톡스美ITC과학적증거로대웅제약균주도용입증,https://view.asiae.co.kr/article/2020081010070726156
6740,2020-08-10,메디톡스美ITC과학적증거통해대웅제약도용혐의입증”,http://www.youthdaily.co.kr/news/article.html?no=44184
6741,2020-08-10,메디톡스ITC과학적증거와사실로대웅제약의메디톡스균주및제조공정도용혐의입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62703
6742,2020-08-10,메디톡스ITC예비판결문에대해대웅제약거짓드러나,http://www.wikileaks-kr.org/news/articleView.html?idxno=92632
6743,2020-08-10,美ITC예비판결문공개메디톡스균주도용명백입증vs대웅제약편향과왜곡의극치,http://www.babytimes.co.kr/news/articleView.html?idxno=38523
6744,2020-08-10,메디톡스대웅의균주도용과학으로입증,https://www.paxnetnews.com/articles/64007
6745,2020-08-10,메디톡스美ITC과학적증거로대웅의균주도용입증,http://www.newsis.com/view/?id=NISX20200810_0001123919&cID=13001&pID=13000
6746,2020-08-10,메디톡스美ITC예비판결문공개대웅제약균주도용사실입증,http://www.econovill.com/news/articleView.html?idxno=407674
6747,2020-08-10,메디톡스대웅제약주장은거짓美ITC가도용혐의명백히입증,http://www.sisafocus.co.kr/news/articleView.html?idxno=245279
6748,2020-08-10,메디톡스美ITC과학적증거로대웅제약균주도용혐의명백히입증,http://www.newsprime.co.kr/news/article.html?no=513925
6749,2020-08-10,메디톡스美ITC대웅제약메디톡스균주도용혐의명백히입증,http://www.medigatenews.com/news/2372213087
6750,2020-08-10,메디톡스ITC대웅제약균주제조공정도용혐의입증,http://news.tf.co.kr/read/economy/1806156.htm
6751,2020-08-10,메디톡스대웅제약ITC예비판결문두고설전,http://www.upinews.kr/newsView/upi202008100025
6752,2020-08-10,메디톡스ITC예비판결문공개대웅제약균주도용혐의명백히입증”,http://theviewers.co.kr/View.aspx?No=1044124
6753,2020-08-10,메디톡스ITC판결문에서대웅균주도용명백히드러나,http://www.koreastocknews.com/news/articleView.html?idxno=56118
6754,2020-08-10,메디톡스미ITC과학적증거로대웅제약의균주도용혐의입증,http://www.cstimes.com/news/articleView.html?idxno=425711
6755,2020-08-10,메디톡스ITC대웅제약의도용과학적으로입증했다,https://hankookilbo.com/News/Read/A2020081009290000259?did=NA
6756,2020-08-10,메디톡스ITC예비판결문대웅제약균주도용과학적증거입증,http://isplus.live.joins.com/news/article/article.asp?total_id=23844902
6757,2020-08-10,메디톡스미국ITC과학적증거로대웅제약균주도용입증,http://www.seoulfn.com/news/articleView.html?idxno=391572
6758,2020-08-10,메디톡스美ITC과학적증거로대웅의균주도용입증,http://www.topstarnews.net/news/articleView.html?idxno=825828
6759,2020-08-10,메디톡스미국ITC과학적증거로대웅제약균주도용입증,http://www.fntoday.co.kr/news/articleView.html?idxno=227616
6760,2020-08-10,대웅대웅제약상승에급등까지특히대웅갑작스런14급등에투자자들놀라,http://www.econonews.co.kr/news/articleView.html?idxno=131850
6761,2020-08-10,메디톡스과학적증거사실로대웅제약혐의입증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1307679
6762,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약도용혐의명백히입증,http://www.wolyo.co.kr/news/articleView.html?idxno=107940
6763,2020-08-10,메디톡스美ITC대웅제약의균주제조공정도용혐의입증”,http://www.mdtoday.co.kr/mdtoday/index.html?no=395618
6764,2020-08-10,메디톡스과학적증거로대웅제약균주도용혐의입증VS대웅제약추론기반한결론,http://www.segye.com/content/html/2020/08/10/20200810513421.html?OutUrl=naver
6765,2020-08-10,대웅제약균주와제조공정도용없어메디톡스보도자료조목조목반박,http://www.pressm.kr/news/articleView.html?idxno=32165
6766,2020-08-10,끝없는대웅제약메디톡스보톡스전쟁최종승자는,http://www.mediapen.com/news/view/547431
6767,2020-08-10,주식대웅대웅제약상승에급등까지훨훨특히대웅갑작스런22급등투자자들어머나,http://www.ggilbo.com/news/articleView.html?idxno=788614
6768,2020-08-10,대웅제약균주제조공정도용없어ITC편향왜곡결정,http://www.medisobizanews.com/news/articleView.html?idxno=71843
6769,2020-08-10,대웅제약균주제조공정도용없었다반박,https://www.ebn.co.kr/news/view/1446106/?sc=Naver
6770,2020-08-10,대웅제약메디톡스주장에반박균주와제조공정도용없어”,https://www.fetv.co.kr/news/article.html?no=61107
6771,2020-08-10,재반박나선대웅제약메디톡스ITC오판번역한억지주장”,http://daily.hankooki.com/lpage/industry/202008/dh20200810144119148390.htm?s_ref=nv
6772,2020-08-10,미국ITC판결문놓고메디톡스균주도용입증vs대웅오판종합,http://yna.kr/AKR20200810041551017?did=1195m
6773,2020-08-10,대웅제약균주및제조공정도용없어”메디톡스에자료공개촉구,http://www.viva100.com/main/view.php?key=20200810010001822
6774,2020-08-10,대웅제약균주와제조공정도용없어”,http://www.econovill.com/news/articleView.html?idxno=407724
6775,2020-08-10,대웅제약균주와제조공정도용없어재차반박하고나서,http://medipana.com/news/news_viewer.asp?NewsNum=261146&MainKind=A&NewsKind=5&vCount=12&vKind=1
6776,2020-08-10,대웅제약균주도용여부유전자분석으로는불가능,https://www.news1.kr/articles/?4021893
6777,2020-08-10,미국ITC판결문에메디톡스균주도용입증vs대웅제약편향과왜곡,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4243610
6778,2020-08-10,균주와제조공정도용없어대웅제약메디톡스보도자료반박,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62722
6779,2020-08-10,대웅제약균주제조공정도용없어메디톡스보도자료반박,https://www.hankyung.com/it/article/202008102008i
6780,2020-08-10,균주와제조공정도용없어대웅제약메디톡스보도자료반박,http://www.nbnnews.co.kr/news/articleView.html?idxno=414147
6781,2020-08-10,메디톡스ITC판결문대웅제약보톡스균주도용입증,http://www.seouleconews.com/news/articleView.html?idxno=56034
6782,2020-08-10,ITC예비결정문두고대립에재반박대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510937040
6783,2020-08-10,메디톡스vs대웅제약ITC예비결정문놓고또공방,http://news.mt.co.kr/mtview.php?no=2020081015173146434
6784,2020-08-10,종합보톡스진실게임재점화메디톡스균주도용확실VS대웅명백한오판,https://www.etoday.co.kr/news/view/1927724
6785,2020-08-10,메디톡스대웅제약ITC예비판결문놓고난타전,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008100334&t=NN
6786,2020-08-10,메디톡스美ITC대웅제약균주및제조공정도용혐의입증,http://www.todaykorea.co.kr/news/articleView.html?idxno=275151
6787,2020-08-10,대웅제약균주제조공정도용없다”메디톡스에ITC제출자료공개촉구,http://www.youthdaily.co.kr/news/article.html?no=44239
6788,2020-08-10,대웅오판”vs메디톡스균주도용입증”미국ITC판결문놓고이견,http://www.sporbiz.co.kr/news/articleView.html?idxno=461893
6789,2020-08-10,대웅제약균주제조공정도용안했다메디톡스보도자료반박,http://www.mediapen.com/news/view/547576
6790,2020-08-10,대웅제약K바이오미국시장저지가이번소송본질,http://www.bosa.co.kr/news/articleView.html?idxno=2132097
6791,2020-08-10,메디톡스ITC예비판결문공개대웅제약도용혐의입증돼,http://www.pharmnews.com/news/articleView.html?idxno=101077
6792,2020-08-10,메디톡스균주도용과학적으로입증VS대웅제약편향왜곡된예비판결의진실곧가려질것,http://www.sportsseoul.com/news/read/944563?ref=naver
6793,2020-08-10,메디톡스대웅제약반박에ITC가확실한증거없이결정했다는주장터무니없다”,https://www.news2day.co.kr/158341
6794,2020-08-10,대웅제약메디톡스억지주장불과균주제조공정도용없어,http://www.newsprime.co.kr/news/article.html?no=513991
6795,2020-08-10,균주와제조공정도용없어”대웅제약메디톡스보도자료반박,http://newsbrite.net/140334
6796,2020-08-10,메디대웅ITC예비판결문놓고동상이몽종합,https://view.asiae.co.kr/article/2020081016041076249
6797,2020-08-10,대웅제약균주제조공정도용없다메디톡스에반박,http://www.newspim.com/news/view/20200810000931
6798,2020-08-10,대웅제약메디톡스균주의혹투성이제조공정도용없다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247730
6799,2020-08-10,메디톡스美ITC대웅균주도용과학적입증”,http://www.segyebiz.com/newsView/20200810517702?OutUrl=naver
6800,2020-08-10,ITC판결문공개에도승복않는메디톡스와대웅제약,http://www.opinionnews.co.kr/news/articleView.html?idxno=37968
6801,2020-08-10,메디톡스ITC서도용판결vs대웅제약편향적결론반박,http://www.wolyo.co.kr/news/articleView.html?idxno=107954
6802,2020-08-10,메디톡스대웅제약美ITC예비판결문놓고또진실공방,http://news.mk.co.kr/newsRead.php?no=820769&year=2020
6803,2020-08-10,대웅제약균주와제조공정도용없어유전자분석의한계”반박,http://www.mdtoday.co.kr/mdtoday/index.html?no=395686
6804,2020-08-10,메디톡스대웅제약ITC판결문두고날선공방,https://www.sedaily.com/NewsView/1Z6IYOU6C5
6805,2020-08-10,메디톡스ITC예비판결문에서대웅제약도용사실명백하게밝혀져,http://www.kdpress.co.kr/news/articleView.html?idxno=96858
6806,2020-08-10,대웅제약메디톡스주장은억지;균주와제조공정도용없었다반박,http://www.kdpress.co.kr/news/articleView.html?idxno=96862
6807,2020-08-10,상반기상위제약사실적보니종근당웃음대웅제약눈물,http://www.wikileaks-kr.org/news/articleView.html?idxno=92672
6808,2020-08-10,보톡스전쟁ITC예비판결진실공방전대웅제약→메디톡스→대웅제약반박재반박,http://www.thepublic.kr/news/newsview.php?ncode=1065597158375514
6809,2020-08-10,메디톡스美ITC과학적증거와사실로대웅제약의메디톡스균주및제조공정도용혐의명백히입증,http://www.thefirstmedia.net/news/articleView.html?idxno=61491
6810,2020-08-10,대웅제약균주와제조공정도용없다메디톡스주장반박,http://www.thefirstmedia.net/news/articleView.html?idxno=61467
6811,2020-08-10,메디톡스ITC예비판결대웅제약균주도용입증,http://www.finomy.com/news/articleView.html?idxno=81519
6812,2020-08-10,땅에서채취했나훔쳤나대웅메디톡스보톡스논쟁재가열,http://health.chosun.com/site/data/html_dir/2020/08/10/2020081003412.html
6813,2020-08-10,대웅제약메디톡스보도자료반박균주와제조공정도용없어,http://www.newslock.co.kr/news/articleView.html?idxno=30204
6814,2020-08-10,대웅제약균주도용여부유전자분석으로는불가능메디톡스주장반박,http://www.updownnews.co.kr/news/articleView.html?idxno=221882
6815,2020-08-10,대웅제약ITC오판균주와제조공정도용없어,https://www.asiatoday.co.kr/view.php?key=20200810010005152
6816,2020-08-10,균주제조공정도용필요도없고동기도없다”대웅제약메디톡스주장정면반박,https://www.donga.com/news/article/all/20200810/102391541/1
6817,2020-08-10,대웅제약美ITC예비결정문메디톡스해석에재반격나서,http://www.medigatenews.com/news/1286432430
6818,2020-08-10,美ITC판결문두고메디톡스균주도용입증vs대웅억지주장,http://news.mk.co.kr/newsRead.php?no=821413&year=2020
6819,2020-08-10,메디톡스대웅제약보톡스진실공방가속화메디톡스ITC예비판결승리로절대우세,http://www.greened.kr/news/articleView.html?idxno=264623
6820,2020-08-11,대웅제약재반박ITC에제출모든자료제한없이공개하면진실가려질것최종승리자신,http://www.segye.com/content/html/2020/08/10/20200810513724.html?OutUrl=naver
6821,2020-08-11,나보타ITC판결문에다시불붙은대웅메디톡스기싸움,https://www.kpanews.co.kr/article/show.asp?idx=215286&category=D
6822,2020-08-11,대웅제약실적보다소송관련불확실성이문제,http://www.g-enews.com/ko-kr/news/article/news_all/202008110637008510442088f476_1/article.html
6823,2020-08-11,메디톡스대웅제약ITC예비판결문놓고격돌소모전심화,https://www.dailian.co.kr/news/view/911455/?sc=Naver
6824,2020-08-11,메디톡스대웅제약균주전쟁갑론을박ITC예비판결문둘러싼갈등,http://www.ntoday.co.kr/news/articleView.html?idxno=74058
6825,2020-08-11,대웅나보타북미매출2분기연속하락코로나직격탄,http://www.dailypharm.com/Users/News/NewsView.html?ID=267325&REFERER=NP
6826,2020-08-11,대웅제약코로나치료제인도임상1상승인,https://www.ebn.co.kr/news/view/1446189/?sc=Naver
6827,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247739
6828,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/08/11/2020081101000.html?utm_source=naver&utm_medium=original&utm_campaign=biz
6829,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.getnews.co.kr/view.php?ud=2020081109145347792fe691f917_16
6830,2020-08-11,대웅제약코로나19치료제인도1상승인,http://www.press9.kr/news/articleView.html?idxno=45497
6831,2020-08-11,대웅대웅제약모두상승세로특히대웅가파른상승세로5상승,http://www.econonews.co.kr/news/articleView.html?idxno=131924
6832,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=123357
6833,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.dailian.co.kr/news/view/911584/?sc=Naver
6834,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.fetv.co.kr/news/article.html?no=61144
6835,2020-08-11,대웅제약니클로사마이드 코로나19 치료제인도임상 1상승인,http://www.economytalk.kr/news/articleView.html?idxno=207490
6836,2020-08-11,대웅제약니클로사마이드임상1상인도서승인코로나19치료제후보물질,http://theviewers.co.kr/View.aspx?No=1044944
6837,2020-08-11,대웅제약니클로사마이드코로나19치료제로인도1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=71853
6838,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020081109291754287
6839,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.lawissue.co.kr/view.php?ud=202008110931106338204ead0791_12
6840,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020081109291754287
6841,2020-08-11,대웅코로나19치료제니클로사마이드인도서임상1상승인,http://health.chosun.com/site/data/html_dir/2020/08/11/2020081101111.html
6842,2020-08-11,대웅제약코로나19치료제인도서1상진행,http://www.bosa.co.kr/news/articleView.html?idxno=2132124
6843,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,https://www.hankyung.com/it/article/202008114444i
6844,2020-08-11,대웅제약인도서코로나19치료임상1상승인올해완료목표,http://moneys.mt.co.kr/news/mwView.php?no=2020081109178090159
6845,2020-08-11,대웅제약코로나19치료제인도임상1상승인,http://www.bokuennews.com/news/article.html?no=193414
6846,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.medigatenews.com/news/3051808455
6847,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.fnnews.com/news/202008110950510176
6848,2020-08-11,대웅제약인도서니클로사마이드코로나19치료제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008110115&t=NN
6849,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=72267
6850,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=44297
6851,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=50248
6852,2020-08-11,대웅제약니클로사마이드코로나19치료제인도서임상1상승인,https://www.etoday.co.kr/news/view/1928045
6853,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.pharmnews.com/news/articleView.html?idxno=101082
6854,2020-08-11,대웅제약코로나치료제19니클로사마이드인도임상1상승인,http://www.newsprime.co.kr/news/article.html?no=514051
6855,2020-08-11,대웅제약니클로사마이드코로나19치료제임상1상승인,http://www.mhj21.com/133861
6856,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인쾌거,http://www.pressm.kr/news/articleView.html?idxno=32179
6857,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=120265
6858,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020081110203285863
6859,2020-08-11,대웅제약코로나19치료제니클로사마이드인도1상승인,http://www.monews.co.kr/news/articleView.html?idxno=212656
6860,2020-08-11,대웅제약코로나19치료제니클로사마이드인도1상승인,http://www.monews.co.kr/news/articleView.html?idxno=212656
6861,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=13945
6862,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인주요선진국임상신속진행,http://www.paxetv.com/news/articleView.html?idxno=97858
6863,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상승인,http://medipana.com/news/news_viewer.asp?NewsNum=261176&MainKind=A&NewsKind=5&vCount=12&vKind=1
6864,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://newsbrite.net/140356
6865,2020-08-11,대웅제약구충제성분코로나19치료후보물질인도서임상,http://yna.kr/AKR20200811062800017?did=1195m
6866,2020-08-11,대웅제약인도에서코로나19치료제임상1상승인,http://news.mt.co.kr/mtview.php?no=2020081110335441985
6867,2020-08-11,대웅제약니클로사마이드코로나치료제인도1상승인,http://www.newsis.com/view/?id=NISX20200811_0001125394&cID=13001&pID=13000
6868,2020-08-11,대웅제약인도서니클로사마이드코로나19치료제임상1상승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=81966
6869,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.sedaily.com/NewsView/1Z6JDWL4B1
6870,2020-08-11,대웅제약코로나19치료제인도1상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001648
6871,2020-08-11,대웅제약구충제성분코로나19치료제인도임상1상승인,http://it.chosun.com/site/data/html_dir/2020/08/11/2020081101579.html
6872,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=102631
6873,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://daily.hankooki.com/lpage/industry/202008/dh20200811104532148390.htm?s_ref=nv
6874,2020-08-11,대웅제약니클로사마이드코로나치료제인도서임상승인,http://news.mk.co.kr/newsRead.php?no=822856&year=2020
6875,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.segyebiz.com/newsView/20200811509768?OutUrl=naver
6876,2020-08-11,대웅제약코로나치료제인도임상1상승인,http://www.upinews.kr/newsView/upi202008110027
6877,2020-08-11,대웅제약코로나19치료제DWRX2003인도서임상1상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065577798981961
6878,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=736909
6879,2020-08-11,대웅제약코로나19치료제인도임상1상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135188&REFERER=NP
6880,2020-08-11,대웅제약태국학회참가보툴리눔톡신나보타강의진행,http://www.consumuch.com/news/articleView.html?idxno=50169
6881,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.lawissue.co.kr/view.php?ud=202008111112378510204ead0791_12
6882,2020-08-11,대웅제약나보타태국미용성형학회서소개,http://www.medisobizanews.com/news/articleView.html?idxno=71863
6883,2020-08-11,대웅제약코로나치료제인도서임상1상승인,https://www.nocutnews.co.kr/news/5392899
6884,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=30215
6885,2020-08-11,대웅제약구충제성분코로나19치료후보물질인도서임상,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4244446
6886,2020-08-11,대웅제약나보타글로벌공략계속태국컨퍼런스강연개최,http://www.press9.kr/news/articleView.html?idxno=45501
6887,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=50260
6888,2020-08-11,대웅제약태국미용피부성형학회버추얼콘퍼런스서나보타강의진행,http://www.youthdaily.co.kr/news/article.html?no=44310
6889,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=395751
6890,2020-08-11,대웅제약태국미용학회서나보타강의진행,http://moneys.mt.co.kr/news/mwView.php?no=2020081111188081018
6891,2020-08-11,대웅제약인도서코로나19치료제임상시작,http://www.whosaeng.com/120008
6892,2020-08-11,대웅제약태국미용피부성형학회서나보타강의,http://www.bosa.co.kr/news/articleView.html?idxno=2132152
6893,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.econovill.com/news/articleView.html?idxno=407841
6894,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.healthinnews.co.kr/news/articleView.html?idxno=13953
6895,2020-08-11,대웅제약태국서나보타강의진행미국대신태국경쟁력강화하나,http://theviewers.co.kr/View.aspx?No=1045385
6896,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.getnews.co.kr/view.php?ud=2020081111460438952fe691f917_16
6897,2020-08-11,대웅제약나보타태국미용피부성형학회서경쟁력알린다,http://medipana.com/news/news_viewer.asp?NewsNum=261192&MainKind=A&NewsKind=5&vCount=12&vKind=1
6898,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.iminju.net/news/articleView.html?idxno=56132
6899,2020-08-11,대웅제약코로나19치료제임상1상인도승인받아전승호신속개발,http://www.businesspost.co.kr/BP?command=article_view&num=191312
6900,2020-08-11,대웅제약태국미용성형학회서나보타경쟁력알려,http://www.newsis.com/view/?id=NISX20200811_0001125592&cID=13001&pID=13000
6901,2020-08-11,대웅제약태국미용피부성형학회서나보타강연개최,https://www.fetv.co.kr/news/article.html?no=61179
6902,2020-08-11,대웅코로나19치료제개발속도인도임상1상승인,http://www.dailymedi.com/detail.php?number=859152&thread=22r05
6903,2020-08-11,대웅제약코로나19치료제인도임상1상승인,http://www.koreaittimes.com/news/articleView.html?idxno=99560
6904,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,https://www.news2day.co.kr/158406
6905,2020-08-11,대웅제약니클로사마이드코로나19치료제로인도1상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=215294&category=D
6906,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=31217
6907,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=31222
6908,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.metroseoul.co.kr/article/20200811500203
6909,2020-08-11,대웅대웅제약오후갑작스런상승에급등특히대웅깜짝10급등에투자자들놀라,http://www.econonews.co.kr/news/articleView.html?idxno=132026
6910,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,http://www.wikileaks-kr.org/news/articleView.html?idxno=92710
6911,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.asiatoday.co.kr/view.php?key=20200811010005700
6912,2020-08-11,뉴스투데이L대웅제약태국미용피부성형학회버추얼콘퍼런스서강연개최,https://www.news2day.co.kr/158410
6913,2020-08-11,대웅제약코로나치료제임상1상승인,http://www.skyedaily.com/news/news_view.html?ID=109951
6914,2020-08-11,대웅제약태국미용피부성형학회서나보타강연,http://www.fnnews.com/news/202008111340183301
6915,2020-08-11,대웅제약태국미용성형학회서나보타경쟁력알려,http://www.econovill.com/news/articleView.html?idxno=407856
6916,2020-08-11,대웅제약태국미용피부성형학회서나보타강연,http://www.mdtoday.co.kr/mdtoday/index.html?no=395792
6917,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,http://kormedi.com/?p=1322061
6918,2020-08-11,대웅제약니클로사마이드해외임상확대추진,http://www.koreastocknews.com/news/articleView.html?idxno=56163
6919,2020-08-11,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://newsbrite.net/140372
6920,2020-08-11,대웅제약니클로사마이드코로나19치료제인도서임상1상승인,https://news.joins.com/article/olink/23440512
6921,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62737
6922,2020-08-11,대웅제약태국미용피부성형학회서강연개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62741
6923,2020-08-11,대웅제약니클로사마이드인도서코로나19치료제임상1상승인,http://kbench.com/?q=node/213134
6924,2020-08-11,대웅제약코로나치료제니클로사마이드인도임상1상승인,http://www.mediapen.com/news/view/547835
6925,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065591016791800
6926,2020-08-11,대웅제약인도서니클로사마이드의코로나19대상임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=824288&year=2020
6927,2020-08-11,ITC예판전문공개되자또다시맞붙은메디톡스와대웅제약,http://www.m-i.kr/news/articleView.html?idxno=737014
6928,2020-08-11,대웅제약인도서코로나19치료제임상1상승인,https://view.asiae.co.kr/article/2020081114591359620
6929,2020-08-11,대웅제약태국미용피부성형학회버추얼컨버런스서나보타소개,http://www.kpinews.co.kr/news/articleView.html?idxno=123419
6930,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://inthenews.co.kr/article-63465/
6931,2020-08-11,ITC예비판결전문공개대웅메디톡스같은내용다른해석,http://mkhealth.co.kr/NEWS/01/view.php?NCode=MKH200810011
6932,2020-08-11,글로벌무대에나보타경쟁력알린다대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=414524
6933,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=414515
6934,2020-08-11,대웅제약인도서니클로사마이드코로나19임상,http://www.seoulfn.com/news/articleView.html?idxno=391714
6935,2020-08-11,구충제성분코로나19치료제임상돌입대웅제약인도서니클로사마이드임상1상승인,https://www.donga.com/news/article/all/20200811/102403197/1
6936,2020-08-11,대웅제약태국미용피부성형학회서나보타강연개최,http://www.mediapen.com/news/view/547889
6937,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.kdpress.co.kr/news/articleView.html?idxno=96874
6938,2020-08-11,대웅메디톡스보톡스논쟁에웃는휴젤2Q국내보톡스매출전년比35↑,http://www.getnews.co.kr/view.php?ud=2020081115523413292fe691f917_16
6939,2020-08-11,대웅제약태국미용피부성형학회서2ndVirtualConference강연,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247768
6940,2020-08-11,대웅제약인니합작사에포디온원액역수출1450억루피아돌파,https://www.theguru.co.kr/news/article.html?no=13192
6941,2020-08-11,대웅제약인도서코로나19치료제니클로사마이드임상1상시험승인,http://www.whitepaper.co.kr/news/articleView.html?idxno=196399
6942,2020-08-11,대웅제약니클로사마이드 코로나19 치료제인도임상 1상승인,http://www.doctorstimes.com/news/articleView.html?idxno=211903
6943,2020-08-11,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.newsian.co.kr/news/articleView.html?idxno=42664
6944,2020-08-11,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://sports.chosun.com/news/ntype.htm?id=202008120100098240006347&servicedate=20200811
6945,2020-08-11,대웅제약인도서구충제성분코로나19치료후보물질임상승인,http://www.dt.co.kr/contents.html?article_no=2020081102109931102003&ref=naver
6946,2020-08-11,대웅제약인도서코로나19치료제임상1상승인받아,http://www.finomy.com/news/articleView.html?idxno=81578
6947,2020-08-11,대웅제약코로나치료제인도임상승인획득,https://www.hankyung.com/it/article/2020081172851
6948,2020-08-11,대웅제약vs메디톡스보톡스전쟁4년마지막퍼즐은,http://www.insightkorea.co.kr/news/articleView.html?idxno=81987
6949,2020-08-11,대웅제약나보타웨비나로태국미용피부성형학회강연,http://www.medigatenews.com/news/1118183009
6950,2020-08-11,대웅제약 코로나19 치료제니클로사마이드 인도임상 1상승인,http://www.greened.kr/news/articleView.html?idxno=264793
6951,2020-08-11,대웅제약인도서코로나19치료제DWRX2003임상1상시험승인,http://www.polinews.co.kr/news/article.html?no=471500
6952,2020-08-12,대웅제약태국미용피부성형학회2ndVirtualConference에서강연개최,http://www.thefirstmedia.net/news/articleView.html?idxno=61572
6953,2020-08-12,대웅제약니클로사마이드코로나19치료제인도임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=61578
6954,2020-08-12,끝나지않는균주전쟁대웅제약메디톡스ITC예비판결문놓고또정면충돌,http://www.youthdaily.co.kr/news/article.html?no=44368
6955,2020-08-12,미ITC예비판결문공개로대웅VS메디톡스공방재점화,http://www.doctorstimes.com/news/articleView.html?idxno=211914
6956,2020-08-12,대웅제약코로나19치료제인도임상1상시험승인,http://weekly.cnbnews.com/news/article.html?no=135405
6957,2020-08-12,대웅대웅제약모두하락부진대웅제약1하락이어대웅소폭하락,http://www.econonews.co.kr/news/articleView.html?idxno=132119
6958,2020-08-12,대웅제약코로나19치료제니클로사마이드인도임상1상승인,http://www.startuptoday.co.kr/news/articleView.html?idxno=50501
6959,2020-08-12,메디톡스대웅제약보톡스전쟁에조용히웃은휴젤,http://biz.newdaily.co.kr/site/data/html/2020/08/12/2020081200051.html
6960,2020-08-12,대웅제약균주도용ITC소송본질은美국익위해K바이오죽이기,http://www.meconomynews.com/news/articleView.html?idxno=44346
6961,2020-08-12,대웅제약코로나19치료제글로벌임상박차,http://newsbrite.net/sub_read.html?uid=140415§ion=sc15
6962,2020-08-12,위키시선공세메디톡스수세대웅제약ITC최종판결은,http://www.wikileaks-kr.org/news/articleView.html?idxno=92799
6963,2020-08-12,제약업계희비유한양행종근당웃고한미대웅울고,http://www.skyedaily.com/news/news_view.html?ID=110024
6964,2020-08-12,대웅제약니클로사마이드코로나19치료제인도임상1상승인,https://www.insight.co.kr/news/298611
6965,2020-08-12,오늘의토막뉴스끝나지않는균주전쟁대웅제약메디톡스ITC예비판결문놓고또정면충돌外,http://www.youthdaily.co.kr/news/article.html?no=44486
6966,2020-08-12,대웅제약vs메디톡스ITC예비판결문놓고또다시격돌,http://www.newsway.co.kr/news/view?tp=1&ud=2020081214454824240
6967,2020-08-13,같은판결문다른요점대웅메디톡스입씨름,http://www.kukinews.com/newsView/kuk202008120320
6968,2020-08-13,배보다배꼽더큰보톡스소송대웅제약美진출에사활,https://www.asiatoday.co.kr/view.php?key=20200812010006510
6969,2020-08-13,대웅제약은보톡스판정에서왜대패했을까,https://www.nocutnews.co.kr/news/5394146
6970,2020-08-13,대웅제약니클로사마이드인도임상에NYT아사히도관심왜,http://news.mt.co.kr/mtview.php?no=2020081218243533352
6971,2020-08-13,대웅모닝컴에어프라이기인데대웅모닝컴제품이아니다,http://www.wikileaks-kr.org/news/articleView.html?idxno=92829
6972,2020-08-13,대웅대웅제약희비엇갈려대웅제약보합반해대웅1상승,http://www.econonews.co.kr/news/articleView.html?idxno=132255
6973,2020-08-13,메디톡스보톡스균주전승소자신vs대웅장기전불사,https://www.ebn.co.kr/news/view/1446612/?sc=Naver
6974,2020-08-14,대웅자회사대웅제약859억규모수출공급계약체결,https://view.asiae.co.kr/article/2020081413592159602
6975,2020-08-14,비즈헬스대웅제약VS메디톡스끝나지않는보툴리눔톡신균주전쟁ITC예비판결문놓고강하게맞붙어,http://www.bizwnews.com/news/articleView.html?idxno=20643
6976,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약,https://www.fetv.co.kr/news/article.html?no=61519
6977,2020-08-14,대웅제약브라질에펙수프라잔860억수출계약,http://www.press9.kr/news/articleView.html?idxno=45548
6978,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.lawissue.co.kr/view.php?ud=202008141402198092204ead0791_12
6979,2020-08-14,대웅제약펙수프라잔브라질과860억규모수출계약,http://www.fnnews.com/news/202008141404184373
6980,2020-08-14,대웅제약브라질에859억펙수프라잔수출계약,http://www.edaily.co.kr/news/newspath.asp?newsid=02584646625867320
6981,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약체결,http://www.ekn.kr/news/article.html?no=517335
6982,2020-08-14,대웅제약브라질제약사에860억원규모펙수프라잔수출,http://www.newspim.com/news/view/20200814000696
6983,2020-08-14,대웅제약브라질1위제약사와860억원규모펙수프라잔수출계약,http://www.viva100.com/main/view.php?key=20200814010002708
6984,2020-08-14,대웅제약859억원규모펙수프라잔수출계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=267477&REFERER=NP
6985,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.metroseoul.co.kr/article/20200814500098
6986,2020-08-14,대웅제약위식도역류질환신약브라질수출860억원규모,http://yna.kr/AKR20200814101300017?did=1195m
6987,2020-08-14,대웅제약위식도역류치료제펙수프라잔브라질수출,http://www.medisobizanews.com/news/articleView.html?idxno=71962
6988,2020-08-14,대웅제약위식도역류질환藥브라질에860억원수출,https://www.hankyung.com/it/article/202008149172i
6989,2020-08-14,대웅제약위식도역류질환약브라질에860억규모수출,http://www.newsis.com/view/?id=NISX20200814_0001130103&cID=13001&pID=13000
6990,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.mediapen.com/news/view/548886
6991,2020-08-14,대웅제약브라질에860억원규모펙수프라잔수출,http://news.mt.co.kr/mtview.php?no=2020081414270647316
6992,2020-08-14,대웅제약위식도역류질환치료제브라질수출860억원규모계약,http://www.startuptoday.co.kr/news/articleView.html?idxno=50861
6993,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약체결,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004075556
6994,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결로중남미서입지굳힌다,http://newsbrite.net/140513
6995,2020-08-14,대웅제약위식도역류질환치료제브라질에860억원어치수출계약,http://news.mk.co.kr/newsRead.php?no=839360&year=2020
6996,2020-08-14,대웅제약위식도역류질환치료제멕시코이어브라질수출길열어,http://www.econovill.com/news/articleView.html?idxno=408324
6997,2020-08-14,대웅제약펙수프라잔브라질에860억규모수출,http://www.bosa.co.kr/news/articleView.html?idxno=2132417
6998,2020-08-14,대웅제약펙수프라잔브라질과860억규모수출계약,http://www.newsway.co.kr/news/view?tp=1&ud=2020081414374214373
6999,2020-08-14,대웅제약펙수프라잔860억규모브라질수출계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247920
7000,2020-08-14,대웅펙수프라잔중남미최대시장브라질진출,http://www.bokuennews.com/news/article.html?no=193573
7001,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질진출,http://www.pinpointnews.co.kr/view.php?ud=2020081414541758382365609d9b_45
7002,2020-08-14,대웅제약위식도역류질환치료제브라질수출,http://www.dailysmart.co.kr/news/articleView.html?idxno=31401
7003,2020-08-14,공시대웅제약859억규모펙수프라잔브라질수출계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2020081415063006724
7004,2020-08-14,대웅제약펙수프라잔860억규모브라질수출계약,http://www.newsprime.co.kr/news/article.html?no=514544
7005,2020-08-14,대웅제약펙수프라잔브라질수출계약체결,https://www.ebn.co.kr/news/view/1446836/?sc=Naver
7006,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.seoulfn.com/news/articleView.html?idxno=392174
7007,2020-08-14,대웅제약펙수프라잔브라질제약사와수출계약체결,http://www.kpinews.co.kr/news/articleView.html?idxno=123704
7008,2020-08-14,위식도역류질환치료제대웅펙수프라잔브라질수출계약체결로중남미서입지굳힌다,http://www.newslock.co.kr/news/articleView.html?idxno=30306
7009,2020-08-14,대웅제약펙수프라잔중남미시장또뚤었다브라질에860억원규모수출,http://moneys.mt.co.kr/news/mwView.php?no=2020081415238067145
7010,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결로중남미서입지굳힌다,http://www.nbnnews.co.kr/news/articleView.html?idxno=415632
7011,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질로중남미입지굳혀,http://www.pressm.kr/news/articleView.html?idxno=32374
7012,2020-08-14,대웅제약브라질에펙수프라잔7300만수출계약,https://www.sedaily.com/NewsView/1Z6KRT57ZE
7013,2020-08-14,대웅제약위식도역류질환치료제브라질수출계약약860억원규모,https://www.donga.com/news/article/all/20200814/102454750/1
7014,2020-08-14,대웅제약펙수프라잔브라질진출7300만달러수출계약,https://www.etoday.co.kr/news/view/1929721
7015,2020-08-14,대웅제약브라질에860억규모수출계약체결,http://www.koreastocknews.com/news/articleView.html?idxno=56306
7016,2020-08-14,대웅제약펙수프라잔브라질에950억규모수출계약,http://www.koreaittimes.com/news/articleView.html?idxno=99691
7017,2020-08-14,대웅제약860억원규모펙수프라잔브라질수출계약체결,http://www.youthdaily.co.kr/news/article.html?no=44728
7018,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔수출860억원규모,http://www.smartfn.co.kr/view.php?ud=20200814145552367d5d29c6899_46
7019,2020-08-14,대웅제약브라질제약사와위식도역류질환치료제수출계약체결,http://www.businesspost.co.kr/BP?command=article_view&num=191924
7020,2020-08-14,대웅제약펙수프라잔브라질수출계약체결로중남미서입지굳힌다,http://www.healthinnews.co.kr/news/articleView.html?idxno=14010
7021,2020-08-14,대웅제약펙수프라잔860억규모브라질수출계약체결,http://www.newstomato.com/ReadNews.aspx?no=990333
7022,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=61714
7023,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.getnews.co.kr/view.php?ud=2020081415594713752fe691f917_16
7024,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약,http://www.anewsa.com/detail.php?number=2200024&thread=10
7025,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,https://www.asiatoday.co.kr/view.php?key=20200814010007866
7026,2020-08-14,대웅제약브라질제약사와펙수프라잔수출계약860억원규모,http://www.sisafocus.co.kr/news/articleView.html?idxno=245642
7027,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62827
7028,2020-08-14,대웅브라질에펙수프라잔860억대수출계약,http://www.dailymedi.com/detail.php?number=859289&thread=22r05
7029,2020-08-14,대웅제약펙수프라잔브라질EMS와860억규모수출계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=396203
7030,2020-08-14,대웅제약위식도역류질환치료제펙수프라잔브라질수출,http://www.finomy.com/news/articleView.html?idxno=81740
7031,2020-08-14,대웅제약브라질에860억규모신약수출,https://news.chosun.com/site/data/html_dir/2020/08/14/2020081403253.html?utm_source=naver&utm_medium=original&utm_campaign=news
7032,2020-08-14,대웅제약위식도역류질환신약펙수프라잔브라질수출,http://it.chosun.com/site/data/html_dir/2020/08/14/2020081403255.html
7033,2020-08-14,대웅제약펙수프라잔브라질진출위식도역류질환치료제PPI약물,http://theviewers.co.kr/View.aspx?No=1051435
7034,2020-08-14,대웅제약위식도역류질환치료제브라질진출,http://www.100ssd.co.kr/news/articleView.html?idxno=70768
7035,2020-08-14,대웅펙수프라잔브라질에860억원수출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94260
7036,2020-08-14,10대제약사중8곳상반기매출증가대웅중외제약적자전환,http://www.consumernews.co.kr/news/articleView.html?idxno=610197
7037,2020-08-14,대웅제약펙수프라잔브라질수출계약체결,http://www.wsobi.com/news/articleView.html?idxno=102876
7038,2020-08-14,대웅제약펙수프라잔브라질7300만弗수출계약,http://www.biospectator.com/view/news_view.php?varAtcId=11087
7039,2020-08-15,기업공시8월14일대웅제약펙수프라잔브라질과860억규모수출계약등,https://www.sedaily.com/NewsView/1Z6L6WOEXO
7040,2020-08-15,연재기획④대웅제약vs메디톡스톺아보기공정기술력차이로희비교차,http://newsclaim.co.kr/View.aspx?No=1051542
7041,2020-08-15,뉴스브리핑8월15일의협2차파업예고대웅제약위식도역류질환신약펙수프라잔브라질수출,http://it.chosun.com/site/data/html_dir/2020/08/14/2020081403390.html
7042,2020-08-15,대웅제약브라질에펙수프라잔860억원수출계약체결,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001797
7043,2020-08-15,대웅제약펙수프라잔중남미최대시장브라질간다860억원규모계약달성,http://www.thepublic.kr/news/newsview.php?ncode=1065596770938898
7044,2020-08-15,대웅제약위식도역류질환치료제펙수프라잔브라질수출계약체결,http://www.polinews.co.kr/news/article.html?no=471903
7045,2020-08-16,대웅제약위식도역류질환치료제펙수프라잔브라질에860억규모수출멕시코이은두번째중남미진출,http://www.econonews.co.kr/news/articleView.html?idxno=132637
7046,2020-08-16,대웅제약신약수출진단키트코로나임상으로돌파구찾나,http://www.mediapen.com/news/view/549209
7047,2020-08-17,대웅바이오경보원료리딩그룹굳건해외매출순항,http://www.dailypharm.com/Users/News/NewsView.html?ID=267509&REFERER=NP
7048,2020-08-17,K바이오역군대웅나보타글로벌진출속도,http://www.dailypharm.com/Users/News/NewsView.html?ID=267476&REFERER=NP
7049,2020-08-17,대웅제약의중남미드림위식도역류질환약펙수프라잔멕시코이어브라질에860억수출,http://www.globale.co.kr/news/articleView.html?idxno=10859
7050,2020-08-17,균주전쟁美ITC예비판결문공개에대웅제약발끈,http://news.mk.co.kr/v2/economy/view.php?year=2020&no=844540
7051,2020-08-17,대웅제약상반기매출5113억81영업익93감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247957
7052,2020-08-17,단독보툴리눔균주한국서찾았다대웅주장은닭똥같은이야기,http://news.mk.co.kr/newsRead.php?no=845825&year=2020
7053,2020-08-17,전승호대웅제약위기를위식도역류질환치료제로활로만들기온힘,http://www.businesspost.co.kr/BP?command=article_view&num=192137
7054,2020-08-18,대웅제약브라질에860억규모펙수프라잔수출중남미입지굳히기,http://www.newsian.co.kr/news/articleView.html?idxno=42763
7055,2020-08-18,뉴욕증시제약바이오옥석가리기메디톡스SK케미칼대웅제약엇갈리는운명,http://www.g-enews.com/ko-kr/news/article/news_all/202008172018575004a01bf698f_1/article.html
7056,2020-08-18,오늘의제약한미약품GC녹십자셀트리온제약대웅제약광동제약,http://www.babytimes.co.kr/news/articleView.html?idxno=38688
7057,2020-08-18,대웅제약마구간서균주발견전혀확인안된잘못된사실,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=247981
7058,2020-08-18,대웅제약균주출처논란에또다시반박사실왜곡지적,http://medipana.com/news/news_viewer.asp?NewsNum=261483&MainKind=A&NewsKind=5&vCount=12&vKind=1
7059,2020-08-18,대웅제약닭똥같은이야기기사는보툴리눔균주악의적보도,http://www.medisobizanews.com/news/articleView.html?idxno=72014
7060,2020-08-18,대웅ITC불공정수입조사국의견서왜곡편향,http://www.dailypharm.com/Users/News/NewsView.html?ID=267532&REFERER=NP
7061,2020-08-18,대웅제약대웅주장닭똥같은이야기보도악의적인왜곡해석,http://www.newslock.co.kr/news/articleView.html?idxno=30347
7062,2020-08-18,대웅제약균주와제조공정도용없어메디톡스보도자료반박,http://www.nbnnews.co.kr/news/articleView.html?idxno=416317
7063,2020-08-18,녹십자대웅등진단키트후발주자해외유통망확보경쟁,http://www.mediapen.com/news/view/549730
7064,2020-08-18,대웅제약균주관련닭똥보도반박기존입장인데새로운내용처럼오인”,https://www.donga.com/news/article/all/20200818/102538588/1
7065,2020-08-18,대웅제약균주출처논란에재반박사실왜곡했다,https://www.dailian.co.kr/news/view/913233/?sc=Naver
7066,2020-08-18,대웅제약균주출처논란에악의적으로왜곡”반박,http://www.mdtoday.co.kr/mdtoday/index.html?no=396445
7067,2020-08-19,CEO리뷰1조클럽마술사대웅제약전승호신약개발가속패달밟는다,https://www.fetv.co.kr/news/article.html?no=61588
7068,2020-08-20,대웅제약파스퇴르硏원자력의학원코로나19치료제해외임상계약,http://daily.hankooki.com/lpage/industry/202008/dh20200820092801148390.htm?s_ref=nv
7069,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248087
7070,2020-08-20,카모스타트개발잰걸음대웅제약한국파스퇴르원자력의학원과맞손,https://www.fetv.co.kr/news/article.html?no=61806
7071,2020-08-20,대웅제약카모스타트코로나19치료제글로벌개발속도,http://www.viva100.com/main/view.php?key=20200820010003553
7072,2020-08-20,오늘의제약대웅제약셀트리온광동제약19일동화약품19일,http://www.babytimes.co.kr/news/articleView.html?idxno=38746
7073,2020-08-20,대웅제약∙파스퇴르연구소∙원자력의학원코로나19치료제해외연구자임상계약,https://biz.chosun.com/site/data/html_dir/2020/08/20/2020082000979.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7074,2020-08-20,대웅제약코로나19치료물질카모스타트글로벌개발,http://www.medisobizanews.com/news/articleView.html?idxno=72074
7075,2020-08-20,대웅파스퇴르연구소원자력의학원코로나19치료제글로벌개발협력나서,http://www.ekn.kr/news/article.html?no=518263
7076,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.press9.kr/news/articleView.html?idxno=45597
7077,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속화,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202008200101&t=NN
7078,2020-08-20,단독인터뷰전승호대웅제약대표ITC예비판결뒤죽박죽최종서뒤집힐것,https://view.asiae.co.kr/article/2020082009463912999
7079,2020-08-20,코로나19치료제백신생산장비지원기관지정소식유나이티드제약GC녹십자대웅제약등,http://www.ccreview.co.kr/news/articleView.html?idxno=279301
7080,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573505571742
7081,2020-08-20,대웅제약카모스타트성분코로나19치료제개발속도낸다,http://www.getnews.co.kr/view.php?ud=2020082009513519692fe691f917_16
7082,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://inthenews.co.kr/article-64865/
7083,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속화,http://www.newsprime.co.kr/news/article.html?no=514937
7084,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발가속화,http://medipana.com/news/news_viewer.asp?NewsNum=261607&MainKind=A&NewsKind=5&vCount=12&vKind=1
7085,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.lawissue.co.kr/view.php?ud=202008200955544418204ead0791_12
7086,2020-08-20,대웅제약코로나19치료제카모스타트글로벌연구박차,http://www.sisafocus.co.kr/news/articleView.html?idxno=245949
7087,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진,http://yna.kr/AKR20200820051900017?did=1195m
7088,2020-08-20,대웅제약코로나19치료제카모스타트해외연구자임상계약체결,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=120617
7089,2020-08-20,대웅제약카모스타트코로나19치료제글로벌개발박차,http://www.newstomato.com/ReadNews.aspx?no=991173
7090,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,https://www.dailian.co.kr/news/view/913591/?sc=Naver
7091,2020-08-20,대웅제약카모스타트글로벌개발가속화나선다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=62894
7092,2020-08-20,대웅제약코로나19치료제카모스타트글로벌개발속도,https://www.etoday.co.kr/news/view/1931339
7093,2020-08-20,대웅제약호이스타정해외연구자임상계약체결임상2상시험착수,http://www.healthinnews.co.kr/news/articleView.html?idxno=14061
7094,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진,http://yna.kr/PYH20200820038400017?did=1196m
7095,2020-08-20,대웅제약코로나19치료제해외연구자임상협약체결,http://www.kpinews.co.kr/news/articleView.html?idxno=123996
7096,2020-08-20,대웅제약카모스타트코로나19치료제글로벌개발속도,http://news.mt.co.kr/mtview.php?no=2020082009591142161
7097,2020-08-20,대웅제약코로나19치료제공동연구계약협약식체결,http://www.pharmnews.com/news/articleView.html?idxno=101146
7098,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://newsbrite.net/140660
7099,2020-08-20,대웅제약카모스타트코로나19치료제로글로벌임상가속화,http://moneys.mt.co.kr/news/mwView.php?no=2020082009438065849
7100,2020-08-20,대웅제약코로나19치료제호이스타정해외연구자임상계약,http://it.chosun.com/site/data/html_dir/2020/08/20/2020082001234.html
7101,2020-08-20,대웅제약파스퇴르연구소원자력의학원코로나19대상카모스타트해외임상맞손,http://news.mk.co.kr/newsRead.php?no=856335&year=2020
7102,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.economytalk.kr/news/articleView.html?idxno=207639
7103,2020-08-20,대웅제약카모스타트글로벌임상가속화,http://www.mhj21.com/134187
7104,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,https://www.hankyung.com/finance/article/202008206341i
7105,2020-08-20,대웅제약카모스타트코로나치료글로벌개발박차,http://www.newsis.com/view/?id=NISX20200820_0001135667&cID=13001&pID=13000
7106,2020-08-20,대웅제약카모스타트코로나19치료제개발가속화공동연구협력관계구축”,http://www.youthdaily.co.kr/news/article.html?no=45154
7107,2020-08-20,대웅카모스타트코로나치료제로해외임상추진,http://www.dailypharm.com/Users/News/NewsView.html?ID=267615&REFERER=NP
7108,2020-08-20,대웅제약카모스타트글로벌개발가속화,http://news.mk.co.kr/newsRead.php?no=856532&year=2020
7109,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=31575
7110,2020-08-20,대웅제약코로나19치료제호이스타정해외임상추진,http://www.pinpointnews.co.kr/view.php?ud=202008201057225020266f8e1a9f_45
7111,2020-08-20,대웅제약한국파스퇴르연구소한국원자력의학원과카모스타트개발협력코로나19치료효과도기대,http://theviewers.co.kr/View.aspx?No=1055216
7112,2020-08-20,대웅제약호이스타정임상2상시험착수하반기3상시험진입목표,http://www.leaders.kr/news/articleView.html?idxno=209557
7113,2020-08-20,대웅제약코로나치료제해외연구자임상계약체결,https://www.ebn.co.kr/news/view/1447436/?sc=Naver
7114,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://kormedi.com/?p=1322613
7115,2020-08-20,대웅코로나19치료제호이스타정글로벌개발추진,http://www.dailymedi.com/detail.php?number=859502&thread=22r05
7116,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=61910
7117,2020-08-20,대웅췌장염치료제해외서코로나19치료제연구자임상,https://view.asiae.co.kr/article/2020082013422833058
7118,2020-08-20,대웅제약카모스타트글로벌개발가속화나선다,http://www.bosa.co.kr/news/articleView.html?idxno=2132709
7119,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진협약,http://www.smartfn.co.kr/view.php?ud=202008201357458531d5d29c6899_46
7120,2020-08-20,대웅제약카모스타트코로나19치료제개발가속화,http://www.newsway.co.kr/news/view?tp=1&ud=2020082014092300222
7121,2020-08-20,대웅제약코로나19치료제카모스타트글로벌공동연구관련협력관계구축,http://www.updownnews.co.kr/news/articleView.html?idxno=222215
7122,2020-08-20,대웅제약∙한국파스퇴르연구소∙한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=417083
7123,2020-08-20,대웅제약코로나19치료제카모스타트글로벌연구협력나서,http://www.monews.co.kr/news/articleView.html?idxno=212842
7124,2020-08-20,대웅제약코로나치료제카모스타트개발잰걸음,http://www.whosaeng.com/120219
7125,2020-08-20,대웅제약파스퇴르연구소코로나19치료제해외연구자임상계약체결,http://www.koreaittimes.com/news/articleView.html?idxno=99798
7126,2020-08-20,대웅제약코로나19치료제카모스타트개발박차,http://www.mediapen.com/news/view/550375
7127,2020-08-20,구충제다음은식도염치료제”대웅제약카모스타트코로나19치료제글로벌임상박차,https://www.donga.com/news/article/all/20200820/102575420/1
7128,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.shinailbo.co.kr/news/articleView.html?idxno=1311447
7129,2020-08-20,뉴스투데이L대웅제약한국파스퇴르연구소한국원자력의학원과코로나19치료제공동연구계약체결,https://www.news2day.co.kr/158991
7130,2020-08-20,대웅제약코로나19치료제호이스타정해외연구자임상개발위한공동연구계약협약,http://www.paxetv.com/news/articleView.html?idxno=98508
7131,2020-08-20,대웅제약호이스타정코로나19치료제해외임상추진,http://sports.chosun.com/news/ntype.htm?id=202008210100179660011905&servicedate=20200820
7132,2020-08-20,대웅제약한국파스퇴르연구소한국원자력의학원코로나19치료제해외연구자임상계약체결,http://www.anewsa.com/detail.php?number=2204328&thread=10
7133,2020-08-20,대웅제약코로나치료제해외임상추진,http://www.dt.co.kr/contents.html?article_no=2020082102101031102001&ref=naver
7134,2020-08-20,대웅제약파스퇴르연원자력의학원호이스타코로나19치료제공동연구,https://www.kpanews.co.kr/article/show.asp?idx=215518&category=D
7135,2020-08-20,대웅제약코로나19치료제해외연구자임상계약체결,http://www.bokuennews.com/news/article.html?no=193740
7136,2020-08-20,대웅제약코로나치료제카모스타트상용화박차,http://www.meconomynews.com/news/articleView.html?idxno=44664
7137,2020-08-20,대웅제약코로나19치료제호이스타정해외연구자임상협약체결,http://www.newslock.co.kr/news/articleView.html?idxno=30427
7138,2020-08-21,대웅제약이온채널플랫폼키운다아이엔테라퓨틱스설립,http://www.ceoscoredaily.com/news/article.html?no=72503
7139,2020-08-21,대웅제약코로나19치료제호이스타정개발박차,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2001974
7140,2020-08-21,기자수첩대웅제약은정말보톡스균주를훔치지않았나,http://moneys.mt.co.kr/news/mwView.php?no=2020082018198037701
7141,2020-08-21,속보정부녹십자대웅제약등코로나19임상비지원결정,https://www.hankyung.com/it/article/202008210503i
7142,2020-08-21,대웅제약한국파스퇴르연구소한국원자력의학원코로나19치료제해외연구자공동연구계약협약,http://www.wsobi.com/news/articleView.html?idxno=103152
7143,2020-08-21,제넥신대웅제약진원생명과학주가오후급반등↑정부코로나백신개발지원,http://kpenews.com/View.aspx?No=1056700
7144,2020-08-21,GC녹십자대웅신풍SK등에코로나19치료제개발비지원,http://www.medisobizanews.com/news/articleView.html?idxno=72122
7145,2020-08-22,글로벌Biz24대웅인피온코로나19치료제임상시험속도인니서줄기세포기반DWP710출시,http://www.g-enews.com/ko-kr/news/article/news_all/202008221042426622500a1b5d6_1/article.html
7146,2020-08-23,대웅제약매출1조올해는흔들전승호건강기능식품에서만회노려,http://www.businesspost.co.kr/BP?command=article_view&num=192896
7147,2020-08-24,올상반기RD투자한미유한대웅녹십자종근당順,http://www.dailymedi.com/detail.php?number=859601&thread=22r05
7148,2020-08-24,대웅제약등주요제약사영업직재택근무전환의약품유통업체는꿈도못꿔,http://theviewers.co.kr/View.aspx?No=1058331
7149,2020-08-25,누드비치서코로나집단감염도진원생명과학녹십자대웅제약신풍제약제넥신주가폭발,http://www.pinpointnews.co.kr/view.php?ud=202008250509171665861beb2d9d_45
7150,2020-08-25,美피부과전문의들ITC에대웅나보타지지의견제출,http://www.dailypharm.com/Users/News/NewsView.html?ID=267736&REFERER=NP
7151,2020-08-25,특징주제넥신SK바이오사이언스진원생명과학코로나19백신개발정부지원소식에급등셀트리온녹십자대웅제약치료제부문도,http://www.ccreview.co.kr/news/articleView.html?idxno=280411
7152,2020-08-25,더벨대웅제약JV스핀오프신약개발통로다변화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202008241452599160103477
7153,2020-08-25,단독메디톡스vs대웅제약보톡스전쟁전체업계후폭풍,http://www.edaily.co.kr/news/newspath.asp?newsid=02312406625870928
7154,2020-08-25,대웅수난시대당뇨약판매계약취소위기,https://www.paxnetnews.com/articles/64530
7155,2020-08-25,대웅대웅제약같은상승세지만흐름달라특히대웅오후갑작스런11급등,http://www.econonews.co.kr/news/articleView.html?idxno=133839
7156,2020-08-25,대웅제약코로나19극복을위한노력치료제개발위해총력,http://www.anewsa.com/detail.php?number=2207931&thread=10
7157,2020-08-26,연매출1000억앞둔제미글로LG대웅결별합의점찾을까,http://medipana.com/news/news_viewer.asp?NewsNum=261844&MainKind=A&NewsKind=5&vCount=12&vKind=1
7158,2020-08-26,연이은악재대웅제약이번엔LG로부터당뇨약계약해지통보,http://www.sisajournal-e.com/news/articleView.html?idxno=222749
7159,2020-08-26,대웅제약개방형협력확대로스타트업액셀러레이팅육성,http://www.economytalk.kr/news/articleView.html?idxno=207747
7160,2020-08-26,대웅제약흔들리는1조클럽위상만회전략은,http://www.mediapen.com/news/view/551768
7161,2020-08-26,대웅제약엑셀러레이터사업으로오픈콜라보레이션확대,http://www.metroseoul.co.kr/article/20200826500374
7162,2020-08-26,대웅제약엑셀러레이터사업으로오픈콜라보레이션확대,http://www.metroseoul.co.kr/article/20200826500388
7163,2020-08-26,발달장애인위한코로나정보책나왔다대웅제약알기쉽게제작,http://www.meconomynews.com/news/articleView.html?idxno=44809
7164,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614309
7165,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614308
7166,2020-08-26,대웅제약국회산업통상자원중소벤처기업위원회위원장상수상,http://www.newsis.com/view/?id=NISI20200826_0016614346
7167,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614349
7168,2020-08-26,국회산업통상자원중소벤처기업위원장상수상한대웅제약,http://www.newsis.com/view/?id=NISI20200826_0016614368
7169,2020-08-26,뉴시스2020한류엑스포나보타로미국진출대웅제약K바이오미래위해노력하겠다,http://www.newsis.com/view/?id=NISX20200826_0001143703&cID=13001&pID=13000
7170,2020-08-26,뉴시스2020한류엑스포기업대상에LG생건농심CJ제일제당대웅제약하이트진로,http://www.newsis.com/view/?id=NISX20200826_0001143722&cID=13001&pID=13000
7171,2020-08-26,대웅제약2020뉴시스KEXPO한류기업대상수상,http://www.newsis.com/view/?id=NISI20200826_0016614385
7172,2020-08-27,대웅제약해외법인흑자전환성장세뚜렷,http://www.press9.kr/news/articleView.html?idxno=45653
7173,2020-08-27,LG화학대웅제약에당뇨치료제제미글로공동마케팅계약해지통보,http://www.mdtoday.co.kr/mdtoday/index.html?no=397163
7174,2020-08-27,대웅제약품질고도화도입지원기업선정,http://www.press9.kr/news/articleView.html?idxno=45655
7175,2020-08-27,대웅제약식약처로부터품질고도화QbD도입지원기업선정,https://biz.chosun.com/site/data/html_dir/2020/08/27/2020082700943.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7176,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248357
7177,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020082709055540106
7178,2020-08-27,대웅제약 식약처품질고도화QbD 도입지원기업선정,http://www.greened.kr/news/articleView.html?idxno=266834
7179,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업에선정,http://www.koreaittimes.com/news/articleView.html?idxno=99945
7180,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.mediapen.com/news/view/552024
7181,2020-08-27,대웅제약식약처품질고도화도입지원기업에선정,http://yna.kr/AKR20200827042800017?did=1195m
7182,2020-08-27,대웅제약식약처품질고도화시스템지원기업선정,https://www.hankyung.com/it/article/202008271447i
7183,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.anewsa.com/detail.php?number=2209292&thread=10
7184,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,https://www.fetv.co.kr/news/article.html?no=62277
7185,2020-08-27,대웅제약식약처의약품설계기반품질고도화시스템도입지원기업으로선정,http://newsbrite.net/140922
7186,2020-08-27,대웅제약의약품품질고도화식약처QbD지원기업으로선정,https://www.etoday.co.kr/news/view/1933947
7187,2020-08-27,대웅제약의약품품질경쟁력강화QbD도입지원기업선정,http://www.viva100.com/main/view.php?key=20200827010004914
7188,2020-08-27,식약처대웅제약에전문컨설팅사업지원의약품품질강화한다,http://moneys.mt.co.kr/news/mwView.php?no=2020082709038077650
7189,2020-08-27,대웅제약식약처맞춤형QbD전문컨설팅지원기업선정,http://www.medisobizanews.com/news/articleView.html?idxno=72251
7190,2020-08-27,대웅제약QbD기반으로최고품질의약품개발나선다”,http://www.youthdaily.co.kr/news/article.html?no=45826
7191,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.bokuennews.com/news/article.html?no=193944
7192,2020-08-27,대웅제약식약처의맞춤형QbD전문컨설팅지원대상으로선정돼,http://news.mk.co.kr/newsRead.php?no=881480&year=2020
7193,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://news.mk.co.kr/newsRead.php?no=881494&year=2020
7194,2020-08-27,대웅제약QbD기반최고품질의약품개발나서,http://medipana.com/news/news_viewer.asp?NewsNum=261912&MainKind=A&NewsKind=5&vCount=12&vKind=1
7195,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020082709210148524
7196,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.ekn.kr/news/article.html?no=519548
7197,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=31863
7198,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.m-i.kr/news/articleView.html?idxno=741061
7199,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.biospectator.com/view/news_view.php?varAtcId=11168
7200,2020-08-27,대웅제약식약처품질고도화시스템지원기업으로선정,http://it.chosun.com/site/data/html_dir/2020/08/27/2020082701208.html
7201,2020-08-27,대웅제약QbD기반최고품질의의약품개발,http://www.newsprime.co.kr/news/article.html?no=515713
7202,2020-08-27,대웅제약식약처QbD도입지원기업선정,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572536477688
7203,2020-08-27,대웅제약식약처부터품질고도화도입지원기업선정,http://www.beyondpost.co.kr/view.php?ud=20200827094430595fb6e4c4ee4_30
7204,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.dailymedi.com/detail.php?number=859766&thread=22r05
7205,2020-08-27,대웅제약식약처품질고도화지원기업선정,http://www.seoulfn.com/news/articleView.html?idxno=393259
7206,2020-08-27,대웅제약식약처품질고도화도입지원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94518
7207,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.marketnews.co.kr/news/articleView.html?idxno=50796
7208,2020-08-27,대웅제약식약처품질고도화도입지원기업선정의약품불량률감소,http://theviewers.co.kr/View.aspx?No=1064030
7209,2020-08-27,대웅제약의약품품질고도화컨설팅업체선정,http://www.dt.co.kr/contents.html?article_no=2020082702109931102001&ref=naver
7210,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업에선정,http://www.datasom.co.kr/news/articleView.html?idxno=108066
7211,2020-08-27,전승호사장대웅제약QbD전문기업선정글로벌품질강화,http://www.wikileaks-kr.org/news/articleView.html?idxno=93679
7212,2020-08-27,대웅제약식약처품질고도화시스템지원기업으로선정,http://inthenews.co.kr/article-66126/
7213,2020-08-27,대웅제약의약품품질고도화도입지원기업선정,http://www.econovill.com/news/articleView.html?idxno=409642
7214,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.pressm.kr/news/articleView.html?idxno=32677
7215,2020-08-27,대웅제약식약처QbD지원기업선정고품질의약품개발,http://www.medigatenews.com/news/2434910577
7216,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업에선정,http://news.mt.co.kr/mtview.php?no=2020082710311143760
7217,2020-08-27,대웅제약식약처QbD도입지원기업선정최고품질의약품개발할것,http://www.sisaweek.com/news/articleView.html?idxno=137031
7218,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1410463
7219,2020-08-27,대웅제약맞춤형QbD전문컨설팅사업지원기업선정,http://www.kpinews.co.kr/news/articleView.html?idxno=124508
7220,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=14166
7221,2020-08-27,대웅제약최고품질의약품개발에한발더,http://www.bosa.co.kr/news/articleView.html?idxno=2133129
7222,2020-08-27,뉴스투데이L대웅제약식약처맞춤형QbD전문컨설팅사업지원기업선정,https://www.news2day.co.kr/159419
7223,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.metroseoul.co.kr/article/20200827500091
7224,2020-08-27,대웅제약QbD기반최고품질의약품개발가속,http://www.dailypharm.com/Users/News/NewsView.html?ID=267846&REFERER=NP
7225,2020-08-27,대웅제약QbD기반최고품질의의약품개발나선다,http://www.insightkorea.co.kr/news/articleView.html?idxno=82357
7226,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=397270
7227,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,https://www.ebn.co.kr/news/view/1448318/?sc=Naver
7228,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=50954
7229,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,https://jhealthmedia.joins.com/article/article_view.asp?pno=22289
7230,2020-08-27,대웅제약식약처QbD도입지원기업으로선정,http://weekly.cnbnews.com/news/article.html?no=135656
7231,2020-08-27,대웅제약식약처QbD도입지원기업선정,http://www.whosaeng.com/120382
7232,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.mhj21.com/134316
7233,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63010
7234,2020-08-27,의약품도품질시대대웅제약글로벌수준으로강화,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135512&REFERER=NP
7235,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.paxetv.com/news/articleView.html?idxno=98884
7236,2020-08-27,제약오늘일동히알테크히알루론산제조법특허취득대웅제약식약처품질고도화QbD도입지원기업선정,http://www.sisaon.co.kr/news/articleView.html?idxno=117302
7237,2020-08-27,대웅한국파마국내QbD도입의선봉장될까,https://www.kpanews.co.kr/article/show.asp?idx=215654&category=C
7238,2020-08-27,대웅제약품질고도화QbD도입지원기업선정,http://www.pinpointnews.co.kr/view.php?ud=2020082712335321642365609d9b_45
7239,2020-08-27,대웅제약식약처품질고도화도입지원기업에선정,https://www.dailian.co.kr/news/view/915287/?sc=Naver
7240,2020-08-27,대웅제약식약처의약품설계기반품질고도화도입지원기업선정,http://www.newslock.co.kr/news/articleView.html?idxno=30581
7241,2020-08-27,대웅제약식약처의의약품설계기반품질고도화지원받아,http://www.businesspost.co.kr/BP?command=article_view&num=193503
7242,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=419238
7243,2020-08-27,오늘의제약에스티팜광동제약대웅제약한미약품26일,http://www.babytimes.co.kr/news/articleView.html?idxno=38922
7244,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://sports.hankooki.com/lpage/economy/202008/sp20200827142843137020.htm?s_ref=nv
7245,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.thefirstmedia.net/news/articleView.html?idxno=62277
7246,2020-08-27,대웅제약식약처품질고도화도입지원기업선정,http://www.koreastocknews.com/news/articleView.html?idxno=56640
7247,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://daily.hankooki.com/lpage/industry/202008/dh20200827145910148390.htm?s_ref=nv
7248,2020-08-27,대웅제약식약처QbD통해의약품경쟁력강화,http://www.skyedaily.com/news/news_view.html?ID=110917
7249,2020-08-27,대웅제약의약품품질고도화컨설팅지원기업선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1314058
7250,2020-08-27,대웅제약식약처로부터품질고도화QbD도입지원기업선정,http://www.newstomato.com/ReadNews.aspx?no=992682
7251,2020-08-27,김창수의e뉴스브리핑대웅제약식약처품질고도화도입지원기업선정外,https://www.fetv.co.kr/news/article.html?no=62355
7252,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.lawissue.co.kr/view.php?ud=202008271752002979204ead0791_12
7253,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정,http://www.worktoday.co.kr/news/articleView.html?idxno=9701
7254,2020-08-27,대웅제약식약처품질고도화QbD도입지원기업선정최고품질의약품개발박차”,https://www.donga.com/news/article/all/20200827/102680920/1
7255,2020-08-27,대웅제약맞춤형QbD전문컨설팅사업최종선정경쟁력↑불량률↓,http://www.100ssd.co.kr/news/articleView.html?idxno=70994
7256,2020-08-28,대웅제약ITC소송패소시에볼루스CB날릴판,https://www.paxnetnews.com/articles/64625
7257,2020-08-28,대웅제약품질고도화도입지원기업선정,http://www.monews.co.kr/news/articleView.html?idxno=213041
7258,2020-08-28,SK케미칼대웅제약스카이조스터공동판매종료,http://www.dailypharm.com/Users/News/NewsView.html?ID=267908&REFERER=NP
7259,2020-08-28,전승호대웅제약반전의발판으로코로나19치료제개발희망품어,http://www.businesspost.co.kr/BP?command=article_view&num=193721
7260,2020-08-29,SKLG대웅등국내대형제약사영업공동전선에변화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002252
7261,2020-08-29,연재기획⑤대웅제약vs메디톡스톺아보기ITC소송의향방은,http://newsclaim.co.kr/View.aspx?No=1066025
7262,2020-08-31,인터뷰대웅제약대표보톡스균주ITC분쟁美엘러간의반독점행위에서시작,https://biz.chosun.com/site/data/html_dir/2020/08/30/2020083001895.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7263,2020-08-31,대웅제약펙수프라잔자신있다지만적자늪탈출할까,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020082816264755027
7264,2020-08-31,K바이오100선대웅이안은한올바이오파마바이오신약갈증푼다,http://www.econovill.com/news/articleView.html?idxno=408822
7265,2020-08-31,대웅제약니클로사마이드신종코로나치료제개발에주목,http://newsbrite.net/sub_read.html?uid=141066§ion=sc74
7266,2020-09-01,삼성바이오로직스첫1조클럽입성유력대웅제약은글쎄,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090111362414390
7267,2020-09-01,대웅제약안풀리네하반기먹구름잔뜩,http://www.sporbiz.co.kr/news/articleView.html?idxno=466801
7268,2020-09-01,대웅제약보톡스소송대형품목판권등악재돌파할까,http://news.mk.co.kr/newsRead.php?no=901672&year=2020
7269,2020-09-01,JW신약대웅제약담당의료기관에스카이조스터판매한다,http://www.mdtoday.co.kr/mdtoday/index.html?no=397835
7270,2020-09-02,대웅제약발달장애인위한참지마요프로젝트로사회공헌활동전개,http://www.businesskorea.co.kr/news/articleView.html?idxno=51192
7271,2020-09-02,대웅제약개방형협력으로경쟁력강화박차,https://www.ebn.co.kr/news/view/1449175/?sc=Naver
7272,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.sentv.co.kr/news/view/578699
7273,2020-09-03,대웅제약파트너사이온바이오파마보툴리눔톡신美FDA임상2상승인,http://daily.hankooki.com/lpage/industry/202009/dh20200903090717148390.htm?s_ref=nv
7274,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,https://www.fetv.co.kr/news/article.html?no=62767
7275,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248595
7276,2020-09-03,이온바이오파마경부근긴장이상임상2상美FDA승인획득대웅미진출본격화,http://www.ekn.kr/news/article.html?no=520949
7277,2020-09-03,대웅제약미국보툴리눔톡신치료시장진출내년임상2상시작,https://www.etoday.co.kr/news/view/1936674
7278,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.youthdaily.co.kr/news/article.html?no=46507
7279,2020-09-03,대웅제약美보톡스치료시장목표임상2상내년시작,http://moneys.mt.co.kr/news/mwView.php?no=2020090309068081830
7280,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://medipana.com/news/news_viewer.asp?NewsNum=262250&MainKind=A&NewsKind=5&vCount=12&vKind=1
7281,2020-09-03,대웅제약미국보툴리눔톡신치료시장진출,http://www.press9.kr/news/articleView.html?idxno=45715
7282,2020-09-03,대웅제약美보툴리눔톡신치료시장진출가속페달,http://www.newsis.com/view/?id=NISX20200903_0001152913&cID=13001&pID=13000
7283,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://news.mt.co.kr/mtview.php?no=2020090309161331634
7284,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.fnnews.com/news/202009030924521425
7285,2020-09-03,대웅제약美FDA서경부근긴장이상적응증임상2상승인선진국보툴리눔톡신치료시장공략,https://biz.chosun.com/site/data/html_dir/2020/09/03/2020090300881.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7286,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.koreaittimes.com/news/articleView.html?idxno=100120
7287,2020-09-03,대웅제약美보툴리눔톡신시장본격진출,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572440791186
7288,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.medisobizanews.com/news/articleView.html?idxno=72423
7289,2020-09-03,대웅제약美보톡스치료시장진출임상2상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090309281376469
7290,2020-09-03,대웅제약파트너사통해미국보툴리눔톡신시장본격진출,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121077
7291,2020-09-03,대웅제약美FDA나보타의경부근긴장이상적응증임상2상승인,http://news.mk.co.kr/newsRead.php?no=908892&year=2020
7292,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://sports.hankooki.com/lpage/economy/202009/sp20200903093910137020.htm?s_ref=nv
7293,2020-09-03,대웅나보타경부근긴장이상임상시험美승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94689
7294,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.pharmnews.com/news/articleView.html?idxno=101226
7295,2020-09-03,대웅제약美치료용보톡스시장진출,http://health.chosun.com/site/data/html_dir/2020/09/03/2020090300999.html
7296,2020-09-03,대웅나보타미국서근육경련치료임상2상승인,https://www.news1.kr/articles/?4046849
7297,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.bosa.co.kr/news/articleView.html?idxno=2133623
7298,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://inthenews.co.kr/article-67451/
7299,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.seoulwire.com/news/articleView.html?idxno=425796
7300,2020-09-03,대웅제약美FDA경부근긴장이상적응증임상2상승인받아,http://www.economytalk.kr/news/articleView.html?idxno=207932
7301,2020-09-03,결혼전재우대웅CT상무이사의장남인혁군,http://www.gasnews.com/news/articleView.html?idxno=92761
7302,2020-09-03,대웅제약미국보툴리눔톡신치료시장진출나선다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1412178
7303,2020-09-03,대웅제약나보타미FDA경부근긴장이상임상2상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009030470&t=NN
7304,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63150
7305,2020-09-03,대웅제약美보툴리눔톡신치료시장진출,http://www.healthinnews.co.kr/news/articleView.html?idxno=14271
7306,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=398000
7307,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출미래먹거리사업기대,http://www.newsprime.co.kr/news/article.html?no=516590
7308,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.onews.tv/news/articleView.html?idxno=29979
7309,2020-09-03,대웅제약美FDA나보타경부근긴장이상임상2상승인,http://it.chosun.com/site/data/html_dir/2020/09/03/2020090301099.html
7310,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상허가획득,http://yna.kr/AKR20200903063500017?did=1195m
7311,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.newstomato.com/ReadNews.aspx?no=993946
7312,2020-09-03,대웅제약美파트너사보툴리눔톡신경부근긴장이상2상임상승인,http://weekly.cnbnews.com/news/article.html?no=135807
7313,2020-09-03,지난해임상시험52증가제약사MSD종근당노바티스대웅순,http://www.medigatenews.com/news/1693287024
7314,2020-09-03,대웅제약美보툴리눔톡신치료시장진출속도,https://view.asiae.co.kr/article/2020090310174623601
7315,2020-09-03,대웅제약나보타美톡신치료시장진출FDA임상2상승인,http://www.viva100.com/main/view.php?key=20200903010000620
7316,2020-09-03,대웅제약보툴리눔톡신제제미국서치료용임상2상승인,https://www.sedaily.com/NewsView/1Z7PMW7ALJ
7317,2020-09-03,대웅제약나보타美FDA경부근긴장이상적응증임상2상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020090310161933023
7318,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://newsbrite.net/141169
7319,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상2상허가,http://www.metroseoul.co.kr/article/20200903500078
7320,2020-09-03,전승호대웅제약사장나보타美시장성공위해끝까지최선,http://www.wikileaks-kr.org/news/articleView.html?idxno=94154
7321,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.pinpointnews.co.kr/view.php?ud=2020090310201479022365609d9b_45
7322,2020-09-03,대웅제약파트너사임상2상승인보톡스시장진출,http://www.mhj21.com/134457
7323,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.m-i.kr/news/articleView.html?idxno=743095
7324,2020-09-03,대웅제약미국FDA나보타경부근긴장이상임상2상승인,http://www.mediapen.com/news/view/554380
7325,2020-09-03,종근당지난해임상시험계획승인1위대웅제약에드파마HK이노엔한미약품도선방,https://biz.chosun.com/site/data/html_dir/2020/09/03/2020090301317.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7326,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.bokuennews.com/news/article.html?no=194208
7327,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상2상허가,https://www.dailian.co.kr/news/view/917075/?sc=Naver
7328,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.todaykorea.co.kr/news/articleView.html?idxno=276107
7329,2020-09-03,대웅제약파트너사이온바이오파마美FDA서임상2상승인,https://www.asiatoday.co.kr/view.php?key=20200903010002071
7330,2020-09-03,대웅제약美보툴리눔톡신치료시장초읽기내년상반기임상2상돌입,http://www.newspim.com/news/view/20200903000483
7331,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.dailysmart.co.kr/news/articleView.html?idxno=32218
7332,2020-09-03,대웅제약나보타미국서경부근긴장이상임상2상승인,http://www.upinews.kr/newsView/upi202009030039
7333,2020-09-03,대웅제약미국보툴리눔톡신시장진출속도,http://www.monews.co.kr/news/articleView.html?idxno=213251
7334,2020-09-03,대웅제약美보툴리눔톡신치료시장진출본격화FDA임상2상승인,http://www.newslock.co.kr/news/articleView.html?idxno=30768
7335,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.segyebiz.com/newsView/20200903511854?OutUrl=naver
7336,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.thepublic.kr/news/newsview.php?ncode=1065575735827748
7337,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.ceoscoredaily.com/news/article.html?no=72862
7338,2020-09-03,대웅제약美보툴리눔톡신치료시장본격진출,http://www.kpinews.co.kr/news/articleView.html?idxno=125044
7339,2020-09-03,오늘의제약메디톡스대웅제약광동제약동화약품유한건강생활,http://www.babytimes.co.kr/news/articleView.html?idxno=39110
7340,2020-09-03,대웅제약美보툴리눔톡신치료시장진출,http://news.mk.co.kr/newsRead.php?no=910162&year=2020
7341,2020-09-03,대웅제약나보타FDA서치료목적임상2상승인획득,http://www.insightkorea.co.kr/news/articleView.html?idxno=82553
7342,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출美임상2상승인,http://www.pressm.kr/news/articleView.html?idxno=32887
7343,2020-09-03,대웅제약치료용보툴리눔톡신미국임상허가획득,http://www.seoulfn.com/news/articleView.html?idxno=394095
7344,2020-09-03,대웅제약미국보툴리눔톡신시장본격진출,https://www.news2day.co.kr/159882
7345,2020-09-03,美FDA대웅제약치료용보툴리놈톡신2상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002478
7346,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.econovill.com/news/articleView.html?idxno=410580
7347,2020-09-03,대웅제약나보타미국치료시장임상내년시작,https://hankookilbo.com/News/Read/A2020090309520004121?did=NA
7348,2020-09-03,대웅제약보툴리눔톡신치료제로미국에서임상2상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=194505
7349,2020-09-03,대웅제약美FDA서보툴리늄톡신임상2상승인받아,http://www.opinionnews.co.kr/news/articleView.html?idxno=39226
7350,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.anewsa.com/detail.php?number=2214929&thread=10
7351,2020-09-03,대웅제약美ITC소송승소자신감승천,http://www.whosaeng.com/120592
7352,2020-09-03,대웅제약FDA나보타경부근긴장이상임상2상승인,http://www.dailymedi.com/detail.php?number=860059&thread=22r05
7353,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.medigatenews.com/news/1709155065
7354,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.businesskorea.co.kr/news/articleView.html?idxno=51283
7355,2020-09-03,대웅제약美보톡스치료시장진출,http://www.finomy.com/news/articleView.html?idxno=82532
7356,2020-09-03,종근당대웅애드파마CJ헬스케어한미약품,http://www.dailymedi.com/detail.php?number=860063&thread=22r05
7357,2020-09-03,대웅제약보툴리눔톡신FDA서치료용임상2상승인美시장본격진출,http://www.thevaluenews.co.kr/news/view.php?idx=160699
7358,2020-09-03,대웅제약美치료용보톡스시장진출본격화,http://www.koreastocknews.com/news/articleView.html?idxno=56824
7359,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://news.kbiz.or.kr/news/articleView.html?idxno=72053
7360,2020-09-03,대웅제약美FDA로부터나보타치료제임상2상승인미용이어치료시장진출박차,https://www.donga.com/news/article/all/20200903/102777447/1
7361,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.worktoday.co.kr/news/articleView.html?idxno=9849
7362,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.lawissue.co.kr/view.php?ud=202009031438273735204ead0791_12
7363,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.nbnnews.co.kr/news/articleView.html?idxno=421288
7364,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.shinailbo.co.kr/news/articleView.html?idxno=1316899
7365,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,https://jhealthmedia.joins.com/article/article_view.asp?pno=22343
7366,2020-09-03,대웅제약미국서치료용보툴리눔톡신임상허가받아,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4269103
7367,2020-09-03,김해시대웅제약자회사김해강소특구에유치,http://www.gimhaenews.co.kr/news/articleView.html?idxno=33698
7368,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.updownnews.co.kr/news/articleView.html?idxno=222765
7369,2020-09-03,특구재단대웅제약바이오분야기술창업기업인큐베이팅협력MOU,http://news.mt.co.kr/mtview.php?no=2020090315234515919
7370,2020-09-03,김해강소특구대웅제약자회사유치,http://www.kndaily.co.kr/news/articleView.html?idxno=166896
7371,2020-09-03,대웅제약협력사이온보툴리눔톡신치료2상美승인,https://www.hankyung.com/it/article/202009031069i
7372,2020-09-03,대웅제약나보타경부근긴장이상치료임상2상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=215826&category=D
7373,2020-09-03,특구진흥재단대웅제약과바이오분야스타트업발굴협약,http://www.ccnnews.co.kr/news/articleView.html?idxno=191468
7374,2020-09-03,특구재단대웅제약특구내히든스타트업발굴협약,http://yna.kr/AKR20200903152300063?did=1195m
7375,2020-09-03,김해강소특구대웅제약자회사유치,http://www.newsis.com/view/?id=NISX20200903_0001153863&cID=10812&pID=10800
7376,2020-09-03,대웅제약미국보툴리눔톡신치료시장본격진출,http://www.thefirstmedia.net/news/articleView.html?idxno=62658
7377,2020-09-03,대웅제약선진국보툴리눔톡신치료시장진출잰걸음,http://www.100ssd.co.kr/news/articleView.html?idxno=71131
7378,2020-09-03,대웅제약장애인고용안정릴레이캠페인동참,http://www.ablenews.co.kr/News/NewsContent.aspx?CategoryCode=0036&NewsCode=003620200903164814218555
7379,2020-09-03,특구재단대웅제약특구를바이오기술창업요람으로,http://www.newsis.com/view/?id=NISX20200903_0001153961&cID=10807&pID=10800
7380,2020-09-03,김창수의e뉴스브리핑대웅제약美보툴리눔톡신치료시장본격진출外,https://www.fetv.co.kr/news/article.html?no=62858
7381,2020-09-03,시경Today제약대웅제약미국보툴리눔톡신치료시장본격진출外,http://www.meconomynews.com/news/articleView.html?idxno=45060
7382,2020-09-03,특구재단대웅제약히든스타트업육성에맞손,http://www.dt.co.kr/contents.html?article_no=2020090302109931731006&ref=naver
7383,2020-09-03,특구재단대웅제약오픈콜라보플랫폼구축,http://www.ggilbo.com/news/articleView.html?idxno=793482
7384,2020-09-03,김해의생명강소특구대웅제약자회사유치,http://www.knnews.co.kr/news/articleView.php?idxno=1333203
7385,2020-09-03,특구재단대웅제약글로벌스타벤처육성을위한오픈콜라보플랫폼구축,http://www.cctoday.co.kr/news/articleView.html?idxno=2091935
7386,2020-09-03,김해시，강소특구에대웅제약자회사유치,http://www.gnmaeil.com/news/articleView.html?idxno=456902
7387,2020-09-03,특구재단대웅제약특구내히든스타트업발굴협약,http://www.fntoday.co.kr/news/articleView.html?idxno=230844
7388,2020-09-04,김해시김해강소특구에대웅제약자회사유치,http://moneys.mt.co.kr/news/mwView.php?no=2020090406408065657
7389,2020-09-04,장애인고용공단경기맞춤훈련센터㈜대웅제약과장애인고용안정캠페인,http://www.greened.kr/news/articleView.html?idxno=267957
7390,2020-09-04,제약街23세가뛴다갑질회장윤재승대웅제약경영복귀시동걸까,http://www.inews24.com/view/1296385
7391,2020-09-04,대웅제약나보타웹세미나개최효과적통증감소시술노하우공유,https://www.fetv.co.kr/news/article.html?no=62887
7392,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.youthdaily.co.kr/news/article.html?no=46639
7393,2020-09-04,대웅제약나보타웹세미나개최,http://www.bosa.co.kr/news/articleView.html?idxno=2133703
7394,2020-09-04,통증감소시술노하우공유대웅제약나보타웹세미나개최,http://www.koreaittimes.com/news/articleView.html?idxno=100155
7395,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571884179922
7396,2020-09-04,대웅제약나보타웹세미나개최,https://www.ebn.co.kr/news/view/1449494/?sc=Naver
7397,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.ekn.kr/news/article.html?no=521199
7398,2020-09-04,대웅제약통증감소시술노하우공개나보타웹세미나개최,http://www.pressm.kr/news/articleView.html?idxno=32927
7399,2020-09-04,대웅제약나보타웹세미나개최,http://www.press9.kr/news/articleView.html?idxno=45726
7400,2020-09-04,대웅제약나보타효과적통증감소시술노하우공유,http://www.econovill.com/news/articleView.html?idxno=410694
7401,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://newsbrite.net/141205
7402,2020-09-04,대웅제약보툴리눔톡신나보타웹세미나개최,http://www.mediapen.com/news/view/554757
7403,2020-09-04,대웅제약나보타웹세미나통증감소시술노하우공유,http://medipana.com/news/news_viewer.asp?NewsNum=262313&MainKind=A&NewsKind=5&vCount=12&vKind=1
7404,2020-09-04,대웅제약나보타웹세미나개최통증완화시술노하우공유,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090409415915600
7405,2020-09-04,대웅제약나보타웹세미나개최비대면마케팅강화,http://www.newsis.com/view/?id=NISX20200904_0001154454&cID=13001&pID=13000
7406,2020-09-04,대웅제약나보타웹세미나개최마케팅강화,http://theviewers.co.kr/View.aspx?No=1071584
7407,2020-09-04,대웅제약나보타웹세미나통증감소시술노하우공유,http://www.medisobizanews.com/news/articleView.html?idxno=72456
7408,2020-09-04,대웅제약나보타웹세미나개최,http://www.monews.co.kr/news/articleView.html?idxno=213275
7409,2020-09-04,대웅제약나보타웹세미나개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63169
7410,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121125
7411,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.healthinnews.co.kr/news/articleView.html?idxno=14283
7412,2020-09-04,대웅제약보툴리눔톡신시술통증완화결과공유,http://www.meconomynews.com/news/articleView.html?idxno=45080
7413,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.metroseoul.co.kr/article/20200904500029
7414,2020-09-04,대웅제약나보타통증감소시술노하우공유웹세미나개최,http://www.whosaeng.com/120625
7415,2020-09-04,대웅제약나보타웨비나개최통증감소시술법공유,http://health.chosun.com/site/data/html_dir/2020/09/04/2020090401376.html
7416,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,https://jhealthmedia.joins.com/article/article_view.asp?pno=22351
7417,2020-09-04,대웅제약나보타라이브세미타성료,http://www.kpinews.co.kr/news/articleView.html?idxno=125150
7418,2020-09-04,대웅제약나보타비대면웹세미나개최효과적인통증감소시술노하우공유,http://www.pinpointnews.co.kr/view.php?ud=2020090410441916652365609d9b_45
7419,2020-09-04,보톡스전쟁대웅메디톡스나란히해외진출,http://www.mkhealth.co.kr/news/articleView.html?idxno=50344
7420,2020-09-04,뉴스투데이L대웅제약나보타웹세미나개최,https://www.news2day.co.kr/159961
7421,2020-09-04,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.anewsa.com/detail.php?number=2215590&thread=10
7422,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.datasom.co.kr/news/articleView.html?idxno=108239
7423,2020-09-04,대웅제약미용성형의료진대상나보타웹세미나진행,http://www.newslock.co.kr/news/articleView.html?idxno=30815
7424,2020-09-04,대웅제약나보타웹세미나개최,http://www.marketnews.co.kr/news/articleView.html?idxno=51253
7425,2020-09-04,대웅제약나보타웹세미나에1200명미용성형의료진참여,http://www.medigatenews.com/news/2724523573
7426,2020-09-04,대웅제약건강기능식품쿠팡서추석특가전진행,http://news.tf.co.kr/read/economy/1810934.htm
7427,2020-09-04,오늘의제약화이자동국생명과학유비케어대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39145
7428,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.lawissue.co.kr/view.php?ud=202009041214118473204ead0791_12
7429,2020-09-04,김해시강소특구에대웅제약자회사유치,http://www.cnbnews.com/news/article.html?no=459420
7430,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.mdtoday.co.kr/mdtoday/index.html?no=398154
7431,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.m-i.kr/news/articleView.html?idxno=743584
7432,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.worktoday.co.kr/news/articleView.html?idxno=9880
7433,2020-09-04,대웅제약나보타웹세미나개최시술노하우공유,http://news.mt.co.kr/mtview.php?no=2020090411401773859
7434,2020-09-04,대웅제약나보타라이브세미나개최,http://news.mk.co.kr/newsRead.php?no=915011&year=2020
7435,2020-09-04,대웅제약나보타통증완화시술법공유온라인세미나개최,https://www.donga.com/news/article/all/20200904/102793201/1
7436,2020-09-04,대웅제약나보타라이브세미나개최,http://www.consumuch.com/news/articleView.html?idxno=50479
7437,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.nbnnews.co.kr/news/articleView.html?idxno=421640
7438,2020-09-04,대웅제약건강기능식품단하루할인판매진행,http://www.newstomato.com/ReadNews.aspx?no=994308
7439,2020-09-04,대웅제약위드코로나시대온택트마케팅주력의료진과여러채널로소통”,http://www.polinews.co.kr/news/article.html?no=473706
7440,2020-09-04,단독대웅제약대상포진백신스카이조스터공동판매때도계약사항어겨,http://news.mk.co.kr/newsRead.php?no=915523&year=2020
7441,2020-09-04,대웅제약나보타웹세미나개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1412563
7442,2020-09-04,대웅제약발달장애인건강한삶위해따듯한동행,http://www.g-enews.com/ko-kr/news/article/news_all/20200904151727484369d76442fa_1/article.html
7443,2020-09-04,대웅제약나보타디지털마케팅강화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1317391
7444,2020-09-04,김창수의e뉴스브리핑대웅제약나보타웹세미나개최효과적통증감소시술노하우공유外,https://www.fetv.co.kr/news/article.html?no=62944
7445,2020-09-04,대웅제약나보타통증감소시술웹세미나열어,https://www.kpanews.co.kr/article/show.asp?idx=215862&category=D
7446,2020-09-04,대웅제약과ITC승소굳치기메디톡스1800억유상증자승부수,http://www.wikileaks-kr.org/news/articleView.html?idxno=94269
7447,2020-09-04,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.paxetv.com/news/articleView.html?idxno=99603
7448,2020-09-05,대웅제약나보타웹세미나개최통증감소시술노하우공유,http://www.updownnews.co.kr/news/articleView.html?idxno=222837
7449,2020-09-05,대웅제약미용성형분야의료진대상나보타웹세미나개최비대면마케팅강화,http://www.econonews.co.kr/news/articleView.html?idxno=135379
7450,2020-09-06,대웅제약나보타웹세미나개최효과적인통증감소시술노하우공유,http://www.thefirstmedia.net/news/articleView.html?idxno=62746
7451,2020-09-07,대웅제약코로나치료제필리핀환자대상1상승인,https://www.ebn.co.kr/news/view/1449674/?sc=Naver
7452,2020-09-07,대웅제약니클로사마이드코로나19필리핀1상승인,http://www.press9.kr/news/articleView.html?idxno=45735
7453,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020090709061892175
7454,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상돌입,http://www.ekn.kr/news/article.html?no=521566
7455,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.viva100.com/main/view.php?key=20200907010001190
7456,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.sentv.co.kr/news/view/578885
7457,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=743944
7458,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀임상1상승인,https://www.fetv.co.kr/news/article.html?no=62986
7459,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀서임상1상승인,http://www.fnnews.com/news/202009070914189239
7460,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://news.mt.co.kr/mtview.php?no=2020090709110525397
7461,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=46795
7462,2020-09-07,대웅제약니클로사마이드코로나19필리핀임상1상승인,https://www.dailian.co.kr/news/view/917791/?sc=Naver
7463,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.lawissue.co.kr/view.php?ud=20200907091758351204ead0791_12
7464,2020-09-07,대웅제약코로나19치료제필리핀임상1상승인,http://health.chosun.com/site/data/html_dir/2020/09/07/2020090700823.html
7465,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=32346
7466,2020-09-07,대웅제약니클로사마이드코로나19필리핀1상승인,http://www.mediapen.com/news/view/555334
7467,2020-09-07,대웅제약코로나19치료제필리핀임상1상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=02004086625897824
7468,2020-09-07,대웅제약코로나19치료제필리핀서임상1상승인받아,https://www.etoday.co.kr/news/view/1937696
7469,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248692
7470,2020-09-07,대웅제약코로나19치료제필리핀서임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090709160278749
7471,2020-09-07,ITC나보타최종판결2달앞으로대웅제약코로나개발집중,http://www.wikileaks-kr.org/news/articleView.html?idxno=94329
7472,2020-09-07,대웅제약코로나19치료제니클로사마이드임상1상승인글로벌임상및개발본격화,http://www.paxetv.com/news/articleView.html?idxno=99638
7473,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.medigatenews.com/news/2983209973
7474,2020-09-07,대웅제약필리핀서도코로나19대상니클로사마이드임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=920885&year=2020
7475,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀서임상1상승인,http://www.econovill.com/news/articleView.html?idxno=410943
7476,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀1상승인,http://www.newsis.com/view/?id=NISX20200907_0001156566&cID=13001&pID=13000
7477,2020-09-07,대웅제약코로나치료제필리핀서임상1상승인,http://www.newspim.com/news/view/20200907000124
7478,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제로임상1상승인,http://yna.kr/AKR20200907040300017?did=1195m
7479,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://news.heraldcorp.com/view.php?ud=20200907000163
7480,2020-09-07,대웅제약필리핀서코로나19치료제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009070086&t=NN
7481,2020-09-07,대웅제약니클로사마이드필리핀임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=262389&MainKind=A&NewsKind=5&vCount=12&vKind=1
7482,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀환자대상임상1상승인,https://www.sedaily.com/NewsView/1Z7RHBTG1A
7483,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://newsbrite.net/141273
7484,2020-09-07,대웅제약필리핀에서코로나19치료제임상1상시험승인,http://www.busan.com/view/busan/view.php?code=2020090709390625584
7485,2020-09-07,대웅제약필리핀서코로나치료제로임상1상승인,https://www.hankyung.com/society/article/2020090706427
7486,2020-09-07,대웅제약코로나19藥니클로사마이드필리핀1상승인,https://www.hankyung.com/it/article/202009070649i
7487,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=398281
7488,2020-09-07,대웅제약필리핀FDA서코로나19치료제임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=125219
7489,2020-09-07,대웅제약니클로사마이드코로나19치료제로필리핀1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=72494
7490,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.newstomato.com/ReadNews.aspx?no=994553
7491,2020-09-07,대웅제약니클로사마이드코로나19치료제PFDA임상1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121194
7492,2020-09-07,대웅제약니클로사마이드코로나19치료제개발본격화기대감조성,http://theviewers.co.kr/View.aspx?No=1072953
7493,2020-09-07,대웅제약필리핀서코로나19치료제임상1상승인,http://www.marketnews.co.kr/news/articleView.html?idxno=51319
7494,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제임상1상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004100565
7495,2020-09-07,대웅제약구충제성분필리핀서코로나치료제로임상1상승인,https://news.joins.com/article/olink/23460492
7496,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://news.mk.co.kr/newsRead.php?no=921126&year=2020
7497,2020-09-07,대웅제약인도이어필리핀서도코로나19임상1상진행,https://jhealthmedia.joins.com/article/article_view.asp?pno=22357
7498,2020-09-07,대웅제약필리핀환자대상니클로사마이드임상1상승인,http://www.newsprime.co.kr/news/article.html?no=516953
7499,2020-09-07,대웅제약니클로사마이드코로나치료제필리핀서1상,http://www.bosa.co.kr/news/articleView.html?idxno=2133811
7500,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상승인,http://www.bokuennews.com/news/article.html?no=194316
7501,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14304
7502,2020-09-07,대웅제약코로나치료제필리핀서임상시험승인,https://www.chosun.com/economy/science/2020/09/07/YBUEVWE3CJCQTOGKDIB725KFFI/?utm_source=naver&utm_medium=original&utm_campaign=news
7503,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009070068&t=NN
7504,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63196
7505,2020-09-07,대웅제약글로벌코로나19치료제개발본격화필리핀임상1상승인,http://kbench.com/?q=node/213880
7506,2020-09-07,대웅제약코로나19치료제필리핀서임상1상승인,http://www.koreaittimes.com/news/articleView.html?idxno=100199
7507,2020-09-07,대웅제약추석앞두고쿠팡서건강기능식품할인기획전진행,http://www.newspost.kr/news/articleView.html?idxno=90072
7508,2020-09-07,오늘의제약메디톡스GC녹십자웰빙대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39180
7509,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=72931
7510,2020-09-07,대웅제약코로나19치료제필리핀임상1상승인,http://www.mhj21.com/134515
7511,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상승인,http://www.pinpointnews.co.kr/view.php?ud=2020090710222124022365609d9b_45
7512,2020-09-07,대웅제약구충제성분코로나19치료제필리핀임상돌입우수한효능에심사2개월단축,https://www.donga.com/news/article/all/20200907/102819362/1
7513,2020-09-07,대웅코로나19치료제필리핀임상1상승인,http://www.monews.co.kr/news/articleView.html?idxno=213318
7514,2020-09-07,대웅니클로사마이드필리핀코로나19환자대상1상승인,http://www.kukinews.com/newsView/kuk202009070080
7515,2020-09-07,대웅제약필리핀에서니클로사마이드코로나19치료제임상1상종합,https://biz.chosun.com/site/data/html_dir/2020/09/07/2020090701261.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7516,2020-09-07,대웅제약구충제필리핀서코로나19임상이번달첫투여,http://moneys.mt.co.kr/news/mwView.php?no=2020090709408056651
7517,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://sports.hankooki.com/lpage/economy/202009/sp20200907103104136980.htm?s_ref=nv
7518,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀환자대상임상 1상승인,http://www.greened.kr/news/articleView.html?idxno=268171
7519,2020-09-07,대웅제약DWRX2003필리핀서코로나19치료제로임상1상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065575356642865
7520,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀임상1상승인,http://www.etnews.com/20200907000054
7521,2020-09-07,대웅니클로사마이드코로나치료제필리핀1상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=268207&REFERER=NP
7522,2020-09-07,대웅제약필리핀서니클로사마이드코로나19임상진행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002573
7523,2020-09-07,제약워치대웅제약니클로사마이드코로나19치료제글로벌임상개발확대外,http://www.newswatch.kr/news/articleView.html?idxno=50865
7524,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인받아,http://www.datasom.co.kr/news/articleView.html?idxno=108284
7525,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀임상1상,http://www.upinews.kr/newsView/upi202009070034
7526,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065575049080571
7527,2020-09-07,인도이어필리핀대웅제약코로나치료제임상승인,http://www.whosaeng.com/120672
7528,2020-09-07,대웅제약구충제성분필리핀서코로나치료제임상계획승인,https://view.asiae.co.kr/article/2020090711331105776
7529,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.pharmnews.com/news/articleView.html?idxno=101244
7530,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상승인,http://www.metroseoul.co.kr/article/20200907500171
7531,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀환자대상임상1상승인,http://www.ezyeconomy.com/news/articleView.html?idxno=104992
7532,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제임상승인,http://www.newsquest.co.kr/news/articleView.html?idxno=78498
7533,2020-09-07,사진뉴스대웅타올금산수해가구돕기1000만원상당물품기탁,http://www.daejonilbo.com/news/newsitem.asp?pk_no=1438424
7534,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=30860
7535,2020-09-07,대웅타올금산수해가구돕기1000만원상당물품기탁,http://www.shinailbo.co.kr/news/articleView.html?idxno=1317894
7536,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀1상승인,http://www.anewsa.com/detail.php?number=2217101&thread=10
7537,2020-09-07,대웅제약니클로사마이드필리핀서코로나19치료제임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4272493
7538,2020-09-07,대웅제약주가니클로사마이드필리핀1상승인소식에소폭상승세,http://www.ccreview.co.kr/news/articleView.html?idxno=283423
7539,2020-09-07,대웅제약필리핀에서코로나19치료제임상1상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=194933
7540,2020-09-07,대웅제약구충제니클로사마이드필리핀서코로나19치료제로임상1상승인,http://news.tf.co.kr/read/economy/1811366.htm
7541,2020-09-07,대웅제약니클로사마이드코로나19치료제임상1상승인쾌거,http://www.pressm.kr/news/articleView.html?idxno=33004
7542,2020-09-07,대웅제약코로나19치료제니클로사마이드필리핀서임상1상,https://www.news1.kr/articles/?4050744
7543,2020-09-07,대웅제약해외서코로나19치료제임상에속도낸다,http://www.seoulwire.com/news/articleView.html?idxno=426051
7544,2020-09-07,대웅제약코로나치료제나올까필리핀서임상1상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=71200
7545,2020-09-07,대웅제약니클로사마이드코로나치료제로필리핀서임상1상승인,http://inthenews.co.kr/article-67927/
7546,2020-09-07,특징주대웅제약코로나19치료제해외임상소식에216↑,http://moneys.mt.co.kr/news/mwView.php?no=2020090714178068368
7547,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.getnews.co.kr/view.php?ud=2020090714204295402fe691f917_16
7548,2020-09-07,대웅제약 코로나19 치료제 필리핀서 임상 1상 승인,http://kormedi.com/?p=1323838
7549,2020-09-07,대웅제약구충제성분필리핀서코로나19치료제로임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4272659
7550,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=422270
7551,2020-09-07,대웅제약코로나19치료제개발탄력붙나,http://www.segye.com/content/html/2020/09/07/20200907515624.html?OutUrl=naver
7552,2020-09-07,LG화학대웅제약제미글로공동판매재협상에관심집중,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002594
7553,2020-09-07,대웅제약코로나19치료제필리핀PFDA로부터임상1상승인,https://www.news2day.co.kr/160091
7554,2020-09-07,대웅제약 니클로사마이드 코로나19 치료제필리핀환자대상임상 1상승인,http://www.economytalk.kr/news/articleView.html?idxno=208006
7555,2020-09-07,대웅미보툴리눔톡신시장본격진출,http://www.womennews.co.kr/news/articleView.html?idxno=202058
7556,2020-09-07,대웅제약구충제성분니클로사마이드필리핀서코로나19치료제로임상1상승인,http://www.topstarnews.net/news/articleView.html?idxno=832047
7557,2020-09-07,위드코로나시대명절선물키워드는건강대웅제약건기식라인업확대,http://www.sportsseoul.com/news/read/955866?ref=naver
7558,2020-09-07,대웅제약필리핀서니클로사마이드코로나19임상,http://www.seoulfn.com/news/articleView.html?idxno=394435
7559,2020-09-07,대웅타올금산수해가구위해1천만원상당물품기탁,http://www.jbnews.com/news/articleView.html?idxno=1305604
7560,2020-09-07,시경Today제약대웅제약니클로사마이드코로나치료제필리핀환자임상1상승인外,http://www.meconomynews.com/news/articleView.html?idxno=45135
7561,2020-09-07,대웅인도이어필리핀서코로나19치료제임상승인,http://www.dailymedi.com/detail.php?number=860206&thread=22r05
7562,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.opinionnews.co.kr/news/articleView.html?idxno=39419
7563,2020-09-07,대웅제약코로나치료제필리핀임상1상승인,http://www.skyedaily.com/news/news_view.html?ID=111527
7564,2020-09-07,대웅제약코로나19치료제필리핀에서임상1상승인,http://daily.hankooki.com/lpage/industry/202009/dh20200907155834148390.htm?s_ref=nv
7565,2020-09-07,부침겪은대웅제약1조클럽재입성가능할까,http://www.wolyo.co.kr/news/articleView.html?idxno=109189
7566,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=9932
7567,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=104232
7568,2020-09-07,대웅제약필리핀서코로나19치료제임상승인받아,http://www.finomy.com/news/articleView.html?idxno=82693
7569,2020-09-07,대웅제약코로나19치료제필리핀환자대상임상1상승인,http://weekly.hankooki.com/lpage/economy/202009/wk20200907170813146380.htm?s_ref=nv
7570,2020-09-07,대웅제약코로나19치료제니클로사마이드인도이어필리핀임상1상승인,http://hobbyen.co.kr/news/newsview.php?ncode=1065600893395394
7571,2020-09-07,김창수의e뉴스브리핑대웅제약코로나치료제니클로사마이드필리핀임상1상승인外,https://www.fetv.co.kr/news/article.html?no=63064
7572,2020-09-07,대웅제약코로나치료제니클로사마이드필리핀임상1상승인,https://www.asiatoday.co.kr/view.php?key=20200907010003655
7573,2020-09-07,대웅제약필리핀서코로나19치료제임상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1318208
7574,2020-09-07,대웅제약니클로사마이드코로나19치료제필리핀임상1상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=486267
7575,2020-09-07,대웅제약니클로사마이드임상1상승인필리핀서코로나환자40명대상첫투여,http://www.dt.co.kr/contents.html?article_no=2020090802101831102002&ref=naver
7576,2020-09-07,대웅타올수해가구돕기물품기탁,http://www.ccdn.co.kr/news/articleView.html?idxno=662772
7577,2020-09-07,대웅타올금산수해가구돕기1000만원상당물품기탁,http://www.cctoday.co.kr/news/articleView.html?idxno=2092326
7578,2020-09-07,대웅제약코로나19치료제로개발중인니클로사마이드필리핀1상승인,http://www.econonews.co.kr/news/articleView.html?idxno=135602
7579,2020-09-07,대웅제약필리핀서니클로사마이드코로나191상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=215924&category=D
7580,2020-09-07,대웅타올금산수해가구돕기1000만원상당물품기탁,http://www.kukinews.com/newsView/kuk202009070498
7581,2020-09-08,국내코로나치료제개발선두그룹부광⋅엔지켐⋅대웅⋅녹십자4곳2상돌입,https://biz.chosun.com/site/data/html_dir/2020/09/07/2020090703096.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7582,2020-09-08,단독대웅제약인니서코로나줄기세포치료제임상착수내년2상추진,https://www.theguru.co.kr/news/article.html?no=13937
7583,2020-09-08,ITC최종판결D60메디톡스대웅제약치열한생존전략,https://www.dailian.co.kr/news/view/917983/?sc=Naver
7584,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.fnnews.com/news/202009080835427327
7585,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.press9.kr/news/articleView.html?idxno=45748
7586,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://medipana.com/news/news_viewer.asp?NewsNum=262460&MainKind=A&NewsKind=5&vCount=12&vKind=1
7587,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.m-i.kr/news/articleView.html?idxno=744344
7588,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종신규출시,http://www.youthdaily.co.kr/news/article.html?no=46907
7589,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.anewsa.com/detail.php?number=2217649&thread=10
7590,2020-09-08,어린이양치습관안심”대웅제약덴티가드랩그립핏칫솔어린이용2종출시,https://www.fetv.co.kr/news/article.html?no=63081
7591,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.whosaeng.com/120695
7592,2020-09-08,대웅제약KC인증받은어린이용덴티가드랩그립핏칫솔출시,http://moneys.mt.co.kr/news/mwView.php?no=2020090809088096578
7593,2020-09-08,오늘의신상품대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.econovill.com/news/articleView.html?idxno=411109
7594,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.mediapen.com/news/view/555801
7595,2020-09-08,대웅제약어린이용덴티가드랩그립핏칫솔2종출시,http://news.mk.co.kr/newsRead.php?no=925663&year=2020
7596,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63226
7597,2020-09-08,칫솔물고씹어도OK대웅제약어린이안심칫솔출시,http://www.newsis.com/view/?id=NISX20200908_0001158007&cID=13001&pID=13000
7598,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://newsbrite.net/141304
7599,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,https://www.ebn.co.kr/news/view/1449882/?sc=Naver
7600,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://news.mk.co.kr/newsRead.php?no=925721&year=2020
7601,2020-09-08,대웅제약어린이용덴티가드랩그린핏칫솔2종출시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065570505447456
7602,2020-09-08,대웅제약어린이용덴티가드랩그립핏칫솔2종출시,http://www.medisobizanews.com/news/articleView.html?idxno=72525
7603,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020090809371410651
7604,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.metroseoul.co.kr/article/20200908500056
7605,2020-09-08,대웅제약안심하고사용할수있는덴티가드랩어린이용칫솔2종출시,https://www.donga.com/news/article/all/20200908/102835572/1
7606,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://news.mt.co.kr/mtview.php?no=2020090808404450507
7607,2020-09-08,대웅제약어린이용덴티가드랩그립핏칫솔출시양치습관케어,http://theviewers.co.kr/View.aspx?No=1074035
7608,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종선보여,http://www.pressm.kr/news/articleView.html?idxno=33017
7609,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=14321
7610,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.bosa.co.kr/news/articleView.html?idxno=2133922
7611,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용출시,http://www.koreaittimes.com/news/articleView.html?idxno=100235
7612,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.kpinews.co.kr/news/articleView.html?idxno=125362
7613,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248765
7614,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.segyebiz.com/newsView/20200908510690?OutUrl=naver
7615,2020-09-08,뉴스투데이L대웅제약덴티가드랩그립핏칫솔어린이용2종출시,https://www.news2day.co.kr/160166
7616,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=32445
7617,2020-09-08,오늘의제약GC녹십자대웅제약KIMCo네이버신테카바이오AI센터제약바이오협회,http://www.babytimes.co.kr/news/articleView.html?idxno=39223
7618,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=422592
7619,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.worktoday.co.kr/news/articleView.html?idxno=9950
7620,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=398455
7621,2020-09-08,대웅제약덴티가드랩어린이용칫솔2종출시,http://www.finomy.com/news/articleView.html?idxno=82739
7622,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.updownnews.co.kr/news/articleView.html?idxno=222945
7623,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.thepublic.kr/news/newsview.php?ncode=1065592793947570
7624,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.lawissue.co.kr/view.php?ud=202009081641378856204ead0791_12
7625,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://weekly.hankooki.com/lpage/life/202009/wk20200908171904147650.htm?s_ref=nv
7626,2020-09-08,대웅제약덴티가드랩그립핏칫솔어린이용2종출시,http://www.thefirstmedia.net/news/articleView.html?idxno=62881
7627,2020-09-08,대웅제약니클로사마이드코로나19치료제필리핀환자대상임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=62898
7628,2020-09-09,이번에는대웅제약코로나19치료제글로벌임상순항,http://www.bosa.co.kr/news/articleView.html?idxno=2134008
7629,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제현지건강인대상투약시작,http://www.lawissue.co.kr/view.php?ud=202009090736487445204ead0791_12
7630,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.m-i.kr/news/articleView.html?idxno=744742
7631,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.sentv.co.kr/news/view/579059
7632,2020-09-09,대웅제약코로나19치료제니클로사마이드인도1상투약시작,https://www.hankyung.com/it/article/202009099047i
7633,2020-09-09,대웅제약코로나19치료제글로벌임상순항중,http://www.medisobizanews.com/news/articleView.html?idxno=72550
7634,2020-09-09,대웅제약인도서니클로사마이드코로나임상1상환자첫투약,http://www.viva100.com/main/view.php?key=20200909010001793
7635,2020-09-09,대웅제약인도서코로나19대상니클로사마이드임상1상투약개시,http://news.mk.co.kr/newsRead.php?no=929777&year=2020
7636,2020-09-09,대웅제약코로나치료제임상순항인도이어필리핀서환자투약,http://news.mt.co.kr/mtview.php?no=2020090908181712425
7637,2020-09-09,대웅제약코로나19치료제니클로사마이드인도1상투약,https://view.asiae.co.kr/article/2020090908292366634
7638,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.getnews.co.kr/view.php?ud=2020090908283818412fe691f917_16
7639,2020-09-09,대웅제약코로나치료제글로벌임상순항,https://www.ebn.co.kr/news/view/1450049/?sc=Naver
7640,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248795
7641,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제안전성확인,http://www.press9.kr/news/articleView.html?idxno=45762
7642,2020-09-09,대웅제약코로나치료제임상순항중인도첫환자투약,http://www.newspim.com/news/view/20200909000098
7643,2020-09-09,대웅제약구충제인도서코로나임상1상환자첫투약,http://moneys.mt.co.kr/news/mwView.php?no=2020090908348093477
7644,2020-09-09,대웅제약코로나19치료제글로벌임상순항인체투약돌입,http://www.ekn.kr/news/article.html?no=522076
7645,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,https://www.fetv.co.kr/news/article.html?no=63174
7646,2020-09-09,대웅제약코로나19치료제인도에서피험자대상투약시작,https://www.etoday.co.kr/news/view/1938636
7647,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항중,https://www.dailian.co.kr/news/view/918334/?sc=Naver
7648,2020-09-09,대웅제약니클로사마이드글로벌임상순항,http://medipana.com/news/news_viewer.asp?NewsNum=262531&MainKind=A&NewsKind=5&vCount=12&vKind=1
7649,2020-09-09,대웅제약인도서니클로사마이드코로나임상1상투약개시”,http://www.newsway.co.kr/news/view?tp=1&ud=2020090909011764969
7650,2020-09-09,대웅제약코로나19치료제글로벌임상순항중,http://www.businesskorea.co.kr/news/articleView.html?idxno=51477
7651,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.fnnews.com/news/202009090905503569
7652,2020-09-09,대웅제약코로나19치료제니클로사마이드인도임상1상투약개시,http://www.newstomato.com/ReadNews.aspx?no=995028
7653,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://newsbrite.net/141346
7654,2020-09-09,대웅제약니클로사마이드코로나19치료제개발글로벌임상순항”,http://www.youthdaily.co.kr/news/article.html?no=47026
7655,2020-09-09,대웅제약코로나19치료제니클로사마이드인도1상투약개시,http://www.anewsa.com/detail.php?number=2218486&thread=10
7656,2020-09-09,대웅제약코로나19치료제니클로사마이드글로벌임상순항,http://health.chosun.com/site/data/html_dir/2020/09/09/2020090900896.html
7657,2020-09-09,대웅제약코로나19치료제개발인도서순항,http://www.wikileaks-kr.org/news/articleView.html?idxno=94491
7658,2020-09-09,대웅제약니클로사마이드코로나1상환자투약시작,http://www.newsis.com/view/?id=NISX20200909_0001159490&cID=13001&pID=13000
7659,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제니클로사마이드임상순항 ,http://www.pressm.kr/news/articleView.html?idxno=33065
7660,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제글로벌임상순항,http://www.koreaittimes.com/news/articleView.html?idxno=100268
7661,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.pharmnews.com/news/articleView.html?idxno=101255
7662,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제후보니클로사마이드환자투약시작,http://theviewers.co.kr/View.aspx?No=1076205
7663,2020-09-09,대웅제약코로나19대상니클로사마이드임상1상투약시작,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4274696
7664,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63249
7665,2020-09-09,대웅제약DWRX2003코로나19치료제인도임상순항중,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571108079927
7666,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.fnnews.com/news/202009090949214597
7667,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248815
7668,2020-09-09,대웅LG화학제미글로공동프로모션지속합의,https://www.ebn.co.kr/news/view/1450120/?sc=Naver
7669,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63258
7670,2020-09-09,대웅제약LG화학제미글로 공동프로모션지속합의,http://www.economytalk.kr/news/articleView.html?idxno=208040
7671,2020-09-09,대웅제약코로나19치료제인도서임상투약시작,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009090110&t=NN
7672,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.ekn.kr/news/article.html?no=522130
7673,2020-09-09,대웅제약1000억규모당뇨약지켰다LG화학공동프로모션2030년까지유지,http://moneys.mt.co.kr/news/mwView.php?no=2020090909488045490
7674,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.medisobizanews.com/news/articleView.html?idxno=72562
7675,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.koreaittimes.com/news/articleView.html?idxno=100275
7676,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항중,http://www.healthinnews.co.kr/news/articleView.html?idxno=14344
7677,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.youthdaily.co.kr/news/article.html?no=47041
7678,2020-09-09,대웅제약LG화학제미글로계속판매한다,http://www.press9.kr/news/articleView.html?idxno=45767
7679,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1413444
7680,2020-09-09,대웅제약LG화학2030년까지제미글로공동프로모션지속,http://daily.hankooki.com/lpage/industry/202009/dh20200909095817148390.htm?s_ref=nv
7681,2020-09-09,대웅제약LG화학 제미글로 공동프로모션지속합의,http://www.greened.kr/news/articleView.html?idxno=268525
7682,2020-09-09,대웅제약인도에서코로나19치료제임상1상투약시작,https://biz.chosun.com/site/data/html_dir/2020/09/09/2020090901176.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7683,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,https://www.kpanews.co.kr/article/show.asp?idx=215958&category=D
7684,2020-09-09,대웅제약LG화학제미글로공동프로모션합의,http://www.sentv.co.kr/news/view/579081
7685,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.ceoscoredaily.com/news/article.html?no=73021
7686,2020-09-09,대웅제약LG화학과제미글로공동프로모션지속,http://www.newstomato.com/ReadNews.aspx?no=995057
7687,2020-09-09,대웅제약LG화학제미글로공동프로모션지속하기로,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090910035613348
7688,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.lawissue.co.kr/view.php?ud=20200909100645379907f28b58b8_12
7689,2020-09-09,대웅제약제미글로판매2030년까지계속LG화학發불확실성제거,http://www.viva100.com/main/view.php?key=20200909010001860
7690,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://newsbrite.net/141355
7691,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.pharmnews.com/news/articleView.html?idxno=101257
7692,2020-09-09,대웅제약코로나19치료제니클로사마이드인도서임상1상투약,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020090910061911440
7693,2020-09-09,대웅제약LG화학당뇨병치료신약제미글로공동프로모션이어간다,https://www.etoday.co.kr/news/view/1938725
7694,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항,http://www.dailysmart.co.kr/news/articleView.html?idxno=32496
7695,2020-09-09,대웅LG제미글로공동프로모션2030년까지지속,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94861
7696,2020-09-09,대웅제약코로나19치료제글로벌임상순항중,http://www.kpinews.co.kr/news/articleView.html?idxno=125469
7697,2020-09-09,대웅제약xLG화학제미글로공동프로모션10년더간다,http://www.upinews.kr/newsView/upi202009090030
7698,2020-09-09,대웅제약LG화학제미글로공동판매지속,http://www.dailypharm.com/Users/News/NewsView.html?ID=268304&REFERER=NP
7699,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.getnews.co.kr/view.php?ud=2020090910260139632fe691f917_16
7700,2020-09-09,대웅제약LG화학당뇨약제미글로공동프로모션지속키로,http://news.mk.co.kr/newsRead.php?no=930606&year=2020
7701,2020-09-09,대웅제약LG화학제미글로공동프로모션10년더,http://www.newsis.com/view/?id=NISX20200909_0001159742&cID=13001&pID=13000
7702,2020-09-09,대웅니클로사마이드인도건강인대상투약,http://www.bokuennews.com/news/article.html?no=194439
7703,2020-09-09,대웅LG2030년까지제미글로공동프로모션합의,http://www.whosaeng.com/120747
7704,2020-09-09,대웅제약코로나19치로졔인도서임상1상돌입,https://www.sedaily.com/NewsView/1Z7SDFZP54
7705,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,https://www.fetv.co.kr/news/article.html?no=63207
7706,2020-09-09,대웅제약LG화학제미글로공동프로모션2030년까지,http://www.medigatenews.com/news/2845976347
7707,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.newsway.co.kr/news/view?tp=1&ud=2020090910300193194
7708,2020-09-09,대웅LG화학당뇨약공동판매계약지속합의,https://www.paxnetnews.com/articles/65096
7709,2020-09-09,대웅제약LG화학당뇨신약제미글로공동판매지속합의,http://www.econovill.com/news/articleView.html?idxno=411329
7710,2020-09-09,대웅제약LG화학과1000억대매출제미글로공동판매10년더,https://www.news1.kr/articles/?4053027
7711,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.bosa.co.kr/news/articleView.html?idxno=2134036
7712,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.metroseoul.co.kr/article/20200909500146
7713,2020-09-09,대웅제약니클로사마이드코로나19치료제임상순항중,http://www.upinews.kr/newsView/upi202009090033
7714,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의양사개발신약상호협력도추진,http://www.segye.com/content/html/2020/09/09/20200909509997.html?OutUrl=naver
7715,2020-09-09,대웅제약코로나치료제글로벌임상순항중,http://www.koreastocknews.com/news/articleView.html?idxno=56965
7716,2020-09-09,대웅제약니클로사마이드글로벌임상시험개시치료제개발본격화,http://www.newsprime.co.kr/news/article.html?no=517289
7717,2020-09-09,대웅제약해지통보LG화학과재계약제미글로10년간판매,http://news.mt.co.kr/mtview.php?no=2020090910505373895
7718,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상투약개시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002677
7719,2020-09-09,대웅제약LG화학과당뇨병치료신약제미글로공동프로모션지속최종합의,http://www.kdpress.co.kr/news/articleView.html?idxno=97285
7720,2020-09-09,대웅니클로사마이드코로나치료제글로벌임상순항중,http://www.whosaeng.com/120749
7721,2020-09-09,오늘의제약대웅제약LG화학아스트라제네카GC녹십자사노피한미약품,http://www.babytimes.co.kr/news/articleView.html?idxno=39267
7722,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://medipana.com/news/news_viewer.asp?NewsNum=262553&MainKind=A&NewsKind=5&vCount=12&vKind=1
7723,2020-09-09,2030년까지함께한다”대웅제약LG화학당뇨병신약제미글로협력최종합의,https://www.donga.com/news/article/all/20200909/102855294/1
7724,2020-09-09,대웅제약LG화학과제미글로공동프로모션지속합의,http://www.mediapen.com/news/view/556253
7725,2020-09-09,대웅제약코로나19치료제인도에서투약안전성확인,http://www.metroseoul.co.kr/article/20200909500164
7726,2020-09-09,대웅제약LG화학과제미글로공동프로모션지속합의,http://news.mk.co.kr/newsRead.php?no=930980&year=2020
7727,2020-09-09,대웅제약LG화학제미글로공동프로모션지속,http://www.choicenews.co.kr/news/articleView.html?idxno=74368
7728,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.healthinnews.co.kr/news/articleView.html?idxno=14355
7729,2020-09-09,대웅제약LG화학제미글로공동프로모션30년까지지속,http://www.consumuch.com/news/articleView.html?idxno=50520
7730,2020-09-09,대웅제약니클로사마이드코로나19치료제인도임상1상투약개시,http://www.mdtoday.co.kr/mdtoday/index.html?no=398565
7731,2020-09-09,대웅제약LG화학제미글로공동프로모션2030년까지지속합의,http://www.mdtoday.co.kr/mdtoday/index.html?no=398564
7732,2020-09-09,대웅제약잇따른계약사항위반으로계약종료구설수논란들여다보니,http://www.startuptoday.co.kr/news/articleView.html?idxno=53725
7733,2020-09-09,대웅제약LG화학당뇨병치료제제미글로공동프로모션지속키로,http://www.pinpointnews.co.kr/view.php?ud=2020090911380219092365609d9b_45
7734,2020-09-09,LG화학대웅제약매출1000억제미글로신화이어간다,http://www.dailymedi.com/detail.php?number=860276&thread=22r05
7735,2020-09-09,대웅제약LG화학과공동프로모션지속합의,http://www.businesskorea.co.kr/news/articleView.html?idxno=51502
7736,2020-09-09,대웅제약구충제성분코로나19치료제인체투약개시서방형주사제로효능차별화”,https://www.donga.com/news/article/all/20200909/102857105/1
7737,2020-09-09,대웅LG진통끝제미글로공동판매재합의,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002684
7738,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.wsobi.com/news/articleView.html?idxno=104411
7739,2020-09-09,대웅제약LG화학제미글로공동프로모션지속,http://www.monews.co.kr/news/articleView.html?idxno=213387
7740,2020-09-09,대웅제약LG화학제미글로공동판매지속키로계약해지논란종식,http://www.todaykorea.co.kr/news/articleView.html?idxno=276354
7741,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.m-i.kr/news/articleView.html?idxno=744896
7742,2020-09-09,대웅제약XLG화학당뇨병치료제제미글로공동프로모션합의,http://weekly.hankooki.com/lpage/economy/202009/wk20200909131641146380.htm?s_ref=nv
7743,2020-09-09,대웅제약LG화학제미글로공동판매10년더,http://www.newspim.com/news/view/20200909000614
7744,2020-09-09,대웅제약코로나19치료제인도임상1상시작전승호속도내겠다,http://www.businesspost.co.kr/BP?command=article_view&num=195325
7745,2020-09-09,대웅제약LG화학당뇨신약제미글로공동프로모션2030년까지지속한다,http://www.betanews.net:8080/article/1231976.html
7746,2020-09-09,대웅제약LG화학당뇨병신약제미글로공동판매2030년까지연장,http://www.businesspost.co.kr/BP?command=article_view&num=195334
7747,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,https://jhealthmedia.joins.com/article/article_view.asp?pno=22373
7748,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.anewsa.com/detail.php?number=2218794&thread=10
7749,2020-09-09,대웅제약LG화학제미글로공동프로모션지속한다,https://www.dailian.co.kr/news/view/918477/?sc=Naver
7750,2020-09-09,대웅제약코로나19치료제니클로사마이드글로벌임상순항중,http://news.kbiz.or.kr/news/articleView.html?idxno=72290
7751,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.nbnnews.co.kr/news/articleView.html?idxno=423000
7752,2020-09-09,대웅제약2030년까지LG화학과제미글로 공동프로모션지속한다,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121341
7753,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제니클로사마이드현지인대상임상시작,http://www.newslock.co.kr/news/articleView.html?idxno=30922
7754,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.nbnnews.co.kr/news/articleView.html?idxno=423037
7755,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.worktoday.co.kr/news/articleView.html?idxno=9987
7756,2020-09-09,대웅제약LG화학당뇨병신약제미글로공동프로모션지속합의,http://www.newsprime.co.kr/news/article.html?no=517363
7757,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.worktoday.co.kr/news/articleView.html?idxno=9991
7758,2020-09-09,대웅제약LG화학제미글로2030년까지공동프로모션최종합의,http://www.k-health.com/news/articleView.html?idxno=50136
7759,2020-09-09,뉴스투데이L대웅제약LG화학과제미글로공동프로모션지속합의,https://www.news2day.co.kr/160290
7760,2020-09-09,대웅제약덴티가드랩그립핏칫솔어린이용2종선봬,https://www.kpanews.co.kr/article/show.asp?idx=215972&category=D
7761,2020-09-09,대웅제약LG화학당뇨병치료신약제미글로2030년까지공동프로모션,http://www.g-enews.com/ko-kr/news/article/news_all/2020090915513158042500a1b5d6_1/article.html
7762,2020-09-09,대웅제약인도서코로나치료제임상1상투약시작,http://www.skyedaily.com/news/news_view.html?ID=111681
7763,2020-09-09,대웅제약LG화학제미글로공동프로모션,http://www.mhj21.com/134571
7764,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.updownnews.co.kr/news/articleView.html?idxno=223022
7765,2020-09-09,대웅제약코로나19치료제니클로사마이드인도서건강인대상투약시작,http://kbench.com/?q=node/213981
7766,2020-09-09,대웅제약LG화학제미글로공동프로모션계약해지없다최종합의,http://theviewers.co.kr/View.aspx?No=1078281
7767,2020-09-09,대웅제약코로나19치료제임상순항,http://www.finomy.com/news/articleView.html?idxno=82820
7768,2020-09-09,대웅제약코로나19치료제니클로사마이드인도서임상1상투약,http://inthenews.co.kr/article-68363/
7769,2020-09-09,대웅제약LG화학당뇨병치료제제미글로공동프로모션지속합의,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004104074
7770,2020-09-09,대웅제약LG화학제미글로공동프로모션이어간다,http://www.finomy.com/news/articleView.html?idxno=82825
7771,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.thefirstmedia.net/news/articleView.html?idxno=62934
7772,2020-09-09,대웅제약니클로사마이드코로나19치료제글로벌임상순항중,https://www.asiatoday.co.kr/view.php?key=20200909010005736
7773,2020-09-09,대웅제약LG화학제미글로공동프로모션지속,http://www.shinailbo.co.kr/news/articleView.html?idxno=1319187
7774,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료제글로벌임상순항중,http://www.thefirstmedia.net/news/articleView.html?idxno=62969
7775,2020-09-09,대웅제약대웅테라퓨틱스코로나19치료제글로벌임상순항중,http://www.doctorstimes.com/news/articleView.html?idxno=212348
7776,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.iminju.net/news/articleView.html?idxno=57219
7777,2020-09-09,뉴스투데이L대웅제약코로나19치료제글로벌임상순항중,https://www.news2day.co.kr/160304
7778,2020-09-09,대웅제약LG화학제미글로공동프로모션지속합의,http://www.thepublic.kr/news/newsview.php?ncode=1065603752208236
7779,2020-09-09,금일제약업계주요이슈대웅제약니클로사마이드코로나19치료제개발글로벌임상순항”外,http://www.youthdaily.co.kr/news/article.html?no=47112
7780,2020-09-09,대웅제약대웅테라퓨틱스니클로사마이드코로나19치료인도임상투약시작,https://www.kpanews.co.kr/article/show.asp?idx=215981&category=D
7781,2020-09-10,대웅제약코로나19치료제니클로사마이드개발본격화,http://www.g-enews.com/ko-kr/news/article/news_all/20200909155716189369d76442fa_1/article.html
7782,2020-09-10,종근당셀트리온대웅제약코로나19치료제해외임상활발,http://daily.hankooki.com/lpage/industry/202009/dh20200910070004148390.htm?s_ref=nv
7783,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.lawissue.co.kr/view.php?ud=202009100905051021204ead0791_12
7784,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,https://www.ebn.co.kr/news/view/1450292/?sc=Naver
7785,2020-09-10,대웅제약2020일자리박람회서인턴십경력직채용,http://www.wikileaks-kr.org/news/articleView.html?idxno=94570
7786,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248858
7787,2020-09-10,대웅제약바이오헬스일자리박람회서채용방향등소개,http://medipana.com/news/news_viewer.asp?NewsNum=262602&MainKind=A&NewsKind=5&vCount=12&vKind=1
7788,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,https://www.fetv.co.kr/news/article.html?no=63288
7789,2020-09-10,대웅제약바이오헬스일자리박람회참가기업문화혁신에집중,http://www.medisobizanews.com/news/articleView.html?idxno=72585
7790,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://www.youthdaily.co.kr/news/article.html?no=47162
7791,2020-09-10,대웅제약2020바이오헬스일자리박람회서채용계획발표,http://sports.hankooki.com/lpage/economy/202009/sp20200910094330136980.htm?s_ref=nv
7792,2020-09-10,대웅제약2020바이오헬스일자리박람회참가채용계획공개,http://www.ekn.kr/news/article.html?no=522373
7793,2020-09-10,대웅제약2020바이오헬스일자리박람회서채용계획발표,http://www.koreaittimes.com/news/articleView.html?idxno=100309
7794,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2020091009434162557
7795,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,https://www.dailian.co.kr/news/view/918666/?sc=Naver
7796,2020-09-10,대웅제약2020바이오헬스일자리박람회참가유튜브생중계로소통,http://theviewers.co.kr/View.aspx?No=1079435
7797,2020-09-10,대웅제약2020바이오헬스일자리박람회서채용계획발표채용박람회도비대면,http://hobbyen.co.kr/news/newsview.php?ncode=1065574767676024
7798,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63280
7799,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.econovill.com/news/articleView.html?idxno=411464
7800,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.healthinnews.co.kr/news/articleView.html?idxno=14367
7801,2020-09-10,대웅제약2020바이오헬스일자리박람회참가코로나사태반영해비대면진행,http://newsbrite.net/141395
7802,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.press9.kr/news/articleView.html?idxno=45777
7803,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://news.mk.co.kr/newsRead.php?no=935234&year=2020
7804,2020-09-10,대웅제약2020바이오헬스일자리박람회참가상시채용계획공개,http://www.pressm.kr/news/articleView.html?idxno=33098
7805,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1413753
7806,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://www.businesskorea.co.kr/news/articleView.html?idxno=51562
7807,2020-09-10,대웅제약2020바이오헬스일자리박람회참가채용계획밝혀,http://www.pinpointnews.co.kr/view.php?ud=2020091010361245662365609d9b_45
7808,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.m-i.kr/news/articleView.html?idxno=745163
7809,2020-09-10,대웅제약비대면바이오헬스일자리박람회참가,http://www.dailysmart.co.kr/news/articleView.html?idxno=32553
7810,2020-09-10,대웅제약LG화학제미글로공동프로모션지속 ,http://www.mkhealth.co.kr/news/articleView.html?idxno=50425
7811,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.metroseoul.co.kr/article/20200910500173
7812,2020-09-10,대웅제약바이오헬스일자리박람회참가,http://www.kpinews.co.kr/news/articleView.html?idxno=125603
7813,2020-09-10,대웅제약유튜브생중계로구직자와소통,http://www.medigatenews.com/news/2633705491
7814,2020-09-10,오늘의제약한미약품대웅제약식약처SK바이오사이언스파우치박사SK케미칼동국제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39304
7815,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.monews.co.kr/news/articleView.html?idxno=213416
7816,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.nbnnews.co.kr/news/articleView.html?idxno=423389
7817,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.mdtoday.co.kr/mdtoday/index.html?no=398745
7818,2020-09-10,대웅제약LG화학제미글로공동프로모션지속합의,http://www.bokuennews.com/news/article.html?no=194492
7819,2020-09-10,대웅제약2020바이오헬스일자리박람회참가,http://www.segyebiz.com/newsView/20200910518564?OutUrl=naver
7820,2020-09-10,이인애의뒷담화당뇨약에대웅제약웃고한미약품울고,http://theviewers.co.kr/View.aspx?No=1080242
7821,2020-09-10,대웅제약2020바이오헬스일자리박람회참가유튜브생중계로소통,http://www.anewsa.com/detail.php?number=2219655&thread=10
7822,2020-09-10,대웅제약인턴십과경력직채용으로투트랙상시채용계획공개,http://www.worktoday.co.kr/news/articleView.html?idxno=10030
7823,2020-09-10,대웅바이오세무조사종료된듯추징금놓고설왕설래,http://www.sisajournal-e.com/news/articleView.html?idxno=223351
7824,2020-09-10,뉴스투데이L대웅제약2020바이오헬스일자리박람회참가,https://www.news2day.co.kr/160381
7825,2020-09-10,대웅제약PCAB주사제개발나선다임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=398803
7826,2020-09-10,김창수의e뉴스브리핑대웅제약2020바이오헬스일자리박람회참가外,https://www.fetv.co.kr/news/article.html?no=63369
7827,2020-09-11,대웅제약2020바이오헬스일자리박람회참가,http://www.thefirstmedia.net/news/articleView.html?idxno=63042
7828,2020-09-11,김길원의헬스노트보톡스가뭐길래메디vs대웅5년째난타전,http://yna.kr/AKR20200910130000508?did=1195m
7829,2020-09-11,대웅PCAB계열위장약경구제이어주사제개발추진,http://www.dailymedi.com/detail.php?number=860370&thread=22r05
7830,2020-09-11,대웅제약LG화학제미글로2030년까지판다,http://weekly.cnbnews.com/news/article.html?no=135946
7831,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.getnews.co.kr/view.php?ud=2020091409040257042fe691f917_16
7832,2020-09-14,대웅제약카모스타트코로나치료제글로벌임상돌입,https://www.ebn.co.kr/news/view/1450703/?sc=Naver
7833,2020-09-14,대웅제약카모스타트글로벌임상속도멕시코연구자임상개시,http://www.sentv.co.kr/news/view/579307
7834,2020-09-14,대웅제약멕시코서카모스타트코로나19임상2상돌입,http://www.viva100.com/main/view.php?key=20200914010002765
7835,2020-09-14,대웅제약멕시코에서코로나19치료제카모스타트임상개시,http://daily.hankooki.com/lpage/industry/202009/dh20200914091019148390.htm?s_ref=nv
7836,2020-09-14,대웅제약카모스타트코로나19치료제글로벌임상돌입,http://medipana.com/news/news_viewer.asp?NewsNum=262751&MainKind=A&NewsKind=5&vCount=12&vKind=1
7837,2020-09-14,대웅제약한국파스퇴르원자력의학원과코로나치료제멕시코임상개시,https://www.fetv.co.kr/news/article.html?no=63496
7838,2020-09-14,대웅제약카모스타트글로벌임상속도낸다,http://www.press9.kr/news/articleView.html?idxno=45795
7839,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상속도,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=248952
7840,2020-09-14,대웅제약한국파스퇴르연구소코로나19치료제멕시코연구자임상개시,http://www.koreaittimes.com/news/articleView.html?idxno=100369
7841,2020-09-14,대웅제약멕시코서코로나치료제연구자임상개시,http://www.newspim.com/news/view/20200914000159
7842,2020-09-14,대웅호이스타정코로나19치료연구자임상멕시코서개시,http://www.kukinews.com/newsView/kuk202009140033
7843,2020-09-14,대웅제약코로나19치료제카모스타트멕시코서2상임상,https://www.etoday.co.kr/news/view/1940215
7844,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자임상개시,http://www.youthdaily.co.kr/news/article.html?no=47447
7845,2020-09-14,대웅제약멕시코서카모스타트코로나19연구자임상,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009140072&t=NN
7846,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상최초돌입,http://www.paxetv.com/news/articleView.html?idxno=100135
7847,2020-09-14,대웅제약호이스타정멕시코서코로나19효과검증임상2상개시,http://yna.kr/AKR20200914037200017?did=1195m
7848,2020-09-14,대웅제약멕시코에서코로나19치료제임상2상진행,https://biz.chosun.com/site/data/html_dir/2020/09/14/2020091400974.html?utm_source=naver&utm_medium=original&utm_campaign=biz
7849,2020-09-14,대웅제약 카모스타트 코로나19 치료제개발글로벌임상최초돌입,http://www.economytalk.kr/news/articleView.html?idxno=208106
7850,2020-09-14,대웅제약코로나19치료제멕시코연구자임상개시,http://www.fnnews.com/news/202009140942183036
7851,2020-09-14,대웅제약코로나19치료제멕시코연구자임상개시,http://www.fnnews.com/news/202009140942183036
7852,2020-09-14,대웅제약경구용코로나치료제카모스타트멕시코임상돌입,http://www.ekn.kr/news/article.html?no=522969
7853,2020-09-14,대웅제약카모스타트멕시코서코로나19치료제임상2상,http://kbench.com/?q=node/214076
7854,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.lawissue.co.kr/view.php?ud=202009140944118248204ead0791_12
7855,2020-09-14,대웅제약코로나19치료제로호이스타정멕시코2상돌입,http://www.medisobizanews.com/news/articleView.html?idxno=72645
7856,2020-09-14,대웅제약호이스타정멕시코서코로나19치료임상2상,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009140114&t=NN
7857,2020-09-14,대웅제약코로나19치료제호이스타정멕시코2상돌입,http://health.chosun.com/site/data/html_dir/2020/09/14/2020091401025.html
7858,2020-09-14,대웅제약호이스타정멕시코서코로나19임상2상,https://view.asiae.co.kr/article/2020091409554738577
7859,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자임상개시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020091409444849527
7860,2020-09-14,대웅제약카모스타트멕시코임상2상돌입임상확대해코로나19치료제개발가속화”,https://www.donga.com/news/article/all/20200914/102919022/1
7861,2020-09-14,대웅멕시코서카모스타트코로나19연구자임상개시,http://www.dailypharm.com/Users/News/NewsView.html?ID=268440&REFERER=NP
7862,2020-09-14,대웅제약호이스타정코로나19치료제로멕시코연구자임상개시,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572241284379
7863,2020-09-14,대웅제약카모스타트멕시코해외연구자2상임상돌입,http://www.newsprime.co.kr/news/article.html?no=517736
7864,2020-09-14,대웅제약식도염치료제코로나用개발멕시코연구자임상2상,http://news.mt.co.kr/mtview.php?no=2020091409553377616
7865,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63329
7866,2020-09-14,대웅제약멕시코서코로나19치료제임상2상진행,http://inthenews.co.kr/article-68981/
7867,2020-09-14,대웅제약멕시코서코로나19치료제카모스타트2상임상돌입,http://it.chosun.com/site/data/html_dir/2020/09/14/2020091401129.html
7868,2020-09-14,대웅제약파스퇴르연구소원자력의학원멕시코코로나19치료제임상시작,http://www.medigatenews.com/news/1735133745
7869,2020-09-14,대웅제약호이스타정멕시코서코로나19치료제로임상2상돌입,http://www.opinionnews.co.kr/news/articleView.html?idxno=39836
7870,2020-09-14,대웅제약카모스타트코로나19치료제글로벌임상돌입,http://sports.hankooki.com/lpage/economy/202009/sp20200914100854137020.htm?s_ref=nv
7871,2020-09-14,대웅제약∙한국파스퇴르연구소∙한국원자력의학원멕시코연구자임상개시,http://www.healthinnews.co.kr/news/articleView.html?idxno=14412
7872,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://newsbrite.net/141476
7873,2020-09-14,대웅제약코로나19치료제카모스타트해외임상돌입,http://www.businesskorea.co.kr/news/articleView.html?idxno=51729
7874,2020-09-14,대웅제약멕시코서코로나19치료제임상2상시작,http://moneys.mt.co.kr/news/mwView.php?no=2020091410008091681
7875,2020-09-14,대웅제약해외임상통해코로나19치료제연구개발가속화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121476
7876,2020-09-14,대웅제약멕시코서카모스타트코로나19치료제임상2상돌입최초글로벌임상,http://theviewers.co.kr/View.aspx?No=1083335
7877,2020-09-14,대웅제약코로나9치료제카모스타트글로벌임상가속화,http://www.pinpointnews.co.kr/view.php?ud=2020091410235517462365609d9b_45
7878,2020-09-14,대웅제약코로나19치료제멕시코연구자임상개시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1414392
7879,2020-09-14,대웅제약카모스타트코로나19치료제멕시코연구자임상돌입,https://www.dailian.co.kr/news/view/919483/?sc=Naver
7880,2020-09-14,대웅메디톡스보톡스분쟁ITC예비결정에미국전문가반박이어져,http://www.fnnews.com/news/202009141031214685
7881,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상가속화멕시코연구자임상최초,http://www.newslock.co.kr/news/articleView.html?idxno=31014
7882,2020-09-14,대웅제약멕시코서코로나19연구자임상2상진행,https://jhealthmedia.joins.com/article/article_view.asp?pno=22398
7883,2020-09-14,대웅제약코로나치료제개발중인호이스타정멕시코서2상임상돌입,https://www.asiatoday.co.kr/view.php?key=20200914010007825
7884,2020-09-14,대웅코로나치료제카모스타트멕시코연구자임상개시,http://www.whosaeng.com/120845
7885,2020-09-14,대웅제약코로나치료제카모스타트멕시코임상2상착수,http://www.upinews.kr/newsView/upi202009140024
7886,2020-09-14,대웅제약카모스타트글로벌임상속도낸다멕시코연구자임상개시,http://www.thepublic.kr/news/newsview.php?ncode=1065576242159129
7887,2020-09-14,코로나19치료제개발속도내는대웅제약,http://www.sisaweek.com/news/articleView.html?idxno=137506
7888,2020-09-14,대웅제약카모스타트글로벌임상속도낸다,http://www.pharmnews.com/news/articleView.html?idxno=101287
7889,2020-09-14,대웅제약멕시코서코로나19치료제연구자임상개시,http://www.mediapen.com/news/view/557507
7890,2020-09-14,대웅제약카모스타트코로나19치료제개발글로벌임상개시,http://www.dailysmart.co.kr/news/articleView.html?idxno=32694
7891,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자2상개시,https://www.hankyung.com/it/article/202009146553i
7892,2020-09-14,대웅제약코로나치료제멕시코서2상임상개시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1135893&REFERER=NP
7893,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009140208&t=NN
7894,2020-09-14,대웅제약펙수프라잔주사제개발나서임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020091411213945123
7895,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.lawissue.co.kr/view.php?ud=202009141124184569204ead0791_12
7896,2020-09-14,대웅제약위식도역류질환치료제국내최초PCAB주사제임상1상승인,http://www.sentv.co.kr/news/view/579346
7897,2020-09-14,대웅제약펙수프라잔주사제개발국내임상1상승인경구제이어제형다양화,https://www.etoday.co.kr/news/view/1940350
7898,2020-09-14,대웅제약펙수프라잔주사제임상1상승인경구제이어제형다양화선도,http://www.healthinnews.co.kr/news/articleView.html?idxno=14426
7899,2020-09-14,대웅제약멕시코서코로나19치료제연구자임상개시,http://www.kpinews.co.kr/news/articleView.html?idxno=125805
7900,2020-09-14,대웅제약PCAB제제펙수프라잔주사제로개발,http://www.dailypharm.com/Users/News/NewsView.html?ID=268454&REFERER=NP
7901,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.econovill.com/news/articleView.html?idxno=411807
7902,2020-09-14,대웅제약카모스타트코로나치료제멕시코2상임상,http://www.bosa.co.kr/news/articleView.html?idxno=2134328
7903,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,https://www.ebn.co.kr/news/view/1450792/?sc=Naver
7904,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63339
7905,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2134333
7906,2020-09-14,대웅제약국내최초PCAB계열주사제임상1상승인,http://daily.hankooki.com/lpage/industry/202009/dh20200914114725148390.htm?s_ref=nv
7907,2020-09-14,대웅제약신약펙수프라잔주사제1상승인정제이어제형개발다양화,http://www.medisobizanews.com/news/articleView.html?idxno=72659
7908,2020-09-14,대웅제약PCAB펙수프라잔주사제변신도전,http://www.monews.co.kr/news/articleView.html?idxno=213493
7909,2020-09-14,대웅제약카모스타트글로벌임상속도,http://www.monews.co.kr/news/articleView.html?idxno=213489
7910,2020-09-14,대웅제약국내최초PCAB주사제임상1상승인,https://www.hankyung.com/it/article/202009146950i
7911,2020-09-14,대웅제약펙수프라잔제형다양화국내최초PCAB주사제1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=47488
7912,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020091412443216519
7913,2020-09-14,대웅제약위식도역류질환치료제펙수프라잔주사제임상승인,https://www.fetv.co.kr/news/article.html?no=63549
7914,2020-09-14,대웅제약위식도역류치료제펙수프라잔주사제임상1상승인,http://news.mt.co.kr/mtview.php?no=2020091413083337637
7915,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.newsprime.co.kr/news/article.html?no=517781
7916,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=73171
7917,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.metroseoul.co.kr/article/20200914500248
7918,2020-09-14,대웅제약펙수프라잔경구제이어주사제까지제형다양화,http://moneys.mt.co.kr/news/mwView.php?no=2020091413258043789
7919,2020-09-14,대웅제약펙수프라잔임상1상승인해외시장공략박차,http://weekly.hankooki.com/lpage/economy/202009/wk20200914134447146380.htm?s_ref=nv
7920,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=746197
7921,2020-09-14,대웅제약호이스타정멕시코서코로나19치료제임상,http://www.seoulfn.com/news/articleView.html?idxno=395180
7922,2020-09-14,대웅제약펙수프라잔주사제개발착수임상1상승인,http://www.viva100.com/main/view.php?key=20200914010002913
7923,2020-09-14,대웅제약카모스타트글로벌임상속도,http://www.newstomato.com/ReadNews.aspx?no=995837
7924,2020-09-14,국내최초대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.koreaittimes.com/news/articleView.html?idxno=100387
7925,2020-09-14,대웅제약펙수프라잔주사제개발임상1상승인받아,http://www.kpinews.co.kr/news/articleView.html?idxno=125827
7926,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.wsobi.com/news/articleView.html?idxno=104663
7927,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.mhj21.com/134637
7928,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,https://view.asiae.co.kr/article/2020091414241721077
7929,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://www.nbnnews.co.kr/news/articleView.html?idxno=424288
7930,2020-09-14,카모스타트글로벌임상속도낸다대웅제약∙한국파스퇴르연구소∙한국원자력의학원멕시코연구자임상개시,http://www.nbnnews.co.kr/news/articleView.html?idxno=424291
7931,2020-09-14,대웅제약펙수프라잔주사제식약처임상1상승인,https://www.news2day.co.kr/160552
7932,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,http://www.newsis.com/view/?id=NISX20200914_0001165255&cID=13001&pID=13000
7933,2020-09-14,대웅제약카모스타트코로나19치료제로글로벌임상첫돌입,http://news.mk.co.kr/newsRead.php?no=948137&year=2020
7934,2020-09-14,대웅제약카모스타트글로벌임상속도,http://www.mdtoday.co.kr/mdtoday/index.html?no=399042
7935,2020-09-14,대웅제약개발중인코로나19치료제2종글로벌임상순항,http://www.metroseoul.co.kr/article/20200914500367
7936,2020-09-14,대웅제약펙수프라잔주사제개발식약처서임상1상승인,https://www.asiatoday.co.kr/view.php?key=20200914010008134
7937,2020-09-14,대웅제약펙수프라잔주사제개발임상1상승인제형다양화,https://www.sedaily.com/NewsView/1Z7UPIV48Y
7938,2020-09-14,대웅제약코로나19치료제연구자임상2상을멕시코에서시작,http://www.businesspost.co.kr/BP?command=article_view&num=195999
7939,2020-09-14,대웅제약펙수프라잔주사제개발임상1상승인,http://www.mediapen.com/news/view/557640
7940,2020-09-14,대웅제약코로나19치료제개발중인호이스타정멕시코연구자임상개시,https://www.news2day.co.kr/160556
7941,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://sports.hankooki.com/lpage/economy/202009/sp20200914153934137020.htm?s_ref=nv
7942,2020-09-14,대웅제약위식도역류질환치료제펙수프라잔주사제임상1상승인제형다양화선도,http://www.paxetv.com/news/articleView.html?idxno=100205
7943,2020-09-14,대웅제약펙수프라잔주사제임상1상승인적응증추가임상병행,https://www.donga.com/news/article/all/20200914/102927202/1
7944,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://www.worktoday.co.kr/news/articleView.html?idxno=10091
7945,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=399075
7946,2020-09-14,대웅제약연이은해외임상소식코로나19치료제개발속도,http://www.sporbiz.co.kr/news/articleView.html?idxno=468757
7947,2020-09-14,대웅제약코로나19치료제카모스타트멕시코연구자임상개시,http://www.newsway.co.kr/news/view?tp=1&ud=2020091415534436345
7948,2020-09-14,대웅제약호이스타정멕시코에서임상2상시작,http://sports.khan.co.kr/news/sk_index.html?art_id=202009141622003&sec_id=561801&pt=nv
7949,2020-09-14,대웅제약국내최초펙수프라잔주사제임상1상승인,http://www.finomy.com/news/articleView.html?idxno=82962
7950,2020-09-14,대웅제약위식도역류치료제펙수프라잔PCAB주사제임상1상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121508
7951,2020-09-14,대웅제약멕시코서코로나19치료제임상2상돌입,http://www.skyedaily.com/news/news_view.html?ID=111993
7952,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인,https://www.dailian.co.kr/news/view/919696/?sc=Naver
7953,2020-09-14,대웅제약위식도역류질환약펙수프라잔먹는약이어주사제개발임상1상승인,http://theviewers.co.kr/View.aspx?No=1084128
7954,2020-09-14,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://newsbrite.net/141510
7955,2020-09-14,대웅제약코로나19치료제카모스타트임상속도”,http://www.econovill.com/news/articleView.html?idxno=411867
7956,2020-09-14,대웅카모스타트코로나19치료제글로벌임상돌입,http://www.dailymedi.com/detail.php?number=860461&thread=22r05
7957,2020-09-14,대웅제약카모스타트코로나19치료멕시코연구자임상2상개시,https://www.kpanews.co.kr/article/show.asp?idx=216092&category=D
7958,2020-09-14,대웅제약펙수프라잔임상1상승인경구제이어제형다양화,https://www.news1.kr/articles/?4058296
7959,2020-09-14,대웅제약카모스타트멕시코해외연구자2상임상돌입,http://www.anewsa.com/detail.php?number=2222024&thread=10
7960,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.anewsa.com/detail.php?number=2222025&thread=10
7961,2020-09-14,대웅제약멕시코서코로나19대상카모스타트의연구자임상2상돌입,http://news.mk.co.kr/newsRead.php?no=949352&year=2020
7962,2020-09-14,대웅제약펙수프라잔주사제1상승인,http://www.press9.kr/news/articleView.html?idxno=45802
7963,2020-09-14,김창수의e뉴스브리핑대웅제약한국파스퇴르원자력의학원과코로나치료제멕시코임상개시外,https://www.fetv.co.kr/news/article.html?no=63584
7964,2020-09-14,대웅제약위식도역류질환신약후보펙수프라잔주사제로도개발한다,http://news.mk.co.kr/newsRead.php?no=949419&year=2020
7965,2020-09-14,대웅제약카모스타트코로나19글로벌임상속도,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002822
7966,2020-09-14,대웅제약췌장염역류성식도염치료제코로나19해외임상2상진행,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004109022
7967,2020-09-14,대웅펙수프라잔주사제1상임상시험식약처승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=94982
7968,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1320881
7969,2020-09-14,대웅제약펙수프라잔주사제임상1상승인,http://it.chosun.com/site/data/html_dir/2020/09/14/2020091402851.html
7970,2020-09-14,대웅제약펙수프라잔주사제식약처임상1상승인,http://www.iminju.net/news/articleView.html?idxno=57493
7971,2020-09-14,금일의제약업계주요기사대웅제약PCAB주사제1상승인국내최초길리어드이뮤노메딕스전격인수外,http://www.youthdaily.co.kr/news/article.html?no=47526
7972,2020-09-14,대웅제약호이스타정코로나효과입증멕시코서임상2상돌입,http://www.dt.co.kr/contents.html?article_no=2020091502101831102002&ref=naver
7973,2020-09-14,대웅제약펙수프라잔PCAB주사제임상1상승인,http://www.medigatenews.com/news/64540601
7974,2020-09-14,속보보령시청보령코로나확진자태안국방과학연구소방문확인대웅ENG근무자,http://www.ccreview.co.kr/news/articleView.html?idxno=285019
7975,2020-09-14,보령시청12번코로나확진자발생남포면50대남성대웅ENG근무코로나1914일,http://www.kdfnews.com/news/articleView.html?idxno=55941
7976,2020-09-14,대웅제약멕시코서코로나19치료제2상임상돌입,http://www.100ssd.co.kr/news/articleView.html?idxno=71356
7977,2020-09-14,대웅제약코로나19치료제카모스타트글로벌임상최초돌입,http://news.kbiz.or.kr/news/articleView.html?idxno=72479
7978,2020-09-15,블루오션PCAB이노엔대웅제약글로벌시장선도,http://www.dailypharm.com/Users/News/NewsView.html?ID=268473&REFERER=NP
7979,2020-09-15,대웅제약펙수프라잔국내첫PCAB주사제1상승인,http://www.biospectator.com/view/news_view.php?varAtcId=11316
7980,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립글로벌신약개발가속화,http://www.m-i.kr/news/articleView.html?idxno=746444
7981,2020-09-15,대웅제약신약개발전문사아이엔테라퓨틱스신규설립,http://www.sentv.co.kr/news/view/579434
7982,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.lawissue.co.kr/view.php?ud=202009150909172150204ead0791_12
7983,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립글로벌신약개발가속화,http://www.ekn.kr/news/article.html?no=523196
7984,2020-09-15,바이오텍설립으로신약개발에나선대웅제약,http://www.wikileaks-kr.org/news/articleView.html?idxno=94837
7985,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.youthdaily.co.kr/news/article.html?no=47558
7986,2020-09-15,대웅제약첫스핀아웃바이오텍아이엔테라퓨틱스설립,http://news.mt.co.kr/mtview.php?no=2020091509014374388
7987,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://www.getnews.co.kr/view.php?ud=20200915091221152fe691f917_16
7988,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249018
7989,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://yna.kr/AKR20200915037900017?did=1195m
7990,2020-09-15,대웅제약이온채널신약개발전문신규바이오텍설립,http://www.medisobizanews.com/news/articleView.html?idxno=72682
7991,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,https://www.fetv.co.kr/news/article.html?no=63620
7992,2020-09-15,대웅제약 신규바이오텍설립으로글로벌신약개발가속화,http://www.greened.kr/news/articleView.html?idxno=269212
7993,2020-09-15,대웅제약신약개발기업아이엔테라퓨틱스설립,https://www.ebn.co.kr/news/view/1450929/?sc=Naver
7994,2020-09-15,대웅제약신규바이오텍설립2025년IPO목표,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009150070&t=NN
7995,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://www.press9.kr/news/articleView.html?idxno=45812
7996,2020-09-15,대웅제약아이엔테라퓨틱스설립글로벌신약개발가속화,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571347157453
7997,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발에속도,https://www.etoday.co.kr/news/view/1940737
7998,2020-09-15,대웅제약바이오텍아이엔테라퓨틱스 신규설립,http://www.koreastocknews.com/news/articleView.html?idxno=57128
7999,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.mediapen.com/news/view/557850
8000,2020-09-15,대웅제약新바이오텍세워글로벌신약개발가속화,http://news.mk.co.kr/newsRead.php?no=950586&year=2020
8001,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://yna.kr/PYH20200915019600017?did=1196m
8002,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://medipana.com/news/news_viewer.asp?NewsNum=262828&MainKind=A&NewsKind=5&vCount=12&vKind=1
8003,2020-09-15,대웅제약비마약성진통제파이프라인중심신규법인설립,https://jhealthmedia.joins.com/article/article_view.asp?pno=22400
8004,2020-09-15,대웅제약신규바이오텍설립신약개발가속화,https://www.paxnetnews.com/articles/65257
8005,2020-09-15,대웅제약아이엔테라퓨틱스설립혁신신약개발가속화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121526
8006,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63364
8007,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020091509334457010
8008,2020-09-15,대웅제약유망신약파이프라인법인화신약개발가속화,http://www.newsprime.co.kr/news/article.html?no=517892
8009,2020-09-15,대웅제약글로벌신약개발가속화신규바이오텍설립,http://www.seoulwire.com/news/articleView.html?idxno=426545
8010,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://www.enewstoday.co.kr/news/articleView.html?idxno=1414664
8011,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.kpinews.co.kr/news/articleView.html?idxno=125896
8012,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스신설,http://www.newspim.com/news/view/20200915000199
8013,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://it.chosun.com/site/data/html_dir/2020/09/15/2020091501060.html
8014,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.mdtoday.co.kr/mdtoday/index.html?no=399148
8015,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스신규설립신약개발가속화,http://newsbrite.net/141525
8016,2020-09-15,대웅제약신약개발전문기업설립2025년IPO목표,http://www.upinews.kr/newsView/upi202009150016
8017,2020-09-15,대웅제약아이엔테라퓨틱스설립으로글로벌신약개발가속화,http://inthenews.co.kr/article-69152/
8018,2020-09-15,대웅제약아이엔테라퓨틱스설립으로글로벌신약개발가속화,http://inthenews.co.kr/article-69152/
8019,2020-09-15,대웅제약아이엔테라퓨틱스설립2025년IPO목표,https://www.asiatoday.co.kr/view.php?key=20200915010008531
8020,2020-09-15,대웅제약아이엔테라퓨틱스신규설립,http://www.businesskorea.co.kr/news/articleView.html?idxno=51812
8021,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.segye.com/content/html/2020/09/15/20200915508614.html?OutUrl=naver
8022,2020-09-15,대웅제약RD전문바이오텍설립신약개발가속화,http://www.econovill.com/news/articleView.html?idxno=411944
8023,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스신규설립,http://www.dailysmart.co.kr/news/articleView.html?idxno=32750
8024,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://sports.hankooki.com/lpage/economy/202009/sp20200915101556137020.htm?s_ref=nv
8025,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://health.chosun.com/site/data/html_dir/2020/09/15/2020091501253.html
8026,2020-09-15,대웅제약글로벌신약개발위해신규바이오텍설립아이엔테라퓨틱스,http://theviewers.co.kr/View.aspx?No=1236432
8027,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립혁신신약연구개발박차,http://www.pressm.kr/news/articleView.html?idxno=33219
8028,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발속도낸다,http://www.pinpointnews.co.kr/view.php?ud=2020091510352861052365609d9b_45
8029,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://www.healthinnews.co.kr/news/articleView.html?idxno=14446
8030,2020-09-15,대웅제약아이엔테라퓨틱스설립글로벌신약개발가속,http://daily.hankooki.com/lpage/industry/202009/dh20200915103918148390.htm?s_ref=nv
8031,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://www.mhj21.com/134658
8032,2020-09-15,대웅제약바이오텍설립글로벌신약개발가속화,http://www.koreaittimes.com/news/articleView.html?idxno=100417
8033,2020-09-15,대웅제약신약개발기업아이엔테라퓨틱스설립,http://www.fnnews.com/news/202009151045517095
8034,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://news.kbiz.or.kr/news/articleView.html?idxno=72512
8035,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://www.newsway.co.kr/news/view?tp=1&ud=2020091510581673747
8036,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://kormedi.com/?p=1324299
8037,2020-09-15,대웅제약신규바이오텍아이엔테라퓨틱스설립,http://www.newstomato.com/ReadNews.aspx?no=996074
8038,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.metroseoul.co.kr/article/20200915500170
8039,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,https://view.asiae.co.kr/article/2020091511225991157
8040,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립신약개발가속화,http://www.newslock.co.kr/news/articleView.html?idxno=31062
8041,2020-09-15,대웅제약아이엔테라퓨틱스설립2025년IPO목표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2002841
8042,2020-09-15,대웅제약신규바이오텍설립해글로벌신약개발가속화,http://www.medigatenews.com/news/607260617
8043,2020-09-15,대웅제약신규바이오텍설립글로벌신약개발가속화,http://www.bosa.co.kr/news/articleView.html?idxno=2134412
8044,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스스핀아웃,https://www.kpanews.co.kr/article/show.asp?idx=216125&category=D
8045,2020-09-15,대웅제약신약개발기업아이엔테라퓨틱스설립,http://www.smartfn.co.kr/view.php?ud=202009151145118270df6c52f68c_46
8046,2020-09-15,대웅제약아이엔테라퓨틱스설립,http://www.monews.co.kr/news/articleView.html?idxno=213548
8047,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립2025년IPO추진”,http://www.viva100.com/main/view.php?key=20200915010003156
8048,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립코오롱제약출신박종덕대표선임,https://www.donga.com/news/article/all/20200915/102941733/1
8049,2020-09-15,대웅제약신약개발전문기업아이엔타라퓨틱스설립,https://www.hankyung.com/it/article/202009151634i
8050,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스분사,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95011
8051,2020-09-15,대웅제약신약개발가속화위해바이오텍설립,http://www.whosaeng.com/120891
8052,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.nbnnews.co.kr/news/articleView.html?idxno=424705
8053,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립글로벌진출가속화,http://www.sportsseoul.com/news/read/958331?ref=naver
8054,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://news.bizwatch.co.kr/article/consumer/2020/09/15/0012/naver
8055,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스신규설립,https://www.news2day.co.kr/160660
8056,2020-09-15,대웅제약신약개발전문아이엔테라퓨틱스설립,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4281392
8057,2020-09-15,대웅제약신약개발분사하여바이오텍신규설립,http://www.joseilbo.com/news/news_read.php?uid=406272&class=27&grp=
8058,2020-09-15,대웅제약신약개발전문회사아이엔테라퓨틱스설립,http://www.worktoday.co.kr/news/articleView.html?idxno=10121
8059,2020-09-15,대웅제약신규바이오텍설립신약개발가속화,http://www.edaily.co.kr/news/newspath.asp?newsid=03693286625900448
8060,2020-09-15,대웅제약신약개발담당아이엔테라퓨틱스설립,http://www.skyedaily.com/news/news_view.html?ID=112061
8061,2020-09-15,기업대웅제약신약개발전문기업아이엔테라퓨틱스설립,https://www.ytn.co.kr/_ln/0102_202009151627251605
8062,2020-09-15,대웅제약스핀오프바이오벤처아이엔테라퓨틱스출범,http://www.dailypharm.com/Users/News/NewsView.html?ID=268518&REFERER=NP
8063,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://www.anewsa.com/detail.php?number=2222713&thread=10
8064,2020-09-15,대웅제약지사제스멕타11월부터잠정생산중단,http://www.dailypharm.com/Users/News/NewsView.html?ID=268519&REFERER=NP
8065,2020-09-15,오픈이노베이션강화나선대웅제약신약개발속도,http://www.sporbiz.co.kr/news/articleView.html?idxno=468934
8066,2020-09-15,대웅제약아이엔테라퓨틱스세워신약개발 ,http://www.seoulfn.com/news/articleView.html?idxno=395370
8067,2020-09-15,대웅제약신약개발전문기업아이엔테라퓨틱스설립,http://www.finomy.com/news/articleView.html?idxno=83018
8068,2020-09-15,대웅제약신약개발전문자회사설립,http://news.mk.co.kr/newsRead.php?no=953843&year=2020
8069,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.updownnews.co.kr/news/articleView.html?idxno=223273
8070,2020-09-15,대웅제약신규바이오텍설립으로글로벌신약개발가속화,http://www.thefirstmedia.net/news/articleView.html?idxno=63227
8071,2020-09-15,대웅제약신약개발자회사아이엔테라퓨틱스대표에박종덕,http://www.businesspost.co.kr/BP?command=article_view&num=196242
8072,2020-09-15,금일제약업계주요기사삼성바이오에피스에이빈시오오리지널과동등성입증”대웅제약신규바이오텍설립外,http://www.youthdaily.co.kr/news/article.html?no=47636
8073,2020-09-15,대웅제약펙수프라잔국내최초PCAB주사제임상1상승인경구제이어제형다양화선도,http://www.thefirstmedia.net/news/articleView.html?idxno=63244
8074,2020-09-15,바이오텍아이엔테라퓨틱스설립대웅제약글로벌신약개발가속도,http://www.dt.co.kr/contents.html?article_no=2020091602101031102001&ref=naver
8075,2020-09-15,일동이어대웅제약도신약개발전문회사설립,http://www.dailymedi.com/detail.php?number=860512&thread=22r05
8076,2020-09-16,매출1조빨간불위태로운대웅제약돌파구는,http://moneys.mt.co.kr/news/mwView.php?no=2020091116058083725
8077,2020-09-16,메디톡스vs대웅제약보툴리눔톡신논쟁미국서가열,http://www.bosa.co.kr/news/articleView.html?idxno=2134449
8078,2020-09-16,K팜강자나야나”전승호의대웅제약신약개발속도낸다,https://www.fetv.co.kr/news/article.html?no=63766
8079,2020-09-16,우리아기배탈나면어쩌나대웅제약스멕타생산중단경쟁제품에밀려매출감소우려도,http://theviewers.co.kr/View.aspx?No=1238511
8080,2020-09-16,대웅제약카모스타트코로나19치료제개발글로벌임상최초돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=63327
8081,2020-09-16,오늘Who전승호대웅제약위식도역류질환주사제효능입증할까,http://www.businesspost.co.kr/BP?command=article_view&num=196413
8082,2020-09-17,美ITC균주도용대웅이의제기수용할까,https://www.paxnetnews.com/articles/65269
8083,2020-09-17,대성에너지대웅제약등45곳인적자원개발우수기관인증총82개사로늘어,http://www.newspim.com/news/view/20200917000432
8084,2020-09-17,대웅제약등82개기업인적자원관리우수기업에선정,https://www.etoday.co.kr/news/view/1941924
8085,2020-09-18,대웅제약불확실성장기화우려하이투자증권,https://www.ebn.co.kr/news/view/1451470/?sc=Naver
8086,2020-09-18,대웅제약소송불확실성장기화우려하이투자증권목표가하향,http://kpenews.com/View.aspx?No=1240550
8087,2020-09-18,미국ITC대웅제약이의제기수용여부21일결정,https://www.dailian.co.kr/news/view/920833/?sc=Naver
8088,2020-09-18,하이투자증권대웅제약소송불확실성장기화우려,http://www.econovill.com/news/articleView.html?idxno=412412
8089,2020-09-19,대웅제약ITC소송불확실성장기화우려목표가↓,https://view.asiae.co.kr/article/2020091916132849148
8090,2020-09-20,대웅제약이온채널신약개발전문기업설립,http://weekly.cnbnews.com/news/article.html?no=136059
8091,2020-09-20,집단소송당한美에볼루스대웅제약영향촉각,https://www.hankyung.com/it/article/2020092098531
8092,2020-09-20,대웅유나이티드코로나19치료제개발가속녹십자라이넥도청신호,http://weekly.cnbnews.com/news/article.html?no=136066
8093,2020-09-21,나보타美판매사에볼루스상대주주집단소송모집봇물대웅제약도연대책임,http://news.mk.co.kr/newsRead.php?no=970812&year=2020
8094,2020-09-21,대웅제약당뇨신약임상2상서효능안전성입증,http://www.econovill.com/news/articleView.html?idxno=412564
8095,2020-09-21,대웅제약당뇨병신약이나보글리플로진혈당강하안전성입증,http://health.chosun.com/site/data/html_dir/2020/09/21/2020092100663.html
8096,2020-09-21,대웅제약이나보글리플로진당뇨환자혈당강하입증,http://www.press9.kr/news/articleView.html?idxno=45861
8097,2020-09-21,대웅제약당뇨신약임상2상결과최초공개혈당강하및안전성입증,http://www.ekn.kr/news/article.html?no=524368
8098,2020-09-21,대웅제약ICDM서이나보글리플로진2상결과발표,https://www.ebn.co.kr/news/view/1451674/?sc=Naver
8099,2020-09-21,대웅제약당뇨신약임상2상서혈당강하안전성입증,http://www.newsis.com/view/?id=NISX20200921_0001172848&cID=13001&pID=13000
8100,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하안전성입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249254
8101,2020-09-21,대웅제약이나보글리플로진당뇨환자혈당강하안전성입증”,http://www.sentv.co.kr/news/view/579747
8102,2020-09-21,대웅제약이나보글리플로진임상2상서혈당강하입증,http://news.mt.co.kr/mtview.php?no=2020092109062450691
8103,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하와안전성입증,http://www.ceoscoredaily.com/news/article.html?no=73365
8104,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://newsbrite.net/141712
8105,2020-09-21,대웅제약SGLT2억제제당뇨병신약임상2상서안전성입증,http://www.newspim.com/news/view/20200921000190
8106,2020-09-21,대웅제약당뇨병신약임상2상에서당뇨환자혈당강하및안전성입증,https://www.fetv.co.kr/news/article.html?no=64075
8107,2020-09-21,대웅제약이나보글리플로진임상2상혈당강하안전성입증,http://medipana.com/news/news_viewer.asp?NewsNum=263102&MainKind=A&NewsKind=5&vCount=12&vKind=1
8108,2020-09-21,대웅제약SGLT2억제제당뇨병신약혈당강하안전성입증”,https://www.etoday.co.kr/news/view/1942858
8109,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://www.lawissue.co.kr/view.php?ud=20200921093929230107f28b58b8_12
8110,2020-09-21,대웅SGLT2억제제당뇨병신약임상2상서안전성입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=33009
8111,2020-09-21,대웅제약2020ICDM서SGLT2억제제당뇨병신약임상2상구연발표,http://www.medigatenews.com/news/2395043730
8112,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상서효과안전성확인,http://yna.kr/AKR20200921044000017?did=1195m
8113,2020-09-21,대웅제약당뇨신약이나보글리플로진2상서혈당강하안전성입증,http://www.medisobizanews.com/news/articleView.html?idxno=72830
8114,2020-09-21,당뇨환자희소식대웅제약이나보글리플로진임상2상서혈당강하및안정성입증,http://kpenews.com/View.aspx?No=1247663
8115,2020-09-21,대웅제약당뇨신약임상2상서효과안전성확인,https://view.asiae.co.kr/article/2020092110011899721
8116,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하및안전성입증,http://www.m-i.kr/news/articleView.html?idxno=748227
8117,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상2상서혈당강하및안전성입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121729
8118,2020-09-21,대웅제약SGLT2억제당뇨신약임상2상서효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2134778
8119,2020-09-21,대웅제약당뇨치료제임상2상서혈당강하안전성입증,http://sports.hankooki.com/lpage/economy/202009/sp20200921100125137020.htm?s_ref=nv
8120,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자의혈당강하및안전성입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092110024251672
8121,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨병환자혈당강하및안전성입증,http://www.fnnews.com/news/202009211006124366
8122,2020-09-21,대웅제약당뇨신약임상2상서당뇨환자의혈당강하안전성입증,http://www.anewsa.com/detail.php?number=2225873&thread=10
8123,2020-09-21,대웅제약이나보글리플로진임상2상서혈당강하효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020092109338080659
8124,2020-09-21,대웅당뇨신약이나보글리플로진2상결과혈당강하부작용↓확인,http://www.kukinews.com/newsView/kuk202009210067
8125,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자 혈당강하안전성확인,http://www.economytalk.kr/news/articleView.html?idxno=208227
8126,2020-09-21,대웅제약SGLT2당뇨병신약이나보글리플로진임상2상환자혈당강하,http://www.kpinews.co.kr/news/articleView.html?idxno=126408
8127,2020-09-21,대웅제약이나보글리플로진임상2상결과발표혈당강하및안전성입증”,http://www.mdtoday.co.kr/mdtoday/index.html?no=399736
8128,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상2상결과발표혈당강하안전성입증”,https://www.donga.com/news/article/all/20200921/103027221/1
8129,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자의혈당강하및안전성입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63505
8130,2020-09-21,대웅제약SGLT2억제제당뇨병신약임상2상서안전성입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020092110270906541
8131,2020-09-21,대웅제약이나보글리플로진당뇨환자혈당강하안전성입증,http://www.newsprime.co.kr/news/article.html?no=518559
8132,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상서효과안전성확인,http://inthenews.co.kr/article-70043/
8133,2020-09-21,대웅제약ICDM서SGLT2억제제후보의임상2상결과발표,http://news.mk.co.kr/newsRead.php?no=971943&year=2020
8134,2020-09-21,대웅제약당뇨병신약혈당강하및안전성입증,http://www.monews.co.kr/news/articleView.html?idxno=213692
8135,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상서당화혈색소눈에띄게감소,https://www.sedaily.com/NewsView/1Z7XWWJT83
8136,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상효과확인,http://www.pinpointnews.co.kr/view.php?ud=2020092110455896542365609d9b_45
8137,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자혈당강하및안전성확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14557
8138,2020-09-21,대웅제약이나보글리플로진임상2상당뇨환자혈당강하안전성입증,http://www.segye.com/content/html/2020/09/21/20200921510069.html?OutUrl=naver
8139,2020-09-21,대웅제약당뇨병신약이나보글리플로진임상2상서안전성입증,http://www.koreaittimes.com/news/articleView.html?idxno=100546
8140,2020-09-21,대웅제약이나보글리플로진임상2상결과공개,http://www.mhj21.com/134750
8141,2020-09-21,곤란해진대웅제약美에볼루스대상집단소송확산,http://www.segyebiz.com/newsView/20200921510980?OutUrl=naver
8142,2020-09-21,대웅제약이나보글리플로진안전성입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=52122
8143,2020-09-21,대웅제약당뇨신약이나보글리플로진2상서효능안전성입증,https://www.hankyung.com/it/article/202009211593i
8144,2020-09-21,국내코로나19치료제어디까지왔나GC녹십자대웅셀트리온본격화,http://www.m-i.kr/news/articleView.html?idxno=748338
8145,2020-09-21,대웅제약국내최초SGLT2신약임상2상혈당강하및안전성입증,http://www.pharmnews.com/news/articleView.html?idxno=101327
8146,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자혈당강하입증”,http://www.youthdaily.co.kr/news/article.html?no=48139
8147,2020-09-21,대웅제약당뇨신약이나보글리플로진혈당강하및안전성입증,http://www.metroseoul.co.kr/article/20200921500266
8148,2020-09-21,대웅제약이나보글리플로진임상2상당뇨환자혈당강하및안전성입증,http://www.newslock.co.kr/news/articleView.html?idxno=31214
8149,2020-09-21,오늘의제약GC녹십자코로나19혈장치료제첫투여한미약품대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39555
8150,2020-09-21,대웅제약당뇨병약이나보글리플로진효과안전성입증,http://www.seoulfn.com/news/articleView.html?idxno=395884
8151,2020-09-21,대웅제약보툴리눔톡신소송의불확실성을단기간에해소는어려워,http://www.businesspost.co.kr/BP?command=article_view&num=197016
8152,2020-09-21,대웅제약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=426445
8153,2020-09-21,대웅제약이나보글리플로진임상2상서혈당강하및안전성입증국내최초SGLT2억제제당뇨병신약,http://www.thepublic.kr/news/newsview.php?ncode=1065591521705868
8154,2020-09-21,대웅제약미국에천문학적손해배상금지불위기균주도용여부관건,http://theviewers.co.kr/View.aspx?No=1248474
8155,2020-09-21,대웅제약개발중인당뇨병신약임상2상서혈당강하및안전성입증,http://www.mkhealth.co.kr/news/articleView.html?idxno=50568
8156,2020-09-21,대웅제약SGLT2당뇨병치료제임상2상효과안전성확인,https://www.dailian.co.kr/news/view/921517/?sc=Naver
8157,2020-09-21,대웅제약2형당뇨병SGLT2저해제2상긍정적,http://www.biospectator.com/view/news_view.php?varAtcId=11361
8158,2020-09-21,대웅제약당뇨치료제임상2상서효과안전성확인,http://www.dt.co.kr/contents.html?article_no=2020092102109931102001&ref=naver
8159,2020-09-21,대웅제약당뇨약이나보글리플로진임상2상결과발표혈당강하및안전성입증,http://theviewers.co.kr/View.aspx?No=1248648
8160,2020-09-21,대웅제약당뇨신약이나보글리플로진임상2상서효과안전성확인,http://hobbyen.co.kr/news/newsview.php?ncode=1065601486107589
8161,2020-09-21,한미약품대웅제약신약임상3상보인다,https://www.sedaily.com/NewsView/1Z7XXGG6MN
8162,2020-09-21,뉴스투데이L대웅제약당뇨병치료제이나보글리플로진임상2상결과최초발표,https://www.news2day.co.kr/161008
8163,2020-09-21,대웅제약이나보글리플로진임상2상서당뇨환자의혈당강하및안전성입증,http://www.wsobi.com/news/articleView.html?idxno=105164
8164,2020-09-21,대웅제약당뇨병치료제임상2상서효과안전성확인,https://biz.chosun.com/site/data/html_dir/2020/09/21/2020092102657.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8165,2020-09-22,대웅제약당뇨병신약이나보글리플로진임상2상에서당뇨환자의혈당강하및안전성입증,http://www.thefirstmedia.net/news/articleView.html?idxno=63537
8166,2020-09-22,대웅제약이나보글리플로진2상서혈당강하안전성입증,https://www.kpanews.co.kr/article/show.asp?idx=216265&category=D
8167,2020-09-22,제약업계소식보령제약투베로멕시코발매대웅제약아이엔테라퓨틱스설립태반주사제라이넥러시아서코로나19치료효과확인종근당바이오시밀러네스벨동남아3개국수출한미헬스케어,http://www.newsian.co.kr/news/articleView.html?idxno=43424
8168,2020-09-22,2020추석선물대웅제약임팩타민코로나19에지친우리가족피로회복,http://www.m-i.kr/news/articleView.html?idxno=748253
8169,2020-09-22,대웅제약당뇨병신약이나보글리플로진혈당강하안전입증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003072
8170,2020-09-22,단독전승호대웅제약대표ITC이의제기수용최선의결과,https://view.asiae.co.kr/article/2020092208260976972
8171,2020-09-22,대웅제약보톡스美판매금지10년ITC재검토결정에메디톡스문제없다,http://moneys.mt.co.kr/news/mwView.php?no=2020092208228030233
8172,2020-09-22,美ITC위원회대웅제약의이의제기일부재검토결정,http://news.mt.co.kr/mtview.php?no=2020092208111871321
8173,2020-09-22,美 ITC대웅이의제기중일부재검토메디톡스재검토는통상적절차,http://www.medisobizanews.com/news/articleView.html?idxno=72862
8174,2020-09-22,보톡스분쟁美ITC위원회대웅제약이의제기중일부재검토,http://www.ekn.kr/news/article.html?no=524615
8175,2020-09-22,보톡스분쟁美ITC위원회대웅제약이의제기중일부재검토,http://www.ekn.kr/news/article.html?no=524615
8176,2020-09-22,메디톡스대웅제약이의제기중일부재검토는통상적절차”,http://www.newsway.co.kr/news/view?tp=1&ud=2020092208522424398
8177,2020-09-22,美ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://www.newsway.co.kr/news/view?tp=1&ud=2020092208520402358
8178,2020-09-22,대웅제약ITC전면재검토결정보톡스분쟁다시원점,http://www.medisobizanews.com/news/articleView.html?idxno=72863
8179,2020-09-22,메디톡스美ITC위원회대웅제약이의일부재검토수용했지만예비판결바뀌는경우거의없어,http://www.entermedia.co.kr/news/articleView.html?idxno=20487
8180,2020-09-22,대웅제약메디톡스보톡스분쟁다시원점,http://www.bosa.co.kr/news/articleView.html?idxno=2134851
8181,2020-09-22,美ITC대웅제약이의제기일부재검토,http://www.newspim.com/news/view/20200922000124
8182,2020-09-22,대웅제약美ITC예비결정오판ITC이의제기수용,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092208255320841
8183,2020-09-22,대웅메디톡스보톡스분쟁원점ITC전면재검토결정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249311
8184,2020-09-22,대웅제약당뇨신약이나보글리플로진효과안전성입증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1323556
8185,2020-09-22,대웅제약당뇨신약이나보글리플로진효과안전성입증,http://www.shinailbo.co.kr/news/articleView.html?idxno=1323556
8186,2020-09-22,대웅ITC전면재검토결정으로보톡스분쟁다시원점,http://www.m-i.kr/news/articleView.html?idxno=748640
8187,2020-09-22,美ITC위원회대웅의이의제기중일부재검토결정메디톡스재검토로예판바뀌는경우매우낮아,http://www.m-i.kr/news/articleView.html?idxno=748632
8188,2020-09-22,미ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점으로,http://www.fnnews.com/news/202009220851426929
8189,2020-09-22,美ITC대웅제약메디톡스균주분쟁예비판결일부재검토결정,http://www.youthdaily.co.kr/news/article.html?no=48207
8190,2020-09-22,대웅제약ITC예비판결재검토보톡스분쟁원점”,http://www.sentv.co.kr/news/view/579828
8191,2020-09-22,대웅제약ITC보톡스도용인정하는예비결정재검토결정”,https://www.etoday.co.kr/news/view/1943288
8192,2020-09-22,대웅제약메디톡스보톡스분쟁2차전美ITC예비판결재검토,http://www.startuptoday.co.kr/news/articleView.html?idxno=54953
8193,2020-09-22,특징주대웅ITC전면재검토결정에보톡스분쟁장초반상승,http://moneys.mt.co.kr/news/mwView.php?no=2020092209048012198
8194,2020-09-22,대웅제약메디톡스보톡스분쟁원점되나美ITC예비판결재검토결정,https://biz.chosun.com/site/data/html_dir/2020/09/22/2020092200795.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8195,2020-09-22,ITC대웅메디톡스분쟁재검토결정이의제기받아들여,http://medipana.com/news/news_viewer.asp?NewsNum=263173&MainKind=A&NewsKind=5&vCount=12&vKind=1
8196,2020-09-22,대웅제약ITC전면재검토결정보톡스분쟁다시원점”,http://www.viva100.com/main/view.php?key=20200922010004563
8197,2020-09-22,미국ITC대웅제약이의제기일부재검토결정,http://inthenews.co.kr/article-70208/
8198,2020-09-22,메디톡스ITC예비판결재검토대웅이의제기에다른통상적이고일반적절차일뿐”,http://theviewers.co.kr/View.aspx?No=1248950
8199,2020-09-22,美에볼루스사예비결정이의제기수용대웅메디톡스보톡스분쟁원점재검토,http://www.pressm.kr/news/articleView.html?idxno=33373
8200,2020-09-22,대웅제약美ITC예비판결재검토결정보톡스분쟁다시원점,http://news.mk.co.kr/newsRead.php?no=975871&year=2020
8201,2020-09-22,대웅제약vs메디톡스보톡스전쟁원점으로ITC전면재검토결정”,https://www.fetv.co.kr/news/article.html?no=64182
8202,2020-09-22,美ITC예비판결일부재검토대웅제약다시원점,http://www.newspim.com/news/view/20200922000159
8203,2020-09-22,美ITC대웅제약이의제기중일부재검토결정”메디톡스통상적일반적절차일뿐”,https://www.fetv.co.kr/news/article.html?no=64186
8204,2020-09-22,메디톡스ITC위원회대웅의일부재검토는통상적이고일반적절차”,http://www.pinpointnews.co.kr/view.php?ud=202009220930049304f090c8dbcb_45
8205,2020-09-22,미국ITC대웅제약메디톡스예비판결일부재검토결정,http://news.tf.co.kr/read/economy/1814241.htm
8206,2020-09-22,대웅제약메디톡스분쟁새국면맞나ITC예비판결재검토종합,http://yna.kr/AKR20200922029551017?did=1195m
8207,2020-09-22,대웅제약ITC재검토결정보톡스분쟁다시원점,http://www.press9.kr/news/articleView.html?idxno=45871
8208,2020-09-22,美ITC대웅제약메디톡스예비결정재검토 ,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95155
8209,2020-09-22,대웅제약美ITC톡신분쟁이의제기에재검토결정,http://www.dailypharm.com/Users/News/NewsView.html?ID=268716&REFERER=NP
8210,2020-09-22,대웅제약ITC이의제기수용보톡스분쟁원점으로,https://view.asiae.co.kr/article/2020092209433957790
8211,2020-09-22,메디톡스통상적절차일뿐vs대웅제약원점재검토,http://www.wikileaks-kr.org/news/articleView.html?idxno=95316
8212,2020-09-22,美ITC재검토결정대웅제약메디톡스보톡스분쟁11월최종결정,http://news.mt.co.kr/mtview.php?no=2020092209280706122
8213,2020-09-22,대웅메디톡스보톡스전쟁 새로운국면맞나,http://www.koreastocknews.com/news/articleView.html?idxno=57349
8214,2020-09-22,미국ITC예비판결뒤집을까대웅제약이의제기수용재검토,https://www.news1.kr/articles/?4066009
8215,2020-09-22,오늘의제약메디톡스vs대웅제약아스트라제네카삼성바이오로직스종근당홀딩스동화약품,http://www.babytimes.co.kr/news/articleView.html?idxno=39588
8216,2020-09-22,ITC예비결정재검토대웅제약원점재검토vs메디톡스통상적절차,http://www.seoulwire.com/news/articleView.html?idxno=426871
8217,2020-09-22,대웅제약메디톡스보톡스분쟁다시원점,http://www.businesskorea.co.kr/news/articleView.html?idxno=52176
8218,2020-09-22,미국ITC메디톡스대웅제약보톡스분쟁재검토,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004117623
8219,2020-09-22,美ITC대웅제약의의제기수용보툴리눔균주논란2R,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136065&REFERER=NP
8220,2020-09-22,대웅제약美ITC예비판결재검토메디톡스통상적인절차반박,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009220095&t=NN
8221,2020-09-22,美ITC위원회대웅의이의제기받아들여,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63529
8222,2020-09-22,ITC대웅메디톡스보톡스분쟁전면재검토,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=121776
8223,2020-09-22,美ITC이의제기재검토대웅메디톡스보톡스분쟁원점,http://www.newsprime.co.kr/news/article.html?no=518736
8224,2020-09-22,메디톡스美ITC대웅의이의제기중일부재검토는통상적인절차,http://www.kpinews.co.kr/news/articleView.html?idxno=126542
8225,2020-09-22,메디톡스美ITC대웅의이의제기중일부재검토는통상적인절차,http://www.kpinews.co.kr/news/articleView.html?idxno=126542
8226,2020-09-22,대웅메디톡스보톡스분쟁ITC예비판결재검토로상황역전,http://news.heraldcorp.com/view.php?ud=20200922000207
8227,2020-09-22,대웅메디톡스끝나지않은보톡스전쟁ITC예비판결재검토,http://www.sisafocus.co.kr/news/articleView.html?idxno=248042
8228,2020-09-22,美ITC대웅제약메디톡스균주분쟁예비판결재검토결정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092210140183018
8229,2020-09-22,대웅제약메디톡스보톡스분쟁2차전ITC예비판결재검토,http://www.newsworks.co.kr/news/articleView.html?idxno=489885
8230,2020-09-22,美ITC예비판결재검토보톡스大戰반격나선대웅제약,http://www.dt.co.kr/contents.html?article_no=2020092202109931102002&ref=naver
8231,2020-09-22,미국ITC나보타사건다시본다대웅메디톡스기싸움이어져,https://www.kpanews.co.kr/article/show.asp?idx=216272&category=D
8232,2020-09-22,ITC보툴리눔균예비판결재검토대웅제약이의수용,https://hankookilbo.com/News/Read/A2020092210210005456?did=NA
8233,2020-09-22,대웅제약美ITC예비판결재검토결정보톡스분쟁다시원점,http://www.dailysmart.co.kr/news/articleView.html?idxno=33100
8234,2020-09-22,대웅제약메디톡스보톡스분쟁ITC전면재검토결정,http://www.healthinnews.co.kr/news/articleView.html?idxno=14595
8235,2020-09-22,미ITC예비판결재검토대웅메디톡스분쟁새국면,http://www.cstimes.com/news/articleView.html?idxno=431645
8236,2020-09-22,ITC예비판결재검토대웅최종승소자신vs메디통상절차종합,https://view.asiae.co.kr/article/2020092210350339302
8237,2020-09-22,대웅제약vs메디톡스새국면美ITC대웅이의신청수용,http://www.dailymedi.com/detail.php?number=860740&thread=22r05
8238,2020-09-22,보톡스분쟁새국면대웅제약美ITC재검토vs메디톡스통상절차불과,http://www.upinews.kr/newsView/upi202009220018
8239,2020-09-22,ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://newsbrite.net/141765
8240,2020-09-22,ITC대웅이의제기일부수용11월6일최종판결,https://www.paxnetnews.com/articles/65464
8241,2020-09-22,대웅제약메디톡스미국소송새국면,http://www.whosaeng.com/121069
8242,2020-09-22,대웅제약메디톡스분쟁원점美ITC예비판결재검토,http://it.chosun.com/site/data/html_dir/2020/09/22/2020092201277.html
8243,2020-09-22,ITC이의제기수용메디톡스통상적절차vs대웅제약다시원점,http://www.mediapen.com/news/view/559932
8244,2020-09-22,美ITC위원회대웅의이의제기중일부재검토결정,http://www.joseilbo.com/news/news_read.php?uid=406755&class=27&grp=
8245,2020-09-22,관심종목메디톡스대웅제약ITC재검토에동시약세,http://www.getnews.co.kr/view.php?ud=2020092210485240872aaae0046f_16
8246,2020-09-22,ITC예비판결재검토대웅제약vs메디톡스새국면,https://ilyo.co.kr/?ac=article_view&entry_id=380566
8247,2020-09-22,ITC전면재검토결정대웅메디톡스보톡스분쟁재점화,https://www.dailian.co.kr/news/view/921684/?sc=Naver
8248,2020-09-22,대웅제약섭취편의성높인비타민2종출시,http://www.press9.kr/news/articleView.html?idxno=45882
8249,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.lawissue.co.kr/view.php?ud=202009221111066710204ead0791_12
8250,2020-09-22,대웅VS메디톡스보툴리눔전쟁ITC재검토,http://www.monews.co.kr/news/articleView.html?idxno=213734
8251,2020-09-22,국립야생동물질병관리원신설야생동물질병대웅체계강화,https://www.asiatoday.co.kr/view.php?key=20200922010013430
8252,2020-09-22,ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009221048156230997
8253,2020-09-22,대웅제약ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://www.ceoscoredaily.com/news/article.html?no=73421
8254,2020-09-22,대웅제약ITC전면재검토결정보톡스분쟁원점”,http://www.econovill.com/news/articleView.html?idxno=412787
8255,2020-09-22,대웅제약섭취편리한비타민건기식대웅비타C등2종출시,http://www.medisobizanews.com/news/articleView.html?idxno=72888
8256,2020-09-22,대웅제약비타민건강기능식품2종출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=52197
8257,2020-09-22,대웅제약섭취편의성높인비타민건기식2종출시,http://medipana.com/news/news_viewer.asp?NewsNum=263201&MainKind=A&NewsKind=5&vCount=12&vKind=1
8258,2020-09-22,대웅제약메디톡스보톡스분쟁다시원점ITC전면재검토결정,http://www.anewsa.com/detail.php?number=2226769&thread=10
8259,2020-09-22,대웅제약비타민건강기능식품2종출시섭취편의성높여,http://www.anewsa.com/detail.php?number=2226774&thread=10
8260,2020-09-22,ITC대웅메디톡스보톡스분쟁재검토결정,http://www.mkhealth.co.kr/news/articleView.html?idxno=50582
8261,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.metroseoul.co.kr/article/20200922500226
8262,2020-09-22,대웅제약비타민건강기능식품2종출시,http://news.mk.co.kr/newsRead.php?no=977352&year=2020
8263,2020-09-22,보톡스분쟁대웅메디톡스美ITC재검토”상반된해석,http://www.biospectator.com/view/news_view.php?varAtcId=11367
8264,2020-09-22,오늘의제약GC녹십자웰빙동아ST슈가논광동제약대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39596
8265,2020-09-22,대웅제약섭취편의성높인비타민건기식2종출시,https://www.fetv.co.kr/news/article.html?no=64239
8266,2020-09-22,대웅제약비타민건강기능식품2종출시섭취편의성개선,http://theviewers.co.kr/View.aspx?No=1249559
8267,2020-09-22,메디톡스손들어줬던ITC예비판결재검토대웅제약승기잡나,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4288467
8268,2020-09-22,대웅제약비타민건강기능식품2종출시,http://news.mt.co.kr/mtview.php?no=2020092213073864271
8269,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://newsbrite.net/141777
8270,2020-09-22,대웅메디톡스보톡스분쟁ITC예비판결재검토로역전,http://news.heraldcorp.com/view.php?ud=20200922000582
8271,2020-09-22,대웅제약섭취편의성높인비타민2종출시,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009221358133510029
8272,2020-09-22,ITC재검토결정에대웅제약메디톡스보톡스분쟁새국면맞나,https://www.fetv.co.kr/news/article.html?no=64255
8273,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=426843
8274,2020-09-22,ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://www.nbnnews.co.kr/news/articleView.html?idxno=426868
8275,2020-09-22,미국국제무역위대웅제약과메디톡스균주다툼의예비판결재검토,http://www.businesspost.co.kr/BP?command=article_view&num=197226
8276,2020-09-22,대웅제약섭취편의성높인비타민건기식2종출시,http://www.econovill.com/news/articleView.html?idxno=412829
8277,2020-09-22,ITC전면재검토결정대웅제약의미있다vs메디톡스통상적절차,http://www.opinionnews.co.kr/news/articleView.html?idxno=40392
8278,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.thefirstmedia.net/news/articleView.html?idxno=63552
8279,2020-09-22,대웅제약美ITC전면재검토결정대웅메디톡스보톡스분쟁다시원점,http://www.kpinews.co.kr/news/articleView.html?idxno=126596
8280,2020-09-22,대웅제약메디톡스ITC예비판결재검토보톡스분쟁원점,http://www.thevaluenews.co.kr/news/view.php?idx=160906
8281,2020-09-22,대웅메디톡스보톡스전쟁다시원점美ITC대웅제약이의제기받아들여재검토,http://www.todaykorea.co.kr/news/articleView.html?idxno=276947
8282,2020-09-22,종합美ITC예비판결재검토결정메디톡스대웅운명뒤바꿀까,https://www.etoday.co.kr/news/view/1943528
8283,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.kpinews.co.kr/news/articleView.html?idxno=126597
8284,2020-09-22,ITC재검토에대웅제약예비판결뒤집고승소VS메디톡스일반절차일상톡톡플러스,http://www.segye.com/content/html/2020/09/22/20200922511406.html?OutUrl=naver
8285,2020-09-22,ITC보톡스전쟁예비판결재검토대웅제약메디톡스반응엇갈려,http://www.sportsseoul.com/news/read/960865?ref=naver
8286,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시비타민제제라인업구축,http://www.updownnews.co.kr/news/articleView.html?idxno=223561
8287,2020-09-22,미ITC예비판결재검토대웅VS메디톡스보툴리눔분쟁새국면,http://www.rapportian.com/news/articleView.html?idxno=127952
8288,2020-09-22,대웅제약메디톡스보톡스분쟁ITC재검토결정,http://www.koreaittimes.com/news/articleView.html?idxno=100591
8289,2020-09-22,이데일리N미국ITC대웅제약메디톡스예비판결일부재검토결정外,http://www.edaily.co.kr/news/newspath.asp?newsid=03585046625902744
8290,2020-09-22,대웅제약메디톡스분쟁새국면맞나ITC예비판결재검토,http://www.seouleconews.com/news/articleView.html?idxno=56804
8291,2020-09-22,대웅제약메디톡스ITC재판새국면분쟁원점”VS절차일뿐”,http://daily.hankooki.com/lpage/industry/202009/dh20200922160530148390.htm?s_ref=nv
8292,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63558
8293,2020-09-22,대웅제약메디톡스보톡스분쟁새국면ITC예비판결재검토,http://www.etnews.com/20200922000230
8294,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.youthdaily.co.kr/news/article.html?no=48276
8295,2020-09-22,보톡스일부재검토대웅제약분쟁원점vs메디톡스통상적절차,http://news.mk.co.kr/newsRead.php?no=978898&year=2020
8296,2020-09-22,대웅제약美ITC예비결정뒤엎나이의제기받아들여져,http://hobbyen.co.kr/news/newsview.php?ncode=1065597228304291
8297,2020-09-22,대웅제약건강기능식품시장강화,http://www.g-enews.com/ko-kr/news/article/news_all/20200922160004160869d76442fa_1/article.html
8298,2020-09-22,단독메디톡스대웅美 ITC 판결왜곡된재검토범위전면일부,http://www.mkhealth.co.kr/news/articleView.html?idxno=50594
8299,2020-09-22,미국ITC예비판결재검토대웅제약메디톡스엇갈린반응,http://sports.hankooki.com/lpage/economy/202009/sp20200922162153137020.htm?s_ref=nv
8300,2020-09-22,보툴리눔균주戰ITC예비판결재검토”장외신경전ING대웅제약이례적”vs메디톡스일반적”,http://www.thepublic.kr/news/newsview.php?ncode=1065591591868682
8301,2020-09-22,ITC예비판결전면재검토결정대웅제약vs메디톡스보톡스분쟁새국면맞나,http://www.updownnews.co.kr/news/articleView.html?idxno=223565
8302,2020-09-22,대웅제약메디톡스發보톡스전쟁ITC재검토결정환영오류잡아승소할것,http://www.newslock.co.kr/news/articleView.html?idxno=31239
8303,2020-09-22,美ITC재검토에대웅제약최종결정승소확신메디톡스통상적인절차일뿐,http://www.mdtoday.co.kr/mdtoday/index.html?no=399982
8304,2020-09-22,대웅메디톡스보톡스분쟁다시원점ITC전면재검토결정,http://www.worktoday.co.kr/news/articleView.html?idxno=10319
8305,2020-09-22,대웅제약메디톡스美보톡스분쟁원점으로ITC예비판정재검토,http://www.finomy.com/news/articleView.html?idxno=83309
8306,2020-09-22,대웅제약비타민시장확대대웅비타C대웅비타D2800IU출시,http://kpenews.com/View.aspx?No=1250269
8307,2020-09-22,대웅제약이의제기에따라ICT전면재검토결정,http://www.medigatenews.com/news/1070289645
8308,2020-09-22,뉴스투데이L대웅제약비타민건강기능식품2종출시,https://www.news2day.co.kr/161093
8309,2020-09-22,김창수의e뉴스브리핑ITC재검토결정에대웅제약메디톡스보톡스분쟁새국면맞나外,https://www.fetv.co.kr/news/article.html?no=64266
8310,2020-09-22,ITC대웅제약손들어줘메디톡스와소송전새국면,http://www.doctorstimes.com/news/articleView.html?idxno=212502
8311,2020-09-22,ITC예비결정전반재검토대웅메디톡스보톡스분쟁오리무중,http://www.thefirstmedia.net/news/articleView.html?idxno=63623
8312,2020-09-22,美ITC위원회대웅의이의제기중일부재검토결정재검토는통상적이고일반적인절차일뿐,http://www.thefirstmedia.net/news/articleView.html?idxno=63611
8313,2020-09-22,대웅메디톡스보톡스분쟁원점으로ITC예비판결재검토,https://www.news2day.co.kr/161096
8314,2020-09-22,금일제약업계주요기사하루만에뒤바뀐합격자제일약품취준생분통美ITC대웅제약메디톡스균주분쟁예비판결일부재검토外,http://www.youthdaily.co.kr/news/article.html?no=48295
8315,2020-09-22,대웅메디톡스보톡스분쟁ITC예비결정재검토,http://www.ajunews.com/view/20200922103454426
8316,2020-09-22,ITC전면재검토결정대웅제약VS메디톡스대립11월6일최종결정,http://medicalworldnews.co.kr/news/view.php?idx=1510937750
8317,2020-09-22,대웅메디톡스분쟁예비판결재검토”,http://www.sentv.co.kr/news/view/579886
8318,2020-09-22,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=400053
8319,2020-09-23,대웅제약섭취편의높인비타민건강기능식품2종선봬,https://www.kpanews.co.kr/article/show.asp?idx=216300&category=D
8320,2020-09-23,균주전쟁5년대웅제약메디톡스11월6일최종결판,http://www.g-enews.com/ko-kr/news/article/news_all/20200922114339528469d76442fa_1/article.html
8321,2020-09-23,ITC재검토결정에재점화되는대웅메디톡스갈등,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003123
8322,2020-09-23,대웅제약불확실성장기화에대한우려,http://www.g-enews.com/ko-kr/news/article/news_all/202009230720003623442088f476_1/article.html
8323,2020-09-23,대웅제약섭취편의성높인비타민건강기능식품2종출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249389
8324,2020-09-23,대웅제약섭취편의성높인비타민2종출시,http://www.polinews.co.kr/news/article.html?no=475289
8325,2020-09-23,WhoIs윤재춘대웅제약대표이사사장,http://www.businesspost.co.kr/BP?command=article_view&num=197361
8326,2020-09-23,ITC예비판결재검토로새국면반격나선대웅제약,https://www.dailian.co.kr/news/view/922127/?sc=Naver
8327,2020-09-24,식품대웅제약임팩타민비타민B8종에생체이용률8배쑥항산화면역력유지에방점,http://news.mk.co.kr/newsRead.php?no=985452&year=2020
8328,2020-09-24,대웅LG동아외자사독주SGLT2억제제도전장,http://www.dailymedi.com/detail.php?number=860824&thread=22r05
8329,2020-09-24,대웅제약상반기구긴자존심하반기회복잰걸음,http://www.sporbiz.co.kr/news/articleView.html?idxno=470119
8330,2020-09-24,대웅제약글로벌제약사장악당뇨병치료제도전전승호국산화의지,http://www.businesspost.co.kr/BP?command=article_view&num=197662
8331,2020-09-25,엎치락뒤치락메디톡스vs대웅제약→앨러간어부지리,http://www.dailymedi.com/detail.php?number=860878&thread=22r12
8332,2020-09-25,티앤엘11월초코스닥상장추진중외제약대웅제약독일로만라우셔등에제품공급,http://www.econonews.co.kr/news/articleView.html?idxno=138162
8333,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63643
8334,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박나서,http://medipana.com/news/news_viewer.asp?NewsNum=263423&MainKind=A&NewsKind=5&vCount=12&vKind=1
8335,2020-09-25,대웅제약신규보툴리눔균주구매예비결정반박증거제출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249541
8336,2020-09-25,대웅제약신규보툴리눔균주구매통해ITC예비결정반박증거제출,http://www.ceoscoredaily.com/news/article.html?no=73566
8337,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092510263566818
8338,2020-09-25,대웅제약미국서보툴리눔톡신구매과거에도쉽게구할수있었다,https://www.dailian.co.kr/news/view/922676/?sc=Naver
8339,2020-09-25,대웅제약보툴리눔균주구매예비결정반박증거제출,http://www.businesskorea.co.kr/news/articleView.html?idxno=52407
8340,2020-09-25,대웅제약보툴리눔균주쉽게구매가능메디톡스반박,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009250129&t=NN
8341,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://newsbrite.net/141926
8342,2020-09-25,대웅제약신규보툴리눔균주구매ITC예비결정반박증거제출,http://www.medisobizanews.com/news/articleView.html?idxno=72990
8343,2020-09-25,대웅제약美ITC에신규보툴리눔균주구매통해예비결정반박증거제출,http://www.kpinews.co.kr/news/articleView.html?idxno=126932
8344,2020-09-25,대웅제약보툴리눔균주어디서나쉽게구할수있어ITC에추가자료제출,https://www.sedaily.com/NewsView/1Z7ZQCSXC3
8345,2020-09-25,대웅제약신규보툴리눔균주구매ITC예비결정반박증거제출,https://www.asiatoday.co.kr/view.php?key=20200925010015911
8346,2020-09-25,보툴리눔균주못산다고대웅제약ITC에반박자료제출,http://www.newsis.com/view/?id=NISX20200925_0001179488&cID=13001&pID=13000
8347,2020-09-25,대웅제약보툴리눔균주구매예비결정반박증거제출,http://www.press9.kr/news/articleView.html?idxno=45916
8348,2020-09-25,대웅제약보툴리눔균주구매가능해”ITC에반박증거자료제출,http://www.viva100.com/main/view.php?key=20200925010005488
8349,2020-09-25,대웅제약신규보툴리눔균주구매예비결정반박증거제출,http://www.newsprime.co.kr/news/article.html?no=519230
8350,2020-09-25,대웅제약ITC에추가자료제출⋯보툴리눔균주어디서나구할수있다,https://biz.chosun.com/site/data/html_dir/2020/09/25/2020092501585.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8351,2020-09-25,대웅제약보툴리눔균주구매가능해ITC예비결정반박증거제출,http://www.newspim.com/news/view/20200925000508
8352,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.medigatenews.com/news/1854856702
8353,2020-09-25,보란듯이새보툴리눔산대웅제약영업비밀아니다,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136167&REFERER=NP
8354,2020-09-25,대웅신규보툴리눔균주구매‥예비결정반박증거제출,http://www.bosa.co.kr/news/articleView.html?idxno=2135169
8355,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.pharmnews.com/news/articleView.html?idxno=101361
8356,2020-09-25,대웅제약비타민건강기능식품2종출시,http://www.wsobi.com/news/articleView.html?idxno=105412
8357,2020-09-25,대웅보툴리눔균주지금도구매가능메디톡스주장오류,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003236
8358,2020-09-25,균주어디서나구할수있다대웅ITC에추가자료제출,https://view.asiae.co.kr/article/2020092513051351457
8359,2020-09-25,대웅제약신규보툴리눔균주구매ITC예비결정반박증거제출,https://www.fetv.co.kr/news/article.html?no=64592
8360,2020-09-25,대웅제약신규보툴리늄균주구매ITC예비결정반박증거제출”,https://www.hankyung.com/it/article/202009250808i
8361,2020-09-25,대웅제약보툴리눔균주신규구매메디톡스영업비밀침해판결반박,https://www.etoday.co.kr/news/view/1944883
8362,2020-09-25,대웅제약보툴리눔균주쉽게구매”예비결정반박증거제출,http://www.mdtoday.co.kr/mdtoday/index.html?no=400433
8363,2020-09-25,대웅제약미국에서새보툴리눔균주구매쉽게구할수있음입증,http://www.businesspost.co.kr/BP?command=article_view&num=197816
8364,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.metroseoul.co.kr/article/20200925500127
8365,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.thefirstmedia.net/news/articleView.html?idxno=63811
8366,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.nbnnews.co.kr/news/articleView.html?idxno=428088
8367,2020-09-25,대웅대웅제약같은상승세지만흐름달라특히대웅오후갑작스런7급등,http://www.econonews.co.kr/news/articleView.html?idxno=138284
8368,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://www.anewsa.com/detail.php?number=2229390&thread=10
8369,2020-09-25,대웅주가상승세보툴리눔균주구매메디톡스반박의견서제출,http://kpenews.com/View.aspx?No=1265518
8370,2020-09-25,대웅제약신규홀A하이퍼보툴리눔균주구매,http://news.mk.co.kr/newsRead.php?no=993620&year=2020
8371,2020-09-25,메디톡스쉽게구매가능한균주를어렵게개발대웅주장대응가치없어,http://www.thefirstmedia.net/news/articleView.html?idxno=63854
8372,2020-09-25,대웅제약신규보툴리눔균주구매통해예비결정반박증거제출,http://newsclaim.co.kr/View.aspx?No=1265543
8373,2020-09-25,대웅제약보톡스균주구매예비판결오판,https://www.ebn.co.kr/news/view/1452610/?sc=Naver
8374,2020-09-25,보툴리눔균주쉽게구할수있다”대웅제약신규보툴리눔균주구매,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009251451271500761
8375,2020-09-25,메디톡스대웅의보톡스균주영업비밀성부정주장대응가치없어,http://news.mk.co.kr/newsRead.php?no=993833&year=2020
8376,2020-09-25,보툴리눔균주구매가능해”대웅제약美ITC에반박자료제출,http://www.youthdaily.co.kr/news/article.html?no=48650
8377,2020-09-25,대웅제약ITC예비판결반박주가5거래일만에반등,http://sports.hankooki.com/lpage/economy/202009/sp20200925155459137020.htm?s_ref=nv
8378,2020-09-25,메디톡스대웅제약균주구매가능놓고재격돌,http://www.newstomato.com/ReadNews.aspx?no=998346
8379,2020-09-25,이데일리N대웅제약보툴리눔균주쉽게구매가능”메디톡스반박外,http://www.edaily.co.kr/news/newspath.asp?newsid=03155366625903728
8380,2020-09-25,대웅제약신규보툴리눔균주구매했다”,http://www.whosaeng.com/121201
8381,2020-09-25,대웅제약보톡스균주구매ITC에반박자료제출,http://daily.hankooki.com/lpage/industry/202009/dh20200925155930148390.htm?s_ref=nv
8382,2020-09-25,대웅제약보툴리눔균주쉽게구매가능메디톡스주장전격반박,http://moneys.mt.co.kr/news/mwView.php?no=2020092514558022443
8383,2020-09-25,대웅제약보툴리눔톡신균주돈으로살수있다”메디톡스생채기내기혈안,http://theviewers.co.kr/View.aspx?No=1265747
8384,2020-09-25,세계심장의날전세계심장질환우려↑대웅제약모비케어로잡아내세요,http://www.newspim.com/news/view/20200925000906
8385,2020-09-25,대웅균주구매도가능vs메디톡스왜자체개발했나,https://www.ebn.co.kr/news/view/1452614/?sc=Naver
8386,2020-09-25,대웅제약보툴리눔균주쉽게구한다ITC예비결정반박,http://www.mediapen.com/news/view/561333
8387,2020-09-25,대웅제약웨어러블심전도기기로심장질환조기진단활성화기대,http://www.sisafocus.co.kr/news/articleView.html?idxno=248278
8388,2020-09-25,금일제약업계주요기사셀트리온그룹내년말까지지주사체제확립”대웅제약美ITC에반박자료제출外,http://www.youthdaily.co.kr/news/article.html?no=48656
8389,2020-09-26,대웅제약신규보툴리눔균주구매예비결정반박증거제출,https://www.kpanews.co.kr/article/show.asp?idx=216425&category=D
8390,2020-09-26,미국vs중국코로나백신최종승자는국내는신풍제약대웅제약진원생명과학등주목,http://www.g-enews.com/ko-kr/news/article/news_all/2020092606465826414e4869c120_1/article.html
8391,2020-09-26,오늘의제약셀트리온3총사합병동화약품동아쏘시오홀딩스대웅제약광동제약,http://www.babytimes.co.kr/news/articleView.html?idxno=39703
8392,2020-09-26,미ITC대웅제약메디톡스보톡스분쟁예비판결재검토外,http://www.cstimes.com/news/articleView.html?idxno=431917
8393,2020-09-26,글로벌Biz24대웅제약건강분야지식공유위한글로벌플랫폼쉐어독출시,http://www.g-enews.com/ko-kr/news/article/news_all/202009261825182720e0eaf3841f_1/article.html
8394,2020-09-28,제약RD대웅동아STGC녹십자일동등성과발표,http://weekly.cnbnews.com/news/article.html?no=136176
8395,2020-09-28,인벤티지랩대웅제약과남성형탈모치료제공동개발계약체결,https://www.news1.kr/articles/?4072145
8396,2020-09-28,대웅제약인벤티지랩과장기지속형남성형탈모치료제개발,http://it.chosun.com/site/data/html_dir/2020/09/28/2020092800480.html
8397,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.sentv.co.kr/news/view/580154
8398,2020-09-28,대웅제약인벤티지랩과주사형남성형탈모치료제공동개발추진,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092809135896817
8399,2020-09-28,대웅제약주사형남성형탈모치료제개발나선다,http://www.ekn.kr/news/article.html?no=525780
8400,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.lawissue.co.kr/view.php?ud=202009280918018088204ead0791_12
8401,2020-09-28,대웅제약주사형탈모치료제공동개발추진,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571815071680
8402,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.press9.kr/news/articleView.html?idxno=45925
8403,2020-09-28,인벤티지랩대웅제약과남성형탈모치료제공동개발계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=400511
8404,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진월1회주사로탈모치료,http://www.getnews.co.kr/view.php?ud=2020092809195379462fe691f917_16
8405,2020-09-28,월1회주사로탈모치료를대웅제약주사형남성형탈모치료제개발추진,http://kpenews.com/View.aspx?No=1266795
8406,2020-09-28,대웅제약탈모주사제공동개발,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95275
8407,2020-09-28,먹는약대신주사”대웅제약주사형남성탈모치료제공동개발추진,https://www.fetv.co.kr/news/article.html?no=64686
8408,2020-09-28,대웅제약남성형탈모치료월1회주사제공동개발,http://www.medisobizanews.com/news/articleView.html?idxno=73018
8409,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249596
8410,2020-09-28,대웅주사형남성형탈모치료제개발추진,http://www.dailypharm.com/Users/News/NewsView.html?ID=268943&REFERER=NP
8411,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.newstomato.com/ReadNews.aspx?no=998519
8412,2020-09-28,대웅제약월1회투여남성형탈모치료제공동개발추진,http://medipana.com/news/news_viewer.asp?NewsNum=263503&MainKind=A&NewsKind=5&vCount=12&vKind=1
8413,2020-09-28,대웅제약인벤티지랩주사형탈모치료제공동개발매일먹는약대신월1회주사,http://theviewers.co.kr/View.aspx?No=1266854
8414,2020-09-28,대웅제약탈모치료제한달에한번맞는주사제로개발,http://moneys.mt.co.kr/news/mwView.php?no=2020092809228049695
8415,2020-09-28,대웅제약주사형남성형탈모치료제공동개발나선다,http://www.youthdaily.co.kr/news/article.html?no=48772
8416,2020-09-28,대웅제약주사형탈모치료제개발13개월에1회투여,http://www.koreastocknews.com/news/articleView.html?idxno=57519
8417,2020-09-28,대웅제약인벤티지랩과남성형탈모주사제공동개발,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202009280075&t=NN
8418,2020-09-28,대웅제약월1회주사치료남성형탈모치료제공동개발,https://www.etoday.co.kr/news/view/1945447
8419,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,https://www.ebn.co.kr/news/view/1452771/?sc=Naver
8420,2020-09-28,대웅제약인벤티지랩과주사형남성형탈모치료제개발나서,http://sports.hankooki.com/lpage/economy/202009/sp20200928094135137020.htm?s_ref=nv
8421,2020-09-28,게시판대웅제약인벤티지랩남성형탈모치료제개발협약,http://yna.kr/AKR20200928044500017?did=1195m
8422,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.newsway.co.kr/news/view?tp=1&ud=2020092809465868879
8423,2020-09-28,상처뿐인보톡스전쟁대웅제약메디톡스나란히적자,http://news.mt.co.kr/mtview.php?no=2020092417451374982
8424,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.mediapen.com/news/view/561741
8425,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://newsbrite.net/141979
8426,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.kpinews.co.kr/news/articleView.html?idxno=127032
8427,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.bosa.co.kr/news/articleView.html?idxno=2135245
8428,2020-09-28,대웅제약월1회주사탈모치료제개발추진,http://www.newsis.com/view/?id=NISX20200928_0001181518&cID=13001&pID=13000
8429,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.m-i.kr/news/articleView.html?idxno=750464
8430,2020-09-28,대웅제약13개월1회주사형남성형탈모치료제공동개발추진,http://www.econovill.com/news/articleView.html?idxno=413531
8431,2020-09-28,대웅제약인벤티지랩과주사형남성형탈모치료제공동개발추진월1회주사로탈모치료,http://www.anewsa.com/detail.php?number=2230669&thread=10
8432,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63674
8433,2020-09-28,대웅제약월1회주사형탈모치료제공동개발추진,http://www.medigatenews.com/news/1834060944
8434,2020-09-28,대웅제약월1회주사탈모치료제개발나선다,http://inthenews.co.kr/article-71151/
8435,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.businesskorea.co.kr/news/articleView.html?idxno=52524
8436,2020-09-28,대웅제약월1회주사형탈모치료제공동개발,http://health.chosun.com/site/data/html_dir/2020/09/28/2020092801282.html
8437,2020-09-28,뉴스투데이L대웅제약장기지속형남성형탈모치료제개발본격화,https://www.news2day.co.kr/161408
8438,2020-09-28,월1회주사로탈모방지대웅제약남성형탈모치료제개발,http://www.metroseoul.co.kr/article/20200928500151
8439,2020-09-28,대웅제약인벤티지랩주사형남성형탈모치료제공동개발추진,http://www.ceoscoredaily.com/news/article.html?no=73610
8440,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009281039434900924
8441,2020-09-28,대웅제약인벤티지랩과월1회주사남성형탈모치료제개발,https://www.hankyung.com/it/article/202009288176i
8442,2020-09-28,대웅제약월1회주사로탈모치료치료제개발,http://www.mhj21.com/134936
8443,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://news.mk.co.kr/newsRead.php?no=999904&year=2020
8444,2020-09-28,대웅제약월1회주사형남성형탈모치료제공동개발추진,http://www.healthinnews.co.kr/news/articleView.html?idxno=14694
8445,2020-09-28,먹는약대신월1회주사로”대웅제약주사형탈모치료제개발본격화,http://www.viva100.com/main/view.php?key=20200928010005947
8446,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.dailysmart.co.kr/news/articleView.html?idxno=33442
8447,2020-09-28,대웅제약주사형남성형탈모치료제개발나서,http://www.bokuennews.com/news/article.html?no=195249
8448,2020-09-28,대웅제약인벤티지랩과장기지속형남성탈모치료제공동개발추진,http://www.businesspost.co.kr/BP?command=article_view&num=198059
8449,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=400611
8450,2020-09-28,대웅제약글로벌지식공유플랫폼출시언택트마케팅강화,https://www.theguru.co.kr/news/article.html?no=14603
8451,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진월1회주사로탈모치료,http://www.paxetv.com/news/articleView.html?idxno=101275
8452,2020-09-28,대웅제약월1회주사로탈모치료가능한치료제본격개발,http://www.koreaittimes.com/news/articleView.html?idxno=100736
8453,2020-09-28,대웅제약인벤티지랩의장기지속형탈모치료후보물질공동개발키로,http://news.mk.co.kr/newsRead.php?no=1000862&year=2020
8454,2020-09-28,월1회탈모주사제개발대웅제약RD착수,http://www.wikileaks-kr.org/news/articleView.html?idxno=95776
8455,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.nbnnews.co.kr/news/articleView.html?idxno=428679
8456,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.enewstoday.co.kr/news/articleView.html?idxno=1417769
8457,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://www.newsworks.co.kr/news/articleView.html?idxno=491585
8458,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://enter.etoday.co.kr/view/news_view.php?varAtcId=188337
8459,2020-09-28,종합대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.getnews.co.kr/view.php?ud=20200928150516431fab1982f6a_16
8460,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://www.ccdn.co.kr/news/articleView.html?idxno=666451
8461,2020-09-28,대웅제약인벤티지랩남성형탈모치료제개발협약,http://www.seoulfn.com/news/articleView.html?idxno=396679
8462,2020-09-28,대웅제약에너씨슬콜레다운관련캐시워크돈버는퀴즈정답 ,http://www.joygm.com/news/articleView.html?idxno=88073
8463,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.fnnews.com/news/202009281553093014
8464,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답이목집중,http://www.newsfarm.co.kr/news/articleView.html?idxno=59521
8465,2020-09-28,종합두번째대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.getnews.co.kr/view.php?ud=202009281622472250fab1982f6a_16
8466,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답업데이트,http://www.ccdn.co.kr/news/articleView.html?idxno=666524
8467,2020-09-28,대웅제약인벤티지랩남성탈모치료주사제공동개발,http://www.finomy.com/news/articleView.html?idxno=83600
8468,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답힌트는,http://www.rapportian.com/news/articleView.html?idxno=128100
8469,2020-09-28,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈추가정답은,http://www.joygm.com/news/articleView.html?idxno=88078
8470,2020-09-28,종합캐시워크정답을한번에28일오후5시10분현재대웅제약에너씨슬성분에디터튼살크림커넬오일성분에디터등4건퀴즈의정답은 ,http://www.bizwnews.com/news/articleView.html?idxno=21197
8471,2020-09-28,대웅제약에너씨슬콜레다운관련캐시워크추가된돈버는퀴즈정답 ,http://www.newsfarm.co.kr/news/articleView.html?idxno=59523
8472,2020-09-28,대웅제약월1회주사남성형탈모치료제공동개발,http://www.shinailbo.co.kr/news/articleView.html?idxno=1326415
8473,2020-09-28,대웅제약벤처월1회주사탈모치료제공동개발본격화,http://www.100ssd.co.kr/news/articleView.html?idxno=71667
8474,2020-09-28,김창수의e뉴스브리핑먹는약대신주사”대웅제약주사형남성탈모치료제공동개발추진外,https://www.fetv.co.kr/news/article.html?no=64780
8475,2020-09-28,매일먹는약대신월1회주사로탈모치료대웅제약공동개발추진,http://daily.hankooki.com/lpage/industry/202009/dh20200928173749148390.htm?s_ref=nv
8476,2020-09-28,금일제약업계주요기사LG화학비만신약美FDA희귀의약품지정대웅제약주사형남성형탈모치료제공동개발外,http://www.youthdaily.co.kr/news/article.html?no=48860
8477,2020-09-28,대웅제약주사형남성형탈모치료제공동개발추진,http://www.thefirstmedia.net/news/articleView.html?idxno=63959
8478,2020-09-28,대웅제약월1회탈모치료주사개발나서,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003310
8479,2020-09-28,매일먹는대신월1회주사”대웅제약13개월지속형탈모치료제공동개발,https://www.donga.com/news/article/all/20200928/103183741/1
8480,2020-09-28,대웅제약에너씨슬콜레다운관련캐시워크돈버는퀴즈정답추가 ,http://www.ccdn.co.kr/news/articleView.html?idxno=666673
8481,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답업데이트,http://www.joygm.com/news/articleView.html?idxno=88083
8482,2020-09-29,대웅제약인벤티지랩과주사형남성형탈모치료제공동개발추진,http://www.g-enews.com/ko-kr/news/article/news_all/2020092817271281762500a1b5d6_1/article.html
8483,2020-09-29,대웅메디톡스보톡스균주출처분쟁균주구매가능여부로변질,http://www.mkhealth.co.kr/news/articleView.html?idxno=50655
8484,2020-09-29,캐시워크돈버는퀴즈오늘29일정답성분에디터튼살크림대웅제약에너씨슬콜레다운,http://daily.hankooki.com/lpage/economy/202009/dh20200929102820138060.htm?s_ref=nv
8485,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답 ,http://www.newsfarm.co.kr/news/articleView.html?idxno=59533
8486,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249691
8487,2020-09-29,대웅니클로사마이드코로나19이어인플루엔자효과확인,http://medipana.com/news/news_viewer.asp?NewsNum=263612&MainKind=A&NewsKind=5&vCount=12&vKind=1
8488,2020-09-29,대웅제약니클로사마이드인플루엔자치료효과도확인,http://health.chosun.com/site/data/html_dir/2020/09/29/2020092901385.html
8489,2020-09-29,종합29일대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답공개,http://www.getnews.co.kr/view.php?ud=202009291113568641fab1982f6a_16
8490,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://newsclaim.co.kr/View.aspx?No=1268896
8491,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63718
8492,2020-09-29,대웅제약니클로사마이드인플루엔자서도효과확인,https://www.sedaily.com/NewsView/1Z81LDE7D4
8493,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자효과확인,http://www.press9.kr/news/articleView.html?idxno=45938
8494,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자에도효과,http://www.seoulwire.com/news/articleView.html?idxno=427275
8495,2020-09-29,대웅제약개발코로나19치료약물인플루엔자도효과,http://www.medisobizanews.com/news/articleView.html?idxno=73069
8496,2020-09-29,대웅니클로사마이드코로나인플루엔자동시효과,http://www.bosa.co.kr/news/articleView.html?idxno=2135377
8497,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.pharmnews.com/news/articleView.html?idxno=101379
8498,2020-09-29,대웅제약니클로사마이드인플루엔자효과확인,http://www.wsobi.com/news/articleView.html?idxno=105607
8499,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.newsway.co.kr/news/view?tp=1&ud=2020092911253394792
8500,2020-09-29,대웅제약니클로사마이드인플루엔자사망률감소확인,https://www.ebn.co.kr/news/view/1453004/?sc=Naver
8501,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=400818
8502,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://newsbrite.net/142056
8503,2020-09-29,특징주대웅제약코로나19치료제인플루엔자동물효과확인소식에상승,http://www.newsprime.co.kr/news/article.html?no=519576
8504,2020-09-29,대웅제약니클로사마이드독감치료가능성확인,http://www.newsis.com/view/?id=NISX20200929_0001183421&cID=13001&pID=13000
8505,2020-09-29,대웅제약니클로사마이드코로나이어인플루엔자도효과확인,http://www.ekn.kr/news/article.html?no=526102
8506,2020-09-29,대웅니클로사마이드코로나19인플루엔자효과,http://www.dailymedi.com/detail.php?number=861025&thread=22r05
8507,2020-09-29,특징주대웅제약니클로사마이드코로나19독감동물실험서사망100억제확인강세,https://www.etoday.co.kr/news/view/1946078
8508,2020-09-29,대웅제약코로나치료제니클로사마이드인플루엔자효과확인,http://www.consumernews.co.kr/news/articleView.html?idxno=613230
8509,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020092911390544326
8510,2020-09-29,대웅제약니클로사마이드코로나19인플루엔자사망률감소효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020092911198060778
8511,2020-09-29,대웅제약대웅모두상승흐름특히대웅제약오전가파른상승세로3상승,http://www.econonews.co.kr/news/articleView.html?idxno=138671
8512,2020-09-29,종합캐시워크정답을한번에29일오전11시45분현재대웅제약에너씨슬성분에디터튼살크림커넬오일성분에디터등4건퀴즈의정답은 ,http://www.bizwnews.com/news/articleView.html?idxno=21208
8513,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자도효과,http://www.econovill.com/news/articleView.html?idxno=413761
8514,2020-09-29,대웅제약니클로사마이드인플루엔자효과확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=52625
8515,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.lawissue.co.kr/view.php?ud=202009291148524469204ead0791_12
8516,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자효과확인,http://www.viva100.com/main/view.php?key=20200929010006190
8517,2020-09-29,대웅제약니클로사마이드인플루엔자서도효과확인,http://www.techholic.co.kr/news/articleView.html?idxno=193890
8518,2020-09-29,대웅제약니클로사마이드독감인플루엔자에도효과,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122032
8519,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://weekly.cnbnews.com/news/article.html?no=136221
8520,2020-09-29,코로나19에효과대웅제약니클로사마이드인플루엔자에도효과확인,http://www.koreaittimes.com/news/articleView.html?idxno=100770
8521,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14738
8522,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.newstomato.com/ReadNews.aspx?no=998844
8523,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자에도효과”,https://www.etoday.co.kr/news/view/1946070
8524,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자효과확인,http://www.onews.tv/news/articleView.html?idxno=33947
8525,2020-09-29,대웅제약니클로사마이드코로나인플루엔자효과확인,http://sports.hankooki.com/lpage/economy/202009/sp20200929130722137020.htm?s_ref=nv
8526,2020-09-29,대웅제약에너씨슬콜레다운성분에디터시카튼살크림캐시워크돈버는퀴즈정답공개,http://www.ccdn.co.kr/news/articleView.html?idxno=666680
8527,2020-09-29,대웅제약코로나치료제독감에도효과확인,http://news.mk.co.kr/newsRead.php?no=1005402&year=2020
8528,2020-09-29,구충제코로나19인플루엔자둘다잡는다대웅제약효력시험통해사망률제로확인,https://www.donga.com/news/article/all/20200929/103193331/1
8529,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.paxetv.com/news/articleView.html?idxno=101382
8530,2020-09-29,대웅제약니클로사마이드코로나19에이어독감치료가능성확인,http://inthenews.co.kr/article-71540/
8531,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.fnnews.com/news/202009291352143296
8532,2020-09-29,대웅제약니클로사마이드코로나19이어인플루엔자도효과확인,https://www.news1.kr/articles/?4074161
8533,2020-09-29,대웅제약코로나19치료제후보물질인플루엔자에도효과보여,http://www.businesspost.co.kr/BP?command=article_view&num=198327
8534,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.dailysmart.co.kr/news/articleView.html?idxno=33538
8535,2020-09-29,대웅제약니클로사마이드코로나19와독감모두효과,http://www.medigatenews.com/news/1261173960
8536,2020-09-29,대웅제약니클로사마이드인플루엔자효과확인,http://www.kpinews.co.kr/news/articleView.html?idxno=127250
8537,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.ceoscoredaily.com/news/article.html?no=73689
8538,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.getnews.co.kr/view.php?ud=2020092914064646672fe691f917_16
8539,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=429085
8540,2020-09-29,대웅제약니클로사마이드코로나19뿐아니라인플루엔자에도효과확인,https://www.fetv.co.kr/news/article.html?no=64870
8541,2020-09-29,대웅제약코로나19치료제후보니클로사마이드독감에도효과,https://www.hankyung.com/it/article/202009293667i
8542,2020-09-29,뉴스투데이L대웅제약니클로사마이드인플루엔자감염사망률감소효과확인,https://www.news2day.co.kr/161533
8543,2020-09-29,대웅제약니클로사마이드인플루엔자에효과,http://www.seoulfn.com/news/articleView.html?idxno=396827
8544,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.worktoday.co.kr/news/articleView.html?idxno=10498
8545,2020-09-29,대웅제약니클로사마이드독감치료효과도확인,http://it.chosun.com/site/data/html_dir/2020/09/29/2020092901907.html
8546,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202009291422250970139
8547,2020-09-29,대웅제약니클로사마이드동물실험서독감에효과,http://www.finomy.com/news/articleView.html?idxno=83659
8548,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.thefirstmedia.net/news/articleView.html?idxno=63990
8549,2020-09-29,대웅제약개발중인코로나치료제독감치료효과확인,https://biz.chosun.com/site/data/html_dir/2020/09/29/2020092902185.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8550,2020-09-29,대웅제약코로나19치료제후보물질DWRX2003독감에도효과확인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065595547200573
8551,2020-09-29,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.anewsa.com/detail.php?number=2231970&thread=10
8552,2020-09-29,김창수의e뉴스브리핑대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인外,https://www.fetv.co.kr/news/article.html?no=64898
8553,2020-09-29,대웅제약니클로사마이드인플루엔자에도효과확인,http://www.mediapen.com/news/view/562455
8554,2020-09-29,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답업데이트,http://www.joygm.com/news/articleView.html?idxno=88104
8555,2020-09-29,대웅제약니클로사마이드코로나19에이어독감에도효과,http://www.metroseoul.co.kr/article/20200929500226
8556,2020-09-29,대웅제약니클로사마이드코로나19도인플루엔자에도효과,https://www.kpanews.co.kr/article/show.asp?idx=216507&category=D
8557,2020-09-30,대웅제약주사형남성형탈모치료제공동개발추진,https://www.kpanews.co.kr/article/show.asp?idx=216522&category=D
8558,2020-09-30,대웅제약에너씨슬콜레다운성분에디터시카튼살크림마미레시피골든아르간커넬오일캐시워크돈버는퀴즈정답업데이트,http://www.ccdn.co.kr/news/articleView.html?idxno=666703
8559,2020-09-30,대웅제약니클로사마이드코로나19에이어인플루엔자서효과확인,http://www.m-i.kr/news/articleView.html?idxno=751047
8560,2020-09-30,대웅제약니클로사마이드코로나19에이어인플루엔자에도효과확인,http://www.thepublic.kr/news/newsview.php?ncode=1065579802518781
8561,2020-10-01,대웅제약니클로사마이드독감치료가능성확인코로나19치료제로개발중,http://www.econonews.co.kr/news/articleView.html?idxno=138847
8562,2020-10-01,대웅제약에너씨슬콜레다운캐시워크돈버는퀴즈정답은,http://www.newsfarm.co.kr/news/articleView.html?idxno=59546
8563,2020-10-01,대웅제약니클로사마이드코로나19이어인플루엔자75개선확인,http://www.newslock.co.kr/news/articleView.html?idxno=31419
8564,2020-10-02,대웅제약에너씨슬콜레다운성분에디터시카튼살크림캐시워크돈버는퀴즈정답은,http://www.joygm.com/news/articleView.html?idxno=88120
8565,2020-10-02,글로벌Biz24대웅제약빠르면내년중인니에코로나19치료제공급,http://www.g-enews.com/ko-kr/news/article/news_all/20201002151013563469d76442fa_1/article.html
8566,2020-10-02,대웅제약신약코로나19인플루엔자트윈데믹사망감소효과동물시험입증,http://weekly.cnbnews.com/news/article.html?no=136238
8567,2020-10-02,종합캐시워크정답정리2일오후7시10분현재대웅제약에너씨슬성분에디터튼살크림등2건퀴즈의정답은 ,http://www.bizwnews.com/news/articleView.html?idxno=21234
8568,2020-10-04,종합캐시워크정답정리4일오전11시현재대웅제약에너씨슬성분에디터튼살크림등2건퀴즈의정답은,http://www.bizwnews.com/news/articleView.html?idxno=21242
8569,2020-10-04,캐시워크대웅제약에너씨슬콜레다운성분에디터시카튼살크림돈버는퀴즈정답은,http://www.ccdn.co.kr/news/articleView.html?idxno=666740
8570,2020-10-04,대웅제약떠난막말논란윤재승회장헬스케어기업미래는,http://www.skyedaily.com/news/news_view.html?ID=113134
8571,2020-10-05,대웅제약개발SGLT2당뇨신약국내임상3상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=269033&REFERER=NP
8572,2020-10-05,대웅제약의정면돌파,https://www.dailian.co.kr/news/view/923879/?sc=Naver
8573,2020-10-05,대웅니클로사마이드코로나이어독감에도효과,http://www.whosaeng.com/121282
8574,2020-10-05,대웅니클로사마이드인플루엔자효과확인,http://www.monews.co.kr/news/articleView.html?idxno=213959
8575,2020-10-05,한경팩트체크균주전쟁에보톡스美수출90급감한대웅제약,https://www.hankyung.com/it/article/202010054698i
8576,2020-10-05,대웅제약주사형남성탈모치료제개발추진,http://www.monews.co.kr/news/articleView.html?idxno=213969
8577,2020-10-05,대웅제약당뇨병치료제DWP16001국내임상3상진입,http://www.mdtoday.co.kr/mdtoday/index.html?no=401116
8578,2020-10-05,대웅제약당뇨약이나보글리플로진임상2건승인개발순항,http://daily.hankooki.com/lpage/industry/202010/dh20201005173126148390.htm?s_ref=nv
8579,2020-10-05,대웅제약주사형남성형탈모치료제공동개발추진,http://www.wsobi.com/news/articleView.html?idxno=105824
8580,2020-10-06,대웅제약국내최초SGLT2억제제당뇨병신약국내임상3상동시승인,http://www.fnnews.com/news/202010061403550066
8581,2020-10-06,대웅제약당뇨신약단독병용요법국내임상3상동시승인,http://www.metroseoul.co.kr/article/20201006500303
8582,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://www.lawissue.co.kr/view.php?ud=202010061410277128204ead0791_12
8583,2020-10-06,대웅제약이나보글리플로진단독요법메트포르민병용요법국내임상3상동시승인,http://www.segye.com/content/html/2020/10/06/20201006514993.html?OutUrl=naver
8584,2020-10-06,대웅제약당뇨신약이나보글리플로진식약처임상3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020100614151145046
8585,2020-10-06,대웅제약당뇨병신약단독병용요법임상3상동시승인,http://www.medisobizanews.com/news/articleView.html?idxno=73165
8586,2020-10-06,대웅제약이나보글리플로진단독및메트포르민병용국내임상3상동시승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63786
8587,2020-10-06,대웅제약이나보글리플로진메트포르민국내임상3상동시승인,https://www.fetv.co.kr/news/article.html?no=65114
8588,2020-10-06,대웅제약SGLT2당뇨신약단독병용3상동시승인,http://www.newsis.com/view/?id=NISX20201006_0001188190&cID=13001&pID=13000
8589,2020-10-06,대웅제약이나보글리플로진국내임상3상승인,http://medipana.com/news/news_viewer.asp?NewsNum=263783&MainKind=A&NewsKind=5&vCount=12&vKind=1
8590,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상동시승인,http://www.g-enews.com/ko-kr/news/article/news_all/2020100614190075512500a1b5d6_1/article.html
8591,2020-10-06,대웅제약당뇨신약이나보글리플로진단독병용국내임상3상승인획득”,http://www.youthdaily.co.kr/news/article.html?no=49287
8592,2020-10-06,대웅제약당뇨신약단독요법및메트포르민병용요법국내임상3상승인,http://www.ekn.kr/news/article.html?no=526892
8593,2020-10-06,대웅당뇨신약아나보글리플로진단독요법임상3상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=249828
8594,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아,http://yna.kr/AKR20201006112600017?did=1195m
8595,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://www.m-i.kr/news/articleView.html?idxno=751906
8596,2020-10-06,대웅제약당뇨약이나보글리플로진국내임상3상승인획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065591308175045
8597,2020-10-06,대웅제약당뇨병신약이나보글리플로진임상3상승인,http://www.upinews.kr/newsView/upi202010060057
8598,2020-10-06,대웅제약이나보글리플로진개발가속단독병용임상3상동시승인,https://www.etoday.co.kr/news/view/1947508
8599,2020-10-06,대웅제약제2형당뇨병신약임상3상계획동시승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010060258&t=NN
8600,2020-10-06,대웅제약당뇨신약단독병용임상3상승인개발박차,http://moneys.mt.co.kr/news/mwView.php?no=2020100614238099527
8601,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=430141
8602,2020-10-06,대웅제약당뇨신약단독병용사용국내임상3상동시승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=33700
8603,2020-10-06,대웅제약당뇨병신약단독및병용국내임상3상승인,https://www.hankyung.com/it/article/202010069765i
8604,2020-10-06,대웅제약당뇨병신약단독병용요법임상3상동시승인,http://sports.hankooki.com/lpage/economy/202010/sp20201006150205137020.htm?s_ref=nv
8605,2020-10-06,대웅제약개발당뇨신약단독병용국내임상3상동시승인,https://biz.chosun.com/site/data/html_dir/2020/10/06/2020100602017.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8606,2020-10-06,대웅국내최초SGLT2억제제당뇨신약개발속도,http://www.dailymedi.com/detail.php?number=861169&thread=22r05
8607,2020-10-06,대웅제약이나보글리플로진단독요법메트포르민병용요법국내임상3상동시승인,http://www.economytalk.kr/news/articleView.html?idxno=208482
8608,2020-10-06,대웅제약국내첫SGLT2i신약메트포르민병용3상착수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136324&REFERER=NP
8609,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아개발총력전,http://www.startuptoday.co.kr/news/articleView.html?idxno=56439
8610,2020-10-06,대웅제약당뇨신약단독병용3상동시승인,https://view.asiae.co.kr/article/2020100615162792532
8611,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://www.kpinews.co.kr/news/articleView.html?idxno=127540
8612,2020-10-06,대웅제약당뇨신약이나보글리플로진단독병용국내임상3상승인획득”,http://www.newsway.co.kr/news/view?tp=1&ud=2020100615184939976
8613,2020-10-06,대웅제약이나보글리플로진국내임상3상승인,http://www.fnnews.com/news/202010061521026625
8614,2020-10-06,대웅제약당뇨병신약이나보글리플로진임상3상계획승인받아,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004131525
8615,2020-10-06,대웅제약당뇨신약단독병용임상3상동시승인오는2023년발매목표,http://www.viva100.com/main/view.php?key=20201006010000771
8616,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상동시승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14787
8617,2020-10-06,뉴스투데이L대웅제약이나보글리플로진단독요법메트포르민병용요법국내임상3상동시승인,https://www.news2day.co.kr/161754
8618,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4301174
8619,2020-10-06,대웅제약이나보글리플로진단독병용요법3상승인,http://www.press9.kr/news/articleView.html?idxno=45962
8620,2020-10-06,제약소식대웅2형당뇨신약국내임상3상승인등,http://www.mkhealth.co.kr/news/articleView.html?idxno=50725
8621,2020-10-06,대웅제약국내최초SGLT2억제제당뇨신약3상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2135595
8622,2020-10-06,대웅제약이나보글리플로진단독병용국내임상3상동시승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=401319
8623,2020-10-06,대웅제약당뇨병신약단독병용요법국내임상3상동시승인,http://health.chosun.com/site/data/html_dir/2020/10/06/2020100602251.html
8624,2020-10-06,대웅제약주사형탈모치료제개발나서,http://www.munhwa.com/news/view.html?no=20201006MW161215523417
8625,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아”,http://www.smartfn.co.kr/view.php?ud=202010061602372255379cda9ab3_46
8626,2020-10-06,대웅제약당뇨병신약단독병용국내임상3상승인,http://www.mhj21.com/135076
8627,2020-10-06,대웅제약당뇨신약이나보글리플로진국내임상3상승인단독요법및메트포르민병용요법동시,http://theviewers.co.kr/View.aspx?No=1272698
8628,2020-10-06,대웅제약이나보글리플로진단독메트포르민병용요법임상3상승인,http://www.newsprime.co.kr/news/article.html?no=519951
8629,2020-10-06,대웅제약당뇨병신약단독병용요법국내임상3상동시승인,https://www.asiatoday.co.kr/view.php?key=20201006010002047
8630,2020-10-06,식약처대웅제약당뇨병신약이나보글리플로진임상3상승인,http://www.finomy.com/news/articleView.html?idxno=83789
8631,2020-10-06,대웅제약이나보글리플로진 단독병용사용임상3상동시승인,http://www.koreastocknews.com/news/articleView.html?idxno=57675
8632,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인받아,http://www.mediapen.com/news/view/563630
8633,2020-10-06,대웅제약국내최초SGLT2억제제당뇨병신약국내임상3상동시승인,http://www.koreaittimes.com/news/articleView.html?idxno=100846
8634,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://www.thepublic.kr/news/newsview.php?ncode=1065599484114575
8635,2020-10-06,대웅제약이나보글리플로진단독요법및메트포르민병용요법국내임상3상동시승인,http://newsbrite.net/142152
8636,2020-10-06,대웅제약제2형당뇨병치료신약임상3상계획승인,http://www.cnews.co.kr/uhtml/read.jsp?idxno=202010061726033150643
8637,2020-10-06,대웅제약당뇨병치료제혁신신약임상3상본격화단독병용시험동시승인,https://www.donga.com/news/article/all/20201006/103270779/1
8638,2020-10-06,대웅제약당뇨병신약이나보글리플로진임상3상착수,http://www.seoulfn.com/news/articleView.html?idxno=397182
8639,2020-10-06,금일제약업계주요기사대웅제약당뇨신약단독병용국내임상3상승인획득”GC북미법인매각대금46억달러수취外,http://www.youthdaily.co.kr/news/article.html?no=49315
8640,2020-10-06,대웅제약이나보글리플로진단독요법메트포르민병용요법임상3상승인,http://www.newslock.co.kr/news/articleView.html?idxno=31513
8641,2020-10-06,대웅제약당뇨병신약단독병용임상3상동시승인,http://news.mt.co.kr/mtview.php?no=2020100614042344962
8642,2020-10-06,대웅제약국내최초SGLT2억제제당뇨신약국내임상3상동시승인,http://www.anewsa.com/detail.php?number=2237616&thread=01r01
8643,2020-10-06,대웅제약SGLT2억제제당뇨병신약이나보글리플로진국내임상3상동시승인,http://www.thefirstmedia.net/news/articleView.html?idxno=64152
8644,2020-10-06,대웅제약국내임상3상동시승인받아,http://www.businesskorea.co.kr/news/articleView.html?idxno=52783
8645,2020-10-06,대웅제약당뇨병치료제임상3상승인받아전승호최고신약개발,http://www.businesspost.co.kr/BP?command=article_view&num=198861
8646,2020-10-06,대웅제약당뇨신약단독요법병용요법임상3상동시승인”,http://www.econovill.com/news/articleView.html?idxno=414350
8647,2020-10-06,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1418897
8648,2020-10-07,글로벌K바이오⑦대웅제약100개국수출네트워크로글로벌헬스케어그룹목표,http://www.g-enews.com/ko-kr/news/article/news_all/20201006135525706569d76442fa_1/article.html
8649,2020-10-07,대웅제약SGLT2당뇨병치료제국내3상진행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003500
8650,2020-10-07,대웅제약나보타양성교근비대임상3상돌입,http://www.ceoscoredaily.com/news/article.html?no=73769
8651,2020-10-07,대웅제약당뇨병신약단독병용요법국내3상동시승인,http://www.consumernews.co.kr/news/articleView.html?idxno=613460
8652,2020-10-07,대웅이나보글리플로진단독및메트포르민병용동시임상3상진행,http://www.whosaeng.com/121365
8653,2020-10-07,대웅제약당뇨신약단독병용국내임상3상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1328371
8654,2020-10-07,오늘의제약한미약품그룹JVM대웅제약6일GC녹십자엠에스6일,http://www.babytimes.co.kr/news/articleView.html?idxno=39897
8655,2020-10-07,대웅제약SGLT2저해제단독병용3상식약처승인,http://www.biospectator.com/view/news_view.php?varAtcId=11490
8656,2020-10-07,대웅제약이나보글리플로진단독병용요법임상3상승인,https://www.kpanews.co.kr/article/show.asp?idx=216646&category=D
8657,2020-10-07,대웅제약SGLT2억제제당뇨병신약단독병용임상3상승인,http://www.medigatenews.com/news/1976589027
8658,2020-10-08,식약처대웅제약구충제코로나치료제임상1상승인,http://www.edaily.co.kr/news/newspath.asp?newsid=04086886625930952
8659,2020-10-08,대웅제약구충제성분코로나19치료제임상1상승인받아,https://cnbc.sbs.co.kr/article_hub/10000998752?division=NAVER
8660,2020-10-08,식약처대웅제약개발코로나19치료제임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=263979&MainKind=A&NewsKind=5&vCount=12&vKind=1
8661,2020-10-08,식약처코로나19치료제대웅제약1상임상승인,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=249967
8662,2020-10-08,대웅제약구충제성분코로나19치료제임상1상승인,https://www.sedaily.com/NewsView/1Z91WGEHQB
8663,2020-10-08,대웅제약DWRX2003코로나19치료제로국내임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63847
8664,2020-10-08,식약처국내개발코로나19치료제대웅제약제품1상임상승인,http://www.ecomedia.co.kr/news/newsview.php?ncode=1065604178494113
8665,2020-10-08,대웅제약DWRX2003코로나치료제임상1상승인,https://www.ebn.co.kr/news/view/1453924/?sc=Naver
8666,2020-10-08,식약처대웅제약DWRX2003코로나치료제임상1상승인,https://www.asiatoday.co.kr/view.php?key=20201008010003786
8667,2020-10-08,식약처대웅제약코로나19치료제임상1상시험계획승인,http://yna.kr/AKR20201008183900017?did=1195m
8668,2020-10-08,식약처코로나19치료제대웅제약DWRX20031상임상승인,http://www.fnnews.com/news/202010081820561243
8669,2020-10-08,대웅제약구충제성분니클로사미드로코로나19치료제임상1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=73231
8670,2020-10-08,대웅제약코로나19치료제식약처임상1상승인,https://www.hankyung.com/it/article/202010080198i
8671,2020-10-08,식약처대웅제약코로나19치료제1상승인,http://www.newsis.com/view/?id=NISX20201008_0001191873&cID=13001&pID=13000
8672,2020-10-08,식약처대웅제약코로나19치료제DWRX2003임상1상승인,http://www.getnews.co.kr/view.php?ud=2020100818222530342fe691f917_16
8673,2020-10-08,대웅제약구충제성분코로나19치료제로임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020100818200966077
8674,2020-10-08,식약처대웅제약코로나19치료제임상1상승인,http://www.medigatenews.com/news/475731186
8675,2020-10-08,대웅제약니클로사미드주사제코로나19에1상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=269262&REFERER=NP
8676,2020-10-08,식약처대웅제약코로나19치료제임상1상승인,http://news.mt.co.kr/mtview.php?no=2020100818381343276
8677,2020-10-08,식약처대웅제약개발코로나19치료제1상승인,http://www.wikileaks-kr.org/news/articleView.html?idxno=96354
8678,2020-10-08,식약처대웅제약구충제코로나치료제임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/10/08/2020100802884.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8679,2020-10-08,식약처대웅제약코로나19치료제1상승인,http://news.mk.co.kr/newsRead.php?no=1033679&year=2020
8680,2020-10-08,대웅제약니클로사마이드코로나19치료제식약처임상1상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020100818498082378
8681,2020-10-08,대웅제약코로나19치료제DWRX2003임상1상본격화,https://www.etoday.co.kr/news/view/1948673
8682,2020-10-08,대웅제약코로나19치료물질DWRX2003국내임상1상승인,https://www.news1.kr/articles/?4081823
8683,2020-10-08,식약처대웅제약코로나19치료제1상임상승인,http://www.m-i.kr/news/articleView.html?idxno=752784
8684,2020-10-08,식약처대웅제약코로나19치료제DWRX2003임상1상승인,http://www.newspim.com/news/view/20201008001400
8685,2020-10-08,식약처대웅제약코로나19치료제DWRX2003임상1상승인,https://www.youthdaily.co.kr/news/article.html?no=49573
8686,2020-10-08,대웅제약코로나19치료제임상1상승인,http://www.cstimes.com/news/articleView.html?idxno=433706
8687,2020-10-09,대웅제약전승호號신약개발잰걸음,https://www.fetv.co.kr/news/article.html?no=65179
8688,2020-10-09,대웅제약코로나19치료제1상임상시험승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=95494
8689,2020-10-09,식약처대웅제약코로나19치료제임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=401773
8690,2020-10-09,식약처대웅제약개발코로나19치료제임상1상승인,http://www.seoulfn.com/news/articleView.html?idxno=397511
8691,2020-10-10,식약처대웅제약코로나19치료제DWRX2003임상시험승인,http://www.gukjenews.com/news/articleView.html?idxno=2087065
8692,2020-10-10,코로나19치료제DWRX2003대웅제약1상임상시험승인국내총20건진행중,http://medicalworldnews.co.kr/news/view.php?idx=1510938072
8693,2020-10-10,대웅제약개발코로나19치료제1상임상승인,http://www.bokuennews.com/news/article.html?no=195625
8694,2020-10-10,식약처대웅제약코로나19치료제임상1상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1419585
8695,2020-10-11,지난주제약업계주요이슈셀트리온코로나19치료제CTP593상승인대웅제약DWRX20031상승인外,http://www.youthdaily.co.kr/news/article.html?no=49610
8696,2020-10-11,대웅제약SGLT2당뇨치료신약임상3상승인받아,http://weekly.cnbnews.com/news/article.html?no=136342
8697,2020-10-11,대웅제약구충제로코로나치료제임상,https://www.hankyung.com/it/article/2020101157671
8698,2020-10-11,대웅제약구충제성분코로나19치료제임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020101118210578589
8699,2020-10-12,대웅글로벌현지법인순항빅파마성장가시권,http://www.dailypharm.com/Users/News/NewsView.html?ID=269290&REFERER=NP
8700,2020-10-12,대웅제약DWRX2003코로나19치료제임상1상승인,http://www.monews.co.kr/news/articleView.html?idxno=214169
8701,2020-10-12,구충제주사한방에코로나19치료”대웅제약부작용해소한니클로사마이드치료제국내임상돌입,https://www.donga.com/news/article/all/20201012/103356598/1
8702,2020-10-12,대웅제약코로나19치료제한국임상승인으로개발가속화,http://medipana.com/news/news_viewer.asp?NewsNum=264021&MainKind=A&NewsKind=5&vCount=12&vKind=1
8703,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.fnnews.com/news/202010120923484158
8704,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://www.ekn.kr/news/article.html?no=527752
8705,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.sentv.co.kr/news/view/580645
8706,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.press9.kr/news/articleView.html?idxno=45987
8707,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=127834
8708,2020-10-12,대웅코로나치료제니클로사마이드국내임상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=269307&REFERER=NP
8709,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://weekly.hankooki.com/lpage/life/202010/wk20201012093057147650.htm?s_ref=nv
8710,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상승인,http://www.viva100.com/main/view.php?key=20201012010001606
8711,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상시작,https://www.etoday.co.kr/news/view/1949130
8712,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=49685
8713,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.mediapen.com/news/view/564854
8714,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020101209302076568
8715,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상한국승인,http://www.lcnews.co.kr/news/articleView.html?idxno=8889
8716,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상,http://www.medisobizanews.com/news/articleView.html?idxno=73252
8717,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상승인,http://www.upinews.kr/newsView/upi202010120010
8718,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.getnews.co.kr/view.php?ud=2020101209395091042fe691f917_16
8719,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250011
8720,2020-10-12,대웅제약코로나19치료제한국임상승인인도필리핀도순항중,https://www.sedaily.com/NewsView/1Z93OZ3Y9V
8721,2020-10-12,대웅제약대웅테라퓨틱스코로나치료제한국임상1상승인,http://www.koreastocknews.com/news/articleView.html?idxno=57782
8722,2020-10-12,대웅제약니콜로사마이드코로나치료제임상승인,https://www.ebn.co.kr/news/view/1454050/?sc=Naver
8723,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573550930541
8724,2020-10-12,대웅제약니클로사마이드성분코로나치료제韓임상승인,http://it.chosun.com/site/data/html_dir/2020/10/12/2020101200864.html
8725,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,https://biz.chosun.com/site/data/html_dir/2020/10/12/2020101200876.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8726,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://newsbrite.net/142281
8727,2020-10-12,대웅제약니클로사마이드의코로나19대상한국임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=1040768&year=2020
8728,2020-10-12,대웅제약코로나치료제니클로사마이드임상1상승인,http://news.mt.co.kr/mtview.php?no=2020101209185151263
8729,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.mhj21.com/135265
8730,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://news.heraldcorp.com/view.php?ud=20201012000245
8731,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상승인,http://www.newsprime.co.kr/news/article.html?no=520442
8732,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://www.fnnews.com/news/202010120949008857
8733,2020-10-12,대웅제약코로나19치료제니클로사마이드식약처임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101209451942151
8734,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,https://www.fetv.co.kr/news/article.html?no=65438
8735,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,https://www.hankyung.com/it/article/202010127276i
8736,2020-10-12,대웅제약코로나19치료제韓임상승인10월시작,http://www.newsis.com/view/?id=NISX20201012_0001193511&cID=13001&pID=13000
8737,2020-10-12,대웅제약코로나19치료제국내임상승인,https://view.asiae.co.kr/article/2020101209591453329
8738,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.lawissue.co.kr/view.php?ud=202010120954467152204ead0791_12
8739,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.m-i.kr/news/articleView.html?idxno=753071
8740,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=33895
8741,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.etnews.com/20201012000022
8742,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,https://www.asiatoday.co.kr/view.php?key=20201012010004573
8743,2020-10-12,대웅니클로사마이드독감동물효력시험서사망률0확인,http://isplus.live.joins.com/news/article/article.asp?total_id=23891627
8744,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://daily.hankooki.com/lpage/industry/202010/dh20201012095526148390.htm?s_ref=nv
8745,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상승인글로벌개발가속화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122273
8746,2020-10-12,대웅제약니클로사마이드글로벌이어한국서도임상승인,http://www.seoulwire.com/news/articleView.html?idxno=427775
8747,2020-10-12,대웅제약코로나치료제니클로사마이드국내임상1상승인,http://inthenews.co.kr/article-72870/
8748,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010120137&t=NN
8749,2020-10-12,대웅제약니클로사마이드코로나19치료제국내임상승인,http://www.newstomato.com/ReadNews.aspx?no=1000221
8750,2020-10-12,대웅제약코로나19치료제니클로사마이드임상1상승인인도필리핀에서도임상,http://www.g-enews.com/ko-kr/news/article/news_all/2020101210113573512500a1b5d6_1/article.html
8751,2020-10-12,대웅제약니클로사마이드코로나임상1상시작이번달환자투여,http://moneys.mt.co.kr/news/mwView.php?no=2020101209288097497
8752,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://www.newspim.com/news/view/20201012000316
8753,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.pinpointnews.co.kr/view.php?ud=2020101210272984662365609d9b_45
8754,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14850
8755,2020-10-12,식약처대웅제약코로나19치료제임상1상시험계획승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010120805457780151
8756,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.koreaittimes.com/news/articleView.html?idxno=100944
8757,2020-10-12,대웅제약니클로사마이드코로나19국내1상승인,http://www.biospectator.com/view/news_view.php?varAtcId=11519
8758,2020-10-12,대웅제약구충제성분코로나19치료제임상1상승인,http://www.econovill.com/news/articleView.html?idxno=414879
8759,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,http://health.chosun.com/site/data/html_dir/2020/10/12/2020101201125.html
8760,2020-10-12,대웅제약서방형니클로사마이드트윈데믹에도효과적,https://jhealthmedia.joins.com/article/article_view.asp?pno=22522
8761,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상승인,https://www.dailian.co.kr/news/view/926368/?sc=Naver
8762,2020-10-12,셀트리온대웅제약코로나19치료제나란히임상승인,http://www.mkhealth.co.kr/news/articleView.html?idxno=50776
8763,2020-10-12,대웅제약코로나19치료제식약처임상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=52981
8764,2020-10-12,대웅제약코로나19치료제니클로사마이드1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2135884
8765,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.metroseoul.co.kr/article/20201012500157
8766,2020-10-12,대웅제약의약품박람회CPhIFestivalofPharma참가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250032
8767,2020-10-12,대웅제약 의약품박람회CPhIFestivalofPharma 참가,http://www.economytalk.kr/news/articleView.html?idxno=208572
8768,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.metroseoul.co.kr/article/20201012500171
8769,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.pharmnews.com/news/articleView.html?idxno=101442
8770,2020-10-12,대웅제약코로나19치료제국내임상1상승인,https://www.nocutnews.co.kr/news/5426361
8771,2020-10-12,주력파이프라인홍보집중대웅제약PhIFestivalofPharma참가,http://kpenews.com/View.aspx?No=1276666
8772,2020-10-12,대웅제약코로나치료제니클로사마이드임상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136424&REFERER=NP
8773,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.ceoscoredaily.com/news/article.html?no=73924
8774,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.finomy.com/news/articleView.html?idxno=83940
8775,2020-10-12,해외매출이국내매출넘는다대웅제약글로벌2025비전,http://www.wikileaks-kr.org/news/articleView.html?idxno=96459
8776,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가주력파이프라인홍보집중,http://newsbrite.net/142305
8777,2020-10-12,대웅제약CPhIFestivalofPharma참가글로벌파트너십강화모색”,http://www.youthdaily.co.kr/news/article.html?no=49717
8778,2020-10-12,대웅제약CPhI참가로글로벌파트너십강화방안모색,http://medipana.com/news/news_viewer.asp?NewsNum=264048&MainKind=A&NewsKind=5&vCount=12&vKind=1
8779,2020-10-12,대웅제약글로벌의약품박람회CPhI에참가,http://www.medisobizanews.com/news/articleView.html?idxno=73270
8780,2020-10-12,대웅제약세계적의약품박람회참가,http://www.businesskorea.co.kr/news/articleView.html?idxno=52994
8781,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.healthinnews.co.kr/news/articleView.html?idxno=14864
8782,2020-10-12,대웅제약글로벌의약품박람회CPhIFestivalofPharma참가,http://www.newsworks.co.kr/news/articleView.html?idxno=493957
8783,2020-10-12,대웅제약CPhIFestivalofPharma참가,http://www.bosa.co.kr/news/articleView.html?idxno=2135901
8784,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,https://www.fetv.co.kr/news/article.html?no=65477
8785,2020-10-12,코로나19셀트리온대웅제약치료제개발한발앞으로,http://www.ajunews.com/view/20201012123039701
8786,2020-10-12,대웅제약글로벌의약품박람회CPhl참가,http://www.monews.co.kr/news/articleView.html?idxno=214202
8787,2020-10-12,특징주대웅제약코로나19치료제임상1상승인주가상승세,http://www.anewsa.com/detail.php?number=2243401&thread=18
8788,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.joseilbo.com/news/news_read.php?uid=408000&class=27&grp=
8789,2020-10-12,대웅제약코로나19치료제니클로사마이드국내임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4306658
8790,2020-10-12,대웅제약의약품박람회서글로벌파트너십강화,http://www.econovill.com/news/articleView.html?idxno=414924
8791,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63864
8792,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63856
8793,2020-10-12,대웅제약 코로나19 치료제니클로사마이드한국임상승인,http://www.greened.kr/news/articleView.html?idxno=272020
8794,2020-10-12,대웅제약코로나치료제니클로사마이드한국임상승인10월투여개시,http://www.newslock.co.kr/news/articleView.html?idxno=31629
8795,2020-10-12,대웅제약글로벌의약품박람회CPhI참가,http://www.mdtoday.co.kr/mdtoday/index.html?no=401923
8796,2020-10-12,대웅제약나보타수면중이갈이증상완화효과입증,http://www.insightkorea.co.kr/news/articleView.html?idxno=83492
8797,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.paxetv.com/news/articleView.html?idxno=101927
8798,2020-10-12,한국유니온제약대웅제약상승에급등까지대웅제약소폭상승이어한국유니온제약12급등,http://www.econonews.co.kr/news/articleView.html?idxno=139975
8799,2020-10-12,대웅제약코로나19치료제국내임상1상시작전승호역량집중,http://www.businesspost.co.kr/BP?command=article_view&num=199478
8800,2020-10-12,식약처대웅제약코로나19치료제임상1상시험계획승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010121410294890277
8801,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.sportsseoul.com/news/read/968563?ref=naver
8802,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=431423
8803,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상시험승인,http://www.thefirstmedia.net/news/articleView.html?idxno=64338
8804,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.thefirstmedia.net/news/articleView.html?idxno=64336
8805,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.nbnnews.co.kr/news/articleView.html?idxno=431428
8806,2020-10-12,대웅제약코로나19치료제니클로사마이드이달중국내임상시험개시,http://kbench.com/?q=node/214812
8807,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상1상시험승인,http://www.kdpress.co.kr/news/articleView.html?idxno=97742
8808,2020-10-12,대웅제약코로나19치료제국내임상1상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=494032
8809,2020-10-12,대웅제약코로나19치료제니클로사마이드韓임상승인,http://www.segye.com/content/html/2020/10/12/20201012514508.html?OutUrl=naver
8810,2020-10-12,대웅제약CPhIFestivalofPharma참가해코로나19치료후보홍보,http://news.mk.co.kr/newsRead.php?no=1043051&year=2020
8811,2020-10-12,대웅제약CPhIFestivalofPharma참가,http://www.lawissue.co.kr/view.php?ud=202010121502248679204ead0791_12
8812,2020-10-12,니클로사마이드관련주대웅제약주가상승기미임상1상시험승인,http://www.ccreview.co.kr/news/articleView.html?idxno=289815
8813,2020-10-12,대웅제약메디톡스어느쪽이신뢰추락할까독한전쟁내달마침표,http://www.wikileaks-kr.org/news/articleView.html?idxno=96478
8814,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.polinews.co.kr/news/article.html?no=476635
8815,2020-10-12,대웅제약코로나19치료제韓임상승인˝10월시작˝,http://www.kbsm.net/default/index_view_page.php?idx=289729&part_idx=320
8816,2020-10-12,대웅제약세계적의약품박람회CPhIFestivalofPharma참가,http://www.ekn.kr/news/article.html?no=527865
8817,2020-10-12,대웅제약코로나19치료제국내임상1상승인,http://news.tf.co.kr/read/economy/1817743.htm
8818,2020-10-12,뉴스투데이L대웅제약코로나19치료제니클로사마이드한국임상1상승인,https://www.news2day.co.kr/162027
8819,2020-10-12,대웅제약세계의약품박람회서코로나19치료제등파이프라인소개,http://www.medigatenews.com/news/2504357643
8820,2020-10-12,대웅제약글로벌의약품박람회CPhIFestivalofPharma참가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003666
8821,2020-10-12,대웅코로나19치료제니클로사마이드국내임상승인,http://www.dailymedi.com/detail.php?number=861370&thread=22r05
8822,2020-10-12,12일특징주총정리대웅제약모르텍스컴투스오성첨단소재초관심코로나치료제원격수업등부각,http://www.ccreview.co.kr/news/articleView.html?idxno=289816
8823,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065593349901584
8824,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.segyebiz.com/newsView/20201012518115?OutUrl=naver
8825,2020-10-12,제약업계소식종근당고촌재단대웅제약한미약품동국제약,http://www.newsian.co.kr/news/articleView.html?idxno=43755
8826,2020-10-12,대웅제약나보타글로벌보툴리눔톡신치료시장진출가속화,http://www.ceoscoredaily.com/news/article.html?no=73951
8827,2020-10-12,대웅제약코로나19치료제니클로사마이드해외이어국내임상승인,http://www.sporbiz.co.kr/news/articleView.html?idxno=471940
8828,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=10662
8829,2020-10-12,뉴스투데이L대웅제약글로벌의약품박람회CPhIFestivalofPharma참가,https://www.news2day.co.kr/162037
8830,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://www.newsworker.co.kr/news/articleView.html?idxno=87872
8831,2020-10-12,대웅제약코로나19치료제임상1상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1330103
8832,2020-10-12,대웅제약세계최대박람회서혁신신약홍보파트너십모색,http://www.100ssd.co.kr/news/articleView.html?idxno=71831
8833,2020-10-12,금일제약업계주요기사셀트리온코로나19항체치료제예방임상개시대웅제약니클로사마이드韓임상1상승인획득外,http://www.youthdaily.co.kr/news/article.html?no=49786
8834,2020-10-12,대웅제약코로나치료제니클로사마이드한국임상1상,http://www.dt.co.kr/contents.html?article_no=2020101302101831102001&ref=naver
8835,2020-10-12,대웅제약글로벌파트너십강화방안모색,http://www.bokuennews.com/news/article.html?no=195701
8836,2020-10-12,대웅제약글로벌의약품박람회참가코로나19치료제개발중제품등홍보,http://www.g-enews.com/ko-kr/news/article/news_all/2020101220275192502500a1b5d6_1/article.html
8837,2020-10-12,대웅제약코로나19치료제니클로사마이드한국임상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=73460
8838,2020-10-13,단신대웅제약코로나19치료제임상1상승인이달중투여,https://www.donga.com/news/article/all/20201012/103374560/1
8839,2020-10-13,대웅제약나보타글로벌보툴리눔톡신치료사업본격화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1419982
8840,2020-10-13,대웅제약코로나치료제국내임상승인,http://www.whosaeng.com/121528
8841,2020-10-13,대웅제약글로벌의약품박람회서코로나19치료제니클로사마이드와카모스타트등홍보,http://theviewers.co.kr/View.aspx?No=1278048
8842,2020-10-13,대웅제약니클로사마이드코로나19치료제개발순항국내임상1상승인,http://www.sisaweek.com/news/articleView.html?idxno=138230
8843,2020-10-13,메디톡스대웅균주戰최종결론연기가능성대두,https://www.ebn.co.kr/news/view/1454253/?sc=Naver
8844,2020-10-13,윤재승전대웅제약회장인성정보지분180억원매각왜,http://www.sisajournal-e.com/news/articleView.html?idxno=224445
8845,2020-10-14,대웅제약흑자전환에도미국ITC소송은리스크투자의견중립,https://www.asiatoday.co.kr/view.php?key=20201014010006496
8846,2020-10-14,대웅제약나보타글로벌보툴리눔톡신치료시장진출가속화,http://www.lawissue.co.kr/view.php?ud=202010131040468860204ead0791_12
8847,2020-10-14,대웅제약내달ITC결과주목투자의견하향NH투자,https://www.etoday.co.kr/news/view/1950161
8848,2020-10-14,하이로우대웅제약단기실적보다다음달ITC최종판결주목해야NH투자증권,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101409055999098
8849,2020-10-14,대웅제약언택트마케팅으로고객접점확장,http://www.seoulwire.com/news/articleView.html?idxno=427913
8850,2020-10-14,시경Today제약코로나시대대웅제약나보타언택트마케팅실시外,http://www.meconomynews.com/news/articleView.html?idxno=46220
8851,2020-10-14,대웅제약코로나19치료신약국내임상1상개시,http://weekly.cnbnews.com/news/article.html?no=136390
8852,2020-10-15,대웅제약子아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.sentv.co.kr/news/view/580906
8853,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250155
8854,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.lawissue.co.kr/view.php?ud=20201015091744865204ead0791_12
8855,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=402447
8856,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.upinews.kr/newsView/upi202010150009
8857,2020-10-15,대웅제약나보타라이브세미나언택트마케팅활발,http://www.consumuch.com/news/articleView.html?idxno=50890
8858,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.pharmnews.com/news/articleView.html?idxno=101477
8859,2020-10-15,대웅제약아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.newspim.com/news/view/20201015000244
8860,2020-10-15,대웅제약비마약성진통제신약호주임상1상착수,http://www.dailypharm.com/Users/News/NewsView.html?ID=269453&REFERER=NP
8861,2020-10-15,대웅제약자회사비마약성진통제호주임상1상계획승인,http://yna.kr/AKR20201015049800017?did=1195m
8862,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제임상1상시작,http://health.chosun.com/site/data/html_dir/2020/10/15/2020101500951.html
8863,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.ceoscoredaily.com/news/article.html?no=74056
8864,2020-10-15,대웅제약자회사아이엔테라퓨틱스진통제호주서임상,http://www.medisobizanews.com/news/articleView.html?idxno=73378
8865,2020-10-15,대웅아이엔테라퓨틱스호주서진통제임상1상진행,http://moneys.mt.co.kr/news/mwView.php?no=2020101509108044318
8866,2020-10-15,대웅제약자회사비마약성진통제임상1상계획호주승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010150125&t=NN
8867,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제1상돌입,http://www.newsis.com/view/?id=NISX20201015_0001198200&cID=13001&pID=13000
8868,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://newsbrite.net/142418
8869,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,https://www.dailian.co.kr/news/view/927422/?sc=Naver
8870,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2020101510314278999
8871,2020-10-15,대웅제약자회사비마약성진통제호주임상1상계획승인,http://news.mk.co.kr/newsRead.php?no=1055683&year=2020
8872,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상,http://www.medigatenews.com/news/2691758826
8873,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상안전한진통제,http://theviewers.co.kr/View.aspx?No=1290345
8874,2020-10-15,대웅제약70조진통제시장도전아이엔테라퓨틱스호주임상1상승인”,http://www.viva100.com/main/view.php?key=20201015010002584
8875,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.healthinnews.co.kr/news/articleView.html?idxno=14940
8876,2020-10-15,대웅제약자회사아이엔테라퓨틱스호주서비마약성진통제임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/10/15/2020101501305.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8877,2020-10-15,대웅제약자회사비마약성진통제호주임상1상계획승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010151107320310992
8878,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상돌입,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101511163757564
8879,2020-10-15,대웅제약나보타라이브세미나서탈모치료정보공유,http://www.sisaon.co.kr/news/articleView.html?idxno=119041
8880,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제호주임상1상돌입,http://www.newstomato.com/ReadNews.aspx?no=1000993
8881,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63932
8882,2020-10-15,대웅제약자회사개발비마약성진통제호주임상1상계획승인,http://www.seoulfn.com/news/articleView.html?idxno=398015
8883,2020-10-15,대웅제약자회사비마약성진통제호주서1상돌입,http://www.whosaeng.com/121656
8884,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상승인,https://www.asiatoday.co.kr/view.php?key=20201015010007824
8885,2020-10-15,코로나19와제약업계6대웅제약오너갑질논란에코로나로실적악화까지오너경영인체제로다시전환하나윤재승전회장경영장악력더욱강력해져,http://www.newsworker.co.kr/news/articleView.html?idxno=88108
8886,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.updownnews.co.kr/news/articleView.html?idxno=224228
8887,2020-10-15,대웅자회사비마약성진통제DWP17061글로벌임상1상돌입,http://www.dailysmart.co.kr/news/articleView.html?idxno=34134
8888,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=432483
8889,2020-10-15,대웅제약자회사호주에서비마약성진통제글로벌임상1상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=200041
8890,2020-10-15,뉴스투데이L대웅제약아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,https://www.news2day.co.kr/162257
8891,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.worktoday.co.kr/news/articleView.html?idxno=10750
8892,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제글로벌임상1상,http://daily.hankooki.com/lpage/industry/202010/dh20201015175941148390.htm?s_ref=nv
8893,2020-10-15,나보타美수출급감에수백억소송비엎친데덮친대웅제약,http://www.dt.co.kr/contents.html?article_no=2020101602101031102001&ref=naver
8894,2020-10-15,대웅제약자회사아이엔테라퓨틱스비마약성진통제DWP17061글로벌임상1상돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=64525
8895,2020-10-16,대웅제약자회사아이엔테라퓨틱스70조원글로벌진통제시장도전첫발,http://www.g-enews.com/ko-kr/news/article/news_all/2020101517040214002500a1b5d6_1/article.html
8896,2020-10-16,더벨대웅제약900억만기채금융권차입으로대응,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202010141602075760104268
8897,2020-10-16,오늘의제약동아제약박카스한미약품동국제약대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=40132
8898,2020-10-19,대웅제약상반기재고자산회전율전년비04회감소한31회,http://www.ceoscoredaily.com/news/article.html?no=73976
8899,2020-10-19,대웅나보타국제미용성형학회참가우수성알려,http://www.dailypharm.com/Users/News/NewsView.html?ID=269558&REFERER=NP
8900,2020-10-19,대웅제약나보타IMCASAsiaClass서우수성알려,http://medipana.com/news/news_viewer.asp?NewsNum=264426&MainKind=A&NewsKind=5&vCount=12&vKind=1
8901,2020-10-19,대웅제약국제미용성형학회참가나보타효능알려,http://www.press9.kr/news/articleView.html?idxno=46042
8902,2020-10-19,대웅제약국제미용성형학회서나보타활용최신시술법공유,http://www.m-i.kr/news/articleView.html?idxno=755297
8903,2020-10-19,대웅제약나보타IMCASAsiaClass2020서우수성알려,http://www.medisobizanews.com/news/articleView.html?idxno=73446
8904,2020-10-19,대웅제약나보타국제미용성형학회서전세계의료진대상우수성알려,https://www.fetv.co.kr/news/article.html?no=66030
8905,2020-10-19,대웅제약 나보타 국제미용성형학회에서전세계의료진대상우수성알려,http://www.lcnews.co.kr/news/articleView.html?idxno=9054
8906,2020-10-19,대웅제약국제미용성형학회서보툴리눔톡신나보타우수성알려,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122525
8907,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,http://www.newsis.com/view/?id=NISX20201019_0001201838&cID=13001&pID=13000
8908,2020-10-19,대웅제약나보타국제미용성형학회에서최신시술법공개,http://www.econovill.com/news/articleView.html?idxno=415773
8909,2020-10-19,대웅제약IMCAS아시아클래스서나보타우수성알려,http://www.kpinews.co.kr/news/articleView.html?idxno=128481
8910,2020-10-19,대웅제약나보타국제미용성형학회심포지엄서효능시술법소개,http://moneys.mt.co.kr/news/mwView.php?no=2020101909218041617
8911,2020-10-19,대웅제약국제미용성형학회서나보타우수성홍보,http://www.ekn.kr/news/article.html?no=529070
8912,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,https://www.hankyung.com/it/article/202010192446i
8913,2020-10-19,대웅제약나보타국제학회서의료진대상우수성알려,http://news.mt.co.kr/mtview.php?no=2020101909280325544
8914,2020-10-19,대웅제약나보타IMCASAsiaClass2020서전세계의료진대상우수성알려,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63973
8915,2020-10-19,대웅제약나보타국제미용성형학회전세계의료진대상우수성알려,http://www.pharmnews.com/news/articleView.html?idxno=101494
8916,2020-10-19,대웅제약전세계의료진대상나보타우수성알려,http://www.newsprime.co.kr/news/article.html?no=521253
8917,2020-10-19,대웅제약국제미용성형학회서나보타우수성알려,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101909411149151
8918,2020-10-19,대웅제약국제미용성형학회서전세계의료진에게나보타우수성알려,http://www.pinpointnews.co.kr/view.php?ud=2020101909590777062365609d9b_45
8919,2020-10-19,대웅제약나보타IMCASAsia서우수성알려,http://www.bosa.co.kr/news/articleView.html?idxno=2136307
8920,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,https://www.dailian.co.kr/news/view/928340/?sc=Naver
8921,2020-10-19,대웅제약국제미용성형학회서전세계의료진에나보타우수성알려,http://www.youthdaily.co.kr/news/article.html?no=50423
8922,2020-10-19,대웅제약나보타IMCASAsiaClass2020서우수성홍보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250270
8923,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020에서전세계의료진대상우수성알려,http://newsbrite.net/142538
8924,2020-10-19,뉴스투데이L대웅제약국제미용성형학회IMCASAsiaClass2020서나보타우수성알려,https://www.news2day.co.kr/162392
8925,2020-10-19,대웅제약나보타국제미용성형학회에서전세계의료진대상,http://www.businesskorea.co.kr/news/articleView.html?idxno=53378
8926,2020-10-19,대웅제약나보타세계의료진에우수성입증,http://health.chosun.com/site/data/html_dir/2020/10/19/2020101901002.html
8927,2020-10-19,대웅제약국제미용성형학회IMCASAsia참여나보타우수성전해,http://www.newslock.co.kr/news/articleView.html?idxno=31833
8928,2020-10-19,균주도용분쟁중이지만우수한보톡스대웅제약국제미용성형학회참가해나보타홍보,http://theviewers.co.kr/View.aspx?No=1293825
8929,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020에서전세계의료진대상우수성알려,http://www.segye.com/content/html/2020/10/19/20201019508993.html?OutUrl=naver
8930,2020-10-19,대웅제약나보타국제미용성형학회서최신시술법공유,http://www.dailysmart.co.kr/news/articleView.html?idxno=34280
8931,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.metroseoul.co.kr/article/20201019500176
8932,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://newsbrite.net/142554
8933,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250283
8934,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,http://www.pressm.kr/news/articleView.html?idxno=33777
8935,2020-10-19,대웅제약호주서코로나19대상니클로사마이드임상1상승인받아,http://news.mk.co.kr/newsRead.php?no=1068377&year=2020
8936,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,https://www.etoday.co.kr/news/view/1951862
8937,2020-10-19,대웅제약니클로사마이드코로나치료호주1상승인,http://www.newsis.com/view/?id=NISX20201019_0001202173&cID=13001&pID=13000
8938,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.ekn.kr/news/article.html?no=529127
8939,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020101911192470954
8940,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.medigatenews.com/news/838683540
8941,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.fnnews.com/news/202010191121390203
8942,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020101911091185602
8943,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상승인,https://www.fetv.co.kr/news/article.html?no=66079
8944,2020-10-19,코로나19치료제선진국다인종임상대웅제약니클로사마이드호주임상1상승인,http://theviewers.co.kr/View.aspx?No=1294027
8945,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://it.chosun.com/site/data/html_dir/2020/10/19/2020101901176.html
8946,2020-10-19,대웅제약코로나19치료제호주1상임상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136589&REFERER=NP
8947,2020-10-19,대웅제약호주서코로나19치료제니클로사마이드임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=128532
8948,2020-10-19,대웅제약호주서코로나19치료제니클로사마이드임상1상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=128532
8949,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.lawissue.co.kr/view.php?ud=202010191128451905204ead0791_12
8950,2020-10-19,대웅제약니클로사마이드코로나19치료제호주1상승인,http://www.medisobizanews.com/news/articleView.html?idxno=73464
8951,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인획득,http://www.youthdaily.co.kr/news/article.html?no=50448
8952,2020-10-19,대웅제약코로나19치료니클로사마이드호주임상1상승인,http://medipana.com/news/news_viewer.asp?NewsNum=264469&MainKind=A&NewsKind=5&vCount=12&vKind=1
8953,2020-10-19,대웅제약코로나9치료제니클로사마이드호주식약청임상1상승인,http://www.newsprime.co.kr/news/article.html?no=521304
8954,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=495909
8955,2020-10-19,대웅제약니클로사마이드코로나19호주1상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2136339
8956,2020-10-19,대웅제약호주식품의약청으로부터코로나19치료제임상1상시험승인,https://www.asiatoday.co.kr/view.php?key=20201019010009829
8957,2020-10-19,대웅제약코로나치료제호주임상1상승인,https://www.ebn.co.kr/news/view/1455055/?sc=Naver
8958,2020-10-19,대웅제약국제미용성형학회에서자체보툴리눔톡신강점알려,http://www.businesspost.co.kr/BP?command=article_view&num=200433
8959,2020-10-19,대웅제약호주서코로나19치료제임상1상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010190178&t=NN
8960,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,https://www.news2day.co.kr/162403
8961,2020-10-19,대웅제약코로나19치료제호주임상1상승인11월니클로사마이드임상돌입”,http://www.viva100.com/main/view.php?key=20201019010003324
8962,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=53405
8963,2020-10-19,대웅제약국제미용성형학회서나보타우수성알려,http://www.shinailbo.co.kr/news/articleView.html?idxno=1332453
8964,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.economytalk.kr/news/articleView.html?idxno=208694
8965,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.press9.kr/news/articleView.html?idxno=46048
8966,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=402812
8967,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,http://www.mdtoday.co.kr/mdtoday/index.html?no=402811
8968,2020-10-19,대웅제약코로나19치료제놓고호주에서임상1상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=200469
8969,2020-10-19,대웅제약코로나19치료제호주임상1상승인글로벌임상박차,http://health.chosun.com/site/data/html_dir/2020/10/19/2020101901442.html
8970,2020-10-19,대웅제약IMCASAsiaClass에서나보타우수성알려,http://www.monews.co.kr/news/articleView.html?idxno=214437
8971,2020-10-19,대웅제약니클로사마이드코로나치료제호주임상1상,http://www.monews.co.kr/news/articleView.html?idxno=214438
8972,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://news.mt.co.kr/mtview.php?no=2020101911365911929
8973,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.sentv.co.kr/news/view/581109
8974,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020참여,http://www.healthinnews.co.kr/news/articleView.html?idxno=14983
8975,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.newstomato.com/ReadNews.aspx?no=1001574
8976,2020-10-19,대웅제약니클로사마이드코로나19호주임상1상승인,https://www.hankyung.com/it/article/202010193809i
8977,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,https://www.dailian.co.kr/news/view/928401/?sc=Naver
8978,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.etnews.com/20201019000166
8979,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020서전세계의료진대상우수성알려,http://www.thebigdata.co.kr/view.php?ud=202010191342017899d0a8833aad_23
8980,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=433336
8981,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.whosaeng.com/121742
8982,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상,http://yna.kr/AKR20201019095700017?did=1195m
8983,2020-10-19,대웅제약호주서코로나19치료제니클로사마이드임상1상승인,http://www.m-i.kr/news/articleView.html?idxno=755505
8984,2020-10-19,대웅제약니클로사마이드호주서코로나19치료제임상1상승인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4313823
8985,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010190271&t=NN
8986,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.dailymedi.com/detail.php?number=861698&thread=22r05
8987,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.ceoscoredaily.com/news/article.html?no=74165
8988,2020-10-19,대웅제약니클로사마이드호주서코로나19치료제임상1상승인,https://news.joins.com/article/olink/23492328
8989,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://inthenews.co.kr/article-74042/
8990,2020-10-19,대웅제약니클로사마이드호주서코로나19치료제임상1상승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010191416300690648
8991,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상”,http://www.smartfn.co.kr/view.php?ud=202010191419502953379cda9ab3_46
8992,2020-10-19,대웅나보타국제미용성형학회서우수성알려,http://www.whosaeng.com/121744
8993,2020-10-19,대웅제약코로나19치료제호주임상1상진입,http://moneys.mt.co.kr/news/mwView.php?no=2020101914038014285
8994,2020-10-19,대웅제약코로나19치료제호주임상1상승인,https://view.asiae.co.kr/article/2020101914285528935
8995,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://daily.hankooki.com/lpage/industry/202010/dh20201019143808148390.htm?s_ref=nv
8996,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=34307
8997,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.thebigdata.co.kr/view.php?ud=202010191426418935d0a8833aad_23
8998,2020-10-19,대웅제약호주서코로나19치료제임상1상승인,https://biz.chosun.com/site/data/html_dir/2020/10/19/2020101901964.html?utm_source=naver&utm_medium=original&utm_campaign=biz
8999,2020-10-19,대웅제약니클로사마이드호주서임상1상승인받아,http://www.mediapen.com/news/view/567005
9000,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=14996
9001,2020-10-19,대웅제약코로나치료제후보물질니클로사마이드호주임상1상승인,http://www.newspim.com/news/view/20201019000913
9002,2020-10-19,대웅제약코로나치료제호주임상1상승인,http://www.koreastocknews.com/news/articleView.html?idxno=58013
9003,2020-10-19,대웅제약구충제성분니클로사마이드호주서코로나19치료제임상1상,http://www.topstarnews.net/news/articleView.html?idxno=840289
9004,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=83731
9005,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.anewsa.com/detail.php?number=2250869&thread=10
9006,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.ftoday.co.kr/news/articleView.html?idxno=207248
9007,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.betanews.net:8080/article/1236849.html
9008,2020-10-19,특징주대웅제약주가상승세구충제성분코로나치료제될까,http://www.anewsa.com/detail.php?number=2250891&thread=18
9009,2020-10-19,대웅제약호주서코로나19치료제임상승인구충제성분니클로사마이드활용,http://www.joseilbo.com/news/news_read.php?uid=408531&class=33&grp=
9010,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.seoulwire.com/news/articleView.html?idxno=428201
9011,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010191558458420693
9012,2020-10-19,대웅제약국제미용성형학회서나보타최신시술법공유,https://www.asiatime.co.kr/news/newsview.php?ncode=1065596712039056
9013,2020-10-19,대웅제약코로나19치료후보니클로사마이드호주임상1상승인,https://www.news1.kr/articles/?4091625
9014,2020-10-19,대웅구충제성분호주서코로나19치료제임상1상,http://news.mk.co.kr/newsRead.php?no=1070467&year=2020
9015,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상승인,https://www.hankyung.com/life/article/2020101947277
9016,2020-10-19,대웅제약메디톡스균주전쟁최종결론연기가능성↑,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010191324398120626
9017,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://sports.hankooki.com/lpage/economy/202010/sp20201019161903137020.htm?s_ref=nv
9018,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.newslock.co.kr/news/articleView.html?idxno=31848
9019,2020-10-19,대웅제약구충제성분코로나19치료제호주서임상1상승인,https://www.sedaily.com/NewsView/1Z96YY8HXT
9020,2020-10-19,대웅제약국제미용성형학회서나보타효능알려,http://www.enewstoday.co.kr/news/articleView.html?idxno=1421476
9021,2020-10-19,대웅제약니클로사마이드호주임상1상승인코로나19치료제개발본격화,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=122570
9022,2020-10-19,대웅제약코로나19치료제니클로사마이드호주서임상1상승인,http://www.thedailypost.kr/news/articleView.html?idxno=76827
9023,2020-10-19,대웅제약호주서니클로사마이드코로나19치료제임상1상승인,http://news.tf.co.kr/read/economy/1819238.htm
9024,2020-10-19,대웅제약주가내일상승할까니클로사마이드호주식품의약청임상1상시험승인,http://www.ggilbo.com/news/articleView.html?idxno=803075
9025,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=64655
9026,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인11월본격임상돌입,http://www.paxetv.com/news/articleView.html?idxno=102505
9027,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.seoulfn.com/news/articleView.html?idxno=398334
9028,2020-10-19,대웅제약니클로사마이드코로나19치료제임상시험승인,http://www.slist.kr/news/articleView.html?idxno=193448
9029,2020-10-19,대웅제약나보타국제미용성형학회IMCASAsiaClass2020에서전세계의료진대상우수성알려,http://www.thefirstmedia.net/news/articleView.html?idxno=64705
9030,2020-10-19,대웅제약니클로사마이드코로나19치료제호주임상1상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=63997
9031,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004145906
9032,2020-10-19,김창수의e뉴스브리핑대웅제약코로나19치료제니클로사마이드호주임상승인外,https://www.fetv.co.kr/news/article.html?no=66121
9033,2020-10-19,대웅제약호주서코로나19치료제임상시작,http://www.finomy.com/news/articleView.html?idxno=84249
9034,2020-10-19,GC녹십자웃고한미대웅울고제약사실적코로나희비,https://www.sedaily.com/NewsView/1Z96Z7C3CD
9035,2020-10-19,대웅제약나보타국제미용성형학회서우수성알려,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004145976
9036,2020-10-19,대웅제약나보타국제미용성형학회서전세계의료진대상홍보,http://www.worktoday.co.kr/news/articleView.html?idxno=10843
9037,2020-10-19,대웅제약코로나19치료제니클로사마이드호주임상1상승인,http://www.econovill.com/news/articleView.html?idxno=500005
9038,2020-10-19,대웅제약코로나19치료제후보니클로사마이드호주임상1상승인,http://www.ajunews.com/view/20201019174205663
9039,2020-10-19,대웅제약국제미용성형학회참가나보타최신시술법공유,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003912
9040,2020-10-19,금일제약업계주요기사대웅제약니클로사마이드코로나19치료제호주임상1상승인바이오일레븐삼바로직스와면역항암제위탁개발생산계약外,http://www.youthdaily.co.kr/news/article.html?no=50488
9041,2020-10-19,대웅제약코로나19치료후보물질호주임상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1332848
9042,2020-10-19,대웅제약코로나19치료제니클로사마이드로호주임상1상승인획득,http://www.iminju.net/news/articleView.html?idxno=58654
9043,2020-10-19,대웅제약구충제성분호주서코로나19치료제임상1상”,http://www.kukinews.com/newsView/kuk202010190463
9044,2020-10-19,대웅제약코로나19치료제호주임상1상승인,http://www.fnnews.com/news/202010191812345025
9045,2020-10-19,대웅제약코로나19치료제호주임상1상시험승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1421526
9046,2020-10-19,대웅제약보툴리눔톡신나보타국제미용성형학회서우수성공유,http://www.dt.co.kr/contents.html?article_no=2020102002101831102002&ref=naver
9047,2020-10-19,시간외거래특징주신테카바이오한솔홈데코급등현대차기아차하락세대웅제약상승,http://www.ggilbo.com/news/articleView.html?idxno=803184
9048,2020-10-19,대웅제약코로나19치료제DWRX2003호주임상1상승인,http://news.kbiz.or.kr/news/articleView.html?idxno=73706
9049,2020-10-19,대웅국제미용성형학회에나보타최신시술법공유,https://www.kpanews.co.kr/article/show.asp?idx=216950&category=D
9050,2020-10-20,대웅제약코로나19치료제호주서1상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2003920
9051,2020-10-20,대웅제약코로나19치료후보물질호주임상1상승인,https://www.nocutnews.co.kr/news/5431455
9052,2020-10-20,특징주대웅제약코로나19치료제호주서인정받고미국가나4상승,http://moneys.mt.co.kr/news/mwView.php?no=2020102009218025989
9053,2020-10-20,특징주대웅제약주가코로나19치료제니클로사마이드1상시험승인소식에상승세기록,http://www.ccreview.co.kr/news/articleView.html?idxno=291461
9054,2020-10-20,대웅전기밥솥보온기능있지만12시간지나면밥이딱딱해요,https://www.news1.kr/articles/?4092434
9055,2020-10-20,대웅소형전기밥솥부적합평가12시간보온후밥굳어,https://www.asiatoday.co.kr/view.php?key=20201020010010753
9056,2020-10-20,소형전기밥솥보온후밥맛쿠쿠보통대웅적합하지않음,http://www.kukinews.com/newsView/kuk202010200166
9057,2020-10-20,쿠쿠대웅밥솥메이커중보온후밥맛가장떨어져,https://www.dailian.co.kr/news/view/928862/?sc=Naver
9058,2020-10-20,전기밥솥밥맛12시간보온후제각각대웅제품보온부적합,http://www.seouleconews.com/news/articleView.html?idxno=57245
9059,2020-10-20,대웅쿠쿠전자등소형전기밥솥12시간보온후밥맛성능차이보여,http://digitalchosun.dizzo.com/site/data/html_dir/2020/10/20/2020102080257.html
9060,2020-10-20,단독대웅제약코로나19치료제3호에100억쏜다,https://www.sedaily.com/NewsView/1Z97FFL37B
9061,2020-10-20,소형전기밥솥보온기능제각각쿠쿠보통대웅적합하지않음,https://zdnet.co.kr/view/?no=20201020173409
9062,2020-10-20,메디톡스대웅주가도원수졌나,http://news.mk.co.kr/newsRead.php?no=1075703&year=2020
9063,2020-10-20,한국소비자원소형전기밥솥품질평가12시간보온후밥맛차이쿠쿠보통대웅부적합,http://www.greened.kr/news/articleView.html?idxno=273027
9064,2020-10-21,대웅제약신약연구개발강화로글로벌시장공략,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202010211404001&code=920100
9065,2020-10-21,주식고민해결스탁솔루션대웅제약현대그린푸드전화문자노란톡상담外,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102113462156029
9066,2020-10-21,美에볼루스집단소송피소균주도용피해봤다대웅영향받을까,https://www.hankyung.com/it/article/202010212863i
9067,2020-10-21,보톡스균주도용의혹대웅제약美파트너사에볼루스9개로펌에집단소송당해,http://www.getnews.co.kr/view.php?ud=2020102115283441342fe691f917_16
9068,2020-10-21,대웅대웅제약900억차입회사채차환용”,http://www.edaily.co.kr/news/newspath.asp?newsid=03680166625935216
9069,2020-10-21,대웅제약900억원차입결정회사채차환위해,https://www.asiatoday.co.kr/view.php?key=20201021010012288
9070,2020-10-22,단독콜린알포세레이트대웅종근당과소송참여하는78개제약사는,http://www.medigatenews.com/news/2536290276
9071,2020-10-22,대웅제약간의날기념해우루사캡슐맨야구시구나섰다,https://www.dailian.co.kr/news/view/929542/?sc=Naver
9072,2020-10-22,공시대웅개발641억원규모강남구삼성동토지및건물처분결정,http://www.newsway.co.kr/news/view?tp=1&ud=2020102211420428132
9073,2020-10-22,대웅제약RD결실의해내년글로벌임상만5건,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102210532182539
9074,2020-10-22,대웅개발641억규모강남구삼성동토지건물처분,http://www.edaily.co.kr/news/newspath.asp?newsid=02719126625935544
9075,2020-10-22,똑똑똑대웅이중턱치료제벨카이라특허깨기연전연승,https://www.kpanews.co.kr/article/show.asp?idx=217066&category=D
9076,2020-10-22,우루사가야구장에서시구를대웅제약우루사와함께하는브랜드데이진행,http://www.insightkorea.co.kr/news/articleView.html?idxno=83840
9077,2020-10-22,시경Today제약대웅제약우루사캡슐맨야구시구이벤트外,http://www.meconomynews.com/news/articleView.html?idxno=46543
9078,2020-10-22,메디톡스대웅제약美ITC소송판결임박,http://www.finomy.com/news/articleView.html?idxno=84414
9079,2020-10-22,대웅제약나보타라이브세미나개최피부미용최신지견공유,http://www.viva100.com/main/view.php?key=20201022010004456
9080,2020-10-22,대웅제약나보타라이브세미나서피부미용최신지견공유,http://www.newscj.com/news/articleView.html?idxno=791810
9081,2020-10-22,대웅의소형전기밥솥보온12시간후에는현저히굳어,http://www.fsnews.co.kr/news/articleView.html?idxno=40137
9082,2020-10-23,단독대웅제약인니서코로나19진단키트판매허가획득,https://www.theguru.co.kr/news/article.html?no=15402
9083,2020-10-23,식약처대웅제약한국아스트라제네카의약품신속한제품화지원,https://www.etoday.co.kr/news/view/1953842
9084,2020-10-23,단독메디톡스대웅제약美ITC소송최종판결2주연기,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010230851031180562
9085,2020-10-23,대웅제약당뇨병치료제최초로신속심사대상지정,http://news.mt.co.kr/mtview.php?no=2020102309212582753
9086,2020-10-23,대웅당뇨신약후보신속심사대상지정허가기간단축,http://www.dailypharm.com/Users/News/NewsView.html?ID=269813&REFERER=NP
9087,2020-10-23,대웅제약제2형당뇨병치료제식약처신속심사대상의약품지정획득,http://www.youthdaily.co.kr/news/article.html?no=50956
9088,2020-10-23,대웅제약한국아스트라제네카의약품신속심사대상지정,http://www.edaily.co.kr/news/newspath.asp?newsid=01902406625935872
9089,2020-10-23,대웅당뇨병치료제신속심사대상의약품지정심사90일단축,http://www.wikileaks-kr.org/news/articleView.html?idxno=97175
9090,2020-10-23,대웅DWP16001AZ셀루메티닙신속심사대상의약품최초지정,http://www.newspim.com/news/view/20201023000189
9091,2020-10-23,대웅제약나보타온라인세미나통해모공축소시술법공유,http://www.upinews.kr/newsView/upi202010230010
9092,2020-10-23,대웅제약DWP16001AZ셀루메티닙신속심사의약품첫지정,http://www.medisobizanews.com/news/articleView.html?idxno=73588
9093,2020-10-23,식약처대웅제약DWP16001아스트라제네카셀루메티닙신속심사의약품지정,http://www.kpinews.co.kr/news/articleView.html?idxno=128982
9094,2020-10-23,대웅제약AZ신약최초신속심사의약품지정,http://www.newsis.com/view/?id=NISX20201023_0001208080&cID=13001&pID=13000
9095,2020-10-23,美ITC메디톡스대웅제약보톡스분쟁최종판결2주연기,https://www.hankyung.com/it/article/202010230782i
9096,2020-10-23,대웅DWP16001AZ셀루메티닙신속심사최초지정,http://www.bosa.co.kr/news/articleView.html?idxno=2136695
9097,2020-10-23,대웅아스트라제네카신약첫신속심사대상지정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1334496
9098,2020-10-23,대웅DWP16001AZ셀루메티닙신속심사대상의약품지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=403502
9099,2020-10-23,식약처대웅아스트라혁신신약첫신속심사지정,http://www.dailymedi.com/detail.php?number=861910&thread=22r05
9100,2020-10-23,美ITC대웅제약메디톡스소송최종결론일2주연기,http://news.mt.co.kr/mtview.php?no=2020102310413618667
9101,2020-10-23,식약처대웅제약당뇨병치료제등신속심사대상지정,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010230141&t=NN
9102,2020-10-23,대웅DWP16001아스트라제네카셀루메티닙신속심사대상지정,http://www.doctorsnews.co.kr/news/articleView.html?idxno=136714
9103,2020-10-23,美ITC대웅제약메디톡스분쟁최종판결2주연기,http://www.newsis.com/view/?id=NISX20201023_0001208267&cID=13001&pID=13000
9104,2020-10-23,식약처신속심사대상의약품지정대웅당뇨병치료제등,http://medipana.com/news/news_viewer.asp?NewsNum=264808&MainKind=A&NewsKind=5&vCount=12&vKind=1
9105,2020-10-23,식약처대웅제약당뇨병치료제등2개의약품신속심사대상지정,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004150929
9106,2020-10-23,종합ITC대웅제약메디톡스보톨리늄톡신균주분쟁2주간연기,http://www.ccreview.co.kr/news/articleView.html?idxno=292325
9107,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64096
9108,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.ekn.kr/news/article.html?no=530128
9109,2020-10-23,대웅제약당뇨병신약이나보글리플로진개발가속화기대,http://medipana.com/news/news_viewer.asp?NewsNum=264814&MainKind=A&NewsKind=5&vCount=12&vKind=1
9110,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://news.kbiz.or.kr/news/articleView.html?idxno=73857
9111,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://daily.hankooki.com/lpage/industry/202010/dh20201023113403148390.htm?s_ref=nv
9112,2020-10-23,대웅제약당뇨병치료제이나보글리플로진신속심사대상의약품지정,http://www.healthinnews.co.kr/news/articleView.html?idxno=15103
9113,2020-10-23,대웅제약이나보글리플로진국내최초신속심사대상지정,http://www.press9.kr/news/articleView.html?idxno=46101
9114,2020-10-23,대웅제약당뇨병신약국내최초신속심사지정,http://www.medisobizanews.com/news/articleView.html?idxno=73602
9115,2020-10-23,대웅제약당뇨병신약이나보글리플로진패스트트랙지정,https://www.sedaily.com/NewsView/1Z98QZK0B9
9116,2020-10-23,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250534
9117,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상지정,https://www.fetv.co.kr/news/article.html?no=66575
9118,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://newsbrite.net/142724
9119,2020-10-23,신속심사의약품첫지정대웅제약아스트라제네카수혜,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136721&REFERER=NP
9120,2020-10-23,대웅제약과메디톡스미국균주소송최종판결11월19일로연기돼,http://www.businesspost.co.kr/BP?command=article_view&num=201232
9121,2020-10-23,대웅이나보글리플로진신속심사선정국내최초,http://www.whosaeng.com/121928
9122,2020-10-23,대웅제약당뇨신약DWP16001신속심사대상지정,https://www.kpanews.co.kr/article/show.asp?idx=217099&category=D
9123,2020-10-23,대웅메디톡스ITC최종결정19일로연기코로나19영향,http://medipana.com/news/news_viewer.asp?NewsNum=264804&MainKind=A&NewsKind=5&vCount=12&vKind=1
9124,2020-10-23,첫신속심사제수혜자는대웅제약아스트라제네카,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2004096
9125,2020-10-23,대웅제약당뇨병신약국내첫신속심사대상의약품지정,http://www.metroseoul.co.kr/article/20201023500109
9126,2020-10-23,대웅제약제2형당뇨병치료제식약처신속심사대상의약품지정획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020102311554812533
9127,2020-10-23,대웅제약당뇨병신약이나보글리프로진국내최초신속심사대상의약품지정,https://www.news2day.co.kr/162733
9128,2020-10-23,국내첫식약처패스트트랙의약품대웅제약당뇨병신약신속심사대상지정,https://www.donga.com/news/article/all/20201023/103593590/1
9129,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.pinpointnews.co.kr/view.php?ud=2020102312405588032365609d9b_45
9130,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.m-i.kr/news/articleView.html?idxno=757280
9131,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.ceoscoredaily.com/news/article.html?no=74351
9132,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://moneys.mt.co.kr/news/mwView.php?no=2020102311398048504
9133,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내첫신속심사대상의약품지정,http://www.ajunews.com/view/20201023130741029
9134,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.thebigdata.co.kr/view.php?ud=202010231130043342d0a8833aad_23
9135,2020-10-23,대웅제약당뇨병치료제이나보글리플로진패스트트랙지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=403552
9136,2020-10-23,메디톡스대웅제약보톡스전쟁최종결론내달19일,http://www.koreastocknews.com/news/articleView.html?idxno=58172
9137,2020-10-23,대웅제약당뇨병신약이나보글리플로진식약처신속심사대상지정,https://www.etoday.co.kr/news/view/1953956
9138,2020-10-23,대웅제약이나보글리플로진신속심사대상의약품지정,http://www.businesskorea.co.kr/news/articleView.html?idxno=53737
9139,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.viva100.com/main/view.php?key=20201023010004609
9140,2020-10-23,대웅제약당뇨병신약 이나보글리플로진 국내최초신속심사대상의약품지정,http://www.greened.kr/news/articleView.html?idxno=273469
9141,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.lawissue.co.kr/view.php?ud=202010231337422114204ead0791_12
9142,2020-10-23,대웅제약당뇨병신약후보국내첫신속심사의약품지정,https://www.hankyung.com/it/article/202010231903i
9143,2020-10-23,대웅제약이나보글리플로진우선순위심사권확보,http://www.mhj21.com/135692
9144,2020-10-23,대웅제약식약처SGLT2억제신약후보신속심사대상지정,http://news.mk.co.kr/newsRead.php?no=1088790&year=2020
9145,2020-10-23,대웅제약라이브세미나열어나보타최신지견공유,http://www.seoulfn.com/news/articleView.html?idxno=398800
9146,2020-10-23,제약워치대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정外,http://www.newswatch.kr/news/articleView.html?idxno=51550
9147,2020-10-23,대웅제약당뇨병치료물질식약처신속심사대상의약품에지정돼,http://www.businesspost.co.kr/BP?command=article_view&num=201257
9148,2020-10-23,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,https://www.asiatoday.co.kr/view.php?key=20201023010013652
9149,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.nbnnews.co.kr/news/articleView.html?idxno=434752
9150,2020-10-23,대웅제약당뇨병치료제이나보글리플로진신속심사대상지정,http://health.chosun.com/site/data/html_dir/2020/10/23/2020102301762.html
9151,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102314352626351
9152,2020-10-23,식약처대웅제약당뇨병 치료제등신속심사대상의약품지정,http://www.rapportian.com/news/articleView.html?idxno=128609
9153,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,https://www.dailian.co.kr/news/view/930139/?sc=Naver
9154,2020-10-23,메디톡스대웅제약보톡스분쟁ITC최종판결2주연기,http://yna.kr/AKR20201023104200017?did=1195m
9155,2020-10-23,대웅제약당뇨병신약신속심사대상의약품으로지정,http://www.thedailypost.kr/news/articleView.html?idxno=76941
9156,2020-10-23,미국ITC대웅제약메디톡스분쟁최종판결2주연기,http://www.econovill.com/news/articleView.html?idxno=501360
9157,2020-10-23,메디톡스대웅제약보톡스분쟁11월중순께최종판결,http://www.smartfn.co.kr/view.php?ud=202010231459402353379cda9ab3_46
9158,2020-10-23,대웅제약 당뇨병신약 이나보글리플로진국내최초 신속심사대상의약품지정,http://www.lcnews.co.kr/news/articleView.html?idxno=9171
9159,2020-10-23,식약처대웅제약당뇨병신약이나보글리플로진신속심사대상지정,http://www.seoulfn.com/news/articleView.html?idxno=398829
9160,2020-10-23,우수한혈당강하효과대웅제약당뇨병신약이나보글리플로진신속심사대상지정,http://theviewers.co.kr/View.aspx?No=1300921
9161,2020-10-23,美ITC메디톡스대웅제약보톡스판결2주연기,https://www.asiatoday.co.kr/view.php?key=20201023010013734
9162,2020-10-23,미국ITC서벌이는메디톡스대웅제약보톡스분쟁최종판결2주연기,http://www.idsn.co.kr/news/articleView.html?idxno=35398
9163,2020-10-23,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,http://www.medigatenews.com/news/3222436576
9164,2020-10-23,메디톡스대웅제약美ITC소송최종판결2주연기,https://www.paxnetnews.com/articles/66390
9165,2020-10-23,대웅제약당뇨병신약이나보글리플로진패스트트랙지정,http://sports.hankooki.com/lpage/economy/202010/sp20201023154847137020.htm?s_ref=nv
9166,2020-10-23,대웅제약당뇨병신약신속심사대상의약품지정,http://www.dailysmart.co.kr/news/articleView.html?idxno=34602
9167,2020-10-23,글로벌Biz24대웅제약인도네시아서코로나19분자진단키트아큐라디텍허가,http://www.g-enews.com/ko-kr/news/article/news_all/20201023154215241269d76442fa_1/article.html
9168,2020-10-23,대웅제약당뇨병신약신속심사대상의약품지정,https://www.ebn.co.kr/news/view/1455864/?sc=Naver
9169,2020-10-23,메디톡스대웅제약美ITC최종판결2주연기내달19일결과,http://www.newspim.com/news/view/20201023001011
9170,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.koreaittimes.com/news/articleView.html?idxno=101253
9171,2020-10-23,美ITC대웅제약메디톡스균주소송전최종판결11월19일로연기,https://www.fetv.co.kr/news/article.html?no=66620
9172,2020-10-23,시그널보톡스분쟁대웅제약메디톡스현금확보비상,https://www.sedaily.com/NewsView/1Z98SHJEBW
9173,2020-10-23,美ITC메디톡스대웅제약최종판결2주연기,http://daily.hankooki.com/lpage/industry/202010/dh20201023162546148390.htm?s_ref=nv
9174,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내첫신속심사대상의약품지정,http://www.sportsseoul.com/news/read/972619?ref=naver
9175,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.mediapen.com/news/view/568422
9176,2020-10-23,메디톡스대웅제약보톡스최종판정연기,https://www.nocutnews.co.kr/news/5434588
9177,2020-10-23,메디톡스대웅제약균주전쟁ITC최종판결2주연기,http://www.newstomato.com/ReadNews.aspx?no=1002738
9178,2020-10-23,대웅제약당뇨병신약국내최초신속심사대상의약품지정,http://www.sisafocus.co.kr/news/articleView.html?idxno=249485
9179,2020-10-23,단독대웅자사보툴리눔균주명홀에이아냐,http://www.mkhealth.co.kr/news/articleView.html?idxno=50933
9180,2020-10-23,美ITC메디톡스대웅제약보톡스분쟁최종판결2주연기,http://www.newsway.co.kr/news/view?tp=1&ud=2020102316522575260
9181,2020-10-23,미국ITC대웅제약메디톡스판결2주연기,https://www.sedaily.com/NewsView/1Z98RX5DSM
9182,2020-10-23,대웅제약당뇨병신약국내최초패스트트랙지정,http://www.pressm.kr/news/articleView.html?idxno=33928
9183,2020-10-23,메디톡스대웅제약보톡스분쟁ITC최종판결2주연기,http://www.mediapen.com/news/view/568433
9184,2020-10-23,메디톡스대웅제약보톡스균주분쟁ITC최종판결2주연기,http://it.chosun.com/site/data/html_dir/2020/10/23/2020102302445.html
9185,2020-10-23,메디톡스대웅제약보톡스분쟁美ITC최종판결2주연기,http://www.edaily.co.kr/news/newspath.asp?newsid=03401366625935872
9186,2020-10-23,식약처대웅제약당뇨신약신속심사대상으로지정,http://www.finomy.com/news/articleView.html?idxno=84468
9187,2020-10-23,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.thefirstmedia.net/news/articleView.html?idxno=64966
9188,2020-10-23,대웅제약당뇨신약이나보글리플로진신속심사의약품지정,http://www.econovill.com/news/articleView.html?idxno=501444
9189,2020-10-24,한국아스트라제네카셀루메티닙대웅제약DWP16001식약처최초신속심사대상의약품지정,http://medicalworldnews.co.kr/news/view.php?idx=1510938305
9190,2020-10-24,대웅제약당뇨병신약이나보글리플로진국내최초패스트트랙의약품지정,http://www.updownnews.co.kr/news/articleView.html?idxno=224580
9191,2020-10-24,식약처신속심사대상의약품최초지정대웅제약한국아스트라제네카,http://www.anewsa.com/detail.php?number=2256887&thread=09
9192,2020-10-25,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010250809244030721
9193,2020-10-25,대웅제약당뇨병신약이나보글리플로진국내최초신속심사대상의약품지정,http://www.thepublic.kr/news/newsview.php?ncode=1065599229814641
9194,2020-10-25,기업자금조달보톡스전쟁대웅제약공모채포기후대출단기차입선회,https://view.asiae.co.kr/article/2020102511070717259
9195,2020-10-26,보톡스분쟁속美ITC조사국대웅나보타영구수입금지해야,http://yna.kr/AKR20201025052900017?did=1195m
9196,2020-10-26,美ITC조사국대웅제약나보타영구수입금지해야,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010260013&t=NN
9197,2020-10-26,대웅제약나보타영구수입금지해야ITC조사국의견서제출,http://www.getnews.co.kr/view.php?ud=2020102606553194732aaae0046f_16
9198,2020-10-26,미국ITC보톡스분쟁에대웅제약나보타수입무기한금지해야,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00008&news_seq_no=4320577
9199,2020-10-26,미무역위대웅제약나보타수입금지무기한으로늘려야”,https://www.chosun.com/economy/science/2020/10/26/AMFLAA35ONECPIAPEJ54KXI6QQ/?utm_source=naver&utm_medium=original&utm_campaign=news
9200,2020-10-26,美ITC조사국예비판결지지대웅제약나보타영구수입금지해야”,http://www.youthdaily.co.kr/news/article.html?no=51124
9201,2020-10-26,美ITC불공정수입조사국대웅제약이의신청반대나보타수입영구금지해야,http://news.mk.co.kr/newsRead.php?no=1094292&year=2020
9202,2020-10-26,보톡스분쟁속美ITC조사국대웅나보타영구수입금지해야종합,http://yna.kr/AKR20201025052951017?did=1195m
9203,2020-10-26,대웅나보타미국진출꿈물거품미ITC영구수입금지”의견,http://news.heraldcorp.com/view.php?ud=20201026000116
9204,2020-10-26,美ITC조사국대웅나보타영구수입금지해야,http://www.dt.co.kr/contents.html?article_no=2020102602109931102001&ref=naver
9205,2020-10-26,보톡스분쟁속美ITC조사국대웅나보타영구수입금지해야,http://www.fntoday.co.kr/news/articleView.html?idxno=237140
9206,2020-10-26,특징주대웅제약과보톡스전쟁메디톡스4↑,http://moneys.mt.co.kr/news/mwView.php?no=2020102609078082836
9207,2020-10-26,대웅제약당뇨병신약신속심사대상의약품지정,http://weekly.cnbnews.com/news/article.html?no=136564
9208,2020-10-26,헬스특집대웅제약임팩타민비타민B로피로회복면역력관리,http://www.newscj.com/news/articleView.html?idxno=792693
9209,2020-10-26,오늘의제약동아제약한국아스트라제네카휴젤23일대웅제약23일,http://www.babytimes.co.kr/news/articleView.html?idxno=40368
9210,2020-10-26,美ITC조사국대웅제약나보타무기한수입금지해야,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010260100&t=NN
9211,2020-10-26,대웅제약ITCOUII의견서는기존주장반복일뿐정정보도요청”,http://daily.hankooki.com/lpage/industry/202010/dh20201026093741148390.htm?s_ref=nv
9212,2020-10-26,美ITC조사국대웅나보타영구수입금지해야대웅근거없는내용,http://www.ekn.kr/news/article.html?no=530447
9213,2020-10-26,메디톡스대웅분쟁속미ITC조사국대웅보톡스영구수입금지대웅의미없는주장,https://biz.chosun.com/site/data/html_dir/2020/10/26/2020102600733.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9214,2020-10-26,대웅제약OUII는美ITC스탭어토니기존주장반복한것,http://www.medisobizanews.com/news/articleView.html?idxno=73627
9215,2020-10-26,美ITC조사국나보타무기한수입금지해야대웅기존주장반복,http://www.upinews.kr/newsView/upi202010260007
9216,2020-10-26,ITC조사국나보타영구수입금지대웅기존주장반복,https://view.asiae.co.kr/article/2020102610270336511
9217,2020-10-26,대웅제약나보타라이브세미나에서피부미용최신지견공유,http://inthenews.co.kr/article-74954/
9218,2020-10-26,美ITC나보타수입무기한금지해야”대웅편향된의견”,https://www.sedaily.com/NewsView/1Z9A4TFEUZ
9219,2020-10-26,마켓인사이트A대웅제약3년만기로900억대출,https://www.hankyung.com/finance/article/202010268813u
9220,2020-10-26,ITC조사국나보타영구수입금지의견제출대웅의미없다종합2보,http://yna.kr/AKR20201025052952017?did=1195m
9221,2020-10-26,대웅메디톡스미ITC소송내달19일결론조사국수입금지고수,https://www.news1.kr/articles/?4098407
9222,2020-10-26,ITC조사국나보타수입금지계속돼야대웅제약이의반박하는의견제출,https://hankookilbo.com/News/Read/A2020102609470002632?did=NA
9223,2020-10-26,美OUII대웅제약나보타수입금지해야”,https://www.seoul.co.kr/news/newsView.php?id=20201027021038&wlog_tag3=naver
9224,2020-10-26,美ITC조사국대웅나보타영구수입금지당연한결과vs기존주장반복,http://www.newspim.com/news/view/20201026000423
9225,2020-10-26,대웅제약신약연구개발강화로글로벌공략나선다,http://www.betanews.net:8080/article/1237803.html
9226,2020-10-26,대웅제약대웅장중주가급락무슨일,http://www.choicenews.co.kr/news/articleView.html?idxno=75670
9227,2020-10-26,美ITC산하조직대웅보톡스제품영구수입금지”,https://cnbc.sbs.co.kr/article_hub/10001000448?division=NAVER
9228,2020-10-26,보툴리눔톡신소송전메디톡스승대웅제약패로결론나나,http://www.newsquest.co.kr/news/articleView.html?idxno=79219
9229,2020-10-26,대웅나보타美진출물거품되나ITC영구수입금지”의견,http://news.heraldcorp.com/view.php?ud=20201026000667
9230,2020-10-26,대웅제약OUII주장예비판결부터반복한편향적의견ITC도인지,https://www.ajunews.com/view/20201026122638094
9231,2020-10-26,대웅메디톡스미ITC소송대웅나보타영구수입금지해야,http://www.thevaluenews.co.kr/news/view.php?idx=161251
9232,2020-10-26,美ITC조사국대웅나보타영구수입금지해야,http://www.edaily.co.kr/news/newspath.asp?newsid=02765046625936856
9233,2020-10-26,대웅제약vs메디톡스보톡스전쟁내달19일美서최종결론,http://4th.kr/View.aspx?No=1303089
9234,2020-10-26,대웅제약신약RD강화로글로벌공략나서나보타성공신화이어간다,http://www.sisaweek.com/news/articleView.html?idxno=138608
9235,2020-10-26,美ITC조사국나보타수입무기한금지해야”대웅편향된의견뿐”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010261122228740971
9236,2020-10-26,美ITC조사국대웅제약나보타무기한수입금지필요,http://www.metroseoul.co.kr/article/20201026500479
9237,2020-10-26,美ITC조사국대웅제약영업비밀침해시나보타무기한수입금지해야,https://www.etoday.co.kr/news/view/1954730
9238,2020-10-26,ITC조사국나보타영구수입금지”의견제출대웅기존주장반복,https://news.joins.com/article/olink/23498322
9239,2020-10-26,美ITC조사국나보타영구수입금지의견제출대웅편향된의견”,http://inthenews.co.kr/article-75028/
9240,2020-10-26,메디톡스주가급등대웅제약급락미국보툴리눔균주소송영향,http://www.businesspost.co.kr/BP?command=article_view&num=201536
9241,2020-10-26,美ITC조사국대웅나보타영구수입금지대웅기존주장반복,https://www.asiatime.co.kr/news/newsview.php?ncode=1065590218172355
9242,2020-10-26,미국ITC조사국대웅제약보톡스제품영구수입금지를”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202010261611001&code=920501
9243,2020-10-26,美ITC의메디톡스지지의견에대웅메디톡스의상반된입장,https://www.asiatoday.co.kr/view.php?key=20201026010015134
9244,2020-10-26,美ITC조사국나보타수입무기한금지해야”대웅제약기존주장의반복”반박,http://www.thepublic.kr/news/newsview.php?ncode=1065596265520734
9245,2020-10-26,미ITC조사국예비판결지지대웅제약편향된의견,http://www.mediapen.com/news/view/569248
9246,2020-10-26,메디톡스대웅분쟁휴젤만홀로웃었다,https://www.sedaily.com/NewsView/1Z9A6W91VR
9247,2020-10-26,ITC조사국대웅제약보톡스미국내수입영구금지해야,https://www.nocutnews.co.kr/news/5435907
9248,2020-10-26,단독대웅나보타제품설명서에Hall균주표기했다가삭제,http://www.mkhealth.co.kr/news/articleView.html?idxno=50959
9249,2020-10-26,美ITC조사국대웅제약이의제기반박대웅나보타영구수입금지해야,http://www.betanews.net:8080/article/1237920.html
9250,2020-10-27,美ITC조사국메디톡스손들어줬다대웅제약나보타수입무기한금지해야”,https://www.chosun.com/economy/science/2020/10/27/LQVIBLDCERATXF5CKVT4266FMI/?utm_source=naver&utm_medium=original&utm_campaign=news
9251,2020-10-27,韓보툴리눔톡신바람잘날없네”악재쏟아진대웅메디톡스,http://it.chosun.com/site/data/html_dir/2020/10/26/2020102602330.html
9252,2020-10-27,3분기원외처방한미종근당대웅HK이노엔유한양행,http://www.dailymedi.com/detail.php?number=862028&thread=22r05
9253,2020-10-27,美ITC산하조직나보타수입무기한금지해야”대웅제약기존주장번복”,http://www.mdtoday.co.kr/mdtoday/index.html?no=403795
9254,2020-10-27,대웅제약美ITC최종판결앞두고900억원대출,http://www.mdtoday.co.kr/mdtoday/index.html?no=403833
9255,2020-10-27,美ITC조사국메디톡스손들어줘대웅제약편향된의견,http://weekly.hankooki.com/lpage/economy/202010/wk20201027113314146380.htm?s_ref=nv
9256,2020-10-27,대웅제약패배로기우는보톡스전쟁,http://www.seouleconews.com/news/articleView.html?idxno=57365
9257,2020-10-27,대웅제약나보타치료시장선점속도연말치료용美임상2상돌입,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102710510178210
9258,2020-10-27,대웅제약당뇨병신약이나보글리플로진첫패스트트랙지정,http://www.doctorsnews.co.kr/news/articleView.html?idxno=136752
9259,2020-10-27,윤재승대웅제약50억원손배청구소송피소백왕기사기로77억원손해,http://www.sisajournal-e.com/news/articleView.html?idxno=224979
9260,2020-10-27,마켓줌인美ITC판결앞둔대웅제약향배는,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102714510144147
9261,2020-10-27,네이버포스트치열한보톡스시장대웅메디톡스휴젤희비엇갈려,http://www.ajunews.com/view/20201027162226044
9262,2020-10-27,휴젤메디톡스대웅국내보톡스3사희비,http://www.edaily.co.kr/news/newspath.asp?newsid=04300086625937184
9263,2020-10-28,메디톡스대웅살얼음판휴젤탄탄대로보톡스지각변동예고,http://news.heraldcorp.com/view.php?ud=20201028000395
9264,2020-10-28,굿닥터대웅제약이나보글리플로진이기대되는이유,http://www.g-enews.com/ko-kr/news/article/news_all/20201028110551120469d76442fa_1/article.html
9265,2020-10-28,대웅제약당뇨병신약이나보글리플로진신속심사대상의약품지정,http://www.kukinews.com/newsView/kuk202010280192
9266,2020-10-28,대웅메디톡스좌불안석휴젤나홀로질주,http://www.sporbiz.co.kr/news/articleView.html?idxno=474188
9267,2020-10-28,대웅제약미국균주소송판결뒤대비하나전승호유동성확보나서,http://www.businesspost.co.kr/BP?command=article_view&num=201914
9268,2020-10-29,단독직원욕설윤재승전대웅회장여전히경영에관여하나,http://www.sporbiz.co.kr/news/articleView.html?idxno=474155
9269,2020-10-29,더벨대웅제약테라퓨틱스인적교류통해RD강화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202010271549108200104294
9270,2020-10-29,대웅제약美터프츠메디컬센터와공동연구협약체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=54061
9271,2020-10-29,대웅제약미국대학병원과니클로사마이드미국임상2상협약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250758
9272,2020-10-29,대웅제약코로나19치료제美터프츠메디컬센터와공동연구,http://medipana.com/news/news_viewer.asp?NewsNum=265081&MainKind=A&NewsKind=5&vCount=12&vKind=1
9273,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.lawissue.co.kr/view.php?ud=202010291102052827204ead0791_12
9274,2020-10-29,대웅제약코로나19치료제美터프츠메디컬센터와공동연구협약,https://www.asiatoday.co.kr/view.php?key=20201029010017880
9275,2020-10-29,대웅제약코로나치료제글로벌임상위해美메디컬센터와연구협약체결,http://www.ekn.kr/news/article.html?no=531283
9276,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제글로벌임상연구협약,http://it.chosun.com/site/data/html_dir/2020/10/29/2020102901250.html
9277,2020-10-29,대웅제약美터프츠메디컬센터와협약니클로사마이드글로벌임상,http://www.mhj21.com/136041
9278,2020-10-29,대웅제약美터프츠메디컬센터와협약니클로사마이드글로벌임상,http://www.mhj21.com/136041
9279,2020-10-29,대웅제약美메디컬센터와코로나19치료제공동연구,http://www.newsis.com/view/?id=NISX20201029_0001215157&cID=13001&pID=13000
9280,2020-10-29,대웅제약美터프츠메디컬센터와니클로사마이드글로벌임상공동연구협약체결,http://www.m-i.kr/news/articleView.html?idxno=759309
9281,2020-10-29,대웅제약美터프츠메디컬센터와니클로사마이드美임상2상진행,http://www.viva100.com/main/view.php?key=20201029010006191
9282,2020-10-29,대웅제약코로나19치료제美임상2상공동임상협약체결,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202010290163&t=NN
9283,2020-10-29,대웅제약니클로사마이드글로벌임상박차美터프츠메디컬센터공동연구협약,http://www.newslock.co.kr/news/articleView.html?idxno=32223
9284,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64237
9285,2020-10-29,대웅제약美터프츠메디컬센터와코로나치료제 공동개발,http://www.upinews.kr/newsView/upi202010290042
9286,2020-10-29,대웅제약니클로사마이드임상美터프츠메디컬센터와공동연구손잡아,http://www.lcnews.co.kr/news/articleView.html?idxno=9290
9287,2020-10-29,대웅제약美터프츠메디컬센터니클로사마이드글로벌임상맞손,http://www.newsprime.co.kr/news/article.html?no=522521
9288,2020-10-29,대웅제약美터프츠메디컬센터와글로벌임상공동연구협약,http://www.dailysmart.co.kr/news/articleView.html?idxno=34863
9289,2020-10-29,대웅제약터프츠와코로나19美2상추진,http://www.press9.kr/news/articleView.html?idxno=46153
9290,2020-10-29,대웅제약美대학병원과코로나치료제임상2상협약,http://news.mt.co.kr/mtview.php?no=2020102911235723999
9291,2020-10-29,대웅제약美터프츠메디컬센터와니클로사마이드글로벌임상협업,http://www.medisobizanews.com/news/articleView.html?idxno=73747
9292,2020-10-29,대웅제약니클로사마이드글로벌임상美터프츠메디컬센터와공동연구협약,http://www.sentv.co.kr/news/view/581843
9293,2020-10-29,대웅제약美터프츠메디컬센터와공동연구협약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=15236
9294,2020-10-29,대웅제약니클로사마이드글로벌임상美터프츠메디컬센터와협약체결,http://www.opinionnews.co.kr/news/articleView.html?idxno=42347
9295,2020-10-29,대웅제약코로나치료제글로벌2상진입에총력전,http://www.bosa.co.kr/news/articleView.html?idxno=2137056
9296,2020-10-29,대웅제약美터프츠메디컬센터와연구협약체결,https://www.ebn.co.kr/news/view/1456755/?sc=Naver
9297,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제공동연구,http://www.youthdaily.co.kr/news/article.html?no=51524
9298,2020-10-29,대웅제약코로나19치료제미국임상가속도,http://www.dailymedi.com/detail.php?number=862134&thread=22r05
9299,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://newsbrite.net/142923
9300,2020-10-29,대웅제약구충제성분코로나19치료제미국임상박차니클로사마이드임상병원과협력,https://www.donga.com/news/article/all/20201029/103695885/1
9301,2020-10-29,대웅제약니클로사마이드공동연구협약체결,http://www.pharmnews.com/news/articleView.html?idxno=101554
9302,2020-10-29,대웅제약니클로사마이드글로벌임상위해美기관과연구협약체결,https://www.fetv.co.kr/news/article.html?no=67057
9303,2020-10-29,대웅제약美터프츠메디컬센터와공동연구계약코로나치료제임상위해,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020102913020390515
9304,2020-10-29,구충제로코로나19치료대웅제약美대학병원과니클로사마이드글로벌임상,http://theviewers.co.kr/View.aspx?No=1313358
9305,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제임상협약,https://www.hankyung.com/it/article/202010292919i
9306,2020-10-29,메디톡스대웅제약소송에휴젤단독질주,http://www.seoulwire.com/news/articleView.html?idxno=428808
9307,2020-10-29,대웅제약코로나19치료제美터프츠메디컬센터와공동연구추진,http://www.kpinews.co.kr/news/articleView.html?idxno=129525
9308,2020-10-29,대웅제약美터프츠메디컬센터와공동연구협약체결,http://www.leaders.kr/news/articleView.html?idxno=218076
9309,2020-10-29,대웅제약코로나19치료제글로벌임상속도,http://sports.hankooki.com/lpage/economy/202010/sp20201029135224137020.htm?s_ref=nv
9310,2020-10-29,대웅제약코로나19치료제후보물질글로벌임상위해美터프츠메디컬센터와협약체결,http://www.ceoscoredaily.com/news/article.html?no=74609
9311,2020-10-29,코로나치료제미국임상에박차대웅제약美대학병원과맞손,http://inthenews.co.kr/article-75555/
9312,2020-10-29,대웅제약코로나19치료제글로벌임상위해美대학병원과연구협약,https://www.etoday.co.kr/news/view/1956342
9313,2020-10-29,대웅코로나치료제글로벌임상2상준비착수,http://www.whosaeng.com/122074
9314,2020-10-29,구충제성분국산코로나치료제개발박차대웅제약美연구센터와임상협약,http://news.mk.co.kr/newsRead.php?no=1111203&year=2020
9315,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=436527
9316,2020-10-29,대웅제약미국터프츠메디컬센터와니클로사마이드공동연구협약,http://www.newstomato.com/ReadNews.aspx?no=1003830
9317,2020-10-29,대웅제약미국메디컬센터와코로나19치료제공동연구,http://www.mediapen.com/news/view/570259
9318,2020-10-29,대웅제약미국터프츠메디컬센터와공동연구협약체결,https://www.dailian.co.kr/news/view/931996/?sc=Naver
9319,2020-10-29,대웅제약美터프츠메디컬센터와협약체결코로나19치료제개발더순조로울것,http://www.paxetv.com/news/articleView.html?idxno=103254
9320,2020-10-29,뉴스투데이L대웅제약코로나19치료제니클로사마이드美임상2상공동연구협약체결,https://www.news2day.co.kr/163129
9321,2020-10-29,대웅제약美터프츠메디컬센터코로나19치료제연구협업,http://kormedi.com/?p=1326493
9322,2020-10-29,김해시대웅제약과세포유전자치료제산업육성한다,http://www.busan.com/view/busan/view.php?code=2020102916124081079
9323,2020-10-29,김해시대웅제약과세포유전자치료제산업육성,http://www.newspim.com/news/view/20201029001050
9324,2020-10-29,대웅제약미터프츠메디컬센터코로나19치료제글로벌임상공동연구협약,https://www.kpanews.co.kr/article/show.asp?idx=217277&category=D
9325,2020-10-29,대웅제약美대학병원과코로나19치료제임상협력,http://www.finomy.com/news/articleView.html?idxno=84723
9326,2020-10-29,김해시대웅제약과세포유전자치료제산업육성한다,http://www.kndaily.co.kr/news/articleView.html?idxno=173824
9327,2020-10-29,대웅제약미국터프츠와니클로사마이드코로나19임상,http://www.seoulfn.com/news/articleView.html?idxno=399443
9328,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.medigatenews.com/news/584913801
9329,2020-10-29,대웅제약미터프츠메디컬센터와코로나19치료제공동연구,http://www.fnnews.com/news/202010291658498632
9330,2020-10-29,경남김해시대웅제약과세포유전자치료제산업육성추진,http://daily.hankooki.com/lpage/society/202010/dh20201029170153148520.htm?s_ref=nv
9331,2020-10-29,대웅제약美터프츠메디컬센터 니클로사마이드글로벌공동연구협약,http://www.economytalk.kr/news/articleView.html?idxno=208952
9332,2020-10-29,대웅제약DWRX2003글로벌임상준비착착,http://www.monews.co.kr/news/articleView.html?idxno=214910
9333,2020-10-29,대웅제약미국터프츠메디컬센터와코로나19치료제임상협력,http://www.businesspost.co.kr/BP?command=article_view&num=202189
9334,2020-10-29,대웅제약개발중인코로나19치료제임상위해美메디컬센터와협력,http://daily.hankooki.com/lpage/industry/202010/dh20201029175414148390.htm?s_ref=nv
9335,2020-10-29,김해시대웅제약과세포유전자치료제산업육성,https://www.news1.kr/articles/?4103166
9336,2020-10-29,보톡스균주도용의혹대웅제약미국최종판결앞두고전전긍긍,https://ilyo.co.kr/?ac=article_view&entry_id=383344
9337,2020-10-29,대웅제약美대학병원코로나19치료제임상시험협업,http://www.100ssd.co.kr/news/articleView.html?idxno=72265
9338,2020-10-29,대웅제약코로나19치료후보물질美임상순항,http://www.shinailbo.co.kr/news/articleView.html?idxno=1337246
9339,2020-10-29,대웅제약코로나19치료제약물임상위해美터프츠메디컬센터와공동연구협약체결,http://www.worktoday.co.kr/news/articleView.html?idxno=11093
9340,2020-10-29,대웅제약美터프츠메디컬센터와코로나19치료제공동연구협약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=404261
9341,2020-10-29,대웅제약니클로사마이드글로벌임상위해美터프츠메디컬센터와공동연구협약체결,http://www.thepublic.kr/news/newsview.php?ncode=1065602875525714
9342,2020-10-29,대웅제약니클로사마이드美터프츠메디컬과공동연구협약,http://www.thedailypost.kr/news/articleView.html?idxno=77090
9343,2020-10-29,김해시대웅제약과세포유전자치료제산업육성한다,https://www.wikitree.co.kr/articles/586143
9344,2020-10-30,대웅제약ITC최종결정승소확신,http://www.medisobizanews.com/news/articleView.html?idxno=73760
9345,2020-10-30,대웅제약의반격ITC최종결정승소확신,http://www.bosa.co.kr/news/articleView.html?idxno=2137093
9346,2020-10-30,대웅제약ITC위원회에오류지적의견서제출최종결정승소확신,http://www.m-i.kr/news/articleView.html?idxno=759695
9347,2020-10-30,대웅제약美ITC에예비결정반박추가의견서제출,https://www.hankyung.com/finance/article/202010305689i
9348,2020-10-30,김해시대웅제약과세포유전자치료제산업육성한다,http://www.anewsa.com/detail.php?number=2263853&thread=10
9349,2020-10-30,김해시대웅제약과세포유전자치료제산업육성,http://www.queen.co.kr/news/articleView.html?idxno=345295
9350,2020-10-30,대웅제약ITC에반박의견서추가제출최종결정승소확신”,http://www.viva100.com/main/view.php?key=20201030010006453
9351,2020-10-30,미국반독점연구소대웅제약ITC예비결정뒤집어야공익의견서제출,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020103008111128039
9352,2020-10-30,대웅제약ITC위원회에의견서제출예비결정오류,http://www.press9.kr/news/articleView.html?idxno=46159
9353,2020-10-30,대웅제약ITC에추가의견서제출최종결정승소확신,http://www.newsis.com/view/?id=NISX20201030_0001216297&cID=13001&pID=13000
9354,2020-10-30,대웅ITC예비결정오류지적이어져최종결정승소확신,http://medipana.com/news/news_viewer.asp?NewsNum=265133&MainKind=A&NewsKind=5&vCount=12&vKind=1
9355,2020-10-30,대웅제약ITC에의견서제출후최종결정승소확신주장,http://www.lcnews.co.kr/news/articleView.html?idxno=9303
9356,2020-10-30,대웅제약메디톡스대상ITC최종결정승소확신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250791
9357,2020-10-30,대웅제약ITC에추가의견서제출균주는어디서든구할수있어”,https://www.sedaily.com/NewsView/1Z9BZ06GQH
9358,2020-10-30,김해시대웅제약과세포유전자치료제산업육성지원,http://www.viva100.com/main/view.php?key=20201030010006448
9359,2020-10-30,막바지이른보톡스균주전쟁대웅제약ITC최종결정승소확신,http://www.consumernews.co.kr/news/articleView.html?idxno=614798
9360,2020-10-30,대웅제약ITC최종결정승소확신의견서추가제출,http://www.businesskorea.co.kr/news/articleView.html?idxno=54108
9361,2020-10-30,대웅제약美ITC에추가의견서제출최종결정승소확신”,http://www.youthdaily.co.kr/news/article.html?no=51627
9362,2020-10-30,보톡스분쟁속대웅제약美ITC예비결정에반박의견서제출,http://yna.kr/AKR20201030033700017?did=1195m
9363,2020-10-30,대웅제약美ITC에추가의견서제출최종결정승소확신”,http://inthenews.co.kr/article-75694/
9364,2020-10-30,내달6일ITC최종판결대웅제약최종결정승소확신,http://www.wikileaks-kr.org/news/articleView.html?idxno=97641
9365,2020-10-30,대웅제약ITC에추가의견서제출반드시승소할것,http://moneys.mt.co.kr/news/mwView.php?no=2020103009328032024
9366,2020-10-30,대웅제약ITC최종결정승소확신ITC위원회에오류지적의견서추가제출,http://www.updownnews.co.kr/news/articleView.html?idxno=224782
9367,2020-10-30,대웅제약美ITC에추가의견서제출최종결정승소확신”,http://www.newsway.co.kr/news/view?tp=1&ud=2020103009325346046
9368,2020-10-30,대웅제약경상남도김해시인제대학교와MOU체결,http://www.lawissue.co.kr/view.php?ud=202010300938156849204ead0791_12
9369,2020-10-30,대웅제약ITC최종결정승소확신한다,http://www.mdtoday.co.kr/mdtoday/index.html?no=404299
9370,2020-10-30,대웅제약김해시인제대학교MOU체결세포유전자치료산업육성,http://www.thebigdata.co.kr/view.php?ud=202010300938377531d0a8833aad_23
9371,2020-10-30,대웅제약경남도김해시와세포유전자치료제산업공동육성,http://www.kpinews.co.kr/news/articleView.html?idxno=129592
9372,2020-10-30,보톡스분쟁속대웅제약美ITC예비결정에반박의견서제출,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010300948105100105
9373,2020-10-30,대웅제약지역사회와MOU세포유전자치료제산업육성,http://www.medisobizanews.com/news/articleView.html?idxno=73770
9374,2020-10-30,대웅제약세포유전자치료제육성위해지역사회와MOU,http://www.newstomato.com/ReadNews.aspx?no=1004045
9375,2020-10-30,대웅제약美ITC예비결정에반박의견서제출,http://it.chosun.com/site/data/html_dir/2020/10/30/2020103000908.html
9376,2020-10-30,대웅제약내달ITC최종결정서승소확신,http://www.whosaeng.com/122099
9377,2020-10-30,대웅제약ITC최종결정승소확신,http://www.wsobi.com/news/articleView.html?idxno=107392
9378,2020-10-30,대웅제약ITC에추가의견서균주기술영업비밀아냐,http://news.mt.co.kr/mtview.php?no=2020103009533698375
9379,2020-10-30,대웅제약지역사회와MOU세포유전자산업육성,http://www.press9.kr/news/articleView.html?idxno=46161
9380,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.ceoscoredaily.com/news/article.html?no=74660
9381,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010300954027600109
9382,2020-10-30,대웅제약세포유전자치료제산업키운다,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020103009490247066
9383,2020-10-30,대웅제약세포유전자치료제산업키운다,http://www.bosa.co.kr/news/articleView.html?idxno=2137115
9384,2020-10-30,대웅제약ITC위원회에예비결정오류지적의견서추가제출승소확신,http://www.healthinnews.co.kr/news/articleView.html?idxno=15254
9385,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,https://www.etoday.co.kr/news/view/1956753
9386,2020-10-30,대웅제약세포유전자치료제산업육성위해지역사회와MOU체결,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123008
9387,2020-10-30,대웅제약지역사회와세포유전자치료제산업육성,http://www.newsis.com/view/?id=NISX20201030_0001216502&cID=13001&pID=13000
9388,2020-10-30,대웅제약지역사회와세포유전자치료제산업육성MOU,https://www.hankyung.com/it/article/202010306280i
9389,2020-10-30,김해시대웅제약과세포유전자치료제산업육성한다外,https://ilyo.co.kr/?ac=article_view&entry_id=383352
9390,2020-10-30,대웅제약타사영업비밀도용한적없다,http://www.segye.com/content/html/2020/10/30/20201030508768.html?OutUrl=naver
9391,2020-10-30,메디톡스대웅제약11월보톡스분쟁최종판결앞두고서로승소자신,https://biz.chosun.com/site/data/html_dir/2020/10/30/2020103001025.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9392,2020-10-30,대웅제약美ITC에예비결정반박추가의견서제출승소확신,http://www.newslock.co.kr/news/articleView.html?idxno=32275
9393,2020-10-30,보톡스분쟁대웅제약ITC최종결정승소확신,http://www.dailysmart.co.kr/news/articleView.html?idxno=34930
9394,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.newsworker.co.kr/news/articleView.html?idxno=90067
9395,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.healthinnews.co.kr/news/articleView.html?idxno=15261
9396,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.pharmnews.com/news/articleView.html?idxno=101560
9397,2020-10-30,대웅제약경남도김해시인제대와함께세포유전자치료제산업육성,http://daily.hankooki.com/lpage/industry/202010/dh20201030103010148390.htm?s_ref=nv
9398,2020-10-30,대웅제약민관학협력해세포유전자치료제산업키운다,http://www.bokuennews.com/news/article.html?no=196561
9399,2020-10-30,대웅제약ITC최종결정승소확신예비결정오류지적의견서추가제출,http://www.newsprime.co.kr/news/article.html?no=522661
9400,2020-10-30,美최악의코로나확산에도대웅나보타깜짝실적,http://www.dailypharm.com/Users/News/NewsView.html?ID=270058&REFERER=NP
9401,2020-10-30,대웅제약美ITC예비결정추가반박서제출,https://view.asiae.co.kr/article/2020103010474189199
9402,2020-10-30,대웅제약경남서세포유전자치료제산업육성,http://www.dailypharm.com/Users/News/NewsView.html?ID=270067&REFERER=NP
9403,2020-10-30,대웅제약美터프츠메디컬센터와코로나치료제공동연구협약체결,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202010291534556310015
9404,2020-10-30,대웅제약세포유전자치료제육성위해지역사회와MOU,http://www.newsway.co.kr/news/view?tp=1&ud=2020103010454516097
9405,2020-10-30,대웅제약지역사회와세포유전자치료제산업육성,https://view.asiae.co.kr/article/2020103010542051207
9406,2020-10-30,대웅제약美ITC예비결정에추가반박의견서제출,https://www.etoday.co.kr/news/view/1956782
9407,2020-10-30,대웅제약경남지역과MOU세포유전자치료제산업육성,http://www.lcnews.co.kr/news/articleView.html?idxno=9317
9408,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,http://www.youthdaily.co.kr/news/article.html?no=51655
9409,2020-10-30,대웅제약지역스타트업인재발굴및지원나서,http://www.segyebiz.com/newsView/20201030509882?OutUrl=naver
9410,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://newsbrite.net/142981
9411,2020-10-30,대웅제약ITC위원회에예비결정오류지적하는의견서추가제출,http://newsbrite.net/142976
9412,2020-10-30,대웅제약ITC에예비결정반박의견서제출,http://www.dailypharm.com/Users/News/NewsView.html?ID=270068&REFERER=NP
9413,2020-10-30,대웅제약ITC최종결정승소확신,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64259
9414,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64268
9415,2020-10-30,대웅제약메디톡스영업비밀사용하지않았다주가는반등다운반등없이하락세,http://www.pinpointnews.co.kr/view.php?ud=202010301115241120861beb2d9d_45
9416,2020-10-30,대웅제약민관학손잡고세포유전자치료제육성한다,http://www.g-enews.com/ko-kr/news/article/news_all/2020103011192698032500a1b5d6_1/article.html
9417,2020-10-30,대웅제약지자체와세포유전자치료제산업육성나선다,http://www.medigatenews.com/news/2672693600
9418,2020-10-30,대웅제약ITC최종결정승소확신예비결정오류지적의견서공개,http://www.consumuch.com/news/articleView.html?idxno=51084
9419,2020-10-30,대웅제약ITC예비판결반박의견서제출,https://hankookilbo.com/News/Read/A2020103009370000243?did=NA
9420,2020-10-30,대웅제약ITC최종결정승소확신,http://www.shinailbo.co.kr/news/articleView.html?idxno=1337389
9421,2020-10-30,대웅제약ITC에예비결정오류지적의견서추가제출최종결정승소확신,https://www.asiatoday.co.kr/view.php?key=20201030010018575
9422,2020-10-30,보톡스분쟁대웅제약美ITC예비결정에반박의견서제출,https://www.nocutnews.co.kr/news/5438671
9423,2020-10-30,보톡스분쟁대웅제약ITC에예비결정오류지적의견서제출승소확신,http://www.sisaweek.com/news/articleView.html?idxno=138771
9424,2020-10-30,대웅제약보톡스분쟁관련美ITC예비결정반박메디톡스기존판결대로될것,http://www.ajunews.com/view/20201030104857754
9425,2020-10-30,대웅제약ITC위원회에의견서추가제출,http://www.dailymedi.com/detail.php?number=862185&thread=22r05
9426,2020-10-30,대웅제약경상남도김해시인제대와세포및유전자치료제산업육성,http://www.businesspost.co.kr/BP?command=article_view&num=202312
9427,2020-10-30,대웅제약세포유전자치료제산업민관학협력체계구축,http://medipana.com/news/news_viewer.asp?NewsNum=265170&MainKind=A&NewsKind=5&vCount=12&vKind=1
9428,2020-10-30,대웅제약경남지역서세포유전자치료제산업육성지원,http://news.mt.co.kr/mtview.php?no=2020103011430859510
9429,2020-10-30,지역인재발굴지원대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://theviewers.co.kr/View.aspx?No=1315193
9430,2020-10-30,대웅제약미국ITC예비결정에대한반박의견서제출,https://www.dailian.co.kr/news/view/932173/?sc=Naver
9431,2020-10-30,대웅제약ITC최종결정승소확신,http://www.thebigdata.co.kr/view.php?ud=202010301335075371d0a8833aad_23
9432,2020-10-30,대웅제약미국ITC예비결정에반박의견서추가제출,http://www.seoulfn.com/news/articleView.html?idxno=399537
9433,2020-10-30,대웅제약ITC위원회에예비결정오류지적하는의견서추가제출,http://www.paxetv.com/news/articleView.html?idxno=103352
9434,2020-10-30,대웅제약지역사회와세포유전자치료제산업키운다,http://www.mediapen.com/news/view/570578
9435,2020-10-30,대웅제약메디톡스와균주소송관련미국국제무역위에의견서더내,http://www.businesspost.co.kr/BP?command=article_view&num=202324
9436,2020-10-30,대웅제약ITC최종결정승소확신”,https://www.fetv.co.kr/news/article.html?no=67172
9437,2020-10-30,대웅제약경남권세포유전자치료제산업육성나서,https://www.fetv.co.kr/news/article.html?no=67175
9438,2020-10-30,대웅제약지역사회와MOU세포유전자치료제산업키운다,http://www.datasom.co.kr/news/articleView.html?idxno=109595
9439,2020-10-30,대웅제약ITC위원회에의견서추가제출승소확신,http://www.thedailypost.kr/news/articleView.html?idxno=77104
9440,2020-10-30,대웅제약세포유전자치료제산업키운다민관학협력체계구축,http://www.thedailypost.kr/news/articleView.html?idxno=77102
9441,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.nbnnews.co.kr/news/articleView.html?idxno=436935
9442,2020-10-30,대웅제약경상남도김해시인제대학교와MOU세포유전자치료제산업육성,http://www.wsobi.com/news/articleView.html?idxno=107457
9443,2020-10-30,대웅제약미국ITC예비결정에반박의견서제출,http://sports.hankooki.com/lpage/economy/202010/sp20201030145549137020.htm?s_ref=nv
9444,2020-10-30,대웅제약ITC최종결정승소확신,http://www.nbnnews.co.kr/news/articleView.html?idxno=436919
9445,2020-10-30,대웅제약ITC에추가의견서제출최종결정승소확신,http://www.ekn.kr/web/view.php?key=20201030010006010
9446,2020-10-30,대웅제약경남시와손잡고세포유전자치료제산업키운다,http://www.ekn.kr/web/view.php?key=20201030010006026
9447,2020-10-30,대웅제약미국ITC제출의견서홈페이지공개,http://www.mediapen.com/news/view/570620
9448,2020-10-30,보톡스분쟁대웅제약美ITC예비결정에반박의견서제출,https://www.asiatime.co.kr/news/newsview.php?ncode=1065594606605917
9449,2020-10-30,대웅제약지역사회와MOU세포유전자치료제산업키울것,http://www.sportsseoul.com/news/read/974993?ref=naver
9450,2020-10-30,대웅제약美ITC에의견서제출보톡스균주영업비밀아니다,http://news.mk.co.kr/newsRead.php?no=1116097&year=2020
9451,2020-10-30,대웅제약메디톡스보톡스판결앞두고의견서제출공방종합,http://yna.kr/AKR20201030033751017?did=1195m
9452,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.thefirstmedia.net/news/articleView.html?idxno=65346
9453,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업육성,http://www.dailysmart.co.kr/news/articleView.html?idxno=34956
9454,2020-10-30,보툴리눔톡신균주분쟁메디톡스대웅제약최종판결앞두고ITC에의견서제출,http://www.getnews.co.kr/view.php?ud=2020103016154246012fe691f917_16
9455,2020-10-30,대웅제약경남김해서세포유전자치료제산업키운다,http://www.finomy.com/news/articleView.html?idxno=84771
9456,2020-10-30,대웅제약지역사회와MOU맺고세포유전자치료제산업키운다,http://www.worktoday.co.kr/news/articleView.html?idxno=11127
9457,2020-10-30,희비갈린3분기유한종근당만족vs동아한미대웅주춤,http://www.sisajournal-e.com/news/articleView.html?idxno=225171
9458,2020-10-30,대웅제약지역사회와손잡고세포유전자치료제산업키운다,https://www.dailian.co.kr/news/view/932476/?sc=Naver
9459,2020-10-30,김창수의e뉴스브리핑대웅제약ITC최종결정승소확신”外,https://www.fetv.co.kr/news/article.html?no=67212
9460,2020-10-30,대웅제약경남도와세포유전자치료제개발맞손,http://www.100ssd.co.kr/news/articleView.html?idxno=72353
9461,2020-10-30,오늘의제약GC녹십자엠에스29일대웅제약동국제약제이브이엠동아ST,http://www.babytimes.co.kr/news/articleView.html?idxno=40523
9462,2020-10-30,대웅제약세포유전자치료제육성위한MOU,http://www.koreastocknews.com/news/articleView.html?idxno=58427
9463,2020-10-30,보톡스판결앞두고대웅제약메디톡스의견서제출공방,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004159172
9464,2020-10-30,뉴스투데이L대웅제약지역사회와함께세포유전자치료제산업키운다,https://www.news2day.co.kr/163238
9465,2020-10-30,보톡스분쟁서승리할것”대웅제약ITC예비결정반박의견추가제출,https://www.donga.com/news/article/all/20201030/103721706/1
9466,2020-10-30,김해시대웅제약과세포유전자치료제산업육성,http://www.cnbnews.com/news/article.html?no=466284
9467,2020-10-31,대웅제약경상남도등세포유전자치료제산업육성협약,https://www.kpanews.co.kr/article/show.asp?idx=217318&category=D
9468,2020-10-31,바이오세미나박준석대웅제약신약센터장차세대먹거리는희귀질환줄기세포치료제”,http://www.viva100.com/main/view.php?key=20201031010006636
9469,2020-11-01,대웅제약경상남도김해시인제대등지역사회와세포유전자치료제산업육성협력,http://www.econonews.co.kr/news/articleView.html?idxno=142516
9470,2020-11-02,ITC소송최종판결임박전운감도는메디톡스대웅제약,https://www.dailian.co.kr/news/view/932417/?sc=Naver
9471,2020-11-02,윤재승전회장일감몰아주기의혹대웅통해개인회사배불려,http://www.sporbiz.co.kr/news/articleView.html?idxno=474700
9472,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.getnews.co.kr/view.php?ud=2020110209045011842fe691f917_16
9473,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참가,http://medipana.com/news/news_viewer.asp?NewsNum=265226&MainKind=A&NewsKind=5&vCount=12&vKind=1
9474,2020-11-02,대웅제약신약개발위한글로벌학술네트워킹강화,http://www.medisobizanews.com/news/articleView.html?idxno=73812
9475,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.sentv.co.kr/news/view/582011
9476,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.press9.kr/news/articleView.html?idxno=46179
9477,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110209094134493
9478,2020-11-02,대웅제약KASBP추계심포지엄참석글로벌학술네트워킹강화,http://www.youthdaily.co.kr/news/article.html?no=51789
9479,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석글로벌네트워킹강화,http://www.ekn.kr/web/view.php?key=20201102010000177
9480,2020-11-02,대웅제약코로나19치료제美임상2상준비중,http://www.wikileaks-kr.org/news/articleView.html?idxno=97764
9481,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,https://www.fetv.co.kr/news/article.html?no=67260
9482,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://newsbrite.net/143057
9483,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석신약개발글로벌네트워킹강화,http://www.lcnews.co.kr/news/articleView.html?idxno=9363
9484,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004160716
9485,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.mediapen.com/news/view/571153
9486,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.monews.co.kr/news/articleView.html?idxno=214969
9487,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.businesskorea.co.kr/news/articleView.html?idxno=54227
9488,2020-11-02,대웅제약신약개발위한글로벌학술네트워킹강화,http://www.bosa.co.kr/news/articleView.html?idxno=2137213
9489,2020-11-02,대웅제약KASBP심포지엄참석학술교류강화,http://www.econovill.com/news/articleView.html?idxno=503023
9490,2020-11-02,대웅제약2020년재미한인제약인협회추계심포지엄참석,http://www.newslock.co.kr/news/articleView.html?idxno=32352
9491,2020-11-02,대웅제약재미한인제약인과코로나19등신약개발논의,http://www.medigatenews.com/news/2791358867
9492,2020-11-02,대웅제약신약개발위한글로벌학술네트워킹강화나서,http://www.betanews.net:8080/article/1238787.html
9493,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석글로벌학술네트워킹강화,http://www.m-i.kr/news/articleView.html?idxno=760296
9494,2020-11-02,대웅제약신약개발위한네트워킹강화,http://www.mhj21.com/136256
9495,2020-11-02,대웅제약 재미한인제약인협회 추계심포지엄참석,http://www.economytalk.kr/news/articleView.html?idxno=209006
9496,2020-11-02,대웅제약재미한인제약인협회KASBP심포지엄참석글로벌학술네트워킹강화”,http://www.viva100.com/main/view.php?key=20201102010000325
9497,2020-11-02,대웅제약지역사회와손잡고유전자치료제산업육성앞장,http://www.monews.co.kr/news/articleView.html?idxno=214978
9498,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.pressm.kr/news/articleView.html?idxno=34116
9499,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64300
9500,2020-11-02,대웅제약메디톡스ITC최종판결임박에여론전점입가경,https://www.fetv.co.kr/news/article.html?no=67303
9501,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.healthinnews.co.kr/news/articleView.html?idxno=15298
9502,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.lawissue.co.kr/view.php?ud=202011021154252607204ead0791_12
9503,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.newsway.co.kr/news/view?tp=1&ud=2020110212331821369
9504,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.dailysmart.co.kr/news/articleView.html?idxno=35047
9505,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.nbnnews.co.kr/news/articleView.html?idxno=437435
9506,2020-11-02,오늘의제약셀트리온GC녹십자엠에스동화약품에스티팜유비케어대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=40575
9507,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.thebigdata.co.kr/view.php?ud=202011021521264894d0a8833aad_23
9508,2020-11-02,한미약품메디톡스대웅제약5년속앓이같은날끝19일최종판결,http://theviewers.co.kr/View.aspx?No=1317640
9509,2020-11-02,대웅제약2020재미한인제약인협회추계심포지엄참석,http://www.enewstoday.co.kr/news/articleView.html?idxno=1424865
9510,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.dt.co.kr/contents.html?article_no=2020110202109931820010&ref=naver
9511,2020-11-02,대웅제약재미한인제약인협회추계심포지엄참석,http://www.mdtoday.co.kr/mdtoday/index.html?no=404580
9512,2020-11-02,메디톡스대웅제약균주소송5년만에마무리승자는,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123104
9513,2020-11-02,대웅제약재미한인제약인협회온라인심포지엄참석,http://www.100ssd.co.kr/news/articleView.html?idxno=72392
9514,2020-11-02,뉴스투데이L대웅제약재미한인제약인협회추계심포지엄참석,https://www.news2day.co.kr/163353
9515,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석,https://www.kpanews.co.kr/article/show.asp?idx=217363&category=D
9516,2020-11-02,대웅제약재미한인제약인협회KASBP추계심포지엄참석신약개발위한글로벌학술네트워킹강화,http://www.thefirstmedia.net/news/articleView.html?idxno=65436
9517,2020-11-03,대웅SGLT2후보제미글로와시너지효과노린다,http://www.dailypharm.com/Users/News/NewsView.html?ID=270143&REFERER=NP
9518,2020-11-03,대웅제약인니서코로나진단키트판매추진,https://www.theguru.co.kr/news/article.html?no=15772
9519,2020-11-03,대웅제약DWP160013상임상3건승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=404665
9520,2020-11-03,대웅제약전승호대표KASBP추계심포지엄참석,http://www.thedailypost.kr/news/articleView.html?idxno=77189
9521,2020-11-04,대웅제약이나보글리플로진신규적응증3상승인,https://www.ebn.co.kr/news/view/1457544/?sc=Naver
9522,2020-11-04,대웅제약이나보글리플로진3제병용요법임상3상승인,http://medipana.com/news/news_viewer.asp?NewsNum=265367&MainKind=A&NewsKind=5&vCount=12&vKind=1
9523,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.lawissue.co.kr/view.php?ud=202011040914196588204ead0791_12
9524,2020-11-04,대웅제약당뇨신약이나보글리플로진3제병용3상승인,http://www.newsis.com/view/?id=NISX20201104_0001221544&cID=13001&pID=13000
9525,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.newsprime.co.kr/news/article.html?no=523145
9526,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진신규적응증으로임상3상승인,https://www.etoday.co.kr/news/view/1958415
9527,2020-11-04,대웅제약당뇨병치료제이나보글리플로진임상3상승인,https://www.fetv.co.kr/news/article.html?no=67514
9528,2020-11-04,대웅제약당뇨병신약이나보글리플로진 국내임상3상승인,http://www.koreastocknews.com/news/articleView.html?idxno=58528
9529,2020-11-04,대웅제약당뇨병신약세번째적응증국내임상3상승인,https://www.hankyung.com/it/article/202011041733i
9530,2020-11-04,대웅제약이나보글리플로진세번째신규적응증으로임상3상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=129925
9531,2020-11-04,대웅제약당뇨병치료신약신규적응증임상3상승인,https://biz.chosun.com/site/data/html_dir/2020/11/04/2020110400679.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9532,2020-11-04,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://moneys.mt.co.kr/news/mwView.php?no=2020110409188050067
9533,2020-11-04,대웅제약당뇨병신약이나보글리플로진3상승인,http://www.medisobizanews.com/news/articleView.html?idxno=73901
9534,2020-11-04,전승호대웅제약사장당뇨병신약2023년발매목표,http://www.wikileaks-kr.org/news/articleView.html?idxno=97899
9535,2020-11-04,대웅제약당뇨신약신규적응증국내임상3상승인획득,http://www.youthdaily.co.kr/news/article.html?no=52053
9536,2020-11-04,대웅제약이나보글리플로진3제병용요법임상3상승인,http://news.mt.co.kr/mtview.php?no=2020110409125689637
9537,2020-11-04,대웅제약당뇨병신약세번째신규적응증임상3상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=250971
9538,2020-11-04,대웅제약당뇨병신약이나보글리플로진국내임상3상승인,http://www.lcnews.co.kr/news/articleView.html?idxno=9444
9539,2020-11-04,대웅제약당뇨신약이나보글리플로진3제병용임상3상승인,http://www.viva100.com/main/view.php?key=20201104010000976
9540,2020-11-04,대웅제약당뇨병신약이나보글리플로진세번째신규적응증으로임상3상,https://www.sedaily.com/NewsView/1ZA9YFU03D
9541,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진3제병용요법3상임상승인,http://weekly.hankooki.com/lpage/life/202011/wk20201104093903147650.htm?s_ref=nv
9542,2020-11-04,대웅제약이나보글리플로진세번째적응증국내임상3상승인,http://www.newspim.com/news/view/20201104000236
9543,2020-11-04,대웅제약당뇨신약이나보글리플로진국내임상3상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020110409412138531
9544,2020-11-04,대웅제약당뇨병치료신약국내임상3상승인적응증확대,http://www.ekn.kr/web/view.php?key=20201104010000888
9545,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=404776
9546,2020-11-04,대웅제약이나보글리플로진적응증확대,http://www.press9.kr/news/articleView.html?idxno=46197
9547,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진임상3상승인,https://www.dailian.co.kr/news/view/933484/?sc=Naver
9548,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=35155
9549,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인받아,http://yna.kr/AKR20201104050200017?did=1195m
9550,2020-11-04,대웅제약당뇨병신약임상3상승인2023년발매목표”,http://health.chosun.com/site/data/html_dir/2020/11/04/2020110400813.html
9551,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.pharmnews.com/news/articleView.html?idxno=101588
9552,2020-11-04,대웅제약당뇨병신약이나보글리플로진임상3상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572515048973
9553,2020-11-04,대웅제약당뇨병신약이나보글리플로진적응증확대,http://www.mhj21.com/136315
9554,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.fnnews.com/news/202011040955532855
9555,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인받아,http://www.fntoday.co.kr/news/articleView.html?idxno=238630
9556,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=54387
9557,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.m-i.kr/news/articleView.html?idxno=761348
9558,2020-11-04,대웅제약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=15361
9559,2020-11-04,세가지약물병용투여대웅제약당뇨약이나보글리플로진국내임상3상승인,http://theviewers.co.kr/View.aspx?No=1320080
9560,2020-11-04,대웅제약당뇨병신약이나보글리플로진DPP4억제제3제병용요법3상임상승인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123171
9561,2020-11-04,대웅제약SGLT2당뇨신약신규적응증3상돌입,http://www.dailypharm.com/Users/News/NewsView.html?ID=270206&REFERER=NP
9562,2020-11-04,대웅제약당뇨병치료신약세번째신규적응증으로국내임상3상승인,http://www.sisaweek.com/news/articleView.html?idxno=138894
9563,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진3제병용임상3상승인,https://www.asiatoday.co.kr/view.php?key=20201104010002437
9564,2020-11-04,대웅제약당뇨병신약이나보글리플로진3제병용3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110410195979056
9565,2020-11-04,대웅제약SGLT2저해제삼중요법도국내3상승인,http://www.biospectator.com/view/news_view.php?varAtcId=11707
9566,2020-11-04,대웅제약이나보글리플로진3제병용임상3상승인,https://view.asiae.co.kr/article/2020110410321948312
9567,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인받아,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011041024438230065
9568,2020-11-04,대웅제약당뇨병치료신약 국내임상3상승인,http://www.upinews.kr/newsView/upi202011040021
9569,2020-11-04,대웅제약당뇨병신약이나보글리플로진3번째적응증3상임상승인,http://www.medigatenews.com/news/994957536
9570,2020-11-04,대웅제약당뇨병치료제이나보글리플로진임상3상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004163301
9571,2020-11-04,대웅제약당뇨치료신약이나보글리플로진신규적응증임상3상승인,http://www.newslock.co.kr/news/articleView.html?idxno=32445
9572,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://newsbrite.net/143132
9573,2020-11-04,대웅제약이나보글리플로진세번째적응증국내3상승인,http://www.newstomato.com/ReadNews.aspx?no=1004939
9574,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.pinpointnews.co.kr/view.php?ud=2020110410533643592365609d9b_45
9575,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진3제병용요법임상3상승인,http://www.newsworks.co.kr/news/articleView.html?idxno=500478
9576,2020-11-04,대웅제약당뇨병신약이나보글리플로진임상3상승인,http://sports.hankooki.com/lpage/economy/202011/sp20201104110152137020.htm?s_ref=nv
9577,2020-11-04,대웅제약이나보글리플로진3번째적응증국내3상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2137407
9578,2020-11-04,대웅제약이나보글리플로진경쟁력강화박차,http://www.whosaeng.com/122223
9579,2020-11-04,대웅제약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64367
9580,2020-11-04,대웅제약당뇨병치료신약임상3상승인,https://www.nocutnews.co.kr/news/5441190
9581,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.bokuennews.com/news/article.html?no=196764
9582,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.thepublic.kr/news/newsview.php?ncode=1065577331848791
9583,2020-11-04,대웅제약당뇨병신약신규적응증으로국내3상추진,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1136934&REFERER=NP
9584,2020-11-04,대웅제약당뇨병치료제병용요법임상3상진행전승호적응증확대,http://www.businesspost.co.kr/BP?command=article_view&num=202963
9585,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.leaders.kr/news/articleView.html?idxno=218868
9586,2020-11-04,대웅제약당뇨병신약세번째적응증임상3상승인,http://www.mediapen.com/news/view/571997
9587,2020-11-04,대웅제약당뇨병치료신약세번째적응증으로임상3상승인,http://www.metroseoul.co.kr/article/20201104500240
9588,2020-11-04,대웅제약당뇨병치료신약세번째신규적응증으로국내임상3상승인,http://www.ceoscoredaily.com/news/article.html?no=74790
9589,2020-11-04,대웅제약이나보글리플로진국내임상3상승인,http://www.thebigdata.co.kr/view.php?ud=202011041105133362d0a8833aad_23
9590,2020-11-04,대웅제약이나보글리플로진국내임상3상승인제2형당뇨병신약,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4330187
9591,2020-11-04,특징주대웅제약주가상승당뇨병치료제임상3상승인,http://www.anewsa.com/detail.php?number=2268867&thread=18
9592,2020-11-04,대웅제약이나보글리플로진국산신약31호개발하기위해도전,http://www.slist.kr/news/articleView.html?idxno=198200
9593,2020-11-04,대웅SGLT2억제제당뇨신약임상3상승인,http://www.dailymedi.com/detail.php?number=862376&thread=22r05
9594,2020-11-04,미국ITC나보타최종판결눈앞대웅예비결정부당,http://www.doctorsnews.co.kr/news/articleView.html?idxno=136859
9595,2020-11-04,대웅제약이나보글리플로진3제병용임상3상승인,http://www.cstimes.com/news/articleView.html?idxno=437320
9596,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=438140
9597,2020-11-04,당뇨신약대웅제약이나보글리플로진국내임상3상승인,https://www.yeongnam.com/web/view.php?key=20201104001455178
9598,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진국내임상3상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=65541
9599,2020-11-04,대웅제약당뇨신약3번째적응증임상3상승인,https://www.econovill.com/news/articleView.html?idxno=503527
9600,2020-11-04,대웅제약당뇨병신약이나보글리플로진3제병용3상승인,http://www.sporbiz.co.kr/news/articleView.html?idxno=500496
9601,2020-11-04,대웅제약당뇨신약이나보글리플로진3제병용임상3상승인,http://www.anewsa.com/detail.php?number=2269014&thread=10
9602,2020-11-04,대웅제약당뇨약이나보글리플로진3제병용임상3상승인획득,http://www.dt.co.kr/contents.html?article_no=2020110402109931102001&ref=naver
9603,2020-11-04,식약처대웅제약당뇨병신약국내임상3상승인,http://it.chosun.com/site/data/html_dir/2020/11/04/2020110402084.html
9604,2020-11-04,대웅제약당뇨병치료신약국내임상3상승인,http://www.skyedaily.com/news/news_view.html?ID=115180
9605,2020-11-04,대웅제약당뇨병치료신약임상3상시험계획식약처로부터승인받았다,http://www.segye.com/content/html/2020/11/04/20201104519081.html?OutUrl=naver
9606,2020-11-04,대웅제약이나보글리플로진병용요법임상3상승인,http://www.doctorstimes.com/news/articleView.html?idxno=212957
9607,2020-11-04,대웅제약메디톡스운명의달ITC승자주목,https://www.econovill.com/news/articleView.html?idxno=503543
9608,2020-11-04,뉴스투데이L대웅제약이나보글리플로진신규적응증으로국내임상3상승인,https://www.news2day.co.kr/163547
9609,2020-11-04,대웅제약당뇨병치료신약임상3상승인2023년발매목표,https://www.vop.co.kr/A00001523887.html
9610,2020-11-04,대웅제약 당뇨병신약 이나보글리플로진국내임상 3상승인,http://www.economytalk.kr/news/articleView.html?idxno=209074
9611,2020-11-04,대웅제약당뇨병치료신약이나보글리플로진세번째신규적응증으로국내임상3상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=11254
9612,2020-11-04,김창수의e뉴스브리핑대웅제약당뇨병치료제이나보글리플로진임상3상승인外,https://www.fetv.co.kr/news/article.html?no=67601
9613,2020-11-04,대웅제약이나보글리플로진3제병용임상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1339469
9614,2020-11-04,내종목을부탁해복잡한계좌해결방법은유니슨대웅,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110417143122528
9615,2020-11-04,대웅제약3Q영업익70억전년비151↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=270239&REFERER=NP
9616,2020-11-04,대웅제약당뇨신약이나보글리플로진3제병용3상승인,http://daily.hankooki.com/lpage/industry/202011/dh20201104175042148390.htm?s_ref=nv
9617,2020-11-04,대웅제약3분기영업익70억원전년比1508↑,http://www.viva100.com/main/view.php?key=20201104010001286
9618,2020-11-04,금일제약업계주요기사대웅제약당뇨신약신규적응증국내3상승인획득식약처뉴젠테라퓨틱스코로나19치료제1상승인外,http://www.youthdaily.co.kr/news/article.html?no=52133
9619,2020-11-04,대웅제약3분기영업이익70억원흑자전환,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110418014122233
9620,2020-11-04,공시대웅제약3분기영업익70억전년比1508↑,http://www.newsway.co.kr/news/view?tp=1&ud=2020110418044193193
9621,2020-11-04,대웅제약3분기매출2489억원영업익70억원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=96077
9622,2020-11-04,대웅제약3분기영업이익70억전년比151↑,http://www.koreastocknews.com/news/articleView.html?idxno=58568
9623,2020-11-04,대웅제약3분기영업이익70억원전년比151↑,https://www.asiatoday.co.kr/view.php?key=20201104010003097
9624,2020-11-04,대웅제약3분기영업익70억원전년比151↑,http://www.newsprime.co.kr/news/article.html?no=523265
9625,2020-11-04,대웅제약3분기매출2489억역대최고전문의약품덕,https://hankookilbo.com/News/Read/A2020110418010001537?did=NA
9626,2020-11-04,대웅제약3분기매출2489억원영업이익70억원,http://newsclaim.co.kr/View.aspx?No=1321370
9627,2020-11-04,대웅제약3분기영업이익70억원전년대비1508↑,http://moneys.mt.co.kr/news/mwView.php?no=2020110418018071427
9628,2020-11-04,대웅제약3분기영업이익70억원전년비151↑,http://www.mediapen.com/news/view/572133
9629,2020-11-04,대웅제약3분기영업이익70억원151증가,http://yna.kr/AKR20201104172100017?did=1195m
9630,2020-11-04,대웅제약3분기실적매출액2489억원영업이익70억원달성,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64382
9631,2020-11-04,대웅제약3분기영업이익70억원전년대비151증가,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011040402&t=NN
9632,2020-11-04,대웅제약3분기순항매출액2489억원영업이익70억원,http://medipana.com/news/news_viewer.asp?NewsNum=265410&MainKind=A&NewsKind=5&vCount=12&vKind=1
9633,2020-11-04,대웅제약3분기매출액2489억원영업이익70억원,http://www.businesskorea.co.kr/news/articleView.html?idxno=54433
9634,2020-11-04,대웅제약3Q매출2489억영업익전년비151증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251017
9635,2020-11-04,대웅제약1분기만에적자탈출전문약사업호조,http://www.dailypharm.com/Users/News/NewsView.html?ID=270241&REFERER=NP
9636,2020-11-04,대웅제약3분기매출역대최고2489억,https://cnbc.sbs.co.kr/article_hub/10001001511?division=NAVER
9637,2020-11-04,대웅제약3분기영업익70억전년比151↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=404871
9638,2020-11-04,대웅제약3분기매출액2489억원영업이익70억원분기매출역대최대,http://www.worktoday.co.kr/news/articleView.html?idxno=11257
9639,2020-11-04,대웅제약3분기순항영업이익70억원흑자전환,http://news.mt.co.kr/mtview.php?no=2020110418554030065
9640,2020-11-04,대웅제약전문의약품실적호조로3분기매출과영업이익모두늘어,http://www.businesspost.co.kr/BP?command=article_view&num=203088
9641,2020-11-04,대웅제약3분기영업익70억전년비151↑,http://www.edaily.co.kr/news/newspath.asp?newsid=04159046625962440
9642,2020-11-04,대웅제약3분기실적맑음전문의약품역대최고,http://www.newsis.com/view/?id=NISX20201104_0001222793&cID=13001&pID=13000
9643,2020-11-04,대웅제약3분기매출2489억원ITC소송등악재뚫고선방,http://www.medisobizanews.com/news/articleView.html?idxno=73925
9644,2020-11-04,대웅제약3분기매출2489억영업이익70억기록,http://www.medigatenews.com/news/1992928868
9645,2020-11-04,대웅제약3분기매출2489억원크레젯등고성장으로전문의약품역대최고경신,http://www.segye.com/content/html/2020/11/04/20201104525058.html?OutUrl=naver
9646,2020-11-04,대웅제약3분기영업익70억원전년비151↑,http://www.ajunews.com/view/20201104195211612
9647,2020-11-04,대웅제약당뇨병신약이나보글리플로진3번째적응증임상3상돌입,https://www.donga.com/news/article/all/20201104/103803775/1
9648,2020-11-04,대웅제약3분기매출2489억원영업이익70억원기록,http://www.wsobi.com/news/articleView.html?idxno=107746
9649,2020-11-04,대웅제약3분기영업익70억전년비1508증가,http://www.newstomato.com/ReadNews.aspx?no=1005128
9650,2020-11-04,대웅제약3분기매출2489억전문의약품역대최고,https://www.etoday.co.kr/news/view/1958867
9651,2020-11-04,대웅제약3분기영업익70억원전년比151↑,https://www.fetv.co.kr/news/article.html?no=67611
9652,2020-11-04,대웅제약3분기영업이익70억원당기순이익262증가,http://www.slist.kr/news/articleView.html?idxno=198307
9653,2020-11-04,대웅제약3분기영업이익70억원전년비151증가,https://www.dailian.co.kr/news/view/933812/?sc=Naver
9654,2020-11-04,대웅제약3분기영업이익70억원전년비151늘었다,http://news.tf.co.kr/read/economy/1822680.htm
9655,2020-11-04,대웅제약당뇨병치료제이나보글리플로진임상3상승인,http://www.thedailypost.kr/news/articleView.html?idxno=77228
9656,2020-11-05,대웅제약3분기매출2489억전년비27늘어,https://www.kpanews.co.kr/article/show.asp?idx=217436&category=D
9657,2020-11-05,대웅제약이나보글리플로진3번째적응증3상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=217438&category=D
9658,2020-11-05,대웅제약 3분기 매출 2489억원영업이익 70억원분기매출역대최고,http://www.greened.kr/news/articleView.html?idxno=274991
9659,2020-11-05,대웅제약최악이미반영했다투자의견목표가↑KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01459606625962768
9660,2020-11-05,클릭e종목대웅제약소송결과반영된주가호실적주목,https://view.asiae.co.kr/article/2020110507534375673
9661,2020-11-05,대웅제약악재반영후정상화중목표가투자의견↑KTB투자증권,https://www.etoday.co.kr/news/view/1958923
9662,2020-11-05,iTN대웅제약현주가는최악의소송결과반영한것목표가↑KTB증권,http://inthenews.co.kr/article-76530/
9663,2020-11-05,대웅제약소송비용축소실적정상화목표가상향,https://www.asiatoday.co.kr/view.php?key=20201105010003166
9664,2020-11-05,대웅제약모두투어코웨이3분기서프라이즈3분기실적브리핑,http://www.pinpointnews.co.kr/view.php?ud=202011050812464838cd1e7f0bdf_45
9665,2020-11-05,대웅제약나보타소송여파로3분기에도실적부진지속,http://www.consumernews.co.kr/news/articleView.html?idxno=615101
9666,2020-11-05,대웅제약소송악재에도실적정상화성공목표가↑KTB투자증권,https://www.dailian.co.kr/news/view/933845/?sc=Naver
9667,2020-11-05,오늘의목표주가녹십자대웅제약↑오이솔루션코웨이↓,https://www.sedaily.com/NewsView/1ZAAFY01EV
9668,2020-11-05,대웅제약소송불안고려해도주가너무낮아목표가↑,https://www.sedaily.com/NewsView/1ZAAEYN6RX
9669,2020-11-05,대웅제약3분기영업이익70억151성장,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011050849036860309
9670,2020-11-05,대웅제약3Q영업이익70억원전년동기比151↑,http://www.youthdaily.co.kr/news/article.html?no=52158
9671,2020-11-05,대웅제약3Q전문의약품매출최고치경신,http://www.press9.kr/news/articleView.html?idxno=46211
9672,2020-11-05,대웅제약ITC소송주가에이미반영목표가8↑KTB,http://www.inews24.com/view/1313910
9673,2020-11-05,대웅제약3분기영업이익전년比151증가전문의약품성장주효”,http://health.chosun.com/site/data/html_dir/2020/11/05/2020110500680.html
9674,2020-11-05,대웅제약3분기영업이익70억원151증가,http://news.mk.co.kr/newsRead.php?no=1134889&year=2020
9675,2020-11-05,대웅제약나보타3분기매출113억기록전년比37↑,http://www.wikileaks-kr.org/news/articleView.html?idxno=97980
9676,2020-11-05,KTB證대웅제약투자의견매수상향주가최악소송결과반영,https://www.hankyung.com/it/article/202011056340i
9677,2020-11-05,대웅제약3Q매출2489억영업익순익전기比흑자전환,http://www.kukinews.com/newsView/kuk202011050039
9678,2020-11-05,미국10년수입금지에도실적선방대웅제약3분기매출액27↑동남아매출성장덕,http://theviewers.co.kr/View.aspx?No=1321809
9679,2020-11-05,대웅제약3분기영업이익151증가전문의약품분기매출최고치경신,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123209
9680,2020-11-05,대웅제약3분기실적발표영업이익70억원151증가,http://www.healthinnews.co.kr/news/articleView.html?idxno=15389
9681,2020-11-05,대웅제약전문의약품호조에3분기영업익전년비151증가,http://sports.hankooki.com/lpage/economy/202011/sp20201105102813137020.htm?s_ref=nv
9682,2020-11-05,대웅제약3분기실적발표매출액2489억원영업이익70억원,http://newsbrite.net/143181
9683,2020-11-05,대웅제약3분기매출액2489억원영업이익70억원알비스판매중단불구역대최고매출경신,http://www.kdpress.co.kr/news/articleView.html?idxno=98299
9684,2020-11-05,대웅제약이나보글리플로진3상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2004470
9685,2020-11-05,대웅제약악재불구3분기날다,http://www.whosaeng.com/122264
9686,2020-11-05,1조클럽제약사실적희비교차유한양행녹십자종근당웃고한미약품대웅제약울고,http://www.consumernews.co.kr/news/articleView.html?idxno=615114
9687,2020-11-05,대웅제약3분기매출액2489억원전문의약품분기매출역대최고경신,http://www.updownnews.co.kr/news/articleView.html?idxno=224990
9688,2020-11-05,대웅제약3분기매출액2489억원영업이익70억원,http://www.bokuennews.com/news/article.html?no=196817
9689,2020-11-05,대웅제약3분기매출2489억전문의약품매출최고치,http://www.meconomynews.com/news/articleView.html?idxno=47071
9690,2020-11-05,대웅제약3Q영업익70억달성전년比151↑,http://www.m-i.kr/news/articleView.html?idxno=762090
9691,2020-11-05,메디톡스대웅최종결론임박관전포인트는,https://www.ebn.co.kr/news/view/1457851/?sc=Naver
9692,2020-11-05,대웅제약3분기실적발표매출액2489억원영업이익70억원,http://www.nbnnews.co.kr/news/articleView.html?idxno=438528
9693,2020-11-05,이인애의뒷담화바이든시대메디톡스대웅제약ITC소송영향은,http://theviewers.co.kr/View.aspx?No=1322857
9694,2020-11-05,대웅제약3분기실적발표매출액2489억원영업이익70억원전년동기대비151증가,http://www.thefirstmedia.net/news/articleView.html?idxno=65657
9695,2020-11-05,금일제약업계주요기사엔케이맥스알츠하이머임상1상순항”대웅제약3Q영업이익70억원外,http://www.youthdaily.co.kr/news/article.html?no=52231
9696,2020-11-05,대웅제약3분기매출액2489억원영업이익70억원보툴리눔톡신나보타국내매출지속성장,http://www.econonews.co.kr/news/articleView.html?idxno=143211
9697,2020-11-06,ETC3분기역대최고매출에도우울한대웅제약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2004494
9698,2020-11-06,더벨CompanyWatch대웅제약알비스빈자리나보타로채웠다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202011041817075720106557
9699,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,http://daily.hankooki.com/lpage/industry/202011/dh20201106090344148390.htm?s_ref=nv
9700,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.kpinews.co.kr/news/articleView.html?idxno=130136
9701,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://www.fetv.co.kr/news/article.html?no=67765
9702,2020-11-06,대웅제약안전보건경영시스템인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020110609098087117
9703,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.press9.kr/news/articleView.html?idxno=46230
9704,2020-11-06,대웅제약오송공장안전보건경영시스템인증안전우수성재입증,http://www.newsprime.co.kr/news/article.html?no=523434
9705,2020-11-06,대웅제약안전보건경영시스템KOSHAMS인증획득,http://medipana.com/news/news_viewer.asp?NewsNum=265493&MainKind=A&NewsKind=5&vCount=12&vKind=1
9706,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://view.asiae.co.kr/article/2020110609243242543
9707,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://view.asiae.co.kr/article/2020110609243242543
9708,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.m-i.kr/news/articleView.html?idxno=762244
9709,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572088112845
9710,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004166180
9711,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.ajunews.com/view/20201106091948474
9712,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=98060
9713,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020110609261545230
9714,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251078
9715,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020110609165347601
9716,2020-11-06,대웅제약오송공장안전보건경영시스템KOSHAMS인증획득,http://www.medisobizanews.com/news/articleView.html?idxno=73965
9717,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득 ,http://www.lcnews.co.kr/news/articleView.html?idxno=9510
9718,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2137589
9719,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.newspim.com/news/view/20201106000234
9720,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득 ,http://www.businesskorea.co.kr/news/articleView.html?idxno=54536
9721,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,https://www.etoday.co.kr/news/view/1959501
9722,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.bokuennews.com/news/article.html?no=196880
9723,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://news.mt.co.kr/mtview.php?no=2020110609511395612
9724,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://www.dailian.co.kr/news/view/934292/?sc=Naver
9725,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.newsworks.co.kr/news/articleView.html?idxno=501137
9726,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=35343
9727,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.newsis.com/view/?id=NISX20201106_0001224707&cID=13001&pID=13000
9728,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.mediapen.com/news/view/572624
9729,2020-11-06,제약오늘동아제약해독제타치온정출시대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.sisaon.co.kr/news/articleView.html?idxno=120053
9730,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.youthdaily.co.kr/news/article.html?no=52298
9731,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.ekn.kr/web/view.php?key=20201106010001537
9732,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득 ,http://www.pressm.kr/news/articleView.html?idxno=34248
9733,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.healthinnews.co.kr/news/articleView.html?idxno=15423
9734,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,http://www.consumuch.com/news/articleView.html?idxno=51176
9735,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011061049396900627
9736,2020-11-06,대웅제약메디톡스美ITC보톡스소송위원회만장일치로재검토승인,https://www.donga.com/news/article/all/20201106/103831632/1
9737,2020-11-06,대웅제약안전성입증안전보건경영시스템KOSHAMS취득,http://www.newsian.co.kr/news/articleView.html?idxno=44453
9738,2020-11-06,대웅제약오송공장안전보건경영시스템인증획득,http://www.upinews.kr/newsView/upi202011060030
9739,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.thebigdata.co.kr/view.php?ud=202011061040523011d0a8833aad_23
9740,2020-11-06,대웅제약오송공장안전보건경영시스템인증취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=405048
9741,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://newsbrite.net/143214
9742,2020-11-06,대웅제약안전보건경영시스템KOSHAMS인증획득,http://www.pinpointnews.co.kr/view.php?ud=202011061125521582365609d9b_45
9743,2020-11-06,대웅제약3분기방긋매출영업익전년比상승,http://www.thedailypost.kr/news/articleView.html?idxno=77256
9744,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득체계적이고효과적인시스템운영할것,http://www.segye.com/content/html/2020/11/06/20201106510610.html?OutUrl=naver
9745,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64411
9746,2020-11-06,대웅제약안전보건경영시스템KOSHAMS획득,http://www.monews.co.kr/news/articleView.html?idxno=215135
9747,2020-11-06,대웅제약산업안전보건공단안전보건경영시스템인증획득,http://www.iminju.net/news/articleView.html?idxno=59226
9748,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://weekly.hankooki.com/lpage/life/202011/wk20201106123641147650.htm?s_ref=nv
9749,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.updownnews.co.kr/news/articleView.html?idxno=225035
9750,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.newstomato.com/ReadNews.aspx?no=1005437
9751,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=438813
9752,2020-11-06,대웅제약오송공장산업안전보건공단안전보건경영시스템인증받아,http://www.businesspost.co.kr/BP?command=article_view&num=203396
9753,2020-11-06,대웅제약오송공장KOSHAMS인증취득업계최상위안전보건경영시스템구축,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123290
9754,2020-11-06,대웅제약안전보건경영시스템인증획득,https://www.econovill.com/news/articleView.html?idxno=503912
9755,2020-11-06,대웅제약안전보건경영시스템인증획득,https://www.ebn.co.kr/news/view/1458057/?sc=Naver
9756,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.thefirstmedia.net/news/articleView.html?idxno=65689
9757,2020-11-06,대웅제약메디톡스보톡스전쟁종지부코앞승기누가잡나,http://www.mediapen.com/news/view/572747
9758,2020-11-06,대웅제약안전보건경영시스템인증획득안전우수성재입증,http://www.anewsa.com/detail.php?number=2271078&thread=10
9759,2020-11-06,대웅제약3분기실적발표,http://www.thebigdata.co.kr/view.php?ud=202011061602596122d0a8833aad_23
9760,2020-11-06,대웅제약오송공장안전보건경영시스템인증KOSHAMS획득,http://www.paxetv.com/news/articleView.html?idxno=103869
9761,2020-11-06,뉴스투데이L대웅제약안전보건경영시스템인증획득,https://www.news2day.co.kr/163769
9762,2020-11-06,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.lawissue.co.kr/view.php?ud=202011061733125454204ead0791_12
9763,2020-11-06,대웅제약오송공장ISO45001획득이어KOSHAMS취득,http://www.thedailypost.kr/news/articleView.html?idxno=77283
9764,2020-11-06,대웅제약안전보건경영시스템인증취득,http://www.shinailbo.co.kr/news/articleView.html?idxno=1340331
9765,2020-11-07,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.sportsseoul.com/news/read/978301?ref=naver
9766,2020-11-08,메디톡스대웅제약보톡스5년분쟁마침표찍나,https://biz.chosun.com/site/data/html_dir/2020/11/07/2020110701166.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9767,2020-11-08,대웅제약안전보건경영시스템인증KOSHAMS획득,http://www.thepublic.kr/news/newsview.php?ncode=1065601662978806
9768,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.lcnews.co.kr/news/articleView.html?idxno=9563
9769,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://medipana.com/news/news_viewer.asp?NewsNum=265558&MainKind=A&NewsKind=5&vCount=12&vKind=1
9770,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.press9.kr/news/articleView.html?idxno=46244
9771,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.ekn.kr/web/view.php?key=20201109010001959
9772,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.youthdaily.co.kr/news/article.html?no=52445
9773,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,https://www.fetv.co.kr/news/article.html?no=67901
9774,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251122
9775,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004168214
9776,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.newsis.com/view/?id=NISX20201109_0001226766&cID=13001&pID=13000
9777,2020-11-09,대웅제약인적자원개발우수기관인증획득,https://www.ebn.co.kr/news/view/1458196/?sc=Naver
9778,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.dailysmart.co.kr/news/articleView.html?idxno=35437
9779,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.k-health.com/news/articleView.html?idxno=50858
9780,2020-11-09,직원성장이곧회사성장대웅제약2020인적자원개발우수기관인증,http://theviewers.co.kr/View.aspx?No=1325238
9781,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.whosaeng.com/122329
9782,2020-11-09,대웅제약인적자원개발우수기관정부인증획득,http://www.medisobizanews.com/news/articleView.html?idxno=74007
9783,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020110909441393196
9784,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.mediapen.com/news/view/573167
9785,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=54620
9786,2020-11-09,대웅제약2020인적자원개발우수기관선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1426421
9787,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.m-i.kr/news/articleView.html?idxno=762734
9788,2020-11-09,대웅제약인적자원개발우수기관인증획득,https://www.econovill.com/news/articleView.html?idxno=504118
9789,2020-11-09,대웅제약2020인적자원개발우수기관인증,https://www.asiatoday.co.kr/view.php?key=20201109010005158
9790,2020-11-09,대웅제약2020인적자원개발우수기관선정,http://www.newspim.com/news/view/20201109000193
9791,2020-11-09,대웅제약2020BestHRD인증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2137671
9792,2020-11-09,대웅제약인적자원개발우수기관인증,http://news.mt.co.kr/mtview.php?no=2020110909593862424
9793,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://newsbrite.net/143278
9794,2020-11-09,대웅제약인적자원개발우수기관인증획득,https://view.asiae.co.kr/article/2020110910133358171
9795,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.healthinnews.co.kr/news/articleView.html?idxno=15449
9796,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.lawissue.co.kr/view.php?ud=202011091014415588204ead0791_12
9797,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=405174
9798,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.viva100.com/main/view.php?key=20201109010002213
9799,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://moneys.mt.co.kr/news/mwView.php?no=2020110909548071699
9800,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.anewsa.com/detail.php?number=2273041&thread=10
9801,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.pharmnews.com/news/articleView.html?idxno=101623
9802,2020-11-09,대웅제약인적자원개발우수기관BestHRD인증획득,http://www.upinews.kr/newsView/upi202011090023
9803,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64444
9804,2020-11-09,대웅제약인적자원개발우수기관으로인정받아,http://www.monews.co.kr/news/articleView.html?idxno=215192
9805,2020-11-09,대웅제약민간대기업부문2020인적자원개발우수기관선정,http://www.kpinews.co.kr/news/articleView.html?idxno=130284
9806,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.pinpointnews.co.kr/view.php?ud=2020110911054273952365609d9b_45
9807,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011091117127350999
9808,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.newslock.co.kr/news/articleView.html?idxno=32597
9809,2020-11-09,대웅제약인적자원개발우수기관인증,http://www.dailymedi.com/detail.php?number=862530&thread=22r05
9810,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.pressm.kr/news/articleView.html?idxno=34299
9811,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.newsworker.co.kr/news/articleView.html?idxno=91144
9812,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573979597454
9813,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.seoulwire.com/news/articleView.html?idxno=429384
9814,2020-11-09,대웅제약2020인적자원개발우수기관인증,http://www.seoulfn.com/news/articleView.html?idxno=400426
9815,2020-11-09,대웅제약인적자원개발우수기관인증획득,http://www.newstomato.com/ReadNews.aspx?no=1005761
9816,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.thebigdata.co.kr/view.php?ud=202011091400407523d0a8833aad_23
9817,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.nbnnews.co.kr/news/articleView.html?idxno=439308
9818,2020-11-09,美ITC보툴리늄균주판결후윤재승전대웅제약회장복귀설솔솔,http://www.sisajournal-e.com/news/articleView.html?idxno=225519
9819,2020-11-09,뉴스투데이L대웅제약인적자원개발우수기관선정,https://www.news2day.co.kr/163862
9820,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.worktoday.co.kr/news/articleView.html?idxno=11340
9821,2020-11-09,대웅제약민간대기업인적자원개발우수기관선정,http://www.skyedaily.com/news/news_view.html?ID=115524
9822,2020-11-09,위기의대웅제약전승호대표다시신뢰할까,http://www.sporbiz.co.kr/news/articleView.html?idxno=501012
9823,2020-11-09,대웅제약인적자원개발우수기관선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1341084
9824,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://www.thedailypost.kr/news/articleView.html?idxno=77315
9825,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.leaders.kr/news/articleView.html?idxno=219539
9826,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.medigatenews.com/news/2683729196
9827,2020-11-09,대웅제약2020인적자원개발우수기관인증획득,http://daily.hankooki.com/lpage/industry/202011/dh20201109170201148390.htm?s_ref=nv
9828,2020-11-09,대웅제약2020인적자원개발우수기관BestHRD인증획득,http://www.thefirstmedia.net/news/articleView.html?idxno=65812
9829,2020-11-09,직원성장이곧회사의성장”대웅제약인적자원개발우수기관인증획득,https://www.donga.com/news/article/all/20201109/103876251/1
9830,2020-11-10,보톡스4사실적희비엇갈려휴온스휴젤웃고메디톡스대웅제약울상,http://www.consumernews.co.kr/news/articleView.html?idxno=615260
9831,2020-11-10,대웅제약내년나보타소송비용축소긍정적,https://www.asiatoday.co.kr/view.php?key=20201110010005916
9832,2020-11-10,대웅제약소송관련불확실성여전중립SK,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011100835214940176
9833,2020-11-10,대웅제약vs메디톡스9일후나보타명운갈린다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1341444
9834,2020-11-11,대웅제약올로스타혈압강하효과SCI급국제학술지등재,http://medipana.com/news/news_viewer.asp?NewsNum=265673&MainKind=A&NewsKind=5&vCount=12&vKind=1
9835,2020-11-11,대웅제약올로스타우수한혈압강하효과입증국제학술지등재,http://www.press9.kr/news/articleView.html?idxno=46258
9836,2020-11-11,대웅제약 올로스타 혈압강하효과美저널등재,http://www.economytalk.kr/news/articleView.html?idxno=209187
9837,2020-11-11,대웅제약올로스타국제학술지등재우수한혈압강하효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=130466
9838,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://www.ftoday.co.kr/news/articleView.html?idxno=208066
9839,2020-11-11,대웅제약올로스타혈압강하입증SCI급학술지등재,http://www.medisobizanews.com/news/articleView.html?idxno=74078
9840,2020-11-11,대웅제약올로스타우수한혈압강하효과입증국제학술지등재,https://www.fetv.co.kr/news/article.html?no=68170
9841,2020-11-11,대웅제약올로스타우수한혈압강하효과국제학술지등재,http://www.newsis.com/view/?id=NISX20201111_0001229658&cID=13001&pID=13000
9842,2020-11-11,대웅제약올로스타임상결과SCI급국제학술지등재,http://www.mhj21.com/136574
9843,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.newsprime.co.kr/news/article.html?no=523793
9844,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011110919405930503
9845,2020-11-11,대웅제약올로스타혈압강하효과연구국제학술지등재,https://www.hankyung.com/it/article/202011116960i
9846,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.pharmnews.com/news/articleView.html?idxno=101648
9847,2020-11-11,대웅제약올로스타우수혈압강하효과입증국제학술지등재,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251218
9848,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2137867
9849,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.businesskorea.co.kr/news/articleView.html?idxno=54789
9850,2020-11-11,손병길왕경숙씨의장남대웅군과이진철울산신문대표이사김혜진씨의장녀윤지양,http://ujnews.co.kr/news/newsview.php?ncode=1065573706037725
9851,2020-11-11,대웅제약올로스타혈압강하효과입증국제학술지등재,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571487720412
9852,2020-11-11,대웅제약올로스타임상결과SCI급국제학술지에등재,http://www.mediapen.com/news/view/573787
9853,2020-11-11,국제적인정받은대웅제약올로스타美치료약저널등재,http://weekly.hankooki.com/lpage/life/202011/wk20201111100250147610.htm?s_ref=nv
9854,2020-11-11,대웅제약올로스타임상연구미국치료학저널등재,https://biz.chosun.com/site/data/html_dir/2020/11/11/2020111100963.html?utm_source=naver&utm_medium=original&utm_campaign=biz
9855,2020-11-11,대웅제약고혈압이상지질혈증치료제임상연구SCI급등재,http://news.mt.co.kr/mtview.php?no=2020111110052554371
9856,2020-11-11,대웅제약올로스타혈압강하및지질농도개선효과확인,http://moneys.mt.co.kr/news/mwView.php?no=2020111110028041306
9857,2020-11-11,혈압콜레스테롤강하효과대웅제약올로스타연구SCI급국제학술지에등재,http://theviewers.co.kr/View.aspx?No=1329119
9858,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.healthinnews.co.kr/news/articleView.html?idxno=15514
9859,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://newsbrite.net/143345
9860,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://www.m-i.kr/news/articleView.html?idxno=763664
9861,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,http://www.anewsa.com/detail.php?number=2275253&thread=10
9862,2020-11-11,대웅제약고정용량복합제올로스타혈압콜레스테롤조절효과입증,https://jhealthmedia.joins.com/article/article_view.asp?pno=22670
9863,2020-11-11,대웅제약올로스타혈압강하및지질농도개선효과,http://www.bokuennews.com/news/article.html?no=197086
9864,2020-11-11,대웅제약올로스타혈압강하효과우수입증,http://www.dailymedi.com/detail.php?number=862632&thread=22r05
9865,2020-11-11,대웅제약복합제올로스타혈압↓복약순응도↑,http://www.biospectator.com/view/news_view.php?varAtcId=11766
9866,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.newslock.co.kr/news/articleView.html?idxno=32683
9867,2020-11-11,뉴스투데이L대웅제약올로스타혈압강하효과SCI급국제학술지등재,https://www.news2day.co.kr/164026
9868,2020-11-11,대웅제약올로스타혈압강하효과입증,http://www.lawissue.co.kr/view.php?ud=202011111243538644204ead0791_12
9869,2020-11-11,보톡스3사희비휴젤방긋대웅선전메디톡스울상,http://www.viva100.com/main/view.php?key=20201111010002969
9870,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,http://www.newstomato.com/ReadNews.aspx?no=1006280
9871,2020-11-11,제약워치대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지등재外,http://www.newswatch.kr/news/articleView.html?idxno=51912
9872,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.newsworker.co.kr/news/articleView.html?idxno=91516
9873,2020-11-11,대웅제약고혈압치료제올로스타SCI급국제학술지에등재,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020111113180019392
9874,2020-11-11,대웅제약올로스타SCI급국제학술지등재,https://www.dailian.co.kr/news/view/935769/?sc=Naver
9875,2020-11-11,대웅제약올로스타혈압강하효과연구국제학술지등재,http://www.monews.co.kr/news/articleView.html?idxno=215294
9876,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.newsworks.co.kr/news/articleView.html?idxno=502466
9877,2020-11-11,대웅제약올로스타혈압강하효과SCI급국제학술지등재,http://www.thebigdata.co.kr/view.php?ud=202011111259447206d0a8833aad_23
9878,2020-11-11,대웅제약올로스타혈압강하효과국제학술지게재,https://www.ebn.co.kr/news/view/1458645/?sc=Naver
9879,2020-11-11,대웅제약올로스타혈압강하효과국제학술지등재,http://sports.hankooki.com/lpage/economy/202011/sp20201111141025137020.htm?s_ref=nv
9880,2020-11-11,대웅제약올로스타임상연구결과국제학술지등재,https://www.econovill.com/news/articleView.html?idxno=504562
9881,2020-11-11,대웅제약올로스타혈압강하효과국제유명학술지등재,http://www.segye.com/content/html/2020/11/11/20201111515387.html?OutUrl=naver
9882,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지등재,http://www.mdtoday.co.kr/mdtoday/index.html?no=405485
9883,2020-11-11,대웅제약올로스타SCI급국제학술지에등재우수한혈압강하효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=65897
9884,2020-11-11,대웅제약올로스타우수한혈압강하효과입증SCI급국제학술지에등재,http://www.nbnnews.co.kr/news/articleView.html?idxno=440103
9885,2020-11-11,술잘마시는남성우대대웅제약성차별채용논란,http://www.newspim.com/news/view/20201111000749
9886,2020-11-11,대웅제약올로스타SCI급국제학술지에등재,http://www.updownnews.co.kr/news/articleView.html?idxno=225186
9887,2020-11-11,대웅제약올로스타혈압강하효과입증국제학술지등재,http://www.thedailypost.kr/news/articleView.html?idxno=77363
9888,2020-11-11,대웅제약올로스타혈압감소효과입증국제학술지에등재,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004171686
9889,2020-11-11,대웅제약올로스타특별한점살펴보니,http://www.slist.kr/news/articleView.html?idxno=200368
9890,2020-11-11,대웅제약올로스타임상연구美치료학저널등재,http://www.dailysmart.co.kr/news/articleView.html?idxno=35612
9891,2020-11-11,대웅제약올로스타ARB스타틴약물대비우수한효과입증,http://daily.hankooki.com/lpage/industry/202011/dh20201111155357148390.htm?s_ref=nv
9892,2020-11-11,대웅제약혈압및이상지질혈증치료제올로스타SCI급국제학술지에등재,http://www.lcnews.co.kr/news/articleView.html?idxno=9667
9893,2020-11-11,대웅제약고혈압치료제우수한혈압강화효과입증연구결과국제학술지등재,https://www.donga.com/news/article/all/20201111/103912238/1
9894,2020-11-11,대웅제약올로스타우수한혈압강하효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64515
9895,2020-11-11,대웅제약올로스타혈압강하효과SCI급국제학술지에등재,http://www.medigatenews.com/news/2941556333
9896,2020-11-11,대웅제약올로스타혈압강하효과입증SCI급국제학술지등재,http://www.consumuch.com/news/articleView.html?idxno=51240
9897,2020-11-12,대웅제약올로스타SCI급국제학술지등재,http://www.enewstoday.co.kr/news/articleView.html?idxno=1427446
9898,2020-11-12,대웅제약올로스타혈압강하효과연구국제학술지등재,http://www.shinailbo.co.kr/news/articleView.html?idxno=1342291
9899,2020-11-12,보톡스균주논란ITC판결19일미뤄져대웅추가자료제출,http://www.wikileaks-kr.org/news/articleView.html?idxno=98411
9900,2020-11-12,장중10이상뛴메디톡스대웅과의ITC본판결에서이길까,http://www.opinionnews.co.kr/news/articleView.html?idxno=42935
9901,2020-11-13,보톡스3사실적희비메디톡스대웅제약박터지는동안휴젤홀로웃었다,http://www.getnews.co.kr/view.php?ud=2020111316092789582fe691f917_16
9902,2020-11-13,위투게더대웅제약코로나19에도참지마요,http://www.seoulfn.com/news/articleView.html?idxno=401021
9903,2020-11-15,D7대웅제약메디톡스보툴리눔톡신균주전쟁승자는,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011150929127220236
9904,2020-11-16,대웅제약vs메디톡스보톡스균주5년전쟁최종판결카운트다운,https://www.fetv.co.kr/news/article.html?no=68604
9905,2020-11-16,인니연구기술부대웅제약등민간제약사와코로나백신개발협업작성와뇰,https://www.theguru.co.kr/news/article.html?no=16203
9906,2020-11-16,보톡스전쟁마침표찍지만내상커진대웅제약메디톡스,https://www.sedaily.com/NewsView/1ZAFIZC2ME
9907,2020-11-17,메디톡스대웅제약보톡스5년분쟁이번주마침표,https://www.dailian.co.kr/news/view/937185/?sc=Naver
9908,2020-11-17,크리스탈지노믹스헬릭스미스일동홀딩스부광약품대웅제약등잇따른바이오신약개발자회사설립,http://www.topstarnews.net/news/articleView.html?idxno=845847
9909,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://medipana.com/news/news_viewer.asp?NewsNum=265940&MainKind=A&NewsKind=5&vCount=12&vKind=1
9910,2020-11-17,대웅제약子아이엔테라퓨틱스AI신약개발기업디어젠과난청치료제개발,http://www.sentv.co.kr/news/view/582933
9911,2020-11-17,대웅제약자회사AI전문기업과난청치료제개발돌입,http://news.mt.co.kr/mtview.php?no=2020111709240534309
9912,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료신약개발,http://www.medisobizanews.com/news/articleView.html?idxno=74229
9913,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발나서,http://www.bosa.co.kr/news/articleView.html?idxno=2138217
9914,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://www.pharmnews.com/news/articleView.html?idxno=101680
9915,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과손잡고난청치료제개발,https://www.fetv.co.kr/news/article.html?no=68679
9916,2020-11-17,대웅자회사아이엔테라퓨틱스AI기업과난청치료제개발,https://www.hankyung.com/it/article/202011176996i
9917,2020-11-17,대웅자회사아이엔테라퓨틱스AI기업과난청치료제개발,https://www.hankyung.com/it/article/202011176996i
9918,2020-11-17,대웅제약아이엔테라퓨틱스AI개발디어젠과난청치료제개발,http://www.press9.kr/news/articleView.html?idxno=46306
9919,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제신약물질발굴돌입,http://www.lawissue.co.kr/view.php?ud=202011170950342505204ead0791_12
9920,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,http://newsbrite.net/143574
9921,2020-11-17,난청치료제개발협력대웅제약자회사아이엔테라퓨틱스AI신약개발기업디어젠과맞손,http://theviewers.co.kr/View.aspx?No=1337401
9922,2020-11-17,대웅제약자회사디어젠과난청치료제개발한다,http://www.dailysmart.co.kr/news/articleView.html?idxno=35869
9923,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI로난청치료제개발,http://www.newsis.com/view/?id=NISX20201117_0001236365&cID=13001&pID=13000
9924,2020-11-17,대웅제약아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020111710170926847
9925,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,https://www.asiatime.co.kr/news/newsview.php?ncode=1065571676055464
9926,2020-11-17,대웅제약자회사AI신약개발전문기업과난청치료제개발맞손,http://yna.kr/AKR20201117062600017?did=1195m
9927,2020-11-17,대웅제약아이엔테라퓨틱스 난청치료제개발,http://www.businesskorea.co.kr/news/articleView.html?idxno=55175
9928,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발나서,http://www.monews.co.kr/news/articleView.html?idxno=215478
9929,2020-11-17,대웅제약자회사AI신약개발전문기업과난청치료제개발,https://www.asiatoday.co.kr/view.php?key=20201117010010892
9930,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://www.newsworker.co.kr/news/articleView.html?idxno=92140
9931,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발돌입,http://www.thebigdata.co.kr/view.php?ud=202011171056421170d0a8833aad_23
9932,2020-11-17,대웅제약자회사AI업체와난청치료제개발,http://www.whosaeng.com/122526
9933,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64629
9934,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제공동개발,http://www.newstomato.com/ReadNews.aspx?no=1007333
9935,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발 추진,http://www.seoulfn.com/news/articleView.html?idxno=401306
9936,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발도전,http://www.updownnews.co.kr/news/articleView.html?idxno=225362
9937,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠AI로난청치료제개발,https://www.econovill.com/news/articleView.html?idxno=505530
9938,2020-11-17,대웅제약인공지능신약개발플랫폼기업과난청치료제개발추진,http://www.businesspost.co.kr/BP?command=article_view&num=204817
9939,2020-11-17,대웅제약아이엔테라퓨틱스AI전문기업디어젠과난청치료제개발돌입,http://www.newslock.co.kr/news/articleView.html?idxno=32900
9940,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,http://www.nbnnews.co.kr/news/articleView.html?idxno=441763
9941,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발협업,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004178084
9942,2020-11-17,보톡스전쟁운명의날대웅제약vs메디톡스승자는누구,https://www.etoday.co.kr/news/view/1962979
9943,2020-11-17,대웅제약3Q누적매출7882억영업익80감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251489
9944,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과AI플랫폼활용난청치료제개발,http://www.mdtoday.co.kr/mdtoday/index.html?no=406120
9945,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발착수,http://www.thefirstmedia.net/news/articleView.html?idxno=66221
9946,2020-11-17,대웅제약자회사아이엔테라퓨틱스디어젠과난청치료제개발,http://www.thedailypost.kr/news/articleView.html?idxno=77500
9947,2020-11-17,대웅제약vs메디톡스보톡스전쟁마침표보인다,http://www.edaily.co.kr/news/newspath.asp?newsid=03837606625966704
9948,2020-11-17,대웅제약자회사아이엔테라퓨틱스난청치료제개발나서,https://health.chosun.com/site/data/html_dir/2020/11/17/2020111702113.html
9949,2020-11-17,코스피2530선약보합마감대웅제약↓메디톡스↑,http://www.opinionnews.co.kr/news/articleView.html?idxno=43097
9950,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI기업손잡고난청치료제개발돌입,http://www.ajunews.com/view/20201117160932343
9951,2020-11-17,대웅제약자회사아이엔테라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,http://www.worktoday.co.kr/news/articleView.html?idxno=11550
9952,2020-11-17,대웅제약임팩타민필수비타민B8종함유구내염등개선환절기건강관리,https://www.sedaily.com/NewsView/1ZAFZI264F
9953,2020-11-17,뉴스투데이L대웅제약아이엔티라퓨틱스AI신약개발전문기업디어젠과난청치료제개발한다,https://www.news2day.co.kr/164470
9954,2020-11-18,대웅스핀오프아이엔디어젠과난청치료제AI개발,http://www.biospectator.com/view/news_view.php?varAtcId=11822
9955,2020-11-18,코스피보합권출발ITC판결앞둔대웅메디톡스동반상승,http://www.opinionnews.co.kr/news/articleView.html?idxno=43107
9956,2020-11-18,유럽산보톡스도입종근당바이오대웅출신임원영입,http://www.dailypharm.com/Users/News/NewsView.html?ID=270650&REFERER=NP
9957,2020-11-18,대웅1일1회유지용법아사콜디알정1600mg도입,http://www.dailypharm.com/Users/News/NewsView.html?ID=270655&REFERER=NP
9958,2020-11-18,대웅제약신풍제약희비엇갈려특히대웅제약낮에급등했다가4상승,http://www.econonews.co.kr/news/articleView.html?idxno=144978
9959,2020-11-18,대웅VS메디톡스보톡스전쟁19일최종결말 ,http://www.mkhealth.co.kr/news/articleView.html?idxno=51176
9960,2020-11-18,대웅제약궤양성대장염치료제아사콜디알정1600mg품목허가승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=406259
9961,2020-11-18,대웅메디톡스균주분쟁운명의날촉각,http://www.sporbiz.co.kr/news/articleView.html?idxno=502038
9962,2020-11-18,대웅제약파트너에볼루스美서보톡스분쟁여론전,https://www.theguru.co.kr/news/article.html?no=16306
9963,2020-11-18,블룸버그에볼루스와대웅트럼프행정부에로비,http://www.mkhealth.co.kr/news/articleView.html?idxno=51178
9964,2020-11-18,오늘Who대웅제약보툴리눔톡신운명19일결정전승호긴하루,http://www.businesspost.co.kr/BP?command=article_view&num=204989
9965,2020-11-19,대웅메디톡스ITC보툴리눔톡신분쟁결과하루앞으로,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64682
9966,2020-11-19,ITC19일최종판결대웅제약vs메디톡스5년전쟁일단락,http://www.newsis.com/view/?id=NISX20201118_0001239013&cID=13001&pID=13000
9967,2020-11-19,건강관리잇템대웅제약임팩타민겨울철면역관리위해비타민B가필요할때,http://www.m-i.kr/news/articleView.html?idxno=766248
9968,2020-11-19,코스피2530선약보합대웅메디톡스ITC본판결하루앞두고약세,http://www.opinionnews.co.kr/news/articleView.html?idxno=43140
9969,2020-11-19,대웅제약나보타글로벌톡신시장서잘나가네,http://news.mk.co.kr/newsRead.php?no=1190014&year=2020
9970,2020-11-19,대웅vs메디톡스5년보톡스전쟁끝난다美ITC19일최종판결,http://news.mt.co.kr/mtview.php?no=2020111910394143409
9971,2020-11-19,대웅최종판결바뀐다”vs메디톡스예비결정그대로”최종결정D1,http://daily.hankooki.com/lpage/industry/202011/dh20201119110008148390.htm?s_ref=nv
9972,2020-11-19,운명의날앞둔대웅제약메디톡스美ITC최종판결임박,http://www.youthdaily.co.kr/news/article.html?no=53519
9973,2020-11-19,대웅제약vs메디톡스보톡스전쟁ITC최종판결임박,http://www.seoulwire.com/news/articleView.html?idxno=430085
9974,2020-11-19,대웅제약vs메디톡스5년균주소송ITC판결D1최후의승자는,https://www.fetv.co.kr/news/article.html?no=68997
9975,2020-11-19,코스피막판반등2547에마감결말앞둔대웅메디톡스모두강세,http://www.opinionnews.co.kr/news/articleView.html?idxno=43162
9976,2020-11-19,메디톡스대웅제약보톡스분쟁미국ITC최종판결임박,http://yna.kr/AKR20201119153600017?did=1195m
9977,2020-11-19,메디톡스VS대웅제약5년보톡스전쟁美ITC최종판결임박,http://www.newsway.co.kr/news/view?tp=1&ud=2020111917060818895
9978,2020-11-19,김창수의e뉴스브리핑대웅제약vs메디톡스5년균주소송ITC최종판결임박마지막승자는外,https://www.fetv.co.kr/news/article.html?no=69008
9979,2020-11-19,대웅제약vs메디톡스균주전쟁5년ITC최종판결결전의날밝았다,http://www.medigatenews.com/news/983629463
9980,2020-11-19,메디톡스대웅제약보톡스분쟁미국ITC최종판결이르면20일새벽,https://www.news2day.co.kr/article/20201119164727
9981,2020-11-20,메디톡스VS대웅제약5년균주분쟁끝날까종합,http://www.ccreview.co.kr/news/articleView.html?idxno=295568
9982,2020-11-20,속보메디톡스대웅제약美ITC최종판결12월16일로연기,https://view.asiae.co.kr/article/2020112007164485509
9983,2020-11-20,메디톡스대웅제약5년간균주분쟁일단락될까,http://www.anewsa.com/detail.php?number=2283805&thread=10
9984,2020-11-20,메디톡스대웅보톡스분쟁ITC최종판결12월16일로재연기,http://yna.kr/AKR20201120019200017?did=1195m
9985,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로연기속보,http://www.edaily.co.kr/news/newspath.asp?newsid=01436646625967688
9986,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로연기상보,https://view.asiae.co.kr/article/2020112007265519913
9987,2020-11-20,속보대웅제약메디톡스美ITC소송최종판결12월16일로연기,https://www.fetv.co.kr/news/article.html?no=69032
9988,2020-11-20,속보美ITC메디톡스대웅제약최종판결다음달16일로연기,http://www.newspim.com/news/view/20201120000037
9989,2020-11-20,메디톡스대웅보톡스분쟁ITC최종판결또연기,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011200031&t=NN
9990,2020-11-20,대웅제약메디톡스균주분쟁ITC최종판결12월16일로재연기,https://www.fetv.co.kr/news/article.html?no=69034
9991,2020-11-20,대웅제약메디톡스균주분쟁ITC최종판결12월16일로재연기,https://www.fetv.co.kr/news/article.html?no=69034
9992,2020-11-20,메디톡스대웅제약美ITC최종판결또연기상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01453046625967688
9993,2020-11-20,메디톡스대웅보톡스분쟁美ITC최종판결12월16일로재연기,https://www.ekn.kr/web/view.php?key=20201120010004870
9994,2020-11-20,美ITC메디톡스대웅의보톡스균주분쟁최종판결12월16일로또연기,http://news.mk.co.kr/newsRead.php?no=1194147&year=2020
9995,2020-11-20,속보대웅제약메디톡스균주분쟁ITC최종판결재연기,http://www.anewsa.com/detail.php?number=2283808&thread=10
9996,2020-11-20,속보대웅제약메디톡스균주분쟁ITC최종판결재연기,http://www.ccreview.co.kr/news/articleView.html?idxno=295576
9997,2020-11-20,대웅제약메디톡스美ITC최종판결내달16일로재연기,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011200741197960443
9998,2020-11-20,美ITC메디톡스대웅제약보툴리눔톡신최종판결내달16일로연기,http://www.newspim.com/news/view/20201120000052
9999,2020-11-20,보톡스분쟁메디톡스대웅ITC최종판결12월16일로또연기,https://biz.chosun.com/site/data/html_dir/2020/11/20/2020112000474.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10000,2020-11-20,美ITC메디톡스대웅제약최종판결12월16일로재연기,https://www.etoday.co.kr/news/view/1964797
10001,2020-11-20,美ITC메디톡스대웅판결내달16일연기,https://www.paxnetnews.com/articles/67559
10002,2020-11-20,대웅제약vs메디톡스보툴리눔톡신균주전쟁종착역오리무중,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251620
10003,2020-11-20,메디톡스VS대웅제약보톡스분쟁ITC최종판결12월16일로재연기,http://www.newsway.co.kr/news/view?tp=1&ud=2020112007564711334
10004,2020-11-20,메디톡스대웅균주분쟁ITC최종판결12월16일로또연기,http://biz.newdaily.co.kr/site/data/html/2020/11/20/2020112000005.html
10005,2020-11-20,대웅메디톡스ITC최종결정또다시연기내달16일,http://medipana.com/news/news_viewer.asp?NewsNum=266156&MainKind=A&NewsKind=5&vCount=12&vKind=1
10006,2020-11-20,메디톡스대웅제약균주분쟁ITC최종판결또연기,http://www.newsis.com/view/?id=NISX20201120_0001240841&cID=13001&pID=13000
10007,2020-11-20,美ITC메디톡스대웅제약보톡스분쟁최종판결또연기,http://www.slist.kr/news/articleView.html?idxno=202823
10008,2020-11-20,ITC메디톡스대웅보톡스전쟁최종판결12월16일로연기,https://www.chosun.com/economy/science/2020/11/20/XJNZPM4F5RAGRF3CV3EFTYMHLE/?utm_source=naver&utm_medium=referral&utm_campaign=naver-news
10009,2020-11-20,또최종판결미룬ICT장기화하는메디톡스대웅제약보톡스전쟁,https://www.sedaily.com/NewsView/1ZAHBIY1K2
10010,2020-11-20,메디톡스대웅제약美ITC최종판결12월로또연기종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01538326625967688
10011,2020-11-20,메디톡스대웅제약美ITC최종판결12월로또연기종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01538326625967688
10012,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로연기속보,https://www.asiatoday.co.kr/view.php?key=20201120010013313
10013,2020-11-20,ITC메디톡스대웅제약최종판결또연기,https://www.econovill.com/news/articleView.html?idxno=506059
10014,2020-11-20,메디톡스대웅보톡스분쟁ITC최종판결12월16일로재연기종합,http://yna.kr/AKR20201120019251017?did=1195m
10015,2020-11-20,대웅메디톡스보톡스전쟁美ITC최종판결재연기,http://news.mt.co.kr/mtview.php?no=2020112008033663446
10016,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로또연기,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011200042&t=NN
10017,2020-11-20,대웅메디톡스보툴리눔톡신영업비밀소송최종판결내달로연기,https://www.kpanews.co.kr/article/show.asp?idx=217847&category=D
10018,2020-11-20,美ITC조사완성도위해대웅메톡최종판결12월16일로또연기,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112008102124153
10019,2020-11-20,ITC대웅제약vs메디톡스최종판결일12월16일로또다시연기,http://www.medigatenews.com/news/3153238346
10020,2020-11-20,종합美ITC최종판결재연기메디톡스승리확신VS대웅제약뒤집기가능,https://www.etoday.co.kr/news/view/1964812
10021,2020-11-20,메디톡스대웅제약ITC최종결론내달16일로재연기,https://www.ebn.co.kr/news/view/1460065/?sc=Naver
10022,2020-11-20,속보메디톡스대웅보톡스전쟁ITC최종판결또연기,http://www.busan.com/view/busan/view.php?code=2020112008255376524
10023,2020-11-20,메디톡스대웅미국ITC최종판결12월16일재연기,http://www.fnnews.com/news/202011200822207258
10024,2020-11-20,메디톡스대웅제약보톡스균주분쟁美ITC판결12월16일로미뤄져,http://www.getnews.co.kr/news/articleView.html?idxno=500677
10025,2020-11-20,대웅제약vs메디톡스ITC소송최종결정12월16일,http://www.shinailbo.co.kr/news/articleView.html?idxno=1345243
10026,2020-11-20,대웅메디톡스ITC최종판결12월16일로재연기,http://www.opinionnews.co.kr/news/articleView.html?idxno=43182
10027,2020-11-20,종합메디톡스대웅제약ITC판결재연기양사해석제각각,http://www.newspim.com/news/view/20201120000090
10028,2020-11-20,美ITC대웅제약보톡스분쟁최종판결연기바이든이결정종합,https://www.hankyung.com/finance/article/202011200245i
10029,2020-11-20,메디톡스대웅제약균주분쟁ITC최종판결또연기종합,http://www.newsis.com/view/?id=NISX20201120_0001240884&cID=13001&pID=13000
10030,2020-11-20,대웅제약메디톡스균주분쟁美ITC최종판결내달16일로재연기,http://www.youthdaily.co.kr/news/article.html?no=53600
10031,2020-11-20,그래픽메디톡스대웅제약보톡스원료분쟁주요일지,http://yna.kr/GYH20201120000400044?did=1363m
10032,2020-11-20,메디톡스대웅보톡스분쟁최종판결재연기,http://news.heraldcorp.com/view.php?ud=20201120000085
10033,2020-11-20,메디톡스대웅제약美ITC최종판결12월16일로또연기종합,https://www.asiatoday.co.kr/view.php?key=20201120010013339
10034,2020-11-20,대웅제약메디톡스美ITC최종판결12월로또연기,http://www.dailypharm.com/Users/News/NewsView.html?ID=270746&REFERER=NP
10035,2020-11-20,美ITC메디톡스대웅보톡스분쟁최종판결또연기종합,https://www.hankyung.com/it/article/2020112002747
10036,2020-11-20,ITC메디톡스대웅제약보툴리눔균주판결12월로연기,http://4th.kr/View.aspx?No=1342912
10037,2020-11-20,미ITC메디톡스대웅제약보톡스분쟁최종판결재연기,http://www.cstimes.com/news/articleView.html?idxno=439537
10038,2020-11-20,대웅제약미국판매사트럼프행정부상대로로비블룸버그폭로,http://www.getnews.co.kr/news/articleView.html?idxno=500688
10039,2020-11-20,대웅제약메디톡스보톡스분쟁ITC최종판결또연기,http://www.seoulwire.com/news/articleView.html?idxno=430147
10040,2020-11-20,종합대웅메디톡스美ITC최종판결재연기에또아전인수,http://news.mk.co.kr/newsRead.php?no=1194436&year=2020
10041,2020-11-20,대웅메디톡스ITC최종판결내달16일로연기,http://www.mkhealth.co.kr/news/articleView.html?idxno=51197
10042,2020-11-20,메디톡스대웅제약보톡스분쟁최종판결또연기,http://moneys.mt.co.kr/news/mwView.php?no=2020112009018015022
10043,2020-11-20,종합메디톡스대웅美ITC최종판결12월16일로재연기,http://www.fnnews.com/news/202011200911525877
10044,2020-11-20,비즈헬스보툴리눔톡신균주전쟁최종승자는ITC다음달16일로대웅제약메디톡스최종판결재연기,http://www.bizwnews.com/news/articleView.html?idxno=21910
10045,2020-11-20,특징주보톡스분쟁판결연기소식에대웅쑥메디톡스뚝,https://www.dailian.co.kr/news/view/938559/?sc=Naver
10046,2020-11-20,메디톡스대웅제약보톡스분쟁ITC최종판결또연기,http://www.mediapen.com/news/view/576307
10047,2020-11-20,메디톡스대웅보톡스분쟁최종판결연기두고아전인수해석,https://biz.chosun.com/site/data/html_dir/2020/11/20/2020112000733.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10048,2020-11-20,메디톡스대웅보톡스분쟁ITC최종판결재연기,http://www.ajunews.com/view/20201120090701951
10049,2020-11-20,ITC최종판결12월로연기대웅메디톡스모두승리자신,http://www.newsprime.co.kr/news/article.html?no=524845
10050,2020-11-20,보톡스분쟁판결또연기대웅제약메디톡스희비엇갈려,http://www.sentv.co.kr/news/view/583211
10051,2020-11-20,美ITC메디톡스대웅제약최종판결내달16일로연기,http://news.mk.co.kr/newsRead.php?no=1194542&year=2020
10052,2020-11-20,메디톡스vs대웅제약보톡스분쟁ITC최종판결12월로재연기,http://daily.hankooki.com/lpage/industry/202011/dh20201120092024148000.htm?s_ref=nv
10053,2020-11-20,보톡스분쟁판결연기메디톡스급락대웅제약상승,https://www.hankyung.com/finance/article/2020112005826
10054,2020-11-20,메디톡스대웅보톡스분쟁ITC최종판결12월16일로,https://hankookilbo.com/News/Read/A2020112008300000264?did=NA
10055,2020-11-20,대웅메디톡스ITC최종판결재연기바이든에공넘기나,https://www.sedaily.com/NewsView/1ZAHC11WQI
10056,2020-11-20,대웅제약美ITC최종판결연기대웅에게유리할것,http://news.mk.co.kr/newsRead.php?no=1194647&year=2020
10057,2020-11-20,미국국제무역위원회메디톡스대웅보톡스분쟁최종판결연기,http://www.segyebiz.com/newsView/20201120503659?OutUrl=naver
10058,2020-11-20,美ITC대웅제약메디톡스보톡스분쟁또연기,http://it.chosun.com/site/data/html_dir/2020/11/20/2020112000794.html
10059,2020-11-20,ITC대웅제약․메디톡스판결내달16일로또연기,http://www.whosaeng.com/122629
10060,2020-11-20,메디톡스대웅제약과보톡스소송최종판결연기에급락,http://news.mt.co.kr/mtview.php?no=2020112009425538811
10061,2020-11-20,메디톡스대웅제약美ITC판결또연기의견분분,http://www.edaily.co.kr/news/newspath.asp?newsid=01925366625967688
10062,2020-11-20,메디톡스대웅보톡스분쟁ITC최종판결12월16일로재연기,https://imnews.imbc.com/news/2020/econo/article/5980500_32647.html
10063,2020-11-20,美ITC판결또연기대웅제약메디톡스누가더유리할까,http://www.wikileaks-kr.org/news/articleView.html?idxno=98881
10064,2020-11-20,특징주메디톡스美ITC최종판결연기에급락대웅제약은강세,http://www.ajunews.com/view/20201120094640986
10065,2020-11-20,TF특징주보톡스분쟁ITC최종판결연기에대웅제약↑메디톡스↓,http://news.tf.co.kr/read/economy/1826002.htm
10066,2020-11-20,메디톡스와대웅제약의보톡스분쟁결론미뤄져,http://www.busan.com/view/busan/view.php?code=2020112009550896286
10067,2020-11-20,메디톡스대웅제약 보톡스전쟁최종판결내달16일로연기,http://www.sporbiz.co.kr/news/articleView.html?idxno=502215
10068,2020-11-20,美ITC최종판결연기메디톡스대웅제약입장은,https://www.paxnetnews.com/articles/67562
10069,2020-11-20,美ITC메디톡스대웅제약판결또연기바이든에공넘기나,http://www.upinews.kr/newsView/upi202011200010
10070,2020-11-20,대웅메톡보톡스분쟁최종판결12월로연기,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112009481128182
10071,2020-11-20,미ITC메디톡스대웅제약보툴리눔제제최종판결내달16일로연기,http://www.kpinews.co.kr/news/articleView.html?idxno=131210
10072,2020-11-20,대웅제약메디톡스ITC판결또다시연기다음달16일최종판결,http://www.g-enews.com/ko-kr/news/article/news_all/20201120085314562469d76442fa_1/article.html
10073,2020-11-20,美ITC메디톡스대웅제약보톡스분쟁최종판결12월로재연기,http://www.ezyeconomy.com/news/articleView.html?idxno=107248
10074,2020-11-20,보톡스전쟁한달더메디톡스대웅제약주가안갯속,http://news.heraldcorp.com/view.php?ud=20201120000251
10075,2020-11-20,메디톡스대웅제약보톡스분쟁ITC최종판결재연기,http://sports.hankooki.com/lpage/economy/202011/sp20201120102211137020.htm?s_ref=nv
10076,2020-11-20,이데일리N메디톡스대웅ITC최종판결12월16일로재연기外,http://www.edaily.co.kr/news/newspath.asp?newsid=02164806625967688
10077,2020-11-20,전화연결옵티머스사태에개미만운다개인판매분모두만기에전액상환연기회수가능10밑돌듯끝나지않는보톡스분쟁美ITC메디톡스대웅제약최종판결내달16일로재연기,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004181972
10078,2020-11-20,대웅메디톡스보톡스분쟁ITC최종판결재연기다음달16일,http://www.wolyo.co.kr/news/articleView.html?idxno=112210
10079,2020-11-20,ITC판결연기메디톡스장중급락vs대웅제약장중강세,http://www.choicenews.co.kr/news/articleView.html?idxno=76549
10080,2020-11-20,메디톡스대웅제약ITC최종판결한달재연기,http://www.seoulfn.com/news/articleView.html?idxno=401709
10081,2020-11-20,메디대웅美ITC최종판결재연기단순연기vs오류검토종합,https://view.asiae.co.kr/article/2020112010583568331
10082,2020-11-20,메디톡스대웅제약ITC최종판결코로나19사태로연기됐다고요,http://www.segye.com/content/html/2020/11/20/20201120505799.html?OutUrl=naver
10083,2020-11-20,대웅제약vs메디톡스지루한균주소송최종판결또연기왜양사해석극과극,http://www.startuptoday.co.kr/news/articleView.html?idxno=61593
10084,2020-11-20,대웅제약메디톡스美ITC최종판결재연기12월16일,http://www.dailymedi.com/detail.php?number=862987&thread=22r05
10085,2020-11-20,메디톡스대웅간보톡스분쟁최종판결또다시연기,http://www.skyedaily.com/news/news_view.html?ID=116261
10086,2020-11-20,대웅제약측美트럼프행정부에로비설나보타수입금지관련,http://news.mk.co.kr/newsRead.php?no=1195560&year=2020
10087,2020-11-20,메디톡스와대웅제약미국균주소송최종판결12월16일로또미뤄져,http://www.businesspost.co.kr/BP?command=article_view&num=205294
10088,2020-11-20,메디톡스대웅제약보톡스분쟁ITC최종판결재연기,http://www.newsfc.co.kr/news/articleView.html?idxno=43631
10089,2020-11-20,한달뒤로또미뤄진보톡스전쟁메디톡스대웅제약주가안갯속,http://news.heraldcorp.com/view.php?ud=20201120000444
10090,2020-11-20,대웅제약메디톡스보톡스분쟁ITC최종판결또연기12월6일로,http://www.newsworks.co.kr/news/articleView.html?idxno=505000
10091,2020-11-20,메디톡스대웅제약보톡스최종판정또연기,https://www.nocutnews.co.kr/news/5450687
10092,2020-11-20,메디톡스대웅보톡스분쟁판결연기에양사엇갈린반응,http://news.tf.co.kr/read/economy/1826029.htm
10093,2020-11-20,ITC메디톡스대웅보톡스분쟁최종판결재연기,https://cnbc.sbs.co.kr/article_hub/10001003111?division=NAVER
10094,2020-11-20,메디톡스대웅제약보톡스분쟁살얼음판한달더ITC최종판결12월16일로또연기,http://theviewers.co.kr/View.aspx?No=1343432
10095,2020-11-20,대웅제약메디톡스보톡스전쟁美ITC최종판결12월로연기,http://www.newslock.co.kr/news/articleView.html?idxno=33055
10096,2020-11-20,보톡스판결연기대웅제약웃고메디톡스울고,http://www.smartfn.co.kr/view.php?ud=202011201247028607d3eee0def8_46
10097,2020-11-20,미국블룸버그메디톡스대웅제약의ITC연기결정은매우흔히있는일”,http://www.kukinews.com/newsView/kuk202011200222
10098,2020-11-20,메디톡스대웅제약보톡스소송최종판결또연기,http://www.munhwa.com/news/view.html?no=2020112001072039342001
10099,2020-11-20,메디톡스vs대웅보톡스분쟁예비판결유지될까ITC최종판결연기배경은,https://www.news2day.co.kr/article/20201120164796
10100,2020-11-20,ITC메디톡스대웅제약보톡스전쟁최종판정또연기,http://www.seouleconews.com/news/articleView.html?idxno=57772
10101,2020-11-20,대웅제약메디톡스보톡스분쟁주요쟁점은,http://www.mediapen.com/news/view/576391
10102,2020-11-20,전화연결코로나193차대유행가능성에기업들확산방지에선제대응회식금지재택근무다시시행끝나지않는보톡스분쟁美ITC메디톡스대웅제약최종판결내달16일로재연기,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004182422
10103,2020-11-20,오후포털사이트상위검색순위메디톡스대웅제약영업비밀침해소송연기,http://www.slist.kr/news/articleView.html?idxno=203084
10104,2020-11-20,메디톡스대웅제약분쟁美ITC판결내달연기어느업체가유리,http://www.sisajournal-e.com/news/articleView.html?idxno=226020
10105,2020-11-20,메디톡스대웅제약美ITC최종판결재연기놓고극명한입장차,https://www.asiatime.co.kr/news/newsview.php?ncode=1065577752039610
10106,2020-11-20,美블룸버그메디톡스대웅제약 ITC 연기결정매우흔한일,http://www.thefirstmedia.net/news/articleView.html?idxno=66400
10107,2020-11-20,메디톡스대웅제약균주전쟁ITC최종판결재연기,http://www.newstomato.com/ReadNews.aspx?no=1008205
10108,2020-11-20,미국에서균주소송최종판결또연기대웅제약전세역전희망품어,http://www.businesspost.co.kr/BP?command=article_view&num=205351
10109,2020-11-20,메디톡스대웅제약보톡스분쟁또연기ITC판결달라지나,https://www.asiatoday.co.kr/view.php?key=20201120010013728
10110,2020-11-20,메디톡스vs대웅최종판결재연기균주공방안갯속,http://www.kukinews.com/newsView/kuk202011200238
10111,2020-11-20,대웅메디톡스보툴리눔균주싸움또연기이슈플러스,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011200186&t=NNv
10112,2020-11-20,대웅메디톡스보툴리눔균주사생결단,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011200167&t=NNv
10113,2020-11-20,김창수의e뉴스브리핑대웅제약메디톡스균주분쟁ITC최종판결12월16일로재연기外,https://www.fetv.co.kr/news/article.html?no=69164
10114,2020-11-20,메디톡스대웅보톡스분쟁美ITC최종판결또연기,http://news.mk.co.kr/newsRead.php?no=1197604&year=2020
10115,2020-11-20,금일제약업계주요기사대웅제약메디톡스美ITC최종판결재연기한미약품4제복합제품목허가획득外,http://www.youthdaily.co.kr/news/article.html?no=53699
10116,2020-11-20,보톡스분쟁ITC최종판결12월16일재연기승리자신”메디톡스대웅엇갈릿해석,http://www.betanews.net:8080/article/1241737.html
10117,2020-11-20,대웅제약메디톡스보톡스분쟁최종판결연기,http://weekly.hankooki.com/lpage/economy/202011/wk20201120213800146380.htm?s_ref=nv
10118,2020-11-21,메디톡스vs대웅제약균주전쟁연기된ITC최종판결누구에게유리할까,http://www.thepublic.kr/news/newsview.php?ncode=1065599253375342
10119,2020-11-22,지난주제약업계주요이슈대웅메디톡스美ITC최종판결또연기한미약품4제복합제품목허가外,http://www.youthdaily.co.kr/news/article.html?no=53730
10120,2020-11-22,메디톡스대웅제약균주분쟁ITC최종판결또연기12월16일로재연기,http://www.econonews.co.kr/news/articleView.html?idxno=145535
10121,2020-11-22,메디톡스VS대웅제약美ITC최종판결연기에아전인수해석,https://www.ekn.kr/web/view.php?key=20201122010005140
10122,2020-11-22,메디톡스대웅제약보톡스분쟁또다시재연기”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011221107045140653
10123,2020-11-22,메디톡스vs대웅제약보톡스전쟁판결또연기美ITC최종판결내달16일로,http://www.smartfn.co.kr/view.php?ud=20201122154411177999c6307fbc_46
10124,2020-11-22,ITC대웅제약메디톡스최종판결재연기내달16일승패갈린다,http://www.mdtoday.co.kr/mdtoday/index.html?no=406544
10125,2020-11-23,종근당바이오대웅나보타본부장영입보톡스공략강화,http://www.dailymedi.com/detail.php?number=863046&thread=22r05
10126,2020-11-23,대웅엘러간상대벨카이라쪼개기특허회피성공,http://www.dailypharm.com/Users/News/NewsView.html?ID=270787&REFERER=NP
10127,2020-11-23,초고함량비타민시장도선점대웅제약임팩타민케어플러스정허가,http://www.medisobizanews.com/news/articleView.html?idxno=74364
10128,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁생산업무협약,https://biz.chosun.com/site/data/html_dir/2020/11/23/2020112300856.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10129,2020-11-23,시지바이오대웅제약자가줄기세포치료제CDMO업무협약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251680
10130,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO협약,http://medipana.com/news/news_viewer.asp?NewsNum=266240&MainKind=A&NewsKind=5&vCount=12&vKind=1
10131,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁개발생산업무협약,http://it.chosun.com/site/data/html_dir/2020/11/23/2020112300927.html
10132,2020-11-23,대웅제약시지바이오자가줄기세포치료제위탁개발생산MOU,http://www.medisobizanews.com/news/articleView.html?idxno=74372
10133,2020-11-23,시지바이오대웅제약과줄기세포치료제위탁개발생산MOU,http://www.press9.kr/news/articleView.html?idxno=46361
10134,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁생산업무협약,http://inthenews.co.kr/article-78645/
10135,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.newstomato.com/ReadNews.aspx?no=1008393
10136,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁개발생산협약,http://www.metroseoul.co.kr/article/20201123500118
10137,2020-11-23,시지바이오자가줄기세포치료제대웅제약에위탁개발생산맡긴다,https://www.etoday.co.kr/news/view/1965600
10138,2020-11-23,콜린알포임상재평가종근당대웅공동임상가닥,http://www.mediapen.com/news/view/576869
10139,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64734
10140,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO협약,https://www.hankyung.com/it/article/202011230402i
10141,2020-11-23,대웅제약펜믹스벨카이라특허두번째허들넘었다,http://medipana.com/news/news_viewer.asp?NewsNum=266257&MainKind=A&NewsKind=5&vCount=12&vKind=1
10142,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=20240
10143,2020-11-23,시지바이오대웅제약자가줄기세포치료제CDMO업무협약체결,http://www.youthdaily.co.kr/news/article.html?no=53837
10144,2020-11-23,대웅제약시지바이오자가줄기세포치료제위탁개발생산업무협약체결,https://www.fetv.co.kr/news/article.html?no=69283
10145,2020-11-23,대웅제약호이스타정코로나19환자대상임상2상대상자모집완료,http://www.sentv.co.kr/news/view/583332
10146,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시목표로임상가속화,http://www.healthinnews.co.kr/news/articleView.html?idxno=20260
10147,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시목표로임상잰걸음,https://www.fetv.co.kr/news/article.html?no=69292
10148,2020-11-23,대웅제약호이스타정내년초코로나19치료제출시목표,http://www.m-i.kr/news/articleView.html?idxno=767905
10149,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.lcnews.co.kr/news/articleView.html?idxno=10092
10150,2020-11-23,대웅제약호이스타정코로나19국내임상선두,http://www.medisobizanews.com/news/articleView.html?idxno=74382
10151,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료내년1월긴급사용승인목표,https://biz.chosun.com/site/data/html_dir/2020/11/23/2020112301651.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10152,2020-11-23,대웅제약코로나치료제호이스타정출시임박내년1월예상,https://www.ekn.kr/web/view.php?key=20201123010005484
10153,2020-11-23,대웅제약카모스타트코로나19임상2상환자모집완료,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112314094377207
10154,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시목표로임상가속화,http://www.lawissue.co.kr/view.php?ud=202011231414314519204ead0791_12
10155,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://newsbrite.net/143846
10156,2020-11-23,대웅제약호이스타정임상2상시험환자모집완료,http://inthenews.co.kr/article-78669/
10157,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,https://www.hankyung.com/it/article/202011231028i
10158,2020-11-23,대웅제약호이스타정2020년1월코로나19치료제로출시기대,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011231418031760023
10159,2020-11-23,대웅제약호이스타정임상2상시험환자모집완료,http://www.economytalk.kr/news/articleView.html?idxno=209494
10160,2020-11-23,대웅제약코로나치료제호이스타정2상환자모집완료,https://www.ebn.co.kr/news/view/1460409/?sc=Naver
10161,2020-11-23,대웅제약호이스타정이르면내년1월코로나19치료제출시가능,http://www.seoulwire.com/news/articleView.html?idxno=430300
10162,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.fnnews.com/news/202011231420559997
10163,2020-11-23,시지바이오대웅제약과줄기세포치료제CDMO협약체결,https://www.econovill.com/news/articleView.html?idxno=506429
10164,2020-11-23,대웅제약호이스타정21년1월코로나19치료제출시목표임상가속화,http://www.thebigdata.co.kr/view.php?ud=202011231421252132d0a8833aad_23
10165,2020-11-23,대웅제약호이스타정임상가속화,http://www.newsworker.co.kr/news/articleView.html?idxno=92915
10166,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집완료내년1월출시기대,https://www.etoday.co.kr/news/view/1965736
10167,2020-11-23,대웅제약내년1월코로나치료제조건부승인받겠다,http://www.newsis.com/view/?id=NISX20201123_0001243784&cID=13001&pID=13000
10168,2020-11-23,대웅제약호이스타정내년코로나19치료제임상가속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251712
10169,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료1월긴급사용승인목표,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011230268&t=NN
10170,2020-11-23,대웅제약개발중인코로나19치료제호이스타정내년1월출시전망,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123801
10171,2020-11-23,대웅제약내년1월코로나19치료제로호이스타정출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=55571
10172,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,https://www.dailian.co.kr/news/view/939273/?sc=Naver
10173,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시목표로임상가속화,http://www.ftoday.co.kr/news/articleView.html?idxno=208464
10174,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집완료,http://www.youthdaily.co.kr/news/article.html?no=53853
10175,2020-11-23,대웅제약코로나19치료제임상2상시험환자모집완료내년1월긴급사용승인목표,http://www.newsworks.co.kr/news/articleView.html?idxno=505602
10176,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.newsway.co.kr/news/view?tp=1&ud=2020112314360611589
10177,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.metroseoul.co.kr/article/20201123500345
10178,2020-11-23,대웅제약호이스타정임상2상대상자모집완료내년1월코로나19치료제출시기대감,https://www.asiatoday.co.kr/view.php?key=20201123010014843
10179,2020-11-23,대웅제약코로나19치료제호이스타정임상2상대상자모집완료,http://www.upinews.kr/newsView/upi202011230053
10180,2020-11-23,대웅제약췌장염치료제코로나19임상2상시작내년사용목표,http://moneys.mt.co.kr/news/mwView.php?no=2020112314378060598
10181,2020-11-23,대웅제약코로나치료제임상2상시험자모집완료,https://health.chosun.com/site/data/html_dir/2020/11/23/2020112301745.html
10182,2020-11-23,대웅제약코로나19치료제호이스타정임상2상시험환자모집완료,http://www.newsfc.co.kr/news/articleView.html?idxno=43656
10183,2020-11-23,대웅제약호이스타정내년코로나19치료제출시기대,http://www.press9.kr/news/articleView.html?idxno=46366
10184,2020-11-23,대웅제약호이스타정코로나19글로벌1차치료제로개발,http://www.newsprime.co.kr/news/article.html?no=525022
10185,2020-11-23,대웅제약호이스타정국내첫코로나19치료제임상2상환자모집완료,http://www.kpinews.co.kr/news/articleView.html?idxno=131348
10186,2020-11-23,대웅코로나19치료제호이스타정내년1월출시가능↑,http://www.wikileaks-kr.org/news/articleView.html?idxno=99011
10187,2020-11-23,대웅제약코로나치료제임상2상환자모집완료,http://www.koreastocknews.com/news/articleView.html?idxno=59119
10188,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.medigatenews.com/news/1482008960
10189,2020-11-23,코로나19치료제개발기대감↑대웅제약호이스타정임상2상대상자모집완료,http://kpenews.com/View.aspx?No=1345976
10190,2020-11-23,대웅제약호이스타정21년1월코로나19치료제출시기대,http://www.pharmnews.com/news/articleView.html?idxno=101735
10191,2020-11-23,대웅제약코로나치료제2상환자모집완료내년1월출시목표,http://sports.hankooki.com/lpage/economy/202011/sp20201123145545137020.htm?s_ref=nv
10192,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료,http://www.mediapen.com/news/view/576998
10193,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시기대감,http://www.dailysmart.co.kr/news/articleView.html?idxno=36193
10194,2020-11-23,시지바이오자가줄기세포치료제대웅제약에위탁생산,http://www.mkhealth.co.kr/news/articleView.html?idxno=51221
10195,2020-11-23,대웅제약코로나치료제내년1월조건부허가신청”,http://www.viva100.com/main/view.php?key=20201123010005794
10196,2020-11-23,대웅제약내년1월코로나치료제조건부승인목표,https://view.asiae.co.kr/article/2020112315124199068
10197,2020-11-23,대웅제약호이스타정1월코로나19치료제로출시기대,http://medipana.com/news/news_viewer.asp?NewsNum=266270&MainKind=A&NewsKind=5&vCount=12&vKind=1
10198,2020-11-23,대웅제약카모스타트코로나19치료제임상가속감기처럼관리하는의약품으로개발”,https://www.donga.com/news/article/all/20201123/104106054/1
10199,2020-11-23,대웅제약호이스타정내년1월코로나치료제로출시목표로임상가속화,http://www.segye.com/content/html/2020/11/23/20201123514950.html?OutUrl=naver
10200,2020-11-23,가속도대웅제약호이스타내년1월출시목표,http://www.monews.co.kr/news/articleView.html?idxno=215686
10201,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시목표,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004184764
10202,2020-11-23,대웅제약내년1월코로나19치료제호이스타정출시목표,http://www.seoulfn.com/news/articleView.html?idxno=401934
10203,2020-11-23,대웅제약호이스타정코로나19임상2상모집완료,http://www.mhj21.com/137009
10204,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.nbnnews.co.kr/news/articleView.html?idxno=443443
10205,2020-11-23,대웅제약코로나19임상2상대상자모집완료,http://www.joseilbo.com/news/news_read.php?uid=410969&class=27&grp=
10206,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64741
10207,2020-11-23,대웅제약코로나19치료제빠르면내년1월출시,https://www.nocutnews.co.kr/news/5452018
10208,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.segyebiz.com/newsView/20201123515409?OutUrl=naver
10209,2020-11-23,대웅제약코로나치료제2상환자모집완료내년1월긴급사용승인목표,http://it.chosun.com/site/data/html_dir/2020/11/23/2020112301921.html
10210,2020-11-23,대웅제약호이스타정임상가속화내년코로나19치료제로출시기대,http://www.ceoscoredaily.com/news/article.html?no=75440
10211,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집완료,https://www.news2day.co.kr/article/20201123500137
10212,2020-11-23,대웅제약코로나19치료제호이스타정내년1월출시예상,http://www.paxetv.com/news/articleView.html?idxno=104911
10213,2020-11-23,대웅제약코로나치료제2상환자모집완료내년초출시목표,http://news.mt.co.kr/mtview.php?no=2020112316141667841
10214,2020-11-23,시지바이오대웅제약과줄기세포치료제CDMOMOU체결,http://moneys.mt.co.kr/news/mwView.php?no=2020112316248074492
10215,2020-11-23,대웅제약코로나19치료제내년1월출시가목표,http://www.shinailbo.co.kr/news/articleView.html?idxno=1346198
10216,2020-11-23,코로나19의타미플루로대웅제약췌장염약호이스타정내년1월코로나19치료제로출시기대,http://theviewers.co.kr/View.aspx?No=1346246
10217,2020-11-23,대웅제약1월코로나치료제출시기대,https://www.econovill.com/news/articleView.html?idxno=506439
10218,2020-11-23,대웅제약호이스타정내년1월코로나19치료제출시기대,http://www.newstomato.com/ReadNews.aspx?no=1008546
10219,2020-11-23,대웅제약호이스타정내년1월코로나치료제조건부승인목표,https://www.asiatime.co.kr/news/newsview.php?ncode=1065598010778433
10220,2020-11-23,대웅제약코로나치료제개발위한임상2상환자모집완료,http://isplus.live.joins.com/news/article/article.asp?total_id=23927843
10221,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.koreaittimes.com/news/articleView.html?idxno=101987
10222,2020-11-23,시지바이오대웅제약과자가줄기세포치료제위탁개발생산협약체결,http://www.anewsa.com/detail.php?number=2286446&thread=10
10223,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료내년1월출시목표”,http://www.mdtoday.co.kr/mdtoday/index.html?no=406698
10224,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=66517
10225,2020-11-23,시지바이오대웅제약과자가줄기세포치료제CDMO업무협약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=66517
10226,2020-11-23,대웅제약코로나19치료제2상환자모집완료내년1월호이스타정출시목표,http://www.anewsa.com/detail.php?number=2286453&thread=10
10227,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대”,http://www.ajunews.com/view/20201123170154395
10228,2020-11-23,대웅제약호이스타정21년1월코로나19치료제로출시기대,http://www.thefirstmedia.net/news/articleView.html?idxno=66532
10229,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시기대,http://www.worktoday.co.kr/news/articleView.html?idxno=11710
10230,2020-11-23,대웅제약호이스타정내년1월코로나19치료제로출시목표임상가속화,http://www.thepublic.kr/news/newsview.php?ncode=1065600415173490
10231,2020-11-23,김창수의e뉴스브리핑대웅제약시지바이오자가줄기세포치료제위탁개발생산업무협약체결外,https://www.fetv.co.kr/news/article.html?no=69307
10232,2020-11-23,대웅제약코로나19치료제호이스타정임상2상실시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1430398
10233,2020-11-23,대웅제약호이스타정1월코로나19치료제출시목표,http://kormedi.com/?p=1327982
10234,2020-11-23,대웅제약코로나치료제호이스타정2상피험자모집완료,http://www.consumernews.co.kr/news/articleView.html?idxno=616107
10235,2020-11-23,대웅제약코로나19치료제임상2상환자모집완료내년1월긴급승인목표,https://www.sedaily.com/NewsView/1ZAIQ6DMH5
10236,2020-11-23,금일제약업계주요기사대웅제약코로나19치료제호이스타정임상2상환자모집완료유한양행레이저티닙2차마일스톤723억원수령外,http://www.youthdaily.co.kr/news/article.html?no=53873
10237,2020-11-23,대웅제약코로나19치료제내년1월출시기대,http://www.100ssd.co.kr/news/articleView.html?idxno=72915
10238,2020-11-23,대웅제약코로나19치료제호이스타정임상2상환자모집마쳐,http://www.businesspost.co.kr/BP?command=article_view&num=205646
10239,2020-11-23,대웅코로나19치료제내년1월출시목표,http://www.medical-tribune.co.kr/news/articleView.html?idxno=96509
10240,2020-11-23,대웅제약코로나치료제내년1월승인목표,http://www.dt.co.kr/contents.html?article_no=2020112402100451102002&ref=naver
10241,2020-11-23,대웅제약코로나19치료제9부능선1월출시기대감,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137276&REFERER=NP
10242,2020-11-23,대웅제약2021년1월코로나19경구용1차치료제승인목표,http://www.newsinside.kr/news/articleView.html?idxno=1095592
10243,2020-11-23,대웅제약코로나19치료제호이스타정임상2상대상자모집완료,http://www.thedailypost.kr/news/articleView.html?idxno=77656
10244,2020-11-23,대웅제약호이스타정코로나19임상2상시험환자모두모집,https://www.kpanews.co.kr/article/show.asp?idx=217932&category=D
10245,2020-11-23,시지바이오대웅제약자가줄기세포치료제CDMO업무협약,https://www.kpanews.co.kr/article/show.asp?idx=217933&category=D
10246,2020-11-24,대웅제약2개월후코로나19치료제출시기대,http://www.doctorstimes.com/news/articleView.html?idxno=213158
10247,2020-11-24,대웅제약코로나19치료제호이스타정임상2상모집완료,http://www.g-enews.com/ko-kr/news/article/news_all/2020112318160948212500a1b5d6_1/article.html
10248,2020-11-24,대웅제약펜믹스벨카이라특허회피성공,http://www.mdtoday.co.kr/mdtoday/index.html?no=406712
10249,2020-11-24,대웅제약코로나19치료제이르면내년1월출시가능성,http://kbench.com/?q=node/216127
10250,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업안정적,http://www.businesskorea.co.kr/news/articleView.html?idxno=55609
10251,2020-11-24,대웅제약신규보툴리눔균주입고완료ITC예비결정오류직접입증,http://www.m-i.kr/news/articleView.html?idxno=768197
10252,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.press9.kr/news/articleView.html?idxno=46379
10253,2020-11-24,대웅제약美서신규보툴리눔균주입고완료법적문제없어,https://www.ekn.kr/web/view.php?key=20201124010005679
10254,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://news.mt.co.kr/mtview.php?no=2020112409411441927
10255,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.lawissue.co.kr/view.php?ud=202011240956548864204ead0791_12
10256,2020-11-24,대웅제약새보툴리눔균주입고나보타사업지속성강화,http://medipana.com/news/news_viewer.asp?NewsNum=266316&MainKind=A&NewsKind=5&vCount=12&vKind=1
10257,2020-11-24,대웅제약신규보툴리눔균주입고완료법적문제없어,http://www.medisobizanews.com/news/articleView.html?idxno=74404
10258,2020-11-24,대웅제약나보타위기새균주로극복,http://www.monews.co.kr/news/articleView.html?idxno=215725
10259,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://www.fetv.co.kr/news/article.html?no=69353
10260,2020-11-24,대웅제약신규보툴리눔균주입고완료ITC관계없이나보타강화,http://www.upinews.kr/newsView/upi202011240018
10261,2020-11-24,대웅국내첫코로나19치료제목표서울대병원임상2상,http://www.dailymedi.com/detail.php?number=863101&thread=22r05
10262,2020-11-24,대웅제약코로나치료제내년1월긴급사용승인목표,http://www.sisaweek.com/news/articleView.html?idxno=139474
10263,2020-11-24,대웅신규보툴리눔균주입고완료,http://www.bosa.co.kr/news/articleView.html?idxno=2138687
10264,2020-11-24,대웅제약新균주로나보타사업지속한다신규보툴리눔균주입고완료”,http://www.viva100.com/main/view.php?key=20201124010005947
10265,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112410115331641
10266,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112410115331641
10267,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.ceoscoredaily.com/news/article.html?no=75454
10268,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011240089&t=NN
10269,2020-11-24,대웅제약신규보툴리눔균주입고완료한∙미정부승인배송절차문제No,http://www.thebigdata.co.kr/view.php?ud=202011241013275603d0a8833aad_23
10270,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화”,http://www.youthdaily.co.kr/news/article.html?no=53940
10271,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.newsis.com/view/?id=NISX20201124_0001244867&cID=13001&pID=13000
10272,2020-11-24,보툴리눔균주신규구매대웅제약ITC최종판결상관없이나보타사업지속,https://www.etoday.co.kr/news/view/1966074
10273,2020-11-24,시지바이오대웅제약과자가줄기세포치료제위탁개발생산MOU체결,http://news.heraldcorp.com/view.php?ud=20201124000304
10274,2020-11-24,대웅보툴리눔균주자사시설입고나보타사업강화,http://www.wikileaks-kr.org/news/articleView.html?idxno=99063
10275,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.kpinews.co.kr/news/articleView.html?idxno=131423
10276,2020-11-24,균주수입으로여론전나선대웅제약나보타사업지속하겠다,https://www.hankyung.com/it/article/202011244194i
10277,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011241026492270228
10278,2020-11-24,시지바이오대웅제약자가줄기세포치료제CDMO업무협약체결,http://www.edaily.co.kr/news/newspath.asp?newsid=02358326625969000
10279,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://www.segye.com/content/html/2020/11/24/20201124508610.html?OutUrl=naver
10280,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,https://www.asiatoday.co.kr/view.php?key=20201124010015419
10281,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.thepublic.kr/news/newsview.php?ncode=1065576447310177
10282,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://newsbrite.net/143882
10283,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251740
10284,2020-11-24,대웅제약신규보툴리눔균주입고보톡스사업지속성강화의도,http://www.newsworks.co.kr/news/articleView.html?idxno=505837
10285,2020-11-24,시지바이오대웅제약과자가줄기세포치료제관련업무협약MOU,http://www.dt.co.kr/contents.html?article_no=2020112402109919053002&ref=naver
10286,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.healthinnews.co.kr/news/articleView.html?idxno=20286
10287,2020-11-24,대웅제약보툴리눔균주국내반입완료ITC와무관하게사업지속”,http://daily.hankooki.com/lpage/industry/202011/dh20201124105328148390.htm?s_ref=nv
10288,2020-11-24,대웅제약시지바이오자가줄기세포치료제CDMO업무협약,http://daily.hankooki.com/lpage/economy/202011/dh20201124105830138060.htm?s_ref=nv
10289,2020-11-24,대웅제약신규보툴리눔균주국내입고완료나보타사업강화나서,http://www.newslock.co.kr/news/articleView.html?idxno=33162
10290,2020-11-24,시지바이오대웅제약과자가줄기세포치료제CDMO협약,http://www.segye.com/content/html/2020/11/24/20201124509840.html?OutUrl=naver
10291,2020-11-24,대웅제약신규보툴리눔균주반입완료나보타사업지속성강화,http://www.pinpointnews.co.kr/view.php?ud=2020112411070399072365609d9b_45
10292,2020-11-24,대웅제약미국서신규보툴리눔균주구매아무런법적문제없었다,https://www.dailian.co.kr/news/view/939573/?sc=Naver
10293,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://newsclaim.co.kr/View.aspx?No=1350401
10294,2020-11-24,대웅제약신규보툴리눔균주입고ITC무관나보타사업지속,http://www.medigatenews.com/news/206717619
10295,2020-11-24,대웅제약신규보툴리눔균주입고,https://view.asiae.co.kr/article/2020112411545020746
10296,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업지속성강화,http://www.newsprime.co.kr/news/article.html?no=525143
10297,2020-11-24,대웅제약소송무관하게보툴리눔톡신사업지속새균주국내반입,http://www.businesspost.co.kr/BP?command=article_view&num=205737
10298,2020-11-24,대웅제약신규보툴리눔균주입고완료,https://www.news2day.co.kr/article/20201124500136
10299,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.updownnews.co.kr/news/articleView.html?idxno=225597
10300,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업이어갈것”,https://health.chosun.com/site/data/html_dir/2020/11/24/2020112401578.html
10301,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=406806
10302,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업이어갈것,https://biz.chosun.com/site/data/html_dir/2020/11/24/2020112401719.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10303,2020-11-24,대웅제약신규보툴리눔균주입고나보타사업강화,https://www.econovill.com/news/articleView.html?idxno=506628
10304,2020-11-24,대웅제약신규보툴리눔톡신균주도입완료,http://www.mediapen.com/news/view/577262
10305,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=443828
10306,2020-11-24,대웅호이스타내년초코로나치료제로출시,http://www.whosaeng.com/122710
10307,2020-11-24,대웅제약신규보툴리눔균주국내반입완료,http://www.whosaeng.com/122713
10308,2020-11-24,대웅제약홀에이하이퍼균주국내반입성공한미정부승인배송절차문제無”,https://www.donga.com/news/article/all/20201124/104124773/1
10309,2020-11-24,코로나19치료제환자모집탄력대웅제약셀트리온완료,http://www.edaily.co.kr/news/newspath.asp?newsid=04063926625969000
10310,2020-11-24,대웅제약보툴리눔균주국내반입절차완료,http://www.shinailbo.co.kr/news/articleView.html?idxno=1346745
10311,2020-11-24,대웅제약홀A하이퍼균주도입ITC판결뒤집을까,http://www.seoulfn.com/news/articleView.html?idxno=402118
10312,2020-11-24,대웅제약신규보툴리눔균주입고완료나보타사업지속성강화,http://www.thefirstmedia.net/news/articleView.html?idxno=66609
10313,2020-11-24,대웅제약신규보툴리눔균주입고완료,http://www.anewsa.com/detail.php?number=2287501&thread=10
10314,2020-11-24,대웅제약코로나19치료제임상2상시험환자모집완료내년1월긴급사용승인목표,http://www.econonews.co.kr/news/articleView.html?idxno=145931
10315,2020-11-25,대웅제약호이스타정코로나19환자대상임상2상대상자모집완료,http://www.kukinews.com/newsView/kuk202011240420
10316,2020-11-25,대웅제약신규보툴리눔균주입고마쳐,https://www.kpanews.co.kr/article/show.asp?idx=217964&category=D
10317,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.press9.kr/news/articleView.html?idxno=46393
10318,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112509013299337
10319,2020-11-25,대웅제약나보타남성형탈모에효과추가임상진행중,http://daily.hankooki.com/lpage/industry/202011/dh20201125090554148390.htm?s_ref=nv
10320,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251792
10321,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=131508
10322,2020-11-25,대웅제약나보타남성형탈모개선효과확인,https://www.ebn.co.kr/news/view/1460730/?sc=Naver
10323,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=266383&MainKind=A&NewsKind=5&vCount=12&vKind=1
10324,2020-11-25,대웅제약나보타남성형탈모에효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2138760
10325,2020-11-25,대웅제약보톡스나보타남성형탈모개선효과입증,https://biz.chosun.com/site/data/html_dir/2020/11/25/2020112500725.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10326,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020112509195982697
10327,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모에효과입증”,http://www.youthdaily.co.kr/news/article.html?no=54056
10328,2020-11-25,보톡스맞았더니머리숱늘었다대웅제약임상서효과입증,http://news.mt.co.kr/mtview.php?no=2020112509213582010
10329,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64788
10330,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.pharmnews.com/news/articleView.html?idxno=101750
10331,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,https://www.fetv.co.kr/news/article.html?no=69443
10332,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.metroseoul.co.kr/article/20201125500059
10333,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,http://www.m-i.kr/news/articleView.html?idxno=768639
10334,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모개선효과입증,http://www.newspim.com/news/view/20201125000221
10335,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.lawissue.co.kr/view.php?ud=202011250943386324204ead0791_12
10336,2020-11-25,대웅제약나보타남성형탈모개선효과입증,http://www.medisobizanews.com/news/articleView.html?idxno=74434
10337,2020-11-25,대웅제약나보타남성형탈모치료기대임상에서효과입증,https://health.chosun.com/site/data/html_dir/2020/11/25/2020112500852.html
10338,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.monews.co.kr/news/articleView.html?idxno=215764
10339,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과,https://www.dailian.co.kr/news/view/939935/?sc=Naver
10340,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://newsbrite.net/143918
10341,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011250955055120511
10342,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://inthenews.co.kr/article-79021/
10343,2020-11-25,대웅제약나보타남성형탈모에효과모발개수유의하게증가,http://www.newsprime.co.kr/news/article.html?no=525259
10344,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.healthinnews.co.kr/news/articleView.html?idxno=20314
10345,2020-11-25,산청군소방서목조문화재합동소방훈련보물제374호신등면율곡사대웅전서,http://www.weeklytoday.com/news/articleView.html?idxno=325744
10346,2020-11-25,대웅제약나보타남성탈모개선효과,https://www.hankyung.com/it/article/202011258815i
10347,2020-11-25,대웅제약나보타남성형탈모효과입증,http://it.chosun.com/site/data/html_dir/2020/11/25/2020112500932.html
10348,2020-11-25,대웅제약보툴리눔톡신나보타임상서남성형탈모효과확인,http://yna.kr/AKR20201125054800017?did=1195m
10349,2020-11-25,대웅제약보툴리눔톡신나보타탈모개선가능성,http://sports.hankooki.com/lpage/economy/202011/sp20201125101522137020.htm?s_ref=nv
10350,2020-11-25,대웅제약보톡스나보타남성형탈모에도효과있다,http://www.getnews.co.kr/news/articleView.html?idxno=501505
10351,2020-11-25,대웅제약나보타남성형탈모에효과입증임상시험결과,http://www.pinpointnews.co.kr/view.php?ud=2020112510184511432365609d9b_45
10352,2020-11-25,대웅제약나보타임상시험서남성형탈모효과입증,https://www.ekn.kr/web/view.php?key=20201125010006038
10353,2020-11-25,대웅제약나보타남성형탈모개선에효과,http://www.dailypharm.com/Users/News/NewsView.html?ID=270898&REFERER=NP
10354,2020-11-25,대웅제약나보타남성형탈모치료제되나,http://newsclaim.co.kr/View.aspx?No=1356351
10355,2020-11-25,대웅제약나보타남성형탈모개선효과美SCI저널게재,http://www.newslock.co.kr/news/articleView.html?idxno=33224
10356,2020-11-25,탈모에도보톡스대웅제약나보타남성형탈모임상시험효과입증,http://theviewers.co.kr/View.aspx?No=1356363
10357,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.newsworker.co.kr/news/articleView.html?idxno=93212
10358,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모효과입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=123878
10359,2020-11-25,대웅제약나보타남성형탈모효과확인,http://www.newstomato.com/ReadNews.aspx?no=1008932
10360,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.dailymedi.com/detail.php?number=863152&thread=22r05
10361,2020-11-25,대웅제약나보타탈모치료제될까임상시험서남성형탈모에효과,http://www.opinionnews.co.kr/news/articleView.html?idxno=43344
10362,2020-11-25,대웅제약나보타탈모적응증청신호남성형탈모효과입증”,http://www.viva100.com/main/view.php?key=20201125010006331
10363,2020-11-25,대웅제약코로나치료제등신약개발속도낸다,https://www.fetv.co.kr/news/article.html?no=69471
10364,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=36310
10365,2020-11-25,대웅제약나보타남성형탈모관련임상시험결과공개,http://www.asiaa.co.kr/news/articleView.html?idxno=8192
10366,2020-11-25,대웅제약나보타임상서남성형탈모치료효과확인,https://www.econovill.com/news/articleView.html?idxno=506841
10367,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모에효과,https://view.asiae.co.kr/article/2020112511443363365
10368,2020-11-25,대웅제약자체보툴눔톡신의남성형탈모개선효과를학술지에실어,http://www.businesspost.co.kr/BP?command=article_view&num=205917
10369,2020-11-25,대웅제약나보타남성형탈모치료효과확인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=96578
10370,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모에효과,http://www.seoulfn.com/news/articleView.html?idxno=402194
10371,2020-11-25,모발이눈에띄게쑥쑥대웅제약나보타남성형탈모치료효과입증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4352158
10372,2020-11-25,보령제약대웅제약제약주모두급등대웅제약6급등이어보령제약17급등,http://www.econonews.co.kr/news/articleView.html?idxno=146059
10373,2020-11-25,대웅제약대웅낮부터갑작스런급등대웅제약5급등이어대웅8급등,http://www.econonews.co.kr/news/articleView.html?idxno=146060
10374,2020-11-25,대웅제약나보타임상시험서남성형탈모치료효과확인,https://www.etoday.co.kr/news/view/1966647
10375,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.thebigdata.co.kr/view.php?ud=202011251307204233d0a8833aad_23
10376,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모효과입증,http://www.medigatenews.com/news/629564329
10377,2020-11-25,대웅제약나보타임상시험서남성형탈모치료효과,https://www.sedaily.com/NewsView/1ZAJN7NW8I
10378,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.koreaittimes.com/news/articleView.html?idxno=102030
10379,2020-11-25,뉴스투데이L대웅제약나보타임상시험서남성형탈모효과입증,https://www.news2day.co.kr/article/20201125500166
10380,2020-11-25,오늘의제약셀트리온GC녹십자웰빙대웅제약GC녹십자엠에스동화약품,http://www.babytimes.co.kr/news/articleView.html?idxno=41247
10381,2020-11-25,대웅제약나보타남성형탈모치료효과입증,http://www.mhj21.com/137093
10382,2020-11-25,특징주대웅제약나보타임상시험서남성형탈모효과입증6↑,http://moneys.mt.co.kr/news/mwView.php?no=2020112513538082382
10383,2020-11-25,대웅제약나보타남성형탈모에효과입증모발개수유의하게증가”,http://www.mdtoday.co.kr/mdtoday/index.html?no=406937
10384,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과나타나,http://www.economytalk.kr/news/articleView.html?idxno=209549
10385,2020-11-25,오후거래급증주점검대웅거래량↑그외종목은,http://www.itooza.com/common/iview.php?no=2020112513355800204
10386,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=444186
10387,2020-11-25,특징주대웅제약보톡스나보타탈모효과에강세,http://news.heraldcorp.com/view.php?ud=20201125000875
10388,2020-11-25,대웅제약나보타남성형탈모에효과입증,http://www.edaily.co.kr/news/newspath.asp?newsid=03234086625969328
10389,2020-11-25,대웅제약보툴리눔톡신나보타남성형탈모효과확인,http://www.mediapen.com/news/view/577678
10390,2020-11-25,나보타보톡스가탈모에효과대웅제약주가↑,http://www.smartfn.co.kr/view.php?ud=202011251353367618d3eee0def8_46
10391,2020-11-25,대웅제약나보타남성형탈모개선효과확인,http://www.koreastocknews.com/news/articleView.html?idxno=59217
10392,2020-11-25,특징주대웅제약보툴리눔톡신나보타탈모효과에강세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004187609
10393,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.lcnews.co.kr/news/articleView.html?idxno=10172
10394,2020-11-25,대웅제약나보타임상1상서남성형탈모치료효과입증,http://weekly.hankooki.com/lpage/life/202011/wk20201125151426147610.htm?s_ref=nv
10395,2020-11-25,대웅제약나보타임상시험에서남성형탈모효과입증,http://www.thepublic.kr/news/newsview.php?ncode=1065590653261782
10396,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202011250295&t=NN
10397,2020-11-25,대웅제약나보타효과안전성확인하는임상시험서남성형탈모치료효과확인,http://www.segye.com/content/html/2020/11/25/20201125516873.html?OutUrl=naver
10398,2020-11-25,대웅제약나보타임상시험서남성형탈모에효과입증,http://www.thedailypost.kr/news/articleView.html?idxno=77695
10399,2020-11-25,오픈콜라보레이션확대하는대웅제약스핀아웃통한신약개발박차,http://www.updownnews.co.kr/news/articleView.html?idxno=225652
10400,2020-11-25,대웅제약보톡스나보타임상시험서남성형탈모치료효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=506419
10401,2020-11-25,기로선대웅제약메디톡스자구책마련사활,http://www.sporbiz.co.kr/news/articleView.html?idxno=502684
10402,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=66672
10403,2020-11-25,대웅제약나보타임상시험에서남성형탈모에효과입증,https://www.asiatoday.co.kr/view.php?key=20201125010016716
10404,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.whosaeng.com/122756
10405,2020-11-25,대웅제약나보타임상시험에서남성형탈모효과입증,http://www.g-enews.com/ko-kr/news/article/news_all/20201125161454334969d76442fa_1/article.html
10406,2020-11-25,의약오늘심기남이대서울병원교수대한소화기내시경연구재단우수논문상수상대웅제약나보타남성형탈모임상시험결과美학술지게재,http://www.sisaon.co.kr/news/articleView.html?idxno=120842
10407,2020-11-25,대웅제약신규보툴리눔균주입고완료ITC결정뒤집어,http://www.thedailypost.kr/news/articleView.html?idxno=77698
10408,2020-11-25,대웅제약나보타임상시험서남성형탈모치료효과확인,http://www.ajunews.com/view/20201125160130665
10409,2020-11-25,대웅제약나보타임상시험서남성형탈모효과,http://www.100ssd.co.kr/news/articleView.html?idxno=72964
10410,2020-11-25,대웅제약나보타남성형탈모개선에효과보여,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005033
10411,2020-11-25,바이든이쥔칼날전운감도는대웅메디톡스LG화학SK이노,http://www.newsprime.co.kr/news/article.html?no=525341
10412,2020-11-25,보톡스가탈모치료제로대웅제약나보타남성탈모증상개선효과입증,https://www.donga.com/news/article/all/20201125/104148918/1
10413,2020-11-25,대웅제약나보타남성형탈모효과입증,http://www.anewsa.com/detail.php?number=2288467&thread=10
10414,2020-11-26,빅히트신풍제약다시상승랠리시동거나코스피200지누스키움증권대웅등새로편입주목,http://www.pinpointnews.co.kr/view.php?ud=202011260715083142861beb2d9d_45
10415,2020-11-26,대웅제약내달ITC소송결과에따라주가향방갈릴전망,https://www.asiatoday.co.kr/view.php?key=20201126010016884
10416,2020-11-26,대웅제약ITC최종결론앞두고있어서그결과가중요”,https://www.news2day.co.kr/article/20201126500027
10417,2020-11-26,STOCK대웅제약ICT소송결과에주목승소시주가상향,http://moneys.mt.co.kr/news/mwView.php?no=2020112608458086856
10418,2020-11-26,대웅제약내달ITC최종결론이후접근권고키움증권,https://www.etoday.co.kr/news/view/1966933
10419,2020-11-26,대웅제약4분기실적회복ITC이슈에주가출렁일것”,https://www.hankyung.com/it/article/202011262843i
10420,2020-11-26,대웅제약주식매수의견제시균주소송의최종결과확인뒤투자,http://www.businesspost.co.kr/BP?command=article_view&num=206058
10421,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.sentv.co.kr/news/view/583594
10422,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급맞손,http://www.viva100.com/main/view.php?key=20201126010006533
10423,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251847
10424,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,https://www.fetv.co.kr/news/article.html?no=69554
10425,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.lawissue.co.kr/view.php?ud=202011260922309274204ead0791_12
10426,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약,http://www.newspim.com/news/view/20201126000218
10427,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.press9.kr/news/articleView.html?idxno=46405
10428,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020112609193124086
10429,2020-11-26,대웅제약글로벌시장에시선바이오의코로나19진단키트판매키로,http://news.mk.co.kr/newsRead.php?no=1216517&year=2020
10430,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.youthdaily.co.kr/news/article.html?no=54185
10431,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64803
10432,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://newsclaim.co.kr/View.aspx?No=1357963
10433,2020-11-26,대웅제약시선바이오코로나진단키트해외공급계약,http://www.newsis.com/view/?id=NISX20201126_0001247894&cID=13001&pID=13000
10434,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급나서,http://medipana.com/news/news_viewer.asp?NewsNum=266444&MainKind=A&NewsKind=5&vCount=12&vKind=1
10435,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://www.asiatoday.co.kr/view.php?key=20201126010016970
10436,2020-11-26,대웅제약시선바이오와코로나신속진단키트6종글로벌판매계약,http://www.medisobizanews.com/news/articleView.html?idxno=74467
10437,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://inthenews.co.kr/article-79196/
10438,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매맡는다,https://www.etoday.co.kr/news/view/1966988
10439,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://www.ekn.kr/web/view.php?key=20201126010006303
10440,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011260932369830797
10441,2020-11-26,대웅제약시선바이오코로나19진단키트해외판매계약,https://www.hankyung.com/it/article/202011263164i
10442,2020-11-26,대웅제약코로나19원스톱진단플랫폼글로벌판매개시,http://weekly.hankooki.com/lpage/economy/202011/wk20201126094511146380.htm?s_ref=nv
10443,2020-11-26,대웅제약시선바이오코로나진단키트6종해외공급계약,http://sports.hankooki.com/lpage/economy/202011/sp20201126094220137020.htm?s_ref=nv
10444,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.dailysmart.co.kr/news/articleView.html?idxno=36356
10445,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.newsworker.co.kr/news/articleView.html?idxno=93392
10446,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약체결,http://www.ezyeconomy.com/news/articleView.html?idxno=107419
10447,2020-11-26,특징주대웅제약소송비용감소수익성회복,http://www.sisaon.co.kr/news/articleView.html?idxno=120871
10448,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://yna.kr/AKR20201126056500017?did=1195m
10449,2020-11-26,대웅제약시선바이오코로나19진단키트판매계약체결,http://www.monews.co.kr/news/articleView.html?idxno=215805
10450,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=20354
10451,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.segye.com/content/html/2020/11/26/20201126508201.html?OutUrl=naver
10452,2020-11-26,대웅제약시선바이오코로나진단키트글로벌판매계약,http://www.koreastocknews.com/news/articleView.html?idxno=59255
10453,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급계약,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572142848875
10454,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.fnnews.com/news/202011260956558755
10455,2020-11-26,대웅제약코로나19진단키트6종해외판매나선다,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4353134
10456,2020-11-26,대웅제약시선바이오코로나19 진단키트 6종 해외공급계약체결,http://www.greened.kr/news/articleView.html?idxno=277477
10457,2020-11-26,대웅제약시선바이오코로나진단키트해외공급계약,https://www.ebn.co.kr/news/view/1461007/?sc=Naver
10458,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.mhj21.com/137112
10459,2020-11-26,원스톱진단플랫폼대웅제약시선바이오와코로나19진단키트6종해외공급계약,http://theviewers.co.kr/View.aspx?No=1358042
10460,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.thebigdata.co.kr/view.php?ud=20201126094624229d0a8833aad_23
10461,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.kpinews.co.kr/news/articleView.html?idxno=131643
10462,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=407027
10463,2020-11-26,대웅제약코로나19진단키트6종해외공급계약,http://www.bosa.co.kr/news/articleView.html?idxno=2138867
10464,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2020112610205750341
10465,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://newsbrite.net/143983
10466,2020-11-26,대웅제약시선바이오코로나19진단키트6종글로벌공급계약,http://www.lcnews.co.kr/news/articleView.html?idxno=10204
10467,2020-11-26,대웅제약연이은구설수성차별채용공고보톡스로비의혹등논란,http://sports.chosun.com/news/ntype.htm?id=202011270100245120016440&servicedate=20201126
10468,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급,http://www.newsprime.co.kr/news/article.html?no=525416
10469,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약체결,http://www.m-i.kr/news/articleView.html?idxno=769207
10470,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.newslock.co.kr/news/articleView.html?idxno=33311
10471,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.seoulfn.com/news/articleView.html?idxno=402315
10472,2020-11-26,대웅제약시선바이오코로나진단키트6종해외판매계약,http://news.mt.co.kr/mtview.php?no=2020112609470967306
10473,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.insightkorea.co.kr/news/articleView.html?idxno=84850
10474,2020-11-26,대웅시선바이오코로나19진단글로벌판매계약,http://www.biospectator.com/view/news_view.php?varAtcId=11893
10475,2020-11-26,대웅제약시선바이오와코로나19PCR진단키트6종글로벌판매계약체결,http://www.marketnews.co.kr/news/articleView.html?idxno=56078
10476,2020-11-26,대웅제약시선바이오진단키트6종해외공급계약,http://www.asiaa.co.kr/news/articleView.html?idxno=8424
10477,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,https://www.sedaily.com/NewsView/1ZAK38GAEK
10478,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급,http://www.newstomato.com/ReadNews.aspx?no=1009208
10479,2020-11-26,대웅제약자체개발보톡스나보타중국서임상3상본격추진,https://www.asiatoday.co.kr/view.php?key=20201126010017306
10480,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약체결,https://www.news2day.co.kr/article/20201126500173
10481,2020-11-26,대웅제약나보타남성형탈모에효과,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137131
10482,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.koreaittimes.com/news/articleView.html?idxno=102075
10483,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.metroseoul.co.kr/article/20201126500255
10484,2020-11-26,대웅제약시선바이오진단키트6종글로벌판권확보,https://health.chosun.com/site/data/html_dir/2020/11/26/2020112601601.html
10485,2020-11-26,대웅제약시선바이오코로나19진단키트판매계약,http://www.dailymedi.com/detail.php?number=863229&thread=22r05
10486,2020-11-26,대웅제약시선바이오머티리얼스의코로나19진단기기해외판매추진,http://www.businesspost.co.kr/BP?command=article_view&num=206105
10487,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.dt.co.kr/contents.html?article_no=2020112602109931102002&ref=naver
10488,2020-11-26,대웅제약시선바이오코로나진단키트6종해외공급계약,http://daily.hankooki.com/lpage/industry/202011/dh20201126141033148390.htm?s_ref=nv
10489,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=444592
10490,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.medigatenews.com/news/1392953050
10491,2020-11-26,대웅제약코로나19진단키트6종해외공급계약체결,http://www.ajunews.com/view/20201126141801234
10492,2020-11-26,대웅제약시선바이오진단키트6종해외공급계약,http://www.bokuennews.com/news/article.html?no=197777
10493,2020-11-26,대웅제약해외에코로나19진단키트공급,http://www.finomy.com/news/articleView.html?idxno=85864
10494,2020-11-26,대웅제약시선바이오코로나진단키트6종글로벌판권확보,http://www.mediapen.com/news/view/578067
10495,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약,http://www.thedailypost.kr/news/articleView.html?idxno=77729
10496,2020-11-26,대웅제약시선바이오코로나진단키트해외공급계약30분안에진단가능,https://www.econovill.com/news/articleView.html?idxno=507194
10497,2020-11-26,대웅제약시선바이오코로나19진단키트해외공급계약체결,https://www.dailian.co.kr/news/view/940525/?sc=Naver
10498,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결토탈솔루션공급체계확립,http://www.paxetv.com/news/articleView.html?idxno=105199
10499,2020-11-26,대웅제약올로스타우수한효과및독보적인기술력주목,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64821
10500,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.edaily.co.kr/news/newspath.asp?newsid=03890086625969656
10501,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외판매,http://www.fntoday.co.kr/news/articleView.html?idxno=241594
10502,2020-11-26,보톡스분쟁ITC최종판결연기대웅제약에호재,http://www.sisaweek.com/news/articleView.html?idxno=139577
10503,2020-11-26,시선바이오대웅제약과코로나19진단키트6종해외판매계약,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004189029
10504,2020-11-26,대웅올로스타효과와기술력에주목,http://www.monews.co.kr/news/articleView.html?idxno=215829
10505,2020-11-26,대웅제약호이스타정코로나19치료데드라인은6시간,http://www.thevaluenews.co.kr/news/view.php?idx=161633
10506,2020-11-26,대웅제약시선바이오코로나진단키트6종해외공급계약30분만에감염여부확인가능,http://www.anewsa.com/detail.php?number=2289275&thread=10
10507,2020-11-26,대웅제약시선바이오와코로나19진단키트6종해외공급계약,https://www.donga.com/news/article/all/20201126/104168086/1
10508,2020-11-26,김창수의e뉴스브리핑대웅제약시선바이오코로나19진단키트6종해외공급계약外,https://www.fetv.co.kr/news/article.html?no=69660
10509,2020-11-26,대웅제약코로나19진단키트6종글로벌공급,http://www.shinailbo.co.kr/news/articleView.html?idxno=1347767
10510,2020-11-26,전승호대웅제약신약개발역량강화해해외시장공략매달려,http://www.businesspost.co.kr/BP?command=article_view&num=206196
10511,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급계약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=66780
10512,2020-11-26,대웅제약나보타소송비용감소긍정신호ITC결론지켜봐야,https://www.econovill.com/news/articleView.html?idxno=507258
10513,2020-11-26,대웅제약시선바이오코로나19진단키트6종해외공급,http://news.kbiz.or.kr/news/articleView.html?idxno=75090
10514,2020-11-27,대웅제약시선바이오코로나19진단키트6종해외공급계약,https://www.kpanews.co.kr/article/show.asp?idx=218038&category=D
10515,2020-11-27,대웅제약코로나19진단키트해외수출나선다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005067
10516,2020-11-27,LG화학한샘대웅제약대학생인재선점겨울인턴모집,http://www.shinailbo.co.kr/news/articleView.html?idxno=1347876
10517,2020-11-27,대웅제약우루사온라인바이럴영상공개,http://www.press9.kr/news/articleView.html?idxno=46417
10518,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64840
10519,2020-11-27,간때문이야로MZ세대어필”대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.fetv.co.kr/news/article.html?no=69704
10520,2020-11-27,대웅제약우루사간때문이야MZ세대시선스틸,http://www.medisobizanews.com/news/articleView.html?idxno=74505
10521,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://medipana.com/news/news_viewer.asp?NewsNum=267516&MainKind=A&NewsKind=5&vCount=12&vKind=1
10522,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.youthdaily.co.kr/news/article.html?no=54329
10523,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.pharmnews.com/news/articleView.html?idxno=101780
10524,2020-11-27,LG화학예금보험公대웅제약한샘유한킴벌리등대학생대졸인턴모집,https://www.news1.kr/articles/?4132248
10525,2020-11-27,대웅제약우루사온라인바이럴영상공개가수노라조간과알약으로변신해큰웃음선사,http://www.anewsa.com/detail.php?number=2289791&thread=10
10526,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.kpinews.co.kr/news/articleView.html?idxno=131747
10527,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.healthinnews.co.kr/news/articleView.html?idxno=20394
10528,2020-11-27,대웅제약우루사노라조온라인바이럴영상∙틱톡챌린지공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=251899
10529,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.bosa.co.kr/news/articleView.html?idxno=2138950
10530,2020-11-27,대웅제약간때문이야로MZ세대사로잡는다,http://www.newsis.com/view/?id=NISX20201127_0001249688&cID=13001&pID=13000
10531,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개간때문이야로MZ세대사로잡는다”,http://newsbrite.net/144059
10532,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개가수노라조와협업,http://www.pinpointnews.co.kr/view.php?ud=2020112710475381232365609d9b_45
10533,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.lcnews.co.kr/news/articleView.html?idxno=10252
10534,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202011271102164110154
10535,2020-11-27,간때문이야대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://theviewers.co.kr/View.aspx?No=1360053
10536,2020-11-27,대웅제약간때문이야MZ세대사로잡는다,https://www.econovill.com/news/articleView.html?idxno=507358
10537,2020-11-27,영상대웅제약간때문이야로MZ세대사로잡는다,http://www.segye.com/content/html/2020/11/27/20201127509369.html?OutUrl=naver
10538,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개간때문이야로MZ세대사로잡는다,http://www.worktoday.co.kr/news/articleView.html?idxno=11824
10539,2020-11-27,뉴스투데이L대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.news2day.co.kr/article/20201127500160
10540,2020-11-27,대웅제약우루사온라인바이럴영상공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065579036817744
10541,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=407204
10542,2020-11-27,대웅제약나보타중국시장진출가시화글로벌영역확장,http://www.lawissue.co.kr/view.php?ud=202011271247137773204ead0791_12
10543,2020-11-27,대웅제약우루사간때문이야댄스챌린지통해MZ세대공략한다,https://www.asiatoday.co.kr/view.php?key=20201127010017963
10544,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개간때문이야로MZ세대사로잡는다,http://www.nbnnews.co.kr/news/articleView.html?idxno=444933
10545,2020-11-27,시경Today건강대웅제약나보타중국시장진출가시화外,http://www.meconomynews.com/news/articleView.html?idxno=47860
10546,2020-11-27,속도강조하는대웅제약호이스타정임상모집선두맞나,http://www.thevaluenews.co.kr/news/view.php?idx=161650
10547,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.newsworker.co.kr/news/articleView.html?idxno=93593
10548,2020-11-27,대웅제약우루사바이럴영상틱톡챌린지공개,https://www.ebn.co.kr/news/view/1461298/?sc=Naver
10549,2020-11-27,대웅제약우루사온라인바이럴영상공개,https://jhealthmedia.joins.com/article/article_view.asp?pno=22765
10550,2020-11-27,종근당1조클럽예약한미대웅가시권,https://www.ebn.co.kr/news/view/1461296/?sc=Naver
10551,2020-11-27,MZ세대사로잡는다대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.updownnews.co.kr/news/articleView.html?idxno=225731
10552,2020-11-27,대웅제약우루사온라인바이럴영상틱톡챌린지공개,http://www.metroseoul.co.kr/article/20201127500105
10553,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.pressm.kr/news/articleView.html?idxno=34841
10554,2020-11-27,대웅제약우루사온라인바이럴영상∙틱톡챌린지공개,http://www.thefirstmedia.net/news/articleView.html?idxno=66838
10555,2020-11-27,대웅제약간때문이야댄스챌린지틱톡서진행,http://www.100ssd.co.kr/news/articleView.html?idxno=73057
10556,2020-11-27,대웅제약우루사바이럴영상∙틱톡챌린지공개,http://www.thedailypost.kr/news/articleView.html?idxno=77769
10557,2020-11-28,대웅제약우루사온라인바이럴영상틱톡챌린지공개,https://www.kpanews.co.kr/article/show.asp?idx=218068&category=D
10558,2020-11-28,대웅제약틱톡서간때문이야댄스챌린지진행MZ세대공략,http://www.updownnews.co.kr/news/articleView.html?idxno=225746
10559,2020-11-29,SK이노베이션대웅제약워라밸기업으로우뚝뭐가달랐나,http://www.segyebiz.com/newsView/20201129509408?OutUrl=naver
10560,2020-11-29,대웅제약나보타임상시험서남성형탈모치료효과입증,http://www.sportsseoul.com/news/read/985905?ref=naver
10561,2020-11-29,대웅제약가수노라조와우루사영상제작,http://www.dailymedi.com/detail.php?number=863321&thread=22r05
10562,2020-11-30,GC녹십자가동률645대제약사중꼴찌대웅제약종근당은110대,http://www.consumernews.co.kr/news/articleView.html?idxno=616333
10563,2020-11-30,대웅제약OTC비만약위드풀공동판매계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=271034&REFERER=NP
10564,2020-11-30,대웅코로나치료제개발총력내년상용화기대,http://www.dailypharm.com/Users/News/NewsView.html?ID=271022&REFERER=NP
10565,2020-11-30,대웅제약12월16일ICT결론이나오면불확실성해소가될듯”,https://www.news2day.co.kr/article/20201130500220
10566,2020-11-30,대웅제약새살연고후시딘마데카솔틈바구니속5년간매출13배증가비결은,http://www.ajunews.com/view/20201130152839996
10567,2020-11-30,인터뷰전승호대웅제약대표ITC최종승소확신끝까지싸워진실밝힐것,http://www.wolyo.co.kr/news/articleView.html?idxno=112555
10568,2020-11-30,대웅제약ITC소송장기화에재정악화순이익률1대PER은363배,http://www.thevaluenews.co.kr/news/view.php?idx=161675
10569,2020-11-30,대웅제약체중감량보조제위드풀공동판매계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=407448
10570,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.fnnews.com/news/202012010947347211
10571,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.fetv.co.kr/news/article.html?no=69986
10572,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.sentv.co.kr/news/view/583870
10573,2020-12-01,대웅제약코로나19올인원치료제DWRX2003정부과제선정,http://www.mhj21.com/137248
10574,2020-12-01,대웅제약코로나치료제정부임상지원과제로최종선정,http://news.mt.co.kr/mtview.php?no=2020120109513899338
10575,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.thebigdata.co.kr/view.php?ud=202012010956092380798818e98b_23
10576,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64902
10577,2020-12-01,대웅제약코로나19치료제정부과제선정내년출시예정,https://www.ekn.kr/web/view.php?key=20201201010000087
10578,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120109493917447
10579,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46446
10580,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46446
10581,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=36606
10582,2020-12-01,대웅제약코로나치료제DWRX2003정부과제선정,https://view.asiae.co.kr/article/2020120110035548543
10583,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정돼”,http://www.youthdaily.co.kr/news/article.html?no=54621
10584,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.hankyung.com/it/article/202012019304i
10585,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.m-i.kr/news/articleView.html?idxno=770821
10586,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=55991
10587,2020-12-01,대웅제약코로나19치료제DWRX2003정부지원과제로선정,http://www.pinpointnews.co.kr/view.php?ud=2020120110031445392365609d9b_45
10588,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020120110015724275
10589,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574635413876
10590,2020-12-01,대웅제약코로나19치료제정부임상지원과제로선정,http://inthenews.co.kr/article-79932/
10591,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.lawissue.co.kr/view.php?ud=202012011012101966204ead0791_12
10592,2020-12-01,특징주대웅대웅제약코로나치료제정부과제선정소식에20급등,https://www.sedaily.com/NewsView/1ZBIJEP6YA
10593,2020-12-01,대웅코로나19치료제DWRX2003정부과제선정,http://www.whosaeng.com/122899
10594,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정내년출시목표,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124104
10595,2020-12-01,政대웅코로나19치료제DWRX2003임상지원확정,http://www.dailymedi.com/detail.php?number=863393&thread=22r05
10596,2020-12-01,대웅제약코로나치료제정부임상지원받아합성의약품중유일,http://moneys.mt.co.kr/news/mwView.php?no=2020120110148068480
10597,2020-12-01,대웅제약코로나19치료제정부과제선정,http://it.chosun.com/site/data/html_dir/2020/12/01/2020120100877.html
10598,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.edaily.co.kr/news/newspath.asp?newsid=02273046625994256
10599,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://daily.hankooki.com/lpage/industry/202012/dh20201201101604148390.htm?s_ref=nv
10600,2020-12-01,특징주대웅제약코로나19치료제정부임상지원사업과제선정에상승세,https://www.etoday.co.kr/news/view/1968740
10601,2020-12-01,대웅제약올인원코로나치료제니클로마사이드정부과제선정,http://www.opinionnews.co.kr/news/articleView.html?idxno=43554
10602,2020-12-01,대웅코로나19치료제정부과제선정임상비용50억지원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=96745
10603,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.newsfc.co.kr/news/articleView.html?idxno=43757
10604,2020-12-01,대웅제약코로나19치료제정부과제선정내년조건부허가추진,https://www.etoday.co.kr/news/view/1968744
10605,2020-12-01,대웅제약니클로사마이드코로나치료제로정부임상지원과제선정,http://www.medisobizanews.com/news/articleView.html?idxno=74597
10606,2020-12-01,대웅제약니클로사마이드코로나19정부과제선정,http://www.biospectator.com/view/news_view.php?varAtcId=11926
10607,2020-12-01,대웅제약코로나19DWRX2003정부과제선정,http://www.wikileaks-kr.org/news/articleView.html?idxno=99478
10608,2020-12-01,특징주대웅제약대웅주가정부코로나치료제임상지원사업선정에가파른상승세,http://www.ccreview.co.kr/news/articleView.html?idxno=296802
10609,2020-12-01,대웅제약코로나19치료제정부과제선정임상50억지원,http://www.ajunews.com/view/20201201102527464
10610,2020-12-01,특징주대웅제약코로나치료제정부임상지원에껑충,http://moneys.mt.co.kr/news/mwView.php?no=2020120110378066978
10611,2020-12-01,대웅제약의DWRX2003코로나19치료제정부과제선정,http://www.monews.co.kr/news/articleView.html?idxno=215962
10612,2020-12-01,대웅제약코로나19치료제정부과제최종선정합성의약품유일,http://www.sisafocus.co.kr/news/articleView.html?idxno=251469
10613,2020-12-01,대웅제약코로나19치료제임상청신호DWRX2003정부과제선정,http://www.viva100.com/main/view.php?key=20201201010000110
10614,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.kpinews.co.kr/news/articleView.html?idxno=131945
10615,2020-12-01,특징주대웅제약코로나19치료제정부임상지원사업과제선정에급등,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004193532
10616,2020-12-01,대웅제약코로나19 치료제정부과제최종선정합성의약품중유일,http://www.greened.kr/news/articleView.html?idxno=278007
10617,2020-12-01,대웅제약코로나19치료제니클로사마이드정부과제선정,http://www.newsprime.co.kr/news/article.html?no=525917
10618,2020-12-01,1일장중코로나주종근당바이오대웅제약파미셀급등,http://www.choicenews.co.kr/news/articleView.html?idxno=76872
10619,2020-12-01,대웅제약코로나치료제정부과제선정,https://www.ebn.co.kr/news/view/1461778/?sc=Naver
10620,2020-12-01,대웅제약코로나19치료제정부과제선정50억원지원,https://health.chosun.com/site/data/html_dir/2020/12/01/2020120101013.html
10621,2020-12-01,특징주대웅제약코로나치료제정부과제선정소식에급등,https://www.ebn.co.kr/news/view/1461779/?sc=Naver
10622,2020-12-01,국내및글로벌임상시험50억원지원대웅제약코로나19치료제DWRX2003정부과제선정,http://www.betanews.net:8080/article/1243157.html
10623,2020-12-01,대웅제약신풍제약오전갑작스런급등대웅제약11급등이어신풍제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=146910
10624,2020-12-01,대웅제약개발중코로나19치료제정부과제선정,http://yna.kr/AKR20201201080700017?did=1195m
10625,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.seoulwire.com/news/articleView.html?idxno=430849
10626,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://kormedi.com/?p=1328374
10627,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.asiaa.co.kr/news/articleView.html?idxno=9235
10628,2020-12-01,대웅제약코로나19치료제정부과제선정내년출시목표,http://www.anewsa.com/detail.php?number=2292714&thread=10
10629,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://newsbrite.net/144215
10630,2020-12-01,대웅제약개발중코로나19치료제정부과제선정,http://www.startuptoday.co.kr/news/articleView.html?idxno=62714
10631,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=407509
10632,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.thepublic.kr/news/newsview.php?ncode=1065577458348898
10633,2020-12-01,대웅제약나보타글로벌보툴리눔톡신치료시장진출가속,http://www.koreaittimes.com/news/articleView.html?idxno=102160
10634,2020-12-01,특징주대웅대웅제약코로나치료제임상지원에훨훨,http://moneys.mt.co.kr/news/mwView.php?no=2020120111178028439
10635,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://medipana.com/news/news_viewer.asp?NewsNum=267697&MainKind=A&NewsKind=5&vCount=12&vKind=1
10636,2020-12-01,대웅제약코로나치료제로개발중인DWRX2003정부임상지원사업과제로최종선정,http://www.segye.com/content/html/2020/12/01/20201201511291.html?OutUrl=naver
10637,2020-12-01,대웅제약메디톡스보톡스전쟁진행형도용이슈도마위,http://www.enewstoday.co.kr/news/articleView.html?idxno=1432307
10638,2020-12-01,대웅제약대웅주가초반뛰어코로나19치료제개발에정부지원받아,http://www.businesspost.co.kr/BP?command=article_view&num=206734
10639,2020-12-01,대웅제약코로나19치료제정부과제선정50억원지원,http://www.insightkorea.co.kr/news/articleView.html?idxno=84998
10640,2020-12-01,대웅제약코로나치료제정부과제선정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137412&REFERER=NP
10641,2020-12-01,대웅제약코로나19치료제정부임상지원대상선정,https://biz.chosun.com/site/data/html_dir/2020/12/01/2020120101199.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10642,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2139169
10643,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.newsworker.co.kr/news/articleView.html?idxno=93906
10644,2020-12-01,대웅제약등국내제약사코로나19치료제개발잰걸음,http://newsclaim.co.kr/View.aspx?No=1363923
10645,2020-12-01,대웅제약코로나19치료제임상예산50억지원받아,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005179
10646,2020-12-01,코스피장중상승코스닥약보합KG동부제철대웅자비스급등,http://www.businesspost.co.kr/BP?command=article_view&num=206753
10647,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=20478
10648,2020-12-01,대웅제약코로나19치료제니클로사마이드정부과제선정,http://www.seoulfn.com/news/articleView.html?idxno=402833
10649,2020-12-01,대웅지사제스멕타결별대비제네릭품목허가,http://www.dailypharm.com/Users/News/NewsView.html?ID=271078&REFERER=NP
10650,2020-12-01,대웅메톡균주싸움ITC연기돼도대웅에유리,http://www.dailypharm.com/Users/News/NewsView.html?ID=271085&REFERER=NP
10651,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정50억지원,http://www.medigatenews.com/news/2605800247
10652,2020-12-01,대웅제약코로나19치료제정부과제선정50억지원,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4357828
10653,2020-12-01,대웅제약코로나19 올인원치료제 니클로사마이드DWRX2003정부과제선정,http://www.lcnews.co.kr/news/articleView.html?idxno=10371
10654,2020-12-01,대웅제약대웅오전부터갑작스런급등대웅제약13급등이어대웅23급등,http://www.econonews.co.kr/news/articleView.html?idxno=146951
10655,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.dailian.co.kr/news/view/941829/?sc=Naver
10656,2020-12-01,대웅제약코로나19치료제정부과제선정50억원지원,http://news.tf.co.kr/read/economy/1828234.htm
10657,2020-12-01,코로나19백신치료제제품출시코앞모더나대웅제약의현상황은,http://weekly.hankooki.com/lpage/economy/202012/wk20201201134915146380.htm?s_ref=nv
10658,2020-12-01,대웅제약코로나19치료후보물질DWRX2003정부과제선정,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012010265&t=NN
10659,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.segyebiz.com/newsView/20201201514507?OutUrl=naver
10660,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제로선정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012011121564690798
10661,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.metroseoul.co.kr/article/20201201500332
10662,2020-12-01,대웅제약올인원코로나19치료제정부로부터가치인정임상지원과제최종선정,https://www.donga.com/news/article/all/20201201/104232245/1
10663,2020-12-01,대웅제약코로나임상정부지원사업선정으로개발빨라질듯,http://www.polinews.co.kr/news/article.html?no=480048
10664,2020-12-01,신풍제약대웅제약제약주내내급등이어져특히신풍제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=146961
10665,2020-12-01,대웅제약코로나19치료제정부과제선정50억지원,http://www.newsis.com/view/?id=NISX20201201_0001253921&cID=13001&pID=13000
10666,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.whitepaper.co.kr/news/articleView.html?idxno=199323
10667,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.news2day.co.kr/article/20201201500186
10668,2020-12-01,대웅제약지사제스멕타제네릭스타빅품목허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=407557
10669,2020-12-01,대웅제약코로나19치료후보물질로정부의임상지원대상에뽑혀,http://www.businesspost.co.kr/BP?command=article_view&num=206765
10670,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=445879
10671,2020-12-01,대웅제약코로나치료제정부임상지원대상선정,https://www.sedaily.com/NewsView/1ZBIK0I3C5
10672,2020-12-01,대웅제약코로나19치료제정부과제선정,http://www.mediapen.com/news/view/579499
10673,2020-12-01,대웅제약코로나19치료제정부과제로선정50억원지원,http://www.thedailypost.kr/news/articleView.html?idxno=77834
10674,2020-12-01,특징주대웅제약주가7상승코로나19치료제정부임상지원대상선정,http://www.anewsa.com/detail.php?number=2292974&thread=18
10675,2020-12-01,대웅제약코로나19치료제DWRX2003정부임상과제선정,http://www.newslock.co.kr/news/articleView.html?idxno=33560
10676,2020-12-01,의약오늘GC녹십자코로나19혈장치료제3차추가생산완료대웅제약코로나19치료제DWRX2003정부과제선정,http://www.sisaon.co.kr/news/articleView.html?idxno=121103
10677,2020-12-01,대웅제약코로나19치료제정부임상지원사업과제로선정50억지원,http://www.newsworks.co.kr/news/articleView.html?idxno=508108
10678,2020-12-01,코로나19올인원치료제대웅제약DWRX2003정부과제선정,http://theviewers.co.kr/View.aspx?No=1364477
10679,2020-12-01,이데일리N대웅제약개발중코로나19치료제정부과제선정外,http://www.edaily.co.kr/news/newspath.asp?newsid=03706406625994256
10680,2020-12-01,대웅제약의코로나19치료후보DWRX2003프로젝트정부과제선정돼,http://news.mk.co.kr/newsRead.php?no=1235666&year=2020
10681,2020-12-01,대웅제약코로나19치료제정부과제선정에날개,http://www.sporbiz.co.kr/news/articleView.html?idxno=503183
10682,2020-12-01,대웅제약코로나19치료제임상지원대상정부과제선정,http://sports.hankooki.com/lpage/economy/202012/sp20201201154713137020.htm?s_ref=nv
10683,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.skyedaily.com/news/news_view.html?ID=117017
10684,2020-12-01,대웅제약코로나19치료제개발에정부지원받는다,http://www.finomy.com/news/articleView.html?idxno=86068
10685,2020-12-01,대웅제약니클로사마이드코로나19치료제정부과제선정,http://www.newstomato.com/ReadNews.aspx?no=1010205
10686,2020-12-01,1일오늘의상한가총정리경보제약대웅제약신풍제약등제약주급등문배철강KG동부제철도상한가,http://www.ccreview.co.kr/news/articleView.html?idxno=296851
10687,2020-12-01,대웅제약코로나19치료제정부로부터50억원지원받는다,http://www.doctorstimes.com/news/articleView.html?idxno=213257
10688,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,https://www.econovill.com/news/articleView.html?idxno=507951
10689,2020-12-01,대웅제약코로나19치료제정부임상지원사업선정,http://www.100ssd.co.kr/news/articleView.html?idxno=73110
10690,2020-12-01,대웅제약ITC판결앞두고코로나치료제호재에활짝상승세이어질까,http://www.opinionnews.co.kr/news/articleView.html?idxno=43585
10691,2020-12-01,대웅제약코로나19치료제정부지원사업대상선정임상비용중50억지원,http://www.kdpress.co.kr/news/articleView.html?idxno=99057
10692,2020-12-01,대웅제약코로나19치료제정부임상지원사업대상선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1432665
10693,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제로선정,http://news.kbiz.or.kr/news/articleView.html?idxno=75266
10694,2020-12-01,대웅제약코로나19치료제DWRX2003정부과제선정,http://www.thefirstmedia.net/news/articleView.html?idxno=66997
10695,2020-12-02,대웅제약코로나19치료제DWRX2003정부과제뽑혀,https://www.kpanews.co.kr/article/show.asp?idx=218155&category=D
10696,2020-12-02,대웅제약코로나19치료제DWRX2003정부과제뽑혀,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137192
10697,2020-12-02,SK하이닉스엔씨소프트기관과외인매수급등KB금융SK케미칼매도신풍제약대웅경보제약훨훨,http://www.pinpointnews.co.kr/view.php?ud=202012020651037934cd1e7f0bdf_45
10698,2020-12-02,대웅제약코로나19치료제DWRX2003정부과제선정임상비용50억지원,http://www.paxetv.com/news/articleView.html?idxno=105536
10699,2020-12-02,대웅제약코로나19치료제정부과제선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1349580
10700,2020-12-02,대웅제약DWRX2003올인원코로나19치료제기대감↑정부과제로선정,http://kbench.com/?q=node/216400
10701,2020-12-02,2일장중코로나주신풍제약껑충vs대웅제약파미셀하락,http://www.choicenews.co.kr/news/articleView.html?idxno=76925
10702,2020-12-02,대웅제약나보타허가변경가능할까,https://www.ebn.co.kr/news/view/1462063/?sc=Naver
10703,2020-12-02,美ITC판결결과전승호대웅제약대표거취에영향줄까,http://www.sisajournal-e.com/news/articleView.html?idxno=226530
10704,2020-12-03,약사속타던스멕타대웅제네릭으로새맥잡나,https://www.kpanews.co.kr/article/show.asp?idx=218151&category=D
10705,2020-12-03,대웅제약벨카이라특허남은1건도회피성공,http://www.dailypharm.com/Users/News/NewsView.html?ID=271155&REFERER=NP
10706,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=20541
10707,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120312052363520
10708,2020-12-03,대웅제약펜믹스벨카이라마지막특허까지올클리어,http://medipana.com/news/news_viewer.asp?NewsNum=267844&MainKind=A&NewsKind=5&vCount=12&vKind=1
10709,2020-12-03,대웅제약코로나치료제효과학인국내2상신청,https://www.ebn.co.kr/news/view/1462266/?sc=Naver
10710,2020-12-03,대웅제약코로나19치료제효과입증국내2상신청,https://www.kpanews.co.kr/article/show.asp?idx=218216&category=D
10711,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.lawissue.co.kr/view.php?ud=202012031216172299204ead0791_12
10712,2020-12-03,대웅제약코로나치료제국내임상2상신청신속효과확인,https://www.fetv.co.kr/news/article.html?no=70278
10713,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://medipana.com/news/news_viewer.asp?NewsNum=267854&MainKind=A&NewsKind=5&vCount=12&vKind=1
10714,2020-12-03,대웅제약코로나19치료제임상2상신청연내환자200명임상계획,https://biz.chosun.com/site/data/html_dir/2020/12/03/2020120301443.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10715,2020-12-03,대웅제약코로나치료제2상승인신청초기폐손상억제효과,http://www.medisobizanews.com/news/articleView.html?idxno=74678
10716,2020-12-03,대웅제약식약처에코로나치료제임상2상IND신청,http://news.mt.co.kr/mtview.php?no=2020120312332819510
10717,2020-12-03,대웅제약코로나치료제신속한효과확인2상신청,http://www.newsis.com/view/?id=NISX20201203_0001256970&cID=13001&pID=13000
10718,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청신속한효과확인,http://www.thebigdata.co.kr/view.php?ud=202012031243249237798818e98b_23
10719,2020-12-03,대웅제약코로나19치료제임상2상신청신속한효과확인”,http://www.viva100.com/main/view.php?key=20201203010000862
10720,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.bosa.co.kr/news/articleView.html?idxno=2139371
10721,2020-12-03,대웅제약코로나치료제국내임상2상신청및신속한효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=407788
10722,2020-12-03,대웅제약코로나19치료제신속한효능확인임상2상신청,https://www.sedaily.com/NewsView/1ZBJHC3I52
10723,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.newsworker.co.kr/news/articleView.html?idxno=94251
10724,2020-12-03,대웅제약코로나19치료제임상2상신청,http://www.sentv.co.kr/news/view/584070
10725,2020-12-03,대웅제약코로나19치료제DWRX2003신속한효과확인임상2상신청,http://www.ezyeconomy.com/news/articleView.html?idxno=107660
10726,2020-12-03,대웅제약코로나19치료제국내임상2상신청신속효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252160
10727,2020-12-03,대웅제약코로나19치료제국내임상2상신청신속한효과확인,http://www.m-i.kr/news/articleView.html?idxno=772010
10728,2020-12-03,대웅제약코로나19치료제니클로사마이드국내임상2상신청,http://it.chosun.com/site/data/html_dir/2020/12/03/2020120301608.html
10729,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.newstomato.com/ReadNews.aspx?no=1010678
10730,2020-12-03,대웅제약코로나치료제항바이러스효과확인식약처임상2상신청,http://moneys.mt.co.kr/news/mwView.php?no=2020120313338024117
10731,2020-12-03,대웅제약니클로사마이드임상2상신청항바이러스항염증효과입증,http://www.newsprime.co.kr/news/article.html?no=526293
10732,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://yna.kr/AKR20201203102600017?did=1195m
10733,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://yna.kr/PYH20201203177200017?did=1196m
10734,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://yna.kr/PYH20201203177000017?did=1196m
10735,2020-12-03,대웅제약코로나19치료제햄스터효능시험서효과확인임상2상신청,https://www.asiatoday.co.kr/view.php?key=20201203010002480
10736,2020-12-03,대웅제약코로나19치료제국내임상2상신청연내200명대상진행,https://www.dailian.co.kr/news/view/942686/?sc=Naver
10737,2020-12-03,美국립보건원이주목하는구충제”대웅제약햄스터시험서빠르고강력한코로나19치료효과입증,https://www.donga.com/news/article/all/20201203/104272227/1
10738,2020-12-03,대웅제약코로나19치료제임상2상신청실험효과,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012030247&t=NN
10739,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청생존율개선가능성확인,http://www.newsworks.co.kr/news/articleView.html?idxno=508799
10740,2020-12-03,대웅제약코로나19햄스터모델서DWRX2003효과확인,http://www.press9.kr/news/articleView.html?idxno=46476
10741,2020-12-03,대웅제약코로나19치료제니클로사마이드국내2상신청,https://www.hankyung.com/it/article/202012039575i
10742,2020-12-03,대웅코로나치료제국내임상2상신청,http://www.whosaeng.com/122992
10743,2020-12-03,대웅제약DWRX2003코로나19치료제임상2상신청,http://www.medigatenews.com/news/1606128493
10744,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=446672
10745,2020-12-03,대웅제약코로나19치료제니클로사마이드임상2상신청,http://www.seoulfn.com/news/articleView.html?idxno=403165
10746,2020-12-03,대웅제약코로나19치료제DWRX2003효과확인국내2상신청”,http://www.youthdaily.co.kr/news/article.html?no=54880
10747,2020-12-03,대웅제약개발코로나치료제항바이러스항염증효과입증식약처임상2상시험계획신청,http://kpenews.com/View.aspx?No=1367566
10748,2020-12-03,대웅제약코로나치료제항바이러스효능확인임상2상신청,https://www.ekn.kr/web/view.php?key=20201203010000937
10749,2020-12-03,대웅제약코로나19치료제니클로사마이드2상신청,http://www.dailypharm.com/Users/News/NewsView.html?ID=271169&REFERER=NP
10750,2020-12-03,대웅제약개발중인코로나19치료제효과확인2상신청,http://daily.hankooki.com/lpage/industry/202012/dh20201203142212148390.htm?s_ref=nv
10751,2020-12-03,대웅제약코로나19치료제국내임상2상신청햄스터서효과확인,http://www.kpinews.co.kr/news/articleView.html?idxno=132162
10752,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청완료,https://www.news2day.co.kr/article/20201203500180
10753,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124212
10754,2020-12-03,대웅제약코로나치료제치료효과확인임상2상신청,http://www.newspim.com/news/view/20201203000927
10755,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://www.dailysmart.co.kr/news/articleView.html?idxno=36795
10756,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청 ,http://www.pressm.kr/news/articleView.html?idxno=34998
10757,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.edaily.co.kr/news/newspath.asp?newsid=03453846625994912
10758,2020-12-03,대웅제약코로나치료제치료효과확인임상2상신청,http://www.newsway.co.kr/news/view?tp=1&ud=2020120314511022302
10759,2020-12-03,대웅제약니클로사마이드국내코로나치료임상2상신청,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012030215&t=NN
10760,2020-12-03,대웅제약코로나치료제 국내임상2상신청,http://www.koreastocknews.com/news/articleView.html?idxno=59510
10761,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://www.dt.co.kr/contents.html?article_no=2020120302109931102002&ref=naver
10762,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청,http://www.metroseoul.co.kr/article/20201203500373
10763,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청항바이러스효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=33660
10764,2020-12-03,대웅제약코로나19치료제임상2상신청햄스터실험서효과,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4360683
10765,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및효과확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=64983
10766,2020-12-03,대웅제약코로나19치료제임상2상신청효과확인,http://www.getnews.co.kr/news/articleView.html?idxno=502955
10767,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청,https://www.etoday.co.kr/news/view/1969949
10768,2020-12-03,대웅제약코로나19치료제신속한효과확인,http://www.businesskorea.co.kr/news/articleView.html?idxno=56177
10769,2020-12-03,대웅제약코로나19치료제니클로사마이드국내2상신청항바이러스효과확인,http://kbench.com/?q=node/216464
10770,2020-12-03,대웅제약코로나19치료제국내임상2상신청신속한효과확인,https://www.econovill.com/news/articleView.html?idxno=508343
10771,2020-12-03,대웅제약코로나19치료제DWRX2003효과확인국내임상2상신청,https://www.news1.kr/articles/?4138874
10772,2020-12-03,대웅제약코로나19치료제국내임상2상신청및신속효과확인,http://www.koreaittimes.com/news/articleView.html?idxno=102227
10773,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.mediapen.com/news/view/580334
10774,2020-12-03,대웅제약햄스터효력시험확인코로나치료제임상2상신청서제출,http://isplus.live.joins.com/news/article/article.asp?total_id=23936720
10775,2020-12-03,대웅제약코로나19치료제DWRX2003임상2상신청항바이러스효과입증,https://health.chosun.com/site/data/html_dir/2020/12/03/2020120302253.html
10776,2020-12-03,코로나치료제속도붙나대웅제약국내임상2상신청,http://newsclaim.co.kr/View.aspx?No=1367830
10777,2020-12-03,대웅제약코로나19치료제니클로사마이드2상신청신속한효과확인,http://www.anewsa.com/detail.php?number=2295286&thread=10
10778,2020-12-03,대웅코로나19전임상항바이러스∙폐염증억제효과,http://www.biospectator.com/view/news_view.php?varAtcId=11964
10779,2020-12-03,대웅제약코로나19치료제햄스터효력시험통해신속한항바이러스및항염증효과입증,http://www.paxetv.com/news/articleView.html?idxno=105697
10780,2020-12-03,대웅제약코로나19치료제임상2상신청,http://www.shinailbo.co.kr/news/articleView.html?idxno=1350518
10781,2020-12-03,대웅제약코로나치료제항바이러스항염증효과입증,http://www.wolyo.co.kr/news/articleView.html?idxno=112747
10782,2020-12-03,대웅제약식약처에코로나19치료제임상2상신청,http://www.finomy.com/news/articleView.html?idxno=86199
10783,2020-12-03,대웅제약코로나치료제식약처임상2상IND신청완료,http://www.monews.co.kr/news/articleView.html?idxno=216068
10784,2020-12-03,햄스터효력시험통과대웅제약코로나19치료제후보DWRX2003효과확인,http://theviewers.co.kr/View.aspx?No=1367862
10785,2020-12-03,햄스터실험에서효과확인대웅제약코로나19치료제국내임상2상신청,http://www.betanews.net:8080/article/1243781.html
10786,2020-12-03,대웅제약코로나치료제로개발중인DWRX2003효과입증임상2상준비,http://www.segye.com/content/html/2020/12/03/20201203521382.html?OutUrl=naver
10787,2020-12-03,대웅제약코로나치료제니클로사마이드효능확인임상2상신청,http://www.sporbiz.co.kr/news/articleView.html?idxno=503429
10788,2020-12-03,김창수의e뉴스브리핑대웅제약코로나치료제국내임상2상신청신속효과확인外,https://www.fetv.co.kr/news/article.html?no=70325
10789,2020-12-03,시경Today제약대웅제약코로나치료제DWRX2003국내임상2상신청완료外,http://www.meconomynews.com/news/articleView.html?idxno=48046
10790,2020-12-03,대웅제약코로나19치료제국내임상2상신청,https://www.asiatime.co.kr/news/newsview.php?ncode=1065600394064438
10791,2020-12-03,대웅제약코로나19치료제국내임상2상신청,http://www.joseilbo.com/news/news_read.php?uid=411804&class=27&grp=
10792,2020-12-03,금일제약업계주요기사英화이자코로나19백신세계첫사용승인대웅제약코로나19치료제국내2상신청”外,http://www.youthdaily.co.kr/news/article.html?no=54899
10793,2020-12-03,특징주대웅제약주가2상승연내코로나19치료제임상2상착수,http://www.anewsa.com/detail.php?number=2295362&thread=18
10794,2020-12-03,코로나19백신보다치료제먼저셀트리온종근당대웅제약1호치료제경쟁,http://www.insightkorea.co.kr/news/articleView.html?idxno=85108
10795,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://newsbrite.net/144356
10796,2020-12-03,대웅제약코로나19치료제니클로사마이드효과입증,http://www.100ssd.co.kr/news/articleView.html?idxno=73168
10797,2020-12-03,대웅제약코로나19치료제DWRX2003임상개발성공가능성매우높아급성폐손상에효과적,http://www.lcnews.co.kr/news/articleView.html?idxno=10480
10798,2020-12-03,대웅제약코로나19치료제임상2상신청,http://www.cstimes.com/news/articleView.html?idxno=441552
10799,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청신속한효과확인,http://news.kbiz.or.kr/news/articleView.html?idxno=75327
10800,2020-12-03,대웅제약코로나19치료제DWRX2003국내임상2상신청및신속한효과확인,http://www.thefirstmedia.net/news/articleView.html?idxno=67148
10801,2020-12-04,대웅제약코로나19치료제DWRX2003국내2상임상신청완료,http://www.g-enews.com/ko-kr/news/article/news_all/20201203165819479469d76442fa_1/article.html
10802,2020-12-04,셀트리온GC녹십자이어대웅제약종근당속도,http://www.dailymedi.com/detail.php?number=863614&thread=22r05
10803,2020-12-04,초고함량비타민대웅도전장한미4제복합제탄생,http://www.dailypharm.com/Users/News/NewsView.html?ID=271175&REFERER=NP
10804,2020-12-04,대웅제약3전3승벨카이라국내후발약시장열리나,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005384
10805,2020-12-04,대웅제약펜믹스벨카이라특허장벽모두깼다,http://www.mdtoday.co.kr/mdtoday/index.html?no=407869
10806,2020-12-04,대웅제약코로나19치료제임상2상신청햄스터실험서효과”,http://www.munhwa.com/news/view.html?no=20201204MW085315313704
10807,2020-12-04,대웅제약경보제약오전부터갑작스런급등대웅제약7급등이어경보제약10급등,http://www.econonews.co.kr/news/articleView.html?idxno=147398
10808,2020-12-04,대웅제약경보제약급등코로나치료제영향,http://www.ajunews.com/view/20201204095410580
10809,2020-12-04,4일장중코로나주셀트리온대웅제약껑충vs제일약품하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77035
10810,2020-12-04,백왕기vs윤재승대웅제약50억손배청구소송17일판결선고불투명,http://www.sisajournal-e.com/news/articleView.html?idxno=226618
10811,2020-12-04,보톡스원조시장은알고있다대웅제약오르는데휴젤뒷걸음,http://news.mk.co.kr/newsRead.php?no=1250177&year=2020
10812,2020-12-06,유한양행대웅제약공동개발약물내년결실대형제약사협업물꼬,https://biz.chosun.com/site/data/html_dir/2020/12/05/2020120501096.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10813,2020-12-06,유한양행대웅제약협업성과내년위궤양신약출시,http://biz.newdaily.co.kr/site/data/html/2020/12/06/2020120600034.html
10814,2020-12-07,대웅제약과참지마요프로젝트대학생교육봉사단3기모집,http://www.metroseoul.co.kr/article/20201207500029
10815,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252236
10816,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.medisobizanews.com/news/articleView.html?idxno=74725
10817,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://medipana.com/news/news_viewer.asp?NewsNum=267951&MainKind=A&NewsKind=5&vCount=12&vKind=1
10818,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.viva100.com/main/view.php?key=20201207010001463
10819,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.youthdaily.co.kr/news/article.html?no=55132
10820,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.press9.kr/news/articleView.html?idxno=46490
10821,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.m-i.kr/news/articleView.html?idxno=772870
10822,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.pharmnews.com/news/articleView.html?idxno=101843
10823,2020-12-07,대웅제약발달장애인돕는참지마요프로젝트3기모집,http://www.asiaa.co.kr/news/articleView.html?idxno=10385
10824,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573055825663
10825,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65017
10826,2020-12-07,대웅제약발달장애인과함께하는참지마요프로젝트대학생교육봉사단3기모집,http://www.pinpointnews.co.kr/view.php?ud=2020120710095883992365609d9b_45
10827,2020-12-07,발달장애인과아름다운동행대웅제약참지마요프로젝트대학생교육봉사단모집,http://kpenews.com/View.aspx?No=1370363
10828,2020-12-07,대웅제약과발달장애인이함께하는아름다운동행참지마요프로젝트대학생교육봉사단3기모집,http://newsbrite.net/144446
10829,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.healthinnews.co.kr/news/articleView.html?idxno=20584
10830,2020-12-07,대웅제약과참지마요프로젝트대학생교육봉사단3기모집,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012071026515760931
10831,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.newsprime.co.kr/news/article.html?no=526567
10832,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.bosa.co.kr/news/articleView.html?idxno=2139515
10833,2020-12-07,대웅제약발달장애인과동행하는대학생교육봉사단모집,http://www.economytalk.kr/news/articleView.html?idxno=209762
10834,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.newsway.co.kr/news/view?tp=1&ud=2020120710450355440
10835,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.enewstoday.co.kr/news/articleView.html?idxno=1433817
10836,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.mhj21.com/137480
10837,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.businesskorea.co.kr/news/articleView.html?idxno=56298
10838,2020-12-07,대웅제약참지마요프로젝트대학생봉사단3기모집,http://www.kpinews.co.kr/news/articleView.html?idxno=132334
10839,2020-12-07,대웅제약발달장애인위한동행프로젝트재시동,http://www.monews.co.kr/news/articleView.html?idxno=216155
10840,2020-12-07,대웅제약과발달장애인의아름다운동행참지마요프로젝트대학생교육봉사단3기모집,http://www.thepublic.kr/news/newsview.php?ncode=1065576252133133
10841,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.mdtoday.co.kr/mdtoday/index.html?no=408085
10842,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://inthenews.co.kr/article-81025/
10843,2020-12-07,유한양행대웅제약공동개발위궤양치료신약내년2분기출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=408087
10844,2020-12-07,대웅제약참지마요프로젝트대학생봉사단3기모집,https://www.econovill.com/news/articleView.html?idxno=508791
10845,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.dailysmart.co.kr/news/articleView.html?idxno=36917
10846,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.wsobi.com/news/articleView.html?idxno=109734
10847,2020-12-07,봉사단100명모집대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://theviewers.co.kr/View.aspx?No=1370904
10848,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집발달장애인감염병학습지원,http://www.lcnews.co.kr/news/articleView.html?idxno=10582
10849,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.nbnnews.co.kr/news/articleView.html?idxno=447494
10850,2020-12-07,시경Today제약대웅제약참지마요프로젝트대학생교육봉사단3기모집外,http://www.meconomynews.com/news/articleView.html?idxno=48142
10851,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.thedailypost.kr/news/articleView.html?idxno=77946
10852,2020-12-07,대웅제약발달장애인과의아름다운동행참지마요프로젝트3기대학생봉사단모집,http://www.thebigdata.co.kr/view.php?ud=202012071552225448d0a8833aad_23
10853,2020-12-07,대웅제약과발달장애인이함께하는참지마요프로젝트,http://www.pressm.kr/news/articleView.html?idxno=35069
10854,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.segyebiz.com/newsView/20201207517910?OutUrl=naver
10855,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.anewsa.com/detail.php?number=2298042&thread=10
10856,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집발달장애인이함께하는아름다운동행,http://www.thefirstmedia.net/news/articleView.html?idxno=67244
10857,2020-12-07,뉴스투데이L대웅제약참지마요프로젝트대학생교육봉사단3기모집,https://www.news2day.co.kr/article/20201207500256
10858,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단모집,http://www.100ssd.co.kr/news/articleView.html?idxno=73251
10859,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,http://www.lawissue.co.kr/view.php?ud=202012071739153117204ead0791_12
10860,2020-12-07,대웅제약참지마요프로젝트교육봉사단모집,http://www.dailymedi.com/detail.php?number=863731&thread=22r05
10861,2020-12-07,대웅제약참지마요프로젝트대학생교육봉사단3기모집,https://www.kpanews.co.kr/article/show.asp?idx=218303&category=D
10862,2020-12-07,종근당GC녹십자대웅제약코로나19치료제개발현황공개,http://www.newsfreezone.co.kr/news/articleView.html?idxno=280065
10863,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.sentv.co.kr/news/view/584309
10864,2020-12-08,비염치료제라인업강화대웅제약코메키나나잘스프레이출시,http://kpenews.com/View.aspx?No=1371884
10865,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시제형다양화,http://www.medisobizanews.com/news/articleView.html?idxno=74768
10866,2020-12-08,대웅제약코메키나나잘스프레이출시비염치료제라인업확장,https://health.chosun.com/site/data/html_dir/2020/12/08/2020120800818.html
10867,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.fnnews.com/news/202012080933437426
10868,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.press9.kr/news/articleView.html?idxno=46508
10869,2020-12-08,대웅제약코에뿌리는코메키나출시비염치료제강화,http://www.newsis.com/view/?id=NISX20201208_0001261726&cID=13001&pID=13000
10870,2020-12-08,대웅제약코메키나나잘스프레이출시라인업강화나서,http://medipana.com/news/news_viewer.asp?NewsNum=268026&MainKind=A&NewsKind=5&vCount=12&vKind=1
10871,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.mediapen.com/news/view/581386
10872,2020-12-08,대웅제약 코에뿌리는비염치료제 코메키나나잘스프레이 출시 비염치료제라인업강화,http://www.greened.kr/news/articleView.html?idxno=278869
10873,2020-12-08,대웅뿌리는비염치료제코메키나나잘스프레이출시,http://www.whosaeng.com/123081
10874,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.segyebiz.com/newsView/20201208506502?OutUrl=naver
10875,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252288
10876,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=20615
10877,2020-12-08,대웅코메키나나잘스프레이출시비염치료제라인업강화,https://www.kpanews.co.kr/article/show.asp?idx=218325&category=D
10878,2020-12-08,대웅제약코에뿌리는비염치료제출시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120809574221398
10879,2020-12-08,대웅제약비염치료제라인업강화코메키나나잘스프레이출시,http://www.youthdaily.co.kr/news/article.html?no=55288
10880,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.lawissue.co.kr/view.php?ud=202012081002467834204ead0791_12
10881,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=56356
10882,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://news.mt.co.kr/mtview.php?no=2020120810080173999
10883,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137581&REFERER=NP
10884,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시비염치료제라인업강화,http://newsbrite.net/144489
10885,2020-12-08,대웅제약뿌리는비염치료제코메키나나잘스프레이출시,http://www.pinpointnews.co.kr/view.php?ud=2020120810362818312365609d9b_45
10886,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.m-i.kr/news/articleView.html?idxno=773386
10887,2020-12-08,대웅제약코에뿌리는코메키나나잘스프레이출시,http://www.medigatenews.com/news/2706655844
10888,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.bosa.co.kr/news/articleView.html?idxno=2139605
10889,2020-12-08,대웅제약뿌리는비염치료제코메키나나잘스프레이출시,https://www.donga.com/news/article/all/20201208/104338872/1
10890,2020-12-08,대웅제약비염치료제라인업코메키나선보여,http://www.thebigdata.co.kr/view.php?ud=202012081052543490c28f8374b3_23
10891,2020-12-08,제약오늘JW생명과학글로벌진출강화지원사업선정대웅제약비염치료제코메키나나잘스프레이출시,http://www.sisaon.co.kr/news/articleView.html?idxno=121403
10892,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,https://www.asiatoday.co.kr/view.php?key=20201208010005029
10893,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65059
10894,2020-12-08,대웅제약뿌리는비염치료제코메키나나잘스프레이출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=36983
10895,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020120812593737790
10896,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.anewsa.com/detail.php?number=2298722&thread=10
10897,2020-12-08,대웅제약코에뿌리는비염치료제출시코메키나나잘스프레이,http://www.lcnews.co.kr/news/articleView.html?idxno=10628
10898,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시스프레이타입,https://www.econovill.com/news/articleView.html?idxno=509037
10899,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.kpinews.co.kr/news/articleView.html?idxno=132451
10900,2020-12-08,대웅제약스프레이타입뿌리는비염치료제 출시,http://www.koreastocknews.com/news/articleView.html?idxno=59631
10901,2020-12-08,대웅제약뿌리는비염치료제코메키나출시,http://www.100ssd.co.kr/news/articleView.html?idxno=73273
10902,2020-12-08,뿌리는비염치료제대웅제약코메키나나잘스프레이출시,http://theviewers.co.kr/View.aspx?No=1372894
10903,2020-12-08,대웅제약코안에뿌리는비염치료제출시코막힘에효과적,http://daily.hankooki.com/lpage/industry/202012/dh20201208153608148390.htm?s_ref=nv
10904,2020-12-08,RD투자한미대웅은늘고녹십자종근당은줄고,http://www.sisaon.co.kr/news/articleView.html?idxno=121405
10905,2020-12-08,대웅제약비염치료제코메키나나잘스프레이출시,http://www.dailymedi.com/detail.php?number=863768&thread=22r05
10906,2020-12-08,대웅제약코안에직접비염치료제코메키나나잘스프레이출시,http://www.thedailypost.kr/news/articleView.html?idxno=77990
10907,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.metroseoul.co.kr/article/20201208500397
10908,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=408281
10909,2020-12-08,재계리포트메디톡스대웅제약균주분쟁시작과끝한쪽은치명타,http://www.sejungilbo.com/news/articleView.html?idxno=30349
10910,2020-12-08,뉴스투데이L대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,https://www.news2day.co.kr/article/20201208500271
10911,2020-12-08,대웅제약비염치료제라인업강화비염치료제코메키나나잘스프레이출시,http://www.updownnews.co.kr/news/articleView.html?idxno=226111
10912,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시비염치료제라인업강화,http://www.thepublic.kr/news/newsview.php?ncode=1065593547917010
10913,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.iminju.net/news/articleView.html?idxno=60301
10914,2020-12-08,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시,http://www.thefirstmedia.net/news/articleView.html?idxno=67352
10915,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.thebigdata.co.kr/view.php?ud=202012090906184222798818e98b_23
10916,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증”,http://www.sentv.co.kr/news/view/584399
10917,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://newsclaim.co.kr/View.aspx?No=1373545
10918,2020-12-09,대웅제약나보타대상포진신경통증감소효과입증,http://www.press9.kr/news/articleView.html?idxno=46514
10919,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.ekn.kr/web/view.php?key=20201209010002199
10920,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.anewsa.com/detail.php?number=2299324&thread=10
10921,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.fetv.co.kr/news/article.html?no=70722
10922,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,http://www.medisobizanews.com/news/articleView.html?idxno=74798
10923,2020-12-09,대웅제약나보타베트남서대상포진후신경통증감소효과입증”,http://www.youthdaily.co.kr/news/article.html?no=55405
10924,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://news.mt.co.kr/mtview.php?no=2020120909151144531
10925,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,https://view.asiae.co.kr/article/2020120909293600789
10926,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120909214790182
10927,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증”,https://jhealthmedia.joins.com/article/article_view.asp?pno=22824
10928,2020-12-09,대웅제약나보타대상포진신경통증감소가능성확인,http://www.newsis.com/view/?id=NISX20201209_0001263258&cID=13001&pID=13000
10929,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,http://inthenews.co.kr/article-81438/
10930,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.m-i.kr/news/articleView.html?idxno=773855
10931,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1434506
10932,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.dailian.co.kr/news/view/944449/?sc=Naver
10933,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://sports.hankooki.com/lpage/economy/202012/sp20201209094249137020.htm?s_ref=nv
10934,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=132506
10935,2020-12-09,대웅제약나보타대상포진후신경통증효과입증,http://www.newsprime.co.kr/news/article.html?no=526901
10936,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573188810586
10937,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증”,http://it.chosun.com/site/data/html_dir/2020/12/09/2020120900826.html
10938,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.hankyung.com/finance/article/202012099116i
10939,2020-12-09,대웅제약나보타연구결과베트남의학저널에게재,http://www.asiaa.co.kr/news/articleView.html?idxno=10913
10940,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252336
10941,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65074
10942,2020-12-09,대웅나보타대상포진후신경통억제입증,http://www.medical-tribune.co.kr/news/articleView.html?idxno=96968
10943,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.monews.co.kr/news/articleView.html?idxno=216244
10944,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020120909551890551
10945,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.healthinnews.co.kr/news/articleView.html?idxno=20633
10946,2020-12-09,대웅나보타대상포진후신경통증감소효과입증,https://www.kpanews.co.kr/article/show.asp?idx=218358&category=D
10947,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://health.chosun.com/site/data/html_dir/2020/12/09/2020120900907.html
10948,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.metroseoul.co.kr/article/20201209500076
10949,2020-12-09,대웅제약보툴리눔톡신나보타대상포진신경통증개선효과,http://yna.kr/AKR20201209058500017?did=1195m
10950,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.pharmnews.com/news/articleView.html?idxno=101863
10951,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.segye.com/content/html/2020/12/09/20201209509143.html?OutUrl=naver
10952,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=56436
10953,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.wsobi.com/news/articleView.html?idxno=109878
10954,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=268106&MainKind=A&NewsKind=5&vCount=12&vKind=1
10955,2020-12-09,대웅제약나보타대상포진후신경통증에효과입증,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124394
10956,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2139697
10957,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=408360
10958,2020-12-09,대웅제약나보타대상포진신경통증감소4주지속,http://moneys.mt.co.kr/news/mwView.php?no=2020120911088037762
10959,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=37058
10960,2020-12-09,대웅제약코로나치료제개발한창DWRX2003임상2상신청완료,http://news.heraldcorp.com/view.php?ud=20201209000554
10961,2020-12-09,대웅제약나보타대상포진후신경통증감소효과,http://www.medigatenews.com/news/2298466540
10962,2020-12-09,오늘의제약美아티바유비케어GC녹십자대웅제약동아제약유한건강생활,http://www.babytimes.co.kr/news/articleView.html?idxno=41688
10963,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.thepublic.kr/news/newsview.php?ncode=1065576681750389
10964,2020-12-09,대웅제약호이스타정코로나경증환자대상치료효과입증,https://www.ekn.kr/web/view.php?key=20201209010002284
10965,2020-12-09,제약사훨훨나는데실적곤두박질한미약품대웅제약왜,https://cnbc.sbs.co.kr/article_hub/10001005078?division=NAVER
10966,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,https://www.fetv.co.kr/news/article.html?no=70793
10967,2020-12-09,대웅제약호이스타정코로나19치료효과입증,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137630&REFERER=NP
10968,2020-12-09,대웅제약호이스타정코로나19치료효과입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=56459
10969,2020-12-09,대웅호이스타정코로나경증환자치료효과입증내년1월치료제제공 ,http://www.upinews.kr/newsView/upi202012090046
10970,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증”,http://www.youthdaily.co.kr/news/article.html?no=55452
10971,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.healthinnews.co.kr/news/articleView.html?idxno=20651
10972,2020-12-09,대웅호이스타정코로나환자치료효과내년1월공급계획,http://www.wikileaks-kr.org/news/articleView.html?idxno=99993
10973,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://medipana.com/news/news_viewer.asp?NewsNum=268123&MainKind=A&NewsKind=5&vCount=12&vKind=1
10974,2020-12-09,대웅제약호이스타정코로나치료제효과확인연내임상종료1월공급목표,http://news.mt.co.kr/mtview.php?no=2020120912322324829
10975,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증,http://www.press9.kr/news/articleView.html?idxno=46522
10976,2020-12-09,대웅제약호이스타정코로나19환자염증개선등치료효과확인,http://www.medisobizanews.com/news/articleView.html?idxno=74818
10977,2020-12-09,대웅제약나보타대상포진후신경통증개선효과확인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4366354
10978,2020-12-09,삼성제약대웅제약제약주모두급등삼성제약13급등이어대웅제약5급등,http://www.econonews.co.kr/news/articleView.html?idxno=148256
10979,2020-12-09,대웅제약호이스타정코로나19경증환자대상치료효과입증,https://health.chosun.com/site/data/html_dir/2020/12/09/2020120901464.html
10980,2020-12-09,대웅제약대웅낮부터갑작스런급등대웅10급등이어대웅제약5급등,http://www.econonews.co.kr/news/articleView.html?idxno=148257
10981,2020-12-09,대웅제약먹는경증코로나약효과확인내년활용목표,https://www.hankyung.com/it/article/202012090265i
10982,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=408396
10983,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.lawissue.co.kr/view.php?ud=202012091307308413204ead0791_12
10984,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.newsworker.co.kr/news/articleView.html?idxno=94940
10985,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.pressm.kr/news/articleView.html?idxno=35135
10986,2020-12-09,제2의타미플루기대감↑대웅제약호이스타정코로나19환자86염증수치정상,https://www.donga.com/news/article/all/20201209/104361212/1
10987,2020-12-09,대웅제약이지덤뷰티2020올리브영어워즈패치국소케어부문3위수상,https://www.sedaily.com/NewsView/1ZBM7TET08
10988,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.lawissue.co.kr/view.php?ud=202012091324515120204ead0791_12
10989,2020-12-09,대웅제약췌장질환치료제코로나19치료효과확인내년1월공급할것,https://biz.chosun.com/site/data/html_dir/2020/12/09/2020120901559.html?utm_source=naver&utm_medium=original&utm_campaign=biz
10990,2020-12-09,대웅제약호이스타정코로나19환자대상오프라벨처방결과공개,https://www.dailian.co.kr/news/view/944603/?sc=Naver
10991,2020-12-09,특징주대웅주가5상승코로나19경증환자치료제개발초읽기,http://www.anewsa.com/detail.php?number=2299693&thread=18
10992,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과기대,http://www.dailysmart.co.kr/news/articleView.html?idxno=37082
10993,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증,http://www.kpinews.co.kr/news/articleView.html?idxno=132565
10994,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.m-i.kr/news/articleView.html?idxno=774072
10995,2020-12-09,대웅제약코에뿌리는비염치료제코메키나나잘스프레이출시비염치료제라인업강화,http://www.nbnnews.co.kr/news/articleView.html?idxno=447916
10996,2020-12-09,대웅제약나보타베트남의학저널에서도우수성인정신경통증감소효과,http://www.lcnews.co.kr/news/articleView.html?idxno=10694
10997,2020-12-09,대웅제약나보타대상포진후신경통증에효과있어,http://www.thedailypost.kr/news/articleView.html?idxno=78000
10998,2020-12-09,대웅코로나19경증중등증환자타깃치료제순항,http://www.dailymedi.com/detail.php?number=863817&thread=22r05
10999,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과및안전성입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020120913405568238
11000,2020-12-09,대웅제약호이스타정경증코로나19환자에게효과,http://www.fnnews.com/news/202012091343581123
11001,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.newsway.co.kr/news/view?tp=1&ud=2020120913460381050
11002,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://daily.hankooki.com/lpage/industry/202012/dh20201209134912148390.htm?s_ref=nv
11003,2020-12-09,대웅제약호이스타코로나환자대상치료효과확인,http://www.newsis.com/view/?id=NISX20201209_0001263720&cID=13001&pID=13000
11004,2020-12-09,미용이어치료시장넘본다”대웅제약나보타대상포진통증감소효과입증,https://www.donga.com/news/article/all/20201209/104361834/1
11005,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://yna.kr/AKR20201209098500017?did=1195m
11006,2020-12-09,호이스타정코로나치료제1호될까대웅제약연내임상종료1월공급목표,http://moneys.mt.co.kr/news/mwView.php?no=2020120913098022891
11007,2020-12-09,대웅제약주가3증가나보타효과호이스타정효과,http://www.ajunews.com/view/20201209134353256
11008,2020-12-09,대웅제약카모스타트경증코로나19염증반응개선”,http://www.biospectator.com/view/news_view.php?varAtcId=12019
11009,2020-12-09,끝나지않는보툴리눔균도용논란대웅제약메디톡스누가거짓말,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012091158481250608
11010,2020-12-09,대웅제약호이스타정코로나환자대상치료효과입증,http://www.segye.com/content/html/2020/12/09/20201209515152.html?OutUrl=naver
11011,2020-12-09,대웅제약여드름패치이지덤뷰티2020올리브영어워즈수상,https://biz.chosun.com/site/data/html_dir/2020/12/09/2020120901781.html?utm_source=naver&utm_medium=original&utm_campaign=biz
11012,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.metroseoul.co.kr/article/20201209500269
11013,2020-12-09,대웅제약호이스타정코로나19치료효과공개염증개선통해증상악화방지기대,http://kpenews.com/View.aspx?No=1374437
11014,2020-12-09,대웅제약호이스타정코로나19경증환자대상연구에서치료효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=510547
11015,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.medigatenews.com/news/1762039024
11016,2020-12-09,대웅제약개발코로나19치료제호이스타CRP검사서유효성확인,https://www.asiatoday.co.kr/view.php?key=20201209010006067
11017,2020-12-09,대웅제약나보타대상포진후신경통증에효과확인,http://www.koreastocknews.com/news/articleView.html?idxno=59678
11018,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://it.chosun.com/site/data/html_dir/2020/12/09/2020120901834.html
11019,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=448266
11020,2020-12-09,나보타대상포진도효과대웅제약주가↑,http://www.smartfn.co.kr/view.php?ud=202012091411093616d3eee0def8_46
11021,2020-12-09,대웅제약호이스타정코로나19경증치료효과,https://view.asiae.co.kr/article/2020120914441557829
11022,2020-12-09,대웅제약나보타대상포진신경통증감소효과입증,https://www.news2day.co.kr/article/20201209500177
11023,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증안전성도확인,http://www.thebigdata.co.kr/view.php?ud=202012091441325830d0a8833aad_23
11024,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과확인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4366534
11025,2020-12-09,대웅제약호이스타정코로나19치료효과연구결과공개,http://www.newsprime.co.kr/news/article.html?no=526976
11026,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012091440173030658
11027,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과확인,http://sports.hankooki.com/lpage/economy/202012/sp20201209145013137020.htm?s_ref=nv
11028,2020-12-09,대웅제약나보타대상포진신경통증감소효과확인,https://www.econovill.com/news/articleView.html?idxno=509234
11029,2020-12-09,대웅제약호이스타정코로나19경증환자대상치료효과입증,http://www.edaily.co.kr/news/newspath.asp?newsid=03096326625996880
11030,2020-12-09,대웅제약호이스타정1월중코로나19관련논문공개,http://weekly.hankooki.com/lpage/economy/202012/wk20201209145451146380.htm?s_ref=nv
11031,2020-12-09,대웅제약호이스타정코로나경증환자치료효과확인”,https://www.chosun.com/economy/science/2020/12/09/IJYG2NBGC5FN3GB5HJWOW2HOUQ/?utm_source=naver&utm_medium=referral&utm_campaign=naver-news
11032,2020-12-09,대웅제약호이스타정환자대상코로나19치료효과확인,https://www.etoday.co.kr/news/view/1972067
11033,2020-12-09,대웅제약호이스타정코로나19치료효과입증됐다,http://news.mk.co.kr/newsRead.php?no=1265735&year=2020
11034,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65079
11035,2020-12-09,대웅제약호이스타정코로나환자대상치료효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2139731
11036,2020-12-09,대웅제약호이스타정코로나환자염증개선효과발표,http://www.monews.co.kr/news/articleView.html?idxno=216255
11037,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://newsbrite.net/144556
11038,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.dt.co.kr/contents.html?article_no=2020120902109931102002&ref=naver
11039,2020-12-09,대웅제약나보타베트남에서대상포진후신경통증감소효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=510614
11040,2020-12-09,뉴스투데이L대웅제약호이스타정코로나19환자치료효과발표,https://www.news2day.co.kr/article/20201209500207
11041,2020-12-09,대웅제약호이스타정코로나경증환자치료효과확인,https://cnbc.sbs.co.kr/article_hub/10001005108?division=NAVER
11042,2020-12-09,대웅제약호이스타정코로나19치료효과1월환자제공목표,http://www.seoulfn.com/news/articleView.html?idxno=403793
11043,2020-12-09,대웅제약나보타대상포진신경통증개선효과,http://www.seoulfn.com/news/articleView.html?idxno=403798
11044,2020-12-09,대웅제약호이스타정코로나19환자대상경구용치료제로효과입증임상2상도속도낸다,http://news.heraldcorp.com/view.php?ud=20201209000915
11045,2020-12-09,대웅제약호이스타코로나19경증환자치료에효과,https://www.sedaily.com/NewsView/1ZBM7UBU1Q
11046,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.pharmnews.com/news/articleView.html?idxno=101866
11047,2020-12-09,대웅제약코로나19치료효과연구결과공개,http://www.shinailbo.co.kr/news/articleView.html?idxno=1352639
11048,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.newstomato.com/ReadNews.aspx?no=1011908
11049,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.mediapen.com/news/view/581960
11050,2020-12-09,대웅제약vs메디톡스톡신논란마침표,http://www.whosaeng.com/123143
11051,2020-12-09,대웅제약호이스타정코로나19치료효과입증,http://www.anewsa.com/detail.php?number=2299952&thread=10
11052,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.worktoday.co.kr/news/articleView.html?idxno=12123
11053,2020-12-09,통증감소및수면질향상대웅제약나보타대상포진후신경통증감소효과입증,http://theviewers.co.kr/View.aspx?No=1374802
11054,2020-12-09,대웅제약나보타베트남현지연구결과대상포진후신경통증감소효과확인,http://www.k-health.com/news/articleView.html?idxno=51369
11055,2020-12-09,대웅호이스타정코로나환자서효과입증,http://www.whosaeng.com/123144
11056,2020-12-09,대웅호이스타정코로나19환자대상효과입증,https://www.kpanews.co.kr/article/show.asp?idx=218374&category=D
11057,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.finomy.com/news/articleView.html?idxno=86442
11058,2020-12-09,김창수의e뉴스브리핑대웅제약호이스타정코로나19환자대상치료효과입증外,https://www.fetv.co.kr/news/article.html?no=70846
11059,2020-12-09,코로나경증환자에효과대웅호이스타정1월공급,http://news.mk.co.kr/newsRead.php?no=1266774&year=2020
11060,2020-12-09,대웅제약호이스타정코로나19경증환자치료효과입증,http://www.sporbiz.co.kr/news/articleView.html?idxno=503974
11061,2020-12-09,대웅제약의그약을코로나19환자들에게투여했더니극적인효과가나타났다,https://www.wikitree.co.kr/articles/599587
11062,2020-12-09,대웅제약자체보툴리눔톡신의대상포진신경통증감소효과확인,http://www.businesspost.co.kr/BP?command=article_view&num=207973
11063,2020-12-09,먹는코로나19치료제나오나대웅제약호이스타정경증환자치료효과입증,https://hankookilbo.com/News/Read/A2020120916310000680?did=NA
11064,2020-12-09,금일제약업계주요기사휴젤레티보中수출첫선적대웅제약호이스타정코로나19환자치료효과입증”,http://www.youthdaily.co.kr/news/article.html?no=55507
11065,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,https://www.news1.kr/articles/?4145053
11066,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,https://www.asiatoday.co.kr/view.php?key=20201209010006382
11067,2020-12-09,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.ezyeconomy.com/news/articleView.html?idxno=107857
11068,2020-12-09,대웅제약호이스타정코로나19경증치료효과확인,http://4th.kr/View.aspx?No=1374932
11069,2020-12-09,대웅제약호이스타정코로나19환자염증억제효과확인,http://www.ajunews.com/view/20201209182204530
11070,2020-12-09,대웅제약호이스타정코로나19환자에서카모스타트의염증개선효과발표,http://www.thefirstmedia.net/news/articleView.html?idxno=67436
11071,2020-12-09,대웅제약나보타대상포진후신경통증감소효과입증,http://www.thefirstmedia.net/news/articleView.html?idxno=67448
11072,2020-12-09,대웅제약호이스타정코로나19환자치료효과입증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4366985
11073,2020-12-10,청룡사대웅전서150년전불화발견,http://www.btnnews.tv/news/articleView.html?idxno=64075
11074,2020-12-10,대웅제약호이스타정코로나19치료효과확인코로나19의타미플루와같은약제,http://www.newsinside.kr/news/articleView.html?idxno=1097303
11075,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,https://www.fetv.co.kr/news/article.html?no=70885
11076,2020-12-10,카모스타트코로나19치료제부상대웅제약등관련株들썩,http://news.mk.co.kr/newsRead.php?no=1268060&year=2020
11077,2020-12-10,특징주대상포진후신경통증감소대웅제약12↑,http://moneys.mt.co.kr/news/mwView.php?no=2020121009108027632
11078,2020-12-10,특징주대웅제약호이스타정코로나치료제효과확인에급등,https://view.asiae.co.kr/article/2020121009195139407
11079,2020-12-10,특징주대웅제약호이스타정코로나19치료효과소식에장초반강세,https://www.sedaily.com/NewsView/1ZBMO5SSI4
11080,2020-12-10,대웅제약코로나치료제기대감이틀째강세,http://news.mt.co.kr/mtview.php?no=2020121009180143055
11081,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=268172&MainKind=A&NewsKind=5&vCount=12&vKind=1
11082,2020-12-10,대웅제약당뇨병성혈관합병증의관리및예방중요성공유”,http://www.youthdaily.co.kr/news/article.html?no=55556
11083,2020-12-10,대웅제약삼성제약제약주희비엇갈려특히대웅제약갑작스런13급등,http://www.econonews.co.kr/news/articleView.html?idxno=148370
11084,2020-12-10,대웅제약안플원출시5주년4차웹심포지엄,http://www.medisobizanews.com/news/articleView.html?idxno=74844
11085,2020-12-10,대웅제약안플원5주년기념웹심포지엄개최,http://www.press9.kr/news/articleView.html?idxno=46531
11086,2020-12-10,대웅제약호이스타정코로나19치료효과소식에강세,https://www.hankyung.com/finance/article/2020121033626
11087,2020-12-10,특징주대웅제약코로나19치료제효과확인소식에상승세,http://www.inews24.com/view/1325418
11088,2020-12-10,특징주대웅제약코로나치료제기대감에10대급등,https://www.dailian.co.kr/news/view/944928/?sc=Naver
11089,2020-12-10,특징주대웅제약코로나19치료제개발기대감에급등,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012100078&t=NN
11090,2020-12-10,특징주대웅제약호이스타정코로나19치료제기대급등,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573042691533
11091,2020-12-10,특징주대웅제약호이스타정코로나치료효과발표에급등,http://news.heraldcorp.com/view.php?ud=20201210000146
11092,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252387
11093,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄,http://www.whosaeng.com/123164
11094,2020-12-10,코스피코스닥동반하락출발무림페이퍼대웅제약베스파급등,http://www.businesspost.co.kr/BP?command=article_view&num=208035
11095,2020-12-10,특징주대웅제약코로나치료제기대감이틀째강세,https://www.econovill.com/news/articleView.html?idxno=509413
11096,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.viva100.com/main/view.php?key=20201210010002498
11097,2020-12-10,특징주대웅제약주가10상승세역류성식도염치료제코로나효과,http://www.anewsa.com/detail.php?number=2300370&thread=18
11098,2020-12-10,코스피미국발악재에273048하락출발대웅제약콜드체인주↑,http://www.opinionnews.co.kr/news/articleView.html?idxno=43913
11099,2020-12-10,특징주대웅제약코로나19치료제기대감에10대상승,http://www.newspim.com/news/view/20201210000215
11100,2020-12-10,특징주대웅제약코로나19치료제기대감에이틀째상승세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004204442
11101,2020-12-10,특징주대웅제약호이스타정코로나19치료제효과에강세,http://www.seoulfn.com/news/articleView.html?idxno=403887
11102,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.healthinnews.co.kr/news/articleView.html?idxno=20663
11103,2020-12-10,특징주대웅제약강세코로나경증환자치료효과,https://www.news1.kr/articles/?4145575
11104,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=132630
11105,2020-12-10,특징주대웅제약코로나19치료제개발기대감에강세,http://www.ajunews.com/view/20201210094613816
11106,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=774373
11107,2020-12-10,특징주대웅제약코로나치료제소식에대웅상승,http://moneys.mt.co.kr/news/mwView.php?no=2020121009498064009
11108,2020-12-10,경보제약대웅제약제약주모두급등경보제약10급등이어대웅제약9급등,http://www.econonews.co.kr/news/articleView.html?idxno=148384
11109,2020-12-10,대웅제약안플원출시5주년4차웹심포지엄개최,http://www.newslock.co.kr/news/articleView.html?idxno=33892
11110,2020-12-10,10일장중코로나주대웅제약엑세스바이오껑충vs제일약품하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77210
11111,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,https://www.ekn.kr/web/view.php?key=20201210010002532
11112,2020-12-10,대웅제약호이스타정코로나19환자상대로치료효과입증”,http://inthenews.co.kr/article-81610/
11113,2020-12-10,특징주대웅제약호이스타정먹는코로나치료제효과기대에급등,http://daily.hankooki.com/lpage/finance/202012/dh20201210100811148310.htm?s_ref=nv
11114,2020-12-10,대웅제약이틀째훨훨왜췌장염치료제호이스타정코로나치료효능호재로,http://www.pinpointnews.co.kr/view.php?ud=202012101012251456861beb2d9d_45
11115,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://news.mt.co.kr/mtview.php?no=2020121009425137680
11116,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://daily.hankooki.com/lpage/industry/202012/dh20201210101641148390.htm?s_ref=nv
11117,2020-12-10,TF특징주대웅제약코로나19치료제효과소식에이틀째강세,http://news.tf.co.kr/read/economy/1830108.htm
11118,2020-12-10,대웅제약항혈전제안플원출시5주년기념4차웹심포지엄개최,http://www.pinpointnews.co.kr/view.php?ud=2020121010382871282365609d9b_45
11119,2020-12-10,대웅제약항혈전제안플원출시5주년기념웹심포지엄진행,https://www.asiatoday.co.kr/view.php?key=20201210010006693
11120,2020-12-10,특징주대웅제약코로나치료효과소식에급등,http://www.skyedaily.com/news/news_view.html?ID=117704
11121,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2139796
11122,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.mediapen.com/news/view/582216
11123,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65100
11124,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.businesskorea.co.kr/news/articleView.html?idxno=56527
11125,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.lawissue.co.kr/view.php?ud=202012101100355120204ead0791_12
11126,2020-12-10,대웅제약췌장질환치료제호이스타정코로나치료효과에급등,http://www.whitepaper.co.kr/news/articleView.html?idxno=199580
11127,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.dailysmart.co.kr/news/articleView.html?idxno=37141
11128,2020-12-10,대웅제약주가초반상승역류성식도염치료제의코로나19치료효과,http://www.businesspost.co.kr/BP?command=article_view&num=208077
11129,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.newsworker.co.kr/news/articleView.html?idxno=95108
11130,2020-12-10,대웅제약겨울철혈류장애및당뇨병성혈관합병증관련웹심포지엄개최,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124442
11131,2020-12-10,대웅제약항혈전제안플원웹심포지엄개최,http://www.100ssd.co.kr/news/articleView.html?idxno=73322
11132,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.thebigdata.co.kr/view.php?ud=202012101221403496798818e98b_23
11133,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.thepublic.kr/news/newsview.php?ncode=1065575814754237
11134,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=408536
11135,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.marketnews.co.kr/news/articleView.html?idxno=57149
11136,2020-12-10,대웅제약이지덤뷰티2020올리브영어워즈서수상,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012100258&t=NN
11137,2020-12-10,대웅대웅제약모두급등대웅15급등이어대웅제약10급등,http://www.econonews.co.kr/news/articleView.html?idxno=148492
11138,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.nbnnews.co.kr/news/articleView.html?idxno=448647
11139,2020-12-10,대웅제약호이스타정코로나19환자대상치료효과입증,http://www.nbnnews.co.kr/news/articleView.html?idxno=448655
11140,2020-12-10,대웅주가돌풍관심백금TA키네마스터등상한가뛰나,http://www.g-enews.com/ko-kr/news/article/news_all/202012101438294961c642673384_1/article.html
11141,2020-12-10,대웅제약코로나치료제호이스타정염증개선효과,http://www.thedailypost.kr/news/articleView.html?idxno=78041
11142,2020-12-10,뉴스투데이L대웅제약안플원출시5주년기념4차웹심포지엄개최,https://www.news2day.co.kr/article/20201210500195
11143,2020-12-10,대웅제약안플원출시5주년4차웹심포지엄개최,https://www.econovill.com/news/articleView.html?idxno=509480
11144,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.anewsa.com/detail.php?number=2300823&thread=10
11145,2020-12-10,특징주대웅주가연이틀급등코로나경증환자치료제효과,http://www.anewsa.com/detail.php?number=2300832&thread=18
11146,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.mhj21.com/137586
11147,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.segyebiz.com/newsView/20201210518815?OutUrl=naver
11148,2020-12-10,10일오늘의상한가총정리남광토건에스씨엠생명과학백금TA상한가대웅대웅제약연이틀급등,http://www.ccreview.co.kr/news/articleView.html?idxno=297880
11149,2020-12-10,호이스타정코로나치료효과대웅제약주가↑,http://www.smartfn.co.kr/view.php?ud=20201210154700502537c00c6b22_46
11150,2020-12-10,대웅제약 호이스타정 경증 코로나19 치료 효과 입증,http://kormedi.com/?p=1328891
11151,2020-12-10,㈜대웅제약이지덤뷰티2020올리브영어워즈수상,http://news.mk.co.kr/newsRead.php?no=1271328&year=2020
11152,2020-12-10,건설음료기계업종강세남광토건흥국FB프리엠스상승백금TA대웅솔본훨훨,http://www.pinpointnews.co.kr/view.php?ud=202012101610522078cd1e7f0bdf_45
11153,2020-12-10,코로나19백신테마강세셀트리온제약대웅제넥신상승우수AMS하이로닉ISC급등,http://www.pinpointnews.co.kr/view.php?ud=202012101621534151cd1e7f0bdf_45
11154,2020-12-10,급등락주짚어보기에스씨엠생명과학백혈병치료제효과확인상한가코로나치료효과대웅대웅제약도강세,https://www.etoday.co.kr/news/view/1972651
11155,2020-12-10,대웅주가무려26상승대웅제약은18코로나19치료제기대감영향,http://www.ajunews.com/view/20201210163842236
11156,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.thedailypost.kr/news/articleView.html?idxno=78043
11157,2020-12-10,대웅제약췌장약호이스타코로나치료효과,https://www.hankyung.com/it/article/2020121062681
11158,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.thefirstmedia.net/news/articleView.html?idxno=67544
11159,2020-12-10,코로나치료제GC녹십자셀트리온독주대웅종근당약진,https://health.chosun.com/site/data/html_dir/2020/12/10/2020121002520.html
11160,2020-12-10,코스피등돌린외국인매도세에소폭하락마감대웅제약태영건설우남광토건급등,http://www.betanews.net:8080/article/1245047.html
11161,2020-12-10,대웅제약호이스타정코로나19치료효과입증,http://news.kbiz.or.kr/news/articleView.html?idxno=75575
11162,2020-12-10,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.newsfreezone.co.kr/news/articleView.html?idxno=281119
11163,2020-12-10,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.ajunews.com/view/20201210232025364
11164,2020-12-11,코로나19치료결국엔먹는약”대웅제약등후발주자들먹는약개발경쟁,https://biz.chosun.com/site/data/html_dir/2020/12/10/2020121002607.html?utm_source=naver&utm_medium=original&utm_campaign=biz
11165,2020-12-11,대웅제약나보타 대상포진후신경통증감소에효과,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005600
11166,2020-12-11,대웅제약안플원출시5주년기념4차웹심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=216322
11167,2020-12-11,대웅제약코로나19환자대상호이스타정치료효과공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005606
11168,2020-12-11,대웅제약호이스타정코로나치료효과확인관련주급등,https://cnbc.sbs.co.kr/article_hub/10001005334?division=NAVER
11169,2020-12-11,신풍제약대웅제약제약주희비엇갈려신풍제약8급락반해대웅제약보합,http://www.econonews.co.kr/news/articleView.html?idxno=148560
11170,2020-12-11,특징주대웅대웅제약주가초관심호이스타정코로나효과입증,http://www.gukjenews.com/news/articleView.html?idxno=2124371
11171,2020-12-11,특징주대웅제약코로나치료제기대감에3거래일째강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02253366625997536
11172,2020-12-11,대웅대웅제약오전갑작스런급등대웅24급등이어대웅제약9급등,http://www.econonews.co.kr/news/articleView.html?idxno=148639
11173,2020-12-11,특징주대웅대웅제약23급등세코로나치료효과보인호이스타정,http://www.anewsa.com/detail.php?number=2301642&thread=18
11174,2020-12-11,대웅대웅제약주가초반뛰어코로나19경증환자치료효과부각,http://www.businesspost.co.kr/BP?command=article_view&num=208291
11175,2020-12-11,코스피코스닥장중동반상승지속대웅KMH녹십자셀뛰어,http://www.businesspost.co.kr/BP?command=article_view&num=208298
11176,2020-12-11,일양약품대웅제약제약주모두급등일양약품14급등이어대웅제약11급등,http://www.econonews.co.kr/news/articleView.html?idxno=148675
11177,2020-12-11,급등주대웅대웅제약과3일째초강세52주최고가,http://www.itooza.com/common/iview.php?no=2020121113263573237
11178,2020-12-11,특징주호이스타정코로나치료효과소식에대웅강세,http://moneys.mt.co.kr/news/mwView.php?no=2020121113418017808
11179,2020-12-11,대웅제약여드름패치이지덤뷰티2020올리브영어워즈수상,http://www.segye.com/content/html/2020/12/11/20201211511631.html?OutUrl=naver
11180,2020-12-11,포인트모바일주가돌풍눈길대웅녹십자셀등상한가도전장,http://www.g-enews.com/ko-kr/news/article/news_all/202012111435092111c642673384_1/article.html
11181,2020-12-11,조필현의시선코로나19치료제개발경쟁녹십자종근당대웅,http://www.wikileaks-kr.org/news/articleView.html?idxno=100151
11182,2020-12-11,대웅제약안플원출시5주년기념웹심포지엄개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005625
11183,2020-12-11,대웅제약지사제스멕타대신복제약만드나,http://www.mediapen.com/news/view/582734
11184,2020-12-11,보험조선바이오株강세한화생명인화정공대웅급등포인트모바일LG상사녹십자셀훨훨,http://www.pinpointnews.co.kr/view.php?ud=2020121116251048cd1e7f0bdf_45
11185,2020-12-11,11일오늘의상한가총정리그린케미칼포인트모바일KMH상한가대웅이번주내내상세,http://www.ccreview.co.kr/news/articleView.html?idxno=297982
11186,2020-12-11,단독대웅제약이엑스데이터에시드투자,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012110365&t=NN
11187,2020-12-12,메톡대웅휴젤균주출처자료질병관리청에제출,http://www.newsis.com/view/?id=NISX20201211_0001267432&cID=13001&pID=13000
11188,2020-12-13,메디톡스대웅보톡스분쟁이번주최종판결또미뤄질까,http://yna.kr/AKR20201211137900017?did=1195m
11189,2020-12-13,ITC메디톡스대웅보톡스분쟁이번주최종판결,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012130015&t=NN
11190,2020-12-13,메디톡스대웅보톡스분쟁이번주최종판결또미뤄질까,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012130912298400303
11191,2020-12-13,베스트워스트대웅대웅제약호이스타정코로나치료효과발표에급등,https://www.etoday.co.kr/news/view/1973148
11192,2020-12-13,메디톡스대웅제약보톡스분쟁이번주최종판결또연기될까,http://kpenews.com/View.aspx?No=1378671
11193,2020-12-13,메디톡스대웅제약보톡스분쟁최종판결3일뒤예정또미뤄질가능성도,http://theviewers.co.kr/View.aspx?No=1378676
11194,2020-12-13,메디톡스와대웅제약균주소송최종판결16일예정미뤄질가능성도,http://www.businesspost.co.kr/BP?command=article_view&num=208435
11195,2020-12-13,메디톡스대웅제약휴젤보툴리눔균균주출처서면조사자료질병관리청에제출,http://www.econonews.co.kr/news/articleView.html?idxno=148877
11196,2020-12-13,대웅제약메디톡스보톡스분쟁이번주최종판결향후여파는,https://www.asiatoday.co.kr/view.php?key=20201213010008060
11197,2020-12-13,메디톡스대웅보톡스분쟁이번주최종판결,https://www.hankyung.com/it/article/2020121334951
11198,2020-12-13,메디톡스대웅제약ITC분쟁이번주결판,http://www.edaily.co.kr/news/newspath.asp?newsid=02145126625998192
11199,2020-12-14,삼성물산LG생활건강매수세LG화학셀트리온신풍제약매도↑그린케미칼대웅대창단조급등,http://www.pinpointnews.co.kr/view.php?ud=202012140654398521cd1e7f0bdf_45
11200,2020-12-14,대형제약사소송건수줄어대웅제약소송건가장많고나홀로증가,http://www.consumernews.co.kr/news/articleView.html?idxno=617173
11201,2020-12-14,대웅대웅제약상승에급등까지대웅3상승이어대웅제약6급등,http://www.econonews.co.kr/news/articleView.html?idxno=148906
11202,2020-12-14,20번세탁해도기능성유지대웅제약퓨어킷항균마스크출시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121410213363276
11203,2020-12-14,대웅제약기능성마스크퓨어킷항균마스크출시,http://www.viva100.com/main/view.php?key=20201214010003319
11204,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,https://www.fetv.co.kr/news/article.html?no=71261
11205,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65171
11206,2020-12-14,대웅제약20번세탁해도기능성유지퓨어킷항균마스크출시,https://www.asiatoday.co.kr/view.php?key=20201214010008378
11207,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://medipana.com/news/news_viewer.asp?NewsNum=268339&MainKind=A&NewsKind=5&vCount=12&vKind=1
11208,2020-12-14,대웅제약20번빨아써도기능유지되는퓨어킷항균마스크출시,http://www.metroseoul.co.kr/article/20201214500130
11209,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.newsway.co.kr/news/view?tp=1&ud=2020121410372413416
11210,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시20번세탁후에도기능성유지,http://www.segye.com/content/html/2020/12/14/20201214505369.html?OutUrl=naver
11211,2020-12-14,대웅제약경제적인다회용기능성마스크퓨어킷항균마스크출시,http://www.medisobizanews.com/news/articleView.html?idxno=74929
11212,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크선보여,http://www.asiaa.co.kr/news/articleView.html?idxno=12033
11213,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.fnnews.com/news/202012141046314854
11214,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.press9.kr/news/articleView.html?idxno=46559
11215,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=56698
11216,2020-12-14,대웅제약다회용마스크퓨어킷항균마스크출시,http://www.bosa.co.kr/news/articleView.html?idxno=2140019
11217,2020-12-14,대웅제약퓨어킷항균마스크출시20번세탁해도기능성유지,https://www.econovill.com/news/articleView.html?idxno=509980
11218,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=20747
11219,2020-12-14,대웅제약기능성마스크퓨어킷항균마스크출시,http://inthenews.co.kr/article-82244/
11220,2020-12-14,대웅제약매디톡스보톡스전쟁16일최종결판패소시치명상,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012141100163540526
11221,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=37315
11222,2020-12-14,대웅제약위생용품라인업강화다회용기능성마스크퓨어킷항균마스크출시,http://www.updownnews.co.kr/news/articleView.html?idxno=226268
11223,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252508
11224,2020-12-14,의약오늘대웅제약기능성마스크퓨어킷항균마스크출시동성제약광노화질환치료제이노바에이크림선봬,http://www.sisaon.co.kr/news/articleView.html?idxno=121654
11225,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.lawissue.co.kr/view.php?ud=202012141141489786204ead0791_12
11226,2020-12-14,대웅제약위생용품라인업강화퓨어킷항균마스크출시,http://www.youthdaily.co.kr/news/article.html?no=55955
11227,2020-12-14,대웅제약20번세탁해도기능유지하는마스크출시,http://daily.hankooki.com/lpage/industry/202012/dh20201214114514148390.htm?s_ref=nv
11228,2020-12-14,메디톡스대웅보톡스분쟁이번주결판,http://www.smedaily.co.kr/news/articleView.html?idxno=96254
11229,2020-12-14,대웅제약다회용마스크퓨어킷항균마스크출시,http://www.consumuch.com/news/articleView.html?idxno=51534
11230,2020-12-14,대웅제약퓨어킷항균마스크출시,https://www.ebn.co.kr/news/view/1463741/?sc=Naver
11231,2020-12-14,대웅제약다회용기능성마스크출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005686
11232,2020-12-14,뉴스투데이L대웅제약퓨어킷항균마스크출시,https://www.news2day.co.kr/article/20201214500182
11233,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=408838
11234,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.newsworker.co.kr/news/articleView.html?idxno=95518
11235,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.marketnews.co.kr/news/articleView.html?idxno=57463
11236,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.segyebiz.com/newsView/20201214508609?OutUrl=naver
11237,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.kpinews.co.kr/news/articleView.html?idxno=132907
11238,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.koreaittimes.com/news/articleView.html?idxno=102442
11239,2020-12-14,대웅제약20번세탁해도기능성유지퓨어킷항균마스크출시,http://www.thebigdata.co.kr/view.php?ud=202012141339063346798818e98b_23
11240,2020-12-14,대웅제약대웅희비엇갈려특히대웅제약급등서오후고꾸라지는주가,http://www.econonews.co.kr/news/articleView.html?idxno=148999
11241,2020-12-14,경보제약대웅제약제약주희비엇갈려경보제약3상승반해대웅제약6급락,http://www.econonews.co.kr/news/articleView.html?idxno=149000
11242,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.ceoscoredaily.com/news/article.html?no=76194
11243,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=271481&REFERER=NP
11244,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012141435406460661
11245,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.anewsa.com/detail.php?number=2303826&thread=10
11246,2020-12-14,대웅제약퓨어킷항균마스크출시,http://www.wsobi.com/news/articleView.html?idxno=110316
11247,2020-12-14,대웅제약다회용마스크퓨어킷항균마스크출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1435848
11248,2020-12-14,메디톡스대웅보톡스분쟁16일최종판결,https://cnbc.sbs.co.kr/article_hub/10001005650?division=NAVER
11249,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크선봬,http://news.mt.co.kr/mtview.php?no=2020121415150080306
11250,2020-12-14,다회용기능성마스크대웅제약퓨어킷향균마스크출시,http://theviewers.co.kr/View.aspx?No=1380170
11251,2020-12-14,16일메디톡스대웅제약보톡스분쟁ITC최종판결패소하면치명상,http://www.getnews.co.kr/news/articleView.html?idxno=504642
11252,2020-12-14,이슈분석대웅메디톡스균주분쟁이번주최종발표국내보톡스업계도불똥,http://www.sporbiz.co.kr/news/articleView.html?idxno=504340
11253,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.bokuennews.com/news/article.html?no=198421
11254,2020-12-14,대웅세탁해도되는기능성항균마스크내놔,http://www.whosaeng.com/123255
11255,2020-12-14,대웅제약20번빨아쓰는다회용기능성퓨어킷항균마스크선봬,https://www.kpanews.co.kr/article/show.asp?idx=218520&category=D
11256,2020-12-14,대웅제약다회용기능성퓨어킷항균마스크출시,http://www.newstomato.com/ReadNews.aspx?no=1012830
11257,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.ajunews.com/view/20201214163527047
11258,2020-12-14,연봉정밀분석27평균연봉한미약품이400만원높고근속연수는대웅제약이3개월더길어,https://www.news2day.co.kr/article/20201214500283
11259,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.thedailypost.kr/news/articleView.html?idxno=78108
11260,2020-12-14,대웅제약메디톡스5년보톡스분쟁결판날까,http://sports.hankooki.com/lpage/economy/202012/sp20201214164806137020.htm?s_ref=nv
11261,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=449480
11262,2020-12-14,대웅메디톡스보톡스분쟁최종판결또미뤄지나,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124563
11263,2020-12-14,대웅제약기능경제성고려한퓨어킷항균마스크출시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1354566
11264,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.dt.co.kr/contents.html?article_no=2020121402109931820008&ref=naver
11265,2020-12-14,메톡vs대웅ITC판결또연기될수도코로나확산바이든취임에영향,http://www.opinionnews.co.kr/news/articleView.html?idxno=44100
11266,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.thefirstmedia.net/news/articleView.html?idxno=67709
11267,2020-12-14,대웅제약다회용기능성마스크퓨어킷항균마스크출시,http://www.worktoday.co.kr/news/articleView.html?idxno=12231
11268,2020-12-14,대웅제약20번세탁후에도기능성유지되는다회용마스크퓨어킷항균마스크출시,http://www.lcnews.co.kr/news/articleView.html?idxno=10873
11269,2020-12-14,제약RD종근당대웅제약코로나19치료제임상진행내역발표,http://www.newsfreezone.co.kr/news/articleView.html?idxno=282022
11270,2020-12-15,대웅제약대웅하락에급락으로무너져특히대웅가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=149046
11271,2020-12-15,미담대웅타올코코베베타올어린이용수건1000장기부,http://www.anewsa.com/detail.php?number=2304525&thread=01r01
11272,2020-12-15,메디톡스대웅보톡스분쟁최종판결세번째연기되나,https://view.asiae.co.kr/article/2020121511404643952
11273,2020-12-15,국산1호코로나치료제주인공은셀트리온대웅제약각축전,http://www.viva100.com/main/view.php?key=20201215010003691
11274,2020-12-15,대웅타올코코베베타올어린이용수건1000장기부,http://www.ccnnews.co.kr/news/articleView.html?idxno=202733
11275,2020-12-15,보톡스전쟁마침표찍을까美ITC메디톡스VS대웅16일최종판결,https://www.etoday.co.kr/news/view/1974005
11276,2020-12-15,대웅제약vs메디톡스보톡스분쟁美ITC최종판결초읽기,https://www.fetv.co.kr/news/article.html?no=71424
11277,2020-12-15,국내코로나19치료제개발어디까지왔나셀트리온과GC녹십자가선두종근당과대웅제약도추격중,http://topclass.chosun.com/daily/view.asp?idx=738&Newsnumb=202012738
11278,2020-12-15,메디톡스대웅제약ITC결판코앞승기누가잡나,http://www.mediapen.com/news/view/583750
11279,2020-12-15,대웅타올코코베베타올어린이용수건1000장기부,http://www.chungnamilbo.co.kr/news/articleView.html?idxno=576286
11280,2020-12-15,기존치료제의변신종근당대웅코로나19치료제개발막바지,http://biz.newdaily.co.kr/site/data/html/2020/12/15/2020121500145.html
11281,2020-12-15,에이스토리루켄테크놀러지스넵튠시장경보에도훨훨아퓨어스대웅서울식품급락,http://www.pinpointnews.co.kr/view.php?ud=202012151554007664cd1e7f0bdf_45
11282,2020-12-15,시경Today건강대웅제약다회용기능성마스크퓨어킷항균마스크출시外,http://www.meconomynews.com/news/articleView.html?idxno=48442
11283,2020-12-15,대웅제약협력사에볼루스美ITC판결앞두고나스닥지수서삭제,http://www.kpinews.co.kr/news/articleView.html?idxno=133032
11284,2020-12-15,콜린알포치매약뭐길래종근당대웅등제약사발동동,https://cnbc.sbs.co.kr/article_hub/10001005827?division=NAVER
11285,2020-12-16,메디톡스vs대웅제약보톡스분쟁판결D1최종결과나오나,http://it.chosun.com/site/data/html_dir/2020/12/15/2020121502655.html
11286,2020-12-16,두차례연기된메디톡스대웅제약최종판결이번엔결판,http://www.youthdaily.co.kr/news/article.html?no=56166
11287,2020-12-16,대웅제약여드름패치이지덤뷰티2020올리브영어워즈수상,http://news.heraldcorp.com/view.php?ud=20201216000108
11288,2020-12-16,미국서보톡스균주소송최종판결앞둔대웅제약덮친악재협력사에볼루스나스닥바이오지수서빠져,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004210828
11289,2020-12-16,제약업계따뜻한손길④대웅제약참지마요ing발달장애인과비대면소통,http://www.wolyo.co.kr/news/articleView.html?idxno=113240
11290,2020-12-16,메디톡스VS대웅보톡스분쟁16일최종판결진쪽은치명상,http://www.newsway.co.kr/news/view?tp=1&ud=2020121517055235620
11291,2020-12-16,코로나19치료제임상셀트리온GC녹십자종근당대웅제약앞서,http://www.kpinews.co.kr/news/articleView.html?idxno=133129
11292,2020-12-16,대웅메디톡스소송비만400억원소모전또미뤄질가능성도,http://daily.hankooki.com/lpage/industry/202012/dh20201216170012148390.htm?s_ref=nv
11293,2020-12-16,오늘의토막뉴스두차례연기된메디톡스대웅제약최종판결이번엔결판外,http://www.youthdaily.co.kr/news/article.html?no=56268
11294,2020-12-16,퇴근길제약Pin앙숙된대웅제약vs메디톡스보톡스분쟁판결D1外,http://www.pinpointnews.co.kr/view.php?ud=20201216174851797f090c8dbcb_45
11295,2020-12-17,보툴리눔톡신3Q처방시장대웅제약나보타1위,http://www.press9.kr/news/articleView.html?idxno=46589
11296,2020-12-17,메디톡스대웅제약휴젤질병청에균주출처자료제출,http://www.ccreview.co.kr/news/articleView.html?idxno=298480
11297,2020-12-17,속보美ITC메디톡스손들어줘대웅제약21개월간수입금지,http://www.newspim.com/news/view/20201217000039
11298,2020-12-17,속보미ITC메디톡스손들어줘대웅제약21개월간수입금지,http://www.getnews.co.kr/news/articleView.html?idxno=505079
11299,2020-12-17,속보메디톡스손들어준美ITC대웅제약21개월간수입금지,https://view.asiae.co.kr/article/2020121706594110877
11300,2020-12-17,다우지수코로나확진폭발다우지수혼조메디톡스대웅제약셀트리온주가에어떤영향,http://www.pinpointnews.co.kr/view.php?ud=202012170700427134861beb2d9d_45
11301,2020-12-17,속보메디톡스손들어준美ITC대웅제약제품21개월간수입금지,https://www.fetv.co.kr/news/article.html?no=71676
11302,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월간수입금지속보,http://www.edaily.co.kr/news/newspath.asp?newsid=01492406625999504
11303,2020-12-17,미ITC메디톡스손들어줘대웅21개월간수입금지,http://www.dailypharm.com/Users/News/NewsView.html?ID=271605&REFERER=NP
11304,2020-12-17,속보美ITC메디톡스손들어줘대웅제약21개월수입금지,https://www.etoday.co.kr/news/view/1974773
11305,2020-12-17,속보미ITC메디톡스손들어줬다대웅제약21개월간수입금지,http://www.ccreview.co.kr/news/articleView.html?idxno=298485
11306,2020-12-17,속보메디톡스손들어준미ITC대웅제약21개월간수입금지,http://www.gukjenews.com/news/articleView.html?idxno=2127729
11307,2020-12-17,미ITC메디톡스손들어줘대웅제약21개월간수입금지,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121707214148316
11308,2020-12-17,속보메디톡스손들어준미ITC대웅제약21개월간수입금지,http://www.anewsa.com/detail.php?number=2306306&thread=10
11309,2020-12-17,ITC최종결과메디톡스손들어줘대웅21개월간수입금지,http://medipana.com/news/news_viewer.asp?NewsNum=268554&MainKind=A&NewsKind=5&vCount=12&vKind=1
11310,2020-12-17,보톡스분쟁서메디톡스승리美ITC대웅제약21개월수입금지”,https://news.joins.com/article/olink/23542289
11311,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월간수입금지,https://www.ekn.kr/web/view.php?key=20201217010004204
11312,2020-12-17,속보메디톡스손들어준ITC대웅제약21개월수입금지,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012170035&t=NN
11313,2020-12-17,메디톡스손들어준ITC대웅제약관세법위반21개월간수입금지1보,http://www.ccreview.co.kr/news/articleView.html?idxno=298487
11314,2020-12-17,속보ITC대웅제약에21개월수입금지판결메디톡스균주분쟁마침표,http://www.anewsa.com/detail.php?number=2306309&thread=10
11315,2020-12-17,보톡스분쟁서메디톡스승소美ITC대웅제약21개월수입금지,http://www.getnews.co.kr/news/articleView.html?idxno=505092
11316,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월수입금지,http://yna.kr/AKR20201217024800017?did=1195m
11317,2020-12-17,美ITC메디톡스에손대웅제약21개월간수입금지,https://www.ebn.co.kr/news/view/1464222/?sc=Naver
11318,2020-12-17,美ITC대웅제약나보타21개월간수입금지,https://www.paxnetnews.com/articles/68669
11319,2020-12-17,속보메디톡스손들어준美ITC대웅제약21개월수입금지,http://news.mt.co.kr/mtview.php?no=2020121707484791349
11320,2020-12-17,보톡스분쟁美ITC대웅21개월수입금지대웅집행정지신청할것,https://biz.chosun.com/site/data/html_dir/2020/12/17/2020121700431.html?utm_source=naver&utm_medium=original&utm_campaign=biz
11321,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월수입금지,https://www.etoday.co.kr/news/view/1974779
11322,2020-12-17,속보美ITC대웅제약나보타21개월수입금지최종결정,http://www.newsis.com/view/?id=NISX20201217_0001273214&cID=13001&pID=13000
11323,2020-12-17,전승호대웅제약대표사실상승리균주도용혐의벗어,https://view.asiae.co.kr/article/2020121707550189093
11324,2020-12-17,보톡스분쟁판결메디톡스승대웅제약21개월수입금지”,https://cnbc.sbs.co.kr/article_hub/10001006039?division=NAVER
11325,2020-12-17,속보메디톡스균주분쟁마무리ITC대웅제약관세법위반21개월간수입금지,http://www.gukjenews.com/news/articleView.html?idxno=2127744
11326,2020-12-17,보톡스분쟁서메디톡스손들어준美ITC대웅제약21개월수입금지,https://www.seoul.co.kr/news/newsView.php?id=20201217500012&wlog_tag3=naver
11327,2020-12-17,속보메디톡스가이겼다미ITC대웅나보타21개월수입금지확정,http://moneys.mt.co.kr/news/mwView.php?no=2020121707548088093
11328,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월간수입금지”,http://www.newsway.co.kr/news/view?tp=1&ud=2020121707514841233
11329,2020-12-17,美ITC나보타21개월수입금지대웅즉각항소,http://www.dailypharm.com/Users/News/NewsView.html?ID=271607&REFERER=NP
11330,2020-12-17,속보美ITC보톡스분쟁최종판결대웅제약나보타21개월수입금지,https://www.hankyung.com/it/article/202012177685i
11331,2020-12-17,ITC대웅제약나보타21개월수입금지,http://www.shinailbo.co.kr/news/articleView.html?idxno=1355681
11332,2020-12-17,美ITC보톡스분쟁서메디톡스손들어줬다대웅제약21개월수입금지,https://www.sedaily.com/NewsView/1ZBPVYQU8U
11333,2020-12-17,속보미국ITC대웅제약나보타21개월간수입금지,http://www.fnnews.com/news/202012170757410833
11334,2020-12-17,대웅제약균주전쟁승리ITC결정영향없이글로벌사업지속확대,http://www.thebigdata.co.kr/view.php?ud=202012170803333229798818e98b_23
11335,2020-12-17,ITC나보타21개월수입금지대웅제약美수출길제동,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137774&REFERER=NP
11336,2020-12-17,5년만에결론난보톡스전쟁美ITC대웅제약21개월간수입금지상보,https://view.asiae.co.kr/article/2020121708070232357
11337,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅21개월수입금지종합,http://yna.kr/AKR20201217024851017?did=1195m
11338,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월수입금지,https://news.sbs.co.kr/news/endPage.do?news_id=N1006127285&plink=ORI&cooper=NAVER
11339,2020-12-17,속보美ITC대웅제약나보타21개월수입금지최종결정,http://www.pinpointnews.co.kr/view.php?ud=20201217081015603861beb2d9d_45
11340,2020-12-17,美ITC메디톡스승리판결대웅제약나보타21개월간수입금지,http://www.sisajournal-e.com/news/articleView.html?idxno=227109
11341,2020-12-17,공시대웅제약코로나치료제DWJ1248임상변경계획식약처승인”,http://www.newsway.co.kr/news/view?tp=1&ud=2020121708134467767
11342,2020-12-17,그래픽메디톡스대웅제약보톡스원료분쟁주요일지,http://yna.kr/GYH20201217000400044?did=1363m
11343,2020-12-17,보톡스분쟁최종승자는메디톡스美ITC대웅21개월수입금지,https://www.asiatoday.co.kr/view.php?key=20201217010010757
11344,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월수입금지,http://news.mt.co.kr/mtview.php?no=2020121707530888891
11345,2020-12-17,대웅제약균주는더이상시비거리아냐ITC위원회예비판결뒤집어,http://www.segye.com/content/html/2020/12/17/20201217503469.html?OutUrl=naver
11346,2020-12-17,메디톡스보톡스전쟁승리대웅즉각항소할것,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012170044&t=NN
11347,2020-12-17,美ITC메디톡스손들어줘대웅제약나보타21개월간수입금지,http://www.newspim.com/news/view/20201217000096
11348,2020-12-17,공시대웅제약식약처코로나19치료제DWJ1248임상시험계획변경승인,http://www.fnnews.com/news/202012170817419394
11349,2020-12-17,4년걸친보톡스분쟁메디톡스승리美ITC대웅제약나보타21개월수입금지”,https://www.fetv.co.kr/news/article.html?no=71680
11350,2020-12-17,메디톡스美ITC대웅나보타21개월수입금지도용혐의밝혀진것,http://www.newspim.com/news/view/20201217000106
11351,2020-12-17,균주전쟁메디톡스승리ITC대웅제약21개월간수입금지판결상보,http://moneys.mt.co.kr/news/mwView.php?no=2020121708158042232
11352,2020-12-17,보톡스전쟁대웅제약패소ITC21개월수입금지조치”,http://www.thevaluenews.co.kr/news/view.php?idx=161897
11353,2020-12-17,미국ITC대웅제약나보타수입금지10년→21개월판결,https://www.news1.kr/articles/?4152845
11354,2020-12-17,대웅제약균주전쟁승리사실상ITC승소,http://www.medisobizanews.com/news/articleView.html?idxno=75020
11355,2020-12-17,메디톡스손들어준美ITC대웅나보타21개월수입금지,http://news.mt.co.kr/mtview.php?no=2020121708160530452
11356,2020-12-17,미국국제무역위원회대웅나보타21개월수입금지,http://www.newstomato.com/ReadNews.aspx?no=1013454
11357,2020-12-17,증시키워드메디톡스대웅제약보톡스분쟁종료삼성전자개인vs외인엇갈린투심,https://www.etoday.co.kr/news/view/1974805
11358,2020-12-17,ITC최종판결에메디톡스제조공정도용혐의밝혀진것VS대웅제약예비판결뒤집혀,http://www.segye.com/content/html/2020/12/17/20201217503574.html?OutUrl=naver
11359,2020-12-17,메디톡스미국에서균주소송승리대웅제약21개월간미국수출금지,http://www.businesspost.co.kr/BP?command=article_view&num=209009
11360,2020-12-17,메디톡스보톡스분쟁최종승자미ITC대웅제약21개월수입금지,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4373870
11361,2020-12-17,대웅메디톡스보톡스분쟁美ITC대웅21개월수입금지”,https://www.chosun.com/economy/science/2020/12/17/YBASQX3UKFEZLPMCRRR2HGZTPU/?utm_source=naver&utm_medium=referral&utm_campaign=naver-news
11362,2020-12-17,메디톡스보톡스균주분쟁승리대웅21개월수입금지,http://biz.newdaily.co.kr/site/data/html/2020/12/17/2020121700009.html
11363,2020-12-17,美ITC메디톡스손들어줘대웅제약21개월간수입금지”상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01649846625999504
11364,2020-12-17,보톡스분쟁서메디톡스승리대웅제약판결뒤집겠다종합,http://it.chosun.com/site/data/html_dir/2020/12/17/2020121700512.html
11365,2020-12-17,대웅제약코로나19치료제임상계획변경승인,http://www.pinpointnews.co.kr/view.php?ud=202012170832468343cd1e7f0bdf_45
11366,2020-12-17,미ITC메디톡스손들어줘대웅제약21개월수입금지,https://www.hankyung.com/economy/article/2020121778037
11367,2020-12-17,대웅제약코로나치료제임상23상시험계획변경승인,http://www.itooza.com/common/iview.php?no=2020121708302808072
11368,2020-12-17,대웅제약코로나치료제임상시험계획변경승인,https://view.asiae.co.kr/article/2020121708394938466
11369,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅21개월수입금지,http://news.heraldcorp.com/view.php?ud=20201217000072
11370,2020-12-17,마침표찍은보톡스전쟁美ITC대웅제약나보타21개월수입금지,http://news.tf.co.kr/read/economy/1832070.htm
11371,2020-12-17,美ITC대웅제약메디톡스최종판결사실상대웅제약승리,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012170823169920401
11372,2020-12-17,메디톡스보톡스분쟁서승리美ITC대웅제약21개월수입금지,http://www.joynews24.com/view/1327505
11373,2020-12-17,美ITC메디톡스손들어줘대웅제약나보타21개월수입금지종합,http://www.newsis.com/view/?id=NISX20201217_0001273295&cID=13001&pID=13000
11374,2020-12-17,美ITC메디톡스손대웅나보타21개월수입금지,http://www.seoulfn.com/news/articleView.html?idxno=404606
11375,2020-12-17,메디톡스손들어준美ITC대웅제약나보타21개월수입금지,http://www.viva100.com/main/view.php?key=20201217010004226
11376,2020-12-17,미ITC메디톡스손들어줘대웅21개월수입금지,http://www.mediapen.com/news/view/584360
11377,2020-12-17,대웅제약코로나19치료제대규모23상변경승인,https://www.asiatoday.co.kr/view.php?key=20201217010010783
11378,2020-12-17,대웅ITC균주영업비밀예비결정완전번복더이상시비거리아냐,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252639
11379,2020-12-17,종합보톡스분쟁서메디톡스승소美ITC대웅제약21개월수입금지,http://www.getnews.co.kr/news/articleView.html?idxno=505104
11380,2020-12-17,메디톡스美ITC최종승소대웅제약나보타21개월수입금지,http://www.kpinews.co.kr/news/articleView.html?idxno=133145
11381,2020-12-17,美ITC대웅제약21개월수입금지”,http://www.sentv.co.kr/news/view/584956
11382,2020-12-17,대웅제약코로나19치료제23상변경승인,http://www.press9.kr/news/articleView.html?idxno=46593
11383,2020-12-17,대웅제약코로나치료제호이스타정대규모임상연구개시,https://www.ekn.kr/web/view.php?key=20201217010004238
11384,2020-12-17,보톡스분쟁서메디톡스승대웅제약21개월간수입금지”,https://www.donga.com/news/article/all/20201217/104484775/1
11385,2020-12-17,ITC보톡스판결에메디톡스도용혐의유죄VS대웅항소할것,https://www.etoday.co.kr/news/view/1974825
11386,2020-12-17,보톡스분쟁메디톡스대웅美ITC판결에둘다우리가승리,http://yna.kr/AKR20201217036400017?did=1195m
11387,2020-12-17,ITC균주영업비밀아냐제조기술은도용대웅21개월수입금지종합,https://www.news1.kr/articles/?4152873
11388,2020-12-17,메디톡스대웅제약분쟁ITC대웅나보타21개월수입금지”,http://www.fnnews.com/news/202012170845475203
11389,2020-12-17,대웅제약코로나19치료제임상3상병합승인획득대규모연구개시”,http://www.youthdaily.co.kr/news/article.html?no=56323
11390,2020-12-17,대웅제약ITC균주는영업비밀아니라고판단사실상승소,http://news.mt.co.kr/mtview.php?no=2020121708460094764
11391,2020-12-17,대웅제약호이스타정23상변경승인으로코로나19치료제개발눈앞,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65270
11392,2020-12-17,대웅제약코로나치료제호이스타대규모23상변경승인,http://www.newsis.com/view/?id=NISX20201217_0001273343&cID=13001&pID=13000
11393,2020-12-17,글로벌코로나19치료제개발눈앞대웅제약호이스타정대규모23상변경승인,http://theviewers.co.kr/View.aspx?No=1385693
11394,2020-12-17,메디톡스승리확신대웅제약의균주와제조공정도용혐의밝혀졌다”,http://www.pinpointnews.co.kr/view.php?ud=202012170905414060f090c8dbcb_45
11395,2020-12-17,대웅제약대웅모두상승세로특히대웅제약가파른상승세로4상승,http://www.econonews.co.kr/news/articleView.html?idxno=149424
11396,2020-12-17,메디톡스보톡스전쟁승리대웅나보타21개월수입금지,http://www.cstimes.com/news/articleView.html?idxno=443427
11397,2020-12-17,대웅제약호이스타정임상23상병합승인코로나19치료제내년1월출시목표,https://www.etoday.co.kr/news/view/1974840
11398,2020-12-17,보톡스분쟁메디톡스승리대웅항소할것”,http://www.newsway.co.kr/news/view?tp=1&ud=2020121709055060262
11399,2020-12-17,ITC나보타21개월수입금지대웅가처분항소,http://www.shinailbo.co.kr/news/articleView.html?idxno=1355709
11400,2020-12-17,美ITC대웅나보타21개월수입금지K보톡스전쟁서메디톡스승리,http://www.m-i.kr/news/articleView.html?idxno=776927
11401,2020-12-17,대웅제약호이스타정대규모임상23상변경승인,https://www.hankyung.com/it/article/202012177991i
11402,2020-12-17,대웅제약호이스타정23상병합승인으로연내대규모연구개시,https://www.dailian.co.kr/news/view/947257/?sc=Naver
11403,2020-12-17,대웅제약호이스타정23상변경승인코로나19치료제개발눈앞,https://www.fetv.co.kr/news/article.html?no=71692
11404,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252641
11405,2020-12-17,메디톡스대웅제약소송패자없다주가동반강세,http://news.mt.co.kr/mtview.php?no=2020121709145562306
11406,2020-12-17,메디톡스보톡스전쟁승대웅제약사실상승소주장,https://www.paxnetnews.com/articles/68671
11407,2020-12-17,ITC최종결과나왔지만대웅메디톡스엇갈린승소해석,http://medipana.com/news/news_viewer.asp?NewsNum=268556&MainKind=A&NewsKind=5&vCount=12&vKind=1
11408,2020-12-17,메디톡스美ITC대웅의균주제조공정도용혐의확정,http://www.press9.kr/news/articleView.html?idxno=46592
11409,2020-12-17,대웅제약ITC명백한오판항소통해최종승리확신,http://www.newspim.com/news/view/20201217000190
11410,2020-12-17,대웅제약균주분쟁승기사실상ITC승소,http://www.press9.kr/news/articleView.html?idxno=46591
11411,2020-12-17,대웅제약코로나치료제호이스타정23상변경승인내년1월출시목표,http://www.viva100.com/main/view.php?key=20201217010004245
11412,2020-12-17,미국ITC대웅제약나보타21개월수입금지,https://www.econovill.com/news/articleView.html?idxno=510632
11413,2020-12-17,메디톡스보톡스분쟁승勝美ITC대웅21개월수입금지,http://www.dailymedi.com/detail.php?number=864106&thread=22r05
11414,2020-12-17,공시대웅제약美ITC나보타21개월수입금지판결,http://www.fnnews.com/news/202012170919168813
11415,2020-12-17,美ITC메디톡스승소판결에엇갈린반응대웅판결뒤집을것,https://www.ekn.kr/web/view.php?key=20201217010004252
11416,2020-12-17,특징주보톡스전쟁에서패소한대웅제약주가는상승세,https://www.sedaily.com/NewsView/1ZBPW15BIS
11417,2020-12-17,특징주대웅제약보톡스소송戰리스크해소에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01866326625999504
11418,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.lawissue.co.kr/view.php?ud=202012170855214348204ead0791_12
11419,2020-12-17,대웅제약호이스타정코로나192상→23상변경승인대규모임상개시,http://www.medisobizanews.com/news/articleView.html?idxno=75024
11420,2020-12-17,보톡스전쟁메디톡스승기미국ITC대웅21개월동안수입금지,http://www.dt.co.kr/contents.html?article_no=2020121702109931820001&ref=naver
11421,2020-12-17,보톡스전쟁결국메디톡스승ITC대웅제약21개월간수입금지,http://www.whitepaper.co.kr/news/articleView.html?idxno=199766
11422,2020-12-17,대웅제약코로나치료제호이스타정대규모23상개시내년1월출시목표,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124650
11423,2020-12-17,나보타美판매금지21개월ITC판결에메디톡스대웅서로승리주장이유는,http://moneys.mt.co.kr/news/mwView.php?no=2020121708398090913
11424,2020-12-17,美ITC메디톡스손들어줬다대웅제약21개월수입금지,http://www.metroseoul.co.kr/article/20201217500017
11425,2020-12-17,메디톡스손들어준美ITC대웅제약나보타21개월수입금지메디톡스주가도훨훨종합,http://www.ccreview.co.kr/news/articleView.html?idxno=298497
11426,2020-12-17,대웅제약ITC예비판결뒤집어사실상승소,http://www.businesskorea.co.kr/news/articleView.html?idxno=56930
11427,2020-12-17,美ITC보톡스분쟁서메디톡스손대웅제약21개월수입금지,http://www.ezyeconomy.com/news/articleView.html?idxno=108070
11428,2020-12-17,대웅제약코로나치료제호이스타정대규모23상변경승인,http://www.fnnews.com/news/202012170919509034
11429,2020-12-17,美ITC최종판결서메디톡스손들어줘대웅나보타21개월영업정지명령,http://www.greened.kr/news/articleView.html?idxno=280249
11430,2020-12-17,ITC메디톡스승소대웅판결뒤집겠다,https://www.ebn.co.kr/news/view/1464274/?sc=Naver
11431,2020-12-17,대웅제약호이스타정코로나19대규모임상23상승인,http://yna.kr/AKR20201217044200017?did=1195m
11432,2020-12-17,균주전쟁美ITC메디톡스손들어줬다대웅제약끝까지싸워진실밝힐것”,http://www.ajunews.com/view/20201217092359832
11433,2020-12-17,메디톡스손들어준美ITC보톡스소송최종판결후대웅제약이더강세왜,http://news.mk.co.kr/newsRead.php?no=1293486&year=2020
11434,2020-12-17,보톡스분쟁메디톡스승美ITC대웅제약나보타21개월수입금지,http://www.etnews.com/20201217000013
11435,2020-12-17,대웅제약호이스타정대규모23상변경승인코로나19치료제개발눈앞,http://www.thebigdata.co.kr/view.php?ud=202012170926078208798818e98b_23
11436,2020-12-17,끝나지않는대웅메디톡스보톡스전쟁절반의승리에2라운드,http://news.heraldcorp.com/view.php?ud=20201217000135
11437,2020-12-17,공시대웅제약美ITC최종결정집행정지가처분신청법원항소제기예정,http://www.newsway.co.kr/news/view?tp=1&ud=2020121709274010612
11438,2020-12-17,보톡스분쟁메디톡스승리미국ITC대웅21개월수입금지”,http://www.busan.com/view/busan/view.php?code=2020121709054942560
11439,2020-12-17,대웅제약메디톡스동반상승5년간의보톡스분쟁끝,https://www.hankyung.com/finance/article/2020121781416
11440,2020-12-17,특징주내가승자”메디톡스대웅제약美ITC판결에개장후급등,http://news.heraldcorp.com/view.php?ud=20201217000134
11441,2020-12-17,대웅제약호이스타정23상병합승인연구연내개시,http://medipana.com/news/news_viewer.asp?NewsNum=268562&MainKind=A&NewsKind=5&vCount=12&vKind=1
11442,2020-12-17,대웅제약호이스타정대규모23상변경승인코로나19치료제개발눈앞,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012170925082250437
11443,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.mhj21.com/137791
11444,2020-12-17,ITC나보타21개월수입금지결정메디톡스대웅유죄확정,http://www.wikileaks-kr.org/news/articleView.html?idxno=100473
11445,2020-12-17,대웅제약코로나치료제호이스타대규모23상변경승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020121709321348235
11446,2020-12-17,특징주보톡스분쟁ITC판결에메디톡스대웅제약동반강세,https://www.news1.kr/articles/?4152976
11447,2020-12-17,보톡스분쟁메디톡스승리대웅제약나보타21개월수입금지,http://www.newsprime.co.kr/news/article.html?no=527827
11448,2020-12-17,ITC나보타21개월수입금지결정대웅제약사실상승소,http://www.medigatenews.com/news/3634299707
11449,2020-12-17,특징주우리가승자대웅제약메디톡스동반강세,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573766742194
11450,2020-12-17,보톡스분쟁대웅제약판결뒤집을것항소하겠다메디톡스승리,http://www.ggilbo.com/news/articleView.html?idxno=816210
11451,2020-12-17,식약처대웅제약코로나치료제호이스타23상변경승인,http://www.beyondpost.co.kr/view.php?ud=20201217094305822246a9e4dd7f_30
11452,2020-12-17,대웅제약코로나치료제호이스타정대규모임상개시,http://www.wolyo.co.kr/news/articleView.html?idxno=113263
11453,2020-12-17,미국ITC대웅제약나보타21개월간수입금지,http://www.queen.co.kr/news/articleView.html?idxno=348613
11454,2020-12-17,대웅제약호이스타정대규모임상23상변경승인,http://www.dt.co.kr/contents.html?article_no=2020121702109931820006&ref=naver
11455,2020-12-17,대웅제약호이스타정임상23상동시에코로나19치료제개발눈앞,http://www.metroseoul.co.kr/article/20201217500057
11456,2020-12-17,나보타21개월수입금지수용못해대웅제약집행정지가처분신청,http://www.wikileaks-kr.org/news/articleView.html?idxno=100479
11457,2020-12-17,대웅제약경구형코로나19치료제개발박차호이스타정대규모23상변경승인,http://kbench.com/?q=node/216881
11458,2020-12-17,美ITC대웅메디톡스보톡스전쟁최종판결대웅21개월수입금지,http://www.enewstoday.co.kr/news/articleView.html?idxno=1436754
11459,2020-12-17,美ITC최종판결에메디톡스승리vs대웅제약사실상승리,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005815
11460,2020-12-17,대웅제약코로나19치료제대규모임상23상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012170107&t=NN
11461,2020-12-17,美ITC보톡스분쟁메디톡스손들어줘대웅제약항소할것,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572431008429
11462,2020-12-17,미국ITC최종판결서대웅제약나보타21개월수입금지종합2보,http://yna.kr/AKR20201217024852017?did=1195m
11463,2020-12-17,대웅제약코로나19치료제호이스타정대규모23상변경승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=409253
11464,2020-12-17,코스피2760선출발ITC판결에메디톡스대웅제약출렁,http://www.opinionnews.co.kr/news/articleView.html?idxno=44205
11465,2020-12-17,대웅제약코로나19치료제DWJ1248임상시험계획변경승인,https://www.asiatoday.co.kr/view.php?key=20201217010010876
11466,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.pressm.kr/news/articleView.html?idxno=35344
11467,2020-12-17,美ITC메디톡스손들어줘대웅ITC판결명백한오류,http://www.upinews.kr/newsView/upi202012170012
11468,2020-12-17,美ITC결국메디톡스손들어줘대웅제약21개월수입금지,http://www.sporbiz.co.kr/news/articleView.html?idxno=504629
11469,2020-12-17,美ITC나보타소송메디톡스손들어줘대웅제약21개월수입금지,http://www.wolyo.co.kr/news/articleView.html?idxno=113260
11470,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅21개월수입금지”,http://news.kmib.co.kr/article/view.asp?arcid=0015332675&code=61141111&cp=nv
11471,2020-12-17,특징주5년만보톡스분쟁끝대웅제약15급등메디톡스3↑,https://www.asiatoday.co.kr/view.php?key=20201217010010888
11472,2020-12-17,소송결과는메디톡스승하지만주가는대웅제약,https://www.chosun.com/economy/stock-finance/2020/12/17/Y7H3XUHJZRH4ZLZMKPIDON4RF4/?utm_source=naver&utm_medium=referral&utm_campaign=naver-news
11473,2020-12-17,대웅메디톡스와ITC소송승리선언,http://www.whosaeng.com/123352
11474,2020-12-17,대웅제약글로벌코로나19치료제개발눈앞,http://www.businesskorea.co.kr/news/articleView.html?idxno=56940
11475,2020-12-17,ITC보툴리눔균주영업비밀아냐메디톡스대웅제약우리가승리,http://www.segye.com/content/html/2020/12/17/20201217505556.html?OutUrl=naver
11476,2020-12-17,대웅제약개발중코로나치료제호이스타정대규모23상변경승인,https://www.econovill.com/news/articleView.html?idxno=510664
11477,2020-12-17,보톡스분쟁메디톡스대웅美ITC판결에둘다우리가승리,http://www.fntoday.co.kr/news/articleView.html?idxno=244420
11478,2020-12-17,막내린균주논란대웅제약보톡스21개월수입금지,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121709382176088
11479,2020-12-17,보톡스분쟁메디톡스승리美ITC대웅제약21개월수입금지,http://www.fntoday.co.kr/news/articleView.html?idxno=244414
11480,2020-12-17,보톡스분쟁美ITC판결놓고우리가이겼다는메디톡스대웅제약,http://www.getnews.co.kr/news/articleView.html?idxno=505122
11481,2020-12-17,美ITC보톡스분쟁서메디톡스에손대웅항소할것”종합,http://www.edaily.co.kr/news/newspath.asp?newsid=02076246625999504
11482,2020-12-17,특징주美ITC판결서패소한대웅제약주가왜오르지,http://daily.hankooki.com/lpage/finance/202012/dh20201217100954148310.htm?s_ref=nv
11483,2020-12-17,대웅호이스타정23상임상연내착수,http://www.whosaeng.com/123359
11484,2020-12-17,메디톡스대웅제약과보톡스전쟁승리美ITC나보타21개월수입금지,http://www.newsquest.co.kr/news/articleView.html?idxno=80380
11485,2020-12-17,美ITC보톡스분쟁최종판결서메디톡스손대웅제약사실상승소”,http://www.thepowernews.co.kr/view.php?ud=2020121710025750213c89f9c076_7
11486,2020-12-17,특징주메디톡스대웅제약美ITC판결에개장후양사모두급등,http://www.fnnews.com/news/202012171016391138
11487,2020-12-17,보톡스분쟁메디톡스승리미ITC대웅제약나보타21개월수입금지,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4374054
11488,2020-12-17,美ITC대웅제약나보타21개월수입금지메디톡스손들어줘,http://www.wsobi.com/news/articleView.html?idxno=110555
11489,2020-12-17,대웅제약코로나19치료제호이스타정대규모23상변경승인,http://www.newstomato.com/ReadNews.aspx?no=1013490
11490,2020-12-17,美ITC대웅vs메디톡스균주도용인정했나안했나갑론을박,http://www.newsis.com/view/?id=NISX20201217_0001273536&cID=13001&pID=13000
11491,2020-12-17,보톡스분쟁美ITC대웅나보타21개월수입중지”,http://www.biospectator.com/view/news_view.php?varAtcId=12091
11492,2020-12-17,올상반기완제의약품생산한미종근당대웅순으로많아,http://www.medisobizanews.com/news/articleView.html?idxno=75031
11493,2020-12-17,보톡스분쟁서메디톡스승리ITC대웅나보타21개월수입금지명령,http://sports.hankooki.com/lpage/economy/202012/sp20201217101944137020.htm?s_ref=nv
11494,2020-12-17,메디톡스대웅제약주가초반다올라균주소송판결에불확실성해소,http://www.businesspost.co.kr/BP?command=article_view&num=209021
11495,2020-12-17,메디톡스보톡스전쟁승리美ITC대웅제약나보타21개월수입금지,http://www.sisafocus.co.kr/news/articleView.html?idxno=252369
11496,2020-12-17,美ITC판결패소에도대웅제약장중급등왜,http://www.choicenews.co.kr/news/articleView.html?idxno=77420
11497,2020-12-17,美ITC대웅제약나보타21개월수입금지명령,http://www.healthinnews.co.kr/news/articleView.html?idxno=20817
11498,2020-12-17,대웅제약호이스타정대규모23상변경승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=20818
11499,2020-12-17,보톡스소송메디톡스대웅제약결국상처만진정한승자는변호사들,http://4th.kr/View.aspx?No=1385610
11500,2020-12-17,메디톡스손들어준美ITC대웅제약나보타21개월수입금지,https://www.hankyung.com/it/article/2020121785157
11501,2020-12-17,미국ITC대웅제약나보타21개월수입금지,https://imnews.imbc.com/news/2020/econo/article/6030015_32647.html
11502,2020-12-17,대웅제약나보타10년수입금지→21개월수입금지영업비밀아닌점인정받아사실상승소,http://www.newslock.co.kr/news/articleView.html?idxno=34119
11503,2020-12-17,보톡스분쟁메디톡스손들어줬다대웅제약항소를통해최종승리를확신한다,http://www.anewsa.com/detail.php?number=2306462&thread=10
11504,2020-12-17,대웅제약코로나19치료제호이스타정식약처23상변경승인,https://health.chosun.com/site/data/html_dir/2020/12/17/2020121701180.html
11505,2020-12-17,美ITC보톡스분쟁최종판결대웅메디톡스또서로승소국내균주출처논란주목,https://biz.chosun.com/site/data/html_dir/2020/12/17/2020121701193.html?utm_source=naver&utm_medium=original&utm_campaign=biz
11506,2020-12-17,메디톡스대웅제약과의보톡스분쟁승리에도주가는비실비실,http://www.g-enews.com/ko-kr/news/article/news_all/202012170915208298edf69f862c_1/article.html
11507,2020-12-17,나보타수입금지10년→21개월대웅제약보톡스전쟁사실상승리,http://news.tf.co.kr/read/economy/1832113.htm
11508,2020-12-17,대웅제약코로나19치료제대규모23상병합승인,http://sports.hankooki.com/lpage/economy/202012/sp20201217104125137020.htm?s_ref=nv
11509,2020-12-17,ITC대웅제약보톡스21개월수입제한명령,https://www.nocutnews.co.kr/news/5466597
11510,2020-12-17,특징주대웅제약보톡스분쟁패소에도강세,https://view.asiae.co.kr/article/2020121710483156503
11511,2020-12-17,대웅제약보톡스균주도용주장뒤집혔다균주전쟁사실상승소판단”,https://www.donga.com/news/article/all/20201217/104487253/1
11512,2020-12-17,전화연결글로벌경제에코로나19백신훈풍파월제로금리유지결정직후백신소식매우긍정적내년2분기경제강할것2년만에마무리된보톡스균주소송메디톡스승리美ITC대웅2,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004211728
11513,2020-12-17,美ITC최종판결에메디톡스승소vs대웅제약사실상승소,http://www.seoulwire.com/news/articleView.html?idxno=431955
11514,2020-12-17,보톡스분쟁서메디톡스승리대웅제약항소할것”,http://www.mdtoday.co.kr/mdtoday/index.html?no=409262
11515,2020-12-17,올해상반기완제의약품생산액10조돌파한미종근당대웅순,http://www.medigatenews.com/news/737436166
11516,2020-12-17,이데일리N美ITC메디톡스손들어줘대웅제약21개월수입금지外,http://www.edaily.co.kr/news/newspath.asp?newsid=02368166625999504
11517,2020-12-17,美보톡스전쟁서메디톡스승대웅제약나보타21개월수입금지,http://www.sportsseoul.com/news/read/993789?ref=naver
11518,2020-12-17,미국제무역위원회대웅제약보톡스제품21개월수입금지,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202012171105001&code=970100
11519,2020-12-17,주식초고수는지금셀트리온3형제인기여전대웅제약도관심,https://www.sedaily.com/NewsView/1ZBPWIMIAF
11520,2020-12-17,보톡스균주전쟁메디톡스승리로끝나대웅나보타21개월수입금지,http://www.babytimes.co.kr/news/articleView.html?idxno=41940
11521,2020-12-17,대웅제약코로나19치료제호이스타정대규모23상변경승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574363084732
11522,2020-12-17,美ITC보톡스분쟁메디톡스손들어줬다대웅21개월수입금지,http://www.startuptoday.co.kr/news/articleView.html?idxno=64453
11523,2020-12-17,부자들은경제신문을읽는다메디톡스승리에도대웅제약동반강세왜,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121711110183456
11524,2020-12-17,서로이겼다대웅vs메디톡스보톡스전쟁결말어떻게된걸까,https://www.seoul.co.kr/news/newsView.php?id=20201217500048&wlog_tag3=naver
11525,2020-12-17,보톡스분쟁美ITC판결메디톡스도용혐의밝혀진것”vs대웅사실상승소”또엇갈린주장,http://www.thepublic.kr/news/newsview.php?ncode=1065578595940852
11526,2020-12-17,대웅제약호이스타정대규모23상변경승인글로벌코로나19치료제개발눈앞,http://www.thepublic.kr/news/newsview.php?ncode=1065574540129046
11527,2020-12-17,1년11개월의싸움미국ITC대웅제약나보타21개월수입금지,https://ilyo.co.kr/?ac=article_view&entry_id=387660
11528,2020-12-17,메디톡스ITC최종결정통해대웅도용혐의밝혀졌다”국내법원검찰언급,https://www.donga.com/news/article/all/20201217/104488446/1
11529,2020-12-17,특징주대웅제약메디톡스와보톡스분쟁패소에도강세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004211805
11530,2020-12-17,8할의성공대웅제약ITC판결여전히불만,http://www.bosa.co.kr/news/articleView.html?idxno=2140370
11531,2020-12-17,대웅제약美파트너스에볼루스합의조건포함해법적문제해결할것”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012171128293930526
11532,2020-12-17,이슈ITC보톡스분쟁메디톡스명분vs대웅제약실리챙겼다,http://www.newspim.com/news/view/20201217000464
11533,2020-12-17,신풍제약대웅제약제약주상승에급등까지신풍제약4상승이어대웅제약14급등,http://www.econonews.co.kr/news/articleView.html?idxno=149512
11534,2020-12-17,국제무역위원회ITC대웅제약나보타21개월수입금지명령,http://www.k-health.com/news/articleView.html?idxno=51509
11535,2020-12-17,대웅제약호이스타정23상변경승인코로나19치료제개발가속도,http://www.sisaweek.com/news/articleView.html?idxno=140188
11536,2020-12-17,대웅메디톡스보톡스전쟁절반의승리에또다시점화,http://news.heraldcorp.com/view.php?ud=20201217000586
11537,2020-12-17,대웅제약호이스타코로나임상대규모23상으로변경,http://daily.hankooki.com/lpage/industry/202012/dh20201217114149148390.htm?s_ref=nv
11538,2020-12-17,美ITC판결놓고대웅제약메디톡스동상이몽,http://news.mt.co.kr/mtview.php?no=2020121711270562956
11539,2020-12-17,메디톡스보톡스전쟁승리美ITC대웅제약제품21개월수입금지”,http://www.munhwa.com/news/view.html?no=2020121701072039342001
11540,2020-12-17,균주전쟁메디톡스절반의승리대웅제약최악피했다”,https://cnbc.sbs.co.kr/article_hub/10001006096?division=NAVER
11541,2020-12-17,美ITC대웅제약21개월수입금지대웅제약항소할것,http://www.lawissue.co.kr/view.php?ud=202012171145557942f4ab64559d_12
11542,2020-12-17,美ITC보톡스분쟁판결에메디톡스균주도용확인vs대웅사실상승리,http://sports.chosun.com/news/ntype.htm?id=202012180100136080008288&servicedate=20201217
11543,2020-12-17,메디톡스판정승미국ITC대웅나보타21개월수입금지판결,http://www.bizhankook.com/article/21131
11544,2020-12-17,특징주보톡스분쟁메디톡스대웅제약장중동반강세,http://yna.kr/AKR20201217089000002?did=1195m
11545,2020-12-17,美ITC대웅제약21개월수입금지메디톡스승리,http://www.obsnews.co.kr/news/articleView.html?idxno=1245310
11546,2020-12-17,미국ITC최종판결서대웅제약나보타21개월수입금지,http://www.seouleconews.com/news/articleView.html?idxno=58245
11547,2020-12-17,美ITC나보타21개월수입금지명령대웅제약사실상승소주장,http://www.newsfc.co.kr/news/articleView.html?idxno=43991
11548,2020-12-17,ITC최종결과두고메디톡스와대웅제약서로승리주장,http://www.monews.co.kr/news/articleView.html?idxno=216541
11549,2020-12-17,대웅제약코로나치료제호이스타정대규모변경승인치료제개발눈앞,http://www.koreaittimes.com/news/articleView.html?idxno=102548
11550,2020-12-17,메디톡스미ITC대웅의균주제조공정도용판결,http://www.kdfnews.com/news/articleView.html?idxno=63541
11551,2020-12-17,한미약품종근당대웅제약녹십자HK이노엔,http://www.dailymedi.com/detail.php?number=864119&thread=22r05
11552,2020-12-17,美ITC최종판결서메디톡스승소대웅항소하겠다”,http://inthenews.co.kr/article-83021/
11553,2020-12-17,대웅제약전승호대표균주사실상기각항소심서999승소할것,http://www.newsis.com/view/?id=NISX20201217_0001273854&cID=13001&pID=13000
11554,2020-12-17,보톡스분쟁서승기잡은메디톡스대웅제약사실상우리의승소,http://kormedi.com/?p=1329320
11555,2020-12-17,대웅제약코로나19치료제호이스타정23상변경승인받아,http://www.newsfc.co.kr/news/articleView.html?idxno=43995
11556,2020-12-17,메디톡스손들어준ITC판결대웅제약판정승주가급등,http://medipana.com/news/news_viewer.asp?NewsNum=268587&MainKind=A&NewsKind=5&vCount=12&vKind=1
11557,2020-12-17,종합美서결론난보톡스전쟁메디톡스이겼지만대웅제약도절반의성공,http://www.viva100.com/main/view.php?key=20201217010004334
11558,2020-12-17,대웅제약코로나19치료제호이스타정대규모23상변경승인,http://www.anewsa.com/detail.php?number=2306659&thread=10
11559,2020-12-17,대웅제약호이스타정코로나19치료제임상23상으로변경,http://www.mkhealth.co.kr/news/articleView.html?idxno=51486
11560,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.wsobi.com/news/articleView.html?idxno=110571
11561,2020-12-17,대웅제약23상변경승인으로코로나19치료제개발가속,http://www.economytalk.kr/news/articleView.html?idxno=209958
11562,2020-12-17,대웅제약ITC최종판정은긍정적이슈KTB證,http://www.itooza.com/common/iview.php?no=2020121711220919092
11563,2020-12-17,美ITC대웅메디톡스보톡스제조기술도용,http://www.finomy.com/news/articleView.html?idxno=86775
11564,2020-12-17,미ITC대웅나보타21개월간수입금지도용혐의일부인정,http://www.doctorstimes.com/news/articleView.html?idxno=213441
11565,2020-12-17,대웅제약미국ITC의21개월금지명령즉각가처분신청승리확신,http://www.ceoscoredaily.com/news/article.html?no=76327
11566,2020-12-17,보톡스전쟁ITC판결메디톡스대웅제약동상이몽,http://www.skyedaily.com/news/news_view.html?ID=118271
11567,2020-12-17,메디톡스대웅제약희비엇갈려메디톡스고꾸라지는주가반해대웅제약17급등,http://www.econonews.co.kr/news/articleView.html?idxno=149539
11568,2020-12-17,대웅제약호이스타코로나치료제대규모23상변경승인,http://www.kpinews.co.kr/news/articleView.html?idxno=133203
11569,2020-12-17,대웅제약호이스타정글로벌코로나19치료제개발눈앞,http://www.bosa.co.kr/news/articleView.html?idxno=2140379
11570,2020-12-17,보톡스분쟁진대웅제약그래도주가는날개달았다,http://www.ajunews.com/view/20201217131258037
11571,2020-12-17,오전시황해운제지제약업종강세HMM신풍제지메디콕스대웅제약훨훨이녹스이스타코급등,http://www.pinpointnews.co.kr/view.php?ud=202012171331086047cd1e7f0bdf_45
11572,2020-12-17,메디톡스대웅제약보톡스분쟁종지부국내후발주자엔악재,http://www.mediapen.com/news/view/584479
11573,2020-12-17,대웅제약코로나치료제임상시험계획변경승인,http://www.edaily.co.kr/news/newspath.asp?newsid=02742086625999504
11574,2020-12-17,대웅제약호이스타정코로나19임상23상변경승인,http://www.seoulfn.com/news/articleView.html?idxno=404693
11575,2020-12-17,대웅제약메디톡스와의나보타관련소송판결에항소,http://www.edaily.co.kr/news/newspath.asp?newsid=02748646625999504
11576,2020-12-17,대웅보톡스21개월수입금지”ITC판결에메디톡스대웅제약모두승리주장,http://news.kmib.co.kr/article/view.asp?arcid=0015333830&code=61141411&cp=nv
11577,2020-12-17,대웅제약먹는코로나19치료제임상23상을식약처로부터승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=209080
11578,2020-12-17,메디톡스대웅보톡스분쟁마무리수순상처만남았다,http://yna.kr/AKR20201217103200017?did=1195m
11579,2020-12-17,대웅제약코로나치료제호이스타정23상변경승인,http://www.koreastocknews.com/news/articleView.html?idxno=59966
11580,2020-12-17,21개월수입금지된나보타대웅제약아메리칸드림향방은,https://www.etoday.co.kr/news/view/1975058
11581,2020-12-17,코로나19치료제개발눈앞대웅제약호이스타정23상변경승인,http://www.thedailypost.kr/news/articleView.html?idxno=78196
11582,2020-12-17,보톡스분쟁메디톡스판정승미ITC대웅제약나보타21개월수입금지명령,http://www.newsworks.co.kr/news/articleView.html?idxno=513007
11583,2020-12-17,대웅제약코로나치료제임상3상대열합류호이스타정임상23상병합승인,https://www.donga.com/news/article/all/20201217/104491277/1
11584,2020-12-17,대웅제약균주도용혐의기각목표가상향할것KTB투자증권,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121714050777622
11585,2020-12-17,미국ITC보톡스분쟁서메디톡스손들어줘대웅제약항소할것 ,http://www.updownnews.co.kr/news/articleView.html?idxno=226417
11586,2020-12-17,대웅은정말균주를훔쳤나ITC판결에도여전히엇갈린주장,http://www.metroseoul.co.kr/article/20201217500292
11587,2020-12-17,ITC메디톡스손들어줬다대웅제약나보타21개월간수입금지,http://www.metroseoul.co.kr/article/20201217500293
11588,2020-12-17,대웅제약코로나19치료제23상병합연내돌입,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137789&REFERER=NP
11589,2020-12-17,대웅제약ITC21개월금지명령에즉각가처분신청ITC결정영향없이글로벌사업지속확대,http://www.thefirstmedia.net/news/articleView.html?idxno=67848
11590,2020-12-17,대웅제약코로나치료제호이스타정대규모23상승인,http://news.mt.co.kr/mtview.php?no=2020121711543666802
11591,2020-12-17,대웅제약코로나19치료제호이스타정23상변경승인,http://www.insightkorea.co.kr/news/articleView.html?idxno=85472
11592,2020-12-17,대웅제약코로나19치료제호이스타정임상23상변경승인,https://www.sedaily.com/NewsView/1ZBPWTBVV8
11593,2020-12-17,메디톡스대웅제약균주전쟁최종판결해석차여전,http://www.newstomato.com/ReadNews.aspx?no=1013575
11594,2020-12-17,보톡스분쟁패소에도대웅제약메디톡스와장중동반강세,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4374442
11595,2020-12-17,대웅제약균주전쟁승리사실상ITC승소,http://www.asiaa.co.kr/news/articleView.html?idxno=12884
11596,2020-12-17,메디톡스대웅제약상대보톡스5년분쟁승리했지만갈등불씨여전,https://www.ekn.kr/web/view.php?key=20201217010004387
11597,2020-12-17,보툴리눔균주공방서웃은메디톡스대웅제약진실밝힐것,http://www.shinailbo.co.kr/news/articleView.html?idxno=1355961
11598,2020-12-17,美ITC대웅제약나보타21개월수입금지메디톡스손들어줘,http://www.thefirstmedia.net/news/articleView.html?idxno=67852
11599,2020-12-17,사실상대웅제약勝소송결과에메디톡스내리고대웅제약오르고,http://news.mt.co.kr/mtview.php?no=2020121714550935351
11600,2020-12-17,대웅제약호이스타정코로나19대규모임상23상승인,http://it.chosun.com/site/data/html_dir/2020/12/17/2020121702042.html
11601,2020-12-17,대웅제약호이스타정식약처로부터23상변경승인코로나19치료제개발속도,https://www.news2day.co.kr/article/20201217500205
11602,2020-12-17,대웅제약주가돌풍왜명신산업에이비프로바이오등급등주관심,http://www.g-enews.com/ko-kr/news/article/news_all/202012171457559211c642673384_1/article.html
11603,2020-12-17,대웅제약폭주막을수없다메디톡스와균주분쟁완화된판결상한가훨훨,http://www.pinpointnews.co.kr/view.php?ud=202012171508397373861beb2d9d_45
11604,2020-12-17,대웅코로나19치료제호이스타정23상변경승인,http://www.kukinews.com/newsView/kuk202012170288
11605,2020-12-17,대웅제약호이스타정대규모임상23상변경승인,http://inthenews.co.kr/article-83074/
11606,2020-12-17,대웅제약대웅마감앞두고폭등에상한가까지대웅제약상한가이어대웅28폭등,http://www.econonews.co.kr/news/articleView.html?idxno=149564
11607,2020-12-17,대웅제약균주전쟁승리사실상ITC승소,http://www.nbnnews.co.kr/news/articleView.html?idxno=450762
11608,2020-12-17,미국ITC판결대웅제약나보타21개월수입금지,http://yna.kr/PYH20201217170500013?did=1196m
11609,2020-12-17,미국수입금지명령받은대웅제약,http://yna.kr/PYH20201217170700013?did=1196m
11610,2020-12-17,미국ITC판결대웅제약나보타21개월수입금지,http://yna.kr/PYH20201217170600013?did=1196m
11611,2020-12-17,미국수입금지명령받은대웅제약,http://yna.kr/PYH20201217170800013?did=1196m
11612,2020-12-17,특징주대웅제약상한가ITC보톡스분쟁패소사실상승소판단,http://www.anewsa.com/detail.php?number=2306832&thread=18
11613,2020-12-17,대웅코로나19치료제개발가속대규모23임상돌입,http://www.dailymedi.com/detail.php?number=864128&thread=22r05
11614,2020-12-17,대웅메디톡스보톡스분쟁승자는대체누구,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124668
11615,2020-12-17,메디톡스대웅보톡스분쟁마무리수순상처만남았다,http://www.fntoday.co.kr/news/articleView.html?idxno=244502
11616,2020-12-17,특징주보톡스분쟁패소에도대웅제약상한가종합,http://yna.kr/AKR20201217089051002?did=1195m
11617,2020-12-17,종지부찍은균주분쟁5년메디톡스대웅제약모두의승리냐상처냐,http://www.ajunews.com/view/20201217151655174
11618,2020-12-17,대웅제약코로나19치료제호이스타정글로벌23상승인,http://www.medigatenews.com/news/842802739
11619,2020-12-17,이슈분석대웅메디톡스균주분쟁최종결론양쪽다상처만,http://www.sporbiz.co.kr/news/articleView.html?idxno=504682
11620,2020-12-17,투자주의루켄테크놀러지스이씨에스폭락넵튠대웅현대바이오에이비프로바이오투자경고에도훨훨,http://www.pinpointnews.co.kr/view.php?ud=202012171544147985cd1e7f0bdf_45
11621,2020-12-17,美ITC소송서진대웅제약은上이긴메디톡스는하락왜,http://news.mk.co.kr/newsRead.php?no=1296255&year=2020
11622,2020-12-17,IB토마토대웅제약미국ITC최종판결리스크선반영,http://www.newstomato.com/ReadNews.aspx?no=1013645
11623,2020-12-17,보톡스전쟁3라운드서대웅제약판정패,https://hankookilbo.com/News/Read/A2020121710030001410?did=NA
11624,2020-12-17,나보타수입금지기한120개월→21개월크게단축메디톡스vs대웅누가승자일까,http://www.segye.com/content/html/2020/12/17/20201217514578.html?OutUrl=naver
11625,2020-12-17,대웅제약코로나19치료제개발기대감에상한가,http://sports.hankooki.com/lpage/economy/202012/sp20201217160949137020.htm?s_ref=nv
11626,2020-12-17,급등락주짚어보기메디콕스대웅제약디아이씨삼화페인트상한가기록,https://www.etoday.co.kr/news/view/1975170
11627,2020-12-17,대웅제약호이스타정23상병합승인코로나19치료제개발목전,http://www.lcnews.co.kr/news/articleView.html?idxno=10993
11628,2020-12-17,대웅제약상한가메디톡스5하락반전속에주가희비,https://www.sedaily.com/NewsView/1ZBPWA217D
11629,2020-12-17,대웅제약코로나19치료제호이스타정식약처임상23상변경승인,http://www.getnews.co.kr/news/articleView.html?idxno=505215
11630,2020-12-17,단독질병관리청대웅보툴리눔균주신고내용다르면고발,http://www.mkhealth.co.kr/news/articleView.html?idxno=51496
11631,2020-12-17,대웅제약호이스타정코로나19임상23상병합승인,https://view.asiae.co.kr/article/2020121716280777298
11632,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.thefirstmedia.net/news/articleView.html?idxno=67879
11633,2020-12-17,코스피277043보합권마감대웅제약상한가,http://www.opinionnews.co.kr/news/articleView.html?idxno=44228
11634,2020-12-17,대웅제약나보타美수출금지에도조용히웃는이유는,https://www.asiatoday.co.kr/view.php?key=20201217010011437
11635,2020-12-17,이인애의뒷담화메디톡스미국에서대웅제약눌렀다국내소송전으로분풀이예고,http://theviewers.co.kr/View.aspx?No=1386863
11636,2020-12-17,17일오늘의상한가총정리대웅제약보톡스분쟁패소불구상한가명신산업3거래일연속강세,http://www.ccreview.co.kr/news/articleView.html?idxno=298548
11637,2020-12-17,메디톡스절반의승리보툴리눔영업비밀아니지만대웅제약관세법위반판결,https://www.news2day.co.kr/article/20201217500250
11638,2020-12-17,백신반도체테마주도대웅대웅제약메디콕스상한가행진이스타코메디포스트새로닉스강세,http://www.pinpointnews.co.kr/view.php?ud=202012171642147124cd1e7f0bdf_45
11639,2020-12-17,모더나화이자아스트라제네카아슬아슬한백신랠리대웅제약신풍제약현대바이오주가가속질주,http://www.pinpointnews.co.kr/view.php?ud=202012171646569760861beb2d9d_45
11640,2020-12-17,대웅제약새벽미국장마감후ITC최종판정공개21개월수입금지명령조치”,https://www.news2day.co.kr/article/20201217500284
11641,2020-12-17,보톡스분쟁서승소한메디톡스대웅제약상대손해배상소송결과주목,http://www.sisajournal-e.com/news/articleView.html?idxno=227140
11642,2020-12-17,대웅제약호이스타정대규모23상변경승인으로글로벌코로나19치료제개발눈앞,http://www.paxetv.com/news/articleView.html?idxno=106694
11643,2020-12-17,보톡스분쟁졌는데상한가간대웅제약왜박해린의뉴스마켓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012170279&t=NNv
11644,2020-12-17,김창수의e뉴스브리핑4년걸친보톡스분쟁메디톡스승리美ITC대웅제약나보타21개월수입금지”外,https://www.fetv.co.kr/news/article.html?no=71827
11645,2020-12-17,美ITC최종판결대웅메디톡스엇갈린승리주장국내이슈는,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012171348003270567
11646,2020-12-17,메디톡스대웅제약모두절반승리끝나지않은균주전쟁,https://www.sedaily.com/NewsView/1ZBPX7XOXJ
11647,2020-12-17,식약처대웅제약코로나19치료제호이스타정23상임상허가,http://www.newsfreezone.co.kr/news/articleView.html?idxno=283222
11648,2020-12-17,17일특징주대웅제약삼화페인트메디콕스에프앤리퍼블릭등6개종목상한가,http://www.newsworks.co.kr/news/articleView.html?idxno=513120
11649,2020-12-17,대웅제약보톡스분쟁패소에도상한가사실상최종승자,https://www.ajunews.com/view/20201217173223307
11650,2020-12-17,메디톡스대웅보톡스분쟁마무리수순상처만남았다종합,http://yna.kr/AKR20201217103251017?did=1195m
11651,2020-12-17,퇴근길제약Pin메디톡스vs대웅제약보톡스전쟁모두가승자外,http://www.pinpointnews.co.kr/view.php?ud=202012171736334853f090c8dbcb_45
11652,2020-12-17,메디톡스vs대웅제약독한전쟁누가이겼나,http://www.wikileaks-kr.org/news/articleView.html?idxno=100541
11653,2020-12-17,대웅제약나보타수입금지가처분신청및항소할것,https://www.news2day.co.kr/article/20201217500304
11654,2020-12-17,대웅제약메디톡스ITC일단락이제는국내소송,http://daily.hankooki.com/lpage/industry/202012/dh20201217181808148390.htm?s_ref=nv
11655,2020-12-17,대웅제약균주소송이어갈태세미국보툴리눔톡신시장포기어려워,http://www.businesspost.co.kr/BP?command=article_view&num=209164
11656,2020-12-17,마감종합기사대웅메디톡스분쟁끝대웅제약과메디콕스모두상한가삼화페인트2연속상한가,http://www.ggilbo.com/news/articleView.html?idxno=816460
11657,2020-12-17,메디톡스대웅제약과기나긴미국균주소송이겨도개운치않다,http://www.businesspost.co.kr/BP?command=article_view&num=209194
11658,2020-12-17,대웅제약호이스타정23상변경승인코로나19치료제개발가속화,http://news.kbiz.or.kr/news/articleView.html?idxno=75802
11659,2020-12-17,대웅메디톡스보툴리눔톡신戰승자는,http://www.newsfreezone.co.kr/news/articleView.html?idxno=283272
11660,2020-12-17,보톡스분쟁메디톡스승소미ITC대웅제품21개월수입금지”,http://www.hani.co.kr/arti/economy/marketing/974802.html
11661,2020-12-17,대웅제약글로벌코로나19치료제개발눈앞호이스타정대규모23상변경승인,http://www.kdpress.co.kr/news/articleView.html?idxno=99498
11662,2020-12-17,미ITC판결두고엇갈린주장메디톡스대웅의도용혐의밝혀져대웅제약사실상승소,http://www.kdpress.co.kr/news/articleView.html?idxno=99499
11663,2020-12-17,상한가종목대웅제약삼화페인트상한가마감뒤이어디아이씨이녹스메디콕스에프앤리퍼블릭상한가,http://www.econonews.co.kr/news/articleView.html?idxno=149568
11664,2020-12-17,마감한국전력연료비연동제도입급등대웅제약ITC패소에도상한가,https://www.asiatime.co.kr/news/newsview.php?ncode=1065623429898524
11665,2020-12-18,﻿미국ITC판결두고또다시대립대웅제약vs메디톡스,http://medicalworldnews.co.kr/news/view.php?idx=1510939337
11666,2020-12-18,2020년상반기완제의약품생산실적한미약품종근당대웅제약순,http://medicalworldnews.co.kr/news/view.php?idx=1510939340
11667,2020-12-18,보톡스분쟁메디톡스손들어준ITC대웅21개월수입금지”,https://www.donga.com/news/article/all/20201217/104500515/1
11668,2020-12-18,끝난듯안끝난보톡스전쟁대웅메디톡스서로이겼다,http://news.mt.co.kr/mtview.php?no=2020121717562682035
11669,2020-12-18,대웅제약나보타21개월수입금지”,http://news.kmib.co.kr/article/view.asp?arcid=0924170155&code=11151400&cp=nv
11670,2020-12-18,서로이겼다는대웅메디톡스보톡스전쟁증시에선,https://www.nocutnews.co.kr/news/5467163
11671,2020-12-18,메디톡스대웅제약상대ITC절반의승리,http://www.edaily.co.kr/news/newspath.asp?newsid=01295606625999832
11672,2020-12-18,코로나확진자폭발모더나도빨리빨리현대바이오대웅제약셀트리온신풍제약주목,http://www.pinpointnews.co.kr/view.php?ud=202012180449143119861beb2d9d_45
11673,2020-12-18,메디톡스對대웅보톡스ITC소송제약업계반응은,http://www.pharmnews.com/news/articleView.html?idxno=101928
11674,2020-12-18,메디톡스손들어줬는데오히려대웅제약30상한가,http://www.dailymedi.com/detail.php?number=864153&thread=22r05
11675,2020-12-18,유한녹십자대웅대원첫레바미피드서방정허가,http://www.dailypharm.com/Users/News/NewsView.html?ID=271634&REFERER=NP
11676,2020-12-18,ITC소송우리가이겼다패자없는대웅메디톡스법정공방,http://www.kukinews.com/newsView/kuk202012170350
11677,2020-12-18,대웅메디톡스균주분쟁다시격랑속으로,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005862
11678,2020-12-18,관심종목ITC판정메디톡스와대웅제약간소송에영향줄수있어하나금융투자,http://www.getnews.co.kr/news/articleView.html?idxno=505296
11679,2020-12-18,증시키워드대웅제약사실상승소”주장에上한국전력연료비연동제소식에강세,https://www.etoday.co.kr/news/view/1975293
11680,2020-12-18,메디톡스美법무법인ITC판결전문내대웅의균주와제조공정도용혐의명확히명시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65306
11681,2020-12-18,대웅제약대웅모두가파른상승세로급등대웅제약15급등이어대웅6급등,http://www.econonews.co.kr/news/articleView.html?idxno=149603
11682,2020-12-18,메디톡스美법무법인ITC판결전문에대웅의균주와제조공정도용혐의명시”,https://www.fetv.co.kr/news/article.html?no=71848
11683,2020-12-18,메디톡스ITC판결문에대웅균주제조공정도용명시,http://medipana.com/news/news_viewer.asp?NewsNum=268634&MainKind=A&NewsKind=5&vCount=12&vKind=1
11684,2020-12-18,특징주대웅제약보톡스분쟁이슈소멸에강세,https://www.etoday.co.kr/news/view/1975334
11685,2020-12-18,메디톡스대웅균주제조공정도용혐의명확히명시,http://www.medisobizanews.com/news/articleView.html?idxno=75062
11686,2020-12-18,특징주대웅제약ITC불확실성해소에이틀째강세,http://www.newspim.com/news/view/20201218000168
11687,2020-12-18,특징주전일상한가찍은대웅제약장초반20대급등,https://www.sedaily.com/NewsView/1ZBQBXKRG6
11688,2020-12-18,메디톡스대웅의균주등도용경위담긴美ITC최종판결문전문공개될것,http://news.mk.co.kr/newsRead.php?no=1297875&year=2020
11689,2020-12-18,기자수첩대웅제약vs메디톡스진정한승자는누구,http://www.seoulwire.com/news/articleView.html?idxno=432021
11690,2020-12-18,메디톡스美법무법인대웅나보타폐기조치진행할것,http://www.newsprime.co.kr/news/article.html?no=527966
11691,2020-12-18,특징주대웅제약연일급등세코로나치료제개발순항,http://www.fnnews.com/news/202012180932381957
11692,2020-12-18,승리자신메디톡스대웅불법행위확정판결전문곧공개,http://www.wikileaks-kr.org/news/articleView.html?idxno=100555
11693,2020-12-18,시장은대웅제약승리메디톡스소송패소하고도강세,http://news.mt.co.kr/mtview.php?no=2020121809345814040
11694,2020-12-18,메디톡스균주출처허위신고한대웅나보타사업불가능,http://yna.kr/AKR20201218043900017?did=1195m
11695,2020-12-18,메디톡스ITC판결문곧공개대웅불법행위확인될것,http://news.mt.co.kr/mtview.php?no=2020121809361653791
11696,2020-12-18,특징주대웅제약장중22대상승신고가경신,https://view.asiae.co.kr/article/2020121809495572179
11697,2020-12-18,메디톡스ITC항소판결전문에대웅균주도용명시,http://www.edaily.co.kr/news/newspath.asp?newsid=01951606625999832
11698,2020-12-18,메디톡스ITC 판결전문에대웅의균주와제조공정도용혐의명확히명시,http://www.thefirstmedia.net/news/articleView.html?idxno=67939
11699,2020-12-18,메디톡스ITC판결전문에대웅제약불법행위공개될것,http://www.kpinews.co.kr/news/articleView.html?idxno=133250
11700,2020-12-18,10년→21개월걱정덜어낸대웅제약에월가도랠리,http://news.mt.co.kr/mtview.php?no=2020121809471167534
11701,2020-12-18,특징주보톡스분쟁마무리대웅제약연일장중급등,http://yna.kr/AKR20201218049100002?did=1195m
11702,2020-12-18,메디톡스美법무법인ITC판결전문에대웅의균주와제조공정도용혐의명확히명시돼,http://news.mk.co.kr/newsRead.php?no=1298075&year=2020
11703,2020-12-18,대웅제약소송불확실성해소에주가훨훨이틀째급등,http://www.g-enews.com/ko-kr/news/article/news_all/202012180941146468edf69f862c_1/article.html
11704,2020-12-18,특징주대웅제약코로나19치료제기대감소송종료에이틀째강세,https://www.asiatoday.co.kr/view.php?key=20201218010011725
11705,2020-12-18,메디톡스ITC판결문에대웅균주제조공정도용명시,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121810005144537
11706,2020-12-18,메디톡스대웅제약보톨리눔톡신제제사업지속불가능할것,http://www.startuptoday.co.kr/news/articleView.html?idxno=64567
11707,2020-12-18,메디톡스ITC판결전문에대웅제약균주도용명시10일내공개,http://www.getnews.co.kr/news/articleView.html?idxno=505320
11708,2020-12-18,대웅제약보톡스분쟁이슈해소에신고가메디톡스도상승,https://www.hankyung.com/finance/article/2020121829166
11709,2020-12-18,메디톡스ITC판결문에대웅균주제조공정도용혐의명시”,http://www.segyebiz.com/newsView/20201218505010?OutUrl=naver
11710,2020-12-18,강세업종제약업종상승세대웅제약20↑,http://www.itooza.com/common/iview.php?no=2020121810101991183
11711,2020-12-18,특징주보톡스분쟁마무리대웅제약연일급등,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004212869
11712,2020-12-18,메디톡스대웅과의국내소송승리자신대웅보톡스사업불가능할것,https://www.asiatoday.co.kr/view.php?key=20201218010011744
11713,2020-12-18,메디톡스ITC대웅이균주와제조공정도용명시,http://www.mkhealth.co.kr/news/articleView.html?idxno=51500
11714,2020-12-18,메디톡스ITC판결문에대웅균주제조공정도용명시,http://sports.hankooki.com/lpage/economy/202012/sp20201218103448137020.htm?s_ref=nv
11715,2020-12-18,대웅제약왜폭등하나봤더니이거였네소송불확실성해소에매수세몰려,http://www.pinpointnews.co.kr/view.php?ud=202012181034008893861beb2d9d_45
11716,2020-12-18,메디톡스美법무법인ITC판결전문에대웅의균주및제조공정도용혐의명시”,https://www.hankyung.com/it/article/202012182800i
11717,2020-12-18,메디톡스ITC에항소할것대웅나보타사업불가능,https://cnbc.sbs.co.kr/article_hub/10001006240?division=NAVER
11718,2020-12-18,메디톡스대웅의균주제조공정도용명백한유죄항소통해바로잡을것,http://www.newspim.com/news/view/20201218000376
11719,2020-12-18,메디톡스ITC판결전문에대웅균주도용명시,http://biz.newdaily.co.kr/site/data/html/2020/12/18/2020121800049.html
11720,2020-12-18,특징주대웅제약전날상한가이어20올라ITC와다른손든시장,http://www.kdfnews.com/news/articleView.html?idxno=63650
11721,2020-12-18,메디톡스대웅나보타허위출처로허가사업지속불가능할것,https://www.etoday.co.kr/news/view/1975388
11722,2020-12-18,머니e종목대웅제약소송불확실성해소에급등에볼루스도2153↑,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020121810542491059
11723,2020-12-18,대웅제약메디톡스둘다항소끝나도안끝났다,http://www.newsis.com/view/?id=NISX20201218_0001275222&cID=13001&pID=13000
11724,2020-12-18,오전시황백신전기차보톡스테마강세현대바이오대웅제약디아이씨훨훨화신네스엠KMH급등,http://www.pinpointnews.co.kr/view.php?ud=202012181120165546cd1e7f0bdf_45
11725,2020-12-18,특징주대웅제약보톡스분쟁선졌지만증시선연일급등,http://daily.hankooki.com/lpage/finance/202012/dh20201218113122148310.htm?s_ref=nv
11726,2020-12-18,대웅제약아이엔테라퓨틱스포스텍KIURI연구단과MOU,http://www.businesskorea.co.kr/news/articleView.html?idxno=57071
11727,2020-12-18,끝보이지않는보톡스전쟁대웅제약가처분항소할것,http://www.sisaweek.com/news/articleView.html?idxno=140236
11728,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,https://www.fetv.co.kr/news/article.html?no=71906
11729,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.healthinnews.co.kr/news/articleView.html?idxno=20869
11730,2020-12-18,보톡스전쟁패한대웅제약17일주식상한가가며의문의1승,http://www.enewstoday.co.kr/news/articleView.html?idxno=1437174
11731,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단공동연구협약체결,http://www.asiaa.co.kr/news/articleView.html?idxno=13032
11732,2020-12-18,대웅제약자회사아이엔포스텍과이온채널구조공동연구협약,http://www.medisobizanews.com/news/articleView.html?idxno=75074
11733,2020-12-18,대웅제약ITC최종결정이후이틀연속강세고공행진,http://medipana.com/news/news_viewer.asp?NewsNum=268659&MainKind=A&NewsKind=5&vCount=12&vKind=1
11734,2020-12-18,균주도용판결호재됐나대웅제약이틀새주가60↑,http://www.dailypharm.com/Users/News/NewsView.html?ID=271666&REFERER=NP
11735,2020-12-18,메디톡스나보타사업불가능vs대웅명백한허위종합,http://yna.kr/AKR20201218043951017?did=1195m
11736,2020-12-18,ITC대웅균주도용판결국내소송영향은,https://www.paxnetnews.com/articles/68696
11737,2020-12-18,대웅제약주가장중뛰어코로나19치료제개발진척부각,http://www.businesspost.co.kr/BP?command=article_view&num=209269
11738,2020-12-18,ITC승소에힘받은메디톡스균주도용한대웅나보타는식약처허가취소대상,http://www.whitepaper.co.kr/news/articleView.html?idxno=199795
11739,2020-12-18,대웅제약vs메디톡스소송전현재진행형,http://www.betanews.net:8080/article/1246139.html
11740,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍연구단과공동연구협약,http://www.metroseoul.co.kr/article/20201218500074
11741,2020-12-18,메디톡스ITC승소에국내소송전도속도균주출처허위신고한대웅나보타허가취소해야,https://www.sedaily.com/NewsView/1ZBQDGF55B
11742,2020-12-18,대웅제약자회사포스텍KIURI연구단과공동연구협약체결,http://www.dailysmart.co.kr/news/articleView.html?idxno=37605
11743,2020-12-18,메디톡스美ITC판결로대웅나보타허가취소대웅명백한허위주장,https://biz.chosun.com/site/data/html_dir/2020/12/18/2020121801637.html?utm_source=naver&utm_medium=original&utm_campaign=biz
11744,2020-12-18,메디톡스ITC판결전문에대웅제약도용혐의명시,http://www.cstimes.com/news/articleView.html?idxno=443712
11745,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍연구단과공동연구협약,http://www.edaily.co.kr/news/newspath.asp?newsid=02525606625999832
11746,2020-12-18,대웅제약대웅내내이어지는급등대웅제약19급등이어대웅11급등,http://www.econonews.co.kr/news/articleView.html?idxno=149690
11747,2020-12-18,보톡스분쟁마무리대웅제약장중20대급등,http://www.startuptoday.co.kr/news/articleView.html?idxno=64593
11748,2020-12-18,메디톡스美ITC판결문에대웅균주도용명시나보타폐기조치할것,https://www.ekn.kr/web/view.php?key=20201218010004642
11749,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.lawissue.co.kr/view.php?ud=202012181406371007204ead0791_12
11750,2020-12-18,美ITC보툴리눔균주영업기밀아니다지고도이긴대웅제약,http://www.meconomynews.com/news/articleView.html?idxno=48538
11751,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍과이온채널구조공동연구협약,http://www.newsworks.co.kr/news/articleView.html?idxno=513388
11752,2020-12-18,메디톡스ITC판결전문에대웅의균주도용명시,https://www.dailian.co.kr/news/view/947881/?sc=Naver
11753,2020-12-18,삼화페인트주가돌풍휴미시스대웅제약등급등주눈길,http://www.g-enews.com/ko-kr/news/article/news_all/202012181430248082c642673384_1/article.html
11754,2020-12-18,먹는코로나치료제나올까대웅제약임상속도낸다,http://www.koreastocknews.com/news/articleView.html?idxno=60018
11755,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍연구진과손잡고신약개발역량강화,https://www.asiatoday.co.kr/view.php?key=20201218010011999
11756,2020-12-18,메디톡스나보타국내허가취소추진대웅제약전승호대표허위주장강력반발,https://www.news2day.co.kr/article/20201218500198
11757,2020-12-18,메디톡스나보타사업폐기시킬것vs대웅명백한허위주장,http://news.mk.co.kr/newsRead.php?no=1299514&year=2020
11758,2020-12-18,경보제약대웅제약제약주모두급등특히경보제약오후갑작스런20급등,http://www.econonews.co.kr/news/articleView.html?idxno=149701
11759,2020-12-18,메디톡스美법무법인10일내공개되는ITC판결전문내대웅의균주와제조공정도용혐의명확히명시돼있어,http://www.kihoilbo.co.kr/news/articleView.html?idxno=902388
11760,2020-12-18,메디톡스美법무법인공개되는ITC판결전문내대웅의균주와제조공정도용혐의명확히명시돼있어,http://www.mrepublic.co.kr/news/articleView.html?idxno=60533
11761,2020-12-18,메디톡스美법무법인공개되는ITC판결전문내대웅의균주와제조공정도용혐의명확히명시돼,http://www.epnc.co.kr/news/articleView.html?idxno=111591
11762,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약,http://www.segye.com/content/html/2020/12/18/20201218510036.html?OutUrl=naver
11763,2020-12-18,끝나지않은보톡스분쟁메디톡스나보타폐기해야vs대웅명백한허위,https://www.sedaily.com/NewsView/1ZBQCK6DL8
11764,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.nbnnews.co.kr/news/articleView.html?idxno=451121
11765,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍키우리연구단과공동연구협약체결,https://www.hankyung.com/it/article/202012183829i
11766,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍과공동연구협약,http://www.thedailypost.kr/news/articleView.html?idxno=78240
11767,2020-12-18,TF특징주대웅제약장중20가량상승중신고가경신,http://news.tf.co.kr/read/economy/1832414.htm
11768,2020-12-18,특징주보톡스분쟁마무리대웅제약이틀간57↑종합,http://yna.kr/AKR20201218049151002?did=1195m
11769,2020-12-18,메디톡스美법무법인ITC판결문에대웅도용혐의명시,http://www.shinailbo.co.kr/news/articleView.html?idxno=1356432
11770,2020-12-18,코로나치료제기대감에대웅제약이틀간주가57급등,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4375657
11771,2020-12-18,보톡스분쟁메디톡스대웅ITC최종판결두고아전인수,http://www.seoulfn.com/news/articleView.html?idxno=404887
11772,2020-12-18,최악피한대웅제약에볼루스소송국내민사로전선확대되나,http://www.kpinews.co.kr/news/articleView.html?idxno=133325
11773,2020-12-18,대웅제약균주소송관련제조공정도용혐의없어항소통해규명”,https://www.fetv.co.kr/news/article.html?no=71944
11774,2020-12-18,대웅제약균주도용직접적증거없어메디톡스주장반박,http://medipana.com/news/news_viewer.asp?NewsNum=268685&MainKind=A&NewsKind=5&vCount=12&vKind=1
11775,2020-12-18,ITC끝나도균주출처논쟁대웅제약도용증거없다고밝혀져”,http://daily.hankooki.com/lpage/industry/202012/dh20201218164641148390.htm?s_ref=nv
11776,2020-12-18,메디톡스균주는영업비밀vs대웅제약도용증거없어,http://www.seoulwire.com/news/articleView.html?idxno=432081
11777,2020-12-18,메디톡스대웅제약ITC분쟁2회전유감기자의눈,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202012181704001&code=940601
11778,2020-12-18,대웅제약도용의직접적증거없다고이미밝혀졌다,http://www.shinailbo.co.kr/news/articleView.html?idxno=1356490
11779,2020-12-18,대웅제약ITC최종결정서도도용의직접적증거없어반박,http://www.medisobizanews.com/news/articleView.html?idxno=75086
11780,2020-12-18,제지건설제약업종강세국일제지한일홀딩스대웅제약급등명신산업삼화페인트디아이씨동신건설상한가행진,http://www.pinpointnews.co.kr/view.php?ud=202012181707259050cd1e7f0bdf_45
11781,2020-12-18,메디톡스ITC항소대웅제약나보타폐기조치진행할것,https://www.econovill.com/news/articleView.html?idxno=510989
11782,2020-12-18,대웅제약ITC최종결정에서도용증거없어메디톡스주장반박,http://www.viva100.com/main/view.php?key=20201218010004745
11783,2020-12-18,대웅ITC최종판결균주․제조공정도용증거없어”,http://www.whosaeng.com/123414
11784,2020-12-18,대웅제약자회사아이엔테라퓨틱스이온채널플랫폼정밀도높인다,http://www.medigatenews.com/news/1450128650
11785,2020-12-18,대웅제약ITC판결달리해석하는메디톡스에반박,http://www.businesskorea.co.kr/news/articleView.html?idxno=57103
11786,2020-12-18,대웅제약자회사이온채널구조공동연구협약체결,http://www.100ssd.co.kr/news/articleView.html?idxno=73584
11787,2020-12-18,메디톡스불법행위공개될것VS대웅제약도용직접증거없어,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012180378&t=NN
11788,2020-12-18,메디톡스균주도용혐의항소대웅사실상승소,http://www.lawissue.co.kr/view.php?ud=202012181750289662f4ab64559d_12
11789,2020-12-18,대웅제약균주도용직접적증거없다美ITC도인정”,https://www.donga.com/news/article/all/20201218/104513491/1
11790,2020-12-18,대웅제약아이엔테라퓨틱스포스텍과공동연구협약체결민관학民官學협력모델구축,http://www.lcnews.co.kr/news/articleView.html?idxno=11041
11791,2020-12-18,뉴스투데이L대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,https://www.news2day.co.kr/article/20201218500283
11792,2020-12-18,보톡스분쟁신경전계속대웅제약ITC판결균주영업비밀침해없다고명시,https://www.asiatoday.co.kr/view.php?key=20201218010012168
11793,2020-12-18,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.anewsa.com/detail.php?number=2308012&thread=10
11794,2020-12-18,대웅제약아이엔테라퓨틱스포스텍키우리연구단과공동연구협약,https://www.donga.com/news/article/all/20201218/104513885/1
11795,2020-12-18,혼돈의보톡스시장대웅제약메디톡스다툼에주목받는종근당,http://www.insightkorea.co.kr/news/articleView.html?idxno=85515
11796,2020-12-18,대웅제약VS메디톡스보톡스분쟁계속둘다항소,http://www.wolyo.co.kr/news/articleView.html?idxno=113397
11797,2020-12-18,ITC최종결론나왔지만메디톡스vs대웅제약논쟁ing,http://www.medigatenews.com/news/2283576148
11798,2020-12-18,대웅제약균주도용직접적증거전혀없다메디톡스주장반박,http://www.thebigdata.co.kr/view.php?ud=202012182004506354d0a8833aad_23
11799,2020-12-18,인도아프리카저개발국코로나19관련특허권리무효화요구아스트라제네카존슨앤존슨관련주에이비프로바이오진매트릭스및삼성바이오종근당대웅제약등주목,http://www.econonews.co.kr/news/articleView.html?idxno=149763
11800,2020-12-19,초점극단치닫는대웅제약메디톡스보톡스균주분쟁,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005915
11801,2020-12-19,위클리제약바이오美ITC대웅나보타21개월수입금지명령外,https://www.etoday.co.kr/news/view/1975580
11802,2020-12-19,메디톡스美법무법인대웅의균주와제조공정도용혐의명확해,http://www.slist.kr/news/articleView.html?idxno=211333
11803,2020-12-19,보톡스분쟁美ITC최종판결에메디톡스대웅항소할것”,http://www.mdtoday.co.kr/mdtoday/index.html?no=409467
11804,2020-12-19,美ITC대웅균주도용”판결전문10일내공개,https://cnbc.sbs.co.kr/article_hub/10001006362?division=NAVER
11805,2020-12-19,주간HOT종목보톡스전쟁메디톡스VS대웅제약,https://view.asiae.co.kr/article/2020121914242116240
11806,2020-12-19,메디톡스대웅제약둘다항소균주도용혐의밝혀져vs균주는영업비밀아니다,http://www.econonews.co.kr/news/articleView.html?idxno=149867
11807,2020-12-19,대웅제약vs메디톡스미국ITC위원회최종판결모두항소,http://medicalworldnews.co.kr/news/view.php?idx=1510939370
11808,2020-12-20,시총100대기업주가살펴보니대웅12월들어162급등눈길,http://www.g-enews.com/ko-kr/news/article/news_all/202012200823326677edf69f862c_1/article.html
11809,2020-12-20,ITC메디톡스vs대웅제약판결에주목하는배터리업계,https://www.etoday.co.kr/news/view/1975661
11810,2020-12-20,하반기우수기업연구소에대웅등56곳지정,http://news.mt.co.kr/mtview.php?no=2020121809344410151
11811,2020-12-21,대웅제약대표호이스타정내달코로나19치료제로출시목표,http://yna.kr/AKR20201218155700017?did=1195m
11812,2020-12-21,메디톡스도대웅제약도아닌앨러간이진정한승자,http://www.bosa.co.kr/news/articleView.html?idxno=2140533
11813,2020-12-21,대웅제약대표호이스타정코로나치료제로출시임박”,http://news.kmib.co.kr/article/view.asp?arcid=0015344070&code=61171911&cp=nv
11814,2020-12-21,대웅제약코로나19치료제임상2상결과연내공개,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012210016&t=NN
11815,2020-12-21,코로나19치료제개발기대에대웅종근당연일최고가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005930
11816,2020-12-21,패자는없다메디톡스대웅제약美ITC최종판결두고우리가勝,http://www.youthdaily.co.kr/news/article.html?no=56457
11817,2020-12-21,대웅제약이달중호이스타정임상2상톱라인결과공개,https://www.hankyung.com/it/article/2020122191937
11818,2020-12-21,대웅파트너사에볼루스주주소송본격화,https://www.paxnetnews.com/articles/68725
11819,2020-12-21,대웅제약대표호이스타정국내첫알약코로나치료제될것,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=4377144
11820,2020-12-21,대웅제약균주전쟁승리나머지오판도바로잡을것,http://www.press9.kr/news/articleView.html?idxno=46616
11821,2020-12-21,대웅제약대표호이스타정코로나19치료제로출시임박”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012210907404170044
11822,2020-12-21,대웅제약코로나치료제1월출시장초반25급등,http://news.mt.co.kr/mtview.php?no=2020122109130728283
11823,2020-12-21,특징주대웅제약코로나치료제개발에3거래일째20대↑,http://www.edaily.co.kr/news/newspath.asp?newsid=01777766626000816
11824,2020-12-21,대웅제약균주전쟁끝났다나머지오판도바로잡겠다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252735
11825,2020-12-21,동화약품대웅제약제약주모두급등대웅제약25급등이어동화약품14급등,http://www.econonews.co.kr/news/articleView.html?idxno=149958
11826,2020-12-21,특징주곰의기운어디까지대웅제약3거래일연속급등,https://www.sedaily.com/NewsView/1ZBRQ2SNCH
11827,2020-12-21,특징주대웅제약코로나19치료제임상결과앞두고상승세,http://www.inews24.com/view/1328423
11828,2020-12-21,대웅제약이달중호이스타정임상2상톱라인결과공개내달출시목표,http://www.getnews.co.kr/news/articleView.html?idxno=505625
11829,2020-12-21,코스피코스닥동반하락출발대웅제약써니전자안랩급등,http://www.businesspost.co.kr/BP?command=article_view&num=209462
11830,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,https://www.ebn.co.kr/news/view/1464738/?sc=Naver
11831,2020-12-21,코스피277272보합권출발대웅제약급등에단일가로거래중,http://www.opinionnews.co.kr/news/articleView.html?idxno=44320
11832,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46621
11833,2020-12-21,대웅제약상한가코로나19치료제임상2상톱라인결과이달공개,http://www.ajunews.com/view/20201221093330696
11834,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252741
11835,2020-12-21,대웅제약일부공정기술침해ITC판결바로잡겠다,http://www.mediapen.com/news/view/585392
11836,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비정부과제선정,http://www.pharmnews.com/news/articleView.html?idxno=101950
11837,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.lawissue.co.kr/view.php?ud=202012210941418072204ead0791_12
11838,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=57150
11839,2020-12-21,대웅제약코로나19치료제임상결과연내공개소식에상한가급등,http://www.g-enews.com/ko-kr/news/article/news_all/202012210935271430edf69f862c_1/article.html
11840,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,https://www.dailian.co.kr/news/view/948365/?sc=Naver
11841,2020-12-21,특징주대웅제약코로나19치료제임상2상결과공개소식에급등,http://www.fnnews.com/news/202012210950546156
11842,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,http://www.youthdaily.co.kr/news/article.html?no=56770
11843,2020-12-21,대웅제약니클로사마이드코로나19치료제정부과제선정,http://www.metroseoul.co.kr/article/20201221500040
11844,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.thebigdata.co.kr/view.php?ud=202012210953442810798818e98b_23
11845,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,https://www.fetv.co.kr/news/article.html?no=72053
11846,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제예비선정,http://news.mt.co.kr/mtview.php?no=2020122109512956472
11847,2020-12-21,대웅제약균주영업비밀가치없다판결논란끝,http://www.wikileaks-kr.org/news/articleView.html?idxno=100677
11848,2020-12-21,특징주대웅제약내달코로나19치료제출시목표기대상한가,https://www.etoday.co.kr/news/view/1976019
11849,2020-12-21,특징주대웅제약급등세코로나19치료제임상2상결과연내공개,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574889352433
11850,2020-12-21,21일장중코로나주종근당대웅제약껑충vs신풍제약하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77520
11851,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,http://www.newstomato.com/ReadNews.aspx?no=1014052
11852,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.kpinews.co.kr/news/articleView.html?idxno=133373
11853,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020122110024276848
11854,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012210091&t=NN
11855,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,http://www.medisobizanews.com/news/articleView.html?idxno=75107
11856,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,https://www.ekn.kr/web/view.php?key=20201221010005049
11857,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122110093131559
11858,2020-12-21,대웅제약균주전쟁은끝났다나머지오판도바로잡을것,http://www.wolyo.co.kr/news/articleView.html?idxno=113416
11859,2020-12-21,대웅제약메디톡스에연일공세영업비밀국내소송서가리자,http://www.medisobizanews.com/news/articleView.html?idxno=75106
11860,2020-12-21,코로나변종의습격모더나화이자에주목셀트리온헬스케어대웅제약유나이티드제약날라가나,http://www.pinpointnews.co.kr/view.php?ud=202012210957466155861beb2d9d_45
11861,2020-12-21,대웅제약 코로나19치료제 생산장비 구축지원 정부과제 선정,http://kormedi.com/?p=1329572
11862,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://sports.hankooki.com/lpage/economy/202012/sp20201221101705137020.htm?s_ref=nv
11863,2020-12-21,대웅제약코로나19치료제니클로사마이드정부과제예비선정,https://health.chosun.com/site/data/html_dir/2020/12/21/2020122100945.html
11864,2020-12-21,상반기긴급사용승인목표대웅제약니클로사마이드코로나19치료제정부과제선정,http://theviewers.co.kr/View.aspx?No=1389610
11865,2020-12-21,대웅니클로사마이드코로나19치료정부과제선정,http://www.dailypharm.com/Users/News/NewsView.html?ID=271727&REFERER=NP
11866,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.newspim.com/news/view/20201221000267
11867,2020-12-21,못말리는대웅제약상한가깜짝왜셀트리온종근당유나이티드제약부광약품도훨훨,http://www.pinpointnews.co.kr/view.php?ud=202012211024158204861beb2d9d_45
11868,2020-12-21,대웅제약니클로사마이드 생산장비구축지원예비선정,http://www.koreastocknews.com/news/articleView.html?idxno=60042
11869,2020-12-21,복지부대웅제약코로나치료제생산장비구축에19억원지원,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=124743
11870,2020-12-21,대웅제약코로나19치료제생산정부지원예비선정 ,http://www.medical-tribune.co.kr/news/articleView.html?idxno=97273
11871,2020-12-21,대웅제약정부코로나19치료제생산장비구축지원과제예비선정,https://biz.chosun.com/site/data/html_dir/2020/12/21/2020122101002.html?utm_source=naver&utm_medium=original&utm_campaign=biz
11872,2020-12-21,대웅제약균주분쟁은끝vs메디톡스국내승소도자신,http://yna.kr/AKR20201221044200017?did=1195m
11873,2020-12-21,대웅제약호이스타정코로나치료제로출시임박23일임상2상결과공개,http://www.dt.co.kr/contents.html?article_no=2020122102109931102003&ref=naver
11874,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,https://www.etoday.co.kr/news/view/1976062
11875,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제선정,http://www.monews.co.kr/news/articleView.html?idxno=216650
11876,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.asiaa.co.kr/news/articleView.html?idxno=13586
11877,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012211039453620134
11878,2020-12-21,대웅제약코로나19치료제장비구축정부과제예비선정”,https://www.hankyung.com/it/article/202012210177i
11879,2020-12-21,대웅제약개발코로나19치료제정부가생산장비구축지원한다,https://www.asiatoday.co.kr/view.php?key=20201221010012936
11880,2020-12-21,대웅제약균주전쟁끝허위주장지속시단호히응징”,http://www.whosaeng.com/123440
11881,2020-12-21,대웅제약균주전쟁끝허위주장지속시단호히응징”,http://www.whosaeng.com/123440
11882,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.newsis.com/view/?id=NISX20201221_0001277524&cID=13001&pID=13000
11883,2020-12-21,대웅제약코로나19치료제정부과제예비선정,http://it.chosun.com/site/data/html_dir/2020/12/21/2020122101094.html
11884,2020-12-21,대웅제약코로나19치료후보물질생산장비지원정부과제선정,http://yna.kr/AKR20201221062500017?did=1195m
11885,2020-12-21,대웅제약코로나19치료제생산장비구축정부지원예정,http://medipana.com/news/news_viewer.asp?NewsNum=268724&MainKind=A&NewsKind=5&vCount=12&vKind=1
11886,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.newsworker.co.kr/news/articleView.html?idxno=96395
11887,2020-12-21,대웅코로나치료제생산장비구축정부과제선정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137835&REFERER=NP
11888,2020-12-21,대웅제약코로나19치료제생산장비구축정부과제선정”,http://www.viva100.com/main/view.php?key=20201221010005124
11889,2020-12-21,대웅제약균주전쟁끝나머지오판도바로잡을것,http://daily.hankooki.com/lpage/industry/202012/dh20201221110010148390.htm?s_ref=nv
11890,2020-12-21,美ITC메디톡스손들어줘대웅제약항소할것”,http://weekly.hankooki.com/lpage/economy/202012/wk20201221111006146380.htm?s_ref=nv
11891,2020-12-21,대웅제약vs메디톡스美ITC최종판결이후에도공방전지속,http://www.startuptoday.co.kr/news/articleView.html?idxno=64709
11892,2020-12-21,특징주대웅제약코로나19치료제기대감에장중상한가,http://yna.kr/AKR20201221065300002?did=1195m
11893,2020-12-21,대웅제약코로나19치료제복지부생산장비구축지원받는다,http://www.ajunews.com/view/20201221102759776
11894,2020-12-21,대웅제약코로나19치료제정부과제예비선정,http://inthenews.co.kr/article-83558/
11895,2020-12-21,강세업종제약업종상승세대웅제약상한가,http://www.itooza.com/common/iview.php?no=2020122110542819693
11896,2020-12-21,특징주대웅제약코로나19치료제개발에상한가,https://www.ebn.co.kr/news/view/1464779/?sc=Naver
11897,2020-12-21,대웅제약코로나19치료제생산장비정부과제선정,https://www.asiatime.co.kr/news/newsview.php?ncode=1065574303871807
11898,2020-12-21,대웅제약코로나19치료제개발생산장비구축비용정부서지원﻿,http://www.pinpointnews.co.kr/view.php?ud=2020122111224175572365609d9b_45
11899,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정,http://www.segye.com/content/html/2020/12/21/20201221506500.html?OutUrl=naver
11900,2020-12-21,대웅제약코로나19치료후보물질생산장비지원정부과제선정,http://news.mk.co.kr/newsRead.php?no=1305357&year=2020
11901,2020-12-21,대웅제약주가초반상한가코로나19치료제임상결과에기대커져,http://www.businesspost.co.kr/BP?command=article_view&num=209499
11902,2020-12-21,대웅제조공정도도용안해vs메디나보타폐기해야,https://view.asiae.co.kr/article/2020122111283964560
11903,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=409594
11904,2020-12-21,대웅제약이달중호이스타정임상2상톱라인결과공개,http://inthenews.co.kr/article-83504/
11905,2020-12-21,정부가구충제코로나치료제생산지원대웅제약19억원규모설비구축지원과제선정,https://www.donga.com/news/article/all/20201221/104568171/1
11906,2020-12-21,대웅제약ITC결정분석결과발표균주전쟁끝났다단언,http://medipana.com/news/news_viewer.asp?NewsNum=268727&MainKind=A&NewsKind=5&vCount=12&vKind=1
11907,2020-12-21,대웅제약ITC균주침해없다고판단공정기술오판도바로잡을것”,http://www.viva100.com/main/view.php?key=20201221010005142
11908,2020-12-21,대웅제약코로나19치료제정부생산장비지원받는다니클로사마이드정부과제선정,http://www.newslock.co.kr/news/articleView.html?idxno=34242
11909,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=37678
11910,2020-12-21,대웅제약니클로사마이드코로나치료제생산장비정부지원선정,https://view.asiae.co.kr/article/2020122111432966895
11911,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65345
11912,2020-12-21,대웅제약코로나치료제생산장비政지원선정,http://www.whosaeng.com/123452
11913,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://kpenews.com/View.aspx?No=1389820
11914,2020-12-21,대웅제약니클로사마이드코로나19치료정부과제예비선정,http://www.seoulfn.com/news/articleView.html?idxno=405055
11915,2020-12-21,대웅제약코로나19치료제지원정부과제예비선정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2005951
11916,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=20899
11917,2020-12-21,대웅제약코로나19치료제3종개발순항중,http://www.bosa.co.kr/news/articleView.html?idxno=2140526
11918,2020-12-21,대웅제약코로나19치료제정부과제예비로뽑혀전승호역량집중,http://www.businesspost.co.kr/BP?command=article_view&num=209496
11919,2020-12-21,대웅제약코로나19치료제정부지원과제예비선정,http://www.mediapen.com/news/view/585520
11920,2020-12-21,대웅제약니클로사마이드코로나19치료제정부지원받는다,http://www.medigatenews.com/news/2237265916
11921,2020-12-21,대웅ITC최종판결오판메디톡스보톡스정체도밝혀야,http://www.upinews.kr/newsView/upi202012210061
11922,2020-12-21,유나이티드제약대웅제약제약주급등에상한가까지대웅제약상한가이어유나이티드제약16급등,http://www.econonews.co.kr/news/articleView.html?idxno=150052
11923,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제뽑혀,https://www.kpanews.co.kr/article/show.asp?idx=218686&category=D
11924,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.koreaittimes.com/news/articleView.html?idxno=102631
11925,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4377452
11926,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,https://www.econovill.com/news/articleView.html?idxno=511244
11927,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.mhj21.com/137847
11928,2020-12-21,대웅제약코로나치료제개발장비에정부지원금,https://www.sedaily.com/NewsView/1ZBRPWR05R
11929,2020-12-21,대웅제약니클로사마이드코로나19치료제구축지원정부과제선정,http://www.m-i.kr/news/articleView.html?idxno=778099
11930,2020-12-21,대웅제약코로나19치료제니클로사마이드정부과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2140620
11931,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.sporbiz.co.kr/news/articleView.html?idxno=504925
11932,2020-12-21,뉴스투데이L대웅제약코로나19치료제생산장비구축지원정부과제선정,https://www.news2day.co.kr/article/20201221500172
11933,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://news.tf.co.kr/read/economy/1832758.htm
11934,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://daily.hankooki.com/lpage/industry/202012/dh20201221135649148390.htm?s_ref=nv
11935,2020-12-21,코로나19치료제개발기대에대웅제약장중상한가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4377502
11936,2020-12-21,美ITC판결에도진흙탕싸움중인메디톡스대웅제약보톡스논쟁,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012211326409940221
11937,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=451662
11938,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.anewsa.com/detail.php?number=2309676&thread=10
11939,2020-12-21,대웅제약엘러간독점을위한소송재판부는반칙허용엘러간은메디톡스이용,http://newsclaim.co.kr/View.aspx?No=1390105
11940,2020-12-21,대웅제약메디톡스균주에대한주장종지부를찍었다,http://www.segye.com/content/html/2020/12/21/20201221510163.html?OutUrl=naver
11941,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비지원정부과제선정,http://www.edaily.co.kr/news/newspath.asp?newsid=03066806626000816
11942,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제선정,http://www.hg-times.com/news/articleView.html?idxno=223729
11943,2020-12-21,대웅제약코로나치료제니클로사마이드생산장비구축지원정부과제선정,http://kbench.com/?q=node/216980
11944,2020-12-21,특징주대웅제약코로나19치료제임상결과기대감에상한가,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004215132
11945,2020-12-21,대웅제약균주전쟁은끝났다ITC최종결정이후후속절차박차,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137437
11946,2020-12-21,대웅제약호이스타정내달코로나치료제로출시예정,https://www.ekn.kr/web/view.php?key=20201221010005188
11947,2020-12-21,대웅제약종근당약물재창출로코로나치료제개발박차,http://www.updownnews.co.kr/news/articleView.html?idxno=226512
11948,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.getnews.co.kr/news/articleView.html?idxno=505721
11949,2020-12-21,끝난줄알았더니메디톡스대웅제약보톡스분쟁공방지속,http://www.sisafocus.co.kr/news/articleView.html?idxno=252576
11950,2020-12-21,대웅제약코로나19치료제생산장비지원정부과제선정,http://www.cstimes.com/news/articleView.html?idxno=443952
11951,2020-12-21,특징주대웅제약코로나치료제기대감에3일간104↑종합,http://yna.kr/AKR20201221119800002?did=1195m
11952,2020-12-21,보톡스전쟁2라운드메디톡스훔쳤다vs대웅훔친증거없다,http://www.mkhealth.co.kr/news/articleView.html?idxno=51532
11953,2020-12-21,경구형코로나백신치료제기대감에명문삼천당대웅제약상한가,http://www.smartfn.co.kr/view.php?ud=202012211526108400d3eee0def8_46
11954,2020-12-21,급등락주짚어보기대웅제약코로나치료제기대감에상테슬라관련주묶인디아이씨급등,https://www.etoday.co.kr/news/view/1976220
11955,2020-12-21,특징주대웅제약코로나19치료제기대감에사흘간104상승,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004215604
11956,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비지원정부과제선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1437870
11957,2020-12-21,대웅제약코로나치료제기대감에3일간104급등,http://www.paxetv.com/news/articleView.html?idxno=106933
11958,2020-12-21,대웅제약균주전쟁끝메디톡스는기술실체밝혀라,http://www.shinailbo.co.kr/news/articleView.html?idxno=1357272
11959,2020-12-21,대웅제약메디톡스균주영업비밀도용은허구국내소송서드러날것,http://www.whitepaper.co.kr/news/articleView.html?idxno=199854
11960,2020-12-21,대웅제약코로나19치료제생산장비구축지원예비선정,http://www.thedailypost.kr/news/articleView.html?idxno=78296
11961,2020-12-21,김창수의e뉴스브리핑대웅제약니클로사마이드코로나치료제생산장비구축지원정부과제선정外,https://www.fetv.co.kr/news/article.html?no=72147
11962,2020-12-21,대웅제약코로나치료제생산장비구축지원선정,http://www.skyedaily.com/news/news_view.html?ID=118512
11963,2020-12-21,코로나19치료제기대감대웅제약종근당주가급등,http://www.dailymedi.com/detail.php?number=864278&thread=22r05
11964,2020-12-21,대웅제약코로나치료제생산장비구축지원정부과제예비선정,http://www.meconomynews.com/news/articleView.html?idxno=48624
11965,2020-12-21,연기금외인개인제약株동반매수일양약품명문제약대웅제약삼천당제약깜짝상한가행진,http://www.pinpointnews.co.kr/view.php?ud=202012211701168335cd1e7f0bdf_45
11966,2020-12-21,양시장상승마감대웅제약상한가쌍용차하락세,https://imnews.imbc.com/replay/2020/nw1700/article/6034017_32510.html
11967,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.lcnews.co.kr/news/articleView.html?idxno=11114
11968,2020-12-21,신풍제약하락끝은어디개미들속탄다대웅제약박셀바이오일양약품명문제약은폭발,http://www.pinpointnews.co.kr/view.php?ud=202012211718339255861beb2d9d_45
11969,2020-12-21,대웅제약코로나치료제승기잡나상한가랠리시동박해린의뉴스마켓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012210377&t=NNv
11970,2020-12-21,금일제약업계주요기사셀트리온스텔라라바이오시밀러글로벌3상개시대웅제약코로나19치료제정부과제선정外,http://www.youthdaily.co.kr/news/article.html?no=56844
11971,2020-12-21,대웅제약주가3거래일동안104올라코로나치료제기대감반영,http://www.newsfc.co.kr/news/articleView.html?idxno=44049
11972,2020-12-21,21일특징주대웅제약일양약품알체라까뮤이앤씨등12개종목상한가,http://www.newsworks.co.kr/news/articleView.html?idxno=514149
11973,2020-12-21,퇴근길제약Pin대웅제약코로나19치료제생산장비정부지원받나,http://www.pinpointnews.co.kr/view.php?ud=202012211737421564f090c8dbcb_45
11974,2020-12-21,ITC본판결에내가이겼다는균주전쟁대웅메톡주가향방은,http://www.opinionnews.co.kr/news/articleView.html?idxno=44362
11975,2020-12-21,대웅제약코로나19치료제생산장비구축지원정부과제예비선정,http://www.100ssd.co.kr/news/articleView.html?idxno=73615
11976,2020-12-21,대웅제약자회사아이엔테라퓨틱스포스텍KIURI연구단과공동연구협약체결,http://www.thefirstmedia.net/news/articleView.html?idxno=68110
11977,2020-12-21,대웅제약니클로사마이드코로나19치료제생산장비구축지원정부과제선정,http://www.thefirstmedia.net/news/articleView.html?idxno=68136
11978,2020-12-21,상한가종목제약주대웅제약일양약품명문제약삼천당제약상한가마감뒤이어디아이씨동신건설까뮤이앤씨알체라등상한가,http://www.econonews.co.kr/news/articleView.html?idxno=150092
11979,2020-12-21,The이슈대웅제약발목잡은ITC의텃새자국산업보호주의결과,http://www.thedailypost.kr/news/articleView.html?idxno=78300
11980,2020-12-22,메디톡스vs대웅제약보톡스분쟁국내소송서시비가리자,http://it.chosun.com/site/data/html_dir/2020/12/22/2020122200319.html
11981,2020-12-22,대웅제약ITC불확실성해소에밸류에이션재조정,http://www.press9.kr/news/articleView.html?idxno=46635
11982,2020-12-22,대웅보툴리눔톡신균주전쟁끝났다주장이유는,http://www.dailypharm.com/Users/News/NewsView.html?ID=271742&REFERER=NP
11983,2020-12-22,빅데이터MSI시장심리톱5SK이마트신세계삼성중공업대웅제약,http://www.newsis.com/view/?id=NISX20201222_0001278624&cID=10403&pID=15000
11984,2020-12-22,모더나화이자백신낭보있지만올라탈까왜변이출현긴장대웅제약셀트리온박셀바이오주목,http://www.pinpointnews.co.kr/view.php?ud=202012220754413360861beb2d9d_45
11985,2020-12-22,코덱스바이오이티에프급등구성종목대웅종근당부광약품셀트리온헬스케어,http://www.betanews.net:8080/article/1246702.html
11986,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.fetv.co.kr/news/article.html?no=72187
11987,2020-12-22,동화약품대웅제약제약주상승에급등까지동화약품7급등이어대웅제약4상승,http://www.econonews.co.kr/news/articleView.html?idxno=150135
11988,2020-12-22,대웅제약나보타다양한온도서역가안정성입증”,http://www.youthdaily.co.kr/news/article.html?no=56889
11989,2020-12-22,포털검색상위종목대웅제약코로나치료제개발기대감에4일연속상승,http://www.g-enews.com/ko-kr/news/article/news_all/202012220918493371edf69f862c_1/article.html
11990,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,https://www.ekn.kr/web/view.php?key=20201222010005348
11991,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://medipana.com/news/news_viewer.asp?NewsNum=268800&MainKind=A&NewsKind=5&vCount=12&vKind=1
11992,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.kpinews.co.kr/news/articleView.html?idxno=133465
11993,2020-12-22,타이쿤의차트의기술박셀바이오목표치적중추가전략대웅제약30만원이분기점된다,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122208465185641
11994,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.asiatoday.co.kr/view.php?key=20201222010013608
11995,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증”,http://www.viva100.com/main/view.php?key=20201222010005416
11996,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.m-i.kr/news/articleView.html?idxno=778601
11997,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.dailian.co.kr/news/view/948701/?sc=Naver
11998,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012220934285290410
11999,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.pharmnews.com/news/articleView.html?idxno=101965
12000,2020-12-22,코스피코스닥동반하락출발디아이씨대웅알체라명문제약뛰어,http://www.businesspost.co.kr/BP?command=article_view&num=209649
12001,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.press9.kr/news/articleView.html?idxno=46641
12002,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122209444280218
12003,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.mhj21.com/137873
12004,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.anewsa.com/detail.php?number=2310404&thread=10
12005,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.businesskorea.co.kr/news/articleView.html?idxno=57226
12006,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=252806
12007,2020-12-22,뉴스투데이L대웅제약나보타다양한온도에서역가안정성입증,https://www.news2day.co.kr/article/20201222500075
12008,2020-12-22,대웅제약나보타다양한온도에서안정성지속성입증,http://www.metroseoul.co.kr/article/20201222500108
12009,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012220088&t=NN
12010,2020-12-22,노터스대웅제약코로나19치료제수익2받는다,https://www.etoday.co.kr/news/view/1976490
12011,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,https://www.econovill.com/news/articleView.html?idxno=511446
12012,2020-12-22,대웅제약나보타다양한온도에서효능효과유지,http://news.mt.co.kr/mtview.php?no=2020122209503417698
12013,2020-12-22,대웅제약나보타다양한온도에서안정성입증,https://health.chosun.com/site/data/html_dir/2020/12/22/2020122200927.html
12014,2020-12-22,대웅제약나보타다양한온도조건역가안정성입증,http://www.newsprime.co.kr/news/article.html?no=528305
12015,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://sports.hankooki.com/lpage/economy/202012/sp20201222100822137020.htm?s_ref=nv
12016,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.thebigdata.co.kr/view.php?ud=202012221009207786798818e98b_23
12017,2020-12-22,대웅제약보툴리눔톡신제제나보타다양한온도에서역가안정성입증,http://www.pinpointnews.co.kr/view.php?ud=2020122210101663242365609d9b_45
12018,2020-12-22,대웅제약나보타다양한온도에서효능효과안정적,http://www.healthinnews.co.kr/news/articleView.html?idxno=20925
12019,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.medisobizanews.com/news/articleView.html?idxno=75146
12020,2020-12-22,대웅제약나보타다양한온도에서안정성입증,http://it.chosun.com/site/data/html_dir/2020/12/22/2020122200968.html
12021,2020-12-22,특징주대웅제약코로나치료제출시기대감에3대상승세,https://www.asiatoday.co.kr/view.php?key=20201222010013698
12022,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,https://www.asiatime.co.kr/news/newsview.php?ncode=1065576063627193
12023,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=37743
12024,2020-12-22,대웅제약보툴리눔제제나보타다양한온도조건서효능유지,http://yna.kr/AKR20201222062700017?did=1195m
12025,2020-12-22,특징주대웅제약상승세끝10대하락,http://www.edaily.co.kr/news/newspath.asp?newsid=02617446626001144
12026,2020-12-22,대웅제약영진약품제약주급등에급락으로희비엇갈려특히대웅제약급등서갑작스런8급락,http://www.econonews.co.kr/news/articleView.html?idxno=150194
12027,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,http://www.businesskorea.co.kr/news/articleView.html?idxno=57251
12028,2020-12-22,대웅제약후보물질DWP212525코로나19치료제정부과제선정,http://www.mhj21.com/137877
12029,2020-12-22,조필현의시선메디톡스vs대웅제약독한전쟁2라운드시작,http://www.wikileaks-kr.org/news/articleView.html?idxno=100800
12030,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.bosa.co.kr/news/articleView.html?idxno=2140741
12031,2020-12-22,대웅제약나보타온도따라효과달라지지않아,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137868&REFERER=NP
12032,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,http://www.seoulwire.com/news/articleView.html?idxno=432262
12033,2020-12-22,대웅제약비임상연구통해나보타역가안정성입증,http://www.pressm.kr/news/articleView.html?idxno=35512
12034,2020-12-22,대웅제약자가면역치료제신약코로나치료제정부과제선정”,http://www.viva100.com/main/view.php?key=20201222010005514
12035,2020-12-22,특징주대웅제약오전장중최고가찍고하락전환,http://moneys.mt.co.kr/news/mwView.php?no=2020122211228022093
12036,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.healthinnews.co.kr/news/articleView.html?idxno=20935
12037,2020-12-22,대웅제약자가면역신약후보물질코로나19치료제로정부과제선정,http://www.medisobizanews.com/news/articleView.html?idxno=75157
12038,2020-12-22,대웅제약코로나19치료제정부과제선정,http://www.press9.kr/news/articleView.html?idxno=46650
12039,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.lawissue.co.kr/view.php?ud=202012221114123452204ead0791_12
12040,2020-12-22,대웅자가면역치료제코로나19치료제정부과제선정,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137872&REFERER=NP
12041,2020-12-22,대웅제약자가면역치료제신약코로나19치료제정부과제로선정,https://www.asiatoday.co.kr/view.php?key=20201222010013862
12042,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://daily.hankooki.com/lpage/industry/202012/dh20201222113010147950.htm?s_ref=nv
12043,2020-12-22,대웅제약신약후보물질코로나19치료제정부과제선정,http://www.dailysmart.co.kr/news/articleView.html?idxno=37766
12044,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://www.newsis.com/view/?id=NISX20201222_0001279277&cID=13001&pID=13000
12045,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.asiaa.co.kr/news/articleView.html?idxno=13800
12046,2020-12-22,특징주코로나치료제株동반하락대웅제약10대급락,https://www.asiatoday.co.kr/view.php?key=20201222010013878
12047,2020-12-22,대웅제약자가면역치료신약코로나19치료제정부과제선정,http://medipana.com/news/news_viewer.asp?NewsNum=268827&MainKind=A&NewsKind=5&vCount=12&vKind=1
12048,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://www.youthdaily.co.kr/news/article.html?no=56920
12049,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,https://www.news2day.co.kr/article/20201222500174
12050,2020-12-22,22일장중코로나주유나이티드제약명문제약껑충vs대웅제약급락,http://www.choicenews.co.kr/news/articleView.html?idxno=77593
12051,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나치료제정부과제선정,http://www.segye.com/content/html/2020/12/22/20201222508356.html?OutUrl=naver
12052,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65401
12053,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65390
12054,2020-12-22,대웅제약코로나19치료제정부과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2140756
12055,2020-12-22,대웅제약나보타상온냉장냉동서효능유지,http://www.seoulfn.com/news/articleView.html?idxno=405221
12056,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19치료제비임상정부과제선정,http://www.newsprime.co.kr/news/article.html?no=528350
12057,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,https://www.fetv.co.kr/news/article.html?no=72245
12058,2020-12-22,대웅제약자체보툴리눔톡신의다양한온도에서효과유지를입증,http://www.businesspost.co.kr/BP?command=article_view&num=209708
12059,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=409791
12060,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://www.newsway.co.kr/news/view?tp=1&ud=2020122212270927538
12061,2020-12-22,대웅제약코로나19치료제정부과제선정,http://www.dailymedi.com/detail.php?number=864318&thread=22r05
12062,2020-12-22,대웅제약자가면역치료제후보물질정부코로나19치료제과제선정,https://biz.chosun.com/site/data/html_dir/2020/12/22/2020122201421.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12063,2020-12-22,대웅제약자가면역치료제후보물질 코로나19 치료제비임상연구개발지원받아,http://www.economytalk.kr/news/articleView.html?idxno=210041
12064,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.koreaittimes.com/news/articleView.html?idxno=102665
12065,2020-12-22,메디톡스vs대웅제약엇갈린ITC최종판결해석끝나지않은국내소송누가웃을까,http://www.thepublic.kr/news/newsview.php?ncode=1065580127084291
12066,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.m-i.kr/news/articleView.html?idxno=778776
12067,2020-12-22,대웅제약자가면역치료제코로나19치료제정부과제선정,http://www.kpinews.co.kr/news/articleView.html?idxno=133520
12068,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.newsworker.co.kr/news/articleView.html?idxno=96597
12069,2020-12-22,대웅제약DWP212525코로나19비임상정부과제선정,https://www.hankyung.com/it/article/202012225298i
12070,2020-12-22,대웅제약자가면역치료제신약정부코로나19치료제비임상과제선정,http://it.chosun.com/site/data/html_dir/2020/12/22/2020122201588.html
12071,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.metroseoul.co.kr/article/20201222500323
12072,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122213505471972
12073,2020-12-22,대웅제약자가면역후보물질코로나치료제정부과제선정,http://news.mt.co.kr/mtview.php?no=2020122213574963177
12074,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.ezyeconomy.com/news/articleView.html?idxno=108249
12075,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제길열리나,http://www.thebigdata.co.kr/view.php?ud=202012221358063569d0a8833aad_23
12076,2020-12-22,대웅제약보톡스나보타다양한온도에서효능효과확인,https://biz.chosun.com/site/data/html_dir/2020/12/22/2020122201668.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12077,2020-12-22,대웅주가18↑자회사대웅제약코로나19생산장비구축지원정부과제선정,http://www.ajunews.com/view/20201222133413780
12078,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,https://www.etoday.co.kr/news/view/1976609
12079,2020-12-22,대웅제약자가면역치료제후보물질정부코로나19치료제과제선정,http://inthenews.co.kr/article-83931/
12080,2020-12-22,대웅제약DWP212525코로나19치료제정부과제선정,http://www.insightkorea.co.kr/news/articleView.html?idxno=85581
12081,2020-12-22,대웅제약자가면역질환신약물질코로나19비임상정부지원,http://yna.kr/AKR20201222105100017?did=1195m
12082,2020-12-22,대웅제약나보타다양한온도에서안정된효능효과입증,http://www.lcnews.co.kr/news/articleView.html?idxno=11158
12083,2020-12-22,대웅제약자가면역질환신약물질코로나19비임상정부지원받아,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4378555
12084,2020-12-22,코로나19치료제가능성인정대웅제약자가면역치료제신약후보물질정부과제선정,http://theviewers.co.kr/View.aspx?No=1392099
12085,2020-12-22,대웅제약자가면역치료제후보물질코로나19정부과제선정,http://www.anewsa.com/detail.php?number=2310674&thread=10
12086,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.getnews.co.kr/news/articleView.html?idxno=505915
12087,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://news.heraldcorp.com/view.php?ud=20201222000765
12088,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012221438452320583
12089,2020-12-22,대웅제약균주전쟁끝났다나머지오판도바로잡을것,http://www.thefirstmedia.net/news/articleView.html?idxno=68172
12090,2020-12-22,대웅제약자가면역치료제코로나치료제정부과제선정내년임상1상,http://moneys.mt.co.kr/news/mwView.php?no=2020122214138073964
12091,2020-12-22,대웅제약자가면역치료제후보물질코로나19정부과제선정,http://www.segyebiz.com/newsView/20201222510965?OutUrl=naver
12092,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.wsobi.com/news/articleView.html?idxno=110930
12093,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.nbnnews.co.kr/news/articleView.html?idxno=452170
12094,2020-12-22,대웅제약자가면역치료제코로나19정부과제선정,http://daily.hankooki.com/lpage/industry/202012/dh20201222151424148390.htm?s_ref=nv
12095,2020-12-22,대웅제약4번째코로나치료제개발돌입자가면역치료제신약후보물질정부과제선정,https://www.donga.com/news/article/all/20201222/104591469/1
12096,2020-12-22,대웅제약자가면역치료제후보물질코로나19비임상정부지원,https://view.asiae.co.kr/article/2020122215182078022
12097,2020-12-22,큰일치른대웅제약반등노릴까,http://www.sporbiz.co.kr/news/articleView.html?idxno=505042
12098,2020-12-22,대웅제약나보타다양한온도서역가안정성입증,http://www.thedailypost.kr/news/articleView.html?idxno=78310
12099,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00013&news_seq_no=4378702
12100,2020-12-22,대웅제약자가면역치료제후보물질코로나치료제정부과제선정,http://www.newstomato.com/ReadNews.aspx?no=1014487
12101,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19치료제가능성인정받아,http://kpenews.com/View.aspx?No=1392299
12102,2020-12-22,대웅DWP212525코로나치료제로政지원선정,http://www.whosaeng.com/123516
12103,2020-12-22,대웅제약자가면역치료제코로나19치료제정부과제선정,http://sports.hankooki.com/lpage/economy/202012/sp20201222154325137020.htm?s_ref=nv
12104,2020-12-22,대웅제약자가면역치료제후보물질코로나19비임상정부지원,https://www.ajunews.com/view/20201222131105751
12105,2020-12-22,대웅제약자가면역치료후보물질정부과제선정,http://www.mediapen.com/news/view/586018
12106,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.medigatenews.com/news/3462032986
12107,2020-12-22,SCI급국제학술지게재대웅제약나보타다양한온도에서역가안정성입증,http://theviewers.co.kr/View.aspx?No=1392517
12108,2020-12-22,대웅제약DWP212525코로나치료제정부과제선정,http://www.monews.co.kr/news/articleView.html?idxno=216715
12109,2020-12-22,대웅제약자가면역치료후보물질코로나19정부과제선정,http://www.seoulfn.com/news/articleView.html?idxno=405281
12110,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19치료제정부과제선정,http://www.thedailypost.kr/news/articleView.html?idxno=78326
12111,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.lawissue.co.kr/view.php?ud=202012221635149033204ead0791_12
12112,2020-12-22,대웅제약자가면역질환신약물질코로나19치료제정부과제선정,http://news.mk.co.kr/newsRead.php?no=1310919&year=2020
12113,2020-12-22,대웅제약자가면역후보물질코로나치료제정부과제선정비임상연구개발비지원,http://www.updownnews.co.kr/news/articleView.html?idxno=226578
12114,2020-12-22,대웅제약나보타다양한온도에서역가안정성입증,http://www.thefirstmedia.net/news/articleView.html?idxno=68204
12115,2020-12-22,대웅제약나보타다양한온도에서안정성 입증,http://www.koreastocknews.com/news/articleView.html?idxno=60118
12116,2020-12-22,코로나변이뭐라고모더나화이자관련주어떡하나대웅제약셀트리온신풍제약셀트리온헬스케어휘청,http://www.pinpointnews.co.kr/view.php?ud=202012221649573747861beb2d9d_45
12117,2020-12-22,대웅제약자가면역치료제후보물질DWP212525코로나19치료제정부과제선정,http://www.thefirstmedia.net/news/articleView.html?idxno=68220
12118,2020-12-22,대웅제약자가면역치료제신약후보물질코로나19비임상정부과제선정,https://www.sedaily.com/NewsView/1ZBS78VH0A
12119,2020-12-22,김창수의e뉴스브리핑대웅제약자가면역치료제후보물질코로나19치료제정부과제선정外,https://www.fetv.co.kr/news/article.html?no=72289
12120,2020-12-22,대웅제약보툴리눔제제나보타다양한온도에서효능유지,http://www.mediapen.com/news/view/586083
12121,2020-12-22,금일제약업계주요기사대웅제약자가면역치료제코로나19정부과제선정제넥신JP모건헬스케어컨퍼런스참가”外,http://www.youthdaily.co.kr/news/article.html?no=56976
12122,2020-12-22,대웅제약코로나19치료제정부과제선정2021년하반기임상1상진입목표,http://www.paxetv.com/news/articleView.html?idxno=107076
12123,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://4th.kr/View.aspx?No=1392658
12124,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제지원과제로뽑혀,http://www.businesspost.co.kr/BP?command=article_view&num=209785
12125,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://news.kbiz.or.kr/news/articleView.html?idxno=75983
12126,2020-12-22,대웅제약자가면역치료제후보물질코로나19치료제정부과제선정,http://www.newsfreezone.co.kr/news/articleView.html?idxno=285107
12127,2020-12-23,대웅제약자가면역치료제DWP212525코로나19치료제정부과제선정,https://www.kpanews.co.kr/article/show.asp?idx=218745&category=D
12128,2020-12-23,대웅제약나보타다양한온도서역가안정성입증,https://www.kpanews.co.kr/article/show.asp?idx=218752&category=D
12129,2020-12-23,종목PICK이달130뛴대웅제약상승끝호재더있나,https://www.asiatoday.co.kr/view.php?key=20201222010014279
12130,2020-12-23,1호메이드인코리아코로나치료제셀트리온대웅제약누가빠를까,https://biz.chosun.com/site/data/html_dir/2020/12/22/2020122202470.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12131,2020-12-23,대웅제약자가면역치료후보물질코로나19치료제정부과제선정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006041
12132,2020-12-23,뉴욕증시코로나변이에다우지수휘청대웅제약셀트리온현대약품유나이티드제약주목을,http://www.pinpointnews.co.kr/view.php?ud=202012230647168143861beb2d9d_45
12133,2020-12-23,고공행진대웅제약주가조정접어드나2일차급락마감,http://medipana.com/news/news_viewer.asp?NewsNum=268847&MainKind=A&NewsKind=5&vCount=12&vKind=1
12134,2020-12-23,대웅제약ITC패소에도훨훨코로나치료제기대감,http://www.cstimes.com/news/articleView.html?idxno=444187
12135,2020-12-23,대웅제약신약후보물질코로나19치료제정부과제선정,http://www.shinailbo.co.kr/news/articleView.html?idxno=1357996
12136,2020-12-23,대웅제약동화약품제약주하락에급락으로무너져대웅제약6급락이어동화약품1하락,http://www.econonews.co.kr/news/articleView.html?idxno=150320
12137,2020-12-23,현대약품대웅제약제약주급등에급락으로희비엇갈려현대약품14급등반해대웅제약6급락,http://www.econonews.co.kr/news/articleView.html?idxno=150331
12138,2020-12-23,국내1호코로나치료제언제나오나셀트리온대웅제약GC녹십자,https://news.imaeil.com/Society/2020122310035192486
12139,2020-12-23,대웅제약뉴트로감성더한한정판대웅우루사360캡슐출시,https://www.ekn.kr/web/view.php?key=20201223010005729
12140,2020-12-23,23일장중코로나주강스템바이오텍껑충vs대웅제약신풍제약하락,http://www.choicenews.co.kr/news/articleView.html?idxno=77625
12141,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://sports.hankooki.com/lpage/economy/202012/sp20201223102749136980.htm?s_ref=nv
12142,2020-12-23,대웅제약연말맞아대웅우루사360캡슐한정판출시,https://biz.chosun.com/site/data/html_dir/2020/12/23/2020122301103.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12143,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://medipana.com/news/news_viewer.asp?NewsNum=268886&MainKind=A&NewsKind=5&vCount=12&vKind=1
12144,2020-12-23,대웅제약뉴트로한정판대웅우루사360캡슐출시,http://news.mt.co.kr/mtview.php?no=2020122310325754483
12145,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.kpinews.co.kr/news/articleView.html?idxno=133612
12146,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65411
12147,2020-12-23,대웅제약대웅우루사360캡슐한정판출시,http://www.medisobizanews.com/news/articleView.html?idxno=75189
12148,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.anewsa.com/detail.php?number=2311520&thread=10
12149,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.youthdaily.co.kr/news/article.html?no=57043
12150,2020-12-23,소중한분에게선물하세요대웅제약대웅우루사360캡슐뉴트로한정판출시,https://www.asiatoday.co.kr/view.php?key=20201223010014692
12151,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.businesskorea.co.kr/news/articleView.html?idxno=57327
12152,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.healthinnews.co.kr/news/articleView.html?idxno=20968
12153,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://news.mk.co.kr/newsRead.php?no=1312935&year=2020
12154,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.mhj21.com/137940
12155,2020-12-23,대웅우루사360캡슐뉴트로한정판출시,http://www.bokuennews.com/news/article.html?no=198799
12156,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.koreaittimes.com/news/articleView.html?idxno=102697
12157,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.dailypharm.com/Users/News/NewsView.html?ID=271826&REFERER=NP
12158,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.dailysmart.co.kr/news/articleView.html?idxno=37829
12159,2020-12-23,종근당대웅콜린알포임상재평가신청급여환수소송준비중,https://cnbc.sbs.co.kr/article_hub/10001006847?division=NAVER
12160,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.lawissue.co.kr/view.php?ud=202012231200476018204ead0791_12
12161,2020-12-23,대웅제약DWP212525코로나19치료제정부과제선정,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137487
12162,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.thebigdata.co.kr/view.php?ud=202012231252377063d0a8833aad_23
12163,2020-12-23,대웅제약뉴트로열풍따라대웅우루사360캡슐한정판출시,http://www.lcnews.co.kr/news/articleView.html?idxno=11203
12164,2020-12-23,유나이티드제약대웅제약제약주하락에급락으로무너져특히유나이티드제약급등서오후갑작스런4하락반전,http://www.econonews.co.kr/news/articleView.html?idxno=150430
12165,2020-12-23,대웅제약연말맞이대웅우루사360캡슐한정판출시,http://www.marketnews.co.kr/news/articleView.html?idxno=58128
12166,2020-12-23,대웅제약복고풍대웅우루사360캡슐한정판출시,http://www.sportsseoul.com/news/read/995617?ref=naver
12167,2020-12-23,대웅제약우루사의변신은계속된다”,http://www.whosaeng.com/123566
12168,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인,http://www.mhj21.com/137947
12169,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.lawissue.co.kr/view.php?ud=202012231428005950204ead0791_12
12170,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.thebigdata.co.kr/view.php?ud=202012231428556889798818e98b_23
12171,2020-12-23,대웅제약코로나19치료제임상2a상서효과확인대규모임상신속진행,http://www.fnnews.com/news/202012231427022865
12172,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인,http://www.press9.kr/news/articleView.html?idxno=46662
12173,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인”,http://www.youthdaily.co.kr/news/article.html?no=57086
12174,2020-12-23,트렌드쫓는건기식대웅제약대웅우루사360캡슐뉴트로한정판출시,http://theviewers.co.kr/View.aspx?No=1393767
12175,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료효과확인,https://www.etoday.co.kr/news/view/1977165
12176,2020-12-23,대웅제약호이스타정임상2a상서코로나치료가능성확인,http://medipana.com/news/news_viewer.asp?NewsNum=268916&MainKind=A&NewsKind=5&vCount=12&vKind=1
12177,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.metroseoul.co.kr/article/20201223500374
12178,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.bosa.co.kr/news/articleView.html?idxno=2140879
12179,2020-12-23,대웅제약임상2a상서호이스타정코로나19치료효과확인,http://it.chosun.com/site/data/html_dir/2020/12/23/2020122302166.html
12180,2020-12-23,대웅제약호이스타정2a상서코로나치료제효과확인”,http://www.viva100.com/main/view.php?key=20201223010005955
12181,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.medisobizanews.com/news/articleView.html?idxno=75203
12182,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65426
12183,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인바이러스진입차단,http://www.paxetv.com/news/articleView.html?idxno=107146
12184,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제가능성확인,http://daily.hankooki.com/lpage/industry/202012/dh20201223144711148390.htm?s_ref=nv
12185,2020-12-23,대웅제약호이스타정임상2a상서코로나치료제가능성확인,https://www.ekn.kr/web/view.php?key=20201223010005851
12186,2020-12-23,대웅제약호이스타2a상서코로나치료제가능성확인,http://www.newsis.com/view/?id=NISX20201223_0001281239&cID=13001&pID=13000
12187,2020-12-23,코로나19치료제가능성확인대웅제약호이스타정임상2a상결과발표계획,http://theviewers.co.kr/View.aspx?No=1393795
12188,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료효과확인,http://yna.kr/AKR20201223113900017?did=1195m
12189,2020-12-23,대웅제약호이스타정임상2a상톱라인결과공개코로나19치료제가능성확인,http://kpenews.com/View.aspx?No=1393919
12190,2020-12-23,호이스타정코로나치료제가능성확인대웅제약임상2상발표,http://www.wikileaks-kr.org/news/articleView.html?idxno=100899
12191,2020-12-23,대웅제약호이스타정2a상서코로나19치료제가능성확인,https://www.hankyung.com/finance/article/202012230279i
12192,2020-12-23,대웅제약대웅폭락에하한가로무너져대웅제약하한가이어대웅26폭락,http://www.econonews.co.kr/news/articleView.html?idxno=150454
12193,2020-12-23,대웅제약상대손해배상소송업체들시점따져소가올릴듯,http://www.sisajournal-e.com/news/articleView.html?idxno=227352
12194,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020122315130939276
12195,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.m-i.kr/news/articleView.html?idxno=779396
12196,2020-12-23,현대바이오대웅대웅제약폭락투자자들어쩌나,http://www.nbnnews.co.kr/news/articleView.html?idxno=452660
12197,2020-12-23,대웅제약호이스타정코로나치료제로가능성확인,https://www.dailian.co.kr/news/view/949282/?sc=Naver
12198,2020-12-23,현대바이오대웅대웅제약폭락투자자들어쩌나,http://www.nbnnews.co.kr/news/articleView.html?idxno=452660
12199,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=20979
12200,2020-12-23,코로나변이백신두달안생산이렇게나빨리현대바이오하한가충격대웅제약셀트리온주가어디로,http://www.pinpointnews.co.kr/view.php?ud=202012231510503718861beb2d9d_45
12201,2020-12-23,대웅제약호이스타정2a임상서코로나19치료효과확인,http://www.seoulfn.com/news/articleView.html?idxno=405427
12202,2020-12-23,의약오늘이대서울병원우수내시경실인증획득대웅제약호이스타정임상2a상결과공개,http://www.sisaon.co.kr/news/articleView.html?idxno=122038
12203,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료효과확인,http://inthenews.co.kr/article-84203/
12204,2020-12-23,대웅제약호이스타정임상결과코로나19치료제가능성확인,http://www.joseilbo.com/news/news_read.php?uid=413301&class=27&grp=
12205,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.finomy.com/news/articleView.html?idxno=87067
12206,2020-12-23,대웅제약 호이스타정 임상 2a상에서 코로나19 치료 효과 확인,http://kormedi.com/?p=1329727
12207,2020-12-23,대웅제약호이스타정임상결과코로나19치료제가능성확인,https://www.fetv.co.kr/news/article.html?no=72383
12208,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.nbnnews.co.kr/news/articleView.html?idxno=452625
12209,2020-12-23,대웅제약호이스타정2a상주평가변수미충족2b3상진행,https://www.econovill.com/news/articleView.html?idxno=511781
12210,2020-12-23,대웅제약임상2a상서호이스타정코로나19치료효과확인,http://www.newslock.co.kr/news/articleView.html?idxno=34395
12211,2020-12-23,대웅제약호이스타정코로나19치료효과임상2a상확인,https://www.news2day.co.kr/article/20201223500271
12212,2020-12-23,우루사의변신은무죄”대웅제약대웅우루사360캡슐뉴트로한정판출시,https://www.fetv.co.kr/news/article.html?no=72388
12213,2020-12-23,대웅호이스타임상2a서코로나19치료제가능성확인,http://www.dailypharm.com/Users/News/NewsView.html?ID=271839&REFERER=NP
12214,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.mediapen.com/news/view/586451
12215,2020-12-23,대웅제약호이스타정2a상임상결과통계적으로유의하지않아,http://www.koreastocknews.com/news/articleView.html?idxno=60159
12216,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제로가능성확인,http://news.kbiz.or.kr/news/articleView.html?idxno=76024
12217,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.medigatenews.com/news/3568144681
12218,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.thedailypost.kr/news/articleView.html?idxno=78347
12219,2020-12-23,대웅제약호이스타정코로나치료효과보였다는데하한가왜,http://moneys.mt.co.kr/news/mwView.php?no=2020122315268079507
12220,2020-12-23,대웅제약알약코로나치료제호이스타정효과확인,http://news.mt.co.kr/mtview.php?no=2020122315500798037
12221,2020-12-23,대웅제약코로나치료제2상실패인데도3상진행,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137902&REFERER=NP
12222,2020-12-23,너무올랐나대웅제약3일간104급등뒤이틀째급락,http://yna.kr/AKR20201223137600002?did=1195m
12223,2020-12-23,대웅제약이틀연속급락차익실현물량대거쏟아져,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4379840
12224,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.ceoscoredaily.com/news/article.html?no=76553
12225,2020-12-23,대웅제약코로나치료제주평가변수통계적으로유의하지않아,http://www.edaily.co.kr/news/newspath.asp?newsid=03758886626001472
12226,2020-12-23,대웅제약호이스타정2a임상Topline결과발표,http://www.whosaeng.com/123574
12227,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.anewsa.com/detail.php?number=2311965&thread=10
12228,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,https://cnbc.sbs.co.kr/article_hub/10001006887?division=NAVER
12229,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,http://www.newsworks.co.kr/news/articleView.html?idxno=514882
12230,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.g-enews.com/ko-kr/news/article/news_all/2020122315583398769d76442fa_1/article.html
12231,2020-12-23,대웅제약대웅우루사360캡슐한정판출시,http://www.mediapen.com/news/view/586497
12232,2020-12-23,대웅제약코로나19치료제임상유효성확인,http://www.skyedaily.com/news/news_view.html?ID=118751
12233,2020-12-23,현대바이오대웅대웅제약하한가종근당바이오에이비프로바이오인바이오폭락투자경고바이오株,http://www.pinpointnews.co.kr/view.php?ud=202012231646329609cd1e7f0bdf_45
12234,2020-12-23,대웅제약호이스타정코로나치료제임상2a상서주평가변수충족못해,http://www.newspim.com/news/view/20201223001145
12235,2020-12-23,대웅호이스타코로나19치유빨라,http://www.finomy.com/news/articleView.html?idxno=87085
12236,2020-12-23,지놈앤컴퍼니석경에이티주가치솟았지만대웅제약현대바이오와르르셀트리온신풍제약은,http://www.pinpointnews.co.kr/view.php?ud=202012231653073813861beb2d9d_45
12237,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.dailymedi.com/detail.php?number=864397&thread=22r05
12238,2020-12-23,대웅제약호이스타정임상2상중간결과발표코로나치료제가능성확인”,https://www.donga.com/news/article/all/20201223/104613670/1
12239,2020-12-23,대웅제약3일간급등뒤이틀연속급락,http://www.startuptoday.co.kr/news/articleView.html?idxno=65088
12240,2020-12-23,대웅제약호이스타정임상에서코로나19치료제가능성확인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065600178296803
12241,2020-12-23,대웅제약임상2상서효과확인국산치료제가시화,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012230256&t=NNv
12242,2020-12-23,대웅제약호이스타정코로나19제거빨랐으나통계적유의성없어종합,http://yna.kr/AKR20201223113951017?did=1195m
12243,2020-12-23,대웅제약호이스타정2a상서코로나19치료가능성확인”,https://www.kpanews.co.kr/article/show.asp?idx=218777&category=D
12244,2020-12-23,대웅제약호이스타2a상서코로나치료제가능성확인,https://www.ajunews.com/view/20201223165336857
12245,2020-12-23,대웅제약호이스타정임상2a상코로나19치료제가능성확인,http://www.ajunews.com/view/20201223164112848
12246,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.worktoday.co.kr/news/articleView.html?idxno=12484
12247,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제로가능성확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=410005
12248,2020-12-23,대웅제약호이스타정임상서통계적유의성확보실패대웅측가능성확인주장,http://news.mk.co.kr/newsRead.php?no=1315421&year=2020
12249,2020-12-23,대웅제약호이스타정코로나19치료제임상서주평가변수충족못해,http://www.kpinews.co.kr/news/articleView.html?idxno=133670
12250,2020-12-23,대웅제약호이스타정2a상서코로나19치료제가능성확인,http://www.bokuennews.com/news/article.html?no=198829
12251,2020-12-23,대웅제약호이스타정임상2a상서코로나치료제가능성확인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1438709
12252,2020-12-23,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.thepublic.kr/news/newsview.php?ncode=1065599035054024
12253,2020-12-23,대웅제약호이스타정코로나19치료제가능성확인,http://www.cstimes.com/news/articleView.html?idxno=444428
12254,2020-12-23,23일특징주LG전자세방전지등10개종목상한가대웅제약등3개하한가,http://www.newsworks.co.kr/news/articleView.html?idxno=514952
12255,2020-12-23,대웅제약먹는코로나19치료제임상2a상에서가능성확인,http://www.businesspost.co.kr/BP?command=article_view&num=210005
12256,2020-12-23,코로나19치료제개발어디쯤왔나셀트리온GC녹십자대웅제약주목,http://www.businesspost.co.kr/BP?command=article_view&num=209919
12257,2020-12-23,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=410035
12258,2020-12-23,코로나확진빛의속도모더나화이자가구원의손길대웅제약현대바이오왜이러나,http://www.pinpointnews.co.kr/view.php?ud=202012231939191741861beb2d9d_45
12259,2020-12-23,마감종합기사LG전자등LG그룹주급등자율주행관련주강세계속돼대웅대웅제약현대바이오하한가,http://www.ggilbo.com/news/articleView.html?idxno=817748
12260,2020-12-23,대웅제약호이스타정코로나19치료가능성확인,http://www.newsfreezone.co.kr/news/articleView.html?idxno=285599
12261,2020-12-23,마감LG전자마그나와전기차부품합작사상한가대웅대웅제약하한가,https://www.asiatime.co.kr/news/newsview.php?ncode=1065615894288705
12262,2020-12-23,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=4380175
12263,2020-12-24,대웅제약대웅우루사360캡슐뉴트로한정판선봬,https://www.kpanews.co.kr/article/show.asp?idx=218799&category=D
12264,2020-12-24,50곳대표종근당대웅바이오콜린알포제제재평가도전,http://www.dailymedi.com/detail.php?number=864411&thread=22r05
12265,2020-12-24,뉴욕증시코로나변이충격끝났나다우지수상승니콜라폭락대웅제약현대바이오주가도주목,http://www.pinpointnews.co.kr/view.php?ud=202012240643306695861beb2d9d_45
12266,2020-12-24,대웅제약특별한악재도없는데급락에멘붕이틀연속장대음봉당분간먹구름,http://www.pinpointnews.co.kr/view.php?ud=202012240657195685861beb2d9d_45
12267,2020-12-24,대웅제약우루사360캡슐뉴트로한정판출시,http://www.ajunews.com/view/20201223184625929
12268,2020-12-24,전파력훨씬강한코로나변이또출연어떡해에이비프로바이오대웅제약셀트리온현대바이오주목,http://www.pinpointnews.co.kr/view.php?ud=202012240802587425861beb2d9d_45
12269,2020-12-24,증시키워드LG전자마그나와합작법인설립소식에상대웅제약코로나19치료제효능논란에하,https://www.etoday.co.kr/news/view/1977393
12270,2020-12-24,특징주전일하한가맞은대웅제약이틀만에주가44빠져,https://www.sedaily.com/NewsView/1ZBT3XDY4K
12271,2020-12-24,뉴투분석실적하락굴욕맞은한미약품과대웅제약의서로다른속사정,https://www.news2day.co.kr/article/20201223500367
12272,2020-12-24,특징주대웅제약반등시도호이스타정효능논란,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012240924019510136
12273,2020-12-24,대웅제약대웅하락에폭락으로무너져대웅제약4하락이어대웅10폭락,http://www.econonews.co.kr/news/articleView.html?idxno=150520
12274,2020-12-24,코로나19알약치료제나올까대웅제약호이스타정임상2a상서치료제가능성확인,http://kbench.com/?q=node/217102
12275,2020-12-24,24일장중코로나주대웅수젠텍급락vs씨젠제넥신상승,http://www.choicenews.co.kr/news/articleView.html?idxno=77685
12276,2020-12-24,단독전승호대웅제약대표호이스타코로나치료제개발자신적극해명,http://moneys.mt.co.kr/news/mwView.php?no=2020122411348013737
12277,2020-12-24,특징주코로나치료제대웅2거래일연속하락세,http://moneys.mt.co.kr/news/mwView.php?no=2020122413118071285
12278,2020-12-24,대웅제약호이스타정임상2a상코로나치료제가능성확인,http://www.monews.co.kr/news/articleView.html?idxno=216805
12279,2020-12-24,대웅제약코로나19치료제개발잰걸음,http://www.g-enews.com/ko-kr/news/article/news_all/20201224115231839069d76442fa_1/article.html
12280,2020-12-24,대웅제약대웅급락에폭락까지대웅제약7급락이어대웅14폭락,http://www.econonews.co.kr/news/articleView.html?idxno=150617
12281,2020-12-24,대웅제약대웅우루사360캡슐뉴트로한정판출시,http://www.thefirstmedia.net/news/articleView.html?idxno=68322
12282,2020-12-24,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.thefirstmedia.net/news/articleView.html?idxno=68324
12283,2020-12-24,대웅제약호이스타정코로나19치료제로통계적유의성확보실패,http://www.mkhealth.co.kr/news/articleView.html?idxno=51570
12284,2020-12-24,대웅제약호이스타정임상2a상에서코로나19치료제로가능성확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=453008
12285,2020-12-24,보톡스전쟁2라운드메디톡스훔쳤다vs대웅훔친증거없다정정,http://www.mkhealth.co.kr/news/articleView.html?idxno=51582
12286,2020-12-24,올라타기겁나는삼성전자폭풍랠리대웅제약현대바이오휘청신풍제약에이비프로바이오상승,http://www.pinpointnews.co.kr/view.php?ud=202012241652385182861beb2d9d_45
12287,2020-12-24,너무올랐나대웅그룹시총이틀새2조7천억감소,http://www.dailypharm.com/Users/News/NewsView.html?ID=271889&REFERER=NP
12288,2020-12-24,대웅제약호이스타정임상2a상결과코로나19치료제가능성UP,http://www.thedailypost.kr/news/articleView.html?idxno=78398
12289,2020-12-25,대웅제약˝호이스타2a상서코로나치료제가능성확인˝,http://www.kbsm.net/default/index_view_page.php?idx=297374&part_idx=318
12290,2020-12-25,코로나빛의속도화이자모더나백신효능글쎄셀트리온대웅제약현대바이오등급등락,http://www.g-enews.com/ko-kr/news/article/news_all/2020122507500649294e4869c120_1/article.html
12291,2020-12-25,대웅ITC리스크넘겼지만코로나19치료제에휘청,http://www.kukinews.com/newsView/kuk202012240304
12292,2020-12-26,대웅제약공포의장대음봉출연외국인기관도매도전환긴숨고르기들어가나,http://www.pinpointnews.co.kr/view.php?ud=202012260925599668861beb2d9d_45
12293,2020-12-26,주간e종목대웅제약주가보톡스에웃고코로나19에울다,http://www.sisajournal-e.com/news/articleView.html?idxno=227431
12294,2020-12-26,3일천하대웅제약아찔한주가등락또다른반전있을까,http://www.opinionnews.co.kr/news/articleView.html?idxno=44524
12295,2020-12-26,코로나변종확산막아낼수있나대웅제약현대바이오신풍제약등급등락속출,http://www.pinpointnews.co.kr/view.php?ud=202012261106039914861beb2d9d_45
12296,2020-12-28,투자주의대성엘텍인포뱅크약세투자경고현대바이오대웅동신건설명신산업폭락,http://www.pinpointnews.co.kr/view.php?ud=202012280731057151cd1e7f0bdf_45
12297,2020-12-28,대웅제약동화약품제약주모두하락흐름대웅제약3하락이어동화약품역시3하락,http://www.econonews.co.kr/news/articleView.html?idxno=150991
12298,2020-12-28,대웅제약호이스타정임상2a상서코로나19치료제가능성확인,http://www.wsobi.com/news/articleView.html?idxno=111209
12299,2020-12-28,대웅제약호이스타임상운이없게20대위약군많았다,http://www.kpinews.co.kr/news/articleView.html?idxno=133860
12300,2020-12-28,단독대웅제약배보다배꼽올영업이익보다훨씬많은소송비용지출,http://www.newsfc.co.kr/news/articleView.html?idxno=44123
12301,2020-12-28,코로나백신믿었지만변이출연에제약주맥빠지네셀트리온대웅제약박셀바이오신풍제약등급등락봇물,http://www.pinpointnews.co.kr/view.php?ud=202012281729547892861beb2d9d_45
12302,2020-12-28,2020제약결산②GC녹십자분기최대영업익한미대웅은부진,http://www.newsprime.co.kr/news/article.html?no=528873
12303,2020-12-29,화이자백신과다투여이런실수를독감처럼유한양행박셀바이오대웅제약셀트리온촉각,http://www.pinpointnews.co.kr/view.php?ud=202012290505341495861beb2d9d_45
12304,2020-12-29,동화약품대웅제약제약주모두상승흐름대웅제약2상승이어동화약품역시2상승,http://www.econonews.co.kr/news/articleView.html?idxno=151194
12305,2020-12-29,대웅제약대웅모두가파른상승세로급등대웅제약8급등이어대웅6급등,http://www.econonews.co.kr/news/articleView.html?idxno=151268
12306,2020-12-30,투자경고현대바이오지엘팜텍포인트모바일대웅인바이오투자주의에이스토리줄줄이상승의미없는시장경보,http://www.pinpointnews.co.kr/view.php?ud=202012300727112482cd1e7f0bdf_45
12307,2020-12-30,대웅제약펙수프라잔13상임상시험계획승인,http://www.pinpointnews.co.kr/view.php?ud=202012300900586608cd1e7f0bdf_45
12308,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인,http://www.sentv.co.kr/news/view/585715
12309,2020-12-30,대웅제약위식도역류질환신약중국3상승인,http://www.press9.kr/news/articleView.html?idxno=46704
12310,2020-12-30,대웅제약위식도역류질환치료제신약中3상승인,http://www.dailysmart.co.kr/news/articleView.html?idxno=38104
12311,2020-12-30,대웅제약펙수프라잔중국13상임상시험계획승인,https://view.asiae.co.kr/article/2020123009120312261
12312,2020-12-30,대웅제약펙수프라잔中임상3상직행2022년완료목표,http://www.viva100.com/main/view.php?key=20201230010007145
12313,2020-12-30,대웅제약펙수프라잔13상임상시험계획승인,http://www.edaily.co.kr/news/newspath.asp?newsid=01853206626003768
12314,2020-12-30,대웅제약위식도역류질환신약중국임상3상승인받아,http://yna.kr/AKR20201230038500017?did=1195m
12315,2020-12-30,대웅제약펙수프라잔중국임상3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020123009044034628
12316,2020-12-30,대웅제약역류성식도염질환치료제펙수프라잔中3상승인,https://www.fetv.co.kr/news/article.html?no=72853
12317,2020-12-30,대웅제약중국서펙수프라잔임상3상돌입,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202012300063&t=NN
12318,2020-12-30,대웅제약펙수프라잔중국3상직행,http://www.medisobizanews.com/news/articleView.html?idxno=75333
12319,2020-12-30,대웅제약위식도역류질환신약펙수프라잔中3상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2141273
12320,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인,https://www.ekn.kr/web/view.php?key=20201230010007046
12321,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인획득,http://www.youthdaily.co.kr/news/article.html?no=57692
12322,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://inthenews.co.kr/article-85127/
12323,2020-12-30,대웅제약신약펙수프라잔中임상3상승인3조5000억규모중국시장공략박차”,https://www.donga.com/news/article/all/20201230/104694523/1
12324,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,http://www.mediapen.com/news/view/588141
12325,2020-12-30,대웅제약위식도역류질환신약中서임상3상승인,https://www.asiatoday.co.kr/view.php?key=20201230010018190
12326,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국임상3상승인,https://www.sedaily.com/NewsView/1ZBVUMX5EZ
12327,2020-12-30,대웅제약펙수프라잔中임상3상승인,http://www.cstimes.com/news/articleView.html?idxno=445118
12328,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,https://health.chosun.com/site/data/html_dir/2020/12/30/2020123000802.html
12329,2020-12-30,대웅펙수프라잔中3상임상승인2022년완료목표,http://www.dailypharm.com/Users/News/NewsView.html?ID=272008&REFERER=NP
12330,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,http://medipana.com/news/news_viewer.asp?NewsNum=269154&MainKind=A&NewsKind=5&vCount=12&vKind=1
12331,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.getnews.co.kr/news/articleView.html?idxno=507142
12332,2020-12-30,대웅제약위식도역류신약중국3상승인,http://www.newsis.com/view/?id=NISX20201230_0001288042&cID=13001&pID=13000
12333,2020-12-30,대웅제약위식도역류질환치료제신약 펙수프라잔 중국 3상승인,http://www.greened.kr/news/articleView.html?idxno=282222
12334,2020-12-30,대웅제약펙수프라잔중국3상승인,https://www.ebn.co.kr/news/view/1465961/?sc=Naver
12335,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.m-i.kr/news/articleView.html?idxno=781090
12336,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.sisaweek.com/news/articleView.html?idxno=140485
12337,2020-12-30,대웅제약위식도역류질환치료제중국3상임상승인,https://biz.chosun.com/site/data/html_dir/2020/12/30/2020123000869.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12338,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004223846
12339,2020-12-30,대웅제약동화약품제약주모두상승흐름대웅제약1상승이어동화약품역시1상승,http://www.econonews.co.kr/news/articleView.html?idxno=151325
12340,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中임상3상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=410550
12341,2020-12-30,대웅제약위식도역류질환치료제중국3상임상승인,https://cnbc.sbs.co.kr/article_hub/10001007582?division=NAVER
12342,2020-12-30,대웅제약위식도역류질환치료제신약중국3상승인,http://www.businesskorea.co.kr/news/articleView.html?idxno=57633
12343,2020-12-30,대웅제약펙수프라잔 中3상승인2022년완료계획,http://www.koreastocknews.com/news/articleView.html?idxno=60292
12344,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.healthinnews.co.kr/news/articleView.html?idxno=21065
12345,2020-12-30,대웅제약위식도역류질환신약중국임상3상승인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065573653803958
12346,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.asiaa.co.kr/news/articleView.html?idxno=15222
12347,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.newspim.com/news/view/20201230000216
12348,2020-12-30,대웅제약위식도역류질환치료제中서3상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=134036
12349,2020-12-30,대웅제약위식도역류질환신약중국서3상승인,https://www.econovill.com/news/articleView.html?idxno=512543
12350,2020-12-30,대웅제약펙수프라잔중국서3상임상시험계획승인,https://www.etoday.co.kr/news/view/1979050
12351,2020-12-30,2상건너뛰고곧바로3상승인대웅제약위식도역류질환약펙수프라잔중국3상승인,http://theviewers.co.kr/View.aspx?No=1400063
12352,2020-12-30,대웅펙수프라잔중국3상승인2022년임상완료,http://www.bokuennews.com/news/article.html?no=198984
12353,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253034
12354,2020-12-30,대웅제약위식도역류질환치료제중국3상승인,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1137981&REFERER=NP
12355,2020-12-30,대웅제약위식도역류질환신약펙수프라잔中3상승인,https://www.hankyung.com/it/article/202012300719i
12356,2020-12-30,대웅제약펙수프라잔中임상3상승인받아,http://www.finomy.com/news/articleView.html?idxno=87276
12357,2020-12-30,대웅제약 위식도역류질환치료제 신약 중국 3상 승인,http://kormedi.com/?p=1330174
12358,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인,http://www.mhj21.com/138066
12359,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국임상3상승인,https://www.dailian.co.kr/news/view/951005/?sc=Naver
12360,2020-12-30,대웅제약펙수프라잔3상中승인받아,http://www.wikileaks-kr.org/news/articleView.html?idxno=101215
12361,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,https://daily.hankooki.com/lpage/industry/202012/dh20201230104251148390.htm?s_ref=nv
12362,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인받아,https://www.kpanews.co.kr/article/show.asp?idx=218920&category=D
12363,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.thebigdata.co.kr/view.php?ud=20201230104916862798818e98b_23
12364,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012301045253540208
12365,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국서3개월만에3상승인,http://www.lcnews.co.kr/news/articleView.html?idxno=11433
12366,2020-12-30,대웅제약위식도역류질환치료제신약 중국 3상승인,http://www.economytalk.kr/news/articleView.html?idxno=210168
12367,2020-12-30,대웅제약위식도역류질환신약중국3상승인,https://sports.hankooki.com/lpage/economy/202012/sp20201230105819137020.htm?s_ref=nv
12368,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.wsobi.com/news/articleView.html?idxno=111410
12369,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔중국3상승인,http://www.pressm.kr/news/articleView.html?idxno=35727
12370,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의브랜드가치증대,https://www.fetv.co.kr/news/article.html?no=72893
12371,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼출시,http://www.viva100.com/main/view.php?key=20201230010007230
12372,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.thebigdata.co.kr/view.php?ud=202012301110389068798818e98b_23
12373,2020-12-30,대웅제약 액상형진통제 이지엔6 리뉴얼소비자편의브랜드가치증대,http://www.lcnews.co.kr/news/articleView.html?idxno=11438
12374,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.businesskorea.co.kr/news/articleView.html?idxno=57650
12375,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004223986
12376,2020-12-30,대웅제약신약펙수프라잔3상中승인주가반등할까,http://www.smartfn.co.kr/view.php?ud=20201230105546623737c00c6b22_46
12377,2020-12-30,대웅제약액상형진통제리뉴얼편의증대,http://www.newsis.com/view/?id=NISX20201230_0001288336&cID=13001&pID=13000
12378,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.medisobizanews.com/news/articleView.html?idxno=75351
12379,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼제형축소등,http://medipana.com/news/news_viewer.asp?NewsNum=269182&MainKind=A&NewsKind=5&vCount=12&vKind=1
12380,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼소비자편의브랜드가치증대”,http://www.youthdaily.co.kr/news/article.html?no=57718
12381,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.healthinnews.co.kr/news/articleView.html?idxno=21084
12382,2020-12-30,소비자편의↑대웅제약액상형진통제이지엔6리뉴얼,http://www.koreaittimes.com/news/articleView.html?idxno=102816
12383,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.whosaeng.com/123669
12384,2020-12-30,대웅제약펙수프라잔中3상승인,http://www.whosaeng.com/123673
12385,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인,http://www.newsprime.co.kr/news/article.html?no=529059
12386,2020-12-30,대웅제약이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65511
12387,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65507
12388,2020-12-30,공시대웅제약위식도역류질환치료제중국3상임상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2020123011412981172
12389,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔中3상승인획득,http://www.newsway.co.kr/news/view?tp=1&ud=2020123011431964125
12390,2020-12-30,제약브리핑대웅제약JW중외제약유유제약,http://4th.kr/View.aspx?No=1400364
12391,2020-12-30,대웅제약이지엔6제형축소기존대비23작게,https://www.asiatoday.co.kr/view.php?key=20201230010018499
12392,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.asiaa.co.kr/news/articleView.html?idxno=15273
12393,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.newslock.co.kr/news/articleView.html?idxno=34621
12394,2020-12-30,대웅제약위식도역류질환치료제의중국임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=210764
12395,2020-12-30,대웅제약액상형진통제이지엔6새단장,https://www.ekn.kr/web/view.php?key=20201230010007146
12396,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.metroseoul.co.kr/article/20201230500196
12397,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.updownnews.co.kr/news/articleView.html?idxno=226804
12398,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.medigatenews.com/news/1653707750
12399,2020-12-30,대웅제약이지엔6리뉴얼소비자편의브랜드가치증대,http://www.thedailypost.kr/news/articleView.html?idxno=78473
12400,2020-12-30,대웅제약펙수프라잔중국3상승인,http://www.newstomato.com/ReadNews.aspx?no=1015904
12401,2020-12-30,대웅제약이지엔6제형축소및패키지변경,http://www.consumuch.com/news/articleView.html?idxno=51667
12402,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,https://jhealthmedia.joins.com/article/article_view.asp?pno=22924
12403,2020-12-30,대웅제약위식도역류질환치료제중국3상승인2022년임상완료목표,http://news.mt.co.kr/mtview.php?no=2020123013442749934
12404,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.thedailypost.kr/news/articleView.html?idxno=78476
12405,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.nbnnews.co.kr/news/articleView.html?idxno=454475
12406,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.nbnnews.co.kr/news/articleView.html?idxno=454462
12407,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,https://www.econovill.com/news/articleView.html?idxno=512609
12408,2020-12-30,대웅제약위식도역류질환신약중국임상3상승인,http://www.whitepaper.co.kr/news/articleView.html?idxno=200081
12409,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼소비자편의증대,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202012301400420180322
12410,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://news.mk.co.kr/newsRead.php?no=1335298&year=2020
12411,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼복용편의성↑,http://news.mt.co.kr/mtview.php?no=2020123014381024032
12412,2020-12-30,대웅제약개발위식도역류질환신약중국임상3상승인,http://www.seoulfn.com/news/articleView.html?idxno=406109
12413,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.mdtoday.co.kr/mdtoday/index.html?no=410622
12414,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.worktoday.co.kr/news/articleView.html?idxno=12619
12415,2020-12-30,대웅제약위식도역류질환신약펙수프라잔중국3상승인,http://www.anewsa.com/detail.php?number=2317618&thread=10
12416,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.anewsa.com/detail.php?number=2317620&thread=10
12417,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼브랜드이미지강화,http://www.m-i.kr/news/articleView.html?idxno=781360
12418,2020-12-30,복용편의성증대대웅제약액상형진통제이지엔6리뉴얼,http://theviewers.co.kr/View.aspx?No=1400903
12419,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼로소비자편의와브랜드가치증대,http://www.thefirstmedia.net/news/articleView.html?idxno=68581
12420,2020-12-30,대웅제약위식도역류치료제중국서임상3상승인,https://www.hankyung.com/it/article/2020123028781
12421,2020-12-30,대웅제약위식도역류질환치료제신약중국3상승인,http://www.ajunews.com/view/20201230160735321
12422,2020-12-30,대웅제약중국서위식도역류질환치료제펙수프라잔3상임상시험승인,http://www.g-enews.com/ko-kr/news/article/news_all/20201230170719190669d76442fa_1/article.html
12423,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.thefirstmedia.net/news/articleView.html?idxno=68596
12424,2020-12-30,김창수의e뉴스브리핑대웅제약역류성식도염질환치료제펙수프라잔中3상승인外,https://www.fetv.co.kr/news/article.html?no=72962
12425,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼출시,http://www.mediapen.com/news/view/588452
12426,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.consumernews.co.kr/news/articleView.html?idxno=618125
12427,2020-12-30,대웅제약신약펙수프라잔중국3상승인,http://www.100ssd.co.kr/news/articleView.html?idxno=73800
12428,2020-12-30,대웅제약위식도역류질환치료제신약펙수프라잔중국3상승인,http://www.newsfarm.co.kr/news/articleView.html?idxno=62525
12429,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.enewstoday.co.kr/news/articleView.html?idxno=1440313
12430,2020-12-30,대웅제약위식도역류질환치료제펙수프라잔中임상3상승인,http://www.enewstoday.co.kr/news/articleView.html?idxno=1440326
12431,2020-12-30,대웅제약소화기관치료제中3상승인,http://www.dt.co.kr/contents.html?article_no=2020123102101031102001&ref=naver
12432,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.medigatenews.com/news/1772400347
12433,2020-12-30,대웅제약액상형진통제이지엔6리뉴얼,http://www.wolyo.co.kr/news/articleView.html?idxno=113950
12434,2020-12-30,대웅제약펙수프라잔中임상3상계획승인취득2022년완료계획,http://www.newsfreezone.co.kr/news/articleView.html?idxno=287472
12435,2020-12-31,대웅제약액상형진통제이지엔6리뉴얼,http://www.bosa.co.kr/news/articleView.html?idxno=2141356
12436,2020-12-31,기업공시12월30일대웅제약위식도역류질환신약중국임상3상승인등,https://www.sedaily.com/NewsView/1ZBWAQJ5M0
12437,2020-12-31,대웅제약액상형진통제이지엔6리뉴얼공개,http://www.monews.co.kr/news/articleView.html?idxno=216931
12438,2020-12-31,대웅제약펙수프라잔중국3상승인완료,http://www.monews.co.kr/news/articleView.html?idxno=216927
12439,2020-12-31,대웅제약위식도역류신약펙수프라잔중국3상승인,http://www.shinailbo.co.kr/news/articleView.html?idxno=1361076
12440,2020-12-31,대웅제약액상형진통제이지엔6리뉴얼소비자편의증대,http://www.segyebiz.com/newsView/20201231505281?OutUrl=naver
12441,2020-12-31,대웅제약이지엔6리뉴얼로소비자편의증대,http://www.wsobi.com/news/articleView.html?idxno=111526
12442,2020-12-31,복지부는아니라는데대웅미운털박힌괘씸죄볼멘소리,https://cnbc.sbs.co.kr/article_hub/10001007772?division=NAVER
12443,2020-12-31,대웅제약펙수프라잔글로벌시장본격도전,http://www.doctorsnews.co.kr/news/articleView.html?idxno=137592
12444,2020-12-31,대웅제약메디톡스법정다툼소송비용에초라한성적표기록,http://www.todaykorea.co.kr/news/articleView.html?idxno=281723
12445,2020-12-31,식약처대웅렘데시비르병용요법3상임상시험승인,https://cnbc.sbs.co.kr/article_hub/10001007819?division=NAVER
12446,2020-12-31,대웅제약코로나치료제호이스타정임상3상승인,http://www.dailypharm.com/Users/News/NewsView.html?ID=272070&REFERER=NP
12447,2020-12-31,대웅제약코로나치료제호이스타병용임상3상승인,https://www.econovill.com/news/articleView.html?idxno=512846
12448,2021-01-02,대웅제약호이스타정국내서코로나중증환자임상3상시작,http://moneys.mt.co.kr/news/mwView.php?no=2021010208588058839
12449,2021-01-03,지난주제약업계주요이슈솔젠트코스닥직상장추진4일이사회대웅제약펙수프라잔中3상승인外,http://www.youthdaily.co.kr/news/article.html?no=57966
12450,2021-01-04,대웅제약췌장염약호이스타정중증코로나19임상3상승인,http://yna.kr/AKR20210103044300017?did=1195m
12451,2021-01-04,대웅제약나보타주이상반응사지경직추가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253084
12452,2021-01-04,대웅제약호이스타정중증코로나치료제임상3상승인,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101040025&t=NN
12453,2021-01-04,대웅제약호이스타정중증코로나임상3상승인,https://view.asiae.co.kr/article/2021010407334990348
12454,2021-01-04,대웅제약코로나19중증환자대상임상3상시험계획승인,http://www.edaily.co.kr/news/newspath.asp?newsid=01479286628914440
12455,2021-01-04,대웅제약췌장염약호이스타정중증코로나19임상3상승인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101040809070390815
12456,2021-01-04,대웅제약중증환자대상DWJ1248임상3상시험계획승인,http://www.itooza.com/common/iview.php?no=2021010408142595446
12457,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,http://www.newsway.co.kr/news/view?tp=1&ud=2021010408103947101
12458,2021-01-04,대웅제약코로나치료제호이스타정국내임상3상승인,https://www.hankyung.com/it/article/202101042298i
12459,2021-01-04,대웅제약코로나치료제DWJ1248임상3상시험계획승인,http://www.pinpointnews.co.kr/view.php?ud=202101040817435786cd1e7f0bdf_45
12460,2021-01-04,대웅제약코로나19치료제DWJ1248임상3상시험계획승인,https://www.asiatoday.co.kr/view.php?key=20210104010000546
12461,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,http://www.getnews.co.kr/news/articleView.html?idxno=507726
12462,2021-01-04,공시대웅제약코로나19치료제호이스타정국내임상3상승인,http://www.fnnews.com/news/202101040829036867
12463,2021-01-04,대웅제약코로나19중증환자대상임상3상시험계획승인,http://news.heraldcorp.com/view.php?ud=20210104000044
12464,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021010408265134373
12465,2021-01-04,대웅제약코로나19치료제중증대상임상3상승인,https://www.sedaily.com/NewsView/22H4HUAEMX
12466,2021-01-04,대웅제약췌장염약호이스타정중증코로나19임상3상승인,https://cnbc.sbs.co.kr/article_hub/10001008005?division=NAVER
12467,2021-01-04,대웅제약코로나19중증환자치료제임상3상시험계획승인,https://view.asiae.co.kr/article/2021010408430947465
12468,2021-01-04,대웅제약호이스타정먹는중증코로나19치료제로임상3상승인,http://www.greened.kr/news/articleView.html?idxno=282728
12469,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,http://www.cstimes.com/news/articleView.html?idxno=445545
12470,2021-01-04,대웅제약췌장염약코로나19치료제임상3상승인,https://biz.chosun.com/site/data/html_dir/2021/01/04/2021010400444.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12471,2021-01-04,대웅제약호이스타정중증코로나19환자대상3상승인획득,https://www.youthdaily.co.kr/news/article.html?no=58050
12472,2021-01-04,대웅제약호이스타정코로나19임상3상승인중증환자1072명목표,http://www.dt.co.kr/contents.html?article_no=2021010402109931102001&ref=naver
12473,2021-01-04,대웅제약코로나치료제중증환자대상임상3상승인,http://news.mt.co.kr/mtview.php?no=2021010408474818670
12474,2021-01-04,대웅제약코로나19치료제호이스타정국내임상3상승인,https://www.dailian.co.kr/news/view/951896/?sc=Naver
12475,2021-01-04,대웅제약호이스타정중증환자대상임상3상시작,http://isplus.live.joins.com/news/article/article.asp?total_id=23961178
12476,2021-01-04,대웅제약호이스타정중증환자대상코로나치료제임상3상승인,http://www.newspim.com/news/view/20210104000058
12477,2021-01-04,대웅제약DWJ1248정국내임상3상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=410853
12478,2021-01-04,대웅제약호이스타정코로나19중증임상3상승인,http://news.tf.co.kr/read/economy/1834925.htm
12479,2021-01-04,대웅제약호이스타정코로나19국내3상돌입,https://www.kpanews.co.kr/article/show.asp?idx=218988&category=D
12480,2021-01-04,대웅제약호이스타정중증코로나치료제임상3상승인,http://news.kmib.co.kr/article/view.asp?arcid=0015387748&code=61171911&cp=nv
12481,2021-01-04,대웅제약호이스타정중증코로나19치료제임상3상승인,http://www.newstomato.com/ReadNews.aspx?no=1016223
12482,2021-01-04,대웅제약호이스타정중증코로나19임상3상승인,https://cnbc.sbs.co.kr/article_hub/10001008009?division=NAVER
12483,2021-01-04,대웅제약코로나19치료제호이스타정임상3상승인,http://www.mediapen.com/news/view/589403
12484,2021-01-04,대웅제약코로나19치료제중증환자대상임상3상시험계획승인,https://www.etoday.co.kr/news/view/1980252
12485,2021-01-04,대웅제약호이스타코로나19치료제임상3상승인,http://www.kpinews.co.kr/news/articleView.html?idxno=134230
12486,2021-01-04,대웅제약호이스타정코로나19중증환자대상3상승인,http://www.press9.kr/news/articleView.html?idxno=46719
12487,2021-01-04,대웅제약코로나19치료제호이스타정임상3상돌입,http://www.ezyeconomy.com/news/articleView.html?idxno=108539
12488,2021-01-04,대웅제약호이스타정이번엔중증코로나19환자대상임상3상시험,http://www.medisobizanews.com/news/articleView.html?idxno=75411
12489,2021-01-04,대웅제약호이스타정중증환자대상국내임상3상승인,http://it.chosun.com/site/data/html_dir/2021/01/04/2021010400574.html
12490,2021-01-04,대웅제약코로나치료제임상3상시험시작주가↑,http://news.mt.co.kr/mtview.php?no=2021010410031757348
12491,2021-01-04,대웅제약호이스타정중증코로나치료제임상3상승인,http://www.whitepaper.co.kr/news/articleView.html?idxno=200160
12492,2021-01-04,특징주대웅제약코로나치료제임상3상승인소식에9대강세,https://www.dailian.co.kr/news/view/951993/?sc=Naver
12493,2021-01-04,특징주대웅제약중증코로나치료제임상3상승인소식에급등,http://www.edaily.co.kr/news/newspath.asp?newsid=02263206628914440
12494,2021-01-04,대웅제약1091상승18만3000원대로시작치료제3상영향,http://www.ajunews.com/view/20210104084910832
12495,2021-01-04,대웅제약과전면전준비메디톡스검사출신부사장영입,http://www.wikileaks-kr.org/news/articleView.html?idxno=101417
12496,2021-01-04,대웅제약대웅모두갑작스런급등대웅제약12급등이어대웅14급등,http://www.econonews.co.kr/news/articleView.html?idxno=152042
12497,2021-01-04,대웅혁신정신으로포스트코로나시대선도,http://www.dailypharm.com/Users/News/NewsView.html?ID=272112&REFERER=NP
12498,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.greened.kr/news/articleView.html?idxno=282807
12499,2021-01-04,신년사전승호대웅제약대표2021년신약개발성과가시화되는한해가될것,https://www.ekn.kr/web/view.php?key=20210104010000282
12500,2021-01-04,신년사전승호대웅제약대표2021년신약개발성과가시화되는한해가될것,https://www.ekn.kr/web/view.php?key=20210104010000282
12501,2021-01-04,신년사전승호대웅제약대표끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.newsway.co.kr/news/view?tp=1&ud=2021010410132295095
12502,2021-01-04,신년사전승호대웅제약사장포스트코로나시대선도해나갈것”,http://kpenews.com/View.aspx?No=1403595
12503,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.press9.kr/news/articleView.html?idxno=46721
12504,2021-01-04,특징주대웅제약코로나19치료제임상3상승인에강세,http://www.inews24.com/view/1331838
12505,2021-01-04,특징주대웅제약세계최초경구용코로나19치료제임상3상시험승인소식에상승세,https://www.etoday.co.kr/news/view/1980321
12506,2021-01-04,전승호대웅제약사장끊임없는혁신으로포스트코로나선도할것”,http://news.mt.co.kr/mtview.php?no=2021010410071258621
12507,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.asiaa.co.kr/news/articleView.html?idxno=15932
12508,2021-01-04,대웅제약코로나19치료제혁신신약등글로벌신약성과가시화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253100
12509,2021-01-04,특징주대웅제약코로나치료제임상3상승인소식에강세,http://www.newspim.com/news/view/20210104000252
12510,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나선도할것,http://www.mediapen.com/news/view/589478
12511,2021-01-04,이종목버핏이라면대웅제약코로나19치료제임상3상승인에급등,https://www.news2day.co.kr/article/20210104500065
12512,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101041009255400893
12513,2021-01-04,대웅제약코로나19치료제중증대상임상3상승인,https://sports.hankooki.com/lpage/economy/202101/sp20210104102300137020.htm?s_ref=nv
12514,2021-01-04,특징주대웅제약중증코로나치료제3상승인에상승세,https://www.news1.kr/articles/?4169658
12515,2021-01-04,코스피코스닥동반상승출발대웅오킨스전자SNK나인테크급등,http://www.businesspost.co.kr/BP?command=article_view&num=211191
12516,2021-01-04,2021신년사전승호대웅제약사장올해신약개발성과본격가시화될것,https://www.asiatoday.co.kr/view.php?key=20210104010000760
12517,2021-01-04,특징주대웅제약코로나19치료제임상3상승인에강세,http://www.ajunews.com/view/20210104102625020
12518,2021-01-04,전승호대웅제약사장코로나위기돌파에전사역량집중,http://www.newsis.com/view/?id=NISX20210104_0001292469&cID=13001&pID=13000
12519,2021-01-04,대웅제약코로나치료제임상3상승인소식에강세,https://biz.chosun.com/site/data/html_dir/2021/01/04/2021010401025.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12520,2021-01-04,대웅제약올해는신약개발성과가시화되는한해,http://www.medisobizanews.com/news/articleView.html?idxno=75412
12521,2021-01-04,대웅제약주가초반뛰어코로나19치료제임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=211194
12522,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도”,http://www.bokuennews.com/news/article.html?no=199110
12523,2021-01-04,2021신년사전승호대웅제약사장혁신통해포스트코로나시대선도할것,http://www.m-i.kr/news/articleView.html?idxno=782124
12524,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도해나갈것”,https://www.fetv.co.kr/news/article.html?no=73151
12525,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도,http://www.newstomato.com/ReadNews.aspx?no=1016265
12526,2021-01-04,신년메시지전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.ceoscoredaily.com/news/article.html?no=76891
12527,2021-01-04,신년사대웅제약혁신과도전으로포스트코로나시대이끌것,https://www.etoday.co.kr/news/view/1980336
12528,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65564
12529,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.segye.com/content/html/2021/01/04/20210104505319.html?OutUrl=naver
12530,2021-01-04,전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도,http://www.upinews.kr/newsView/upi202101040027
12531,2021-01-04,신년사전승호대웅제약대표끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.polinews.co.kr/news/article.html?no=481778
12532,2021-01-04,대웅제약혁신으로포스트코로나시대선도,http://www.bosa.co.kr/news/articleView.html?idxno=2141547
12533,2021-01-04,특징주대웅제약5대강세호이스타정중증환자대상임상승인,https://www.ebn.co.kr/news/view/1466421/?sc=Naver
12534,2021-01-04,대웅제약전승호사장끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.thebigdata.co.kr/view.php?ud=202101041050286995798818e98b_23
12535,2021-01-04,대웅제약포스트코로나시대선도할것”,http://www.mhj21.com/138153
12536,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.segyebiz.com/newsView/20210104505606?OutUrl=naver
12537,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도,https://www.econovill.com/news/articleView.html?idxno=513036
12538,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나선도할것,http://www.getnews.co.kr/news/articleView.html?idxno=507780
12539,2021-01-04,2021신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.seoulwire.com/news/articleView.html?idxno=432908
12540,2021-01-04,대웅제약혁신통해포스트코로나시대선도”,http://www.whosaeng.com/123730
12541,2021-01-04,전승호대웅제약사장끊임없는혁신포스트코로나시대선도할것”,http://www.viva100.com/main/view.php?key=20210104010000385
12542,2021-01-04,전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도할것,http://www.anewsa.com/detail.php?number=2320783&thread=10
12543,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로포스트코로나시대선도,http://www.insightkorea.co.kr/news/articleView.html?idxno=85794
12544,2021-01-04,대웅제약코로나19치료제의중증환자대상임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=211212
12545,2021-01-04,대웅제약호이스타정코로나19중환자대상임상3상돌입,http://inthenews.co.kr/article-85838/
12546,2021-01-04,전승호대웅제약대표올해신약개발성과가본격적으로가시화되는한해가될것,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021010411091889804
12547,2021-01-04,대웅제약끊임없는혁신통해포스트코로나시대선도,http://medipana.com/news/news_viewer.asp?NewsNum=269311&MainKind=A&NewsKind=5&vCount=12&vKind=1
12548,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101040196&t=NN
12549,2021-01-04,대웅제약호이스타정렘데시비르병용치료제로임상3상,http://news.mt.co.kr/mtview.php?no=2021010410241308944
12550,2021-01-04,신년사전승호대웅제약사장올해신약개발성과가시화,https://biz.chosun.com/site/data/html_dir/2021/01/04/2021010401353.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12551,2021-01-04,대웅제약신년사전승호대표글로벌혁신신약개발로K팜글로벌리더도약,http://www.g-enews.com/ko-kr/news/article/news_all/2021010411340937862500a1b5d6_1/article.html
12552,2021-01-04,신년사전승호대웅제약사장혁신으로포스트코로나시대선도”,http://www.edaily.co.kr/news/newspath.asp?newsid=03050406628914440
12553,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.pressm.kr/news/articleView.html?idxno=35816
12554,2021-01-04,대웅호이스타정코로나19중증환자임상3상실시,http://www.dailymedi.com/detail.php?number=864708&thread=22r05
12555,2021-01-04,전승호대웅제약대표뛰어난약효안전성확보제약회사최우선가치,http://www.newsprime.co.kr/news/article.html?no=529337
12556,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.dailysmart.co.kr/news/articleView.html?idxno=38277
12557,2021-01-04,대웅제약전승호사장올해신약개발성과가시화될것,http://www.consumuch.com/news/articleView.html?idxno=51687
12558,2021-01-04,대웅제약코로나치료제호이스타정임상3상승인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004228063
12559,2021-01-04,특징주대웅제약중증코로나19치료제임상3상승인소식에강세,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004228061
12560,2021-01-04,2021신년사전승호대웅제약사장한국형글로벌기업도약할것,http://www.newslock.co.kr/news/articleView.html?idxno=34777
12561,2021-01-04,전승호대웅제약사장코로나위기돌파에전사역량집중,http://www.wsobi.com/news/articleView.html?idxno=111624
12562,2021-01-04,대웅제약2021신년사끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.paxetv.com/news/articleView.html?idxno=107793
12563,2021-01-04,이데일리N대웅제약코로나19중증환자대상임상3상시험계획승인外,http://www.edaily.co.kr/news/newspath.asp?newsid=03384966628914440
12564,2021-01-04,2021년대웅제약온라인시무식,http://yna.kr/PYH20210104116500017?did=1196m
12565,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.nbnnews.co.kr/news/articleView.html?idxno=455435
12566,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도할것,http://www.medigatenews.com/news/612336739
12567,2021-01-04,전승호대웅제약사장급격한변화속끊임없는혁신이뤄야,http://www.100ssd.co.kr/news/articleView.html?idxno=73852
12568,2021-01-04,대웅코로나치료제3상승인,http://news.mk.co.kr/newsRead.php?no=6979&year=2021
12569,2021-01-04,대웅제약끊임없는혁신약효와안전성최우선가치”,http://www.biospectator.com/view/news_view.php?varAtcId=12199
12570,2021-01-04,신년사전승호대웅제약사장끊임없는혁신으로한국대표제약사자리매김,https://www.dailian.co.kr/news/view/952106/?sc=Naver
12571,2021-01-04,대웅제약과소송메디톡스부장검사출신부사장으로영입,http://4th.kr/View.aspx?No=1404198
12572,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.pharmnews.com/news/articleView.html?idxno=102066
12573,2021-01-04,2021신년사전승호대웅제약사장혁신으로포스트코로나시대선도할것,https://daily.hankooki.com/lpage/industry/202101/dh20210104150617148390.htm?s_ref=nv
12574,2021-01-04,신년사GC녹십자한미약품대웅제약보령제약,https://www.ajunews.com/view/20210104145817335
12575,2021-01-04,전승호대웅제약사장올해코로나19치료제등신약개발성과가시화”,https://www.donga.com/news/article/all/20210104/104760956/1
12576,2021-01-04,전승호대웅제약사장혁신으로포스트코로나시대선도”,http://www.mdtoday.co.kr/mdtoday/index.html?no=410937
12577,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도,http://www.businesskorea.co.kr/news/articleView.html?idxno=57846
12578,2021-01-04,대웅제약코로나19치료제호이스타정중증환자대상임상3상승인,http://kbench.com/?q=node/217272
12579,2021-01-04,신년사전승호대웅제약대표끊임없는혁신으로포스트코로나시대선도해나갈것”,http://theviewers.co.kr/View.aspx?No=1404433
12580,2021-01-04,전승호대웅제약사장혁신으로포스트코로나시대선도,http://www.finomy.com/news/articleView.html?idxno=87430
12581,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.thedailypost.kr/news/articleView.html?idxno=78546
12582,2021-01-04,대웅제약온라인신년시무식개최포스트코로나시대선도해나갈것,http://www.lcnews.co.kr/news/articleView.html?idxno=11565
12583,2021-01-04,신년사대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것”,http://www.thepublic.kr/news/newsview.php?ncode=1065592352849821
12584,2021-01-04,대웅제약올해펙수프라잔등글로벌신약개발성과가시화될것,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=125053
12585,2021-01-04,전승호대웅제약대표호이스타정연구지속할것,http://www.mdtoday.co.kr/mdtoday/index.html?no=410955
12586,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.dt.co.kr/contents.html?article_no=2021010402109931102006&ref=naver
12587,2021-01-04,대웅제약전사적역량집중해위기돌파할것신년사밝혀,http://www.sportsseoul.com/news/read/998986?ref=naver
12588,2021-01-04,신년사전승호대웅제약사장코로나19위기돌파에역량집중,http://www.newsworks.co.kr/news/articleView.html?idxno=517444
12589,2021-01-04,신년사전승호대웅제약사장혁신으로포스트코로나시대선도,http://it.chosun.com/site/data/html_dir/2021/01/04/2021010402306.html
12590,2021-01-04,대웅제약온라인신년시무식진행,http://www.lawissue.co.kr/view.php?ud=202101041649459852204ead0791_12
12591,2021-01-04,대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.newsworker.co.kr/news/articleView.html?idxno=97928
12592,2021-01-04,대웅제약혁신으로포스트코로나선도”,http://www.thevaluenews.co.kr/news/view.php?idx=162103
12593,2021-01-04,대웅제약한미녹십자등온택트시무식으로새해첫근무시작,http://www.ajunews.com/view/20210104171803536
12594,2021-01-04,금일제약업계주요기사대웅제약호이스타정중증코로나19환자대상3상승인한국유나이티드제약NASH치료제임상2상진입外,http://www.youthdaily.co.kr/news/article.html?no=58146
12595,2021-01-04,대웅제약끊임없는혁신포스트코로나시대선도할것,http://www.shinailbo.co.kr/news/articleView.html?idxno=1362273
12596,2021-01-04,시무식대웅제약끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.thefirstmedia.net/news/articleView.html?idxno=68731
12597,2021-01-04,대웅제약2021년온라인시무식혁신강조,https://www.kpanews.co.kr/article/show.asp?idx=219019&category=D
12598,2021-01-05,유가증권기업공시4일대웅제약등,https://www.hankyung.com/finance/article/2021010564811
12599,2021-01-05,대웅제약엔트레스토성분약생동성시험돌입복제약개발나서,http://www.ceoscoredaily.com/news/article.html?no=76947
12600,2021-01-05,전승호대웅제약대표끊임없는혁신으로포스트코로나시대선도해나갈것,http://www.bizwnews.com/news/articleView.html?idxno=22598
12601,2021-01-05,대웅제약대웅가파른하락세로무너져대웅제약5하락이어대웅역시5하락,http://www.econonews.co.kr/news/articleView.html?idxno=152203
12602,2021-01-05,대웅제약대웅오후갑작스런급등대웅제약19급등이어대웅24급등,http://www.econonews.co.kr/news/articleView.html?idxno=152297
12603,2021-01-05,대웅제약주가장중급등코로나19치료제임상3상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=211524
12604,2021-01-05,이종목버핏이라면코로나임상3상승인대웅제약나비효과에대웅도급등,https://www.news2day.co.kr/article/20210105500204
12605,2021-01-05,신년사전승호대웅제약사장신약개발성과가시화되는시기,http://www.meconomynews.com/news/articleView.html?idxno=49050
12606,2021-01-05,특징주대웅제약코로나치료제임상3상승인소식에강세,http://www.fnnews.com/news/202101051431026736
12607,2021-01-05,5대제약사女임원비율한미20대대웅은유리천장심각,http://www.sisaon.co.kr/news/articleView.html?idxno=122559
12608,2021-01-05,특징주노터스대웅제약이버멕틴코로나치료제가능성에주가급등,http://www.ccreview.co.kr/news/articleView.html?idxno=301156
12609,2021-01-05,특징주노터스대웅제약주가가파른상승세이유,http://www.anewsa.com/detail.php?number=2322197&thread=18
12610,2021-01-05,코스피마감시황동학개미외인기관꺽었다삼성제약한솔로지스틱스대웅제약삼성제약,http://www.smartfn.co.kr/view.php?ud=202101051543511254260ddb1f94_46
12611,2021-01-05,5일오늘의상한가총정리삼성제약한솔로지스틱스대웅넷게임즈노터스피플아이오동신건설포인트모바일주가강세,http://www.ccreview.co.kr/news/articleView.html?idxno=301162
12612,2021-01-06,백신접종시작했지만사망자폭발화들짝박셀바이오현대바이오삼성제약대웅제약주목,http://www.pinpointnews.co.kr/view.php?ud=202101060517068748861beb2d9d_45
12613,2021-01-06,휴젤강세속대웅제약메디톡스장기소송전종료변수,http://www.dailymedi.com/detail.php?number=864789&thread=22r05
12614,2021-01-06,대웅제약식약처3상승인1년간9건국내사중최다,http://www.press9.kr/news/articleView.html?idxno=46745
12615,2021-01-06,메디톡스대웅제약넘어이번엔식약처행정처분피할까,https://daily.hankooki.com/lpage/industry/202101/dh20210106071515148390.htm?s_ref=nv
12616,2021-01-06,투자경고동신건설셀젠텍박셀바이오대웅제약초강세투자주의오킨스전자글로스퍼랩스선바이오급등시장경보株훨훨,http://www.pinpointnews.co.kr/view.php?ud=202101060723309594cd1e7f0bdf_45
12617,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.thebigdata.co.kr/view.php?ud=202101060926177605798818e98b_23
12618,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253214
12619,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인”,https://www.youthdaily.co.kr/news/article.html?no=58309
12620,2021-01-06,대웅제약올로스타국제학술지심장학저널등재,http://www.asiaa.co.kr/news/articleView.html?idxno=16265
12621,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,https://www.ekn.kr/web/view.php?key=20210106010000887
12622,2021-01-06,대웅제약올로스타우수한효과확인,http://www.press9.kr/news/articleView.html?idxno=46751
12623,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.fetv.co.kr/news/article.html?no=73395
12624,2021-01-06,대웅제약올로스타개별약제병용보다효과우수,http://www.medisobizanews.com/news/articleView.html?idxno=75487
12625,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.pharmnews.com/news/articleView.html?idxno=102097
12626,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.mediapen.com/news/view/590374
12627,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인”,http://www.viva100.com/main/view.php?key=20210106010000993
12628,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.m-i.kr/news/articleView.html?idxno=783046
12629,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과,http://medipana.com/news/news_viewer.asp?NewsNum=269442&MainKind=A&NewsKind=5&vCount=12&vKind=1
12630,2021-01-06,대웅제약고혈압복합제개별약제병용때보다우수,http://www.newsis.com/view/?id=NISX20210106_0001295343&cID=13001&pID=13000
12631,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.metroseoul.co.kr/article/20210106500080
12632,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.newsway.co.kr/news/view?tp=1&ud=2021010609564277854
12633,2021-01-06,대웅제약올로스타개별약제병용요법대비효과확인,http://www.kpinews.co.kr/news/articleView.html?idxno=134455
12634,2021-01-06,대웅제약올로스타개별약제병용요법보다효과우수,https://daily.hankooki.com/lpage/industry/202101/dh20210106100239148390.htm?s_ref=nv
12635,2021-01-06,대웅제약올로스타혈압강하및이상지질혈증개선효과확인,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=125126
12636,2021-01-06,대웅제약올로스타개별약제병용요법대비효과우수,http://www.pressm.kr/news/articleView.html?idxno=35901
12637,2021-01-06,대웅제약올로스타개별약제병용요법효과확인,http://www.mhj21.com/138251
12638,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101061007160020533
12639,2021-01-06,대웅제약복합제올로스타개별약제병용요법보다우수한효과확인,https://www.etoday.co.kr/news/view/1981334
12640,2021-01-06,대웅제약 올로스타 개별약제 병용 요법 대비 효과 뛰어나,http://kormedi.com/?p=1330614
12641,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.hankyung.com/it/article/202101061991i
12642,2021-01-06,대웅제약올로스타혈압강하이상지질혈증개선우수확인,http://news.mt.co.kr/mtview.php?no=2021010610043838078
12643,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과입증,http://www.dailysmart.co.kr/news/articleView.html?idxno=38410
12644,2021-01-06,오늘의제약SK바이오사이언스유비케어대웅제약,http://www.babytimes.co.kr/news/articleView.html?idxno=42460
12645,2021-01-06,대웅제약올로스타개별약제병용대비저밀도지단백콜레스테롤감소,http://www.newsprime.co.kr/news/article.html?no=529651
12646,2021-01-06,현대약품대웅제약제약주희비엇갈려현대약품15급등반해대웅제약1하락,http://www.econonews.co.kr/news/articleView.html?idxno=152389
12647,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.healthinnews.co.kr/news/articleView.html?idxno=21183
12648,2021-01-06,대웅제약올로스타병용요법대비효과우수,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1138075&REFERER=NP
12649,2021-01-06,대웅제약올로스타개별약제병용요법대비효과우수,http://www.bosa.co.kr/news/articleView.html?idxno=2141760
12650,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.asiatoday.co.kr/view.php?key=20210106010002631
12651,2021-01-06,대웅제약올로스타심장학저널CardiologyJournal12월호등재,http://www.businesskorea.co.kr/news/articleView.html?idxno=57973
12652,2021-01-06,대웅제약올로스타개별약제병용보다효과우수,https://view.asiae.co.kr/article/2021010610543204694
12653,2021-01-06,대웅제약올로스타개별약제병용군대비우수효과,https://sports.hankooki.com/lpage/economy/202101/sp20210106105308137020.htm?s_ref=nv
12654,2021-01-06,대웅제약올로스타개별약제병용대비우수효과,http://www.dailypharm.com/Users/News/NewsView.html?ID=272223&REFERER=NP
12655,2021-01-06,대웅제약올로스타혈압이상지질혈증개선효과확인,https://health.chosun.com/site/data/html_dir/2021/01/06/2021010601325.html
12656,2021-01-06,대웅제약올로스타개별약제병용대비효과우수,https://www.econovill.com/news/articleView.html?idxno=513480
12657,2021-01-06,대웅제약올로스타개별약제병용요법대비우수,https://www.ebn.co.kr/news/view/1466840/?sc=Naver
12658,2021-01-06,대웅제약올로스타개선효과국제학술지등재,http://www.wikileaks-kr.org/news/articleView.html?idxno=101576
12659,2021-01-06,제약오늘대웅제약올로스타개별약제병용요법대비효과확인JW중외제약기업미디어플랫폼으로홈페이지리뉴얼,http://www.sisaon.co.kr/news/articleView.html?idxno=122599
12660,2021-01-06,대웅제약올로스타개별약제병용요법대비효과우수,http://www.anewsa.com/detail.php?number=2322948&thread=10
12661,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.newsworks.co.kr/news/articleView.html?idxno=517976
12662,2021-01-06,중증코로나치료제개발나선6개社녹십자종근당속도전대웅다품종전략,https://biz.chosun.com/site/data/html_dir/2021/01/06/2021010601524.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12663,2021-01-06,대웅제약올로스타연구국제학술지심장학저널등재,http://www.100ssd.co.kr/news/articleView.html?idxno=73917
12664,2021-01-06,뉴스투데이L대웅제약올로스타우수한혈압강하이상지질혈증개선효과확인,https://www.news2day.co.kr/article/20210106500115
12665,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.thepublic.kr/news/newsview.php?ncode=1065576568106159
12666,2021-01-06,대웅제약올로스타개별약제병용요법대비효과우수,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006466
12667,2021-01-06,대웅제약고혈압과이상지질혈증복합제효능을국제학술지에실어,http://www.businesspost.co.kr/BP?command=article_view&num=211678
12668,2021-01-06,대웅올로스타개별약제병용요법대비우수하다,https://www.kpanews.co.kr/article/show.asp?idx=219082&category=D
12669,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572996881131
12670,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.lcnews.co.kr/news/articleView.html?idxno=11627
12671,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.mdtoday.co.kr/mdtoday/index.html?no=411136
12672,2021-01-06,대웅제약올로스타우수한복약순응도혈압강하효과확인,http://www.thedailypost.kr/news/articleView.html?idxno=78602
12673,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.nbnnews.co.kr/news/articleView.html?idxno=456272
12674,2021-01-06,대웅제약올로스타개별약제병용요법比효과우수,http://www.upinews.kr/newsView/upi202101060067
12675,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004230603
12676,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65623
12677,2021-01-06,대웅제약고혈압약올로스타개별약제병용요법대비우수효과입증,http://www.kukinews.com/newsView/kuk202101060243
12678,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://www.dailian.co.kr/news/view/953042/?sc=Naver
12679,2021-01-06,종목이슈코로나19잡는구충제니클로사마이드대웅노터스도기대감↑,http://www.newspim.com/news/view/20210106000914
12680,2021-01-06,대웅제약올로스타LDLC감소치병용군대비3배,http://www.skyedaily.com/news/news_view.html?ID=119776
12681,2021-01-06,대웅제약올로스타혈압강하이상지질혈증개선효과확인,http://www.sporbiz.co.kr/news/articleView.html?idxno=506418
12682,2021-01-06,대웅제약올로스타병용요법대비우수한효과확인,http://www.medigatenews.com/news/870021021
12683,2021-01-06,대웅제약올로스타개별약제병용요법대비우수효과확인,http://www.newstomato.com/ReadNews.aspx?no=1016999
12684,2021-01-06,제약업계소식JW중외제약기업미디어플랫폼으로홈페이지리뉴얼대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.bizwnews.com/news/articleView.html?idxno=22639
12685,2021-01-06,심장학저널에등재대웅제약올로스타혈압강하및이상지질혈증개선효과확인,http://theviewers.co.kr/View.aspx?No=1407530
12686,2021-01-06,대웅제약올로스타연구국제학술지등재,http://www.shinailbo.co.kr/news/articleView.html?idxno=1363293
12687,2021-01-06,브리핑JW중외제약대웅제약보령제약,http://4th.kr/View.aspx?No=1407256
12688,2021-01-06,대웅올로스타개별약제병용대비LDLC감소효과,http://www.bokuennews.com/news/article.html?no=199266
12689,2021-01-06,대웅제약복합개량신약올로스타개별약제병용요법대비우수한효능확인,https://www.donga.com/news/article/all/20210106/104801403/1
12690,2021-01-06,대웅제약올로스타개별약제병용요법대비우수한효과확인,http://www.thefirstmedia.net/news/articleView.html?idxno=68864
12691,2021-01-06,대웅제약올로스타임상결과SCI급학술지등재,http://www.newsfreezone.co.kr/news/articleView.html?idxno=288873
12692,2021-01-07,30대제약사CEO15명3월임기만료대웅제약등실적부진에연임물음표,http://www.consumernews.co.kr/news/articleView.html?idxno=618354
12693,2021-01-07,대웅제약올로스타개별약제병용요법대비우수한효과확인,https://jhealthmedia.joins.com/article/article_view.asp?pno=22951
12694,2021-01-07,여의도주식왕대웅제약vs드림시큐리티여의도를달굴종목은,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021010621002130430
12695,2021-01-07,대웅제약올로스타연구국제학술지심장학저널등재,http://www.wolyo.co.kr/news/articleView.html?idxno=114161
12696,2021-01-07,대웅제약동화약품제약주희비엇갈려대웅제약2하락반해동화약품소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=152557
12697,2021-01-07,경주외동읍㈜대웅솔루션마스크1만2000장기탁,http://www.kbsm.net/default/index_view_page.php?idx=298634&part_idx=320
12698,2021-01-07,대웅솔루션230만원상당의마스크12000장기탁,http://www.onews.tv/news/articleView.html?idxno=44206
12699,2021-01-08,요동치는국내보톡스시장대웅메디톡스반격가능할까,https://www.dailian.co.kr/news/view/953488/?sc=Naver
12700,2021-01-08,대웅제약동화약품제약주모두하락세로대웅제약3하락이어동화약품역시3하락,http://www.econonews.co.kr/news/articleView.html?idxno=152743
12701,2021-01-08,대웅대웅제약하락에급락으로무너져대웅9급락이어대웅제약4하락,http://www.econonews.co.kr/news/articleView.html?idxno=152795
12702,2021-01-09,경주㈜외동읍소재대웅솔루션마스크12000장기탁,http://www.job-post.co.kr/news/articleView.html?idxno=14205
12703,2021-01-11,국민연금작년대웅동아줄이고한독한올늘렸다,http://www.dailypharm.com/Users/News/NewsView.html?ID=272334&REFERER=NP
12704,2021-01-11,동화약품대웅제약제약주가파른하락세로급락대웅제약6급락이어동화약품5급락,http://www.econonews.co.kr/news/articleView.html?idxno=153195
12705,2021-01-12,이낙연셀트리온GC녹십자대웅제약등국내제약사와코로나19치료제개발상황점검,http://www.topstarnews.net/news/articleView.html?idxno=855526
12706,2021-01-12,특징주코로나19치료제기대감↑셀트리온대웅제약등강세,http://www.newspim.com/news/view/20210112000166
12707,2021-01-12,대웅제약동화약품제약주모두상승세로돌아서대웅제약3상승이어동화약품소폭상승,http://www.econonews.co.kr/news/articleView.html?idxno=153314
12708,2021-01-12,녹십자셀트리온대웅제약불러모은與K치료제중요,https://biz.chosun.com/site/data/html_dir/2021/01/12/2021011201177.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12709,2021-01-12,대웅대웅제약상승에급등까지대웅7급등이어대웅제약5상승,http://www.econonews.co.kr/news/articleView.html?idxno=153371
12710,2021-01-12,이낙연셀트리온대웅제약GC녹십자등코로나19치료제개발점검,http://www.topstarnews.net/news/articleView.html?idxno=855594
12711,2021-01-12,특징주코로나19치료제대웅14상승,http://moneys.mt.co.kr/news/mwView.php?no=2021011213218088362
12712,2021-01-12,경남제약대웅제약제약주상승에급등까지특히경남제약오후갑작스런24급등,http://www.econonews.co.kr/news/articleView.html?idxno=153403
12713,2021-01-12,치료제개발어디까지왔나셀트리온대웅제약GC녹십자각축전,http://www.ajunews.com/view/20210112152800743
12714,2021-01-12,이상목대웅솔루션대표마스크1만2000장236만원상당전달,http://www.ksilbo.co.kr/news/articleView.html?idxno=785015
12715,2021-01-12,아주경제오늘의뉴스종합치료제개발어디까지왔나셀트리온대웅제약GC녹십자각축전外,http://www.ajunews.com/view/20210112221309989
12716,2021-01-12,대웅솔루션울산북구사회복지시설에마스크후원,http://www.iusm.co.kr/news/articleView.html?idxno=898140
12717,2021-01-12,대웅솔루션울산북구사회복지시설마스크후원,http://www.ujeil.com/news/articleView.html?idxno=268611
12718,2021-01-13,대웅제약동화약품제약주모두하락세로특히대웅제약3낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=153473
12719,2021-01-13,경남제약대웅제약제약주상승에급등까지특히경남제약가파른하락세로6급락,http://www.econonews.co.kr/news/articleView.html?idxno=153595
12720,2021-01-14,대웅제약ITC균주논쟁종결균주영업비밀성부정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253457
12721,2021-01-14,ITC최종결정전문공개대웅제약균주논쟁종결선언,http://www.bosa.co.kr/news/articleView.html?idxno=2142248
12722,2021-01-14,코로나K치료제셀트리온다음은어디부광약품엔키켐생명과학신풍제약종근당대웅제약제넥신주목,http://www.pinpointnews.co.kr/view.php?ud=202101140642176381861beb2d9d_45
12723,2021-01-14,대웅제약ITC균주논쟁종결균주는영업비밀아니다,http://www.medisobizanews.com/news/articleView.html?idxno=75659
12724,2021-01-14,ITC최종판결전문공개에대웅제약메디톡스엇갈린해석,http://medipana.com/news/news_viewer.asp?NewsNum=269801&MainKind=A&NewsKind=5&vCount=12&vKind=1
12725,2021-01-14,곧K코로나치료제나오나관련주셀트리온대웅제약녹십자종근당주가는,http://www.ajunews.com/view/20210114072727918
12726,2021-01-14,메디톡스대웅이 부정하게 메디톡스 균주 취득범죄밝혀져,http://www.medisobizanews.com/news/articleView.html?idxno=75661
12727,2021-01-14,메디톡스대웅美결과도해석차도용입증vs영업비밀아냐,http://biz.newdaily.co.kr/site/data/html/2021/01/14/2021011400006.html
12728,2021-01-14,메디톡스대웅제약보톡스분쟁최종판결문공개후2차전,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101140040&t=NN
12729,2021-01-14,국산코로나19치료제셀트리온이어GC녹십자대웅제약종근당도허가신청채비,http://www.topstarnews.net/news/articleView.html?idxno=855894
12730,2021-01-14,메디톡스대웅제약보톡스분쟁ITC판결문공개균주는영업비밀아니다”,https://www.fetv.co.kr/news/article.html?no=73924
12731,2021-01-14,보톡스분쟁ITC판결문공개됐지만대웅메디톡스끝까지간다”,http://news.heraldcorp.com/view.php?ud=20210114000070
12732,2021-01-14,美ITC보톡스판결문놓고대웅제약vs메디톡스아전인수해석,https://www.ekn.kr/web/view.php?key=20210114010002836
12733,2021-01-14,국산코로나19치료제셀트리온이어GC녹십자대웅제약종근당줄이어개발,http://www.kwnews.co.kr/nview.asp?aid=221011300149
12734,2021-01-14,메디톡스美ITC최종판결전문공개대웅에끝까지책임물을것”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=202101140856001&code=940601
12735,2021-01-14,보톡스분쟁ITC판결문공개됐지만대웅제약메디톡스갈등지속,http://www.greened.kr/news/articleView.html?idxno=284397
12736,2021-01-14,보톡스분쟁ITC판결전문공개메디톡스대웅서로엇갈린해석내놔,http://www.getnews.co.kr/news/articleView.html?idxno=509649
12737,2021-01-14,보톡스분쟁ITC최종판결전문공개대웅제약메디톡스또엇갈린해석,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021011408543676139
12738,2021-01-14,미ITC최종판결대웅이메디톡스기술도용,http://www.medical-tribune.co.kr/news/articleView.html?idxno=97870
12739,2021-01-14,메디톡스美ITC최종판결전문공개대웅제약이부정하게균주취득,http://www.pinpointnews.co.kr/view.php?ud=20210114090422468f090c8dbcb_45
12740,2021-01-14,ITC최종판결전문공개대웅제약메디톡스여전히엇갈린해석,http://www.newstomato.com/ReadNews.aspx?no=1018488
12741,2021-01-14,대웅제약이훔쳤다”메디톡스가거짓말”계속되는보톡스전쟁,https://news.joins.com/article/olink/23564842
12742,2021-01-14,美ITC보툴리눔톡신소송판결문공개대웅메디톡스제각각해석,http://www.newspim.com/news/view/20210114000155
12743,2021-01-14,美ITC전문공개대웅이부적절하게메디톡스균주획득,http://www.mkhealth.co.kr/news/articleView.html?idxno=51782
12744,2021-01-14,美ITC대웅메디톡스균주훔쳤다쐐기,http://www.edaily.co.kr/news/newspath.asp?newsid=01948326628917720
12745,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.press9.kr/news/articleView.html?idxno=46814
12746,2021-01-14,대웅제약메디톡스ITC최종판결전문공개에온도차,http://www.cstimes.com/news/articleView.html?idxno=446984
12747,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004238292
12748,2021-01-14,대웅메디ITC최종판결전문공개에도엇갈린해석,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1004238291
12749,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101140067&t=NN
12750,2021-01-14,메디톡스대웅보톡스분쟁미ITC판결문공개균주는영업비밀아니다,http://www.ajunews.com/view/20210114082406983
12751,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.sentv.co.kr/news/view/586589
12752,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.kmedinfo.co.kr/news/articleView.html?idxno=65738
12753,2021-01-14,대웅제약CDMO사업돌입첨단바이오의약품제조업허가취득,https://www.fetv.co.kr/news/article.html?no=73938
12754,2021-01-14,대웅제약CDMO신사업진출첨단바이오의약품제조업허가,http://www.viva100.com/main/view.php?key=20210114010003034
12755,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격돌입,https://www.ekn.kr/web/view.php?key=20210114010002874
12756,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thebigdata.co.kr/view.php?ud=202101140929599116798818e98b_23
12757,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=253462
12758,2021-01-14,대웅제약첨단바이오의약품제조업허가CDMO사업돌입,http://medipana.com/news/news_viewer.asp?NewsNum=269810&MainKind=A&NewsKind=5&vCount=12&vKind=1
12759,2021-01-14,대웅제약메디톡스보톡스분쟁ITC판결문공개,https://www.ebn.co.kr/news/view/1467888/?sc=Naver
12760,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격진출,https://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2021011409330435566
12761,2021-01-14,대웅제약첨단바이오의약품제조허가취득CDMO사업돌입,https://www.hankyung.com/it/article/202101141017i
12762,2021-01-14,대웅제약의약품위탁생산사업진출식약처제조업허가취득,https://health.chosun.com/site/data/html_dir/2021/01/14/2021011400860.html
12763,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업시작,http://www.medisobizanews.com/news/articleView.html?idxno=75669
12764,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,http://www.metroseoul.co.kr/article/20210114500039
12765,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,https://www.dnews.co.kr/uhtml/view.jsp?idxno=202101140938277630440
12766,2021-01-14,대웅제약의약품위탁생산사업진출허가취득,https://biz.sbs.co.kr/article_hub/20000000341?division=NAVER
12767,2021-01-14,메디톡스대웅美ITC최종판결전문공개에도평행선,http://www.kpinews.co.kr/news/articleView.html?idxno=135058
12768,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572775786692
12769,2021-01-14,美ITC메디톡스대웅제약균주분쟁판결문공개균주는영업비밀아냐,https://www.sedaily.com/NewsView/22H94HIZKF
12770,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,https://www.asiatime.co.kr/news/newsview.php?ncode=1065572775786692
12771,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,https://www.etoday.co.kr/news/view/1984295
12772,2021-01-14,전문대웅제약균주논쟁종결선언메디톡스향별도고소방침,http://www.thevaluenews.co.kr/news/view.php?idx=162206
12773,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2021011409434230980
12774,2021-01-14,美ITC전문공개대웅제약도용입증vs영업비밀아냐,https://biz.sbs.co.kr/article_hub/20000000332?division=NAVER
12775,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.medigatenews.com/news/2750202155
12776,2021-01-14,ITC최종결정전문공개대웅제약vs메디톡스2차전,http://it.chosun.com/site/data/html_dir/2021/01/14/2021011400900.html
12777,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,https://www.kpanews.co.kr/article/show.asp?idx=219268&category=D
12778,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,https://sports.hankooki.com/lpage/economy/202101/sp20210114094913137020.htm?s_ref=nv
12779,2021-01-14,ITC최종판결전문공개됐지만대웅메디톡스보톡스분쟁은ing,http://www.viva100.com/main/view.php?key=20210114010003052
12780,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,https://sports.hankooki.com/lpage/economy/202101/sp20210114094913137020.htm?s_ref=nv
12781,2021-01-14,美ITC대웅메디톡스균주훔쳤다쐐기종합,http://www.edaily.co.kr/news/newspath.asp?newsid=02109046628917720
12782,2021-01-14,대웅첨단바이오약제조업허가CDMO사업진출,http://www.dailypharm.com/Users/News/NewsView.html?ID=272456&REFERER=NP
12783,2021-01-14,보톡스논란또시작이야메디톡스훔쳐갔다Vs대웅제약분석법오류있다,http://moneys.mt.co.kr/news/mwView.php?no=2021011409438085571
12784,2021-01-14,보톡스분쟁메디톡스대웅제약ITC판결문두고여전히입장차,http://www.mediapen.com/news/view/592733
12785,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://yna.kr/AKR20210114057400017?did=1195m
12786,2021-01-14,대웅제약바이오의약품위탁개발생산사업진출,https://biz.chosun.com/site/data/html_dir/2021/01/14/2021011400959.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12787,2021-01-14,대웅제약균주영업비밀성부정논쟁종결vs메디톡스도용행위명백,http://www.consumernews.co.kr/news/articleView.html?idxno=618787
12788,2021-01-14,대웅제약균주도용맞고메디톡스균주영업기밀틀리다,http://www.wikileaks-kr.org/news/articleView.html?idxno=102043
12789,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입”,https://www.youthdaily.co.kr/news/article.html?no=59175
12790,2021-01-14,대웅제약ITC균주논쟁종결메디톡스허위증언고소할것,http://newsclaim.co.kr/View.aspx?No=1416209
12791,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.ceoscoredaily.com/news/article.html?no=77403
12792,2021-01-14,대웅제약첨단바이오의약품제조업허가취득쾌거,http://www.pressm.kr/news/articleView.html?idxno=36083
12793,2021-01-14,대웅제약첨단바이오의약품제조업허가획득CDMO사업본격화,http://www.pinpointnews.co.kr/view.php?ud=2021011410061536182365609d9b_45
12794,2021-01-14,대웅제약바이오의약품위탁개발생산사업진출CDMO관련제조업허가취득,https://www.donga.com/news/article/all/20210114/104917277/1
12795,2021-01-14,보톡스분쟁재점화메디톡스도용입증vs대웅영업비밀아니다,http://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202101140111&t=NN
12796,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,http://www.fnnews.com/news/202101141015584478
12797,2021-01-14,대웅제약첨단바이오의약품CDMO사업진출,https://www.ebn.co.kr/news/view/1467921/?sc=Naver
12798,2021-01-14,대웅제약메디톡스美ITC최종판결전문놓고설왕설래,https://www.hankyung.com/it/article/202101140583i
12799,2021-01-14,메디톡스VS대웅제약보톡스전쟁다시불붙나ITC최종판결놓고서로비난,https://www.etoday.co.kr/news/view/1984355
12800,2021-01-14,메디톡스거짓말”vs대웅허위주장고소”보톡스전쟁재점화,https://biz.chosun.com/site/data/html_dir/2021/01/14/2021011401096.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12801,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.bokuennews.com/news/article.html?no=199494
12802,2021-01-14,메디톡스대웅제약ITC판결나왔지만또해석전쟁,http://www.newsis.com/view/?id=NISX20210114_0001304893&cID=13001&pID=13000
12803,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://it.chosun.com/site/data/html_dir/2021/01/14/2021011401097.html
12804,2021-01-14,대웅제약첨단바이오의약품제조업취득CDMO사업돌입,http://www.economytalk.kr/news/articleView.html?idxno=210453
12805,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.newslock.co.kr/news/articleView.html?idxno=35229
12806,2021-01-14,ITC최종결정문에대웅제약오판승소할뜻밝혀,http://www.businesskorea.co.kr/news/articleView.html?idxno=58459
12807,2021-01-14,대웅제약동화약품제약주모두상승세로대웅제약3상승이어동화약품1상승,http://www.econonews.co.kr/news/articleView.html?idxno=153683
12808,2021-01-14,대웅제약첨단바이오의약품제조업허가취득세포치료제제조개발판매올인원패키지,http://www.paxetv.com/news/articleView.html?idxno=108607
12809,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.businesskorea.co.kr/news/articleView.html?idxno=58465
12810,2021-01-14,제이엘케이대웅제약과플랫폼기술개발공급계약체결,http://www.pinpointnews.co.kr/view.php?ud=20210114103726340cd1e7f0bdf_45
12811,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://news.mt.co.kr/mtview.php?no=2021011410010652708
12812,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMP사업돌입,http://www.mhj21.com/138425
12813,2021-01-14,대웅제약바이오의약품제조업허가취득CDMO본격진출,https://www.econovill.com/news/articleView.html?idxno=514702
12814,2021-01-14,대웅제약첨바법힘입어바이오사업도전장,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1138230&REFERER=NP
12815,2021-01-14,美ITC최종판결전문공개대웅이부정하게메디톡스균주취득,http://www.sisajournal-e.com/news/articleView.html?idxno=228112
12816,2021-01-14,美ITC최종판결공개메디톡스대웅제약엇갈린해석,http://www.newsprime.co.kr/news/article.html?no=530614
12817,2021-01-14,더벨대웅제약세포치료제CDMO사업본격화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=202101141009304160107590
12818,2021-01-14,대웅제약바이오의약품제조업허가취득CDMO사업돌입,http://www.healthinnews.co.kr/news/articleView.html?idxno=21327
12819,2021-01-14,대웅대웅제약모두가파른상승세로급등대웅8급등이어대웅제약5급등,http://www.econonews.co.kr/news/articleView.html?idxno=153699
12820,2021-01-14,대웅메디톡스美ITC판결문전문공개두고입장차팽배,http://www.sporbiz.co.kr/news/articleView.html?idxno=507352
12821,2021-01-14,대웅제약균주도용美ITC판결전문공개,https://www.paxnetnews.com/articles/69794
12822,2021-01-14,끝나지않은보톡스전쟁메디톡스권리반환등책임묻겠다”vs대웅허위주장”,https://jhealthmedia.joins.com/article/article_view.asp?pno=22997
12823,2021-01-14,대웅제약의약품위탁개발생산사업진출식약처허가취득,http://www.sisaweek.com/news/articleView.html?idxno=140901
12824,2021-01-14,보톡스분쟁심판못한美ITC대웅이균주훔쳤지만영업비밀아니라처벌못해,http://news.mk.co.kr/newsRead.php?no=43824&year=2021
12825,2021-01-14,대웅제약메디톡스ITC최종판결전문공개에엇갈린해석,http://www.seoulwire.com/news/articleView.html?idxno=433871
12826,2021-01-14,셀트리온이어GC녹십자대웅제약코로나19치료제줄섰다,http://www.kyeongin.com/main/view.php?key=20210114010002607
12827,2021-01-14,대웅제약첨단바이오의약품제조업자격취득CDMO사업진출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=97884
12828,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.whosaeng.com/124022
12829,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.bosa.co.kr/news/articleView.html?idxno=2142282
12830,2021-01-14,대웅제약에호재CDMO사업뭐길래,http://www.todaykorea.co.kr/news/articleView.html?idxno=282427
12831,2021-01-14,대웅제약첨단바이오제조업허가CDMO사업돌입,http://www.newsis.com/view/?id=NISX20210114_0001305112&cID=13001&pID=13000
12832,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.dailysmart.co.kr/news/articleView.html?idxno=38804
12833,2021-01-14,메디톡스대웅제약균주도용여부로2차전예상,http://www.k-health.com/news/articleView.html?idxno=51918
12834,2021-01-14,美ITC대웅제약메디톡스균주도용해유전적증거가입증,http://www.thepowernews.co.kr/view.php?ud=2021011411281944547a517a52c2_7
12835,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.dt.co.kr/contents.html?article_no=2021011402109931102009&ref=naver
12836,2021-01-14,ITC전문공개에도대웅제약메디톡스엇갈린주장논란지속,http://isplus.live.joins.com/news/article/article.asp?total_id=23970378
12837,2021-01-14,대웅제약도의약품위탁개발생산사업진출,http://www.dailymedi.com/detail.php?number=865204&thread=22r05
12838,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.onews.tv/news/articleView.html?idxno=44907
12839,2021-01-14,대웅제약CDMO사업진출첨단바이오의약품제조업허가취득,http://www.lawissue.co.kr/view.php?ud=202101141136451184204ead0791_12
12840,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.segyebiz.com/newsView/20210114509115?OutUrl=naver
12841,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.smartfn.co.kr/view.php?ud=202101141147502799d5d29c6899_46
12842,2021-01-14,대웅제약바이오의약품제조업허가CDMO사업도전장,http://www.seoulfn.com/news/articleView.html?idxno=407533
12843,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.koreaittimes.com/news/articleView.html?idxno=103094
12844,2021-01-14,대웅제약식약처로부터첨단바이오의약품제조업허가받아,http://www.businesspost.co.kr/BP?command=article_view&num=212816
12845,2021-01-14,보폭넓히는대웅제약바이오의약품위탁생산사업진출,http://www.skyedaily.com/news/news_view.html?ID=120573
12846,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.newsworker.co.kr/news/articleView.html?idxno=99088
12847,2021-01-14,대웅제약균주영업비밀아냐”메디톡스대웅이제조기술도용,http://www.fnnews.com/news/202101141221314562
12848,2021-01-14,대웅제약균주논쟁종결”쐐기,http://www.whosaeng.com/124026
12849,2021-01-14,ITC최종판결문대웅제약메디톡스또다시엇갈리는해석,http://www.medigatenews.com/news/1374414101
12850,2021-01-14,제이엘케이대웅제약과1억규모AIDB플랫폼기술개발공급계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=411888
12851,2021-01-14,대웅제약바이오의약품위탁개발생산사업본격진출,http://news.mk.co.kr/newsRead.php?no=44532&year=2021
12852,2021-01-14,네버엔딩보톡스분쟁메디톡스대웅제약판결문정반대해석,http://www.upinews.kr/newsView/upi202101140043
12853,2021-01-14,대웅제약첨단바이오의약품제조업허가취득세포치료제제조개발판매,http://www.lcnews.co.kr/news/articleView.html?idxno=11862
12854,2021-01-14,美ITC최종판결전문공개엇갈린해석내놓은대웅과메디톡스,http://www.m-i.kr/news/articleView.html?idxno=785990
12855,2021-01-14,메디톡스대웅제약ITC최종판결전문공개서로다른해석,http://www.mdtoday.co.kr/mdtoday/index.html?no=411878
12856,2021-01-14,메디톡스대웅제약ITC최종판결전문엇갈린해석2차전예고,https://www.asiatime.co.kr/news/newsview.php?ncode=1065581428546524
12857,2021-01-14,같은판결다른해석대웅제약vs메디톡스계속되는증거논쟁,http://www.newsquest.co.kr/news/articleView.html?idxno=80956
12858,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thepublic.kr/news/newsview.php?ncode=1065574504865641
12859,2021-01-14,판결문도입맛대로메디톡스vs대웅제약계속된신경전,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006750
12860,2021-01-14,대웅제약메디톡스균주공방계속최종판결전문놓고도해석제각각,http://www.businesspost.co.kr/BP?command=article_view&num=212860
12861,2021-01-14,보톡스분쟁ITC최종판결문공개대웅메디톡스해석차,https://sports.hankooki.com/lpage/economy/202101/sp20210114141855137020.htm?s_ref=nv
12862,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.anewsa.com/detail.php?number=2331059&thread=10
12863,2021-01-14,보톡스분쟁메디톡스대웅제약ITC판결문두고도설전,http://www.finomy.com/news/articleView.html?idxno=87876
12864,2021-01-14,ITC판결문공개에도대웅메디분쟁계속국내영향관심,http://news.mt.co.kr/mtview.php?no=2021011414314875334
12865,2021-01-14,대웅제약보톡스분쟁ITC최종판결문공개우리도기술력있는기업이다,http://www.anewsa.com/detail.php?number=2331085&thread=10
12866,2021-01-14,대웅제약vs메디톡스ITC판결문공개에도입장차여전,http://www.shinailbo.co.kr/news/articleView.html?idxno=1366130
12867,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.nbnnews.co.kr/news/articleView.html?idxno=459055
12868,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.m-i.kr/news/articleView.html?idxno=786084
12869,2021-01-14,대웅제약첨단바이오의약품제조업정부허가취득,http://www.100ssd.co.kr/news/articleView.html?idxno=74064
12870,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=411901
12871,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thedailypost.kr/news/articleView.html?idxno=78781
12872,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입ㅍ,http://www.worktoday.co.kr/news/articleView.html?idxno=12907
12873,2021-01-14,대웅제약CDMO진출첨단바이오의약품제조업허가,https://view.asiae.co.kr/article/2021011415203448107
12874,2021-01-14,미국ITC최종판결전문공개대웅제약메디톡스이번엔해석전쟁,http://www.insightkorea.co.kr/news/articleView.html?idxno=86062
12875,2021-01-14,美ITC최종판결대웅부적절한수단으로균주획득했다,http://www.mrepublic.co.kr/news/articleView.html?idxno=61988
12876,2021-01-14,불붙은코로나19치료제개발대웅종근당녹십자주목,http://www.mediapen.com/news/view/592879
12877,2021-01-14,美ITC최종판결문대웅이메디톡스균주훔친사실명백,http://www.metroseoul.co.kr/article/20210114500396
12878,2021-01-14,美ITC최종판결대웅제약부정하게균주도용했다,https://www.thepublic.kr/news/newsview.php?ncode=1065594702964499
12879,2021-01-14,美ITC대웅부정하게메디톡스균주취득해유전자분석결과가근거,http://www.epnc.co.kr/news/articleView.html?idxno=113718
12880,2021-01-14,美ITC대웅부정하게메디톡스균주도용”유전자분석결과로입증해,http://www.kbsm.net/default/index_view_page.php?idx=299330&part_idx=333
12881,2021-01-14,美ITC최종판결공개대웅제약메디톡스균주뺏었다,http://www.kihoilbo.co.kr/news/articleView.html?idxno=906406
12882,2021-01-14,美ITC유전자분석결과들며대웅제약이메디톡스균주도용했다밝혀,http://www.anewsa.com/detail.php?number=2331180&thread=10
12883,2021-01-14,비즈헬스美ITC최종판결대웅부정하게메디톡스균주취득,http://www.bizwnews.com/news/articleView.html?idxno=22743
12884,2021-01-14,美ITC유전자분석결과근거내세워대웅메디톡스균주도용,http://www.mhns.co.kr/news/articleView.html?idxno=425738
12885,2021-01-14,美ITC최종판결발표대웅제약메디톡스균주훔쳐,http://www.kgdm.co.kr/news/articleView.html?idxno=734500
12886,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,https://www.lkp.news/news/article.html?no=11807
12887,2021-01-14,美ITC대웅제약메디톡스균주도용”,http://www.beyondpost.co.kr/view.php?ud=2021011415525859796cf2d78c68_30
12888,2021-01-14,美ITC최종판결전문공개대웅이부정하게메디톡스균주취득유전자분석으로범죄행위밝혀져,http://www.incheonilbo.com/news/articleView.html?idxno=1075598
12889,2021-01-14,대웅제약첨단바이오의약품위탁개발사업본격진출,http://www.joseilbo.com/news/news_read.php?uid=414784&class=27&grp=
12890,2021-01-14,美ITC판결문전문서대웅메디톡스균주도용명시,http://news.mk.co.kr/newsRead.php?no=45696&year=2021
12891,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.monews.co.kr/news/articleView.html?idxno=300461
12892,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.thereport.co.kr/news/articleView.html?idxno=8553
12893,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://www.newspim.com/news/view/20210114000904
12894,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.newsfarm.co.kr/news/articleView.html?idxno=63187
12895,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격화,http://www.whitepaper.co.kr/news/articleView.html?idxno=200657
12896,2021-01-14,공매도대웅제약이틀간공매도174건공매잔고12억원,http://www.pinpointnews.co.kr/view.php?ud=202101141631283288f090c8dbcb_45
12897,2021-01-14,셀트리온국산1호코로나19치료제초읽기2호쟁탈전나선대웅제약녹십자종근당,https://biz.chosun.com/site/data/html_dir/2021/01/14/2021011402338.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12898,2021-01-14,대웅제약바이오의약품위탁개발생산사업시작,http://www.finomy.com/news/articleView.html?idxno=87893
12899,2021-01-14,대웅제약CDMO사업진출바이오의약품제조업허가받아,https://www.hankyung.com/it/article/2021011437171
12900,2021-01-14,대웅제약첨단바이오의약품제조업허가취득,http://www.newstomato.com/ReadNews.aspx?no=1018728
12901,2021-01-14,시경Today제약대웅제약첨단바이오의약품제조업허가취득外,http://www.meconomynews.com/news/articleView.html?idxno=49391
12902,2021-01-14,김창수의e뉴스브리핑메디톡스대웅제약보톡스분쟁ITC판결문공개균주는영업비밀아니다”外,https://www.fetv.co.kr/news/article.html?no=73986
12903,2021-01-14,ITC최종판결공개에대웅VS메디톡스갈등재점화,http://www.doctorstimes.com/news/articleView.html?idxno=213718
12904,2021-01-14,대웅제약첨단바이오의약품위탁개발생산사업진출,http://www.consumernews.co.kr/news/articleView.html?idxno=618841
12905,2021-01-14,퇴근길제약Pin메디톡스ITC최종판결전문공개대웅제약겨냥外,http://www.pinpointnews.co.kr/view.php?ud=202101141728185449f090c8dbcb_45
12906,2021-01-14,금일제약업계주요기사종근당나파벨탄코로나19환자치료”美ITC대웅제약메디톡스균주戰서균주는영업비밀아니다外,http://www.youthdaily.co.kr/news/article.html?no=59248
12907,2021-01-14,美ITC최종판결전문공개대웅이부정하게메디톡스균주취득,http://www.thefirstmedia.net/news/articleView.html?idxno=69246
12908,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.thefirstmedia.net/news/articleView.html?idxno=69240
12909,2021-01-14,대웅제약美ITC균주는 영업비밀아니라고판단,http://www.thefirstmedia.net/news/articleView.html?idxno=69249
12910,2021-01-14,끝나도끝난게아니다대웅메디톡스ITC판결해석온도차,https://daily.hankooki.com/lpage/industry/202101/dh20210114182555148390.htm?s_ref=nv
12911,2021-01-14,대웅제약첨단바이오의약품제조업허가취득CDMO사업진출,http://news.kbiz.or.kr/news/articleView.html?idxno=76720
12912,2021-01-14,국산코로나치료제쏟아진다셀트리온이어종근당대웅제약등도허가대기,http://4th.kr/View.aspx?No=1417399
12913,2021-01-14,대웅제약바이오의약품위탁개발생산사업진출,http://www.newsfreezone.co.kr/news/articleView.html?idxno=290884
12914,2021-01-14,美ITC최종판결또이견대웅메디톡스허위증언등별도고소”vs메디톡스대웅증거등왜곡”,http://medicalworldnews.co.kr/news/view.php?idx=1510939832
12915,2021-01-14,메디톡스대웅제약보톡스전쟁최종판결양사우리가이겼다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1444276
12916,2021-01-15,뉴욕증시바이든경기부양기대다우지수상승출발박셀바이오현대바이오대웅제약삼성제약등촉각,http://www.pinpointnews.co.kr/view.php?ud=202101150153377846861beb2d9d_45
12917,2021-01-15,대웅제약첨단바이오의약품제조업허가취득,http://www.segye.com/content/html/2021/01/14/20210114504984.html?OutUrl=naver
12918,2021-01-15,ITC판결문전문공개메디톡스대웅끝까지간다,https://www.dailian.co.kr/news/view/955622/?sc=Naver
12919,2021-01-15,대웅제약ITC최종판결전문분석논쟁종결선언,http://www.monews.co.kr/news/articleView.html?idxno=300477
12920,2021-01-15,대웅이틀간공매도898건공매잔고28만株규모,http://www.pinpointnews.co.kr/view.php?ud=202101150827256041cd1e7f0bdf_45
12921,2021-01-15,대웅제약첨단바이오의약품CDMO사업본격화,http://www.shinailbo.co.kr/news/articleView.html?idxno=1366345
12922,2021-01-15,대웅제약ITC최종판결인정못해”메디톡스끝까지책임물을것,http://theviewers.co.kr/View.aspx?No=1417965
12923,2021-01-15,대웅제약동화약품제약주지지부진대웅제약소폭상승이어동화약품2하락,http://www.econonews.co.kr/news/articleView.html?idxno=153847
12924,2021-01-15,대웅제약첨단바이오의약품제조업허가취득CDMO사업본격돌입,http://kormedi.com/?p=1331323
12925,2021-01-15,대웅대웅제약모두가파른상승세대웅5상승이어대웅제약역시5상승,http://www.econonews.co.kr/news/articleView.html?idxno=153930
12926,2021-01-15,대웅제약메디톡스보톡스전쟁진행중추가소송도불사,http://www.enewstoday.co.kr/news/articleView.html?idxno=1444437
12927,2021-01-15,대웅제약첨단바이오의약품제조업허가취득CDMO사업돌입,http://www.wsobi.com/news/articleView.html?idxno=112395
12928,2021-01-15,셀트리온이어국산코로나2호치료제누가될까GC녹십자이어대웅제약종근당가시권진입,http://www.newswatch.kr/news/articleView.html?idxno=53020
12929,2021-01-15,대웅제약호이스타정서울성모병원서코로나19치료제사용추진,https://www.donga.com/news/article/all/20210115/104943977/1
12930,2021-01-15,오늘Who대웅제약바이오의약품위탁개발전승호줄기세포주믿어,http://www.businesspost.co.kr/BP?command=article_view&num=213122
12931,2021-01-15,1000대기업매출1500조돌파대웅제약종근당셀트리온헬스케어에스엘파트론파워로직스등매출1조클럽가입,http://www.econonews.co.kr/news/articleView.html?idxno=153945
12932,2021-01-16,대웅제약1415일공매도328건공매잔고119억원규모,http://www.pinpointnews.co.kr/view.php?ud=202101160952024570f090c8dbcb_45
12933,2021-01-16,대웅제약호이스타정서울성모병원서사용할까공매도잔고12억육박,http://www.thekpm.com/view.php?ud=2021011614542438087addc4692d_17
12934,2021-01-17,길어지는조정대웅제약언제반등외국인기관뚜렷한매수없어개미들초조,http://www.pinpointnews.co.kr/view.php?ud=202101171114454394861beb2d9d_45
12935,2021-01-17,대웅제약올로스타임상결과美치료학저널등재”,http://www.dailymedi.com/detail.php?number=865291&thread=22r05
12936,2021-01-18,제약사비장의무기⑧신약에기대거는대웅제약사업다각화사활,http://www.cstimes.com/news/articleView.html?idxno=447220
12937,2021-01-18,공정위ICT독과점남용잡는다구글브로드컴대웅제약타깃,http://www.edaily.co.kr/news/newspath.asp?newsid=02394406628919032
12938,2021-01-18,공정위구글사건전담조직가동돌비대웅제약도조만간제재,http://news.mt.co.kr/mtview.php?no=2021011809491440211
12939,2021-01-18,동화약품대웅제약제약주모두하락세로특히동화약품가파른하락세로4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=154248
12940,2021-01-18,공정위지식재산권남용행위로대웅제약제재하나,http://www.dailypharm.com/Users/News/NewsView.html?ID=272569&REFERER=NP
12941,2021-01-18,공정위ICT독과점전담팀개편네이버구글대웅배민감시망에,http://www.whitepaper.co.kr/news/articleView.html?idxno=200761
12942,2021-01-19,상대적소외제약바이오주언제반등박셀바이오대웅제약삼성제약한국파마주목,http://www.pinpointnews.co.kr/view.php?ud=202101190513561528861beb2d9d_45
12943,2021-01-19,코로나19치료제부터CDMO까지대웅제약세포치료제기지개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=2006871
12944,2021-01-19,대웅제약이틀간공매도257건공매잔고118억규모,http://www.pinpointnews.co.kr/view.php?ud=202101190754008310cd1e7f0bdf_45
12945,2021-01-19,대웅이틀간공매도933건공매잔고125억규모,http://www.pinpointnews.co.kr/view.php?ud=202101190756021444cd1e7f0bdf_45
12946,2021-01-19,대웅제약동화약품제약주모두가파른하락세대웅제약4낙폭이어동화약품역시4낙폭,http://www.econonews.co.kr/news/articleView.html?idxno=154427
12947,2021-01-19,특허극복무덤스프라이셀대웅보령도전장,http://www.dailypharm.com/Users/News/NewsView.html?ID=272615&REFERER=NP
12948,2021-01-19,질병청대웅제약보툴리눔균주현장조사대상포함,http://www.kpinews.co.kr/news/articleView.html?idxno=135495
12949,2021-01-20,코로나타격이후추가불황삼성전자박셀바이오한국파마대웅제약씨젠필룩스는,http://www.pinpointnews.co.kr/view.php?ud=202101200640015143861beb2d9d_45
12950,2021-01-20,대웅제약BMS스프라이셀특허에도전장,http://www.mdtoday.co.kr/mdtoday/index.html?no=412375
12951,2021-01-20,보령제약대웅제약제약주상승에급등까지특히보령제약오전갑작스런8급등,http://www.econonews.co.kr/news/articleView.html?idxno=154615
12952,2021-01-20,과기부종근당대웅코로나치료제상반기상용화추진,https://biz.chosun.com/site/data/html_dir/2021/01/20/2021012001174.html?utm_source=naver&utm_medium=original&utm_campaign=biz
12953,2021-01-20,종근당대웅바이오콜린알포임상재평가단독진행,http://www.dailypharm.com/Users/News/NewsView.html?ID=272661&REFERER=NP
12954,2021-01-20,과기부코로나19치료제후보종근당대웅제약,http://www.dailymedi.com/detail.php?number=865440&thread=22r01
12955,2021-01-20,백신접종에도코로나확산여전씨젠GC녹십자대웅제약한미약품주목을,http://www.pinpointnews.co.kr/view.php?ud=202101201544439549861beb2d9d_45
12956,2021-01-20,동학개미나흘만에폭풍매수삼성전자LG화학삼성SDI박셀바이오대웅제약상승,http://www.pinpointnews.co.kr/view.php?ud=202101201714393139861beb2d9d_45
